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Severe Streptococcus pyogenes infections in Europe (Strep-EURO satellite symposium)
S1 Project Strep-EURO: a presentation
C. Schale´n, A. Jasir
Lund, S
Severe invasive group A streptococci (GAS; Streptococcus pyogenes) continue to
evoke concern in many Western countries since high fatality rates and
devastating complications are noted by streptococcal toxic shock syndrome,
necrotizing fasciitis and others. The main objective of the project Strep-
EURO is to improve understanding, at the European (EU) level, of the
epidemiology of severe disease caused by GAS. The project is divided into
seven work packages distributed between participating centers. We intend to
improve systems for EU-wide surveillance by setting up protocols for
identiﬁcation of cases of severe GAS disease, collection of bacterial isolates
and by construction of a database with clinical and laboratory information. A
diagnostic network amongst EU and associated countries for characterization
of GAS and rapid exchange of information will be created. To achieve an
integrated picture of these infections, molecular methods for typing and
clonal assessment of clinical isolates will be used. Identiﬁcation methods for
epidemiological markers will be harmonized at all participating laboratories.
Strains will also be analyzed for antibiotic susceptibility, and resistance
determinants will be traced. Emerging antibiotic resistance in GAS and its
impact on treatment of severe disease will be studied. Furthermore, patho-
genic aspects of severe GAS disease, such as proteolytic activation of the
contact system, and selected virulence factors, such as surface proteins and
superantigens, will be investigated. Finally, data obtained will be analyzed in
order to allow for suggestions on new preventive measures against severe GAS
disease.
S2 Molecular typing of group A streptococci
A. Jasir
Lund, S
Severe infections, common outbreaks, nonsuppurative complications and
emerging antibiotic resistance are important reasons for epidemiological
studies of group A streptococci (GAS). Classically, deﬁnite typing of GAS
resides in identiﬁction of the M type using antiserum to the type-speciﬁc M
protein; however, antisera for M typing are exceedingly difﬁcult to raise and
therefore seldom available even at specialized centers. Similarly, opacity factor
(OF) typing GAS has only been used to a limited extent. As more commonly
applied, GAS may be roughly classiﬁed into about 30 types by T-agglutina-
tion. New molecular methods for typing and clonal assessment of GAS
include emm-typing by capture-PCR-ELISA, emm-gene N-terminal sequen-
cing, emm-gene polymorhism, pulse-ﬁeld gel electrophoresis (PFGE). For
capture-PCR-ELISA, the part of the gene corresponding to the type-speciﬁc
determinants of the M protein is ampliﬁed and then hybridized against gene
probes of a number of M types, immobilized in a microtiter system. The
captured DNA has been labeled with ﬂuorescein and is detected by antibodies
to ﬂuorescein coupled with horse radish peroxidase. By PFGE, chromosomal
DNA is cleaved by rare cutting endonucleases, such as Sma1, yielding
approximately 15–30 very large DNA fragments. These pieces are then
separated in a gel, the resulting pattern being used for typing and clonal
identiﬁcation of strains. For emm-gene polymorphism typing, PCR primers
amplifying the major part of the emm gene are used. The amplicon is cleaved
by two suitable restriction endonucleases and then analyzed by gel electro-
phoresis. By this method, even variation within a single M type can be
diagnosed, which is of high importance for clonal identiﬁcation. Recently,
emm-gene N-terminal sequencing has been increasingly applied and resulted
in the recognition of more than 150 emm-types. These correspond both to
earlier known M-types and represent new types where serological identiﬁca-
tion has not been developed.
S3 Clonal identiﬁcation of group A streptococci
R. Lu¨tticken
Aachen, D
In the past, conventional typing based on the surface protein antigens T and
M, sometimes supplemented by the serum opacity reaction (SOR) and anti-
SOR typing, were relied on to study the epidemiology of Streptococcus pyogenes
(‘the group A streptococcus’) infections. However, many questions related to
the spread and outbreaks of severe streptococcal disease could not be answered
when using these traditional methods. In the strep-EURO project, molecular
methods will be applied to elucidate questions such as the following:
1 Are S. pyogenes strains found in recent severe infections different from
‘historical’ isolates of the same M (emm) type;
2 are there predominant ‘invasive’ clones which can be differentiated from
‘noninvasive’ isolates (e.g. from pharyngitis);
3 does a change occur in predominant clones over the study time;
4 what is the rate of geographic variation among invasive isolates;
5 can the spread of antibiotic resistance in S. pyogenes be explained using
molecular typing and subtyping methods;
6 which different subtyping methods have to be employed to answer these
and other questions in the epidemiology of severe S. pyogenes disease?
It is planned to use the following methods on the streptococcal strains
collected in the project:
1 On all isolates: emm-typing (see presentation of Dr A. Jasir);
2 on selected strains: multilocus sequence typing (MLST), pulsed ﬁeld gel
electrophoresis (PFGE), sequencing of the genes sic and drs (for appropriate
emm-types); sequencing of other genes e.g. of superantigens and other
virulence factors known to display genetic polymorphism.
The value of these and other molecular subtyping methods will be established
in the course of the project.
S4 Invasive disease caused by group A streptococci in
Sweden during 1997 and 2002
J. Darenberg, B. K. G. Eriksson, V. Romanus, B. Olsson-Liljequist,
M. Norgren, B. Henriques Normark
Stockholm, Huddinge, Umea˚, S
Group A Streptococci (GAS) may cause a variety of symptoms ranging from
superﬁcial skin infections and tonsillitis to severe invasive disease including
necrotizing fasciitis and streptococcal toxic shock syndrome. In this study, we
performed a prospective surveillance of invasive infections caused by GAS in
Sweden during 1997 and 2002. Clinical isolates were collected from patients
with invasive disease (years 1997 and 2002) and also from noninvasive cases
(year 1997) in Sweden. Isolates were characterized by antibiotic susceptibility
testing, T-typing, and by using molecular methods such as PFGE, emm-
sequencing, MLST, and superantigen determination. Also, clinical and
epidemiological data were collected about the patients, and were correlated
to clonality.
S5 High frequency of group A streptococci type M 89
invasive infections in Italy
G. Oreﬁci, R. Creti, C. von Hunolstein
Rome, I
During 1994–96, 80 Group A Streptococci (GAS) isolates from cases of
invasive infections were received for serotyping. As high number of strains
(32/80, 40%) were nontypable (NT) with our standard M-typing antisera, the
emm genes were ampliﬁed by PCR and sequenced. Forty-four percent of NT
strains belonged to emm89 type, which resulted, together with type M1 (16/
80 cases), the type most frequently (19/80 cases) responsible for invasive
infections in Italy. In particular, type emm89 was signiﬁcantly associated with
necrotizing fasciitis (8/26 cases) and bacteremia (8/27 cases). One strain was
isolated from a case of meningitis and 2/24 strains were from streptococcal
toxic shock syndrome. No case associated with emm89 was fatal. All emm89-
type strains were positive for the production of opacity factor (OF) and had a
T-pattern corresponding to B3264, 3/B3264, or 3/13/B3264. All strains were
high producers of protease; all strains carried speB, whereas were negative for
speC and speA genes. The pulsed-ﬁeld gel electrophoresis proﬁle of all emm89
strains was similar but distinct from those strains belonging to other types or
untypable. Strains belonging to emm89 were also isolated from several cases of
skin lesions and GAS pharyngitis. It looks likely that pharyngeal strains
represent a reservoir for invasisve diseasese.
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S6 Emergence of a clone of S. pyogenes resistant to
bacitracin
L. Mihaila-Amrouche, J. Loubinoux, A. Bouvet
Paris, F
Objectives: A prospective survey of acute pharyngitis was conducted from
November 2000 to June 2001, in Bourgogne, a region of France, involving 20
general practioners. The aim was to study the frequency of antimicrobial
resistance of Streptococcus pyogenes responsible for pharyngitis.
Methods:Streptococcal pharyngitis was ﬁrst diagnosed by the positivity of the
Biostar Strep A Optical Immunoassay (International Microbio). It is a rapid
test that detects the group A antigen. A second throat swab was cultured on
Columbia blood agar plate and allowed to isolate 247 strains of S. pyogenes
from 282 patients. Biotyping, T-typing, and emm-typing were carried out
with the Rapid ID Strep 32 (BioMerieux), agglutination method, and
sequence analysis, respectively. Pulsed-ﬁeld gel electrophoresis was performed
on strains with similar markers. Susceptibility to 12 different antibiotics,
including bacitracin, was tested by the disk diffusion method. The minimal
inhibitory concentrations (MICs) of macrolides (erythromycin, azithromycin,
and josamycin), clindamycin, and tetracyclin were determined by the agar
dilution method according to the guidelines of the ‘Comite´ de l’Antibio-
gramme de la Socie´te´ Franc¸aise de Microbiologie’(CA-SFM). The major
genetic determinants of macrolides resistance (ermB, ermTR, and mefA)
were investigated by multiplex PCR assay.
Results: Thirty out of 247 isolates of S. pyogenes (12.1%) were found to be
resistant to bacitracin. All these strains were also resistant to high levels of
macrolides and clindamycin (MICs 32mg/L) associated with the ermB
gene. High levels of resistance to kanamycin and streptomycin were detected
in 30 and 27 strains, respectively. Most of these multiresistant strains were of
biotype 1, serotype T28, and type emm28, and represented more than 40% of
the emm28 strains. The pulsed-ﬁeld gel electrophoresis showed a homogeneity
among these strains.
Conclusion:These results conﬁrm the spread of a strain of S. pyogenes biotype
1, T28, emm28, characterized by an unusual resistance to bacitracin. The
spread of this clone during an 8-month period among the whole area of the
survey might have been favored by the association of high levels of resistance
to macrolides. Bacitracin-resistant strains have already been isolated from
invasive infections. Therefore, the detection of S. pyogenes should not be relied
by the positivity of the bacitracin susceptibility test.
S7 Antibiotic resistance of group A streptococci in
Romania during 1998–2002
V. Ungureanu, I. Ciuca, M. Straut
Bucharest, RO
Group A streptococci (GAS) strains collected by the National Reference
Laboratory for streptococci during 1998–2002 were isolated mainly from
respiratory infections (acute tonsillitis and scarlet fever), skin infections, and
healthy carriers. T-agglutination subtyping was performed and T pattern 5/
11/12/27 was predominant. GAS strains included in this study were tested for
susceptibility to 10 antibiotics (penicillin, cefotaxime, cefuroxime, cepha-
lothin, erythromycin, clindamycin, tetracycline, chloramphenicol, oﬂoxacin,
and vancomycin). Our results revealed that isolates from Romania were
uniformly susceptible to b-lactams, but to a variable degree resistant to
alternative antibiotics, such as macrolides, lincosamides, tetracycline, and
ﬂuoroquinolones. The frequency of tetracycline resistance within GAS
was 51%, whereas erythromycin resistance was rather rare accounting for
only 6.5%. Phenotypes of erythromycin resistance were identiﬁed further by a
double disk diffusion test. M phenotype was the most common. On the basis
of a triple disk diffusion test, strains resistant to macrolide, lincosamide, and
streptogramin (MLS) were assigned further to the corresponding inducible
MLS subtypes. In Romania, the current resistance rate of GAS to erythro-
mycin seems to remain relatively low compared with those of other European
countries, but continued surveillance of macrolide resistance in GAS is
recommended.
S8 Antibiotic resistance among group A streptococci
H. U. Nielsen, A. M. Hammerum, N. Frimodt-Møller
Copenhagen, DK
An overview of the most important problems of resistance in GAS will be
presented based on the literature and our own experience from Denmark.
The major antibiotic resistance problems in GAS during the last two decades
have been resistance toward the macrolides and tetracycline. Incidence of
erythromycin resistance levels of up to 100% in some third-world countries
has been reported, while levels of up to 50% have been published from
European countries. In Denmark, the incidence is still low, i.e. in the range of
0–5%. In most studies, a close relationship between macrolide use and
development of resistance has been proven. On the other hand, erythromycin
resistance has remained low in Denmark in spite of a rather high macrolide
use. The distribution of macrolide resistance genes is different in European
countries, the reason for which is unknown. The genotypes can easily be
determined from the phenotypic characteristics, e.g. from susceptibility
testing with erythromycin and clindamycin. Tetracyklin resistance levels in
Danish GAS has been surprisingly high considering that these drugs are not
used for treatment of GAS infections. The genetic background recently
elucidated will be presented. Penicillin resistance in GAS has never been
reported, but there is still discussion whether penicillin tolerance exists in
these bacteria. A few reports on PBP changes in GAS have been published.
Whether this could precede real resistance towards penicillins should be
subjected to future investigations.
Designing successful antibiotic strategies (Symposium arranged with the BSAC)
S42 Systematic review of interventions to improve
antibiotic prescribing: hospital inpatients
E. Brown
Bristol, UK
Although 80–90% of all antibiotic prescriptions for human use are issued in
the community, resistance to these drugs is a more serious and acute problem
in the hospital setting. In response to the inexorable increase in resistance
rates, government and other authoritative bodies have called for reductions in
inappropriate antibiotic prescribing, with the expectation that the trend will
be reversed. However, none of these bodies has speciﬁed the processes by
which this outcome is to be achieved and, to date, there have been no
published guidelines, based on systematic reviews, which have deﬁned the
optimal interventions or combination of interventions. In 1993, the British
Society for Antimicrobial Chemotherapy convened a working party with the
speciﬁc aim of addressing this issue. In the course of performing a systematic/
Cochrane review, the working party produced a comprehensive database
comprising of 665 articles published since 1980. Only 296 of these contained
original data and all but 77 (26%) of the 296 papers were excluded on the
grounds of inadequate methodology, i.e. they were not randomized control
trials, controlled before and after studies, or interrupted time series with
adequate numbers of data points before and after the intervention. The
ﬁnal 77 articles are currently being evaluated according to a protocol
devised by the Cochrane Effective Practice and Organization of Care
Group. However, despite fulﬁlling the criteria for inclusion, many of these
articles suffer from one or more ﬂaws in their design and/or execution. It is
likely, therefore, that at least some of the recommendations made by the
working party will be based on expert consensus, rather than robust evidence.
For the time being, it is reasonable to assume that a combination of
interventions will be necessary in order to have a maximum impact on
the prescribing practices. Potential measures that might comprise an antibiotic
control plan include a formulary, with restrictions on the prescribing of
selected drugs, some form of constraint on the duration of prescriptions,
evidence-based guidelines for antibiotic usage, laboratory control, and
educational measures.
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Re-evaluating pharmacokinetics/pharmacodynamics relationships: a critical appraisal
S43 The relationships between bacterial killing, the MIC,
PK/PD indices and antibacterial effect
J. W. Mouton
Nijmegen, NL
TheMIC is the in vitro reference value to describe the activity of an antibiotic
against microorganisms. This value is obtained by incubation of a deﬁned
inoculum over a certain period of time, and thus does not represent the effect
of an antimicrobial at a speciﬁc point in time, but rather the effect of the
antibiotic over a period of time, the incubation period. The MIC is read at a
ﬁxed concentration. In vivo however, concentrations decline over time and
the effect of the antibiotic thus changes over time. At some concentration, the
killing effect of the antibiotic is less than a certain value and bacteria will start
growing. Using the Hill equation with variable slope, it is shown that this
concentration is not equal to the MIC. Simulations using ranges of values for
killing rate, growth rate and slope factor show that for beta-lactam antibiotics
the static concentration is close to the MIC value and that this may explain
why concentrations in vivo need to be above the MIC, while regrowth of
bacteria occurs when concentrations decline below the MIC. For concen-
tration dependent antibiotics such as aminoglycosides and quinolones, the
static concentration is shown not to be equal to the MIC, and in general is
much lower. This observation may explain why bacteria do not regrow
immediately after concentrations have declined below the MIC and thus, the
presence of phenomena such as Post Antibiotic Effect.
S44 The use of in vitro models to predict emergence of
resistance
A. MacGowan
Bristol, UK
Pharmacokinetic/pharmacodynamic (pK/pD) invitro models have been
increasingly used to assess dosing regimens in terms of reducing the risk
of resistance occuring as well as predictions on efﬁcacy. Invitro models have an
advantage over animal systems in that much larger bacterial populations (up to
10Eþ 10 cfu) can be exposed to antibiotic. Resistance can be measured by
changes in MIC before or after drug exposure, the ability of the bacteria to
grow on agar containing a single MIC multiple (i.e. 4 MIC) or on agar
containing a range of MIC multiples (i.e. 1MIC, 2MIC, 4MIC, etc.).
If this latter approach is used, then changes in the bacterial population pro-
ﬁle can be assessed. Most work in this area has been conducted on the
ﬂuoroquinolone class, and the following factors are important in: (a) pre-
dicting resistance in bacterial species, (b) drug exposure measured by AUC/
MIC or Cmax/MIC, (c) duration of exposure, (d) agent tested, (e) initial
bacterial population heterogeneity, and perhaps, (f ) existing resistance
mechanism. The relationship between drug exposure and resistance follows
an inverse quadratic relationship, being lowest at low and high AUC/MIC
values. The mutant prevention concentration (MPC) may also have a role in
prediction of resistance which is not inconsistent with the concept of a
quadratic relationship outlined above. Staphylococcus aureus and P. aeruginosa are
commonly used in model systems as resistance occurs more rapidly than other
species such as S. pneumoniae. It remains to be established if extrapolations
made on these organisms can be justiﬁed for others.
S46 How predictive is PK/PD for antimicrobial agents
B. Rouveix
Paris, F
MIC of antimicrobials, in combination with plasma concentrations achieved
during therapy, are generally used to predict clinical and microbiological
efﬁcacy. Based on invitro data, b-lactams and macrolides are said to be time-
dependent and concentration-independent, whereas aminosides and ﬂuoro-
quinolones are concentration-dependent and time-independent. Time-kill,
dynamic testing, and animal models have been used to establish predictors of
efﬁcacy such as time >MIC, AUC/MIC, and Cmax/MIC. For aminosides
and ﬂuoroquinolones, it is thought that Cmax/MIC ratios must exceed 10, or
AUC/MIC ratios must be 125 (for Gram-negative organisms) or 30 (for
Gram-positive organisms). Yet, the relationship between PK/PD parameters
and clinical outcome has rarely been investigated in man. Moreover, existing
clinical trials suffer from several drawbacks such as their retrospective nature.
PK/PD parameters are usually calculated on the basis of MIC and AUC tables
rather than on individually determined values. The predictability of these
parameters should now be revised. Optimization of Cmax/MIC ratio max-
imizes b-lactam efﬁcacy in infections caused by penicillin nonsusceptible
pneumococci, while t>MIC and Tmax or AUC/MIC are the best dynamic
predictors of the microbiologic and clinical efﬁcacy of ﬂuoroquinolones in
patients with pneumococcal infection. AUC breakpoints such as 125 cannot
be adopted for antibiotics of all classes because very different serum con-
centration proﬁles can result in the same AUC. Moreover, there are con-
siderable variations in PK/PD calculations in individuals, and predictors of
efﬁcacy appear to be drug- and pathogen-speciﬁc. In the case of mild
community-acquired infections, antibiotics should ideally be administered
at relatively high dosage and short dosing intervals. In contrast, in difﬁcult
situations (e.g. immunodeﬁciency or high MIC values), individually adjusted
PK/PD parameters might be a valid basis for the choice of dosage schedule.
One of the recent strategies for ﬁghting antibiotic resistance is that few
mutants will arise if antibiotic concentrations block the most resistant mutant.
This led to the concept of the mutant prevention concentration (MPC),
which prevents the growth of ﬁrst-step mutants. Antibiotics and dosage
schedules should now be assessed by taking into account the time that drug
concentrations in sera and tissue exceed the MPC.
Improving diagnosis and treatment of viral infections of the central nervous system (Joint symposium arranged
with the IDSA)
S47 Diagnosis of herpesvirus infections of the CNS:
a virologist’s challenge
G Palu`
Padua, I
Human herpesviruses, in particular, herpes simplex virus types 1 and 2, and
also cytomegalovirus, Epstein-Barr virus, varicella-zoster virus, and human
herpesvirus 6 and 7 are responsible for numerous infections of the central
nervous system (CNS). Due to the large spectrum of clinical signs and
symtoms associated with herpesvirus infections of the CNS, many of which
are nonspeciﬁc or atypical, diagnosis often represents a challenge for both
clinicians and microbiologists. A presumptive diagnosis is based on the
patient’s history, clinical signs, EEG proﬁles, radiological imaging, and
CSF analyses, even though these investigations may be normal at early stages
of disease. The availability of CSF PCR-based diagnostic techniques has
allowed for rapid and accurate diagnosis, leading to speciﬁc therapeutic
interventions and shortened patient stays. CSF–PCR provides a higher
sensitivity and speciﬁcity than viral isolation and serological tests, such as
intrathecal antibodies. The use of CSF–PCR has expanded, for instance, the
awareness of mild or atypical HSVencephalitis that represents 16–25% of the
cases. Besides CSF–PCR, PCR analysis of CNS tissue also plays an important
role in the diagnosis of herpetic infections of the CNS. However, due to the
capability of the herpesviruses to persist in the host tissue in a latent state, PCR
results obtained from tissue specimens must be interpreted cautiously, since
viral genomic material may be present even in the absence of an active viral
infection. Negative PCR results provide evidence against a role of herpes-
viruses as the causative agents. In addition, analysis of speciﬁc viral gene
transcripts in selected CNS cell preparations by RT-PCR techniques can
provide a deﬁnitive insight as towhether the herpesvirus is passively carried by
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bystander inﬂammatory cells, is latent, or is in an active replication state. In
addition to qualitative PCR, quantitative PCR, that allows the number of
viral DNA copies in the CSF to bemeasured, has shown signiﬁcant prognostic
value. Finally, newly developed quantitative real-time PCR assays, making
results available at a much earlier time, signiﬁcantly enhance the impact of the
diagnosis on clinical intervention, reducing the need for empiric treatment,
and providing the opportunity to monitor the ongoing therapy from the
virological viewpoint.
Urinary tract infections: new insights into virulence and pathogenesis (Joint symposium arranged by ESCMID/ICAAC)
S51 Virulence in Klebsiella: use of molecular techniques
and animal models
K. A. Krogfelt, C. Struve
Copenhagen, DK
Background: Klebsiella pneumoniae is a common cause of urinary tract
infection (UTI) and pneumonia, especially in immunocompromised indivi-
duals. Epidemiological studies have revealed that K. pneumoniae infections are
frequently preceded by colonization of the intestine. The gastrointestinal tract
is host to a very complex microﬂora, which is the most important reservoir for
transmission of bacteria.
Objectives: To identify genes involved in the ability of K. pneumoniae to
colonize the intestine and infect the urinary tract.
Methods: A novel multiscreening signature-tagged mutagenesis assay (MS-
STM) was developed. In the MS-STM assay, PCR-ampliﬁed tags present in
the inoculum as well as recovered pools from each infection model were
simultaneously subjected to hybridization using each speciﬁc tag as a probe.
Hereby, screenings of a mutant library in more than one infection model was
signiﬁcantly eased compared to the traditional STM methodology.
Results and conclusions: Mutants were identiﬁed being attenuated in both
the intestinal colonization as well as the UTI model, and more important
mutants attenuated in the UTI model only were identiﬁed. Transposon
insertion sites in attenuated mutants were, among others, in genes encoding
well-known K. pneumoniae virulence factors such as lipopolysaccharide and
capsule, as well as genes of so far unknown function. Additional studies have
shown the importance of K. pneumoniae capsule in UTI. The bacteria seem to
have speciﬁc strategies for colonization and survival in the different host
organs. The regulation of presentation/expression of these features is still
unknown.
S53 Bacterial virulence factors: are they important to
know for the treating physician?
P. Ulleryd
Gothenburg, S
Urinary tract infection (UTI) is the result of interactions between bacterial
virulence and host defense mechanisms at several levels. In individuals with
normal urinary tracts, to cause infection, bacteria have to be equipped with
certain properties, i.e. virulence factors, making it possible to overcome
host defenses. Such infections are designated as uncomplicated, and typically
occur in young, healthy, nonpregnant females. The dominating uropathogen,
Escherichia coli, possesses an array of virulence properties that participate at
different stages of the infectious process. Adhesins mediating attachment to
epithelial cells seem to play an important role in colonization of mucosal
surfaces and the ascent of bacteria into the urinary tract. E. coli isolated in
urine from women with uncomplicated pyelonephritis more often belong to
certainO :K :H serotypes andmore frequently express virulence factors like P
ﬁmbriae, hemolysin, and aerobactin than E. coli strains in the fecal ﬂora of
persons not having UTI or those isolated from patients with asymptomatic
bacteriuria or acute cystitis. However, when host defenses are compromised,
as in patients with functional or structural abnormalities of the urinary tract,
infections are often caused by a diversity of less virulent E. coli strains. Obvious
clear-cut correlations with speciﬁed types of UTIs are missing. One reason for
this could be that many virulence factors seem to be encoded by ﬂexible
genetic elements called pathogenicity islands and that the regulation of gene
expression may act independently or in concert. In all, the pathogenetic role
of adhesins and other virulence factors such as toxins and siderophores have
not been fully elucidated. As an example, only a small number of E. coli strains
from men with various types of UTI have been characterized as regards
virulence properties. In a retrospective study, E. coli isolates from 74 men with
febrile UTI were phenotypically analyzed. Awide array of O :K :H serotypes
commonly associated with acute pyelonephritis in women were identiﬁed.
There was a higher frequency of hemolytic strains among patients with
febrile UTI (74%) and a lower frequency of P ﬁmbriated (51%) and aero-
bactin-positive strains (46%) than previously encountered in women with
uncomplicated acute pyelonephritis. A prospective study investigating both
phenotype and genotype corroborates the ﬁndings. Are these results impor-
tant to know for the treating physician?
Health care workers as a source of infection (Joint symposium arranged with SHEA)
S55 Prevention of transmission of HBV and HCV from
health care workers to patients: towards a European
consensus?
H. L. Zaaijer
Amsterdam, NL
Recently, representatives from several countries met to devise common
recommendations for prevention of transmission of viral hepatitis from
medical personnel to patients. In the past, health care workers (HCWs) were
voluntarily vaccinated against hepatitis B to protect them from occupational
infection. Over 45 reports describe transmission of hepatitis B virus (HBV)
from HCWs to patients. HCWs who are immune for hepatitis B cannot
acquire and transmit HBV to patients during exposure-prone procedures
(EPPs). Obviously, patients should be protected from iatrogenic HBV infec-
tion by mandatory vaccination of HCWs. Can vaccination be mandatory? It
seems justiﬁed that an employer demands vaccination of applicants for a job
involving EPPs. However, HCWs already employed may refuse vaccination
on various grounds. It seems reasonable that refusing HCWs undergo
mandatory screening for HBV infection regularly. When vaccinated, HCWs
show an antibody response below 100 IU/L. The presence of HBV must be
ruled out because a signiﬁcant number of HBV carriers have low levels of
anti-HBs. Recently, a surgeon who showed 252 IU/L anti-HBs after vacci-
nation was found to be HBV infected. He transmitted HBV to three patients.
This incident suggests that all EPP-performing HCWs should be tested for
presence of HBV, irrespective of the vaccination status. In Europe, the
proportion of HBV carriers among HCWs ranges from 0.3 to 3%. The
US excludes HBV-positive HCWs from performing EPPs if they test positive
for the HBV e-antigen. In addition, the UK and Ireland exclude e-antigen
negative HCWs with HBV viral loads above 1000 cp/mL. In Holland, HBV-
positiveHCWsare excluded fromEPPs if theviral load is above100.000 cp/mL.
The consensus panel proposes a cut-off level of 10.000 cp/mL, balancing
the risk of transmission and the loss of medical specialists. Since 1992, the
WHO advocates worldwide vaccination of infants against HBV. Several
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north-west European countries decided to limit vaccination to at-risk groups.
As a result of this policy, the general population remained vulnerable to HBV
infection, and in the future patients, HCWs and blood donors still may acquire
and transmit HBV. The estimated prevalence of hepatitis C virus (HCV)
infection among European HCWs ranges from 0.2 to 3%. The consensus
panel did not reach agreement on how to manage HCV infected HCWs who
perform EPPs.
S57 Health care workers as a source for
hospital-acquired diarrhea
D. Gerding
Chicago, USA
Objective:Discuss the evidence implicating health care workers (HCW) as a
source of spread of organisms causing diarrhea in the hospital, particularly
Clostridium difﬁcile.
Methods:Literature review, personal experience, and unpublished study data.
Results: C. difﬁcile-associated diarrhea (CDAD) is the most frequently iden-
tiﬁed cause of nosocomial diarrhea. This organism persistently contaminates
the hospital environment through the formation of spores that persist for
prolonged periods. The hands of hospital workers have been documented to
be contaminated frequently by C. difﬁcile following contact with patients who
are asymptomatically colonized or who have CDAD, or by contact with the
environment of these patients. HCW do not carry C. difﬁcile in their stools
more frequently than nonhealth care workers, and are at risk of CDAD only if
they are taking antibiotics. Evidence that healthcare workers transmit C. dif-
ﬁcile are indirect, and based on a signiﬁcant decrease in CDAD rates in a
controlled trial of glove wearing by HCW (P< 0.05). Cases of CDAD caused
by a speciﬁc strain of C. difﬁcile have been associated with care by the same
HCW teams on a hospital ward and were not associated with geographic
proximity of the patients. Waterless alcohol hand hygiene products are not
sporicidal and may not be effective in removingC. difﬁcile spores, but their use
has not been documented to be associated with increased CDAD rates to date.
Conclusion: HCW are a source of C. difﬁcile transmission to patients, pre-
sumably via hand contact. Gloving, and possibly hand washing, have demon-
strated beneﬁt in reducing CDAD rates.
S58 Prevention and control of methicillin-resistant
Staphylococcus aureus and vancomycin-resistant
pathogens
W. Jarvis
Atlanta, USA
Objectives: To discuss control of antimicrobial-resistant pathogens in health-
care settings.
Methods: Review of national surveillance data and published intervention
studies.
Results: Since 1980, Centers for Disease Control and Prevention (CDC)
National Nosocomial Infections Surveillance (NNIS) system data have shown
that the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) keeps
increasing every year; currently approximately 50% of S. aureus isolates
causing hospital-acquired infections are resistant to methicillin. Similarly,
since 1989, vancomycin-resistant enterococci (VRE) have rapidly emerged;
currently, approximately 25% of enterococci causing hospital-acquired infec-
tions are resistant to vancomycin. Since 1997, eight patients have been
diagnosed with vancomycin-intermediate resistant S. aureus (VISA) infections
and, in 2002, the ﬁrst vancomycin-resistant S. aureus (VRSA) infection was
documented in USA. Over the past decade, approximately 150 000 patients
have died of these infections in US hospitals. Antibiotic use (emergence) and
patient-to-patient transmission (spread) are the two most important risk
factors for infections caused by antibiotic-resistant pathogens. CDC guide-
lines recommend that patients with ‘epidemiologically important antibiotic-
resistant pathogens’, like MRSA, VRE, VISA, or VRSA, should be cared for
using contact precautions. A variety of studies have shown that person-
to-person transmission is facilitated by the unknown iceberg of the colonized
patient. Recently, several studies have used active surveillance cultures to
detect both infected and colonized patients; these studies have shown that
MRSA can be controlled in a facility, and that VRE was eradicated or
signiﬁcantly reduced in 32 healthcare facilities in a region.
Conclusion: If all healthcare facility personnel start implementing programs of
active surveillance cultures for these pathogens, healthcare-associated MRSA
and VRE infection rates (and the resulting emergence of community-
acquired MRSA, and hospital-acquired VISA and VRSA) could begin falling
(or fail to further emerge) for the ﬁrst time in decades.
Insight into the epidemiology of bacterial resistance
O59 Referred cases of urinary tract infections caused by
strains of Escherichia coli producing extended-spectrum
beta-lactamases in a pediatric hospital
E. Lebessi, P. Tassios, C. Svensson, L. Tzouvelekis, D. Kafetzis,
N. Legakis, M. Foustoukou
Athens, GR
Objective: To conduct an epidemiologic survey of urinary tract infections
(UTIs) caused by Escherichia coli strains producing extended spectrum beta-
lactamases (EC-ESBLs), occurring in infants referred to our hospital, without
obvious predisposing factors.
Methods: During routine infection – control monitoring of multiresistant
pathogens, a cluster of EC-ESBL was noted among urine pathogens isolated
from infants in December 1998. Worksheets were reviewed retrospectively,
and the ﬁrst such isolate was noted to have occurred in December 1998.
Subsequently, it was decided to collect epidemiologic data for all EC-ESBL
urine isolates retrospectively from December 1998 to January 1998 and
prospectively from January 1999 to December 1999. All cases of infection
were classiﬁed as referred to or acquired in the hospital. Susceptibility to
antimicrobials was tested by a disk diffusion method according to the NCCLS
criteria. Production of ESBLs was detected by the double disk synergy test
(DDST). Molecular typing was carried out by pulse – ﬁeld gel electrophoresis
(PFGE).
Results: During the study period, 40 episodes of UTI caused by EC-ESBL
were diagnosed in 40 patients. Of these, only four were considered to be
acquired in the hospital. The remaining 36 cases were classiﬁed as ‘referred’.
The study population consisted of 28 boys and 12 girls. Of these, 33 (82%)
patients were younger than 12months. All these infants, except three, had
their ﬁrst episode of UTI. Urinary tract abnormalities were found in 40% of
patients, with vesicoureteric reﬂux being predominant. EC-ESBL strains
accounted for 3.1 and 6.5% of total E. coli isolated from urine cultures during
1998 and 1999, respectively. All EC-ESBL isolates were susceptible to
imipenem and ciproﬂoxacin. Resistance rates to other antibiotics were, as
follows: cefepime, 2.5%; amoxicillin/clavulanate and piperacillin/tazobactam,
5%; gentamicin, 85%; amikacin, netilmicin and tobramycin, 87.5%; tri-
methoprim-sulfamethoxazole, 20%. A single phenotype (A) was observed
among infants (20/33, 60%) from December 1998 to December 1999. All
these infants had been born from November 1998 to March 1999 in the same
maternity hospital (MH-I) in Athens. PFGE revealed nine distinct types (A-I).
Twenty of 28 tested isolates belonged to PFGE type A; all had originated from
MH-I.
Conclusions: None of the referred infants had obvious predisposing factors
associated with infection caused by ESBL strains. The majority of EC-ESBL
strains were found to be acquired in MHs.
O60 Enterococci and coagulase-negative staphylococci
disseminate frequently between intensive care unit patients
C. Edlund, C. Agvald-O¨hman, B. Lund
Stockholm, S
The intensive care unit (ICU) is often proposed to be the part of the hospital
with the highest frequency of nosocomial infections. Enterococci and coa-
gulase-negative staphylococci (CNS) both constitute increasingly important
nosocomial problems worldwide, especially in severely ill and immunocom-
promised patients, mainly due to intrinsic and acquired antimicrobial resistance
Clinical Microbiology and Infection, Volume 9, Supplement 1, 2003 5
Objectives: To investigate the colonization pattern in the respiratory tract of
mechanically ventilated ICU patients and bacterial transmission within and
between patients, with speciﬁc regard to enterococci and CNS.
Methods:Twenty consecutive patients undergoing incubation at an ICU in a
Swedish hospital were included. Samples were collected from the oropharynx,
the subglottic space, the stomach and the trachea within 24 h of incubation
and then every third day until day 18, thereafter every ﬁfth day until day 33.
Enterococca and CNS isolates (n¼ 170 and 199, respectively) were geno-
typed with pulsed-ﬁeld gel electrophoresis. The minimum inhibitory con-
centration (MIC) was determined for ﬁve clinical relevant antimicrobial
agents by the agar dilution method.
Results: Enterococci – Seven clones occurred each in at least two patients and
13 of 17 colonized patients were involved in at least one transmission event.
One of the patients shared strains with six other patients. CNS – Seven clones
were each isolated from two or more patients. Eleven out of 20 patients were
involved in between one, and up to six, transmission events. The risk of
acquiring an epidemic strain increased with prolonged treatment at the ICU.
The majority of the strains expressed multiple resistance, but none of the
enterococci was vancomycin resistant.
Conclusions: Transmission of resistant enterococci and CNS between
mechanically ventilated patients seems to be frequent since a total of 17/
20 patients were involved in at least one transmission event. Although
transmission of bacteria does not necessarily lead to infection, it is nevertheless
an indication that infection control measures can be improved. Registration of
nosocomial infection rates will greatly underestimate the true number of
bacterial transmissions between hospitalized patients.
O61 Incidence of enterococcal surface protein in
glycopeptide-resistant Enterococcus faecium during its
emergence in a Greek intensive care unit
E. Papadomichelakis, E. Platsouka, C. Routsi, R. Willems, M. Bonten,
O. Paniara, C. Roussos
Athens, GR; Bilthoven, Utrecht, NL
Objectives: Enterococcal surface protein (esp) gene, a potent virulent factor,
has been recently detected in glycopeptide-resistant E. faecium (GREF)
infection-derived isolates spreading in hospitals (Lancet 2001;357:853-55).
We searched for the esp gene in GREF strains during their emergence in the
ICU of a tertiary care hospital.
Methods: Between February 1999, when ﬁrst detected, and April 2001, 21
GREF strains of VanA phenotype were isolated from the same number of
patients at the multidisciplinary ICU of ‘Evangelismos’ Hospital. Clinical data
from all these patients were collected. Identiﬁcation of strains and antibiotic
susceptibility testing by MIC were performed. All isolates were examined for
the presence of vanA and vanB genes by polymerase chain reaction (PCR)
analysis. Also, the presence of the esp gene was detected by esp PCR.
Results:All patients were acutely ill, aged 51þ 18 years, with a high Apache II
score on admission (19þ 5), long length of ICU stay (50 days, median, range
12–320) and had a high ICU mortality (48%). GREF acquisition was noted
late during ICU stay (30 days, median, range 9–150, postadmission) following
a long duration of vancomycin and/or third-generation cephalosporin ther-
apy. The vanA glycopeptide resistance genotype was found in all isolates. The
esp gene was present in 17 out of the 21 (90%) tested isolates. Blood was the
most common source of the esp gene positive strains (n¼ 7), followed by
drainage (n¼ 4), pus (n¼ 3), intravascular catheters (n¼ 2) and urine (n¼ 1).
The four esp gene negative strains were detected in ﬂuid of wound or drainage.
No signiﬁcant association was detected between ICU mortality and the
presence of the esp gene.
Conclusion: A high incidence of esp gene was detected in infection-derived
E. faecium strains, in our ICU, especially in blood isolates. This ﬁnding
documents the emergence and dissemination of highly virulent E. faecium
strains among ICU patients.
O62 Antibiotic susceptibility among bacteria in
29 Swedish intensive care units
H. Hanberger, L. Burman, O. Cars, M. Erlandsson, H. Gill, S. Lindgren,
L. E. Nilsson, B. Olsson-Liljequist, S. Walther, ICU-STRAMA Study
Group
Objectives: To evaluate the incidence of antibiotic susceptibility among
bacteria isolated from patients in 29 Swedish ICUs during 1999–2000.
Methods:Consecutive specimens collected on clinical indications from ICU
patients, were cultured and tested for susceptibility to routinely used anti-
biotics. Susceptibility testing was performed on 7766 initial clinical isolates
using a disk diffusion method according to the Swedish Reference Group for
Antibiotics (SRGA).
Results: The most dominating isolates were in percentage: CoNS 17.8,
followed by Candida spp. 13.1, Staphylococcus aureus 8.4, Escherichia coli
8.2%, Enterococcus faecalis 6.9, Streptococcus spp. 6.8, Klebsiella spp. 4.4, Pseu-
domonas aeruginosa 3.9, Enterobacter spp. 3.5, Enterococcus faecium 3.5. Ceftazi-
dime/Cefotaxime showed a broad activity (>96%) against E. coli andKlebsiella
spp. but also against P. aeruginosa (ceftazidime), Serratia spp. and S. maltophilia
(88–92%), but lower rates for Enterobacter spp. (67%) and Acinetobacter spp.
(20%). High susceptibility to ciproﬂoxacin was seen among E. coli, Enterobacter
spp., Klebsiella spp. and Serratia spp. (mean 90–95%). Corresponding ﬁgures
were for; Acinetobacter spp. 89%, P. aeruginosa 85%, S. maltophilia 68%, S. aureus
15%, CoNS 3.6%, E. faecalis 0.8% and E. faecium 0.4%. All species showed
high susceptibility to imipenem (96%) except P. aeruginosa (70%), E. faecium
(11%) and S. maltophilia (0%). Also for Netilmicin a high susceptibility was
found among E. coli, Enterobacter spp., Klebsiella spp., P. aeruginosa, S. aureus,
Serratia spp. (>96%) andAcinetobacter spp. (91%) but not for CoNS (54%). The
MRSA-rate was only 2% and most MRSA-isolates came from one ICU. The
oxacillin resistance among CoNS was >70%. The local susceptibility rate
among P. aeruginosa ranged 57–100% for imipenem, 82–100% for ceftazidime
and 67–100% for ciproﬂoxacin.
Conclusions:The results in this study were in line with previous Swedish and
Scandinavian ICU surveillance studies showing high antibiotic susceptibility
among most bacteria except for lower rates of antibiotic susceptibility among
P. aeruginosa. There was no correlation between local consumption of carba-
penem, ceftazidime and ciproﬂoxacin and resistance to these drugs in
P. aeruginosa (P¼ 0.87, 0.22 and 0.87, respectively) which indicated a need
for local hygienic interventions against the transmission of resistant P. aeru-
ginosa rather than restrictions of antibiotic usage.
O63 Epidemiology of multidrug-resistant Pseudomonas
aeruginosa in a Tel Aviv medical centre
V. Aloush, S. Navon-Venezia, Y. Igra, S. Cabili, Y. Carmeli
Tel Aviv, IL
Objectives: Multi-drug resistant (MDR) Pseudomonas aeruginosa (PA)
may result in adverse outcomes. This study was designed to under-
stand the spread and to determine risk factors (RF) for MDR PA at our
institution.
Methods: Molecular analysis using PFGE of selected MDR PA, collected
during a 10month period. Epidemiological investigation and a case-control
study comparing cases with control patients that were matched to cases by
ward, calendar time, and length of stay (LOS) until inclusion. Data on
demographics, primary diagnosis, active comorbidities (AC), procedures/
devices, and treatment were collected from patients’ records. Analyses were
performed using conditional logistic regression.
Results:During the study period 82 cases with MDR PA from 20 wards were
identiﬁed. Thirty-six unique patients isolates were typed using PFGE and
revealed 12 different clones. Two of the clones dominated; clone A (10 cases)
which caused an outbreak in the ICU (7 cases within 3months) and spread to
other wards, and clone B (9 cases) which did not cluster in time and/or space.
In the case-control study 82 cases (age 65, 60% male, 1.2 AC), were included
and had mean LOS to isolation of 17 days. Cases were compared to 82
matched controls (age 63, 50% male, 1.3 AC). In univariate analysis: transfer
from another institution, previous ICU stay, invasive device, number of
antimicrobials, and severity of illness, were signiﬁcant RF. AC of malignancy
was protective. The multivariate model included ICU stay (OR 10.1,
P¼ 0.04), being bedridden (OR 3.5, P¼ 0.04), having invasive devices
(OR 13.9, P¼ 0.02), number of antibiotics (OR 1.8, P¼ 0.01) and malig-
nancy (OR 0.2, P¼ 0.03). When each class of antibiotics was included in the
model third generation cephalosporins (OR 9.6, P¼ 0.003) and aminoglyco-
sides (OR 6.1, P¼ 0.04) were unique RF.
Conclusions: MDR PA belonged to multiple clones and appeared on many
wards. A dominant clone spread from ICU to other wards. RF analysis
identiﬁed previous ICU stay, being bedridden, and multiple invasive devices
were signiﬁcant RF for MDR PA. Heavy antibiotic treatment, and particu-
larly treatment with third generation cephalosporins and aminoglycosides are
important RF for MDR PA.
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O64 First results of Escherichia coli resistance monitored
by the European Antimicrobial Resistance Surveillance
System (EARSS)
E. W. Tiemersma, G. Kahlmeter, P. Schrijnemakers, J. E. Degener,
G. Cornaglia and EARSS participants
Objectives: In 2001, routinely generated antimicrobial susceptibility test
results for invasive E. coli were added to the European Antimicrobial Resis-
tance Surveillance System (EARSS). We present the ﬁrst susceptibility results
for aminopenicillins (amoxicillin/ampicillin), aminoglycosides (gentamicin/
tobramycin), ﬂuoroquinolones (ciproﬂoxacin/oﬂoxacin) and third-genera-
tion cephalosporins (ceftazidime and cefotaxime/ceftriaxone).
Methods: The EARSS protocol requires laboratories to report interpretative
susceptibility results (S, I, R) of E. coli isolates. Only ﬁrst isolates of a patient
are accepted. Between January 2001 and October 2002, EARSS received
results of 20 511 isolates from 332 laboratories in 22 countries. We calculated
proportions of resistant (R)E. coli isolates per country.Median resistance levels
were those reported by the median country after ranking countries from low
to high resistance.
Results:Aminopenicillin resistance in E. coli was above 25% in all countries
(median: 44%). Resistance to gentamicin and tobramycin exceeded 10%
in some countries but the median was only 4%. Countries with the highest
resistance levels to aminopenicillins (southern and eastern Europe) also
exhibited the highest resistance rates to aminoglycosides. Fluoroquinolone
resistance appeared to be a problem in many countries. The median
resistance levels were 8% in 2001 and 12% in 2002, which is noticeably
higher than the levels reported in previous publications. Resistance to
third generation cephalosporins was still uncommon, although levels
were higher than 5% in many eastern European countries. Resistance to
three or more different classes of antimicrobials occurred in 7.5% of E. coli
strains.
Conclusion: In E. coli, resistance to several classes of antimicrobials is common
throughout Europe, mostly in southern and eastern countries and in Israel.
The high resistance levels to single antimicrobial classes, the relatively high
prevalence of multidrug resistance and the high level of ﬂuoroquinolone
resistance are of concern and will be closely monitored.
O65 Susceptibility patterns are unchanged over three
years in community-acquired lower respiratory
Streptococcus pneumoniae and Haemophilus inﬂuenzae in
the UK and Ireland
R. Reynolds, D. Felmingham, BSAC Working Party on Respiratory
Resistance Surveillance
Objective: To monitor trends over time in the antimicrobial susceptibility of
pathogens associated with community-acquired lower respiratory tract infec-
tion.
Methods: Two thousand and twenty-seven S. pneumoniae and 2810 H. inﬂu-
enzae from lower respiratory specimens were collected from 20 laboratories in
the UK and Ireland in the winters of 1999–2000, 2000–01 and 2001–02,
excluding duplicates within 2weeks and patients in hospital more than 48 h.
Isolates were centrally tested by BSAC agar dilution MIC method and
categorized by BSAC breakpoints.
Results: The tables show the percentage of resistant [intermediate]
isolates.
The results, like those of other databases, point to a small reduction in
resistance of S. pneumoniae to beta-lactams. Hints of a possible upward trend in
resistance can be seen only for trimethoprim/H. inﬂuenzae and ciproﬂoxacin/
S. pneumoniae, the latter probably due to the breakpoint falling on the shoulder
of the distribution. The full MIC distributions show that susceptibility patt-
erns have generally remained very similar throughout the three study years.
Conclusion: In contrast to reports of increasing resistance from some other
European countries, patterns of resistance in community-acquired lower
respiratory tract pathogens in the UK and Ireland appear to have been stable
over the last three years.
O66 Susceptibility to penicillin of invasive compared
with respiratory Streptococcus pneumoniae and relationship
with age
R. Reynolds, D. Felmingham, D. Livermore, BSAC Working Party on
Resistance Surveillance
Objective: To compare antimicrobial susceptibility in invasive and commu-
nity-acquired lower respiratory tract S. pneumoniae, taking account of patient
age.
Methods:One thousand three hundred and twenty-eight S pneumoniae from
lower respiratory specimens were collected from 20 laboratories in the UK
and Ireland in the winters of 1999–2000 and 2000–2001, excluding duplicates
within 2weeks and patients in hospital more than 48 h. Two hundred and
twenty-seven S pneumoniae from blood cultures were collected from 24
laboratories in 2001. Isolates were tested centrally by BSAC agar dilution
MIC method (respiratory isolates at GRMicro and bacteremia at ARMRL),
and categorized by BSAC breakpoints (mg/L).
Results:We have shown previously that respiratory S. pneumoniae show a U-
shaped relationship between patient age and nonsusceptibility to penicillin
and other antimicrobials, signiﬁcant in multivariate analysis. The bacteremia
isolates showed the same relationship, and there was no evidence of any
difference in susceptibility between isolates from blood and lower respiratory
sources. The table shows the results for penicillin.
Amoxicillin, cefotaxime, ciproﬂoxacin, erythromycin and tetracycline were
also tested against both respiratory and blood isolates. There was no difference
in susceptibility between the two, except with ciproﬂoxacin where the blood
isolates typically had MICs one doubling dilution higher than respiratory
giving an apparent but probably spurious difference in resistance of 31 vs. 5%.
Conclusions:Antimicrobial susceptibility in S. pneumoniae depends on patient
age, but there is little evidence of difference between invasive and noninvasive
disease in the UK and Ireland.
S. pneumoniae
antimicrobial
R [I range] (mg/L)
1999–2000
n¼ 661
2000–2001
n¼ 667
2001–2002
n¼ 699
Penicillin, 2 [0.12-1] 0.9 [9.8] 0.3 [9.9] 0.7 [7.0]
Amoxicillin, 2 1.2 1.3 0.9
Cefaclor, 2 12.0 10.5 7.6
Cefuroxime, 2 8.2 6.3 5.4
Cefotaxime, 2 0.2 0.1 0.0
Erythromycin, 1 13.3 11.2 12.2
Clindamycin, 1 5.9 4.3 4.3
Ciprofloxacin, 4[2] 5.4 [94.6] 5.1 [94.9] 8.7 [91.3]
Tetracycline, 2 8.9 7.9 5.9
Trimethoprim, 1 100.0 100.0 100.0
Moxifloxacin, 2 0.3 0.3 1.1
H. influenzae
antimicrobial
R [I range] (mg/L)
1999–2000
n¼ 936
2000–2001
n¼ 958
2001–2002
n¼ 916
Ampicillin, 2 15.2 16.0 16.3
Amoxicillin, 2 21.2 20.8 22.1
Amoxicillin-clavulanate, 2 7.8 4.0 5.2
Cefaclor, 2 98.8 92.8 91.3
Cefuroxime, 2 19.0 15.8 17.2
Cefotaxime, 2 0.0 0.0 0.0
Erythromycin, 16 [1-8] 3.7 [95.7] 2.8 [96.1] 4.8 [94.4]
Ciprofloxacin, 2 0.1 0.0 0.1
Tetracycline, 2 3.5 2.6 2.4
Trimethoprim, 1 9.7 11.4 17.0
Moxifloxacin, 2 0.0 0.0 0.1
Age range
Bacteremia Respiratory
Number RþI/total %RþI Number RþI/total %RþI
0-4 2/18 11 13/79 16
5–24 0/12 0 8/71 11
25–49 1/39 3 16/254 6
50–74 6/75 8 59/622 9
75þ 11/81 14 43/301 14
Age not known 0/2 1/1
Overall 20/227 10 140/1328 11
Rþ I¼ resistantþ intermediate, i.e. MIC 0.12mg/L.
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O67 Presence of class 1 integrons in Enterobacteriaceae
from human, food, and animal reservoirs
A. Fluit, A. Box, E. Duijkeren, D. Mevius, J. Verhoef
Utrecht, Lelystad, NL
Introduction: Class 1 integrons are associated with multiresistance (MR) in
Enterobacteriaceae due to their frequent presence on resistance determinant
carrying conjugative plasmids. The role of different reservoirs in the trans-
mission of resistance determinants is poorly understood. In previous studies
we observed 11 different integron types (I–XI) at the neurodivision of our
hospital [AAC 2001, 45 : 2961] and 19% of the isolates from newly admitted
patients possessed an integron, including types V and VII [JCM. 2002,
40 : 3038]. The aim was to characterize integrons in Enterobacteriaceae from
human, food and animal samples.
Methods: Gentamicin- and cotrimoxazole-resistant clinical isolates were
obtained from dogs (n¼ 14) and horses (n¼ 27). Escherichia coli screening
isolates were obtained from swine (n¼ 620), calves (n¼ 310) and chickens
(n¼ 621). Screening isolates were tested for nine noncross-reacting antibio-
tics. Meat samples were obtained at two supermarkets. All isolates were
characterized by integrase (int)- and CS-speciﬁc PCR. CS-PCR ampliﬁca-
tion products were characterized by restriction enzyme analysis.
Results: Among the isolates from dogs 10 were int-positive and at least two
types of integron were found, including type V and XII. Among the 20 int-
positive horse isolates at least four integrons were discovered, including types V,
VIII, andXII. A total of 21 isolates (3.3%) from swinewereMR. Twelve isolates
were int-positive and at least two integron types could be identiﬁed, including
type VII. Forty-ﬁve isolates (14.5%) from calves were MR and 35 were int-
positive. At least six different integron typeswere present, including types V, VII
andXII. Fifty chicken isolates (8.1%)wereMR, 38 (6.1%)were int-positive and
at least four integron types were found, including types V, VII, and XII. Both
meat samples were int-positive, but only one sample was also CS-PCR
positive. In this sample integron types V and VII were present. These data
suggest that, integrons from farm animals contribute in part to the antibiotic
resistance observed in the hospital setting. It can be argued that isolates
harboring an integron are more prone to acquire additional resistance deter-
minants.
Conclusion: Several types of integron are shared among human, food and
animal isolates indicating that resistance determinants present among (farm)
animals may contribute to the problem of MR Enterobacteriaceae in the
hospital setting.
O68 Quality assessment of antibiotic susceptibility
testing by laboratories participating in the European
Antimicrobial Resistance Surveillance System (EARSS) in 2002
P. M. Schrijnemakers, N. Bruinsma, G. Kahlmeter, J. E. Degener,
C. Walton, J. W. Mouton, G. Cornaglia, P. Courvalin and EARSS
participants
Objectives:The goal of this third external quality assurance (EQA) exercise of
EARSS is the ongoing assessment of comparability in susceptibility test results
across countries and guidelines.
Methods:A set of ﬁve strains; S. aureusU2A1556 (mecA, penA, rpoB, ant40),
E. faecium U2A805 (vanB, aph20-aac60, ant309, erm), E. coli U2A1557 (IRT),
E. coliU2A1526 (blaCTX-M, aac3-V, ant30, gyrA), and S. pneumoniae (penR,
aph30-III, ant309, ermB, cat, parC, TpRSuR), were provided by CRAB
(Centre National de Re´fe´rence des Antibiotiques) and distributed by UK-
NEQAS (United KingdomNational External Quality Assessment Scheme) to
the laboratories participating in EARSS. The laboratories were asked to
report methods and guidelines used for speciation, MIC-determination
(when performed) and clinical susceptibility categorization (S, I and R).
Results were considered ‘concordant’ if the reported categorization agreed
with the designated interpretation of three reference laboratories.
Results: Overall, 642 (93%) of 690 laboratories from 26 countries reported
results. Most of them used NCCLS guidelines (71%). For the E. faecium, the
overall concordance was high for amoxicillin/ampicillin (98%), gentamicin
(98%), vancomycin (90%) and teicoplanin (96%) but low for species identi-
ﬁcation (87%). For the S. pneumoniae the overall concordance was high for
oxacillin (98%), penicillinG (98%), erythromycin (95%) and clindamycin
(93%) but low for ceftriaxone/cefotaxime (48%). Both E. coli strains had a
high concordance for amoxicillin/ampicillin (98–100%), gentamicin (99%)
and ciproﬂoxacin (96–100%). Importantly, the concordance for detection of
ESBL production was high (93–95%). The results for the S. aureus are not
available yet.
Conclusion: The third EQA exercise of EARSS had again a high overall
concordance, conﬁrming that the resistance surveillance as monitored by
EARSS is valid. However, the 13% misidentiﬁcation of the E. faecium should
be dealt with by the laboratories. The low concordance for the susceptibility
of the S. pneumoniae to ceftriaxone/cefotaxime most probably occurred
because the low breakpoint (S 0.5mg/L, NCCLS) was only one dilution
step from the intended result (MIC¼ 1mg/L).
Emerging bacterial problems in pediatric infections
O69 Longitudinal carriage of Pneumococcus in
kindergarten children in Hong Kong
C. Lo, M. Boost, M. M. O’Donoghue
Kowloon, HK
Introduction: Young children under the age of ﬁve are recognized as a risk
group for carriage of antimicrobial resistant Streptococcus pneumoniae and are
more susceptible to pneumococcal infections. A cross sectional study of
kindergarten children in Hong Kong had shown a carriage rate of 19% with
more than 50% of strains being nonsusceptible to penicillin. However, the
pattern of prolonged carriage of penicillin resistant strains in this community is
unknown.
Objectives: To investigate longitudinal nasopharyngeal carriage of S. pneu-
moniae among children attending kindergarten. The antimicrobial resistance
patterns and risk factors for persistence were also investigated.
Methods:Nasopharyngeal swabs were collected from 680 children attending
six different kindergartens on three occasions over a 5month period and
questionnaires providing demographics and medical history for risk factors
were completed by their parents. S. pneumoniae was isolated and antibiotic
susceptibilities determined using standard methods.
Results:On the ﬁrst occasion, the carriage of S. pneumoniae was 19.7% (134)
whereas the carriage rate on the second occasion decreased to 12.3% (75) and
to 10.2% (70) on the third occasion. Thirty-three (24.6%) children of the 134
initially carrying S. pneumoniae were found to be carriers on the ﬁrst two
samplings. Of these 33 isolates, 63.6% were not susceptible to penicillin. On
the third sampling only eight children of the original carriers were still
colonized with S. pneumoniae and all strains were penicillin resistant. Seventy-
ﬁve percent of persistently carried strains were multiply drug resistant. On
each occasion other children had acquired S. pneumoniae and 10 children who
had been noncolonized on the ﬁrst sampling were positive on the second and
third occasions. Age and antibiotic prescription within the last month were
found to be risk factors for resistance. Sex, family size, number of siblings,
physician consultation and hospitalization were not signiﬁcantly associated
with carriage.
Conclusion: This is the ﬁrst study of longitudinal carriage of S. pneumoniae
performed in Hong Kong. Results for carriage are similar to those observed
elsewhere in that the majority of isolates were only carried for a short period
of time. However, rates of antibiotic resistance are much higher than those in
most developed countries. Persistent carriage was found to be more common
for antibiotic resistant strains.
O70 Invasive pneumococci in the pediatric population
of Germany: Epidemiology and coverage of the 7 valent
pneumococcal conjugate vaccine, 1997–2001
R. R. Reinert, A. Siedler, M. Herrmann, R. Lu¨tticken, R. v. Kries,
A. Al-Lahham
Aachen, Berlin, Munich, D
Objectives:Pneumococcal disease is a major cause of morbidity and mortality,
especially among children. A nation-wide study of invasive pneumococcal
disease among children <16 years of age was started in 1997 in Germany.
Methods: Pediatric hospitals and their clinical microbiological laboratories
were asked to report invasive pneumococcal infections among children and to
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send the pneumococcal isolates to the NRCS for conﬁrmation of species
diagnosis, antibiotic susceptibility testing by the microbroth dilution method
and serotyping by the quellung reaction. Multilocus sequence typing (MLST)
was performed according to standard methods.
Results: Two thousand two hundred and eight cases were reported by the
laboratories and hospitals. Capsular typing was carried out for 892 isolates and
showed serotypes 14 (24.1%), 1 (8%), 18C (7.4%), 19F (7.4%), 23F (7.1%),
and 6B (5.9%) to be the most prevalent. The percentage of cases per age group
covered by the 7-valent pneumococcal conjugate vaccine including the
potentially cross-protective serotype six A was 69.5% (age group, 6–
11months), 76.8% (1 years) and 74.6% (2–4 years). Three hundred and ﬁfty
isolates of pneumococcal meningitis were serotyped and the coverage of the
7-valent vaccine among children of 1 year of age was 81.2%. Erythromycin A
resistance has increased from 12.9% in 1997 to 27.4% in 2001, which is mostly
due to the increase of the incidence of serotype 14 from 16.3% in 1997 to
28.1% in 2001 (almost 50% of strains of serotype 14 are erythromycin-
resistant). The percentage of penicillin resistance (IþR) was 5.6%. four
(0.4%) isolates were highly penicillin-resistant (MIC> 2mg/L). Fifty-eight
penicillin resistant (IþR) strains were characterized by serotyping andMLST.
Serotypes 23F (22.4%) and 14 (20.7%) were the most prevalent serotypes
among penicillin resistant isolates. 34.5% of all sequence types of the 58
penicillin resistant isolates were Spanish clones with variable sequence types
mainly ST-557 (8.6%) and ST-156 (8.6%).
Conclusions: Macrolide resistance is increasing in Germany. Penicillin and
cefotaxime resistance rates still are one of the lowest world-wide. The 7-valent
conjugate vaccine covers over 90% of all antibiotic resistant pneumococcal
strains.
O71 Changing epidemiology of purulent Meningitis in
children due to HIV infection
H. H. Luyombya, R. Kulume, L. Musoke
Kampala, UG
Background: The impact that HIV infection has had on the epidemiology of
purulent meningitis in children has not been well characterized.
Objective: To determine the etiology and clinical differences in purulent
meningitis in HIV infected (HIV-positive) and HIV uninfected (HIV-nega-
tive) children.
Methods: Children with purulent meningitis were enrolled between March
2001 and March 2002 and their hospital records reviewed.
Results:One hundred and forty-two of the 154 children had a deﬁnitive HIV
result, of which 44% were HIV-positive. The median age of HIV-positive and
HIV-negative children was 8.5months and 50%were male. The proportion of
organisms isolated between HIV-positive and HIV-negative children, respec-
tively, (P< 0.0001) were S. pneumoniae 75 vs. 26%:Hemophilus inﬂuenzae type
b 11 vs. 41%: Neisseria meningitidis 5 vs. 16%, S. agalacticiae 5 vs. 10% In
addition there was one case of Cryptococcus neoformans and Escherichia coli and
no organism was identiﬁed in 2 and 5% of HIV-positive and HIV-negative
children, respectively. Difference on cerebro-spinal ﬂuid (CSF) analysis
betweenHIV-positive andHIV-negative children included a lower neutrophil
(median 249 vs. 400 cells/mL, P¼ 0.02 and lymphocyte count (median 25 vs.
70 cells/mL, P¼ 0.02) Gram stain (97 vs. 80%, P¼ 0.002) and culture (97 vs.
70% cells/mL P¼ 0.002) on CSF were more likely to be positive in HIV-
positive than in HIV-negative children, respectively. Neurologic morbidity
(31 vs. 29%) and mortality (28 vs. 16%) did not differ between HIV-positive
and HIV-negative children, respectively. In HIV-positive children, meningitis
due to S. pneumoniaewas associatedwith a higher mortality than organisms (34
vs. 7%, respectively, P¼ 0.004).
Conclusion: The HIV epidemic has resulted in S. pneumoniae replacing
H. inﬂuenzae type b as the dominant cause in children. An attenuated immune
response to bacteria invading into CSF may explain differences noted in CSF
analysis between HIV-positive and HIV-negative children.
O72 Impact of wide vaccination of children with
pneumococcal conjugate vaccines on antibiotic
resistance
L. Temime, D. Guillemot, P. Boelle
Paris, F
Objectives: Strains of Streptococcus pneumoniae resistant to penicillins have
widely spread in the community in the last decades. New conjugate vaccines,
which protect against both invasive disease and asymptomatic carriage,
may help control this evolution. Here, we investigate the impact of
the introduction of a conjugate pneumococcal vaccine for a given
proportion of children on carriage of S. pneumoniae and of resistant strains
in particular.
Methods: We have developed a mathematical model of the carriage of
S. pneumoniae in an age-structured population. Bacterial strains are described
by their serotype and a resistance level which is susceptible to increase with
exposure to antibiotics; they spread in the community through interindividual
transmission. A 7-valent vaccine is administered to a portion of the children
under 1 year-old. The vaccine protects against carriage of the serotypes
included in its composition. The parameters describing the natural history
of colonization of S. pneumoniae, the frequency of contacts and the character-
istics of antibiotic treatments were estimated from the literature. We inves-
tigated the changes in the proportion of carriers and in the distribution of
resistance levels in terms of penicillin G MIC, both with and without
vaccination.
Results: With vaccination, carriage of vaccine-type strains decreases to very
low levels, typically in 20–30 years in epidemiologically realistic conditions.
Simultaneously, strains not included in the vaccine spread in the community,
so that the overall carriage rate remains stable. Surprisingly, vaccination does
not affect the extent at which antibiotic resistance is selected. In all cases, the
distribution of resistance levels peaks on high levels (MIC> 2mg/L) after
20 years. The same results are obtained even with a vaccine optimally designed
to include all serotypes currently exhibiting a decreased susceptibility to
penicillin G.
Conclusion: Serotype replacement phenomenon rapidly follows vaccination,
so that the overall carriage rate is not subject to major changes. Moreover, the
distribution of resistance levels of all pneumococcal strains is the same after
20 years, irrespective of vaccination. This mathematical modeling suggests
that vaccination alone may not be successful in controlling the burden of
antibiotic resistance in S. pneumoniae.
O73 Impact of pneumococcal conjugate vaccines and
antibiotic policies on the incidence of meningitis due to
penicillin G-resistant S. pneumoniae
L. Temime, P. Boelle, D. Guillemot
Paris, F
Objectives: S. pneumoniae is among the leading causes of bacterial meningitis
in the western world. Moreover, the outcome of the disease may worsen now
that strains of S. pneumoniae with high levels of resistance to penicillin G are
increasingly common. New conjugate vaccines, which protect against both
invasive disease and asymptomatic carriage, may help decrease the burden of
resistance. However, their long-term effects on disease and on resistance
selection are not well known yet. Using mathematical modeling, we inves-
tigated the impact of a conjugate pneumococcal vaccine on the incidence of
S. pneumoniae meningitis and among these infections, the portion of cases
resistant to penicillin G.
Methods: We have developed a mathematical model of the selection of
pneumococcal resistance to penicillin in an age-structured population. Zero
to 100% of children under 1 year-old receive a conjugate vaccine which
protects them against carriage of seven serotypes included in its formulation
but not against other serotypes. The model takes into account the main
parameters describing the natural history of colonization of S. pneumoniae, the
frequency of contacts and the characteristics of antibiotic treatments, which
were estimated from the literature. We investigated the time changes of the
incidence rate of S. pneumoniae meningitis and in particular of penicillin G
resistant cases. We also studied the impact of different treatment policies
intended to reduce antibiotic exposure of children on the number of cases
prevented by vaccination over 15 years.
Results: With vaccination, the carriage rate of S. pneumoniae – all strains
combined – remains stable. In the same respect, at most 5% of the overall
number of meningitis cases in 15 years can be prevented by vaccination. After
approximately 20 years, penicillin G resistant meningitis constitute the near
totality of cases of S. pneumoniae meningitis, independently of vaccination.
However, vaccination combined to a strategy where the treatment frequency
of all children is reduced by half enables the prevention of up to 25% of
resistant meningitis cases in a 15 year period. This gain remains large even for
vaccination rates as low as 20%.
Conclusion:Vaccination alone may not be sufﬁcient to decrease the burden of
resistant pneumococcal meningitis. However, reducing antibiotic use after the
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introduction of vaccination would reduce the incidence of highly resistant
cases and therefore improve outcomes in this disease.
O74 Impact of routine Hib vaccination in the Czech
Republic and analysis of Hemophilus inﬂuenzae isolates by
molecular methods
P. Krizova, V. Lebedova, J. Kalmusova, J. Felsberg, R. Haugvicova,
W. Hryniewicz, A. Skoczynska
Prague, CZ; Warsaw, PL
Objectives: The aim of the study was to assess the impact of routine Hib
vaccination and to study the clonality ofHemophilus inﬂuenzae b (Hib) isolated
in an active surveillance program.
Methods: Routine vaccination of infants against invasive disease caused by
Hib under 1 year of age was introduced in the Czech Republic in July 2001.
The active surveillance of invasive Hib disease was introduced in the Czech
Republic nation-wide in January 1999. H. inﬂuenzae isolated in the active
surveillance program in 2001 were investigated using classical methods
(serotyping, biotyping) and 20 selected Hib isolates by molecular methods
(polymerase chain reaction – PCR, randomly ampiﬁed polymorphic DNA
analysis – RAPD, pulsed-ﬁeld gel electrophoresis – PFGE and multilocus
sequence typing – MLST).
Results:A total incidence of Hib invasive disease ranged between 1.0 and 1.1/
1 00 000 population before the introduction of routine Hib vaccination (in
1999 and 2000). The highest incidences in both years were in the age groups
0–11months (17.1/1 00 000, and 15.6/1 00 000, respectively) and 1–4 years
(17.4/1 00 000, and 20.9/1 00 000, respectively). The active surveillance data
for 2001 and 2002 indicate the decrease of Hib invasive disease in the target
age group (0–11months) after the introduction of routine Hib vaccination, in
which the age speciﬁc morbidity was 15.6/1 00 000 in 2001 and 3.3/1 00 000
in 2002). A total number of 249 isolates was obtained in the active surveillance
program in 2001. Among those strains 184 wereH. inﬂuenzae and 64 of these
were Hib isolated from invasive disease. Biotyping of 63 Hib strains from
invasive disease showed biotype I. Twenty Hib strains isolated in ﬁrst quarter
of 2001 were typed bymolecular methods. Eighteen of them showed identical
RAPD patterns and 18 identical PFGE proﬁles with minor differences. Six
isolates investigated by MLST showed ST-6.
Conclusion:The results of active surveillance indicate decrease of Hib invasive
disease in the target age group under the inﬂuence of mass Hib vaccination of
infants. Hib strains isolated from invasive disease showed homogeneity in
RAPD, PFGE and MLST patterns.
Acknowledgements:This study was supported by research grant NI/6803-3
of the Internal Grant AgencyofMinistry of Health of the CzechRepublic and
made use of the Multi Locus Sequence Typing website (http://haemophi-
lus.mlst.net). We thank Dr K. Jolley (University of Oxford, UK) for kind
editing of the text.
O75 Clonal analysis of Neisseria meningitidis and
vaccination strategy in the Czech Republic
P. Krizova, J. Kalmusova, M. Musilek, J. Felsberg, R. Haugvicova,
D. Caugant
Prague, CZ; Oslo, N
Objectives:Clonal analysis of meningococcal populations allows to assess the
epidemiological situation and to recommend appropriate vaccination strategy
for the country.
Methods: Strains isolated from invasive meningococcal disease (IMD) are sent
to the National Reference Laboratory for Meningococcal Infections in
Prague for further investigation by classical methods (slide agglutination,
Whole Cell ELISA) and molecular methods (multilocus electrophoresis –
MLEE andmultilocus sequence typing –MLST).MLST is made according to
the method described at the MLSTwebsite (http://neisseria.mlst.net). The
results of strains isolated from IMD in the period 1980–2001 are presented.
Results:An emergency epidemiological situation of IMD started in the Czech
Republic in 1993, when a new clone, N. meningitidis C, ET-15/37, ST-11,
occurred. The new meningococcal clone caused increased IMD morbidity
and case fatality rate. After 7 years of high prevalence of that clone, we have
noticed the prevalence of serogroup B since 2000. However, the strains of
serogroup B belong to the hypervirulent complexes (ET-5/ST-32 complex
and ST-18 complex) and case fatality rate remains at a high level. A strategy of
targeted vaccination of parts of the population at highest risk was adopted in
1993. This targeted vaccination has been used less frequently now, as we have
noticed a decreasing incidence of IMD and a decreasing percentage of
serogroup C. Mass vaccination with meningococcal conjugate C vaccine
is not planned.
Conclusion: The emergency situation caused by hypervirulent complex N.
meningitidis C, ET-15/37, ST-11 is over in the Czech Republic, without mass
vaccination, and hypervirulent complexes ofN. meningitidis B, ST-32 and ST-
18, have started to replace serogroup C strains even though they do not reach
such a high percentage asN. meningitidisC, ST-11 in the past.Mass vaccination
with meningococcal conjugate C vaccine is not planned in this epidemio-
logical situation.
Acknowledgements:This study was supported by research grants NI/6882-3
and NI/7109-3 of the Internal Grant Agency of Ministry of Health of the
Czech Republic and EU project no. QLK2-CT-2001-01436 and made use
of the Multi Locus Sequence Typing website (http://neisseria.mlst.net) sited
at the University of Oxford and funded by the Wellcome Trust. We thank
Dr K. Jolley (University of Oxford, UK) for kind editing of the text.
O76 Early intestinal bacterial colonization and
necrotizing enterocolitis in premature infants: The putative
role of Clostridium
M. F. De La Cochetie`re, H. Piloquet, D. Darmaun, J. P. Galmiche,
J. C. Roze´
Nantes, F
Necrotizing enterocolitis (NEC) is among the most severe conditions that can
affects preterm infants. Although the etiology of NEC remains unknown,
initial bacterial colonization could play a pivotal role in the development of
NEC. To further explore the putative relationship between pathogen micro-
organisms and NEC, we conducted a prospective case-control study in 12
preterm infants with a new approach based on molecular techniques. Over an
inclusion period of 24months, 12 neonates of <34weeks admitted in the
neonatal unit were enrolled in a prospective study aimed at a description of the
pattern of bacterial colonization in that population of infants. Within this
study group, three infants happened to develop cataclysmic NEC and
subsequently died. The group therefore includes three cases of NEC, and
nine control infants without evidence of NEC, who were matched for
gestational age and birth weight. Stools samples were saved at weekly intervals
from all infants. Polymerase chain reaction and temporal temperature gradient
gel electrophoresis of 16S ribosomal DNAwere used to detect the establish-
ment of bacterial communities in the digestive tract. A salient feature of the
bacteriological pattern was observed only in the three infants who later
developed NEC: a band corresponding to theClostridium perfringens subgroup
could be detected in early samples, and prior to diagnosis, whereas there was
no evidence for this speciﬁc band in any of the nine controls. To our
knowledge, the current report is ﬁrst to demonstrate that the use of molecular
techniques based on the study of bacterial 16S rRNA genes allowed the
recognition of a Clostridium perfringens species in the ﬁrst 2weeks of life of
three infants who later displayed symptoms of NEC. A signiﬁcant temporal
relationship was thus established between early colonization by Clostridium
and the later development of NEC. Compared with conventional bacter-
iological culturing methods, the use of this new molecular approach to
analyze the gastrointestinal ecosystem should therefore allow a more complete
and rapid assessment of intestinal ﬂora. The current data do not, however,
constitute deﬁnite proof that the identiﬁed bacterial species was a causative
agent in the development of NEC. But they outline the promise of this new
technique based on molecular biology, and suggest that large scale studies on a
much wider population at high risk of NEC may be warranted.
O77 Bacteremia due to Pseudomonas spp. other than
Pseudomonas aeruginosa in children
V. Krcmery, E. Grey, J. Korcova, E. Bilikova-Buckova, M. Mrazova,
M. Kacmarikova
Bratislava, SK
Objectives: To assess risk factors and outcome of bacteremia due to Pseudo-
monas spp. other than Pseudomonas aeruginosa in children.
Mehods:Among 240 cases of bacteremia within 3 years nationwide survey of
Pseudomonas bacteremia, 11 (4.8%) were due to Non-aeruginosa Pseudo-
monas spp. and the rest due to Pseudomonas aeruginosa, Burkholderia cepacia and
Stenotrophomonas maltophilia. Here we present 11 cases of bacteremia in
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immunocompromised children caused by Pseudomonas spp. other than Pseu-
domonas aeruginosa. We compared Pseudomonas bacteremias with X2 tst (EPI
INFO computerized package). Blood cultures were incubated within the
BACTEC (BBL) system and identiﬁed with VITEK centralized system (Bio
Me´rieux), antimicrobial susceptibilities were tested with disk diffusion test
according to the NCCLS.
Results: All patients with bacteremia survived, one case did not even receive
therapy: a heart transplant child, which was discharged from the hospital day
before the positive blood culture was reported (after 5 days of incubation). All
10 children were successfully cured with ceftazidime (4), cefotaxim (4),
cefepime (1) and azthreonam (1).
Conclusions: Surprisingly, the mortality in our group of non-aeruginosa
Pseudomonas spp. bacteremia patients was different than we have seen in child
with Pseudomonas aeruginosa bacteremia (20–33%) and Acinetobacter bau-
mannii bacteremia (26%). We have no explanation for this difference. Also
antimicrobial susceptibility of Pseudomonas putida and other Pseudomonas
spp. was higher in comparing to Pseudomonas aeruginosa, where among
169 bacteremias, 32% were resistant to ciproﬂoxacin and 7–10% to ceftazi-
dime.
O78 Enteroaggregative Escherichia coli associated with
acute diarrhea in children, a case-control study
S. Salmanzadeh-Ahrabi, E. Habibi, K. MoezArdalan, H. Edalatkhah,
V. Bakaev, M. R. Zali
Tehran, IR
Objectives: Enteroaggregative Escherichia coli (EAEC) is an emerging food-
borne pathogen in developed as well as developing countries. In the present
case-control study the role of EAEC in acute diarrhea among children under
5 years of age was investigated in Karaj, Tehran province, Iran. PCR of mixed
culture, which has been evaluated as a highly sensitive method, was used for
detection of EAEC in fecal samples.
Methods: During a 3month period form May to July of 2002, 102 acute
diarrhea patients, under 5 years of age, from different medical centers in the
city of Karaj and 29 matched controls without diarrhea were included in the
study. DNA was extracted from the primary mixed culture of fecal samples
and subjected to PCR by a pair of primers targeting 630 base pair region of
pCVD432 plasmid. As many colonies as required, were assayed for ﬁnding the
isolate carrying the target sequence. The chi-square test was used for statistical
analysis.
Results: Among the 102 acute diarrhea patients under 5 years of age inves-
tigated in our study (Median: 10months, range: 2months to 5 years, Inter-
quartile range: 6–18months), 37 (36.3%) were positive for EAEC, while only
three (10.3%) of controls yielded EAEC in their stool specimens. The
characteristics and the clinical symptoms of the patients with acute diarrhea
were vomiting in 31 (69.6%), watery stool in 46 (45.5%), mucus in stool in 59
(42.2%), bloody stool in seven (6.9%), and fever in four (3.9%) of our cases
(Table 1). EAEC was signiﬁcantly more frequent in patients with acute
diarrhea than in controls (P< 0.01).
Conclusion: These results suggest that EAEC should be considered as an
important diarrheal pathogen among children under 5 years of age in Karaj,
Iran.
Helicobacters – Update 2003 (Symposium arranged by EHSG)
S92 Lipopolysaccharides of Helicobacter spp.
characteristics and role in pathogenesis
A. Moran
Galway, IRL
Like other Gram-negative bacteria, Helicobacter spp. contain lipopolysacchar-
ides (LPSs), a family of phosphorylated glycolipids, in their outer membranes.
In the human gastroduodenal pathogen Helicobacter pylori, LPSs have been the
subject of intensive investigation as pathogenic factors. H. pylori LPS has low
immunological activities, attributed to the unique structure of its lipid A
component, and is considered to contribute to the ability of the bacterium to
chronically colonize the gastric mucosa. On the other hand, differences in
core oligosaccharide (COS) structure of the LPSs has been implicated in the
induction of pepsinogen and laminin interaction, as well as the virulence of
strains particularly those associated with duodenal ulcers. Nevertheless,
serological studies have shown that, compared to enteric bacteria, there
are epitopes in the COS that are conserved and unique to H. pylori LPS,
which may represent candidate epitopes in immunodiagnostic or vaccine
development. Furthermore, H. pylori LPSs mimic Lewis (Le) blood group
determinants, particularly Lex and Ley, in their O-chains, but the role of
this mimicry has been a matter of intensive debate. Nevertheless, evidence
exists that this mimicry can inﬂuence colonization in the gastric mucosa by
(i) Lex/Ley aiding camouﬂage of the bacterium in the mucosa or (ii) Lex
acting as a bacterial adhesin. On the other hand, chronic infection byH. pylori
can lead to a breakdown in immunological tolerance and LPS-expressed
Lex/Ley have been implicated in the development of autoreactive antibodies
against the gastric proton pump and in the development of atrophic gastritis.
More recently, investigations have been performed on the LPSs of non-
H. pylori gastric (H. felis, H. canis, H.musteale, H. bizzozeronii) and enterohe-
patic (H. hepaticus, H. bilis, H. pullorum, H. rappini) helicobacters. H.mustelae
and H. hepaticus produce low-, whereas the others produce high-molecular-
mass LPSs. Also, unlike H. pylori (with Le antigens) and H.mustelae (with
blood group A), no similar molecular mimicry was observed in the other
LPSs. Furthermore, a general absence of serological cross-reactivity with
the core of H. pylori LPS was observed indicating the occurrence of differ-
ing COS which could be exploited in immunodiagnostics. Furthermore,
detailed chemical analysis of the LPSs has revealed the occurrence of novel
sugars and distinctive sugar compositions which could prove of diagnostic
value.
The European Centre for Control of Infectious Diseases: what model will meet the challenge
S95 The European Centre for Infectious Diseases:
a project at the size of Europe’s needs and historical mission
M. Tibayrenc
Montpellier, F
The European Centre for Infectious Diseases (ECID) has been proposed
6 years ago (1–2) to face the threat of emerging and reemerging infectious
diseases. Inspired from the US Centers for Disease Control, it aims at settling
in Europe a centralized structure with walls, relayed by outstations and
corresponding centers, all Internet-connected. The missions of the ECID
would be 3-fold: (a) path-breaking, holistic research avoiding redundancies
with the research programs of the existing centers; (b) centralized surveillance
and control respecting the national sovereignties; (c) professional trainings.
The ECID should look for the active participation of Eastern Europe, former
USSR and Turkey, and should establish privilege links with developing
Table 1 Clinical symptoms and other characteristics of 102 patients with acute
diarrhea at hospitals or clinics in Karaj, Tehran, Iran
Clinical and other characteristics Number Percent in cases
Diarrhea:
Frequencya 6.47 2.16 –
Watery 46 45.5
Mucus 59 42.2
Blood 7 6.9
Vomiting 31 69.6
Anorexia 19 18.6
Lethargy 62 60.8
Abdominal pain 6 5.9
Feverb 4 3.9
aMean SD number of loose or watery stools per 24 h.
bTemperature more than 38.58C.
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countries (‘microbes ignore borders’). The project has been challenged by the
supporters of the ‘virtual CDC’ (electronic networking of the existing centers
(3–5); a position until recently retained by the European Parliament (5). The
bioterrorism threat led the Parliament to adopt the concept of a centralized
structure (6–7). However, the project still is too shy, and even if it goes in the
right direction, will not be enough to efﬁciently control major bioterrorism
threats and epidemics. Research and collaborative strategies are proposed to
make the ECID an efﬁcient tool toward reaching these goals (8).
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Antifungal immunotherapy (Joint symposium arranged with the ICHS)
S97 Adjunctive cytokine therapy against moulds: where
do we stand?
E. Roilides
Thessaloniki, GR
Invasive infections due to ﬁlamentous fungi (IFIs) have become a major cause
of increased morbidity and mortality in immunocompromised patients.
Genetic and acquired (disease- or therapy-related) risk factors predispose
to IFIs. Factors that modulate the host immune response against molds are
hemopoietic cytokines [granulocyte colony-stimulating factor (G-CSF),
granulocyte-macrophage CSF (GM-CSF) and macrophage CSF (M-CSF)],
Th1 cytokines [interferon-gamma (IFN-gamma), interleukin (IL)-15], Th2
cytokines (IL-4 and -10) and other cytokines. Hemopoietic cytokines have
been shown not only to enhance the phagocytic function against several
pathogenic molds but also to increase the number of phagocytes in vivo.
While Th1 cytokines do not increase the number of phagocytes, they have
been generally shown to enhance their antifungal activity against Aspergillus
spp. and other pathogenic molds. Th2 cytokines have been found to suppress
the antifungal activity of phagocytes. The beneﬁcial effects of certain hemo-
poietic and Th1 cytokines have been translated to some degree of favorable
outcome of invasive aspergillosis in immunocompromised animal models. In
addition, neutralization of Th2 cytokines improves outcome of murine
invasive aspergillosis. Cytokines may be administered to patients in different
stages of their disease: prophylactically at the beginning of granulocytopenia to
shorten its duration, preemptively at the onset of febrile granulocytopenia and
therapeutically upon diagnosis of a probable or deﬁnite IFI during granulo-
cytopenia. In addition, they can be given as prophylactic or therapeutic
intervention in high-risk nongranulocytopenic hosts. Transfusions of gran-
ulocytes from healthy donors are another mode for immune reconstitution of
profoundly granulocytopenic patients with difﬁcult-to-treat mold infections
under investigation. Hemopoietic cytokines or IFN-gamma combined with
antifungal chemotherapeutic agents such as polyenes, newer azoles or echi-
nocandins as well as hemopoietic cytokines combined with granulocyte
transfusions appear to have enhanced effectiveness against clinically relevant
molds. Anecdotal case reports and a few nonrandomized clinical studies
support use of certain cytokines in prevention or treatment of IFIs. However,
randomized studies with the speciﬁc aim to examine the impact of cytokines
on IFIs remain to be performed.
S98 Host defense mechanisms against fungal infections:
a comprehensive perspective
C. Lyman
Bethesda, USA
There aremultiple defensemechanisms that function cooperatively in the host
response to fungi. As a result, infections with these organisms are mild and
self-limiting in hosts with an intact immune system. The normal defense
mechanisms involved are multifactorial, but may be classiﬁed as either innate
or acquired resistance. Innate mechanisms act immediately and are the ﬁrst
line of defense against fungi. These include natural barriers such as intact skin,
which protects against infection caused by fungi that colonize the skin, or
intact epithelial linings of the respiratory, gastrointestinal and genitourinary
tracts that also act as mechanical, microbiological, and chemical barriers to
fungi. Circulating proteins such as transferrin are inhibitory to the growth of
some fungi, including Candida albicans, Histoplasma capsulatum, and mem-
bers of the Mucorales family. While many fungi are resistant to lysis by
terminal components of the complement system, factors released in the
complement cascade are important in resistance to infections with C. albicans,
Aspergillus fumigatus, and Cryptococcus neoformans. Phagocytic cells, including
polymorphonuclear leukocytes, monocytes, macrophages, eosinophils and
dendritic cells are an extensively studied, critical component of the innate
response to fungal infections. Oxygen radicals, peroxides, nitric oxide and
cationic proteins are generated by these cells in varying degrees in response to
different organisms, and may result in their inhibition, damage, or death.
Further activation of these phagocytic cells is accomplished by release of
proinﬂammatory cytokines and chemokines by T cells, as well as other
phagocytes. Production of regulatory cytokines is a critical component of
acquired resistance to systemic fungal infections. The pattern of release of
these proteins may distinguish between increased resistance and susceptibility,
with a strong Th1 response providing protection and a strong Th2 response
resulting in increased disease severity. While antibodies may play a beneﬁcial
role in cryptococcosis and candidiasis, their overall importance in other fungal
infections remains unclear. Thus, the innate and adaptive immune systems are
ﬁnely tuned arms of the host response that cooperate extensively in con-
trolling and/or preventing fungal infections.
Prevention of surgical infections (Symposium arranged with the ESGNI)
S100 Recent developments to prevent surgical
infections
J. Kluytmans
Breda, NL
Objective: To evaluate recent developments in the prevention of surgical
infections.
Methods: Review of the literature.
Results: The most interesting developments have been made regarding the
preoperative preparation of the patient. Especially, the strong effects of
preoperative warming of the patient at whole or the incision site locally
on the SSI rate are impressive and warrant more investigations. Also, the
effects of strict control of the perioperative blood glucose levels and of
preoperative eradication of nasal carriage of S. aureus have resulted in lower
surgical infection rates and should be studied in more detail.
Conclusions: The protective effect of local and systemic warming before the
surgical procedure has been described twice in well-designed studies.
Although a ﬁnal judgment about the effectiveness can only be made after
more extensive investigations, there seems little against this cheap and save
measure. Therefore, in settings with a high SSI-rate the implementation of
preoperative warming can be justiﬁed. Before widespread implementation
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of preoperative eradication of nasal carriage of S. aureus can be promotedmore
extensive investigations should be performed.
S101 Surveillance of surgical site infections in
abdominal surgery
N. Troillet
Sion, CH
Background: Surgical site infections (SSI) have a clear impact on morbidity,
mortality and costs. They represented >25% of all nosocomial infections
found in Swiss hospitals during prevalence surveys organized by the Swiss–
Noso network in 1996, 1999, and 2002 (asymptomatic bacteriuria not
included). Surveillance, including feedback of their SSI rates to surgeons,
has been shown an effective preventive measure.
Methods: In 1998, ﬁve community hospitals and one tertiary-care university
hospital in Western Switzerland initiated a surveillance program based on the
principles of the US National Nosocomial Infections Surveillance (NNIS)
system with the objectives to reduce the rates of SSI, to develop a quality
indicator, and to better understand the epidemiology of SSI in these settings.
Results: As of December 31, 2001, 7368 patients who underwent abdominal
or thoracic surgery had been included. A follow-up at one month was
available for 96% of them. Overall, 601 patients (8.2%) suffered from SSI
(42% superﬁcial incisional, 28% deep incisional, 30% organ or space infec-
tions). Two hundred and four of them (34%) were diagnosed postdischarge.
Two hundred and forty-two (40%) had to undergo percutaneous or surgical
drainage. Seventy-one (12%) were re-admitted for the treatment of their
infection. SSI rates varied between interventions from 2% (herniorrhaphy) to
19.9% (colon surgery), and from 5.2 to 10.5% between hospitals. Multivariate
analysis showed that the three variables included in the NNIS index did
signiﬁcantly predict SSI in digestive surgery (contamination class, OR¼ 1.6
[1.5–1.8]; ASA score, OR¼ 1.4 [1.2–1.6]; duration > T, OR¼ 1.9 [1.5–
2.4]), together with other variables such as the number of procedures done
during the intervention (>1 procedure, OR¼ 1.5 [1.2–1.9], or a re-inter-
vention for a non infectious complication (OR¼ 3.0 [1.9–4.6]). The use of a
laparoscope was found protective (OR¼ 0.4 [0.3–0.5]). Odds ratios
adjusted for the NNIS index and allowing intersurgeon and interhospital
comparisons were periodically provided to surgeons or infection control
committees, respectively. This program motivated speciﬁc measures such as
the implementation of the 1999 CDC guidelines for the prevention of SSI.
SSI rates in the different hospitals were consistently lower in 2001 than in
1998.
Conclusion: Multicentric surveillance of SSI according to the NNIS prin-
ciples proved suitable and useful in the Swiss setting, at least in digestive
surgery.
Emerging ﬂea-borne rickettsioses
S103 Flea borne bacteria and bacterial diseases
D. Raoult
Marseille, F
In developed countries human beings are exposed to pet ﬂeas (cat and dogs) as
exposure to rat ﬂeas dramatically decreased. Several emerging diseases have
been associated withCtenocephalides felis the cat ﬂea. The bacteria found in cat
ﬂeas are Bartonella quintana, B. henselae, B. clarridgeiae, B. koehlerae, Rickettsia
felis andR. typhi. B. henselae is the agent of cat scratch disease in human beings.
It can also cause bacillary angiomatosis, retinitis, meningoencephalitis and
endocarditis. It is associated with chronic asymptomatic bacteremia in cats. It
is transmitted to humans by cat scratch or bite and sporadically by ﬂeas. B.
quintana is the agent of human diseases including trench fever, bacillary
angiomatosis, endocarditis and chronic bacteremia. Some cases have been
associated with cat ﬂeas. There are no clear evidence of human diseases caused
by B. clarridgeiae or B. koehlerae which causes chronic bacteremia in cats. R.
typhi is the agent of murine typhus, it is usually transmitted by rat ﬂeas. It was
identiﬁed on C. felis, obtained from opossums, in California. R. felis is a new
worldwide agent of a new spotted fever. It was found in ﬂeas from America,
Africa and Europe. Human cases were reported in Europe and America. In
conclusion, pet ﬂeas represent a threat for human health.
Viral pathogens in water: a revived threat
S104 Caliciviruses: like a ﬁsh in water
C. -H. von Bonsdorff
Helsinki, FIN
Noroviruses, belonging to human caliciviruses, are largely recognized as the
major cause of foodborne outbreaks. Their dominant role has also been
documented in community-based studies on gastrointestinal disease. Thus
noroviruses are also the most abundant of the human pathogenic viruses
released in the environment. Their resistance to physicochemical stress
facilitates their survival in the environment. The large number of distinct
noroviruses together with a shortlived immunity elicted by the infection
makes the population susceptible for repeated outbreaks. Both vomit and stool
of a norovirus victim is highly infectious. Person-to-person transmission is
considered most common, but spread via surfaces, food or water is increas-
ingly recognized. The bulk of the excreted virus is released into sewage. The
processes used in sewage treatment allow in many instances the virus to pass
infectious into receiving water bodies. Thus noroviruses are well suited for
waterborne spread. There are several ways by which contaminated water may
reach us. The ‘classical’ route is through bivalve molluscs, mainly oysters.
Their role as hepatitis A virus source has been well established and is still a
serious threat. Noroviruses are also well suited for this spread and trans-
continental outbreaks have been described both in USA and in Europe due to
widely distributed oysters from a single contaminated bed. The role of fresh
produce contaminated through irrigation as a source of norovirus outbreaks is
not well documented. Based on epidemiological evidence frozen berries,
especially raspberries, have commonly been connected to outbreaks. Here
also multinational outbreaks have been indicated. Recreational use of water is
apparently also a way to catch a norovirus infection. Swimming pools and spas
are at risk of contamination. The most efﬁcient way of delivering the virus is
through drinking water. We have earlier reported on a major waterborne
norovirus outbreak in Finland comprising about 2500 diseased in a com-
munity of 5000 inhabitants (Kukkula et al. J Inf Dis 1999; 180: 1771–1776).
Since then, we have obtained patient and water samples from altogether 28
outbreaks. Of these, 18 were caused by noroviruses as evidenced by virus in
patient stool samples. In eight of the above mentioned waterborne outbreaks
the norovirus could be detected in water samples, too. In all except, one case
drinking water was the suspected source of infection.
S105 Hepatitis A and other viruses in shellﬁsh
A. Bosch, G. Sa´nchez, F. -X. Abad, R. -M. Pinto´
Barcelona, E
Human pathogenic viruses accumulate within the edible tissues of shellﬁsh
grown in sewage contaminated waters. Current standards rely solely on
bacteriological parameters and do not ensure the prevention of shellﬁshborne
viral gastroenteritis and hepatitis. Among the causative agents of these
shellﬁshborne diseases, Norwalk-like viruses (Norovirus) and hepatitis A
virus (Hepatovirus) are the most relevant in terms of occurrence and severity,
respectively. Recently, an outbreak of hepatitis A, affecting 183 people, was
caused by consumption of coquina clams, imported frozen from Peru.
Hepatitis A virus and other enteric viruses were detected in this shellﬁsh
which met all EU standards. F-speciﬁc RNA bacteriophages are proposed as
alternative indicator microorganisms. Yet, exhaustive work is required to
ascertain their validity, since discordances between the occurrence of these
surrogates and that of actual viruses in shellﬁsh has been reported. In the
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meantime, the safest approach for the prevention of shellﬁshborne viral
diseases, is to monitor for the presence of Norwalk-like viruses and hepatitis
A virus in shellﬁsh and shellﬁsh growing areas. Currently available molecular
procedures provide tools for the speciﬁc and sensitive detection of viral
pathogens in shellﬁsh, thus enabling a safer evaluation of its virological quality.
However, quality control and quality assurance issues must be solved, as well as
simpliﬁcation and automation, before molecular procedures could be adopted
by routine monitoring laboratories.
Cellular transport of antimicrobials
S107 Mammalian peptide transporters as targets for
delivery of antimicrobials and other drugs
H. Daniel
Freising-Weihenstephan, D
Cellular uptake of amino acids in form of di- and tripeptides occurs in
mammals by the two plasma membrane peptide transport systems PEPT1 and
PEPT2. PEPT1 is mainly expressed in the apical mem-brane of epithelial cells
of the small intestine and is responsible for the absorption of dietary di- and
tripeptides and structurally related drugs such as selected b-lactam antibiotics,
peptidase and protease inhibitors as well as designed prodrugs. PEPT2 in
contrast shows a more widespread expression within the organism. In kidney,
it mainly mediates the reabsorption of ﬁltered di- and tripeptides and
peptidemimetics, but its role in other tissues such as lung, mammary gland,
choroid plexus, glia cells and others has not yet been determined. Both
transporters have been characterized as proton-dependent and electrogenic by
coupling of peptide movement across the membrane to movement of protons
down an inwardly directed electrochemical proton gradient. We are expres-
sing the transporters in yeast cells and Xenopus oocytes and analyze function by
ﬂux studies and electrophysiological methods. As the transporters accom-
modate thousands of different peptides as well as a large number of drugs, we
systematically analyzed the structural requirements for binding and transport.
The current state on understanding of the structure-afﬁnity relationship will
be presented. For drug delivery purposes a new screening system has been
developed that allows compounds to be identiﬁed easily that utilize the
transporters for uptake into tissues that provides a high bioavailability. Most
recently, we have also established lines of transgenic C. elegans and mice that
allow analysis of the phenotypical consequences of gene knock out encoding
the corresponding peptide transporters in these animals and by use of GFP-
and LacZ-constructs a detailed analysis of sites of gene expression was
performed.
S108 Efﬂux transporters and HIV drugs in the brain
A. G. de Boer, I. C. J. van der Sandt, D. D. Breimer
Leiden, NL
Introduction: The brain is a sanctuary site for HIV and contributes to the
reinfection of the whole body from the brain. Therefore, anti-HIV drugs,
particularly protease inhibitors (PI’s), have to enter the brain to inhibit the
replication of the virus there. However, several anti-HIV drugs are substrates
for efﬂux transporters.
Objective: To study the role of efﬂux transporters in the transport of the PI’s
(amprenavir, ritonavir and indinavir) HIV drugs across the in vitro blood–
brain barrier (BBB).
Methods: For the in vitro studies, we have used a BBB model comprising a
coculture of bovine brain capillary endothelial cells and rat astrocytes. In
addition, the LLC-PK1 wildtype, the MDR1-transfected LLC-PK1, the
MRP1-transfected LLC-PK1 and the Caco-2 cell lines were used to study the
involvement of efﬂux transporter in the transport of PI’s.
Results: The data indicate that in the BBB model amprenavir, ritonavir
and indinavir showed transport polarity. The inhibitors LY335979, verapamil
and SDZ-PSC 833 were able to reduce this transport polarity indicating that
these PI’s are substrates for the P-glycoprotein (Pgp) cation transporter.
Similar data were obtained in the MDR1- transfected LLC-PK1 cell line
and in the Caco-2 cell line. Surprisingly, in the MRP1-transfected cell line
probenecid reduced transport polarity of ritonavir and indinavir indicating
that these compounds are also substrates for the MRP1-anion-transporter.
Conclusions: Amprenavir, ritonavir and indinavir are substrates for Pgp. In
addition, ritonavir and indinavir are also substrates for the MRP1-efﬂux
transporter.
Emerging infectious diseases
O109 Emerging tick-born zoonoses in Eastern Croatia
J. Topolovec, A. Antolovic-Pozgajn, D. Puntaric, D. Vukovic,
V. Barisic-Drusko
Osijek, HR
Objectives: Speciﬁc IgG antibody titers to Ehrlichia chaffensis, HGE agent, B.
divergens, B. burgdorferi and rickettsia species in group of 100 hospitalized and
unhospitalized patients, who have experienced tick bite, were examined.
Methods: A serological testing was performed in group of about hundred
persons, who have experienced tick bite. About on half of them were
hospitalized (some of them for TBE, most of them for LB), other half visited
their GP, because of treat of developing some of tick-born-diseases. A sero-
logical testing was performed by commercial ELISA test for LB, and IFA test
for HGE agent, E. chaffensis, B. divergens and rickettsia species and using
reconvalescent sera, taken about 3weeks after tick bite, or after admitting to
hospital. Examined persons differ by occupation, place of living, age and sex.
Results: There are still no data of circulation of these zoonotic agents in our
area, and our goal was only to ﬁnd out is there any sign of this circulation in
the Eastern Croatian countries. We found three B. divergens positive sera, ﬁve
HGE agent positive sera, two E. chaffensis positive sera, ﬁve rickettsia species
positive sera (four RMSF group, one tiphus group), and 32 LB positive sera
(all patients whowere hospitalized for LB). Total number of sera is small, sowe
did not made any statistical analysis. Of course, all similar investigations like,
we have had a huge number of persons with possibility of high exposure to
tick bite.
Conclusion: In the Eastern Croatian countries, we found sera from persons
who experienced tick bite seropositive on HGE agent, E. chaffensis, B.
divergens, rickettsia species and LB agent. That is way more detailed investiga-
tions of reservoirs, vectors and patients must be provided.
O110 Emerging infections due to nonfermenter bacilii
G. Revathi, S. Kariuki
Nairobi, KEN
Introduction:Non fermenter bacilii are ubiquitous in the environment such
as soil, water, plants and decaying organic material including foodstuffs. They
are found in all moist areas in the hospitals where they can resist most of the
common disinfectants. They can cause signiﬁcant infections in the immu-
nocompromised. Kenya is currently in the grip of HIV/AIDS pandemic with
60% hospital admissions being HIV positive. In the Aga Khan hospital
Nairobi, several clinical isolates are found to be nonfermenter bacilii from
these patients. Currently internationally accepted guidelines are not available
for the antimicrobial sensitivity testing of several members of this group of
bacteria.
Methods: Clinical microbiology lab at the Aga Khan Hospital is a fully
equipped modern facility for carrying out all standard bacteriological pro-
cedures. Blood cultures are performed by Bactec9060 (Becton Dickinson).
Gram negative bacilii are identiﬁed by API system (Biomerieux). API20NE is
used for nonfermenter bacilii. Identiﬁcations were conﬁrmed whenever
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necessary at the center for microbilogy research at Kenya Medical Research
institute. Results over the past 3 years were compiled for this report.
Results: Around 10960 Gram negative rods were isolated during the study
period out of which 1041 (9.5%)were nonfermenters. Eight hundred eighty-
four (85%) comprised of Pseudomonas aeruginosa, Burkholderia cepacia and Ps.
putida. Interestingly, rare isolates like Ralstonia picketii, Sphingomonas spiriti-
vorum, Cryseomonas meningosepticum, Ochrobacterium anthropi, Photobacterium
damsela and Agro bacterium species were isolated from signiﬁcant clinical
infections. Ninety-six nonfermenters could not be identiﬁed since the
API proﬁles were not found in the data bank. Majority of the isolates were
multi drug resistant to most of the broad spectrum Antibiotics when tested by
the NCCLS disc diffusion protocol. Around 80% of the patients suffering
these infections had highly complicated clinical course despite broad spectrum
combination antibiotics regimens.
Conclusions: Better methods of identiﬁcation are required for scientiﬁc
documentation of these infections. Guidelines on clinical management and
in vitro sensitivity testing of the isolates are urgently required for saving the life
of the immunocompromised.
O111 Seroprevalence of Crimean–Congo hemorrhagic
fever in the Sistan va Baluchestan province of Iran
K. Holakouie Naieni, S. Izadi, S. R. Majdzadeh, F. Rakhshani,
S. Chinikar, A. Nadim, B. Hooshmand
Tehran, Zahedan, IR
Objectives: Since 1999, there have been more than 137 conﬁrmed Crimean-
CongoHemorrhagic fever (CCHF) cases from different parts of Iran. There is
no idea about the real prevalence of this disease in Iran. The main objective of
this study was the determination of the CCHF seroprevalence rate, using
speciﬁc ELISA methods, in the Sistan va Bluchestan province which has the
highest number of CCHF cases in Iran.
Methods: In this cross-sectional study, 300 people were sampled using
probability proportional to size cluster sampling method from the general
population of Zabol and Zahedan districts located in the northern half of the
province. In addition to blood sampling of each subject, the following
variables were checked for them through a questionnaire: personal informa-
tion (age, sex, job), past history of tick bite, contact history with livestock,
history of slaughtering, presence of an animal place at home.
Results: The results showed that only seven (2.36%) of the subjects were
positive for anti-CCHF IgG. The most important risk factor for antibody
positive subjects were those related to having or taking care of domestic
animals at home (P¼ 0.020). The education level of the antibody positive
subjects was signiﬁcantly lower (P¼ 0.005). None of the antibody positives
people had history of tick bite or contact with a conﬁrmed or suspected case of
CCHF, however, all of them have history of contact with livestock. Three of
the antibody positives were Afghan refugees inhabited in these districts.
Conclusion:The CCHF Seroprevalence rate in Sistan va Bluchestan province
was lower than our expectations. This study reveals some of the behaviors
and life styles that predispose persons to the disease. We hope to ﬁnd
more information through another study, which has been sponsored by
WHO (EMRO) in the same setting and with 6months follow-up for the
determination of the CCHF incidence rate in the Sistan va Bluchestan
province.
O112 The efﬁcacy of oral Ribavirin in the treatment of
Crimean-Congo hemorrhagic fever in Iran
M. Mardani, M. Keshtkar Jahromi, K. Holakouie Naieni, M. Zinali
Tehran, IR
Crimean-Congo Hemorrhagic fever (CCHF) is a lethal hemorrhagic fever
caused by a tick-borne virus. There are few reports on the efﬁcacy of oral
ribavirin in the treatment of CCHF patients. This study was designed as a
historical cohort with 187 clinically suspected cases since June 1999 to the end
of September 2001. Only 139 of 187 suspected cases were treated with oral
ribavirin based on the availability of the drug. A total of 81 of 187 cases were
serologically conﬁrmed to have the disease. The two groups (treated and
nontreated) were compared for the incidence of outcome (Survival). Ninety-
seven (69.8%) of 139 suspected treated cases and 61 (88.4%) of 69 conﬁrmed
treated cases were survived. Based on this study, the efﬁcacy of oral ribavirin is
measured equal to 80% and 34% in conﬁrmed and suspected groups,
respectively. We conclude that oral ribavirin is an effective treatment for
hemorrhagic form of CCHF patients. We should be aware of the limitations
of observational studies. However, there is no randomized control trial in the
literature, and it can not be performed in future due to medical ethics.
Therefore the results of this study could provide a valuable information in
deciding how to treat CCHF patients
Bacterial pathogenesis
O113 Occurrence of the enterococcal surface protein
Esp and in vitro adhesion properties of vancomycin-
susceptible Enterococcus faecium isolates of different
origins
B. Lund, C. Edlund
Stockholm, S
Background: The enterococcal surface protein, Esp, has been suggested to
have a role in enterococcal virulence.
Objectives: To determine if vancomycin-susceptible Enterococcus faecium
(VSE) isolates of different origin, i.e. blood culture isolates, normal intestinal
microﬂora, and probiotic products, differ in the occurrence of the esp gene
and in their ability to adhere to gut the mucosal cells.
Methods:A total of 61 E. faecium isolates – 29 derived from blood cultures of
patients hospitalized in Sweden, 30 from the normal intestinal microﬂora of
healthy Swedish volunteers, and two different probiotic strains – were
investigated. An inoculum of approximately 107 viable bacteria were added
to a conﬂuent grown human colon cancer cell line (Caco-2) and incubated for
2 h. Nonadhered bacteria were washed away and the number of adhered
bacteria were determined with viable count after lysis of the eukaryotic cells.
Carriage of the esp gene was detected by PCR using esp-speciﬁc primers.
Results:There was no difference between the groups of isolates in their ability
to adhere to the Caco-2 cells. Approximately half of the infection-derived
E. faecium isolates carried the esp gene, while none of the probiotic strains and
only two of the normal microﬂora isolates were positive for the esp gene.
Conclusions: Clinical isolates and normal microﬂora isolates of E. faecium
seem to adhere equally well to Caco-2 cells. Presence of the esp gene does not
seem to affect the adhesion of E. faecium strains to these epithelial cells.
Enrichment of esp in the clinical isolates indicates that esp might be of
importance to virulence in E. faecium.
O114 The autolysin atlE is possibly involved in
the maintenance of in vivo foreign body infections
in Staphylococcus epidermidis
S. J. Vandecasteele, W. Peetermans, R. Merckx, J. Van Eldere
Leuven, B
Objectives: Foreign body-associated infections (FBI) are a major cause of
morbidity and mortality. During FBI, an initial adhesion of the bacteria is
followed by accumulation and bioﬁlm formation. The atlE encodes gluco-
samidase and amidase involved in peptidoglycan cleavage during cell division
in Staphylococcus epidermidis. AtlE-negative mutants have a reduced virulence
in in vivo models for FBI and a decreased adhesion to polystyrene invitro. The
current study aims to evaluate the expression of the atlE gene during in vitro
and invivo foreign body-associated growth.
Methods: The expression of atlE was quantiﬁed in S. epidermidis with RT
quantitative PCR as the cDNA/gDNA quotient as previously described
(BBRC, 2002). AtlE expression was followed over time invitro in NaCl 0.9%
in planktonic (104 samples) and sessile (104 samples) bacteria and invivo in a
rat model for foreign body infections in sessile bacteria (293 samples). In vitro
time points were 0, 10, 35, 60, and 180min. Invivo time points were 0 and
15min, 1, 2, 4, 6, and 12 h, and 1, 2, 7, and 14 days.
Results: In vitro inoculation in NaCl 0.9% induced a decrease in atlE
expression in sessile and planktonic bacteria (P< 0.0001; one-way ANOVA).
This decrease was slower and less pronounced in the sessile group (P¼ 0.002;
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two-way ANOVA). In vivo implantation of the infected catheter induced a small
nonsigniﬁcant increase in atlE expression that peaked at t¼ 60min, followed
by a nonsigniﬁcant dip at t¼ 1 day. Expression levels after 2 h were identical
as those after 1 and 2weeks. The net evolution of atlE expression was given
by log10 (atlE expression)¼ (1.372)þ (7.08 106) time, with a R2¼
0.01. These constant expression levels contrast with those observed in many
other genes studied.
Discussion:Our data do not support an important role of the atlE in the initial
adhesion of S. epidermidis to polyurethane catheters. The constant expression
levels of the atlE gene throughout the course of invivo FBI however suggest,
but do not prove a role (primary or secondary), in the maintenance of in vivo
FBI.
O115 The inﬂuence of antibiotics on the production of
shiga toxins
A. Liptakova, L. Siegfried, J. Rosocha, E. Birosova, H. Sehnalkova,
M. Molokacova, D. Kotulova
Kosice, Bratislava, SK
Background: The clinical and public health importance of infection by shiga
toxin-producing Escherichia coli (STEC) have become increasingly recognized
internationally since the early 1980s. STEC is associated with human disease
including mild diarrhea, severe bloody diarrhea, and hemolytic uremic
syndrome (HUS). Because antimicrobial agents may play a role in the
pathogenesis of severe STEC disease, chemotherapy for STEC infections
or complications remains controversial. We report three cases of HUS caused
by Stx2-positive STEC. The patients were treated by cephalosporins because
of complications (respiratory tract infection). We found that cephalosporins
were able to enhance production of shiga toxin 2 invitro.
Methods: The clinical STEC strains were incubated with ampicillin/sulbac-
tam,meropenem, cefepime, piperaciline, piperacilline/tazobactam, cefotaxime,
ceftazidime, gentamycine, amikacin, ciproﬂoxacine, and trimethoprime/sulfa-
methoxazole using dilution method. After incubation, the shiga toxin was
separated and the presence of shiga toxins was conﬁrmed by ELISA with
monoclonal antibodies against Stx2. We used Mann–Whitney U-test for
statistical analysis.
Results: On the basis of ELISA tests, we have found that ciproﬂoxacin,
trimethoprime/sulfamethoxazole (P< 0.001), amikacine, gentamycine, and
cefepime (P< 0.01) and cefotaxime, ceftazidime, piperaciline, piperacilline/
tazobactam (P< 0.05) signiﬁcantly induced the production of shiga toxin 2.
Shiga toxin production was not inﬂuenced by meropenem and ampicillin/
sulbactam.
Conclusions: It is important not only to isolate STEC from HUS patients but
also to detect the inﬂuence of antibiotics which are used in hospitals (and were
given in cases reported in this study) to shiga toxin production. On the basis of
our results, the physicians disrupted cephalosporine therapy. All three patients
suffering from HUS have survived with no serious sequelae.
O116 Characterization of the penetration ability and
cytotoxicity of Serratia marcescens
L. -H. Su, C. -H. Chiu, C. Chu, T. -L. Wu, J. T. Ou, T. V. Riley,
B. J. Chang
Taoyuan, TW; Perth, AUS
Objectives:To characterize the penetration ability and cytotoxicity of clinical
isolates of Serratia marcescens that caused either invasive or noninvasive
infections.
Methods: Nineteen each of blood and urinary isolates of S. marcescens were
examined invitro for their ability to penetrate a Madin–Darby canine kidney
(MDCK) epithelial cell monolayer by using a membrane ﬁlter system.
Bacteria were inoculated at a ratio of 100 : 1 (bacteria:cell) to the apical
surface of MDCK cell monolayer. The viable bacteria in the basolateral
mediumwere plate-counted at several time intervals. The cytotoxicity against
MDCK cells was assessed by measuring the concentration of lactose
dehydrogenase (LDH) released from the cells into the medium. The Chi-
square test was used for statistical analysis.
Results: Signiﬁcantly more blood than urinary isolates were detected in the
basolateral medium after 6 h (18 vs. 10; P< 0.01) incubation. Nine blood
isolates compared to only two urinary isolates were high penetrators
(>1 000 0000CFU/mL; P< 0.05). A similar signiﬁcant difference in cyto-
toxicity between the two groups was also found (17 blood vs. 9 urinary;
P< 0.05). The average LDH level of all blood isolates at 6 h after inoculation
was 157 74U/L (median, 168U/L) and that of all urinary isolates was
92 63U/L (median, 58U/L). LDH level increased proportionally as the
number of bacteria that penetrated increased, indicating a close association of
the penetrative ability of bacteria to their cytotoxicity. By using a ﬂuorescent
acridine orange-crystal violet staining method, viable bacteria were observed
intracellularly at 2 h, and the amount increased at 3 h, indicating the invasive
ability of S. marcescens and a possible mechanism of transcytosis penetration.
Further characterization of the cytotoxicity indicated that viable whole
bacteria were required to induce cytotoxicity invitro, and neither toxic
exoproducts produced during growth nor intracellular materials were respon-
sible for the cytotoxic effect. Inhibition of RNA and protein synthesis
abolished the cytotoxicity as well as the penetration.
Conclusions: Although other mechanisms may be involved, the abilities to
penetrate epithelial barriers and the associated cytotoxicity are important
virulence factors contributing to invasive infections associated with
S. marcescens.
O117 Mucoidy in Stenotrophomonas maltophilia – a
potential virulence factor in cystic ﬁbrosis-associated
lung infection?
G. Lee, M. Denton, K. Kerr
Leeds, Harrogate, UK
Background: Stenotrophomonas maltophilia (Sm) is an emerging pathogen in
cystic ﬁbrosis-associated lung disease, but putative virulence factors of the
bacterium are not well-characterized. Pseudomonas aeruginosa (Pa) is an
established pathogen in CF and production of alginate by Pa (resulting in
a mucoid phenotype) is recognized to play a key role in the pathogenesis of
pulmonary infection. The isolation of a mucoid strain of Sm prompted an
investigation to identify factors which might regulate expression of mucoidy
by Sm.
Methods: Six strains of Sm of clinical and environmental origin, including
mucoid strain E13 and two control strains of Pa, were used. The stability of the
mucoid phenotype (MP) was investigated by repeated subculture on to blood
and nutrient agar at 20, 30, and 378C (as antibiotic resistance phenotype and
exoenzyme production in Sm is associated with growth temperature).
Expression of mucoidy in Sm strains was determined following growth under
conditions of increased osmolarity (media supplemented with 0.5, 1, 2, and
5% w/v NaCl), dehydration (media supplemented with 0.5, 1, 3, 4, 5,7, and
10% v/v ethanol), and nitrogen and phosphate limitation (N and AP media) –
all of which induce mucoidy in Pa. To determine whether the genes for
mucoidy in Smwere plasmid-associated, plasmid extraction using commercial
and in-house methods were used.
Results:Mucoidy persisted in strain E13 after 20 serial subcultures, irrespec-
tive of the growth medium/temperature; however, optimum conditions for
mucoidy were growth on blood agar at 308C for 48 h. Increased osmolarity
was associated with onset of mucoidy in two isolates most notably at 2%NaCl.
Dehydration was associated with production of a mucoid phenotype in one
strain at a range of ethanol concentrations at 20 and 308C. Growth on N and
AP media was not associated with mucoidy. The failure of AP medium to
induce mucoidy suggests the MP it is not associated with alginate. Plasmids
were not detected in strain E13.
Discussion:Mucoidy in strain E13 appears a stable phenomenon. Although a
limited number of strains were tested, mucoidy could be induced under
conditions of increased osmolarity and dehydration at lower growth tem-
peratures. Mucoid strains of Sm from clinical and environmental sources are
extremely rare, but as most laboratories incubate sputum and other specimens
at 378C, these strains may go undetected and the importance of the mucoid
phenotype might be underestimated.
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Vaccines
O118 Additive effect of inﬂuenza and pneumococcal
polysaccharide vaccine in prevention of hospitalization
and mortality in elderly persons
A. Ortqvist, B. Christenson, J. Hedlund, P. Lundbergh
Stockholm, S
Objective: The use of inﬂuenza and pneumococcal vaccines has been limited
in many countries, partly due to uncertainties regarding vaccine effectiveness
in the elderly people. The aim of this study was therefore to assess the
effectiveness of inﬂuenza and pneumococcal vaccination, separately and in
combination, in reducing need for hospital treatment and death in an elderly
population.
Methods: A prospective population-based intervention cohort study. All
individuals 65 years and older (n¼ 258 754) in Stockholm County, Sweden,
were offered vaccination during a 2-month campaign. Data on end-point
diagnoses during the follow-up year (December 1, 1999 to November 30,
2000) were obtained from the administrative database in Stockholm County
Council. Main outcome measures were incidence of hospital admissions, days
of hospital treatment, and deaths due to inﬂuenza, pneumonia, invasive
pneumococcal disease (IPD), cardiac failure, and chronic obstructive pul-
monary disease (COPD).
Results: Vaccination was performed in 124 702 (48%) persons, whereof
72 107 received both vaccines, 29 346 only the inﬂuenza, and 23 249 only
the pneumococcal vaccine. Compared with the unvaccinated cohort, a
tendency for a lower incidence of hospitalization due to inﬂuenza, pneu-
monia, and IPDwas seen in persons vaccinatedwith only one of the inﬂuenza,
or pneumococcal vaccines. However, vaccination with both vaccines were
additive, with a reduction of hospital admissions for inﬂuenza (37%), pneu-
monia (29%), IPD (44%), cardiac failure (12%), and COPD (9%). This
reduction was statistically signiﬁcant for all investigated diagnoses, except
for IPD (OR 0.56; 95% CI 0.30–1.05) where the total number of patients was
small. In-hospital mortality for pneumonia (OR 0.65) and cardiac failure (OR
0.64) was signiﬁcantly lower in those who received both vaccines.
Conclusions:Vaccination with inﬂuenza and pneumococcal vaccines together
was effective in reducing need for hospital admission and deaths from
inﬂuenza and inﬂuenza-related diseases. Our data also support that pneumo-
coccal vaccination alone is about 70% effective in prevention of IPD in the
elderly, and indicate that the vaccine may be effective in preventing pneu-
monia overall, although to a low degree.
O119 Identiﬁcation and immunogenicity of a naturally
processed measles virus peptide eluted from class II
HLA-DRB10301
I. Ovsyannikova, K. Johnson, S. Naylor, D. Muddiman, G. Poland
Rochester, USA
Objectives: The identiﬁcation and characterization of antigenic epitopes of
infectious pathogens by CD4þ T-cells has been a major research interest. The
rapid characterization of deﬁned peptides that are critical to viral immunity,
including measles, has been signiﬁcantly enhanced by mass spectrometry
(MS). Hence, we can describe for the ﬁrst time the direct identiﬁcation of
class II HLA-DRB10301 (DR3) measles-derived peptide from measles virus
(MV)-infected EBV-transformed B cells.
Methods: We developed a B-cell line derived from a measles seropositive
human individual homozygous for the HLA-DR3 allele. We infected EBV-B
cells with live MV (Edmonston strain) at a multiplicity of infection of 1 PFU/
cell. We puriﬁed peptides associated with the DR3 molecules by immu-
noafﬁnity and obtained peptide sequences by nano-scale reversed phase
HPLC coupled to tandem MS (nano-LC/MS/MS). We evaluated recall
immune responses by measuring MV and measles peptide lymphoprolifer-
ation.
Results: A class II, 19 amino acid peptide derived from a single measles
phosphoprotein (P), ASDVETAEGGEIHELLRLQ, exhibited the capacity to
stimulate peripheral blood mononuclear cell responses. The MV-P epitope
(residues 179–197) sharing the HLA-DR3 binding motif was recognized by
T-lymphocytes of healthy subjects (n¼ 95, aged 11–18 years) who were
previously immunized against measles. MV-stimulation indices (Sis; median
4.1, range 0.5–29.1) were generally higher than measles P peptide SIs. Sixteen
of the 95 subjects (17%) had P-lymphoproliferation SIs greater than 3.0
(median 1.4, range 0.5–20.3), indicating peptide antigenicity and recognition.
Among the 60 subjects who responded to MV stimulation, 12 also responded
to the measles P peptide (Spearman’s correlation coefﬁcient¼ 0.38;
P< 0.001). We observed no proliferation in healthy subjects to randomly
chosen measles fusion peptide from the MV proteome.
Conclusions: These data provide direct evidence that measles-derived anti-
genic peptides were processed by antigen-presenting cells, presented in the
context of HLA class II molecules, and were recognized by peripheral blood
T-cells from healthy individuals immunized with measles vaccine. The study
of cell-mediated immune responses to measles-derived peptides in immune
persons should provide signiﬁcant insight into the design and development of
new subunit vaccines.
O120 Protection against leptospirosis after DNA
immunization with the hemolysin-associated protein
Hap1-encoding gene in gerbils (Meriones unguiculatus)
C. Branger, B. Chatrenet, F. Aviat, I. Suard, C. Fillonneau, A. Aubert,
J. M. Bach, G. Andre-Fontaine
Nantes, Nice, F
Background: Leptospirosis is a widespread human and animal disease caused
by pathogenic leptospires. The medical and economic losses caused by such
forms of the zoonotic disease justify the use of Leptospira vaccines in human
or animal populations at risk. However, available vaccines enhance a lipo-
polysaccharide-directed immune response, which is serogroup-speciﬁc. So,
these bacterins provide no cross-protection between the different serogroups
of pathogenic leptospires.
Objectives: Our previous work determined that immunization with the
haemolysis-associated protein Hap1 (designated as LipL32 by Haake)
expressed by adenovirus induced in gerbils a signiﬁcant protection against
a virulent Leptospira challenge, while the recombinant protein Hap1 did not
induce any signiﬁcant protection. To avoid the use of adenovirus vector, we
checked clinical protection against lethal challenge by DNA vaccination
system even if the efﬁcacy of DNA vaccination was recognized essentially
in antiviral immunity.
Methods:The hap1 gene from Leptospira interrogans ss serovar autumnalis (aut)
and L. kirshneri serovar grippotyphosa (grip) was cloned in pCDNA3.1.
Gerbils were immunized with plasmid vectors encoding for hap1 gene under
control of cytomegalovirus enhancer–promoter: two intramuscular immu-
nizations with 100mg of plasmid DNA were performed after a pretreatment
by cardiotoxin, controls received DNA empty plasmid in the same conditions.
Three weeks after the second vaccination of plasmid DNA, all gerbils were
challenged by intraperitoneal injection. Each animal received 10e7 leptospires
in 0.5mL of fresh culture of the virulent L. interrogans ss serovar canicola.
Gerbils were daily observed, the mortality rate was recorded for 28 days after
challenge.
Results: The humoral immune response of gerbils immunized with either
pCDNA3.1-hap1(grip) or pCDNA3.1-hap1(aut) was analyzed by IgG ELISA
against the recombinant protein Hap1. Statistical analysis of mortality inci-
dence and survival curves of gerbils were realized: the two groups of animals
vaccinated with the protein Hap1 expressed by plasmid were signiﬁcantly
protected against lethal onset of Leptospirosis.
Conclusion: Our results show that the cross-protective effect within patho-
genic strains of Leptospira shared by Hap1 protein could be mediated
by DNA plasmid vector. This ﬁnding should facilitate the design and
development of new generations of vaccines against bacteria and especially
L. interrogans sl.
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Betalactamases evolution in Europe: from nature to manufacture
S122 Antibiotic pressure and beta-lactamase selection
D. M. Livermore
London, UK
Beta-lactamases probably have a natural role in cell-wall metabolism, but their
recent evolution, especially the selection of transferable types, has been
predicated by the clinical use of beta-lactam antibiotics. In broad terms,
the rise of the new enzyme types has followed the introduction of new beta-
lactam classes. Thus, penicillins G and V selected for penicillinase-producing
Staphylococcus aureus, and the antigram-negative penicillins in the 1960s
selected for plasmid-mediated beta-lactamases, principally TEM types, in
their target organisms. More recently, oxyimino-cephalosporins have been
selected for extended-spectrum beta-lactamases (ESBLs) and AmpC-
depressed Enterobacter and Citrobacter spp., whilst beta-lactamase inhibitors
have selected various inhibitor-resistant enzymes and beta-lactamase hyper-
producers. Reports of acquired carbapenemases are accumulating, perhaps
reﬂecting the increased use of carbapenems against cephalosporin-resistant
strains. It is much less clear why particular enzymes within classes have spread
locally, nationally, internationally, or not at all. Why is TEM-1 vastly more
successful than any other acquired penicillinase? Why, in the late 1980s and
early 1990s, did CTX-M enzymes become the predominant ESBLs of
southern S. America, whilst TEM and SHV mutants predominate in Europe,
Asia, and the USA? Is the recent spread of CTX-M types in Spain and Poland
a harbinger that they will supplant TEM and SHV types in Europe, too. If so,
why? Why have so few TEMmutants (but so many more exotic ESBLs) been
reported from Japan? And, perhaps most critically, to what extent are
carbapenems the primary selectors for the VIM, IMP, and other carbapene-
mases that are now appearing, allowing that these enzymes are also potent
causes of resistance to other beta-lactams, which may also be selectors?
S123 PER and VIM: a local nuisance or more than this?
H. Vahaboglu
Kocaeli, TR
During the last two decades, extended-spectrum beta-lactamases (ESBLs)
have been disseminated worldwide among the members of the family
Enterobacteriaceae.More than 150 enzymes with extended-spectrum activity
have been identiﬁed so far. Most of these are the mutants of narrow-spectrum
beta-lactamases, TEM1-2 or SHV1. These TEM and SHVmutants have been
rarely detected among P. aeruginosa and Acinetobacter species. Recently, how-
ever, enzymes with extended-spectrum activity from molecular classes A, B,
and D appeared among P. aeruginosa and Acinetobacter. A molecular ‘class A’
enzyme, PER-1, was ﬁrst identiﬁed in a P. aeruginosa strain in 1993. Later, this
enzyme was found to be widespread among nosocomial P. aeruginosa and
Acinetobacter isolates in Turkey. Prevalence of PER-1 producers in other
countries, however, remained relatively low. On the other hand, a novel
carbapenemase, VIM-1, was identiﬁed in Italy. The strain was a carbapenem-
resistant P. aeruginosa that had been isolated in 1997 from a nosocomial
infection. Retrospective analysis of an outbreak in a Greek university hospital,
however, revealed the existence of VIM-1 producers in 1996. Three muta-
tional variants of VIM-1 have been identiﬁed so far. The members of this
novel carbapenemase family have been detected in Korea and Taiwan as well.
Since P. aeruginosa and Acinetobacter are signiﬁcant nosocomial pathogens,
intercontinental spread of carbapenemases and Class A ESBLs among these
species deserves interest.
S125 The world of oxacillinases
W. P. Sougakoff
Paris, F
When compared to classes A and C, the class D beta-lactamases display very
speciﬁc properties. They are the smallest serine enzymes and, with regard to
their catalytic activity, they are characterized by a fairly large diversity of
substrate proﬁles and by a high hydrolytic activity against oxacillin and
cloxacillin. At the genetic level, most of these enzymes are on plasmids or
integrons so that their genes disseminate readily in clinical isolates. They are
also characterized by a wide variety of amino acid sequences which are all
distantly related to the class A and C enzymes (less than 20% of identity). An
important subgroup of mutant gene coding for enzymes showing an extended
spectrum of activity has been recently identiﬁed. Most of the mutant enzymes
differ from OXA-10 by a few amino acid substitutions, and are capable of
hydrolyzing the later cephalosporins such as ceftazidime. The clinical pro-
blems posed by class D beta-lactamases are increased by the fact that these
enzymes show very low level sensitivity to inhibition by clavulanic acid. Our
knowledge on the catalytic mechanism of the class D beta-lactamases is still
limited. Recently, the ﬁrst crystal structures for class D beta-lactamases were
determined (PDB 1EWZ, 1FOF, 1H8Z), showing that the class A, C, and D
enzymes share an overall common fold. However, class D beta-lactamases
have been shown to form dimers in solution, with maximal activity observed
for the dimeric form in the presence of cations such as zinc. Differences
adjacent to the active site have been identiﬁed in comparison to the two other
classes of serine beta-lactamases. For instance, there is no counterpart in class
D enzymes to the residues proposed to act as general base in either class A or C
(Glu166 and Tyr150, respectively), suggesting that the mechanism by which
the OXAs hydrolyze beta-lactam antibiotics differs from the mechanism
operating in the classes A and C. In the class A, the active-site serine found
at position 70 in element 1 (Ser-x-x-Lys) plays the role of nucleophile in
acylation, with Glu166 acting as a general base activating Ser70 during
acylation and promoting a water molecule for hydrolysis of the acyl-enzyme
intermediate during deacylation. In class D enzymes, the serine in the Ser-x-
x-Lys motif would also act as nucleophile, but it is the carbamylated form of
the lysine residue that would act as general base in both the acylation and
deacylation steps of the catalytic mechanism.
Epidemiology of antibiotic resistance and consumption in Europe (Joint symposium arranged with the
ARPAC/EARSS/ESAC)
S127 Antibiotic consumption in Europe: ﬁrst results
from ESAC
H. Goossens, M. Elseviers, M. Ferech, R. Vander Stichele
Antwerp, B
Objectives: ESAC, granted by DG/SANCO of the European Commission
(project number: 2001/SID/136), is an international network of national
surveillance systems, aiming to collect comparable and reliable antibiotic use
data. During a 2-year period (November 2001–October 2003), actionswill be
taken to harmonize the registration of antimicrobial consumption in all
European Countries. A data collection system will be developed allowing
to produce comprehensive national data on volume of antibiotic consump-
tion, in ambulatory and in hospital care. Standardized national data will be
assembled in a European database for subregional comparison of antibiotic use
in relation to antibiotic resistance patterns and socioeconomic and general
health parameters.
Methods: ESAC started effectively during the European Conference on
antibiotic use in Europe in Brussels, November 2001. It was decided to start
data collection retrospective for the period 1997–2001, separately for ambu-
latory care and hospitals, on a quarterly base using the WHO ATC/DDD
classiﬁcation. Until now, 19 out of 31 participating countries were able to
deliver complete requested data, seven could deliver part of the data, and
three could deliver spring 2003. Only for two countries, no retrospective
data will become available in the near future. A register of all antibiotic
products in all package forms available in each country will be updated on a
regular base and published on the ESAC website. In the future, national
registers will form the base for aggregation of the consumption data enabling
validation of the quality of the prospective ESAC data delivery system.
Prospective data collection will start mid 2003. Additionally, a database will
be constructed containing a comprehensive list of publications in the ﬁeld
of antibiotic consumption, information of all ongoing European research
projects, and of all European campaigns aiming to inﬂuence antibiotic
consumption.
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Conclusion:Retrospective annual data for the period 1997–2001 are available
for most countries, and detailed prospective data for 2002 will be accessible for
scientists and health authorities in order to link utilization data to resistance
patterns and to assess the impact of intervention strategies.
S128 Quality of antibiotic consumption data and
opportunities for benchmarking
D. Monnet, M. Ferech
Copenhagen, DK; Wilrijk-Antwerp, B
For several decades and with the exception of Nordic countries, very little was
known on antibiotic use in Europe (EU). In 2001, Cars et al. (Lancet 2001;
357: 1851–3) used a combination of commercial data on sales from IMS
Health and of data from national systems to provide the ﬁrst open comparison
of antibiotic use in primary health care in EU. In 2002, the ‘European
Surveillance of Antimicrobial Consumption’ (ESAC) project funded by DG-
SANCO of the EC extended this benchmark to other EU countries.
Problems with IMS Health data include difﬁculty to access the data for
public health research, varying sample sizes among countries, and absence of
control for parallel export/import within the EU. ESAC data will be made
fully accessible for research, and are presently reﬁned to correct for possible
underestimating of antibiotic consumption in a few countries where collec-
tion is based on reimbursement claims, when (a) some antibiotics are not
reimbursed and therefore excluded from data collection, (b) costs of medicines
below a certain threshold are not reimbursed and therefore not registered, or
(c) copayment level is high and it is possible to buy antibiotics over-the-
counter, outside the reimbursement system. For hospitals, data were recently
or will soon be reported by ESAC and by ‘Antibiotic Resistance Prevention
and Control’ (ARPAC), ESCMID’s initiative funded by DG-Research of the
EC, respectively. While ESAC aims at setting up a surveillance system to
obtain national consumption ﬁgures, ARPAC focuses on getting antibiotic
use and other relevant data from individual hospitals. In both projects, the
numerator is the number of deﬁned daily doses (DDDs) as deﬁned by the
WHO Collaborating Centre for Drug Statistics Methodology. However,
concerns were raised about the quality of denominator data, i.e. the number of
occupied bed-days or patient-days, and it might prove preferable to use the
number of inhabitant-days to report national consumption ﬁgures. For
individual hospitals, stratiﬁcation by hospitalization unit seems essential as
an attempt to control for patient case-mix, and provide data useful for
benchmarking. In conclusion, additional efforts are needed to improve the
comparability of antibiotic consumption data, both in primary health care and
in hospitals. These efforts are needed if we want to make sense of the
differences in level and patterns of use observed among European countries.
S129 Consumption of antibiotics and resistance
to Streptococcus pneumoniae: results of an
EARSS/ESAC pilot study
N. Bruinsma, M. Elseviers, P. Schrijnemakers, R. Vander Stichele,
J. Degener, H. Goossens and EARSS and ESAC participants
Objective: European Antimicrobial Resistance Surveillance System (EARSS)
and European Surveillance of Antibiotic Consumption (ESAC) explored the
linkage of their databases investigating the relationship between antibiotic
consumption and the resistance to Streptococcus pneumoniae (SPN) in Belgium
and the Netherlands.
Materials: Penicillin susceptibility testing data on the ﬁrst isolate of every
patient with SPN infection was extracted from the EARSS database for the
period 1999–2001. Total antibiotic consumption in ambulatory care in the
period 1997–2001 according to ATC/DDD classiﬁcation was obtained from
the ESAC database.
Results: A total of 3004 invasive isolates from Belgium and 2215 from the
Netherlands was reported to EARSS in the period 1999–2001. A remarkable
higher proportion of penicillin nonsusceptible S. pneumoniae (PNSP) was
found in Belgium (14%) compared to the Netherlands (1%). Accordingly,
total antibiotic consumption in ambulatory care was almost three times higher
in Belgium (30, 29, and 27 DDD/1000 inhabitants/day (DID) for 1999,
2000, and 2001, respectively) compared to the Netherlands (10 DID for all
3 years). Proportional use of penicillins was comparable in both countries,
small spectrum penicillins were relatively used more in the Netherlands. Per
smaller geographical area (province), no relationship was found between
antibiotic consumption and resistance patterns within each country. Seasonal
ﬂuctuations, with highest antibiotic consumption during winter periods,
were observed in both countries and were most pronounced in Belgium.
Although a comparable ﬂuctuation in the number of invasive isolates was
found, no clear seasonal ﬂuctuations in the proportion of PNSP could be
observed. For consumption as well as for resistance, no clear trend over time
was observed. Consequently, time series analysis for further exploration of the
relationship between consumption and resistance could not be used.
Conclusions: The present pilot study indicates a strong relation between the
proportion of PNSP and the amount of antibiotics used in ambulatory care in
Belgium and the Netherlands. No relationship between antibiotic consump-
tion and resistance over time could be observed. This pilot study conﬁrmed
that the linkage between both databases is feasible, enabling a more in-depth
investigation of the intriguing relationship between consumption and resist-
ance in the future.
S130 Inventory of antibiotic resistance and use patterns
in European hospitals: ﬁrst results from ARPAC
F. M. MacKenzie
Aberdeen, UK
ARPAC is a concerted action project funded by the Research Directorate
General of the EC. ARPAC stands for antibiotic resistance, prevention and
control. Its objectives are to lay the foundations for a better understanding of
the emergence and epidemiology of antibiotic resistance, and to evaluate and
harmonize strategies for prevention and control of antibiotic resistant patho-
gens in European hospitals. Speciﬁc aims are to identify antibiotic polices and
prescription patterns associated with low resistance rates and to identify
infection control policies associated with lower incidence rates of transmis-
sible antibiotic-resistant strains. The study is being conducted by four
ESCMID study groups: ESGAP, ESGARS, ESGNI, and ESGEM. The
project website is at http://www.abdn.ac.uk/arpac/index. At the beginning
of 2003, the number of participating hospitals stood at 267, although hospitals
are still actively being encouraged to join the project. Fourteen out of 16
European Union countries are represented and 20 out of 22 other European
countries are represented. Initial results on methods of antibiotic susceptibility
testing, prevalence of nine alert organisms and antibiotic use during 2001 will
be presented. The alert organisms include methicillin-resistant S. aureus
(MRSA), vancomycin Enterococci (VRE), carbapenem-resistant A. baumannii,
quinolone-resistant E. coli, K. pneumoniae resistant to the third generation
cephalosporins, and P. aeruginosa resistant to the carbapenems, aminoglyco-
sides, quinolones, ceftazidime, and cefepime. Data are being collected for
both the whole hospital and for the hospitals’ ICUs (excluding coronary care
units). Data on use of all antibiotics during 2001 are also being collected for
the whole hospital and ICUs. Antibiotic use data is being collected using the
ABC-calc spreadsheet designed for the purpose at the Statens Serum Institute
by D. Monnet. Antibiotic use data will be measured in deﬁned daily doses per
1000 patient days. Data on the patterns of antibiotic resistance and use across
Europe will be presented.
Emerging issues in febrile neutropenia patients (Joint symposium arranged with EORTC/IFIG/IATG)
S131 When to add a glycopeptide in an era of
multiresistance?
A. Cometta
Lausanne, CH
The empiric initiation of broad-spectrum antibiotics at the onset of fever in
granulocytopenic cancer patients (GCP) has been considered a standard
therapy for more than two decades. In the 1960–70s, empirical antibiotic
regimens were designed for optimal coverage of Gram-negative infections,
which were predominant. However, since the mid 1980s, infections caused by
Gram-positive (Gþ) bacteria, especially coagulase-negative staphylococci and
viridans streptococci, have increased in frequency. As a result, considerable
controversy has been generated as to the need for empirical speciﬁc anti-Gþ
therapy at the onset of treatment of fever in GCP. A previous trial of the
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IATG-EORTC and of the NCI of Canada (JID 1991; 163: 951) did not
support the empiric use of vancomycin given at fever onset in GCP with Gþ
bacteremia. A retrospective review of Gþ infections in 550 episodes of febrile
neutropenia (Ann. Int. Med. 1988; 108: 30) showed similar results. However,
inclusion of a glycopeptide in initial empirical therapy may be justiﬁed for
selected GCP with conditions such as shock, strong suspicion of catheter-
related infection, or known colonization with Gþ bacteria resistant to beta-
lactame antibiotics. Frequent changes of antibiotics are a common practice in
GCP with persistent fever despite the absence of clinical deterioration and/or
the documentation of a microorganism resistant to the allocated regimen. In
three large trials (AAC 1996; 40: 1108; Ann. Int. Med 1994; 120: 834; CID
2001; 32: 381), the most frequent treatment modiﬁcation was the addition of
a glycopeptide, mainly on the grounds of persistent fever after 3–4 days of
empiric therapy. In a recent double-blind trial, we assessed whether the
addition of vancomycin would reduce the time to defervescence in GCPwith
persistent fever within 48–60 h after the start of empiric monotherapy. Of 763
eligible febrile GCP, 165 with persistent fever were randomized to receive
either vancomycin or placebo. The difference in the median time to
defervescence was not statistically signiﬁcant. Moreover, the number of
GCP who defervesce, of subsequent infections with Gþ bacteria and the
rate of addition of amphotericin B, were also similar in both groups. This
study suggests that the empiric addition of vancomycin is of no major beneﬁt
in persistently febrile GCP.
S133 Further infections: factors relating the frequency
and outcome
M. Akova
Ankara, TR
The successful control of initial infectious episode of neutropenia and fever
may be followed by emergence of secondary febrile episodes, especially in
those patients with various risk factors. In all trials conducted by EORTC-
IATG, further infections (or interchangeably named ‘superinfections’) are
deﬁned as ‘any episode of fever and/or infection in a neutropenic patient
which is not present at initial evaluation, and developed either during
antibiotic therapy or within 1week after discontinuation’. Several risk factors
for the development of these infections were previously described. A recent
analysis of two large trials performed by EORTC-IATG between 1991 and
1994 involved 1508 patients. Of these patients, 836 responded to the initial
empirical treatment. Further infections developed in 129 cases (15.4%). Less
than 5% of the patients developed a further infection before day 4. The
median time to develop a superinfection was 10 days. Multivariate analysis at
the time of the randomization in the trial indicated that age above 16 years and
presence of an IV line were predictive for superinfections. A diagnosis of an
underlying disease other than acute leukemia was ‘protective’. Presence of a
clinically documented infection might be associated with a lower rate of
superinfections. A further analysis including variables assessed at day 4 after
initiation of empirical therapy revealed that in addition to above-mentioned
factors stable or increasing granulocyte counts and a granulocyte count of
>100/mm3 at day 4 were both independently ‘protective’ against further
infections. Mortality was statistically signiﬁcant in those patients with super-
infections than thosewithout having it (5.4% vs. 1.4%, respectively; P< 0.01).
Overall, these data underline the signiﬁcance of superinfections in high-risk
febrile neutropenic patients, and may allow to differentiate those who are
under risk of developing such infections.
S134 Persistently febrile patients: what to do when
everything fails
C. Viscoli
Genoa, I
Two therapeutic strategies have been advocated in persistently febrile and
neutropenic patients not responding to the initial empiric antibacterial
therapy. Empiric antifungal therapy. The possible efﬁcacy of this approach
came from two open-label studies performed on both sides of the Atlantic on
small patient populations. Pizzo and coworkers randomized 50 patients who
were still febrile and granulocytopenic after 7 days of empirical antibacterial
therapy and were lacking any documentation of infection, to either discon-
tinue all antibiotic treatments (16 patients), to continue the same combination
as the initial treatment (16 patients) or to add empirical amphotericin B (18
patients). Combining the results of the two groups without amphotericin B,
four patients developed a deep mycosis, one had Candida esophagitis and one
had severeCandida mucositis. Among the 18 patients receiving amphotericin B
there was only one severe mycosis (Pseudallescheria boydii). The International
Antimicrobial Therapy Co-operative Group of the EORTC randomized 132
persistently febrile and granulocytopenic cancer patients not responding to
empirical antibacterial therapy and affected with a fever of unknown origin or
a clinically documented bacterial infection, to receive empirical amphotericin
B or to continue their antibacterial coverage without modiﬁcation. There was
no statistically signiﬁcant difference between the two groups in terms of
resolution of fever. In a subset analysis, no death due to fungal infection
occurred among the patients receiving empirical amphotericin B compared to
four in the other group (P¼ 0.05) and the number of documented fungal
infections was higher in patients not receiving amphotericin B (6 vs. 1;
P¼ 0.1). Empiric glycopeptide addition. The utility of empirical glycopep-
tide addition was analyzed in two placebo-controlled studies. In the ﬁrst study
(Erjavec Z et al. JAC 2000), no difference was found between teicoplanin and
placebo among 114 patients receiving imipenem monotherapy. In the second
study (Cometta et al. for the EORTCAntimicrobial Therapy Group, ICAAC
2001), no difference was found between vancomycin and placebo among 165
patients receiving empirical therapy with piperacillin–tazobactam. In con-
clusion, there is little evidence that any predisposed approach can be
recommended in the persistently febrile and neutropenic patient. In these
patients every treatment modiﬁcation should be tailored to the speciﬁc clinical
situation and to local epidemiological patterns. No modiﬁcation with watch-
ful waiting can be an option for the experienced physician. Hopefully, in the
future we will stop treating fevers and start treating infections in neutropenic
patients.
Diagnostics on the verge of a revolution (Joint symposium arranged with FEMS)
S135 The emerging brave new world of microbiology
S. P. Borriello
London, UK
A revolution is occurring in nucleic acid analysis, bioinformatics, data storage
and retrieval, nanotechnology, physics, microelectronics, and polymer, solid
state and combinatorial chemistry. These seemingly disparate ﬁelds are being
combined and applied to the detection, identiﬁcation, and characterization of
pathogens. The once science ﬁction scenario of taking a drop of blood, urine
or saliva and within an hour knowing whether or not a pathogen is present, its
type designation and its antimicrobial resistance potential will soon be a reality.
The application of mass spectrometry to microbiology (MALDI-ToF and
SELDI-ToF) is also set to have a major impact. These developments,
particularly with regard to near patient testing, have important implications
for the delivery of health care. They will have an impact on primary care,
prescribing practice, organization of pathology laboratories, counseling
services, surveillance and epidemiology, and for medico-legal practice. (S.
P. Borriello [1999] BMJ 319: 298–301). New molecular methodologies are
facilitating real-time strain differentiation for out-break investigations with
detection of antimicrobial susceptibility potential. Further, new light is being
shed on epidemiology of infectious diseases for established diseases, and new
pathogens are being uncovered.
S136 Laboratory diagnostics: from eminence based to
evidence based
M. Ieven
Edegem, B
The overload of medical information and technical possibilities and the
increasing need for cost control of medical interventions led to the concept
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of evidence-based medicine (EBM). Evidence-based diagnostic microbiology
is an integral part of EBM. Diagnostic tests should thus be scrutinized for the
evidence on which they are based. The criteria have been clearly summarized
by Sackett et al. (2000) towhich one criterion should be added: the evaluation
should be done on a sufﬁciently large number of specimens of patients to
reduce the conﬁdence interval of the result. For each laboratory test the
question should be asked howmuch the information obtained by a test will be
beneﬁcial for the patient and at what cost. Criteria to be applied to the
comparison between tests have been better deﬁned, particularly when a new
test is more sensitive than the previously used standard test: these will be
discussed. Exclusion criteria for several categories of specimens, e.g. urine and
stool specimens submitted to the laboratory have been proposed and are
largely implemented. Exclusion criteria for other specimens such as sputum,
herpes simplex detection in CSVor urine testing forMycobacterium tuberculosis
could also be proposed and will be discussed. In other instances tests could/
should be limited to patients with particular risk factors such as in screening
tests for Chlamydia trachomatis or human papilloma virus. One of the most
difﬁcult area is that of the respiratory tract infections. Factors related to the
specimen, to the detection methods and to the patient are responsible for the
important uncertainty of many laboratory results. As a result of the low
sensitivity and speciﬁcity of sputum examinations, efforts should be reoriented
and resources should be reinvested in alternative techniques to improve
signiﬁcantly the diagnosis and management of respiratory infections. For
many applications nucleic acid ampliﬁcation tests resulted in important
diagnostic progress. For each of these tests, their contribution in routine
diagnosis should be validated taking into account not only the validity of the
test but also the prevalence of the disease. Finally, a cost beneﬁt analysis
should reveal the opportunity for the introduction of diagnostic tests. In
conclusion, much evaluation exercises and thinking remains to be done for
EBM. This can only be realized in close collaboration between clinicians and
microbiologists.
S137 Real-time PCR – why and where not
M. Altwegg
Zurich, CH
As compared to ‘conventional PCR’ which measures the concentration of a
speciﬁc product (the amplicon) at the end of the ampliﬁcation process, ‘real-
time PCR’ refers to the possibility of continuously monitoring the increasing
amount of accumulated product. Even though this monitoring is not really
continuous, it allows to follow the kinetics of the reaction and thus provides a
new approach to quantitation. The term ‘homogenous’ PCR which is often
used instead of ‘real-time PCR’ indicates that ampliﬁcation and detection of
the amplicon ore done in the same closed reaction vessel eliminating the need
for further amplicon analysis by gel electrophoresis, Southern blotting,
microtiter plate hybridization, etc. The advantages of real-time PCR are:
(1) reduced susceptibility to carry-over contamination, (2) shorter turnaround
time (depending on the platform used), (3) less hands-on time, and (4) the
potential for easier quantitation over a greater range (5–6 logs) than con-
ventional PCR (2–4 logs).Whereas the ﬁrst three aspects are similarly valid for
most diagnostic applications, quantitative analysis has signiﬁcantly improved
the clinical usefulness of results in the ﬁeld of virology only, especially for
organisms detected in blood or serum. In contrast, quantitation in bacterial
diagnostics may to a large extent be considered inadequate because of varying
quality of the specimens analyzed, nonhomogenous distribution of patho-
genic organisms in specimens, dependence of PCR-efﬁciency on total
amount of nucleic acids in a specimen, etc. Despite these limitations, clinical
diagnostic laboratories may proﬁt to a large extent from these new techno-
logical developments which have already resulted in a number of different
chemistries used (Fluorescence Resonance Energy Transfer/FRET, 50 nucle-
ase assay/TaqMan, Molecular beacons, SybrGreen in combination with
melting curves) as well as in a variety of different equipment.
New antibiotics and pharmacokinetics
O139 Ertapenem 1g once a day is highly effective for
treatment of community-acquired and mixed infections in
adults with diabetes
R. Isaacs, R. Gesser, H. Teppler, I. Friedland, K. McCarroll, G. Woods
West Point, USA
Objectives: In clinical trials, ertapenem, a once-a-day parenteral beta-lactam
licensed in Europe in April 2002, was highly effective for treatment of
complicated intra-abdominal (IAI), acute pelvic (PI), complicated skin–skin
structure (SSSI), and complicated urinary tract infections (UTI) and com-
munity-acquired pneumonia (CAP). Ertapenem vs. comparator cure rates in
these trials were: IAI, 176/203 (87%) vs. 157/193 (81%); PI, 153/163 (94%)
vs. 140/153 (92%); SSSI, 152/185 (82%) vs. 147/174 (84%); UTI, 229/256
(89%) vs. 204/224 (91%); CAP, 335/364 (92%) vs. 270/294 (92%). Such
infections in patients with diabetes often are more difﬁcult to treat. Objectives
of this post hoc analysis were to examine demographic/disease characteristics
of patients with and without diabetes, and compare the efﬁcacy of ertapenem
in diabetic patients with piperacillin–tazobactam (PT) and ceftriaxone
(CRO).
Methods: Seven randomized, double-blind comparative trials assessing the
efﬁcacy of ertapenem, 1 g once a day, were conducted worldwide. Com-
parator agents, considered standard of care, were PT 3.375 g Q6H (IAI, PI,
SSSI) and CRO 1 g once a day (CAP, UTI). Clinical and/or microbiologic
efﬁcacy was assessed in evaluable patients at prespeciﬁed timepoints post-
therapy, deﬁned by indication.
Results:Of the 3255 patients treated in seven trials, 493 (15%) had diabetes. In
all studies except PI, diabetics were older than those without diabetes.
Compared to patients without diabetes, in IAI, CAP, and UTI studies,
respectively, a lower proportion of diabetics had appendicitis, Pneumonia
Severity Index ‘T3, and acute pyelonephritis’. Duration of therapy was similar
in those with and without diabetes in all studies. Among diabetics, treatment
groups were generally similar with respect to demographic, disease, and
treatment characteristics. Cure rates (%) (clinical and microbiologic for
IAI; clinical for PI, SSSI, CAP; microbiologic for UTI) for evaluable patients
with diabetes are shown in the Table 1.
Conclusions: In the subgroup of patients with diabetes, ertapenem was highly
effective for treatment of SSSI, CAP, and UTI. Ertapenem alsowas efﬁcacious
in diabetics with IAI and PI, but the numbers of patients were small. Cure
rates for SSSI and UTI were lower in diabetics than patients without diabetes,
but were similar for ertapenem and PT or CRO.
O140 Invitro activity of Oritavancin and comparator
agents against Streptococcus pneumoniae collected from
European Laboratories during 2000–2001
D. Sahm, M. Jones, C. Thornsberry, J. Loutit, S. Porter,
R. Blosser-Middleton, J. Karlowsky
Herndon, USA; Hilversum, NL; Brisbane, USA
Objectives: S. pneumoniae (SP) is a common causative agent of both com-
munity-acquired and hospital respiratory tract infections worldwide. The
increasing prevalence of antimicrobial resistance among SP, including multi-
drug resistance (MDR), threatens the use of empiric therapies and creates
treatment challenges for physicians. Oritavancin (ORI) is a novel semisyn-
thetic glycopeptide that has shown in vitro activity against SP, including
isolates that are resistant to commonly prescribed antimicrobials.
Methods: We examined the activity of ORI and comparator agents against
561 SP collected from patient specimens at hospital laboratories in 15
European countries during 2000–2001. Isolates were selected to include
both susceptible (S) and resistant (R) phenotypes. Isolates were centrally tested
by NCCLS broth microdilution, and MICs were interpreted using the 2002
NCCLS published breakpoints.
IAI PI SSSI Overall CAP UTI Overall
Ertapenem 5/6 (83) 9/9 (100) 41/56 (73) 55/71 (77) 38/40 (95) 34/43 (79) 72/83 (87)
PT 16/18 (89) 8/9 (89) 36/47 (77) 60/74 (81) – – –
CRO – – – – 35/39 (90) 35/43 (81) 70/82 (85)
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Results: Based on MIC90, ORI (0.002mg/L) activity was superior to
vancomycin (VAN; 0.25mg/L), linezolid (1mg/L), and quinupristin–dalfo-
pristin (0.5mg/L). ORI showed consistent activity against penicillin (PEN) S
(n¼ 368), PEN I (n¼ 117) and PEN R (n¼ 76) isolates with MIC90s of
0.002, 0.002, and 0.004mg/L, respectively. Similarly, ORI showed consistent
activity against non-MDR (n¼ 532; ORI MIC90, 0.002mg/L) and MDR
isolates (n¼ 29; ORI MIC90, 0.004mg/L), including those that were
resistant to four antimicrobial classes (PEN, erythromycin, levoﬂoxacin,
trimethoprim–sulfamethoxazole). In comparison, VAN showed an MIC90
of 0.25mg/L against both non-MDR and MDR SP.
Conclusions:ORI demonstrated superior in vitro activity against S and R SP,
with MIC90s ﬁve to nine doubling dilutions lower than VAN and the
comparator agents tested. ORI is currently in Phase III clinical trials for
the treatment of Gram-positive infections.
O141 In vitro activity of daptomycin against
vancomycin-resistant enterococci, linezolid-resistant
vancomycin-resistant enterococci, methicillin-resistant
Staphylococcus aureus and penicillin-resistant pneumococci
K. Piper, M. Rouse, J. Steckelberg, R. Patel
Rochester, USA
Objectives: The in vitro activity of daptomycin was studied against clinical
isolates of vancomycin-resistant enterococci (VRE), linezolid-resistant VRE
(LRVRE), methicillin-resistant Staphylococcus aureus (MRSA), and penicillin-
resistant (MIC 2mg/mL) Streptococcus pneumoniae (pRSp).
Methods: Vancomycin resistance genotype was determined by PCR ampli-
ﬁcation with primers speciﬁc for the vancomycin resistance associated genes
vanA, vanB, vanC-1 and vanC-2/3. DaptomycinMIC values were determined
using broth microdilution in 0.1mL total volume of cation supplemented
Mueller–Hinton broth (CAMHB) supplemented to a ﬁnal calcium concen-
tration of 50mg/L with an initial inoculum of 10 104 cfu per well of
logarithmically growing bacteria. Pneumococcal MIC media was supple-
mented with 3% lysed horse blood.MIC tests were incubated 18 h in room air
at 35 8C. Daptomycin MBC values were determined by subculture of the
MIC tests. Time-kill studies (expressed as log 10 cfu/mL) were performed in
25mL CAMHB (50mg/L calcium) with an initial inoculum of 104 to
106 cfu/mL and incubated for 24 h at 35 8C, room air. Bactericidal activity
was deﬁned as 99.9% killing (3 log 10 decrease in cfu/mL) of the initial
inoculum.
Results:The results of daptomycin susceptibility testing are summarized in the
table below as MIC90, MIC range, MBC90, and MBC range (mg/mL).
Time-kill studies with 11 LRVRE demonstrated3 log 10 cfu/mL reduction
of initial inoculum after 24 h with concentrations of 32 mg/mL or less of
daptomycin.
Conclusions: Daptomycin is active in vitro against VRE, LRVRE, MRSA
and pRSp. Daptomycin showed bactericidal activity in time-kill studies
against LRVRE.
O142 Iclaprim, a novel broad-spectrum antibiotic
S. Hawser, K. Islam
Munchenstein, CH
In recent years, there has been an alarming increase in microbial resistance to
current clinical therapies. For example, up to 50% of staphylococci are
resistant to methicillin (MRS) and resistance to vancomycin is increasing
(VISA/GISA). Importantly, it had been predicted that staphylococci could
exhibit high-level resistance to vancomycin and at least two cases of such
resistance have recently been reported (VRSA). If such resistance spreads then
only few life-saving alternatives will remain for the clinicians. Similarly,
increasing resistance to many drugs by streptococci and other respiratory
tract pathogens is making therapy of such infections (RTI) more and more
difﬁcult. Iclaprim (formerly AR-100) is a new compound that was designed
to have expanded activity against Gram-positive and Gram-negative organ-
isms by speciﬁcally and selectively inhibiting bacterial dihydrofolate reductase.
This synthetic diaminopyrimidine derivative exhibits broad-spectrum activity
against major pathogens, including multidrug resistant pathogens. Iclaprim is
particularly active against MRS, VISA/GISA, macrolide and quinolone-
resistant strains. The compound also exhibits good activity against respiratory
tract pathogens such as multidrug resistant streptococci andH. inﬂuenzae. Pre-
clinical and Phase I studies suggest that Iclaprim could prove to be a useful
agent for severe hospital infections as well as RTI. The compound is currently
in Phase II clinical trials.
O143 Dalbavancin: phase 2 demonstration of efﬁcacy
of a novel, weekly dosing regimen in skin and soft tissue
infections
E. Seltzer, B. Goldstein, M-B. Dorr, J. Dowell, M. Perry, T. Henkel
King of Prussia, USA
Objectives:Dalbavancin (DAL) is a novel semisynthetic glycopeptide in phase
3 development, more active in vitro and in animal models than vancomycin or
teicoplanin. The PK proﬁle and in vitro and in vivo activity of DAL against
Gram-positive bacteria, including most drug resistant strains, predict that a
single dose will provide therapeutic concentrations for at least one week. The
objectives of this study were to compare the safety and efﬁcacy of two DAL
regimens to investigator-speciﬁed standard of care (comparator) in patients
with skin and soft tissue infections (SSTI).
Methods: This phase 2 randomized, controlled study was conducted in adult
patients with SSTI involving deep skin structures or requiring surgical
intervention. Patients were randomized to one of three arms: DAL
1100mg i.v. single dose; DAL 1000mg i.v. day 1 and 500mg i.v. on day
8, or comparator for 7–21 days. Adverse events and labs were assessed. Blood
samples for PK were collected from patients on DAL. The primary endpoint
was clinical response at follow up (FU) in clinically evaluable patients.
Results: Sixty-two pts were enrolled. The majority (89%) of SSTI were
classiﬁed as deep infection. The most common comparators were clindamy-
cin, ceftriaxone, vancomycin and cefazolin. Mean comparator group treat-
ment duration was 15 days. The most common pathogen was S. aureus (38%
MRSA). Outcomes in the evaluable populations were as follows:
DAL 2 doses resulted in numerically higher response rates than DAL 1 dose or
comparator. There was no difference in outcomes for MRSAvs. MSSA. Both
regimens maintained plasma concentrations well above the MIC90 of the
S. aureus isolates (0.12mg/L) through at least a week following the last dose.
DAL was well tolerated. AEs were infrequent and similar across study arms.
There were no trends in any lab abnormalities in DAL treated pts.
Conclusion:This is the ﬁrst efﬁcacy data for a new glycopeptide with a novel
dosing regimen. DAL was well tolerated; two weekly doses were effective in
deep SSTI and comparable to standard of care. DAL is currently under study
in phase 3 clinical trials for SSTI.
O144 A randomized, double-blind, placebo- and
positive-controlled study of the effects of a new
antibacterial, TD-6424 on cardiac repolarization (the QTc
interval) in healthy subjects
S. Barriere, F. Genter, E. Spencer, M. Kitt, D. Hoelscher, J. Morganroth
South San Francisco, Austin, Philadelphia, USA
Background:TD-6424 (TD) is a new antibiotic that exerts rapid, concentra-
tion-dependent bactericidal activity against clinically important Gram-
Organism No. Isolates MIC90 MIC Range MBC90 MBC Range
vanA VRE 11 4 1–4 16 2–16
vanB VRE 11 4 0.5–4 16 2–32
vanC1 VRE 7 – 1–2 – 8–32
vanC2/3 VRE 8 – <0.125–0.25 – 4–8
vanA LRVRE 11 4 0.5–8 16 1–16
MRSA 33 0.5 0.125–1 4 0.25–8
pRSp 25 0.125 All 0.125 0.125 0.125–0.25
Endpoint
DAL 1 Dose
n¼ 20
DAL 2 Doses
n¼ 21
Comparator
n¼ 21
Clinical success
at FU (%, n/N)
61.5
(8/13)
94.1
(16/17)
76.2
(16/21)
Micro success at
FU (%, n/N)
27.3
(3/11)
72.7
(8/11)
64.3
(9/14)
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positive bacteria. Unlike other glycopeptides, TD inhibits bacterial lipid
synthesis in addition to peptidoglycan synthesis. Clinical doses are expected to
be 7.5–15mg/kg once daily. Preclinical and early clinical data suggested a
possible effect of TD on prolonging the QTc interval in this dosage range.
Objectives: To determine the effects of TD on the QTc interval in healthy
human subjects.
Methods: 160 subjects (94M, 66 F) were randomized into 4 groups to receive
TD at a dose of 7.5mg/kg or 15mg/kg, placebo (TD vehicle) or moxi-
ﬂoxacin 400mg (positive control). Moxiﬂoxacin is widely used, and is known
to prolong the QTc interval by approximately 9ms following i.v. adminis-
tration. All medications were administered once daily for 3 days as 60min i.v.
infusions. Sixteen ECGs were obtained over 24 h following an infusion of
D5W (baseline) and following the Day 3 infusions of each medication. ECG’s
were analyzed digitally in a blinded fashion by a core lab. QT data were
corrected for heart rate by Fridericia’s method (QTcF), and are displayed as
mean and maximum (max) change from baseline.
Results: Complete data are available from 151 subjects. No subject had a
QTcF 450ms and none experienced clinically signiﬁcant ECG abnorm-
alities. Preliminary results are displayed in the table.
Mean change in QTcF for moxiﬂoxacin, serving as the assay sensitivity
positive control, was signiﬁcantly greater than the other groups, and all active
treatment groups were greater than placebo. The TD groups were not
signiﬁcantly different from each other. Placebo-corrected mean change in
QTcF values for TD 7.5mg/kg, 15mg/kg and moxiﬂoxacin are 3.8ms,
4.8ms, and 9.1ms, respectively.
Conclusions: These data demonstrate minimal (<5ms) prolongation of the
QTc interval by TD, even at the highest dose that is likely to be used clinically.
In this study, the change in QTc for TD was less than that observed for
moxiﬂoxacin.
O145 Efﬁcacy and tolerability of long-term pleconaril
chemoprophylaxis for picornavirus illness in adults
F. Hayden, S. Liu, S. Villano, M. McKinlay
Charlottesville, Exton, USA
Background: The investigational orally administered, capsid-binding, anti-
picornavirus drug pleconaril has shown to be effective for treatment of
picornavirus colds in adults.
Objectives: To assess the tolerability and efﬁcacy of long-term pleconaril in
preventing picornavirus morbidity.
Methods:We conducted a randomized, double-blind, placebo (P)-controlled
study during August–October 2001; 1069 healthy adults were enrolled at 13
centers and randomized in a 1 : 1 : 1 ratio to pleconaril 400mg QD or BID or
P for 6weeks. The main efﬁcacy outcome was laboratory proven, self-
diagnosed picornavirus colds.
Results: Documented picornavirus illnesses were observed in 20% of P, 13%
of pleconaril QD, and 12% of pleconaril BID recipients (P< 0.01, pleconaril
QD or BID vs. P). Picornavirus-associated missed school or work (32–36%
reductions), functional impairment (38–43%) and sleep disturbance (38–43%)
were all signiﬁcantly reduced in pleconaril recipients compared to P. Dis-
continuations due to possible adverse events were observed in 3% P, 4%
pleconaril QD, and 6% pleconaril BID. Headache, nausea, and diarrhea were
among the most frequently reported adverse events in all treatment groups.
Among women taking oral contraceptives, menstrual disorders were reported
two to three times more frequently in the pleconaril groups compared to P.
Conclusions: Pleconaril is the ﬁrst oral antiviral chemoprophylactic agent
proven to reduce picornavirus morbidity in adults. Pleconaril was generally
well tolerated when used for prolonged dosing, although it showed evidence
of drug interactions with oral contraceptives.
O146 Pharmacokinetic interactions of Ceftazidime and
Amikacin in healthy volunteers
G. Adamis, E. J. Giamarellos-Bourboulis, M. G. Papaioannou,
J. Kosmidis, H. Giamarellou, P. Gargalianos
Athens, GR
Objectives: In vitro ﬁndings on the synergy between ceftazidime and
amikacin onmultidrug resistant isolates (Giamarellos-Bourboulis et al. DMID
1997; 29: 81) create the necessity to study any probable pharmacokinetic
interaction between them.
Methods: Antimicrobials were administered single and in combination in six
healthy volunteers at 15-day intervals. One gram of ceftazidime was admin-
istered intravenously within 30min followed or not by the bolus infusion of
0.5 g of amikacin. Blood and urine samples were collected at regular time
intervals and drug serum levels were estimated by a microbiological assay. The
indicator strain applied for the estimation of the levels of ceftazidime became
resistant to amikacin after serial exposure to sequentially increased concen-
trations. The strain applied for the estimation of the levels of amikacin became
resistant to ceftazidime by a similar method.
Results: Mean Cmax, AUC, serum half-life, clearance and percentage 8-h
urine excretion of ceftazidime when administered single were 26.50mg/L,
69.76mg/h.l, 01.59 h, 286.10mL/min and 57.99%, respectively. They were
changed to 25.55mg/L (pNS), 82.03mg/h.l (pNS), 01.70 h (pNS),
208.51mL/min (pNS) and 35.40% (pNS), respectively, after co-administra-
tion with amikacin. Respective values for amikacin when administered single
were 13.04mg/L, 38.43mg/h.l, 02.80 h, 293.30mL/min and 71.75%. They
were changed to 19.59mg/L (P¼ 0.007), 60.35mg/h.l (P¼ 0.05), 02.51 h
(pNS), 141.03mL/min (pNS) and 82.19% (pNS), respectively, after coad-
ministration with ceftazidime.
Conclusions: The co-administration of ceftazidime and amikacin does not
affect pharmacokinetics of ceftazidime. It does, however, increase the dis-
tribution of amikacin as deﬁned by increases of Cmax and AUC without
affecting its rate of elimination. The described increases of distribution might
be helpful for the eradication of infections bymultidrug resistant isolates when
both agents are prescribed.
O147 Concentrations of piperacillin and tazobactam in
bone of different origin
B. Al-Nawas, M. Kinzig-Schippers, F. So¨rgel, P. Shah
Mainz, Erlangen, Frankfurt, D
Objectives: The concentrations of piperacillin and tazobactam in bone have
been studied for hip bone of mostly cancelous structure. Jaw bone is known to
have different histologic and mechanical characteristics.
Methods: The penetration dynamics of piperacillin (PIP)-tazobactam (TAZ)
into facial and hip bone tissues were investigated in 10 healthy patients
undergoing surgical bone resections for orthognatic reasons. All patients had
similar age, bodyweight and renal clearance. The drug was administered at the
start of surgery in a single dose [4 (PIP)þ 0.5 g (TAZ) i.v.]. Depedning on the
surgical procedure 1–4.5 h later bone and plasma samples were drawn. A mass
spectroscopy technique LC-MS/MS was used to study the drug concentra-
tions.
Results: The concentration ratios of PIP-TAZ were 4.3–10.2 in facial bone
(n¼ 6), 7.6–7.9 in hip bone (n¼ 2) and 5.8–9.3 in plasma. The mean ratios of
drug concentrations in bone and plasma for facial and hip bone were 5–45 and
3–20%, respectively, for PIP and 4–36 and 4–16%, respectively, for TAZ.
Conclusions: The bone/plasma ratio seemed to be higher for facial bone
however, a large range should be taken into account. The PIP/TAZ ratio was
similar in facial and hip bone and in plasma. According to earlier studies this
indicates sufﬁcient antibeta-lactamase activity of TAZ in facial bone.
O148 Pharmacokinetics of sulbactam and piperacillin in
critically ill patients during continuous veno-venous
hemodiaﬁltration
F. D. Wagner, S. Knagge, R. Hetzer
Berlin, D
Objective: Continuous extracorporeal treatment of acute renal failure is
frequently used in critically ill patients. Likewise, patients presenting with
Placebo TD 7.5mg/kg TD 15mg/kg Moxifloxacin
No. of subjects 39 39 34 39
Day 3 Mean change QTcF 1.0ms 2.8ms 3.8ms 8.1ms
30ms 0 0 0 0
Day 3 Max change QTcF 38ms 46ms 63ms 55ms
30 to <60ms 5 (13%) 9 (23%) 6 (18%) 15 (38%)
60ms 0 0 1 (3%) 0
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sepsis and multiple organ failure are often treated with piperacillin and beta-
lactamase inhibitors. Although frequently administered, pharmacokinetic data
of sulbactam during continuous veno-venous hemodiaﬁltration (CVVHD)
are scarce and inconclusive. We, therefore, investigated the pharmacokinetics
of sulbactam in combination with piperacillin in critically ill patients with
anuric renal failure reliant upon CVVHDF.
Methods: Single dose pharmacokinetics were studied in nine patients after
short-time infusion of 1 g sulbactam in combination with 1, 2 or 4 g
piperacillin. In addition, multiple dose pharmacokinetics were investigated
at steady-state in six patients receiving 1 g sulbactam b.i.d. or t.i.d. in
combination with piperacillin 2 g b.i.d., 4 g b.i.d. or 4 g t.i.d. Pharmacokinetic
parameters were determined from repeated blood and dialysate sampling up to
12 h after sulbactam dosing.
Results: Sulbactam pharmacokinetics – for the single dose, total clearance (Cl)
was 84 37mL/min, Cl by CVVHD (ClCVVHDF) was 24 10mL/min
and elimination half-life (t1/2) 5.9 1.5 h.Multiple dose pharmacokinetics at
steady state for the b.i.d. and t.i.d. sulbactam dosing schedules were: Cl 71 vs.
37mL/min, ClCVVHDF 21 vs. 11mL/min and t1/2 5.2 vs. 10.6 h, respec-
tively. Piperacillin Cl was in the order of 60mL/min, ClCVVHDF 15mL/
min and t1/2 6 h. There was no pharmacokinetic interaction between
sulbactam and piperacillin. Sulbactam and piperacillin clearances were sig-
niﬁcantly correlated (r¼ 0.71, P< 0.001), but not t1/2. The data indicate a
higher than expected sulbactam accumulation and a reduction of nonrenal
drug elimination during t.i.d. treatment.
Conclusion:Differing from previous recommendations the optimal dosage of
sulbactam is proposed to be 1 g b.i.d. in anuric atients reliant upon CVVHDF.
Pathogenetic mechanisms of bacterial infections
O149 Structural characterization of cytokine inducible
lipoteichoic acid by use of synthetic derivatives
S. Deininger, A. Stadelmaier, S. von Aulock, S. Morath, R. Schmidt,
T. Hartung
Constance, D
Objectives:There is increasing evidence that lipoteichoic acid (LTA) from the
cytoplasmic membrane of Gram-positive bacteria is an immunostimulatory
counterpart to lipopolysaccharide (LPS). We have addressed LTA of Staphy-
lococcus aureus as a foremost Gram-positive pathogen. Chemical synthesis of
biologically active LTA based on the structure of LTA from S. aureus was
carried out.Wemodiﬁed the structure of this synthetic LTA and used a human
whole blood cytokine release assay to deﬁne the key components of the LTA
molecule necessary for inﬂammatory stimulation. Furthermore, we examined
the toll-like receptor (TLR) dependency of the derivatives.
Methods:Blood of healthy donors was stimulated with native LTA of S. aureus
or synthetic derivatives in a standardized ex vivo whole blood test. Peritoneal
cells were isolated fromTLR2 deﬁcient and wildtype (wt) mice and incubated
with native LTA or derivatives. The cytokine release was determined in the
supernatants by ELISA.
Results: The synthetic LTA (D-Ala-LTA) consists of a gentiobiosyl-sn-
dimyristoylglycerol anchor joined to six glycerophosphate units carrying
four D-alanine and one GlcNAc substituent. Native LTA has 30–50 glycer-
ophosphate units with similar substituents. After stimulation of whole blood
with native or synthetic LTA we observed an equal cytokine pattern and
potency. Replacing D-alanine by L-alanine attenuated the stimulatory activity
indicating stereoselective recognition. LTA anchor alone is less potent in
inducing cytokines though it is necessary for biological activity of LTA.
Replacement of the GlcNAc by a further D-alanine substituent played no
decisive role in the biological activity of LTA. Synthetic LTA without the
gentiobiose subunit also had no signiﬁcant effect on cytokine release.
Peritoneal cells with a homozygous TLR2 defect showed no signiﬁcant
cytokine release after stimulation with native LTA or derivatives.
Conclusions: Taken together, the key components of the LTA molecule
necessary for stimulation of monocytes are the LTA anchor with two fatty
acids and a glycerophosphate backbone with D-alanine substituents.
O150 Polymorphism of TLR2 or 4 does not affect human
or murine Chlamydia pneumoniae infection
K. Gueinzius, M. Mueller, A. Mayer, T. Hartung, C. Hermann
Constance, D
Objectives: Chlamydia pneumoniae has a sero-prevalence of 70% in adults and
leads to persistent infections, which have been linked to chronic inﬂammatory
diseases like atherosclerosis. Functionally, defective polymorphisms of toll-like
receptors (TLR), crucial for the recognition of bacteria by the innate immune
system, have been associated with susceptibility to bacterial infections. Since
TLR2 and, at least in part, TLR4 are mandatory for macrophages to respond
to C. pneumoniae, we investigated the effect of homozygous and heterozygous
nonfunctional polymorphisms of TLR2 and 4 on the susceptibility of humans
and mice towards C. pneumoniae.
Methods: Bone marrow derived macrophages (BM) from wild-type (wt)
mice or mice with a homozygous or heterozygous nonfunctional mutation of
TLR2 or 4 were incubated with 10exp6C. pneumoniae for 24 h and TNF and
IL-6 release was detected by ELISA. Wt mice and mice with a homozygous
defect in TLR2 or 4 were infected intranasally with 10exp6C. pneumoniae and
the bacterial burden of lung and bronchoalveolar ﬂuid (BAL) was determined
at day 18 after infection by a highly sensitive and speciﬁc real-time PCR.
Anti-C. pneumoniae IgG was determined by microimmunoﬂuorescence test
(MIF) adapted for mice. Blood of 160 healthy donors was genotyped for the
Arg753Gln and for the Asp299Gly polymorphism of TLR2 and TLR4,
respectively, anti-C. pneumoniae IgG and IgA were analyzed by MIF and
whole blood cytokine response was determined.
Results: BM derived from wt mice or mice with a homozygous or hetero-
zygous mutation of TLR2 or 4 responded similarly towards stimulation with
C. pneumoniae while BM from mice with a homozygous defect in TLR2
showed a signiﬁcantly decreased release of cytokines. After infection with
C. pneumoniae, the bacterial load of lung and BAL of wt mice and mice with a
homozygous defect in TLR2 or 4 was alike and all groups developed
comparable anti-C. pneumoniae IgG levels. Of the 160 donors 6.3% were
found to be heterozygous for the TLR2 and 9.4% heterozygous for TLR4
polymorphism, prevalence of anti-C. pneumoniae IgG and IgA was similar in
all groups. No apparent differences in cytokine response to C. pneumoniae
were found.
Conclusions: Taken together, these data indicate that in vivo neither a
functional TLR2 nor TLR4 is necessary for effective clearance of
C. pneumoniae in murine infection, but at least a functional TLR2 allele is
necessary for adequate cytokine response. For humans, no dependence of
anti-C. pneumoniae sero-prevalence on heterozygous TLR polymorphisms
was observed.
O151 Heterozygous dysfunctional toll-like receptor 2
and 4 polymorphisms do not affect the cytokine response
of blood leukocytes
S. von Aulock, N. Schro¨der, S. Traub, K. Gueinzius, R. Schumann,
T. Hartung, C. Hermann
Constance, Berlin, D
Objectives: Functionally defective heterozygous polymorphisms of the toll-
like receptor (TLR)-2, which is crucial for the recognition of Gram-positive
bacteria and TLR4, the key receptor for Gram-negative bacteria, have
recently been associated with predisposition to infectious diseases and ather-
osclerosis, which was attributed to changes in inﬂammatory responses. To test
this hypothesis, we investigated the effect of nonfunctional heterozygous
TLR2 and 4 polymorphisms on bacteria-induced cytokine release in humans
and mice.
Methods: Blood from 160 healthy donors was genotyped for the Arg753Gln
and the Asp299Gly polymorphism of TLR2 and 4, respectively, and the
cytokine release inducible by Gram-positive or Gram-negative bacteria and
bacterial cell wall components was determined in a standardized ex vivo
whole blood test. Bone marrow-derived macrophages (BM) from wild-type
(wt) mice or mice with a homozygous or heterozygous nonfunctional
mutation of TLR2 or 4 were incubated with different bacterial stimuli
and TNF and IL-6 release were determined by ELISA.
Results: Nine per cent of the 160 donors were heterozygous and 0.6%
homozygous carriers of the TLR4 polymorphism. Their cytokine release in
response to 1 mg LPS/mL did not differ signiﬁcantly from the wild-type
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carriers for any cytokine (TNFa, IL-1b, IL-6, IFNg, G-CSF) or eicosanoid
(prostaglandin E2, thromboxane, leukotriene B4) measured except for IL-10.
The same held true for serum cytokines and C-reactive protein. To exclude
that differences become evident only at lower stimulus concentrations or in
response to live pathogens, 10 subjects with heterozygous polymorphism and
12 wild-type controls were recruited for a follow-up study. They responded
alike, except for IL-10 formation, to a series of concentrations of LPS and live
E. coli. A total of 6.3% of the 160 donors were heterozygous carriers of the
TLR2 polymorphism and six of them could be recruited again for ex vivo
stimulations with serial dilutions of lipoteichoic acid and whole S. aureus.
However, their response was not different from wild-type controls for any
endpoint. The bacteria-induced cytokine release of BM derived from mice
with heterozygous polymorphisms of TLR2 or 4 was comparable to wt mice,
but signiﬁcantly reduced for BM derived from mice with a homozygous
mutation.
Conclusion: These data argue against an alteration of inﬂammatory responses
towards pathogens conferred by a heterozygous polymorphism of TLR2 or 4.
O152 Apoptosis-resistant proﬁle of neutrophil
granulocytes during acute exacerbation of chronic bronchitis
M. Ioanas, M. W. R. Pletz, A. De Roux, H. Lode
Berlin, D
Background: The pathogenesis of acute exacerbations of chronic bronchitis
(AECB) is not fully understood. A responsible pathogen is usually isolated in
only 50–80% of the AECB. A major feature of AECB appears to be the
massive invasion of activated neutrophils into the bronchial tree. Basically, this
neutrophil inﬁltration is the result of the chemotactic activity of cytokines. In
addition, there is evidence that apoptosis resistance of these cells could also
increase the total granulocyte count.
Methods: Twenty-two hospitalized patients with AECB were included.
Three sequential heparin blood samples were obtained at admission, after
3–5 days and before discharge. Apoptosis was induced by incubating the
isolated granulocytes at 37 8C and 5%CO2 for 18 h. Apoptotic rate before and
after induction was measured by ﬂow-cytometry (Annexin V/7 AAD stain-
ing) and by cell microscopy (chromatin condensation). Apoptosis rates during
AECBwere contrasted usingWilcoxon test. The correlation between the two
methods of measurement was evaluated by Pearson’s coefﬁcient.
Results: Apoptosis resistance of granulocytes was decreasing during the
AECB. The mean percentages of apoptotic granulocytes were 36.5% on
admission day, 42% after 3–5 days and 51% at discharge. There was a
statistically signiﬁcant difference between apoptosis rates on the ﬁrst day
and at discharge (P¼ 0.034). The methods used for measuring apoptosis
showed a high level of correlation (r¼ 0.745, P< 0.01).
Conclusion: During acute exacerbations of chronic bronchitis, neutrophil
granulocytes show an apoptotic resistant behavior that is diminishing
progressively after treatment and clinical remission.
O153 GM-CSF limits the intracellular growth of
Listeria monocytogenes in THP-1 macrophages
S. Carryn, F. Van Bambeke, M. -P. Mingeot-Leclercq, P. M. Tulkens
Brussels, B
Objectives: Listeria monocytogenes is a life-threatening pathogen that affects
mainly immunosuppressed patients. GM-CSF, a cytokine that induce macro-
phages, monocytes and polymorphonuclears production, differentiation and
activation, is clinically used as immunostimulator after chemotherapy and in
immunocompromized patients. It has been shown that mice knocked out for
the gene that codes for GM-CSF are more susceptible to L. monocytogenes
infection and are dying more rapidly. We have thus investigated whether
GM-CSF would have a direct inﬂuence on the intracellular growth of
L. monocytogenes in a model of THP-1 human macrophages.
Methods:GM-CSF receptors were quantiﬁed on THP-1 cells by measuring
the speciﬁc binding of [125I]-GM-CSF. To assay the effect of GM-CSF,
THP-1 macrophages were preincubated with several concentrations of
GM-CSF (respectively 5, 10, 20, and 40 ng/mL) during 24 and 48 h, washed
and infected with L. monocytogenes (AAC, 46 : 2095–2103). The number of
viable bacteria (CFU) was determined after 5 h of incubation. We compared
these results to the effect of IFN-gamma (a cytokine known to strongly limit
intracellular L. monocytogenes growth).
Results: THP-1 macrophages display high afﬁnity GM-CSF receptors
(KD¼ 13.87 pM, number of receptors per cell: 100). GM-CSF decreases
the number of CFU in a concentration-dependent manner when above a
threshold concentration. Indeed, at 5 ng/mL, there was no difference with the
control, at 10 ng/mL there was 9.2 0.8% of growth reduction and reached a
maximal effect at 20 ng/mL with 19.9 1.8 (no further reduction was
obtained with 40 ng/mL). There was no difference between 24 and 48 h
of preincubation. After 24 h of preincubation at 100U/mL, IFN-gamma
reduced the growth of 40.9 0.5%. To conﬁrm that the effect was mediated
by the GM-CSF itself, cells were preincubated with 20 ng/mL of GM-CSF
and 2.5mg/mL neutralizing monoclonal antibodies against the GM-CSFR-
alpha subunit, and the effect of GM-CSF was then abolished.
Conclusion: GM-CSF limits the intracellular growth of Listeria monocyto-
genes inside THP-1 human macrophages but is less potent than IFN-gamma.
O154 Increased neurogenesis after experimental
Streptococcus pneumoniae meningitis
J. Gerber, T. Bo¨ttcher, S. Bunkowski, W. Bru¨ck, U. Kuhnt, R. Nau
Go¨ttingen, D
Objectives: Proliferation of neural progenitor cells is increased in response to
several modes of brain injury. In this study, proliferation of progenitor cells
after experimental S. pneumoniae meningitis and expression of neuronal
marker proteins suggesting differentiation into mature neurons was investi-
gated.
Methods: Male C57BL/6 mice (n¼ 35) were infected by injection of log 4
CFU of S. pneumoniae into the right forebrain. Controls (n¼ 30) received an
injection of saline. 24 h later antibiotic therapy was initiated with ceftriaxone
100mg/kg twice daily over 5 days. On day 2, 6, 10 and 16 after infection four
respective groups of mice (six infected animals, six controls) received ﬁve
intraperitoneal injections of bromodeoxyuridine (BrdU) 50mg/kg at 3-h
intervals and were sacriﬁced 18 h later. To assess long-term survival of BrdU-
labeled cells, 6 infected animals and 6 controls were treated with BrdU
(50mg/kg) twice daily from day 7 until day 10 after infection and were killed
4 weeks thereafter.
Results: All mice infected with S. pneumoniae developed meningitis. 5 mice
died during the acute phase of meningitis and were excluded from the
analysis. The other animals fully recovered from the infection. Repeated
tight-rope tests revealed a higher impairment of physical activity in meningitic
mice compared to noninfected controls (P¼ 0.001). At 6 days after infection,
the density of BrdU-labeled progenitor cells in the dentate gyrus of the
hippocampal formation was higher in the meningitis group than in controls,
[median (25th/75th percentile): 22.2/mm2 (16.7/26.4) vs. 8.7/mm2 (5.8/
9.5); P¼ 0.004]. At 2 and 10 days after infection differences almost reached
statistical signiﬁcance (P¼ 0.06). Survival of newborn cells 4 weeks after the
last BrdU injection was higher after meningitis than in controls as indicated by
double-labeling for BrdU and the neuronal marker MAP-2 [33.8/mm2 (3/
80.8) vs. 0.7/mm2 (0.4/2.8); P¼ 0.005]. Approximately 60% of BrdU-
labeled cells differentiated into neurons as indicated by MAP-2 labeling.
Cells stained also positive for the neuronal markers TUC-4 and beta-tubulin.
Conclusion: In a mouse model of S. pneumoniae meningitis, proliferation of
neural progenitor cells was enhanced in the subgranular layer of the dentate
gyrus. Cells differentiated into mature neurons as indicated by expression of
TUC-4, MAP-2 and beta-tubulin. Endogenous repair mechanisms may limit
the consequences of neuronal destruction after meningitis.
O155 Alveolar macrophage depletion in murine
pneumococcal pneumonia
H. Marriott, L. Prince, P. Ince, P. Hellewell, M. Whyte, D. Dockrell
Shefﬁeld, UK
Objectives: Alveolar macrophages (AM) contribute to the host defence
against pulmonary pathogens. The role of AM in host defence was examined
in a murine model of resolving pneumococcal pneumonia.
Methods: Pneumonia was induced in adult female C57BL6 mice by intra-
tracheal instillation of 104 colony forming units (cfu) of type 1 Streptococcus
pneumoniae (Spn). PBS was instilled as control. Depletion of AM was with
intranasal pulmonary delivery of liposome encapsulated clodronate 48 h prior
to Spn infection (AM–). Controls (AMþ) were similarly treated with PBS
(PBS-AMþ) or PBS-ﬁlled liposomes (lip-AMþ). 24 h after Spn infection
bronchial alveolar lavage ﬂuid (BALF) was collected. Numbers of cells in
BALF were counted by hemocytometer, and cell type determined by light
microscopy of cytospins. Bacterial load was determined in lung homogenates
and blood. Apoptosis was detected by Annexin-V staining and morphology.
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Results: AM depletion was 64% at 72 h, P< 0.05 vs. PBS-AMþ and
enhanced AM apoptosis was observed in AM–. Spn recovered from the lung
was greater in AM– (median (25%,75% percentile), 6 103 (1.5 103,
5 104)) than AMþ (PBS-AMþ 0 (0, 83); lip-AMþ 2.5 102 (0, 1.3
103)), P< 0.05 vs. PBS-AMþ. Bacteremia was observed in 1/7 AM–, 0/8
PBS-AMþ and 1/8 lip-AM–. There was a greater number of polymorpho-
nuclear leukocytes (PMN 103) in Spn treated AM– mice 12.8 (6.7, 33.4)
than AMþ groups; PBS-AMþ 1.8 (0.8, 2.5), P< 0.05 vs. AMþ, or lip-
AMþ 3.1 (1.1, 14.5)), which were similar to non infected groups (AM– 1.5
(0.6, 4.1); PBS-AMþ 2.7 (1.9, 3.6); lip-AMþ 3.3 (3, 5.7)).
Conclusion:AM depletion was associated with reduced bacterial clearance at
24 h, and increased PMN inﬂux suggesting AM contribute to host defence in
the lung against Spn.
O156 Treatment of experimental sepsis by
multidrug-resistant Pseudomonas aeruginosa with
thalidomide
N. Bolanos, I. Dontas, G. Laoutaris, D. Perrea, T. Dosios,
H. Giamarellou, E. J. Giamarellos-Bourboulis
Athens, GR
Objectives: The increased prevalence of nosocomial infections by multidrug
resistant (MDR) isolates renders the necessity for effective immunomodula-
tion. Thalidomide, that reduces half-life of mTNFa (Calabrese et al. Am J
Med 2000, 108: 487), was applied in an experimental model of sepsis by
MDR P. aeruginosa.
Methods: Sepsis was induced after the intraperitoneal injection of an 8log10
inoculum of one MDR isolate of P. aeruginosa in 64 male Wistar rats. The
isolate was resistant to ceftazidime, imipenem, ciproﬂoxacin and amikacin.
Thalidomide powder diluted in seed oil was administered by an orogastric
catheter at a dose of 50mg/kg in 24 rats 30min before bacterial challenge. At
the same time interval seed oil was administered by the same route in 20 rats;
20 rats served as controls. Survival was recorded and cumulative survival was
estimated by Kaplan–Meier analysis. Comparisons were performed by log-
rank test.
Results:Mean SE of survival of controls was 18.60 1.84 h and of animals
administered seed oil 12.60 0.60 h (p: 0.036 compared to controls). No
animal-control remained alive after 36 h and no animal administered seed oil
remained alive after 24 h. Mean SE of survival of animals treated with
thalidomide was 30.50 6.62 h (P< 0.001 compared to both other groups).
No animal treated with thalidomide remained alive after 144 h.
Conclusions: Pre-treatment with thalidomide delayed considerably the
advent of sepsis and of subsequent death in an experimental model of sepsis
by MDR P. aeruginosa. These results merit further clinical evaluation.
O157 Early alterations of serum oxidant potential in the
pathogenesis of sepsis by multidrug-resistant
Pseudomonas aeruginosa
V. Koussoulas, A. Dionyssiou-Asteriou, E. J. Giamarellos-Bourboulis,
S. Skiathitis, T. Adamis, D. Perrea, H. Giamarellou
Athens, GR
Objectives: To investigate the correlation of the early changes of the redox
potential to the alteration of antioxidant status, on experimental sepsis by a
multidrug- resistant P. aeruginosa.
Methods: Seven male rabbits were applied. Sepsis was induced after the
intravenous administration of onemultidrug-resistant P. aeruginosa isolate from
a catheter inserted into the right jugular vein. Blood was sampled at regular
time intervals for the determination of the concentrations of malondialdehyde
(MDA), of total antioxidant status (TAS) and of tumor necrosis factor (TNFa).
The concentration of MDAwas estimated by the thiobarbiturate assay and of
TNFa by the cytotoxic inﬂuence of serum on the cell line L929 from
ﬁbroblasts. The determination of TAS was assessed by a chromometric
method depending from the time and temperature.
Results:Mean SD ofMDAwas 10.80 4.29M before bacterial inoculation;
it was changed to 12.70 7.92, 14.7 3.08, 15.73 2.68, 13.8 2.94,
17.22 0.22 and 11.42 4.45M at 15, 30, 60, 120, 150 and 210min after
bacterial inoculation, respectively. Mean SD of TNFa was 93.3 52.2,
76.1 40.9, 59.0 46.2, 210.0 105.2 and 210.0 105.2 pg/mL 30, 60,
120, 150 and 210min after bacterial inoculation, respectively. Mean SD of
TAS was 1.54 0.19mM before bacterial inoculation; it was changed to
1.38 0.54, 1.16 0.90, 1.26 0.28, 1.45 0.57, 1.36 0.85 and 1.59
0.11mM at 15, 30, 60, 120, 150 and 210min after bacterial inoculation,
respectively. A positive correlation was found between concentrations of
MDA and TAS (P¼ 0.017).
Conclusions: Analysis of results indicates the signiﬁcant and early augment-
ation of the redox potential during experimental sepsis by multidrug- resistant
P. aeruginosa. That increase seems to correlate with equivalent alterations of
antioxidant status, leading to the conclusion that the intrinsic antioxidant
mechanisms of resistance are activated in an effort to restrain the septic
process. Future studies on the administration of antioxidant therapy on the
early course of sepsis are mandatory.
O158 Streptococcus pyogenes virulence genes might
predict outcome
B. J. M. Vlaminckx, E. M. Mascini, J. Schellekens, L. Schouls,
F. J. Schmitz, J. Verhoef
Utrecht, Bilthoven, NL
Objective: Group A streptococcal (GAS) meningitis is a rare but
serious condition, representing about 2% of all invasive GAS infections. A
number of protein-binding factors (PBFs), facilitating bacterial adherence to
certain host tissues, have been identiﬁed. In this study we assessed the genetic
make-up of these PBFs and exotoxins in GAS isolates from meningitis
patients.
Methods: All GAS meningitis patients between 1992 and 1995 in the
Netherlands were registered. The occurrence of death or systemic extra-
neurological complications was evaluated. All patient-isolates were subjected
to T-serotyping and M-genotyping, and were tested for nine exotoxin genes
and 11 PBF-genes by PCR. We assessed the correlation between T/M type,
toxin/PBF-gene proﬁle and clinical outcome.
Results: Twenty-seven patients with clinically and microbiologically deﬁned
GAS meningitis were included. Ten out of 26 patients, evaluated for clinical
outcome, developed extraneurological complications, including two patients
who died. The predominantM-types wereM1 (9/27),M6 (5/27) andM3 (3/
27). The nine genes encoding exotoxins speA/speB/speC/speF/speG/speH/
speJ/ssa and smeZ were found in 48; 100; 33; 100; 93; 4; 37; 30 and 37% of all
isolates, respectively. The 11 PBF genes, i.e. cpa/cpa-1/fbp-54/prtf-1/prtf-2/
prtf-15/sfb/fba/pfbp/sciA/sciBwere detected in 4; 26; 30; 19; 4; 4; 11; 33; 4; 59
and 89% of all isolates, respectively. Fba, fbp-54, cpa-1 and speJ were only
identiﬁed in M1 isolates. SpeAwas only recognized in either M1 or M3 types
and prtf-15 was exclusively associated with M6.
Conclusion: Ssa, which was not related to any M-type, was the only factor
correlating to the occurrence of complications or death (RR¼ 4; w2¼ 4.40
(P< 0.05)). The apparent clinical signiﬁcance of virulence genes in strepto-
coccus pyogenes warrants further research.
The case for getting it right ﬁrst time in nosocomial infections (Symposium arranged by AstraZeneca)
S159 Introduction from the chairman: the case for
‘getting it right ﬁrst time’ in nosocomial infections
G. Park
Cambridge, UK
The incidence of nosocomial infections has increased steadily over 25 years.
These infections are a serious threat to hospitalized patients and are associated
with increased rates of mortality, morbidity, duration of hospitalization and
intensive care unit stay, and considerable cost impact. Most nosocomial
infections arise from invasive procedures, presence of indwelling devices
and cross-transmission on the hands of medical personnel. Bacteria frequently
implicated include enteric bacilli (Escherichia coli,Klebsiella spp. andEnterobacter
spp.), Staphylococcus aureus (particularly methicillin resistant strains), coagulase-
negative Staphylococcus, nonfermentative Gram-negative bacilli (Pseudomonas
aeruginosa and Acinetobacter spp.) and enterococci. Recently, the level of
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antimicrobial resistance has increased sharply among these pathogens, redu-
cing the effectiveness of many classes of antimicrobials used to treat these
infections. There is considerable evidence to support the concept that ‘getting
it right ﬁrst time’ – by using appropriate empiric antimicrobial therapy early in
the course of a nosocomial infection – reduces mortality, morbidity, and
overall costs. Selection of appropriate antimicrobial therapy needs an accurate
diagnosis and assessment of patient risk factors. We need a thorough under-
standing of the microbial cause, anticipated resistance patterns of the infecting
organisms and the properties of the antimicrobials available for treatment,
namely, spectrum of activity and potency (including against resistant strains),
pharmacokinetic and tolerability/safety data. Appropriate initial treatment
may be the broadest spectrum monotherapy or a combination regimen which
should be amended when results from the cultures and susceptibility tests
become available. This strategy can improve clinical outcome, reduce costs
and may help to reduce the emergence of resistance within the microbio-
logical environment. This symposium will examine the importance of
appropriate initial antimicrobial therapy in the management of nosocomial
infections, the reasons for inappropriate initial therapy, and the consequences.
Using case histories, a panel of multidisciplinary experts will examine the
current and optimal management of two common nosocomial infections –
nosocomial pneumonia and surgical infections – and discuss strategies to try to
increase the frequency with which we ‘get it right ﬁrst time’.
S160 Making the ﬁrst choice the right choice
M. Kollef
St Louis, USA
Nosocomial infections are associated with signiﬁcant morbidity and mortality.
It is critical that they are treated appropriately by initiating suitable anti-
microbial treatment early in the course of infection. Usually, this means
starting with the broadest spectrummonotherapy until the infecting pathogen
is identiﬁed, then reducing the antimicrobial spectrum. There may be
circumstances when a narrower spectrum antimicrobial is appropriate initial
therapy. This will allow successful treatment of high-risk patients and avoid
unnecessary antibiotic use and resistance. In a recent study of patients with
infections requiring admission to the medical/surgical ICU, we found that
patients receiving adequate antimicrobial therapy had a signiﬁcantly
(P< 0.001) lower rate of hospital mortality (12% vs. 52%; RR¼ 4.26)
and infection-related mortality (18% vs. 42%; RR¼ 2.37) than those receiv-
ing inadequate antimicrobial treatment; inappropriate antimicrobial treatment
was the most important independent determinant of hospital mortality. In this
study, inadequate antimicrobial treatment was deﬁned as ineffective treatment
of a microbiologically documented infection at time of identiﬁcation, either
through absence of antimicrobials directed at one of the underlying patho-
gens, or use of an agent to which the causative pathogen was resistant. Among
patients with nosocomial infections in this study, lack of coverage for Gram-
negative bacteria resistant to the administered third-generation cephalospor-
ins accounted for most instances of inadequate antimicrobial treatment. Risk
factors for receiving inadequate therapy included prior exposure to anti-
biotics, prolonged length of hospital stay, presence of invasive devices,
presence of a bloodstream infection, increasing APACHE II score and
decreasing patient age. Other investigators have also demonstrated a statis-
tically signiﬁcant association between the initial administration of adequate
empiric antimicrobial treatment and reduced hospital mortality in patients
with ventilator-associated pneumonia (VAP) and patients with nosocomial
blood stream infections (Table 1). Inappropriate antimicrobial therapy has also
been shown to increase mortality in patients with other serious infections such
as postoperative peritonitis. As well as reducing mortality, early use of
adequate empiric antimicrobial therapy has been shown to signiﬁcantly
reduce duration of hospital stay and time in the ICU, which is an important
resource consideration.
Performance by design – developing solutions for efﬁcacy against drug-resistant Streptococcus pneumoniae
(Symposium arranged by GlaxoSmithKline)
S163 Standards of antibacterial performance
R. Finch
Nottingham, UK
Drug development and clinical use of antibiotics continues to evolve. While
antibiotic resistance remains an important determinant for drug development
and therapeutic choice, pharmacokinetic and pharmacodynamic parameters are
having an ever-increasing inﬂuence on dosage regimens. Recently, licensed
new therapies are largely directed at serious hospital-associated Gram-positive
infections. However, in the community, therapeutic choice is largely dependent
on well established agents from limited classes of antibiotics. In order to
maximize beneﬁts from such agents, it is appropriate that dosage regimens
be reviewed in the light of new knowledge, particularly in the area of
pharmacokinetics and pharmacodynamics. This symposium will address the
scientiﬁc and clinical data that support the design and development of a new
pharmacokinetically enhanced formulation of amoxicillin/clavulanate.
S164 Elements of design: the knowledge on which to
build
A. MacGowan
Bristol, UK
Pharmacodynamics is a tool to enable antibiotic dosing to be optimized in
terms of pathogen clearance and prevention of resistance. This applies to
susceptible wild-type bacterial populations and those strains which
have known mechanisms of resistance. For most antibiotic drug classes, a
combination of animal and in vitro evaluations have resulted in deﬁnition of
the dominant pharmacodynamic index for efﬁcacy, the AUC/MIC, Cmax/
MIC or T>MIC. For b-lactams, the T>MIC is the index that is best
correlated to bacterial efﬁcacy. The magnitude of the pharmacodynamic
index required for bacteriological cure depends on the species treated, family
of b-lactam studied, drug protein binding, immune status of the host and
degree of bacterial clearance required. Larger T>MIC values are required to
kill bacteria that have a static effect. Deﬁning the magnitude of the pharma-
codynamic index also helps to deﬁne the values for clinical breakpoints and
hence the categorization of strains as clinically sensitive or resistant. The
T>MIC for any agent can be increased by larger doses, more frequent dosing
or provision of slow release formulations. Such approaches may mean that
bacteria previously ‘resistant’ will now respond to therapy. Clinically, impor-
tant resistance is therefore not an absolute phenomenon but is greatly
inﬂuenced by drug formulation and dosing regimen.
S165 Building in efﬁcacy: developing solutions to
combat drug-resistant Streptococcus pneumoniae
M. R. Jacobs
Cleveland, USA
The development of our understanding of the pharmacokinetic (PK) and
pharmacodynamic (PD) principles that determine antimicrobial efﬁcacy has
advanced substantially over the last 10 years. We are now in a position to
use PK/PD principles to set targets for antimicrobial design and optimization
so that we can predict eradication of speciﬁc pathogens or of resistant variants
when agents are used clinically. Optimization of PK/PD parameters to
Table 1
Study Patient type (no.)
Mortality
P
Adequate
antimicrobial
therapy %
Inadequate
antimicro-
bial therapy %
1 Medical/surgical ICU (n¼ 2000) 12.2 52.1 <0.001
2 Mechanically ventilated
nosocomial pneumonia (n¼ 50)
37.5 91.2 <0.001
3 VAP (n¼ 430) 16.2 24.7 <0.04
4 VAP (n¼ 113) 15.4 37.0 <0.05
5 Bloodstream infections (n¼ 492) 28.4 61.9 <0.001
6 Bloodstream infections (n¼ 3413) 20.0 34.0 <0.0001
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enable the treatment of resistant pathogens may not be possible with many
current agents. For example, this is difﬁcult to achieve with many oral
cephalosporins due to lack of dose linearity of PK or the need for substantial
changes to the PK proﬁle to achieve adequate time aboveMIC (T>MIC) for
penicillin-nonsusceptible pneumococci. For macrolides, PK/PD parameters
are adequate against macrolide-susceptible pneumococci, but not against
macrolide-resistant strains with efﬂux or ribosomal-methylase mediated
resistance, or against Haemophilus inﬂuenzae, which has intrinsic macrolide
efﬂux mechanisms. While older quinolones, such as ciproﬂoxacin had
inadequate PK/PD proﬁles against pneumococci, newer quinolones meet
the required PK/PD targets against quinolone-susceptible pneumococci, but
not against all quinolone-resistant strains. Aminopenicillins, such as amoxi-
cillin, have linear PK and have a good safety proﬁle even at high doses.
Although current formulations of amoxicillin and amoxicillin/clavulanate
have retained efﬁcacy against most, but not all, penicillin-nonsusceptible
Streptococcus pneumoniae, additional coverage is required to combat the growing
problem of drug-resistant strains. The new pharmacokinetically enhanced
oral formulation of amoxicillin/clavulanate, 2000/125mg b.i.d. (AUGMEN-
TIN XRTM), was designed using PK/PD principles to be able to eradicate
S. pneumoniae with amoxicillin MICs of up to at least 4mg/L, which includes
most penicillin-resistant isolates. For amoxicillin and amoxicillin/clavulanate,
a T > MIC of 35–40% of the dosing interval (based on blood levels) is
predictive of high bacteriological efﬁcacy. This target was met by the design of
a unique bilayer tablet incorporating 437.5mg of sustained-release sodium
amoxicillin in one layer plus 562.5mg of immediate-release amoxicillin
trihydrate and 62.5mg of clavulanate potassium in the second layer, with
two tablets administered for each dose. This unique design extends the
bacterial killing time by increasing the T>MIC to 49% of the dosing
interval against pathogens with MICs of 4mg/L, and 35% of the dosing
interval against pathogens with MICs of 8mg/L. Based on these results, this
new amoxicillin/clavulanate formulation should be highly effective in treating
respiratory tract infections due to drug-resistant S. pneumoniae as well as b-
lactamase-producing pathogens, such asH. inﬂuenzae andMoraxella catarrhalis.
S166 Proof of concept: performance testing in models
W. Craig
Madison, USA
Since time aboveMIC (T>MIC) is the pharmacokinetic/pharmacodynamic
(PK/PD) parameter correlating with efﬁcacy of amoxicillin against Strepto-
coccus pneumoniae, studies were performed in the neutropenic mouse-thigh
infection model to determine the percentage of time the serum concentra-
tions need to exceed the MIC for susceptible strains and resistant ones with
MICs of up to 8mg/L. The duration of time required for a bactericidal effect
(at least a 2-log kill) was similar for all strains and varied from 35 to 40% of the
dosing interval. The new pharmacokinetically enhanced formulation of
amoxicillin/clavulanate (AUGMENTIN XRTM 2000/125mg b.i.d.) has a
T > MIC of 49% against bacterial strains with MICs of 4mg/L, and 35%
against strains with MICs of 8mg/L, which exceed the>35–40% predictive
of high bacteriological efﬁcacy. In vitro models provide a difﬁcult test for
antimicrobial efﬁcacy due to the absence of a host immune response, so
efﬁcacy in immunocompetent humans would be expected to be higher.
However, in in vitro models, amoxicillin/clavulanate 2000/125mg b.i.d.
achieves signiﬁcant bacterial killing against strains of S. pneumoniaewith MICs
of 4mg/L and in some strains with MICs of 8mg/L. Animal models, such as
the rat model of respiratory tract infection, do take into account host immune
effects and are therefore a more accurate indicator of bacteriological efﬁcacy in
humans. In addition, dosing in the rat is adjusted to simulate the pharmaco-
kinetics of dosing in humans. In a rat model of pneumonia, amoxicillin/
clavulanate 2000/125mgwas highly effective against S. pneumoniae strains with
amoxicillin MICs of 4 or 8mg/L. Against strains with amoxicillin MICs of
4mg/L, amoxicillin/clavulanate 2000/125mg b.i.d. was signiﬁcantly more
effective than the conventional 875/125mg b.i.d. formulation, azithromycin
and levoﬂoxacin, even though all levoﬂoxacin MICs were 1mg/L. Follow-
ing infection with S. pneumoniae strains with amoxicillin MICs of 8mg/L, the
amoxicillin/clavulanate 2000/125mg b.i.d. formulation was more effective
than the conventional amoxicillin/clavulanate formulations 875/125 t.i.d. and
b.i.d. and 1000/125mg t.i.d., and had similar or better efﬁcacy than azithro-
mycin or levoﬂoxacin, depending on the strain. These data indicate the
potential beneﬁt of therapy with amoxicillin/clavulanate 2000/125mg
b.i.d. compared with conventional formulations and other marketed anti-
microbials in the treatment of respiratory tract infection and, if conﬁrmed by
clinical trials, supports a susceptible breakpoint of at least 4mg/L.
S167 Performance in practice: bacteriological efﬁcacy in
patients with drug-resistant Streptococcus pneumoniae
J. Garau
Barcelona, E
Using pharmacokinetic/pharmacodynamic (PK/PD) principles, amoxicillin/
clavulanate (AMX/CA) 2000/125mg b.i.d. (AUGMENTIN XRTM) was
designed to provide adequate levels of AMX over the 12-h dosing interval to
eradicate penicillin-resistant Streptococcus pneumoniae (PRSP, penicillin
MICs 2mg/L) with AMX MICs of at least 4mg/L. The efﬁcacy of
AMX/CA 2000/125mg in patients with RTIs caused by S. pneumoniae,
including isolates with elevated PEN (2–16mg/L) MICs, was evaluated.
Data from 10 clinical studies were combined: seven randomized (1 : 1),
double-blind, controlled trials (ITT, n¼ 3377) [AMX/CA 2000/125mg
b.i.d. vs. levoﬂoxacin 500mg o.d. in acute bacterial sinusitis (ABS); levo-
ﬂoxacin 500mg o.d. in acute exacerbations of chronic bronchitis (AECB);
clarithromycin 500mg b.i.d. in AECB; AMX/CA 875/125mg b.id./t.i.d.
and 1000/125mg t.i.d. in community-acquired pneumonia (CAP)] and three
noncomparative studies (ITT, n¼ 3024) (two in ABS, one in CAP). The
bacteriological per-protocol (PP) population at follow-up (FU, Day 14–39)
comprised 1295 patients for AMX/CA 2000/125mg and 241 for compara-
tors. With AMX/CA 2000/125mg at FU, outcome was successful (clinical
success and eradication/presumed eradication) in 85/90 (94.4%) patients with
S. pneumoniae in comparative studies and 419/443 (94.6%) in noncomparative
studies (94.6% success overall), and with comparators 59/70 (84.3%) were
successes. In the AMX/CA 2000/125mg group at FU, 53/535 S. pneumoniae
isolates were resistant to PEN. At FU, 51/52 (98.1%) patients with PRSPwere
successes, including 7/7 with AMX MICs of 4mg/L and 7/8 with AMX
MICs of 8mg/L. There were six PRSP isolates in the comparator group (two
isolates were from one patient), and 3/5 patients in this group were successes.
In conclusion, AMX/CA 2000/125mg demonstrated clinical success against
51/52 patients with PRSP, including 14/15 strains with AMX MICs of
4–8mg/L. These results for the PK-enhanced formulation of amoxicillin/
clavulanate 2000/125mg are in line with the high efﬁcacy against PRSP
predicted using PK/PD parameters.
Emerging techniques for the rapid diagnosis of infectious diseases
K175 Emerging techniques for the rapid diagnosis of
infectious diseases
M. Uhlen
Stockholm, S
High-throughput systems for analysis of genetic variability and afﬁnity-
reagent based proteomics have been set-up based on ‘in-house’ designed
robotic workstations. The analysis of single nucleotide polymorphisms is
based on pyrosequencing (Ronaghi, Uhlen and Nyren, Science 1998; 281:
363–5). Microﬂuidic applications will be discussed suitable for bacterial and
viral typing as well as analysis of antibiotic or antiviral resistance. New
approaches for in vitro selection of afﬁnity reagents will also be discussed.
The afﬁnity reagents are based on afﬁbodies (Nord et al. Nature Biotechnol-
ogy 1997; 15: 772–7) allowing robust ‘artiﬁcial antibodies’ suitable for
applications such as protein ‘chips’.
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Carbapenem-hydrolyzing beta-lactamases: a last frontier for beta-lactamases?
S176 Zn-carbapenemases: the ultimate danger?
J.-M. Fre`re, C. Bebrone, C. Anne, C. Moali, M. Galleni
Lie`ge, B
Carbapenems exhibit very distinct behaviors in the presence of the various
classes of beta-lactamases. Imipenem acylates most class A enzymes slowly and
deacylation is also slow, so that it behaves as a sluggish substrate. Class C
enzymes are more rapidly acylated but again, deacylation is slow. In these
cases, the enzyme is transiently immobilized as an acylenzyme. Some class D
enzymes appear to hydrolyze carbapenems, but this activity is still poorly
characterized. The metallo-beta-lactamases (MBLs, class B) usually behave as
efﬁcient carbapenemases. Of particular interest are the class B2 enzymes
produced by Aeromonas whose activity seems to be restricted to carbapenems.
When compared to those of other MBLs, the sequences of these enzymes
exhibit some speciﬁc residues including one of the Zinc ligands, an Asn
replacing the His116 found in enzymes of classes B1 and B3. The N116H
mutation, which restores the situation found in the latter enzymes decreases
the carbapenemase activity but does not restore the broad speciﬁcity spectrum
characteristic of class B1. The additional N220G mutation further decreases
the carbapenemase activity but strongly increases that against all other
sustrates, which yields a broad spectrum enzyme with a rather low but
signiﬁcant activity. Residue 220 is situated just before the Cys 221 which
is an important Zn ligand in subclasses B1 and B2. A characteristic of the class
B enzymes of known structure is the presence of a ‘ﬂexible ﬂap’ near the active
site. The inﬂuence of this ﬂap in subclass B1 has been studied by site-directed
mutagenesis. It mainly affects the binding of several substrates, but relatively
less so for carbapenems. Up to the present time, several metallo-beta-
lactamase have been found to signiﬁcantly hydrolyze most clinically useful
beta-lactams with the sole exception of aztreonam. To ﬁght these enzymes, it
is thus quite important to try to discover speciﬁc inhibitors which are not
general Zn-ligands.
S177 Phylogenesis and epidemiology of the
metallo-beta-lactamases: a guided tour
G. M. Rossolini
Siena, I
Objectives: Metallo-beta-lactamases (MBL) were discovered later than ser-
ine-beta-lactamases and are mechanistically and evolutionarily unrelated to
the latter enzymes. Notable features of MBL are the potent carbapenemase
activity, a usually broad substrate proﬁle, and resistance to conventional
inhibitors. Although MBL are less prevalent than serine-beta-lactamases in
the clinical setting, the number of known MBL has increased steadily during
recent years, and these enzymes are currently regarded as emerging resistance
determinants of increasing relevance in gram-negative pathogens. The
objective of this presentation is to provide an updated overview on the
epidemiology and the origin of these enzymes.
Methods:Results of experimental data from our laboratory and data from the
scientiﬁc literature will be integrated to elaborate an overview on issues
concerning evolution and epidemiology of MBL.
Results: the MBL family (class B) currently includes at least 19 different
enzymes, with multiple allelic variants known for most of them. Members of
this family can be divergent from each other by more than 90% of the amino
acid sequence, but retain a conserved fold. Structural diversity is associated to
considerable functional diversity within the family. According to structural
similarities MBL are clustered in three different subclasses (B1, B2, and B3),
and appear to be evolutionarily related to other proteins of unknown or
diverse diverse functions (e.g. glyoxalase, esterase, sulfatase). MBL have
been detected in species of phylum XII (Proteobacteria), XIII (Firmicutes)
and XX (Bacteroidetes), and are encoded either by resident chromosomal
genes or by genes acquired by recent horizontal transfer. From the clinical
standpoint, the most relevant are the IMP- and VIM-type enzymes, that
exhibit an exceedingly broad susbtrate speciﬁcity and are encoded by mobile
elements (integron-borne gene cassettes). These enzymes are spreading
among Enterobacteriaceae, Pseudomonas aeruginosa,Acinetobacter spp. and other
gram-negative nonfermenters and, to-date, have been reported in at least
three continents (Asia, Europe and the Americas).
Conclusions: MBL constitute a growing family of enzymes of increasing
importance. Secondary MBL are now widespread and could become a global
problem. Efﬁcient monitoring of these enzymes is essential to understand
their epidemiology and to develop strategies for containment. Work sup-
ported in part by EU contract HPRN-CT-2002–00264.
S178 Carbapenemase activity of nonmetallo enzymes
P. Nordmann
Le Kremlin-Biceˆtre, F
Whereas most of the carbapenem-hydrolyzing beta-lactamases belong to the
group of Ambler class B metallo-enzymes, several beta-lactamases belonging
to the Ambler class A and class D have extended spectrum to carbapenems. A
few clavulanic acid-inhibited class A beta-lactamases possess a substrate proﬁle
extended to carbapenems and aztreonam. This is the case of the chromo-
somally encodedNMC-A, IMI-1, and SME-1/2 enzymes that are from rare
clinical isolates of Enterobacter cloacae and Serratia marcescens in Europe and the
USA and more recently from Enterobacter sakazakii isolates from US rivers.
The clavulanic-acid inhibited beta-lactamase KPC-1 represents a more
important threat since it is plasmid-mediated and has a spectrum of activity
that include carbapenems and expanded-spectrum cephalosporins. It has been
reported from K. pneumoniae from three cities in the USA with one major
outbreak. A variant of the plasmid- and integron-located extended-spectrum
beta-lactamase GES-1 gene, blaGES-2 was recently found in P. aeruginosa in
South Africa. It has hydrolysis spectrum extended weakly to carbapenems and
GES-2-producing strains have been involved in a nosocomial outbreak. The
chromosome-encoded SHV-38 enzyme in K. pneumoniae is a point-mutant
derivative of the narrow-spectrum SHV-1 enzyme and is the only example of
a SHV-type enzyme with low level extension of its spectrum to imipenem.
Some of the growing carbapenem resistance in Acinetobacter spp. is associated
with weak Ambler class D carbapenemases that are mostly chromosome-
encoded. These enzymes belongs to two clusters, one of them (OXA-24-
related) associated with Iberia and the other (OXA-23-related) more scat-
tered. A novel plasmid-encoded enzyme, OXA-42 has been discovered
recently from a Turkish K. pneumoniae isolate. It has strong activity against
carbapenems.
S179 Slow hydrolysis and permeability deffects
L. Martı´nez-Martı´nez
Seville, E
Expression of b-lactamases that hydrolyze carbapenems with low efﬁciency
may lead to carbapenem resistance in strains showing decreased permeability,
usually because of porins loss. Modiﬁed lipopolysaccharide has also been
implicated in resistance to carbapenems, but its actual contribution need
additional studies. In strains producing efﬁcient carbapenemases, altered
permeability increases the level of resistance. Hyperproduction of chromo-
somal AmpC (which hydrolyzes carbapenems poorly) plus porin loss has been
related to carbapenem resistance in enterobacteria, particularly Enterobacter
spp., Citrobacter freundii and Serratia marcescens. Blocking AmpC activity
abolishes resistance to carbapenems, and revertants re-expressing lost porins
also become carbapenem-susceptible. Imipenem permeates faster than mer-
openem through outer membrane, but the highest stability of meropenem to
most b-lactamases usually translates into lower MICs of the latter. In some
enterobacteria (Proteus, . . .) resistance to carbapenem has been described in
strains deﬁcient in an outer membrane protein, but the lost protein seems not
to be a porin, and the resistance is more likely associated to PBP changes.
Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases
(EBSL) are susceptible to carbapenems, even when the two major porins
(OmpK35 andOmpK36) of the species are lost, because these agents are (with
a few exceptions) poor substrates of ESBL. K. pneumoniae may become
resistant to carbapenems because of either carbapenemase production or
the combination of porin loss plus plasmid-mediated AmpC (p-AmpC)
production. Carbapenem-resistance in Escherichia coli has also been related
to porin loss and production of p-AmpC. The role of minor enterobacterial
porins (OmpK37 ofK. pneumoniae, . . .) in carbapenem resistance is still poorly
known. In Pseudomonas aeruginosa loss of porin OprD in strains producing
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AmpC causes resistance to imipenem, and decreases the activity of merope-
nem. A similar ﬁnding has been observed in strains producing speciﬁc
carbapenemases such as VIM-1. Carbapenems that penetrate using OprD-
independent pathways show good in vitro activity against AmpC(þ)/OprD(–
) P. aeruginosa, supporting the importance of the coordinated expression of
both mechanisms. In Acinetobacter baumannii the importance of altered
permeability as a mechanism involved in carbapenem-resistance has still to
be proved. New data on the regulation of bacterial permeability (for example
the recently described role of Zn in regulation of OprD, or the relationship
between porin loss and active efﬂux in K. pneumoniae) will contribute to our
understanding of the role of permeability on the resistance of Gram-negative
bacteria to carbapenems.
Harmonization of quinolone breakpoints in Europe (Symposium arranged with EUCAST)
S181 Breakpoints – the EMEA experience
B. Aronsson
London, UK
The European Medicines Evaluation Agency and its scientiﬁc committee for
proprietary medicinal products (CPMP) evaluates new medicinal products in
the centralized procedure. After a recommendation by the CPMP amarketing
authorization that covers the whole EU is obtained. Since the EMEA
operations started in January 1995 only three antibacterial products (ertape-
nem, telithromycin and trovaﬂoxacin) have been licensed via the EMEA.
Many applicants have preferred to go the national routes for marketing
authorization applications including those for many antibiotics giving
them the opportunity to focus on speciﬁc markets if they wish. This
may partly be due to a lack of harmonization in the evaluation of the beneﬁts
and risks for antibacterial agents. The CPMP efﬁcacy working partly in
recognition of the need for harmonized assessments has developed three
guidelines on the evaluation of antibacterial products, on the use of PK/PD
data in drug development for antibacterials and on the information that
should go into the harmacodynamic section of the SPC. In the latter case, an
ongoing revision of the guidelines recognizes the existence of national and
European bodies for setting breakpoints. Collaboration on the EU level in
setting these breakpoints for new antibacterial products would facilitate EU
harmonization and could beneﬁt EU regulatory assessment of new antibac-
terial agents.
S185 Harmonization of ﬂuoroquinolone breakpoints
in Europe
D. Brown, G. Kahlmeter and J. W. Mouton
Cambridge, UK; Va¨xjo¨, S; Nijmegen, NL
The European Committee on Antimicrobial Susceptibility Testing (EUCAST),
convened by the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) together with the national breakpoint committees in
France, Germany, Norway, Sweden, The Netherlands and United Kingdom,
has started a process for harmonizing European antimicrobial breakpoints. This
process will be presented by EUCAST and commented on by the European
Medicines Evaluation Agency (EMEA). The EUCAST has agreed on deﬁni-
tions for clinical breakpoints and epidemiological cut-off values for the
measurement of antimicrobial resistance development. We have furthermore
gathered a large number of MIC distributions from many sources which, apart
from being used in the process of setting breakpoints and epidemiological cut-
off values, will be available to all via the EUCAST internet website (http://
www.eucast.org). The process by which EUCAST sets clinical and epidemio-
logical breakpoints for new and older drugs will be presented. It involves
evaluation of clinical data, microbiological data, PK/PD data and Monte Carlo
simulation. EUCAST has deﬁned harmonized tentative clinical breakpoints
and decided on epidemiological cut-off values for the ﬂuoroquinolones. These
will be presented together with wild-type MIC distributions and a new
software for accessing the MIC distributions.
Meningococcal disease
S186 Recent developments in pathogenesis and clinical
practice
R. C. Read
Shefﬁeld, UK
There have been numerous advances in diagnosis and management of
meningococcal disease over the past 3 years. Our knowledge of the patho-
genesis of this disease has also increased considerably. The presentation,
severity, and compartmentalization of the infection varies widely between
patients. There are new algorithms to aid diagnosis in patients with undiffer-
entiated disease, and the use of PCR has permitted nonculture diagnosis and
will, in the future, permit rapid diagnosis and typing. There have been
worrying developments in antimicrobial sensitivity to beta-lactams so that in
some regions of Europe, efﬁcacy of penicillin can no longer be universally
assumed. Dealing with the potential community and nosocomial dissemina-
tion of the infection has also been made easier by improvements in our
understanding of transmission dynamics. Disease occurs when the meningo-
coccus translocates from the nasopharynx to the bloodstream and dissemi-
nates. The virulence factors which determine the success of the pathogen in
each of these environments have been partly established but we still do not
fully understand which host and microbial factors interact to permit invasion
and disease. There has been progress in human genetic susceptibility studies,
and a number of gene variations that inﬂuence innate immunity which are
associated with susceptibility and severe meningococcal disease have been
determined.
S188 Molecular epidemiology and typing
of Neisseria meningitidis
M. C. J. Maiden
Oxford, UK
Meningococcal disease remains an important cause of morbidity andmortality
world wide. Despite a long history of research, dating back to the earlier part
of the last century, comprehensive vaccines against Neisseria meningitidis, the
etiologic agent of meningococcal disease, are yet to be developed. Attempts to
control meningococcal disease are confounded by meningococcal diversity
and epidemiology, with disease outbreaks occurring sporadically and unpre-
dictably notwithstanding the frequent occurrence of this bacterium as a
commensal in the upper respiratory tract of adult humans. Epidemiological
studies, especially those that exploit molecular characterization techniques
combined with evolutionary and population genetic approaches, have been
highly informative in elucidating the biology of this paradoxical pathogen.
Meningococcal populations sampled from the throats of healthy individuals
are both genetically and antigenically highly diverse, while those recovered
from disease aremore limited in their diversity. It is know known that the great
majority of disease in the latter half of the twentieth century was caused by as
few as a dozen major disease-associated genotypes, with six of these being
predominant. Different genotypes tend to be associated with different
epidemiological characteristics and with certain antigenic components,
especially the capsular polysaccharide. Detailed genetic studies of meningo-
cocci from carriage and disease are beginning to reveal the reasons for
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meningococcal diversity and to deﬁne ever more precisely the genotypes
responsible for disease. These studies are also enabling the effects of popula-
tion-scale immunization on the evolution of the meningococcus to be
evaluated.
S189 Meningococcal surface components: implications
for pathogenesis and vaccine development
T. Tønjum
Oslo, N
Neisseria meningitidis is the major cause of bacterial meningitis and septicemia
worldwide. Its most important virulence factors are associated with the outer
membrane, among them the capsule, pili, opa-proteins, porins and LPS. The
expression patterns of genes encoding these components vary concomitantly,
creating excessive amounts of meningococcal variants. Neisserial cell surface
variation serves as an adaptive mechanism which can modulate tissue tropism,
immune evasion and survival in the changing host environment. Genome
alterations due to horizontal gene transfer and various recombinational events,
as well as environmental DNA damaging agents, will constantly challenge the
gene pool of N. meningitidis. Mechanisms for rapid genome variability,
adaptability and maintenance are a necessity to ensure meningococcal ﬁtness
and survival. The unstable expression of surface components make menin-
gococcal vaccine development an unusual challenge. Various surface exposed
components should still be evaluated for meningococcal vaccine purposes. To
be effective, a meningococcal vaccine must induce bactericidal and/or
opsonic antibodies against one or more of the cell surface components
expressed by N. meningitidis. The vaccine candidate must be sufﬁciently
conserved and presented on the surface by all meningococcal strains.
The capsular vaccines are relevant for serogroup A and C strains, however,
the capsule of meningococcal serogroup B strains is poorly immunogenic.
A number of other neisserial outer membrane components need to
be considered for vaccine purposes to cover all serogroups; in addition to
the virulence components listed, some of the current candidate structures
are NspA, TbpA and various lipoproteins. The strategy to achieve novel
and efﬁcient vaccines must involve single component characterization as
well as a combined genomic and proteomics-based approach; vaccine
candidates must be tested for protective efﬁciency alone and in
relevant combinations, such as in the naturally occurring outer membrane
vesicles. The dynamics of meningococcal genomic changes and genome
maintenance/DNA repair affect the net outcome in terms of DNA sequence
variability and conservation. The effect of genome dynamics on meningo-
coccal surface exposed virulence factors and vaccine candidates will be
discussed.
Clostridium difﬁcile disease: incidence and interventions (Symposium arranged with the ESGCD)
S190 Preventing cross-transmission of
Clostridium difﬁcile
A. C. Simon
Brussels, B
The incidence of Clostridium difﬁcile (CD) among outpatients is relatively low.
In the hospital setting, the acquisition rate is much higher and varies
depending on the type of ward and the eventual presence of an epidemic
situation. Contamination can occur from two separate sources. The ﬁrst one is
the emergence, following antibiotic treatment, of a strain already present in
the gut in very low quantities, and the second one is the acquisition from
contact with healthcare personnel workers hands, infected patients or their
environment. Patients with CD-associated diarrhea (CDAD) typically have
large numbers of organisms in their stools and constitute the main reservoir,
although asymptomatic carriers also contribute to a lesser extent to the spread
of CD. It has been shown that, in the case of CDAD, the patients’ environment
is rapidly contaminated by spores that can persist for several months despite
extensive cleaning. The environment becomes a secondary reservoir. Hands
of healthcare workers are frequently contaminated and are the main vector of
transmission. Contaminated tools such as thermometers have also been
incriminated. Beside all measures aiming at decreasing risk factors, interrup-
tion of horizontal transmission of CD is the main control measure. This is
based on contact precautions and environmental disinfection. Clinical bac-
teriology laboratories and infection control units play a major role in
implementing control measures as soon as a positive case is diagnosed. Contact
precautions such as isolation or cohorting, handhygiene and gloving have
been successful in limiting the transmission of CD in hospitals. There is no
evidence that the use of gowns in itself is efﬁcient because it is usually
implemented along with other measures. There is considerable circumstantial
evidence about the role of environmental disinfection in decreasing the spread
of CD. Daily room environmental cleaning with a disinfectant has been
demonstrated successful in reducing the numbers of new CDAD cases.
Phosphate-buffered hypochlorite and solutions of aldhehydes have been
shown to signiﬁcantly reduce the ward contamination rate. A recent study
provided evidence that, contrary to chlorine based products, cleaning
agents may increase the sporulation capacity of CD. Although research on
nosocomial CD has come a long way since the late 70 s, CD lives up to its
name by continuing to be a difﬁcult nosocomial infection to deal with in our
hospitals.
S191 Reducing the burden of Clostridium
difﬁcile-associated diarrhea
T. Riley
Perth, AUS
Clostridium difﬁcile is the most common cause of diarrhea in hospital patients.
The main risk factors for Clostridium difﬁcile-associated diarrhea (CDAD) are
exposure to antibiotics and exposure to the organism. Attention to infection
control and antibiotic prescribing behavior are obvious approaches to pre-
vention of CDAD at a hospital level. In our hospital a steady rise in incidence
of CDAD was observed during the 1980s that was related to cephalosporin
use. In 1998, a review of antibiotic prescribing by the hospital’s Drugs and
Therapeutics Committee resulted in an almost total ban of ceftriaxone.
Ceftriaxone use (measured by annual cost) fell substantially from
A$250 000 in 1998 to A$32 000 in 1999. This policy change was followed
by a 50% drop in the number of CDAD cases in 1999, a decrease that persisted
into 2000. These ﬁndings suggest that it is possible to control CDAD by
regulating antibiotic prescribing in the hospital. For individual patients, many
of whom have recurrent CDAD, probiotic therapy may have a place. Several
papers have reported the use of Lactobacillus GG in children and adults with
recurrent CDAD. We have carried out two studies with yoghurt containing
lactobacilli. In the ﬁrst of these, patients given clindamycin for furunculosis
were randomized to receive either yoghurt or no yoghurt while on therapy.
Although the sample size was small, those taking yoghurt had a signiﬁcantly
reduced incidence of diarrhea and CDAD. In the second study, over 650
hospital patients taking antibiotics were given yoghurt daily and the impact on
CDAD assessed. Over a 3-month period there was a 50% reduction in both
the incidence of symptomatic diarrhea and CDAD. Saccharomyces boulardii
therapy is also suitable for patients with recurrent disease. Our experiences
with S. boulardii are limited, however, so far, we have treated 25 elderly
patients with recurrent CDAD with vancomycin plus S. boulardii (500mg bd)
for a week, followed by another 3weeks of just S. boulardii. Twenty-three of
the 25 patients responded with one patient suffering recurrence of disease and
one patient lost to follow-up.
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S192 Prevention of Clostridium difﬁcile infection at
the bedside
M. H. Wilcox
Leeds, UK
Clostridium difﬁcile infection is an iatrogenic disease and therefore in theory is at
least partially preventable. Whilst most diagnosed cases are hospitalized
patients, there may be a signiﬁcant burden of unrecognized C. difﬁcile
infection in the community accounting for up to 28% of laboratory detected
cases. While C. difﬁcile diarrhea is more common in older patients (80% of
diagnosed cases affect in-patients aged65 years), increasing age per se is not a
risk factor for infection severity. Signiﬁcant risk factors for severe C. difﬁcile
diarrhea include functional disability, cognitive impairment, and recent
endoscopy. There are controlled prospective and/or retrospective data indi-
cating that some broad spectrum antibiotics, including ureidopenicillins (e.g.
piperacillin–tazobactam) and ciproﬂoxacin, are signiﬁcantly less likely to
induce C. difﬁcile infection in comparison with cephalosporins such as
cefotaxime. Effective control of C. difﬁcile in the hospital requires both
antibiotic control and prevention of environmental seeding and spread of
the bacterium. Restriction of cephalosporin and/or clindamycin prescribing,
and avoidance of excessive duration surgical antibiotic prophylaxis can be used
to reduce nosocomial C. difﬁcile infection. Feedback of data on rates of
antibiotic prescribing and C. difﬁcile infection should be the starting point to
controlling hospital endemics. Infection control measures such as improved
hand cleansing and use of tympanic or disposable thermometers have
been demonstrated to be effective at reducing the incidence of nosocomial
C. difﬁcile infection. Surveillance data indicate that epidemic C. difﬁcile strains
exist, and that the major such strain can be widely distributed in the hospital
environment, both as a cause and result of nosocomial diarrhea. Hence, efforts
should be concentrated on the control of such epidemic strains, and source
isolation of symptomatic patients is important to prevent their dissemination.
There are new data on the effectiveness of environmental decontamination
regimens, in particular hypochloirte-based cleaning to help control nosoco-
mial C. difﬁcile infection.
S193 Prevalence and epidemiology of Clostridium
difﬁcile in Eastern Europe
E. Nagy
Szeged, HUN
To day C. difﬁcile is accepted as the causative agent of a large number of
nosocomial diarrhea. Besides these,C. difﬁcile probably plays a more important
role than previously thought in community-acquired diarrhea after antibiotic
treatment. The main pathogenic factors are A and B toxins, but more and
more information are collected about the presence of variant strains lacking
one or both toxins, or those with characteristic changes in their toxin genes
and producing a binary toxin. The importance to isolate C. difﬁcile from
diarrhoeal patients, to characterize their toxins and to use comparable typing
methods for epidemiological purposes, is well recognized in Western Euro-
pean countries, however, only few data are available from the Eastern part of
Europe. Prevalence data for the C. difﬁcile infections in hospital wards differ
from country to country mainly due to the differences in the methodology
and the interest of the clinicians to get a correct diagnosis of the nosocomial
diarrhea. During a 1-year period in a university hospital in Szeged (Hungary)
out of 570 diarrhea feces obtained from different wards 120 (21%) proved to
be C. difﬁcile toxin positive, using the cytotoxicity assay when the testing was
initiated by the lab and out of 375 samples for which the physicians had
requested examinations 58 (18.3%) was positive with a toxin A EIA detection
method. During the next 6-month period when all watery feces samples
obtained from the different wards were cultured for C. difﬁcile and the toxin
detection was carried out by the cytoxicity assay from the supernatant of the
isolated strains, 29% of the samples were positive. Selected isolates were typed
by PCR ribotyping, which revealed basic differences between the Hungarian
isolates and those collected from different West European countries. Among
the 15 different ribotypes found among the 65 isolates, 087 was the most
predominant whereas 001 is the most frequently isolated ribotype among the
isolates from other countries. Two nontoxigenic C. difﬁcile strains showed a
new type. Despite of the fact that toxin A negative/toxin B positive isolates
appeared in many countries, in our laboratory out of 153 C. difﬁcile strains
none of them showed this toxin type. As PCR ribotyping is not used generally
in different countries andmany different typingmethods are used, it is difﬁcult
to calculate to day the overall clonal spread of C. difﬁcile in Europe.
War, famine and infectious diseases
S194 The bugs of war
A. M. Geddes
Birmingham, UK
Infections have been major inﬂuences on many military campaigns, not
infrequently being the principal factor that has made the difference between
victory and defeat. Examples includemalaria and dysentery in South-East Asia
in World War II, gas gangrene in the trenches in World War I, meningococcal
infection in military recruits and sexually transmitted diseases in most
campaigns. The advent of certain chemotherapeutic agents such as the
sulfonamides, penicillin and antimalarial drugs has had profound inﬂuences
on certain campaigns. The ﬁrst part of this presentation will explore these
factors and also other infections associated with war. The second part of the
presentation will address the early history of bioterrorism.
S195 Medical preparations for defense against
biological terrorism
E. Eitzen
Washington, DC, USA
The Department of Health and Human Services in the United States is
engaged in an aggressive effort to develop and acquire the medical counter-
measures necessary to protect and defend US citizens against biological
terrorism. The speaker will discuss the history of biological terrorism, the
ways that terrorists might use biological agents against us, and how these
agents might affect the victims. He will brieﬂy present some lessons learned
from the antrax attacks which occurred in 2001 in the US, and discuss how
those lessons might apply to future defensive efforts. Finally, he will offer
insights into ways that countries might be better prepared to manage the
consequences of such attacks and hopefully give potential perpetrators pause
in their desire to use such potentially deadly agents against our societies.
S196 Arboviruses as potential bioterrorist
weapons – implications for surveillance and control
M. S. Green
Tel Hashomer, IL
Recent large outbreaks of West Nile Virus (WNV) infection in Europe,
North Africa, theMiddle East and North America, have provided insight into
the potential threat of arboviruses as bioterrorist weapons. Several features
make these viruses attractive for bioterror. They are readily accessible. Out-
breaks are difﬁcult to identify in the early stages and once the virus has
established itself in the environment, it can spread rapidly. The insect vectors
can be extremely difﬁcult to control. Furthermore, the disease usually affects
both humans and animals, resulting in both suffering due to morbidity and
mortality and substantial economic costs. In 2000, there was a large outbreak
of WNV infection in Israel with 428 cases and 37 deaths. During the year
following discharge from hospital, a further 39 patients died, yielding a
mortality rate signiﬁcantly higher than expected after controlling for age.
In addition, many patients complained of persistent symptoms. These ﬁndings
demonstrate the potential for signiﬁcant long-term effects among those
infected. The outbreak in the United States in 2002, which resulted in more
than 4000 cases and 273 deaths, also caused signiﬁcant morbidity and
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mortality among a large variety of birds and animal species. In order to meet
the challenge of early detection and monitoring of intentionally caused
arbovirus outbreaks, greatly improved surveillance systems are necessary. This
will require close collaboration between the public health, clinical and
veterinary communities, as well as the authorities responsible for insect
control. In addition, substantially increased investment is required to
develop more effective vector control methods, new vaccines and therapeutic
drugs.
Views on antibiotic use
O198 Antibiotic resistance prevention and control
(ARPAC): results of a ﬁrst questionnaire on hospital
demographics, available data and policies
F. M. MacKenzie, J. Bruce, M. J. Struelens, H. Goossens, K. J. Towner,
I. M. Gould on behalf of the ARPAC Steering Group, ARPAC
Participating Hospitals
Objectives: ARPAC is a concerted action project funded by the Research
Directorate-General of the EC. It aims to lay the foundations for a better
understanding of the emergence and epidemiology of antibiotic resistance and
to evaluate and harmonize strategies for prevention and control of antibiotic
resistant pathogens in European hospitals. The ﬁrst phase of the project set out
to establish the demographic characteristics of the participating hospitals and
their ability to provide necessary data.
Methods: In order to recruit hospitals to the project, 2476 ESCMID
members were sent a 59-question, questionnaire. It asked for their willingness
and ability to supply data on hospital demographics, susceptibility data for
nine alert organisms (including MRSA, VRE and several resistant Gram-
negatives), antibiotic consumption data and information on antibiotic and
infection control policies.
Results: At the end of 2002, 266 hospitals had expressed an interest in
participating in ARPAC. Data are presented only for the 235 European
hospitals. Fourteen out of 16 EU countries and 20 out of 22 other European
countries were represented. Hospital characteristics: 71% were teaching
hospitals with an average of 805 total beds and 38 ICU beds. Susceptibility
data and alert organisms: 82% hospitals had data on a computer database and
79% could exclude duplicate isolates, 74% had experienced an outbreak of at
least one alert organism in the last 5 years and 62% carried out active screening
for MRSA. Antibiotic consumption and demographic data: 74% hospitals
stored their data on a computer database, 58% used the WHO ATC
classiﬁcation for antibiotics, 50% used deﬁned daily doses, and 91% could
supply the number of occupied bed days per year. Antibiotic policies: 33%
hospitals reported the existence of a national antibiotic policy and 63% the
existence of a local policy. Infection control policies: 33% hospitals reported
the existence of a national infection control policy and 85% the existence of a
local policy, 51% reported the existence of national guidelines for the isolation
of patients with resistant bacteria and 78% the existence of local guidelines.
Sixty-three percent typed ALERT organisms locally and 58% also used
reference laboratories.
Conclusions: By collecting the above data, ARPAC will provide a broad
picture of the epidemiology of antibiotic resistant nosocomial pathogens in
European hospitals and the range of activities conducted for their prevention
and control.
O199 Consumption of antibiotics in hospital care in
Europe: ﬁrst results of the ESAC retrospective data
collection
M. Elseviers, M. Ferech, R. Vander Stichele, H. Goossens
Antwerp, B
Objectives: ESAC (European Surveillance of Antibiotic Consumption,
granted by DG SANCO of the EC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2001), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: HC use data were provided sent by 22 countries; two were
unsuitable for international comparison, due to late data delivery in an
idiosyncratic format (CZ, PT). In six countries (BG, ES, HR, IT, LT,
PL), sample (not census) data were collected.
Results: In 2001, HC use in Europe varied between less than 1.5 DID in NL,
NO, SE, SK and DK to more than 3.5 DID in FI and FR. HC use varied
between ﬁve (SK) and 17% (FI) of total consumption in the different
European countries. The median (range) proportion of use in 2001 of
penicillins (PEN), cephalosporins (CEP), carbapenems (CAR), glycopeptides
(GLYC) and quinolones (Q) represented 46% (14–86), 19% (1–35), 1% (<1–
3), 1% (0–3) and 9% (1–16) of total HC use, respectively; the median (range)
CEP generations represented (from ﬁrst to fourth): 20% (2–39), 51% (3–87),
25% (8–73) and 1% (0–5) of total CEP use. Consumption was particularly low
for PEN (<20%) in BG, FI, and ITand was low for CEP (<7%) in FR and LV.
Consumption was high for: CARB (>2%) in ES and SE; for GLYC (>2%) in
ES, GR, and IT; for Q (>13%) in ES, FI, SE, SI, and SK.
Conclusions: In HC, a wide variation in total use of PEN, CEP and Q, as well
as within the CEP generations were observed. Countries do not seem to
cluster in regional supra-national consumption patterns.
O200 Consumption of antibiotics in ambulatory care in
Europe: ﬁrst results of the ESAC retrospective data
collection
M. Elseviers, M. Ferech, R. Vander Stichele, H. Goossens
Antwerp, B
Objectives: ESAC (European Surveillance of Antibiotic Consumption,
granted by DG SANCO of the EC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2001), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: AC use data were provided by 25 countries; 19 were suitable for
international comparison. The remaining ﬁve were not comprehensive (AT,
LT), or not separable from total data, including HC (BG, CZ, IS, TR).
Results: In 2001, AC use in Europe varied between 10.0 DID (NL) and 32.9
DID (FR). Other high consumers were (in decreasing order) GR, IT, LU, PL,
PT, BE and SK, all with a total use >24 DID. During the observation period
of 5 years, consumption clearly increased in GR and PL and decreased in BE
and ES. High seasonal ﬂuctuations in AC use (mean increase> 30% in quarter
one and four compared to quarter two and three) were observed in BE, GR,
PL and SI. High seasonal ﬂuctuations were particularly noted in countries
with high consumption (r¼ 0.77). In 2001, median (range) proportional use
of penicillins (PEN), cephalosporins (CEP), tetracyclines (TET), macrolides
(M) and quinolones (Q) was 45 (31–63), 11 (< 1–23), 10 (2–23), 15 (6–23)
and 7% (1–14) of total use, respectively; the median (range) proportion of
small spectrum PEN, ampicillin/amoxicillin and combination with clavulanic
acid was 10 (<1–66), 45 (12–84), and 32% (<1–59) of total PEN use,
respectively. Large regional differences could be observed in consumption
patterns. Northern European countries (NO, SE, FI, DK, NL, LV) are low
consumers using relatively narrow spectrum PEN and TET more extensively
and less CEP and Q. Southern European countries (PT, IT, GR, FR) are high
consumers using no longer narrow spectrum PEN, but exceptionally high
proportions of CEP, M and Q.
Conclusions: Intriguing high variation in AC use in Europe was observed
and needs to be related to determinants of use and variation in resistance
patterns.
Clinical Microbiology and Infection, Volume 9, Supplement 1, 2003 33
O201 Methodological problems encountered within the
ESAC retrospective data collection
M. Ferech, M. Elseviers, R. Vander Stichele, H. Goossens
Antwerp, B
Objectives: ESAC (European Surveillance of Antibiotic Consumption,
granted by DG SANCO of the EC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, date accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
2002).
Methods: Data were collected by a pre-established protocol, deﬁning a
common format. Additional information was collected by questionnaire:
mid-year country population, covered population, nature of ATC/DDD
assignment process, data provider characteristics; the number of country bed
days (BD) and the BD calculation technique. AC data were to be expressed in
DDD/1000 in./day (DID), while HC data in DDD/100 BD.
Results: The following methodological problems were encountered:
	 Data originate from disparate sources (sales/reimbursement, census/
sample data).
	 Bias is possible from extrapolation from sample data or incomplete census
data.
	 The ATC/DDD assignment process may not be streamlined; most
countries stated to have used ATC/DDD 2002 versions, but we observed
nonstandardized assignment of DDDs for combinations and substances
without ofﬁcial DDD and failure to shift G04A (urinary antiseptics) into
J01.
	 The number of BDs is a problematic denominator; it proved difﬁcult
to reliably and timely estimate BDs and to determine the proportion of
long-term rehabilitation or psychiatric BDs.
	 The mix between AC/HC is varying, as data from nursing homes, day
care centers and policlinic prescribers are differently assigned to AC or
HC.
	 In reimbursement data, bias in comprehensiveness is possible in Austria,
Lithuania, Spain, and Portugal, either because of OTC sales or peculi-
arities in the reimbursement system.
	 In sales data, parallel export or import needs to be determined, as it may
distort the validity of the population exposure estimate (e.g. Greece).
Conclusions: Due to uncertain reliability of BD data, their application as a
comparable denominator at the international level is jeopardized; hence, we
decided to express national HC use data in DID, as in AC. In the upcoming
prospective ESAC data collection, it will be possible to adequately deal with
most of the methodological problems, encountered in the retrospective data
collection.
O202 Data collection performance in the European
surveillance of antibiotic consumption: results for the
1997–2001 retrospective data collection
R. Vander Stichele, M. Ferech, M. Elseviers, H. Goossens
Antwerp, B
Objectives: ESAC (European Surveillance of Antibiotic Consumption,
granted by DG SANCO of the EC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, date accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002).
Methods: Data were collected according to a pre-established protocol,
deﬁning a common format. Additional information was collected by quest-
ionnaire: mid-year country population, covered population, nature of the
ATC/DDD assignment process, data provider characteristics, and country
bed days.
Results: Data from 26 countries were delivered. Two current EU countries
were yet missing (Germany and Ireland) and two ﬁrst wave EU countries
(Cyprus, Estonia). In addition, data from Bulgaria, Croatia, Iceland, Norway
and Turkey were available. Two countries could only deliver aggregated total
data (Iceland, Turkey), two countries only AC data (Austria, England), one
country only HC data (Malta), two countries only total and HC data
(Bulgaria, Czech Republic), and 19 countries were able to deliver both
AC/HC data separately. Hence, AC data were available from 25 countries and
HC data from 22 countries. AC data were reimbursement data in 11
countries; in the remaining 14 countries, sales data were provided, collected
from companies in two (France, Greece), from wholesalers in nine (Bulgaria,
Croatia, Finland, Iceland, Latvia, Norway, Poland, Turkey) and from com-
munity pharmacists in three countries (Denmark, the Netherlands, Sweden);
in four countries (Austria, Lithuania, the Netherlands, Poland), sample (not
census) data were collected. In all but one country (Belgium), HC data were
sales data (as hospitals are budgeted in most countries). Nine countries
(Belgium, Denmark, England, Finland, Greece, the Netherlands, Poland,
Slovenia, and Sweden) were able to deliver quarterly AC data for all 5 years.
Conclusions: For the ﬁrst time, a credible alternative to industry sources has
been established for the collection of internationally comparable data on
antibiotic consumption in Europe, based on cooperation between regulatory
authorities, scientiﬁc organizations, health insurers, and professional
organizations.
O203 The impact of cycling antibiotics in a surgical ICU:
the Cyclone Trial
H. J. van Loon, M. R. Vriens, A. C. Fluit, A. Troelstra, A. Vos,
C. van der Werken, J. Verhoef
Utrecht, NL
Objective: This study was performed to examine the impact of rotating
different antibiotic classes, quinolone and beta-lactams, on microbiologic
resistance rates, during ﬁxed time intervals, on a Surgical Intensive Care Unit
(SICU).
Methods: Between February 2001 and October 2002, antibiotic policy was
rotated in ﬁve periods of 4months. The ﬁrst cycle levoﬂoxacin was the
empiric antibiotic of choice, followed by cefpirome in the second cycle. The
third cycle levoﬂoxacin was reintroduced and replaced by piperacillin/tazo-
bactam in the fourth cycle. During the last cycle physicians used the hospital
guidelines, with no predominant antibiotic of choice. Sputa and rectal
cultures were taken on admission, during their stay and on discharge from
the SICU. All cultures and susceptibility patterns were analyzed according to
standard microbiological procedures. Resistant strains were stored, for geno-
typing at a later stage.
Results: Four hundred and twenty-six patients were admitted resulting in
3655 unique isolates. Cycle 1 showed a statistically signiﬁcant increase in
resistance to ciproﬂoxacin (RR 0.3; CI 0.2–0.5) and a decrease in piper-
acillin/tazobactam resistance (RR 3.3; CI 1.7–6.5). During the second cycle
there was a statistically signiﬁcant decrease in quinolone resistance and an
increase to the beta-lactams. After reintroduction of levoﬂoxacin in Cycle 3
there was again an increase in quinolone resistance (RR 0.4; CI 0.3–0.6).
Cycle 4 showed increased resistance to all study antibiotics. In the ﬁnal period
(Cycle 5), resistance levels to all study antibiotics decreased.
Conclusion: Our study shows that changing antibiotic policy has impact on
microbiologic resistance patterns. Restriction of levoﬂoxacin showed a
decrease in quinolone resistance in Cycle 2. However, an increase was seen
again after reintroduction of levoﬂoxacin, with a possible prolonged effect
during Cycle 4. This could imply that levoﬂoxacin should have been
reintroduced after a longer interval, or that, due to the chromosomal aspect
of resistance, quinolones might not be the appropriate choice in cycling.
Impact of other factors such as, inﬂux/efﬂux, cross-contamination, choice of
antibiotic pressure and mutation rates still remain unclear. Possibly, quantify-
ing these factors with modeling can give us better insight in which antibiotics
to use and what we can expect.
O204 Adherence to local hospital guidelines for surgical
antimicrobial prophylaxis. A multicenter audit in Dutch
hospitals
M. E. E. van Kasteren, B. -J. Kullberg, A. S. de Boer, J. Mintjes-de
Groot, I. C. Gyssens
Nijmegen, Bilthoven, Utrecht, Rotterdam, NL
Objective: To study the adherence to local hospital guidelines for antimi-
crobial prophylaxis in surgery and explore reasons for nonadherence.
Methods: Prospective multicenter audit of elective procedures, without prior
suspicion of infection, in 13 Dutch hospitals. Antibiotics prescribed were
compared with the local hospital guideline for antibiotic choice, duration of
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prophylaxis, dose, dosing interval and timing of the ﬁrst dose by reviewing
medical records, anesthesia records, nurses’ reports and medication charts.
Results: Between January 2000 and January 2001, 1763 procedures were
studied. Antibiotic choice, duration, dose, dosing interval and timing of the
ﬁrst dose were concordant with the hospital guideline in 90, 83, 89, 43 and
50%, respectively. The most important barriers to local guideline adherence
were lack of awareness due to ineffective distribution of the most recent
version of the guidelines, lack of agreement of surgeons with the local hospital
guidelines, and environmental factors such as organizational constraints in the
surgical suite and in the ward.
Conclusion: This study shows that the adherence to local hospital guidelines
for surgical prophylaxis in the Netherlands is generally good. However,
especially adherence to guidelines on dosing interval and timing needs
improvement. When improving the quality of antimicrobial prophylaxis in
surgery, efforts should be put in developing guidelines acceptable to surgeons,
in adequate distribution of the guidelines and facilitating logistics. Audits of
surgical prophylaxis may help hospitals to identify barriers to guideline
adherence.
O205 Antibiotic consumption and public attitude:
questions and answers
A. Kapaskelis, A. Antoniadou, B. San Josse, M. Nikolaides,
G. Koratzanis, H. Giamarellou
Athens, GR
Objectives: Efforts to reduce antibiotic consumption both in the hospital and
the community have been globally linked to the combat against antimicrobial
resistance. Public attitude components are essential in guiding the develop-
ment of antibiotic policy programs and campaigns in the community.
Methods:A survey to evaluate public opinion and beliefs about antibiotic use
was conducted in Greece – a country with antibiotic overconsumption and
increased resistance rates – through a mailed questionnaire. Three thousand 41
(3041) completed forms were collected out of 5500 dispensed (55%).
Seventy-two per cent (72%) were from the greater area of Attica (more than
half the country’s population) and all social, economic, education levels and
occupations were represented.
Results:Male to female ratio was 1 : 1.17 and 80% of the responders were 16–
44 years of age. Although the majority (80–88%) knew that antibiotic use can
lead to resistance and ineffectiveness of antibiotics and that antibiotics are not
innocent drugs to be taken without prescription (72%), 35–65% of responders
believed that antibiotics can have antiviral and defervescent effects and offer
cure against common cold. Seventy-ﬁve percent (75%) had a course of
antibiotics during the previous 6months and among them 40% for symptoms
of a viral illness. Of interest is that 85–90% expressed that they consult a doctor
to have an antibiotic and that 20% of the population surveyed had some kind
of side-effects from antibiotics. Misconceptions and misuse beliefs were
greater among the older (>75 years), the younger (<24 years) and those
living in the province.
Conclusions: In Greece, antibiotic policy campaigns should aim at increased
awareness among consumers about the ineffectiveness of antibiotics against
viral illnesses and at improving prescribing habits among primary care
physicians.
O206 The use of overnight diagnostic tests to guide
antibiotic prescription in general practice
F. M. MacKenzie, J. P. Reid, I. M. Gould
Aberdeen, UK
Objectives: Antibiotic prescribing is a target for control in most countries in
both primary and secondary care. In the Grampian region of Scotland, an
accelerated bacteriological laboratory examination (ABLE) service has been
made available within primary care over the last 24months in a bid to reduce
antibiotic prescribing. This service and its impact on antibiotic prescribing are
now described.
Methods: As part of the ABLE service, there is a twice-daily delivery of
samples from general practice to the laboratory backed up by the availability of
overnight culture and sensitivity results reported either electronically or by
telephone. Antibiotic prescribing data for the region were collated and
supplied by the National Reimbursement scheme. Laboratory data were
extracted from the laboratory information system.
Results: During 1997 there were 88 antibacterial items prescribed per 100
patients in the Grampian region compared to 84 for the whole of Scotland. In
2001, there were 65 antibacterial items prescribed per 100 patient in
Grampian and 70 for the whole of Scotland. The majority of general practices
make use of the ABLE scheme to some extent. In 2001 the general practices
which made high use (greater than 100 samples per year) of the ABLE system
(n¼ 9) prescribed 56 antibacterials per 100 patients whereas practices which
did not take part in the scheme (n¼ 21) prescribed 68.5 antibacterials per 100
patients. During 2001, 2485 samples were received for processing by the
ABLE route. Most common samples were urines (46.8%), throat swabs
(25.2%) and sputum samples (10.9%).
Conclusions:Use of the ABLE scheme is associated with a reduced number of
antibiotic prescriptions and may be responsible for greater reduction in
prescriptions in the Grampian region compared with the rest of Scotland.
O207 Comparison of antimicrobial prescribing in a
regional infection unit and two medical admission units
A. Cadwgan, K. Wares, N. Finneran, R. Laing, D. Nathwani
Aberdeen, Dundee, UK
Objectives: To assess the quality of recording of sepsis markers prior to the
commencement of antmicrobial therapy as well as the adherence to local
antimicrobial guidelines with regard to the agent used and route of admin-
istration. To compare this with data gathered in a Regional Infection Unit.
Methods: Data was gathered in a Regional Infection Unit (IU) as a pilot for
the main study in Medical Admissions Units (MAUs) across Scotland, data
from the ﬁrst 349 patients in two centers as part of the main study is shown.
Data regarding sepsis markers, antimicrobial agent and route used as well as the
grade of doctor prescribing them was recorded. In addition it was recorded
whether blood for culture had been obtained prior to commencing anti-
microbials. All clinical data was recorded from the admission medical notes
within 24 h of admission to hospital.
Results: Data was collected as part of the main study from two MAUs, this
followed a pilot study including data from an IU. In the main study the mean
age was 68.5 years with a male to female ratio of 55 : 45. With regard to
markers of sepsis: 55 patients (16%) had a fever, 13% were hypothermic and
15% did not have their temperature recorded. Thirty-nine percent had a
HR> 100/min and 3% did not have their HR recorded. Respiratory rate was
>30 in 7% but not recorded in 55%.White blood cell count was raised (>10)
in 52% and not recorded in 15%. Regarding compliancewith local guidelines,
the choice of antimicrobial was in accordance in 51% and the route compliant
in 46%. This is markedly at odds with data from the IUwere these ﬁgures were
86 and 92%, respectively. Blood cultures were taken in 96% of patients in the
IU but only 27% in the MAUs, in only 12 cases (3.5%) were these positive. In
four cases the antimicrobial was changed as a result of the blood culture isolate
and in all four of these the initial choice of antimicrobial was out with the local
policy.
Conclusion: Recording of sepsis markers in the admission notes of patients
commenced on antimicrobial therapy is poor particularly with respect to
respiratory rate. Adherence to antimicrobial guidelines is poor in MAUs in
terms of choice and route of administration, but much better in the IU.
Culture of appropriate specimens was very poor in the MAUs.
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Diagnostics: from gene to machine
O208 Multiplex real-time PCR detection of respiratory
viral targets
K. Templeton, S. Scheltinga, M. Beersma, A. Kroes, E. Claas
Leiden, NL
Objectives: To develop two multiplex real-time PCR reactions for diagnosis
of inﬂuenza virus A (FA), inﬂuenza virus B (FB), respiratory synctial virus
(RSV), parainﬂuenza viruses 1 (PIV1), 2 (PIV2) and 3 (PIV3) and to assess for
use in the diagnostic setting.
Methods:Monoplex real-time PCR assays using molecular beacons as probes
were developed for each virus. The molecular beacons were labeled with
FAM (FA/PIV3), HEX (PIV1), Texas RED (FB/PIV2) and RSV (Cy5) so
that discrimination in a single tube could be determined in one multiplex for
FA, FB and RSV and in the other multiplex for PIV1, PIV2 and PIV3.
Sensitivity for the assays was obtained by comparison with viral culture by 10-
fold serial dilutions of the six different viruses to give a 50% tissue culture
infective dose (TCID50). Speciﬁcity was obtained by testing each reaction
with a range of respiratory viral pathogens. Clinical utility of the assays was
assessed by performing viral culture on 220 respiratory samples and comparing
to PCR. Culture was performed in shell vials of HEL, LLCK2 and HEp2.
Immunoﬂoresence (IF) was performed at 3 days and to conﬁrm any cyto-
pathic effect (Dako, Imagen). The nucleic acids were extracted from stored
samples using theMagnapure (Roche) and run in the twomultiplex reactions.
Results: The same limit of sensitivity was seen in the monoplex reactions and
multiplex reactions, 0.01 TCID50 for FA, 0.001 TCID50 for FB, 0.01
TCID50 for RSV, 0.01 TCID50 for PIV1, 0.001 TCID50 for PIV2 and
0.1 TCID50 for PIV3. The speciﬁcity of both the monoplex and multiplex
assays were also the same and no other viral respiratory pathogens were
detected. In the clinical testing 15 (7%) (two FA, one FB, nine RSV, one
PIV1, two PIV3) were positive by cell culture for one of these six pathogens.
By multiplex PCR 29 (13%) (two FA, one FB, 15 RSV, ﬁve PIV1, six PIV3)
were found positive. Nine of the samples positive only by multiplex PCR
were from patients with another sample culture positive. Using this real-time
PCR methodology results for 30 samples could be obtained in 5 h, including
extraction.
Conclusions: The two multiplex real-time PCR for FA, FB, RSV, PIV1,
PIV2, PIV3 provides sensitive and speciﬁc diagnosis for these respiratory viral
pathogens, which are often investigated by direct IF as rapid results are
important. This assay provides a sensitive and rapid method and is suitable for
diagnostic use and may improve patient management and diagnosis.
O209 Evaluation of a new quantitative ELISA for
Chlamydia pneumoniae serology in comparison to the
microimmunoﬂuorescence test
C. Hermann, A. Oehme, E. Straube, T. Hartung
Constance, Jena, D
Objectives: We have previously shown ( JCM 2002, 40 : 1603–9) a high
variation of 11 different commercial assays for C. pneumoniae serology with
regard to sensitivity and speciﬁcity using sera from healthy donors. This study
showed that the microimmunoﬂorescence test (MIF) still represents the gold
standard although having the disadvantage of subjective evaluation and
laborious performance. We extended this approach now to clinical samples
and focused on the evaluation of a new quantitative ELISA in comparison to a
reference MIF deduced from our previous study.
Methods: Panel 1, 80 serum samples, collected from pneumoniae patients and
panel 2, 50 serum samples selected with low IgG in MIF from COPD, upper
respiratory tract and pneumoniae patients were analyzed for anti-C. pneumoniae
IgG and IgA by the SeroFIAMIF (Savyon) and by SeroCP Quant (Savyon), a
quantitative ELISAwhich allows to deﬁne antibody titers comparable to MIF.
All MIF were performed and analyzed blindly by the same two experienced
persons. panel 3 consisted of 80 serum samples from children negative in both
MIF and PCR from tonsillae or adenoid tissue.
Results: On the basis of the SeroCP Quant ELISA, the sero-prevalence of
anti-C. pneumoniae IgG and IgA in panel 1 was 80 and 66%, respectively (MIF
IgG: 81% and IgA: 75%). The concordance of the results of the MIF and
SeroCP Quant for panel 1 were 94% for determination of IgG and 86% for
IgA. The speciﬁcity of SeroCPQuant compared to MIF was 97% for IgG and
96% for IgA, the sensitivity was 81% for IgG and 65% for IgA. All samples
which were false negative in SeroCP Quant had very low titer in the MIF.
Comparison of the antibody titers measured by MIF and SeroCP Quant in
panel 1 showed a high agreement (IgG: r¼ 0.92; IgA: r¼ 0.84). The sera in
panel 2 were selected from patients with C. pneumoniae infection which
displayed low IgG levels. For this second panel, the concordance of the MIF
results and SeroCP Quant were above 90% for both IgG and IgA. Again, the
antibody titers showed a good correlation (r¼ 0.8). All 80 children were
negative for IgG and IgA in SeroCP Quant, except for one with a low IgG
titer.
Conclusion: The results of this study show that a partially automated ELISA
like the SeroCP Quant resulted in sero-prevalence, sensitivity, speciﬁcity and
titer levels very similar to MIF. The additional advantage of time saving and
objective reading argues for the quantitative ELISAs as a new gold standard in
serology.
O210 Comparison of mono and multiplex real-time
NASBA for the detection of M. pneumoniae, C. pneumoniae
and L. pneumophila in respiratory specimens
K. Loens, T. Beck, P. Sillekens, M. Overdijk, D. Ursi, M. Ieven,
H. Goossens
Wilrijk, B; Boxtel, NL
Introduction: The advantage of nucleic acid ampliﬁcation techniques
(NAAT) is their extreme sensitivity and speciﬁcity when compared to
traditional techniques. A practical shortcoming of the high speciﬁcity is
the detection of only the infectious agent that is searched for. Multiplex
formats should solve this problem. This may however, lead to a decreased
sensitivity in comparison to the individual tests, losing part of the advantage of
NAAT. Therefore, there is a need for a comparison between mono and
multiplex NAAT.
Objectives: The aim of the study was to develop a real-time multiplex
NASBA assay for the detection of M. pneumoniae, C. pneumoniae and
L. pneumophila in respiratory specimens based on NASBA ampliﬁcation of
16S rRNA target sequences using the NucliSens Basic Kit1 (bioMe´rieux).
Methods: Oligonucleotide primers were derived from the M. pneumoniae,
C. pneumoniae and L. pneumophila 16S rRNA. The assay was developed using
the NucliSens Basic Kit. For real-time detection, molecular beacons were
used. Speciﬁcity was established on a panel of bacterial strains. The analytical
sensitivity of the assay was determined by testing dilutions of aM. pneumoniae
and C. pneumoniae reference strain, and different L. pneumophila serotypes and
Legionella species in lysisbuffer, or added to pools of respiratory specimens.
Subsequently, a limited number of M. pneumoniae, C. pneumoniae and
L. pneumophila positive and negative clinical specimens were analyzed. The
results obtained with the multiplex NASBA were compared to the results
obtained with the mono real time assays.
Results: Speciﬁc detection of the 16S rRNA-derived amplicons was achieved
by each method. The sensitivity of the multiplex assay was comparable to the
sensitivity of the mono-real time assays although the multiplex assay seems to
be a little less sensitive than the mono assays: 16/17 of M. pneumoniae PCR
positive specimens, 2/2 of C. pneumoniae PCR positive specimens and 5/6 of
L. pneumophila positive specimens were positive by multiplex NASBA,
whereas all 100 PCR negative specimens were conﬁrmed by multiplex
NASBA.
Conclusions: The real-time multiplex NASBA could become a fast, useful
and userfriendly diagnostic tool for the detection of M. pneumoniae,
C. pneumoniae and L. pneumophila in respiratory specimens. Further evaluation
on larger numbers of clinical specimens is necessary.
O211 Molecular panels may help deﬁne the etiology of
acute viral gastroenteric syndromes
C. Minosse, M. S. Zaniratti, S. Calcaterra, F. Carletti, M. Pisciotta,
P. Narciso, G. Anzidei, M. R. Capobianchi
Rome, I
Objectives: Several viruses, including enteroviruses, rotaviruses, adeno-
viruses, noroviruses and astroviruses, may be involved in acute viral
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gastroenteritis; however, a high proportion of diseases remains undiagnosed,
due to the lack of appropriate laboratory methods. Since virus cultivation is
not applicable to most enterotropic viruses, we used molecular methods to
investigate virus prevalence in fecal specimens of patients with acute none-
pidemic gastroenteritis (ANEG).
Methods:Retrospective evaluation was carried out on fecal specimens sent to
the laboratory in the period December 2000–September 2002, stored at
808C. Nucleic acids were extracted by the Boommethod. Primer sets to be
used in RT-PCR or PCR were deducted from literature. Nested sets of
primers were used for enteroviruses, HAV,HEV, and adenoviruses. Amplicons
were visualized by ethydium bromide staining. Virus identiﬁcation and
genotype assignment were obtained by RFLP and/or sequence analysis of
PCR products.
Results: The analyzed samples were 103. Based on the speciﬁc medical
request accompanying each specimen, only 15 cases (14.6%) would have been
correctly diagnosed. When applying the entire panel of PCR, 37 samples
(35.9%) resulted positive to one or more viruses: 10 samples (9.7%) gave
positive results to enteroviruses; rotaviruses were documented in 12 cases
(11.6%); astroviruses and Norwalk virus were found in four and ﬁve cases (3.9
and 4.8%), respectively. Adenoviruses were found in 10 cases (9.7%); HAV
was found in two cases (1.9%); no case was HEV-positive. Among pos-
itive samples, multiple viral genomes were detected in ﬁve cases (4.8%),
involving rotavirusþ adenovirus (one case), enterovirusþ rotavirus (two
cases), rotavirusþ astrovirus (one case), rotavirusþ adenovirusþ entero-
virus (one case).
Conclusion: The results indicate high virus prevalence in feces from
ANEG patients, involving most frequently rotaviruses, adenoviruses and
enteroviruses. The concomitant release of multiple viruses is not rare. Based
on the speciﬁc medical request, only less that half of cases would have been
diagnosed as virus-associated, while the application of the entire panel
substantially ampliﬁed the rate of virus detection. Our data indicate the
urgent need for establishment of sensitive and speciﬁc molecular diagnostic
panels able to concomitantly investigate the presence of enterotropic viruses,
to be applied in the screening of both sporadic and epidemic forms.
O212 Repetitive element sequence-based PCR using
Intergenic Dyad Sequences: a new typing method for
nonencapsulated Hemophilus strains
G. Bruant, S. Watt, R. Quentin, A. Rosenau
Tours, F
Objectives: Our aim was to develop a repetitive element sequence-based
PCR (rep-PCR) assay as a typing method for nonencapsulated Haemophilus
strains using a primer based on short repeated elements called Intergenic Dyad
Sequences (IDSs), which have been described in severalHaemophilus genomes
and only in two other bacterial genera.
Methods:This study included 90Haemophilus strains: 66 nontypeable clinical
isolates of Haemophilus inﬂuenzae (NTHi) from genital and respiratory tract
infections, four reference strains, and 20 genital strains belonging to a cryptic
genospecies of Haemophilus. IDS-PCR was carried out in high
stringency conditions (2.5mM MgCl2 and annealing temperature of 508C)
with Pfu Turbo DNA polymerase. The resulting patterns were visualized by
ethidium bromide staining, photographed, and compared with the help of a
computer program. Statistical analysis: (Chi-square test and two-tailed Fisher’s
exact test) and determination of the discrimination index (D) were
realized.
Results: The IDS-PCR technique was rapid, easy to perform and reprodu-
cible, with a high discriminatory capacity. The 70 NTHi strains were
extremely diverse, yielding 66 different banding patterns (D> 0.99). Epi-
demiologically related strains gave similar or identical ﬁngerprints and all of
the unrelated strains except two showed different patterns. For the 20 genital
strains usually identiﬁed as being biotype IV NTHi and belonging to a cryptic
genospecies of Haemophilus with a remarkable genetic homogeneity, four
bands were signiﬁcantly present and six bands were signiﬁcantly absent from
the ﬁngerprints (P< 0.01). The 20 strains were clustered in 11 closely related
proﬁles (D¼ 0.91). This method improved the differentiation previously
obtained within this species by ribotyping and multilocus enzyme electro-
phoresis.
Conclusion: These results suggest that IDS-PCR is a reliable and discrim-
inatory method for the typing of NTHi strains and can be used to distinguish
cryptic genital strains from NTHi strains.
O213 Molecular identiﬁcation of eight bacteria involved
in bacterial meningitis by PyrosequencingTM technology
C. by Fock, S. Hjalmarsson, M. Krabbe, L. Engstrand
Uppsala, S
Objectives:Bacterial meningitidis is a serious infection caused by a number of
bacterial species. Untreated, the infection can lead to permanent debilitation
or death. We have developed a molecular method that can identify and
differentiate between the eight species most commonly the cause of bacterial
meningitis: Neisseria meningitidis, Haemophilus inﬂuenzae, Streptococcus pneumo-
niae, Streptococcus agalactiae, Listeria monocytogenes, Staphylococcus aureus, Escher-
ichia coli and Enterobacter cloacae.
Methods: The method presented here is a single PCR ampliﬁcation of a
region within the 16S rRNA gene followed by a DNA sequencing step using
Pyrosequencing technology. The two sequencing primers (MenDf and
MenFr) used in the DNA analysis were chosen to target a conserved region
followed by a highly variable DNA sequences of the 16S gene.
Results: A total of 78 strains including reference strains were used in
optimization of the method. In order to measure the validity of the test,
the ﬁrst base that differentiates one strain from the other eight was inspected in
the sequencing results. In this way, 97.4% of the tested bacterial strains were
successfully typed using the sequencing primers MenDf and 98.7% byMenFr.
Experiments to determine the sensitivity of the method was performed both
using dilutions of DNA templates, as well as on dilutions of bacteria added
before DNA preparation. The sensitivity and the accuracy of the method will
be discussed.
Conclusions: The method presented in this study is a DNA sequencing
method for rapid and accurate identiﬁcation of the eight most common
bacteria causing bacterial meningitis. Added together, the two obtained DNA
sequencing strings (each of about 30 bases) carried enough discrim-
inatory power for proper species identiﬁcation of the bacteria involved in
this disease.
O214 Modeling the combined predictive value of ELISA
and Western blot for Lyme disease in a Danish population
with a Bayesian network
R. B. Dessau, F. Skov
Næstved, Nykøbing Falster, DK
Objectives: To asses the speciﬁcity and predictive value of the routine ELISA
test by measuring the prevalence of antibodies in the healthy adult population
(blood donor samples), and to make an assessment of the added value of a
‘conﬁrmatory’ Western blot in a theoretical model.
Methods: IgM and IgG serology was performed with IDEIATM Borrelia
burgdorferi IgG and IgM (DAKO); Western blot was performed with Lyme
Blot IgG and IgM (DAKO) on the positive samples. Modeling of a Bayesian
network using a graphical development software (http://www.hugin.dk).
The Bayesian network models the probability of active Lyme disease con-
sidering the test results in the context of other variables such as false positives,
previous Lyme disease.
Results: In 382 blood donors 6 (approximately 2%) were ELISA IgG positive,
all six were alsoWestern blot positive. Seven were ELISA IgM positive, one of
these only wasWestern blot IgM positive. None of these ELISA positive had a
history of Lyme disease. However, eight other ELISA IgM and IgG negative
donors had been treated for Lyme disease.
	 As an example the prediction of the model in a patient population
suspected of Lyme arthritis the pretest probability of disease was set at 1%.
	 The predictive probabilities of Lyme disease for IgM positive/IgG
negative does not differ signiﬁcantly from the pretest probability.
	 The predictive probabilities of Lyme disease for IgG positive/IgM
negative ranged from 14% in the ELISA IgG positive to 3% in the
Western blot negative.
Conclusions:
(1) If both IgM and IgG is ELISA positive, the probability of Lyme disease is
relatively high, and there is no need for Western blot.
(2) If IgG ELISA is positive, a positive Western blot does not help to
distinguish between previous and current Lyme disease. If Western blot
negative the probability of Lyme disease is somewhat lower.
(3) IgM results are of limited value in the diagnosis of possible Lyme arthritis,
because of low sensitivity and speciﬁcity. IgMWestern blot does not seem
change the calculated probability of Lyme disease.
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(4) Building and using a Bayesian model may support the understanding of
the limitations of Lyme serology. However the ﬁnal diagnostic decision
rests with the clinician based on the total evaluation of the patient.
O215 Evaluation of laboratory diagnostics for
diphtheria within European Union member states and
associated countries
C. Kelly, A. Efstratiou Partners of the DIPNET programme and the
European Laboratory Working Group on Diphtheria (ELWGD)
Objectives: The DIPNET programme is a diphtheria surveillance network
(DG SANCO 122/SID/2001) led by the PHLS with representatives that
include the key microbiologists and epidemiologists from 15 member states
and nine associated countries. One of the main objectives of DIPNET is to
determine criteria for the standardization of protocols for the microbiological
and epidemiological surveillance of diphtheria. This project will enable the
evaluation of optimal methods and typing strategies and support their
dissemination to reference centers worldwide.
Methods: In September 2002, questionnaires were sent to diphtheria labora-
tories throughout Europe to ascertain details regarding the reference services
provided within their country, laboratory diagnostic testing procedures,
epidemiological typing studies, availability of culture collections, andmethods
of population immunity screening. Information regarding current methodol-
ogies for biotyping and identiﬁcation of pathogenic corynebacteria including
primary selective media, biotyping, toxigenicity testing, and antibiotic sensi-
tivity testing were requested.
Results: Seventy-one percent of the centers that received the questionnaire
were national reference centers for their country, although a further 10% had
applied for designation. Ninety percent of the centers provided a service for
their entire country and 19% also provided a services for cultures referred from
other countries. The number of isolates received, the number of diphtheria
cases identiﬁed, and the proportion that were associated with travel all varied
greatly between countries. The importance placed on diphtheria as a public
health priory was perceived differently in the various countries. Only 23% of
the countries questioned routinely screened throat swabs for the presence of
pathogenic corynebacteria. There was some variability in the methodologies
and control strains used for biotyping tests and the Elek test. Thirty-three
percent of the centers performed epidemiological typing, the most common
was ribotyping. Seventy-six per cent of the centers performed serological
testing for diphtheria antitoxin levels.
Conclusions: Standardization of methodologies for reference laboratories is
essential, especially for toxigenicity testing and molecular typing. Given the
immense public health implications associated with the isolation of a toxigenic
diphtheria strain, laboratory diagnostic expertise must be maintained.
O216 Ruling out Bacillus anthracis: Evaluation of
methodology
J. Papaparaskevas, M. Papadimitriou, D. P. Houhoula,
N. Mageropoulou, G. Saroglou, N. J. Legakis, L. Zerva
Athens, GR
Objectives: A panel of conventional tests is applied for the rapid and
reliable identiﬁcation of Bacillus anthracis (BA). During a 12-month period,
199 environmental samples suspected of being contaminated with BA
spores were submitted for examination and 72 Bacillus strains (all non-
BA) were isolated. These strains were used to validate and optimize
conventional and molecular methodology for identiﬁcation or ruling out
of BA.
Methods: Seventy-two non-BA Bacillus strains isolated from environmental
samples were studied retrospectively. Morphology and hemolysis types were
compared on human, horse and sheep blood agar plates (BAP-hu, BAP-ho,
BAP-sh). The presence of a capsule was determined after plating on nutrient
agar with 0.7% NaHCO3 and India ink staining. Motility was tested in H2O
and TSB at 0 and 2 h of incubation. Selectivity of PEA (selective for non BA
strains) and PLET agar (selective for BA strains) were evaluated. Three PCR
assays targeting a 152 bp (chromosomal), a 747 bp (pOX1 plasmid) and a
264 bp (pOX2 plasmid) sequence of BAwere used for deﬁnitive identiﬁcation
of BA.
Results: Discrepant results of colony morphology (type of hemolysis,
Medousa head and ground glass appearance) were detected in 45 (62%)
isolates grown on the three different BAPs. Beta-hemolytic colonies were
produced by 62, 61 and 51 isolates (86, 85 and 71%) plated on BAP-ho, BAP-
hu, BAP-sh, respectively. Motility at 0 h of incubation was detected in 33
(46%) and 45 (63%) isolates tested in H2O and TSB, respectively
(P< 0.00001). Incubation of 2 h in TSB revealed 13 (81%) additional motile
strains, while 3 strains tested in H2O lost motility (P< 0.00128). Twenty-four
isolates grew on PLET agar (speciﬁcity 67%) and all except 1 grew on PEA
agar (sensitivity 97%). Capsule was produced by 2 isolates (incidence 3%).
While plasmid sequences were not detectable by the respective PCR assays
(speciﬁcity 100%), the chromosomal sequence was ampliﬁed in 7 isolates
(speciﬁcity 90%). Five of these strains were among the 24 that grew on PLET
agar (P¼ 0.037).
Conclusions: In order to improve timely identiﬁcation of BA isolates, plating
on BAP-ho or BAP-hu andmotility testing after incubation in TSB for 2 h are
recommended. Chromosomal DNA PCR demonstrates speciﬁcity problems
and needs to be complemented with testing for plasmid sequences. Although
PLETagar supported the growth of a considerable number of non-BA strains,
it is still useful as a screening plate.
O217 Comparative evaluation of the VITEK 2 Advanced
Expert System in ﬁve UK hospitals
T. Winstanley, J. Barry, A. Brown, U. Lakhani, D. Petts, V. Ensor,
C. Warren
Shefﬁeld, Birmingham, Dundee, London, Essex, UK
Objectives: A multicenter study was carried out to evaluate the performance
of VITEK1 2 AES in comparison with the routine antibiotic susceptibility
methodology of ﬁve UK Clinical Microbiology laboratories and with a
reference agar dilution method.
Methods: Laboratories tested a collection of 82 strains (nine enterococci, 29
staphylococci, 36 strains of Enterobacteriaceae and eight Pseudomonas aeru-
ginosa) selected on the basis of their challenging and characterized resistance
mechanisms. Over 5000 MICs were determined with VITEK1 2 in the ﬁve
centers.
Results: In comparison with the reference MIC method, VITEK1 2 gave an
overall essential agreement of 96.5% (enterococci), 96.7% (staphylococci) and
95.5% (Gram negative bacilli). Corresponding category (SIR) agreements
with VITEK1 2 were 98.0, 95.8 and 94.4% (overall 95.1%). Using ﬁve
routine methodologies, category agreement ranges were 92.1–100% (mean
95.3%), 95.7–100% (mean 97.1%) and 89.5–96.5% (mean 93.5%) for the
three organism groups with an overall agreement of 95.0%. In contrast to
VITEK1 2 AES, routine microbiology laboratories did not attempt to detect
resistance mechanisms for every antibiotic studied. VITEK1 2 AES achieved
100% agreement with reference data for resistance mechanisms in enterococci
(where applicable, routine methods achieved 73.7, 52.6 and 52.6% agree-
ment); 83.3% agreement with reference data for staphylococci (routine
methods achieved 76.7, 66.7, 60.0 and 56.7% agreement) and 68.2% agree-
ment with reference data for Gram negative bacilli (routine methods achieved
68.2, 52.3, 34.1 and 22.7% agreement).
Conclusions: The success of VITEK1 2 AES may be attributable to the
use of a heavy inoculum in a broth test, which may account for better
expression of resistance mechanisms compared to their expression in agar-
based tests.
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Current issues in the treatment of respiratory tract infections with antibiotics (Symposium arranged by Pﬁzer)
S226 Characteristics of antibiotic classes used for
treatment of lower respiratory tract infections
A. I. M. Hoepelman
Utrecht, NL
Antibiotics are the mainstay of treatment for community-acquired pneu-
monia. Current guidelines for their empiric use are based largely on clinical
experience and/or their in vitro activity. Treatment options are simpliﬁed if an
etiologic diagnosis is established or highly likely on the basis of rapid tests, such
as Gram staining, antigen detection, or ampliﬁcation techniques. The selec-
tion of antimicrobial agents is based on multiple variables, including the
severity of illness, the patient’s age and ability to tolerate side-effects, clinical
features and comorbidity, prior exposure to antibiotics, the epidemiological
setting, and treatment cost, as well as the prevalence of drug resistance among
respiratory pathogens. Numerous antimicrobial agents are available for the
treatment of lower respiratory tract infections (RTIs), but beta-lactams,
macrolides, the azalide azithromycin, and ﬂuoroquinolones are used most
frequently. The agents should be compared on a variety of levels: pharma-
cological properties, adverse effects, drug interactions, dosing regimens, and
pharmacoeconomics are of particular importance. The pharmacokinetic and
pharmacodynamic properties of individual compounds can be integrated to
predict whether the antimicrobial concentration at a particular body site will
be effective. Antimicrobial agents that have time-dependent activity should be
administered in a manner that optimizes the time for which the serum
concentration exceeds the pathogen’s minimal inhibitory concentration
(MIC). Antibiotics in this category include beta-lactams, erythromycin,
clarithromycin, trimethoprim-sulfamethoxazole (TMP-SMX), and clinda-
mycin. By contrast, antimicrobial agents, such as ﬂuoroquinolones, that have
concentration-dependent activity should be administered so as to maximize
the degree to which the peak serum concentration exceeds the pathogen’s
MIC. Antibiotics used to treat RTIs should be effective against the most
common pathogens. It is increasingly important to consider activity against
beta-lactamase-producing organisms, penicillin-resistant Streptococcus pneumo-
niae, and atypical pathogens. The current advantages and weaknesses of beta-
lactam/beta-lactamase inhibitor combinations, TMP-SMX, tetracyclines,
macrolides, cephalosporins, azalides, and ﬂuoroquinolones will be reviewed.
Clinical studies are required to conﬁrm that advantages predicted on the basis
of pharmacological arguments translate into real improvements in clinical
outcomes. Some of these studies will be discussed.
S227 Atypical pathogens in lower respiratory tract
infections
F. Blasi
Milan, I
The term ‘atypical pathogens’ indicates a number of microorganisms that can
cause so-called ‘atypical pneumonia’ and other respiratory (and probably
nonrespiratory) diseases. The most important bacteria included in this group
are Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella species.
M. pneumoniae infection occurs worldwide without signiﬁcant seasonal
ﬂuctuations, and is both endemic and epidemic. Legionella species have been
consistently isolated from a variety of manmade water reservoirs during
nosocomial and community-acquired outbreaks. Direct inhalation from
Legionella-contaminated water supply systems is the most likely mode of
transmission. Patient isolation is not mandatory, as no evidence of person-to-
person transmission has been reported. The incidence of Legionella infection,
which occurs worldwide, is highly variable ranging from 1 to 27% of cases of
community-acquired pneumonia (CAP). The clinical severity of Legionella
pneumonia ranges from mild respiratory disease to fulminating pneumonia.
C. pneumoniae has been recognized as a cause of respiratory tract infections and
is considered the most common nonviral, intracellular, human respiratory
pathogen. C pneumoniae accounts for 6 to 20% of cases of CAP, depending on
several factors, such as the setting of the population studied, the age group
examined, and the diagnostic methods used. The frequency of pneumonia
due to atypical pathogens has varied considerably during the past decade.
However, these pathogens have become accepted as relatively common causes
of pneumonia in both outpatient and inpatient settings, and are often present
as coinfections. Studies have shown improved outcomes for CAP patients
who received therapeutic regimens effective against atypical respiratory
pathogens. As well as their involvement in CAP, there is evidence of a role
for Mycoplasma andC. pneumoniae in both acute and chronic asthma. Both in
vitro and animal model studies suggest that atypical agents may play a role in
the pathogenesis of the disease. Preliminary data on C. pneumoniae chronic
infection in patients with chronic obstructive pulmonary disease indicate this
agent as a plausible modulator of the natural history of chronic bronchitis and
emphysema. This modulation is thought to be attributable to the toxic effect
of C. pneumoniae on bronchial epithelial cells, ciliostasis, and the ability of the
organism to increase chronic inﬂammation through pro-inﬂammatory cyto-
kine production.
S228 Pneumococcal resistance in perspective
W. Bishai
Baltimore, USA
Although rates of resistance among pneumococci are rising for important
drug classes such as beta-lactams, macrolides, and ﬂuoroquinolones, a debate
remains as towhether there is a corresponding increase in the rate of treatment
failure. This controversy may also be viewed as whether microbiologic
resistance determinations in vitro are predictive of treatment outcome in
vivo. A number of studies have addressed the question of whether clinical
outcome is affected by the presence of penicillin resistance in patients with
pneumococcal disease. While it is generally accepted that drug-resistant
Streptococcus pneumoniae (DRSP) meningitis is associated with a poor outcome
when penicillin alone is used, treatment failure in DRSP respiratory tract
infections has yet to be demonstrated convincingly. Clinical studies of
pneumococcal pneumonia and/or bacteremia have assessed the treatment
outcome following infection by DRSP compared with the course of infection
by drug-susceptible isolates among the same population. Some studies have
also evaluated outcome according towhether the patient received appropriate
therapy for DRSP. A number of factors might contribute to the observed lack
of clinically signiﬁcant outcome differences between drug-susceptible and
drug-resistant pneumococcal infections. Amajor difference is that many of the
drugs used to treat pneumococcal infection achieve high levels of tissue and
plasma concentration, while the NCCLS break points for intermediate and
full resistance are relatively low. A second factor that may play a role in clinical
outcome is the immunomodulatory activity of macrolides. Recent studies of
patients with severe pneumonia have demonstrated a beneﬁcial effect of dual
therapy with a beta-lactam plus macrolide over monotherapy, usually with a
ﬂuoroquinolone. These new data, as well as information on current guidelines
for managing community-acquired pneumonia in the setting of potential
resistance, will be discussed.
S229 The current role of macrolides in the treatment
of CAP
M. Niederman
Mineola, USA
Macrolides remain an important therapeutic option in the management of
community-acquired pneumonia (CAP), being suitable for use either as
monotherapy in selected patients without complex disease, or as part of a
combination regimen in complicated patient populations. Although some
experts have viewed quinolones as the ﬁrst-choice treatment for CAP, this
view is not expressed in the latest American Thoracic Society guidelines,
which recommend macrolide monotherapy for both outpatients and inpa-
tients with no cardiopulmonary disease and a low risk of infection with
drug-resistant Streptococcus pneumoniae (DRSP) or enteric gram-negatives.
Azithromycin is more cost-effective than a broader-spectrum regimen in
qualifying inpatients, and a macrolide/beta-lactam combination is as effective
as quinolone monotherapy for individuals managed anywhere except the
intensive care unit. There, patients require either a macrolide or a quinolone,
combined with other agents, depending on whether risk factors for infection
with Pseudomonas aeruginosa are present. In appropriate patients, macrolide
monotherapy is not only cost-effective but also represents the most focused
therapy possible, avoiding unnecessary broad-spectrum coverage, which
could drive future antibiotic resistance. Used in combination with a beta-
lactam, macrolide therapy provides coverage of atypical pathogen coinfection,
affording reductions in both mortality and length of stay, compared with
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beta-lactam monotherapy. A beta-lactam/macrolide combination is also an
important, effective alternative to quinolone monotherapy; CAP patients
recently treated with a quinolone have an enhanced risk of infection with a
quinolone-resistant pneumococcus. Although macrolide-resistant pneumo-
cocci are becoming more prevalent, this has rarely led to clinical failure,
except in patients incorrectly assigned to macrolide monotherapy. The
relatively low rate of clinical failure with this therapy may be due to resistance
being commonly mediated by an efﬂux, and not a ribosomal, mechanism,
which produces a level of resistance that can generally be overcome by the
excellent penetration of macrolides into respiratory secretions. Ribosomal
resistance is more of a potential clinical concern, and patients at risk of
infection with DRSP should receive macrolides in combination with selected
beta-lactams. Used in this way, macrolides remain a safe and valuable option
for the therapy of CAP, both in and out of the hospital.
What can a molecular typing service mean for a clinician (Symposium arranged with ESGEM)
S230 What contribution does molecular typing make to
patient care?
H. Humphreys
Dublin, IRL
In the management of an individual patient with infection, the identiﬁcation
of a pathogen and conﬁrmation of its anti-ineffective susceptibilities are the
major priorities. However, the typing of pathogens has a signiﬁcant role to
play in the management of the individual patient and in the management of
infection generally. Clusters of infection are common, including in hospitals,
and it is important to try to determine whether these occur by chance, from a
common source, or as a result of cross-infection. Typing, especially using
molecular methods, is the most useful approach to determining which of
these is most likely. Examples include clusters of pseudomonal infection in
ICU or the pattern of MRSA infections throughout a hospital. In the case of
the individual patient who has a serious bloodstream infection, it can be
difﬁcult to distinguish recurrence, i.e. failure to eradicate in the ﬁrst instance,
from re-infection, i.e. a second infection with a different strain. This
distinction has signiﬁcant implications for therapy as recurrence may require
a surgical approach as well as antibiotics. Typing of organisms in this setting
therefore has the potential to guide more effective management of the
individual patient. The challenges for molecular typing are to answer these
and other questions, not only reliably, but within a realistic time-frame. In this
way, infection may be prevented by earlier recognition of cross-infection and
antibiotics better targeted on the basis of a deeper understanding of the
pathogenesis.
S231 Molecular typing for infection control: when, how,
and how much?
P. T. Tassios
Athens, GR
Everybody knows that successful infection control relies on successful team
work. So how can molecular typing, with its increasingly diverse and
sophisticated methods, become a truly integrated contributor to infection
control?
	 When (in which cases? how often?) should molecular typing information
be requested regarding a nosocomial infection? When (how fast? how
frequently?) should the answers from typing be given?
	 How (which methods? in answer to what kind of questions?) can
molecular typing information help in the most economical and produc-
tive way? How should typing results be interpreted? And how could they
be used to assist infection control decisions?
	 How much sophistication in molecular typing is useful? How much
should clinicians expect from molecular typing data? And how much
should they rely on them.
To illustrate and partly answer the above (and other related) questions,
examples from the presenter’s experience and the published literature will
be used – but, more importantly, challenges and contributions from the
participating audience are encouraged and will be gratefully taken up.
Epidemiology and management of multidrug-resistant tuberculosis in Europe
S232 DNA typing of Mycobacterium tuberculosis
isolates for epidemiological research
D. van Soolingen, P. de Haas, P. Supply, H. van Deutekom, M. Sebek,
K. Lambregts, K. Kremer
Bilthoven, NL; Lille, F; Amsterdam, Den Haag, NL
Objective:To give an overviewof the main achievements of the application of
DNA typing of Mycobacterium tuberculosis isolates.
Methods: Molecular epidemiology on basis of IS6110 restriction fragment
length polymorphism (RFLP) typing.
Results: In the Netherlands, from 1993 on strain typing has been used to
support the contact tracing. Before IS6110RFLP typing results were reported
to the regional TB nurses, the relationship between patients was ‘expected’ in
462 (21%) patients. After cluster feedback on basis of RFLP analysis,
epidemiological links were documented in 551 (25%) cases and assumed
in 432 (20%) cases. Unfortunately, not all identical DNA ﬁngerprints of M.
tuberculosis isolates indicate recent transmission. Even with extended inter-
views not all transmissions can be explained. Recently, a part of the isolates of
patients with known and unknown links grouping in clusters on the basis of
IS6110 RFLP typing were subjected to VNTR typing. Four of 11
clusters comprising patients with unknown links were re-grouped in smaller
clusters on the basis of VNTR typing. Recently, it was found in Ho ChiMinh
City, Vietnam, that 25% of the relapses after curative treatment are due to
infections caused by new strains. In the Netherlands 29/183 (16%)
isolates from patients with reported tuberculosis infection or disease before
1981 were found in recent-transmission clusters presumably reﬂecting re-
infection. With DNA ﬁngerprinting it was found that, in the Netherlands, in
the period 1993–2000, 2.4% of the positiveM. tuberculosis cultures were due to
laboratory cross-contamination. Furthermore, it was demonstrated that ﬁve
patients contracted severe M. bovis BCG infections caused by nosocomial
transmission in pharmacies. Strain typing in different geographic areas has
revealed that the population structure of M. tuberculosis differs signiﬁcantly
between settings with a low and a high incidence of tuberculosis. In Asia, the
M. tuberculosis Beijing genotype is highly prevalent, and this genotype is
associated with drug resistance in some areas. Research on the immuno-
pathology caused by strains of differentM. tuberculosis genotypes in a BALB/c
mouse model revealed that Beijing genotype strains are also extremely
virulent.
Conclusion: DNA typing of M. tuberculosis isolates has greatly facilitated the
possibilities to study transmission of tuberculosis at various scales. The new
insights into the population structure of this bacterium will contribute to
future vaccine development.
S233 Current and future drug treatment for tuberculosis
P. D. O. Davies
Liverpool, UK
Isoniazid and rifampicin are the most important drugs in the treatment of
tuberculosis. The effective mycobacterial killing power of isoniazid rapidly
renders the patient sputum smear negative and therefore noninfectious.
Rifampicin is the best drug at eliminating persistent organisms and therefore
enables treatment to be reduced to less than a year. A third drug, pyrazinamide,
given in combination with the ﬁrst two drugs for the initial two months
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enables treatment to be reduced to a total of six months. In practice, because of
increased drug resistance, a fourth drug, usually ethambutol is also given for
the ﬁrst two months or until sensitivity results are available. Streptomycin can
be used as an alternative to ethambutol in severe disease such as tuberculous
meningitis. Because of the increasing problem of drug resistance the older
second line drugs are still necessary. broadly these fall into two categories, oral
drugs such as cycloserine, PAS, thiacetazone and ethionamide and injectables
such as amikacin, kanamycin and capreomycin. No new drugs have been
developed speciﬁcally for tuberculosis since rifampicin, 40 years ago but a
number of newer drugs have been found to have activity againstM. tuberculosis.
Of these, the quinilones, oﬂoxacin and ciproﬂoxacin have been found to be
effective in clinical trials. Clarithromycin, the combination of clavulanic acid
and amoxicillin and clofazimine are also effective againstM. tuberculosis. New
approaches using immunomodulation are of limited use. Gene modifaction
such as alteration of the expression of isocitrate lyase, important for bacterial
resistance in the mouse, may also be of use in the future.
Emerging viral zoonoses
S234 Hantaviruses: from asymptomatic infections in
rodents to major human pathogens
A. Vaheri
Helsinki, FIN
Pathogenic European hantaviruses include Puumala (PUUV) and Saaremaa
(SAAV) causing mild HFRS, and Dobrava (DOBV) causing severe HFRS.
These infections may be diagnosed using IgG and IgM EIAs based on the use
of capture antibodies and recombinant baculovirus-expressed nucleocapsid
(N) proteins. The early IgG response is towards N protein. IgG antibodies to
glycoproteins (G1 and G2) develop at convalescence and are more type
speciﬁc. For point-of-care diagnostics, sensitive 5-min IgM-antibody tests
were developed. Serological screening of rodents followed by PCR, genetic
analysis and virus isolation led to discovery of Tula virus (TULV) from
European common voles and Topografov virus (TOPV) from lemmings.
TULV can infect humans but the pathogenicity of TULV and TOPV is not
known. Phylogenetic analyses show that (i) hantaviruses coevolve with their
natural carrier rodents, (ii) genetic variants are clustered according to their
geographic origin, (iii) hantaviruses in individual hosts are represented as
closely related variants (quasispecies), (iv) host-switching can occur during the
evolution of hantaviruses, and that (v) recombination and reassortment can
occur within a genotype. The pathogenesis of HFRS is not well understood.
Increased capillary permeability is thought to be involved. PUUV infection
induces dominant and polyclonal cytotoxic T-lymphocyte responses to the N
protein. In cell culture, hantaviruses cause little or no cytopathic effect.
PUUV-N interacts with the Fas-mediated apoptosis enhancer Daxx and G1 is
apoptotic unless coexpressed with N or the mitochondrial apoptosis inhibitor
Bcl-2. Thus, PUUV may regulate apoptosis. A monkey model for PUUV-
induced HFRS may elucidate the pathogenetic mechanisms. The severity of
NE is associated with HLA B8 DR3 haplotype and correlates with the relative
ease of RT-PCR detection of PUUV sequences from patient blood and urine.
In contrast, HLA B27 is associated with a mild course of NE. As a late
consequence 20% of NE patients develop elevated blood pressure and
proteinuria. Some patients develop hypophyseal insufﬁciency. Studies are
in progress to develop antivirals from phage-display peptide libraries and use
of recombinant proteins (N protein, and G1 and G2 from separate constructs)
as vaccine candidates.When the protective capacity was studied in a bank vole
infectionmodel using DNA immunization, best protection was obtained with
PUUV-N.
S235 West Nile fever: commotion about a (re-)
emerging virus in Europe
H. Zeller, S. Murri, I. Marendat, I. Schuffenecker
Lyon, F
West Nile (WN) virus is an arbovirus from the Flaviviridae family, transmitted
by mosquitoes. It was initially isolated from human in Uganda in 1937. Birds
are involved in the cycle of transmission of the virus as amplifying hosts.
Humans and horses are sensitive to the virus and considered as accidental
dead-end hosts. The geographic distribution included Africa, the Middle
East, India and Southern Europe.West Nile virus was initially considered as an
minor arbovirosis, with no apparent pathogenicity in birds, and usually
inducing a non symptomatic or mild ﬂue-like illness in humans. However
some cases of encephalitis were reported in the 1950s in Israel, in France in
1962–1963 both in humans and horses, and fatal cases in India in children.
Since the last 10 years, several outbreaks with unusual patterns are reported
mostly in the Mediterranean basin with fatal encephalitis cases mainly among
elderly people: Algeria in 1994, Romania in 1996, Tunisia 1997, Russia
(Volgograd) in 1999 and epizootics in horses in Morocco in 1996, Italy 1998
and France in 2000. In 1997–1998, in Israel, WN was identiﬁed in migrating
storks and domestic birds (geese) with clinical symptoms of encephalitis and
paralysis. A large epidemic occurred in 2000. A similar viral strain suddenly
emerged inNewYork during the summer 1999 killing various species of birds
along with cases with fatalities in humans. The virus is now well established in
the NewWorld and the bird mortality is a key indicator for WN surveillance
there. In contrast in Europe no unusual fatalities in birds were noticed during
the last outbreaks. In Israel in 2000, several strains of WN virus were
cocirculating. Phylogenetic studies have shown two main lineages among
the identiﬁedWN strains. Strains from lineage I are circulating in Africa, India
and are responsible for the outbreaks in Europe and in the Mediterranean
basin. Strains from lineage II are circulating only in Sub Saharan Africa and
Madagascar. Studies of the genetic susceptibility of the hosts are in progress.
The immediate adaptation of WN virus in North America shows the
capacities of this arbovirus to disseminate in a continent due to the wide
variety of competent mosquito vectors, the possible role of ticks and the
movements of birds. The virus may circulate widely among birds and
mosquitoes in Europe and a close surveillance may reveal the presence of
the virus in different locations. West Nile viral activity was reported in France
in 2001 and 2002 in monitored sentinel birds in the Camargue area, as well as
in Romania with yearly identiﬁed encephalitis cases in humans since 1997.
West Nile virus will circulate in Europe in 2003 but the occurrence of
outbreaks still remains unpredictable.
Arthropod-borne viral diseases and viral hemorrhagic fever: a threat to Europe?
S236 Molecular biology and pathogenicity of Marburg
and Ebola viruses
H.-D. Klenk
Marburg, D
Marburg and Ebola viruses which are indigenous to tropical Africa cause
fulminant hemorrhagic fever in man and nonhuman primates with mortality
rates up to 90%. Outbreaks are rare, but usually attract a lot of public attention
because of the dramatic course of the disease. The pathophysiological changes
that make these virus infections so devastating are not fully understood, but it
appears that vascular leakage, dysregulation of cytokine production, and
immune suppression are important mechanisms in pathogenesis. The mole-
cular biology of Marburg and Ebola viruses which together constitute the
ﬁlovirus family has been analyzed in recent years in some detail. Filoviruses
have a nonsegmented negative-stranded RNA genome encoding seven
structural proteins: four components of the ribonucleoprotein complex
(NP, VP30, VP35, and L), two matrix proteins (VP40 and VP24), and the
spike glycoprotein. In addition, there are nonstructural, soluble glycoproteins
that are derived from the glycoprotein gene by transcipitional editing and
post-translational processing. The role of these proteins in virus replication,
pathogenesis and immune protection will be discussed.
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S237 Crimean–Congo hemorrhagic fever: a public health
risk for countries of the European Union?
F. M. Cancellotti, I. Capua
Legnaro, I
Crimean–Congo hemorrhagic fever (CCHF) virus is the etiological agent of
a tick-borne zoonosis present in Africa, Asia and eastern Europe which causes
human illness with an approximately 30% fatality rate. The virus is a member
of the Nairovirus genus of the family Bunyaviridae. The disease is widely
distributed in Asia, Africa and eastern Europe. With reference to the
European Union it has been reported in Greece, France and Portugal –
however, it should be stated that the evidence for France, Portugal and
Turkey is based on very limited observations. The virus has been isolated
primarily from cattle, sheep, goats, ostriches and hares and antibodies have
been detected in a range of wild and domestic vertebrates. Infection can be
transmitted by ticks of several genera although experimental and
ﬁeld evidence indicate that the most efﬁcient vectors appear to be members
of the genus Hyalomma. In fact, the world distribution of the virus
coincides with the distribution of these ticks. The virus causes mild infection
with transient viremia in farm and wild animals, while it causes a severe
clinical condition in human beings. The disease is a hemorrhagic fever with a
fatality of 30%. Clinical symptoms are determined by liver and endothelial
damage and impairment of hemostasis. Platelet counts drop dramatically and
there is evidence of widespread hemorrhages. Disseminated intravascular
coagulopathy occurs and contributes to further tissue damage. The present
paper reviews the potential risks of introducing the disease into the European
Union through the movement of live animals or of animal products
from African and Eastern European countries. In particular, the actions
undertaken to prevent the introduction of infected animals or vectors
through the importation of ostriches and ostrich products into the EU are
discussed.
Issues on screening for Chlamydia
S238 Screening programs for Chlamydia are
effective, and cost-effective
G. Schmid
Geneva, CH
Background:The introduction of nonculture tests forChlamydia trachomatis in
the early 1980s enabled widespread screening of women. In the latter 1980s,
the ﬁrst multiyear regional screening program among women resulted in
population prevalences dropping to <0.5 those of initial prevalences. Over
time, and with the advent of increasingly sensitive tests, additional community
and regional screening programs have demonstrated similar falls in prevalence.
That these falls in prevalence are accompanied by lessened rates of pelvic
inﬂammatory disease (PID) was ﬁrst reported from a controlled trial by
Scholes et al. These ﬁndings are supported by data from other intervention
programs, showing that testing is associated with lessened rates of PID and its
complications. That screening programs for young women are cost-effective
has been shown in a number of cost-effectiveness studies. The study designs
are heterogeneous, and cost-saving threshold prevalences for screening range
from a low of about 4% to as high as 14%, with general clustering at about 5–
7%, a threshold prevalence below that found in most populations of young,
sexually active women. Current dilemmas include how best to use newer,
noninvasive Chlamydia tests; how to identify women at highest risk; how to
detect or treat infected male partners; and, at what prevalence of infection will
we no longer recommend screening. Fewer data have examined whether
screening young men leads to lessened rates of complications or to lessened
rates of infection in women. Using noninvasive testing on urine, limited
modeling suggests screening is cost-effective at prevalences at or lower than
those of young women, and prevalence surveys largely ﬁnd prevalences of
infection among young males that rival prevalences among young females.
The few data of the impact that screening young women has on male
prevalences of infection suggest the impact is minimal.
Conclusion: Screening programs forC. trachomatis among young women have
been successful in both decreasing prevalence of infection and complications
of infection. They should be continued, althoughmodiﬁcations must be made
as test options and prevalences change. There are fewer data addressing the
value of screening of young males, although from a clinical and epidemiologic
view, such programs ‘make sense’.
S239 Issues on screening for Chlamydia
A. Meheus, V. Verhoeven, D. Avonts
Antwerp, B
Urogenital Chlamydia trachomatis (CT) is the most common curable sexually
transmitted infection in the developed world, with high prevalence rates in
different settings and population groups. CT is a major cause of pelvic
inﬂammatory disease, ectopic pregnancy and infertility. The economic and
human costs of managing these complications are considerable. The infection
is largely asymptomatic, so early detection strategies are important in pre-
vention and control. However, there are still some gaps in the evidence which
limit support for routine screening. Further research on feasibility and cost-
effectiveness is needed before large-scale screening programs can be imple-
mented. Knowledge of the natural course of CT infection is limited. The
need for screening is dictated by the frequency of serious complications, but
estimations are mostly derived from studies in symptomatic women or from
case-control studies. There is evidence that the rate of complications in
asymptomatic infections is lower than previously thought. This ﬁnding affects
cost-effectiveness calculations. There is no consensus on who is to be
screened. Risk factors for infection vary in time and in different settings,
and criteria for selective screening are setting-speciﬁc. There is evidence that
selective screening of women reduces the incidence of PID. The effectiveness
of screening men in reducing complications in women, in reducing transmis-
sion, or in improving men’s health have not been studied sufﬁciently. It is not
known to what extent screening of selected population or patient groups has
impact on CT prevalence in the general population. The development of
highly sensitive and speciﬁc DNA-ampliﬁcation tests has made noninvasive
testing possible, but these diagnostics should be carefully used in routine
clinical practice or in community screening programs. Conﬁrmatory testing is
recommended to avoid false positive diagnoses but this is not yet a routine.
Furthermore, there are few data to relate a positive ampliﬁcation test with
clinical outcome. Treatment is assumed to be very effective, but microbio-
logical cure has only been studied in the short term. Relapse-or reinfection
rates are insufﬁciently known, but are important to determine screening
intervals. Finally, potential harms from screening have not been studied. These
include stigmatization, fear for infertility and partner discord, and can greatly
affect the quality of peoples’ lives.
New experimental systems: studying bacterial pathogenesis in ameba and nematodes (Symposium arranged
with the ENSEI)
S240 Analysis of bacterial virulence in an ameba host
M. Benghezal, S. Cornillon, P. Cosson
Geneva, CH
Bacterial virulence is a measure of the ability of a bacterium to cause a disease
when confronted to a host organism. Practical and ethical problems limit
severely the use of mammalian hosts, and this has led to the deve-
lopment of alternative host models. We have used Dictyostelium amoebae to
study the complex relationship between bacteria and phagocytic cells. In this
simple system we performed genetic analysis to identify virulence genes in
Klebsiella pneumoniae bacteria, as well as host resistance genes in the ameba
host.
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S241 Caenorhabditis elegans and the study of universal
bacterial virulence factors
J. J. Ewbank
Marseille, F
For certain pathogens capable of infecting a broad range of organisms, there
exist universal virulence factors, necessary for full pathogenicity regardless of
the host. This has been most clearly demonstrated by Ausubel and colleagues
for the human opportunistic pathogen Pseudomonas aeruginosa. As a conse-
quence, one can use nonmammalian model systems, including the nematode
worm Caenorhabditis elegans, to assay for such virulence factors. A signiﬁcant
number of pathogens of C. elegans that provoke a range of diseases, are now
known, including the opportunistic human pathogen Serratia marcescens. After
explaining the practical advantages associated with the use of C. elegans, and
brieﬂy reviewing previous studies, the results of a screen for S. marcescens
virulence factors will be presented.
New aspects of anaerobic infections (Symposium arranged with the ESGARAB)
S242 Characterization of anaerobic bacteria using
MALDI-TOF-mass spectrometry: a novel approach to
characterizing pathogenic microbes
H. N. Shah
London, UK
Changes in global temperature, man’s increased travel and a large number of
agro-economic practices are some of the factors now believed to be con-
tributing to the emergence and re-emergence of many human infections.
Consequently microbiological surveillance is likely to be increased drama-
tically to cater for these needs thus requiring high-throughput techniques that
are simple to perform, reproducible, require minimal sample preparation and
can be compiled and interrogated though assembled databases. MALDI-
TOF-mass spectrometry in a novel technique that fulﬁlls many of these
criteria and is likely to have a major impact in such applications. Only a few
bacterial cells are required for analysis and there is virtually no sample
preparation. Cells are simply placed on a very small sample well (1.5mm
diameter) of an inert stainless steel target plate, a minute amount of an organic
reagent (referred as a matrix solution) added and left to dry for a few minutes.
During this period, the matrix solution cocrystallises with the molecules on
the surface of intact cells. The admixture is then placed into the sample port of
theMALDI-TOF-MS and the energy of a laser beam directed at it. Part of this
energy is transferred to the sample and some molecules are ionized while
others are desorbed (hence the acronym MALDI – matrix-assisted, laser
desorption/ionization). The ions which are negatively and positively charged
travel through a tube within an electrical ﬁeld to a detector at the opposite
end, depending on the mode in which the instrument is set. If for example,
the instrument is set in the positive mode, only negative ions will reach the
detector. The smallest ions will have the fastest ‘ﬂight time’ (hence the
abbreviation ‘TOF, Time of Flight’) and will arrive ﬁrst at the detector and
produce an electrical signal which is seen as a peak on the recorder. This
provides an accurate measurement of the molecular weight of that ion. As
more ions arrive, the output recorder generates a complex proﬁle of the ions
present in a sample in less than 2min These can range from just a few to several
hundred thousand Daltons and covers the molecular masses of proteins which
are orders of magnitude greater than simple organic compounds. Several
factors such as the type of matrix solution, sample preparation, etc. will
inﬂuence the range of ions seen in the mass spectrum. Based on large numbers
of samples, we set up our protocol to collect ions within the range of 500–
10 000Da for comparative analysis of microbes. The microorganisms analyzed
represent many diverse branches of the bacterial kingdom but with a strong
bias towards human pathogens. For every group studied so far, a unique mass
spectrum has been recorded. We are currently assembling a database of these
mass spectral ﬁngerprints in a large collaborative study at three centers;
Micromass UK Ltd (Waters Cooperation), Manchester Metropolitan Uni-
versity and the PHLS, London. One of the great beneﬁts of this multicentre
study is access to bacterial cultures from the National Collection of Type
Cultures. This, the oldest such depository in the world (from 1920), contains
several thousand well-characterized reference microorganisms that are being
used to assemble this core database. The generated database contains the mass
spectral proﬁles of over 2000 species and is now being used to test ﬁeld isolates
from hospitals, etc. It is too early to provide deﬁnitive answers on whether
ﬁeld isolates will be sufﬁciently similar to those present in the database to
enable its rapid identiﬁcation, but early results on approximately 200 isolates
show over 80% success. This is expected to improve as the database expands to
include more species. Mass spectrometry has been used traditionally for
analysis of small molecular weight compounds (c. 1000Da) which often
necessitated prior puriﬁcation or crystallization. The ions in these samples
were produced by a powerful electron beam which fragmented the molecule
to produce a characteristic mass spectrum. The larger molecular ion enabled
an accurate determination of its molecular weight while the fragmentation
pattern of the molecule also helped to piece together its chemical structure.
Because of the size and share complexity of proteins, this powerful technique
remained outside the scope of biomolecules. MALDI-TOF-MS has drama-
tically changed this and is ﬁnding many applications across the ﬁelds of
biology and medicine. In the application discussed here, viz the rapid
identiﬁcation of microbes, there may be additional beneﬁts relating to the
topology of the cell as the data is assembled and analyzed. The bacterial surface
of a cell is dynamic and many pathogenic factors e.g. attachment molecules
that enable cells to adhere to speciﬁc tissues to initiate disease, toxins,
antibiotics resistant molecules, cell-signaling molecules, etc. are located here.
Since MALDI-TOF-MS produces a mass ﬁngerprint of the surface compo-
nents of intact cells, this may shed light on the changes in virulence and
pathogenicity of certain species and help identify novel epitopes and possible
vaccine targets in the process of screening.
S243 Fifty years with anaerobes, or how lucky can
one guy be?
S. Finegold
Los Angeles, USA
I never heard about anaerobes in college (though a Bacteriology major), nor
in medical school, except for a brief introduction to gas gangrene, tetanus and
botulism. I didn’t have formal training in anaerobic bacteriology so I taught
myself, not very well and not very quickly. As a medical student in 1948–
1949, I did bacteriologic studies on dog feces under a Department of Surgery
protocol. ‘Anaerobes’ were grown by inoculating stool dilutions on Brewer
plates. Facultative anaerobes were not recognized, so everything growing on
these plates was called an anaerobe. In 1951, I saw, but did not recognize as
such, my ﬁrst patient with an anaerobic infection; he had putrid empyema
with negative culture of the pus. In 1954, I ﬁrst isolated an anaerobe,
subcultured it, and identiﬁed it as a ‘Bacteroides’. My mentor, Dr William
Hewitt, encouraged me to isolate 100 anaerobes and do antimicrobial
susceptibility studies on them; this almost scared me out of the ﬁeld.
Reviewing the literature was exciting (but difﬁcult, because this antedated
personal computers). I was amazed by how much the French and German
scientists knew in the late 1800 s. I ﬁnally met other people interested in and
knowledgeable about anaerobes and learned a great deal from them. Included
among these were such masters as Louis DS. Smith Ron Gibbons, Peg
Holdeman and Ed Moore, Trevor Willis, Andre Prevot, and Ivan Hall. I had
the pleasure of several extended discussions with Louis Smith, and proﬁtable
and fun visits to the laboratories of Robert Hungate, the VPI group, and Bud
Dowell at CDC. I began clinical studies on anaerobic infections in the mid-
1950s and was amazed at how frequently anaerobes were involved in a wide
variety of processes. I also began bowel ﬂora studies about this time, although I
did do one study as a medical student that was published in 1951 – my very
ﬁrst paper. At ﬁrst, I used line gas, but fortunately our local gas supply was not
very toxic to anaerobes. Eventually, we used cylinders of known gases, an
anaerobic chamber, and a gas chromatograph. Later, we did cellular fatty acid
determinations. Finally, we are doing molecular work, with G þ C deter-
minations, 16S rRNA sequencing, DNA–DNA hybridization, real-time
PCR, etc. One of our major projects currently is evaluating the role of
bowel ﬂora in autism.
Clinical Microbiology and Infection, Volume 9, Supplement 1, 2003 43
In vitro activity of various antibiotic compounds
O244 Comparison of in vitro activity of moxiﬂoxacin
and ciproﬂoxacin against clinical isolates of Acinetobacter
baumannii from hospitals in the UK
R. P. Spence, K. J. Towner
Nottingham, UK
Objectives: To compare the in-vitro activity and mechanisms of resistance of
moxiﬂoxacin and ciproﬂoxacin against clinical isolates of Acinetobacter bau-
mannii from UK hospitals.
Methods:MICs of ciproﬂoxacin and moxiﬂoxacin were determined by E-test
for 226 nosocomial isolates of A. baumannii. PCR was used to screen for
chromosomal mutations in the gyrA and parC genes. Isolates resistant to
ciproﬂoxacin and sensitive to moxiﬂoxacin were examined for the ability to
generate spontaneous moxiﬂoxacin-resistant mutants in the presence of
increasing concentrations of moxiﬂoxacin.
Results: Based on BSAC guidelines, 49.1% (111) of isolates were resistant to
ciproﬂoxacin, and 39.4% (89) showed moxiﬂoxacin resistance. MICs of
moxiﬂoxacin were generally lower than those of ciproﬂoxacin, and no isolates
were moxiﬂoxacin-resistant and ciproﬂoxacin-sensitive. A gyrA mutation at
Ser-83 was found in all ciproﬂoxacin-resistant isolates. Single mutations in
both the gyrA and parC genes at codons Ser-83 and Ser-80, respectively, were
located in all but two of the ciproﬂoxacin and moxiﬂoxacin-resistant isolates.
Ciproﬂoxacin-resistant, moxiﬂoxacin-sensitive isolates generated sponta-
neous moxiﬂoxacin-resistant mutants at up to 8 their initial MIC. However,
none of the mutants generated displayed high-level moxiﬂoxacin resistance
(>8mg/L). The mechanism of resistance to moxiﬂoxacin in these mutants
appeared to be either altered permeability or efﬂux pump-mediated as none of
the mutants possessed the parC mutation associated with moxiﬂoxacin
resistance. Furthermore, the moxiﬂoxacin resistance generated was highly
unstable and was lost if mutants were subcultured onto agar lacking moxi-
ﬂoxacin.
Conclusions: Moxiﬂoxacin demonstrated greater activity than ciproﬂoxacin
against clinical A. baumannii isolates in vitro. A mutation in the gyrA gene
conferred resistance to ciproﬂoxacin in A. baumannii. Mutations in gyrA and
parC genes were required for signiﬁcant resistance to moxiﬂoxacin, although
altered permeability and efﬂux pumps may also be involved. Moxiﬂoxacin-
resistant mutants were not readily selected in vitro at moxiﬂoxacin concen-
trations found in vivo. Moxiﬂoxacin retained potentially useful activity against
some multidrug resistant A. baumannii isolates and could be a useful
therapeutic alternative to ciproﬂoxacin for the treatment of A. baumannii
infections.
O245 In vitro activity of antibiotic combinations against
multiresistant Gram-negative isolates from cystic ﬁbrosis
patients
K. E. Milne, F. M. MacKenzie, I. M. Gould
Aberdeen, UK
Objective: Multi-resistant Gram-negative isolates from cystic ﬁbrosis (CF)
patients were sent from CF centers around Scotland to assess best therapeutic
antibiotic combinations. A league table of appropriate combinations was
constructed.
Methods: Isolates were collected between February 1999 and March 2002.
Ninety-four Pseudomonas aeruginosa, 31 Burkholderia cepacia, 22 Stenotropho-
monas maltophilia and ﬁve Achromobacter xylosoxidans were tested to a variety
of antibiotic combinations using the E-test method with 24 h incuba-
tion. Fractional inhibitory concentration indices were calculated. Six
hundred and ninety-three antibiotic combinations were tested including:
289 aminoglycoside/beta-lactam, 175 ciproﬂoxacin (CIP)/beta-lactam,
51CIP/nonbeta lactam, 42 colistin (COL)/nonbeta lactam, 76
ceftazidime (CAZ)/nonbeta lactam and 60minocycline (MIN)/CAZ or
cotrimoxazole (COTRIM). Each combination was tested on 10–70 bacterial
isolates.
Results: Six percent combinations were synergistic, 30% additive, 63%
indifferent and 1% antagonistic.
Top three synergistic combinations were CAZ/amikacin (AMIK) (24%),
CAZ/gentamicin (GENT) (18%) and CAZ/MIN (15%). The following
combinations showed no synergy: amikacin/imipenem, tobramycin
(TOB)/Meropenem (MERO), CIP/TOB, COL/TOB, COL/CIP,
MERO/CIP, CO-TRIM/CIP and COTRIM/CHLOR. The most fre-
quently additive combinations were TOB/MERO (48%), CAZ/TOB
(46%), CIP/MERO (45%) and CAZ/CHLOR (44%). CIP/TOB (8%)
CIP/COL (8%) and CAZ/COTRIM (9%) showed the least additive effect.
CIP/TOB (92%) and CIP/COL (91%) showed the most indifference. One
hundred and sixty-nine out of 460 combinations were synergistic or additive
against P. aeruginosa, 47/150 against B. cepacia, 20/45 against S. maltophilia and
11/23 against A. xylosoxidans.
Conclusion:Overall, very little antagonism was demonstrated (1.5%) for any
combination although the level of synergy was disappointing (6.1%) Even
though most interactions were either additive or indifferent, results were
considered clinically useful.
O246 Determination of antimicrobial activity of
Quinupristin/Dalfopristin and linezolid against
Enterococci and Staphylococci using disk diffusion method
H. Arslan, O¨. Kurt Azap, F. Timurkaynak, E. Kuru Inci, S. Karaman
Ankara, TR
Objectives: To determine the in vitro activity of Quinupristin/Dalfopristin
(Q/D) and Linezolid (LZD) against recent clinical isolates of enterococci and
staphylococci.
Methods: A hundred and seventy isolates of Staphylococcus aureus (87 methi-
cillin sensitive and 83 methicillin resistant), 76 isolates of enterococci (7
vancomycin resistant) were tested for susceptibility against Q/D (15 mg) and
LZD (30mg). Enterococci were typed to the species level by BBL Crystal
System1.
The strains were isolated from wounds, urine, blood, respiratory tract
infections. The disk diffusion method was performed according to the
National Committee for Clinical Laboratory Standards (NCCLS), 2002.
Staphylococcus aureus ATCC 25923 was used for quality control.
Results:Of the 76 enterococci isolates, seven were vancomycin resistant (six
Enterococus fecalis, one Enterococcus fecium). The disribution of remaning
vancomycin sensitive strains were as follows: 56 E. fecalis (81%), nine E.
fecium (13%), one E. casseliﬂavus (1.5%), one E. rafﬁnosus (1.5%),1 E. avium
(1.5%), one E. durans (1.5%). All enterococci (including the vancomycin
resistant isolates) were sensitive to LZD. The results of disk diffusion test
performed by using Q/D and LZD are shown in Table 1.
Conclusion: Gram-positive infections have outnumbered gram-negative
infections in clinical microbiology laboratories and resistance to ﬁrst line
antimicrobial agents is a major problem among gram-positive bacteria.
Since all strains of enterococci are sensitive, linezolid seems to be an alternative
agent for neterococcal infections regardless of the species. Both Q/D and
LZD are promising agents for treatment of especially nosocomially acquired
infections.
Table 1 Antimicrobial susceptibility of Q/D and LZD against Staphylococci and
enterococcia
Quinupristin/Dalfopristin (Q/D)b Linezolid (LZD)
Resistant
(R)
Inter-
mediate
(I)
Sensitive
(S)
Resistant
(R)
Inter-
mediate
(I)
Sensitive
(S)
S. aureus
MRSA (n¼ 83) 11 (13.3%) 0 72 (86.7%) 4 (4.9%) – 79 (95.1%)
MSSA (n¼ 87) 9 (10.3%) 0 78 (89.7%) 1 (1.1%) – 86 (98.9%)
Enterococcus spp.
E. faecalis (n¼ 56) – – – 0 0 56 (100%)
E. faecium (n¼ 9) 0 2 (22.3%) 7 (77.7%) 0 0 9 (100%)
Enterococcus spp.
(n¼ 4)c
3 (75%) 0 1 (25%) 0 0 4 (100%)
Vancomycin resistant enterococci (n¼ 7)
E. faecalis (n¼ 6) – – – – – 6 (100%)
E. faecium (n¼ 1) 0 0 1 (100%) 0 0 1 (100%)
aAccording to the NCCLS 2002 criteria.
bBecause E. faecalis is intrinsically resistant to Q/D, the disk diffusion test was not performed.
cE. durans: Q/D:R, LZD:S; E. casseliflavus: Q/D:R, LZD:S; E. durans: Q/D:R, LZD:S; E. avium: Q/
D:S, LZD: S.
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O247 Topoisomerase II mutations in susceptible
pneumococci: the need for revised NCCLS levoﬂoxacin
breakpoints
D. Low, C. Duncan, J. de Azavedo, A. McGeer, D. Bast
Toronto, CAN
Objectives: Streptococcus pneumoniae strains that have reduced susceptibility to
the ﬂuoroquinolones as a result of ﬁrst-step mutations in the type II
topoisomerase genes, parC and gyrA, are more likely to acquire second-step
mutation and become fully resistant. Detection of strains with ﬁrst-step
mutations is essential in order to predict the emergence of resistance and
to make better treatment decisions in using FQs for treatment. Since
levoﬂoxacin (levo) is often used by laboratories to predict susceptibility to
other quinolones, we evaluated the ability of current NCCLS levo suscept-
ibility breakpoints (>4mg/mL) to predict such isolates.
Methods:A total of 16 626 clinical isolates of S. pneumoniae were collected as
part of a 1993–02 Canada-wide surveillance program of which 4332 had levo
MICs of >1mg/mL. The parC gene of 172 isolates with a levo MIC 2mg/
mL and 166 isolates with a MIC of 1mg/mL were ampliﬁed by PCR and the
nucleotide sequence determined.
Results: Of the 172 isolates with a levo MIC of 2mg/mL, 103 (60%) had a
ParC substitution (78 at Ser-79 and 25 at Asp-83). Of the 166 isolates with
a levo MIC of 1mg/mL, 31 (19%) had a substitution in ParC (27 at Ser-79
and four at Asp-83). Substitutions at Ser-79 included tyrosine, phenylalanine
and alanine. Substitutions at Asp-83 included asparagines, serine, glycine and
valine. Of ﬁve randomly chosen isolates with a levo MIC of 0.5mg/mL, one
had a Ser-79-Phe substitution.
Conclusion:Of 338 isolates with a levoﬂoxacin MIC<4mg/mL, 40% had a
ﬁrst-step parC mutation indicating that a signiﬁcant number of strains
harboring ﬁrst-step mutations remain undetected when using the current
NCCLS levo breakpoint. Although not all ﬁrst step mutants would be
detected, reducing levoﬂoxacin susceptibility breakpoints to¼ 1mg/mL
would improve detection of strains with ﬁrst-step mutations.
O248 A 4year global evaluation of the susceptibility of
Candida species to Fluconazole (one year for Voriconazole)
by disk diffusion
D. Sheehan and The Global Antifungal Surveillance Group
Objectives: The in vitro activity of ﬂuconazole against 79 664 yeast isolates
was determined employing a disk diffusion method recently endorsed by the
NCCLS. Pathogenic yeasts were tested from mid-1997 through 2001 and
study data was contributed by 89 centers in 35 countries. The in vitro activity
of voriconazole was also determined against 18 569 yeasts collected in
2001.
Methods: All isolates were tested employing a commercially prepared 25 mg
ﬂuconazole disk (1mg disk for voriconazole). Inoculum was equivalent to a
0.5 McFarland turbidity standard and the medium employed was Mueller-
Hinton agar supplemented with 2% glucose and 0.5mg/mL methylene blue.
Test plates were incubated for 18–24 h, and automatically read and electro-
nically recorded with BIOMIC Image Analysis Systems. Duplicate isolates
and uncontrolled test results were not analyzed. Fluconazole zone interpretive
criteria was reported as per NCCLS accepted guidelines: Susceptible
(S) 19mm, Susceptible-Dose Dependent (S-DD) 15–18mm, Resistant
(R) 14mm.
Results: 98.4% of 52 987 C. albicans were susceptible to ﬂuconazole. The
highest resistance rate for C. albicans was found in Ecuador (8.6% of 512
isolates). There was a decrease over time in the percentage of C. albicans
isolated, from 69.7% in 1997–98 to 63% in 2001 along with an increase in the
isolation rates for C. tropicalis and C. parapsilosis. The overall susceptibility of
ﬂuconazole against allCandida species (excludingC. krusei) was 93.0% (S only)
or 96.1% (Sþ S-DD). Zone diameters were reported for voriconazole but
interpretive criteria have not yet been determined.
Conclusions: Disk diffusion is a rapid, reproducible, and cost-effective assay
to determine the susceptibility of Candida species to ﬂuconazole, and may
serve as a basis for the development of disk diffusion for other antifungal
agents.
Mechanisms of resistance and of antibiotic action
O249 The development of vancomycin (VAN) resistance
in Staphylococcus aureus
R Howe, A. Noel, B. Palmer, M. Wootton, S. Tomaselli, M. Avison,
T. Walsh, A. MacGowan
Bristol, UK
Objectives: Staphylococcus aureus with intermediate resistance to VAN (VISA)
is rare. Strains with hetero-resistance (hVISA) have been reported to comprise
up to 20% of MRSA in some parts of the world. It is possible that the hVISA
phenotype represents a partially resistant stage in the development of full
resistance. We have studied this by comparing the ease of selection of VAN
resistance in hVISA, VAN-sensitive, methicillin-resistant (MRSA), and
VAN-sensitive and methicillin-sensitive (MSSA) S. aureus.
Methods: Five MSSA, seven MRSA, and seven hVISA (deﬁned by popula-
tion analysis) were tested. Resistance selection was by serial daily subculture in
increasing VAN concentrations in Mueller–Hinton broth for 28 days. VAN
MICs were performed by NCCLS agar incorporation methodology on MH
agar on isolates from day 0 (D0), 7, 14, 21, and 28 of selection. Population
analyzes were performed on all strains by inoculating an overnight broth
onto Brain Heart Infusion agar containing a range of vancomycin concen-
trations from 0 to 48mg/L. Colonies were counted after 48 h incubation at
3508C.
Results: The table shows the number of strains of each starting
phenotype acquiring vancomycin resistance after 7, 14, 21 and 28 days of
VAN selection. hVISA strains developed vancomycin resistance most rapidly
and all acquired resistance during the 28 days of selection. Population analysis
showed that fully vancomycin susceptible strains (MSSA, MRSA) passed
through a stage of hetero-vancomycin resistance during the development of
resistance.
Conclusions: Hetero-vancomycin resistance is an intermediate stage in the
development of full vancomycin resistance in S. aureus.
O250 Activity of quinolones against Mycobacterium
tuberculosis DNA gyrase: inhibition of DNA supercoiling
and DNA cleavage assays
A. Aubry, X. Pan, L. M. Fisher, V. Jarlier, E. Cambau
Paris, F; London, UK
Objectives:Our objective was to study the DNA gyrase of M. tuberculosis for
its enzymatic activity and its afﬁnity for quinolones. Since gyrase is the only
quinolone target in mycobacteria, the concentrations of quinolones necessary
to inhibit the enzyme might correlated with the MICs againstM. tuberculosis.
Methods: Because M. tuberculosis is a very slow growing and pathogenic
bacteria, gyrA and gyrB genes of M. tuberculosis were cloned into pET29a and
Number of strains (%) with MIC
>4mg/L
No. of
strains
Starting
MIC (range) Day 7 Day 14 Day 21 Day 28
MSSA 5 1–2 0 (0) 1 (20) 1 (20) 4 (80)
MRSA 7 0.5–2 0 (0) 0 (0) 3 (43) 2 (29)
HVISA 7 1–4 1 (14) 4 (57) 6 (86) 7 (100)
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pET19b, respectively, and expressed in Escherichia coli in order to produce
gyrase safely in a large quantity. The concentrations necessary to inhibit the
catalytic activity (IC50) of DNA gyrase of M. tuberculosis and to generate
gyrase-mediated cleavable complex (CC50) were determined for 23 classical
and new quinolones.
Results: Soluble 97 kDa GyrA and 72 kDa GyrB proteins were obtained and
were free of host E. coli gyrase activity. Equimolar amounts of the GyrA and
GyrB subunits reconstituted a functional enzyme with the activities of ATP-
dependent DNA supercoiling (activity of 103U/mg), ATP-independent
DNA relaxation, andDNA cleavage. The IC50 determined for 23 quinolones
correlated with the MICs (r¼ 0.87): e.g. MIC of sparﬂoxacin, moxiﬂoxacin,
oﬂoxacin, enoxacin and nalidixic acid were 0.25, 0.5, 1, 8 and 128mg/L,
respectively, and their IC50 were 2, 5, 11, 50 and 1100mg/L, respectively.
This allows to propose the inhibition of DNA supercoiling as a test for
screening the new compounds that might have antituberculosis activity, a
IC50lowerthan15mg/LpredictingactivityagainstM.tuberculosis.Thecleavable-
complex assay was non valid without ATP because the DNA relaxation activity
hampered the visualization of the cleaved band. The CC50 determined in
presence of ATP were 4mg/L for sparﬂoxacin, 6mg/L for moxiﬂoxacin,
20mg/L for oﬂoxacin, and 6mg/L for ciproﬂoxacin.
Conclusion: The afﬁnity for quinolones of M. tuberculosis DNA gyrase
correlated with MICs. These ﬁndings will allow to investigate quinolone
structure-activity relationship and to screen compounds with promising
activity against M. tuberculosis.
O251 Optimal timing of prophylactic antibiotics in
surgery corresponds with a peak in penicillin-binding
protein expression in infecting bacteria
S. J. Vandecasteele, J. Van Eldere, R. Merckx, W. Peetermans
Leuven, B
Objectives: The probability of surgical-wound infections in clean-contam-
inated surgery is the lowest when prophylactic antibiotics are given between
2 h before incision and the time of incision. Administration between incision
and 3 h after incision and between 3 and 24 h after incision increases the risk
for infection 2.4 and 5.8 times, respectively (NEJM, 1992, 326, 281–6).
Surgical wound infections are often related to foreign bodies such as sutures,
drains and prosthesis. This study aims to evaluate penicillin-binding protein
expression (the target of beta-lactam antibiotics) during the ﬁrst 24 h of in vivo
foreign body related infection.
Methods:One hundred and sixty polyurethane fragments were contaminated
with a homogenously methicillin-resistant Staphylococcus epidermidis and
implanted subcutaneously in a rat model for foreign body infections. The
samples were explanted at 8 time points (0, 15, 120, 240, 360, 720 and
1440min) during the ﬁrst day of infection and the expression of pbp2a gene
was quantiﬁed with RT quantitative PCR as the cDNA/gDNA quotient as
previously described (BBRC, 2002).
Results: After implantation, pbp2a expression increased and peaked between
15 and 60min, whereafter a progressive decrease was observed (P< 0.001 for
evolution, 1-way ANOVA; with expression at t¼ 15, 60 and 120min being
signiﬁcantly higher than expression at t¼ 1 day, Bonferroni test). The mean
peak expression after 60min of in vivo infection was 11.1 times higher than the
mean through expression after 24h of in vivo infection (P< 0.0001, t-test).
Discussion: pbp2a has a higher expression during early but not during late in
vivo foreign-body associated growth. Thus, the prophylactic administration of
antibiotics in the hours before incision results in peak tissue-concentrations
when the molecular target have their highest expression level. When the
prophylactic antibiotics are given too early, tissue concentrations will already
be below the MIC at the time of infection. When the prophylactic antibiotics
are given too late, the molecular targets of these antibiotics will already have a
lower expression level.
O252 Emergence and spread of CTX-M-15 producing
Escherichia coli isolates resistant to ﬂuoroquinolones and
with a variable resistance to aminoglycosides and
tetracycline
M. H. Nicolas-Chanoine, V. Leﬂon-Guibout, C. Jurand, S. Bonacorsi,
E. Bingen, M. Roger
Boulogne, Paris, F
Objectives:Molecular study of three multiresistant E. coli isolates (A: resistant
(R) to gentamicin (GEN) and tetracycline (TET), susceptible (S) to amikacin
(AMI); B: R to AMI and TET, S to GEN, and C: S to aminoglycosides
(AMG) and TET) responsible for 12, 89 and 13 new cases of urinary tract
infection (UTI) or colonization, respectively, in a 650 bed geriatric hospital
over a 1 year period. Isolates A and B were detected in October 2001 whereas
isolate C was detected in April 2002.
Methods: The plasmid-mediated multiresistance was studied by mating
experiments, plasmid extraction, gene ampliﬁcation and sequencing.
The three epidemic isolates were compared with nine sporadic UTI
E. coli, obtained over the same period, regarding Ramdom Ampliﬁed
Polymorphic DNA (RAPD) proﬁle, phylogenetic group and 10 virulence
factors.
Results: Isolates A, B and C harbored only one plasmid of about 80 kb and
two bla genes, TEM-1B and CTX-M-15. Although the AMG resistance
phenotype was different for isolates A and B, these isolates harbored the same
aac(6 0)-1b gene which was not found in the isolate C susceptible to AMG.
Isolates A, B and C displayed the same RAPD proﬁle which differed from the
eight different proﬁles displayed by the nine control isolates. Isolates A, B and
C belonged to the phylogenetic group B2 whereas two control isolates
belonged to this group, one to group B1, three to group D and two to
group A. Neither papC and papG genes nor sfa/foc and SfaS genes were
found in the three epidemic isolates whereas at least one of these genes
was found in four out of the nine control isolates. Genes aer, fyuA, Irp2 and
the sequence TSPEA4 were found in isolates A, B and C whereas they were
not found in all control isolates. Only one isolate (control) harbored the hly
and cuf1 genes. The two control isolates which displayed the same RAPD
proﬁle also displayed the same phylogenetic group (D) and virulence factors
(n¼ 5).
Conclusion: Although the three epidemic isolates differed from each other
concerning the AMG and TET resistance pattern, all the molecular studies
performed strongly suggest that they belong to the same clone. The different
AMG resistance pattern could be explained by a variable expression or the loss
of the acc (6 0)-1b gene, as this gene has often been found in integrons. As the
epidemic clone does not appear more virulent than the eight randomly
chosen clones to which the control isolates belong, other factors must have
contributed to the fantastic spread of this clone.
O253 Increased prevalence of multiresistant
Enterobacteriaceae during an Enterobacter cloacae
outbreak: coincidence or transfer of resistance
genes?
N. Al Naiemi, B. Duim, J. E. M. de Bruijn, P. H. M. Savelkoul,
L. Spanjaard, E. de Jonge, J. Dankert, A. Bart, M. D. de Jong
Amsterdam, NL
Objectives: During an outbreak in an Intensive Care Unit (ICU) of an
aminoglycoside-resistant, extended spectrum beta-lactamase (ESBL)-positive
Enterobacter cloacae, an increased prevalence of several other Enterobacteriaceae
with similar resistance patterns was observed. We investigated whether this
could be ascribed to interspecies transfer of resistance genes.
Methods: Relatedness between E. cloacae was determined with ampliﬁed
fragment length polymorphism (AFLP) analysis. Plasmids were isolated from
10 outbreak strains and 42 multidrug-resistant Enterobacteriaceae isolated
from ICU patients during the outbreak. For restriction fragment length
polymorphism (RFLP) analysis, plasmids were digested with EcoRI. Transfer
of resistance was investigated by conjugation experiments. PCR and sequence
analysis, using generic primers for the TEM and SHV beta-lactamase genes
was performed.
Results: AFLP analysis identiﬁed that the E. cloacae outbreak was caused by a
single clone. Aminoglycoside resistance and ESBL phenotype could be
transferred separately via conjugation. Analysis of the transconjugants showed
that these antibiotic resistance determinants were located on different plas-
mids. The speciﬁc RFLP patterns of both plasmids were observed in the
epidemic clone as well as in several other Enterobacteriaceae, indicating
interspecies plasmid transfer. PCR and sequence analysis revealed the pre-
sence of an SHV-12 ESBL gene in the epidemic E. cloacae and other
Enterobacteriaceae. The precise extent of transfer of the SHV-12 ESBL-
and aminoglycoside-resistance genes to other strains is currently investigated.
Conclusion: Our ﬁndings indicate the simultaneous occurrence of spread of
resistance plasmids via interspecies transfer and a clonal outbreak of E. cloacae
carrying the same plasmids. Beside relatedness between strains, characteriza-
tion of transferable resistance genes deserves attention in hospital epidemiology.
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The gastro-intestinal tract: the source and impact of nosocomial infections
O254 Incidence of Clostridum difﬁcile associated
diarrhea after lower limb surgery
P. Sharma, R. Bomireddy
Stoke-on-Trent, London, UK
Objectives: Clostridium difﬁcile is a Gram-positive anaerobic organism that is
readily transmitted via hand contact. Due to the use of broad spectrum
antibiotics,C. difﬁcilemay cause a variety of disease ranging frommild diarrhea
to the potentially fatal pseudomembranous colitis. Elderly patients are more
susceptible to infection with C. difﬁcile, and therefore early diagnosis and
treatment is essential to prevent serious complications arising. Our aim was to
quantify the incidence of C. difﬁcile associated diarrhea in elderly patients
undergoing lower limb surgery, and to determine its outcome.
Methods:A retrospective analysis was performed of the case notes of 739 (460
female: 279 male) patients who underwent lower limb surgery (Total hip
replacement, Total knee replacement, or internal ﬁxation of a femoral
fracture) between November 1999 and June 2001. Of this group 29 patients
(25 female: 4 male) were identiﬁed to have suffered with C. difﬁcile associated
diarrhea within 6weeks of surgery. The case notes of these patients were
analyzed in depth to elucidate details of the diagnosis and management of
the Clostridium infection, the presence of additional risk factors was also
noted.
Results: On average, patients developed diarrhea 21 days after surgery. All
patients were given three doses of intravenous cefuroxime during the
perioperative period, and 21 patients received further antibiotic therapy
during the postoperative period. In 23 cases treatment with metronidazole
was instituted, in ﬁve cases vancomycin was commenced and no treatment
was commenced in one case. The majority of cases resolved with treatment
however, six patients died following infection with C. difﬁcile.
Conclusion: In our series the incidence of C. diffcile associated diarrhea,
following lower limb surgery, was 3.9% and a case fatality rate of 21%
occurred. C. difﬁcile associated diarrhea is a potentially fatal condition,
particularly in an elderly population, who often have signiﬁcant comorbidity.
Greater awareness of the condition and a high index of suspicion are required
for prompt diagnosis and treatment. As always, antibiotics should be used
judiciously in this group of patients.
O255 Genotyping of toxin A-negative Clostridium
difﬁcile strains from outbreaks in different countries
R. J. van den Berg, D. H. Oyib, L. Dijkshoorn, C. H. W. Klaassen,
E. C. J. Claas, E. J. Kuijper
Leiden, Nijmegen, NL
Objectives: Clostridium difﬁcile has been recognized as a cause of nosocomial
diarrhea and pseudomembranous colitis. The enteropathogenicity is asso-
ciated with the production of enterotoxin A (308 kDa) and cytotoxin B
(270 kDa). Clinical isolates usually produce both toxin A and B, but an
increasing number of reports mention severe infections caused by toxin A-
negative, toxin B-positive strains. The aim of this study was to investigate the
relatedness of toxin A-negative strains from eight different countries.
Methods:Reference strains of C. difﬁcile (29 known serotypes) were included
in this study as control strains. Tox A-negative, tox B-positive strains (n¼ 59)
were obtained from outbreaks in eight countries. Two to three tox A-negative
strains of each country were used (total n ¼ 18) for genotyping and for
determination ofMLS resistance. In addition, 10 unrelated tox A-positive, tox
B-positive isolates of C. difﬁcile were included. Tox A-negative strains were
deﬁned as strains with a deletion in the toxin A gene. PCR-ribotyping, based
on ampliﬁcation of the intergenic spacer region between the 16S and the 23S
rRNA genes, was used as the standard typing technique. This technique was
compared to ampliﬁed fragment length polymorphism (AFLP) using restric-
tion, selective ampliﬁcation and analysis with the GelComparII system.
Clindamycin (MLS) resistance was tested by a PCR for the ErmB gene.
Results: Using PCR ribotyping, 29 reference strains yielded 25 genotypes.
Indistinguishable were serotypes H and K, A7 and A11, and A14 and S4.
AFLP discriminated 25 types of 27 different serotypes, but was not able to
separate type A7 from type A11, and A14 from S4. PCR-ribotyping produced
eight genotypes among the 10 unrelated strains, and ﬁve types for the 18 tox
A-negative strains. AFLP yielded eight genotypes among the 10 unrelated
strains, and six types for 16 tox A-negative strains. Clindamycin resistance was
found in 13 of 18 tox A-negative strains, and in two of the 10 unrelated strains
(P¼ 0.008).
Conclusions:Outbreaks of tox A-negative strains in different countries are not
due to clonal spread of a speciﬁcC. difﬁcile strain. The results also indicate that
AFLP has a higher discriminatory power than PCR-ribotyping especially for
tox A-negative C. difﬁcile strains. In addition, a remarkable high percentage
(72%) of tox A-negative C. difﬁcile strains shows resistance to clindamycin due
to the presence of the ErmB gene.
O256 Fusidic acid and metronidazole in the treatment
of Clostridium difﬁcile -associated diarrhea: a double-blind
randomized controlled trial
M. Wullt, I. Odenholt
Malmo¨, S
Objective: To compare the efﬁcacy of fusidic acid and metronidazole for
treatment of a ﬁrst episode of Clostridium difﬁcile-associated diarrhea (CDAD).
Methods: An investigator-initiated prospective, randomized, double-blind,
multicentra trial was performed in 131 patients with a ﬁrst episode of CDAD.
The patients were randomized to receive either fusidic acid, 250mg orally
t.i.d. or metronidazole, 400mg orally t.i.d. for 7 days. After 1week of
treatment, clinical and bacteriological cure were determined on days 8–13
and clinical and bacteriological recurrences on days 35–40.
Results: Fifty-nine evaluable patients received fusidic acid and 55 received
metronidazole. On the ﬁrst follow-up, 83% of the patients in the fusidic acid
group and 93% of the patients in the metronidazole group were clinically
cured (P¼ 0.116). There was no difference in bacteriological cure (78 vs.
77%; p ¼ 0.939) at that time. On the second follow-up, clinical symptoms
reoccurred in 27% of patients treated with fusidic acid and in 29% of patients
treated with metronidazole (P¼ 0.971). Bacteriological recurrence was seen
in 13% in the fusidic acid group and in 10% in the metronidazole group.
Bacteriological persistence was seen in 9% and 16%, respectively. There was
no difference in side-effects.
Conclusions: Fusidic acid was shown to be as effective as metronidazole in
the cure of a ﬁrst episode of CDAD both in clinical and microbiological
terms.
O257 The clinical outcome of bloodstream infection due
to extended spectrum beta-lactamases producing Klebsiella
pneumoniae: a case-control study
C. Kang, S. Kim, H. Kim, S. Park, Y. Choe, M. Oh, E. Kim,
K. Choe
Seoul, KOR
Background: The bloodstream infections due to extended spectrum beta-
lactamases (ESBL)-producing Klebsiella pneumoniae are increasingly being
recognized. The current study was conducted to evaluate treatment outcome
of bloodstream infection due to ESBL-producing K. pneumoniae.
Methods:Database at the Clinical Microbiology Department was reviewed to
identify the patients with K. pneumoniae bacteremia. The blood isolates of
K. pneumoniae, stored from January 1998 to April 2002 in deep freezer, were
tested for ESBL production by NCCLS guidelines and/or double-disk
synergy test. Sixty patients with bacteremia due to ESBL-producing K. pneu-
moniae (case patients) were compared with 159 matched control patients with
bacteremia due to non-ESBL-producing K. pneumoniae. Medical records of
the case and control patients were reviewed.
Results: There were no signiﬁcant differences in age, sex, APACHE II score,
and the primary site of infection between case and control group. Complete
clinical response rate, evaluated at 72 h after initial antibiotic treatment, was
higher in control group (13.3 vs. 40.3%, P-value< 0.001), whereas treatment
failure rate was higher in cases (33.3 vs. 11.9%, P-value< 0.001). Time to
defervescence was longer in cases than controls (mean day standard devia-
tion, 6.05 3.15 vs. 3.43 2.27; P-value< 0.001). Overall 7 day mortality
rate was 20% (12/60) in cases and 15.7% (25/159) in controls (P-
value¼ 0.451). Overall 30-day mortality rate was 30% (18/60) in cases
and 24.5% (39/159) in controls (P-value¼ 0.410). When evaluating patients
with bacteremia due to ESBL-producing organism, excluding patients who
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received inadequate deﬁnitive antibiotic treatment, the 30 day mortality for
delayed effective antibiotic treatment was not higher than that for initial
effective antibiotic treatment (9.1 vs. 11.1%, P-value¼ 1.000).
Conclusions: In K. pneumoniae bacteremia, patients infected with ESBL
producer had higher initial treatment failure rate than patients with non-
ESBL producers. However, production of ESBL was not associated with
higher mortality if antibiotic treatment was adjusted appropriately when
antimicrobial susceptibility results were returned.
O258 Vibrio cholera can survive and grow in free-living
Acanthameba castillanii
G. Sandstro¨m, H. Abd
Stockholm, S
It is widely accepted that the aquatic environment is the reservoir of toxigenic
V. cholera and that aquatic habitats can support survival of toxigenic bacterial
clones by providing protective or nutrient microabode. Due to the fact that
cholera is considered as a waterborne disease it has been suggested that a
symbiotic relation between different plankton and the bacterium exists.
However, the reservoir of survival and multiplication of V. cholera between
epidemics are fare from completely disclosed. Acanthameba species are free-
living ameba commonly found in natural aquatic systems. As part of bio-ﬁlms
in aquatic environments, free-living ameba and bacteria are involved in
complex interactions and it is known that Acanthameba species are environ-
mental hosts for several human pathogens. To further add light to the
ecological niche of V. cholera, V. cholera strain O139 was cocultivated with
Acanthameba castillanii to ﬁnd out if a symbiotic relation could be identiﬁed. It
was found that bacteria survived and multiplied at least during 7 days in the
presence of ameba. On the contrary if ameba was excluded, V. cholera
disappeared totally from cultures after 4 days. Bacteria that grow and survived
in ameba were found to be intracellularly located. The localization of bacteria
was in the cytoplasmic compartment of ameba and not in vacuols as could be
expected. Six days post infection of ameba, cytolysis occurs. In conclusion,
these results give additional insights to the ecological niche of V. cholera and
might contribute to the understanding of the bacterial behavior between
epidemics.
Vaccine and other approaches to control tuberculosis
S260 Comparative genomics as a tool for tuberculosis
vaccine design
S. T. Cole
Paris, F
The availability of complete genome sequences of the leading human
pathogens, Mycobacterium tuberculosis, M. lepre and M. bovis, the progenitor
of the vaccine strain M. bovis BCG, provides us with an unprecedented
knowledge base. Armed with powerful informatics tools and extensive
databases, including those of the human and mouse genomes, we are now
in a stong position to develop new vaccines to prevent tuberculosis using
hypotheses derived in silico. These hypotheses can be tested experimentally
using appropriate animal models to evaluate novel vaccine candidates that
include, among others, various recombinant BCG strains, attenuated deri-
vatives of M. tuberculosis, combinations of puriﬁed antigens, adjuvants and
nucleic acid vaccines.
S261 The challenges encountered in the clinical
evaluation of new vaccines, including TB immunogens,
are both scientiﬁc and operational
S. McCormack
London, UK
The challenges during early development are largely technical, and frequently
candidates cannot be manufactured on the scale required because scientiﬁc
obstacles prevent production of a sufﬁciently pure and stable lot for use in a
clinical trial. An understanding of pathogenesis and the availability of relevant
animal models in which to assess safety and immunogenicity are essential;
identiﬁcation and access to these models can present scientiﬁc and operational
challenges, respectively. The appropriate population for the ﬁrst safety trial
will depend on the intended target population for Phase III. It is critical to
have a valid measure of immunogenicity when selecting candidate immuno-
gens/regimens to proceed to Phase III. Cellular immune responses are
difﬁcult to quantify with accuracy, and candidate TB vaccines face the same
scientiﬁc challenges that HIVand malaria immunogens do in this regard. For
ﬁeld trials to assess efﬁcacy, the site and population will be determined ﬁrstly
by whether the aim is to prevent, or treat, disease. Knowledge of the local
epidemiology is critical to planning the sample size. For the result to have
validity, a high proportion (>85%) need to be retained in follow-up, and this
can be a considerable operational challenge in more mobile populations.
Other logistic issues include storage and distribution of supplies. Taking a
candidate forward from the laboratory to evaluation in a Phase III efﬁcacy trial
requires a multidisciplinary approach from the outset with basic scientists
working closely with epidemiologists and trialists, supported by regulatory
and administrative experts. Many different departments within a pharma-
ceutical company would be involved in such an initiative, and this is mirrored
in the public sector by the emergent vaccine networks. Interesting times lie
ahead for TB, HIV and malaria mergent vaccine networks. Interesting times
lie ahead for TB, HIV and malaria.
Tracing new faces of known bacterial resistances (Symposium arranged with the ESGARS)
S264 Spread, magnitude and actual prevalence of
resistance to newer ﬂuoroquinolones
J. Vila
Barcelona, E
Broad use of ﬂuoroquinolones, such as ciproﬂoxacin or norﬂoxacin, has been
followed by the emergence of resistance, which is mainly due to mutations in
the gyrA and parC genes, encoding the A subunits of the DNA gyrase and
topoisomerase IV, the protein targets for quinolones. However, mutations in
genes associated with a decrease in drug accumulation or an increased efﬂux of
the drug can also contribute to the ﬁnal level of quinolone resistance. Several
models of microorganisms can be considered according to the effect of
mutations in the above mentioned genes on the MIC of ﬂuoroquinolones,
among these we can enphasize: (i) Microorganisms such as Pseudomonas
aeruginosa and Acinetobacter baumannii, in which a single mutation is sufﬁcient
to cause clinically important levels of resistance to old ﬂuoroquinolones
(ciproﬂoxacin and norﬂoxacin), but not to the newer ﬂuoroquinolones
(levoﬂoxacin and moxiﬂoxacin); (ii) Enterobacteriaceae and Neisseria gonor-
rhoeae are among this group of microorganisms in which multiple mutations
are required to generate clinically important resistance. In this group, several
mutations generating clinical important level of resistance to old ﬂuoroqui-
nolones also affect the new ﬂuoroquinolones to a similar extend; (iii)
Campylobacter jejuni, in which a single mutation produces a high level of
resistance to old ﬂuoroquinolones and a moderate resistance to new ﬂuoro-
quinolones; (iv) Streptococcus pneumoniae,in which the mutations in either the
gyrA or in parC genes affect the MIC of the ﬂuoroquinolones differently.
Newer ﬂuoroquinolones are incorporated into guidelines for treatment of
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patients with lower respiratory tract infections. Fluoroquinolone resistance
has recently begun to emerge in S. pneumoniae, albeit at low levels. In some
cases this emergence has been related to the spread of a quinolone-resistant
clone, but this does not seem to be the rule. Most recent reports have shown
that ciproﬂoxacin resistance in S. pneumoniae from Canada, Spain and other
countries during 2000 has remained at about the same levels since 1998 and
that the susceptibility of this microorganism to levoﬂoxacin, gatiﬂoxacin and
moxiﬂoxacin is about 99%. However, in other countries such as Croatia or
Hong Kong higher ﬂuoroquinolone resistance rates have been reported. To
maintain this high level of susceptibility to the newer ﬂuoroquinolones in
S. pneumoniae several mesures can be taken.
S265 Ketolides vs. streptococci: are bacteria changing
their mind?
G. Cornaglia
Verona, I
In the very recent years, the map of macrolide resistance in streptococci has
been updated, and more light has been shed on the different phenotypes and
molecular mechanisms involved. Most data stem from investigations on the
activity of telithromycin, and provide us with information about this com-
pound, too. According to the breakpoints that have been ofﬁcial in Europe
since July 2001, namely S (0.5mg/mL), I (1–2mg/mL) and R (>2mg/mL),
telithromycin was active against 99.4% of the strains tested in Western Europe
and against 98.5% of the strains tested in Eastern and Central Europe.
However, the actual MICs values are usually lower than in the erythromy-
cin-susceptible strains, thus denoting a clear reduction in ketolide activity.
The presence of an erm(B) gene impairs the in vitro activity of telithromycin in
roughly 5% of isolates, possibly following the dimethylation of N6 amino
group of adenine 2058. Mutational sequence alterations can also affect
telithromycin afﬁnity, and mutations in ribosomal proteins and in 23S rRNA
– originally reported in macrolide-resistant pneumococci – are now found in
macrolide-resistant S. pyogenes, too. Telithromycin MICs appear to be dis-
tinctly higher in the M-type erythromycin-resistant strains, and experiments
with telithromycin 3H found it was pumped out by S. pyogenes isolates
endowed with an mef(A) gene. Even though efﬂux is usually not sufﬁcient
to have S. pyogenes classiﬁed as ‘telithromycin-resistant’, the possibility of
being affected by this resistance mechanism is a very disturbing ﬁnding, mostly
for its possible additive effect to another mechanism of reduced susceptibility
and for the possibility that this may represent a ﬁrst step towards acquiring
higher resistance levels (i.e. via a different resistance mechanism). Even
though telithromycin does not share complete cross resistance with erythro-
mycin and other macrolides, premarketing studies already evidenced its
possibility of being affected by several resistance mechanisms, and postmar-
keting surveillance looks be essential to detect how this compound will
behave, given that consumption of macrolides in upper respiratory tract
infections is indeed widespread, and has been held responsible for the
resistance upsurge in all major outbreaks so far described.
Quality control in molecular diagnostics (Symposium arranged with the ESGMD)
S268 Clinical virology and standardization in molecular
diagnostics
H. Niesters
Rotterdam, NL
The introduction of molecular technologies has had an enormous impact on
routine clinical virology and has totally revolutionalized the ﬁeld of laboratory
medicine. However, technological problems like the lack of sensitivity, false
positivity and the inability to detect different genotypes of a virus with equal
sensitivity, hampered the introduction of these techniques in routine diag-
nostics. About a decade ago, the ﬁrst quality control program for blood borne
viruses were initiated by the Dutch blood bank and the European study group
of viral hepatitis (EUROHEP). This program has been very valuable for the
introduction of ampliﬁcation-based technology in routine diagnostics, but
initially only focused on the blood borne viruses HBV, HCVand HIV-1. The
last few years, more effort has been made to introduce these quality control
programs more routinely for other viruses, like HSV, CMV, EBV and the
enteroviruses. and the list of viruses is still growing. With the introduction of
real-time technologies, more laboratories are currently introducing molecular
diagnostics routinely, and even perform the assays on a day-to-day basis. But
performing assays accurately is only one part of quality control; lack of
standardization is a second problem. Only a limited number of international
standards, deﬁned for only a single genotype, have been introduced for testing
blood and blood-products. and the directions into which diagnostics labora-
tories are moving with standardization are not very clear. Although it cannot
be denied that an enormous progress has been made with the introduction of
molecular diagnostics in clinical virology, some ﬁnal hurdles have to be taken
before standards can be used routinely (or not).
S269 The detection of Mycobacterium tuberculosis:
does it work?
G. T. Noordhoek
Netherlands, NL
The laboratory performance for detection of Mycobacterium tuberculosis com-
plex by nucleic acid ampliﬁcation tests (NAT) was evaluated by distributing
proﬁciency panels that consisted of sputum samples which resembled smear-
positive and smear-negative patient specimens, and a serial dilution of bacteria
in saline. The distributions were organized by the Quality Control for
Molecular Diagnostics (QCMD) TB program and the performance of
different NATs was analyzed in combination with a questionnaire on the
applied methods. The 2001-panel consisted of eight sputum specimens: two
negative samples, two strong positive samples containing 50 000 CFU of
Mycobacterium bovis BCG in 250mL sputum, two samples with 6500 CFU/
250mL, and two samples with 650 CFU/250mL. The samples with 650
CFU/250mL were considered to represent ‘smear-negative’ samples. Among
the four samples diluted in PBS there was one negative, one sample with 1000
CFU/mL M. bovis BCG, one with 100 CFU/mL, and one sample with 10
CFU/mL. The last sample was not included in the analysis. The panel was sent
to 82 laboratories in 23 countries. Seventy-eight participants (95.2%) con-
tributed a total of 85 evaluable data sets. The percentage of correct results on
the eight sputum samples was 86.3%. Of the examinations of sputum speci-
mens considered as ‘smear-negatives’ only 61% were reported positive. The
percentage of correct results on the three PBS samples was 89%. The total
number of false positive results was 11 (4.3%), these were reported in seven
data sets. In 37.6% of data sets an ‘in-house’ NAT method was used and in
62.4% this was a commercial assay. The percentage of data sets achieving
correct results on all sputum samples was 35.3 and 37.8%, respectively. For the
PBS samples this was 45.8 and 41.5%. The results of this study show that the
performance of detection of M. tuberculosis by NAT has improved since
previous studies. The percentage of false-positives has decreased considerably.
However, a large number of procedures still lack sufﬁcient sensitivity for
application on smear-negative samples. For reason that the ampliﬁcation
methods will be further introduced and accepted in the routine clinical
laboratory it is essential that the quality of NATs are monitored regularly by
distribution of proﬁciency panels by independent organizations such as
QCMD.
S270 Composition, evaluation and control of external
quality control panels
A. Linde
Solna, S
In Clinical Chemistry the methods used often provide exact results. This is
seldom the case in microbiology. From most assays relative values or only
positive or negative results are obtained. Even in modern methods such as
quantitative PCR, there are systematic variations between assays The absence
of an absolute truth makes both the composition and quality material for
external QC difﬁcult. Different examples of such difﬁculties will be given in
my presentation. Most important in the composition of a panel is that the
material is clinically relevant. The targeted level of clinical sensitivity and
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speciﬁcity when a routine clinical material is examined should be predeﬁned.
Thus, knowledge concerning normal distribution of levels of antibodies,
microbes or microbial genes is needed. The actual testing of a panel is costly
for the participants. Optimal information must be obtained with a minimum
of samples. For some serological analyzes, the antigens used may vary so that
numerical comparisons are impossible and only interpretation of clinical status
may be asked for. A reference method for the component to be examined
must be decided and information concerning must be given. If there are
international standards available, QCmaterial must be related to such standard
materials. Further, reference laboratories outside the producer should exam-
ine any material before and after distribution to participants. Stability of the
material under different, relevant conditions must also be examined. Only
samples giving concordant results at the reference laboratories should nor-
mally be used. Sometimes this is not possible, and to deal with such and other
problems there should always be a professional advisory board involved in the
composition and evaluation of panels. Composition of forms and reports and,
if used, scoring systems should also be discussed in detail in these groups. In
the evaluation of results methods used by participants, result presentations and
the wording used for results interpretation may vary among participants. To
facilitate information and standardization of reports, the forms should as far as
possible be of the multiple-choice type. Meetings in which participants are
allowed to discuss panels and/or interactive web-sites are also prerequisites for
creation of QC-programs that will meet the needs of the microbiological
laboratories.
Pneumococcal disease: new developments
S273 Host immune response during pneumococcal
carriage
J. Weiser, T. McCool, T. Cate
Philadelphia, Houston, USA
Objectives:The immune response to pneumococcal surface structures during
human carriage was examined in a model of experimental human pneumo-
coccal colonization.
Methods: Following intranasal challenge of healthy, uncolonized adults with
either a 23F or 6B clinical isolate, a portion of the subjects became colonized.
Serum from the colonized and uncolonized groups was used to determine the
titer of antibody speciﬁc to pneumococcal surface components under con-
sideration for a protein-based vaccine. These vaccine candidates included
pneumococcal surface protein A (PspA), choline-binding protein A (CbpA),
lipoteichoic acid, IgA1 protease, pneumolysin, proteinase maturation protein
A, and pneumococcal surface adhesin A.
Results: Only PspA and CbpA were immunogenic in colonized subjects as
determined by a statistically signiﬁcant rise in the serum IgG titer measured by
ELISA. The serum IgG response to PspA, shown previously to correlate with
susceptibility to becoming colonized, was localized to an immunodominant
region of N-terminal portion of PspA. This region is highly variable in amino
acid sequence between pneumococcal strains. Despite the sequence diversity
in the immunodominant regions of both PspA and CbpA, a signiﬁcant strain
to strain cross-reactivity in the serum IgG response following experimental
human carriage was observed.
Conclusions:These ﬁndings support the need for further investigation of the
human antibody response to PspA and CbpA and the potential use of these
proteins as novel vaccine antigens for the prevention of pneumococcal
colonization.
S274 Impact of novel and not so novel vaccines
H. Kayhty
Helsinki, FIN
Pneumococcus is at all ages a major cause of morbidity and mortality
worldwide. Young children have the highest rates of pneumococcal disease.
In industrialized countries, the most common diseases are otitis media and
sinusitis, but pneumococcus is also a common cause of invasive disease. In
developing countries, pneumonia of young children is the most common
disease caused by pneumococcus. Elderly and adults with chronic diseases are
also at high risk for invasive pneumococcal disease. Resistance to penicillin
and other antimicrobial agents is becoming common. Thus there are multiple
reasons for ﬁnding efﬁcient ways to prevent pneumococcal diseases. In 1983,
licensed pneumococcal vaccine consists of 23 pneumococcal capsular poly-
saccharides. It is recommended to be used among elderly and individuals older
than 2 years with an increased risk of pneumococcal disease. In USA, half of
the elderly population has received the PS vaccine and its effectiveness against
invasive pneumococcal disease has been documented. However, its effective-
ness against pneumonia has been very low or zero. Furthermore, this vaccine
cannot be used among young children. It does not evoke a protecting immune
response at young age. The ﬁrst pneumococcal conjugate vaccine was licensed
in 2000 in the US and in 2001 in several industrialized countries, including
the EU, for use among children 5 years of age and younger. The vaccine
contains seven serotypes and it has been designed for the epidemiological
situation in the US. The vaccine is highly effective against invasive disease, but
it prevents also a considerable part of otitis media caused by the vaccine
serotypes, and pneumonia and carriage. The coverage of the present seven-
valent vaccine is not optimal for many parts of the world. Thus new conjugate
vaccines containing nine or more serotypes are now in clinical phase II and
phase III trials. In addition to the coverage, the price and the availability of the
seven-valent vaccine have slowed down its introduction in the vaccination
programs of even many rich countries, not to speak about the developing
countries. The next generation pneumococcal vaccines have new antigens
and novel approaches to increase the immune response. Several pneumococcal
proteins that are shared by all pneumococcal strains have been tested success-
fully in preclinical studies and some are already in the clinical trials. It is hoped
that these antigens could cover all pneumococci, and be cheaper than
conjugate vaccines.
Hazards of modern life? Bacterial infection and blood borne viruses
O275 Community-acquired pneumonia management in
34 French emergency departments: a 2-week prospective
survey
D. Elkharrat, E. Mathieu, D. Brun-Ney, Y. Pe´an, C. Jordy, B. Garo,
F. Staikowski, A. Scheimberg, M. Pecking for the Ed-Vigil’Roc Group
Purpose: To identify management site and antimicrobials (AM) for commu-
nity-acquired pneumonia patients (CAPP) managed in 34 French Emergency
Departments (ED).
Methods: Consecutive CAPP with presumed community-acquired infec-
tions (CAI) were enrolled. Patients aged18 years with CAP are analyzed for
this study. The Fine severity score (FSS), as designed in the PORT study, was
calculated and CAPP classiﬁed in ﬁve risk-classes but no aspect of manage-
ment was discussed with doctors. Main endpoints are adequacy between (i)
admission rate and FSS (ii) AM therapy and European Guidelines.
Results: In 14 days, 2856 patients with CAI, aged 52.0 24.0 years, were
included. In 482 (16.9%) with presumed CAP, age was 66.9 21.3 years. [CI
95: 64.8–68.9; P< 10–4], sex ratio 60% M, 72% had 1 chronic condition
and 38.2% 1 CAP risk factor. Their FSS is less severe than in the PORT
study (N¼ 54 525): 1¼ 10.3 vs. 9.4%; 2¼ 20.4 vs. 15.8%; 3¼ 22.9 vs. 17.9%;
4¼ 34 vs. 33.5% and 5¼ 11.3 vs. 23.2%; P< 10–4). Based on IDSA
recommendations regarding FSS, 30.7% (classes 1þ 2) would be ambulatory,
22.9% (3) would require a brief observation period before discharge and
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45.3% (4þ 5) an hospitalization. Only 70 (14.5%), were actually discharged.
Of 412 hospitalized, 148 (36%) were manageable at home (P< 10–4).
European AM Guidelines suggest amoxicillin or macrolides in risk-free
CAPP (30.7% in the present study), coamoxiclav for CAPP not severe but
with a risk factor (22.9%), and 3GCmacrolides ﬂuoroquinolones in
severe CAPP (45.3%). In the ED 461 antibiotics were prescribed in 375
CAPP (1.2/CAPP). Over 75% received a monotherapy (mainly coamoxi-
ciclav 48.3%, amoxicillin 12.3% and 3GC 8.0%); 22% were given an AM
combination.
Conclusions: The annual incidence of CAP in the 34 EDs is estimated at
12 566 or 1.8% of non trauma patients (i) CAP admission rate in French EDs is
>85% although home treatment is suggested for >50%. These differences
may denote that ED doctors are unaware of the FS use and/or overcautious
when CAP ambulatory treatment is considered. (ii) There are discrepancies
between guidelines and actual AM therapy: coamoxiclav appears to be
overprescribed, 3GC underprescribed.
Acknowledgement:We are grateful to all our colleagues for their participa-
tion and to Laboratoires Roche for their support.
O276 Community-acquired lower respiratory tract
infections in 137 French emergency departments.
Projections for the European Union
D. Elkharrat for the French LRTI Study Group RESAU
Community-acquired Lower Respiratory Tract Infections (CALRTI) are
frequent in emergency departments (ED) worldwide. Purposes of this pro-
spective survey: identify the epidemiology of acute exacerbation of COPD
(AECOPD) and pneumonia (CAP), and infer implications for EU.
Methods: Consecutive CARTI pts. aged 18 years. were included. Antho-
nisen criteria, Fine score and their usefulness for management were circulated
among doctors. Duration of study per ED is 3weeks or when four patients
with mild/moderate CAP or AECOPD free of Chronic Respiratory Insuf-
ﬁciency (COPD-) are included.
Results: In 11.0 5.2 days, we included 1603 CALRTI patients aged
68.2 19 years, sex ratio 58% M; 844 were CAP [Fine 1–5: 18, 19, 24,
27, 10%], 554 AECOPD (215þ/339–), 205 miscellaneous. AECOPD are
older than CAP pts. (72.1 14 vs. 66.6 20.3 years; P< 0.0005) and more
often hospital-managed (90 vs. 79.9%; P< 0001). However, more CAP than
AECOPD receive antimicrobials (AM) in the ED (83.0 vs. 58%; P< 0.001);
AM combination is more frequent in CAP than COPD (25.7 vs. 19.7%) and
in COPDþ than COPD– (28.4 vs. 15.1%). Management site was the home,
the ED-Observation Unit or the hospital in, respectively, 20.1% CAP vs. 10%
AECOPD, 16.9 vs. 14% and 61.6 vs. 74.7% (P< 0.001). By contrast, current
guidelines would recommend the home in 37% of the CAP study patients, the
home after an observation period in 24% and the hospital in 37%. Based on a
total of 126 588 visits in the 137 EDs, CALRTIs accounted for 2.9% of non
trauma pts. with a ratio of 2 CAP/1 AECOPD. Extrapolated to the seven
million (M) French ED-non trauma pts. in 2001, 98 000 CAP and 63 000
AECOPD would be expected. Assuming incidences of 12–16 CAP and 41
AECOPD/1000 population may apply to EU citizens (380 M), it would
translate into 4.5–6M CAP and 15M AECOPD annually. National ED
attendances in EU vary widely from 70% of the general population (Spain)
to 23% (France) to32% (UK). However, if French ﬁgures are an indication,
2.5% of European COPD (0375M) and 10–20% CAP (0.45–1.2M) may be
managed in the ED.
Conclusions: (i) French EDs are the ﬁrst management site for a great many
CALRTI patients. This may well reﬂect the current situation in EU. (ii)
Pending conﬁrmation, it would be worthwhile designing LRTI management
guidelines for European EDs, with emphasis on orally administered AM and
home management whenever safe and appropriate.
Acknowledgement: We wish to thank all colleagues of the 137 EDs and
Aventis-France for logistical support.
O277 The prevalence of Panton-Valentine leukocidin
toxin in Scottish Staphylococcus aureus
E. K. Girvan, Z. Al-Doori, G. Edwards, D. Morrison, C. Gemmell
Glasgow, UK
Objectives: There is increasing international concern about community
acquired MRSA (CA-MRSA). Several CA-MRSA lineages identiﬁed
outside the UK have been shown to have a particular variant of the DNA
coding for methicillin resistance (SCCmec type IV) and to be able to produce
the Panton Valentine leukocidin toxin (PVL). This toxin has also been
reported in MSSA, and is associated with furunculosis and skin abscesses.
It has also been linked to necrotizing pneumonia, which led to fatalities in
children. It was our objective to screen Scottish Staphylococcus aureus clones for
the presence of the PVL toxin.
Methods:A representative isolate of 29 MRSA and 15 MSSA Scottish PFGE
deﬁned clones were tested by PCR for the presence of the PVL gene.
Subsequent testing of clonal variants was carried out if the initial screening of
clonal representatives proved positive for PVL. Isolates positive for PVL were
also tested for other staphylococcal toxins (exfoliative toxins A and B and
Toxic Shock Toxin-1). A brief clinical history of the positive isolates was
recorded.
Results: Of the 29 MRSA clones tested, three clones (Scottish MRSA
(SMRSA) -116, -124 and -153) were positive for PVL. Further testing
revealed that all ﬁve clonal variants of SMRSA-116, 2/11 clonal variants
of SMRSA-124 and three epidemiologically unrelated SMRSA-153 isolates
were positive for PVL. Of the 15 MSSA clones tested, only two epidemio-
logically unrelated isolates of a single clone – SMSSA-16 (a methicillin
sensitive variant of EMRSA-16) were positive for PVL. None of the PVL
positive isolates were positive for exfoliative toxins A or B, or Toxic Shock
Toxin-1.
Conclusions: It has been shown that the PVL toxin is present in
Scottish MRSA and MSSA clones, albeit in small numbers. Extrapolating
our current results this would equate to 0.1% of all Scottish S. aureus
referred to the Reference Laboratory, being positive for the PVL toxin.
The clinical history indicated an association of the PVL toxin with skin
infection.
O278 Diabetes and case-fatality in pneumococcal
bacteremia – a 10-year population-based cohort study in
Denmark
R. W. Thomsen, H. C. Schønheyder, H. -H. Lervang, S. P. Johnsen,
H. Hundborg, H. T. Sørensen
Aalborg, Aarhus, DK
Objectives: It has been suggested that patients with diabetes mellitus carry a
higher risk of death after invasive pneumococcal disease when compared to
nondiabetic patients. This is an important reason for offering pneumococcal
immunization to patients with diabetes. We conducted a population-based
historical cohort study to assess the impact of diabetes on case-fatality rate in
community-acquired pneumococcal bacteremia (CAPBAC).
Methods: All patients with CAPBAC in North Jutland County from
January 1992 to December 2001 were identiﬁed in a regional bacteraemia
registry. Using the personal identiﬁcation number assigned to every resident
in Denmark, identiﬁcation of patients with diabetes was done by cross-linkage
with (i) a regional prescription database (providing information on exposure
to antidiabetic drugs) and (ii) the regional hospital discharge registry.
We performed a record review for all CAPBAC cases with diabetes to
validate the diagnosis. Information on potential confounders was obtained
from the hospital registry. Vital status at day 30 was determined
through the Civil Registration System. Survival in patients with diabetes
compared to patients without diabetes was assessed by logistic regression
analysis.
Results: We conﬁrmed 63 (9.1%) cases of diabetes among 689 patients
admitted with CAPBAC. Ninety-four percent were type 2 diabetes
and 57% were males. Patients with diabetes were signiﬁcantly older (median
age 71.9 years) than patients without diabetes (65.0 years). Mean blood
glucose on admission was 14.3mmol/L, and 9.5% had ketoacidosis at or
during admission. The proportion with medium/high comorbidity scores
was greater among diabetic patients, especially due to previous myocardiac
infarction and congestive heart failure. Crude 30-day case-fatality was lower
in patients with diabetes: 11.5 vs. 15.2%. After adjustment for sex, age and
comorbidity, the odds ratio of 30-day case-fatality in diabetic patients was
0.53 (95% conﬁdence interval, 0.23–1.23) as compared to the nondiabetic
group.
Conclusion: Patients with diabetes and community-acquired pneumococcal
bacteraemia seem to have a lower 30-day case-fatality rate compared to their
nondiabetic counterparts.
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O279 Bacteremic E. coli urinary tract infection:
relationship between Quinolone susceptibility and
prognosis in a series of 1429 episodes
J. A. Martı´nez, J. P. Horcajada, M. Almela, A. Smithson, M. Velasco,
F. Marco, J. Vila, J. Mensa
Barcelona, E
Background: In E. coli, ciproﬂoxacin-resistance (ciproR) has been associated
with less putative uropathogenic virulence factors and invasiveness. However,
little is known about the role of ciproR on the outcome of bacteremic urinary
tract infections (UTI).
Objective: To evaluate the eventual association of ciproR with shock and in-
hospital mortality in patients admitted with bacteremic E. coli UTI.
Methods: Analysis of an existing, prospectively collected database gathered
during a 11-year period at Hospital Clı´nic of Barcelona (Spain). Several
logistic regression models were built taking shock and in-hospital mortality as
dependent variables. Explanatory variables included demographics, under-
lying diseases, prognosis of the underlying disease, neutropenia, presence of
structural or functional abnormalities of the urinary tract, indwelling bladder
catheter, prior antibiotic therapy, nosocomical acquisition of the infection,
shock, ciproR and appropriateness of empiric therapy.
Results: A total of 1429 patients were evaluated. Mean (SD) age was 64.6
(18.3) years and 447 (31%) were male. In 249 episodes (17%), a ciproR strain
was involved. 126 episodes (9%) were complicated by shock and 39 (3%) were
fatal. In univariate analysis, ciproR was associated with both shock
(OR¼ 2.43, P< 0.0001) and death (OR¼ 2.16, P¼ 0.025). Multivariate
analysis selected age (OR¼ 1.03 per year, P< 0.0001), bladder catheteriza-
tion (OR¼ 1.72, P¼ 0.034), liver cirrhosis (OR¼ 2.08, P¼ 0.012), neu-
tropenia (OR¼ 3.69, P¼ 0.007) and ciproR (OR 1.86, P¼ 0.005) as
independently associated with shock, and shock (OR 32, P< 0.00001), liver
cirrhosis (OR¼ 2.76, P¼ 0.045) and a rapidly or ultimately fatal underlying
disease (OR¼ 2.49, P¼ 0.034) as the best predictors of death. Because of
shock can be an intermediate circumstance in the path to death, a second
model without this variable was built, which selected age, bladder catheter-
ization, liver cirrhosis and neutropenia but not ciproR as independent
predictors of in-hospital mortality.
Conclusion:Once in the bloodstream, ciproR E. coli strains seem to be no less
prone than their ciproS counterparts to cause severe sepsis or be associated
with a fatal outcome.
O280 Bacterial pneumonia in HIV-infected patients:
comparative study of Streptococcus pneumoniae and
Legionella pneumophila sg. 1
A. Garcı´a Cruz, M. L. Pedro-Botet, N. Sopena, M. Garcia-Nun˜ez,
E. Reynaga, M. J. Dominguez, C. Rey-Joly, M. Sabria`
Badalona, E
Background:Bacterial pneumonia is common in patients with HIV infection
causing high morbidity and mortality. Bacterial pathogens have become more
common with the use of HAART and successful prophylaxis against Pneu-
mocystis carinii. Several bacterial pathogens cause pneumonia in HIV patients,
Streptococcus pneumoniae being the most common. The incidence of Legionella
pneumonia (LP) in HIV-infected patients is uncertain but morbidity and
mortality of LP are signiﬁcantly higher in HIV vs. non HIV patients.
Objective: To compare individual risk factors, clinical features and mortality
of pneumonia by S. pneumoniae and L. pneumophila sg 1 in HIV-infected
patients.
Methods:Data related to HIVand pneumonia were retrospectively collected.
18 HIV patients with pneumonia by L. pneumophila sg 1 (group 1) and 48 by
S. pneumoniae (group 2) were included. Diagnosis was deﬁnitive in all cases.
Results:Most patients in the two groups were males with a mean age of 38.4
(group 1) and 35.4 (group 2).Among individual risk factors other than HIV
infection, chemotherapy was more frequent in group 1 (P¼ 0.01). LP was
more frequently nosocomial (27.8 vs. 4.2%) (P¼ 0.01). Patients in group 1
had a higher mean CD4 count (P¼ 0.009), a lower mean viral load
(P¼ 0.02), had AIDS less frequently (P¼ 0.04) and received antiretroviral
therapymore frequently than group 2 (P¼ 0.001). Class IVand Vof Fine were
more frequent in group 1 (P¼ 0.004). Dyspnea was present in 12(75%) vs. 22
(45.8%) of groups 1 and 2, respectively (P¼ 0.05). Extrarespiratory symptoms
were present in 10 (62.5%) vs. 11 (22.9%) patients in groups 1 and 2,
respectively (P¼ 0.006). Hyponatremia (P¼ 0.001) and an increase in CK
(P¼ 0.01) were signiﬁcantly more frequent in group 1. No radiological
differences were seen at presentation. On outcome, clinical and radiological
complications were more frequent in group 1 with respiratory failure and
bilateral involvement being of note in group 1 (P¼ 0.005 and P¼ 0.0009,
respectively). Hospital stay was longer in group 2 (P¼ 0.03). Lastly, mortality
was signiﬁcantly higher (P¼ 0.01) in those with LP.
Conclusions: Morbidity and mortality are signiﬁcantly higher in HIV
patients with L. pneumonia than S. pneumoniae despite a better immunological
status.
O281 The impact of treatment with Pegylated
interferon and ribavirin on ART prescribing in
HIV-HCV coinfected patients
S. Hopkins, E. Brannigan, F. Lyons, H. McDermott, F. Mulcahy,
C. Bergin
Dublin, IRL
Introduction: Successful treatment for HCV infection in coinfected patients
may be complicated by interactions betweenHCVandHIV therapies. In vitro
studies have shown an interaction with ddI and other NRTIs and RBV.
Methods: A prospective study of interventions in patients on stable HIV
treatment who commenced HCV treatment was undertaken, monitoring
interactions, side-effects and marrow support requirements, run in tandem
with a pharmacokinetic substudy of RBV and NRTIs. Statistics were per-
formed using nonparametric tests on SPSS.10.
Results: Of those patients on ART prior to commencing HCV treatment
(N¼ 32), 60% were infected with HIVand HCV through IDU; 30% through
blood products; 20% through sexual contact. 80%were male and mean age was
37years (R: 24–49). All patients were virologically suppressed (VL< 50cpm)
and mean CD4 count was 607 106/L (range 204–1219 106/L). All patients
were on ART, min. of 3 drugs, consisting of 2NRTIs and PI/NNRTI/3rd
NRTI. 45% were on d4T, 55% on ZDV, 25% on ddI, 80% on 3TC, 10% on
TFV. 20% patients were interchanged from ddI to another NRTI prior to
commencing HCV treatment. 30% of patients received marrow support, 85%
were on ZDV; 25% of patients received erythropoetin (mean duration 4–
16weeks); 10% received blood products; and 10% received GCSF. 40% of
patients who commenced HCV therapy whilst on ZDV as part of their ART
regimen were interchanged to another NRTI because of hematological inter-
actions. 10% of patients required dose modiﬁcation of anti-HCV therapy
(reduction in P-ifn dosage in 5% and in RBV dosage in 5%). Signiﬁcant
reductions in Hb or ANC were more likely if patients commenced HCV
therapy on ARTregimens that included ZDV (P< 0.001). No patients experi-
enced lactic acidosis, pancreatitis or neuropathy. All patients have remained
virologically suppressed onHCV treatment. There was a signiﬁcant reduction in
total CD4 count on HCV treatment (607 vs. 432 106/L; P¼ 0.001), how-
ever, the CD4% remained similar (32 vs. 34%; P¼ 0.301). HCV treatment
response remained unaffected by the clinical interaction with similar outcomes
occurring in those on all ART regimens and comparable to mono-infected
patients.
Conclusion: While no patients discontinued HCV treatment because of
hematological interactions with ART, it is a cause of signiﬁcant morbidity
in this group. Supportive interventions with erythropoetin, GCSF &/or
interchange of ARTwhere such a choice was available, were associated with a
successful outcome in this cohort.
O282 Implementing prevention of mother to child HIV
transmission (PMTCT) programme: challenges and lessons
learned
K. Rashidah, N. Lucy
Kampala, UG
Introduction:Every year in Uganda, around 40 000 babies get HIV infection.
TheMinistry of Health started to implement a PMTCT service free of charge
from January 2000. At present, ﬁve sites are operational in government
hospitals.
Objective:Monitoring and evaluation of performance, intersite comparison,
assessment and discussion of major problems faced.
Methodology: Counseling and testing was offered to all women attending
antenatal clinic (ANC). Rapid tests were used and results were available the
same day. Short antiretroviral courses (NVP) were offered in the late
pregnancy period of PMTCT. Modiﬁcation of obstetrical care and support
on infant feeding issues were also part of the service.
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Results: In the 1st year of intervention, 18 326 women were counseled,
11 995 were tested and 1531 found HIV positive. Of those positive, 891 were
enrolled and started ARVand 710 have delivered in the program. Only around
50% of women – babies care came for follow up at week 6. Difference
between the sites performances were evident both in absolute number and in
percentage. Particularly sites which had ‘‘extra manpower’’ were able to
counsel 92% of all new ANC attendance and to provide ARV to 32% of their
estimated HIV positive population. But sites without any ‘‘extra manpower’’
were able to counsel only 17% of all new ANC attendance and to provide
ARV to only 4% of their estimated HIV population. HIV prevalence found
during PMTCTwas consistent with coming from sentinel sites: Kampala sites
had 13%, rural sites 10%. Use of formula milk was higher in urban setting.
Conclusion: The uptake of the PMTCT program has been fairly good.
However there is need to look critically at human resource capacity of the
implementing sites if the intervention has to reach of the beneﬁciaries.
O283 Protection against HSV-2 infection by HSV-1: a
population-based transversal study
P. Meylan, V. Wietlisbach, D. Buenzli, R. Sahli
Lausanne, CH
Objectives: HSV-1 and HSV-2 share numerous antigenic determinants,
raising the possibility that HSV-1, frequently acquired in childhood, may
protect against subsequent HSV-2 infection. Controversial data have been
reported in this respect both in transversal and longitudinal studies. The aim of
the present paper is to report on HSV-1 and -2 interaction in the Swiss
population, as detected in a seroprevalence study.
Methods: Three thousand one hundred and ten sera (MONICA health
survey) randomly selected from the general population were assayed by type-
speciﬁc ELISA (gG-based, Focus Technologies) for HSV-1 and -2 IgG. Data
were examined by logistic and decision tree analysis.
Results:Overall, the prevalence was 80.5% for HSV-1 and 18.9% for HSV-2.
In males, the age-adjusted odd ratio (OR) of being infected by HSV-2 when
infected byHSV-1, compared toHSV-1 uninfected was 0.74 (CI95: 0.5–1.11,
P¼ 0.143). In females, the corresponding OR was 0.59 (CI95: 0.40–0.86,
P¼ 0.006). By multivariate analysis using all predictors, the ORs were,
respectively, 0.79 (CI95: 0.52–1.23, P¼ 0.30) and 0.58 (CI95: 0.39–0.85,
P¼ 0.006). By classiﬁcation tree analysis, the population was split into ﬁve
strata of increasing risk for HSV-2 infection using demographic predictors of
HSV-2 infection. In males, only the average HSV-2 risk stratum showed a
borderline reduced HSV-2 prevalence in HSV-1 positive subjects (OR: 0.62,
P¼ 0.032). In females, the difference in HSV-2 prevalence in HSV-1 positive
vs. negative subjects increased with the risk for HSV-2 infection in a dose
dependent manner, with an OR reaching a minimum of 0.37 (CI95 0.19–
0.75, P¼ 0.005) in the highest HSV-2 risk stratum.
Conclusion: In this transversal study, a reduced HSV-2 prevalence was
observed in HSV-1 infected adults. This effect was mostly contributed by
females at high risk for acquiring HSV-2. Our data perhaps explain con-
troversial reports, with a protective effect demonstrated dependent on the risk
for HSV-2 infection in the study population. Protection in females only is
reminiscent of the results of the recent GSK gD2 vaccine.
O284 12 months Lamivudine therapy in children with
chronic hepatitis B
T. G. Wozniakowska-Gesicka, J. K. Kups, A. Dzwonek
Lodz, PL; London, UK
Introduction:The aim of the study was to assess a 12months administration of
lamivudine in children with chronic hepatitis B.
Methods:The study included 24 children (14 boys, 10 girls) aged 7–18-year-
old who have not responded to interferon alfa therapy. The diagnosis was
established according to current classiﬁcation criteria. Lamivudine was admi-
nistrated 100mg daily for 12months. In the course of the treatment, in four
weeks time, ALT activity, hemoglobin levels, leukocyte and trombocyte
counts in peripheral blood were determined. Moreover, in 12weeks time,
protrombin index and protein fraction were analyzed. Serologic markers of
hepatitis B virus infection and presence of HBV- DNAwere measured before,
after six months and at the end of the treatment. In the whole group of the
studied children a liver biopsy was performed before therapy. (histological
evaluation according to Knodell and Scheuer) In the assessment of the
effectiveness of the Lamivudine therapy we took into consideration the loss
of HBV-DNA in serum and seroconversion in HBe/anty-HBe system as well
as normalization ALT and AST activity.
Results: After 12months applied Lamivudine inhibition of HBV replication
and normalization of ALT and AST activity were observed in 10 children
(41.7%); in six of them the replication was combined with seroconversion
HBe/anty-HBe and normalization ALTand ASTactivity. 14 children (58.3%)
have not eliminated HBV-DNA also have not obtained the seroconversion.
However, six children presented ALT normalization, seven children decreased
and one child twice increase in ALT activity. Side-effects of treatment were
not observed in any of the studied children.
Conclusions: (i) One- year of Lamivudine therapy leads to inhibition of HBV
replication and normalization ALT and AST in 25% children with chronic
hepatitis B. (ii) Therapy is well tolerated and does not cause side-effects.
Molecular mechanisms of antibiotic resistance
O285 Mutations in 23S rRNA associated with linezolid
resistance in Streptococcus pneumoniae
V. I. Enne, A. Macphie, A. R. Noel, K. E. Bowker, P. M. Bennett,
T. R. Walsh, A. P. MacGowan, R. A. Howe
Bristol, UK
Objectives: Linezolid, the ﬁrst oxazolidinone in clinical use, is licensed in the
UK for the treatment of pneumonia and thus far clinical strains of S. pneu-
moniae have all been susceptible (irrespective of their penicillin resistance
phenotype). Resistance in other organisms such as enterococci and staphy-
lococci has been due to mutations at the ribosomal target site. The object of
the current study is to determine the genetic basis of linezolid resistance in
laboratory-selected pneumococcal isolates.
Methods: Three pneumococcal strains were studied: SMH506, SMH155,
and SMH683 with penicillin MICs of 0.004, 0.75 and 0.25mg/L, respec-
tively. Parental strains were subjected to daily serial subculture in Mueller-
Hinton broth containing increasing linezolid concentrations for 28 days.
Microbroth dilution MICs were performed by NCCLS methods for line-
zolid, chloramphenicol, gentamicin, tetracycline, clarithromycin, and clin-
damycin on isolates from days 0 and 28. The sequence of domain Vof the 23S
rRNA gene of the parents and mutants was obtained from PCR amplicons.
Results: Linezolid MICs of the parent strains SMH506, SMH155 and
SMH683 were 0.5, 1.0 and 1.0mg/L and 32, 32 and 4 mg/L, respectively,
after 28 days of linezolid selection. SMH506 & SMH155 showed a >32 fold
increase in chloramphenicol MIC with the development of linezolid
resistance while SMH683 showed a >32 fold decrease in the clarithromycin
& clindamycin MICs following linezolid selection. Both SMH506 and
SMH155 carried the substitution G2576U in the 23S rRNA gene with
an additional substitution (C2611U) in the latter strain. SMH683 carried an
insertion in the 23S rRNA gene resulting in the addition of GU after C2626.
Conclusions: Selection of linezolid-resistant S. pneumoniae can be achieved in
vitro. The development of linezolid resistance may be associated with
alterations in susceptibilities to other ribosomally acting agents. Linezolid
resistance in S. pneumoniae is associated with the mutation G2576U, which has
been implicated in linezolid resistance in other organisms. Insertion of bases in
the 23S rRNA gene has not previously been linked to reduced linezolid
susceptibility in any organism.
O286 Over-expression of a novel RamA from
Enterobacter cloacae confers carbapenam resistance in E. coli:
report from the SENTRY Antimicrobial Surveillance Program
M. Toleman, R. Jones, T. Walsh
Bristol, UK; Iowa, USA
Objective: To analyze the determinant of carbapenam resistance in an ICU
clinical strain of Enterobacter cloacae isolated in New York City as part of the
SENTRY Antimicrobial Surveillance Program (2001).
Methods: The isolate was cultured from a wound infection in a 43-year-
old male in the neurosurgical ICU. A gene bank of Enterobacter cloacae strain
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15-649I genomic DNA was constructed in the cloning vector pK18 using
standard molecular biology techniques. The ampliﬁed gene bank was used to
transform E. coli DH5-alpha and plated on media containing both ampicillin
and the serine lactamase inhibitor BRL42715. All clones isolated harbored the
same plasmid (pMATEcNY) which was further used to transform Escherichia
coli SN03 (ampC negative). The insert of pMATEcNY was sequenced on
both strands by the dideoxy-chain termination method with a Perkin-Elmer
Biosystems 377 DNA sequencer and sequence analysis was performed using
DNAstar software. MICs of various antimicrobials were determined using E-
test strips (AB biodisk, Solna, Sweden) on Mueller-Hinton agar.
Results: Sequence analysis revealed that pMATEcNY contained an insert of
1100 bp including the entire ramA of E. cloacae. The sequence of ramA is
unique and shows approximately 35% difference from the ramA of Klebisella
pneumoniae. The MICs to imipenem and meropenem of E. coli DH5-alpha
and E. coli SN03 containing pMATEcNY increased over 20times relative to
the untransformed parent. Additionally the MIC to ceftazidime increased
from 0.38 to >256mg/ml.
Conclusions: E. cloacae isolate 15–649I possesses a unique RamA protein.
Over-expression of the transcription factor RamA in E. coli causes a large
decrease in it’s susceptibility to carbapenems and ceftazidime.
O287 Quantitative determination of mRNA for efﬂux
pump proteins in ﬂuoroquinolone resistant Pseudomonas
aeruginosa strains
H. Oh, J. Stenhoff, S. Jalal, B. Wretlind
Stockholm, S
Objective: To investigate the role of efﬂux pumps and mutations in DNA
gyrase subunits A and B and topoisomerase IV subunits C and E in
ﬂuoroquinolone (FQ) resistance in P. aeruginosa.
Methods:Quinolone resistance determining regions (QRDR) of gyrA, gyrB,
parC, and parE genes were sequenced from 19 clinical P. aeruginosa strains with
MICs to norﬂoxacin ranging from 1 to >256mg/L). Susceptibilities to
ceftazidime, amikacin, tobramycin, tetracycline and imipenem were also
determined. mRNA for pump proteins for efﬂux pumps MexAB-OprM,
MexCD-OprJ, MexEF-OprN and MexXY were determined as cDNA by
real-time PCR using the LightCycler.
Results: Increased amounts of mRNA for MexB was found for 10 strains,
none of which had mutations in the regulatory gene mexR. mRNA for
MexD was hyperproduced in ﬁve strains, one of which had a mutation in the
regulatory gene nfxB. Six strains overproduced MexF, and one strain, also
resistant to amikacin, hyperproducedMexY.One strain with high norﬂoxacin
MIC (256mg/L) did not overproduce any of the investigated pump proteins.
Generally, no unequivocal correlation was seen between amount of expressed
efﬂux pumps and resistance to known substrates for respective pump. How-
ever, all strains overproducingMexBwere resistant to tetracycline. Alterations
in GyrA were found in all strains, and in GyrB in four strains. Three of these
strains (MICs 16, 16 and 256mg/L, respectively) had GyrA (Thr83 to Ile) and
GyrB (Thr146 to Asn). One strain, MIC of norﬂoxacin >256mg/L with
GyrA (Asp87 to Asn) had three alterations in GyrB (positions 234, 238 and
266). Three strains had alterations in ParE, and two of these strains had no
alterations in QRDRof ParC. The third strain (MIC> 256) had ParC (Phe74
to Ile) and ParE (Glu460 to Val) alterations.
Conclusions: Hyperproduction of efﬂux pump proteins is common among
FQ resistant strains, and many of these have no mutations in genes for the
regulatory proteins. This suggests the presence of unidentiﬁed regulatory
mechanisms for expression of efﬂux pump proteins. The results also indicate
that overexpression of efﬂux pumps do not necessarily lead to increased
resistance. Alterations in both subunits of gyrase and topoisomerse IV seem to
be more important than efﬂux pumps in highly FQ resistant P. aeruginosa.
O288 Identiﬁcation of a carbapenem-hydrolyzing class A
beta-lactamase, KPC-2, in two clinical strains of Enterobacter
cloacae and Escherichia coli
S. Petrella, M. Renard, R. Bismuth, L. Bodin, V. Jarlier, W. Sougakoff
Paris, F
Objectives: Enterobacter cloacae 7506 and Escherichia coli 2138 were isolated
from a peritoneal liquid. Both isolates showed decreased susceptibility to
imipenem and resistance to extended-spectrum cephalosporins and aztreo-
nam, the activity of beta-lactam antibiotics being restored in the presence of
clavulanic acid.
Mehods: DNA ampliﬁcations were carried out with primers designed to
amplify the genes coding for the class A carbapenemases NMC-A, SME-1 and
KPC-1 and for the class A penicillinases TEM-1 and SHV-1. Plasmid DNAs
of E. cloacae 7506 and E. coli 2138 were prepared with a Qiagen plasmid DNA
Maxi kit and were subjected to electroporation into E. coli Top10. Catalytic
activities on imipenem and others beta-lactams were determined from crude
extracts using an Uvikon 940 spectrophotometer.
Results: The MIC value of imipenem for E. cloacae 7506 and E. coli 2138 was
1mg/mL. Accordingly, a low but signiﬁcant catalytic activity was detected
with imipenem from crude extracts prepared from the two strains. Sequencing
of a PCR amplicon obtained by using KPC-1-speciﬁc primers revealed the
presence of a blaKPC-2 gene in E. coli 2138 and E. cloacae 7506. At the amino
acid level, KPC-2 was found to be a single point mutant of KPC-1
(Ser175Gly) weakly related to other class A beta-lactamases, with 54% identity
to the carbepenem-hydrolyzing beta-lactamase SME-1 from Serratia mar-
cescens S6, and 38% identity to the class A penicillinase TEM-1. The presence
of a blaTEM gene along with blaKPC-2 was conﬁrmed in E. cloacae 7506 and
E. coli 2138 by speciﬁc DNA ampliﬁcation and sequencing. Analysis of the
plasmid preparation obtained from E. cloacae 7506 revealed the presence of at
least two plasmids in this clinical strain. Resistance to extended-spectrum
cephalosporins (cefotaxime, ceftazidime and aztreonam) but not to carbape-
nems (imipenem) could be transfered by electroporation of the E. cloacae 7506
plasmid preparation into E. coli Top10. The presence of blaTEM, but the
absence of blaKPC-2, in the transformants was conﬁrmed by DNA ampli-
ﬁcation. No plasmid was detectable in E. coli 2138, suggesting that the beta-
lactamase genes blaKPC-2 and blaTEM were located on the chromosome of
this strain.
Conclusion:Here, we report for the ﬁrst time the presence of a carbapenem-
hydrolyzing class A beta-lactamase (KPC-2) in E. coli, a worrying ﬁnding
which underlines the possible spread of class A carbapenemases among the
Enterobacteriaceae.
O289 Molecular analysis of fusidic acid resistance in
Staphylococcus aureus
S. Besier, A. Ludwig, V. Brade, T. A. Wichelhaus
Frankfurt am Main, D
Background: Fusidic acid is a potent antibiotic against severe gram-positive
infections that interferes with the function of elongation factor G (EF-G),
thereby leading to the inhibition of bacterial protein synthesis. Resistance to
fusidic acid has been demonstrated to occur rapidly in vitro and has been
observed with increasing frequency in vivo.
Objectives: This study was aimed at analyzing the mechanism of fusidic acid
resistance in Staphylococcus aureus.
Methods and results: It could be demonstrated that fusidic acid resistance in
Staphylococcus aureus results from point mutations within the chromosomal
fusA gene encoding EF-G. Sequence analysis of fusA revealed mutational
changes that cause amino acid substitutions in 10 fusidic acid-resistant clinical
S. aureus strains as well as in 10 fusidic acid-resistant S. aureus mutants isolated
under fusidic acid selective pressure in vitro. Fourteen different amino acid
exchanges were identiﬁed that were restricted to 13 amino acid residues
within EF-G. To conﬁrm the importance of observed amino acid exchanges
in EF-G for the generation of fusidic acid resistance in S. aureus, three mutant
fusA alleles encoding EF-G derivatives with the exchanges P406L, H457Y,
and L461K were constructed by site-directed mutagenesis. In each case,
introduction of the mutant fusA alleles on plasmids into the fusidic acid-
susceptible S. aureus strain RN4220 caused a fusidic acid-resistant phenotype.
The elevatedminimal inhibitory concentrations of fusidic acid determined for
the recombinant bacteria were analogous to those observed for the fusidic
acid-resistant clinical S. aureus isolates and the in vitro mutants containing the
same chromosomal mutations.
Conclusions:The presented data provide evidence for the crucial importance
of individual amino acid exchanges within EF-G for the generation of fusidic
acid resistance in S. aureus.
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O290 Detection of a new SHV-type ESBL in a
Klebsiella pneumoniae clinical isolate from the Netherlands
A. Mazzariol, E. Roelofsen, R. M. G. Hendrix, O. Lovato, A. Voss,
G. Cornaglia
Verona, I; Enschede, Nijmegen, NL
Objectives: A Klebsiella pneumoniae isolate resistant to third-generation-
cephalosporins (3-GCs) was found in August 2001 in a wound culture of
an ICU trauma patient admitted to a tertiary-care 1000-bed (18-bed ICU)
teaching hospital situated in the Eastern part of the Netherlands. The patient
had never been hospitalized before. Up to the end of 2002, Klebsiella strains
with the sameRFLP andRAPDwere isolated from a total of 85 ICU patients.
The index strain (K. pneumoniae KPN-15) was investigated as for the presence
of an ESBL.
Methods: Antimicrobial susceptibility testing was performed by microdilu-
tion and interpreted according to the latest NCCLS documents. The presence
of an ESBL was investigated by means of a double-disk synergy test. Iso-
electric focusing (IEF), polymerase chain reaction (PCR) and sequencing
were carried out by standard procedures.
Results: MICs were 128mg/mL for both aztreonam and ceftazidime and
16 mg/mL for cefotaxime. The presence of an ESBL was also suggested by the
synergies detected between clavulanic acid and 3-GCs in the disk-diffusion
assay. Spectrophotometric analysis of crude sonic extracts conﬁrmed that 3-
GCs were hydrolyzed with fast kinetics. The IEF visualized a beta-lactamase
with isoelectric point (pI) of 8.2. PCR was performed using primers speciﬁc
for the bla(SHV) gene, and yielded a product of about 950 bp that – after
sequencing – was found to code for a polypeptide differing from SHV-1 by
two aminoacids, namely L31Q and E235K. The PCR product was success-
fully cloned in Escherichia coli XL10, causing an increase in the 3-GC MICs
that paralleled those of K. pneumoniae KPN-15.
Conclusions:The L31Qmutation was already described in SHV-29, SHV-35,
SHV-37 and SHV-40. The E235K mutation was described only very recently
in a new enzyme (SHV-45) found in a Brazilian isolate of K. pneumoniae. To
our best knowledge, this is the ﬁrst time that both mutations are simulta-
neously found in the same enzyme, which must be regarded as a novel
addition to the list of SHV-type beta-lactamases.
O291 A variety of CTX-M-type beta-lactamases
identiﬁed among E. coli isolates in Greece
I. Galani, M. Souli, A. Balasca, Z. Chrisouli, H. Giamarellou
Maroussi, GR
Objectives: The plasmid-mediated CTX-M-type beta-lactamases constitute
the most rapidly growing family of extended spectrum beta-lactamases
(ESBLs). They are much more active against cefotaxime than ceftazidime
and they have been identiﬁed over an extremely wide geographic area
(Europe, South America, Japan and Mediterranean countries). In Greece,
Mavroidi et al. have recently reported the ﬁrst isolation of an E. coli strain
producing CTX-M-3 in a Greek hospital. In our clinical laboratory, E. coli
strains which are resistant to cefotaxime, ceftriaxone and susceptible to
ceftazidime have been isolated at a rate of 7.5% in the years 2001–2002.
Six non clonally related E. coli isolates with ESBL phenotype were analyzed
for their beta-lactamase content and for the blaCTX-M carrying.
Methods: Six E. coli strains isolated from urine (5 strains) and pus (1 strain),
were collected during the period 2001–2002 and studied. Susceptibility
testing was performed by the agar diffusion (Kirby-Bauer) test and a com-
mercial broth microdilution method (Sensititre Ltd, West Sussex, UK), using
the National Committee for Clinical Laboratory Standards guidelines (M7-
A5, Vol. 20, No. 2, 2000). Epidemiological typing was performed by pulse
ﬁeld gel electrophoresis (PFGE). Beta-lactamases were determined by iso-
electric focusing (IEF) and the presence of a CTX-M gene was
identiﬁed by PCR (Dutour et al. 2002, AAC, 46: 534–7). Sequencing of
the blaCTX-M- PCR products were performed by MWG-THE Genomic
Company.
Results: PFGE analysis showed that the six E. coli isolates were not clonally
related. Extracts of cultures of ﬁve strains contained two beta-lactamases with
pI values of 5.6 (TEM-type) and 8.6 (CTX-M-type). Three beta-lactamases
with pI values of 5.6, 6.1 and 8.6 were identiﬁed from the extract of the
sixth strain. Sequence analysis of the blaCTX-M PCR products identiﬁed
the blaCTX-M-3 in three cases the blaCTX-M-15 in two cases and a
blaCTX-M-15 derivative in one case. This enzyme differed from CTX-
M-15 by one amino acid substitution in position ABL109 (Asn to Ser). This
enzyme conferred a lower level of resistance to ceftazidime than the CTX-M-
15.
Conclusions: It is evident that the presence of CTX-M-type ESBLs in E. coli
isolates is established in Greece. Both blaCTX-M-3 and blaCTX-M-15 are
present in our collection of strains which represents in- as well as outpatients.
A probably new enzyme was also identiﬁed in one of the isolates tested.
O292 Expanded-spectrum resistance to fourth
generation cephalosporins (cefpirome, cefepime) due to a
four amino acid deletion in the H-10 helix of the
chromosome-encoded AmpC enzyme of a Serratia
marcescens clinical isolate
L. Poirel, H. Mammeri, P. Be´mer, H. Drugeon, P. Nordmann
Le Kremlin Bicetre, Nantes, F
A multiresistant Serratia marcescens strain was isolated from a urinary tract
infection of a patient hospitalized in Nantes hospital in 2001. This isolate was
resistant to amino-, carboxy- and ureidopenicillins, susceptible to cefotaxime
and ceftriaxone and of intermediate susceptibility to ceftazidime and cefe-
pime. No synergy was found between beta-lactams and clavulanic acid using
the double-disk synergy test. Cloning of whole-cell DNA of this S. marcescens
isolate gave E. coli clones harboring a cephalosporinase resistance phenotype.
However, a high-level resistance to ceftazidime, cefepime and cefpirome was
associated to susceptibility to ticarcillin and cefoxitin. Genetic analysis of the
insert of one recombinant plasmid identiﬁed an Ambler class C beta-lactamase
gene that encoded a 374 amino acid protein identical to the known AmpC
cephalosporinase of Serratia marcescens S3, except for a four amino acid
deletion located in the H-10 helix. Kinetic analyzes indicated that
this enzyme was able to hydrolyze cefepime and cefpirome. This work
underlined that resistance to the latest developed cephalosporins (cefepime,
cefpirome) may occur in Enterobacteriaceae that results not only from
amino acid substitutions but also from deletions in the AmpC-type beta-
lactamase.
O293 Characterization of integrons carrying VIM-2 in
Pseudomonas spp. from Portugal
S. Quinteira, O. Cardoso, J. Sousa, L. Peixe
Vila Nova de Famalica˜o, Coimbra, Porto, P
Objectives:The present study was aimed at the investigation of metallo-beta-
lactamases in Pseudomonas isolates and characterization of associated integrons.
Methods: During the years of 2001–2002, the presence of metallo-beta-
lactamases in imipenem resistant strains was investigated, using a bioassay and a
PCR multiplex for blaVIM and blaIMP genes, both in clinical Pseudomonas
aeruginosa isolates (n¼ 90), collected in different hospitals, as well as in Gram
negative rods (n¼ 60) isolated from hospital wastewater. The characterization
of integrons containing the metallo-enzyme genes was possible through
sequencing. Four isolates of P. aeruginosa, previously characterized as VIM-2
producers, were also included in this study. Macrorestriction of chromosomal
DNAwith XbaI enzyme followed by PFGE was performed and patterns were
analyzed to determine a possible interhospital spreading of the resistant strains.
Results: Four bioassay positive Pseudomonas spp. isolates (3 P. aeruginosa and 1
P. alcaligenes) were detected, with VIM-2 being the only identiﬁed metallo-
enzyme. The association of VIM-2 to the In58 integron was found by
sequencing in all the seven clinical VIM-2 producing isolates of P. aeruginosa.
However, from these seven isolates, four different clones were detected by
PFGE. A Pseudomonas alcaligenes, isolated from hospital wastewater, was found
to produce VIM-2, with this cassette gene inserted in a class 1 integron, In56.
Conclusions: This is the ﬁrst report of a VIM-2 enzyme that is inserted in an
In56 integron in a nonclinical isolate and, to our knowledge, the ﬁrst report of
VIM-2 in P. alcaligenes. The ﬁnding that P. alcaligenes, from a wastewater
sample, carried the same gene cassettes as those previously described in clinical
isolates of other bacteria of human importance was an interesting observation.
Although clonal spread was observed for four clinical isolates, it is of interest
that several P. aeruginosa from different geographic regions of Portugal, during
the 1995–2002 period, presented VIM-2 associated to In58 integron. Pro-
duction of VIM-2 beta-lactamase presents an emerging threat of carbapenem
resistance among Pseudomonas spp. in Portugal.
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O294 Multi-drug resistance associated with MexXY
expression in clinical isolates of Pseudomonas aeruginosa
from a Texas hospital
D. J. Wolter, N. D. Hanson, P. D. Lister
Omaha, USA
Objectives:Multi-drug resistant (MDR) strains of Pseudomonas aeruginosa (PA)
are a signiﬁcant therapeutic problem facing clinicians. The expression of broad
substrate efﬂux pumps is primarily responsible for the MDR phenotypes.
Four of these pumps have been characterized to date in PA. MexEF-OprN is
one pump which can cause resistance to multiple classes of drugs including
ﬂuoroquinolones (FQs). In addition, overexpression of this pump correlates
with a concomitant down-regulation in expression of a porin, oprD, resulting
in carbapenem resistance. Recently, a hospital in Texas encountered several
PA isolates resistant to both FQs and carbapenems. The purpose of this study
was to determine if the mechanism responsible for this multidrug resistance
involved the overexpression of MexEF-OprN.
Methods: To test this hypothesis, seven clinical isolates from the Texas
hospital were analyzed and compared to a wild-type PA strain, PAO1.
Antimicrobial susceptibility testing was performed by agar dilution in accord-
ance with NCCLS guidelines. Expression of the porin, oprD, and four
MDR efﬂux pumps (mexAB-oprM, mexCD-oprJ, mexEF-oprN, and
mexXY) was measured by isolating total RNA and performing semiquanti-
tative reverse-transcriptase PCR (RT-PCR) using speciﬁc internal primer
pairs.
Results: In addition to FQ and carbapenem resistance, each isolate also
displayed resistance to the aminoglycosides, gentamicin and amikacin. All
seven isolates showed a decrease in the expression of oprD compared to
wild-type PA PAO1. Interestingly, none of the seven clinical isolates over-
expressed the mexEF-oprN pump. Instead, six isolates overexpressed the
mexXY pump.
Conclusions: In conclusion, multidrug resistance to the FQs and carbapenems
in these clinical isolates was not a result of the overexpression of the mexEF-
oprN pump. Instead, resistance to these agents might be attributed to the
overexpression of mexXY and the down-regulation of oprD expression.
These data are signiﬁcant because it is the ﬁrst report of differential expression
between the mexXY efﬂux pump and porin, oprD. Further studies are
warranted to identify the mechanism of correlation between these two
resistance mechanisms, or to determine if they are correlated at all.
New opportunities in the therapy of fungal diseases
K312 New opportunities in the therapy of fungal diseases
J. H. Rex
Macclesﬁeld, UK
The availability of new drugs, innovative diagnostic tools, and standardized
susceptibility testing methods has opened new vistas in medical mycology, but
a review of these tools also highlights areas for future study. Who should be
treated? This is the single largest knowledge gap. For cryptococcosis and
histoplasmosis, the pace of the disease usually permits antigen-based detection
methods to supplement culture-based methods reliably. However, the quicker
pace of invasive candidiasis and aspergillosis means that diagnostic testing must
be done serially and that test sensitivity must be high. Due to the unreliability
of cultures, empirical clinical management rules have often been necessary.
In a step forward, commercially supported antigen-based testing systems
for aspergillosis and candidiasis have emerged and appear promising
( J Antimicrob Chemother 2002; 49 : 11). These tools have not, however,
gained widespread acceptance or licensure. Prophylactic therapy seems in
some settings to reduce the strength of the signal detected by these
nonculture-based systems, thus making the best balance between sensitivity
and speciﬁcity even more elusive. What treatment is best? The laboratory
view: standardized tools for testing of yeasts and moulds have facilitated
interlaboratory collaborative comparisons. However, proofs of in vivo rele-
vance of these data are few, with major knowledge gaps existing for moulds,
amphotericin B, and the echinocandins (Clin Infect Dis 2002; 35 : 982). An
understanding of the pharmacodynamic predictors of response is proving
invaluable in reducing the complexity of this area.What treatment is best? The
clinical view: new drugs have been licensed in recent years (voriconazole and
caspofungin) and novel drug candidates (antibodies, transcription inhibitors,
and others) are under development. But, evaluating new compounds (or
combinations of compounds) remains a signiﬁcant hurdle for developers, as
successful comparative trials for most mycoses have usually required dozens of
centers to collaborate over periods of several years. Even with such intensive
efforts, only selected questions can be answered. Guidelines for clinical
diagnosis have been proposed (Clin Infect Dis 2002; 34 : 7) and are deﬁnitely
facilitating study implementation. But generation of data on drug activity in
humans will remain slow and tedious until convincing nonculture-based
diagnostic tools are available.
Antibiotics and programmed cell death in bacteria
K313 Programmed cell death in bacteria and antibiotics
S. Boaz, R. Hazan, M. Reches, H. Engelberg-Kulka
Jerusalem, IL
Programmed cell death (PCD), deﬁned as an active process which results in
cell suicide, refers to any form of cell death mediated by an intracellular death
program, no matter what triggers it. The existence of toxin–antitoxin gene
pairs (also called ‘addiction modules’) on extrachromosomal elements of
Escherichia coli, and particularly the discovery of homologous modules on
the bacterial chromosome, suggest that a potential of programmed cell death
may be inherent in bacterial cultures. We have reported on the ﬁrst described
prokaryotic chromosomal PCD system. This is the E. coli mazEF regulatable
chromosomal toxin–antitoxin module in which mazF encodes a stable toxin,
MazF, and mazE encodes a labile antitoxin, MazE, that overcomes the lethal
effect of MazF. In addition, we have shown that cell death mediated by the
E. coli mazEF module can be triggered by several antibiotics (rifampicin,
chloramphenicol, and spectinomycin) that are general inhibitors of transcrip-
tion and/or translation. These antibiotics inhibit the continuous expression of
the labile antitoxin MazE, and as a result, the stable toxin MazF causes cell
death. Our recent results further increase the repertoire of antibiotics that
trigger the mazEF-mediated PCD to include sulfonamides and trimethoprim,
known to cause thymine starvation by inhibiting the folic acid metabolism.
The effect of thymine starvation on PCD deserves a special attention. As early
as 1954, Cohen and Barner discovered that a thymine auxotrophic mutant of
E. coli undergoes cell death in response to thymine starvation. This pheno-
menon, called thymineless death (TLD), is also found in many other organ-
isms from prokaryotes to eukaryotes. Though TLD has been investigated
intensively, its molecular mechanism has not yet been explained. Thus, the
results of our work showing that thymine starvation is a trigger for a built-in
death program provide a new insight to an old enigma. In addition, the E. coli
mazEF-mediated PCD network may have implications to this of other
bacteria, including pathogenic one, and may enable to design a new gen-
eration of antibiotics targeted directly against participants in this network.
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New strategies of HIV/AIDS vaccine development: from basic science to clinical trials
K314 New strategies of HIV/AIDS vaccine
development: from basic science to clinical trials
B. Ensoli
Rome, I
Substantial failure of HIV env-based vaccines to induce sterilizing immunity
and to protect monkeys from infection with heterologus virus strains have
favored the development of new strategies aimed at controlling infection and
at preventing disease onset. To these goals, Tat, the transactivator of HIV-1was
chosen as a novel vaccine candidate. The Tat protein is produced very early
after infection, is key to the virus life cycle and to AIDS pathogenesis, is
immunogenic and well conserved among HIV subtypes in key functional and
immunogenic domains. A Tat-speciﬁc immune response in humans or
monkeys correlates with nonprogression to AIDS. In addition, Tat activates
DC function and drives Th-1-type immune responses that are key to virus
control. Vaccination of cynomolgus monkeys (Mks) with biologically active
HIV-1 Tat protein or DNA has proven to be safe, immunogenic and to
contain primary infection with the SHIV89.6P. In addition, protection
correlates with the presence of CD8 þ CTLs and CD8-mediated antiviral
activity. No residual virus hidden in resting cells has been detected in any of
the protected Mks either in the plasma or in lymph nodes, after two years of
follow up and upon two boosts with tetanus toxoid, a stimulus known to
activate virus replication. Safety and immunogenicity data have been con-
ﬁrmed by two new protocols and Tat (protein or DNA) has shown to be safe
also in monkeys with AIDS. Based on these data, preventive and therapeutic
phase I clinical trials are being started in Italy. In addition, immunological,
virological and feasibility studies for phase II/III trials are being conducted in
South Africa and Uganda. The results indicate that there is an high sequence
homology and an extensive immune cross-recognition between Tat B clade,
that is used for phase I studies in humans, and Tat from clades A, C and D
viruses that are found in Uganda and South Africa, strongly supporting the
concept that a Tat-based vaccine can be universally applied. Based on these
data, second generation vaccines based on Tat alone or combined with
structural genes and delivered by the mucosal route are being developed for
preclinical testing (safety, immunogenicity, efﬁcacy) in prime-boost regimens.
The challenge of the fungi (Symposium arranged by EFISG)
S316 What is the role of new diagnostic methods in
the clinical management of invasive fungal infections
H. Hebart, J. Loefﬂer, H. Einsele
Tubingen, D
Invasive fungal infections have emerged as an increasing cause of morbidity
and mortality in immunocompromised patients. Candida and Aspergillus
infections account for 80–90% of invasive fungal infections in patients with
hematological malignancies, and rare fungal pathogens have been reported
with increasing frequency. Early initiation of antifungal therapy is regarded to
be crucial to reduce the high mortality rate of invasive aspergillosis. Cultures
from blood are very rarely positive in patients with invasive aspergillosis, and
even cultures from bronchoalveolar lavage ﬂuid become positive usually at
advanced stages of the disease only. Sensitive assays for the detection of
Aspergillus- andCandida-speciﬁc circulating antigens have been developed and
the results look promising. PCR assays have emerged as powerful tools with
high sensitivity and speciﬁcity for the diagnosis of a broad variety of fungal
pathogens. Major improvements have been achieved to ensure a reliable
release of nucleic acids out of fungal cells. We and others could demonstrate
PCR to be useful for rapid, sensitive and speciﬁc detection and identiﬁcation
of a variety of the most frequent and also emerging fungal pathogens. DNA
extracted out of various clinical materials including whole blood, serum,
plasma, tissue samples, and cerebrospinal and bronchoalveolar lavage ﬂuid
could be ampliﬁed by the use of these techniques. Recent advances including
real-time PCR, which allows for the online quantiﬁcation of the DNA-load,
as well as the DNA-chip technology will help to establish nucleic acid-based
detection methods in the routine microbiological laboratory. In a prospective
study in 84 recipients of an allogeneic SCT, PCR-screening allows to identify
patients at high risk for subsequent onset of invasive aspergillosis. Moreover,
PCR-positivity in bronchoalveolar lavage samples taken at the time of
transplant was found to be a strong predictor for invasive aspergillosis in
recipients of an allogeneic stem cell transplant. Prospective studies evaluating
the potential beneﬁts of early therapy based on these methods in patients at
high risk for invasive fungal infections are warranted.
S318 Emergence of antifungal drug resistance and the
role of establishing standardized diagnostic assays
J. L. Rodriguez-Tudela
Majadahonda, E
During the last decades an increasing of invasive fungal infections has been
detected. A substantial number of them do not respond to conventional
treatments. It is obvious, that most of these infections affect to immuno-
supressed patients and thus, many factors can inﬂuence on the outcome of the
process. One of these factors can be that the infection is caused by fungi
exhibiting resistance to antifungals. In this context, the laboratory should be
able to detect this situation and inform in an understandable way. Although,
there are not totally accepted breakpoints for antifungals and fungi, useful
information can be obtained of a standardized antifungal susceptibility test.
There are several examples that can illustrate this assumption: (i) resistance of
C. albicans and C. glabrata to azole drugs; (ii) intrinsic resistance of C. krusei to
ﬂuconazole; (iii) resistance to azole drugs of Aspergillus fumigatus; (iv) multi-
resistance of Scedosporium proliﬁcans; (v) etc. These useful lessons were learned
from the observation of poor outcomes and high CMIs of the respective fungi
and opened the door for the development of standardized methodologies.
Nowadays, these standardized methodologies allow a common language for
all Mycology community. With the introduction of new classes of antifungals
and the increasing detection of new fungal pathogens, susceptibility testing
will be more necessary in the clinical setting and therefore the existence of
standardized methodologies is essential.
Malaria
S320 Malaria during pregnancy. What do we know?
Where are we now?
C. Menendez
Barcelona, E
The increased risk to malaria infection and disease in pregnancy is supported
by consistent epidemiological observations from different endemic regions
that go back to the early 30 s of the past century. The negative effects of
malaria in the woman and the fetus depend of the level of prepregnancy
immunity against malaria, which in general reﬂects the level of exposure to the
infection. Thus, in areas of low and unstable endemicity malaria may be a
common cause of maternal and perinatal mortality, whereas it is rarely a direct
cause of death in settings of stable transmission, though it may indirectly
contribute to it through the development of anemia in the woman and low
birth weight in the fetus. Parity inﬂuences the susceptibility and severity of the
infection with lower risk with increasing parity. In semi-immune women the
placenta is a preferential site for parasite invasion which is associated with
lower birth weight and prematurity of the newborn. Several host and parasite
factors have been proposed to explain the increased risk of malaria during
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pregnancy and speciﬁcally the placental invasion. Although, the exact
mechanisms are not yet fully understood, the inﬂammatory response in
the placental intervillous spaces associated with malaria may be instrumental
in the induction of bad pregnancy outcomes through the liberation of
immunological factors. The AIDS epidemic is changing the classical epi-
demiological observations to an increased severity of malaria disease and loss
of the parity pattern of the infection. Whether malaria also worsens or
accelerates HIV progression is not yet known. Malaria control during
pregnancy relies on a combination of different strategies from clinical manage-
ment, chemoprophylaxis through intermittent preventive treatment and
insecticide treated nets. Avoiding malaria in the pregnant woman is a public
health priority in endemic countries, although is rarely implemented. Further
operational research and support for the implementation and execution of
already available malaria control tools should be ﬁrst in the agenda of
international agencies.
S322 Malaria vaccines: from the laboratory to the ﬁeld
B. Genton
Basel, CH
The demonstration of the (i) acquired protective immunity in adults living in
endemic areas, (ii) cure of malaria patients with passive transfer of speciﬁc
immunoglobulines, and (iii) protection conferred by vaccination with spor-
ozoites attenuated by radiation, justiﬁes the search for a malaria vaccine. Given
the improbability that a vaccine directed against a single antigen will be
completely protective, the preferred option is to combine several antigens of
different stages of the parasite in a multicomponent multistage vaccine which
is likely to protect both travelers and populations living in endemic areas.
Potential technologies include recombinant proteins, synthetic peptides and
DNA vaccines, the relevant genes encoding for malaria antigens being
inserted into a plasmid or a live vector such as vaccinia or poxvirus. A
number of human trials with several antigens and technologies have been
carried out in the last 10 years. Three vaccines have undergone testing in the
ﬁeld in phase IIb or III trials. SPf66, including three synthetic peptides, has
been extensively evaluated in different epidemiological settings; its overall
efﬁcacy was 23%, and only 2% in African infants, the most susceptible
group. The circumsporozoite recombinant protein fused with the antigen
S of the hepatitis B virus (RTS,S) and formulated in a potent adjuvant led to a
high, but short-term, level of protection against infection and disease in
Gambian adults. The ﬁrst pure asexual blood-stage vaccine including three
antigens of the merozoite stage (MSP1&2 and RESA, combination B) had an
efﬁcacy of 62% to reduce parasite density in Papua New Guinean children. A
malaria vaccine that can reduce the burden of disease in the most affected
populations is thus an achievable goal, each trial providing additional
knowledge about mechanisms of protection as well as about new vaccine
technology.
Evidence-based infection practice: maximizing outcome (Symposium arranged with the BIS)
S326 Evaluating performance through evidence based
standards
D. Nathwani
Dundee, UK
Although the goal of evidence based guidelines is not to create standards of
care against which quality can be assessed many local and national organiza-
tions are using guidelines for this purpose. Such clinical standards, based on
existing evidence, would be subsequently used as the criterion for evaluating
the quality of care provided by an organization or individual units or
departments. Such quality assurance may be undertaken through an internal
or external peer review or through an accreditation process. In the United
Kingdom, as in Australia, guidelines and clinical standards underpin much of
the quality, or more recently, the clinical governance agenda. This process
aims to make it a statutory responsibility for each organization to be
accountable for ensuring monitoring and improving the quality of
healthcare it provides. These clinical standards primarily enable identiﬁcation
of the essentials that need to be right in the treatment of particular conditions
if outcomes for the patients are to be optimized. Standards can be set at
several levels: minimal, normative and exemplary. It is important to recognize
which level should be applied to any standard as minimal standards are
primarily aimed at promoting basic levels of care by identifying those
areas or professionals who perhaps require remedial, or in rare cases
even punitive action. Outcome related standards are deemed as the ‘gold
standard’ of performance measurement but in reality they are difﬁcult to
capture, particularly in the short term. Increasingly process or to a lesser
extent structure measures are deemed more attractive, especially if they are
linked through evidence to outcomes. Indeed, guidelines or care pathways
will outline intervention or processes of care that lead to a desired
outcome. For example in the revised British Thoracic Society Community
Acquired Pneumonia Guideline (Thorax 2002) the timely administration
(within 4 h of admission) of appropriate intravenous antibiotic therapy is
deemed to have an important bearing for a positive outcome in patients
hospitalized with severe community acquired pneumonia. This is regarded as
an important, unambiguous, evidence based, simple and measurable process
standard that is valued by clinicians, quality administrators and patients. Poor
performance on a process measure gives a clear indication of the remedial
action that is required, and this can be linked to an incentive to bring
about positive change. On the other hand a commonly used crude
outcome marker of death is more difﬁcult to interpret as it is insensitive
to the quality of healthcare received and can be inﬂuenced by a range of other
factors. In Scotland the development of Clinical Standards has been under-
taken by the Clinical Standards Board for Scotland, now renamed NHS
Quality Improvement Scotland (http://www.nhshealthquality.org) and
more recently by the Scottish Infection Standards and Strategy Group
(SISS; http://www.rcpe.ac.uk). This work is used to illustrate standards
development and implementation.
From genes to therapeutics (Symposium arranged with the ISC)
S328 Integrated computational platforms for
antibiotics research: applications in target validation and
compound evaluation
L. Macko, J. Paquette, K. Klein, J. Koenig, M. Soloviev, J. Traechslin,
J. Cox, E. Porter, H. Fischer
Basel, CH; Munich, D
The exponentially increasing number of sequenced microbes, together with
the growing use of DNA microarray technologies have resulted in a ﬂood of
DNA sequences and mRNA proﬁling data. Here, we will present newly
developed data analysis strategies that support the identiﬁcation and prior-
itization of small molecules as development candidates for novel antibiotics. In
a ﬁrst step, it will be shown how large-scale genome comparisons can be used
to identify and functionally characterize essential proteins that are amenable to
target-based compound screening. In a second step, an in-silico reconstruction
of a pathogen’s genetic regulatory networks is demonstrated. This technique
helps to pinpoint the promoters that are activated only for deﬁned types of
antibiotic stress, such as cell wall synthesis inhibition. Reporter assays employ-
ing cells that carry reporter genes fused to such promoters are an attractive
alternative to the classical target-based assays, as they enable mechanism-
speciﬁc cellular screening strategies. As opposed to the computational tech-
nologies supporting assay development, we have also developed a system that
automatically determines the mechanisms-of-action of uncharacterized
bioactive compounds. This technology is based on a ‘reference compendium’
of mRNA signature proﬁles triggered by well-characterized antibiotics. A
data analysis technique is presented that identiﬁes mechanism-speciﬁc marker
genes. Pattern recognition algorithms enable an automated classiﬁcation of
the molecular mechanism employed by the compounds under investigation.
The mRNA-based MOA classiﬁcations are of particular relevance for a
systematic evaluation of bioactive natural products as a starting point for
the development of new antimicrobial agents. It also helps in guiding
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the downstream chemical development process (‘MOA tracking’). In sum-
mary, it will be demonstrated that integrated computational systems continue
to have a major impact on antibiotics target identiﬁcation and validation, assay
development and compound optimization. As such, computational biology
and bioinformatics will play an important role in streamlining the antimi-
crobial discovery and development process.
S330 Structure in drug discovery
R. E. Hubbard
Cambridge, UK
The continuing investment in genomics and proteomics technologies is
generating an increasing number of potential targets for therapeutic
intervention. Target validation remains a serious issue, but the main challenge
in drug discovery is to identify small molecules that will have the desired effect
on the function of the target and then to optimize the physico-chemical and in
vivo properties of the compounds to provide useful drugs. Recent advances in
structural biology provide descriptions of the structure and mechanism of an
increasing number of drug targets. A variety of techniques drawn from the
methods of crystallography, NMR, cheminformatics, computational and
medicinal chemistry allow detailed understanding of the relationship between
structure and activity. When combined, these methods provide a rational
approach to design that can exploit structural information to improve
performance and success at both these hit identiﬁcation and lead optimization
phases of drug discovery. In this presentation, I will review the various
methods and applications of structure based drug discovery and demonstrate
that, for some targets, these methods can have a dramatic impact on the speed
and effectiveness of drug discovery.
MRSA: from typing to control
O334 The HARMONY methicillin-resistant
Staphylococcus aureus (MRSA) database
B. Cookson, S. Murchan, M. Enright, W. Witte and the HARMONY
MRSA Typing Group
Objectives:MRSA now comprise a global challenge to healthcare establish-
ments. The HARMONY MRSA database was developed with European
Union Grant funding to enable the tracking of strains and to inform risk
assessment for control procedure design and application.
Methods: Ten countries were involved in the original project; others have
joined, e.g. Ireland, Portugal, Poland, Scotland, Slovenia, Canada and Aus-
tralia. Pulsed ﬁeld gel electrophoresis (PFGE) has been standardized and is
now published. Other techniques outlined below have been added to the
database which includes details of epidemicity and virulence.
Results: Typing data on the www include phage patterns, toxin, resistotype
and antibiograms so important to infection control and epidemiological
studies. MecRIA typing has shown at least three introduction of the methi-
cillin resistance gene into S. aureus. A novel binary typing system and FAFLP
have also been used. The PFGE database is now externally accessible via the
BIONUMERICS program. We are piloting the downloading of the database
and ways of updating it interactively with reference centers and the ESCMID
ARPAC project. MLSTand SCCmec performed interactively with the Bath/
Oxford Wellcome center have provided further insights into the evolution of
these different MRSA. New, and further spread of MRSA EU clones are
described, criteria for referral of isolates to a typing laboratory were agreed. A
standardized approach to International MRSA nomenclature will permit
country-speciﬁc names, the rule-sets varying according to a country’s MRSA
endemicity. Interactions with other EU projects such as DG SANCO’s
EARSS and HELICS projects are also being progressed.
Conclusions: The establishment of the MRSA database has established as
esprit de cours in the EU and will inform the epidemiology, risk assessment
processes and success of control measures as well as the emergence of new
resistances in MRSA such as to linezolid and the glycopeptides.
O335 Evaluation of pulsed-ﬁeld gel electrophoresis,
random ampliﬁcation of polymorhic DNA and plasmid
proﬁle analysis methods in genotyping of nosocomial MRSA
isolates
K. Sener, M. A. Saracli, C. H. Acikel, L. Doganci
Ankara, TR
Objective: Plasmid proﬁle analysis (PPA), random ampliﬁcation of poly-
morphic DNA (RAPD), and pulsed ﬁeld gel electrophoresis (PFGE) are three
most valuable epidemiological tools for genotyping of methicillin resistant
Staphylococcus aureus (MRSA) strains. Aim of this study was to evaluate those
three methods in respect of their cost, reproducibility and discriminatory
power.
Methods: Eighty one nosocomial MRSA isolates with unknown genetic
relatedness from a Turkish tertiary care training military hospital were
genotyped by PPA, RAPD and PFGE methods.
Results:All the isolates (100%) were typed by RAPD and by PFGE, however,
eight (9.9%) isolates could not be typed by PPA since they lacked plasmid
DNA. Reproducibility of all the three methods were found to be 100%.
Discriminatory powers of PPA, RAPD and PFGEmethods were calculated as
48.6, 61.1, 80.1%, respectively. The costs of typing per isolate were $3.9 for
PPA, $7.3 for RAPD and $34.1 for PFGE.
Conclusion: Out of the three methods tested, PFGE allowed the most
effective discrimination of MRSA strains. However, it was more time
consuming and technically demanding, and required use of specialized and
expensive equipment. Although PPA and RAPD were less discriminant than
PFGE, these methods were technically simple, quick and cheaper. When PPA
and RAPD were combined together they had equal discriminatory power to
PFGE in this respect. So, it might be emphasized that PPA and RAPD
methods could be preferred for screening purposes at ﬁrst while PFGE as
conﬁrmatory test in typing of MRSA isolates.
O336 Prevention of MRSA on an ICU – analysis of the
impact of body decontamination
F. M. MacKenzie, E. J. Watson, D. Pacitti, D. Noble, S. Stott, D. Stuart,
I. M. Gould
Aberdeen, UK
Objective: MRSA is endemic in most teaching hospitals in the UK. Within
these hospitals, the ICU usually plays a big role in its generation, maintenance
and dissemination. Conventional infection control measures have, so far,
failed to control such outbreaks. In Aberdeen Royal Inﬁrmary (ARI) an
intervention based on whole body decontamination was implemented in a bid
to control new cases of MRSA.
Methods:The setting was the ICU in ARI consisting of eight beds plus a ﬁve-
bed overspill area. Over a period of 12months from 1 May 2001, three
protocol changes were made. Firstly, all patients admitted to the ICU were
screened on admission for MRSA (nasal, throat, axilla and groin swabs).
Secondly all received six hourly nasal ointment treatment (fucidin, naseptin
and tetracycline rotated weekly). Thirdly, all patients had a daily bed bath in
4% chlorhexidine. Patients found to be MRSA positive were barrier nursed.
Apart from admission MRSA screen and topical regimen, there was no
change in intensive care or antibiotic prescribing policy throughout the
period of the study. MRSA prevalence data were obtained via the laboratory
computer system for the 12-month study period and the previous 24months.
Results: In the 24months prior to the study, there were 1232 admissions to
the ICU and 194 new cases of MRSA identiﬁed in the unit. The ﬁve most
common sites from which MRSA was isolated were endotracheal aspirates
(902 MRSA positive), bronchoalveolar lavages (163 MRSA positive), sputum
(125 MRSA positive), central line tips (86 positive) and tracheal aspirates (59
MRSA positive). During the 12-month period of the study, 691 patients were
admitted and 41 new MRSA cases were identiﬁed, 22 of which were
identiﬁed via the admission screen. A total of 1592 surveillance samples were
submitted. Of these, 29 nasal, 27 throat, 10 groin and 6 axilla specimens were
MRSA positive. The reduction in new cases from 16% (prior to intervention)
to 6% (during intervention) was statistically signiﬁcant (P< 0.01). The topical
prophylactic regimen was easy to institute and well received by staff who
Clinical Microbiology and Infection, Volume 9, Supplement 1, 2003 59
perceive it to have been very successful. There was no antibiogram change
over the study period.
Conclusions: Instigation of MRSA screening on admission and barrier
nursing of new MRSA cases combined with a topical regimen led to a
signiﬁcant reduction in the number of new cases of MRSA in the ICU over
the 12month study period.
O337 Sucessful infection control practices for reducing
the nosocomial transmission of methicillin-resistant
Staphylococcus aureus in a university hospital
V. Tomic, P. Svetina-Sorli, D. Trinkaus, A. Widmer, A. Trampuz
Golnik, SVN; Basel, CH; Rochester, USA
Objectives:Aim of the study was to evaluate the effectiveness and feasibility of
a strict infection control strategy to contain cross-transmission of MRSA in a
237-bed tertiary teaching hospital in an area with a high level endemic
MRSA.
Methods: Until 1998 we only occasionally detected MRSA in clinical
specimens from patients admitted to our hospital. From 1999 to 2001 we
gradually built a control program which in 2002 included screening of
potential MRSA carriers with deﬁned risk factors (transfer from other
hospitals’ ICU or nursing home, surgery in last year, previous colonization
with MRSA), consistent use of alcoholic hand rub instead of washing with
soap and water and decolonization of patients from whom MRSA was
recovered.
Results: During 5 years period, we detected 225 patients colonized or
infected with MRSA and 1100 patients with MSSA. In 1998 the prevalence
rate was 4.5 patients per 1000 admissions and 8.0, 7.7, 5.7, 6.8 per 1000
admissions in 1999, 2000, 2001, 2002, respectively. Average age of patients
withMRSAwas 63.3, 68.7, 66.7, 69.5, 72.3 in 1998, 1999, 2000, 2001, 2002,
respectively. At the beginning sputum and tracheal aspirate were the most
common sample positive for MRSA, while in 2002 nasal swab became the
predominant sample. Precentage of isolates classiﬁed as nosocomially acquired
during stay in our hospital was 28, 44, 34, 20 and 0% in 1998, 1999, 2000,
2001 and 2002, respectively. Time from patient admission to collection of ﬁrst
positive sample was 9.6, 15.3, 8.1, 5.5 and 2.6 days in 1998, 1999, 2000, 2001
and 2002, respectively.
Conclusion: In a country in whichMRSA has been endemic, implementation
of strict infection control program (hand disinfection instead of washing,
screening, isolation precautions, decolonization)is essential in preventing
intrahospital MRSA transmissions.
O338 Relationship between methicillin-resistant
S. aureus outbreaks in two Scottish hospitals
F. M. MacKenzie, J. -M. Lopez-Lozano, D. L. Monnet, M. Camacho,
R. Wilson, D. Stuart, A. Beyaert, I. M. Gould
Aberdeen, UK; Alicante, E; Copenhagen, DK; Murcia, E
Objective: Previous work investigated the relationship between antimicrobial
use and the outbreak of methicillin resistant S. aureus (MRSA) in Aberdeen
Royal Inﬁrmary (ARI), a large tertiary referral teaching hospital in the
Grampian region of Scotland. The present study investigated the relationship
betweenMRSAoutbreaks in ARI and a long stay geriatric hospital,Woodend
Hospital (WH) in the same region by means of time series analysis (TSA).
Methods: Data on monthly, nonduplicate, nonsurveillance S. aureus (includ-
ing MRSA) and antibiotic use were collected in both hospitals from January
1996 to January 2002. Dynamic regression models were adjusted to measure
relationships between data sets.
Results: Percentage MRSA in ARI rose from <1% in 1996 to 38% in
February 2000, before it started to decline. WH had an independent
MRSA outbreak mid-1997 to mid-1998, which then followed the ARI
outbreak (Figure 1). TSA showed that: (i) Prior to 1999, percentage MRSA
in ARI followed percentage MRSA in WH (lag¼ 1month), whereas after
1999, percentage MRSA in ARI lead percentage MRSA in WH
(lag¼ 1month); (ii) percentage MRSA in ARI was closely related to previous
macrolide, 3rd-generation cephalosporin and ﬂuoroquinolone use in ARI,
whereas percentageMRSA inWHwas related to previousWHmacrolide use
only.
Conclusion:A dynamic relationship was found between MRSA outbreaks in
two hospitals in the same region. The original outbreak in the long stay
geriatric hospital initiated the outbreak in the teaching hospital, then the
teaching hospital lead the geriatric hospital outbreak. Patient ﬂux between
hospitals can explain this relationship. Additionally, antibiotic use in each
individual hospital maintained the respective outbreaks.
O339 Molecular epidemiology of methicillin-resistant
Staphylococcus aureus clinical isolates in Taiwan
Y-C. Huang, L-H. Su, T-L. Wu, T-G. Young, P-Y. Chen, P-R. Hsueh,
T-Y. Lin
Kweishan, Taoyuan, Changhua, Taichuang, Taipei, TW
Background: Methicillin-resistant Staphylococcus aureus (MRSA) has become
an important nosocomial pathogen and the increasing prevalence is a world-
wide problem. In most major hospitals in Taiwan, MRSA accounts for 50–
80% of all S. aureus isolates. However, a nationwide molecular epidemiology
of the MRSA isolates has not yet been studied extensively.
Materials and methods:During July, 2000 and October, 2001, a total of 595
MRSA clinical isolates were collected from six medical centers distributed in
northern, central and southern Taiwan. The sources of specimens included
blood, pus, sputum, body ﬂuids, urine and catheter tips. The genotyping
method used was pulse ﬁeld gel eletrophoresis with SmaI digestion.
Results: A total of 31 genotypes with 97 type-subtypes were identiﬁed.
Subtypes could be identiﬁed in seven genotypes. There were 15 genotypes in
Hospitals I and VI, respectively, and six genotypes in Hospitals II, III, IVand V,
respectively. 433 isolates (73%) were shown to belong to a major type (type A,
29 type-subtypes). This type was the only type prevailing in all six hospitals
and the predominant clone in each hospital, accounting for 46–89% of the
isolates in each hospital. Genotype C (16 type-subtypes) was the 2nd
dominant type, accounting for 9% of all isolates, and was distributed in ﬁve
hospitals. Genotype D (11 type-subtypes), E (ﬁve type-subtypes) and B (six
type-subtypes) were distributed in ﬁve, four and three hospitals, respectively.
The other 26 genotypes were minor.
Conclusion: The majority of the isolates shared a common PFGE pattern,
indicating the presence of a single, epidemicMRSA clone prevailing in major
hospitals in Taiwan.
O340 Absence of vancomycin-resistance in MRSA in
the Tyrol, Austria 2002
D. Orth, A. Eigentler, M. Eller, M. Fille, F. Allerberger, M. Dierich
Innsbruck, A
Objectives:Methicillin-resistant Staphylococcus aureus (MRSA) is an important
cause of hospital- and community-acquired infections. It was the aim of this
study to elucidate the incidence of vancomycin-intermediate sensitive (VISA)
and vancomycin-resistant S. aureus (VRSA) in the Tyrol and to compare the
MRSA rates of the various levels of medical care.
Methods:All MRSA strains isolated in 2002 in two laboratories serving all of
the Tyrol (catchment area: population of 670 000) were screened for vanco-
mycin resistance by use of a plate test: brain heart infusion agar containing
6mg/L of vancomycin; spot inoculation with 10mL of an McFarland 0.5
inoculum; incubation at 368C for 24 h. Susceptible colonies were further
evaluated using E-test. Strains that are inhibited by doses less than or equal to
4mg/L are considered susceptible to vancomycin, those with MICs at or
above 32 as resistant. For comparingMRSA rates between primary, secondary
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and tertiary medical facilities, inital isolates only (one MRSA per patient)
were studied using Hybase 5.1.
Results: At the ‘University Lab.’ a total of 6302 S. aureus isolates (including
1604 MRSA) and at the ‘Lab. Moest’ 646 isolates (including 13 MRSA) were
diagnosed in 2002. All MRSA strains were susceptible to vancomycin.
Methicillin resistance was found in 13.8% of all initial S. aureus strains cultured
at the University: MRSA comprised 3.0% of S. aureus isolates from primary
care facilities (physician ofﬁces), 13.7% of isolates from secondary care
facilities (peripheral hospitals), and 19.4% of isolates from a university hospital.
In this tertiary care facility 10.1% of S. aureus from outdoor patients were
methicillin-resistant, 21.0% from patients of general wards, and 31.0% from
patients of intensive care units (ICUs). MRSA comprised 1.0% of S. aureus
isolates from primary care facilities (physician ofﬁces) sending their specimens
to the ‘Lab. Moest’.
Conclusions: The emergence of VISA and VRSA underscores the need for
vigilance for the problem of antimicrobial resistance. Studying a closed
catchment area, we were unable to demonstrate occurrence of VISA or
VRSA in the Tyrol but found that the incidence of MRSA showed drastic
differences between the various health care settings. Care must be taken when
comparing MRSA rates between different regions without stratiﬁcation for
the levels of the health care settings.
O341 Are there community-acquired MRSA in Central
Europe?
W. Witte
Wernigerode, D
Objectives: Early detection of emergence and spread of MRSA among the
community (C-MRSA).
Methods:
	 MRSA surveillance by a National Reference Laboratory for Staphylococci.
	 Study on nasal carriage of MRSA.
	 Molecular typing of MRSA by SmaI-macrorestriction patterns, PCR
detection of resistance and virulence associated genes.
Results:Among 9871 MRSA infections in Germany from 1998 to 2000, 6%,
were in nonhospitalized patients attending GP’s for different reasons. All of the
patients affected had a previous history of hospitalization. Molecular typing
attributed the majority of these MRSA to clonal groups of MRSAwhich are
also prevalent in hospitals. Among 611 patients admitted to an ear, nose and
thought ambulatory practice and to hospital emergency seven (0.9%) revealed
positive for nasal carriage of MRSA. The patients had been hospitalized or at
least in personal contact to hospitals during 6months prior to this examina-
tion. Molecular typing uniformly attributed these isolates to the epidemic
MRSA most frequent in nosocomial infections in this area: Barnim epidemic
MRSA (syn. EMRSA 15; ST22). There have been family outbreaks of deep
skin infections with S. aureus belonging to the same SmaI-macrorestriction
cluster and possessing luk f/s (Panton-Valentine leucocidin), however, none of
these isolates possessed mecA.
Conclusions: There are no indications to emergence of C-MRSA in Central
Europe independent upon hospitals.
O342 Prevalence and risk factors of
methicillin-resistant Staphylococcus aureus carriage at
hospital admission
I. Casas, M. Esteve, I. Andre´s, M. Caraballo, N. Sopena, L. Matas,
M. -L. Pedro-Botet, E. Reynaga, M. Sabria`
Badalona, E
Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) continues
to be an important nosocomial pathogen, although the prevalence of
community-acquired MRSA is rising. However, the prevalence of carriage
at hospital admission and the related risk factors are not well-known.
Objective: To determine the prevalence of MRSA carriage at hospital
admission and the related risk factors to deﬁne patients susceptible to screen-
ing at admission.
Methods: A transversal study was performed in a university hospital in
Badalona, Spain. A randomized sample of patients admitted to hospital
(excluding pediatric and obstetric patients) was screened within the ﬁrst
24 h of admission (nasal swab, pressure sores and wound cultures). Demo-
graphic and clinical data, and risk factors were also collected. Preliminary
results, from October 2001 to December 2002, are presented.
Results: A total of 752 patients were screened, 13 being MRSA nasal carriers
(prevalence 1.7%). Signiﬁcant risk factors of MRSA carriage at admission
were: age (P¼ 0.015), Barthel’s index (P¼ 0.022), nursing home stay within
the last 12months (P< 0.0001), emergency admission (P¼ 0.04)and prior
hospital admission within the last year (P¼ 0.008). Other non signiﬁcant
variables were: diabetes, open wounds, prior antibiotic treatment within the
last 6months, hemodialysis and urinary catheter. However, only previous
nursing home stay remained signiﬁcant onmultivariate analysis (OR: 17.7; IC
95%:2.3–136.4).
Conclusions: The prevalence of MRSA carriers at admission is low. Patients
admitted from a nursing home had the highest risk of MRSA carriage at
hospital admission.
O343 Epidemiological changes in methicillin-resistant
Staphylococcus aureus infection 10years after its initial
appearance in a university hospital, Spain
N. Sopena, I. Andre´s, I. Casas, M. Caraballo, M. Esteve,
M. Garcı´a-Nun˜ez, M. L. Pedro-Botet, E. Reynaga, M. Sabria`
Badalona, E
Background: Since 1990 the HUGTiP, a 600-bed university hospital, has
faced an hiperendemic situation of MRSA infection.
Objectives: To analyze changes in incidence, epidemiological, clinical and
microbiological characteristics of MRSA infection in HUGTiP during two
time periods.
Methods: Period 1: December 1990 to December 1996; period II: July 2000
to February 2002. Epidemiological, clinical an microbiological data were
collected.
Results: In period I, 462 cases of MRSAwere registered and in period II, 107
new cases. The incidence of MRSA (2.9/1000 vs. 4.6/1000 admissions,
P< 0.001) and the cases originating in the ICU (29 vs. 54.8%, P< 0.001)
decreased signiﬁcantly in the second period, while the nursing home and
community-acquired cases (21.4 vs. 1.7%, P< 0.001)increased signiﬁcantly
during this period. The most frequent isolation sites of MRSA were nasal
(53.7% in period I vs. 40.2% in period II), respiratory (26 vs. 30.8%), bed sores
(9.9 vs. 14%), surgical wounds (9.9 vs. 15%) and blood cultures (9 vs. 18.7%).
The rate of nasal carrier decreased signiﬁcantly (P¼ 0.01) in the second
period and the rate of bacteremia increased signiﬁcantly in the second period
(P¼ 0.02), although the incidence of bacteremia did not vary signiﬁcantly (4
vs. 5.3/1000 admissions). In the second period a signiﬁcant increase was
observed in MRSA sensitive to gentamicin compared to the previous period
(35.5 vs. 10.4%, P< 0.001). The rate of patients colonized at discharge was
high and increased signiﬁcantly in the second period (54.2 vs. 41.4%,
P¼ 0.02).
Conclusion: Ten years after the introduction of MRSA in HUGTiP, the
incidence and nosocomial-acquisition of SARM has decreased, although the
nursing home and community-acquired cases has increased. On the other
hand, the rate of gentamicin sensitive MRSA (35.5 vs. 10.6%, P< 0.001) has
increased signiﬁcantly. Finally, the rate of colonized discharged patients is
higher, although the role this may have on community transmission of MRSA
is unknown.
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O344 Inﬂuence of BCG vaccination on tuberculin skin
test: up to what size?
F. Tissot, G. Zanetti, P. Francioli, J. -P. Zellweger, F. Zysset
Lausanne, CH
Objective: To investigate the inﬂuence of prior BCG vaccination on tuber-
culin skin test (TST) at different cutoff sizes, and to compare it to the inﬂuence
of several indicators of a possible tuberculosis (TB) infection, in an adult
population with high vaccination rate and low TB incidence.
Methods: From 1991 to 1998, all new employees at the Centre Hospitalier
Universitaire Vaudois, Lausanne, Switzerland, underwent a TSTwith 2TU
RT23. A booster injection was administrated in case of an initial reaction
<10mm. Information was obtained on demographic characteristics, history
of prior BCG vaccination, prior TB infection, travel to TB endemic country,
employment in TB endemic country, contact with active TB and prior
TSTs.
Results: Among 5117 subjects, the inﬂuence of BCG vaccination upon TST
varied across categories of ages (likelihood ratio test: P¼ 0.0001): BCG
vaccination was the strongest predictor of a positive TST among employees
under 40 years at cutoff values of 10mm (OR 15.0 in employees <30 years
and 12.4 in employees 30–39), 15mm (OR 9.2 and 12.2, respectively) and
18mm (OR 4.5 and 9.7, respectively). Among employees >40, however,
vaccination was a predictor only at a cutoff value of 10mm (OR 2.8). On the
other hand, BCG vaccination had no signiﬁcant effect on tests greater than
20mm whatever the age group.
Conclusion: Interpretation of tests up to 18mm among BCG-vaccinated
individuals under 40 years of agemust be donewith caution in areas of lowTB
incidence. Except for persons who have never been vaccinated, TST up to
18mm is more likely to be the result of prior vaccination than infection and
should not systematically lead to preventive treatment.
O345 Mycobacterium testing trends in clinical
laboratories in Europe; a review of the UK NEQAS quality
assessment scheme for Mycobacteria culture, 1992–2002
C. Walton
London, UK
Objectives: To evaluate the results from clinical diagnostic microbiology
laboratories taking part in the UK NEQAS quality assessment scheme for
Mycobacteria culture between 1992 and 2002, and to assess whether the trend
of increasing use of rapid methods of mycobacterial testing is improving ‘time
to positive’ reporting of results.
Methods:Quality assessment of Mycobacteria culture was performed. Parti-
cipants are required to report on the presence of ‘mycobacteria’ and on the
time taken to obtain a positive result. A survey questionnaire organised in
2002 addressed the use of CAMLiC (Continuous Automated Mycobacterial
Liquid Culture) and molecular methods.
Results:The overall level performance with the Mycobacteria culture quality
assessment specimens has remained consistently high with an average success
rate of 94%. The mean ‘time to positive’ reporting has decreased from 24 to
17 days. A total of 269 participants in the questionnaire survey on methods
returned responses by the closing date. The percentage of participants using
CAMLiC methods was 70%; using DAT molecular methods on clinical
specimens was 30% and using molecular methods as conﬁrmation of identity
of mycobacteria species was 35%.
Conclusions: The increase in the use of rapid culture methods for the
detection of Mycobacterium tuberculosis has resulted in an overall reduction
in ‘time to positive’ data as reported by participants and has provided an
indication of participants’ ability to meet the 21 day target for detection and
identiﬁcation of M. tuberculosis as recommended by the Centers for Disease
Control and Prevention, Atlanta, GA, USA. Tuberculosis was identiﬁed as a
key priority by the Chief Medical Ofﬁcer of the United Kingdom in his new
strategy for infectious diseases (2002). As a consequence, the results of
UK participants were reviewed to provide an insight, as a baseline, into
the ability of UK clinical diagnostic microbiology laboratories to meet the
new challenge.
O346 Clinical evaluation of VIDAS PROBE MTB
compared to MTD2 for the detection of Mycobacterium
tuberculosis
D. Fuller, L. Jasper, R. Buckner, T. Davis, J. Kelly, B. Rice
Indianapolis, Rockland, USA
Objectives: To evaluate the performance of the VIDAS PROBE Mycobacter-
ium tuberculosis (MTB) Test (bioMerieux, Inc., RocklandMA) as compared to
the Gen-Probe (San Diego, CA)Mycobacterium Direct Test (MTD2) for the
detection and identiﬁcation of Mycobacterium tuberculosis (Mtb) complex.
Additionally, a series of studies were conducted to establish specimen stability
for the MTB assay. These included: fresh unprocessed specimen; deconta-
minated/digested (D/D) sediment; processed lysate and amplicon; fresh
(refrigerated) vs. frozen (208C) sediment and lysate; and the impact of
freeze-thaw cycles on sediment and lysate stability.
Methods: The MTB test is an automated, target-ampliﬁed test used to
qualitatively detect Mtb complex rRNA from D/D sediments. The
MTD2 test qualitatively detects Mtb complex rRNA from D/D sediments.
Discordant results for the MTB/MTD2 comparison were resolved using
conventional culture methods (inoculation to BACTEC 12Bmedia, followed
by subculture to Middlebrook 7H10 and Lowenstein-Jensen media if
positive).
Results: A total of 102 sediments were tested by MTB and MTD2 with 25
positive by both methods and 75 were negative by both methods. The two
discordant samples (MTB positive, MTD2 negative) were both AFB and
culture positive. Therefore after resolution of discordant samples by culture,
the sensitivity and speciﬁcity or the MTB test were both 100%. Results from
the stability studies determined that unprocessed specimens were stable for up
to 8 days at 2–88C; D/D sediment was stable for up to 48 h at room
temperature (RT) and up to 7 days at 2–88C; processed lysate was stable
up to 8 h RT and 7 days at 2–88C; amplicon was stable 48 h at 378C in the
AMPstation instrument and 72 h stored at 2–88C; no signiﬁcant difference in
the results of fresh vs. frozen sediments or lysates was observed; and ﬁve freeze-
thaw cycles had no effect on the stability of sediments or lysates.
Conclusions: The VIDAS PROBE MTB Test provides rapid, ampliﬁcation
and detection of Mtb with a built-in internal control (no false negative results
due to inhibitors). This study showed enhanced performance of the MTB
assay compared to MTD2 in terms of sensitivity, automation, and technician
hands on time. Specimen and procedural stability also allow increased testing
and workﬂow ﬂexibility.
1This device has not been approved by the US FDA and is not commercially available.
O347 Varying prevalence of mutations in katG gene
codon 315 in isoniazid-resistant Mycobacterium tuberculosis
isolates from the Middle East
S. Ahmad, E. Mokaddas, Z. Khan
Safat, KWT
Objectives: To rapidly screen and to determine the prevalence of S315T and
other mutations at codon S315 in the katG gene that confer clinically
signiﬁcant resistance to isoniazid in isoniazid-resistant Mycobacterium tubercu-
losis isolates recovered from tuberculosis (TB) patients in the Middle East.
Methods: All isoniazid-resistant (n¼ 37) and 22 -susceptible clinical
M. tuberculosis isolates from Kuwait obtained in 2001 were analyzed. Addi-
tionally 67, 28 and 17 isoniazid-resistant and 18, seven and six -susceptible
M. tuberculosis isolates from Kuwait, Dubai and Beirut, respectively, that were
analyzed previously including the isolates with no AGC to ACC (S315T)
mutation were also tested. The presence of mutations was detected by PCR
ampliﬁcation of the DNA region around codon S315 in the katG gene
followed by restriction digestion with Msp I or MspA1 I to generate
restriction fragment length polymorphism. The genotyping of the isolates
was performed by touchdown double-repetitive-element-PCR.
Results:The mutation AGC to ACC (S315T) was detected in 22 (59%) while
any mutation at codon S315 of the katG gene was present in 24 (65%) of 37
isoniazid-resistant isolates from Kuwait recovered from TB patients in 2001.
The two isolates with other mutations at codon S315 were recovered from a
patient of Middle Eastern origin and South Asian origin. The genotyping
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studies showed that majority of the isolates carrying mutations at codon S315
exhibited unique DNA banding patterns. Re-analysis of isoniazid-resistant
M. tuberculosis isolates showed that one of 21, one of 10 and two of 11 isolates
(all recovered from patients of Middle Eastern origin) with no AGC to ACC
mutation from Kuwait, Dubai and Beirut, respectively, contained other
mutations at codon S315 of the katG gene. None of the susceptible strains
contained any mutation at codon S315.
Conclusions: The data show that mutations other than AGC to ACC
substitution at codon S315 in the katG gene occur more frequently in M.
tuberculosis isolates recovered from Middle Eastern patients and should be
incorporated in a rapid screen for detecting mutations in the katG gene
conferring isoniazid-resistance.
Acknowledgements: Supported by Kuwait University Research Adminis-
tration grant MI 116.
O348 Molecular identiﬁcation of Mycobacteria using
PyrosequencingTM technology
M. Krabbe, A. Alderborn
Uppsala, S
Objectives: We have developed a molecular method based on Pyrosequen-
cing technology for the identiﬁcation of mycobacterial species involved in
atypical mycobacterial infections.
Methods: Pyrosequencing technology is a DNA sequencing-by-synthesis
method based on the detection of the release of pyrophosphate (1). This
technology is an easy to use technique for accurate and consistent analysis of
DNA sequences. In this study we have targeted the variable rnpB gene
encoding the RNA subunit of the enzyme RNaseP (2) in Mycobacteria for
the identiﬁcation of mycobacterial species involved in atypical mycobacterial
infections. Atypical mycobacteria cause a wide variety of infections such as
abscesses, septic arthritis and osteomyelitis and populations at risk include
individuals with pre-existing lung disease and immunocompromised persons.
In this study, a single PCR ampliﬁcation of a region in the rnpB gene is
followed by one sequencing reaction using Pyrosequencing. The automati-
cally obtained sequence string was then compared with reference DNA
sequences and identiﬁed.
Results: The molecular identiﬁcation method was tested on DNA from
reference strains as well as clinically isolates of mycobacteria. The sequencing
quality of this GC-rich DNA was signiﬁcantly improved by the inclusion of
single-strand binding protein (SSB) added after the annealing of the sequen-
cing primer. Sequence data and evaluation towards the rnpB sequence of
reference strains will be presented.
Conclusion: A short region of the rnpB gene was shown to be highly
informative and useful in rapid DNA sequencing by Pyrosequencing. Applied
in clinical microbiology laboratories, this method could simplify and speed-up
the identiﬁcation of these slow-growing and often hard-to identify myco-
bacterial species.
References
1. Nyre´n P., Pettersson, B., and M. Uhle´n, M. Solid Phase DNA minisequencing by an enzymatic
luminometric inorganic pyrophosphate detection assay. Anal. Biochem. 1993; 208:
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2. Herrmann, B., Winqvist, O., Mattsson, J.G., and L.A. Kirsebom. Differentiation of Chlamydia spp.
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O349 Low sensitivity of ultrasonography for the early
diagnosis of amebic liver abscess
L. Elzi, G. Laifer, P. Sendi, U. Fluckiger, S. Bassetti
Basel, CH
Objectives: Amebic liver abscess (ALA) is the most common extraintestinal
manifestation of Entameba histolytica infection. Worldwide 100 000 people are
estimated to die each year from amebic colitis and ALA. In Switzerland ALA is
uncommon, usually occurring in immigrants or travelers returning from
tropical and subtropical areas. Early diagnosis and prompt initiation of therapy
is essential to reduce the mortality rate, which reaches 5–30% in case of
complications. Abdominal ultrasonography (US) is considered to be the
method of choice for diagnosing ALA, with a sensitivity of 95% reported
in the literature. However, we observed several cases of ALA missed by
US. The aim of this study was to investigate the clinical presentation of ALA
and the sensitivity of US for the early diagnosis of ALA in a nonendemic
region.
Methods:Retrospective study of all patients with liver abscess hospitalized at
the University Hospital Basel between 1989 and 2002. Data were collected by
chart review.
Results: Sixty-three patients were included in the study. 19 patients were
diagnosed with ALA and 44 patients with pyogenic liver abscess (PLA).
Clinical presentation and laboratory results were not signiﬁcantly different in
the two groups, except for travel and immigration history, which was more
frequent in patients with ALA (84 vs. 11%, P< 0.01). In all patients with ALA
and in 25 patients (57%) with PLA abdominal US was initially performed.
Liver abscesses were identiﬁed by US in 11/19 (58%) patients with ALA
compared with 23/25 (92%) of patients with PLA (P¼ 0.01). Body mass
index, number, size and location of abscesses, and duration of symptoms were
similar in both groups.
Conclusions: In contrast to the data reported in the literature, in our study US
had a low sensitivity (58%) for the early diagnosis of ALA. This result may
reﬂect the particular pathogenesis of ALA, which starts with ischemia and
progressive necrosis, initially not detectable by US, while the abscess develops
later by the conﬂuence of microabscesses caused by the lytic effect of
E. histolytica. Pending serologic results, the diagnosis of ALA is based on
the clinical presentation, recognition of epidemiologic risk factors and early
use of noninvasive imaging studies. We recommend to perform an abdominal
CT-scan in patients with a history and clinical ﬁndings suggestive of ALA, if
US is initially normal.
O350 A new combination with dihydroartemisinin,
piperaquine, trimethoprim and primaquine, compared to
atovaquone-proguanil for falciparum malaria in Vietnam
P. T. Giao, P. J. de Vries, L. Q. Hung, T. Q. Binh, N. V. Nam, P. A. Kager
Ho Chi Minh City, VN; Amsterdam, NL; Phan Thiet, VN
Objectives: Dihydroartemisinin is a member of the highly active group of
artemisinin antimalarials. Piperaquine is a bisquinoline, effective against
chloroquine resistant parasite strains. A new antimalarial drug combination
of dihydroartemisinin, piperaquine, trimethoprim and primaquine (CV8(R),
DPTP) was recently launched in Vietnam for the treatment of P. falciparum
infections. Tolerance, pharmacodynamics and efﬁcacy of DPTP were studied
and compared to atovaquone plus proguanil (Malarone(R), AP).
Methods: In a randomized open label study, patients with P. falciparummalaria
received four dosages of DTPT (64/640/180/10mg, n¼ 82) or three dosages
of AP (1000/400mg, n¼ 79) both over three days. Vitals and parasite counts
were recorded every 8 h. After recovery and discharge, patients were followed
up with weekly blood smears for 28 days. Parasite clearance kinetics were
analyzed with a mixed effects population dynamic model.
Results: Tolerance to both study drugs was good, no signiﬁcant side-effects
were recorded. All patients recovered rapidly. The mean (95% CI) parasite
elimination half life was 6.8 (6.2–7.4)h and 6.5 (6.1–6.9) h for DPTP and AP,
respectively (P¼ 0.41). The mean total parasite clearance timewas 35 (31–39)
h and 34 (31–38) h, respectively (P¼ 0.9). Fever clearance times were 25 (22–
27) h and 24 (21–26) h, respectively (P¼ 0.4). Recrudescence/reinfection
occurred in 6 and 5%, respectively (OR¼ 0.84, 95% CI¼ 0.18–3.81). There
were no signiﬁcant differences between the two regimens with respect to
tolerance, cure rate or parasite dynamics. Parasite dynamic parameters were
not predictive of outcome.
Conclusions:DPTP and AP both offer equally rapid recovery and radical cure
rates from falciparum malaria in an area with multidrug resistant malaria.
Antimalarial combinations with dihydroartemisinin and piperaquine are
cheap and effective and very promising for employment in developing
countries. This is the ﬁrst study which shows that AP induces equally rapid
parasite clearance in vivo as artemisinin based combinations.
O351 Artesunate with meﬂoquine at various intervals
for nonsevere falciparum malaria in Vietnam
L. Q. Hung, P. J. de Vries, P. T. Giao, T. Q. Binh, N. V. Nam, P. A. Kager
Ho Chi Minh City, VN; Amsterdam, NL
Objectives: Artesunate (As) is a potent drug for the treatment of Plasmodium
falciparum malaria. Combination with meﬂoquine (M) is thought to delay the
development ofM-resistance and to prevent recrudescencewhich occurs after
As-monotherapy. Besides, there are indications that timing of administration
of M after an initial As dose is important. To study the effects of a combination
of As with M in Vietnam, where M was always applied in combination
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regimens, and to study the effects of different timing of M, a treatment study
was performed and the meﬂoquine population pharmacokinetics were
assessed.
Methods: Three hundred and sixty patients with uncomplicated falciparum
malaria received 4mg/kg As and thereafter were randomly allocated, in a
double blind fashion, to administration of 15mg/kg M at the same time (A),
8 h later (B) or 24 h later (C). M-placebo was used to complete three dosages
for all patients. All patients were admitted until parasite and fever clearance
(PCT and FCT). Thereafter they were followed for 4weeks. Four plasma
samples were drawn for measurement of M-concentrations. M-pharmaco-
kinetics was assessed with a nonlinear mixed effect population model.
Results: All patients recovered with a mean FCT of 24 h and PCT of 42 h.
Recrudescence/reinfection rates were 26, 26 and 33% for regimens A, B and
C, respectively. There were no signiﬁcant differences with respect to PCT,
FCT and outcome. For the M-pharmacokinetics a terminal elimination half
life of 319 h was entered in the population model. The mean Cmax (range)
was 2888 (869–10442)mg/L, well above the generally accepted in vivo MIC
of sensitive parasite strains (500mg/L). The area under the concentration time
curve (AUC) was 833771 (574327–1666844) h/mg/L. Early recrudescence
was associated with a high initial parasite count (P< 0.001) but not with
parasite clearance rate, M-Cmax or M-AUC.
Conclusions: A single dose of 4mg/kg artesunate plus 15mg/kg meﬂoquine
is not effective enough in Vietnam. The parasite clearance dynamics are
dominated by the effects of artesunate. A concentration effect relationship was
not detected for meﬂoquine. The data indicate that Vietnamese parasite
strains have already developed a moderate degree of meﬂoquine resistance
despite the fact that meﬂoquine was always applied in combination therapy.
There is no effect of different timing of the meﬂoquine dose within the ﬁrst
24 h after an initial artesunate dose.
O352 Mansonella perstans infection in a cohort of
HIV-infected adults in Uganda
M. Brown, P. Nkurunziza, J. Pickering, P. Khaukha, M. Kizza, P. Mawa,
C. Watera, J. Whitworth, A. Elliott
London, UK; Entebbe, UG
Objectives:Research into the effects of helminth infestation on the immune
response to HIV may provide insights into the pathogenesis of HIV disease in
Africa. As helminths have been shown to suppress type 1 immune responses
against unrelated antigens it has been hypothesised that coinfection would
have a detrimental effect on HIV disease. Filarial infections are common
throughout tropical Africa and have not been studied in an HIV-infected
population. The prevalence of infection with Mansonella perstans was studied
in an established cohort of HIV-infected adults, during a longitudinal study of
interactions between helminths and HIV.
Methods: Six hundred and sixty-three adults, attending one of two HIV
clinics in Entebbe as part of a prospective cohort, were recruited into the
current study between March 2001-March 2002. Stool and blood samples
were collected, 400mg Albendazole was administered and patients were
followed up 6months later. Examination for M. perstans was performed by
a modiﬁcation of Knott’s method, on all patients at enrolment into the study.
At the 6month follow-up visit all those who had been found to be positive for
M. perstans at enrolment were re-screened, as well as one in seven of those who
were negative at enrolment. A whole blood cytokine assay was used to assess
antigen-speciﬁc and mitogen-induced responses.
Results: Microﬁlaria of M. perstans were detected in 49 (7.6%) subjects. Co-
infection with other helminths was common.Manual work (P¼ 0.03), lack of
electricity at home (P¼ 0.001) and living further from the lake shore
(P¼ 0.02) were associated with infection. On re-screening at 6months,
68% of the positive subjects were still positive, compared with only 1% of
initially negative subjects. M. perstans infection was strongly associated with
eosinophilia (P< 0.001). Median CD4þ T-lymphocyte count was higher in
those with M. perstans than in those without (369 cells/mm3 vs. 252 cells/
mm3, P¼ 0.02). Subjects with M. perstans were less likely to exhibit an
interferon gamma response to mycobacterial antigen in vitro (P¼ 0.03).
Conclusion: M. perstans infection is common among HIV-infected adults in
Entebbe especially among those of lower socio-economic status. The associa-
tion between M. perstans and a higher CD4þ T-lymphocyte count is unex-
pected. This observation, in conjunction with that of a diminished immune
response toMycobacterium tuberculosis in these patients, is the subject of further
study.
O353 The therapeutic effects of eucalyptus, myrtus,
ferula, artemisia, allium and urtica extracts against
cutaneous leishmaniasis caused by Leishmania major in
small white mice (out-bred)
M. Emami, M. Mohebali, M. R. Niakan Lahiji, L. Babaee Khou
Tehran, IR
Protozoan parasites of the genus Leishmania are the causative agent of
leishmaniasis. Clinical manifestations of leishmaniasis in humans range from
mild cutaneous lesions to fatal visceral involvement. In this investigation, the
therapeutic effects of seven herbal drugs, namely Eucalyptus, Myrtus, Ferula,
Artemisia (two species), Allium and Urtica dioica on cutaneous leishmaniasis,
caused by Leishmania major, are studied. For the purposes of this study, the L.
major (MRHO/IR/76/ER) amastigotes that were taken from active lesions
randomly were injected into the lab mice subcutaneously. It should be
mentioned that promastigotes which are isolated from the N.N.N (Novy
Mac Neal and Nicolle) medium could also be used. The animals were divided
into three groups: (i) Test, which is treated by the use of the aforementioned
herbs (ii) Control 1 which receives no treatment and (iii) Control 2 or Placebo
(as the solvant of the essence or extracts was Ethanol 96, it was used to this
group). After the formation of lesions which takes 1–3months after leish-
mania inoculation, the specimens were prepared, the number of amastigotes
were counted and the diameter of the lesions were measured. The treatment
was local, twice a day for a month. At the end of the treatment period the
lesions were sampled and their diameter were measured (if remained). The
results showed that among the aforementioned herbs, the essence of Euca-
lyptus and Artemisia (one of species) reduced the diameter of lesions or caused
them to disappear completely. It was also caused a remarkable reduction in the
number of parasites or their complete omission. In the Placebo and Control
groups no change was noticed in the size of lesions or the number of parasites.
Even in most cases the number of parasites and the diameter of lesions
increased. To ﬁnd the effective substance existing in these essence, further
investigations are recommended.
The rise and fall of macrolide antibiotics in streptococcal infections
S362 Macrolides and streptococci: an historical
perspective
G. Cornaglia
Verona, I
Over the past few years increased rates of macrolide resistance have constantly
been reported in streptococci, somehow paralleling the increased clinical use
of old and news macrolides in upper respiratory tract infections. The last
decade witnessed the spread of macrolide resistance in Europe, mostly in the
Mediterranean countries, in both Streptococcus pneumoniae and Streptococcus
pyogenes. Until very recently, susceptibility reports on S. pyogenes from the
United States had constantly shown low levels of erythromycin resistance, but
in January 2001, during a longitudinal study of schoolchildren in Pittsburgh,
M-type erythromycin resistance was indeed detected in 48% of pharyngeal
isolates of group A streptococci, and this clonal outbreak also affected the
wider community. The role of low-level resistance and the clinical importance
of the different macrolides must be carefully considered. The semisynthetic
macrolides derivatives basically show the same cross resistance as erythromy-
cin. In spite of apparently favourable in-vitro results, the use of 16-membered
ring macrolides against inducible MLSB-resistant isolates should also be
regarded with caution, on the basis of previous experience with the other
cases of ‘dissociated’ resistance. It is worth reminding that the susceptibility of
IR staphylococcal strains to noninducing MLSB antibiotics in the clinical
setting proved to be of limited value because of the rapidity with which
constitutively resistant mutants were selected from these strains, resulting in
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clinical and bacteriological relapse. Owing to the totally different mechanism
of resistance, the use of 16-membered ring macrolides would seem safer
against those isolates endowed with anM phenotype, but this use has not been
implemented by clinical evidences. Moreover, the possibility of curing low-
level-resistant streptococcal strains with higher doses of macrolides should be
viewed with extreme caution, and it would appear to be hazardous at the very
least to apply the same considerations regarding S. pneumoniae and penicillin G
to another species, albeit in the same bacterial genus, and to a completely
different class of antibiotic.
S363 Interactions ofmacrolideswith the streptococcal cell
R. Leclercq
Caen, F
Macrolides inhibit protein synthesis by binding to the large 50S ribosomal
subunit. Interactions of macrolides with the ribosome have been precisely
determined in Deinococcus radiodurans and are supposed to be similar in the
case of streptococcal ribosomes. Streptococci use two ways to resist macro-
lides: target site modiﬁcation by methylation or mutation that prevents the
binding of the antibiotic to its ribosomal target and efﬂux of the antibiotic.
Modiﬁcation of the ribosomal target confers cross resistance to macrolides and
related antibiotics which have overlapping binding sites, such as the linco-
samides, whereas efﬂux affects only some macrolides and confers a lower level
of resistance. Target modiﬁcation is mostly related to the synthesis of
ribosomal methylases encoded by erm(B) or erm(TR) (subset of erm(A) class)
genes. The erm(B) genes are usually borne by conjugative transposons and the
spread of macrolide resistance in pneumococci might result both from
dissemination of clonal strains, of horizontal transfer of the conjugative
element and possibly from DNA exchange between strains by transformation
followed by recombination. Efﬂux is due to the synthesis of pumps belonging
to the MFS family and encoded by large transposable elements. Recently,
laboratory strains and clinical isolates of streptococci, including S. pneumoniae,
beta-hemolytic and oral streptococci harboring ribosomal mutations have
been reported. In survey studies, these strains represent generally less than 2%
of erythromycin-resistant streptococci but can reach higher percentages in
certain countries. Various mutations of ribosomal structures, including 23S
ribosomal RNA, L44 and L22 proteins have been characterized. The
emergence of resistance by mutational alteration is intriguing. This type of
resistance may have remained undetected in the past by lack of adequate
technique or, alternatively, the resistant mutants may have emerged and spread
recently. It is conceivable that the use of new long-acting macrolides with
different pharmacokinetics may have contributed to modulation of the
selective pressure exerted against streptococci and to selection of new
resistance genotypes.
Tropical medicine in returning travelers
S366 Tropical medicine in returning travelers: dengue
A. T. A. Mairuhu, D. P. M. Brandjes, E. C. M. van Gorp
Amsterdam, NL
Since the early 1950s, dengue is recognized not only to cause a benign febrile
illness but also to present itself as a potentially life-threatening disease. The
severest forms, known as dengue hemorrhagic fever and dengue shock
syndrome, are generally thought to be a result of the occurrence of two
main pathophysiological changes. One is increased vascular permeability that
gives rise to loss of plasma from the vascular compartment, with impending
shock when plasma loss gets critical. The second change is a disorder in the
hemostatic system involving vascular changes, thrombocytopenia and throm-
bocytopathia. Increasing evidence also suggest coagulation and ﬁbrinolytic
abnormalities to play a more pivotal role in the hemostatic changes than
currently perceived. Mechanisms that may be decisive in the development of
dengue hemorrhagic fever are the infecting strain or an immune enhancement
in which heterotypic antibodies enhance virus replication in macrophages.
Over the last 50 years both the incidence and distribution of dengue has
increased steadily making it the most important of arthropod-borne viral
diseases. Particularly countries in the South-east Asian region fell victim to a
dramatic increase of the incidence and clinical severity of dengue with
annual numbers of dengue hemorrhagic fever exceeding 200 000 in the
1990s. An increase of epidemics was also observed in several countries in the
Americas following the same pattern in Asia. Infection with dengue
therefore appears to be a realistic threat to travelers to endemic areas, where
they have the potential to acquire and from where they could spread the virus.
However, structured data on the epidemiology and clinical course of dengue
infection in travelers is scarce. Several studies reported serological evidence of
recent dengue virus infections in febrile patients after they returned from
endemic areas to range from 7% to 45%. Studies assessing seroconversion to
dengue antibodies in travelers to endemic areas demonstrated it to be
substantial, although the majority of study subjects did not report to have
experienced dengue-like illnesses. Nevertheless, an increased frequency of
travel in conjunction with subclinical dengue infections might be of impor-
tance especially if the immune enhancement theory holds true. Continuous
surveillance of imported dengue is therefore necessary to determine whether
increased travel is accompanied with an increase in numbers of severe
disease.
S367 Water- and food-related infections from exotic
places
C. Hatz
Basel, CH
Travelers may encounter manifold infections in tropical and subtropical areas.
Many viral, bacterial and parasitic diseases are water-borne causes of health
problems during and after stays in various countries. Disorders related to
scarce water and poor hygiene, including water-washed skin infections such as
lice, scabies, bacterial and fungal infections may affect low-budget travelers
and long-time expatriates in rural areas. Water-based infections caused by
parasites which need intermediate hosts for their development (e.g. schisto-
somiasis) are found among residents of endemic areas. Water-related insect
and other vectors transmit diseases such as malaria, ﬁlariasis, and yellow fever
which may affect persons returning or immigrating from endemic countries.
An overview of the frequency and the importance of such infections among
travelers, long-term expatriates and migrants provides insight into the differ-
ential diagnosis that is of growing importance to the medical practitioners in
industrialized countries.
S368 Melioidosis
Y. Suputtamongkol
Bangkok, TH
Melioidosis, an infectious disease caused by the Gram negative bacterium
Burkholderia pseudomallei, is endemic in South-east Asia and Northern
Australia. The disease occurs mostly in people with underlying disorders.
Clinical manifestations of melioidosis are protean, vary from benign soft tissue
infection to fulminant bacteremia. Melioidosis causes diagnostic problems in
endemic and especially in nonendemic areas. Laboratory diagnosis relies
mainly on the isolation of B. pseudomallei from clinical specimens. Serological
tests for early detection of melioidosis is of limited value. Many efforts have
been made to develop new molecular and immunological techniques for
diagnostic use. Treatment of melioidosis remains unsatisfactory. Clinical and
microbiological responses are slow despite appropriate antimicrobial therapy.
Two to 4weeks of ceftazidime remains the treatment of choice for severe
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melioidosis. Imipenem and sulperazone/salbactam therapy are probably as
good as ceftazidime, but high dose amoxicillin- clavulanate is slightly
inferior in term of clinical responses, but is equally effective at reducing
mortality. Trials are on going to assess a combination of ceftazidime with
cotrimoxazole (trimetroprim- sulfamethoxazole). For oral treatment, the
‘conventional’ regimen of chloramphenicol, doxycycline and cotrimoxazole
is still the treatment of choice. Amoxicillin-clavulanate is an alternative
and should be used in children and pregnant women. Failure rate of
either oﬂoxacin or ciproﬂoxacin with or without azithromycin treatment
or doxycycline treatment alone is high. Total treatment duration in most case
should.
S369 Exotic fungus infections in the returning traveler
B. Dupont
Paris, F
Endemic mycoses are a health threat for travelers to areas endemic for these
infections. In Europe histoplasmosis is the most frequent imported disease and
coccidioidomycosis is an emerging imported mycose. Penicilliosis became
rare since the introduction of active antiretroviral therapy in patients with
AIDS. Blastomycosis, sporotrichosis cases are rare. Paracoccidioidomycosis,
chromomycosis, mycetoma or entomophthomycosis are diseases of immi-
grants not of travelers. Histoplasmosis in Europe: An epidemiological study
conducted in Europe by ECMM (coordinator: Ruth Ashbee) collected 127
cases in 12 countries (1995–99). The areas of contamination were Black
Africa and Central and South America. 27% of patients had a recent infection.
The most common symptoms were non speciﬁc: fever 61%, cough 38%.
AIDS (41%) and exposure to birds, bats or cave (28%) were the most common
risk factor. Blood culture in immunocompromised patients and histology of
the lung were the most often positive methods of diagnosis. Itraconazole and
amphotericin B were the usual treatment. A retrospective study on Histo-
plasma duboisii infections in France (1968–94) collected 26 cases including two
in AIDS. Areas of contamination were Central and West Africa where mean
duration of residencewas 12 years (2–24) Fever was often absent. Localizations
were: lymph nodes (13), skin (9), lungs (6), bones (5), intestine, adrenal gland,
tonsil, spleen, pericardium, breast: 1 each. Disease was disseminated in 10/23
non AIDS imported cases. Diagnosis relied on biopsy, pus aspiration or
sputum/BAL examination Outcome was characterized by a high relapse rate,
surgery plaid a major role in recovery. Seven patients with coccidioidomycosis
were diagnosed in France, mostly in recent years: three pneumopathies: two
primary infections and one laboratory contamination, one skin ulceration and
three meningitis. Two additional recent cases occurred in persons attending
the world championship of model airplane ﬂying in Kern County, California.
Physicians should be aware of the name of the diseases, there epidemiology,
areas of endemicity and symptoms. Among the causes of respiratory, skin/
mucosae or CNS symptoms, ‘exotic’ fungal infections should be listed. The
cornerstone of diagnosis is the systematic enquiry into traveling in recent
(primary infection) or past history (late reactivation).
Probiotics: coming into clinical use?
S370 Clinical efﬁcacy of probiotics: current knowledge
and future challenges
A. Ouwehand, S. Salminen
Turku, FIN
Introduction: A probiotic has been deﬁned by the ILSI Europe working
group as ‘a viable microbial food supplement which beneﬁcially inﬂuences the
health of the host’. The safety and efﬁcacy of probiotics have to be scien-
tiﬁcally demonstrated in human studies for each strain and product.
Efﬁcacy of probiotics: Speciﬁc probiotics have been demonstrated to be
effective both in the treatment and reducing the risk of infant diarrhea in a
meta-analysis. Efﬁcacy has been shown in antibiotic diarrhea in infants. Other
forms of diarrhea, such as antibiotic associated diarrhea in adults and travelers’
diarrhea show promise, but further studies are needed to verify the efﬁcacy of
any of the studied strains. Signiﬁcant improvement of atopic eczema in infants
given diets supplemented Biﬁdobacterium lactis Bb12 or Lactobacillus rhamnosus
GG have been reported. L. rhamnosus GG administered pre- and postnatally
for 6 months to children succeeded to reduce the prevalence of atopic eczema
to half as compared with infants receiving placebo. These results suggest that
probiotics may have potential in controlling inﬂammatory responses, also
beyond the gut. Japanese studies on L. casei Shirota indicate a reduction in the
risk of bladder cancer and a reduction in the recurrence of superﬁcial bladder
cancer after surgery may be associated with oral L. casei intake. These studies
need to be conﬁrmed also in populations consuming western type diets.
Other areas of intensive research with probiotics include inﬂammatory gut
diseases. Positive results for some probiotic strains have been reported and
combinations of probiotic strains have been used. However, more human
studies need to be conducted prior to any conclusions on efﬁcacy can be
made.
Conclusion: Several human studies are available concerning the use and
efﬁcacy of probiotics. The evidence indicate rotavirus diarrhea and antibiotic
associated diarrhea in infants as the major areas of proved efﬁcacy. Other
indications of probiotic use still need reconﬁrmation. All probiotic strains are
different and their identiﬁcation and characteristics should be well-deﬁned. It
is important to clearly identify each strain for efﬁcacy assessment.
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S371 Probiotics: a border between efﬁcacy and safety
M. R. Gismondo
Milan, I
Since the days of Metchnikoff, it has been proposed that consumption of
probiotics would improve the health and well-being of the host. Some known
beneﬁcial effects of probiotics include: (1) reduction in the severity and
duration of microbial diarrhea; (2) prevention of traveler’s diarrhea; (3)
reduction in the risk of relapsis after Clostridium difﬁcile-associated diarrhea;
(4) prevention (or reduction) of antibiotic-associated diarrhea. Some data are
now beginning to arise in regard to the usefulness of probiotics in extra-
intestinal diseases (reduction of pneumonia in children with cystic ﬁbrosis;
stimulation of antibody reaction in vaccination, etc.). Still now beneﬁcial
effects of some probiotics are based on intuitive hypothesis. The results of
studies, often carried out without randomized protocols, have been rather
conﬂicting, and, so far, no consistent picture has emerged. Clinical diseases
due to deleterious metabolic effects have never been reported. However, in
order to take full advantage of the beneﬁcial effects of probiotics, we ought to
know more about efﬁcacy and safety. The border between these parameters is
still unclear.
S373 Future directions for probiotics in clinical medicine
R. A. Oberhelman
New Orleans, USA
Probiotic agents are nonpathogenic, live microorganisms, found among the
normal ﬂora, that produce a positive effect on the health and well being of the
host. Studies have shown potential medical beneﬁts using probiotics for
treatment and prevention of a variety of infections on mucosal surfaces,
including pediatric gastroenteritis and vaginitis. The future of probiotics will
depend in part on further elucidation of basic mechanisms, allowing scientists
and clinicians to maximize their health beneﬁts. Some evidence points to a
potential role for probiotic agents in the prevention of sexually transmitted
diseases and HIV-1 transmission. Recent studies suggest that the production
of H2O2, rather than the particular species of Lactobacillus, is the essential
factor for regulation of the vaginal ﬂora. Hydrogen peroxide-generating
Lactobacillus acidophilus at high concentrations may also be viricidal for
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HIV-1. In the future, lactobacilli may play an important role in protecting
women against several sexually transmitted diseases. Probiotics may also aid in
the control of multiresistant organisms on mucosal surfaces. Anecdotal reports
demonstrate that probiotic strains can be used to displace multiresistant
organisms, such as methicillin-resistant Staphylococcus aureus on decubitus
ulcers. The alarming increase of inappropriate antibiotic use and bacterial
resistance, along with renewed interest in ecological methods to prevent
infections, will make will make this an attractive ﬁeld for future research. The
stimulatory effect of probiotics on mucosal and systemic immunity and their
effect as immunomodulators suggest that probiotics may also aid in vaccine
development. This is supported by studies demonstrating adjuvant activity and
enhanced immune responses from orally administrated LactobacillusGG.More
experimental and clinical studies are needed to clarify the role of probiotics as
immunomodulators, not only for gastrointestinal infectious diseases but also
for inﬂammatory and allergic conditions. With further research, this tradi-
tional medical therapy may still prove to be one of our most effective tools
against new and emerging pathogens that continue to defy modern medicine
in the twenty-ﬁrst century.
Short course on antibiotic treatment
S374 Short course antibiotic treatment: the rationale
C. Carbon
Paris, F
Short course antibiotic (AB) treatments may have potential positive econom-
ical and ecological impacts. Three facts have already been established (i)
increasing AB usage in many countries, with an important percentage of
undue usage (ii) increasing bacterial resistance (R), and (iii) clear causality
relationship between AB usage and R. AB policies should include decreasing
undue usage, control of transmission of bacteria carrying R factors and
optimal usage for established indications. Too long AB courses must be
considered as undue usage, contributing to extension of R. Shortening AB
courses may help (i) decrease AB pressure in the environment (ii) improve
compliance and (iii) control extension of R. Achieving short courses is
feasible in many common situations as far as the optimal drug is chosen
on the following bases: activity against strains carrying R factors, pharma-
cokinetics, selective potential, and cost-effectiveness. Above all, the most
important parameter to be taken into consideration is the choice of a dose and
dosing regimen in adequacy with the pharmacokinetic/dynamic properties of
the drug, with the primary goals of avoiding underdosing and allowing a true
cidal effect. This is a primary requirement to make short courses feasible.
Indeed, it has been demonstrated that underdosing is a signiﬁcant risk factor
for selection of AB R strains. The efﬁcacy of shortened courses has been
demonstrated in many common situations. However, more clinical informa-
tion is needed to generalize that concept to the most frequent indications for
AB therapy. New AB compounds should demonstrate their ability to reduce
the length of therapy. A positive impact of short courses of AB treatment on
bacterial resistance has been established through an epidemiological study
(Guillemot, JAMA, 1998), clinical trials (Shrag, JAMA, 2001; Harbarth,
Circulation, 2000) and an intervention study (Guillemot, ICAAC, 2001).
Therefore, shortened courses of AB treatment together with the use of
optimal doses should be considered as a key component of any national
policy for judicious use of AB, keeping in mind the need to preserve the
quality of care. Finally, attention should be paid in the future to demonstrate
the cost/effectiveness of strategies aiming at reducing duration of AB therapy,
taking into account not only the economical short-term impact, but also, the
long-term beneﬁcial effect on bacterial R.
Hospital water – is it safe? (Symposium arranged with the HIS)
S379 Invasive aspergillosis and hospital water
A. Warris
Nijmegen, NL
With the continuing increase in the number of severely immunocompro-
mised patients, hospitals are faced with the growing problem of invasive
aspergillosis and other opportunistic fungal infections. Since treatment of
these infections is difﬁcult and the outcome is often fatal, preventive measures
are of major importance in the control of invasive ﬁlamentous fungal
infections. Nosocomial invasive aspergillosis is thought to be primarily air-
borne, however, despite the use of appropriate hospital air ﬁltration systems,
the incidence of this infection continues to increase. Together with the lack of
genetic relatedness between airborne strains and those causing invasive disease,
it is tempting to speculate about the existence of other routes of transmission.
There has been an increase in data supporting hospital water as a potential
source of ﬁlamentous fungi and, in particular, A. fumigatus. Furthermore,
earlier suggestions that a wet route of transmission might exist can be found in
anecdotal reports linking invasive aspergillosis with aspiration of contaminated
surface water in near-drowning patients. Molecular characterization of
A. fumigatus isolates recovered from water (at various locations inside and
outside the hospital) and patients has been performed to establish if such a wet
route of transmission exists. A. fumigatus strains genotyped by ampliﬁed
fragment length polymorphism showed genotypic relatedness between clin-
ical isolates recovered from two patients and strains isolated from water. These
results suggest that patients with invasive aspergillosis can be infected by strains
originating from water. How the transmission of waterborne A. fumigatus
takes place, is not known. Aerolization may play a role in this transmission
taking into account the site (lungs) of infection. The recent ﬁndings might
have signiﬁcant impact on the measures that are taken to prevent invasive
aspergillosis in high-risk patients. Additional measures directed to water
quality and activities leading to aerolization of water might be required.
Restriction of exposure of high-risk patients to contaminated aerosolized
water, such as showers, has been suggested. It should be emphasized that the
level of contamination of hospital water varies between hospitals and coun-
tries, depending on the source of the water. Further characterization of the
relative importance of each route of transmission is required to allow
implementation and evaluation of preventive measures.
HIV treatment: state of the art 2003
S384 Complications of antiretroviral drugs
E. Bernasconi
Lugano, CH
Identiﬁcation and characterization of drug toxicity, i.e. clinical presentation,
spectrum of severity, and risk factors, has become a priority as prolonged
utilization of antiretroviral drugs makes long-term side-effects a critical issue
for the management of HIV-infected patients. Data from the Swiss HIV
cohort study demonstrated that more than two-third of patients presented one
or more clinical or laboratory abnormalities, which could have been caused by
antiretroviral drugs. In the last few years, metabolic disorders (hyperlipidemia
and insulin resistance) and abnormalities in body fat distribution (lipodystro-
phy) have increasingly drawn the physician’s attention. In a experimental
model, protease inhibitors were shown to inhibit proteosomal degradation of
nascent apolipoprotein B. This ﬁnding supports the role of protease inhibitors
in the development of hypertriglyceridemia and high cholesterol level. The
increasing age of the HIV-infected population and the high prevalence of
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hyperlipidemia raise a concern about a possible increase of cardiovascular
morbidity. The recent observation of increased incidence of angina pectoris
and myocardial infarction in patients from the HOPS cohort requires con-
ﬁrmation from the analysis of larger databases. Lipodystrophy, which was
initially attributed to protease inhibitors, has also been observed in patients
treated with a double combination of nucleoside reverse transcriptase inhi-
bitors. We and others have shown a strong association between lipodystrophy
and the use of stavudine. Potential new toxicities, such as bone disorders,
underscore the complexity of the issue, and the possibility that long-term
exposure to antiretroviral agents may unmask additional adverse effects. Drug
toxicity may cause discontinuation of treatment or failure. Patients should be
carefully monitored for side-effects of antiretroviral treatment to prevent loss
of adherence and the development of viral resistance.
S385 Therapeutic drug monitoring
D. M. Burger
Nijmegen, NL
The use of Therapeutic Drug Monitoring (TDM) has received an increasing
amount of interest during the last years. Some national guidelines (e.g. France,
United Kingdom, the Netherlands) have now included TDM as part of the
diagnostic set up for a patient, but development of TDM in other countries is
still in its infancy. Recently, consensus has been reached among HIV
pharmacologists about the current knowledge how to perform TDM of
antiretroviral agents. TDM may be particularly useful in the following
situations:
	 Virological failure
	 Intoxication
	 Drug – drug interactions
	 Nonadherence
There are numerous studies showing that drug levels are related to antiviral
effect, but this has not yet resulted in a consensus on a therapeutic range for
these agents. Nevertheless, data have now been presented of two randomized
controlled clinical trials showing that TDM of nelﬁnavir and indinavir in
treatment-naı¨ve patients improves the therapeutic outcome of these patients
over 1 year. In contrast, disappointing results have been presented of TDM in
second-line regimens, but these studies had signiﬁcant methodological ﬂaws
to draw any conclusions. It is generally expected, however, that use of TDM in
second-line or salvage regimens (i.e. when drug resistance may be present)
will only be useful if also information is known regarding resistance (the IQ
concept). Several studies are now underway that will give us information how
to use TDM in the near future.
Pharmacodynamics of antibiotics
O386 Comparative pharmacodynamics of ABT492 and
levoﬂoxacin with Staphylococcus aureus in an in vitro
dynamic model
I. Lubenko, S. Vostrov, Y. Portnoy, S. Zinner, A. Firsov
Moscow, RUS; Boston, USA
Objective:To compare the kinetics of killing/regrowth of S. aureus exposed to
ABT492 and levoﬂoxacin (LFX) over wide ranges of the ratio of area under
the curve (AUC) to MIC.
Methods: A clinical isolate of methicillin-resistant S. aureus (MICs 0.02 of
ABT492 and 0.6mg/L of LFX) was exposed to bi-exponentially decreasing
concentrations of ABT492 (a distribution half-life of 2.1 h, an elimination
half-life of 23 h) and monoexponentially decreasing concentrations of LFX
(an elimination half-life of 6.8 h). The single doses of ABT492 and LFX were
designed to provide the same AUC/MIC range, from 60 to 480 h. In addition,
clinically achievable AUC/MICs were simulated: 870 h with ABT492 and
70 hwith LFX. The total antimicrobial effect was expressed by its intensity (IE
– area between the control growth and the time-kill/regrowth curves).
Results:The time courses of viable counts that reﬂect killing and regrowth of
S. aureus exposed to the quinolones yielded similar patterns. At the AUC/
MIC ratios studied, regrowth followed a remarkable reduction in bacterial
numbers. However, at a given AUC/MIC ratio, the maximal reductions in
the starting inoculum of ABT492-exposed S. aureus were greater than with
LFX. The times to regrowth were shorter with ABT492 than LFX, because of
the relatively rapid fall in ABT492 concentrations to the MIC level, at least at
AUC/MICs of 60–480 h. At the higher AUC/MIC ratio (870 h) that is
provided by clinical doses of ABT492, regrowth of S. aureus was observed
much later than with simulation of the clinically achievable AUC/MIC of
LFX (70 h). A speciﬁc AUC/MIC relationship of IE was inherent in each
quinolone. At a given AUC/MIC ratio, the effect of ABT492 was less
pronounced than LFX over AUC/MIC ratios from 60 to 480 h. However,
at the AUC/MIC of 870 h that corresponds to a 400-mg dose of ABT492, for
example, the IE was 2.5 times greater than that of a 500-mg dose of LFX
(AUC/MIC 70 h).
Conclusion:These data suggest that ABT492 may be more efﬁcient than LFX
against staphylococci at clinically achievable AUC/MIC ratios.
O387 Are AUC/MIC and Cmax/MIC predicting
pharmacological indices for the activity of ciproﬂoxacin
against Escherichia coli ?
A. Barger, C. Fuhst, B. Wiedemann
Bonn, D
Objectives: It is common use nowadays to evaluate antibiotics by calculation
of pharmacological indices. The International Society for Antimicrobial
Pharmacology (ISAP) proposed to use AUC/MIC and Cmax/MIC values
for the prediction of the activity of concentration dependent antibiotics like
ciproﬂoxacin (CIP). By comparison of kill kinetics in batch cultures and in a
in vitro model we examined this hypothesis.
Methods: Concentrations which resulted in equal AUC/MIC (0–800) and
Cmax/MIC (0–33.3) were applied in batch cultures and in in vitro models, and
kill kinetics of E. coli [MICCIP: 0.03125mg/L] were performed over 24 h. In
the batch culture, different constant CIP concentrations (0.5- to 32-fold
MIC) were applied and in the in vitro modelE. coliwas exposed to initial doses
of CIP from 1- to 64-fold MIC, that were eliminated with the half-life of 4 h.
To compare the antibacterial effect of CIP the areas above the kill curves
(AAC) were determined: negative values indicate bacterial growth whereas
positive values indicate a bacterial reduction.
Results:The maximal effect in the batch culture and in the in vitro model was
observed at a AUC/MIC value of 100. Higher doses (AUC/MIC 200–800)
did not show a higher efﬁcacy of CIP on E. coli. Within the range of
concentration dependency there were no comparable effects of CIP at equal
AUC/MIC and Cmax/MIC values in batch cultures and in the in vitro model
(Table 1).
Conclusions: CIP shows a dose-effect-relationship against E. coli only in a
narrow range. The hypothesis that AUC/MIC and Cmax/MIC are predictors
for the activity of CIP cannot be generalized because only high AUC/MIC
respectively. Cmax/MIC values, where the maximal effect is already achieved,
resulted in similar effect of CIP against E. coli. The concentration-time proﬁle
is important for the effect of CIP on E. coli.
O388 Efﬁcacy and pharmacodynamics of CB-181963
(CAB-175), a new cephalosporin
J. Alder, T. Li, D. Yu, X. Zhang, A. VanPraagh, J. Silverman,
L. Mortin
Lexington, USA
Objectives: CB-181963 (formerly CAB-175) is a new cephalosporin with
potent activity against a broad spectrum of pathogens including MRSA
Table 1 Concentration range with differences in the activity of CIP against E. coli
AUC/MIC Cmax/MIC batch culture AAC in vitro model AAC
0 0 48.08 44
12.5 0.52 16.26 51.5
25 1.04 43.51 31.6
50 2.08 102.9 114.3
100 4.17 120.6 138.9
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(methicillin resistant S. aureus). The objective was to determine the efﬁcacy
and to quantify the pharmacodynamic parameter predictive of efﬁcacy for
CB-181963 against MRSA, E. coli, and K. pneumoniae.
Methods: A thigh infection model of normal (nonimmunosuppressed) mice
was used to investigate the efﬁcacy of CB-181963. Mice were infected by
intramuscular inoculation of 1 105 to 1 107 cfu of MRSA, E. coli, or
K. pneumoniae. Mice were treated subcutaneously with CB-181963, vanco-
mycin, ceftriaxone, or saline control. Dosage was once, twice, or thrice daily
for three days starting the day of infection. At 72 h postinfection, thigh tissue
was harvested and dilution plated for quantiﬁcation of bacterial burden.
Efﬁcacy was determined based on time over MIC (T>MIC), total drug
exposure over MIC (AUC/MIC), and maximal serum concentration over
MIC (Cmax/MIC).
Results:CB-181963 was protective against MRSA, E. coli, and K. pneumoniae
thigh infections in mice. The pharmacodynamic parameter most predictive of
efﬁcacy in mice was T>MIC, although AUC/MIC also correlated well in
some cases. CB-181963 was effective against MRSA at T>MIC values equal
to 15% of the dosage interval. Efﬁcacy against E. coli and K. pneumoniae
infections required a T>MIC values of 34% of the dosage interval. Because
CB-181963 is more potent against E. coli and K. pneumoniae (MIC90¼ 0.06–
0.13mg/mL) compared to MRSA (MIC90¼ 2–4mg/mL), the overall serum
concentrations required to produce effective T>MIC values are similar for
MRSA and Gram-negative infections.
Conclusions:CB-181963 produced efﬁcacy against MRSA and Gram-nega-
tive bacterial infections of mouse thigh tissue. The lower T>MIC values
required for efﬁcacy against MRSA compared to E. coli or K. pneumoniae are
an interesting feature of this new cephalosporin. The T>MIC values
required for efﬁcacy (15% for MRSA, 34% for Gram-negative bacteria)
warrents further study to determine the clinical potential of this
cephalosporin.
O389 Concentration-dependent selection of resistant
mutants of Streptococcus pneumoniae exposed to
moxiﬂoxacin in an in vitro dynamic model: a population
analysis
A. Firsov, I. Lubenko, D. Gilbert, S. Zinner
Moscow, RUS; Providence, Cambridge, USA
Objectives: Our recent study with ﬂuoroquinolone-exposed Staphylococcus
aureus, examined the mutant selection window (MSW) hypothesis, i.e. the
concentration range from the MIC to the mutant prevention concentration
(MPC), within which it is proposed that resistant mutants are selected. A
quinolone-independent relationship of resistance to the ratio of 24-h area
under the curve (AUC) to MIC was reﬂected by a bell shaped curve with a
maximum at an AUC/MIC ratio of 43 h. To further examine the MSW
concept, S. pneumoniaewas exposed tomoxiﬂoxacin concentrations below the
MIC, above the MPC and between the MIC and MPC, i.e. within theMSW.
Methods:Daily administration of moxiﬂoxacin for three days was mimicked
using a two-compartment dynamic model with peripheral units containing
108 CFU of S. pneumoniae ATCC 49 619/ml as a starting inoculum. Changes
in S. pneumoniae susceptibility were examined by plating the specimens onto
moxiﬂoxacin-free agar and agar containing 4MIC and 8MIC of moxi-
ﬂoxacin. To compare the effects produced by each dose, the area between the
control curve and the time-kill curve (ABBC) was calculated within the ﬁrst,
second and third dosing interval (ABBC-1–3, respectively).
Results:Based on both 4MIC and 8MIC data, maximal fs were associated
with moxiﬂoxacin concentrations between the MIC and MPC (AUC/MICs
24–47 h) and minimal fs with concentrations below the MIC (AUC/
MICs< 10 h) and above the MPC (AUC/MICs> 100 h). A Gaussian-like
function ﬁts the AUC/MIC-dependent resistance frequency (f ) with the
central point at AUC/MIC of 42 h where resistant mutants are selectively
enriched, without such selection at AUC/MICs< 10 h and AUC/
MICs> 100 h. These ﬁndings are consistent with a comparative analysis of
the ABBCs: at the lower AUC/MIC ratios (6–24 h) and the higher AUC/
MICs (74–224 h) when fs were minimal, ABBC-2 and -3 were similar. At the
intermediate AUC/MICs (24–47 h), when fs weremaximal, the ABBC-3was
less than the respective ABBC-2.
Conclusions: This study suggests that (i) most pronounced selection of
resistant mutants of S. pneumoniae and S. aureus occurs at similar AUC/MICs
of moxiﬂoxacin (ii) there is a strong relation between resistance and the
antimicrobial effect of moxiﬂoxacin, and (iii) these ﬁndings support the MSW
concept.
O390 Pharmacodynamic comparison of linezolid and
daptomycin against Gram-positive bacterial infections in
cancer patients by Monte Carlo simulation
P. Smith, P. Kelchlin, B. Booker
Buffalo, USA
Objectives: Pharmacodynamic (PD) indices such as AUC/MIC and time
above MIC have been linked to clinical outcome for numerous antibiotics.
The AUC/MIC ratio has been found predictive of linezolid (LZD) outcome
in animals and in humans (D. Andes, AAC 2002; C. Rayner, ICAAC 2000),
and of daptomycin (DAP) in animals (A. Louie, AAC 2001). Our objective
was to determine the probability of achieving PD targets with LZD and DAP
in our institution.
Methods: Two hundred and ﬁfty-seven Gram-positive blood isolates were
collected from hospitalized cancer patients, and MICs determined in dupli-
cate by macrobroth dilution, according to NCCLS standards. Calcium
supplementation was utilized in all daptomycin experiments. Resultant MICs
and published PK data for LZD and DAP was used to conduct Monte Carlo
simulations (MCS) of 5000 patients (Crystal Ball 2000). Target 24-h AUC/
MIC ratios were set for LZD at 83 (D. Andes, AAC 2002), and at 517 and 246
for DAP to achieve 80% maximal kill and stasis, respectively (A. Louie, AAC
2001). The probability of achieving these targets was evaluated at the standard
doses of 600mg q12h for LZD and 6mg/kg q24h for DAP; DAP protein
binding was accounted for.
Results:The overall MIC50,90 (range) for LZD and DAP was 2,4 (0.125–64)
and 1,4 (0.03–8); there were 119 enterococci (82 vancomycin resistant), 128
staphylococci, and 10 other. The mean (SD) AUC/MIC ratio for LZD was
116.2 (119), with a target attainment probability against these organisms of
63.7%; 51.9% achieved an AUC/MIC ratio of 100. The mean (SD) AUC/
MIC ratio for DAP was 1311 (2279), with a target attainment probability of
73.8% for stasis, and 63.4% for 80% maximal kill.
Conclusions: Both LZD and DAP demonstrated activity against pathogens
collected from our institution, however, based on this analysis PD target
attainment was higher with DAP for stasis endpoints. The somewhat low
target attainment rates were primarily a result of higher MICs observed in the
enterococci, relative to staphylococci. The LZD results are also in concor-
dancewith clinical trial results against VRE, in which approximately 67% cure
rates were reported (Zyvox package insert); similar clinical data is not available
for DAP. These results also suggest that higher doses and/or combination
therapy may be necessary in some patients to achieve optimal cure rates in our
institution, especially against VRE.
O391 Intensity of the antimicrobial effect as a tool in
pharmacodynamic studies using in vitro models: new
aspects
A. Firsov
Moscow, RUS
Objectives:Prediction of the antimicrobial effect (AME) based on its relation-
ships to the MIC-related pharmacokinetic variables, i.e. area under the curve
(AUC), peak concentration (Cmax), etc., is the primary goal of in vitro studies
that simulate antibiotic pharmacokinetics. Using endpoints that consider only
extent but not duration of AME, the AUC/MIC or Cmax/MIC relationships
may often be established at the AUC/MICs lower than those achieved
clinically. At the relatively high AUC/MICs typical for many antibiotic-
pathogen pairs, reasonable relationships may be seen using the intensity of
AME (IE) that considers both extent and duration of AME.
Methods: To demonstrate the signiﬁcance of AME duration, the concentra-
tion/MIC-time curves that reﬂect daily dosing of moxiﬂoxacin and levo-
ﬂoxacin at the same AUC/MIC ratiowere generated using half-lives of 12 and
6 h, respectively. The accumulation factors were calculated for the speciﬁc
case when the trough concentration of levoﬂoxacin but not moxiﬂoxacin is
equal to the MIC.
Results: Simulations of the quinolone pharmacokinetics predicted a 20%
increase of theCmax/MIC ratio of moxiﬂoxacin vs. a 2% increase of theCmax/
MIC of levoﬂoxacin during the treatment. This highlights the impact of
unexhausted antimicrobial potential of moxiﬂoxacin’s trough concentrations
on AME observed at the steady-state conditions. The different AMEs of
moxiﬂoxacin and levoﬂoxacin resulted from their different potentials can
accurately be reﬂected by IE but not other endpoints. Based on the IE analysis
of quinolone AMEs on Staphylococcus aureus, the predicted breakpoints
for grepaﬂoxacin and levoﬂoxacin (AUC/MIC 78 h and Cmax/MIC 13,
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respectively) were close to those established in clinical settings (75 h and 12,
respectively).
Conclusion:Being the only metric having a physical signiﬁcance (IE describes
the total amount of killed bacteria), IE may be determined at the relatively
high AUC/MICs including clinically achievable values. IE shows reasonable
AUC/MIC or Cmax/MIC relationships of AME and allows clinically relevant
predictions of AUC/MIC and Cmax/MIC breakpoints.
O392 Pharmacodynamics of cefepime–aztreonam
combination against Pseudomonas aeruginosa isolated from
cystic ﬁbrosis patients
D. Wolter, M. Reisbig, N. Hanson, P. Lister
Omaha, USA
Objectives: Previous studies have demonstrated that cefepime (FEP)–aztreo-
nam (ATM) is effective in preventing the emergence of resistance during
treatment of Pseudomonas aeruginosa in an in vitro pharmacokinetic model
(IVPM). ATM was shown to competitively inhibit the AmpC cephalospor-
inase and enhance the activity of FEP, even against depressed mutants. The
study objective was to further evaluate the FEP-ATM combination against
clinical isolates of P. aeruginosa from cystic ﬁbrosis patients.
Methods: Five strains selected provided a range of susceptibilities from
susceptible to high-level resistance. Log-phase cultures (107108 cfu/
mL) were inoculated into the IVPM and exposed to peak concentrations
observed in human serum after doses of 1 g of FEPor ATM, or a combinations
of each. Drugs were dosed at 0 and 12 h, human pharmacokinetics were
simulated and changes in viable counts were measured at 0, 2, 4, 6, 12, and
24 h. Samples removed at 24 h were also plated into agar containing FEP
(4MIC) to detect mutants.
Results: With the susceptible strains, all three regimens provided 2.5–3 logs
killing through 6 h. Viable counts increased substantially in FEP-treated
cultures and a resistant subpopulation was detected. In contrast, no resistant
mutants were detected in cultures treated with ATM or FEP-ATM, and FEP-
ATM provided the greatest level of killing over 24 h (3.5–4 logs). Against an
intermediate strain, FEP and ATM alone only provided 1–1.5 logs of killing
over 24 h, while FEP-ATM provided three logs of killing over 24 h. With one
resistant strain, neither FEP or ATM showed any bacterial killing, whereas
FEP-ATM decreased viable count approximately one log. With second
resistant strain, FEP and ATM decreased viable counts two logs followed
by inoculum regrowth. In contrast, no inoculum regrowth was observed with
FEP-ATM and viable counts decreased a total of three logs over 24 h.
Conclusions: FEP-ATM provided signiﬁcant bactericidal activity against four
of ﬁve strains isolated from cystic ﬁbrosis patients, including one highly
resistant strain. Although resistant mutants were selected from two strains with
FEP, no resistant mutants were selected with either ATM or FEP-ATM.
These data, in combination with previously published data, suggest that FEP-
ATM may be an effective combination for the treatment of P. aeruginosa
infections, and further studies are warranted.
O393 Pivampicillin enhances the activity of ampicillin
against intracellular bacteria: studies in a model of J774
macrophages infected with Listeria monocytogenes
H. Chanteux, M. -P. Mingeot-Leclercq, F. Van Bambeke, P. Tulkens
Brussels, B
Objectives:Pivampicillin, a basic ester prodrug of ampicillin is accumulated in
high extent in J774 macrophages (ICAAC 2001–2070, ECCMID 2002:
P1349; Chanteux et al. Pharm Res, in press). Since only ampicillin is active
against bacteria and ester bond are unstable in biological media, we inves-
tigated the ability of PIVA to regenerate intracellular free ampicillin and to be
useful to control intracellular infections.
Methods: J774 macrophages were infected with Listeria monocytogenes (bac-
teria to cell ratio 7 : 1) during 1 h for phagocytosis. Cells were washed with
PBS and incubated with ampicillin or pivampicillin. At suitable intervals, cells
were washed, scraped, lyzed in water, and the lyzates used for determination
of viable bacteria by colony counting. Intracellular ampicillin was assayed
using an enzymatic method relying on the capacity of the drug to inhibit
bacterial D-D-carboxypeptidase (Fre`re et al. AAC 1980; 18: 506–510).
Results: At an extracellular concentration of 10 the MIC of ampicillin,
ampicillin and pivampicillin were mainly bacteriostatic in a 5-h time period.
However, when the extracellular concentration was reduced to 0.5 the
MIC, only pivampicillin remained bacteriostatic whereas AMPI was inactive.
Upon 20 h incubation, pivampicillin lost activity in relation to its hydrolysis in
the extracellular milieu (half-life 35min). Assay for intracellular ampicillin
showed a high level of accumulation after 5 h incubation with pivampicillin
whereas incubation with free ampicillin showed no drug accumulation
(cellular to extracellular ratio 1). This high accumulation decreased over
time and at 12 h incubation with pivampicillin, the level of intracellular
ampicillin is the same as ampicillin alone. If medium was renewed every 5 h
during infection, activity persisted all over the experimental period (20 h).
Conclusions: Pivampicillin is accumulated in macrophages and release large
amounts of ampicillin. We suggest that pivampicillin could be a useful drug in
the control of intracellular infections.
O394 Pharmacodynamics and potential clinical role of
garenoxacin against anaerobic pathogens
G. E. Stein, E. J. C. Goldstein
East Lansing, Santa Monica, USA
Objectives: Garenoxacin (G) is a new desﬂuoroquinolone with a broad
spectrum of antimicrobial activity including anaerobes such as Bacteroides
group organisms (MIC90 8.0mg/mL). Moreover, G has been shown to be
rapidly accumulated by B. fragilis. Following a 600-mg dose of G, the Cmax
and AUC24 are approximately 10mg/mL and 100mg h/mL, respectively
(Wise et al. Antimicrob Agents Chemother 2002; 46: 242). Results of
time-kill studies found that G was bactericidal at 2MIC after 48 h against
Bacteroides group isolates. In an in vitro pharmacodynamic (PD) model,
AUC/MIC ratios 50 provided bactericidal activity and prevention of
regrowth in postexposure cultures of Bacteroides group isolates. An analysis
of these PD ratios was conducted against B. fragilis group organisms based
upon human pharmacokinetic parameters.
Methods: PD ratios (Cmax/MIC, AUC/MIC) for G against B. fragilis group
isolates (Snyderman et al. Antimicrob Agents Chemother 2002; 46: 3276)
were calculated and are shown in the table.
Results:The peak serum concentration (Cmax) following a 600-mg dose of G
is at least 2 higher than the geometric mean for each group of isolates, and
the AUC/MIC ratios are50 with the exception of B. valgatus (Table).
Conclusion:PD ratios can be attained that would suggest a therapeutic role for
G against B. fragilis group isolates. Ongoing clinical trials will determine the
viability of G in the treatment of anaerobic infections.
O395 Urine bactericidal activity of gatiﬂoxacin and
moxiﬂoxacin against nosocomial uropathogens
G. E. Stein, S. L. Schooley, D. P. Nicolau
East Lansing, Hartford, USA
Objectives: The methoxyﬂuoroquinolones, gatiﬂoxacin (G) and moxiﬂox-
acin (M) have similar in vitro activity against uropathogens but signiﬁcantly
different amounts of these drugs are recovered in the urine (G¼ 73%;
M¼ 20%). In this investigation, we measured urine concentrations and
the bactericidal activity of G and M in urine (UBA) against four different
uropathogens (nine isolates) by microdilution techniques.
Methods: Eleven normal healthy male volunteers were given a single dose of
G (400mg) followed one week later by a single dose of M (400mg). Urine
samples were collected prior to and at 2, 6, 12, and 24 h after the dose of each
drug, and stored at 708C. Urine levels (HPLC procedure) and cidal titers
(NCCLSmethodology) were determined at each time period for each subject
against isolates of E. coli, K. pneumoniae, P. aeruginosa, and E. faecalis.
Results: Urine concentrations were signiﬁcantly higher with G. Mean peak
(2 h) levels were 250mg/mL with G and 83mg/mL with M. Cidal titers in
urine were usually higher and more prolonged with G compared to M
(Table). This was especially evident against the two strains of P. aeruginosa.
Organism (no.) Mean MIC (mg/mL) Cmax/MIC AUC/MIC
B. distasonis (36) 1.8 5.6 56
B. fragilis (288) 0.9 11.1 111
B. ovatus (61) 1.7 5.9 59
B. thetaiotaomicron (136) 1.6 6.25 62
B. uniformis (11) 2.0 4.8 50
B. valgatus (35) 4.2 2.4 24
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Conclusion:Both G and M produced prolonged UBA against these common
nosocomial uropathogens with the exception of P. aeruginosa. In contrast to G,
a single dose of M exhibited little to no UBA against the two strains of
P. aeruginosa.
Fungi: disease, diagnosis and therapy
O396 Caspofungin treatment of invasive candidiasis in
cancer patients
M. DiNubile, D. Hille, C. Sable, N. Kartsonis
West Point, USA
Background: Invasive candidiasis (IC) is often a complication of cancer and its
therapy. In a large international study of IC, caspofungin (CAS) was as
effective as and better tolerated than amphotericin B (AmB) (NEJM 2002;
25: 2020–9). CAS could provide a therapeutic option for cancer patients (pts)
with IC.
Methods: We evaluated cancer pts enrolled in a double-blind randomized
trial of CAS (50mg/day after a 70mg loading dose) versus AmB (0.6–0.7 for
non-neutropenic and 0.7–1.0mg/kg/day for neutropenic (500/mL) pts to
treat clinically and microbiologically documented IC. Study design had
therapy end 14 days after the last positive culture; pts responding to IV
therapy could be switched to oral ﬂuconazole after 10 days. All treated pts
with conﬁrmed IC were included in a modiﬁed intention to treat (MITT)
analysis. A favorable response required complete resolution of signs and
symptoms plus documented or presumptive eradication of Candida.
Results: Seventy-four of 224 (33%) pts in the MITT population had active
malignancies (30 hematologic and 44 solid tumors). Twenty-ﬁve (83%)
hematologic cancers were acute or chronic leukemia. Twenty-two (50%)
solid tumors were related to the GI tract: 14 colon, four gastric, four
esophageal. Other common sites (n> 2) included six pancreatic, three
bladder, and three gynecologic. Pts with hematologic cancer were younger
than those with solid tumors (median (range) age: 49 (19–74) vs. 59 (19–81)
years) and had higher baseline APACHE II scores (median (range): 20 (0–28)
vs. 14 (5–35)). Neutropenia was present on entry in 23 (77%) pts with
hematologic cancer (22 had leukemia) and in one (3%) pt with a solid tumor.
Candidemiawas demonstrated in 29 (97%) and 36 (82%) pts with hematologic
and solid organ cancers. Most commonly isolated Candida spp. are shown in
Table 1. Table 2 shows response rates at the end of study therapy. CAS- (7/14)
and AmB-treated (4/10) neutropenic pts responded favorably. CAS (3/10)
and AmB (3/7) pts with profound neutropenia at baseline (<100/mL) had
favorable responses. CAS (4/6) and AmB (4/7) pts whose neutropenia
resolved responded, compared to 3/8 CAS and 0/3 AmB pts with persistent
neutropenia.
Conclusions: Less than 30% of pts in our IC study had underlying cancer,
usually leukemia or GI tumors. Although C. albicans was the single most
frequent isolate in cancer pts, >50% of cases were due to nonalbicans spp.
Response rates were lower for neutropenic than non-neutropenic pts. Over-
all, 70% of cancer pts had a favorable response to CAS, when only 56% of pts
had such a response to AmB.
O397 Radiologic ﬁndings in acute invasive pulmonary
aspergillosis: Utility and reliability of halo sign and
air-crescent sign for diagnosis and treatment of IPA in
high-risk patients
R. E. Greene, H. T. Schlamm, P. Stark, JW. Oestmann, C. Durand, P. F.
Troke, T. F. Patterson, R. Herbrecht, J. R. Wingard, J. E. Bennett, O.
Lortholary, D. W. Denning, P. Ribaud, B. de Pauw, R. H. Rubin – The
Global Aspergillus Study Group and the Invasive Fungal Infection Group
of the EORTC
Objectives:To characterize initial imaging ﬁndings in acute invasive pulmon-
ary aspergillosis (IPA); to evaluate utility and reliability of the halo sign (HS)
and air-crescent sign (ACS) for diagnosis and treatment of IPA in high-risk
patients.
Methods: Baseline imaging and/or mycology and treatment response (TR)
were reviewed for 343 patients who participated in a recent prospective
comparative aspergillosis treatment study. Baseline HS or ACS, conﬁrmed by
an independent data review committee (DRC), met criteria for IPA in
patients with hematopoietic stem cell transplant (HSCT) or hematologic
condition (HC) with neutropenia. Independent diagnoses of IPA by DRC
radiologists, based on standard deﬁnitions, were compared with those of site
investigators.
Results: In 254 patients with DRC-conﬁrmed baseline diagnosis of IPA, 141/
254 (56%) had at least one nodular lesion with HS and 15/254 (6%) had ACS.
One hundred and thirty-eight of 254 (54%) patients had both mycologic and
CT data at baseline: 59/138 (43%) had either HS or ACS (48 had HS, 11 had
ACS). Seventy-nine patients had baseline diagnosis of IPA based on mycology
alone (without HS or ACS on CT): 66/79 (84%) had nodular lesions
including 41 with unsharp margination (UM). In the 13 remaining patients,
seven had consolidations, two had centrilobular opacities, and one had each of
the following: cavitary lesion, non-nodular infarct (NNI), ground-glass
opacity (GGO), pleural lesion. TR was satisfactory in 79/154 (51%) patients
with HS or ACS on CT, and was satisfactory in 51/95 (54%) with HS or ACS
on CTwithout supporting mycology. In contrast, TR was satisfactory in only
30/98 (31%) with a baseline diagnosis of IPA based on mycology alone. HS or
ACS was conﬁrmed by the DRC in 95/148 (64%) of patients entered into the
study by the site investigator with a diagnosis of IPA based on CTalone. The
major radiologic ﬁndings in the 53 nonconﬁrmed cases included nodular
lesions in 48/53 (91%), with UM in 39.
Conclusions: Nodular lesions with HS and ACS dominated baseline radi-
ologic ﬁndings in these patients with IPA. The TR data support a hypothesis
that patients at risk of IPA presenting with nodular lesions with HS or ACS
beneﬁt from antifungal therapy even with absent mycologic ﬁndings. Non-
reproducibility of HS may result from difﬁculty in differentiation of HS from
UM.
Median duration of UBA (h)
MIC (mg/mL) organism G M G M
E. coli 0.06 0.125 24 24
2.0 2.0 24 12
K. pneumonia 0.125 0.06 24 24
1.0 2.0 24 6
P. aeruginosa 2.0 4.0 24 2
4.0 8.0 6 0
E. faecalis 0.5 0.25 24 24
2.0 2.0 24 24
Table 1
C. albicans C. tropicalis C. parapsilosis C. glabrata C. krusei
Cancer (76 isolates) 31 (41%) 15 (20)% 12 (16%) 8 (11%) 5 (7%)
Hematologic (27) 8 (30%) 9 (33%) 3 (11%) 0 (0%) 4 (15%)
Solid tumors (49) 23 (47%) 6 (12%) 9 (18%) 8 (16%) 1 (2%)
Table 2
CAS AmB Total
Cancer (74 patients) 23/33 (70%) 23/41 (56%) 46/74 (62%)
Hematologic (30) 11/18 (61%) 6/12 (50%) 17/30 (57%)
Solid tumors (44) 12/15 (80%) 17/29 (59%) 29/44 (66%)
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O398 Rhodanine-3-acetic acid derivatives as potent
inhibitors of fungal protein: mannosyl transferase
1 (PMT1)
D. J. Haydon, K. A. Duffy, C. M. S. Galley, J. C. Neuss,
M. G. Orchard, D. I. C. Scopes, C. R. Stubberﬁeld, K. Young
Abingdon, UK
The incidence of life-threatening fungal infections has multiplied dramatically
as the population of immunocompromised individuals has increased. Present
therapeutic options are limited to three main classes of compound: polyenes,
azoles, and candins. The utility of polyenes is limited by nephrotoxicity, and
resistance is emerging to azoles. There is, therefore, a need for new antifungal
compounds with novel modes of action for use in treating or preventing such
fungal infections. O-linked mannoproteins constitute a signiﬁcant compo-
nent of the fungal cell wall of Candida and other pathogenic fungi, and are
believed to confer the cell surface properties involved in adhesion and host
interactions. The key step in the biosynthesis of these mannoproteins is
catalyzed by a family of protein:mannosyl transferases (PMTs). Deletion of the
PMT1 gene fromCandida albicans results in a strain that is no longer virulent in
animal models. The strain also shows several phenotypes associated with cell
wall defects. A library of 50 000 compoundswas screened against PMT1, and a
series of weak inhibitors (IC50 c. 50mmol) were identiﬁed. The synthesis of
analogs of these inhibitors resulted in the discovery of compounds with
IC50< 200 nmol, and good oral bioavailability. PMT1 inhibitors confer the
phenotypes of the pmt1 knockout strain upon treated cells. These phenotypes
include clumping, increased sensitivity to aminoglycosides, failure to form
pseudo-hyphae in response to a range of stimuli, reduction in chitinase, and
reduced adhesion. The compounds are also active against other members of
the PMT family of enzymes. The range of phenotypes reﬂects the many
functions of the mannoproteins, however, it is not clear which is responsible
for the loss of virulence invivo. The compounds are active against many other
fungi, suggesting that PMT1 function is conserved across a range of fungal
species. Data demonstrating the activity of these compounds invitro and
invivo will be presented.
O399 A proteomics approach to study virulence in the
pathogenic fungus Aspergillus fumigatus
T. C. Yeomans, K. England, A. D. W. Dobson
Cork, IRL
Aspergillus sp. are saprophytic fungi, which are found in a wide variety of
environmental niches. Aspergillus fumigatus is the most readily associated with
human infection, with other species being identiﬁed as causative agents in
some cases (A. niger, A. nidulans, A. terreus, and A. ﬂavus). The average human
may inhale several hundred conidia per day. In a healthy individual, these will
be dealt with by innate immune mechanisms and cause no infection.
However, if an immunosuppressed individual becomes exposed to Aspergillus
conidia and an infection occurs which persists, the outcome is often fatal.
There are several factors that may be involved in the virulence of A. fumigatus
including pigments, adhesins, toxic molecules, and enzymes. A proteomics-
based approach has been taken to help identify proteins which may be
associated with the virulence of A. fumigatus. Spores harvested from A. fumi-
gatus were inoculated into a cell line of human epithelial lung cells (HEL)
grown in cell culture media (CCM) (virulent model) and into CCM only
(avirulent model). Proteins were extracted at days 4 and 5 from the virulent
model, when RT-PCR had indicated expression of various putative virulence
factors, and from the avirulent model at day 5 which served as a control.
Samples were analyzed following two-dimensional (2-D) gel electrophoresis.
A number of differentially expressed proteins were detected with the protein
proﬁles of days 4 and 5 being signiﬁcantly different from the control. These
proteins were subject to MALDI-ToF MS (Matrix-Assisted Laser Deso-
rption/Ionization-Time of Flight Mass Spectrometry) analysis to elucidate
their identity. Preliminary analysis has shown some similarity to a fatty acid
synthetase from A. parasiticus and a DNA topoisomerase II from A. ochraceus
and A. ﬂavus.
O400 An open phase II study of the efﬁcacy of
micafungin (FK463) alone and in combination for the
treatment of invasive aspergillosis (IA) in adults and children
A. J. Ullmann, J. A. Van Burik, P. McSweeney, V. Ratanatharathorn,
J. Raymond, V. L. de Morais, J. McGuirk, W. Lau, D. Facklam,
S. Koblinger, M. Reusch, K. Marr, T. F. Patterson, D. W. Denning
Mainz, D; Minnesota, Denver, Michigan, Pennsylvania, USA; Oswaldo
Cruz, BR; Deerﬁeld, USA; Munich, D; Seattle, San Antonio, USA;
Manchester, UK
Objectives:To assess the efﬁcacy of micafungin as primary and salvage therapy
of IA, alone and in combination with other antifungal drugs.
Methods: Patients (pts) with probable or proven IA failing, likely to fail or
intolerant of 3 days licensed antifungal therapy were enrolled in a multi-
national phase II study. Micafungin was substituted for (monotherapy group),
or added to therapy (combination group) and given once daily at a starting
dose of 75mg/day or 1.5mg/kg if 40 kg. Dose escalation was allowed.
Response was assessed clinically, radiologically, and mycologically and
recorded as complete, partial, stable or failure. All enrolments were reviewed
by an expert panel. Per protocol analysis included pts who received7 days of
micafungin and had conﬁrmed IA on review (PP population). A separate
analysis of PP population who failed7 days of prior antifungal therapy at full
therapeutic doses (salvage group) was done.
Results: Two hundred and eighty-three pts were enrolled, aged from 9 weeks
to 84 years (mean 37 years); 63 (22.3%) were<16 years, 181 (64%) were male,
81 (29%) neutropenic (<500/mm3). One hundred and four (36%) completed
therapy and 165 (57%) died. 60% of adults had a dose escalation, and 25%
received 200mg/day. Median duration of dosing was 34 days in adults and
37 days in children. A total of 179 were in the PP population. Response
(CRþPR) was seen in 27/38 (45%) in monotherapy group, and 50/141
(35%) in the combination group. Allogeneic HSCT pts (19/70, 27%) and
leukemic pts (32/64, 50%) responded. One hundred and twenty pts were in
the salvage group; 115 received combination therapy. Response (CRþPR)
was seen in 39/120 (33%), 11/49 (22%) in allogeneic HSCT pts, and 22/45
(49%) in leukemic pts. Responses were seen for all Aspergillus spp., except
A. terreus (0/7). Few attributable SAEs were observed.
Conclusions: Micafungin is effective in the treatment of IA, alone or in
combination, and carries very few adverse reactions.
O401 Real-time PCR is superior to galactomannan and
mannan ELISA for the early detection of invasive fungal
infection in hematology patients
N. Jordanides, E. Allan, M. Copland, L. McClintock, M. Devaney,
K. Stewart, P. Johnson, A. Parker, T. Holyoake, B. Jones
Glasgow, Edinburgh, UK
Invasive fungal infections (IFI) are an increasingly important cause of mor-
bidity and mortality in patients with hematologic malignancy and stem cell
transplantation, yet remain difﬁcult to diagnose. We have designed a pro-
spective, blinded study to compare screening with a real-time, pan-fungal
PCR assay using the LightCycler technique with ELISA for galactomannan
(GM) and mannan (M) for the early detection of IFI in immunocompromised
hematology patients. Between December 2000 and December 2001, 133
patients (204 treatment episodes) were recruited. On admission, and twice
weekly, clotted and EDTA blood samples were collected during each treat-
ment episode and analyzed using PCR to detect 18S ribosomal fungal DNA
and the Platelia Aspergillus and Candida ELISA. There were 22 cases of
EORTC deﬁned IFI: 3 proven, 9 probable and 10 possible. The sensitivity
of the PCR was 10 CFU/mL for Candida DNA and 20 CFU/mL for
Aspergillus DNA. Positive PCR results were recorded in 84.1% of patients
(range 1–14 samples). In 50/204 (24.5%) treatment episodes, PCR was se-
quentially positive. In a further 84/204 (41.2%) treatment episodes, PCR
was positive either on a single occasion (52/204, 25.5%) or intermittently
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(32/204, 15.7%). Of the 50 episodes with sequential PCR positivity, 14 were
graded as EORTC proven (3/3 episodes), probable (7/9 episodes), or possible
(4/10 episodes). In 9 of these 14 episodes, sequential PCR positivity was
documented between 1 and 71 days (mean 28, median 27) prior to com-
mencement of empiric antifungal therapy. Sequential PCR positivity was also
detected in 36 episodes that were EORTC negative. In 10, sequential PCR
positivity resolved with neutrophil recovery; in 11 whilst still neutropenic;
and in a further 5, the patients developed IFI in subsequent episodes. The
negative predictive value of a negative or single/intermittent positive result for
proven/probable IFI was 98.7%. Of 82 episodes analyzed with the M ELISA,
1 sequential and 7 single positives were recorded, all with no evidence of IFI.
Positive GM ELISA results were recorded in 22/204 episodes; 1 was
sequential positive and had proven IA while in a case with a single positive
there was evidence of probable IA. In 183 episodes with negative GM ELISA
results, there were 19 cases of IFI. These results provide evidence that
prospective screening using PCR is a useful diagnostic tool for early detection
of IFI and is superior to GM and M ELISA.
O402 Identiﬁcation of novel cell surface proteins in
Candida albicans and investigation of their role in adhesion
and virulence
C. Alberti-Segui, A. Morales, D. Willins, H. Halem, H. Xing,
Q. Zeng, K. Weinstock, G. Cottarel, M. Kessler, B. Rogers
Waltham, USA
Objectives: Candida albicans is responsible for the majority of hospital-based
fungal infections and is a particularly important pathogen in immunocom-
promised patients, where it can cause superﬁcial mucocutaneous infections as
well as life-threatening systemic infections. We are seeking new ways to
identify C. albicans cell surface proteins involved in adhesion (an early step in
pathogenesis) or virulence.
Methods and results: Towards that end, we developed a computational
biology approach and identiﬁed 210 potential cell surface proteins. Among
the pool of 210 candidates that fulﬁlled the bioinformatics criteria, we
selected a subset of 6 proteins (named CSF1–6 for cell surface factors) for
further biologic characterization. We ﬁrst showed that all CSF genes are
expressed by RT-PCR and then disrupted both alleles using a two-step gene
disruption method. We further investigated the effect of the loss of each CSF
gene on cell wall integrity, adhesion to mammalian cells, and virulence in an
animal infection model. As a result, we identiﬁed two adhesins and four
additional factors that are important for cell wall integrity and virulence.
Conclusion:Assuming that all six CSF proteins are major Candida cell surface
proteins, they represent promising targets for the development of new
antifungal drugs, therapeutic antibodies, and/or vaccines.
O403 A phase 2 dose-ranging study of the safety and
efﬁcacy of anidulafungin in invasive candidiasis
D. Krause, B. Goldstein, M. Wible, G. Kilfoil, T. Henkel
King of Prussia, USA
Introduction: Anidulafungin (VER002) is a novel cyclic lipopeptide anti-
fungal agent of the echinocandin class. In vitro, anidulafungin is highly active
against Candida and other fungal pathogens. We have previously shown that
steady state is rapidly achieved with a loading dose. The pharmacokinetic
proﬁle and antimicrobial spectrum of anidulafungin suggest that it may be
useful in serious fungal infections, including invasive candidiasis (IC).
Objectives: To evaluate the clinical and microbiologic efﬁcacy and safety of
three dose regimens of anidulafungin in patients with IC.
Methods: Adult patients (pts) at least 18 years of age with documented IC,
including candidemia or histologic or culture evidence of infection in a
normally sterile site, and expected survival>72 h, were randomized to one of
three dose regimens: Arm A: 100mg intravenous (i.v.) loading dose on Day 1
followed by 50mg IV daily (100/50mg); Arm B: 150/75mg; Arm C: 200/
100mg. Pts received treatment for 2weeks beyond cure or improvement, up
to 42 days. A test of cure (TOC) visit occurred 2weeks after end of therapy
(EOT). Safety evaluations included standard lab assessments and recording of
adverse events (AEs). The primary efﬁcacy analysis was global response in the
evaluable population at TOC. A successful global response required a
successful clinical and microbiologic outcome.
Results:One hundred and twenty-three pts were enrolled, 120 (40 in each arm)
received at least one dose of anidulafungin. At baseline, the most common
species wasCandida albicans, accounting for about half of all isolates, followed by
C. glabrata. Mean APACHE II score was 15.6. The overall mean duration of
therapy was 17 days. There was a trend to greater response in the higher dose
arms. The number and proportion of pts with a successful global response in the
evaluable population at EOT and TOC are shown in the Table 1.
AEs, including serious AEs, and laboratory safety data did not differ by group.
Per pathogen responses were similar among all species.
Conclusion: Anidulafungin appears effective in the treatment of IC. Higher
doses are as well tolerated as the lowest dose regimen, and may provide
superior efﬁcacy. A deﬁnitive Phase 3 trial is underway.
O404 Correlation between Sensititre-YeastOne1
method and the proposed procedure for antifungal
susceptibility testing of the European Committee on
Antibiotic Susceptibility Testing
M. Cuenca-Estrella, E. Mellado, A. Gomez-Lopez, G. Garcia-Effron,
M. J. Buitrago, J. L. Rodriguez-Tudela
Majadahonda, Madrid, E
Objectives: The European Committee on Antibiotic Susceptibility Testing
(EUCAST) has developed a proposed standard for antifungal susceptibility
testing of yeasts based on reference procedure of NCCLS M27-A, but
incorporating modiﬁcations (RPMI-2% glucose, inoculum size of 105
CFU/mL, spectrophotometrical reading) in order to get an automated AFST
and to shorten the incubation period for MIC determination from 48 to 24 h.
We have analyzed the correlation between EUCAST procedure and the
commercial method Sensititre-YeastOne, a microplate-based procedure for
in vitro testing of amphotericin B (AB), ﬂuconazole (FLZ), itraconazole
(ITZ), ketoconazole (KTZ), and ﬂucytosine (FC).
Methods:A total of 60Candida spp. clinical isolates (10 each C. albicans (CA),
C. tropicalis (CT), C. parapsilosis (CP), C. glabrata (CG), C. krusei (CK), C. lusi-
taniae (CL)) were tested. CK ATCC6258 and CPATCC22019 were included
as QC strains. Triplicate testing on three separate days was performed.
Analysis: (i) Correlation: intraclass correlation coefﬁcient (ICC), over a
maximum value of 1; (ii) agreement (AGR): discrepancies of no more than
two 2 dilutions.
Results:Overall, the correlation was 0.92 and the AGR was 75%. By species,
the poorest correlation values were obtained for CT isolates, which exhibited
a percentage of AGR of 56%. By antifungal agents, the lowest correlation
values were obtained for AB, with ICC and AGR values of 0.29 and 50.5%,
respectively. The correlation for azole resistant isolates were excellent. The
Sensititre-YeastOneMICs of FLZ and ITZ for azole resistant strains were>32
and >0.5mg/L, respectively.
Conclusions: (1) The correlation between EUCAST procedure and Sensi-
titre-YeatsOne method is high with average correlation values of 0.92 and
AGR percentages of 75%.
(2) The methods are not comparable for AB.
(3) Sensititre-YeastOne method detects azole resistant strains.
O405 High-risk patients, candidemia and antifungal
susceptibility proﬁle: 7-year clinical audit in four high-risk
units of a tertiary care hospital
A. Guleri, G. D. Corcoran, A. B. J. Speekenbrink
Glasgow, UK
Introduction: Signiﬁcant morbidity and mortality is associated with oppor-
tunistic fungal infections in immunocompromised patients. An audit of
antifungal susceptibility proﬁles of candidemic isolates obtained from patients
in high-risk units (hematology, nephrology, oncology and intensive trauma
unit) of the Western Inﬁrmary and Gartnavel General Hospital, Glasgow, was
carried out over a 7-year period (1996–2002).
Table 1
Group
time point
100/50mg,
n/N (%)
150/75mg,
n/N (%)
200/100 mg,
n/N (%)
EOT 21/26 (81) 25/28 (89) 23/26 (88)
TOC 13/19 (68) 19/23 (83) 19/23 (83)
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Objective:The aimwas to establish baseline data of the prevalence of different
Candida species in fungemic episodes in the four high-risk units of the
hospitals and correlation with their antifungal susceptibility proﬁle.
Methods: Data on yeast isolates and antifungal susceptibility proﬁle in blood
cultures from patients in these units were audited.
Results: Forty-one isolates were obtained from 52 episodes of candidemia
from 40 patients. Candida albicans (51.2%) was the commonest isolate overall,
followed byC. parapsilosis (24.4%), and C. glabrata (14.6%). In oncology units:
C. parapsilosis accounted for 50% (8/16) isolates, followed by C. albicans in
31.25% (5/16), while in hematology units C. parapsilosis and C. albicans
accounted for 33.3% (2/6) isolates each. C. glabrata closely followed in
incidence in all the four areas. All isolates demonstrated in vitro susceptibility
to amphotericin B. Susceptibility to Fluconazole and Itraconazole was 85.7
and 95.3%, respectively, for C. albicans, 80% for both agents for C. parapsilosis,
0 and 16.7%, respectively, for C. glabrata, 0% for both agents for C. krusei.
Distribution of the different candida species and varying sensitivity proﬁles is
discussed.
Conclusion: Candida albicans was the commonest yeast causing candidemia.
However, the high prevalence of Candida species other than C. albicans
in 48.8% of isolates is striking. C. parapsilosis was the commonest isolate in
the oncology units and use of total parental nutrition (TPN) in these patients
may be a factor. Results of antifungal susceptibility testing (AFST) justify
use of amphotericin B as empirical choice in candidemia pending identiﬁca-
tion and AFST. This work is a useful yardstick to prospectively
compare the efﬁcacy of newer azoles and echinocandins with current anti-
fungal agents.
Staphylococcal and catheter associated hospital-acquired infections
P406 An extended-source outbreak of
Staphylococcus epidermidis infections among patients
undergoing cardiac surgery
R. Bou, M. Peris, J. Perpin˜a´n, P. Ramos, A. Aguilar Infection Control
Team
Objectives: To describe the ﬁrst Staphylococcus epidermidis outbreak detected
among cardiac surgery patients in our newHospital, to identify the cause and/
or source of the outbreak and to prevent the occurrence of new cases.
Methods:Design, retrospective cohort study. Setting, a 260-bed community
referral center. Probable case deﬁnition, valve surgery patient operated in
Hospital de la Ribera (HR) with clinical diagnosis of endocarditis and/or
mediastinitis from January 2002 to June 2002. Study population, patients
undergoing valve surgery in HR from January 2000 to June 2002. S. epi-
dermidis were identiﬁed by MicroScan Pos panel (Dade MicroScan). DNA
typing with Pulsed Field Gel Electrophoresis was not performed.
Results: From January to March 2002 several cases of mediastinitis and
endocarditis among patients undergoing cardiac surgery were detected. In
2000, there was no case detected. During the ﬁrst 4months of 2001, incidence
of infection was 5.1% (2/39). On the same time frame in 2002 incidence was
11.7% (4/34). There were no alternative explanations for this increase such as
changes in nosocomial infection surveillance, preoperative, intraoperative or
postoperative procedures. Four additional cases were detected, one in May
and three in June. Overall, eight patients developed infection including four
with mediastinitis and endocarditis, three with mediastinitis and one with
endocarditis. The epidemic curve suggested an extended-source outbreak.
Therewere no statistical differences between cases and controls with respect to
age, gender, preoperative hospital stay, antimicrobial prophylaxis, time on
bypass, central venous catheter duration, NNIS risk index or ICU stay.
Patients with underlying illness such as COPD were 5.3 times more likely
to become cases (95% CI 1.4–20.3). Mean duration of surgery was higher in
non cases 162.4 (57.8) vs. 123.8 (23.7) (SD, min), P¼ 0.002. All of the
infections occurred in patients following aortic valve replacement, P¼ 0.02.
Of all staff evaluated there were no associations with infection. Environmental
investigations did not provide additional information.
Conclusions:There was no point-source associated with infection. The cause
of this outbreak was likely multifactorial. Changes suggested during the
investigation included improvement of patient skin preparation, preoperative
hand/forearm antisepsis, antimicrobial prophylaxis and surgical attire which
contributed to the resolution of the outbreak.
P407 Nosocomial bloodstream infection with multiple
location due to multiresistant Staphylococcus hemolyticus
M. Tsironi, P. Andriopoulos, M. Kalkani, A. Vounassis,
G. Assimakopoulos, M. Dionisopoulou
Sparta, GR
Introduction: Nosocomial infections, and especially bacteremia, are serious
causes of morbidity and mortality, especially when present multiresistant
microorganisms. This report describes a case of sepsis due to Staphylococcus
haemolyticus with multiple location.
Methods and Results:Results: A 76-year-old woman was admitted because
of fever, respiratory distress, tachycardia, anemia and fatigue. Ten weeks ago,
she underwent a laparoscopic bile resection, complicated by pneumonia and
liver abscess which was drained surgically. Her past medical history included
seizures under antiepileptic treatment, possibly due to cysticercosis. The
admission laboratory tests revealed WBCs 26800/mL 103 (82% neutro-
phils), Ht 29.2%, ferritin 685 ng/mL, elevated transaminase levels and ESR
111mm/1 h, while blood pressure was 80/40mmHg. A central venous
catheter was used as a well as a vesical one. Two sets of blood cultures and
a urine one were taken and piperacillin–tazobactam (4.5mg 4, i.v.) plus
amikacin (500mg 2, i.v.) were administered. On day 10, two new sets of
blood cultures because of fever 408C were taken. Blood cultures were carried
out by BACTEC 9050 system (Becton Dickinson). The venous catheter was
changed and cultured, but the cultures were negative. Transesophageal
echocardiogram revealed aortic valve vegetation. Three bottles of blood
cultures and a urine one grew Staphylococcus haemolyticus. Species identiﬁcation
was performed by Gram-stain, catalase test(þ) and coagulase test by Staphy-
tect Plus system-Oxoid(–) and APISTAPH (Biomerieux). Susceptibility test
was performed by disc diffusion method (Kirby-Bauer in Muller Hinton
agar). The strain was resistant to penicillin, gentamycin, amikacin, piper-
acillin–tazobactam ciproﬂoxacin, clindamycin, imipenem and but susceptible
to vancomycin, rifampicin netilmicine and teicoplanin. Pseudomonas spp. was
isolated from a skin lesion culture. The therapy was replaced by vancomycin
(500mg 4, i.v.) plus rifampicin (300mg 3, i.v.) that were administered to
the patient for 4weeks. The patient on day 17 was afebrile and she exited the
hospital, with clinical and laboratory improvement.
Conclusions: Though nosocomial infections have a high mortality rate
frequent blood cultures enable accurate diagnosis and optimal treatment in
patients with risk factors (catheters, previous long-term hospitalization) and
multiresistant nosocomial strains.
P408 Incidence and clinical signiﬁcance of
Staphylococcus lugdunensis: a prospective microbiological
and clinical study
E. Cercenado, O. Cuevas, O. Pe´rez-Olaso, J. Martı´nez-Alarco´n,
E. Bouza
Madrid, E
Objectives: To evaluate the incidence and clinical signiﬁcance of Staphylo-
coccus lugdunensis in a teaching general hospital over a 4-month period.
Methods: From September 2002 (when we started a routine protocol
searching for S. lugdunensis in our hospital) to December 2002, all S. lugdu-
nensis recovered in our microbiology laboratory were studied. The isolates
were identiﬁed using the MicroScan system and conﬁrmed by an additional
positive ornithine decarboxylase test. Susceptibility testing was performed by
the broth microdilution method using the MicroScan system and beta-
lactamase production was detected using the nitrocephin test. All patients
from whom S. lugdunensis was isolated were prospectively followed up.
Results:Over the study period a total of 906 coagulase-negative staphylococci
were isolated. Among those, 19 isolates (2%) were S. lugdunensis. All but two
were beta-lactamase negative, all were methicillin-susceptible and susceptible
to multiple antimicrobials. The origins of the 19 isolates were wound (12),
joint ﬂuid (2), umbilical (1), abscess (1), CSF (1), IV catheter (1), and ear ﬂuid
(1) and corresponded to 17 patients hospitalized in 11 different wards. Eight
patients (47%) were infected and nine were colonized. Among the infected
patients (62% females, median age 73 years; seven adults and one neonate),
seven (87.5%) presented underlying diseases (four organic, two tumoral and
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one HIVþ). In ﬁve cases S. lugdunensiswas nosocomially acquired. Infections
were: wound infection (4), omphalitis (1), renal abscess (1), prosthetic joint
infection (1), and catheter-related infection (1). The infection was polymi-
crobial in four cases (50%). Seven patients recovered with adequate treatment.
One patient died but mortality was not attributable to S. lugdunensis infection.
Conclusions: In our hospital S. lugdunensis represents 2% of all coagulase-
negative staphylococci isolates, and this microorganism is susceptible to
multiple antimicrobials. Only half of the isolates of S. lugdunensis have clinical
signiﬁcance, and infections due to S. lugdunensis present good evolution with
adequate antimicrobial treatment. The isolation of S. lugdunensis should not be
discarded as a contaminant without careful consideration.
P409 Does enteritis due to methicillin-resistant
Staphylococcus aureus actually exist? – Clinical and animal
study
T. Ohara
Tochigi, JP
Objective:Although Staphylococcus aureuswas considered to be responsible for
antibiotic-associated colitis, the role of S. aureus is now the subject of debate.
The present study was performed in order to determine whether methicillin-
resistant Staphylococcus aureus (MRSA) is capable of causing enteritis and
whether recovery of MRSA from stool specimens originated from patients
with diarrhea implies MRSA enteritis.
Methods: Clinical study – we reviewed 163 patients diagnosed with MRSA
enteritis between 1992 and 2001 in a teaching hospital in Japan and 34 case
reports of MRSA enteritis published in medical journals since 1990. Of the
197 cases, 21 cases were selected using our criteria. These criteria were as
follows: (1) presence of diarrhea (2) subsequent dominant or single recovery of
MRSA from stool specimens (3) negative results of toxins and cultures of
Clostridium difﬁcile (4) obvious improvement after treatment with vancomycin.
Animal study –we adapted the streptomycin-treatedmurinemodel of chronic
mucosal colonization. IC mice ﬁrst received 1mg of streptomycin per mL of
drinking water for 5 days and then orally ingested 107 CFU/mL H2O of
MRSA (streptomycin) for 1–5 days and stool cultures were performed
periodically.
Results:The average age of the 21 patients (11 males, 10 females) suggested to
have MRSA enteritis, was 61.4 years. Most of the 21 patients showed fever
and abnormal white blood cell counts. Nineteen patients had previously been
prescribed more than one antibiotic before diarrhea occurred. Although the
antibiotics tended to be broad-spectrum, relationships between speciﬁc
antibiotics and occurrence of enteritis were not observed. Two patients died
of multiple organ failure. In animal models, chronic colonization withMRSA
for up to 10weeks was determined by fecal culture. Stools of MRSA-
colonized mouse became soft but not diarrheal. A single day of MRSA
ingestion with no combined use of antibiotics was sufﬁcient for enteric
colonization with MRSA.
Conclusion: Although diarrheal diseases, of which the cause is strongly
suggestive of MRSA, actually exist, the clinical courses in the present study
were varied. Moreover, MRSA easily colonizes in the gastrointestinal mucosa
and colonization is sustained for long periods. Mere recovery of MRSA from
stool specimens does not indicate MRSA enteritis and other causative factors
may be involved.
P410 The isolation of GISA following prolonged
glycopeptide therapy
A. Leanord, R. Yates, B. Jackson, L. Kean, G. Edwards
Lanarkshire, Glasgow, UK
Objectives: The description of the isolation of a glycopeptide intermediate-
resistant S. aureus (GISA) following glycopeptide therapy.
Methods: Case study.
Results: A patient who developed post operative complications was admitted
to our ITU. She developed an MRSA bacteremia that was treated with
vancomycin. During this period she developed tricuspid endocarditis, and
required an combination of glycopeptide antibiotics (plus rifampicin) for a
total of 75 days. TheMIC to vancomycin of her MRSA increased from 0.5 to
16mg/L, and to teicoplanin from <4 to 16mg/L, resulting in treatment
failure and death. A series of Infection Control measures were put in place.
Conclusions: In this case a GISA arose from the prolonged (75 days) use of
glycopeptide antibiotics, to treat a tricuspid endocarditis, resulting in treat-
ment failure.
P411 Rate of carriage of MRSA in children undergoing
cardiac surgery
K. Harvey-Wood, C. L. Williams
Glasgow, UK
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) is recognized
as a major cause of Hospital Acquired infection in the UK. Surgical wound
infection is one of the most frequent MRSA-induced infections with often
disastrous consequences. In order to reduce the risk of MRSA infection we
have introduced screening prior to cardiac surgery and are now able to
evaluate the rate of MRSA colonization in these patients.
Methods: Three hundred and forty nine patients were admitted to the unit
between August 2001 and December 2002, 191 were male and 158 were
female. Of these 321 patients admitted for cardiac surgery had nasal, throat
swabs and swabs of any pre-existing wound sites cultured.
Results: Of 321 patients, 12 were found to be colonized with MRSA. Five
were positive on nasal swabs and multiple sites, four on throat swabs alone.
The overall positivity rate was 3.7%.
Discussion and conclusions: Anecdotally it is thought that MRSA coloniza-
tion/infection is less common in the pediatric setting. However, a study in
Nashville showed that 1.2% (6 out of 500) of children at well-child visits at
either a university hospital pediatric clinic or a private pediatric ofﬁce were
positive for MRSA. This was supported by another study in which 0.6% (3
out of 500) healthy children less than 16 years of age attending for well child
care in Chicago were again positive for MRSA. However, at present little is
known aboutMRSA carriage rates amongst children in the UK. A recent UK
study in which adult patients admitted to general surgical and orthopedic ward
were studied for MRSA colonization revealed an MRSA prevalence of 5.3%
of whom 65% were nasal carriers and 35% had MRSA colonization else-
where. The rate of 3.7% found in pediatric patients is lower than that found in
adult patients screened prior to surgery but is higher than the prevalence in the
general adult population in the UK. Little is known of the incidence of
MRSA in pediatric populations but the organism appears more widespread in
children who are about to undergo cardiac surgery than in the general adult
population. From the point of view of effective screening four of the MRSA
positive patients were identiﬁed on throat swab alone. The fact that throat and
perianal site swabs have a higher sensitivity in identifying children colonized
with MRSA than nasal swabs alone is similar to the ﬁndings in a previous
Canadian study in children and has important implications for screening
pediatric populations.
P412 Linezolid: in vitro activity and clinical effectiveness
in cardiac surgery intensive care unit patients
T. Y. Vostricova, S. T. Kuznetsova, N. V. Beloborodova
Moscow, RUS
Objective: To study in vitro sensitivity of MRS CN and Enterococcus spp. to
Linezolid. To assess its clinical effectiveness in cardiac surgery patients with
various nosocomial infections caused by troublesome grþ cocci.
Methods: I stage (in vitro): 90 sequential strains of grþ cocci (MRS CN
n¼ 60, Enterococcus spp. n¼ 30), cultivated in microbiology laboratory from
blood (n¼ 45), sputum (n¼ 32), urine (n¼ 5), wounds (n¼ 5) and cardiac
valves (n¼ 3). Following NCCLS recommendations diffuse disk test were
used to assess bacterial sensitivity. All strains (100%) of MRS CN and
Enterococci spp. were sensitive to linezolid in vitro, dependless their sensitivity
to other antibiotics. II stage (clinical): 10 patients, including pediatric (n¼ 3,
3months-12 years) and adult (n¼ 7, 17–65 years) with nosocomial infections
caused by multiresistant grþ cocci. Infective endocarditis (n¼ 4), pneumonia
(n¼ 2), wound infection (n¼ 3), sepsis (n¼ 1). MRS was cultivated from
samples in all cases. Glycopeptides could not be administered in six cases due
to: intolerability of vancomycin (n¼ 1), kidney failure (n¼ 1), vamcomycin
ineffectiveness (four cases). Linezolide was administered to all patients per os
(tablets or suspension): 600mg twice a day to adult patients and daily dose of
10mg/kg in two intakes for pediatric patients. The treatment course was
5 days in three cases and 10 days in seven cases. Monotherapy with linezolide
administered in one case and combined therapy with other antibiotics in the
other nine. Symptoms decrease including fall of temperature and positive
dynamics in hemogramm started from the fourth day of therapy. No toxic or
other side-effects were registered.
Conclusions:
1. Linezolide effectiveness against MRS CN is comparable with that of
vancomycin.
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2. Linezolide is effective against all Enterococci dependless their sensitivity/
resistance to other antibiotics.
3. Linezolide is an optimal alternative to vancomycin, especially in cases
when vancomycin is contraindicated.
4. Absence of nefrotoxicity allows to recommend Linezolid as a drug of
choice in cases of kidney failure and multiorgan failure.
P413 Colonization with vancomycin-resistant
Enterococci among hemodialysis patients in Greece
E. Baimakou, J. Papaparaskevas, P. T. Tassios, P. Kalocheretis,
E. Kouskouni, L. Zerva
Athens, GR
Objective: Sparse data are available on infection or colonization with Van-
comycin-Resistant Enterococci (VRE) in Greece. The purpose of this study
was to evaluate the incidence of VRE colonization among patients treated in
Renal Dialysis Units located in the same region and characterize strains by
phenotypical and genotypical methods.
Materials and methods: During a 4-month period (1/9–30/12/01) rectal
swabs or fecal specimens were obtained from 334 consenting patients and
were plated on Enterococossel agar (Becton Dickinson) with 6mg/L vanco-
mycin (Elli-Lilly). Patients were treated in four Dialysis Units (Units I to IV)
located in Western Attica. Unit I is located within the major hospital of this
area, which serves as a referral center for these patients. Demographical data
were collected by a questionnaire. Isolates were identiﬁed to the genus level by
standard methods and speciated by ATB (BioMerieux) and a multiplex PCR
assay. Susceptibility testing was performed by Vitek (BioMerieux) and con-
ﬁrmed byE-test (AB Biodisk) and PCR.DNAﬁngerprinting of VRE isolates
was performed by Pulsed Field Gel Electrophoresis (PFGE).
Results: Thirteen Enterococcus faecalis strains were identiﬁed by PCR (inci-
dence 3.9%, range among Units 3–4.8%), which were vancomycin resistant
by Vitek and E-test and possessed the vanA gene. Resistance to ampicillin,
erythromycin, ciproﬂoxacin, vancomycin, teicoplanin and streptomycin was
the predominant phenotype (8 out of 13 isolates, 62%). DNA ﬁngerprinting
allocated the 13 VRE isolates into six different types designated A (two
strains), B (six strains), C (two subtype strains) and D to F (one strain each).
Unit IV demonstrated two VRE clusters consisting of type A and type B
isolates (two and four strains, respectively). Type B isolates were shared by
three Units: Unit II (one strain), Unit III (one strain) and Unit IV (four
strains). Units I and IV shared the two subtype C strains. Male gender
(P< 0.02), frequent hospitalizations (P< 0.001) and recent onset of hemo-
dialysis treatment (P< 0.05) were positively associated with VRE coloniza-
tion.
Conclusions: VRE colonization is reported for the ﬁrst time among hemo-
dialysis patients in Greece. Despite the low number of isolates, sharing of
PFGE types in-between Units was demonstrated indicating spread of
VRE clones among patients and, possibly, ineffective infection control
measures.
P414 Effect of opening of a cohort unit on MRSA
bacteremia rates
S. F. FitzGerald, F. Fitzpatrick, C. Fallon, A. Flynn, E. Noctor,
L. E. Fenelon
Dublin, IRL
Objectives: Following the opening of a MRSA cohort unit in January 2001, a
signiﬁcant reduction in MRSA acquisition rates within our hospital was seen.
As MRSA colonization is a risk factor for MRSA bacteremia, it was
postulated that this reduction in colonization may lead to a fall in MRSA
bacteremia.
Methods:From January 2000 to June 2002, all episodes of Staphylococcus aureus
bacteremia were recorded prospectively. MRSA bacteremia rates were com-
pared before and after opening of the unit. Comparisons were also made with
national data from EARSS.
Results: No signiﬁcant reduction in MRSA bacteremia rates was seen
following opening of the cohort unit. However, nationally, there was an
increase inMRSA bacteremia during this period. Prior to the cohort unit, the
MRSA bacteremia rate in our hospital closely correlated with the national
average (w2¼ 0.003). After the unit opened our MRSA bacteremia rates were
consistently lower than the national average, though not achieving signiﬁ-
cance (w2¼ 2.26).
Conclusions:Although MRSA bacteremia rates did not fall signiﬁcantly after
opening of a dedicated cohort unit, the rates remained similar and did not
follow the increasing trend nationally. A cohort unit, by reducing MRSA
acquisition rates in our hospital, may have contributed to the MRSA
bacteremia rates remaining static and not mirroring the national increase
during the study period.
P415 Staphylococcus aureus oxacillin-resistant:
assessment of factors associated with acquisition in
hospitalized patients
S. B. Ricardo, G. P. Matta-Machado, E. S. Moreira
Belo Horizonte, BR
Oxacillin-resistant S. aureus (MRSA) remain as an important pathogen
detected in the majority of hospitals and is responsible for an increasing
number of colonization and nosocomial infections. Recent reports have also
noticed the emergency of community-acquired strains of MRSA. Many
factors were associated with nosocomial acquisition of these resistant strains.
Characteristics permitting recognition of patients harboring MRSA would
aid infection control efforts to reduce intrahospital dissemination of such
strains and choice of empiric therapy pending culture and susceptibility
results. A prospective laboratory-based study was carried out with clinical
isolates of S. aureus in a 550-beds tertiary care providing, university hospital, in
Belo Horizonte, Brazil. Only one bacterial sample was selected for each
patient. The strains were evaluated by using the presence of mecA gene,
detected by PCR, as deﬁnitive criteria for MRSA and non-MRSA (MSSA).
During four consecutive months, 103 patients were selected for interview and
had their hospital records reviewed. Among them, 36 (35%) had MRSA and
67 (65%) had MSSA. Following the CDC criteria, 36 patients in MRSA
group were classiﬁed as: three (2.9%) community-acquired infection, 26
(25.2%) nosocomial-acquired infection, seven (6.9) colonization; and 67
patients in the MSSA group as: 24 (23.3%) community-acquired infection,
32 (31%) nosocomial-acquired infection, 11 (10.7) colonization. Multivariate
analysis identiﬁed receipt of antimicrobial agent in the 6months preceding
admission [odds ratio (OR)¼ 4.0; 95% CI, 1.3–12.8], presence of diabetes
mellitus (OR¼ 4.9; 95% CI, 1.1–20.2); chronic break in the skin (OR¼ 3.2;
95% CI, 1.1–9.4); admission from other health care institution (OR¼ 4.0;
95% CI, 1.0–15.2); and >10 days hospitalization (OR¼ 3.4; 95% CI, 1.0–
11.0) to be independently associated with the presence of MRSA strain.
Further investigation of those three patients with MRSA, classiﬁed as having
community-acquired infection, revealed that all of them had recent hospi-
talization and chronic peripheral ulcers, but could not ﬁll the CDC criteria for
nosocomial-acquired infection. Our date demonstrated that, in the popula-
tion studied, some factors should be considered when making decisions about
isolation and empiric antimicrobial therapy for patients with suspected
staphylococcal infection. Community-acquired MRSA does not seem to
be a problem for the moment.
P416 Central venous catheter-related infections:
risk factors and the effect of glycopeptide antibiotics
S. O¨ncu¨, H. O¨zsu¨t, A. Yildirim, P. Ay, N. Cakar, H. Eraksoy,
S. Calangu
Aydin, Istanbul, TR
Objectives: Although central venous catheters (CVCs) have signiﬁcant
beneﬁts in many clinical situations, the increase in their use over the last
20 years has been associated with at least a doubling of resultant nosocomial
infections. We undertook a prospective study of all new central venous
catheters inserted into patients in the intensive care unit, in order to identify
the risk factors and to determine the effect of glycopeptide antibiotics on
catheter-related infections.
Methods:All patients admitted tomedical, neurosurgical and surgical ICUs of
Istanbul Faculty of Medicine between January 2001 and December 2001 who
submitted to CVCs were included in the study. The catheters used were triple
lumen and made of polyurethane material (Arrow, Erding, Germany). The
catheter was the ﬁrst or any subsequent inserted into a patient. Current ward
protocols were observed prior to catheter insertion. Catheters were cultured
by semiquantitative method and blood cultures done when indicated. Data
were obtained on patient age, gender, unit, primary diagnosis on admission,
catheter insertion site, duration of catheterization, whether it was the ﬁrst or a
subsequent catheter and glycopeptide antibiotic usage.
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Results: During the study period 300 patients with central venous catheters
were prospectively studied. Ninety-one (30.3%) of the catheters were colo-
nized and infection was found with 50 (16.7%) catheters. No signiﬁcant
differences were found for age, gender, unit, primary diagnosis, repeated
catheterization and TPN use. Infection was diagnosed with higher rate in
catheters inserted via jugular vein in comparison with subclavian vein (95%
CI: 1.32–4.81, P¼ 0.005). The incidence of infection was higher in catheters
which were kept in place for more than 7 days (95% CI: 1.05–3.87, P¼ 0.03).
The incidence of infectionwas also higher in nonantibiotic using patients than
patients who were using glycopeptide antibiotics during catheterization (95%
CI: 1.49–5.51, P¼ 0.005). Of the 50 cases of CRI, most of the organisms
causing infection were Gram-positive cocci (n¼ 38, 76%), with the most
commonly isolated organism being S. aureus (n¼ 32, 64%).
Conclusion: Duration of catheterization and catheter insertion site were
independent risk factors for catheter-related infection. Use of glycopeptide
antibiotics during catheterization seems to have protective effect against
catheter-related infection.
P417 Evaluation of catheter reinsertion as a risk factor
for recurrent catheter-related blood stream infection
(CR-BSI)
A. Erbay, O. Ergonul, M. Samore
Salt Lake City, USA
Objective: To evaluate risk factors for recurrent CR-BSI following intravas-
cular catheter removal.
Materials and methods: Patients who had CR-BSI followed by catheter
removal and reinsertion between January 1998 to February 2002 at the
University Hospital of Utah were included in the study. Recurrent CR-BSI
was deﬁned as positive blood cultures after three negative cultures, coupled
with positive catheter tip culture or no other new source of infection evident.
Results: Twenty-ﬁve (28%) of 89 patients had recurrent CR-BSI; 16 patients
with persistent bacteremia were excluded from the analysis presented here.
Recurrence was higher among burn patients than other patient types
(P¼ 0.038). Use of guide-wire exchange and time to reinsertion was similar
across recurrent and nonrecurrent patient groups (P> 0.5). The ﬁrst CR-BSI
occurred a mean of 19 days after catheter insertion whereas recurrence
developed a mean of 12 days after reinsertion. Coagulase-negative staphylo-
cocci were the most common cause of reinfection.
Conclusion: Recurrent CR-BSI in this population was associated with
admission to the burn service. Catheter reinsertion time was not a signiﬁcant
predictor of recurrent infection.
P418 Antibiotic lock therapy for the treatment of
staphylococcal Hickman catheter-related bacteremia
J. L. del Pozo, M. Lamata, A. Aguinaga, M. Fdez-Alonso, C. Panizo,
N. Garcı´a-Ferna´ndez, J. Leiva, R. Dı´az
Pamplona, E
Objectives:Hickman central venous catheters are commonly used to provide
vascular access in patients requiring prolonged intravenous treatment. Infec-
tion is one of the leading complications. Removal of the catheter is the
mainstay of therapy in the management of these infections. The antibiotic
lock therapy (ALT) has been suggested to be useful to treat catheter-related
bloodstream infections in order to avoid catheter removal. This study carried
out in a selected group of patients with Hickman catheter-related bacteremia
(HCRB) due to staphylococci, analyzes the efﬁcacy of ALT to treat these
infections.
Methods:A total of 22 episodes of HCRB occurred in 16 patients. There was
no tunnel tract or exit site infection in any of the cases. No evidence of other
sources for the infection was assessed after a careful physical examination. To
diagnose HCRB without removal of the suspected catheter, paired quanti-
tative blood cultures (QBC) were obtained through the two lumens of the
catheter and through a peripheral vein. Several solution locks were used:
vancomycin (2mg/mL) in 13 cases, teicoplanin (10mg/mL) in 5, vanco-
mycin (5mg/mL) in three and teicoplanin (2mg/mL) in one. Sodium
heparin was added to these solutions. Antibiotic locks were instilled into
the catheter lumen and were allowed to dwell for 12–72 h. Themean duration
of ALTwas 11.9 days (range 5–21 days). All the patients received a variable
course of systemic antibiotics. QBC were obtained 72 h after the end of
treatment. The persistence or recurrence of fever and bacteremia led to
catheter removal and culture.
Results:Etiologies included coagulase negative staphylococci (20 isolates) and
S. aureus (2). None of the catheters were removed within the antibiotic lock
and no serious complications occurred during treatment in any case. Twelve
episodes were successfully treated with one course of ALT (vancomycin was
used in seven cases and teicoplanin in ﬁve). There was a relapse of the
bacteremia in 10 cases (vancomycin was used in nine cases and teicoplanin in
one); two of these catheters were removed within 72 h after the end of
treatment and in the remaining eight episodes there was a response to a second
course of treatment.
Conclusions: The majority of HCRB with staphylococci can be cured
without device removal using ALT. Solutions locks containing teicoplanin
seems more effective than vancomycin ones probably due to physical or
chemical reactions of vancomycin with sodium heparin.
P419 Efﬁcacy of antibiotic lock therapy to treat venous
access port-related bacteremia
J. L. del Pozo, A. Aguinaga, M. Lamata, S. Herna´ez, M. Santisteban,
J. Leiva, R. Dı´az
Pamplona, E
Objectives: Venous access ports have become essential devices for the
management of chronically ill patients. Port-related bacteremia (PRB) is a
serious complication; in these cases the general approach is to remove the
port. There are limited data concerning the efﬁcacy of antibiotic treatment of
PRB without port removal. We analyzed the outcome of 50 PRB treated
with antibiotic lock therapy (ALT) plus systemic antibiotics.
Methods: Fifty episodes of PRB occurred in 45 patients (cases of S. aureus or
yeast infections were excluded because ports were routinely removed to
prevent more serious complications). There were no signs of pocket infection
in any case. Paired quantitative blood cultures were obtained to diagnose
PRB. Several solution locks were used: vancomycin (2mg/mL) in 27 cases,
teicoplanin (10mg/mL) in 10, cefazolin (10mg/mL) in three, vancomycin
(2mg/mL) plus gentamicin (2mg/mL) in two, gentamicin (2mg/mL) in one,
levoﬂoxacin (5mg/mL) in one and trimethoprim-sulfamethoxazole (4/
76mg/mL) in one. Sodium heparin was added to these solutions except
in the case of levoﬂoxacin, in which macroscopic precipitation was noted.
Antibiotic locks were instilled daily into the port and were allowed to dwell
for 8–24 h. The mean duration of ALTwas 11.68 days (range 3–21 days). All
the patients received a variable cycle of systemic antibiotics according to the
clinical course. Ports were removed when fever persisted beyond 3 days of
therapy or in the event of persistent relapses.
Results: Etiologies included coagulase negative staphylococci (37 isolates),
Corynebacterium spp. (5), Propionibacterium acnes (3), Enterococcus faecium (2),
Pseudomonas mendocina (1), Ralstonia pickettii (1) and Enterobacter cloacae (1). No
Characteristic Recurrent infection Non-recurrent Total
No. 25 48 73
Age 45.8 16.2 47.7 16.1
Gender, male 13 30 43
Diagnosis
Burn 10 9 19
Malignancy 1 4 5
Transplant 0 5 5
Trauma 2 6 8
Type of catheter
Multilumen 21 30 51
Hemodialysis 1 3 4
Peripherally inserted CVC 2 2 4
Hickman 2 7 9
Central Venous ports 0 2 2
Other 0 4 4
Organism
Coagulase-negative staphylococcus 15 15 30
Staphylococcus aureus 6 17 23
Enterococcus 2 6 8
Pseudomonas aeruginosa 1 4 5
Other Gram-negative organisms 1 3 4
Candida species 0 3 3
Time intervals (day)
Catheter insertion to CR-BSI 19.4 42.5 20.9 49.1
CR-BSI to catheter removal 1.3 1.8 1.8 1.8
Catheter removal to reinsertion 0.5 1.5 0.2 0.8
Reinsertion to reinfection 12.1 10.4
Guide-wire exchange of catheter 8 12 20
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serious complications occurred during ALT. Two ports were removed within
72 h after the end of treatment because of relapsing bacteremia. There was a
response to ALT (defervescence and control negative blood cultures after the
end of the treatment) in 44 (88%) episodes, and in the remaining four cases
there was a relapse of the bacteremia. In all the relapses a second course of ALT
was administered; infection was cured in one case and port was removed in
three cases.
Conclusions: An attempt to treat PRB with ALT plus antibiotics, without
port removal, is reasonable if the patient is clinically stable and has no signs of
sepsis syndrome.
P420 Clinical features and management of cardiac
device infections
M. Sanz, A. Ferna´ndez Cruz
Madrid, E
Objective: To review clinical and microbiological features of infected cardiac
devices (CD) (pacemakers and automatic implantable deﬁbrilator), diagnostic
procedures and therapy and follow-up.
Methods:All medical records of patients admitted to Hospital de La Zarzuela
with infected cardiac devices between January 98 and December 02 were
reviewed in a protocolized manner. We considered a CD was infected if there
was: (i) purulent drainage of generator pocket; (ii) a positive culture of the
generator pocket; (iii) persistent bacteriemia without other obvious source in
a patient with a CD with or without local inﬂammatory signs.
Results: Five CD infections (four pacemakers and one automatic implantable
deﬁbrilator) were diagnosed in the study period. All patients were male, with
an age range between 53 and 70 years. They had no risk factors for infection,
except one who was diabetic. Only two of the CD were implanted in our
hospital and antibiotic prophylaxis was not administered. Previous manipula-
tion was recorded in two cases, but no local complications preceding infection
were described. Three patients had generator and cables infection and the
remaining two had endocarditis. Blood cultures were positive in three of four
cases. Echocardiogram was performed in every case with positive results in
two cases. All but one had local inﬂammatory signs and fever was present in
80% of patients. The median time to diagnosis was 90 days. In one case
S. aureus was responsible for the infection, in other patient the infection was
caused by Enterococcus spp. and in two cases coagulase-negative staphylococci.
Cultures were negative in the remaining patient. Treatment consisted of
parenteral antibiotics and removal of the entire system except in one case
which was treated only with antibiotics and debridation of generator. One out
of four cases required extracorporeal surgery A pacemaker was reimplanted in
all patients who required removal of the infected one. There were no relapses,
with a median time of follow-up of 765 days.
Conclusion:CD infection is an uncommon but serious clinical problem. Early
diagnosis is important in order to prevent systemic infection and endovascular
dissemination; physicians should always consider this diagnosis in any patient
with a permanent pacemaker or implantable deﬁbrilator with fever or local
signs. Aggressive management with antibiotics and removal of the system is
usually curative. Reinfection of the new implants is unusual.
P421 Adsorption of antibiotics on functionalized
polyurethanes as a strategy to prevent intravascular
catheter-associated infections
I. Francolini, R. Di Rosa, A. Piozzi, W. Marconi, G. Donelli
Rome, I
Objectives: Intravascular catheters are essential for the management of
hospitalized patients, especially those admitted to intensive care units, even
if microbial infections are frequently associated to their use. Microrganisms
adhere to catheter surfaces by forming sessile multicellular communities
encased in a hydrated matrix of polysaccharides and proteins, resulting in
a slimy layer known as bioﬁlm. The mode of microbial growth in bioﬁlm is
linked to the chronic nature of these infections and to their resistance to
systemic antibiotic therapy.
Methods: The present research is focused on the development of in vitro
experimental models to prevent catheter-related infections based on the
adsorption of antibiotic molecules on polyurethanes, the most frequently
employed polymers in catheter fabrication. The four antibiotics tested were
cefamandole nafate, amoxicillin, rifampin and vancomycin. The amount of
the antibiotics adsorbed was determined by UV-VIS spectroscopy while the
kinetics of the antibiotic release from the polymers was studied performing
washings in saline solution. The antibacterial activity of the realized polymer-
antibiotic systems was assessed in vitro by the Kirby Bauer test and by the
optical microscopy observation of the polymeric surfaces.
Results: To ﬁnd out the chemical properties of the polymers optimizing both
the antibiotic adsorption and release, we functionalized polyurethanes with
acidic and basic groups. The presence in the polymer side chain of basic
functional groups able to establish ionic interactions with the acidic groups of
the tested antibiotic molecules resulted to be the better condition for
antibiotic adsorption. As the antibiotic release is concerned, cefamandole
nafate and vancomycin exhibited the strongest drug–surface interaction both
showing a release value of about 15% in 48 h of washing vs. release values for
rifampin and amoxicillin of about 30 and 40%, respectively. As the anti-
bacterial activity is concerned the best results were obtained with cefamandole
and rifampin adsorbed on basic polymers in that an inhibition zone was
detected till 8 days and 8months, respectively.
Conclusions: The satisfactory results obtained open new perspectives to
realize intravascular devices recalcitrant to microbial colonization and provid-
ing long-term protection especially for patients hospitalized for severe dis-
eases.
P422 Prospective evaluation of central line associated
colonization or infection by ﬁve different methods
A. Yinnon, A. Feigin, B. Rudensky, Y. Schlesinger, D. Raveh
Jerusalem, IL
Objective: To test ﬁve different methods to identify line sepsis in real time.
Methods: In a prospective, clinical-microbiological study all central lines (CL)
inserted in our hospital over 6months were included. Routine CL cultures
were obtained daily; if positive, ﬁve methods for detecting bacteremia were
applied: (i) coupled peripheral venipuncture-CL cultures with measurement
of time until positivity, (ii) isolator counts, (iii) acridine orange stain, (iv)
endoluminal brush, and (v) tip culture. Results were correlated with clinical
status pertaining infection.
Results: The study included 78 catheters (35 femoral, 23 subclavian and 20
jugular) from 47 patients, and 321 blood cultures (of which 128, or 40% were
positive). No speciﬁc point in time was found to mark a signiﬁcant change in
the rate of culture growth. There was a non-signiﬁcant trend toward earlier
contamination of femoral lines. A correlation was found between short time
till growth in a blood culture and high colony counts in the isolator of the
same sample. A small ratio of time to growth in the CL culture divided by time
to growth in the peripheral culture correlated with line sepsis. A positive CL
culture led to the drawing of 43 parallel CL-peripheral cultures, the results of
which were classiﬁed as follows: (i) absence of growth of both central and
peripheral cultures suggests transient colonization, not requiring treatment or
line removal (14/43, 33%). (ii) Growth of the peripheral but not the CL
culture indicates true sepsis, unrelated to the line, and the CL needs not to be
removed (2/43, 5%). (iii) Growth of only the central culture after 24 h often
indicates line colonization that may not require removal of the line, but
observation only (8/43, 19%). (iv) Growth of the CL culture <24 h could
suggest either line-associated sepsis or sepsis that is not line-related. Growth of
the peripheral culture set at a signiﬁcant time-interval after the central one
became positive, may indicate line-associated sepsis, mandating removal of the
line (8/43, 19%) or unrelated sepsis (11/43, 26%); however, these data do not
allow for real-time separation and many physicians would remove a CL after a
CL culture from a central-peripheral couple grew positive <12 h.
Conclusion:A positive blood sample, randomly drawn via a CL should lead to
obtainment of a new CL culture, concurrent with at least one peripheral vein
culture, with measurement of time until growth. Implementation of this
approach could prevent unnecessary removal of as many as 24/43 (56%) of
central lines.
P423 Molecular epidemiology of catheter-related sepsis
caused by coagulase-negative staphylococci
M. Mueller-Premru, P. Cernelc
Ljubljana, SI
Objectives: Catheter-related sepsis (CRS) caused by coagulase-negative
staphylococci (CNS) is common in patients with hematologic disease. It
can be conﬁrmed by isolation of bacteria of the same species and of the same
type from peripheral blood and the catheter tip or port or from blood drawn
through the catheter (CVC). Because clinical signs of CRS in these patients
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are usually scarce and it is difﬁcult to differentiate CNS sepsis from blood
culture contamination, we tried to conﬁrm by molecular typing that 14
patients with CNS isolated from peripheral blood and CVC had CRS.
Methods: In 14 patients CNS were isolated from peripheral blood, and in
addition in nine of them from blood drawn through the catheter, in two from
catheter port, and in three from catheter tip (CVC). Bacteria were identiﬁed
and antimicrobial susceptibility to penicillin, oxacillin, erythromycin, clin-
damycin, rifampicin, gentamicin, ciproﬂoxacin, vancomycin and teicoplanin
was determined according to NCCLS. Bacteria were typed by Pulsed Field
Gel Electrophoresis (PFGE).
Results: In all 14 patients CNS isolated from peripheral blood and CVC
belonged to the species S. epidermidis. In all patients isolates from blood were
susceptible to vancomycin and teicoplanin, in one only to oxacillin, in three to
erythromycin and clindamycin, in nine to rifampicin, in three to gentamicin,
in two to ciproﬂoxacin and in none to penicillin. In 13 patients antibiotic
susceptibilities from peripheral blood and CVC isolates matched, and in one
they did not. PFGE patterns of S. epidermidis from peripheral blood and from
CVC matched in 10 patients.
Conclusion: In 10 of 14 patients catheter-related sepsis was conﬁrmed by
identical PFGE patterns of S. epidermidis from blood and CVC. In four
patients, where PFGE patterns were different, there was a possibility of mixed
infection or of blood culture contamination.
P424 Colonization incidence of intravascular catheters
and catheter-related bacteremia
T. Gkioka, C. Tsigalu, A. Grapsa, S. Mela, E. Pita, G. Kampuromiti
Alexandroupolis, GR
Objectives: The aim of this study was to evaluate the rate of catheter-related
bacteremias (CRB) in relation to the incidence of intravascular catheters
colonization (IVC).
Materials and methods: One hundred and forty eight intravascular tips of
catheters were cultured in our laboratory in a period of 2 years (2000–2001)
and also peripheral blood cultures from the same patients (pts). All specimens
of catheters were processed with (i) the ‘roll plate’ semiquantitive method
(Maki technique), (ii) qualitative after incubation in thioglycolate broth and
subcultured in blood agar andMcConkey agar. Blood cultures were incubated
in automated BaCT/Alert System (Biomerieux). Identiﬁcation to species
level was performed by the automated Wider-Difco.
Results: Positive cultures were obtained from 48 (32%) of the 148 pts with
(IVC) of which 30 pts (20%) had also positive blood cultures. Of the isolated
52 microorganisms from the catheter cultures coagulase-negative staphylo-
cocci accounted for 24 (46%), Gram-negative bacilli for 14 (27%), fungi for
ﬁve (10%) and Staphylococcus aureus ﬁve (10%). Less often were isolated other
microorganisms as Corynebacterium spp., Enterococcus spp., etc. (7%). Acineto-
bacter spp. were the most isolated microorganisms (n¼ 9, 17%) followed by
Pseudomonas spp. (n¼ 3, 5%) and Enterobacter spp. (n¼ 2, 4%). In 12 cases (8%)
the same pathogens were isolated from IVC and blood cultures. CNS
represented 58%, fungi 25% and Gram-negative bacilli 17%.
Conclusions:
1. These results indicated that the colonization rate of IVC was (32%)
according to the literature. The CRB rate was found to be 20%.
2. About the bacterial spectra in our patients the predominant pathogens was
CNS followed by Gram-negative bacilli and fungi.
3. It is recommended that blood cultures should be combined with IVC-tips
cultures because bloodstream infection could be caused by different
bacteria than those of colonized IVC.
4. CRBwas uncommon in our experience probably because of extended use
of antibiotics and the right evaluation of the explantation time of the
catheters.
P425 Bioﬁlm forming capacity of neurosurgical
Staphylococcus epidermidis isolates
F. M. Fitzpatrick, H. Humphreys, E. C. Smyth, J. P. O’Gara
Dublin, IRL
Staphylococcus epidermidis is a common cause of prosthetic device-related
infections in the neurosurgical intensive care unit (NICU). Enzymes encoded
by the staphylococcal ica operon synthesize a polysaccharide intercellular
adhesin required for bioﬁlm formation, which represents an important
virulence determinant. The principle objective of this study was to conduct
a genotypic and phenotypic analysis of bioﬁlm forming capacity among
NICU staphylococcal isolates. Nine S. epidermidis isolates were collected
prospectively from CSF and ventricular drain tips in the NICU; ﬁve were
associated with neurosurgical device-related infection and three were
regarded as contaminants. All isolates were methicillin resistant. Using a
PCR assay the majority of isolates (7/9) were found to contain the ica operon.
Bioﬁlm-forming capacity under standard laboratory and stress inducing
conditions was evaluated in an attempt to more accurately reﬂect the role
of the bioﬁlm phenotype in vivo. Under standard laboratory conditions only
one ica-positive isolate was capable of bioﬁlm formation. However, under
stress inducing conditions all seven ica-positive isolates were bioﬁlm positive.
The two isolates in which the ica operon was absent were unable to form
bioﬁlm under any growth condition. NaCl was the most effective bioﬁlm-
promoting stimulus and enhanced bioﬁlm production in six isolates. Using
RT-PCR, the role of ica operon expression in bioﬁlm formation was
demonstrated and revealed a strong correlation between ica operon activation
when isolates were grown at 428C and in NaCl, and enhanced bioﬁlm
formation. However, as individual clinical isolates had differential responses to
the stress inducing conditions examined, the icaR regulatory gene and ica
operon promoter sequence were sequenced to examine if genetic variation
was responsible for the observed differential regulation of bioﬁlm formation.
However, no sequence variation was detected suggesting that a trans acting
factor may contribute to differential regulation of bioﬁlm formation in
individual isolates. These results conﬁrm that the presence of the ica operon
alone is not sufﬁcient for bioﬁlm formation and that regulation of ica operon
expression by local environmental conditions may play a key role in bioﬁlm
associated neurosurgical device-related infections.
Viral disease (not HIV, herpes or hepatitis)
P426 AFP surveillance in Kosova
L. Gashi, N. Ramadani, A. Kalaveshi
Pristina, YU
Purpose: Epidemiological characteristics of poliomyelitis situation in Kosova,
the success of active AFP surveillance, possibilities for stopping circulation of
polio virus by the year 2003 and eradication of the disease by the year 2005.
Methods: Surveillance data, epidemiological assessment by using descriptive
component, the retrospective observation of the phenomenon by time,
reporting data from active AFP surveillance, communicable disease surveil-
lance and Immunization coverage reported in the Department of Epidemiol-
ogy.
Results: Since 1991 through 2002, 54 suspected cases of poliomyelitis have
been registered in the territory of Kosova with two lethal cases. The highest
number of cases was noticed during 1996 (25), with morbidity of 1.16 and
lethality of 4.0. Last 5 years no cases of poliomyelitis have been registered.
Type I, II, III of ‘wild virus’ of polio was isolated in 12 cases. Nine cases were
negative and other threewere not typiﬁed. Last 4 years no case of poliomyelitis
was recorded. During sub-NID in Kosova, which was implemented in six
rounds in the year 1996 in the age-group 0–5 years with polio immunization
were covered 97% of the children, in 1997 (93%) and 1998 (80%). During this
period 80% of the children have been completely covered with immuniza-
tion. Active surveillance of AFP has been undertaken from April 1997
through 2002, 38 AFP cases have been registered. During this period, the
largest number of cases, 11 altogether, was registered in 1998, mostly from
Prishtina region, where in total we have registered 14 AFP cases.
Conclusions:Thanks to high immunization coverage against poliomyelitis no
cases of poliomyelitis have been registered within the last 5 years, it is foreseen
that by the end of year 2003 the transmission of wild polio virus can be
interrupted and the ground set for the eradication of the disease by the year
2005, the goal set up by health authorities in Kosova. To accomplish it, an
active surveillance of polio has been undertaken as well as a vaccination target
established for the next years. It is expected that the percentage of the
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population to be vaccinated will be of 90% in 2002, 90% by 2003 and 95% in
2004.
P427 Rotaviral infections among child inpatients in a
clinic of infectious diseases, Pilsen, Czech Republic. Results
of a longitudinal study, 1986–2001
P. Pazdiora, J. Ta´borska´, M. Svecova´
Pilsen, CZ
Objectives: Rotaviruses are the most frequent etiological agent among
patients with diarrheal diseases. Longitudinal data could be the basis for
the start of vaccination.
Methods: The importance of rotaviruses was analyzed among children’s in-
patients during years 1986–2001. Detected rotaviruses from years 1999–2002
were serotypized with monoclonal antibodies.
Results: In years 1986–2001 were examined 4615 younger children with
gastrointestinal diseases. Rotaviruses were observed among 25.6% patients,
their occurrence changed in different years between 14 and 41%. The
incidence of rotavirus acute gastroenteritis among different age groups was
as follows: children under 7months-15.0%, 7–12months 28.2%, 13–
24months 32.0%, 25–36months 27.7%, older 18.8%. The highest incidence
rate was during March (43.9%), the lowest during November (16.5%).
Among 1162 patients without gastrointestinal symptoms rotaviruses were
detected 52 (4.5%). Nosocomial rotaviral infection was laboratory detected
in 258 of 4410 infants repeatedly examined during the hospitalization (i.e.
5.8%).These infections protracted hospitalization on average by 4 days. G-
serotypization was investigated in 260 stools. The type was detected 185 (i.e.
71.2%).The most frequent serotypes were types G1 and G3 (42, respectively
17%).
Conclusion: The results conﬁrm frequent occurrence of rotaviral infections
among hospitalized chidren. The distribution of serotypes is similar to other
European countries.
Acknowledgement: Grant support: IGA MZ Czech Republic N. 6036–3.
P428 Prevalence of mumps virus antibodies in
population of Poland
W. Janaszek-Seydlitz, B. Bucholc, T. Wysokinska, P. Gorska,
G. Gniadek, J. Slusarczyk
Warsaw, PL
Objective: Mumps is an acute, highly contagious viral disease. Although
mostly causing a mild childhood disease, mumps virus may also affect adults,
among whom complications such as meningitis and orchitis are relatively
common. The annual incidence of mumps in Poland is in range of 100–570
per 100 000 population with epidemic peak every 2–3 years. Till now mumps
vaccination has not been included in national immunization program in
Poland. National decision to implement large-scale mumps vaccination
should be based on sero-epidemiological analyzes. So, before establishing
the mumps vaccination schedule the prevalence of mumps virus antibodies in
population was carried out.
Methods: Anonymized residual serum samples were collected from indivi-
duals at age 1–30 years attending selected hospitals and Public Laboratories
between February and October 2001. Two hundred and thirty samples were
collected from each age group (1–4; 5–9; 10–14; 15–19; 20–24 and 25–
30 years of age), giving a total of 1390 samples. Serum samples were assayed for
mumps-speciﬁc IgG in human serum using a commercially available enzyme-
linked immunosorbent assay kit (Virotech, Germany). Antibody concentra-
tions were expressed in arbitral units per milliliter (VE/mL). Samples with
titers below 9VE/mL were regarded as negative.
Results:The annual incidence of mumps in Poland is in range of 100–570 per
100 000 population with epidemic peak every 2–3 years. The results of
serological survey have indicated the differences in proportion of positive
serum samples according to age. The proportion of positive serum samples
(>11VE/mL) was only 24.1% for children aged 1–4 years; 45.4% for children
aged 5–9 years; 72.5% for age group 10–14 years and over 85% for persons
aged 15–30 years. The age group 1–4 is most vulnerable for mumps infection,
and this is a target group for vaccination.
Conclusion: The high proportion on individuals with negative titers of
speciﬁc mumps IgG antibodies justiﬁes the introduction of mass immuniza-
tion against mumps in Poland. Because Poland has adopted a goal of
elimination indigenous measles by the year 2007, the combination of mumps
with measles and rubella vaccines instead of monovalent measles vaccine for
children aged 13–15months is recommended.
P429 Seroprevalence of Varicella zoster virus antibody
in 2002 in Poland
B. Bucholc, W. Janaszek-Seydlitz, P. Gorska, T. Wysokinska,
G. Gniadek, J. Slusarczyk
Warsaw, PL
Objective: Varicella (chickenpox) is an acute, highly contagious viral disease
with world-wide distribution. Due to its extremely contagious nature,
varicella is experienced by almost every child or young adult. During
1990–93 VZV, infections in Poland about 220 000 cases were reported;
during last 3 years this number decreased and oscillates about 100 000. Of
these, approximately 759–1200 required hospitalization and 2–3 died. VZV
vaccine is not foreseen in current Vaccination Program in Poland. Surveillance
for VZV infection and seroepidemiological studies will be necessary for
evaluation of vaccination efﬁcacy and timing of booster dose. Surveillance of
Herpes Zoster will bring more precise information on extent of VZV
infection
Methods:Seroprevalence study on VZVantibodies in Poland comprised 1048
persons, up to 40 years old. Among them were 559 females and 489 males.
Anonymous serum samples collected from venous blood were obtained from
three hospitals in Warsaw and six other places. For serological testing
commercial test kit was used, Enzyme Immunoassay for the determination
of IgG antibodies to VZV in human serum or plasma0, manufactured by
Hycor (Germany), distributed by Dia Sorin (Italy).
Results:Results of our study are following. The examined sera with anti VZV
antibodies in relation to patients’ age Percentage of positive results was highest
in age group 15 and remained on similar, constant level about 70–80% in older
age groups. Children up to age 15 are weakly protected from VZV infection.
Age group 0–5 is most vulnerable for infection-protective level of anti-VZV
antibodies had maximum 10% of children and this is the target group for
vaccination. In older age groups seroconversion rate grows, but still only 40–
60% of children age 10 had antibodies. Our study displayed no statistically
signiﬁcant differences within age groups between females and males. Dis-
tribution of anti-VZVantibodies among females is as follows: 73% of results
were positive and 27% were negative.
Conclusion: Results of our seroepidemiological studies and experience of
countries vaccinating against VZV indicates that mass vaccination in Poland
would modify epidemiological situation by reduction of chickenpox cases
indicate for necessity of vaccination in Poland.
P430 Link between prevalence of human Papillomavirus
D. infection in the upper respiratory tract of mother and her
child
D. Velyvyte, A. Laiskonis, R. Dumciene, A. Gozdzicka-Jozeﬁak
Kaunas, LIT; Poznan, PL
Objectives: Our aim was to evaluate the link between prevalence of human
papillomavirus (HPV) infection in the upper respiratory tract of mothers and
their children.
Methods: The group of random selected 110 children (47 girls and 63 boys,
mean age, 2.7 years, range, 1–8 years) were treated for upper respiratory tract
infections in the Kaunas Clinical Hospital of Infectious Diseases, and these
children’s mothers (mean age, 27.2 years, range, 19–43 years) were examined.
Routine laryngological examination was performed. Pharyngeal swabs of all
persons were taken and analyzed for the presence of HPV DNA. Polymerase
chain reaction (PCR) was performed as described by Tucker et al.
Results: HPV infection was detected in 48.18% (53/110) of children. HPV
DNAwas determinate in nearly one third (35/110, 31.82%) of mothers. HPV
infection was established in children of HPV positive mothers in almost all
cases (94.29%, P< 0.001). Mostly viral types identiﬁed in HPV positive
mothers coincided with viral types identiﬁed in their children (in 57.58% of
cases). In 24.24% of cases viral types were only partly coincident. There were
identiﬁed only low-risk HPV types 6 and 11 in children and low-risk HPV
types 6 and 11 with high-risk HPV type 16 in their mothers in all partly
coincident cases. There were identiﬁed different HPV types in 18.18% of
cases of HPV positive mothers and their children. There were identiﬁed only
high-risk HPV-16 in mothers and only low-risk HPVs (type 6 and 11) in
children in all above-mentioned conﬂicting cases of detected viral types. In
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order to make certain that HPV infection of the upper respiratory tract can be
prognosed for child if his mother has HPVs in her upper respiratory tract, a
correlation test was carried out. It was established that odds ration of HPV
infection of the upper respiratory tract for child increases 45.3 times, when his
mother has HPVs in her upper respiratory tract. Probability, that child will
have HPV when his mother has HPV, is 0.94.
Conclusions: HPV persistence in the upper respiratory tract of mother is a
signiﬁcant important factor, allowed to make the prognosis of HPV infection
of the upper respiratory tract for her child.
P431 A survey of Crimean-Congo hemorrhagic fever in
Iran
S. Chinikar, R. Mirahmadi, V. Mazaheri, P. Nabeth, M. F. Saron
Tehran, IR; Dakar, SN
Objectives: Crimean-Congo Hemorrhagic Fever (CCHF) is a zoonotic
arboviral disease caused by a virus of Nairovirus genus (Bunyaviridae) and
is transmitted by tick bite and nosocomially. After an epidemic of Viral
Hemorrhagic Fever (VHF) in 2000 in Iran in a survey from 2000 to 2002 by
the lab of arbovirus of the Pasteur institue of Iran with collaboration of the
WHO reference center (Pasteur institue of Dakar), we tested 450 suspected
patient sera for CCHF and some other VHFs like Yellow Fever (YF), Rift
Valley Fever (RVF) and Dengue2 (D2).
Methods:We have tested the sera by speciﬁc ELISA method for IgM and IgG
detection against CCHF, YF, RVF, and D2 and also by RT-PCR technique for
detection a fragment in the small segment of the CCHF virus genome.
Results:CCHF results, the results show between 450 suspected cases, there is
178 IgM positive cases (39.55%), 166 IgG positive (36.8%) and 31 RT-PCR
positive cases most of the IgM positive cases (conﬁrmed cases) are from the
south-east of Iran (neighbourhood of Afghanistan).
The numbers of suspected and conﬁrmed cases according to the years are as
follow: 2000:56 suspected, 20 conﬁrmed, 4 deaths; 2001:166 suspected, 61
conﬁrmed, 7 deaths; 2002: 228 suspected, 97 conﬁrmed, 7deaths; 70% of
patients were male and 30% female
All conﬁrmed cases had the three main clinical signs of CCHF disease, like:
fever hemorrhages and thrombocytopenia. Between conﬁrmed cases 35%
were farmers and butchers. Note: All sera were negative for YF, D2 and RVF.
Conclusion:Our results show CCHF is the main etiological cause of VHFs in
Iran. Because the viremia period is very short in CCHF patients we found a
few RT-PCR positive samples, therefore analysis of the humoral response
(IgM and IgG) is the best way of detection. The increase in the number of
patients in these 3 years, could be due to a rising incidence of the disease in
Iran, or as a result of improved case ﬁnding by physicians and also due to
progress in the diagnostic methods in our lab.
P432 Outbreak of measles in Kaunas, Lithuania
A. Laisˇkonis
Kaunas, LIT
The aim of the study: to investigate the epidemiological and clinical data of
measles infection in adults during the measles outbreak in Kaunas in year
2002.
Materials and methods: Prospective analysis of 34 measles cases in adults,
treated at Kaunas hospital of infectious diseases from February through May,
2002. Diagnosis of measles was conﬁrmed by detection of IgM antibodies
against measles virus in serum.
Results: An outbreak started with a cluster of four cases during the second
decade of February. The index case traveled to Poland within 3weeks before
the onset of disease. The median age of measles cases was 25 years (range, 17–
36 years). Twenty-ﬁve (74%) of patients were females. Two out of 34 (6%)
patients had received a single dose of vaccine against measles, in 32/34 (94%)
patients the vaccination history was not known. In four cases nosocomial
transmission of measles to hospital staff has been established. Complications of
measles were observed in 14/34 (41%) of cases. Most common complication
of measles was pneumonia in 8/34 (24%) cases. Otitis media and tonsillitis
were diagnosed for 2/34 (6%) cases each, meningoencephalitis and sinusitis for
1/34 (3%) cases each, respectively. No mortality due to measles was observed
during the study period. In all but one case diagnosis of measles was conﬁrmed
by detection of IgM antibodies against measles virus in serum. In one case
diagnosis was based by typical clinical picture and contact within 3weeks with
a person with laboratory conﬁrmed infection.
Conclusion: Measles in adults is important infection due to high rate of
complications. Efforts should be made towards extension of vaccination
against measles for young adults.
P433 Hepatitis in hemorrhagic fever with renal
syndrome
D. Cengic, N. Koluder, S. Mehanic, E. Cengic, N. Bajramovic,
M. Hadzovic
Sarajevo, BIH
Background: Bosnia and Herzegovina is endemic area for hemorrhagic fever
with renal syndroma (HFRS) caused with virus from Hantaan group. The
Hantaviruses are viral species in the Bunyaviridae family of viruses. Until now
few species as Fojnica I, II and III and Sarajevo, have been isolated in our
patients.
Objective: To point out to hepatotropic potential of Hantaan virus.
Methods: During 2002, 20 hospitalized patients due to hemorrhagic fever
with renal syndrome (HFRS) were enrolled. Diagnosis was etiologically
conﬁrmed by enzyme-linked immunosorbent assay (ELISA), with detection
of antihantaviral-speciﬁc immunoglobulin M (IgM). Three patients out of 20
came from urban centers and rest of them (17) were from rural areas. The
patients were ranged in age from 10 to 63 years with average age of 31; four
were female and 16 were male. The patients with previous hepatic diseases
were excluded at the beginning.
Results: On admission to the hospital, 18 patients out of 20 had elevated
concentrations of liver transaminases. At the beginning the values of these
enzymes were modest. During the progression these values were growing
with no correlation with level of azotemia. The levels of liver transaminases
declined to average values, till the end of ﬁrst month. Modest elevation of
bilirubin was found in just three patients. The enlargement of liver observed
by ultrasonography, were found in total number of patients. One patient died
due to hemorrhagic shock caused by excessive ﬁbrinolysis in terminal phase of
renal insufﬁciency. For other patients ﬁnal outcome was complete recovery.
Conclusion: Since 18 out of 20 patients had veriﬁed hepatitis, Hantaan virus
with its possible hepatotropic effect can complicate in addition clinical picture
and prognosis of this severe type of hemorrhagic fever.
P434 Unusual presentation of an acute common
Epstein-Barr virus infection
L. Gofﬁn, B. Lukusa, J.-C. Maquet, S. Malekzadeh Milani,
C. Fonteyne, C. Devalck, A. Vergison
Brussels, Mons, B
The spectrum of infections associated with Epstein-Barr Virus (EBV) ranges
from self-limited mononucleosis in normal hosts to progressive infections in
patients with disorders of immunity. We describe the case of a 2 1/2-year-old-
boy with a 4-day history of high fever, maculo-papular rash with petechiae
and upper respiratory tract infection. Twenty-four hours before admission, he
developed an important edema of the lower limbs. On admission, the child
was pale with generalized edema and ﬂorid petechial cutaneous rash including
palms and soles. At physical examination, generalized lymphadenopathy and
ﬁrm hepatosplenomegaly were also noted. Blood analysis showed marked
pancytopenia, high C-reactive protein, low serum albumin and biological
signs of dehydration. EBV speciﬁc IgM were increased in the absence of IgG.
EBV blood antigenemia was very high (100.000 copies/mL). Lymphocyte
population and immunoglobulin levels were normal. Initially, the severity of
this EBV disease suggested the diagnosis of hemophagocytic lymphohistio-
cytosis; prolonged high fever, pancytopenia and hypertriglyceridemia were
present but myelogram was normal and didn’t demonstrate any sign of
erythrophagocytosis. Clinical course was marked by an increasing hepato-
megaly (reaching 15 cm below the costal margin), without any liver failure.
Evolution was otherwise spontaneously rapidly favorable. At discharge,
pancytopenia had resolved and EBV antigenemia had fallen to
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35 000 copies/mL. This child presented an unusual dramatic form of acute
EBV infection in the absence of any predisposing factor.
P435 Detection of Epstein-Barr virus genes in
aggressive non-Hodgkin’s lymphoma using polymerase
chain reaction
N. Abu-Khadr
Alexandria, EGY
Epstein-Barr virus (EBV) has been found as an asymptomatic infection in all
human communities. It is associated with many lymphoid neoplasms. In vitro
studies showed that activation of EBV latent genes protect human lympho-
cytes from apoptotic cell death. The frequent association of EBV sequences
with many lymphoid malignancies raises the hypothesis that EBV has a direct
role in lymphomagenesis. Egypt is a North African country that differs
markedly from equatorial Africa both ethnically and environmentally. The
aim of the present work was to determine the frequency of EBV infection in
NHLs in Egypt and whether viral infection contributed to clonal expansion
and malignant transformation or not. Also to study the frequency of EBV
subtypes in order to identify the pattern of Egyptian NHL whether endemic
or sporadic. As well as to investigate the correlation of bcl-2 expression with
that of the latent EBV gene. Forty retrospective cases of Non-Hodgkin’s
Lymphoma (NHL) were classiﬁed as follows: 15 cases large cell lymphoma, 15
cases Burkitt’s lymphoma (BL), 10 cases lympholastic lymphoma. Ten cases of
reactive follicular hyperplasia (non neoplastic) as control. All cases were
analyzed by PCR assay for the presence or absence of multiple EBV genotypes
(EBNA-3C), and clones (LYDMA gene). Bcl-2 immunohistochemical study
was performed to clarify the correlation of bcl-2 expression with the latent
EBV gene. Our ﬁndings revealed hat EBV was detected in 34 cases of
aggressive NHLs, all cases were found to be polyclonal by LYDMM gene,
PCR assay was of type 2 EBV. For control cases, all were positive for
polyclonal EBV type 2. Large cell lymphoma, BL and lymphoblastic lym-
phoma were 80%, 87% and 90% positive for EBV, respectively. As regards the
immunohistochemical ﬁndings it was found that 67.5% were positive by
immunoistaining for bcl-2 while 32.5%were negative. From the positive cases
87% were large cell lymphoma, 56% were BL, and 50% were lymphoblastic
lymphoma. All the control cases were negative for bcl-2. It is concluded from
the present study that a signiﬁcant correlation exists between the expression of
bcl-2 and HBV infection as well as the different histologic grades of NHLs. It
seems that the tumorogenic role of EBV is doubtful. It does not precede to
development of tumor, possibly it has occurred after clonal expansion.
P436 Detection of human Papillomavirus and
Epstein-Barr virus in tumors of head and neck region using
polymerase chain reaction
N. Abu-Khadr
Alexandria, EGY
Fifty cases of head and neck (NH) tumors were included in this study. Biopsies
included 10 nasopharyngeal carcinoma (NPC), two laryngeal polyps, nine
squamous cell carcinomas (SCCs) of the larynx, one adenocarcinoma of
paransal sinuses (sinonasal carcinoma), four carcinomas of salivary glands, one
anaplastic carcinoma of thyroid gland, three SCCs of the lip, four SCCs of the
tongue, two ﬁbroepithelial polyps of the tongue, four facial skin carcinomas
and 10 metastatic SCCs of cervical lymph nodes (LN) (of unknown primary).
PCR assay was used to detect Epstein-Barr Virus (EBV) nuclear antigen 1
(EBNA-1) gene to detect the presence of EBV. In order to determine the
clonality of EBV in the EBNA-1 positive cases, primers speciﬁc for LYDMA
gene were used. Primers directed against the EBNA-3C gene were used to
differentiate between type 1 and type 2 EBV strains. PCR using general
primers targeting the HBV L1 region and HBV 16 E6A1 B/E6A2 speciﬁc
for the E6 open reading frameswere used for screening human papilloma virus
(HPV) DNA and detecting HPV 16, respectively. Genomic EBV EBNA-1
was detected by PCR in 30 of 50 (60%) head and neck (HN) tumors. Using
LYDMA gene PCR assay, 12 of the previous positive tumors (40%) were
monoclonal indicating that EBV was the rate-limiting step in carcinogenesis.
All of NPCs were positive for EBV EBNA-1 and were all monoclonal. In
addition one of nine cancer larynx and one of the cancer lip were proved to be
monoclonal. For the human papillomavirus (HPV), 8 (16%) of 50 HN tumors
were positive usingHPV genral primers in assay (GPs). Seven (87.5%) of those
positive tumors were PCR positive for the highly oncogenic HPV 16 DNA.
Positive tumors were NPC (10%), SCC of larynx (22.5%), sinonasal carci-
noma (100%) SCC of lip (33.3%), SCC of tongue (25%) and one (10%)
metastatic SCC of cervical LN. Coexistence of EBV-DNA (monoclonal for
LYDMA gene) and HPV-type 16-DNA was observed in two tumors in our
study (one was nasopharyngeal carcinoma and the other was SCC of lip).
Results of our study concluded that EBV (type 2 strain) and HPV-16 play an
important role in carcinogenesis and are associated with a far greater spectrum
of HN tumors than expected. PCR is recommended as a useful and reliable
method for detection of EBV and HPV-DNAs within the tumor cells. Also
our results indicate that when performing PCR assay for HPV-DNA in HN
tumors, it is enough to use only the set of GPs.
P437 Experimental oral coxsakievirus B4 infection of
mice
S. Bopegamage, M. Stara, A. Vargova, A. Petrovicova,
M. Benkovicova, P. Gomolcak, J. Kazar
Bratislava, SK
Objectives: Mice infected intraperitoneally have been widely used to study
the pathogenesis of coxsackieviruses (CV). Since under natural conditions
enteroviruses infect their hosts via the gastrointestinal tract, the interaction of
the virus with the gut-associated lymphoid tissue may inﬂuence the course of
infection.
Methods: The viral kinetics and histopathological changes were followed in
different organs after the oral gavage of immunocompetent Swiss albino mice
(strain ICR) with CVB4. For location of viral antigen in the small intestine,
immunohistochemistry was employed.
Results: In the acute stage of infection the virus replication was observed in
the heart, spleen, thymus, pancreas, small and large intestines. Infection was
accompanied by viremia and by histological evidence of myocarditis but
absence of the changes in the exocrine and endocrine pancreas. A longitudinal
presence of the infectious virus was shown in the spleen and in the small
intestines (till day 52 p.i.). The viral antigen was located in the smooth muscles
of the muscular wall of the small intestine by immunohistochemistry. Though
mild myocarditits was observed as early as on day 10 p.i., necrotic changes in
the myocard with mononuclear inﬁltration and ﬁbrosis were demonstrated on
day 71 p.i.
Conclusions: The oral route of infection provides an excellent model for
studying the pathogenesis of CVB infections.
P438 The efﬁcacy of oral Ribavirin in the treatment of
81 proved cases of Crimean-Congo hemorrhagic fever
in Iran
M. Mardani
Tehran, IR
Crimean-Congo Hemorrhagic fever (CCHF) is a lethal hemorrhagic fever
caused by a tick-borne virus. There are few reports on the efﬁcacy of oral
ribavirin in the treatment of CCHF patients. This study was designed as a
historical cohort with 187 clinically suspected cases since June 1999 to the end
of September 2001. Only 139 of 187 suspected cases were treated with oral
ribavirin based on the availability of the drug. Eighty-one of 187 cases were
serologically conﬁrmed to have the disease. The two groups (treated and
nontreated) were compared for the incidence of outcome (Survival). Ninety-
seven (69.8%) of 139 suspected treated cases and 61 (88.4%) of 69 conﬁrmed
treated cases were survived. Based on this study, the efﬁcacy of oral ribavirin is
measured equal to 80 and 34% in conﬁrmed and suspected groups, respec-
tively. We conclude that oral ribavirin is an effective treatment for hemor-
rhagic form of CCHF patients. We should be aware of the limitations of
observational studies. However, there is no Randomized Control trial in the
literature, and it can not be performed in future due to medical ethics.
Therefore the results of this study could provide a valuable information in
deciding how to treat CHF patients.
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P439 Evaluation of a new automated assay for the
detection of HBs antigen on the VIDAS analyzer
B. Weber, F. Simon, M. Gueudin, J. Ritter, P. Volle, M. Lesenechal
Junglinster, LUX; Rouen, Lyon, Bois Guillaume, Marcy l’Etoile, F
Objective: The detection of HBsAg is used as the ﬁrst-line diagnostic test for
hepatitis B virus infection. It is also used for the follow-up of chronic carriers.
VIDAS HBsAg Ultra is a new assay for the qualitative detection of hepatitis B
surface antigen on the VIDAS analyzer using the ELFA technique. This study
was performed to determine the sensitivity and speciﬁcity of this new assay.
Methods: Fresh samples were tested in parallel with the VIDAS HBsAg Ultra
and ABBOTT AxSym HBsAg (V2) assays during a multicenter study
performed in France in 2002. The VIDAS HBsAg Ultra assay is easy to
use and can be run in 60 or 90min (short and long protocol). The SPR, which
is the solid phase receptacle is coated with two monoclonal anti-HBs
antibodies selected for their binding capacity towards wild type as well as
modiﬁed HBs antigen. After incubation and washing steps, the sandwich
complexes are detected by the substrate (4-methyl-umbelliferyl phosphate),
giving a ﬂuorescence signal proportional to the concentration of antigen
present in the sample. The tested population was determined according to the
common technical speciﬁcities requested for the CE marked registration. For
the sensitivity determination, the population combined 400 positive speci-
mens including subtype consideration and 20 seroconversion panels. The
analytical sensitivity was assessed for the VIDAS HBsAg Ultra assay using the
French standard (ng/mL), as well as the two standards from the National
Institute for Biological Standards and Control (IU/mL). For the speciﬁcity
determination, 5000 unselected donors, 200 hospitalized patients and 100
potentially cross-reacting blood-specimens were tested.
Results: The analytical sensitivity was found to be 0.12 ng/mL and 0.08 ng/
mL using the short and the long protocol, respectively. The speciﬁcity was
determined as being 100%. This study provides data comparing the clinical
speciﬁcity and sensitivity of the VIDAS HBsAg Ultra assay vs. the ABBOTT
AxSym HBsAg assay by using seroconversion’s panels, panels from the
Etablissement Franc¸ais du Sang and also serum samples from patients with
chronic and acute hepatitis B.
Conclusion: These results demonstrate that the VIDAS HBsAg Ultra assay
combines a high sensitivity and speciﬁcity with the advantages of a rapid and
reliable fully automated immunoanalyzer.
P440 Determination of hepatitis B virus (HBV) and
genotype D with simple PCR
C. Eroglu, H. Leblebicioglu, M. Gunaydin, D. Turan, M. Sunbul,
S. Esen, A. Sanic
Samsun, TR
Objectives:Different HBV genotypes have shown characteristic geographical
distributions, which is important epidemiologically. HBV strains have been
classiﬁed into eight different genotypes, of which genotype D is prevalent in
Turkish population.
Methods: HBV genotype D shows a 33-bp deletion in pre-S1 region that
explains their smaller genomic size (3182 bp). This deletion facilitates the
identiﬁcation of genotype D. For discrimination of genotype D from other
genotypes with PCR a pair of primers in pre-S1 region was designed.
Genotype D easily could be differentiated from other genotypes with using
size of PCR products such as 79 and 112 bp in with genotype D and A,
respectively, in agarose gel electrophoresis.
Results: Forty-four sera which were identiﬁed as genotype D (n¼ 40) and
genotype A (n¼ 4) with restriction fragment length polymorphism (RFLP)
method were included in this study. With using this PCR method, the
genotypes were correctly identiﬁed and also it this test was able to detect HBV
DNA at 1000 genomes/mL.
Conclusions: In conclusion, this method is quick (5 h) and it will contribute
to epidemiological study of HBV in high-prevalence area of genotype D
also it simultaneously can determine genotype D and HBV DNA
positivity.
P441 Prevalence of hepatitis B infection in Bandar
Abbas, Iran
S. Zare, M. Rajaei, G. Farshidfar
Bandar Abbas, IR
Objectives: Early diagnosis of sexually transmitted diseases such as Hepatitis B
is critical for maternal and infant health. The objective of this study was to
estimate the prevalence and the risk factors of hepatitis B virus (HBV)
infection in pregnant women in Bandar Abbas, south of Iran
Methods:A cluster sampling method with a sample size 540 pregnant women
attending antenatal clinics at the university hospital of Bandar Abbas between
March 2001 and February 2002 was used. Sera from all samples were assayed
for hepatitis B surface antigen (HBsAg) by a commercial enzyme linked
immunosorbent assay kit. A questionnaire, including demographic details of
all sample units such as age, occupation, jaundice or hepatitis history,
remarriage history, transfusion history, parity, history of treated for sexually
transmitted diseases (STD) was completed for each sample unit.
Results: Prevalence of hepatitis B virus in pregnant women was estimated as
2.2% (95% CI: 1–3.5%). One infected case with jaundice history and another
case with hepatitis B history was found. The results revealed an inverse
relationship between the infection and education level (relative risk for low
level education¼ 2.21; 95% CI: 1.3–5.4; P< 0.05) but no statistical associa-
tion was found between hepatitis B infection and age, parity, history of
previous treated STDs, anemia, blood transfusion, jaundice history and
remarriage history (P> 0.05).
Conclusion:Based on these preliminary results, HBsAg test as a routine test for
hepatitis B infection in the area’s population is recommended.
P442 Two-year study of hepatitis B infection prevalence
in a major Greek hospital
V. Karabassi, M. Pouyiouka, C. Petrochilou, A. Tsiriga, K. Kotoula,
C. Kontou-Castellanou
Athens, GR
Objectives: The purpose of this study was to perform a serological analysis of
hepatitis B virus (HBV) infection prevalence in the patients of a Greek major
hospital within a 2-year period.
Methods: During the two last years 2001–2002, sera from 12 632 patients
(10 472 in-patients and 2160 out-patients), were tested for the detection of
HBV markers. There were two groups of patients, Group A: 4052 patients
(2996 in-patients, 1056 out-patients) who were controlled for HBV surface
antigen (HBsAg) and Group B: 8580 patients (7476 in-patients and 1104 out-
patients) who were controlled for the HBV markers: HBsAg, HBeAg, anti-
HBe, anti-HBcore, anti-HBs. All tests were performed by MEIA methodol-
ogy (AXSYM-ABBOTT).
Results: In Group A of the 2996 in-patients and 1056 out-patients were found
to be positive for HBsAg 60 (2%) and 33 (3.1%), respectively. In Group B of
the 7476 in-patients and 1104 out-patients were, respectively: 3488
(46.7%)488 (44.2%) seronegative for HBV markers, 488 (6.5%)138
(12.5%) positive for HBsAg, 1184 (15.8%)69 (6.3%) positive for anti-
HBs due to HBV vaccination, 2316 (31%)409 (37%) negative for HBsAg
and positive for the rest HBV markers. Of the 488 in-patients and 138 out-
patients with positive HBsAg were found to be positive, respectively, for HBV
markers: 392 (80%)123 (89%) for HBsAg–anti-Hbcore–anti-HBe, 40
(8.2%)15 (11%) for HBsAg–anti-HBcore. Of the 2316 in-patients and
409 out-patients with negative HBsAg and positive the rest HBV markers
were, respectively, positive: 880 (38%)139 (34%) for anti-HBs–anti-HBe–
anti-HBcore, 888 (38.3%)99 (24.2%) for anti-HBs–anti-HBcore, 340
(14.7%)75 (18.4%)for anti-HBcore, 208 (9%)96 (23.4%) for anti-
HBcore–anti-HBe.
Conclusions:This study showed that there is a signiﬁcant prevalence of HBV
infection in the patients of our hospital (37.5% for in-patients, 49.5% for out-
patients). The effort for the prevention must be continual and the control
measures with the systematic hepatitis B vaccination should be strictly
enforced.
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P443 A review of hepatitis B transmission in an
organized registry center, Tehran, Iran
A. Hekmatdoost, H. Mohaghegh Shalmani, M. R. Zali
Tehran, IR
Objectives:Hepatitis B viral (HBV) infection is a worldwide disease. HBV is
mainly parentally transmitted via blood and blood products or by sexual or
prenatal exposure. In this study, we examined the routes of HBV transmission
among the patients who were referred to our center.
Methods: A case-series study was conducted in patients who were seropo-
sitive for hepatitis B surface antigen (HbsAg) in Taleghani Hospital, Tehran,
Iran, during July 2001 to July 2002.
Results: A total 260 patients (173 males, 87 females) were studied with mean
age of 39.9 14.9 years and a range of 9–98 years. Possible routes for HBV
transmission were: family history of HBV infection (23.4%), history of major
surgery (15.3%), history of transfusion (13.4%), shared shaving razors (10.4%),
cupping (8.8%), tattooing (8.4%), history of HBV in mother (6.5%), history of
HBV in spouse (4.2%), suspicious sexual contact (3.8%), intravenous drug
abuser (2.6%) and the history of dialysis (0.3%). A total of 35.7% of cases
seemed to have no risk factor.
Conclusion: According to our results, HBV transmission in Iran is similar to
other countries with moderate prevalence. In our study, many of the patients
did not express any risk factor. So, the education can help to prevent spreading
of the virus.
P444 Prevalence of HBsAg in Albanian blood donors
V. Durro, Z. Abazaj, I. Qendro, M. Mero, L. Fuga, V. Spahiu,
A. Shamku, E. Korkuti
Tirana, AL
Background: In order to complete the national epidemiological data collected
each year in Albanian blood donor population, a national prospective study
has been undertaken since 2000 to determine the prevalence of HBsAg in
blood donors.
Material andmethod: In this study are tested 18 876 donors. From them 9.4%
(1781 donors) have been voluntary donors (VDs), 31.2% (5890) family
replacement donors (FDs), 58.2% (10 990) regular donors (RDs) and
1.13% (215) ﬁrst time donors (FTDs). The sample are tested in NBTS for
HBsAg by ELISA method (ABBOTT third generation). The data are
collected from individual sheet. Chi-square and Z-tests are used for statistical
analysis.
The result: The prevalence of HBsAg in blood donors is 3.4%. In voluntary
donors the HBsAg prevalence is 7.5%, FDs 8%, RDs 0.2% and FTDs 9.8%.
Over the 3-year periods in voluntary donors the HBsAg prevalence ranged
from 4.5 to 8.5%, in family replacement donors from 7.9 to 8.2%, in regular
donors from 0 to 0.4% and ﬁrst time donors from 3.2 to 14.2%. We observed
that the HBsAg prevalence has a decline tendency both in VDs (8.5–4.5%)
and RDs (0.4–0%) and a increasing tendency in FDs (7.9–8.2%) and FTDs
(3.2–14.2%). According to sex the HBsAg prevalence in men is 9.4% and
women 3.8%. Over the 3-year periods the prevalence in men has a decline
tendency (9.8–8.5%) and increasing tendency in women (2.5–5.2%). Accord-
ing to age group, the HBsAg is 10.5% in 30–39 age group, 8.8% in 17–29 age
group, 5.8% in 40–49 age group, 3.5% in 50–60 age group.
Conclusion: The prevalence of anti-HCV is higher in FTDs (9.8%) and FDs
(8%) than VDs (7.5%) and RDs (0.4%). According to sex the prevalence is
higher in men than women. According to age group the prevalence is higher
in 30–39 age group. The higher HBsAg prevalence in blood donors explain
with higher prevalence in general population. The decreasing HBsAg in
blood donors explain with improved blood donors screening and selection
method, and vaccinated of general population for HbsAg since in childhood.
Considering the quality of blood we always recommend for voluntary blood
donations.
P445 Nosocomial acute viral hepatitis in a teaching
hospital of infectious diseases, Romania – results of a 4-year
study (1998–2001) after introducing CDC case deﬁnitions
A. Radulescu, I. Bocsan, D. Carstina, V. Zanc, S. Cocean, L. Lungu,
I. Ghita, R. Florea
Cluj-Napoca, RO
Objectives: To establish the impact of presumed nosocomial acute viral
hepatitis type B, C and non A–C (AVH) in the Cluj-Napoca Teaching
Hospital of Infectious Diseases, after introducing the hepatitis B vaccination in
the National Vaccination Programme (1995) and the conﬁrmatory serological
testing for acute viral hepatitis A, B and C (1998).
Methods: We retrospectively studied all AVH (1916 cases) admitted in the
Cluj-Napoca Hospital of Infectious Diseases between 1998 and 2001. We
designed a database using the medical records comprising of: demographic
data, premorbid conditions, questionnaire about possible nosocomial and
other exposures, bilirubin, SGPT, other biochemical tests, the main serolo-
gical markers for AVH (IgM anti-HAV, IgM anti-HBc, third generation HCV
EIA). EPI6 software was used for statistical analysis.
Results: The incidence rates of AVH type B were signiﬁcantly decreasing
representing 254 cases 13% of all cases, while type C and non A–C AVH
demonstrated an increasing trend with 201 cases – 10.4% of all cases.
Presumed nosocomial hepatitis type B and C represented 30 and 34.8%,
respectively.Major perceivable risks for nosocomial AVH type Bwere surgical
and dental procedures (32 and 29.7%, respectively), with only one docu-
mented post-transfusion AVH. The same major risks were established for
AVH type C (48 and 22%) but with a much higher risk for postransfusional
AVH, eight cases, 11%. AVH type B and C in dialyzed patients occurred in 5.3
and 4.3% of presumed nosocomial cases. No signiﬁcant differences in clinical
manifestations and immediate prognosis were found in comparison with the
community-acquired AVH type B and C.
Conclusions:The WHO eradication project of hepatitis B demonstrates very
good results with only three cases in children, under a good notiﬁcation of
cases (mandatory hospitalization for all AVH). Nosocomial exposures might
be less important than revealed due to an increased perception upon the
hazards represented by medical procedures, still they should be considered.
Post-transfusional AVH type C remains higher than expected probably due to
paid blood donations.
P446 Fibronectin levels in chronic viral hepatitis and
response of this protein to interferon therapy
O¨. Kandemir, G. Polat, E. Ahin, O¨. Bagdatoglu, H. C¸amdeviren,
A. Kaya
Mersin, TR
Objectives: In this study, the plasma ﬁbronectin levels in the cases of chronic
hepatitis B and C infection and this protein’s response to the interferon
therapy were examined.
Methods: Totally, 38 patients of chronic hepatitis, 21 of them being hepatitis
B, 17 of them being hepatitis C; and 24 healthy blood donors, as the control
group, took part in this study. The quantitative determinations of ﬁbronectin
in plasma samples were performed with the Bohring Nephelometer BN 100
(N Antiserum to Human Fibronectin, code no OUND, Dade Behring
Marburg GmbH, Marburg Germany).
Results: It was observed that the ﬁbronectin plasma levels of the control group
were signiﬁcantly higher than those of the patient group before the therapy
(P¼ 0.043). After the interferon therapy of 6months, the difference between
the ﬁbronectin levels of 16 examined patients before and after the treatment
was found signiﬁcant (P¼ 0.001). A negative correlation was detected
between the ﬁbronectin levels before the therapy and the inﬂammatory grade
as far as the histopathology of the illness was concerned (r¼0.49), which is a
statistically signiﬁcant value (P¼ 0.002). The correlation between the levels of
ﬁbronectin and the stage of the ﬁbrosis was found insigniﬁcant statistically
(P¼ 0.225). When comparing the levels before and after the therapy, as far as
ALTand AST values were concerned, it was observed that both parameters fell
signiﬁcantly after the therapy (P¼ 0.002). However, no correlation was
observed between the ﬁbronectin levels and ALT, AST before and after
the therapy. To conclude, ﬁbronectin can be a useful marker for showing the
hepatic inﬂammation and damage in the cases of chronic hepatitis, and can
also be used in the evaluation of the response to the interferon therapy like
other bio-chemical parameters (ALT, protrombin activity, etc.).
P447 Neuropeptidergic control of immune response,
following antiviral treatment, in chronic hepatitis B patients
I. S. Elefsiniotis, I. Magaziotou, I. Glynou, I. Ketikoglou, K. D.
Pantazis, A. Moulakakis, H. Kada, C. Mavrogiannis
Athens, GR
Objectives: Lamivudine is a nucleoside analogue with potent antiviral activity
against hepatitis B virus (HBV). Pituitary adenylate cyclase activating poly-
peptide (PACAP) is a multifunctional neuropeptide, produced within the
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lymphoid microenvironment, inducing the production of Th2-type cyto-
kines. The aim of our study was to investigate the possible alterations of plasma
PACAP-38 levels, in chronic hepatitis B (CHB) patients, during lamivudine
treatment and to compare them with the biochemical, virological and
histological data.
Methods: Plasma PACAP-38 levels were measured in 25 CHB patients,
before the beginning and after the completion of a 52-week lamivudine
treatment period and in 22 healthy blood donors (HD), using competitive
radio-immune analysis (RIA). Statistical evaluation of data was done using
ANOVA and student’s t-test (P< 0.05).
Results: Virological breakthrough (VB) was observed in seven patients (28%)
at week 52 of treatment. Histological improvement was observed in 21 CHB
patients (84%), despite the emergence of YMDDmutations. Plasma PACAP-
38 levels were signiﬁcantly lower in CHB patients at baseline than in HD
(22.62 8.27 pg/mL vs. 65.18 12.61 pg/mL, P< 0.001). Signiﬁcant ele-
vation of plasma peptide levels was observed in CHB patients after the
completion of lamivudine treatment period (22.62 8.27 pg/mL vs.
49.60 16.45 pg/mL, P< 0.001), even in the subgroup of those who
exhibited YMDD variants (21.63 8.57 pg/mL vs. 49.80 15.66 pg/mL,
P¼ 0.006).
Conclusion: The elevation of plasma PACAP-38 levels in treated CHB
patients, following the lamivudine-induced elimination of viremia, suggests
a possible shift to a Th2 immune response, resulting in biochemical and
histological remission of liver disease.
P448 Proﬁle of anti-HBcAg response of Th lymphocytes
in children with acute hepatitis B
A. Szkaradkiewicz, A. Jopek, J. Wysocki
Pozna, PL
Objectives: The study aimed at evaluation of the secretory anti-HBcAg
response of peripheral blood Th lymphocytes in children with acute hepatitis
B.
Methods: The studies included 12 children, aged 10–16 years with acute
hepatitis B. T CD4 lymphocytes were isolated from peripheral blood using
the biomagnetic technique (Dynal) and rHBcAg stimulated cytokine pro-
duction (IFN-gamma, IL-4, IL-2, IL-5 and IL-10) estimated by ELISPOT
assays (Mabtech; R&D Systems) in 24 h cultures. Studies were performed in
the ﬁrst week of disease and during the recovery.
Results: In the studies, two patterns of Th secretory response were detected.
Already in the ﬁrst week of the disease, the in vitro response to rHBcAg
included presence INF-gamma, IL-2, IL-4, IL-5 and IL-10 producing cells,
with prevalence of cells producing Il-2 and IFN-gamma. During recovery the
number of IL-10 producing cells signiﬁcantly increased while the numbers of
cells producing the remaining cytokines demonstrated a signiﬁcant decrease.
Conclusion: The presented results point to the Th1-type speciﬁc cytokine
pattern in the course of acute hepatitis B and the selective prevalence of IL-10
secretion during the recovery.
P449 Subacute liver failure resulting from hepatitis B
virus reactivation after chemotherapy for acute
myeloid leukemia
Z. Ozkurt, M. Ertek, A. Kadanali, S. Erol, M. Parlak
Erzurum, TR
Hepatitis B virus (HBV) reactivation is a well-described complication in
cancer patients who receive cytotoxic chemotherapy and may result in fatal
liver damage. We report a case of a 45-year-old-man with acute myeloid
leukemia (M1) who developed subacute liver failure from reactivation of
HBV after chemotherapy. He was an asymptomatic HBV carrier previously.
Two-month after chemotherapy, he admitted to the hospital with complain of
malaise, anorexia, vomiting, dark urine and icter, and he was hospitalized. On
physical examination icter and hepatomegaly was noted. Laboratory ﬁndings
showed that elevated liver enzyme, very high levels of bilirubine (40mg/dL),
and coagulopathy. HBsAg, anti-HBc and anti-HBe were positive and HBV
DNA by PCR was 1.4 105 copy/mL. In addition to supportive therapy,
lamuvidine 100mg/daily was initiated. In 3-month subacute liver failure
developed ascites and changes of personality was added to clinical picture
despite lamuvidine therapy. This case indicates the importance of HBsAg
screening before chemotherapy, and the need to lamuvidine prophylaxis for
prevent HBV reactivation in HBsAg positive cases. After reactivation of HBV,
unfortunately prognosis may be poor and lamuvidine therapy may be
insufﬁcient.
P450 Fatty liver and viral hepatitis
G. Oracz, P. Socha, M. Pronicki, K. Iwanicka, J. Socha
Warsaw, PL
Objectives: Steatosis is a common histological ﬁnding in liver biopsy,
associated with some metabolic disorders, but it can be also found in other
diseases. The aim of our study was to identify fatty liver in all available liver
biopsies and to ﬁnd associations with viral hepatitis (HBV, HCV).
Methods:We searched liver biopsy database of our Department from 1980 to
2001 (No 3352) for fatty liver (>5% steatosis), and then searched for viral
hepatitis infection. We estimated degree of steatosis (5–33% mild, 33–66%
moderate and >66% severe) and fat deposition (macrovesicular/microvesi-
cular/mixed). Diagnosis, clinical data, treatment, control liver biopsies and
Cole index were recorded and analyzed.
Results:Among 103 pts with fatty liver we identiﬁed 36 children (22 boys, 14
girls, aged 1.1–16.1, mean 7.49 years) with viral hepatitis. Mild steatosis was
found in 24, moderate in ﬁve and severe in seven cases. Histology revealed
macrovesicular steatosis in 17 cases and microvesicular in seven (mixed in 12).
Seven patients were obese (Cole index> 120%). Two cases of Wilson’s
disease and single cases of autoimmune hepatitis and operated craniophar-
yngioma were found. HBV (No 24) was the most common diagnosis.
Seventeen patients were found to have HCV infection. Coinfection
HBV/HVC was observed in four cases. AlAt activity was increased in 28
pts. Only 7 of 32 examined children had abnormal liver sonograms suggestive
of liver steatosis. Both in group of HBV (No 16, 66%) and HCV (No 11,
64.7%) infection the most commonwas mild steatosis. Six children with HBV
had control liver biopsy after ﬁnishing interferon therapy. All of them had
HbeAg seroconversion and had no steatosis in control biopsy.
Conclusions:
1. Our data indicate that HCV as well as HBV infection may be associated
with liver steatosis.
2. Effective treatment of HBV infection can result with disappearing steatosis.
3. There is a limited application of liver ultra sonogram to detect steatosis.
P451 Prevalence of precore mutants in anti-HBe positive
chronic HBV carriers in Babol, Iran 1999–2002
M. R. Hasanjani Roushan
Babol, IR
Objectives: Hepatitis B virus precore mutants are associated with highly
productive infection in Anti-HBeþ chronic HBV carriers. These chronic
HBV carriers are predisposed for developing of active hepatitis. The aim of
this study was determination of the prevalence of precore mutants in chronic
anti-HBeþ HBV carriers in Babol, Iran.
Methods: This prospective study, was conducted on patients with HbsAgþ,
anti-HBeþ chronic HBV carriers, from April 1998 to September 2002. In all
cases, HBV DNA was assayed by PCR. Data were analyzed by SPSS.
Prevalence of precore mutants in males and females was compared by chi-
square test.
Results: Of 257 cases of anti-Hbeþ chronic HBV carriers (mean age SD,
32.3 11.4 years) HBV DNAwas positive in 222 (86.4%) cases. HBV DNA
was positive in 136 (87.2%) of 156 males and 86 (85.1%) of 101 females cases
(P¼ 0.71).
Conclusions:These results show the high prevalence of HBV precore mutants
in Iran.
P452 Histological activity index and its relation to
alanine aminotransferase level in precore mutants chronic
hepatitis B
M. R. Hasanjani Roushan, M. Shefai, E. Shaﬁgh
Babol, IR
Objectives: Elevated level of alanine aminotransferase (ALT) in chronic HBV
carriers is associated with liver damage. The purpose of this study was to assess
the relation between elevated levels of ALTwith liver injuries.
Methods: Liver biopsy samples from 74 cases of anti-HBeþ, HBV DNAþ
individuals with ALT more than 40 IU were studied from September 1999 to
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September 2002. Histological activity Index (HAI) score more than three
with relation to ALT levels both more and less than 1.5 and 2 times of the
upper limit of normal (ULN), were compared with w2 and ﬁsher’s exact tests
separately.
Results: A total of 74 cases (63 males and 11 females) with mean age,
31.3 12 years were studied. HAI< 3, between 3 and 8 and more than 8
were seen in 21.7, 63.6 and 14.7%, respectively. Nineteen cases with ALT
levels less than 1.5 and 55 cases with ALT levels more than 1.5 times of the
ULN, HAI more than 3 was seen in 78.9 and 78.2%, respectively (P¼ 0.6). In
35 cases with ALT levels more than two times of the ULN, HAI more than
three was seen in 74%, but in 49 subjects with ALT levels less than two times of
the ULN, HAI was seen in 65.3% (P¼ 0.29)
Conclusions:Histological evaluation of liver is suggested for all patients with
precore mutants chronic HBV infection with ALT levels more than 40 IU.
P453 Comparative analysis of free and combined
ﬁbronectin contents in acute and chronic hepatitis B
P. Khaykin
Dnipropetrovsk, UKR
Objectives: The aim of the research was carrying out of comparative analysis
of free and combined with circulated immune complexes (CIC) ﬁbronectin
(FN) contents in acute and chronic hepatitis B.
Methods: Fifty-seven patients with acute hepatitis B (group 1), 32 patients
with chronic hepatitis B (group 2) and 30 healthy persons were investigated.
The parameters were determined in plasma at the ﬁrst day of stay in the
hospital and in 1month. Contents of free and combined FNwere determined
using ELISA, FN degradation products – using Western blot with the rabbit
antibodies to FN, level of CIC – using precipitation with 3% PEG 6000.
Results: In acute hepatitis B, the average contents of free FN was higher than
in control group and chronic patients (t¼ 6.93; P< 0001; t¼ 8.63;
P< 0001). Lowering of free FN contents was observed in dynamic
(t¼ 5.23; P< 0001). The level of CIC at the ﬁrst investigation in both
groups exceeded such in a control group (t¼ 6.14; P< 0001; t¼ 5.11;
P< 0005). In acute hepatitis B the lowering of a CIC level (t¼ 3.92,
P< 0.01) was observed. It was determined that concentration of combined
FN was higher in acute hepatitis patients than in control group and chronic
hepatitis (U¼ 83.2; P< 0.05;U¼ 68.3; P< 0.05). We detected products of a
combined FN degradation in the majority of the chronic hepatitis B patients,
in group 1 – less than for half of patients and in control group only in 1/6.
Conclusion:
1. In patients with acute hepatitis B the contents of free and combined FN
increase in the beginning of disease and decrease in the dynamics
simultaneously with a level of CIC;
2. In patients with chronic hepatitis reduced contents of free and combined
FN and degradation of combined FN are observed.
P454 Acute hepatitis due to brucellosis
R. Ozaras, A. D. Celik, A. Mert, F. Tabak, R. Ozturk
Istanbul, TR
Objectives: Brucellosis is an acute or chronic infectious disease involving
several organs. Liver function tests are usually only slightly elevated. Acute
hepatitis due to brucellosis is quite rare. We report two cases of acute hepatitis
due to Brucella infection.
Case 1: A 37-year-old woman, a clinical microbiology laboratory worker,
presented with fever, headache, arthralgia on knee, anorexia, and nausea.
Temperature was 37.58C, pulse 80/min. Physical examination was normal.
WBC 4000/mm3 with 50% lymphocytes, 40% neutrophils, 10% monocytes,
CRP 10.5mg/L (N< 5mg/L), total bilirubin 0.61mg/dL, ALT 552 IU/mL,
AST 473 IU/mL, alkaline phosphatase 352 IU/mL. Prothrombin time was
normal. Anti-HBs was (þ); anti-HCV and anti-HAV IgM were (–). Agglu-
tination tests (Rose Bengal and Wright; 1/1280) were (þ). Brucella sp. was
isolated from blood cultures on the ﬁfth day. Doxycycline and rifampicin were
given for 6weeks. On the day 4, the fever subsided, and on day 15, liver
enzymes returned to normal values.
Case 2: A 20-year-old man was admitted with polyartralgia, difﬁculty in
walking and morning stiffness. He had been ﬁrst treated as ankylozing
spondylitis with corticosteroids and salazopryin. He had responded to the
treatment clinically, the drugs had been tapered and discontinued within
3months. Then fever and diarrhea developed. Three days later, he had been
initiated ciproﬂoxacin but not responded. On admission, temperature was
398C, pulse 80/min. Physical examination was normal. WBC 6000/mm3
with 50% lymphocytes, 40% neutrophils, 10% monocytes, CRP 10.5mg/L,
total bilirubin 0.61mg/dL, direct bilirubin 0.17mg/dL, ALT 392 IU/mL,
AST 328 IU/mL, ALP 232 IU/mL. HBsAg, anti-HBcIgM, anti-HCV and
anti-HAV IgM were (–). Agglutination tests (Rose Bengal and Wright; 1/
1280) were (þ). Brucella sp. was isolated from blood cultures on the ﬁfth day.
Doxycycline and rifampicin were given for 6weeks. The treatment was
interrupted due to drug eruption and diarrhea. After 10 days, rifampisin and
streptomycin were started. Fever subsided within 1week, liver enzymes
returned to normal within 3weeks.
Conclusion: Brucellosis may be presented with elevated liver enzymes and
should be considered in the differential diagnosis of acute hepatitis in the
countries where brucellosis is endemic.
P455 Hepatitis A virus infection in adults
E. Dimitrovska, M. Dimitrovska, D. Ristevska, F. Vuckov,
R. Dimitrovski
Bitola, Skopje, MK
Introduction:Hepatitis A viral infection (HAVi) has a worldwide distribution
and causes clinical disease more frequently in children than adults. The
severity of the disease ranges from subclinical infection, classic clinical
infection, and very rarely to fulminant hepatitis and death. No transition
to chronic active hepatitis is observed, but in more than 15% relapse occurs.
Objectives: The aim of our study is to present our experience with HAVi in
adults and to show that the course of this infection can be severe with
prolonged clinical course and relapsing forms.
Materials and methods: During a period of 5 years, 325 patients with
diagnosis viral hepatitis, were treated in our department. Two hundred ﬁve
patients were with HAVi (63%). Clinical signs and symptoms of liver
disorders, biochemical markers (bilirubin total, ALAT, ASAT, gamma GT,
alkal, phosphatase, ﬁbrinogen, CRP, total proteins) had been analyzed in 46
patients aged 35–70 years. All of the patients presented a serious and long
course of the disease with high levels of bilirubinemia (110–458mmol/L, and
serum increased transaminases activity (ALAT: 10.804–38.098 nKat/L;
ASAT: 5.986–29.831 nKat/L). Signs of cholestasis were present in 19 patients,
acute cholecystitis and choleangitis had been present in 5 patients. Fulminant
form with dead developed in one 23-year-old student. Our patients were
treated from 32 to 45 days in our department. Normalizing of the biochemical
changes was in 70%. One-month later abnormal ALAT and ASAT were
registered in nine patients. Relapse was in two patients with alcohol abuse.
Conclusion:HAVi is a great and signiﬁcant problem in our region. The acute
HAVi in adults is severe and with risk of complications, prolonged clinical
course and relapses.
P456 Sero-epidemiological characteristics of hepatitis A
in the region of Bitola, Macedonia
M. Dimitrovska, E. Dimitrovska, D. Ristevska, R. Dimitrovski
Bitola, Skopje, MK
Objectives: Infection with Hepatitis A virus (HAV), remains a signiﬁcant
health problem worldwide. The aim of our study is to present the seroepi-
demiological characteristics of HAV in our region for the period of 3 years
(1999–2002).
Material and methods: We have analyzed 398 sera, which were obtained
from 211 men and 187 women. They were tested for anti-HAV IgG and anti-
HAV IgM antibodies by ELISA (Abbot-USA). Children under 2 years of age
and blood-transfusion recipients were excluded from the study. According to
the place of living, 152 persons were living in our town, and the other 246
persons were from the surrounding villages.
Results: The persons examined were assigned to two age groups (A) 167
children 2–15 years old, and (B) 231 adults 16–70 years old. In group A 68
(41%) persons were IgG positive and among them 21 (12.5%) were seropo-
Parameters Control group, n¼ 30
Group 1, n¼ 57 Group 2, n¼ 32
1 day In 1month 1 day In 1month
Free FN (mg/mL) 240.7 36.2 421.1 92.8 284.6 52.2 193.8 48.2 186.4 37.4
CIC (mg/mL) 1.52 0.29 2.31 0.36 1.76 0.34 2.19 0.42 2.22 0.31
Combined FN (mg/mL) 0.25 0.09 0.38 0.1 0.29 0.14 0.19 0.09 0.21 0.09
FN degradation products 5/30 22/57 12/57 24/32 26/32
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sitive to IgM antibodies also. In group B 176 (76%) subjects were anti-HAV
IgG positive and only 15 (6.5%) developed acute hepatitis and were IgM
positive.
Conclusions: The high percentage (59%) of children negative for anti-HAV
IgG antibodies coupled with the fact that most of the adults (76%) had
developed protective immunity against HAV suggests that our area has shifted
from high endemic to intermediate-low endemic status for hepatitis A
infection. The great number of susceptible children is a potential risk for
the development of a serious prolonged icteric infection during the adult-
hood. In this context, immunization against HAV might be considered to be
performed during the ﬁrst years of life.
P457 Duration of seropositivity of IgM anti-HAV after
acute viral hepatitis A infection
Z. Kuruu¨zu¨m, O. O¨zgenc¸, A. Havuk, N. Inan, M. Erdenizmenli
Izmir, TR
Viral hepatitis A infection is still a global public health care problem specially
in some certain parts of the world. Like many other countries, this disease,
which is caused by the hepatitis A virus (HAV), is endemic in some regions of
Turkey with poor hygienic conditions. The exact diagnosis of acute hepatitis
A can be made easily by the ﬁnding of IgM anti-HAV, which is necessary for
the diagnosis of acute hepatitis A, in the serum of the patients. It can be
detectable serologically in serum by the time of onset of disease in a patient
with either clinical symptoms or biochemical evidence of the acute hepatitis.
In this prospective study, we have planned to investigate the duration of IgM
anti-HAV seropositivity in patients with acute hepatitis A. The study was
performed at SSK Izmir Teaching Hospital, which is a social security hospital
with 650 beds, between November 1995 andMay 2001. A total number of 68
patients were enrolled in the study who applied to the Department of
Infectious Diseases and Clinical Microbiology, presenting with typical clinical
symptoms and laboratory ﬁndings and whom IgM anti-HAV were detected
for the purpose of exact diagnosis of acute hepatitis A. These patients were
then asked to apply for regular controls and serummeasurements of IgM anti-
HAV were performed for every 3months. All of the serologic testiness for
IgM anti-HAVwere performed by EIA. The results obtained in the end of the
study were as follows; IgM anti-HAV had disappeared in the sera of four
(5.9%) patients after 3months, in six (8.8%) patients in the second quarter, 38
(55.9%) in the third quarter, 13 (19.1%) in the fourth quarter and two (2.9%)
in the ﬁfth quarter. The duration of the seropositivity in the remainder ﬁve
patients were 21months in two (2.9%) patients, 33months (1.4%), 36months
(1.4%) and 46months (1.4%) in one patient, respectively. Finally, we can
conclude that in the sera of the majority of patients (70.6%) with acute
hepatitis A, the IgM anti-HAV titters were found to be below detectable levels
by EIA tectonics after 9months, while the same duration can be as long as
46months after the onset of the infection.
P458 Survey of protection from hepatitis A in the last
guide school students in Yazd
J. Ayatollahi
Yazd, IR
Objective:Hepatitis A, a viral disease, is spread by the fecal-oral route. Anti-
hepatitis A IgM is detectable in serum 45–60 days after the onset of symptoms.
Titers of anti-HAV from IgG class rise with convalescence and the antibody
usually persists for many years. Recovery from infection is associated with
lifelong immunity.
Methods: In this cross-sectional study. Anti-HAV from IgG class against HAV
was examined among 226 students include 113 males and 113 females in Yazd
guide schools by ELISA method. Variables such as sex, age, parent’s job,
parent’s education, and economic status also were purposed.
Results:Mean age of individuals was 14.17 years.18 (8 males and 10 females)
out of total 226 had not IgG against the virus, which is considered as
nonimmune. There was no signiﬁcant correlation between sex, parent’s
job and parent’s education and immunity to HAV.
Conclusion:Hepatitis A infection usually occurs during early life years in Yazd
and administration of normal serum immunoglobuline for preventing HAV
infection in adults older than 14-year-old is not recommended.
P459 The study of prevalence of hepatitis B and C
markers in patients with hepatocellular carcinoma
H. Kalantari, M. Jalali
Isfahan, IR
Objectives: The aim of this study was to evaluate the prevalence of chronic
HBV, HCV infections in Iranian patients who were known cases of H.C.C.
Methods: During the years 1999–2002, patients who were known cases of
H.C.C, serologic tests of viral markers (HBV, HBV DNA, HCV, HDV) were
examined and the results were recorded.
Results:Twenty-three patients (16 males and 7 females) with a mean age of 50
and a range of 40–60 were included in this study. Twenty-one (91%) were
chronic carriers of HBV, amongst whom 12 (62%) patients were HBV DNA
positive, 2 (9%) had no chronic infections of HBV, HCV. Three (13%) had
positive markers of HBV, HCV, but in none of them was only HCV marker
present. Twelve (52%) of HBV patients had super infection with HDV.
Conclusion: Chronic HBV infection was the most common risk factor of
H.C.C. This result is expectable because in our country the prevalence of
chronic HBV is high.
P460 Association between seropositivity of antibodies
against Helicobacter pylori and hepatitis A virus in Iran:
evidence regarding shared risk factors of transmission
M. Nasrolahei, A. Khalilian
Sari, IR
Objective:There is a hypothesis that infections ofHelicobacter pylori (H. pylori)
and hepatitis A virus (HAV) have a strong association, suggesting similar
modes of transmission. The aim of this study was to know whether the
hypothesis was true in Iran and to determine the prevalence of coincidence of
both infections in the same individual.
Methods:Subjects were 372 healthy individuals (age range of 3–81 years) who
underwent health check program in Sari, Iran. Blood samples and ques-
tionnaire data were collected. Serum sample from each subject was analyzed
for H. pylori IgG antibody by enzyme linked immunosorbent assay and for
HAV IgG antibody by microparticle enzyme immunoassay. The association
between seropositivity of anti-HP and anti-HAVantibodies was examined for
the statistical signiﬁcance by w2 and Fisher exact tests. Multiple logistic
regression analysis was used to derive multivariate adjusted Odds ratio
(ORs) and it’s 95% Conﬁdence Interval (CI).
Results: Thirty-one subjects (8.3%) below the age of 20 were seropositive for
H. pylori and 47 (12.6%) were seropositive for HAV. In adults, 232 (62.3%)
were seropositive for H. pylori and 274 (73.6%) were seropositive for HAV.
Two hundreds and 87 subjects (77.15%) were seropositive for both H. pylori
and HAV infections in the same time (P¼ 0.0001, 95% CI¼ 1.24–
2.96,OR¼ 2.12). The prevalence of coincidence of both infections was
7.2% among children, 59.6% among adults, 19.3% in male and 41.4% in
female. Forty four (11.8%) subjects were seronegative for both H. pylori and
HAV (P< 0.0001). One hundred and eight (29%) subjects were seronegative
for H. pylori only and 52 (13.9%) were seronegative for HAVonly. Anti-HAV
seroprevalence was (16.6%) among anti-H. pylori seronegative and (1.3%)
among anti-H. pylori seropositive individuals. The association between anti-
HAVand -H. pylori seropositivity were statistically signiﬁcant after adjustment
for age and sex through multiple logistic regression analysis (P¼ 0.003,
OR¼ 2.12, 95% CI¼ 1.24–2.96). There was a signiﬁcant relation between
coincidence of both infections and age (P¼ 0.002, OR¼ 6.9, 95%
CI¼ 4.07–11.85). Length of schooling and occupation as surrogate for
socio-economic status (P¼ 0.0001, OR¼ 1.15, 95% CI¼ 0.61–2.16).
Conclusion:There was a strong association between seropositivity ofH. pylori
and HAV antibodies in Iran which reﬂects a relation between routes of
transmission for HAV and H. pylori.
Clinical Microbiology and Infection, Volume 9, Supplement 1, 2003 87
Mechanisms of antimicrobials
P461 Stable changes in antibiotic sensitivity and cell
wall structure associated with a transient cell wall deﬁcient
phenotype in Staphylococcus aureus
E. R. Fuller, F. Nattress, G. Horne, P. J. Cook, R. Ellis,
T. Fawcett
Durham, South Shields, UK
Objectives:Cell wall deﬁcient bacteria (CWDB) have been associated with a
number of disease processes such as burn site infections and sarcoidosis, but
little is known about the triggers that cause the loss of cell wall, in vivo, or the
consequences of cell wall deﬁciency on bacterial metabolism. Our objectives
were to characterize the changes in antibiotic sensitivity and cell wall structure
that occur when Staphylococcus aureus cells undergo a transient cell wall
deﬁcient phenotype.
Methods:We induced cell wall deﬁcient variants of S. aureus, on media with
high osmotic potential, in the presence of sublethal levels of penicillin.
Antibiotic sensitivity proﬁles were determined under BSAC guidelines for
disc diffusion tests; enzyme sensitivity and mass spectrometric methods were
used to analyze cell wall structure.
Results: CWDB were resistant to beta-lactams, stained Gram-negative, had
lost the typical staphylococcal cell arrangement and had an indistinct margin.
When cells were allowed to recover their wall by passage in the absence of
penicillin, they displayed stable resistance to beta-lactam antibiotics and
altered sensitivity to several other classes of antibiotic. In this revertant state,
they also displayed decreased sensitivity to lysis by lysostaphin and an altered
signature on intact cell matrix assisted laser desorption/ionization time of
ﬂight mass spectrometry.
Conclusions: S. aureus cells which have been induced to transiently lose their
cell wall, in the presence of penicillin, acquire stable resistance to beta-lactams
and have altered sensitivity to several other classes of antibiotics. We hypothe-
size that the change in antibiotic sensitivity proﬁle is due in part to altered
structure of the regenerated bacterial cell wall.
P462 Penicillin binding protein proﬁles of
Aeromonas veronii bv. sobria
K. Westphal, P. M. Bennett, B. Wiedemann
Bonn, D; Bristol, UK
Objectives: Members of the genus Aeromonas are emerging pathogens that
pose a threat especially to immunocompromised patients and patients with
severe diseases. To be able to map out effective therapeutic strategies it is
important to understand the mechanism of action of the available antibiotics
and also to understand the mechanisms of resistance towards these substances.
Beta-lactam antibiotics have been shown to bind to and inhibit penicillin
binding proteins (PBPs) causing a disruption of the cell wall metabolism and
eventually cell lysis. Until now nothing is known about the PBPs ofAeromonas
veronii. We identiﬁed the PBPs in membrane preparations of A. veronii bv.
sobria by using biotinylated ampicillin, in order to create a basis for further
studies of the cell wall metabolism which might also be linked to beta-
lactamase induction.
Methods: Biotinylated ampicillin was used to speciﬁcally mark the PBPs in
membrane preparations of A. veronii. After separation by SDS–PAGE the
proteins were transferred onto a pvdf membrane by Western blotting.
Unspeciﬁc binding sites were blocked with 5% milk powder. The membrane
was ﬂooded with a streptavidin-peroxidase-conjugate which binds speciﬁcally
to biotinylated ampicillin and which was detected by ECL reagents on an X-
ray ﬁlm.
Results: Using biotinylated ampicillin at a concentration of 40 mg/mL nine
bands were detected with molecular masses between 20 and 100 kDa. A
sample containing no biotinylated ampicillin was used as a negative control.
There was one band in this sample which must be considered to bind
nonspeciﬁcally to streptavidin.
Conclusions: Eight PBPs with molecular masses between 20 and 100 kDa
were identiﬁed in membrane preparations of A. veronii by using biotinylated
ampicillin. This ﬁnding will be the starting point for further studies of the role
of PBPs in cell wall metabolism of A. veronii using deletion mutants that miss
one of the eight PBPs.
P463 Inoculum effects with cephalosporins in
Plesiomonas shigelloides are due to formation of enormous
ﬁlaments
S. Burak, I. Wiegand
Bonn, D
Objectives: The species Plesiomonas shigelloides is mainly associated with
gastrointestinal diseases. However, more severe complications as septicaemia
and meningitis in patients with preexisting health problems have also been
described. Appropriate antibiotic therapy is necessary. Therefore, detailed
knowledge about resistance mechanisms in this species is needed. P. shigelloides
has been described as an organism showing pronounced inoculum effects in
susceptibility testing for cephalosporins. We investigated if these inoculum
effects are due to the production of beta-lactamases.
Methods:Three strains of P. shigelloideswere used (clinical and environmental
isolates). Beta-lactamases were characterized by activity tests, SDS–PAGE and
isoelectric focusing. MIC values for 15 cephalosporins were determined by
microdilution methodology using inocula of 1 105CFU/mL and
1 106CFU/mL. The morphology of cells was determined by light micro-
scopy. One E. coli and one P. stuartii strain were used as comparative strains for
microscopy after cephalosporin treatment. For one P. shigelloides isolate kill
kinetics with 0125mg/mL cefpodoxime were determined using batch cul-
tures with inocula of 1 105CFU/mL and 1 106CFU/mL.
Results: Two P. shigelloides strains were shown to be beta-lactamase positive.
They harboured a constitutively expressed noninducible enzyme with a
molecular weight of 29 kDa and pI values of 4.9 and 5.3. The cephalosporin
susceptibility of the P. shigelloides strains including the lactamase-negative
isolate showed a dependency on the inoculum size. The MIC for most
cephalosporins increased 64-fold or more with the higher inoculum. Exam-
ination of cells from cavities of the MIC microtitre plates with inocula of
1 106CFU/mL revealed a very strong ﬁlamentation for most cephalospor-
ins. The length of the ﬁlaments ranged from 100 mm up to 2mm. Far shorter
ﬁlaments were seen for E. coli and P. stuartii. The kill kinetic with cefpodoxime
for P. shigelloides revealed similar kill curves for both inocula with an elimina-
tion of viable cells after 8–10 h.
Conclusions:The inoculum effect seen with cephalosporins is not due to the
possession of a beta-lactamase but can be attributed to extensive ﬁlamentation
of the single cells. This should be considered when interpreting theMIC data.
Even if cephalosporins kill the cells during infection there might be a
deleterious effect due to increased LPS production caused by excessive
ﬁlamentation.
P464 A quantitative assessment of dose-dependent
beta-lactam induced ﬁlament-formation in Gram-negative
bacteria
J. Buijs, A. S. M. Dofferhoff, J. W. Mouton, J. W. M. van der Meer
Heerlen, Nijmegen, NL
Objectives: Beta-lactam-antibiotics block Penicillin-binding-proteins (PBPs),
locatedintheoutermembraneofGram-negativebacteria.Previously,weshowed
that binding toPBP-1 leads to a quickbacterial lysis, and release of small amounts
ofendotoxin(ET).BindingtoPBP-3causes formationof longstrandsofbacterial
material (ﬁlaments).Afterﬁlament lysis, largeamountsofETare released,andthis
might cause an excessive cytokine-response with a further deterioration in
clinical course. Beta-lactams have speciﬁc binding afﬁnities for the different
types of PBP, often in a dose-dependentmanner. For ceftazidime andcefotaxim,
PBP-3bindingoccurs in lowdosages,PBP-1binding inhighdosages.Aimofour
studywas to assess the concentrations at which these changes in binding-afﬁnity
occur, using several Gram-negative strains.
Methods: Three bacterial strains (E. coli ATCC 25922, P. aeruginosa ATCC
27853 en K. pneumoniae ATCC 43816) were tested with ceftazidime and
cefotaxim at 9 dose-levels (0, 0.1, 1, 5, 10, 20, 30, 40 and 50mg/L).
Overnight cultured strains were incubated during 4 h. For each specimen,
Gram-stains and bacterial counts were performed.
Results: The dose-level at which afﬁnity changed from PBP-3 to PBP-1,
differed per combination. For ceftazidime, concentrations exceeding 30mg/L
prevented ﬁlament formation in all strains tested. Using cefotaxim, these levels
had to be higher than ﬁve and 10mg/L for E. coli and K. pneumoniae,
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respectively. However, for pseudomonas, concentration-levels above 40mg/L
were required. These minimum concentrations were not related to the MICs
for the respective bacteria and antibiotics. In pseudomonas-cultures, ﬁlament-
formation did not occur at sub-MIC dose-levels, in contrast to E. coli and
K. pneumoniae cultures.
Conclusions: The changes in PBP-binding pattern are speciﬁc for each
combination of antibiotic and bacterial strain, and are independent of MICs
for these combinations. Given the possible negative effects of ﬁlament
formation, dose levels should be kept at relatively high levels during the ﬁrst
hours of treatment, particularly when using beta-lactams with a dose-depen-
dent afﬁnity for different PBPs.
P465 Induction of ﬁbronectin-binding proteins by
subinhibitory levels of ciproﬂoxacin in quinolone-resistant
Staphylococcus aureus occurs independently from the sigma
B transcription factor activity
D. Li, A. Renzoni, T. Estoppey, C. Bisognano, P. Francois, W. Kelley,
D. Lew, J. Schrenzel, P. Vaudaux
Geneva, CH
Objectives: We previously reported up-regulation of ﬁbronectin-binding
proteins (FnBP) and promotion of ﬁbronectin-mediated adhesion by sub-
MICs of ciproﬂoxacin (CFX) in quinolone-resistant (QR) topoisomerase IV-
gyrase double mutants of S. aureusNCTC strain 8325. This study evaluates the
potential inﬂuence of the transcription factor Sigma B (SigB) in the CFX-
triggered up-regulation of FnBP, using mutants of QR strain RA1 expressing
different levels of SigB activity.
Methods: The rsbU 8325-derived strain RA1 exhibits low levels of SigB
activity. Strain TE1 is a transposon-inactivated sigB knockout mutant of RA1.
Strain TE2 is a rsbUþ cis complemented derivative of RA1 whose SigB
activity is restored. Surface display of FnBP was evaluated by bacterial
adhesion and ﬂow cytometry. Steady-state levels of fnbA and fnbB mRNAs
were assayed by quantitative RT-PCR (TaqMan) and correlated with mRNA
levels of sigB and SigB-speciﬁc target gene asp23. CFX-promoted responses
were tested at 4mg/L (1/8 MIC for each strain) of CFX.
Results: Following growth in CFX-free medium, the different SA strains
showed a positive correlation between their FnBP surface display and their
SigB activity. Compared to the sigB mutant TE1, ﬁbronectin-mediated
adhesion of rsbU and rsbU restored strains RA1 and TE2 increased by
50 and 100%, respectively. Steady-state sigB mRNA by the rsbU restored
strain TE2 was 5–6-fold higher than that of its rsbU parent RA1. Steady-state
mRNA of the SigB-dependent target gene asp23was seven-fold higher in the
rsbU restored strain TE2 than in the rsbU parent RA1, and 100-fold higher
than in the sigBmutant TE1. In contrast, after growth in the presence of CFX,
adhesion of strains TE1, RA1, and TE2, increased by 83, 60, and 60%,
respectively, compared to CFX-free medium. CFX-exposed strains TE1,
RA1, and TE2 showed 2- and 3-fold increases in fnbA and fnbB steady-state
mRNA levels, respectively, regardless of their different SigB activities.
Conclusions: SigB can up-regulate FnBP surface display and bacterial adhe-
sion in QR strains but is not required for the CFX-promoted response that
likely involves another independent stress response pathway.
P466 Global distribution of serotypes in
Streptococcus pneumoniae isolated from pediatric patients
in the PROTEKT 1999–2000 surveillance study
D. J. Farrell, M. Robbins, E. Winsor
London, UK
Background: The 7-valent pneumococcal conjugate (7-V) vaccine contains
polysaccharides from serotypes 4, 6B, 9V, 14, 18C, 19F and 23F. Cross-
coverage is thought to extend to other serotypes (ST) within the same
serogroup (SG) although this may differ from one SG to the other. The
aim of this study was to determine the global distribution of S. pneumoniae STs
in a large population of phenotypically and genotypically deﬁned pediatric
isolates.
Methods: S. pneumoniae isolates were collected worldwide from children aged
14 years with community-acquired RTIs. MICs were determined at a
central laboratory using the NCCLS broth microdilution method and inter-
preted using NCCLS breakpoints. Macrolide resistance (MacR) mechanisms
were determined by PCR in erythromycin-resistant isolates (MIC 1mg/L).
Serotyping was performed using antisera obtained from the Statens Serum
Institute Reference Laboratory (Copenhagen, Denmark).
Results:A total of 775 isolates of S. pneumoniaewere typed. Overall, 59.7% of
STs and 74.8% of SGs were covered by 7-V; however, there was considerable
variation between various subpopulations (location, age, site of infection).
MacR, and penicillin resistance (PenR) were high in the vaccine STs. MacR
mechanisms differed in prevalence between the various STs. The SGs of most
of the isolates outside of the coverage of the vaccine belonged to either SG 3,
11 or 15. Thirteen out of 24 SG 15 and 2/24 SG 11 isolates weremultiresistant
(MacR, PenR, tetracycline-resistant). SG 3 is considered one of the more
virulent SGs and ranked as the ﬁfth most prevalent SG in the study. Six of the
41 SG 3 isolates were MacR (erm(B)-mediated) and TetR (but PenS).
Telithromycin was highly active against all serotypes (MIC50 0.015mg/L,
MIC90 0.25mg/L and range 0.002–1mg/L).
Conclusions:Globally, three SGs of S. pneumoniaewere found to represent the
major proportion of isolates outside of the 7-V vaccine coverage. As with STs
covered by the vaccine, MacR and PenR in these isolates were high. MacR
and TetR in the virulent SG3 strains is unexpected and of concern. Teli-
thromycin demonstrated excellent activity against all STs in this pediatric
population. These data suggest that the use of telithromycin in pediatric
populations vaccinated with 7-V may be more effective than macrolides or
penicillins in limiting serotype replacement.
P467 The fungicidal activity of eugenol on Candida
spp. results from a primary lesion of the cell membrane
C. B. Tavares, C. Pina-Vaz, A. G. Rodrigues, S. Costa-de-Oliveira,
E. Pinto, L. Salgueiro, C. Cavaleiro, M. J. Gonc¸alves, A. Palmeira,
J. Martinez-de-Oliveira
Porto, Coimbra, P
Objectives: Eugenol is the major constituent (85.3%) of the essential oil of
Syzygium aromaticum (Eugenia caryophylla). The oil has high antimicrobial
activity, similar to eugenol, although its mechanisms of activity remain yet
unclear.
Material and methods: The minimal inhibitory concentration (MIC) and
minimal fungicidal concentrations (MFC) to essential oils and eugenol were
determined for 10 Candida strains (three C. albicans, two C. tropicalis, two
C. glabrata, one C. krusei, one C. guillermondii, one C. parapsilosis). Germ tube
formation in presence of subinhibitory concentrations was also assessed.
Additionally, following a short incubation of the yeast cells with eugenol,
ﬂow cytometry analysis was performed after staining with propidium iodide
(PI, a ﬂuorescent probe that selectively stains cells with severe membrane
damage). Studies of interactions between eugenol and ﬂuconazole using the
Checkerboard method (1) were also performed.
Results:MIC andMFCwere similar, ranging between 0.31 and 1.25 mL/mL.
Germ tube formation was inhibited at concentrations lower than those which
inhibited growth. Following a short incubation period PI penetrated most of
the yeast cells, meaning that the cell membrane was disintegrated by the drug.
No synergistic or antagonistic effects were found between eugenol and
ﬂuconazole.
Conclusions: Eugenol shows a fungicidal activity on Candida spp. by lesion of
the cell membrane. Our data supports the use of Syzygium aromaticum (Eugenia
caryophylla) for topical use in mucocutaneal Candidosis, as an isolated agent or
in association with ﬂuconazole, in case of being devoid of side-effects. One-
Scott EM, Tariq VN, McCrory RM. Demonstration of synergy with
ﬂuconazole and either ibuprofen, sodium salicylate, or propylparaben against
Candida albicans in vitro. Antimicrob Agents Chemother 39 : 2610–2614,
1995.
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P468 In vitro activity of ertapenem against anaerobes
isolated from the respiratory tract
D. Pie´rard, I. Wybo, K. Vandoorslaer, E. Roebben, P. Rosseel,
S. Lauwers
Brussels, B
Objectives: To test the activity of ertapenem and other antibiotics against
anaerobes isolated prospectively from the lower and upper respiratory tracts,
and to compare their susceptibility with that of anaerobic isolates from other
body sites.
Methods: Fifty-three anaerobic isolates from the lower (21) and upper (32)
respiratory tracts (RT), as well as 49 isolates from various other body sites (N-
RT) were tested with E-tests against penicillin (PEN), clindamycin (CLI),
amoxicillin/clavulanic acid (AUG), moxiﬂoxacin (MOX), ceftriaxone (CTR)
or cefoxitin (CFX) and ertapenem (ERT).
Results:MIC 50 and MIC 90 values (mg/L) are presented in the table below.
The higher susceptibility of respiratory tract isolates is mainly due to the
different distribution of isolated species: only three isolates belonged to the
Bacteroides fragilis group (BAF), while the others were 26 other Gram-negative
bacilli (OGNB), 17 cocci (COC) and seven nonsporeforming Gram-positive
bacilli (NSFGPB). The NRT isolates were 22 BAF, 5 OGNB, 7 Clostridium
spp., 9 NSFGPB and 6 COC.
Conclusions: This study conﬁrms the excellent antianaerobic activity of
ertapenem against anaerobic isolates from the respiratory tract: the MIC
90 values were lower than that of any antibiotic commonly used in respiratory
tract infections. All isolates were susceptible, as it was also the case for AUG,
while, respectively, 22.6% were resistant to PEN, 18.9% to CTR, 11.3% to
CLI and 1.9% to MOX.
P469 Single i.v. doses of ertapenem are not associated
with clinically signiﬁcant QTc prolongation
G. Mistry, G. Herman, L. Xi, A. Majumdar, P. Deutsch, C. Shamblen,
K. Lasseter
Rahway, Blue Bell, West Point, Miami, USA
Objectives: Ertapenem is a parenteral once daily beta-lactam antibiotic. QTc
prolongation has been associated with an increased incidence of a potentially
fatal arrhythmia, Torsades de Pointes. While studies in cats with high doses of
ertapenem did not reveal any signiﬁcant QTc prolongation, the purpose of
this study was to evaluate the effects of peak drug concentrations on QTc
interval in healthy subjects. In order to provide a safety margin, instead of a 1 g
dose, the dose approved for clinical use by worldwide regulatory agencies, a
2 g i.v. dose was administered in this study.
Methods:Twenty-four subjects, 10 men and 14 women, received a single 2 g
i.v. dose of ertapenem (N¼ 20) or placebo (N¼ 4), infused over 30min, in a
randomized, double-blind, parallel-panel study. ECGmeasurements and assay
of plasma concentrations of ertapenem were obtained at predose, end of
infusion, and 1.5 h from the start of infusion. QTc intervals were machine-
and manually calculated using Bazett’s equation. QTc prolongation was
assessed based on regulatory guidelines where a QTc interval change of
>60ms over baseline or an absolute value >450ms in men or>470ms in
women are clinically signiﬁcant.
Results: No subject met the criteria for clinically signiﬁcant QTc interval
prolongation. No postdose QTc intervals were >30ms over baseline for
machine-calculated values. For manually determined QTc intervals, two
subjects out of 20 who received ertapenem and one out of four who received
placebo had increases in QTc interval of borderline signiﬁcance (>30ms but
<60ms). The mean concentration of ertapenem was 282.9mg/mL at 0.5 h
and 166.9mg/mL at 1.5 h postdose, consistent with previous studies.
Conclusion: Single 2 g i.v. doses of ertapenem are not associated with
clinically signiﬁcant prolongation of the QTc interval in healthy subjects.
P470 Comparative activity of ertapenem and other
antibiotics against recent Belgian isolates of Enterobacter
aerogenes
Y. Glupczynski, C. Berhin, Y. De Gheldre, P. De Mol, M. Struelens
GDEPIH/GOSPIZ Enterobacter aerogenes Study Group
Objectives: Ertapenem (ERTA) is a new once-a-day parenteral carbapenem
with enhanced activity against Enterobacteriaceae, gram-positive and anae-
robes. This study aimed to compare the activity of ERTA with that of
imipenem (IMI), meropenem (MERO) and other comparators against 285
E. aerogenes isolates collected in 61 Belgian hospitals during the period 2000–
2001 as part of a national survey.
Methods: MICs were performed by E-test and by agar dilution following
NCCLS guidelines (2001).
Results: The activity of ertapenem and other comparators (MIC50 and
MIC90 in mg/mL, percentage strains not susceptible at NCCLS susceptibility
breakpoints) is shown in the table.
The carbapenems appeared as the three most active compounds against E.
aerogenes isolates with MERO>ERTA¼ IMI in terms of intrinsic activity
based on the MIC50 value. No difference in activity was noted for ERTA nor
for the other carbapenems against ESBL-positive vs. ESBL-negative
E. aerogenes strains. On the other hand the activity of most other antibiotics
was markedly reduced against ESBL-positive isolates.
Conclusions: ERTA is a new parenteral beta-lactam antibiotic demonstrating
high potency against multiresistant E. aerogenes isolates irrespective of ESBL
production. Owing to its interesting pharmacokinetic properties, ERTA may
prove as an interesting adjunct to the limited number of agents currently
available for the treatment of infection caused by multiresistant E. aerogenes.
P471 Activity of ertapenem against S. pneumoniae with
reduced penicillin susceptibility
J. Van Eldere, J. Verhaegen
Leuven, B
Objectives: To compare the susceptibility of S. pneumoniae with reduced
penicillin-susceptibility to commonly used respiratory b-lactam antibiotics
and to ertapenem
Methods: 200 S. pneumoniae isolates were randomly selected from the Belgian
national reference collection. All isolates were from invasive infections and
isolated in 2001 and 2000. Seventy-ﬁve isolates had a Pen MIC> 1 (peni-R),
100 had a Pen MIC> 0.125 and <1 (peni-I) and 25 strains had a Pen
MIC< 0.125 (peni-S). All strains were tested against amoxicillin, ertapenem,
cefotaxime, cefuroxime and imipenem. The method used was E-test on
Mueller-Hinton agar supplemented with blood. S. pneumoniae ATCC 46916
was used as control strain.
Results: see Table 1.
PEN CLI AUG MOX CTR CFX ERT
RT MIC 50 0.064 0.023 0.047 0.094 0.19 NA 0.023
MIC 90 >32 12 0.38 2 >32 NA 0.125
N-RT MIC 50 4 1 0.25 0.5 NA 4 0.19
MIC 90 >32 >256 1 16 NA 24 1
Antibiotics Range MIC50 MIC90
% not susceptible
(NCCLS breakpoint)
Ertapenem 0.03–32 0.25 0.5 2.5
Imipenem 0.03–32 0.25 1 2.5
Meropenem 0.03–32 0.06 0.12 0.3
Cefepime 0.03–64 1 8 6.7
Temocillin 0.12–128 16 32 16.3
Ceftazidime 0.12>256 >256 >256 86.2
Ciprofloxacine 0.03–128 32 64 86.6
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Conclusion: Increasing MIC values for penicillin and amoxicillin lead to
increasingMIC values for ertapenem, but resistant isolates were not yet found.
The MIC ratio’s for ertapenem vs. the other antibiotics tested change little
with increasing MIC-values. On the basis of the MIC distribution curves and
MIC50 values, it appears that ertapenem is two-fold more active than
ceftriaxone, two to four-fold more active than amoxicilline and two-fold
less active than imipenem.
P472 Comparative in vitro activities of panipenem
against clinical isolates of aerobic and anaerobic bacteria
K. Lee, J. H. Yum, D. Yong, R. Okamoto, M. Inoue, Y. Chong
Seoul, KOR; Sagamihara, JP
Objective: Panipenem (PAPM) has a broad-spectrum antibacterial activity
and used for treatment of blood stream, respiratory and other infections. In
this study in vitro activities of PAPM against clinical isolates of aerobic and
anaerobic bacteria were compared to those of other drugs.
Methods: Aerobic bacteria were isolated in 2001 and anaerobic bacteria in
2000–2001 from patients at a tertiary-care hospital in Korea. Antimicrobial
susceptibility was tested by NCCLS agar dilution methods. For the inter-
pretation of MIC of PAPM, imipenem (IPM) breakpoint was used.
Results:MIC ranges of PAPM were similar to those of IMP and meropenem
(MPM) for all of the aerobic and anaerobic bacteria tested. MIC ranges of
PAPM were: 0.125mg/L for methicillin-susceptible (MS) Staphylococcus
aureus, MS coagulase-negative staphylococci, group A and B streptococci,
pneumococci, and M. catarrhalis; 2mg/L for H. inﬂuenzae; 1mg/L for
E. coli, K. pneumoniae, K. oxytoca, C. freundii, E. aerogenes, P.mirabilis and P. vul-
garis; 2mg/L for E. cloacae and M.morganii; 0.12–8mg/L for S. marcescens;
0.03–16mg/L for Providencia spp.; 0.12–128mg/L for A. baumannii; 0.25–
128mg/L for P. aeruginosa. MIC ranges of PAPM were¼<1mg/L for
Peptostreptococcus spp.; 0.06mg/L for C. perfringens; 8mg/L for B. fragilis;
32mg/L for B. thetaiotaomicron. All of the gram-positive cocci and M. catar-
rhalis were interpreted susceptible to PAPM. All of the H. inﬂuenzae were
susceptible to PAPM. All of the Enterobacteriaceae except 8% of Providencia
spp., and except 27% of A. baumannii and 27% of P. aeruginosawere susceptible
to PAPM. None of Peptostreptococcus, C. perfringens and B. fragilis was resistant
to PAPM. Resistance rate of B. thetaiotaomicron to PAPM was 7%.
Conclusion: In vitro activity of PAPMwas similar to those of IPM andMPM.
All of the isolates were susceptible to PAPM except some isolates of Providencia
spp. and B. thetaiotaomicron, and signiﬁcant proportion of A. baumannii and
P. aeruginosa, suggesting usefulness of PAPM for the treatment of most
infection including mixed ones.
P473 Interpretive breakpoints for susceptibility testing
of bacteria against penicillin G/Sulbactam in the disk
diffusion test according to the German DIN Standard 58940
J. Brauers, D. Pfruender, M. Kresken
Bonn, Karlsruhe, D
Objectives: For a speciﬁc beta-lactam/beta-lactamase inhibitor combination,
the German Institute of Standards (DIN) usually deﬁnes the same minimal
inhibitory concentration (MIC) breakpoints as for the beta-lactam alone. For
penicillin G (sulbactam) the breakpoints are 0.125mg/L (susceptible),
0.25–1mg/L (intermediate), and 2mg/L (resistant). Sulbactam is added to
penicillin G at a ﬁxed concentration of 8mg/L. Here we present data from a
multicenter study in order to determine inhibition zone diameter (IZD)
breakpoints for penicillin G/sulbactam.
Methods: In 10 laboratories, MICs and IZDs according to DIN Standard
58940 were determined in parallel for 1324 fresh clinical isolates, mainly of
Staphylococcus aureus (n¼ 352), streptococci (n¼ 90), Enterococcus faecalis
(n¼ 181), Acinetobacter spp. (n¼ 35), Escherichia coli (n¼ 305) and other
Enterobacteriaceae (n¼ 333). Test disks were loaded with 10 micrograms
each of penicillin G and sulbactam. To determine IZD breakpoints, we ﬁrst
performed a linear regression analysis and subsequently the error rate-
bounded method described by Metzler and de Haan ( J Infect Dis 1974,
130, 588–594).
Results:The statistical analysis of theMIC and IZD data revealed a correlation
coefﬁcient (r) of 0.5597. In cases where r is below 0.85, the DIN requests to
apply the error rate-bounded method. Using this method, the following
breakpoints were determined for interpreting IZDs: 20mm (resistant), 21–
25mm (intermediate), and 26mm (susceptible). Both the rates of very
major and major errors were at an adequate low level of 0.6 and 2.5%,
respectively. The rate of minor errors was 21.1%.
Conclusion: Penicillin G/sulbactam disks loaded with 10/10 micrograms are
suitable for routine susceptibility testing. The breakpoints determined were
recently approved by the DIN.
P474 Activity of meropenem against Gram-negative
isolates from a Polish pediatric intensive care unit – part of
the MYSTIC (Meropenem Yearly Susceptibility Test
Information Collection) Program, 1997–2002
J. Patzer, D. Dzierzanowska, A. Pawinska, P. Turner
Warsaw, PL; Macclesﬁeld, UK
Objectives: To assess the in-vitro activity of meropenem (MEM) and eight
other antibiotics against Gram-negative isolates from a pediatric intensive care
unit (ICU) in Poland.
Methods: Six hundred Gram-negative isolates were obtained from clinical
specimens of children hospitalized in the ICU during 1997–2002. The isolates
were identiﬁed using conventional methods. Minimum inhibitory concen-
trations (MICs) of MEM, imipenem (IMP), piperacillinþ tazobactam, cefo-
taxime, ceftazidime, cefepime, gentamicin (GM), tobramycin (TM) and
ciproﬂoxacin (CIP) were determined using the NCCLS agar dilution
method.
Results: The collection of Gram-negative isolates included Escherichia coli
(n¼ 90), Enterobacter cloacae (n¼ 122), Klebsiella oxytoca (n¼ 46), Klebsiella
pneumoniae (n¼ 106), Serratia marcescens (n¼ 27), Acinetobacter baumannii
(n¼ 52), Pseudomonas aeruginosa (n¼ 123) and other species (n¼ 34).
MEM and IMP were the most active of the agents tested with >90% of
all species, with the exception of P. aeruginosa, susceptible at NCCLS break-
points. MIC90 values (mg/L) of MEM remained relatively constant over the
6-year period at 0.03–0.125 for Enterobacteriaceae, one for A. baumannii and
eight for P. aeruginosa. MIC90 values (mg/L) of IMP were 0.25–0.5 for
Enterobacteriaceae, 1 for A. baumannii and 16 for P. aeruginosa. CIP had
MIC90 values of 0.015–2mg/L against all isolates, with the exception of
A. baumannii (16mg/L). Resistance to aminoglycosides (GM and TM) was a
characteristic of >40% of tested isolates. The incidence of beta-lactamase-
producing isolates remained at a relatively constant but high level during the
6-year period (18.5–47.7%). Incidence of AmpC production was higher than
ESBL production in each year of the study.
Conclusions: MEM and IMP were the most active antibiotics tested (>90%
susceptibility for all species except P. aeruginosa), with no observed reduction
in activity over 6 years.
P475 Beta-lactamase production and susceptibility of
Capnocytophaga to beta-lactam antibiotics
Z. Tamanai-Shacoori, N. Burggraeve, A. Jolivet-Gougeon,
L. Desbordes, M. Cormier, M. Bonnaure-Mallet
Rennes, F
Objectives: In recent years, the antimicrobial susceptibility spectrum of
anaerobie gram-negative rods has undergone gradual change. The emergence
of bacteria resistance to beta-lactam antibiotics should be noted. Beta-
lactamase is the major cause of bacterial resistance to beta-lactam antibiotics.
Previous studies have reported the beta-lactamase production, by 34 from 43
clinical pharyngeal isolates of Capnocytophaga spp. in Department of Pediatric
Oncology (CHU, Rennes, France).
Table 1
Peni-S Peni-I Peni-R
MIC50 MIC90 MIC50 MIC90 MIC50 MIC90
Imi 0.006 0.012 0.094 0.125 0.125 0.5
Amoxy 0.012 0.016 0.38 1 0.75 1.5
Cefur 0.016 0.094 1.5 2 2 3
Ceftria 0.016 0.032 0.25 0.5 0.5 0.5
Erta 0.012 0.023 0.19 0.38 0.25 0.5
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Methods: In this study, the beta-lactamase of 5 from the 34 strains, which
belong all to Capnocytophaga ochracea were biochemical and genetic analyzed.
These beta-lactamase positive strains resistant to ﬁrst and second generation
cephalosporins were markedly different in antimicrobial susceptibility to third
generation cephalosporins. The crude beta-lactamase extract was prepared by
sonication and triton treatment.
Results: Beta-lactamase activity was conﬁrmed by nitroceﬁn test. Isoelectric
focusing experiments with crude extracts achieved as a single band with an
estimated pI of 5.6. Plasmid DNA isolated by alkaline lysis followed by
electrophoretic analysis showed three plasmidic bands in two strains. For the
three other strains, we detected no plasmid, indicating a chromosomal
location of the beta-lactamase gene, without excluding a mobilizable trans-
poson.
Conclusion: These results could explain signiﬁcant divergence susceptibility
to beta-lactam antibiotics, when the transposon was inserted into the chro-
mosome or plasmid locus.
Acknowledgement: Supported by Conseil Re´gional de Bretagne.
P476 In vitro activity of eight oral cephalosporins
against Borrelia burgdorferi
K.-P. Hunfeld, R. Ro¨del, T. A. Wichelhaus
Frankfurt, D
Objectives: To test larger numbers of Borrelia burgdorferi isolates derived from
different clinical and geographic sources against oral cephalosporins.
Methods: This study investigated the in vitro activity of eight oral cepha-
losporins, in addition to ceftriaxone and apramycin, against 17 isolates of the
B. burgdorferi complex, including one B. valaisiana and one B. bissettii tick
isolate. Minimal inhibitory concentrations (MICs) were determined by a
standardized colorimetric methodology in BSK-medium after 72 h of incu-
bation. The rank order of potency on a mg/mL basis for the substances with in
vitro activity against B. Burgdorferi was ceftriaxone (MIC90: 0.06 mg/
mL)> cefuroxime-axetil (MIC90: 0.25 mg/mL)> ceﬁxime (MIC90: 1 mg/
mL), cefdinir (MIC90: 1 mg/mL)> cefpodoxime (MIC90: 8 mg/mL)> ce-
/mL)> ceftibuten (MIC90: 32mg/mL)> cefetamet-pivoxil (MIC90:
>32 mg/mL), loracarbef (MIC90: 32mg/mL) > apramycin (MIC90:
>64 mg/mL).
Conclusions: Our study demonstrates the superior in vitro effectiveness of
ceftriaxone in addition to good to excellent activity on the part of the oral
agents cefuroxime-axetil, ceﬁxime, and cefdinir against B. burgdorferi under
strictly standardized test conditions.
P477 Comparative in vitro activity of cefpodoxime with
other cephalosporins against different isolates of
Enterobacteriaceae
M. Altindis, O. C. Aktepe, Z. Cetinkaya
Afyon, TR
Objectives: Cefpodoxime proxetil is a new orally administered third-gen-
eration cephalosporin. This study was performed to compare the in vitro
activity of cefpodoxime (CPD) with other cephalosporins commonly used in
isolates of Enterobacteriaceae.
Methods:A total of 100 strains belonging to Enterobacteriaceae (45 E. coli, 32
Klebsiella, 5 Enterobacter, 5 Proteus, 2 Morganella, 3 Providencia, 3 Serratia and 5
others) were collected from patients admitted to our hospital during the last
two years period. Antibiotic susceptibilities were determined by standard disc
diffusion procedure and the evaluation was done according to NCCLS
criteria. CPD discs was provided by Sankyo Co. Japan. Tested other cepha-
losporins were cefepime (FEP), ceftazidime (CAZ), ceftriaxone (CRO),
cefoperazone (CEP), cefaclor (CEC) and ceﬁxime (CFM).
Results: For all isolates, the susceptibility to CPD was 71%. CPD showed a
broad spectrum and potency inhibited 71, 63 and 80%, respectively, of E. coli,
Klebsiella and Proteus-Providencia-Morganella strains. CPD was found more
active than CRO, CEP, CEC and CFM. The susceptibility to CAZ and FEB
were equal, for E. coli, Klebsiella and Proteus-Providencia-Morganella group,
respectively, 73, 69 and 80%.
Conclusions: These results showed that cefpodoxime had a good in vitro
activity similar to CAZ and FEB, against Enterobacteriaceae. However the
overall susceptibitiy rates to cephalosporins that we determined, indicates a
rising resistance problem on these antibiotics.
P478 Postmarketing surveillance study with
piperacillin/tazobactam in patients with moderate or severe
infections
K.-F. Bodmann, E. Leitner
Hildesheim, Munster, D
Objectives: piperacillin/tazobactam (P/T) is a widely used combination of
the acylaminopenicilline piperacillin and the betalactamase inhibitor tazo-
bactam. The objective of this Postmarketing Surveillance Study (PMS)
conducted in 2000/2001 in Germany was to investigate the efﬁcacy and
safety of P/T in patients with moderate and severe infections.
Methods: A total of 7470 patients (mean age of 60 years) were treated with
P/T. Fifty-seven percent weremale, 42% female. Over 90% of the patients had
moderate or severe respiratory tract infections (pneumonia), intra-abdominal
infections (peritonitis, appendicitis, cholangitis), skin/soft tissue infections,
other infections (urinary tract infections, FUO, sepsis) or more than one
infection. Eighty-ﬁve percent of the patients had concomitant diseases
(mainly cardiac disorders, diabetes mellitus, neoplasia). Thirty-one percent
received a previous antibiotic treatment (mostly cephalosporines and chino-
lones).
Results: P/Twas given 8.6 days in average. Eighty-six percent of the patients
received P/T as a calculated antibiotic treatment. Seventy-six percent of
patients were treated with P/T i.v. every 8 h 22% of the patients received a
combination therapy (mostly aminoglycosides (12%) and chinolones (14%)).
Surgery was performed in 49% of the patients (mostly in intra-abdominal and
skin/soft tissue infections). Sixteen percent of patients had a change-over of
therapy (in most cases to chinolones and carbapenems). A clinical response
(cure or improvement) was stated in 87% of patients. An analysis of subgroups
of patients with severe infections, patients treated on ICUs and mechanically
ventilated patients also proved the result. The clinical cure or response rates
were conﬁrmed by an improvement of selected laboratory ﬁndings (tem-
perature, leucocytes, CRP). In 63% of patients susceptibility data were
documented. The microbiological ﬁndings of the isolated pathogens showed
a high susceptibility (87%) of the most common strains. Adverse events
occurred in only 7.2% of patients, only 1.8% of them were drug-related. The
most common reactions were diarrhea, exanthema, hypokalaemia and allergy.
Conclusions: High response rates of P/T in the treatment of patients with
moderate or severe infections were observed. P/T has an excellent safety
proﬁle. Clinical and microbiological response rates during routine treatment
conﬁrm data of previous clinical trials.
Epidemiology of resistance 1
P479 Reduced susceptibility of penicillin in Viridans
Group Streptococci in the oral cavity in patients with
hematological diseases
K. Westling, I. Julander, P. Ljungman, A. Heimdahl, A. Thalme,
C. E. Nord
Stockholm, S
Objectives: Viridans Group Streptococci (VGS) have become common
pathogens causing septicemia in patients with hematological diseases. A
reduced susceptibility to penicillin is reported (Westling, Scand J Infect
Dis 2002; 34: 316–9).
Methods: Fifty patients from the Division of Hematology 2000–2002 with
either newly diagnosed acute leukemia or patients in whom autologous
peripher stem cell transplant was performed participated in the study. Samples
were collected from saliva by mouthwash with 10mL saline. The collection of
samples was performed once a week. Aerobic and anaerobic cultures were
performed. The typing of VGS was made using mitis salivarius blood agar
(Difco). API STREP and API ZYM (Biome´rieux, Lyon) were used for
identiﬁcation of VGS strains. Antibiotic susceptibility testing to penicillin for
92 Abstracts
the isolated VGS was performed with the E-test method (AB Biodisk, Solna,
Sweden) on Mueller-Hintons medium. Isolates of VGS resistant to penicillin
(MIC> 2.0mg/L) were also tested for susceptibilities to linezolid, erythro-
mycin, vancomycin and ciproﬂoxacin. Clinical data as fever and mucositis on
admission were registered. Chemotherapy, ongoing antibiotic treatment,
antibiotic prophylaxis, as well as previous antibiotic treatment up to 1 year
before start of the study were registered.
Results:One patient was excluded because of a Staphylococcus aureus infection
in the stem cell harvest. In 48/49 patients VGS was isolated from the oral
cavity. Twelve of 48 (25%) patients had VGS strains that were resistant to
penicillin (MIC> 2.0mg/L). Eleven of the isolates were identiﬁed as Strep-
tococcus mitis and one as Streptococcus sanguis. The patients that harboured
penicillin resistant VGS (MIC> 2.0mg/L) had more septicemias (P¼ 0.04)
and more days of treatment with trimethoprim-sulphametoxazole than
patients with susceptible or intermediately resistant VGS (P¼ 0.04). There
were no other statistical signiﬁcant differences between the two groups. Four
of 12 isolates resistant to penicillin were also resistant to erythromycin
(MIC> 0.5mg/L).
Conclusions:We summarize that 25% of the patients had oral VGS resistant to
penicillin that is higher than expected. This group of patients gets higher
burden of antibiotic therapy due to infections after chemotherapy that might
select penicillin resistant VGS strains.
P480 Epidemiology and resistance pattern of
bacteremia pathogens in medical patients over a 6-year
period
T. Peppas, E. Lyberopoulos, B. Kandyla, H. Lydataki, F. Karakostas,
E. Falidea, H. Fotiadou-Pappas, M. Savvala, S. Pappas
Piraeus, GR
Objective: To estimate difference regarding epidemiology, outcome and
resistance (R) to antimicrobials of medical patients with bacteremia (B), over
a 6-year period, i.e. 1997–2002.
Methods: Prospective demographic, clinical and microbiology, as well as
hospital stay and outcome, data entry of medical patients with documented B.
Time January 1997 to December 2002. Data entry and analysis in IBM
compatible PC using EPI5-Info (CDC, 1993) programme. Sensitivity as by
Kirby-Bauer, statistics by Yates corrected/2.
Results:Documented B in a total of 301 pts (M: 47.2%, F: 52.8%) mean age
69.6 years. Chronic disease present in 79.5%, and nosocomial Aˆ in 24.5% of
patients. More frequent pathogens were E. coli (37%) S. aureus (15.6%), and
most common source of B was the urinary tract (42%). Main difference
between ﬁrst and second half of the studied period was the rise of Klebsiella sp.
from 2.1 to 12.6% and relative rise of Enterococcal B and Candidemias.
Regarding R data of Gram-pathogens, signiﬁcance was most prominent to
3rd generation cephalosporins [rising from 6.9 to 20.4%, P¼ 0.024] and
ciproﬂoxacin [9.0–19.4%, P¼ 0.06]. The annual rise of Gram þ cocci
percentage is noted, without, fortunately, a rise to either MRSA rates or
glycopeptide R. Mean hospital stay was 13.4 days and mortality during stay
was 18%, though not always directly attributed to B.
Conclusions: The constant variability of B pathogens, the appearance of less
expected ones, and mainly R proﬁle changes deem continuous surveillance
and awareness, to ensure the optimal empirical antimicrobial choice based on
the most recent data of the given milieux.
P481 Detection of rifampicin and izoniazid resistance in
Mycobacterium tuberculosis strains from Samara Region
(Central Russia)
F. Drobniewski, V. Nikolaevsky, T. Brown, M. Ruddy, Y. Balabanova,
Y. Bazhora, I. Fedorin, S. Kuznetsov, N. Malomanova, E. Elizarova,
O. Tyutneva, L. Chulpanova
London, UK; Odessa, UKR; Samara, RUS
Introduction: Recently high rates of tuberculosis incidence and prevalence
are observed in civilian and prisons sectors in Russia. One of the main reasons
for high morbidity levels and ineffectiveness of treatment is wide spreading of
drug resistant Mycobacterium tuberculosis strains, but accurate and comprehen-
sive information on levels of drug resistance among strains circulating in
Central Russia is unavailable.
Objective:Rifampicin and izoniazid resistance detection in TB isolates from
Samara (Central Russia) civilian and prison TB hospitals and dispensaries in
2000–2002 by revealing mutations in rpoB, katG and inhA genes using
Macroarray technique.
Methods: A total of 342 M. tuberculosis isolates were tested using Macroarray
method. It is based on multiplex ampliﬁcation of rpoB, katG and inhA genes
fragments (with three pairs of biotin labeled primers) following by dot-
hybridization with normal and mutant oligonucleotide probes (fragments of
rpoB, katG and inhA genes in which mutations occur) immobilized on nylon
membrane strips. Mycobacterial DNA was extracted by heating of cell
suspensions following by chloroform extraction. Streptavidin-alkaline phos-
phatase color development system was used for visualization of results.
Results and conclusions: In total, 78.8% of isolates was determined to be
resistant to one or more drugs. From those, 66.3%were resistant to rifampicin
and 92.9% to izoniazid. Izoniazid resistance in themost part of isolates (88.4%)
was due to the mutation in 315 codon of katG gene. The percentage of
resistant mycobacteria was higher in those isolated from prisoners than from
civilians (84.7 and 75.1%, respectively). From resistant isolates 165 specimens
(48.2%) possessed mutations both in rpoB and katG (or inhA) genes and were
determined as multidrug resistant (MDR). It proves the fact that rifampicin
resistance is very often combined with izoniazid resistance and serves as
indicator of MDR. Very high prevalence of MDR M. tuberculosis strains in
Central Russia reﬂects general TB situation in Russian Federation and other
countries of the former Soviet Union and is a serious problem for doctors and
public health in general.
P482 Clinical experience of linezolid in a UK teaching
hospital
D. Nathwani, K. Gray
Dundee, UK
Introduction: Linezolid, an oxazolidinone antibiotic, has a unique mode of
action and is effective against a broad range of resistant and sensitive gram
positive infections. In order to prevent misuse of this useful agent the
antibiotic committee for Tayside hospitals decided on a number of strategies
to control prescribing. These included agreement on appropriate clinical
situations for use of linezolid (below), all prescriptions are subject to approval
by infection specialists and continual monitoring by clinical pharmacists.
Objectives: Review the clinical experience of linezolid use and compliance
with our guidelines.
Method:Clinical pharmacists recorded information on all patients prescribed
linezolid and ensured approval had been obtained from an infection specialist.
Medical notes were reviewed retrospectively for patients prescribed linezolid
since its introduction (19months). Data were collected on organisms, pre-
vious therapy, indications, duration of therapy, clinical and microbiological
outcomes and linezolid related adverse reactions.
Results: Forty courses of linezolid were prescribed, notes were reviewed for
33 of these patients. A number of patients ﬁtted more than one criteria for use
of linezolid (n¼ 45). See table.
There was 100% compliance with our guidelines. Seventy-six percent of
prescriptions for linezolid were for indications not currently licensed in the
UK. The majority of patients (27) were treated for MRSA/MRSE infections.
Eleven patients had a bone or joint infection. Thirty patients had previously
been treated with a glycopeptide. The mean duration of therapy was 23 days.
28/33 patients had clinical outcome documented and 26 (92%) were classiﬁed
as cure or improved. 8/33 patients had a linezolid related adverse reaction, all
were fully reversible.
Conclusions: Compliance with our guidelines was excellent and our control
measures for prescribing have proved effective. Linezolid was used in awide of
range of clinical scenarios with good outcomes. This study represents the ﬁrst
Clinical situation %
VRE 9
Hypersensitivity or intolerance to previous regimen 24
Clinical failure or lack of improvement 11
Poor IV access 7
Patient no longer wishing IV therapy 24
Deteriorating renal function 9
Drug interaction with rifampicin or concern about hepatotoxicity 7
Facilitation of hospital discharge by switching to oral therapy 9
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documented UK experience of the use of linezolid since its introduction in
2001.
P483 Multiple resistance is rare in community-acquired
lower respiratory tract infection in the UK and Ireland
R. Reynolds, D. Felmingham, BSAC Working Party on Respiratory
Resistance Surveillance
Objective: To assess levels of multiple antimicrobial resistance in pathogens
associated with community-acquired lower respiratory tract infection.
Methods: 1328 Streptococcus pneumoniae, 1894 Hemophilus inﬂuenzae and 845
Moraxella catarrhalis from lower respiratory specimens were collected from 20
laboratories in the UK and Ireland in the winters of 1999–2000 and 2000–
2001, excluding duplicates within 2weeks and patients in hospital more than
48 h. Isolates were centrally tested by BSAC agar dilution MIC method and
categorized by BSAC breakpoints (mg/L).
Results:The table shows results for representatives of beta-lactam, macrolide,
quinolone and tetracycline classes.
No isolate was resistant to all four drug classes.
Ninety-one (6.9%) of 1328 S. pneumoniae were resistant to two or more drug
classes, of which 12 (0.9%) were R to three and 79 (5.9%) wereR to only two.
Triple Rwere: 8 (0.6%) AMOX/TET/ERY; 3 (0.2%) CIP/TET/ERY; and 1
(0.1%) AMOX/CIP/ERY. Double R (excluding triple R) were: 70 (5.3%)
TET/ERY; 6 (0.5%) CIP/ERY; 2 (0.2%) AMOX/TET; and 1 (0.1%)
AMOX/ERY. Fifty-eight isolates (4.4%) were triple reduced-S: 51 (3.8%)
PEN(IþR)/TET-R/ERY-R; 5 (0.4%) PEN(IþR)/CIP-R/ERY-R and 2
(0.2%) PEN(IþR)/CIP-R/TET-R. 54 (2.9%) of 1894 H. inﬂuenzae were
resistant to two or more drug classes, of which 1 (0.1%) was R to three and 53
(2.8%) were R to only two. The only triple R was AMP/TET/ERY. Double
R (excluding triple R) were: 47 (2.5%) AMP/TET; 5 (0.3%) AMP/ERY; and
1 (0.1%) TET/ERY. 845 M. catarrhalis were all CIP-S and ERY-S so there
were no triple R. The only double R was 1 AMP/TET.
Conclusion:This study establishes an extremely low baseline level of multiple
resistance in community-acquired lower respiratory tract infection in the UK
and Ireland for comparison with future years.
P484 Emergence of CTX-M-15 extended spectrum
beta-lactamase producing Enterobacteriaceae in Bulgaria,
Romania and Turkey
I. Schneider, E. Keuleyan, R. Markovska, E. Dragijeva, N. Go¨nu¨llu¨,
Z. Aktas, C. Bal, D. Buiuc, A. Bauernfeind
Munich, D; Soﬁa, BG; Istanbul, TR; Iasi, RO
Objectives: ESBL CTX-M-15 producing Enterobacteriaceae were ﬁrst
identiﬁed in India and Japan in 2000. Recently CTX-M-15 was detected
in Bulgaria and Poland. We screened ESBL producers from Bulgaria,
Romania and Turkey to explore further dissemination of this beta-lactamase
in countries of the Balkan peninsula.
Methods: ESBL producing Enterobacteriaceae isolated from clinical speci-
mens between 1997 and 2002 were screened for the production of CTX-M-
15 by the ratio of their MICs for Cefotaxime and Ceftazidime. MICs were
determined by an agar dilution technique according to NCCLS guidelines.
Further analysis included transfer of plasmids and isoelectric focusing of crude
homogenates. To identify the blaCTX-M-15 gene, the PCR product obtained
usingoligonucleotides binding to theﬂanking regionof thegenewas sequenced.
Results: Four E. coli strains, one each from Galati County Hospital, Galati,
Romania; Hospital of Istanbul Faculty of Medicine, Istanbul, Turkey; Pedia-
tric Hospital and ambulatory of Medical University, Soﬁa, Bulgaria; and one
K. pneumoniae from Military Hospital, Soﬁa, Bulgaria demonstrated a MIC
ratio for cefotaxime/ceftazidime equal to or above 2 indicating the production
of a cefotaximase. In all strains the encoding genewas located on a conjugative
plasmid. All produced an enzyme with a pI slightly above that of CTX-M-3.
The bla-genes could be ampliﬁed with CTX-M group speciﬁc primers.
Sequencing of the genes and deduction of the amino acid sequence demon-
strated identity with CTX-M-15. Epidemiological typing of the E. coli
isolates revealed no relatedness between the different isolates. However spread
of plasmids may have occurred as identical plasmid ﬁngerprints were detected.
Conclusion:CTX-M-15 producing organisms spread further in Bulgaria and
emerged for the ﬁrst time in Romania and Turkey.
P485 Detection of extended spectrum beta-lactamases
in Klebsiella pneumoniae
N. Erben, I. Ozgunes, A. Kiremitci
Eskisehir, TR
Extended-spectrum beta-lactamases (ESBLs) confer resistance to newer
cephalosporins and penicillin with expanded-spectrum activity. ESBLs are
mostly plasmid-mediated enzymes. ESBLs were ﬁrst described in 1983.
ESBLs can be detected by double disk synergy (DDS), modiﬁed DDS
(MDDS) and E-test methods. In this study the presence of ESBL was
investigated by DDS and MDDS methods in 100 Klebsiella pneumoniae strains
isolated from clinical specimens such as urine (47), blood (24), wound (11)
and other sites (18). The presence of ESBL was detected in 15% of isolates by
DDS method and in 47% of isolates by MDDS method. K. pneumoniae strains
were also tested for susceptibility to aztreonam, cefotaxime, ceftazidime,
cefoperazone, cefoxitin and imipenem. Intermediate susceptible isolates were
classiﬁed as resistant. The ratio of resistant isolates were found as 59% for
aztreonam, 50% for cefotaxime, 50% for ceftazidime, 60% for cefoperazone,
12% for cefoxitin and 0% for imipenem. In-vitro susceptibilities of 47 ESBL
producing K. pneumoniae strains to these antibiotics found as 0% for aztreo-
nam, 4.25% for cefotaxime, 4.25% for ceftazidime, 4.25% for cefoperazone,
89.3% for cefoxitin and 100% for imipenem. Because of the high prevalence
of ESBL producing strains of K. pneumoniae isolated from clinical specimens
clinical microbiology laboratories must effectively detect and report the
presence of ESBL routinely.
P486 Analysis of dihydropteroate synthase genotype of
Pneumocystis carinii from AIDS patients with recurrent
pneumonia
A. Nahimana, M. Rabodonirina, J. Helweg-Larsen, I. Meneau,
P. Francioli, J. Bille, P. M. Hauser
Lausanne, CH; Lyon, F; Copenhagen, DK
Objective: Failure of sulfa or sulfone prophylaxis is associated with mutations
in Pneumocystis carinii gene coding for dihydropteroate synthase (DHPS). We
investigated whether selection of these mutations can occur within patients
under drug pressure.
Methods: DHPS genotype was analyzed in patients with two separate
episodes of P. carinii pneumonia (PCP). P. carinii was typed using the PCR-
single-strand conformation polymorphism multilocus method.
Results: In ﬁve of seven cases with both episodes caused by the same P. carinii
type, a switch to mutant DHPS strain from either wild type DHPS or a mixed
wild type/mutant DHPS between ﬁrst and second episode of PCP was
observed. The two remaining patients had a mutant strain already at the ﬁrst
episode. All patients had received treatment or maintenance therapy with
cotrimoxazole or dapsone.
Conclusion:The results suggest that P. cariniiDHPS mutations can be selected
de novo within patients under drug pressure.
P487 Increased treatment failure after 3-day courses of
nitrofurantoin and trimethoprim for urinary tract infections
in women
W. Goettsch, R. Janknegt, R. Herings
Utrecht, Sittard, NL
Objectives: To assess the incidence rate and the determinants of treatment
failure after antimicrobial therapy of urinary tract infections in women.
Antibiotic
S. pneumoniae
% R(MIC),
%I [MIC range]
H. influenzae
%R (MIC),
%I [MIC range]
M. catarrhalis
%R(MIC)
penicillin (PEN) 0.6 (2), 9.9 [0.12–1] nr nr
amoxicillin (AMOX) 1.3 (2) nr nr
ampicillin (AMP) nr 15.6 (2) 91.0 (2)
erythromycin (ERY) 12.3 (1) 3.3 (16), 0 (1)
95.9 [1-8]
ciprofloxacin (CIP) 5.3 (4), 0.1 (2) 0 (2)
94.7 [2]
tetracycline (TET) 8.4 (2) 3.1 (2) 0.2 (2)
S ¼ susceptible, I ¼ intermediate, R ¼ resistant, nr ¼ not reported.
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Methods: The rate and the determinants of treatment failure after antimi-
crobial therapy of urinary tract infections were assessed in a cohort of 16703
Dutch women who received a course (3, 5 or 7 days) of trimethoprim,
nitrofurantoin or norﬂoxacin between January 1, 1992 throughDecember 31,
1997 and who were between 15 and 65 years at the day of ﬁrst use. A further
prescription for one of these three antibiotics or for cotrimoxazole, amox-
icillin, ciproﬂoxacin or oﬂoxacin, within 31 days after the end of the initial
therapy was deﬁned as an indicator for failure of the initial treatment.
Determinants of treatment failure were identiﬁed 1 year prior to the start
of the ﬁrst dispensing.
Results: Treatment failure rate was 14.4% in patients treated with trimetho-
prim and nitrofurantoin and 9.6% in patients treated with norﬂoxacin. A
multivariate analysis showed that 5- (RRnit 0.67, 95% CI 0.57–0.82, RRtri
0.82, 95% CI 0.73–0.91) and 7-day (RRnit 0.64, 95% CI 0.53–0.77, RRtri
0.85, 95% CI 0.71–1.02) trimethoprim and nitrofurantoin treatment
appeared to be more effective than a 3-day treatment (reference category).
Compared to a 3-day nitrofurantoin treatment (reference) a 7 days norﬂoxacin
treatment had the lowest treatment failure rate (RR 0.42, 95% CI 0.30–0.57).
Other factors increasing treatment failure rates were the age of the patient, the
year of therapy and previous hospitalization. In contrast, previous use of oral
contraceptives, hormonal replacement therapy, antidiabetics and oral corti-
costeroids did not signiﬁcantly affect the treatment failure rate.
Conclusions: Most national guidelines on the therapy of uncomplicated
urinary tract infections in women advise to prescribe 3-day courses of
trimethoprim and/or nitrofurantoı¨n. However, our data indicate that for
certain groups of female patients (for example, the older and recently
hospitalized) a 3 days course may not be sufﬁcient. Therefore, we suggest
that the optimal antimicrobial therapy for the treatment of urinary tract
infections in women is not only based on predeﬁned standards but also on
background information of the patient.
P488 Decreased invasive capacity of penicillin-resistant
pneumococci
L. Moreno-Nun˜ez, R. Barba, L. Cirilo, J. E. Losa, M. Velasco,
A. Espinosa, J. Valverde, A. Delgado-Iribarren
Madrid, E
Objective: Streptococcus pneumoniae is a major cause of morbidity and mortality
in all age groups. In a few year penicillin nonsusceptible pneumococci have
emerged worldwide as a new threat. The objective of our study was to
determine the relationship between susceptibility and virulence.
Methods:We collected data regarding all strains of S. pneumoniae which were
identiﬁed in our hospital in Madrid during a 44-month period from April
1998 to December 2001. Susceptibility patterns to penicillin were classiﬁed as
intermediate (MIC 0.125 to <2.0mg/mL) and resistant (MIC> 2.0mg/mL)
as recommended by NCCLS.
Results: During the study period 229 different strains were identiﬁed. Of
these, 83 (34%) were recovered from normally sterile sites (blood and
cerebrospinal and pleural ﬂuid). Diagnosis included pneumonia (69 patients),
fever without obvious focus or infection (1 patients), meningitis (2), cellulites
(5), spontaneous bacterial peritonitis (1), bartolinitis (1), conjunctivitis (15),
otitis (16) and respiratory infections (135). Forty-four patients had some
degree of recognized immunocompromised, which was due to HIV infection
in 10 patients, neoplasic disease in 23 (13 hematological neoplasia), 8 chronic
renal impairment, 1 esplenectomy and 12 chirrosis. The proportion of isolates
that were nonsusceptible or resistant to antimicrobials was 47.3%. In sterile
specimens the rate of susceptibility was 39.5% and in nonsterile specimens
27.6% (P¼ 0.048). To further assess the independent value of this association,
we performed logistic regression analysis with penicillin resistance as the
dependent variable. Bacteriemic disease (OR 0.52 CI 95% 0.29–0.94) and
mortality (OR 2.3 CI 95% 1–5.6) were independently associated with the
presence of penicillin resistance.
Conclusion:Our data suggest that penicillin resistant pneumococci is less able
to cause invasive infection, and the presence or resistance increase the
mortality.
P489 Epidemiology of the staphylococcal bloodstream
infections in a teaching university hospital in Turkey and an
analysis of methicillin-resistant Staphylococcus aureus
isolates with pulsed-ﬁeld gel electrophoresis
B. Aygen, A. Yoruk, O. Yildiz, E. Alp, S. Kocagoz, B. Su¨merkan,
M. Doganay
Kayseri, Ankara, TR
Objectives: To determine the characteristics of community-acquired and
nosocomial staphylococcal bloodstream infections (BSIs) and to identify
clonal relationship of methicillin-resistant Staphylococcus aureus (MRSA) iso-
lates by pulsed-ﬁeld gel electrophoresis (PFGE).
Methods: Two hundred and ﬁfteen patients with staphylococcal BISs were
evaluated prospectively between June 1999 and June 2001. Various risk
factors, severity of the infection, complications and mortality were investi-
gated. Clonal relationship between MRSA isolates was analyzed by PFGE.
Results:Of the 215 patients, 16.3%were community-acquired BSI and 83.7%
nosocomial BSI. Twenty three of 35 (65.7%) patients with community-
acquired BSI and 75.6% patients with nosocomial BSI had an underlying
disease. Surgical intervention, foreign body, mechanical ventilation and total
parenteral nutrition, and previous antibiotic treatment were found to be
important risk factors for nosocomial BSI group. Secondary BSI was found to
be higher (62.9%) in community-acquired infections than nosocomial infec-
tions (27.8%). On the other hand, primary BSI was higher in nosocomial
infections (72.2%) (P> 0.05). Nosocomial staphylococcal BSIs, catheter-
related infection was observed in 72.3% of patients. Five of 35 (14.3%) with
community-acquired BSI and 22 (12.2%) with nosocomial BSI died because
of infection. Suppurative complication rate was signiﬁcantly higher in the
community-acquired infections (22.9%) than nosocomial infections (5%)
(P< 0.05). S. aureus was the etiologic agent in all patients with commu-
nity-acquired BSIs. Of nosocomial BSIs, the pathogen was S. aureus in 78.9%
and remaining 21.1% CNS. Methicillin resistance rate was 68.9%. The
analysis of 80 MRSA isolates with PFGE showed that 10 different main
clones (A–J) were present. Sixty-one of 80 (76.3%) isolates were belong to A
clone.
Conclusions: Staphylococcal BSIs lead to high mortality and signiﬁcant
complications. The source of infection is generally intravascular catheter
in nosocomial primary BSIs. The rate of methicillin resistance among the
nosocomial isolates is high. Majority of MRSA isolates belong to same clone.
We believed that a strict use of infection control measurements will prevent
MRSA spreading in our hospital.
P490 Lack of selection of monensin-resistant bacteria
M. McConville, J. Gate, T. Shryock
Tranent, Basingstoke, UK; Greenﬁeld, USA
Objectives: The concern over the use of antimicrobial agents in food animal
production and their potential to select for drug resistance in the microﬂora of
these animals has prompted regulatory authorities to request studies to assess
the potential for resistance to arise with consequent cross-resistance to other
therapeutic agents. Monensin is a polyether ionophore administered as a feed
additive to cattle and poultry to control coccidial infections or to improve
growth performance. This study is intended to develop a workable method to
assess the potential for monensin-resistant bacteria to arise in vitro among
normally susceptible bacterial species, in comparison to two unrelated
antibiotics.
Methods: Four bacterial species (E. coli, E. faecalis, S. aureus, C. perfringens)
were each serially subcultured 20 times in broth medium supplemented with
sublethal concentrations of monensin, nalidixic acid or tetracycline or no
supplementation. Antibiotic concentrations were increased during subculture
where tolerance became apparent. The susceptibility of isolates obtained at
passage 1, 10 and 20 to the three antibiotics plus an additional six unrelated
antibiotics (gentamicin, ampicillin, erythromycin, streptomycin, chloram-
phenicol, clindamycin) were determined using standard agar dilution
methods.
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Results: None of the four organisms exposed to monensin yielded isolates
with signiﬁcantly increased MIC values. In contrast, exposure to comparator
antibiotics shifted nalidixic acid MICs against E. coli from 2 to >128mg/mL
and against C. perfringens from 4 to >128 mg/mL and for E. fecalis the tetra-
cycline MICs shifted from 16 to 128mg/mL. No shifts were observed among
the control cultures in the absence of antibiotic. Cross-resistance to unrelated
products was not observed even where decreased susceptibility emerged.
Conclusions: Resistance to monensin by mutation and selection does not
occur in vitro under the experimental conditions tested in contrast to the two
comparator antibiotics.
P491 Epidemiology of antimicrobial agents resistance
to Streptococcus pneumoniae strains gained in Far East
Russia: new results
V. Turcutiycov, N. Kondrashova
Vladivostok, RUS
Objectives:Resistance of main respiratory pathogens to antimicrobial agents
has recently become the chief problem in treating infections of lower
respiratory tract all over the world. The Russian Far East is not an exception.
The whole world conducts control policy over resistance to antimicrobial
agents and the problem is regularly researched in Europe andWestern Russia.
Nevertheless, there is still lack of data concerning such wide territory as the
Russia Far East completely different from western Russia in terms of living
standards of urbans and rurals, age and ethnic composition. Our study is the
ﬁrst to determine the susceptibility patterns of various classes of antimicrobial
agents against S. pneumoniae isolates from Vladivostok. We used such anti-
microbial agents as penicillin, ceftriaxone, cefotaxime, ciproﬂoxacin, levo-
ﬂoxacin, chloramphenicol, clindamycin, and erythromycin.
Methods:We had worked with 134 isolates of S. pneumoniae from lab of the
Vladivostok Navy Hospital. Accordingly to NCCLS standards we used disco
diffusion method (DDM) and method of dilution in broth for the determin-
ing of minimal inhibitory concentrations (MICs). The lowest concentration
of antibiotic giving no visible growth was determined to be the MIC.
Results: Among all the penicillin resistant isolates (23%), 84% showed
intermediate resistance and 16% were highly resistant to penicillin. Of the
penicillin resistant isolates, 8.4% were resistant to erythromycin, 13.8% were
resistant to third generation cephalosporins, and 10% were resistant to
clindamycin. There was an overall resistance of 15% for ﬂuoroquinolones.
Conclusion:The high level of erythromycin and penicillin resistance reported
emphasizes the global trend of increasing resistance. The most applied agents
in our region are erythromycin, ciproﬂoxacin and penicillin. Control of the
problem of antimicrobial resistance will require more judicious and appro-
priate use of antimicrobials, the development of new agents with novel targets
of action, and strategies for preventing disease from occurring in the ﬁrst
place. In addition, the pursuit of an understanding of resistance mechanisms
and pharmacodynamics as they relate to clinical outcome must be an ongoing
effort, and that knowledge must be applied to the development of
more effective approaches for the treatment of community-acquired pneu-
monia.
P492 Current state of antimicrobial resistance of
S. pneumoniae in Russia: results of prospective
multicenter study (PEHASus-I, phase ‘B’)
R. S. Kozlov, O. V. Sivaja, O. I. Kretchikova, L. S. Stratchounski on
behalf of the PEHASus Project Group
Smolensk, RUS
Objectives: To determine the antimicrobial resistance of clinical strains
S. pneumoniae isolated in adults and children.
Methods:This study was conducted in 20 cities (Chelyabinsk, Ekaterinburg,
Irkutsk, Jakutsk, Jaroslavl, Kazan, Kovrov, Krasnodar, Moscow, N-Novgorod,
Novosibirsk, Novokuznetsk, Saint-Petersburg, Smolensk, Stavropol, Tju-
men, Tomsk, Rjazan, Upha, Voronezh) in different regions of Russia in
2001–2002. Identiﬁcation of the strains was done on the basis of colony
morphology, Gram stain, optochin susceptibility and bile solubility tests.
Susceptibility to penicillin G (PEN), amoxicillin (AMO), amoxicillin/cla-
vulanate (AMC), cefotaxime (CTX), cefepime (CFP), imipenem (IMP),
erythromycin (ERY), azithromycin (AZI), clarithromycin (CLA), mideca-
mycin (MID), clindamycin (CLI), telithromycin (TEL), levoﬂoxacin (LEV),
tetracycline (TET), cotrimoxazole (SXT), chloramphenicol (CHL), vanco-
mycin (VAN) was determined by broth microdilution. Breakpoints were
those of NCCLS (2002) except for TEL (0.5; 1;>/¼ 2mg/L) and MID
(4;>8mg/L).
Results: The total of 581 nonduplicate clinical strains of S. pneumoniae were
included in this study. The susceptibility testing results are presented in the
Table.
Conclusions: All b-lactams retained high activity against S. pneumoniae. High
resistance to TETand SXT compromises their usage for the empirical therapy
of pneumococcal infections. LEV, TEL and VAN demonstrated excellent in
vitro activity against both penicillin- and macrolide-resistant strains.
P493 Evaluation of perioperative antibiotic therapy in
an oncology ENT department
F. O. Mallaval, A. C. Vautrin, N. Fonsale, P. Y. Roman, A. Carricajo,
M. Roussier, J. Pascal, J. M. Prades, G. Aubert
Saint-Etienne, F
Objectives: To evaluate the efﬁcacy and the consequences on bacterial
ecology of peroperative antibiotic therapy in oncological surgery.
Methods: A prospective study from March 2001 to August 2002. Ninety-
eight patients undergoing initial oncological ENT surgery were included.
Antibiotic therapy, instituted during induction of anesthesia (D0), comprised
amoxicillin þ clavulanic acid (AUG) 1 g 3/24 h with gentamicin (GEN)
3mg/kg/24 h. GENwas prescribed fromD0 toD2 and AUG fromD0 to D5.
Peroperative samples of nasal and tracheal secretions (TS) were taken for
bacteriological analysis. Bacteriological analysis were performed for post-
operative samples taken on days 6 and 20 (TS and peritracheal pus).
Results: Peroperative: Nasal and TS samples were obtained from 96/98
patients, with TS samples alone being taken from 2/98 patients. Twenty-
seven percent (26/96) of nasal samples and 60% of TS samples (59/98) were
positive. Seventy-three microorganisms were isolated (duplicate organisms for
same patients excluded): 22 Staphylococcus aureus (SAU), 10 Haemophilus sp.
(HAE), 6 Streptococcus pneumoniae (PNE), 4 Pseudomonas aeruginosa (PSE), 23
enterobacteria (EN) (7 E. coli, 3 Klebsiella sp., 2 Enterobacter sp., 2 Serratia sp., 3
Proteus sp., 3 Morganella sp. . . .), 4 yeasts and 4 other bacteria. 45/73 (62%)
were sensitive to AUG and 62/73 (86%) were sensitive to GEN, with 66/73
(90%) being sensitive to both GEN and AUG.
Postoperative: 73/98 patients provided one or more postoperative samples.
At least one sample was positive for 57/73 (78%) patients. One hundred
thirteen microorganisms were isolated (duplicate organisms for same patients
excluded): 16 SAU, 4 HAE, 2 PNE, 5 PSE, 56 EN (16 E. coli, 11Klebsiella sp.,
3 Enterobacter sp., 5 Serratia sp., 6 Proteus sp., 8 Morganella sp., 10 Acinetobacter
sp., 2 Stenotrophomonas maltophilia, 6 yeasts and 12 other bacteria. 46/113
(40%) were sensitive to AUG and 104/113 (92%) were sensitive to GEN, with
106/113 (93%) being sensitive to both GEN and AUG.
Conclusions: Combined AUGþGEN as recommended by the SFAR, for
head and neck surgery, appeared to be effective against the majority of bacteria
isolated preoperatively in ENT surgery patients in our hospital. Prolonged
prescription of this drug combination could, however, lead to selection of
ﬂora resistant to AUG. A study of the clinical dossiers of 98 patients is now
being conducted. In view of these results, the department of ENT surgery is
MIC Breakpoints
Antimicrobial S I R I/R%
MIC90,
mg/L
MIC range,
mg/L
PEN 0.06 0.121 2 10/0 0.125 0.0042
AMO 2 4 8 0 0.06 0.032
AMC 2 4 8 0 0.06 0.034
CTX 0.5 1 2 1/0 0.03 0.0081
CFP 0.5 1 2 2/0 0.06 0.0081
IMP 0.12 0.250.5 1 3/0 0.06 0.0081
ERY 0.25 0.5 1 01 Aug 0.06 0.0162
AZI 0.5 1 2 01 Aug 0.125 0.034
CLA 0.25 0.5 1 01 Aug 0.06 0.0162
MID 1  1 0/5 0.5 0.034
CLI 0.25 0.5 1 0/3 0.03 0.0162
TEL 0.5  4 0 0.03 0.0020.25
LEV 2 4 8 0 1 0.12516
TET 2 4 8 Mrz 25 16 0.2532
SXT 0.5 01 Feb 4 26 May 2 0.06-8
CHL 4  8 0/9 4 0.068
VAN 1   0 0.5 0.034
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currently evaluating reduction of the duration of per-operative antibiotic
therapy.
P494 Effect of Lactobacillus F19 on antibiotic resistant
microorganisms in the intestinal microﬂora
A˚. Sullivan, A. Johansson, B. Svenungsson, C. E. Nord
Stockholm, S
Objectives:To examine if administration of Lactobacillus F19 in conjunction
with treatment with penicillin G prevents establishment of resistant strains of
enterococci, enterobacteria and Bacteroides spp. in the intestinal tract.
Methods: Twenty subjects admitted to the hospital receiving treatment with
penicillin G were recruited to the study. None of them had taken any
antimicrobial drug within the 3 months preceding the study. The adminis-
tration of antibiotics followed the routines at the Division of Infectious
Diseases at HuddingeUniversity Hospital. The patients were randomized into
one treatment and one placebo group and received either powdered milk only
or milk with added freeze-dried Lactobacillus F19. The products were given
twice daily for 14 days. Stool specimens were collected before administration
of antibiotic and probiotic products on day 1, on day 10 and 30 days after the
start of administration. The specimens were diluted and inoculated on
selective and nonselective media. Five colonies of enterococci, enterobacteria
and Bacteroides spp. were isolated from samples of each subject on days 1, 10
and 30. The MICs of penicillin G were determined and penicillin resistant
isolates were tested for MIC of clinically relevant antimicrobial agents.
Results: No major changes occurred in the normal aerobic or anaerobic
microﬂora during the study period apart from increased numbers of enter-
ococci on day 30 in the active group. The total numbers of resistant
micrororganisms remained at the same level in both groups during the study
period. One strain of E. faecium isolated on day 10 from an individual in the
active group was resistant to penicillin G, ampicillin, imipenem and cipro-
ﬂoxacin. Before the administration of antimicrobial agents a number of
enterobacteria revealed decreased susceptibility to ampicillin and piperacil-
lin/tazobactam. The MIC values increased on day 10 and decreased again on
day 30 in both groups. Isolates of Bacteroides spp. showed reduced susceptibility
to ampicillin/clavulanic acid, cefoxitin, cefoperazone and clindamycin
before, during and after administration of penicillin G. There were no
differences between the patient groups. Two isolates from two patients in
the placebo group showed reduced susceptibility to imipenem and metro-
nidazole.
Conclusions: The probiotic preparation used in this study did not have any
effect on the establishment of antibiotic resistant strains during administration
of penicillin G.
P495 Serotypic analysis of Streptococcus pneumoniae
involved in adult respiratory tract infections in France,
2000–2001
H. B. Drugeon, M. E. Juvin, N. Moniot-Ville
Nantes, Paris, F
Objectives: The objective of this study was to determine the distribution of
serotypes (ST) of S. pneumoniae (SP) strains involved in adult respiratory tract
infections and their susceptibility to antibiotics.
Methods: Six hundred seventy-ﬁve strains of SP were collected in 30 French
hospitals during the winter 2000–2001. Each participating center collected
over a 6-month period ﬁve consecutive strains per month from respiratory
tract infections of adult patients. MICs were determined by the agar dilution
method. Determination of capsular STwas performed with speciﬁc antisera
(Statens Serum Institute, Copenhague) with the quellung reaction.
Results:The most prevalent STwere the following: 23F (n¼ 111, 16.4%), 19
A (n¼ 60, 8.9%), 19F (n¼ 60, 8.9%), 14 (n¼ 58, 8.6%), 9 V (n¼ 56, 8.3%),
6B (n¼ 50, 7.4%), 3 (n¼ 40, 5.9%) and 6 A (n¼ 34, 5%). Other ST had a
frequency <5%. 52.4% of the strains were covered by the conjugate hepta-
valent vaccine and 80.6% by the 23-valent polyosidic vaccine. The suscept-
ibility rates to penicillin (P)/erythromycin (E) were the following: all strains:
49/52.3; ST 23F: 24.3/35.1; ST 19A: 31.7/26.7; ST 19F: 48.3/26.7; ST 14:
10.3/19; ST 9V: 21.4/55.4; ST 6B: 22/26; ST 3: 97.5/97.5; ST 6 A: 55.9/53.
No strain was resistant to telithromycin.
Conclusions:The results of this study show that two thirds of respiratory tract
infections in adults were caused by 8 ST, 5 and 7 of them being, respectively,
covered by heptavalent and 23-valent vaccines. The most resistant STwas the
ST 14 followed by the ST 6B. The 23F ST, most frequently isolated had also a
high rate of resistance to both P and E.
P496 Evaluation of drug resistance of mycobacterium
tuberculosis complex in urinary and respiratory samples of
patients with active TB disease
A. De Santis, A. Simone, G. Barra-Parisi, M. Rutigliano,
V. De Letteriis, M. Schiralli
Bari, I
Objective: Twenty-eight patients (Tisiatric Ward, San Paolo Hospital, Bari,
Italy) with both urinary and pulmonary active TB disease were investigated
from January to December 2002 with regard to the susceptibility to four most
commonly used antibiotics for TB therapy.
Methods: Twenty-three sputum, 1 urine, 3 bronchial lavage, and 1 pleuric
liquid obtained from the patients were positive for Mycobacterium tuberculosis
(M.T.) complex. Each sample which resulted positive derived from a single
patient. M.T. complex species were isolated by using liquid broth 7H9, and
the method utilized for drug-susceptibility testing was the ﬂuorescence test
(MGIT 960, Becton Dickinson). Drug susceptibility has been evaluated for
Streptomycin (SM), Isoniazid (INH), Rifampin (RIF), and Ethambutol
(EMB).
Result: The results are summarized as follows:
Conclusions: Our results highlight the general increase in our area of drug-
resistance for Mycobacterium tuberculosis complex; in particular it appears to be
noteworthy- the increase in drug-resistance for more than one antibiotic,
when compared with most recent reports.
P497 Study of drug resistance in pulmonary
tuberculosis patients in Shandong, China
Y. Deng, Y. Liu, S. Sun, C. Yu, Y. Wang
Jinan, CHN
Objective: To evaluate the pattern of drug resistance among pulmonary
tuberculosis patients with sputum acid-fast bacilli smear-positive.
Methods:During 1999, all sputum smear-positive patients in 30 clinics were
intake with their names, ages, sex, address, symptoms, and disease history
registered at the same time. Patients with 1 month or less of prior treatment
were deﬁned as new cases; those previously treated for more than 1 month
were deﬁned as retreatment cases. Their drug resistance patterns were
obtained by sputum culture for acid-fast bacilli (AFB) and sensitivity testing
with isoniazid (H), rifampicin (R), streptomycin (S) and ethambutol (E) in
proportion method.
Results:Of the 2106 patients evaluated, 1875 (89.0%) were culture-positive.
Of the 1875 patients aged 14–86 years, 1331(71.0%)were male and 544
(29.0%) were female, 404 (21.5%) were resistant to one or more drugs,
1553 (82.8%) were new cases and 322 (17.2%) were retreatment cases. Of new
cases, 259 patients were resistant to one or more drugs and the primal
resistance rate was 16.7% (95%CI was 14.8% to 18.6%). Of retreatment
cases, 145 patients were resistant to one or more drugs and the acquired
resistance rate was 45.0% (95%CI was 37.7–52.3%). Of these 1875 patients,
resistance to one drug was observed in 208 patients (11.1%), to two drugs in
119 (6.3%), to three drugs in 50 (2.7%) and to four drugs in 27 (1.4%). Single
drug resistance was most commonly seen with isoniazid (132 patients, 8.5%)
in new cases, and streptomycin (41 patients, 12.7%) in retreatment cases.
New cases Relapses Total patients (%)
21 7 28 100
Full susceptibility 11 4 15 53.57
Resistance
Streptomycin (SM) 2 – 2 7.14
Isoniazid (INH) 3 – 3 10.7
Rifamphin (RIF) – – – 0
Ethambutol (EMB) 2 – 2 7.14
INHþ RIF (MDR) 1 2 3 10.71
INHþSMþEMB 2 – 2 7.14
INHþRIFþEMB (MDR) – 1 1 10.71
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Multidrug-resistant (MDR) cases were not common: only 2.4% of the isolates
from new cases and 15.2% of those from retreatment cases were MDR.
Conclusion:Drug resistance is a major problem in the treatment of pulmonary
tuberculosis. Detection of drug resistance patterns and treatment with second-
line antituberculosis drugs in appropriate regimens are necessary in the
treatment of failure and relapse cases in order to reduce the emergence of
multidrug-resistant tuberculosis. Continued monitoring of treads in drug
resistance following DOTS implementation is needed.
P498 Glycopeptide-resistant Staphylococci in Greece
M. Maniati, E. Petinaki, F. Kontos, A. Pratti, D. Petropoulou-Milona,
L. Spaliara, G. Ganteris, M. Economou, D. Kairis, Z. Bersos,
C. Koutsia-Carouzou, E. Malamou-Lada, A. Maniatis
Larissa, Athens, GR
Objectives: Staphylococci with decreased susceptibility to glycopeptides have
been reported worldwide. The purpose of the present study was to determine
the prevalence of glycopeptide-resistant staphylococci in two different areas of
Greece.
Materials:Methods: In this study, three hundred seventy Staphylococcus isolates
(120 S. aureus and 250 coagulase-negative staphylococci) clinically signiﬁcant,
collected between January to December 2002, from hospitalized patients in
seven Greek hospitals (ﬁve in the rural area of Thessaly and two in the urban
area of Athens) were included. The identiﬁcation to species level was
performed by coagulase test and API Staph System (BioMerieux). Routine
antibiotic susceptibility testing was done by the disk diffusion method. MICs
to oxacillin and to glycopeptides (vancomycin and teicoplanin) was assessed by
agar dilution method according to NCCLS guidelines. Isolates with decreased
susceptibility to vancomycin or teicoplanin were typed using PFGE, and were
also examined for the presence of vanA, vanB, vanC1, 2, 3 genes coding for
vancomycin resistance in enterococci.
Results: Among S. aureus isolates none was found to be intermediate or full
resistant to glycopeptides. Among coagulase-negative staphylococci though
26 isolates (10.4%) (20 S. epidermidis, 5 S. haemolyticus and one S. hominis), all
methicillin-resistant, exhibited resistance to teicoplanin (MIC Y´16mg/L).
Cross resistance to vancomycin was detected in 18 isolates (MIC: 8–16mg/L).
The remaining eight isolates exhibited susceptibility to vancomycin (MICs:
3–4mg/L). PFGE analysis revealed the presence of nine different patterns. No
isolate was found to carry van genes.
Conclusion: S. aureus isolates remain susceptible to glycopeptides so far. On
the other hand, coagulase-negative staphylococci express resistance to gly-
copeptides (10.4%). This resistance was strongly correlated with the increased
consumption of teicoplanin in Greek hospitals the last years emphasizing the
need for glycopeptide resistance surveillance.
P499 Common proﬁle in three multidrug-resistant
Staphylococcus aureus strains isolated from blood cultures
from two different cities in Romania, 1997–2001
I. Codita, M. Straut, M. Popa, O. Dorobat, I. Nistor, N. Popescu,
R. Papagheorghe, C. Ghita, T. Turcu
Bucharest, Iassy, RO
Objectives: (a) To develop a model for the microbiological investigation of
nosocomial infections with multidrug resistant Staphylococcus aureus (S. aureus),
(b) To obtain preliminary data on the epidemiology of multidrug resistant
S. aureus isolated from nosocomial infections in Romania.
Methods: (a) S. aureus strains were identiﬁed using the coagulase, clumping
factor, Novobiocine and beta-galactosidase tests. (b) Antimicrobial Resistance
Testing was performed using the NCCLS standards. (c) Phage typing was
done in accordance with the Colindale IUMSCommittee for Staphylococcus
Typing recommendations. (d) The HARMONY protocol for PFGE mole-
cular typing was adapted for obtaining the strains proﬁle. We included 32
Methicillin Resistant Staphylococcus aureus (MRSA) strains in the molecular
study.
Results: (a) 28 from the 32 MRSA strains (87.85%) showed a high Oxacilline
MIC (class 3 in the Thomasz classiﬁcation). (b) No strain was VRSA or VISA.
(c) Only 31.25% of the strains were Peﬂoxacine susceptible. (d) 84.38% of the
strains showed a K-R, T-R, G-R aminoglicosides susceptibility pattern (e)
Only 35.20% from the 32 MRSA strains were Rifamycine susceptible. (f)
Only 40.62% from the 32 strains were bacteriophage susceptible. (g) We
found the same proﬁle for three strains isolated in the 1997–2001 interval in
two different cities sited in the Northern and in the Southern part of Romania
(two hospitals in Iassy and one in Bucharest).
Conclusions: (a) The model used in this study enabled us to obtain a
comparable phenotypic and molecular characterization of the strains. (b)
We found a high proportion of multidrug resistant strains. (c) Based on the
preliminary results on the molecular proﬁle of the strains we appreciate that
there is a need to go deeper in the study of the multidrug resistant MRSA in
Romania, especially in big, academic hospitals.
P500 High prevalence of mupirocin resistance among
coagulase-negative Staphylococci in Greece
M. Maniati, F. Kontos, I. Spiliopoulou, A. Pratti, D. Petropoulou-
Milona, Z. Bersos, S. Koutsorinaki, E. Petinaki, E. Malamou-Lada,
A. Maniatis
Larissa, Patras, Athens, GR
Objectives: In Greece, mupirocin ointment 2% (20.000mg/L) is used for
therapy of superﬁcial skin infections such as impetigo, infected eczema and
wound infections. In the present study, we investigated the incidence of
mupirocin resistance in staphylococci (S. aureus and coagulase-negative sta-
phylococci) isolated during 2000–2002 in Greek hospitals.
Methods:A total of 150 S. aureus and 200 coagulase-negative isolates (CNS),
obtained sporadically from patients at three hospitals of Greece (Central,
South-western and Athens) were screened for resistance to mupirocin. All
isolates were tested by disk diffusionmethod (DD), using a 5-mg/Lmupirocin
disk, and by MICs determination (E-test). The detection of ile-2 gene was
assessed by PCR. Molecular typing of mupirocin-resistant isolates was
performed by PFGE.
Results: Of the 150 S. aureus isolates, two isolates (1.3%) were mupirocin-
resistant by DD test. In the E-test, these isolates expressed MICs higher than
1024mg/L. Among CNS, mupirocin-resistance was detected by DD test in
60 isolates (30%), including 54 S. epidermidis, 4 S. haemolyticus and 2 S hominis.
The majority of these isolates (42, 70%) showed high-level resistance (MICs
higher than 1024mg/L), while the remaining isolates expressed MICs
ranging from 12 to 64mg/L (low-level resistance). All high-level mupirocin
resistant isolates possessed the ile-2 gene. This gene was not detected among
the low-level mupirocin resistant isolates. PFGE revealed the presence of
different clones for S. aureus and CNS.
Conclusions: Resistance to mupirocin remains low in S. aureus isolates in
Greece. Among CNS we have found higher rates of mupirocin resistance
(30%), with 21% high and 9% low-level resistance. Continued surveillance for
mupirocin resistance appears prudent where institutions utilize large amounts
for topical control of cutaneous or catheter-related infections
P501 Metallo-beta-lactamase positive Pseudomonas
isolates – Clinical experience with the ﬁrst VIM positive
isolates in the UK
H. Schuster, B. Cookson, G. Duckworth, D. Livermore, N. Woodford
London, UK
Objectives:We conducted an investigation into the epidemiology of the ﬁrst
seven Verona imipenemase (VIM) positive Pseudomonas isolates in the United
Kingdom. It was important to ascertain if those isolates had been brought into
the country from areas where those isolates are more prevalent or if they had
occurred spontaneously. We also focused on the infection control measures
that had been put into place.
Methods: We visited the hospitals where VIM positive isolates had been
isolated and conducted a case note review and interviewed the infection
control teams with help of a questionnaire. We assessed risk factors such as any
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recent travel abroad or contact with patients from abroad, antibiotics usage
prior to isolating VIM positive isolates along with disease related data such as
underlying diseases, duration of hospitalization or stay on intensive care units.
Results:AVIM bearing Pseudomonas aeruginosa isolate has been isolated in the
United Kingdom in 2001 followed by further P. aeruginosa isolates from 5
patients and a P. putida isolate from one patient in 2002. Two patients were
bacteremic with the VIM positive isolates whereas the remaining ﬁve patients
were ﬁrst positive from sputum. Most patients had been given beta-lactam
antibiotics and quinolones before the isolate were isolated. Particularly
ciproﬂoxacin featured as an antibiotic that had been given to most of the
patients. Carbapenems had not been given in all cases. All patients had been
hospitalized for greater 3weeks receiving antibiotics during this period before
VIM positive isolates had been isolated. Evidence of cross-infection based on
molecular typing of isolates occurred in one hospital only involving two
patients.
Conclusions: VIM positive isolates have become a reality for the UK and it
seems that the numbers of isolates are increasing. The isolates seem to have
evolved in the UK save those from twoGulf states patients. Antibiotic pressure
seems an important factor highlighting the importance of prudent use of
antimicrobials in clinical practice. It was intriguing that the isolates
showed low virulence especially when causing bacteremia and one might
question if the organisms might be less ﬁt as a result of carriage of multidrug
resistance elements. The importance of infection control measures has
been demonstrated for all cases and strict source isolation of patients is
paramount coupled with reinforcement of standard precautions to prevent
cross-infection.
P502 Antibiotic-resistant patterns of 131 Shigellae
isolates
M. Zangeneh, M. Jamshidi
Tehran, IR
Objectives: Evaluation of antibiotic resistance patterns of Shigellae isolates.
Methods: Study area Amiralmomenin hospital, from March 1998 to March
2002.
Type of study:Descriptive, analytical, cross-sectional and retrospective. From
all patients with diarrhea stool sample were collected and stool exam and stool
culture were done. Antimicrobial sensitivity were performed. The antibiotic
discs were: ampicillin, aamikacin, cefotaxim, ceftizoxim, ciproﬂoxacin, cotri-
moxazol, gentamycin, nalidixicacid, nitrofuratoin, tobramycin.
Results: From 2588 diarrheal cases, 131(5/07%)were found positive for
Shigella sp, 62(47/3%)cases were women, 69(52/7%) cases were men. The
antibiotic resistance proﬁle were: Resistant to ampicillin 127 cases (96/9%),
amikacin 10(7/7%), ceftizoxim 5(3/8%), cefotaxim 3(2/3%), ciproﬂoxacin
2(1/5%), cotrimoxazol 110(84%), nalidixic acid 13(9/9%), nitrofuratoin
25(19/1%), tobramycin 47(35/8%), gentamycin 49(37/4%).
Discussion: Shigellae species play a major role in diarrhea in Iran and their
antibiotic patterns are of importance to shigellosis control. Cotrimoxazol
(84%) and ampicillin resistance (96/9%) were important ﬁnding in this study.
ciproﬂoxacin, cefotaxim, ceftozoxim, nalidixic acid are drugs of choice for
shigelosis. Sensitivity test and antibiotic resistance are needed in shigllosis
control.
Molecular diagnosis and characteristics of Staphylococcus aureus
P503 Rapid detection of methicillin-resistant
Staphylococcus aureus (MRSA) in blood cultures by
gene probe hybridization assay (EVIGENE)
K. Levi, K. J. Towner
Nottingham, UK
Objectives: Bacteremia caused by Staphylococcus aureus, and the increasing
prevalence of methicillin-resistant strains, are a major cause for concern
worldwide. As conventional culture and antibiotic susceptibility techniques
take 48 h to identify MRSA from the time a blood culture is positive,
empirical use of glycopeptides is common. Use of a rapidmolecular technique
for the identiﬁcation ofMRSA from positive blood cultures would allow early
and appropriate treatment decisions to be made. This study evaluated a rapid
gene probe hybridization assay in comparison with PCR and conventional
culture for the detection of MRSA in blood cultures.
Methods: The EVIGENE MRSA Detection Kit (Statens Serum Institut,
Copenhagen, DK) uses gene probe technology to identifyMRSA on the basis
of the mecA gene, which encodes for PBP20, in conjunction with the nuc
thermostable nuclease gene speciﬁc for S. aureus. In accordance with the
manufacturer’s instructions, 1mL samples from blood cultures positive for
Gram-positive cocci in clusters were incubated for 3 h in Mueller–Hinton
broth prior to lysis and the addition of mecA, nuc and 16S rRNA probes.
Hybridization, capture and detection of probe–target complexes were carried
out in a microwell strip format with results obtained in <3.5 h. EVIGENE
results were compared with those obtained by mecA/femB PCR and
conventional culture on ORSA (Oxacillin Resistance Screen Agar; Oxoid)
plates.
Results: In a survey of 200 blood cultures positive for putative staphylococci,
the EVIGENE kit identiﬁed 18 samples as MRSA-positive. Of these, 17 were
also positive by PCR. The sample that was EVIGENE-positive PCR-
negative was also positive by PCR and latex agglutination when isolated
bacterial colonies were tested. Incubation on ORSA and subsequent latex
agglutination of deep blue colonies identiﬁed 16 samples as MRSA-positive.
No false-positive EVIGENE MRSA identiﬁcations arose from the detection
of mecA and nuc sequences from separate isolates.
Conclusion:The EVIGENEMRSADetection Kit is a speciﬁc, simple-to-use
molecular assay that enables the identiﬁcation of MRSA in blood culture
samples within a working day without any of the drawbacks of PCR. Rapid
identiﬁcation of MRSA from blood cultures would enable timely and
appropriate treatment and the reduction of empirical glycopeptide use.
P504 Clinical evaluation of a novel isothermal signal
ampliﬁcation assay (CytAMPTM) for rapid detection of
methicillin-resistant Staphylococcus aureus
K. Levi, C. Bailey, A. Bennett, P. Marsh, D. L. N. Cardy, K. J. Towner
Nottingham, Adderbury, UK
Objectives: To evaluate a prototype isothermal ampliﬁcation assay for the
rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) from
patient screening swabs.
Methods: The prototype CytAMPTM MRSA assay (Cytocell Ltd) was
evaluated with 396 clinical isolates of bacteria and 100 sets of MRSA
screening swabs. Bacteria for speciﬁcity tests were taken direct from overnight
cultures grown on agar plates, while the swabs were incubated overnight at
308C in brain heart infusion broth containing oxacillin (2mg/L). Both were
then examined for MRSA by: (i) the CytAMP assay; (ii) conventional culture
on oxacillin-resistance screening agar (ORSA; Oxoid) followed by latex
agglutination tests; (iii) mecA/femB PCR. The CytAMP assay is based on
isothermal signal-mediated ampliﬁcation of RNA technology (SMART),
which generates multiple copies of an RNA signal. This signal is detected by
an enzyme-linked oligosorbent assay, which generates a color signal in a 96-
well microtiter plate. The CytAMP MRSA assay detects the presence of the
coa (coagulase) and mecA genes, thereby simultaneously identifying the
presence of S. aureus and methicillin/oxacillin resistance. Results are obtained
in 3.5 h.
Results: Initial experiments indicated that the CytAMP limit of detection was
1E5–1E6 CFU/assay, equivalent to 1E6–1E7 CFU/mL in the overnight
broth. This level of growth was obtained with an initial MRSA inoculum of
10–50CFU. CytAMP and PCR both detected 113 MRSA among the 396
clinical isolates of bacteria. Conventional culture indicated the presence of
109 MRSA, but this result concealed signiﬁcant false-positive (19) and false-
negative (23) results compared with themolecular methods. Discrepant results
were also observed between the culture and the molecular methods for the
100 sets of screening swabs. CytAMP and PCR were generally in agreement,
but six screening broths were negative by CytAMP and positive by PCR. Five
of these contained between 1E2 and 1E5 CFU per assay (below the CytAMP
detection limit) and the sixth contained 1E6 CFU/assay.
Conclusions: The prototype CytAMP assay was speciﬁc for MRSA, but was
slightly less sensitive than PCR. This may be advantageous in the clinical
environment where PCR yields apparent false-positive results, possibly
following cross-contamination or detection of dead cells. The CytAMP assay
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is user-friendly for nonmolecular biologists and lends itself well to the
workﬂow of a diagnostic laboratory, generating results for the hospital ward
before lunchtime the next day.
P505 Rapid identiﬁcation of staphylococci and the
mecA and nucA genes from Bactec blood culture bottles by
using the LightCycler System
M.Ruiz, M. J. Torres, L. A. Arroyo, T. Prados, J. C. Palomares, J. Aznar
Seville, E
Objectives:To examine the feasibility for detection of Staphylococcus aureus and
Coagulase negative staphylococci (CoNS), and identiﬁcation of methicillin
resistance directly in positive BACTEC blood culture bottles using the
LightCycler system.
Methods: One hundred and ﬁfty-three consecutively positive blood culture
bottles (BACTEC 960 Roche Diagnostics) obtained from 74 patients were
collected. Bottle contents that signaled positive were Gram stained, and
inoculated onto 5% sheep blood agar; if gram-positive cocci in clusters were
seen, a 1mL aliquot for PCR was also immediately removed and stored at
708C until tested for molecular assay. Thirteen positive bottles with
microorganisms other than staphylococci were included as controls. A
molecular assay based on automated DNA extraction protocol with aMagNA
Pure LC instrument and real-time PCR with a Light-Cycler instrument
(Roche Diagnostics) was evaluated in 153 positive blood bottles. Oligo-
nucleotide primers and ﬂuorescence-labeled hybridization probes, designed
for ampliﬁcation and sequence-speciﬁc detection of both a 408 bp fragment
within themecA gene and a 279 bp fragment within the S. aureus-speciﬁc nucA
gene were obtained from TIB MolBiol (Berlin, Germany).
Results: Twenty-two bottles which yield MRSA strains were correctly
identiﬁed by the nucA and mecA PCR assay. However, in one bottle, a mixed
culture of MRSA and MSSA was found giving PCR-positive for both nucA
and mecA. All the 41 bottles which yield MSSA gave positive results for the
nucA but negative results for the mecA gene. The 48 bottles that yield
methicillin-resistant CoNS strains were correctly identiﬁed by PCR. In
the 21 bottles with MSCoNS, nucA PCR was negative, but in this later
case, two bottles gave positive results for mecA gene, and were considered as
false positives by PCR. The sensitivity and speciﬁcity of the nucA gene assay
were 100%, identifying all the S. aureus correctly. The sensitivity and
speciﬁcity of the PCR assays for detection of methicillin resistance with
the mecA gene in bottles containing S. aureus and CoNS were 100 and 97.5%,
respectively.
Conclusion: This is a sensitive and highly speciﬁc method to identify
staphylococci in positive blood cultures, allowing discrimination between
methicillin-suceptible and -resistant strains.
P506 Highly sensitive and speciﬁc LightCycler assay for
the detection and differentiation of pathogenic-important
Staphylococcus species
R. Schueffner, M. Auer, U. Zeilfelder, G. Haberhausen
Penzberg, D
Background: Staphylococci are facultative anerobe Gram-positive spherical
bacteria that grow in grape-like clusters, chains or pairs. They are ubiquitously
present in the human microﬂora, especially on skin and mucosal surfaces. Of
the so far known Staphylococcus species, Staphylococcus aureus, S. epidermidis,
S. haemolyticus and some other coagulase-negative staphylococci (CoNS) are
of major medical interest. S. aureus and S. epidermidis cause most of the
nosocomial infections in intensive care units (ICU) resulting from surgical
wound infections and intravascular catheter contamination, and leading to
bacteremia and endocarditis. Moreover, staphylococci are responsible for
severe hospital-acquired infections such as Osteomyelitis, septic arthithis and
pneumonia.
Methods: Here, we describe the development of a highly reliable, sensitive
and speciﬁc LightCycler assay for research use based on hybridization probes.
Results: The test allows PCR ampliﬁcation, detection and differentiation of
S. aureus DNA and the most important CoNS DNA. Differentiation is
performed by melting curve analysis of amplicons subsequent to the PCR.
Melting curve analysis reveals a single peak for S. aureus at 628C, which can
clearly be differentiated from CoNS peaks showing up at a lower temperature
(51–578C). Reliability of the system is given by coampliﬁcation an homo-
logues internal control (IC) within each reaction. Spiked into the lysis buffer
prior to extraction, the IC acts as an extraction and inhibition control in each
individual sample in order to avoid false negative results. The described
LightCycler Staphylococcus assay gives a sensitivity of less than 10 geq/reaction
as determined by the Probit analysis.
Conclusion:The assay has been shown to be a fast and highly reliable research
tool to differentiate S. aureus from the most important CoNS. It is suitable for
a wide variety of research applications.
P507 IcaA and IcaD bioﬁlm-controlling genes in
staphylococci: PCR-based detection in clinical samples of
patients with septic arthritis
J. Benedı´k, M. Grijalva, R. Horva´th, M. Dendis, Z. Rozkydal
Brno, CZ
Objective: Many factors of virulence, including the ability to form slime
(bioﬁlm), seem to be important in the pathogenesis of staphylococcal septic
arthritis. Coexpression of icaA and icaD genes has been demonstrated
necessary for bioﬁlm formation in strains of Staphylococcus epidermidis and
S. aureus. Although culture and phenotypic tests for discrimination of bioﬁlm-
forming strains are important aids, rapid molecular assays capable of detecting
icaA or icaD genes might contribute with valuable and timely information for
clinicians treating septic arthritis patients.
Methods:Two separate PCR-based assays were developed targeting the locus
of icaA and icaD of the staphylococcus genome. The assays were assembled as
duplex systems, which included the icaA or icaD product and a second product
based on universal bacterial 16S rRNA primers.
Results: Thirteen synovial ﬂuid samples from patients with staphylococcal
septic arthritis (PCR-detected) were tested on both icaA and icaD systems. A
scale of positive controls from a bioﬁlm-forming S. epidermidis strain was used
for testing the analytical sensitivity of the assays. Two out of the 13 tested
strains were icaA and icaD PCR-positive, one sample was icaA-positive only
and eight were icaD-positive only.
Conclusions: Our results show that the presence of icaA or icaD genes in
staphylococci from this group of staphylococcal septic arthritis samples is
rather low. Since icaA is the main gene controlling bioﬁlm formation in
staphylococci, only the two icaA- or icaD-positive strains might be able to
form bioﬁlms. The assays may be performed directly on clinical samples.
P508 Detection of the Panton-Valentine leukocidin
gene in Staphylococcus aureus by LightCycler PCR: clinical
and epidemiological aspects
D. Johnsson, P. Molling, K. Stralin, B. Soderquist
Orebro, S
Objectives: Panton-Valentine leukocidin (PVL) is an exotoxin produced by
Staphylococcus aureus, affecting human leukocytes and promoting necrotizng
tissue reactions. Recent studies have shown PVL-producing S. aureus strains to
cause severe necrotizng pneumonia and primary skin infections. The aim of
this study was investigate the prevalence of PVL-positive S. aureus in a Swedish
setting, and for that purpose, a rapid and simple real-time PCR for detection
of the PVL gene was developed.
Methods: S. aureus isolated from three different groups of patients were
investigated: S. aureus septicemia, cutaneous infections and respiratory tract
infections. A real-time PCR assay utilizing the LightCycler instrument with
SYBR-Green-I (Roche Diagnostics, Mannheim, Germany) was developed
for detection of the PVL gene.
Results: The PVL locus was detected in 1 of 65 strains from patients with
S. aureus septicemia. In cutaneous cultures, collected consecutively during
2 days, 1 of 43 S. aureus isolates was found carrying the gene. On the other
hand, in cutaneous methicillin-resistant S. aureus (MRSA) isolates collected
since 1999, 15/25 were found to be PVL-positive. All of these MRSA were
community-acquired and consisted of at least four different clones, according
to the pulsotype found by pulsed-ﬁeld gel electrophoresis. Also, all other
S. aureus (non-MRSA) isolates from patients with skin infections, stored at the
Department of Microbiology for various reasons during this period (n¼ 48),
were analyzed, whereof one was tested positive. Finally, in all S. aureus strains
isolated from the respiratory tract found stored in the same manner at the
laboratory since 1999 (n¼ 56), four strains were positive for the PVL gene;
none of these were MRSA. Two of these PVL-positive isolates were from a
prospective study of pneumonia etiology during 1999–2002 including 31
S. aureus isolates.
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Conclusions: Application of the LightCycler System represents a simple,
reliable, reproducible and rapid PCR for detection of PVL gene in S. aureus.
The PVL gene was detected in isolates from patients with recurrent primary
skin infections and S. aureus pneumonia, but PVL does not seem to be an
important virulence factor in the pathogenesis of staphylococcal septicemia.
Remarkably, all PVL-positive cutaneous MRSA were community acquired
and comprised of at least four different clones.
P509 Development of molecular probe using RAPD and
REP for diagnosis of Staphylococcus aureus infection
N. S. Mariana, V. Neela, E. Amghalia
Selangor, MY
Objectives: The objective of the research is to develop a molecular probe for
the rapid identiﬁcation of an important nosocomial pathogen, Staphylococcus
aureus. One of the major causes of intensive care unit mortality and morbidity
is nosocomial infection. S. aureus causes multitude of infectious diseases, and is
also known to confer multiple drug resistance. The conventional method for
identiﬁcation is time consuming and laborious. In this study, application of
genomics using randomly ampliﬁed polymorphic DNA (RAPD) and repe-
titive sequence PCR (REP) were utilized to establish DNA ﬁngerprints of
pathogen, and from the established ﬁngerprint, a molecular band was
identiﬁed to be used as a probe for the identiﬁcation of the pathogen.
Methods: Fifty S. aureus isolates from different hospitals in Malaysia were
ﬁngerprinted byRAPD, using arbitraryOPAE primers (6, 10, 11, 14, and 15),
and REP using three primers designed from three unique repetitive sequences
that were distributed over the entire S. aureus genome. Ampliﬁcations were
performed in a volume of 25 mL of PCR cocktail containing genomic DNA,
one of the arbitrary or REP primers, dNTPs mix, and Taq polymerase.
Ampliﬁcation was performed for 35 cycles for 1min at 948C, 1min at 368C,
and 2min at 728C, followed by the one single extension cycle for 7min at
728C. The products were electrophoresed, and the molecular probes were
visually identiﬁed.
Results:All isolates were conﬁrmed as S. aureus by the conventional methods.
Electrophoresis of ampliﬁed products using the RAPD and REP techniques
revealed DNA bands with different patterns. The number of DNA fragments
for an isolate ranged from 1 to 16 bands. REP-PCR produced three
molecular markers, positions 500, between 1500 and 2000 bp, and slightly
above 750 bp, in all S. aureus isolates but not in other genera studied. The band
at position 500 bp was chosen to be the molecular probe because of the small
size and sharpness, clarity and distinction. The markers for RAPD were
500 bp for OPAE14 and 750 bp for OPAE15. Again, the most suitable RAPD
molecular probe is the 500 bp because of the size.
Conclusion:Based on the results, REP probe would be a more suitable probe
to be developed as a diagnostic probe for identifying local S. aureus isolates.
The reason for this is that the primers for REP were designed from the
repetitive sequence found in S. aureus genome, while the RAPD primers were
random primers.
P510 BioPlex1 technology: application to the
simultaneous differentiation and quantiﬁcation of
staphylococcal epidermolysins A and B
O. Joubert, D. Keller, H. Monteil, L. Talbot, G. Prevost
Strasbourg, Marnes-la-Coquette, F
Objectives: Staphylococcal epidermolysins A (ETA) and B (ETB) from
Staphylococcus aureus are proteases associated with staphylococcal scalded skin
syndrome and bullous impetigo of young children, which constitute a risk of
epidemics in nurseries and pediatrics. Caution of suspected cases remains
frequently asked. Interestingly, the BioPlex1 technology (Bio-Rad) offers a
rapid and quantitative assay of antigens or antibodies in a single well.
Methods: BioPlex1 is supported by a simultaneous cytometry-based detec-
tion of colored beads activated by antibodies or antigens and a phycoerythrin
(PE) ﬂuorescence-generated signal. Beads, differently colored by a mix of two
ﬂuorophores/pigments, deﬁne 100 different color regions. PE ﬂuorescence
matches with the streptavidin and biotinylated antibodies or antigens. Anti-
bodies immobilized on beads can interact with sampled antigens, and further
have been recognized by the biotinylated antibodies. Association of several
different beads in a single well allows multiple detections.
Results: After the covalent binding of afﬁnity-puriﬁed rabbit polyclonal
antibodies onto beads and the biotinylation of the same antibodies, the
system was evaluated towards the detection of the two corresponding puriﬁed
ETA and ETB from strain culture supernatants. The method offered valuable
measures from 10 to 25 000 ﬂuorescence arbitrary units corresponding to
concentrations ranging from 1 to 16 000 pg/mL, respectively, with a >99%
correlation factor in linear regression curves. Controls evidenced a satisfying
speciﬁcity. Repeatability essentially depends on activated beads with variation
<2% between 2 and 16 ng/mL,<8% between 60 and 2 ng/mL, and from 8 to
15% between 1 and 60 pg/mL. When a series of S. aureus strains previously
typed by radial gel immunoprecipitation (IP) (26 were ETA–/ETB–, 24
ETAþ/ETB–, 9 ETA–/ETBþ, 26 ETA–/ETB–), correlation was obtained
for 98.8% of the strains. Amounts of ETB appeared more variable than those
of ETA, but supernatants must be diluted 1/10 000 and 1/50 000. If fact, one
strain was revealed ETB-producer by BioPlex1 whereas not by IP, and the
presence of etb gene was further conﬁrmed by PCR.
Conclusions: The BioPlex1 assay appears as a progressive, rapid, reprodu-
cible, and easy-to-apply method for multiple assessment of antigens in a single
well from a small sample, as was given as an example with staphylococcal
epidermolysins, and at least as sensitive as ELISA.
P511 Highly sensitive and speciﬁc LightCycler assay for
detection and differentiation of Enterococcus faecalis and
Enterococcus faecium DNA
C. Zoelch, U. Zeilfelder, G. Haberhausen
Penzberg, D
Background:Enterococcus faecalis and E. faecium are two Gram-positive bacteria
which are part of the normal human microﬂora of the intestine and the upper
respiratoral tract. Since they are of ubiquitous spread, they are playing an
important role in nosocomial infections. Especially, vancomycin-resistant
Enterococcus (VRE) strains are of increasing threat in intensive care units
(ICU) causing nosocomial bacteremia, surgical wound, or urinary tract
infections. Due to the fact that Enterococcus ssp. contains intrinsic resistance
against most known antibiotics, they are a major source of superinfections.
Methods: We have developed a highly speciﬁc and sensitive real-time PCR
for use on the LightCycler instrument using hybridization probes.
Results: Intended as a life science research tool, the assay is able to detect and
differentiate the two most frequent Enterococcus pathogens: E. faecalis and
E. faecium in nucleic acid preparations from bacterial cultures, blood cultures
and biological samples. Differentiation of both species is accomplished by
using melting curve analysis on the LightCycler instrument subsequent to
PCR ampliﬁcation. Melting peaks for both E. faecalis and E. faecium are clearly
distinguishable at 58 and 548C, respectively. Moreover, the LightCycler assay
offers a sensitivity corresponding to 10–20 genome equivalents/reaction
(geq/PCR).Putative inhibitory effects (e.g. from interfering compounds
within the sample), which might lead to false-negative results, are controlled
by coampliﬁcation of an internal control (IC) within each reaction. This IC is
designed to be ampliﬁed by the same primer pair but detected by an additional
hybridization probe. Furthermore, the assay is fully compatible with the PCR
workﬂow system, which further improves robustness, convenience, and
reliability of the assay.
Conclusions: Our LightCycler Enterococcus test describes a versatile highly
sensitive and speciﬁc assay to differentiate E. faecalis and E. faecium. It is
perfectly suited for a wide range of research applications.
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P512 Development and validation of 14 LightCycler
real-time PCR assays for the quantiﬁcation or qualitative
detection of common viral and bacterial infections in various
specimen types
T. Krech, S. Chong, X. Song, T. Bruderer, D. Jang, J. B. Mahony,
A. K. Petrich, K. Luinstra, S. Castriciano, M. Smieja, M. Chernesky
Kreuzlingen, CH; Hamilton, CAN
Objectives: Quantitative measurements of microbial pathogen nucleic acids
in clinical specimens may be indicative of disease severity, infectiousness, or a
measure of treatment response. Our objectives were to develop eight quan-
titative and six qualitative assays on the Roche LightCyclerTM instrument
which could be applied to specimens routinely submitted to a diagnostic
laboratory. Validation of the methods was performed on clinical specimens
containing viruses or bacteria determined by other diagnostic methods such as
culture, DFA, or PCR.
Methods:PCR primers and probes for each organismwere designed based on
the product size, absence of secondary structure, melting temperatures, and
speciﬁcity conﬁrmed by an NCBI database search. Positive controls (ATCC
strains) for each target were cloned into the pGEM-T vector and quantiﬁed by
spectophotometry. All assays were optimized for magnesium chloride and
probe concentrations. PCR efﬁciencies were calculated for both cloned
controls and clinical samples of urine, buffy coat, cervical swabs, nasopharyn-
geal secretions, feces, and serum, mocked with microorganism. Assays were
compared to qualitative PCR and other diagnostic methods by more than one
technologist. Quantitative protocols were developed and validated for CMV;
HPV 16, 18, 31; RSV;HCV;C. trachomatis, and Bordetella pertussis. Qualitative
assays were developed for parainﬂuenza 1, 2, 3; Inﬂuenza A and B; and
enteroviruses. Assays used FRET probe hybridization. The HPV assays used
SYBR green and the enterovirus test applied Taqman chemistry.
Results:Optimized PCR assays yielded ampliﬁcation curves that were steep,
well-shaped, had early crossing points of 20–30 cycles for the high copy
number controls, and were evenly spaced with 10-fold dilutions of the target.
The PCR efﬁciency for the cloned controls and the clinical specimens were
similar and ranged from 1.7 to 2.1. Assays demonstrated a lower range of
detection of 1–100 copies. The sensitivity of the assays ranged from 83.3 to
100%, and speciﬁcity ranged from 90 to 100%. Variations of results between
technologists or diagnostic methods were minimal.
Conclusions: These protocols, with their rapid turnaround, provide new
molecular tools for detecting and measuring viral and bacterial load in clinical
specimens from patients with respiratory disease, transplant acquired or
reactivated CMV infection, sexually transmitted human papillomavirus or
chlamydia, hepatitis C virus, or enterovirus infections.
P513 Identiﬁcation of viruses and bacteria by real-time
nucleic acid sequence-based ampliﬁcation (NASBA)
S. Myhr, E. Fykse, J. Strand Olsen, F. Karlsen, T. Nordstrøm,
G. Skogan
Kjeller, Klokkarstua, N
Objectives: Nucleic acid sequence-based ampliﬁcation (NASBA) is a robust
RNA-ampliﬁcation technology developed during the last decade and used to
detect a number of pathogenic viruses and bacteria. Advantages of the method
compared toRT-PCR includes that theNASBA reaction is isothermal (418C)
and, thus, does not require a thermocycler, and that DNA-free RNA is not
required as a template, as the ampliﬁcation is selective for RNA. This makes
NASBA suitable for miniaturization into lab-on-a-chip systems. The short-
time objective of this study has been to test the NASBA method on several
model organisms in our laboratory: MS2 phage, HPV virus, and Bacillus cereus.
Important aspects are sensitivity and speciﬁcity of the method compared to
RT-PCR. Subsequently, we will develop NASBA detection protocols for
different microorganisms related to biological warfare, and ﬁnally adapt the
optimized laboratory protocols to a microchip (protoype is developed) with
the ability to simultaneously detect a number of these organisms in real time.
Methods:Nucleic acids (RNAþDNA)were isolated fromMS2 phage, HPV
virus, and B. cereus using the NucliSens Basic Isolation kit (OrganonTeknika).
For B. cereus, the lysis buffer did not lyse the cells, and the bacteria were
subjected to ultrasound (while in the lysis buffer). Tenfold dilution series of
RNAwas ampliﬁed using the NucliSens NASBA kit (OrganonTeknika). For
HPV, we used the HPV-proofer kit (NorChip AS). Ampliﬁcation was
performed in several different ‘PCR machines’.
Results: Very good detection limits were obtained for both MS2 phage (one
phage particle) and HPV virus (0.01 pmol/mL), and no signals were obtained
for the negative controls (other RNA viruses and sterile water). For the MS2
sample, some free RNA may have been present in the phage lysate used
(contributing to the good detection limit). For B. cereus, no ampliﬁcation was
detected. This was found to be due to the defect beacon probes (two different
set of primers and probes were tested). Ampliﬁcation in the SmartCycler and
I-cycler yielded equally good results, while in the LightCycler it reduced the
ampliﬁcation efﬁciency, and sensitivity was seen.
Conclusions: NASBA appears to be a sensitive and robust method for
detection of microorganisms. However, beacon design is critical, and several
sets of primers and beacons should be tested for each organism.
P514 Identiﬁcation of bacterial species using 16S rDNA
signature sequences
S. Chatellier, D. Childress, L. Aftuck, B. Lacroix, V. Blanc, B. Blanc,
K. Weinstock, D. Moir
La Balme Les Grottes, F; Waltham, USA; Ve´nissieux, F
Objective: The objective of this study was the construction of a large set of
16S rDNA signature sequences to be used on a molecular tool platform for
rapid bacterial detection and identiﬁcation.
Methods: Sequencing of 16S rDNAwas performed on 1324 bacterial samples
representing 565 species, according to phenotypic identiﬁcation. 16S rDNA
sequences were fragmented in 20 or 30mer segments. Blast searches against
GenBank and Ribosomal Database Project databases were performed. The
segments that displayed a perfect match or a homology with one mismatch
with a single species were selected as species-speciﬁc probes. Experimental
validation of the species speciﬁcity of some of these probes identiﬁed in silico
was conducted by real-time PCR assays.
Results: A total of 2724 30mer probes and 25 346 20mer probes were found
unique and speciﬁc for 325 and 648 different species represented in available
databases, respectively. Twenty-ﬁve of the 30mer probes speciﬁc for clinically
important organisms such as Enterococcus faecalis and Streptococcus agalactiaewere
then used as TaqMan probes to check their species speciﬁcity. Up to 16 isolates
of the same species for which the 30mer probes were speciﬁc and up to 27
isolates belonging to as many as 18 other species were tested by a real-time
PCR. A positive ampliﬁcation signal was only obtained for isolates belonging
to the species expected to be targeted by the 30mer probe in all but one case.
When only two or three mismatches were needed within the probe sequence
to eliminate its species speciﬁcity, isolates of highly related species gave a
delayed ampliﬁcation signal that could still be differentiated from a true
positive signal. Overall, TaqMan results agreed with the results expected based
on the sequences of the probes and the 16S rDNA.
Conclusions: A large set of bacterial species was used to deﬁne 16S rDNA
signature sequences in silico. The species speciﬁcity of a subset on these probes
was successfully veriﬁed by Taqman PCR assay. These ﬁndings provide useful
information to develop rapid bacterial identiﬁcation kits based on 16S rDNA
signature sequences.
P515 Restriction-fragment length polymorphism
(RFLP)-PCR as a mechanism to discriminate between closely
related organisms in a complex ecosystem
J. M. Park, A. S. Low, F. M. MacKenzie, I. M. Gould, I. R. Booth
Aberdeen, UK
Objectives: PCR-based methodologies for interstrain discrimination were
established, based on previous observations that the major porin gene (ompC)
sequences are highly diversiﬁed in clinical isolates of Escherichia coli. The aim
was to study the diversity of the E. coli population in the stool of a patient with
E. coli septicemia, and to characterize the infecting E. coli.
Methods:Ten colonies of E. coli from a positive blood culture and 20 colonies
of E. coli from the stool of the same patient were analyzed. RFLP analysis was
carried out on the porin genes ompC, ompF, lamB, ompA, chuA, and phoE, and
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the cytoplasmic proteins gloA and mdh. In addition, PFGE was carried out,
and metabolic patterns and antibiograms were established for the isolates.
Sequencing of a hypervariable region of the 16 s rRNAwas also carried out.
Results: RFLP analysis of the porin genes differentiated two clusters of fecal
E. coli, one of which was identical to the strain recovered from the blood
culture. The same discriminatory pattern was also obtained for gloA, whereas
analysis of mdh was uninformative. The results mirrored those obtained by
PFGE, indicating that the PCR-based method is equally as useful as the
established technique. Sequencing of the 16s rRNA gene region did not
discriminate between any of the isolates. When the isolates were analyzed by
metabolic patterns and antibiograms, it was found that the strains that were
not separated by molecular methods (PFGE and RFLP of porin genes) could
be differentiated further. Melibiose and sucrose utilization were found to vary
across the 30 isolates. In addition, the isolates exhibited MIC values for
amoxicillin that ranged from 4 to 1024mg/L. These differed further in the
presence of clavulanic acid. Using these additional properties the major group
of fecal organisms, identiﬁed by RFLP analysis, was further divided into three
subgroups with shared metabolic properties and antibiograms. Thus, even
sophisticated molecular approaches may overlook population diversity.
Conclusions: This suggests that the genes for outer membrane proteins are
reliable indicators of strain diversity, but that other simpler physiological tests
retain a role in discriminating between isolates. These indicated that a group
of strains classiﬁed as identical by the molecular methods were clearly diverse
with respect to their more general biochemical properties.
P516 Dynamics of the PCR positivity in patients with
invasive meningococcal disease
E. Jindrichova, V. Maresova, P. Krizova, J. Kalmusova, O. Dzupova
Prague, CZ
Objectives:The PCRmethod is widely used for the detection of theNeisseria
meningitidis (Nm), but the dynamics of PCR positivity was not yet studied.We
describe ﬁrst results of our project, which is focused on the determination of
the time-period after the onset of antibiotic therapy (a.o.ATB) when the
DNA of Nm is still detectable in cerebrospinal ﬂuid (CSF) and blood. The
dynamics of PCRwas evaluated in the relationship to the clinical course of the
illness and compared to classical diagnostic methods.
Methods:We assessed the dynamics of the PCR in 19 patients hospitalized at
the clinic of infectious diseases with laboratory-conﬁrmed invasive menin-
gococcal disease (sepsis and/or meningitis). The CSF was collected in the day
of admission and control CSF samples during the hospitalization according to
health status. Blood samples were collected from the 1st to the 7th day of
hospitalization. The DNA was isolated by Qiagen kit, and nested PCR
method was used. PCR products were detected on the 2% gel electrophoresis.
We performed the PCR in 29 CSF and 62 serum samples.
Results:Csf: In the day of admission, 16 of 17 CSF samples were positive, six
of them after the onset of antibiotic therapy (three of them 1 day a.o.ATB.,
two of them 2 days a.o.ATB, one of them 3 days a.o.ATB). In 12 patients,
control lumbar punction was performed, six with positive (two of them 3 days
a.o.ATB, one of them 4, 5, 6, 7 days a.o.ATB) and six with negative result (one
of them 5 days a.o.ATB, three of them 6 days a.o.ATB, one of them 8, 12 days
a.o.ATB). Serum: on the day of admission, 9 of 14 serum samples were
positive, three of them a.o.ATB (2 days a.o.ATB). In samples collected three
or more days a.o.ATB, the DNA of the Nm was not detected.
Conclusions: We conclude that till the 3rd day a.o.ATB, majority of the
samples were positive. The longest period, when we conﬁrmed etiologic
agens was 7 days a.o.ATB. The evidence of presence of the pathogen and the
identiﬁcation of the serogroup are useful for assessment of correct diagnostic
schemes, serves as an important resource for epidemiological analysis, and may
result in valuable surveillance.
P517 Multilocus sequence analysis of meningococci in
Scotland 20years ago
C. B. Sullivan, M. A. Diggle, R. L. Davies, S. C. Clarke
Glasgow, UK
Objectives: Multilocus sequence analysis methods were used for the typing
of meningococci in Scotland from 1982 to 1984 using a fully automated
procedure. Neisseria meningitidis is an important cause of meningitis and
bacteremia worldwide, and this study provides much needed long-
term epidemiological data that are essential for understanding the meningo-
coccus and will provide information for determining future vaccine
policy.
Methods: Multilocus sequence analysis was performed which involved
sequencing seven housekeeping genes (abcZ, adk, aroE, fumC, gdh, pdhC,
pgm) (MLST) and antigenically variable genes. Housekeeping alleles and
sequence types were assigned by examining the MLST database (http://
neisseria.org/nm/typing/mLst/). The STs were assigned to lineages with the
program BURST that resolved lineages. If the lineage had previously been
identiﬁed, then the previously associated ST was used for the name. The
antigenically variable genes that were studied were mynA, siaD, and porA. The
mynA indicates serogroup A, siaD genes provide the capsule type for
serogroups B, C, Y, and W135, respectively. The porA gene is an outer-
membrane protein (OMPs), which is used for serosubtyping. Three variable
regions were looked at within porA VR1, VR2, and VR3, and they were
assigned the correct variant names using the porA variable region database
(http://neisseria.org/nm/typing/pora/) for VR1, VR2, and VR3 (http://
www.show.scot.nhs.uk/smprl/).
Results: One hundred and ﬁfty isolates that were present in Scotland
from 1982 to 1984 were successfully characterized for MLST and for
porA. Those isolates, which had previously not been assigned a serogroup,
had characterization of the siaD gene performed. Of the 150 isolates, it
was found that around 40% of these had a newMLST type (i.e. a combination
of alleles that had previously not been found). From analysis of porA, it was
found that the majority were of standard types. The main serogroups were B
and C.
Conclusion:This has provided a unique insight into the population dynamics
and evolution of meningococci causing invasive disease within Scotland. It has
shown that there was a large number of STs that have not been seen before
compared to the last few years, where MLST had become routine laboratory
procedure within Scotland. It has also shown that there has been little change
within the porA gene over the last 20 years, and has given much needed
information towards vaccine development.
P518 Multilocus sequence typing of Haemophilus
inﬂuenzae isolates in Scotland
M. Diggle, S. Clarke
Glasgow, UK
Objectives:The success of current vaccination programs against Hib is due in
part to the effect of vaccination on decreasing carriage of the organism. Seven
serotypes of the bacterium have been identiﬁed on the basis of capsular
polysaccharides. Until the implementation of widespread vaccination pro-
grams, type b Haemophilus inﬂuenzae was the most common cause of
meningitis in children between the age of 6months and 2 years. Recently,
there has been an increase in the number of isolates causing disease; moreover,
a signiﬁcant proportion of these have been nontypable. A semiautomated
procedure for MLSTwas applied to isolates ofH. inﬂuenzae during 2002. This
allows the unambiguous characterization of all invasive isolates throughout
Scotland for both typable (encapsulated) and nontypable (noncapsulated)
isolates. The initial database can be found at http://haemophilus.mlst.net and
presently contains the allelic proﬁles of over 130 isolates.
Results: A total of 42 invasive isolates were received from regional micro-
biology laboratories throughout Scotland. Only 59% were typable and all
were serotype b strains. The remaining 41% were nontypable. All these
isolates were successfully characterized using the SMPRL semiautomated
MLST system.
Conclusion: Conjugate vaccines against H. inﬂuenzae type b have been
available for a decade. There is therefore a possibility of a decrease in
protection in those immunized early on in the campaign and the potential
for a shift in serotype distribution. It is therefore important to determine
the serotype and MLST of H. inﬂuenzae strains causing invasive disease in
Scotland. Such data can help inform future vaccine policy and highlight at a
nucleotide level the changes that are occurring under selective pressure of the
H. inﬂuenzae population.
P519 Comparing the population structure of group B
streptococcus from Israel with strains from the UK and USA
by using multilocus sequence typing
N. Bisharat, N. Jones, K. Oliver, D. Crook, T. Peto
Oxford, UK
Objectives: Group B streptococcus (GBS) or Streptococcus agalactiae is one of
the leading infectious causes of neonatal meningitis and septicemia in the
developed world. However, GBS is rarely a cause of neonatal sepsis in some
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parts of the world. The best estimate of neonatal GBS infection in Israel shows
an incidence ranging from 0.3 to 0.6 per 1000 live births compared with an
incidence ranging from 0.9 to 1.8 per 1000 live births in the UK and USA.
One hypothesis for such differences may be that different strains of GBS
circulate in low-incidence countries compared to high-incidence countries.
We used multilocus sequence typing (MLST) to study the population
structure of strains originating from Israel, UK, and USA.
Methods:A total of 103 isolates of GBS were collected from Israel, 50 isolates
were collected from healthy asymptomatic pregnant mothers and 53 isolates
were collected from disease-associated cases. Forty-two isolates (21 carriage
isolates from healthy asymptomatic pregnant mothers and 21 invasive isolates)
were included from the UK, and 22 isolates (16 invasive and 6 carriage) were
included from USA. We applied MLST and capsular serotyping to all the
isolates.
Results: Multilocus sequence typing revealed 39 sequence types (ST) in the
Israeli collection, ST 23 was more common in the invasive group and ST 19
was more common in the carriage group (for all the collections). Sixty-ﬁve
percent of all the invasive neonatal isolates from the UK and USA had ST 17,
and 50% of the Israeli-invasive neonatal isolates had ST 17. Only 6% of the
Israeli carriage strains were ST 17. All isolates with ST 17 complex (ST 17 and
its single and double locus variants) were identiﬁed as expressing capsular
serotype III.
Conclusion: ST 17 complex is the most common ST in invasive neonatal
disease both in Israel, the UK, and USA. The relatively low incidence of
invasive neonatal disease in Israel might be due to lowmaternal carriage of less
virulent strains (ST 17 complex).
P520 Identiﬁcation and differentiation of the Brucella
vaccine strain Rev-1 from the natural Brucella strains in
human disease
S. Mitka, A. Ifantidou, E. Chaidouli, A. Kansouzidou
Thessaloniki, GR
Background: Brucellosis is a worldwide zoonosis. National control programs
of eradication including the vaccination of sheep and goats with the strain
Rev-1 (Aˆ.melitensis biotype 1) were developed in order to eliminate the
human disease. Human infection with the vaccine strain Rev-1 has been
reported, but this disease cannot be identiﬁed because of the difﬁculty in
differentiating of natural Brucella melitensis strains from the vaccine strain Rev-
1 with conventional methods. The aim of this report is the study and
differentiation of the Rev-1 vaccine strain from the natural Brucella strains
in humans with PCR technique and digestion with restriction endonuclease.
Materials and methods: Four groups of specimens were examined: (1) 5
prototype strains of B. abortus, B. melitensis (biotypes 1, 2, 3) and Rev-1 strain;
(2) 13 B.melitensis biotype I strains that were isolated from humans; (3) 5
serum samples from patients that were suspected for Rev-1 disease; and (4) 11
serum samples from patients without evidence of Rev-1 disease. In PCR
ampliﬁcation, the Brucella omp2 gene that encodes a protein of the outer
membrane, was used as DNA target. The PCR product was digested with the
restriction enzyme Pstl. All the strains were tested for susceptibility to
streptomycin with the disk diffusion method.
Results: All Brucella strains and serum samples from patients gave a positive
PCR result producing a 282 bp band. The digestion of the ampliﬁed DNAs
revealed the fragments 238- and 44 bp in prototype strains and the fragments
282-, 238-, and 44 bp in the Rev-1 strain (group 1). In 11 out of 13 strains
isolated from patients (group 2), the fragments 238- and 44 bp were revealed
(natural strains), while in the other 2, the fragments 282-, 238-, and 44 bp
(Rev-1) were revealed. These two strains presented resistance to streptomy-
cin, while the other 11 strains were sensitive. The digestion of the ampliﬁed
DNA revealed the fragments 282-, 238-, and 44 bp (Rev1 disease) in ﬁve
serum samples of group 3 and the fragments 238- and 44 bp (natural strain-
disease) in 11 serum samples of group 4.
Conclusions:The results of this study conﬁrmed that the strain Rev-1 causes
human disease in Greece. The PCR technique and the digestion with PstI
facilitate the identiﬁcation and differentiation of the Rev1 vaccine strain from
natural Brucella strains. These techniques also contribute to the diagnosis and
differentiation of the human brucellosis according to these agents, when the
causative Brucella strain is not isolated.
P521 Use of broad-range bacterial 16S real-time PCR in
the diagnosis of CNS infections
A. C. Mendes, M. L. Amorim, J. M. Cabeda, J. M. Amorim
Porto, P
Objectives: To develop a molecular method able to detect accurately and
rapidly, bacterial DNA in cerebrospinal ﬂuid (CSF) samples, and to evaluate it
against cultural methods.
Methods: A broad-range real-time PCR assay, targeting the bacterial 16S
rDNA gene, was designed and optimized in SmartCycler system (Cepheid,
USA) using universal primers and a TaqMan probe, whose sequence was
previously described (Greisen et al.). A set of ATCC strains were used as
positive controls. The analytical sensitivity was evaluated with serial dilutions
of Escherichia coli and Staphylococcus aureus ATCC strains spiked into negative
CSF samples previously tested by the PCR assay. Nucleic acids were extracted
in MagnaPureLC (Roche, Germany) after enzymatic lysis of Gram-positive
bacterial cell wall, using disposable material previously decontaminated by
UV (UV Crosslinker, Appligene). To prevent the ampliﬁcation of contam-
inating DNA, a batch of negative extraction and ampliﬁcation controls were
included. The optimized PCR protocol was further applied to 74 CSF
samples with known cultural results.
Results:The optimized PCR protocol was able to detect at least 160CFU/mL
of S. aureus and 200CFU/mL ofE. coli. No ampliﬁcationwas found in negative
controls. With CSF samples, interpretation problems were observed in ﬁve
sampleswith late positive results, which led to the deﬁnition of a cycle threshold
value of 30 in order to differentiate true positive results from possible weak
contaminations (false positive). Comparing with cultural results, we found 16
true positive results, 51 true negative results, 3 false positive results, and 4 false
negative results.
Conclusions: Using as reference method, the cultural results, the real-time
PCR assay developed for the detection of bacterial DNA in CSF samples,
showed a sensitivity of 80%, speciﬁcity of 94.5%, a positive predictive value of
84%, and a negative predictive value of 92.7%. Together with its short turn-
around time (3.5 h), the present results support the potential for the clinical
application of this method if an additional identiﬁcation step is included. This
would provide a more accurate result, clarifying the bacterial nature (patho-
genic or contamination), thus improving the predictive positive value of the
test.
P522 Puriﬁed reagents enable automated DNA
extraction for highly sensitive PCR in microbiology
R. Zielenski, T. Sause, C. Kriegbaum, M. Bollwein, U. Reischl,
J. Steinbiss
Penzberg, Regensburg, Mannheim, D
Objective: In the past deployment of PCR in pathogen, detection was
restricted by interference due to contamination of reagents with traces of
DNA from target organisms. Reagent purity on a new level was required to
allow highly sensitive detection of DNA of pathogenic bacteria and fungi.
Although several commercial systems for preparation of DNA from different
specimen are available, no focus was directed to contamination of extremely
low concentration (<10 organisms) of microbial DNA. New highly sensitive
ampliﬁcation and detection kits especially designed for the LightCycler
Instrument require a combination of pure sample preparation reagents suited
for lysis of pathogenic microorganisms and DNA isolation.
Methods: We did succeed now in developing highly puriﬁed reagents for a
DNA isolation procedure applicable for a variety of specimens on theMagNA
Pure LC Instrument. This level of purity was achieved by an optimized
production process for prevention of contamination of microbial DNA. The
performance was tested in several experiments. Specimens were pretreated for
liquefying, lysis of microorganisms, and solubilization of DNA. Then, a fully
automated extraction process on the MagNA Pure LC Instrument was
performed. It starts with binding DNA to silica surfaced magnetic particles
(MGPs) due to chaotropic salt conditions and high ionic strength. Unbound
substances are removed by several washing steps. Puriﬁed DNA is eluted by
low-salt buffer. The elute is ready for PCR on the LightCycler Instrument.
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These elutes were utilized in subsequent analysis with the LightCycler
Instrument.
Results: The kit did not show any background signal in our tests. DNA
preparations were tested up to 45 cycles with highly sensitive DNA detection
kits for the LightCycler Instrument for S. aureus, Pseudomonas aeruginosa, and
Candida albicans. No single sample preparation showed positive reaction in
replicate runs. The applicability to different research samples, e.g. blood
culture media, urine, BAL, swab was proved in a microbiological laboratory in
combination with assays on the LightCycler Instrument. Data showed
excellent performance in dilution series and inoculation experiments.
Conclusion:We conclude that DNA depletion from sample pretreatment and
extraction reagents enable highly sensitive and speciﬁc PCR assays for a
variety of pathogens from different specimen. Such an extraction method is
perfectly suited for a wide range of research applications.
P523 Multiplex PCR and reverse dot blot hybridization
using amniotic ﬂuid for the diagnosis of intrauterine
infection
J. Yi, J.-K. Lee, E.-C. Kim
Seoul, KOR
Objectives: Premature birth comprises 10% of all deliveries, and is the most
important cause of perinatal morbidity and mortality. Furthermore, sequelae
due to premature birth, such as cerebral palsy, can be social problems. As
prenatal intrauterine infection has recently been identiﬁed to be a cause of
premature birth, accurate diagnosis of the amniotic infection by microorgan-
isms became important. Nevertheless, if the causative agents of intrauterine
infection such as anaerobes, fungi, and mycoplasmas are to be detected by
conventional culture systems, various special media and culture conditions are
required, which leads to longer detection time, markedly reduced sensitivity,
and thus to the clinical uselessness. We report here the development of the
technique using multiplex PCR and reverse dot blot hybridization for the
diagnosis of amniotic microbial infection.
Methods: Gram-positive bacteria, Gram-negative bacteria, Candida albicans,
Candida spp., Ureaplasma urealyticum, Mycoplasma hominis, Gardnerella vaginalis,
Mobiluncus spp., Peptostreptococcus spp., Bacteroides fragilis, and Streptococcus
agalactiae were the selected microorganisms to be detected. Multiplex
PCR was performed mainly using the primers derived from the common
sequences of 16S rRNA, but speciﬁc sequences were used as primers for some
species. 50-primers were labeled with biotin. DNA probes speciﬁc to each
species were designed from internal sequences of the ampliﬁed products. The
DNA probes were attached to nylon membrane by dot blotter and UV
irradiation and the ampliﬁed products from the multiplex PCR were sub-
sequently hybridized. These were then made to react with streptavidin–
alkaline phosphatase conjugate and NBT/BCIP for color development.
Human beta-globin gene was used for the positive control.
Results: Standard strains and clinical isolates showed speciﬁc reaction patterns
of reverse dot blot hybridization according to each species. The experiment
with amniotic ﬂuid samples in which the presence of microorganisms had
been conﬁrmed by species-speciﬁc PCR also showed the results that are equal
to the ones obtained by the PCR.
Conclusions: The technique described here using multiplex PCR and dot
blot hybridization is thought to help the diagnosis of prenatal intrauterine
infection by detecting microorganisms in amniotic ﬂuid, and thus, to possibly
enable the prevention of premature birth by early treatment of intrauterine
infection.
P524 New approach in epidemiology
of Streptococcus agalactiae infection
A. Dmitriev, E. Shakleina, L. Tkacikova, J. Jelinkova, I. Mikula
Saint-Petersburg, RUS; Kosice, SK; Prague, CZ
Objectives: Streptococcus agalactiae (group B streptococcus; GBS) is the leading
causative agent of invasive neonatal diseases of human and mastitis of the dairy
cows. Integration of IS elements, e.g. IS1548, ISSa4, IS1381 in GBS genome
can inactivate the virulence properties of GBS. Recently, we performed the
analysis of human GBS for the presence of different IS elements. The goal of
the present study was to analyze the presence of IS elements in bovine GBS in
order to compare bovine and human strains. Another subject of interest was to
investigate the IS-based typing as a tool for classiﬁcation and molecular
epidemiology of GBS.
Methods:A total of 101 GBS strains isolated from the dairy cows were tested.
These strains were analyzed by Southern hybridization and multiplex PCR.
Bacterial DNA was isolated by phenol/chloroform extraction. Southern
hybridization was accomplished with the ‘DNA Labeling and Detection
Kit’, Roche (Germany). The computer techniques were used for selection of
the speciﬁc primers and the analysis of DNA fragments.
Results: Serotyping of 101 bovine GBS strains revealed that most of the strains
were nontypable. Multiplex PCRwas developed to analyze the presence of IS
elements in bovine GBS. It was found that IS861 presented in 29 strains
(28.7%), IS1548 presented in 9 strains (8.9%), ISSa4 presented in 48 strains
(47.5%) and IS1381 presented in 26 strains (25.7%). A total of 28 bovine GBS
strains (27.7%) did not possess any of IS elements, 36 strains (35.6%) possessed
one of the IS elements, 35 strains (34.7%) possessed two IS elements, and 2
strains only (1.9%) possessed three different IS elements. The strains with four
different IS elements were not found. Taken together, 10 different combina-
tions of IS elements in bovine GBS were discovered. The signiﬁcant
difference in the presence of IS elements in bovine strains was demonstrated
in comparison with the presence of IS elements in human strains recently
analyzed (Dmitriev A et al., unpublished). These data probably indicate that
only a part of GBS strains can infect both animal and human.
Conclusions: These data demonstrate that combinations of IS elements in
GBS genome can be used as effective criteria for molecular epidemiology. In
the future, this approach can be used as an additional tool for the epidemio-
logical control and prevention of other bacterial infections.
P525 Clostridium perfringens in antibiotic-associated
diarrhea
T. Ojanen, A. Heikinheimo, J. Horsma, N. Simelius, M-L. Katila
Kuopio, Helsinki, FIN
The aim of the present study was to estimate the role of Clostridium perfringens
in antibiotic associated diarrhea (AAD). Fecal specimens of 100 patients with
suspected AAD were analyzed for the presence of C. difﬁcile by cultivation
(CCEY), antigen detection (Triage), and detection of toxin (Triage; Oxoid).
The specimens were also cultured for C. perfringens (P; TSC; SFP), tested for
presence of C. perfringens enterotoxin using passive latex agglutination (pet-
RPLA), and analyzed by in-house PCR for enterotoxin coding gene.
C. difﬁcile was recovered by culture in 24 specimens (24%). Eleven of them
were also toxin A positive. C. difﬁcile antigen was detected in 21 specimens
(21%), 20 of themwere also positive by culture.C. perﬁngenswas isolated in 52
specimens (52%). Only one of the culture positive specimens (2%) was
positive for enterotoxin by pet-RPLA agglutination. Enterotoxin gene was
detected in nine specimens including the pet-RPLA positive specimen. In
seven of them, C. perfringens was also isolated by culture. Only two of the
specimens carrying C. perfringens enterotoxin gene was positive for C. difﬁcile
by culture.C. perfringens, which is part of the normal fecal ﬂora, was isolated in
52% of fecal specimens. Only one specimen (2%) contained enterotoxin. On
the other hand, enterotoxin gene was found in nine specimens. Whether the
gene is only seldom expressed or the method of the toxin detection is not
sensitive enough, remains to be investigated. The occurrence of the C. per-
fringens enterotoxin gene (9%) was almost similar to the occurrence of toxin A
of C. difﬁcile, which is known to be associated with AAD. C. difﬁcile toxin A
and C. perfringens enterotoxin gene were not simultaneously recovered in any
specimen.
P526 Alternative specimen types for the detection of
Chlamydia trachomatis infection utilizing the VIDAS PROBE
Chlamydia trachomatis test
S. Reilly, A. Hern, M. DeBiasio, C. Rogers
Rockland, USA
Objective: The aim of this study was to evaluate the ability of the VIDAS
PROBE CT Test to detect Chlamydia trachomatis (CT) infections in several
alternative specimen types including anal–rectal, pharyngeal, and culture
media (2-SP) swabs.
Methods: The VIDAS PROBE CT test is an automated assay for the
ampliﬁcation and qualitative detection of Chlamydia trachomatis 23S rRNA.
Chlamydia trachomatis infections are the most prevalent bacterial sexually
transmitted diseases (STD) worldwide. STDs, including chlamydia, are
transmitted among all sexually active people through vaginal, anal, and oral
sex. Anal–rectal and pharyngeal swabs were collected from the study subjects
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attending an STD clinic. Study subjects were enrolled based on several ‘at risk’
sexual behaviors, which included engaging in anal–rectal sex, cunnilingus,
and fellatio without a condom.
Results: In anal–rectal and pharyngeal swabs, the VIDAS PROBE CT Test
demonstrated excellent sensitivity (7/7 and 5/5, respectively) and speciﬁcity
(60/60 and 24/24, respectively) as compared to PCR. Inhibition, as mon-
itored by a coampliﬁed internal control, was observed in less than 1.0%
(1/156) of the specimens tested. Analytical sensitivity of the test was evaluated
by serially diluting CT elementary bodies (EB) in both anal–rectal and
pharyngeal swab matrices. Data indicate that the assay’s analytical sensitivity
in anal–rectal and pharyngeal swabmatrices is comparable to that of traditional
swab matrices. In addition, 63 swab specimens were collected in collection
devices containing traditional chlamydial cell culture media (2-SP). The
recovery rate for the VIDAS PROBE CT Test was 100% (3/3) without
incidence of contamination (60/60) or inhibition (0/63).
Conclusions: The VIDAS PROBE CT Test’s sensitivity and speciﬁcity for
alternative specimen types suggests the feasibility for a wide range of sampling
methods to complement the traditional urine, urethral, and endocervical swab
samples.
This product has not been cleared by the United States FDA and is not yet available for
commercial use.
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P527 Changes of microbial ﬂora and wound
colonization in burn patients
S. Erol, U. Altoparlak, M. N. Akcay, F. Celebi, M. Parlak
Erzurum, TR
Objective: To determine the time-related changes of microbial colonization
of burn wounds and body ﬂora of burned patients.
Methods:A prospective study was carried out in the burn unit of an university
hospital, Erzurum, Turkey. Patients who were hospitalized at least 3weeks or
more over a period of 7months (May–November 2002) were enrolled in the
study. Periodic swabs were taken from burn wound, nasal, axillary, inguinal,
and umblical region of the patients on admission and 7th, 14th, and 21st days
of hospitalization.
Results: Fifty-one patients were included in the study. The mean age was
15 years (range 7months60 years) and the mean body surface area burned
was 22.9% (range 5–75%). Mean hospital stay time was 36.5 days (range 21–
100 days). A total of 1098 microbial isolates were detected during the study
period (254 were on admission, 275 at 7th, 266 at 14th, and 303 at 21st days).
Coagulase-negative staphylococci (CNS, 63.0%) and Staphylococcus aureus
(19.7%) were the most prevalent isolates in admission cultures, followed
by diphteroids (3.1%). The time-related changes of microbial ﬂora showed a
gradual decrease in the number of isolates of CNS, while there was a marked
increase in the numbers of S. aureus and P. aeruginosa from admission to 21st
day. At the 21st day, the most frequent organisms were S. aureus (37.6%), CNS
(34.7%), and P. aeruginosa (16.2%), followed by Enterobacter (2.6%) andCandida
spp. (2.3%). Unfortunately, the rates of methicillin resistance of these two
staphylococci strains were increased constantly (10 to 87.7% in S. aureus
strains, and 14.4 to 76.2% in CNS strains). Isolation of other organisms
was uncommon by comparison. The study, in addition, revealed that while
35.3% of burn wounds were sterile on admission, microbial colonization
reached 86.3%within the ﬁrst week and 100%within 2weeks after admission.
Nasal carriage of methicillin-resistant S. aureus increased from 3.9 to 21.6% at
the 7th day and 62.7% at the 21st day.
Conclusion: The nature of microbial wound colonization and ﬂora changes
should be taken into consideration in empirical antimicrobial therapy of
burned patients.
P528 Four prevalence surveys of hospital-acquired
infections in a Greek hospital
S. Kastanakis, S. Doukakis, L. Tzimis, P. Chatzilias, M. Campanieris,
M. Kalaitzakis, M. Kalloniatou, E. Aliﬁeris
Chania, GR
Objectives: As is well known, the surveillance of hospital-acquired infections
(HAIs) is an important component of an effective nosocomial infection
control program. Prevalence surveillance is a rapid and inexpensive way to
estimate the problem of HAIs. To study the problem of nosocomial infections
in our hospital, four prevalence studies were made from our team during the
years 1994–2000.
Methods: The ﬁrst and the second studies included 288 patients each, the
third 265 patients, and the fourth 273 patients (the total number of hospi-
talized patients at the time of the study).
Results: In the ﬁrst study, a nosocomial infection was found in 20 patients, in
the second in 15 patients, in the third study in 13 patients, and in the fourth in
21 patients. The overall prevalence of HAIs was 6.9, 5.2, 4.9, and 7.7% for the
four studies, respectively. In the ﬁrst study, among HAIs, urinary tract
infections were 12 (60.0%), lower respiratory tract infections were 6
(30.0%), and surgical site infections were 2 (10.0%). In the second study,
urinary tract infections were 4 (26.7%), lower respiratory tract infections were
2 (13.3%), surgical site infections were 5 (33.3%), and bloodstream infections
were 4 (26.7%). In the third study, urinary tract infections were 6 (46.1%),
lower respiratory tract infections were 3 (23.0%), surgical site infections were
3 (23.0%), and bloodstream infections was 1 (7.7%). In the fourth study,
urinary tract infections were 7 (33.33%), lower respiratory tract infections
were 5 (23.80%), upper respiratory tract infections were 4 (19.04%), surgical
site infections were 3 (14.28%), and others were 2 (9.52%). The use of
antibiotics among the hospitalized patients was found to be 47.2, 60.1, 58.5,
and 64.1% for the four studies, respectively. The incidence of multiresistant
bacteria was primarilyEnterococcus spp. and secondarily Pseudomonas aeruginosa,
Enterobacter spp., Klebsiella pneumoniae, Escherirchia coli, Staphylococcus aureus,
S. epidermidis. Regarding age, the highest incidence of HAIs occurred in the
third age group. Unjustiﬁed prescription of prophylactic chemotherapy was
found despite the suggestions of the infection control committee.
Conclusions:Repeated prevalence surveillance is a valid way to estimate the
problem of HAIs.
P529 Microbial ﬂora identiﬁed from infected wounds at
a reference tertiary care hospital in Northern Italy.
Epidemiology and temporal trend in a prospective study,
1998–2002
R. Manfredi, A. Nanetti, M. Ferri, S. Morelli, R. Valentini, L. Calza,
F. Chiodo
Bologna, I
Objective: To assess the positive rate of cutaneous swabs of wound infections
in patients (pts) followed at our University Hospital since 1998, on the ground
of a number of temporal, clinical, microbiological, and antimicrobial sensi-
tivity features of the most common isolated pathogens.
Methods: Over 1100 specimens from infected cutaneous wounds (mostly
surgical in origin) were sent to our reference laboratory, with a cumulative
positivity rate of 39.1%, declining from the year 1999 (39.6%) to the year 2002
(33.1%; P< 0.001).
Results: The majority of samples (82.4%) were identiﬁed from hospitalized
the pts, compared with outpatients and the day-hospital pts. Both rate and
spectrum of microbial isolation did not vary according to specimen origin, but
Staphylococcus aureus largely prevailed (177 strains, with an incidence progres-
sively increasing over time), followed by Pseudomonas aeruginosa (90 isolates),
Enterococcus faecalis (65 strains), and Escherichia coli (41 isolates).Candida glabrata
was retrieved thrice in the year 2001. Invitro antimicrobial susceptibility
assays pointed out a complete sensitivity of S. aureus to glycopeptides (teico-
planin and vancomycin), while a progressively decreasing activity was shown
by imipenem, ceftazidime, norﬂoxacin, netilmicin, amikacin, piperacillin-
tazobactam, and ciproﬂoxacin, and a sensitivity lower than 50% was detected
for penicillin, coamoxiclav, cefotaxime, ceftriaxone, erythromycin, clary-
thromycin, clindamycin, chloramphenicol, rifampicin, gentamycin, and
cotrimozaxole, and methicillin resistance was even regarded in 55.7% of
the isolates. When considering P. aeruginosa, only colistin was effective on all
tested strains, followed by imipenem, ceftazidime, ciproﬂoxacin, piperacillin-
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tazobactam, amikacin, tobramycin, and aztreonam, while piperacillin, mezlo-
cillin, and gentamycin did not reach a 50% sensitivity rate.
Conclusion:Wound infections (mostly surgical ones) can be borne by a very
large etiology spectrum, so that the resort to microbial isolation and invitro
antimicrobial assay are mandatory for an appropriate management. The
elevated intrinsic and acquired antimicrobial resistance demonstrated by
the two most frequent pathogens retrieved in our experience (S. aureus
and P. aeruginosa), depend on hospitalization itself, large and prolonged
administration of broad-spectrum antimicrobial agents as preventive and
therapeutic measures, surgery, and other invasive diagnostic and therapeutic
procedures.
P530 Legionella in Tehran hospitals’ water supplies
R. Hosseini Doust, A. Mohabbati Mobarez
Tehran, IR
Objectives:Hospital-acquired legionnaires’disease has become a global public
health issue. The overall risk for acquisition of Legionella is multifactorial, with
host susceptibility (immunosuppressed patients, especially organ transplant
recipients and elderly patients with chronic lung disease are at highest risk) and
degree of colonization within the water supply as the most important factors.
The aim of this survey was to provide information about probable Legionella
contaminations of Tehran (capital of Iran) hospital water sources.
Methods: Fifty water samples were collected from transplant units in 4 L
containers. The (hot and cold) water samples were ﬁrst concentrated by
passing through 0.22mm ﬁlters and then pretreated to remove free-living
legionella-like organisms. The selective and nonselective media (BCYE agar)
were prepared by L-Cystein and iron salts as enrichments. The BCYE plates
were inoculated with 0.1mL of each water sample and were incubated in
humidiﬁed atmosphere with 5–10% CO2 at 378C for up to 2weeks along
with positive control.
Results:Legionella species were isolated frommore than 50% of water samples.
Legionella pneumophila were predominant between the isolates.
Conclusion: The results of the investigation conﬁrmed the existence of
legionnares’ disease bacterium risk in hospital transplant units.
P531 A 2-year retrospective study of nosocomial
candidemia in a new Greek hospital
H. Moraitou, G. Georgoulias, P. Morfou, D. Nikita
Athens, GR
Objective: Candidemia is a serious bloodstream infection, and the incidence
of nosocomial fungal infection has increased in recent years. The aim of this
study was to analyze the epidemiology of nosocomial candidemia in a new
Greek tertiary care hospital whose activity started in 2000.
Methods: The periods (A) 1 November 2000–31 October 2001 (ﬁrst year of
the hospital’s full activity) and (B) 1 November 2001–31 October 2002
(second year) were studied retrospectively for all episodes registered as
candidemia. The blood cultures were processed and cultured automatically
with Bactec 9240 system, and the identiﬁcation of fungi was performed with
Api 20C AUX system.
Results: During period (A), 7.346 patients were admitted to Henry Dunant
Hospital and six cases of candidemia (0.81 cases/1000 admissions, or 4.4% of
all bacteremia cases) were detected. The clinical strains isolated were Candida
albicans (33.3%), Prototheca spp. (33.3%), C. glabrata (16.6%), and C. tropicalis
(16.6%). The same strain was isolated from other sites, such as bronchial
secretions, sputum, pus, urine, and intravenous catheter in all but two patients
(66.6%). Four patients were hospitalized in intensive care units (66.6%) and
two (44.4%) in medical wards. During period (B), 23.723 patients were
admitted to the hospital and 27 cases of candidemia (1.1 case/1000 admissions,
or 8.7% or all bacteremia cases) were registered. The clinical strains isolated
were C. albicans (59.2%), C. glabrata (18.5%), C. guillermondii (11.1%), C. tro-
picalis (3.7%),C. parapsillosis (3.7%), andCryptococcus laurenti (3.7%). The same
strain was isolated from other sites, such as bronchial secretions, sputum,
urine, and intravenous catheter in 18 patients (66.6%). Eight patients (29.6%)
were hospitalized in intensive care units, seven (25.9%) in medical wards, six
(22.2%) in renal dialysis unit, and six (22.2%) in surgical wards.
Conclusions: In our hospital, C. albicans is still the most frequent yeast strain
isolated from blood cultures. A slight increase of nosocomial candidemia was
noted during the second year of the hospital’s activity, which should be
attributed to the larger number of admissions, the wider spectrum of clinical
syndromes admitted to our hospital during the second year, and to the
expansion of certain departments such as hematology, oncology, and ICU.
P532 Nosocomial fungal infections in pediatric
patients – a prospective study
M. M. Lopes, R. Barros, I. Peres, M. Serelha, M. T. Neto, G. Freitas
Lisbon, P
Objectives: The magnitude of the nosocomial fungal infections (NI) in
children has never been deeply studied in Portugal. In order to contribute
to a better knowledge about this Public Health problem, we performed a
study in the pediatric Hospital D. Estefaˆnia, aiming to determine the
incidence, sites, risk factors, and to identify the predominant infecting
organisms.
Methods: A prospective study was conducted in infants admitted to this
hospital between January 1 1998 and March 31 2000. Standard deﬁnitions by
the CDC were used. Statistical analysis was performed using the CDC
software EPI info 6.0. Categorical variables were analyzed by univariate
analysis with the w2. Signiﬁcance was deﬁned as P< 0.05, and Odds ratios
with 95% conﬁdence intervals were calculated. Multivariate analysis by
stepwise logistic regression was used to select risk factors that best predicted
the occurrence of NI.
Results: NI rate in that period was 3.0 per thousand patients (67/22.124)
increasing from 1.3/1000 in 1998 to 5.3/1000 in 1999. The incidence rate
was signiﬁcantly higher in intensive care units (2.5%) than in all different
wards (0.17%). Bloodstream (30.7%), gastrointestinal (14.9%), and urinary
tract (10.4%) were the most frequent types of NI reported. Candida albicans
(65.2%), C. parapsilosis (27.5%), C. tropicalis (5.8%), and Saccharomyces cerevisiae
(1.5%) were the organisms associated to NI. Patients’ age with NI ranged from
6 days to 13 years (median 3 years). Five risk factors for hospital-acquired
infection were identiﬁed in univariate analysis: anemia (Odds ratio (OR),
6.28; 95% conﬁdence interval (CI), 1.3–30.2), intravenous catheterization
(OR, 2.96; CI, 1.4–6.5), antibiotics (OR, 2.83; CI, 1.2–6.8), parenteral
nutrition (OR, 2.43; CI, 1.2–5.0), and hospitalization period for longer than
3months (OR, 2.25; CI, 1.0–5.0). However, after adjustment by multivariate
analysis, only the previous use of antibiotics stayed as the main risk factor to
nosocomial fungal infection (OR, 2.86; CI, 1.0–7.9). The adjustment
identiﬁed the male sex as another potential risk factor (OR, 2.33; CI,
1.1–5.0) that was not detected in univariate analysis.
Conclusions: This study conﬁrms their importance as a heavy burden on
health services. The analysis of epidemiological features of NI in the pediatric
population contributed to propose surveillance measures in order to reduce
their incidence and to improve a better control on risk factors.
P533 Most often isolated microorganisms from
peritoneal dialysates in a public hospital, Poland
M. Kochowska-Bronk, M. Bronk, L. Naumiuk, A. Samet,
B. Rutkowski
Gdansk, PL
Objectives: To evaluate the frequency of microorganisms isolated from
peritoneal ﬂuids patients with continuos ambulatory peritoneal dialysis
(CAPD).
Methods: From CAPD patients with peritonitis symptoms, 96 peritoneal
ﬂuid samples were collected. The specimens were inoculated on solid media
after centrifugation. Aerobic, anaerobic, and broth cultures in Bact/Alert
(bioMe´rieux) were initiated. The pellet was Gram-stained.
Results: In the period from January to December 2002, 42 of the 94 dialysates
were positive (44.6%), four of the positives were polymicrobial. Following
microorganisms were isolated in monocultures: Staphylococcus epidermidis (20),
S. aureus (7), Stenotrophomonas maltophilia (3), Candida albicans (2), Klebsiella
pneumoniae (1), Streptococcus oralis (1), Pseudomonas sp. (1), C. parapsilosis (1). In
polymicrobial infections: Enterococcus faecalisþC. tropicalis (2), E. fae-
ciumþC. albicans (1), S. epidermidisþE. faecalisþProteus mirabilis (1), Bacter-
oides vulgatusþB. uniformisþE. faecium(1).
Conclusion:Themost prevalent etiologic agents of peritonitis in patients with
CAPDwere S. epidermidis (47.6%) and S. aureus (16.7%).Candida isolates were
responsible for six episodes of peritonitis, three of them polymicrobial.
Utilization of different solid and broth media enabled good recovery of
various microorganisms and appropriate antibiotic therapy based on micro-
biologic results.
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P534 Prevalence study of hospital-acquired infection in
a Greek university hospital: ﬁrst announcement
M. Kantzanou, M. Maniati, V. Drosou, A. Gaki, A. Maniatis
Larissa, GR
Objectives: A one-point prevalence study of hospital-acquired infections
(HAI) was ﬁrst carried out in a Greek University Hospital. The aim of this
project was to organize a surveillance of HAI in a recently established tertiary
hospital. The education of the Infection Control Team on surveillance
methods was one of the major objectives of this study.
Methods: A total of 254 patients hospitalized in 15 wards were recorded in a
1-day study. All departments (surgery, internal medicine, orthopedic, obste-
trics, and gynecology, neurosurgery, gastroenterology, pediatric) and intensive
care units (coronary disease, neonatal, respiratory) of the University hospital
were included in this surveillance study. Special attention was paid to recruit
all the patients.
Results: The overall prevalence of HAI was found to be 5.9%. The most
common HAI recorded involved urinary tract infections (33%), followed by
lower respiratory tract infections (20%), bloodstream infections (13%), and
surgical site infections (6.6%). The greatest prevalence rate was found in the
department of Internal Medicine (26.6%) followed by the adult intensive care
unit (20%). The duration of hospitalization, the total number of used devices,
and invasive procedures were signiﬁcantly correlated with HAI. Positive
cultures were found in 66.6% of the cases. The most frequently isolated
microorganisms were: Enterococcus faecalis (40%), Pseudomonas aeruginosa (30%),
Candida sp. (10%), Escherichia coli (10%), Proteus mirabilis (10%). The
administration of antibiotics was also recorded. The prevalence of antibiotic
usage among the hospitalized patients was found to be 40%.
Conclusions: The ﬁrst prevalence study of HAI in a newly established Greek
University Hospital showed lower percentages of infections and antibiotic
usage in comparison with similar surveillance studies, which were recently
carried out in other countries or in other Greek hospitals. These results
emphasize the need of rational antibiotic usage to decrease the pharmacy
expenses and discourage the development of resistant microoorganisms in a
new hospital environment.
P535 Two-point prevalence studies of hospital-acquired
infections in the orthopedic departments of 14 Greek
hospitals
A. Gikas, J. Papadakis, P. Nikolaidis, J. Pediaditis, G. Kioumis,
S. Levidiotou, S. Maltezos, S. Metalidis, E. Anevlavis, G. Starakis,
G. Chaliotis, S. Kastanakis, D. Kofteridis, M. Roubelaki, Y. Tselentis
Heraklion, GR
Objectives: Hospital-acquired infections (HAIs) are associated with signiﬁ-
cant morbidity and mortality. The aim of this study was to investigate the
prevalence rates of HAIs, the responsible microorganisms involved, and the
antibiotic use in patients admitted in orthopedic departments in 14 Greek
hospitals.
Methods: Two-point prevalence studies of HAIs were carried during the
years 1999 and 2000. HAIs were recorded according to the CDC deﬁnitions.
Results: Seven thousand one hundred and twenty hospitalized patients were
registered during the studies. Five hundred and seventy-one (8%) of them
were admitted in orthopedic departments. Out of them, 256 (44.8%) were
men. Their median age was 64 (range: 1–95) years. During the study, 56/571
(9.8%) cases of HAI were identiﬁed. Thirty out of 56 patients (53.6%) had a
surgical site infection (SSI), 20 (35.7%) had an urinary tract infection (UTI),
and seven (12.5%) had a lower respiratory tract infection (LRTI). Three
hundred and ninety-seven (69.5%) patients had a recent operation. In 45/397
(11.3%), a HAI was registered. Among the 174 patients who did not have a
surgical procedure, in 11 (6.3%), a HAI was identiﬁed (P¼ 0.068). However,
the type of surgical wound was one of the main risk factors for the presence of
HAI. Thirty-one HAIs out of 357 (8.7%) patients with clean or clean–
contaminated operation were recorded, and 13/40 (32.5%) patients with
contaminated or dirty operation had a HAI (P< 0.0001). Responsible
microorganism was found in 28 out of 56 (50.0%) cases, and 34 strains were
isolated. The majority of them were Gram-negative bacteria (70.6%). The
most frequently isolated microorganisms were: P. aeruginosa (20.6%), Staphy-
lococcus aureus (17.6%), Acinetobacter spp. (17.6%), Escherichia coli (11.8%), and
Enterococcus faecalis (11.8%). The use of antibiotics and the purpose of
administration were also recorded. The prevalence of antibiotic use for
any reason was 74.9%. Between them, prophylactic therapy was administered
more frequently (72.3%) than the empirical (20.3%) or rational (7.4%)
therapy.
Conclusion: Our data suggested that prevalence of HAIs and SSIs in ortho-
pedic departments in 14 Greek hospitals was 9.8 and 4.5%, respectively. In the
patients with HAI, Gram-negative microorganisms were the most frequently
isolated pathogens. More than half (54.2%) of the hospitalized patients were
on antibiotic therapy for prophylaxis.
P536 Prevalence of hospital-acquired infections in
surgical patients in Greek hospitals – Results from two
nationwide prevalence surveys
P. Nikolaidis, J. Pediaditis, M. Roumbelaki, S. Metallidis,
S. Levidiotou, S. Kartali, G. Kioumis, E. Maltezos, E. Anevlavis,
G. Haliotis, H. Kolibiris, Y. Tselentis, A. Gikas
Hellenic Society for Infection Control, GR
Objective:The purpose of the present study was to estimate the prevalence of
hospital-acquired infections (HAIs) and surgical site infections (SSIs) in
operated patients in Greek hospitals.
Methods:Data for this study were derived from the database created after two
nationwide prevalence studies (1999 and 2000). The Greek Infection Control
Network designed and coordinated the two-point prevalence surveys.
Results:Among the 1037 patients who had at least one operation in the 1999
survey, 129 patients developed 148 (14.27%) HAIs. A total of 1093 operations
were registered and 49 SSIs (4.5%) were found. Among the 868 operated
patients in the 2000 survey, 82 patients developed 88 (10.13%) HAIs. A total
of 902 operations were registered and 38 SSIs were detected (4.2%). SSIs were
found to be 33.1% of all HAIs in 1999 and 43.2% of all HAIs in 2000.
Respiratory tract infection represented 22.9 and 19.3%, urinary tract infec-
tions 18.2 and 17.0%, and bloodstream infections for 11.5 and 9.0%, between
all HAIs for 1999 and 2000, respectively. The median length of time elapsed
from admission to operation for patients without HAI was 1 day, and was
signiﬁcantly different from the patients who developed HAI (median 3.0–
3.5 days). The median time (length of stay) from operation to discharge for
patients without HAI was 7–8 days, and was signiﬁcantly different in patients
who developed HAI (26.5–28 days). The day of the study, 72.4–77.8% of the
operated patients was under antibiotic therapy. The median duration of the
prophylactic antibiotic use in surgical patients was 4–5 days.
Conclusion:The rates of HAIs and SSIs in operated patients have been, for the
ﬁrst time, estimated in Greek hospitals. Rates seem to be high, but a sufﬁcient
number of operations must be registered and analyzed for each operative
procedure category in order to create benchmarks and compare rates between
hospitals. Length of stay in the hospital as well as the duration of the
prophylactic administration of antibiotics in these patients was found to be
unacceptably high. National plan for the surveillance and control of HAIs
must be developed in Greece in order to estimate (thoroughly) the situation
and try to implement evidence-based infection control policies in our
country.
P537 Infections in a general hospital delivery
department in a country with limited resources
N. Milic, V. Pavlov, M. Saric, D. Drndarevic
Belgrade, Pozarevac, YU
Objectives: There were a few data about the frequency of infections in
delivery departments in which new born children were born on time, in good
health and general conditions, and were only shortly hospitalized. Data that
have been announced in developed countries show the low incidence
between 0.3 and 3.1/100 new-born children. The incidence rates were
much higher in neonatology ICUs. There were almost no data from the
countries under limited resources. Health institutions in Republic of Serbia
were under serious lack of material and ﬁnancial resources during the most
recent years. Prevalence studies of hospital infections in health institutions
during 1999, that included 678 new born children, show the high prevalence
(14.6%) of hospital infections. Taking in account that the ordinary delivery
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department and ICU were not considered separately for the explanation of
such high rate of hospital infections, there was a need for special investigation.
Methods: During 9months, in delivery department with 42 baby beds, 3
delivery boxes, and 1–11 child births per day, the constant, radical, round-the-
clock surveillance was implemented. The data about the new-born children
were collected during the hospitalization as well as 7 days after the relieve.
During the surveillance, there were in use CDC (USA) deﬁnitions and
criteria in form of handbook adapted to domestic health institutions. The
incidence rate was calculated on 100 new born healthy children.
Results: In the period from January 01–September 30 2002, 1169 new-born
children were under constant, radical, round-the-clock epidemiology sur-
veillance. Forty-eight hospital infections were registered (incidence rate was
4.1%). Infections were registered during each month of the whole period, but
with different incidence rate. The highest incidence rate was in April (6.8%),
and the lowest in June (0.7%). After the highest incidence rate in April, special
controlled general measures for prevention of hospital infection were imple-
mented. According to the anatomic localization, the most frequent were
infection of umbilicus (18) and skin, eye sight, and septicemia (10). Etiology
diagnosis was established in 45% of the clinical demonstrated infections. The
most usual cause was Staphylococcus aureus.
Conclusion: Infection in ordinary delivery departments under the limited
resources was not a big problem if the general measures for its prevention were
strictly implemented.
P538 A microbiological and epidemiological survey of
cutaneous swabs from inpatients, submitted for culture in a
5-year period. Hospital- versus community-acquired
infection
R. Manfredi, A. Nanetti, R. Valentini, S. Morelli, M. Ferri, L. Calza,
F. Chiodo
Bologna, I
Objective: To assess the epidemiological and bacteriological proﬁle of cuta-
neous swabs performed in hospitalized patients (pts).
Methods:All skin swabs, purulent material, and other swabs performed from
different body sites due to diagnostic or surveillance purposes were prospec-
tively evaluated since 1998, with special attention focused on their commu-
nity-acquired origin (outpatients, day-hospital pts, material obtained within
72 h of hospitalization), versus nosocomial-acquired one (inpatients admitted
for >72 h).
Results:Of the 5381 swabs, 26.8% were from pts hospitalized since >3 days,
but cumulative positivity rate did not prove different versus that of community
samples, also considering temporal trend, nosocomial infection accounted for
32% of episodes, with the greatest frequency in the year 2001 (36.6%) versus
2000 (28.2%), while community-acquired rate was 32.9% (35.7% in 1999 vs.
30.4% in 2000). S. aureus was the most common organism, with a higher
incidence retrieved in community samples (56.2%; P< 0.01), followed by
P. aeruginosa and E. coli, whose origin was linked to the hospital environment
(27.9 and 10.7%, respectively; P< 0.02 and P< 0.04, respectively), while no
difference was found in the distribution of E. faecalis according to the pts
location. Invitro susceptibility testing showed signiﬁcant differences between
nosocomial isolates versus community ones. All S. aureus strains were com-
pletely sensitive to glycopeptides, followed by cotrimoxazole and netilmicin
(>90%), and cefotaxime, ceftriaxon, coamoxiclav, clindamycin, and chlor-
amphenicol (>75%); methicillin-resistance was 45.6% for hospital strains
versus 19.8% for community isolates (P< 0.001). P. aeruginosawas completely
susceptible to colistin, followed by a >90% sensitivity for ceftazidime and
imipenem, and a >60% rate for piperacillin-tazobactam, aztreonam, cipro-
ﬂoxacin, and tobramycin, although nosocomial origin was borne by greater
resistance levels (P< 0.05–0001) against ureidopenicillins, ceftazidime,
aztreonam, tobramycin, and amikacin.
Conclusion: The resort to skin swabs (especially for surveillance purposes)
becomes increasingly frequent so that laboratories process these specimens
with growing frequency: from 902 samples in 1998 to >1500 in 2000–2002;
P< 0.001). As a result, interpretation becomes difﬁcult for clinicians who
have to distinguish colonization from invasive infection in the compromised
pts. Both etiology and antibiotic sensitivity are notably inﬂuenced by the
environment and the selective pressure exerted on colonizing or infecting
organisms.
P539 Bacteriological monitoring of purulent and biopsy
material from infection of skin and soft tissues at a
university hospital in Bologna, Italy: a prospective
surveillance study
A. Nanetti, R. Manfredi, S. Morelli, M. Ferri, R. Valentini, L. Calza,
F. Chiodo
Bologna, I
Objective:To assess the positivity rate of cutaneous swabs of wound infections
in patients (pts), followed at our University Hospital since 1998, on the
ground of a number of temporal, clinical, microbiological, and antimicrobial
sensitivity features of the most common isolated pathogens.
Methods: Over 1100 specimens from infected cutaneous wounds (mostly
surgical in origin) were sent to our reference laboratory with a cumulative
positivity rate of 39.1%, declining from the year 1999 (39.6%) to the year 2002
(33.1%; P< 0.001).
Results: The majority of samples (82.4%) were identiﬁed from hospitalized
pts, compared with outpatients and day-hospital pts. Both rate and spectrum
of microbial isolation did not vary according to the specimen origin,
but Staphylococcus aureus largely prevailed (177 strains, with an incidence
progressively increasing over time), followed by Pseudomonas aeruginosa (90
isolates), Enterococcus faecalis (65 strains), and Escherichia coli (41 isolates).
Candida glabrata was retrieved thrice in the year 2001. Invitro antimicrobial
susceptibility assays pointed out a complete sensitivity of S. aureus to glyco-
peptides (teicoplanin and vancomycin), while a progressively decreasing
activity was shown by imipenem, ceftazidime, norﬂoxacin, netilmicin, ami-
kacin, piperacillin-tazobactam, and ciproﬂoxacin, and a sensitivity lower than
50% was detected for penicillin, coamoxiclav, cefotaxime, ceftriaxone, ery-
thromycin, clarythromycin, clindamycin, chloramphenicol, rifampicin, gen-
tamycin, and cotrimozaxole, and methicillin resistance regarded even 55.7%
of isolates. When considering P. aeruginosa, only colistin was effective on all
tested strains, followed by imipenem, ceftazidime, ciproﬂoxacin, piperacillin-
tazobactam, amikacin, tobramycin, and aztreonam, while piperacillin, mezlo-
cillin, and gentamycin did not reach a 50% sensitivity rate.
Conclusion: Wound infections (mostly surgical ones) can be borne by a
very large etiology spectrum so that the resort to microbial isolation and
invitro antimicrobial assay are mandatory for an appropriate management.
The elevated intrinsic and acquired antimicrobial resistance demonstrated
by the two most frequent pathogens retrieved in our experience (S. aureus
and P. aeruginosa), depend on hospitalization itself, large and prolonged
administration of broad-spectrum antimicrobial agents as preventive and
therapeutic measures, surgery, and other invasive diagnostic and therapeutic
procedures.
P540 Nosocomial infections surveillance based on
microbiology laboratory
G. Gattuso, A. Scalzini, D. Tomasoni, C. Chiarelli, R. Stradoni,
G. Quartaroli
Mantua, I
Objective: Surveillance of the temporal trend of incidence and prevalence of
the microorganisms in cultured strains, selected among those at high-risk of
nosocomial infection (NI) (from ICU, Hemodialysis, neonatal ICU, etc.), to
observe abnormal situations (e.g. risk of NI clusters, ‘alert’ microorganisms,
‘alert’ events).
Materials and methods: From June 2001, we recorded and processed with
Excel the results of the microbiological cultures (performed in the department
of intensive care, neonatal intensive care, hemodialysis, infectious diseases,
respiratory diseases) to obtain the following information: (1) number of
microbiological samples; (2) average (SD)of samples for patients; (3) total
number of positive and negative samples; (4) number of samples for each type
of material with percentage of positivity; (5) comparison between positive
blood cultures from central venous catheter (CVC) and peripheral vein (to
diagnose catheter-related bloodstream infections).
Results: The monthly process permitted to follow the frequency of micro-
organisms monitoring the positive strains from June 2001 till now. In ICU, the
mostly found microorganism was P. aeruginosa followed byCandida spp., while
in hemodialysis, S. aureus and coagulase-negative followed by Candida.
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Conclusions: Analysis of laboratory data permitted the developing of more
suitable measures to decrease the incidence of infections (e.g. asepsis of the
wards, increased attention to the right nursing: hand washing, ‘good practice’
standards, guidelines adherence).
Future aims:
1. Beginning the analysis in others wards;
2. going on with monthly process and also with corrective measures;
3. correctly diagnosing the NI cases; and
4. continuing the training of health professionals.
P541 Post-intervention frequency of bacteriuria, pyuria
and bacteremia in outpatients who have undergone cysto-
urethroscopy
H. Turan, U. Balci, F. S. Erdinc, N. Tulek, C. Germiyanoglu
Ankara, TR
Objectives: Urinary tract infections are the most common nosocomial
infections. About 80% of nosocomial urinary tract infections are associated
with the use of urethral catheters. Another 5–10% occur after genitourinary
manipulation such as cystourethroscopy. The necessity of antimicrobial
prophylaxis prior to cystourethroscopy is controversial. The aim of this study
was to determine the rate of bacteriuria, pyuria, and bacteremia in outpatients
who underwent cystourethroscopy and was not administrated antimicrobial
prophylaxis prior to intervention.
Methods: Seventy-one patients who underwent cystourethroscopy for var-
ious indications and did not have bacteriuria were included. In the study,
patients were not given antimicrobial prophylaxis. A midstream urine sample
was taken before and 48 h after the procedure. Blood culture was taken 1 hour
after cystourethroscopy. Patients were questioned for newly developed
symptoms 48 h after cystourethroscopy. Blood cultures were taken again
from patients who presented with fever.
Results: Six patients (8%) developed signiﬁcant bacteriuria: four of them were
asymptomatic and six of the patients (8%) developed pyuria without signiﬁcant
bacteriuria. Bacteremia was not determined in any of the patients. The
association between presence of pyuria prior to procedure and development
of signiﬁcant bacteriuria after the procedure was signiﬁcant (P< 0.05).
Conclusion: In our study, the rate of occurrence of signiﬁcant bacteriuria after
cystourethroscopy was 8%, and bacteremia did not develop. Thus, we
conclude that cystourethroscopy is safe and a well-tolerated procedure.
The microscopic evaluation of the urine should be carried out even if the
patients do not have symptoms after the procedure, as asymptomatic bacter-
iuria may develop after cystourethroscopy. The presence of pyuria prior to the
intervention is a risk factor, and the patients who have pyuria should be
followed up due to the fact that signiﬁcant bacteriuria may develop in these
patients. We conclude that administrating prophylactic antibiotics for patients
who have sterile urine prior to cystourehtroscopy is unnecessary.
P542 Contribution of VIGI@ct1 software to nosocomial
infection control in a 920-bed French hospital
C. Eloy, B. Burgaud, P. Janian
Troyes, F
Objectives: A 6-year retrospective study was performed to analyze the
contribution on the Infection Control Program of VIGI@ct (bioMe´rieux)
epidemiology software to detect and alert on suspected nosocomial infections
(NI) and multidrug-resistant bacteria (MDR).
Materials andmethods: In the ﬁrst period (P1: 1997–99), administrative and
specimen-related data were collected, entered manually and analyzed using
EpiInfo (TM; CDC, Atlanta). The suspected NI were detected manually on a
monthly basis. In the second period (P2: 2000–2002, study ongoing for 2002),
VIGI@ct, connected to both the Laboratory Information System and
Microbiology Automated Systems, was used to gather all the data automa-
tically. In case of suspected NI or MDR isolates, a real-time alert with a
questionnaire is printed out and sent to both the infection control team (ICT)
and the clinician to conﬁrm the infection, and add any relevant information.
Results: In P1, the time-consuming manual data entry only enabled us to
perform limited data analysis (i.e. incidence rate (IR) on presumptive NI,
evolution of the susceptibility to antibiotics of the most frequently isolated
bacteria). In P2, data from the questionnaires enabled us to calculate and
analyze iatrogenic and endogenous conﬁrmed NI IR, acquired versus
imported methicillin-resistant S. aureus (MRSA) IR. Information such as
the bacteriemia portal of entry and attributable deaths were also analyzed.
Documented evolution of the susceptibility to antibiotics of the most fre-
quently isolated bacteria were given to the clinicians. On analyzing the data,
we noted a correlation between the 4% decrease of MRSA and the 15%
decrease of the vancomycin hospital daily dose. Evaluation of the infection
protocol’s efﬁciency was performed to implement better protocols to control
the spread of infection (e.g. 23% decrease in urinary tract infections due to
catheter after 6months) (Table 1).
Conclusion: The VIGI@ct software helps us provide clinicians and the ICT
with real-time and relevant information on NI and MDR. The rapid and
efﬁcient feed-back from clinicians and the ICT enables us to improve the
analysis of infection control data, and help the ICTact rapidly to increase the
efﬁciency of the infection control program.
Table 1
1997 1998 1999 2000 2001 2002
No. of inpatients 34643 35773 35185 34121 33675 27327
Suspected NIIR 3.23 4.24 4.64 – – –
Confirmed NIIR – – – 2.69 2.76 2.93
Iatrogenic – – – 1.52 1.49 1.53
Endogenous – – – 1.17 1.27 1.40
Acquired versus
Imported MRSAIR
– – – 0.27/0.73 0.20/0.91 0.22/0.96
11-month data
Fungal infections therapy
P543 Diagnosing and monitoring of invasive
aspergillosis during antifungal therapy by polymerase chain
reaction: an experimental study in mice
C. Lass-Flo¨rl, C. Speth, A. Mayr, R. Wu¨rzner, H. Dietrich
Innsbruck, A
Objectives: Invasive aspergillosis is one of the commonest causes of death due
to infection in neutropenic cancer patients and recipients of allogenic stem
cell transplants. Early diagnosis of infection is important as early treatment
with antifungal drugs may increase the patient survival. Recently, we eval-
uated twice the value of weekly screening for circulating fungal DNA using
polymerase chain reaction (PCR) of whole blood samples. The results
indicate the usefulness when screening for Aspergillus in patients at risk.
Hence, positive results became negative shortly after commencement of
antifungal treatment, and did not correlate with underlying invasive fungal
infections. In this study, we evaluated the value of PCR for diagnosing and
monitoring of invasive aspergillosis during amphotericin B therapy.
Methods:Thirty-six female BALB/c mice were infected with Aspergillus spp.
Mice were treated either with amphotericin B or glucose for 10 days. For
diagnosing and monitoring PCR, microscopy and culture of tissues and blood
were performed. The PCR results of treated animals were compared to those
of untreated animals. DNA extraction was performed using recombinant
lyticase, the genes of the 18S rRNAwere ampliﬁed with PCR using speciﬁc
primers, and amplicons were detected by PCR-ELISA.
Results: In the group of amphotericin B application, 27 (64.3%) tissue samples
were positive by PCR, 32 (76.1%) by microscopic examination, and 20
(47.6%) by culture. In the control group, 30 (71.4%) tissue samples were
positive by PCR, 31 (73.8%) by microscopic examination, and 28 (66.6%) by
culture (P¼ 0.34). Of the 48 blood samples tested over a period of 8 days
following Aspergillus infection, 14 (58.3%) samples in the control group and 7
(29.1%) in the amphotericin B group were positive (P< 0 .05).
Conclusion: The results suggest that this PCR assay is a sensitive tool for
detection of Aspergillus in infected tissues, independent of an existing therapy.
Monitoring of blood cannot be recommended by PCR during amphotericin
B application, since negative results did not exclude organ infections.
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P544 Combination posaconazole and amphotericin B
therapy against pulmonary aspergillosis and systemic
candidiasis in mice
A. Cacciapuoti, L. Najvar, R. Bocanegra, M. Gurnani, S. Hernandez,
J. Halpern, F. Menzel, J. Graybill, D. Loebenberg
Kenilworth, San Antonio, USA
Objectives:Combination posaconazole (POS), a triazole in Phase III clinical
trials, has broad-spectrum activity against fungi; amphotericin B (AmB) is the
gold standard for treatment of severe invasive fungal infections (SIFI).
Combination therapy of SIFI is increasingly important, but there is concern
about antagonism between triazoles and AmB.
Methods: (A) Studies with Aspergillus ﬂavus (AF) were done in two inde-
pendent laboratories, using cortisone acetate-compromised mice exposed to
AF conidia in inhalation ﬂasks. Treatment was with water (controls), POS
alone (10, 2mg/kg, PO), AmB alone (5, 1mg/kg, IP) or combinations
(POS10þAmB5, POS2þAmB1) concomitantly (days 1–7 postinfection,
PI) or sequentially (POS days 1–7 PI, AmB days 2–7 PI); 8–12mice per group.
Survival was followed for 8 days (analyzed by log-rank test) and lungs cultured
from dead mice daily, and survivors on day 8 (analyzed by Mann–Whitney
test). (B) Studies with Candida albicans (CA, done only at SPRI) used normal
mice infected i.v. with 5 106 or 1 107CFU per mouse (four strains
tested). Treatment with water (control), POS alone, AmB alone, or con-
comitant POSþAmB began 4 h PI and continued once daily for 4 days, using
four-dose levels of each drug in all possible combinations (checkerboard); 10
mice per group. Survival was observed for 10 days (pooled data from two
studies per strain analyzed by Wilcoxon’s tests).
Results: (A) With AF-infected mice, increased survival and lung burden
reductions, relative to controls with POS alone and POSþAmB, were
similar, while AmB alone was variable. (B) With CA-infected mice, survival
of mice, relative to controls, treated with POSþAmB was either more
effective or similar to POS or AmB alone in >99% of 128 comparisons.
Conclusions: POSþAmB combinations were not antagonistic against pul-
monary aspergillosis in compromised mice dosed concomitantly or sequen-
tially, or systemic candidiasis in normal mice dosed concomitantly.
P545 Galleria mellonella, an in vivo model for the
pathogenicity and treatment of Aspergillus infections
J. Rooke, D. Law, D. Denning
Manchester, UK
Objectives: Aspergillus spp. are a frequent cause of infection amongst immu-
nocompromised patients; therefore, the need for more active antifungal drugs
is great. In this study, the Greater Wax Moth, Galleria mellonella, was
investigated as a simple in vivo model for the pathogenicity and treatment
of Aspergillus infections.
Methods:Wax moth larvae were infected with several strains of Aspergillus by
inoculation with 10mL of washed spore suspension (2 103 to 6 106 cfu
per larvae, dependent on organism) through the cuticle of the last pro-leg.
This inoculum was sufﬁcient to cause death in 90% of the test group between
days 3–4. Infected larvae were treated with amphotericin B (AMB), itraco-
nazole (ITZ), or ketoconazole (KTZ) at 0.05mg/g immediately postinfec-
tion, maintained at 308C, and monitored daily. Control larvae received no
treatment and all died between days 3–4.
Results: In this model, pathogenicity is both critically dose and strain
dependent, and a hierarchy of pathogenicity was observed as follows: A. ﬂavus
>A. niger>A. terreus>A. fumigatus. Treatment of A. fumigatus (AF210m,
AF293) infection was successful with AMB (100 and 80% survival, respec-
tively) and ITZ (100 and 90%), but mortality was high when treated with
KTZ (10% survival for both strains). An invitro and invivo ITZ resistant
strain of A. fumigatus was found to be resistant to ITZ (10% survival) in this
model also. AMB and KTZ had poor activity against A. terreus-infected larvae
compared to those treated with ITZ (100% survival).
Conclusion: The data from this study correlate well with both invitro MIC
data and invivo murine models infected with Aspergillus. We therefore
conclude that the use of this convenient and inexpensive model could provide
a useful tool in the screening of novel compounds for in vivo antifungal
activity while avoiding some of the ethical issues and costs associated with
other animal models.
P546 Safety and tolerability of caspofungin therapy for
elderly patients with invasive candidiasis or invasive
aspergillosis
M. DiNubile, C. Sable, N. Kartsonis
West Point, USA
Background: Elderly patients may be particularly susceptible to drug-related
adverse events (DRAEs). Invasive fungal infections have been traditionally
treated with amphotericin B (AmB) despite its frequent toxicity and poor
tolerability. Caspofungin (CAS) is a new, generally well-tolerated intravenous
(i.v.) antifungal drug with activity against Candida and Aspergillus in vitro and
in clinical trials. CAS may provide a useful therapeutic option for elderly
patients with IC or IA under some circumstances.
Methods: Patients 65 years of age, enrolled in a double-blind, randomized
trial of CAS (50mg/day after a 70mg loading dose) versus AmB for
documented IC, or in an open-label, noncomparative study of CAS for
deﬁnite or probable IA in patients refractory to and/or intolerant of standard
therapy. Patients with IC were to be treated for 14 days after the last positive
Candida culture; patients responding to i.v. therapy could be switched to oral
ﬂuconazole (400mg/day) after 10 days. Clinical response and status of
immunosuppression dictated the duration of CAS therapy for IA patients.
Adverse events determined by the investigator to be deﬁnitely, probably, or
possibly related to CAS were considered to be DRAEs.
Results:There were a total of 58 elderly patients treated with CAS in the two
studies (43/114 (38%) IC and 15/90 (17%) IA). Median (range) age was 71
(65–84) years; 53% were men. Nine (60%) of the IA patients were intolerant
to other antifungal drugs. Median (range) duration of CAS therapy was 12 (1–
23) days for IC and 28 (5–77) days for IA. Fifteen (26%) patients experienced
clinical DRAEs; none was serious. Speciﬁc clinical DRAEs found in >3% of
elderly CAS recipients were phlebitis (5%), nausea (3%), and vomiting (3%).
Nine (16%) patients had laboratory DRAEs; none were serious. Speciﬁc
laboratory DRAEs found in >3% of the elderly CAS recipients were
hyperbilirubinemia (4%); elevated direct bilirubin (5%), alkaline phosphatase
(7%), and ALT (5%); and decreased serum potassium levels (4%). No one
discontinued CAS due to a DRAE. There were no drug-related deaths.
Conclusions: Caspofungin therapy at a dose of 50mg/day appeared to be
generally well tolerated in this subgroup of elderly patients from two studies of
invasive fungal infections. The type and frequency of DRAEs in elderly
patients treated with CASwere comparable to DRAEs in overall CAS-treated
patients. No serious DRAEs or study discontinuations due to DRAEs were
noted in 58 elderly patients with IC or IA who received CAS therapy.
P547 Successful treatment of Trichosporon asahii
infection with caspofungin and liposomal
amphotericin B
M. Bassetti, S. Ferrando, A. Briozzo, V. Del Bono, A. Ferrazin,
A. Di Biagio, D. Bassetti
Genoa, I
Objectives: Trichosporon asahii is an emerging fungal pathogen seen particu-
larly in immunologically compromised patients. There are many reported
cases of hematogenously disseminated infections with this life-threatening
yeast, and no obviously effective antifungal therapy is available. The echi-
nocandins are a promising new class of drugs with broad antifungal activity
that demonstrate to be effective in combination with amphotericin B.
Methods:A 54-year-old man was admitted to our hospital onMarch 2002 for
an acute myeloid leukemia (AML). He received two cycles with high-dose
chemotherapy with subsequent bone marrow aplasia. After a few days of this
treatment, the patient developed fever (Tamax, 39.58C). He was started in
antibiotic therapy as well as in antimicotic therapy. After 1week, ﬂuconazole
was stopped and the patient was started in liposomal amphotericin B
(L-AMB) 300mg daily i.v.; one of the two bottles of blood cultures during
the fever was positive for T. asahii. After 3 days of L-AMB due to the
persistency of positive blood cultures and fever, the patient was started on
voriconazole 800mg i.v. the ﬁrst day, then 600mg i.v. During the following
days, due to the worsening of the overall conditions, alteration of the renal
function, and increase in the bilirubinemia (10.2mg/dL), the dosage of
voriconazole was reduced to 400mg i.v. daily. During such a therapy, three
of the six bottles of blood cultures resulted positive for T. asahii. The
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antimicogram demonstrated complete sensitivity to AMB, intermediate to
ﬂuconazole, and resistance to itraconazole and voriconazole. Therefore,
voriconazole was stopped and the patient was started on L-AMB 350mg
daily and caspofungin 70mg the ﬁrst day, then 50mg daily. The condition of
the patient continued to deteriorate: bilirubin reached 37.3mg/dL, creatinin
6.2mg/dL, azotemia 254mg/dL, and uric acid 19.7mg/dL. After 2 days of
combination of L-AMB and caspofungin, three bottles of blood cultures were
negative. Seven days later, the patient died due to the resurgence of leukemia.
Conclusions: Echinocandins invariably demonstrate high MICs when tested
against Trichosporon spp. In this case, amphotericin B demonstrated invitro
activity against T. asahii, while azoles were resistant. The combination of
caspofungin and high-dose L-AMB appear to be an effective treatment
solution for the T. asahii fungemia.
P548 Successful therapy of cerebral
phaeopyphomycosis due to Ramichloridium mackenziei
with the new triazole posaconazole (SCH56592)
H. Al-Abdely, A. Alkhunaizi, J. Al-Tawﬁq, M. Hassonah, M. Rinaldi,
D. Sutton
Riyadh, Dhahran, SA; San Antonio, USA
Background: R. mackenziei, a dematiaceous fungus geographically restricted
to theMiddle East, is a rare cause of cerebral phaeohyphomycosis. There have
been no reported cases in which the patient survived despite surgery and
antifungal therapy. In an experimental murine model of cerebralR. mackenziei
infection, posaconazole (POS) was superior to amphotericin B (AMB) and
itraconazole (ITZ) in prolonging survival and reducing brain fungal burden,
suggesting a possible role of POS for the treatment of this disease.
Objective: To describe a clinical case of phaeohyphomycosis due to
R. mackenziei that was treated successfully with POS.
Clinical case: A 62-year-old man who had received a kidney transplant
3months earlier was admitted to the hospital after experiencing left-sided
hemiparesis and hemisensory loss. A CT scan of the brain showed a 2 2 cm
ring-enhancing lesion in the right parieto-frontal region. Aspirates of the
lesion grew a black mould upon culture that was identiﬁed as R.mackenziei.
Despite several weeks of AMB lipid complex 5mg/kg/day IV and oral ITZ
200mg twice daily, anMRI showed progression of the original lesion coupled
with multiple new satellite lesions. Therapy was switched to liposomal AMB
5mg/kg/day i.v., oral ITZ 200mg twice daily, and oral 5-ﬂucytosine (5FC)
25mg/kg thrice daily. A repeat MRI showed further evidence of disease
progression; a craniotomy with evacuation of the large abscess was performed.
Minimum inhibitory concentration values of the fungal cultures from
the craniotomy specimen were <1mg/mL for AMB, ITZ, and POS, and
8–16mg/mL for 5 FC. AnMRI 2weeks later showed enlargement of multiple
satellite lesions. At this time, current antifungal drugs were discontinued and
POS 800mg daily (200mg qid) was initiated. The patient tolerated POS well
with no apparent side-effects, and was switched to maintenance therapy with
400mg bid after initial partial response. Over the next 18months, several
MRIs of the brain showed reduction and subsequent disappearance of the
multiple satellite lesions with some enhancement at the original abscess site.
Conclusion: Treatment with POS in this immunocompromised patient
resulted in clinically signiﬁcant symptomatic and radiological improvements
after other therapies failed. This case supports the use of POS as salvage
therapy for serious dematiaceous fungal infections of the central nervous
system and suggests that additional studies are warranted.
P549 Our experience in the treatment of 40 cases with
candidal balanoposthitis
N. Como, D. Kraja, B. Tila
Tirana, AL
Objectives:The acknowledgement of the real possibilities of the treatment of
candidal balanitis and balanoposthitis.
Methods: We analyzed the efﬁcacy of three treatment tactics for 40 cases of
age 14–67 years with candidal balanitis or balanoposthitis, observed during
March 1995–August 2002. We used three treatment tactics: etiologic treat-
ment only locally; locally etiologic treatment; and oral and surgical treatment
when the results were weak, although etiologic therapy. Local treatment: 16
cases were treated with Nizoral cream (Yanssen, ketoconazole 2%, tube of
30 g) applied twice per day for 14 days, 24 cases were treated with Pevaryl
cream (Cilag, econazole 1%, tube of 30 g) applied as mentioned above. Oral
treatment: 15 cases were treated with Nizoral (Yanssen, ketoconazole in
tablets of 200mg) 2 1 tablet per day for 14 days; with Diﬂucan (Pﬁzer,
ﬂuconazole in tablets of 150mg) taking three doses 150mg within an interval
of 10 days, one dose to the next one.
Results:From 24 cases (13 with prepuce), which took only local treatment, 13
cases were cured (four of them with prepuce); also 54.16% of the total were
cured and 30.76% of patients with prepuce. For 11 patients (nine cases with
prepuce), where local treatment failed, oral treatment was applied, which
cured eight patients (four of them with prepuce). So 72.72% of the total and
55.55% of the patients with prepuce were cured. For four patients, where the
systematic treatment failed, circumcision was done which solved the problem.
While from 16 patients (seven with prepuce), which were treated locally and
orally since the beginning, 12 patients were cured (four patients with
prepuce), so 75% of the total and 57.14% of those with prepuce were cured.
In three cases, where the treatment failed circumcision was successfully
applied. Surgery tactic had been altogether applied in seven patients,
17.5% of all cases (two of them with acute balanoposthitis and ﬁve with
chronic balanoposthitis).
Conclusions: With local antimycotics, 54.16% of all cases or 30.76% of the
patients with prepucewere cured; with local antimycotics and oral ones, 72.72
up to 75% of all cases or 55.55 up to 57.14% of patients with prepuce were
cured; surgery tactic was necessary on 17.5% of all patients or 9.09% on the
acute cases and on 27.77% of the chronic ones.
P550 Treatment of oral candidiasis in HIV/AIDS patients
S. Kapere
Kampala, UG
Objective: To study breakdown of oral candidiasis, the most common
opportunistic fungal infection in HIV-positive persons, with itraconazole
capsules, the existing modalities of treatment not yielding satisfactory results.
Methods: Seventy-two persons were selected who are HIV-positive and
having oral candidiaisis. Oral candidiasis was diagnosed by fungal culture and
KOH smear. Treatment was given with itraconazole capsules 200mg daily for
15 days. Four patients were dropouts and the rest 56 patients were regularly
followed up to 6months.
Results: All the 56 patients were cured of candidiasis clinically after a mean
period of 5 day and mycologically after a mean period of 12 days. Out of the
56 patients who had completed treatment and follow up, eight patients had a
reinfection after 4months. The rest 36 did not have oral candidiasis after a
follow up period of 5months.
Conclusion: As the cure rate (56 out of 72¼ 15%) of oral candidiasis with
itraconazole capsules 200mg daily for 15 days is convincing, this may be
chosen as the treatment for oral candidiasis, which is one of the most common
opportunistic infections in HIV/AIDS patients.
P551 Antifungal strategies in febrile neutropenic
patients with acute leukemia
R. Fanci, C. Paci, C. Casini, F. Leoni
Florence, I
Objectives: The practice of starting empirical antifungal therapy in persis-
tently febrile neutropenic patients is very frequent. Conventional ampho-
tericin B (Con-A) remains the gold standard for suspected or proven fungal
infections. Although adverse effects are common, the recent development of
liposomal formulations (L-Amb) allows antifungal therapy to be administered
with potentially improved efﬁcacy and reduced toxicity. To evaluate the
efﬁcacy of L-Amb in persistently febrile high-risk patients or with proven or
suspected fungal infections who had not tolerated or not responded to Con-
A, febrile episodes in acute leukemic patients were examined.
Methods: Febrile episodes were deﬁned according to EORTC; fungal
infections were deﬁned according to Mycoses Study Group. Initially, we
used Con–A (1–2mg/kg/day) and we switched to the L-Amb (1–3mg/kg/
day) if the patient had severe adverse effects; patients who were receiving two
or more nephrotoxic drugs concurrently were given L-Amb from the start.
Results:During 1998–2001 period, 149 patients were enrolled and a total of
178 febrile episodes occurred. Of 82 organisms isolated in 73 bacteremias,
fungi were responsible for four cases of sepsis (5%). Antifungal therapy was
performed in 21 febrile episodes (11%); Con-A was used as initial therapy in
11 patients (pts), L-Amb in 10 patiens. The switching of Con-A to Lip-Awas
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performed in six patients, the switching of Lip-A to Con-A in one patient
(54.5 and 10%, respectively). Evaluable episodes for antifungal therapy
were six in Con-A treatment (four FUO, one fungemia due to C. tropicalis,
one suspected fungal pneumonia) and 15 in Lip-A (six FUO, three fungemia
due to C. famata,C. albicans,C. Krusei; ﬁve suspected fungal pneumonia, one
proven Aspergillosis). Overall, of patients treated with antifungal therapy,
successful outcome was achieved in 17 patients (81%): 83% with Con-A, 80%
with Lip-A, and death in four patients (19%): 17% with Con-A and 20% with
L-Amb. Causes of failure were one FUO in Con-A, two FUO and one
C.Krusei fungemia in L-Amb. In Con-A treatment, adverse effects were
important in hypokalemia in four patients and immediate reaction in two
patients; in L-Amb treatment, we documented one acute reaction.
Conclusion: Our results conﬁrm that L-Amb is an effective agent for fungal
infections and is far less toxic than conventional form of this drug. However,
in some cases, other strategies including high doses of L-Amb or new agents as
voriconazole or caspofungin must be considered.
P552 Invitro activity of a new polyene SPK-843 against
Candida spp., Cryptococcus neoformans, and Aspergillus
spp. clinical isolates
A. S. Kantarcioglu, A. Yucel, V. Vidotto
Istanbul, TR; Turin, I
The most commonly occurring infections among immunocompromised
patients are candidiasis, cryptococcosis, and aspergillosis. The treatment of
invasive fungal infections has essentially been limited to amphotericin B
(AMB) and azoles. Due to dose-limiting nephrotoxicity of AMB and intrinsic
or acquired resistance to azoles leading to therapeutic failure, efforts in
antifungal pharmacology increased to develop safe and effective drugs.
SPK-843, an amide derivative of Partricin A, produced by a mutant strain
of Streptomyces aureofaciens, has recently been introduced as a promising
antifungal agent under investigation, and as less toxic in comparison to
AMB. The invitro fungicidal and fungistatic activity of the new developing
water-soluble polyene antifungal SPK-843 was compared with that of AMB
against clinically signiﬁcant Candida albicans (n¼ 70), nonalbicans Candida
(n¼ 39), Cryptococcus neoformans (n¼ 49), and Aspergillus spp. (n¼ 36) isolates
according to the broth macrodilution reference method for yeasts (M27-A) of
NCCLS and the broth macrodilution modiﬁcation of NCCLS reference
method for ﬁlamentous fungi (M38-P). Antibiotic medium 3 was used for
testing Candida and Aspergillus spp. isolates and Yeast Nitrogen Base medium
for C. neoformans strains supplemented with 2% glucose. C. albicans ATTCC
90028, C. krusei ATCC 6258, C. parapsilosis ATCC 22019, C. neoformans
ATCC 90112, and Paecilomyces variotii ATCC 22319 were used as quality
control strains with knownMIC values. MICs were deﬁned as the lowest drug
concentration causing 100% inhibition for both test antifungals (MIC-0). The
minimal fungicidal concentration (MFC) was determined by plating 100mL
from each MIC drug dilution having no growth or fewer than three colonies
onto SDA incubated at 308C until growth was seen in the growth control
subculture. The MFC was the lowest drug concentration having no growth.
Five isolates of C. albicans, 18 (three of each species) of nonalbicans Candida
strains, ﬁve of C. neoformans and 15 (three of each species) of Aspergillus spp.
were randomly selected and tested again against each drug to assess the
reproducibility of the tests. MIC ranges (micrograms per mililiter) for
C. albicans, nonalbicans Candida,C. neoformans, and Aspergillus strains, respec-
tively, were as follows: SPK-843 – 0.007–4, 0.007–8, 0.007–4, and 0.007 to
higher than 16 (geometric mean MIC 0.16, 0.28, 0.05, and 0.23mg/mL,
respectively); AMB – 0.015–16, 0.03–16, 0.03–2, and 0.06 to higher than 16
(geometric mean MIC 0.50, 1.01, 0.05, and 0.67mg/mL, respectively). The
MFCs (micrograms per mililiters) for C. albicans, nonalbicans Candida,
C. neoformans, and Aspergillus strains were as follows: SPK-843 – 0.03–16,
0.03–16, 0.03–8, and 0.007 to higher than 16 (geometric mean MFC 0.66,
1.01, 0.24, and 0.81mg/mL, respectively); AMB – 0.125–16, 0.25–16, 0.03–
8, and 0.06 to higher than 16 (geometric mean MFC 1.53, 2.22, 0.24, and
1.84mg/mL, respectively). For all isolates, SPK-843 and AMBwere fungicidal
in 90.0, 97.1% ofC. albicans, 89.7, 100% of nonalbicans Candida, 91.8, 97.9%
of C. neoformans, and 88.6, 94.3% of Aspergillus isolates, respectively. The tests
were considered valid when the control isolates had the expected values. SPK-
843 demonstrated lower in vitro MIC and MFC values than AMB against
Candida spp. andC. neoformans and comparable (species dependent) to those of
AMB againstAspergillus spp. tested. The data obtained in the present study, are
encouraging for further studies including in vitro tests, clinical trials, and
animal experiments and accumulation of data will better clarify its therapeutic
efﬁcacy in deep mycosis specially due to most prevalent infections caused by
Candida spp., C. neoformans, and Aspergillus spp.
P553 Aspects of antifungal action of the novel
antimicrobial agent N-chlorotaurine
M. Nagl, G. Pilz, R. Arnitz, E. M. Lemberger, A. Fuchs, R. Wu¨rzner
Innsbruck, A
Objectives: N-chlorotaurine (NCT, ClHN-CH2-CH2-SO3-), a long-lived
oxidant produced by human neutrophils, has broad-spectrum microbicidal
activity against bacteria, fungi, and viruses. Bacteria have been demonstrated
to lose virulence after short, sublethal incubation times in NCT solution.
Methods and results: Different strains of Candida exposed to NCT for
sublethal times showed a lag of regrowth in broth media (postantifungal
effect). The adherence to epithelial cells was also reduced in Candida albicans
pretreated with NCT. In the presence of micromolar NCT, the concentration
of secreted aspartyl proteases of yeasts decreased, while millimolar NCT killed
the fungi. Besides these impacts on virulence factors, there is some evidence
that fungal spores treated with NCT for sublethal time undergo enhanced
phagocytosis by leukocytes compared to mock-treated ones.
Conclusions:These results provide support that application of NCT in fungal
infections may not only act via killing of these pathogens but also via
attenuation of their virulence and via synergism with innate immunity.
Emerging infections: problems for the clinician
P554 Invasive Hemophilus inﬂuenzae disease in Italy
due to encapsulated strains other than b
M. Cerquetti, R. Cardines, G. Renna, P. Spigaglia, M. Cioﬁ degli Atti,
P. Mastrantonio
Rome, I
Objectives: Encapsulated Hemophilus inﬂuenzae expresses one of the six
structurally and antigenically distinct polysaccharide capsules (a–f ). Immu-
nization of infants with conjugate vaccine against H. inﬂuenzae serotype b
(Hib) has dramatically decreased the incidence of invasive Hib disease in the
developed countries. However, the potential emergence of nonvaccine
preventable encapsulated strains other than b, has been suggested. In Italy
Hib vaccine was licensed in February 1995 and vaccination is voluntary. The
objective of the study was to monitor and characterize the encapsulated strains
other than b circulating in Italy.
Methods: In the present study, 198H. inﬂuenzae strains, isolated from invasive
disease in Italy between June 1997 and September 2002, were tested by a PCR
method to determine their capsular genotype. The other than b encapsulated
isolates were further analyzed for susceptibility to ampicillin, beta-lactamase
production, pulsed-ﬁeld gel electrophoresis (PFGE) patterns.
Results:By PCR, 128 type b strains, 60 nonencapsulated isolates, 1 b-strain, 5
type e and 4 type f isolates were identiﬁed. No type a, c, and d strains were
found. All the type e cases occurred in adult or elderly patients, three
presenting with bacteremia and two with meningitis, and were detected
between January 2000 andDecember 2001. One of the four type f cases was in
a child with meningitis, whereas the remaining three cases, two with
bacteremia and one with meningitis, were in adults. The type f cases were
detected over the 5-year period. All the isolates were susceptible to ampicillin;
none produced beta-lactamase. Two clearly different PFGE patterns were
found among the type e isolates. A close genetic relationship was observed
among type f strains.
Conclusions: The reporting of nine cases of invasive H. inﬂuenzae disease
caused by serotype other than b strains demonstrated the need for continuous
monitoring of invasiveH. inﬂuenzae infection. The large majority of cases due
to encapsulated strains other than b occurred in an adult population although
one type f case was strikingly reminiscent of the childhood Hib disease. Since,
until now, no data on the presence of type e infection have been reported in
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Italy, our results suggest the possible emergence of invasiveH. inﬂuenzae type e
disease in our country.
P555 A comparative analysis of adult and pediatric
infective endocarditis in a developing country
M. Alam, M. Tariq, G. Munir, A. Ansari, A. Akhtar, N. Akhtar,
R. Smego Jr
Karachi, Multan, PAK
Objectives: The aim of the study was to compare and contrast the pattern of
the disease between the adult and the pediatric age groups.
Methods: All the patients with infective endocarditis admitted between
January 1997 and December 2001 to the Aga Khan University Hospital,
Karachi, Pakistan were included. SPSS version 11.0 was used for statistical
analysis.
Results: A total of 66 patients were admitted between January 1997 and
December 2001. Twenty-two patients belonged to the pediatrics age group
(14 years) and 44 were adults. The mean age for the pediatric and adult
patients were 5.8 4.8 and 40 17 years, respectively. Sex ratio was 0.8:1
(M:F) for the pediatric patients while for the adults it was 3.4:1 (M:F). Adult
males were more likely to be diseased, and it was a statistically signiﬁcant
difference (P< 0.05). Mean duration of symptoms at presentation were 43
and 49 days for the pediatric and adult patients, respectively. Majority of the
patients in both the groups presented with fever. A murmur of cardiac origin
and splenomegaly were the other common presenting features. Adult patients
were more likely to have disease involvement of the native or prosthetic valve
while the pediatric patients had more signiﬁcant involvement of congenital
cardiac defects (P< 0.05). There were no signiﬁcant differences in terms of
neurologic and renal complications between the two groups. Rheumatic
heart disease was documented more commonly as a predisposing condition in
adults (P< 0.05) and congenital heart diseases were found to be highly
signiﬁcant predisposing conditions in the pediatric patients (P< 0.001).
Other risk factors were not found to be signiﬁcantly different between the
two groups of patients. There were no differences in the two groups in terms
of microbiologic results and the ability of echocardiogram to detect vegeta-
tions. However, congenital cardiac defects were more signiﬁcantly found to
be the sites of vegetation in the pediatric age group (P< 0.05). Over all in-
patient mortality was 27.7% in both the age groups and there were no
differences in the clinical outcome.
Conclusion: Our study highlights that pediatric infective endocarditis is a
different entity from the adult disease in terms of predisposing conditions and
the site of involvement. Rheumatic heart disease was found to be a major risk
factor for the adult disease while congenital heart diseases weremore common
in the pediatric age group.
P556 Hemodialysis patients are not a high-risk group
for HTLV I/II infections
M. L. Mateos, J. Chacon, C. Alarcon, J. L. Teruel
Madrid, E
Objectives: Based on the high prevalence of HTLV antibodies, some invest-
igators consider hemodialysis patients as a high-risk group for HTLV infec-
tions. Blood transfusions are not in the origin of the infections given the low
prevalence in blood donors. On the other hand, we must consider that the
enzyme immunoassays generally used for screening anti-HTLV antibodies
may give false positive results. If these positive results are not conﬁrmed with
more speciﬁc tests, such as PCR, the prevalence may be overestimated. Our
aim is to study the real prevalence of anti-HTLV in order to consider routine
screening for this virus.
Methods: The presence of anti-HTLV I/II antibodies was studied in serum
samples using a commercial enzyme immunoassay (Abbott HTLV I/II EIA).
The study included 55 hemodialysis patients (mean time in hemodialysis
73.6months, range 4–278, mean age 60.6months, range 26–80). Repeatedly
reactive samples were further examined by Western blot (WB) and an in-
house PCR.
Results: Of the 55 samples tested, only one (0.5%) was repeatedly reactive.
When tested byWB, the result was interpreted as indeterminate since only the
p24 protein band was present. Interestingly, no nucleic acid was detected by
PCR, excluding HTLV I/II infection. Therefore, the actual prevalence of
HTLV infections in our study was 0%.
Conclusion: As a consequence of the virtually null prevalence of anti-HTLV
antibodies in our country, routine screening is not required in hemodialysis
patients. However, we must be aware of the changing epidemiologic situation
given the increasing number of immigrants from endemic areas.
P557 Re-emergence of meningococcal disease in Taiwan
P-R. Hsueh
Taipei, TW
Background: The annual incidence (per 100 000) of meningococcal disease
(meningitis and septicemia) in Taiwan was 0.94 in 1953, declined to 0.001 in
1980, and was 0 during the period from1980 to 1987. It re-emerged with a
0.09 (per 100 000) incidence in 1997 and a 0.07 (per 100 000) rate in 2000.
From January 2001 to December 2001, a remarkable increase in the number
of cases of meningococcal disease (43 cases, 0.19/100 000) was noted.
Methods: The susceptibility of 43 preserved isolates of Neisseria meningitides
(41 from patients treated in 2001 and one each from patients treated in 1998
and 2000, respectively) to 15 antimicrobial agents was tested by the agar
dilution method. Their serogroups were determined by the agglutination
method and genotypes were identiﬁed by PFGE and random ampliﬁed
polymorhic DNA patterns. Data on serogroups of 128 isolates from 128
patients with meningococcal disease treated from January 1995 to December
2001 were available.
Results:Among the 128 patients treated from 1995 to 2001, the mean age was
19.4 years and 67 (52.3%) were male. A total of 20 patients (15.6%) died, and
the mortality rate was 11.1% in 1995, 30.8% in 1999, and 25.6% in the 2001
outbreak. The majority of the 128 isolates belonged to serogroups B (48.4%)
and W135 (35.9%). In 1999, serogroup B isolates accounted for 84.6% of all
isolates (11 out of 13 isolates), but in 2001 serogroup B prevalence decreased
remarkably (32.6%) while, at the same time, the prevalence of serogroup
W135 (41.9%) increased and serogroup Y emerged (18.6%). Three isolates
(7.0%) were resistant to penicillin (MICs 0.12 mg/mL), and all were beta-
lactamase negative. Among the 43 isolates in 2001, nine domestic clones were
identiﬁed and four major clones, i.e. clones 1 (serogroupW135, 17 isolates), 3
(serogroup Y, 8 isolates), 4 (serogroup B, 9 isolates), and 5 (serogroup B, 4
isolates) had disseminated in different regions of Taiwan. None of the 43
patients had any relationship (travel or contact history) with the 2000 or 2001
Hajj pilgrimage.
Conclusions: Epidemiologic information and typing results indicate that
wide dissemination of a limited number of domestic clones of N.meningitides,
particularly serogroups W135, B, and Y contributed to the 2001 outbreak
in Taiwan. The two clones of serogroup W135 involved in this outbreak
were genetically different from the 2000 or 2001 Hajj-related W135
clone.
P558 Leptospirosis in Greece: 1998–2002
A. Papa-Konidari, A. Antoniadis
Thessaloniki, GR
Leptospirosis is a worldwide zoonotic disease caused by pathogenic spir-
ochetes belonging to the genus Leptospira. We report the epidemiologic data
of leptospirosis cases in Northern Greece, which occurred between the last
5 years (1998–2002). During this time period, a number of 60 hospitalized
leptospirosis cases were laboratory diagnosed. The majority of cases were
observed in rural areas among males, most of them farmers, or ﬁshers. The age
affected was 40–60 years. Cases occurred from June to December, with a peak
in August. The disease had usually a severe formwith a case fatality rate of 8%.
Main signs and symptoms were fever, headache, myalgia, while most of the
patients present liver and renal involvement. Jaundice was present in 80% of
the cases. Pulmonary involvement was rare. Antileptospiral antibodies (IgM)
using ELISAwere detected in all of them, while high titers of IgG antibodies
were detected in serum samples taken during convalescence. In three cases,
early diagnosis of the disease was achieved by PCR; IgM antibodies in these
cases were detected 3–5 days later. Leptospiral DNAwas detected in a patient’s
urine sample 65 days after onset of the disease. A number of four serum
samples were sent to Institute Pasteur for microscopic agglutination test, and it
was found that all of them showed high titers to serovar L. icterohemorrhagiae.
The main syndrome that is presented with similar symptoms in Greece is
hemorrhagic fever with renal syndrome caused by hantaviruses, and differ-
ential diagnosis is essential. Treatment included penicillin and supportive
management. As weather conditions are changing and global temperature is
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increasing, leptospirosis tends to be a re-emerging disease, and precautions
have to be taken in order to prevent epidemics.
P559 Re-emergence of acute Q-fever in Israel
J. Bishara, S. Pitlik, D. Hershkovitz
Petach-Tikva, IL
Objectives: Q-fever is a worldwide zoonosis caused by Coxiella burnetii, a
potential agent of bioterrorism. Although Q-fever is endemic in Israel, the
incidence of the disease is unknown.
Methods: We analyzed the epidemiology of all diagnosed cases of acute Q-
fever in Israel between 1991 and 2001. These cases were identiﬁed through
the records of the only two diagnosing laboratories in the country. Demo-
graphic data, ethnicity, seasonality, and geographic distribution were retrieved
from the laboratory records.
Results: There were 221 patients with median age of 45 years (range:
1–93 years) and a male predominance of 60%. The disease occurred yearly
during the study period with an annual number of cases ranging from 4 to 46
(mean: 20 cases), with a peak incidence 58% (129 cases) occurring between
May and August. From 1997 to 2001, the annual incidence of Q-fever
increased 10-fold (from 0.09 to 0.90 per 100 000 people) among the Jewish
population while remained almost unchanged (from 0 to 0.08 per 100 000
people) among the Arab population.
Conclusions:Continuous surveillance and reinclusion of Q-fever on the list of
notiﬁable diseases in Israel are required.
P560 Skin manifestations of 101 cases of murine typhus
S. Kastanakis, S. Doukakis, K. Nikiforakis, G. Polimili, A. Xini,
A. Gogou, F. Axioti, C. Daskalaki, I. Bompolaki
Chania, GR
Objectives:Rickettsia typhi is the etiologic agent of murine typhus, a zoonotic
disease with a worldwide distribution. The main clinical picture of murine
typhus includes the classical triad of fever, headache, and a macular or
maculopapular rash. The aim of our presentation was to study the skin
manifestations in murine typhus.
Methods: One hundred and one patients with compatible clinical status of
murine typhus and high serologic titers of antibodies against R. typhi, were
studied from our team, between January 1993 and December 1998.
Results: Presence of rash (macular or maculopapular) was noted in 81/101
patients (80.1%). Sixty-three out of one hundred and one patients (62.4%)
presented with rash on admission, and 18 patients (17.8%) presented skin
lesions during hospitalization. The rash was macular in 44/81 patients (54.3%)
and maculopapular in 37/81 patients (45.7%). The lesions involved the trunk
in 47/81 patients (58.0%), but in 34/81 patients (39%) the extremities were
involved. The rash was centrifugal, and the lesions persisted for a period of
about 4 days (range: 1–9 days).
Conclusions:The appearance of murine rash represents a clue to the diagnosis
of infection from R. typhi, but our study showed that in a percentage of 20%
there is a delay in its appearance and in a percentage of 20.0% no rash
observed. In these cases, only a high index of clinical suspicion can lead the
physician to an earlier administration of speciﬁc antibiotic treatment.
P561 Blood picture in murine typhus: a study of 101
cases
S. Kastanakis, I. Bompolaki, S. Doukakis, K. Bambili, E. Vittorakis,
A. Galis, A. Xini, A. Gogou, N. Christodoulakis, D. Triantaﬁllidou
Chania, GR
Objectives: It is well known that themost frequent hematologic abnormalities
in murine typhus (infection from Rickettsia typhi) include anemia, an early
mild leukopenia and thrombocytopenia. The aim of our presentation was to
study the blood picture in murine typhus.
Methods: One hundred and one patients with compatible clinical status of
murine typhus and high serologic titers of antibodies against R. typhi, were
studied from our team, during a period of time between January 1993 and
December 1998. Three blood samples were obtained from each patient for
the study of their hematologic abnormalities. The ﬁrst sample was obtained on
admission, approximately 9 days after the onset of the disease. The second
sample approximately 2weeks after the ﬁrst. The third sample, taken from the
half of the patients, was obtained 1month after the second.
Results: On admission (ﬁrst sample), 31/101 patients (30.6%) presented
anemia, 10/101 patients (9.9%) presented leukopenia, and 50/101 patients
(49.5%) presented thrombocytopenia. No patient presented leukocytosis. The
median value of hemoglobin, white blood cells, and platelets was 12.7 g/dL,
5.9 103/mL and 146 103/mL, respectively. Two weeks later (second
sample) anemia was presented in 57/101 patients (56.4%), 3/101 patients
(2.9%) presented leukopenia, 3/83 patients (4%) presented leukocytosis, and
16/101 patients (15.8%) presented thrombocytopenia. The median value of
hemoglobin, white blood cells and platelets was 11.4 g/dL, 6.9 103/mL,
and 218 103/mL, respectively. One month later (third sample) 11/46
patients (23.9%) had anemia and 2/46 patients (4.3%) presented thrombo-
cytopenia. No one patient presented leukopenia or leukocytosis. The mean
value of hemoglobin, white blood cells, and platelets was 12.5 g/dL,
6.3 103/mL, and 224.5 103/mL, respectively.
Conclusions:Our study showed that early thrombocytopenia and anemia are
frequent in murine typhus, and that white blood cells count is usually normal.
P562 Life-threatening infections due to group B
Streptococcus: an emerging pathogen in nonpregnant
adults
A. Pefanis, S. Kanavaki, M. Kagia, I. Kostara, V. German,
E. Alexandraki, S. Triantafyllou, S. Karambela, M. Makarona
Athens, GR
Background:The incidence of invasive infection due to group B streptococci
(GBS) has increased during recent years in nonpregnant adult patients (pts),
especially in elderly pts, with chronic immunosuppressive diseases, such
alcoholism, diabetes, neoplasia, and HIV infection.
Objective: To present four cases of GBS bacteremia treated in our hospital
during the second-half of the year 2002. No case of GBS bacteremia occurred
during the last decade in this 750 bed general hospital. Case 1: A 56-year-old-
female pt with no history of any underlying disease was admitted because of
high fever with chills and four to ﬁve daily diarrheal bowel movements. Six
out of six blood cultures were positive for GBS. The transesophageal ECHO
of the heart revealed aortic valve vegetations. The pt was treated successfully
with ceftriaxone (2 g, o.d., i.v. for 6weeks), but due to severe cardiac failure
she undertook valve replacement 1month after discharge. Colonoscopy
revealed a benign polyp of the colon. Case 2: A 68-year-old, diabetic male
pt was admitted because of fever and rapidly deterioratingmental status during
the previous 24 h. Treatment with ceftriaxone (2 g b.i.d., i.v.) was commenced
immediately after spinal tap, suggestive for bacterial meningitis. GBS was
isolated from both cerebrospinal ﬂuid and blood cultures. Few hours later the
comatose pt was transferred to the ICU, but he died 24 h later. Case 3: A 86-
year-old female pt with a history of heart failure and suspect lung cancer was
admitted because of severe malaise, fever and cellulitis of the left lower limb.
Two out of two blood cultures were positive for GBS. She was treated
successfully with cefuroxime (750mg b.i.d., i.v., for 2weeks). Case 4: A 62-
year-old male pt with a history of alcoholic cirrhosis was admitted because of
variceal hemorrhage and aspiration pneumonia. Four out of four blood
cultures were positive for GBS. He was treated successfully with piperacil-
lin/tazobactam (4 g/500mg t.i.d., i.v.). All four GBS strains were susceptible
to penicillin.
Conclusion:GBS, a previously uncommon pathogen (except in neonates and
pregnant women) represent an emerging pathogen, especially in the elderly.
This is in accordancewith recent reports from other countries (Clin Infect Dis
2001; 33: 556–61).
P563 Clinical and epidemiologic study of Crimean
hemorrhagic fever and hemorrhagic nephroso-nephritis in a
region of Bulgaria
N. Popivanova, I. Stoilova
Plovdiv, BG
Objective: Crimean hemorrhage fever (CHF) and hemorrhagic nephroso-
nephritis (HNN) are serious medical problems due to their grave clinical
course, high lethality, and speciﬁc epidemiologic distribution.
Materials and methods: Thirteen cases of hemorrhage fever (seven with
CHF and six with HNN) were presented. Cases were etiologically proven by
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virologic and serologic tests in the National arbo-viral laboratory. Main
epidemiologic indicators and basic clinical and laboratory data were studied.
Results and discussion: Four cases (57.17%) of seven with CHF ﬁnished
lethally. For the country, lethality varies from 11.11 to 14.29%. Most patients
tended farm animals in home yard, and they suffered tick bite 10–20 days
before clinical symptoms. HNN shows low rate of annual mortality. In the last
years, lethal exit is very rare. Males present risk gender group for HNN related
to profession – military servants, construction workers in the endemic
mountain regions, etc. Average age of 32 years is lower than that of the
CHF patient – 54 years. All cases were registered in typical season early spring,
summer, and late autumn. All patients come from same endemic for HNN
mountainous region. Data shows that focus demonstrates periodical activity.
The cases were marked by intensive contamination of habitat with rodents.
The major mechanism of infection is alimentary by contaminated drinking
water and food. Serious fact is that one of the patients lives in outskirts of
Plovdiv. Obviously enduring deratization in endemic regions and populated
areas is of great value.
Conclusion:Analysis epidemiologic and clinical data is of great value for early
diagnosis. This decreases risk of lethal exit for patients with CHF and HNN.
The results demonstrate main directions of efﬁcient epidemiologic control:
concrete medical information about reservoirs and mechanisms of transmis-
sion of CHF and HNN among population, especially highly risk groups;
preventive planned desacarizations and desratizations aimed to regulate
population density of vectors and reservoirs in endemic foci. Early diagnosis
and aggressive substitution therapy of bleeding as well as hyperimmune
gamma-globulin application in CHF and early prevention of cerebral and
pulmonary edema in the period of acute kidney failure by artiﬁcial clearance
methods – hemodyalisis performing in HNN are of most importance for the
favorable outcome of the diseases.
P564 The study of prevalence of etiology and outcome
of septic shock patients admitted to an obstetric and
gynecologic department
Z. Shahshahan, S. Boroomand
Isfahan, IR
Objectives: The incidence of sepsis, the precursor of septic shock, has
continued to increase over past decades. The aim of this study was to evaluate
the outcome and etiology of septic shock in Iranian patients.
Methods:During the years 2000–2002, we examined the blood, urine, uterus
discharge culture of patients who were known cases of septic shock and the
outcome and etiology of the patients were recorded.
Results: Four hundred patients with a mean age of 30 and a range of 25–35
were included. The prevalence of etiology was 299 (74%) septic abortion, 55
(14%) endometritis, 27 (7%) pyelonephritis, and 10 (2.5%) chorioamnionitis,
and 172 (43%) died. The results of culture were: Escherichia coli (50%),
Klebsiella (20%), Enterobacter sp. (15%), Streptococcus sp. (10.5%), and others
(4.5%).
Conclusion: According to this study illegal abortion was the most common
cause of septic shock, therefore education effective methods of contraception
are recommended to women.
P565 Tick-borne encephalitis – outcomes from severe
courses
V. Struncova, D. Sedlacek, E. Kasal, I. Novak, R. Kotas, M. Svevova´,
P. Pazdiora
Pilsen, CZ
Objectives:Review of outcomes from the most severe courses of tick-borne
encephalitis (TBE) with patients in West Bohemian region in 1992–2001.
Methods: Evaluation of anamnestic data, clinical features, laboratory diag-
nostic, treatment, complications, sequela, and fatal courses. Analysis based on
the review of patient’s data admitted on Department of Infectious Diseases,
database of Regional Institute of Public Health, summary of year results of
virologic laboratory and autopsy protocols. Our set consists of 628 patients
(108 below 15 years) with median age of 37.2 years (range: 1–82 years), 63%
were male. The severe courses are those with permanent motoric sequela or
lethal courses.
Results:We noticed the severe courses with 18 patients (inclusive seven fatal).
Encephalomyelitis was a leading clinical feature in all cases. We observed
permanent sequela in 11 patient (1.7%) monopareses and parapareses of the
upper extremities with eight patients, quadripareses with one female (age of
37 years), hemipareses with one male, cerebellar symptoms with one male.
Median age of patients with motoric outcomes is 37.5 years (range:
18–61 years), eight are males. Duration of hospital stay ranges from 6weeks
to 2 years inclusive rehabilitation measures. The median age with lethal cases
(seven patients, 1.1%) was 55.5 years (34–69 years), four males. These courses
of encephalomyelitis were developed to bulbar symptomatology, respiratory
failure, quadrupareses, and impaired consciousness. We noticed the death was
more often connected with basic chronic diseases (hypertension, ischemic
cardiac disease, diabetes mellitus, obesity, immunodeﬁciencies (M. Hodg-
kin)), and with intensive care too (artiﬁcial ventilation, treatment with
corticosteroids, plasmapheresis). Two patients died due to ventilation pneu-
monia, two patients of heart failure, one of brain death and autopsy in two
patients was not done. The patients died in the period of 20 days till 13weeks
after the beginning of the second stage of disease.
Conclusion:We stated the basic information of severe courses and lethal cases
with patients who suffered from TBE. Our patients with chronic internal
diseases or persons with extreme load between two stages of disease show
higher risk of permanent motoric outcomes and mortality. There is an
elementary rule – to be vaccinated against TBE and do not become ill.
P566 Acute disseminated encephalomyelitis associated
with Borrelia burgdorferi
S. van Assen, L. M. E. Staals, F. Bosma, W. J. G. Melchers,
B. G. Fikkers, M. Lammens, P. Vos, B.-J. Kullberg
Nijmegen, NL
Objective: To describe the association between acute disseminated encepha-
lomyelitis (ADEM) and a cerebral infection with Borrelia burgdorferi (neuro-
borreliosis).
Methods: A 45-year-old man developed acute bilateral visual loss, menin-
gism, fever, and paraparesis, followed by a ﬂat tetraparesis, locked-in syn-
drome, autonomic disregulation, and eventually death. CSF was examined,
cerebral MRI and MRA were performed, an extensive work-up for under-
lying infectious causes was done (using culture, serology, and molecular
techniques on blood, CSF, and brain tissue) and ﬁnally autopsy was per-
formed.
Results: CSF showed a pleiocytosis (94% granulocytes) and an elevated
protein level, but no intrathecal antibody production. MRI/MRA on day
5 demonstrated extensive white matter lesions in frontal and parietal lobes,
medulla oblongata, pons, and subcortical areas, compatible with ADEM,
while MRI on day 1 only demonstrated two hypodense lesions in the
myelum. OnWestern blot, an IgM response, with a clear B. burgdorferi speciﬁc
22 kDa band and a weaker 34 kDa band, was present. Infection with known
causative agents of ADEM was ruled out. PCR on CSF samples showed
B. burgdorferi DNA. At histopathologic examination of the brain at autopsy,
perivenous demyelinization and perivascular T-lymphocytic inﬁltration were
seen. Finally, PCR for B. burgdorferi-DNA of involved brain tissue was
positive.
Conclusions: Neuroborreliosis can cause white matter lesions, but the rapid
progression, the ﬁndings onMRI and the histopathologic results at autopsy in
this case best ﬁt ADEM. This disorder is thought to be mediated by
autoreactive CNS-speciﬁc T cells, that attack shared epitopes of the possible
causative microorganism and the myelin. These targets have been demon-
strated in patients with neuroborreliosis. To our knowledge this is the ﬁrst
report describing an association between B. burgdorferi and ADEM.
P567 Septal panniculitis: a new clinical presentation of
acute Bartonella hensela infection in a healthy man
A. Safdar
Houston, USA
Objective:The disease spectrum of Bartonella (Rochalimae) henselae has evolved
considerably since the original description of oculoglandular syndrome in
1889. A wide variety of infections may lead to panniculitis, B. henselae has
been associated with erythema nodosum, however, septal panniculitis in this
setting has not been described.
Case report: A 34-year-old white man presented with painful, erythematous
nodules involving the proximal upper and lower extremities 8weeks after he
buried two outdoor, domestic cats that had died suddenly. Profound fatigue,
myalgia, and joint pain was prominent. He was modestly ill appearing,
afebrile, and had generalized lymphadenopathy. An 8 cm arciform lesion
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on the right shoulder had bright erythematous borders, and a violaceous
center, on histologic examination, severe inﬂammation of the subcutaneous
tissue was accompanied with prominent fat necrosis. White blood counts was
11 700 cells/mL, and a negative workup included, normal serum AST, ALT,
ACE levels, ESR, and negative serology for HIV-I, HIV-II, Borrelia burgdorferi,
Ehrlichia chaffeensis, Histoplasma capsulatum, Blastomyces dermatitidis, Coccidioides
immitis, Chlamydia trachomatis, Coxiella burnetii, Brucella spp., Yersinia enteroco-
litica, and antibodies against native DNA. B. henselae IgG titers were markedly
elevated (>1024; IgM< 20, by IFA). Detectable serum IgG (256; IgM< 20,
by IFA) for B. quintana was regarded as intragenus antigen cross-reaction. CT
scan of thorax, abdomen, and pelvis, and total body gallium scan were also
normal. Response to i.v. azithromycin (AZM; 500mg) was seen in 96 h and
after the third relapse following discontinuation of antimicrobial agent, he
received 12week AZM-therapy and complete response was observed after
serum IgG titers (<64 by IFA) had became nondetectable at the end of the
3month treatment course.
Conclusion: B. henselae may be considered in evaluating patients with septal
panniculitis.
P568 Tales from the riverbank: Mycobacterium microti
pulmonary infection mimicking malignancy
N. E. Jenkins, M. B. Beadsworth, V. Martlew, T. J. Neal, F. J. Nye,
N. J. Beeching
Liverpool, UK
Objectives: We introduce a Mycobacterium microti pulmonary infection in an
immunosuppressed HIV-positive patient diagnosed with spoligotyping tech-
niques. The treatment of this led to a worsening of his illness, and further CT
scanning suggested the diagnosis of pulmonary malignancy. Further investi-
gations were required to exclude this and continue successful anti-myco-
bacterial treatment.
Method/results: This 33-year-old patient with hemophilia A had been
diagnosed with HIV in 1996. He gave a history of 3months worsening
hemoptysis with some minor weight loss but no night sweats. On examina-
tion, he appeared moderately unwell. A chest X-ray revealed left upper lobe
shadowing and sputum specimens were highly positive for acid-fast bacilli.
Blood tests showed CD4 count 46 106. Renal and liver functions were
normal. He was commenced on broad spectrum anti-mycobacterials with the
intention of treatingM. tuberculosis andM. avium complex. He improved and it
was decided to commence antiretroviral medication. At a 3weeks follow-up
appointment, he had continued to improve. About 9weeks after his initial
presentation he attended the ward unwell. On examination, he was spiking
fevers over 388 and there were new palpable lymph nodes. An urgent CT scan
of the chest revealed a 6 cm 3 cm solid mass reported as ‘almost certainly
solid neoplasm.’ A brochoscopy revealed an area of irregular nodular tissue. A
MTB complex PCR performed on the struggling mycobacterial culture was
positive. The bronchial biopsy revealed narcotizing granulomatous bronchitis,
with no acid-fast bacilli, fungal spores or other organisms. M.microti was
identiﬁed using spoligotyping methods. We think that he had suffered a
paradoxical, immune reconstitution reaction. The anti-mycobacterials were
reintroduced without problems.
Conclusions: M.microti is a slow-growing member of the tuberculosis com-
plex. Its place as a pathogen in humans has been proposed by a handful of case
reports. Compared to RFLP, spoligotyping is a PCR-based test that can be
quickly and cheaply performed, even on struggling mycobacterial cultures.
M.microti is an unusual infection associated with small rodents. It has only
been introduced as a human pathogen by novel genetic techniques, which
begs the question of its true incidence as a cause of pulmonary disease.
P569 Actinomycetoma of the thumb caused
by Gordona terrae
M. W. H. Wulf, X. Bakker, P. H. M. Spauwen, T. Schu¨lin
Nijmegen, NL
In 2001, an 18-year-old patient from Sierra Leone presented himself with a
painless lesion on the left thumb (tenar region) that had been slowly
progressive for almost 4 years. There were multiple sinuses draining pus
and granules. The patient had received no previous treatment, and there
were no other complaints. X-ray of the hand showed no bone involvement.
Cultures of swabs and granules remained sterile. Surgical debridement was
performed. Examination of biopsy material showed sporadic leukocytes with
sporadic Gram-positive rods. Culture on sheep-blood agar yielded raised,
rough, salmon-colored colonies after 5 days of incubation at CO2. Gram stain
of cultures showed nonbranching Gram-positive rods. ZN/kinyoun stains
were negative. Susceptibility testing was performed by disc diffusion on
sheep-blood agar. Biochemical determination as Rhodococcus species was
performed with biochemical tests (Api Coryne, Biomerieux), and Gordona
terrae (formerly Rhodococcus terrae) was identiﬁed by means of 16S rRNA gene
sequencing. This aerobic, Gram-positive, slightly acid-fast, nonmotile short
rod belongs to the family of the Nocardiaceae, genus Gordona. It does not
form spores or capsules and does usually not produce aerial hyphen. G. terrae
has been isolated from soil and sputum. Only a few cases of human infection
are described. To our knowledge, this is the ﬁrst description of a mycetoma
caused by G. terrae. After surgery, the patient received 2weeks of doxycycline
100mg once daily with a starting dose of 200mg. The lesion healed, and no
relapse has occurred.
P570 Thigh abscess caused by Actinomyces neuii in
an adult patient
A. Karaitianou, A. Saliveros, K. Papaefstathiou, E. Anagnostou,
G. Kouppari
Athens, GR
Objective:A case of thigh abscess in an adult patient caused byActinomyces neui
ssp. anitratus is presented.
Methods: Surgically obtained purulent material from the thigh abscess was
inoculated in the appropriate culture media for the detection of both aerobic
and anaerobic bacteria. Direct microscopic examination of the clinical
material stained with Gram stain was used. Classic methods and API Systems
were used for the identiﬁcation, Kirby Bauer method for the examination of
the susceptibility pattern, and E-test for the detection of MIC to penicillin G
were performed.
Case report: A 62-year-old man with a skin abscess of the left thigh came to
the emergencies. In the past, he was treated surgically followed by antibiotic
treatment for abscesses located in different sites of his body without any
microbiologic examination of the pus. He is a heavy smoker, overweight and
6months before he was treated surgically for a tibia fracture of the left leg.
During the last 2 years, he has suffered from pulmonary disease. He has no
fever and he was treated surgically and with antibiotics: cefaclor 500mg 3
for 10 days. From the culture of the pus, A. neuii ssp. anitratus was isolated in
pure culture and it was susceptible to penicillin G, ampicillin, amoxycillin/
clavulanic acid, cefaclor, cefotaxime, oﬂoxacine, erythromycin, and resistant
to metronidazole. Abundant leukocytes and Gram(þ) bacteria were observed
at the direct microscopic examination of the sample. Fifteen days later the
patient reported automatic rupture of a new abscess of the right thigh. He was
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treated surgically and with ampicillin/sulbactam for 10 days. From the culture,
Staphylococcus lugdunensis was isolated, which was susceptible to ampicillin/
sulbactam. We also found a decrease of leukomatines and an increase of a1, a2
and g globulins (inversion), CRP 6.79mg/L and RF 434 IU/mL.
Conclusions: Actinomyces neuii may be the cause of different abscesses and
endophthalmitis. In this case, it was thought to be the cause of the infection
because it was isolated in pure culture and it was also observed in the direct
examination of the clinical specimen.
P571 Increasing incidence of Stenotrophomonas
maltophilia isolation in a Greek general hospital
A. Pefanis, S. Kanavaki, E. Galani, S. Karabela, E. Eustathiadou,
M. Makarona, H. Giamarellou
Athens, GR
Objective: To study the incidence of Stenotrophomonas maltophilia (SM)
infection or colonization in patients admitted to Sotiria General Hospital,
a tertiary care hospital in Athens, Greece, during 2001–2002.
Results: During the 5-year period 1998–2002, we observed a signiﬁcant
increase in the incidence of SM isolation from clinical specimens from
hospitalized patients. From a total of 31 298 isolated microbial strains, 238
strains were characterized as SM. The incidence was increased by sixfold from
the beginning to the end of the 5-year period (from 0.2 to 1.8%, respectively).
One hundred and seventy-nine (75%) strains were isolated between 1/1/2001
and 30/9/2002. Eighty-six (48%) of the isolated strains were derived from
sputum, 48 (27%) from blood, 22 (12%) from bronchial secretions, 12 (6.7%)
from pus, 5 (2.8%) from urine, 5 from pleural ﬂuid and 1 from the tip of a
central vein catheter. Some of these isolations probably represent colonization
rather than true infection. However, the fact that a signiﬁcant percent of SM
strains were isolated from the blood underscores the signiﬁcance of SM as an
emerging nosocomial pathogen. Regarding the antibiotic susceptibility,
97.2% of the strains were susceptible to cotrimoxazole, 90% were susceptible
to ciproﬂoxacin, and 82.7% were susceptible to ticarcillin/clavulanic acid,
while 98.4% of the strains were resistant to imipenem/cilastatin. A great
variety of antibiotic susceptibility phenotypes was observed, suggesting that
there were no epidemic clusters of infection in the hospital. These ﬁndings
were conﬁrmed in part by applying molecular techniques (PFGE) in a small
(n¼ 30) number of strains isolated from blood cultures.
Conclusion: Stenotrophomonas maltophilia represents a signiﬁcant emerging
nosocomial pathogen in our hospital.
P572 Nosocomial bacteremia due to Stenotrophomonas
maltophilia: an analysis of 41 episodes
R. Caylan, N. Kaklikkaya, G. Yilmaz, K. Aydin, F. Aydin, I. Ko¨ksal
Trabzon, TR
Objectives: Stenotrophomonas maltophilia is recognized as an important noso-
comial pathogen, and in recent studies, it has been increasingly reported as a
cause of severe infections. In view of the serious S. maltophilia infections that
may be encountered in the immunocompromized patients or those patients
that are under antibiotic pressure, we evaluated the clinical features and
signiﬁcance of S. maltophilia in our patients.
Methods:Forty-one patients with S. maltophilia bacteremia were screened out
of inpatient population that were admitted to the hospital from various causes
between the years 2000 and 2002. Results of this group of patients were
compared with those diagnosed as P. aeruginosa bacteremia during the same
period.
Results: Similar demographic features were noted in both groups. S. mal-
tophilia bacteremia was diagnosed on the 17.4 8.8 hospitalization day and
P. aeruginosa bacteremia was diagnosed on 11.8 5 hospitalization day
(P¼ 0.001). The most frequently used antibiotic prior to the bacteremia
in the S. maltophilia group was determined as carbapenems (61%), and in
P. aeruginosa group the penicillins (63.4%) were the most commonly used
antibiotic. Sensitivity of the isolates of S. maltophilia was as follows: cotri-
moksazol 95%, TIC/CL 80%, seftazidim 14.8%, ciproﬂoxacin 14.3%, imi-
penem 9.4%. Mortality rates due to infection was signiﬁcantly higher in the
S. maltophilia bacteremia group (P¼ 0.04).
Conclusions: S. maltophilia bacteremia is a severe clinical infection in patients
who are exposed to broad-spectrum antibiotics and are admitted in the
hospital for prolonged periods. Treatment of S. maltophilia is difﬁcult because
of its resistance to commonly used broad spectrum antibiotics. Mortality rates
due to infection may be decreased by rapid initiation of antibiotics as
determined by invitro active antibiotic studies.
P573 Can we really assert therapy of invasive
meningococcal disease (IMD) to prehospital care?
E. Kasal, I. Chytra, V. Struncova, P. Krizova, L. Roznovsky
Plzen, Prague, Ostrava, CZ
Objectives: Early prehospital application of antibiotics (PAA) in suspected
IMD has been discussed for more than 20 years. Results of many studies were
different and most studies proved no statistically signiﬁcant difference in
mortality in groups with and without PAA. One study even proved higher
mortality in the group with PAA than without PAA. So, where is the
problem?
Methods: We compared results of PAA in patients with IMD in the Czech
Republic treated in 1996–2001 (164 patients) – group 1, where mortality in
groups with and without PAA was 7.8% vs. 10.4% (P¼ 0.55) and group 2
from West Bohemian region (113 patients), where mortality was 12.5% vs.
20% (P¼ 0146). Survival in both groups was higher in groups with PAA, but
not statistically signiﬁcant difference. During studying of factors, which can
play a role in different numbers we found out the difference in the IMD
severity in both groups (29% of septic patients in group 1 vs. 51% in group 2).
Higher severity of IMD in group 2 corresponds with mortality – 16.2% vs. 9%
in group 1. Suspected diagnosis of IMO in prehospital care was established in
group 1 in 30% of cases, in group 2 in 55% of cases. PAAwas realizedmostly in
the hospital, rarely by general practitioner or prehospital emergency services.
We have experienced that aggressive therapy initiated by prehospital emer-
gency services based on consultation with our center improved survival in
IMD. To improve situation in prehospital care, proposal of Standard of
prehospital care in IMD was published.
Results: Despite activities to unify principles of complex therapy of IMD in
prehospital care, situation in the Czech Republic is not optimal. Neglected
primary prehospital care for patients with IMD can facilitate development of
severe sepsis with high mortality rate.
Conclusions: Awareness of IMD among all parts of prehospital medical
services and conditions for sufﬁcient and complex prehospital care enable
to improve survival of patients suffering by this disease. Not only PAA, but
complex prehospital care is effective. Permanent system of education con-
trolled by specialized centers can improve this situation.
Acknowledgement: Supported by Grant GACR NI-7109-3.
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P574 Variations in B-lactam susceptibilities between
organisms expressing the plasmid-encoded AmpC
B-lactamase CMY-2 is attributed to variable gene expression
M. D. Reisbig, N. D. Hanson
Omaha, USA
Objectives: CMY-2 is a plasmid-encoded (PE) AmpC B-lactamase of Citro-
bacter origin often reported in North America. Current literature suggests
discrepancies in MIC data among transconjugants expressing similar AmpCs
are greater than what can be explained by experimental variation. The PE
blaCMY-2 is not inducible but contains the35 and10 promoter elements
that drive the expression of the C. freundii chromosomal ampC gene from
which blaCMY-2 originated. The purpose of this study was to identify the
promoter regions and RNA expression patterns from two Klebsiella pneumo-
niae (Kp) and two Escherichia coli (Ec) isolates expressing CMY-2 and correlate
those ﬁndings with MIC patterns and plasmid copy number.
Methods: The strains used in the study were Kp249 and KpV50, and EcL1
and EcB1, all encoding blaCMY-2 in the absence of ESBLs. Susceptibilities to
several representative B-lactam antibiotics were determined by agar dilution.
A 1.5 kb fragment containing the blaCMY-2 structural gene and 50-ﬂanking
region was ampliﬁed by PCR and sequenced. Steady-state RNA expression
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levels and transcriptional start sites were determined by primer extension
analysis. Gene copy number was determined by comparative PCR analysis.
Results:MICs of the drugs tested against EcL1 were identical or within one
dilution to those of KpV50. While susceptibility testing of KpV50 revealed
MICs four- to eightfold higher than those determined for Kp249 and EcB1,
the RNA expression levels for KpV50, EcL1, and EcB1 were 5.7, 3, and 1.6-
fold higher, respectively, compared to RNA expression by Kp249. The gene
copy number for KpV50 and EcL1 was four while the gene copy number for
Kp249 and EcB1 is two. In addition, the start site of transcription for blaCMY-
2 was located 160 bp upstream of the structural gene start codon.
Conclusions: These data indicated that the differences in MICs for these
strains reﬂected the level of RNA expression and correlated with the gene
copy number, not variations in the structural enzyme or promoter sequences.
In addition, a newly identiﬁed promoter was mapped to an insertion element
160 bp upstream of blaCMY-2. Variation in gene expression did not reﬂect
differential expression between strains. These data suggest that variation in
MICs observed in the literature may be due to variations in the level of ampC
gene expression. Therefore, the expression of PE ampC genes is an important
determinant in the resistance phenotype observed in these strains.
P575 Derepression of inducible plasmid-mediated AmpC
beta-lactamase DHA-1 at high mutational frequency after
exposure to cephalosporins and aztreonam
B. J. Kimbowa, K. S. Thomson
Omaha, USA
Objectives: Isolates of Enterobacteriaceae possessing plasmid-mediated
AmpC beta-lactamases (pAmpCs) can be susceptible invitro to third gen-
eration cephalosporins (3GCs) and aztreonam (ATM). It is unknown if
therapy with these agents will be successful or select less susceptible mutants,
or how frequently the selection of resistance may occur. Therefore an invitro
study was designed to determine the potential for mutational resistance to
emerge in a clinical strain of Klebsiella pneumoniae (KP) possessing the
inducible pAmpC (ipAmpC) DHA-1 after exposure to various beta-lactam
agents.
Methods:The DHA-1 producing strain was susceptible to imipenem (IPM),
cefepime (FEP), cefotaxime (CTX), ceftriaxone (CRO), and ATM. It was
exposed to (i) increasing concentration gradients of CTX, FEP, ATM, and
IPM and (ii) the same agents at concentrations 4, 8 and 16 above the
MIC.Mutants selected were tested by NCCLS agar dilution methodology for
changes in susceptibility to the selecting agents and to CRO, piperacillin/
tazobactam (P/T), ciproﬂoxacin (CIP), amikacin, and chloramphenicol
(CHL).
Results: ATM and CTX selected mutants derepressed for AmpC production
withMICs of ATM, 3GCs and P/T increasing 32- to 512-fold and exceeding
resistance breakpoints, while the MICs of IPM and FEP remained unchanged
or only moderately increased (two- to eightfold), and remained in the
susceptible range. The derepressed mutants selected by CTX and ATM
occured at high mutational frequencies of approximately 105. FEP also
selected a derepressed mutant but only with the gradient plate method (i.e.
frequency <109). Unlike the 3GCs and ATM, IPM did not select any
derepressed mutants but instead selected a mutant that was more resistant to
CHL.
Conclusions:These data indicate that this ipAmpC producing strain of KP can
readily develop broad beta-lactam resistance on exposure to 3GCs and ATM,
and that FEP can also select derepressed mutants but less readily. The ﬁndings
shed more light on what may occur during therapy of infections caused by
pathogens that harbor ipAmpCs.
P576 Analysis of the blaVIM gene context from Italy
reveals novel resistant cassettes: report from the SENTRY
Antimicrobial Surveillance Program
M. Toleman, D. Bennett, R. Jones, T. Walsh
Bristol, UK; Iowa, USA
Objective:To analyze isolates with metallo-beta-lactamase (MBL) genes, both
blaIMP and blaVIM, reported in Italy since 1999. Very little is known of the
variation with respect to their genetic context. Therefore, as part of the
SENTRY Antimicrobial Surveillance Program, we genetically analyzed 22
Pseudomonas aeruginosa isolates possessing MBLs from three different Italian
cities.
Methods: For ampliﬁcation of IMP, VIM, and SPM genes and the adjacent
genes intI1, aacA4, aph, aadA1, and qacED1, PCR was performed using AB-
gene Expand Hi-ﬁdelity master mix PFU/proof reading TAQ polymerase
and dNTPs. Primers were designed within the middle of each gene for a given
cassette to examine the genetic context of theMBL gene. Sequencing of PCR
amplicons was undertaken on both strands by the dideoxy-chain termination
method. Sequence analysis was performed using the Lasergene DNASTAR
software package. Alignments and phylogenetic analysis was obtained using
Clustal W and PAM 250 matrix.
Results: Positive PCR products from screening known MBL genes were
found in 16/16 strains (blaVIM) from Genoa and 4/4 strains from Catonia
(blaVIM), but no PCR products were found from the two isolates from
Rome. Sequencing of the blaVIM PCR products from all sites showed it to be
blaVIM-1. The genetic context of blaVIM was assessed by PCR and showed
different gene arrangements to that previously reported. Of the 16 isolates
from Genoa, one isolate (75–3634) gave a PCR pattern indicating that the 30
end of the cassette had been deleted and that this casette consists of intI1,
blaVIM-1 and aacA4 only. One isolate from Catonia (85–2394) gave a PCR
pattern indicating that the cassette no longer carries the aph gene.
Conclusions:P. aeruginosa strains 75–3634 and 85–2394 carry novel blaVIM-1
cassettes. These data clearly indicates that while most mobile genetic con-
structs are stable, some are undergoing genetic rearrangements resulting in
either gene replacement or gene deletion within epidemic or endemic regions
for MBLs.
P577 Cloning of a hybrid metallo-beta-lactamase gene
conferring a novel IMP variant blaIMP-13 in Pseudomonas
aeruginosa in Italy: report from the SENTRY Antimicrobial
Surveillance Program
M. Toleman, R. Jones, T. Walsh
Bristol, UK; Iowa, USA
Objective: To analyze the determinant of carbapenem (imipenem and
meropenem) resistance in a clinical strain of Pseudomonas aeruginosa isolated
in Rome as part of the SENTRY Antimicrobial Surveillance Program in
2001.
Methods: A gene bank of P. aeruginosa strain 86-1457I genomic DNA was
constructed in the cloning vector pK18 using standard molecular biology
techniques. The ampliﬁed gene bank was used to transform Escherichia coli
DH5-a and plated on media containing both ceftazidime and the serine
lactamase inhibitor BRL42715. All clones isolated harbored the same plasmid
(pMATPsRM). The insert of pMATPsRM (1.8 kb) was sequenced on both
strands by the dideoxy-chain termination method with a Perkin Elmer
Biosystems 377 DNA sequencer, and sequence analysis was performed using
DNAstar software.
Results:The clones when expressed in E. coli conferred low-level ceftazidime
resistance (4mg/L). Sequence analysis revealed the presence of a metallo-
beta-lactamase gene that belonged to the blaIMP family, designated blaIMP-
13. The amino acid sequence of IMP-13 diverges from the amino acid of
IMP-1 by 14.5% after the ﬁrst 90 residues of the N-terminus. Functional
changes of particular interest and not present in any other IMP metallo-beta-
lactamase were G138E, Y181H, and N236K. Near the N-terminus of the
truncated IMP-13 (three residues away from the zinc binding motif HFHSD)
was situated the LacZ forming a IMP-LacZ hybrid protein. All clones
containing blaIMP-13 contained the truncated gene and the fused LacZ/
IMP-13 protein in exactly the same location. Truncated IMP-13 demon-
strated a weak metallo-beta-lactamase activity.
Conclusions: P. aeruginosa strain 81-11963 A contains a novel metallo-beta-
lactamase gene, blaIMP-13. All clones containing blaIMP-13 contained a
truncated form of the protein that could still produce a protein with detectable
metallo-beta-lactamase activity.
P578 Acquisition or evolution of the SHV
beta-lactamase gene on the Klebsiella pneumoniae
chromosome?
M. Avison
Bristol, UK
Objectives: It is widely accepted that the SHV beta-lactamase gene evolved
on the chromosome of Klebsiella pneumoniae. The evidence for this includes
the ﬁnding that over 95% ofK. pneumoniae strains carry SHV, but that very few
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other members of the genus carry the gene, except on plasmids. In order to
test this theory, we examined the location and type of beta-lactamase gene in a
plasmid-deﬁcient strain of K. pneumoniae.
Methods: K. pneumoniae strain MGH78578 was isolated at Massachusetts
General Hospital from the sputum of a 66-year-old male patient conﬁned to
the ICU in 1994. Genome sequence for this strain was examined for the
presence of any sequences related to known beta-lactamase genes using
http://genome.wustl.edu/gsc/Blast/client.pl.
Results:Genome sequence analysis revealed thatMGH78578 carries an SHV-
2 beta-lactamase gene. The gene is clearly chromosomal because overall
context analysis indicates the presence of typical ‘housekeeping’ genes in the
vicinity of SHV-2. The local context of the gene, however, reveals the
presence of an IS26 element, the associated transposase gene, and multiple
copies of the IS26 Right and Left repeats. Searches for this region of
the MGH78578 chromosome in general nucleotide databases revealed
fragments of the SHV-2 chromosomal region in a number of SHV-2 contain-
ing plasmids found in organisms such as Salmonella enterica sv. Typhimurium,
Shigella ﬂexneri and Pseudomonas aeruginosa. When present in plasmids, the
SHV-2 region fromK. pneumoniaeMGH78578 is often jumbled, and the IS26
element is not always present.
Conclusions: SHV-2 is chromosomal in K. pneumoniae MGH78578. This
does not mean, however, that the gene evolved in this organism. It could be
that the genewas carried onto the chromosome from a plasmid as part of IS26.
Alternatively, the presence of IS26 next to SHV-2 on the chromosome of
K. pneumoniaeMGH78578 could explain the proliﬁc mobilization of this gene
onto plasmids. Whether the insertion of SHV-2 onto the K. pneumoniae
chromosome, or indeed the insertion of IS26, thus allowing SHV-2 mobi-
lization, is an ancient event remains to be seen.
P579 Characterization of an unusual extended-spectrum
beta-lactamase from Proteus mirabilis
N. Camino, A. Morente, T. Alarcon, L. Perez, C. Toro, M. Martinez,
A. Enriquez, M. Baquero
Madrid, E
Objectives:The aim of this study was to identify the extended-spectrum beta-
lactamase produced by a Proteus mirabilis strain from an adopted Indian child
with urinary tract infection.
Methods:Two strains of P. mirabiliswere isolated from two urine samples from
an Indian child adopted by a Spanish family; one was isolated in June 1999 and
the other in December 1999. The susceptibility proﬁle of the two P.mirabilis
was determined using automated microdilution MicroScan method, and
production of ESBL activity was identiﬁed using double-disk synergy test
with two cephalosporins: ceftazidime and cefotaxime. Beta-lactamases were
extracted by ultrasonication, supernatants containing crude enzyme extracts
were analyzed by isoelectric focussing on ampholine polyacrylamide gels (pH
3.5–9.5) using a Multiphor II electrophoresis System (Pharmacia Biotech),
and betalactamases were visualized with an overlay of nitroceﬁn.
Results: The two isolates were highly resistant to ampicillin (MIC> 16
mg/L), ticarcillin (MIC> 64mg/L), cefazoline (MIC> 16mg/L), cefurox-
ime (MIC> 16mg/L), cefotaxime (MIC> 32mg/L), ceftazidime (MIC>
16mg/L), and cefepime (MIC> 16mg/L), but susceptible to amoxicillin-
clavulanic acid (MIC< 4/2mg/L) and cefoxitin (MIC< 8mg/L). Theywere
also resistant to gentamicin (MIC> 8mg/L), tobramycin (MIC> 8mg/L),
amikacin (MIC> 16mg/L), trimethoprim-sulphamethoxazole (MIC>
2/38mg/L), and fosfomycin. Synergy was observed between clavulanic acid
and cefotaxime and ceftazidime. Isoelectric focussing analysis revealed the
presence of two beta-lactamases with pI of 7.6 and approximately 5.5.
Conclusions: The presence of ESBL-producing P.mirabilis is increasing, and
getting an important epidemiologic and geographical variability. Detection of
strains withmechanisms of resistance infrequent in European countries should
be considered in immigrant patients or in adopted children.
P580 Resistance to third-generation cephalosporins and
putative ESBL production in a urinary isolate of Salmonella
enterica serovar Virchow
U¨. G. Bahar, T. Demiray, E. Kandirali, N. Apaydin, A. Mert
Ankara, TR
Objectives: Extended spectrum beta-lactamases (ESBL) were ﬁrst detected in
Klebsiella pneumoniae, but in the recent years they have been reported with
growing incidence in other Enterobacteriaceae taxa. In the Salmonella genus,
ESBLs have been detected mainly in serovars Typhimurium and Enteritidis.
Here we report ESBL production in a urinary isolate of Salmonella enterica
serovar Virchow.
Methods: A 13-year-old girl had her spinal cord damaged during spinal
surgery for scoliosis, turned out to be paraplegic and was intermittently
catheterized. Her urine samples were routinely sent to our laboratory, where a
S. enterica serovar Virchow was isolated in November 2002. Antimicrobial
susceptibility testing was performed by disk diffusion and interpreted accord-
ing to the NCCLS. The presence of an ESBL was investigated by means of a
double-disk synergy test agar, of the combined disk method and of E-test.
Results: The identiﬁcation was conﬁrmed at the species and serovar level at
Hifzisihha Institute. The isolate proved resistant to cephalosporins, including
the third-generation compounds. The presence of an ESBLwas also suggested
by the synergies detected between clavulanic acid and cefotaxime, ceftazi-
dime, or aztreonam in the disk diffusion assay, with a typical deformation of
the inhibition zone, as well in the other tests performed. The isolate was
resistant to trimethoprim-sulfamethoxazole, but susceptible to quinolones
and aminoglycosides. The patient had no symptom of urinary tract infection.
She had no previous gastrointestinal disease; her stool cultures were negative,
and ultrasonography of her gallbladder did not show any evidence that she was
a chronic carrier of the microorganism.
Conclusions: To our best knowledge this is the second published report of
S. enterica serovar Virchow producing ESBL. The only previous report was
about one strain isolated from stools of four Spanish patients with gastro-
enteritis, and in that case the ESBL was identiﬁed as CTX-M-9. The fact that
our strain was more resistant to cefotaxime than to ceftazidime suggests the
possibility of a cefotaximase type enzyme, as well.
P581 Extended-spectrum beta-lactamase producers
among Enterobacteriaceae of patients in Bulgarian hospitals
R. Markovska, E. Keuleyan, M. Sredkova, D. Ivanova, E. Dragijeva,
V. Genova, R. Gergova, I. Mitov
Soﬁa, Pleven, BG
Methods: Forty-one strains identiﬁed as ESBL producers (Klebsiella pneumo-
niae, 26; K. oxytoca, 1; Escherichia coli, 8; Citrobacter freundii, 2; Enterobacter
cloacae, 4) were collected from four medical centers in Soﬁa and Pleven during
2000–2002. MICs were determined by an agar dilution technique according
to NCCLS guidelines. Further analysis included conjugative plasmid transfer
and isoelectric focusing.
Results:MICofceftazidimerangedfrom8to>512mg/Landofthatcefotaxime
from2 to512mg/L.Forall strains,MICof ceftazidimewashigherorequal to the
MICofcefotaxime. Inall strains, sulbactamincombinationwithceftazidimeand
cefotaxime showed an inhibitory effect. Ceftazidime resistancewas transferrable
in 35 strains. There are two clusters of strains. One cluster (33 strains ofKlebsiella
and Enterobacter) demonstrated three different beta-lactamases with isoelectric
points of 5.4–5.6 (TEM-type), 7.0–7.6, and 8.2 (SHV-type). Transconjugants
fromthis strainsonIEFhadbandsat5.4–5.6and8.2.Anothercluster (eight strains
ofKlebsiella,Citrobacter,E. coli) demonstrated beta-lactamases focussing between
6.3and6.5,whichsuggestTEMtype.ThepIdatawere fromtransconjugants and
wild-type strains. Enterobacter, Citrobacter showed additional bands suggested
chromosomal beta lactamases.
Conclusion: During the investigation period, ESBL of the SHV- and
TEM-type were dominating among Enterobacteriaceae in Bulgarian
hospitals.
P582 The characteristics of aminoglycosides resistance
in nosocomial Gram-negative strains in Russia
G. K. Reshedko
Smolensk, RUS
Objectives: To determine phenotypes and mechanisms of resistance to
aminoglycosides in nosocomial Gram-negative strains in ICUs in Russia.
Methods:A total of 648 nosocomial Gram-negative aminoglycoside-resistant
strains isolated in ICUs of 14 Russian hospitals were examined. The samples
were sputum, wound samples, abdominal drains, urine, and blood. The
mechanisms of aminoglycoside resistance were determined by aminoglyco-
side resistant pattern (AGRP) method. The following aminoglycosides were
used: kanamycin, neomycin, gentamicin, tobramycin, netilmicin, isepamicin,
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amikacin, 5-epi-sisomicin, 20-N-ethyl-netilmicin, 60-N-ethyl-netilmicin,
fortimicin, apramycin, lividomycin, and butirosin.
Results: The predominant phenotypes of aminoglycosides resistance
were: gentamicin-tobramycin-netilmicin (44.9%), gentamicin-tobramycin
(22.2%), and gentamicin-tobramycin-netilmicin-amikacin (13.8%). The gen-
tamicin-tobramycin-amikacin-isepamicin phenotype was determined only in
4.2% of examined strains and gentamicin-tobramycin-netilmicin-amikacin-
isepamicin phenotype was found in 4% of strains. The most frequent
mechanism of resistance was the production of aminoglycoside modifying
enzymes. The prevalent enzymes were: AAC(3)-V, 46.9%; ANT(20), 27.9%;
AAC(60)-I, 11.4%; APH(30)-VI, 11,9%. The rare enzymes were: AAC(3)-I,
2.5%; AAC(3)-IV, 1.2%; AAC(20)-I, 1.1%; AAC(3)-III, 0.6%. The majority
of tested strains produced 2–6 enzymes simultaneously (83.5%), including the
APH(30)-I enzyme, causing resistance to kanamycin and neomycin.
Conclusions:The leading mechanism of aminoglycoside resistance in Russian
Gram-negative nosocomial strains was the production of aminoglycoside
modifying enzymes. According to the obtained data, determination of
aminoglycoside resistance mechanisms in given hospital is essential for the
rational choice of aminoglycoside for empirical therapy of nosocomial
infections.
P583 Diversity of IMP-type metallo-beta-lactamases in
carbapenem-resistant clinical isolates of Pseudomonas spp.
from Italy
J. D. Docquier, C. Mugnaioli, F. Luzzaro, G. Amicosante, A. Toniolo,
G. M. Rossolini
Siena, Varese, L’Aquila, I
Objectives: The production of an acquired metallo-beta-lactamase (MBL),
mainly in Pseudomonas and Acinetobacter species, confers a broad-spectrum
resistance to nearly all beta-lactam antibiotics, including third- and fourth-
generation cephalosporins, and carbapenems, that is not reversible by
mechanism-based inactivators. The lack of clinically useful inhibitors and
the mobility of MBL-encoding genes promoting their spread among impor-
tant opportunistic pathogens also account for their notable relevance in the
clinical setting. The IMP-type MBLs represent a heterogeneous family of
closely related variants, encoded by mobile gene cassettes inserted into
integrons, that have been reported from the Far East, Europe, North and
South America. Here we report a molecular characterization of clinical
isolates of Pseudomonas spp. producing IMP-type MBLs collected in Italy,
in the period 1999–2002.
Methods: Carbapenem-resistant clinical isolates were screened for MBL
production by molecular methods (multiplex PCR, colony blot) and by
phenotypic tests (EPI microdilution test). The nature of the determinants and
their genetic background were determined by DNA sequencing of PCR-
ampliﬁed cassette arrays of blaIMP-carrying integrons.
Results: Four IMP producers were detected among a total of 24 MBL-
producing isolates of Pseudomonas spp., two Pseudomonas aeruginosa producing
the IMP-2 enzyme and one Pseudomonas putida producing the IMP-12
enzyme from the University Hospital of Varese (northern Italy), and one
P. aeruginosa producing a new IMP-variant, named IMP-13, from the Hospital
of Atri (central Italy). The different blaIMP determinants were encoded by
gene cassettes of different phylogenies that were carried by integrons of
heterogeneous structure. Apart from blaIMP-12, that was carried by a
nonconjugative medium-sized plasmid, the other determinants appeared to
be located on the chromosome. The new IMP-13 enzyme shares 85% identity
with IMP-1, and is closer to IMP-2 and IMP-8 (92–93% identity).
Conclusions: blaIMP genes are rarely detected among MBL-producing
clinical isolates from Italy. A remarkable heterogeneity of enzymes structure
and genetic background was found. The sequence of a new IMP-type
determinant, named IMP-13, quite divergent from any other known
IMP-type determinant, is reported.
P584 Molecular characterization of integrons from
Klebsiella pneumoniae
M. Correia, T. Conceic¸a˜o, N. Faria, A. Duarte
Lisbon, P
Introduction: Integrons are genetic elements that contain the determinants of
a recombination system that is able to capture gene cassettes, most frequently
antibiotic resistance genes, such as aminoglycoside-modifying enzymes and
beta-lactamases. Integron-driven gene capture probably extends beyond the
dissemination of antibiotic resistance genes to the more general process of
evolution of bacterial genomes.
Objective:Molecular characterization of integrons from Klebsiella pneumoniae
isolates.
Methods: Five multiresistant strains of K. pneumoniae collected between 1980
and 1999 at a University Hospital in Lisboa were selected for this study. Total
DNA preparations were used in PCR experiments with speciﬁc primers for
each class of integrons and/or gene cassettes. For each strain, the amplicons
obtained from three independent reactions were sequenced on both strands.
Results: All isolates revealed the presence of one or two integrons, which
contained at least one antibiotic resistance gene cassette, belonging to classes 1
or 3. The two isolates from 1980, resistant to streptomycin, presented a class 1
integron with an aadA1 gene cassette, similar to that previously found in Tn21
from Shigella ﬂexneri. In the strain isolated in 1991 was found a class 1 integron
with one gene cassette similar to dfrV, which conferred resistance to tri-
methoprim. The isolate collected in 1995, presented two integrons, one
identical to that found in the strain from 1991, and a class 3 integron, with a
GES-1-like gene cassette. The isolate collected in 1999 presented only a class
3 integron with two gene cassettes, whose genes encoded a GES-1 extended-
spectrum beta-lactamase and an AAC(60)-I enzyme conferring resistance to
kanamycin.
Conclusions: Two different classes of integrons were found in the K. pneu-
moniae strains. The same strain showed different classes of integrons, class 1 and
class 3. The same class 1 integron was found in strains isolated in 1991 and
1995, suggesting a degree of stability of these genetic elements over a 4 year
period. This report provides further evidence of the wide distribution of
integrons and their potential to contribute to antibiotic resistance.
P585 Characterization of antimicrobial resistance and
integrons in Salmonella from Portugal
P. Antunes, N. Pestana, J. C. Sousa, L. Peixe
Porto, P
Objectives: The purpose of this study was to determine the antimicrobial
resistance patterns of Salmonella of different origins, and to detect and
characterize class I integrons, in order to identify the resistance genes located
therein.
Methods:This study included a total of 100 isolates of Salmonella collected in
Portugal during 2002. Isolates were from human (n¼ 27) and nonhuman
(n¼ 73) (foodborne, waterborne and environmental) sources, and belonged
to several serogroups. TheMICs for 10 antimicrobial agents were determined
by the agar dilution method, and the results were analyzed according to the
NCCLS standards. The presence of class I integrons were tested by PCR,
using the primers 50CS30CS, for all the sulfamethoxazole resistant isolates
(n¼ 24) and for 29 isolates with other susceptibility proﬁles. The isolates with
one or more amplicons were also tested for the presence of sul1 gene, using
50CS-sul1B primers. The 50CS primer was used in combination with several
primers for antibiotic resistance genes (ant-(30 0), pse-1, and dhfr-1) to deter-
mine the content of the variable regions of the integrons.
Results: Seventy-ﬁve percent of the isolates were resistant to one or more of
the antimicrobial agents tested. Resistance to nalidixic acid (36%), tetracycline
(35%), streptomycin (33%), sulfamethoxazole (24%), ampicillin (23%), tri-
methoprim (17%) and chloramphenicol (11%) was observed. The most
frequent multiresistant phenotype, observed in nine isolates (serogroups B
and C1), was to ampicillin, chloramphenicol, streptomycin, sulfonamides, and
tetracycline (ACSSuT), found alone or simultaneously with trimethoprim.
Class I integrons were present in 19 multiresistant isolates (serogroups B and
C1), which ranged in size between about 1000–2000 bp. In four isolates
(serogroup B), two different integrons (1000 and 1200 bp) were simulta-
neously identiﬁed. The sul1 gene was localized in all the integron types
obtained in the present study. The ant-(30 0) gene, alone or in combination
with other resistance genes, was found in variable regions of 18 integrons.
Furthermore, gene cassettes encoding the pse-1 and dhfr-1 gene were found in
several integrons.
Conclusions: Our study of Portuguese isolates suggests a high incidence of
multidrug resistance in Salmonella of different origins and a possible role for
integrons in the acquisition of resistance genes.
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P586 Detection and characterization of class 1 and 2
integrons in Shigella strains isolated in Senegal
A. Gassama, A. Aidara-Kane, D. Chainier, F. Denis, M. C. Ploy
Dakar, SN; Limoges, F
Objectives: This study aimed to evaluate the contribution of integrons in
multi resistant strains of Shigella.
Methods: Thirty Shigella strains belonging to serotypes ﬂexneri (n¼ 14),
dysenteriae A1(n¼ 13), and sonnei (n¼ 3), and six Shigella strains which were
not agglutinated with classic antisera were isolated from 1997 to 2000 from
diarrheal adult patients in an university teaching hospital and an urban
hospital, in Dakar. Strains were resistant to ampicillin, ticarcillin, tetracycline,
trimethoprim-sulfamethoxazole, and chloramphenicol. Integrons belonging
to classes 1, 2, and 3 were screened for by PCRusing primers speciﬁc for intI1,
intI2, and intI3 genes. Gene cassettes were identiﬁed by sequencing.
Results: Integrons were detected in 30 strains (83%): 12 strains contained a
class 1 integron, four strains contained a class 2 integron, and 14 strains
contained two integrons, one of class 1, and one of class 2. All strains
belonging to an unknown serotype contained both class 1 and 2 integrons.
No class 3 integron was detected. Eleven class 1 integrons do not contain the
open reading frames usually found in the 30 segment (qacED1, sul1 and
ORF5). For class 1 integrons, the size of the inserted fragment varied from 0.7
to 1.8 kb. Seven strains had an integron that contained a single cassette dfrA5
or dfrA15, both conferring resistance to trimethoprim. The remaining class 1
integrons contained two cassettes: oxa1-aadA1a, dfrA15-aadA1a, dfrA1-
aadA2, oxa30-aadA1a. For class 2 integrons, strains carried the same three
cassettes as those found in Tn7 (dfrA1, sat and aadA1), but in most cases, the
aadA1 cassette was missing. Eleven RAPD proﬁles were identiﬁed: three
among Shigella dysenteriae A1, two among S. ﬂexneri, two among S. sonnei, and
four among Shigella spp. The integron carriage was unrelated to the RAPD
proﬁle.
Conclusions:Various integron structures were detected in 30 out of 36 clinical
isolates of Shigella indicating that these elements are largely spread among
multiresistant strains of Shigella. dfr gene cassettes were highly prevalent; this is
due in part to the intensive use of trimethoprim in combination with
sulfonamide to treat diarrheal illnesses in Senegal.
P587 Mechanism of resistance to nalidixic acid in
Aeromonas spp. clinical isolates
J. Ruiz, L. Soler, F. Gallardo, M. Chacon, M. Figueras, J. Vila
Barcelona, Reus, E
Objective: To investigate the mechanisms of resistance to nalidixic acid in
strains of Aeromonas spp. isolated from different clinical sources.
Methods: Fourteen clinical isolates of Aeromonas spp. (one Amedia, eight
Averonii biotype sobria, three Acaviae, and two Ahydrophila) recovered from
different clinical sources were identiﬁed to species level by 16S rDNA-RFLP,
while the biotype of the A. veronii isolates was determined on the basis of the
arginine dihydrolase positive reaction and negative response to bilis-aesculin
hydrolysis and ornitine decarboxylase production. TheMICs of nalidixic acid
and ciproﬂoxacin were determined by the E-test method. Finally, the
presence of mutations in the gyrA and parC genes was analyzed by PCR
and sequencing.
Results: Ten out of 11 nalidixic acid resistant isolates presented a mutation in
position 83 of the gyrA gene resulting in the amino acid substitution Ser to Ile
in ﬁve isolates, and Ser to Arg in the other ﬁve. The remaining isolate
presented a mutation in position 80 of parC gene generating the amino acid
change Ser to Ile. No differences were observed in the levels of MIC of
nalidixic acid and ciproﬂoxacin between the isolate presenting a
single mutation in parC gene and those presenting a single mutation in
the gyrA gene. None of those 11 isolates presented resistance to ciproﬂoxacin,
but all had a decreased susceptibility to this antimicrobial agent with
MICs ranging from 0.047 to 0.25mg/L. No mutation was found in either
the gyrA or parC genes was found among the three nalidixic acid susceptible
isolates.
Conclusions:Mutations in the gyrA gene are the most relevant mechanism of
nalidixic acid-resistance among Aeromonas spp. In addition, the presence of a
single mutation in parC gene might confer similar level of resistance to
nalidixic acid to that produced by the mutation in the gyrA gene.
P588 Zinc eluted from siliconized latex urinary catheters
decreases OprD expression causing carbapenem resistance
in Pseudomonas aeruginosa
M. C. Conejo, I. Garcı´a, L. Martı´nez-Martı´nez, L. Picabea, A. Pascual
Seville, E
Objective: The activity of carbapenems against Pseudomonas aeruginosa (Pae)
decreases in the presence of siliconized latex urinary catheters (SLUCs). This
effect is not due to drug inactivation or increased beta-lactamase activity, but it
is associated with the loss of an OprD-like protein and the expression of a new
outer membrane protein (OMP) of about 50 kDa. This study was undertaken
to investigate which of the SLUC componets are responsible of the decreased
carbapenem activity against Pae grown in the presence of SLUCs.
Methods: Segments of SLUCs were analyzed for elements by a particle-
induced-X-ray-emission technique (PIXE). Elements were also investigated
in cation-adjusted Mueller–Hinton broth (MH) and in eluate from SLUCs
(four 1 cm segments in length/mL ofMH, 378C, 24 h) by inductively coupled
plasma atomic emission spectrometry (ICP-AES). MICs of imipenem (IPM)
(Merck, Sharp and Dhome, Madrid, Spain) against Pae PAO1 and its OprD-
deﬁcient mutant were determined by a microdilution assay according to
NCCLS guidelines. OMP proﬁles were determined by SDS–PAGE, and
further analyzed by matrix-assisted laser desorption/ionization time-of-ﬂight
(MALDI-TOF) mass spectrometry after in-gel trypsin digestion.
Results: PIXE analysis revealed that zinc was the most abundant element
found in SLUCs, followed by silicon, phosphorus, sulfur, and chlorine.
Finally, traces of copper, titanium, chromium and manganese were also
detected. Zn content in MH and in eluate was 0.29 and 36.8mg/L,
respectively, as determined by ICP-AES. Zn concentrations in MH lower
than 5.7mg/L did not affect IPM activity against Pae PAO1, while Zn
concentrations between 5.7 and 18.9mg/L determined a fourfold increase in
the MIC. IPM activity in eluate and in MH supplemented with Zn to a
concentration equivalent to that found in eluate (36.8mg/L) was the same
(MIC: 8mg/L). On the other hand, MICs of IPM against the OprD-deﬁcient
mutant were the same (8mg/L) in all the media tested. Both Pae PAO1 and its
OprD-deﬁcient mutant showed the same OMP proﬁle when grown in either
eluate or Zn-supplemented MH. Analysis of tryptic fragments from the OMP
lost in eluate and in Zn-supplemented MH ﬁtted OprD (formerly OprD2),
and the new OMP expressed in those media was identiﬁed as OprD3.
Conclusion:Zn eluted from siliconized latex urinary catheters inhibits OprD2
expression, the porin responsible for carbapenem entry into Pae.
P589 Dissemination and characterization of integrons
type 1 among epidemiologically unrelated clinical isolates of
Acinetobacter baumannii from Spanish hospitals
A. Ribera, F. Ferna´ndez-Cuenca, A. Beceiro, G. Bou, L. Martı´nez-
Martı´nez, A. Pascual, J. M. Cisneros, J. Rodrı´guez-Ban˜o, J. Pacho´n,
J. Vila
GEIH-AB 2001 project
Objectives: To study the presence of integrons type 1 in 71 strains of
Acinetobacter baumannii, resistant to beta-lactam antibiotics and aminoglyco-
sides, isolated from 28 hospitals of Spain in November, 2000.
Methods: To achieve this aim, susceptibility testing to these antibiotics were
carried out by a microdilution method. The epidemiologic relationship was
determined in previous studies by REP-PCR and PFGE. PCR ampliﬁcation
of Class I integrons and DNA sequencing were done using primers and
conditions previously described.
Results: Of a total of 71 epidemiologically unrelated strains of A. baumannii,
21 (29.58%) presented this type of integrons. Fifteen out of the 21 strains with
integrons (71.42%) showed the presence of a 750 bp product which contained
a single aadB allele encoding an AAD(20 0)-Ia aminoglycoside adenyltransfer-
ase. Three out of the 21 strains (14.28%) yielded an ampliﬁcation product of
approximately 2200 bp. Direct sequencing of the amplicon revealed the
presence of three gene cassettes, the ﬁrst containing an aacA4 allele encoding
an AAC(60)-Ib aminoglycoside acetyltransferase, the second containing an
ORF coding for a yet undetermined product named orfO and found also in
other integrons, and the third containing the blaoxa-20 gene. Two out of the
21 strains (9.52%) gave an ampliﬁcation product of approximately 800 bp.
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Direct sequencing of this amplicon revealed the presence of a single gene
cassette that contained an aacA4 allele encoding an aminoglycoside 60-N-
acetyltransferase AAC(60)-Ib which was identical to that found in the above-
mentioned integron. To ﬁnish, only one isolate (4.76%) showed an amplicon
of approximately 2500 bp containing four gene cassettes. The ﬁrst cassette
contained an aacC1 determinant encoding an AAC(3)-Ia aminoglycoside
acetyltransferase, followed by two open reading frames (ORFs) coding for
unknown products that are carried by two cassettes. The fourth cassette
contained an aadA1a determinant encoding an AAD(30 0)-Ia aminoglycoside
adenyltransferase.
Conclusions: Our results conﬁrm the high prevalence of integrons found
in A. baumannii by other authors and also show the potential risk of
integron dissemination among genotypically distinguishable strains of this
microorganism.
P590 Plasmid proﬁles from one strains of Aeromonas
caviae isolated from ﬁsh
M. Deldari, K. Shahzamani, A. Fazeli, A. Tavakoli, R. Yazdani
Tehran, IR
Objectives: The aim of this study was to determine plasmid-mediated
tetracycline resistance in one strains of Aeromonas caviae isolated from ﬁsh
and comparative between two methods to detect the plasmid present in this
strain and to calculate precisely the molecular weight of the plasmid.
Material and methods: Resistant Aeromonas strain were incubated in mixed
culture with mutant Escherichia coli ‘DH5 alpha’ recipient strains susceptible to
tetracycline. Then, the strain was examined for the loss of resistance phe-
notypes by curing with ethidium bromide (EB) at 5, 10, 20, 40, 80, 180, and
320mg/mL concentrations and SDS 10 g/L. Plasmid DNAwas isolated by the
modiﬁed method of Kado and Liu and Holmes and Quigley and separated by
horizontal electrophoresis at 150V, 110mA for 5 h.
Results: The results of tetracycline-resistant plasmid proﬁles show size of
plasmid was 10 kb (approximately 6 106 molecular weight), curable and
transferable plasmid was detected. Comparison between Holmes and Quigley
methods with Kado and Liu modiﬁcation methods used to detect plasmids in
this study yielded evidence that the best resolution of plasmid bands and
repeatable were achieved with the methods of Kado and Liu.
Conclusions:Results analysis conﬁrmed that loss of resistance phenotype was
accompanied by loss of plasmid DNA. This study highlights the potential
pathogenicity and growing incidence of resistance within clinical and envir-
onmental isolates ofAeromonas. The increasing use of antibiotics in the human
population, animal and pisciculture have provided antimicrobial resistance in
soil and aquatic microorganisms. Moreover, the aquatic and gut bacteria come
in frequent intimate contact with other organisms bearing transferable
R-plasmids.
P591 Induction of multiple antibiotic resistance in
Escherichia coli strains by diazepam, phenobarbital, and
valproic acid
M.-M. Tavı´o, L.-T. Macia`, M. Perilli, G. Amicosante
Las Palmas De Gran Canaria, E; L’Aquila, I
Objectives: Salicylate (SL), sodium benzoate (SB), and other compounds may
induce marRAB transcription in Escherichia coli leading to an increased MarA
protein expression (a 15 kDa cytoplasmic protein), OmpF loss, and multiple
antibiotic resistance (Mar). Diazepam (DZ), phenobarbital (PB) and valproic
acid (VP) are used in the treatment of epilepsy. Urinary infections are frequent
in children with epilepsy. DZ, PB, and VP are mainly excreted by the renal
route unaltered or conjugated. Their role as marRAB inducers has not been
previously studied. The objective of the present study was to compare the
effect of DZ, PB and VP with SL and SB on the induction of Mar in E. coli
strains.
Methods:Higher, lower and equal concentrations to the mean therapeutical
doses per day (MTD) of DZ, PB, and VP were assayed to determine their
inducing effect of Mar in the Ag100 and KL16 E. coli strains. The Ag112
(marR mutant) and JF703 (deﬁcient in OmpF) strains were used as controls.
Cefoxitin (FOX), nalidixic acid (NA), norﬂoxacin (NOR), tetracycline (TE),
and chloramphenicol (CL) MICs were determined with and without 5mM
SL, 20mM SB, DZ, PB, and VP. The effect of 5mM SL, 20mM SB, DZ,
PB, and VP in the outer membrane proteins (OMPs) was analyzed by
electrophoresis in SDS–PAGE. The expression of MarAwas studied in crude
cell extracts (CCE) and analyzed by SDS–PAGE.
Results: The presence of 5mM VP (in the range of MTD), 5mM PB, and
0.25mM DZ (four- to tenfold maximum MTD) or higher concentrations of
these just like SL and SB increased the FOX, NA, NOR, TE, and CL MICs
from two- to eightfold and led to OmpF loss in the Ag100 and KL16 strains.
Electrophoresis of CCE from the Ag100 strain obtained after incubation with
the above-mentioned concentrations of DZ, PB, VP, SL, and SB and CCE
from the Ag112 strain showed a 15-kDa protein which was absent in CCE
from the Ag100 strain grown without DZ, PB, VP, SL, or SB. Mar phenotype
induction by DZ, PB, VP, SL, or SBwas always associated with concentrations
of these compounds which were close (two- to fourfold lower) to their
respective MICs in the assayed strains.
Conclusions: DZ, PB, and VP induced a Mar phenotype in E. coli strains
similar to that which was derived frommarRAB activation by SL or SB. Only
DZ, PB, VP, SL, or SB concentrations, which were close to their respective
MICs in the assayed strains, induced Mar phenotype.
P592 Elimination of R-plasmids under inﬂuence of the
pulsed electrical discharge
I. S. Azizov, E. T. Turgunov, D. Babenko
Karaganda, KAZ
Objectives: Study of inﬂuence of pulsed electric discharges (PED) on stability
of inheritanceR-plasmids in antibiotic-resistant strains of Staphylococcus aureus.
Methods: For research, 20 methicillin-resistant strains of S. aureus (MRSA)
were selected, allocated from the surgical patients with pyoinﬂammatory
diseases of the bottom respiratory ways that described plasmid resistance to
tetracycline, kanamycin and ryfampycin. Processing PED of 10mL bacterial
suspension (109 CFU/mL) spent during 5, 10, and 15 s with the minimal
frequency of following pulses, then made sowing on meat–peptonic agar. In
clinical isolates and cultures which have undergone the inﬂuence of PED,
minimal inhibitory concentrations (MIC) of antibiotics were determined by
methods of agar dilution, and presence of plasmids was determined by a
method of electrophoresis in agarous gel.
Results: PED is characterized by presence of a complex of the factors, major
of which are: a shock hydraulic wave, ultraviolet irradiation, ultrasonic
cavitation, local increase of temperature, generation of the active forms of
oxygen, and also minimal concentration of metals, emulsiﬁed from a surface
of electrodes as a result of electroerosion. At processing PED, the bacterial cell
is exposed to powerful stressful inﬂuence that at long-term inﬂuence (more
than 10 s) is shown by destruction of a cell, and at short-term inﬂuence (5 s)
promotes loss of stability of inheritance R-plasmides by bacterial cell, that was
conﬁrmed by authentic decrease in MIC (to kanamycin and ryfampycin
<2mg/mL, to tetracycline <4mg/mL). The comparison of plasmids struc-
tures of strains before processing PED has revealed loss of R-plasmids by cells
subjected to inﬂuence.
Conclusions:At short-term inﬂuence PED onMRSA cells, the infringement
of stability of inheritance R-plasmids is observed.
P593 Sequence analysis of dhfr, dhps and pfcrt genes in
Plasmodium falciparum isolates from school children in
Iringa Rural District, Tanzania
C. Severini, L. Mboera, M. Menegon, F. Molteni, G. Majori
Rome, I; Dar-es Salaam, TZ
Introduction: The resistance of Plasmodium falciparum to sulfadoxine-
pyrimetamine (SP) is linked to mutations occurring in the genes coding
for dihydrofolate reductase (DHFR) and for dihydropteroate synthetase
(DHPS). Their effect on the SP resistance phenotype has been well estab-
lished. Differently, the mechanism of P. falciparum chloroquine resistance has
not yet been clearly elucitated, and several candidate genes have been
proposed so far (pfmdr1, cg2). Recently, a new transporter gene, the pfcrt
has been identiﬁed, and the mutations detected in his nucleotide sequence
were always detected in resistant P. falciparum isolates in a number of studies.
Objectives: Within the framework of the Italy/Tanzania malaria control
project, a survey was carried out in six villages of Iringa district. Resistance
level to antifolates in P. falciparum by sequence analysis of dihydropteroate
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synthetase and dihydrofolate reductase among school children was deter-
mined. Chloroquine resistance was also analyzed in view of its possible
extended use by population in spite of the antimalarial drug policy adopted.
Methods: A molecular screening on dhfr, dhps, pfcrt genes was carried out on
P. falciparum isolates. Plasmodial DNA was extracted from blood smears by a
QIAGEN kit, and from IsoCode Stix according to the manufacturer’s
instruction. Molecular diagnosis on all samples was done. Samples conﬁrmed
positives for P. falciparum were submitted to PCR with primers speciﬁc for
each target gene. The amplicons from dhfr, dhps and pfcrt genes of 718, 748,
and 211 bp, respectively, that contain the most important point mutations
were sequenced at the MWG Biotech and the results analyzed by dedicated
computer program.
Results:The results relevant to a total of 47 P. falciparum isolates from the study
area were reported: 108-DHFRmutant alleles account for 74% (32/43) of the
isolates screened. On the contrary, 436 and 437 DHPS mutant alleles account
for only 14.8% (4/27) and 22.2% (6/27), respectively. no. 76-PfCRT mutant
alleles have been detected in the 10 P. falciparum isolates so far screened for this
codon.
Viral and parasitic infections in children
P594 Comparison of serum amyloid A protein and
C-reactive protein concentrations in hospitalized
children with viral infections
K. Themeli-Digalaki, E. Orcopoulou, S. Galani, S. Velmachou,
C. Koutsia-Carouzou
Athens, GR
Objectives:To investigate the clinical signiﬁcance of serum amyloid A (SAA)
in viral diseases and relation between SAA and C-reactive protein (CRP) in
hospitalized children.
Methods: We examined 95 children with viral infections including HSV-1,
EBV, CMV, ECHOVIRUSpool, COXSACKIE B1-6, RSV, 20 with Myco-
plasma pneumoniae pneumonia and 25 as healthy controls. The children aged
6months14 years old (mean 6.2 years). Viral infections were diagnosed
according clinical ﬁndings and serologic evaluations. SAA and CRP con-
centrations were determined by using Latex agglutination nephelometric
immunoassay. Student’s t-test and regression analysis were used for statistical
analysis.
Results: In 95 out of 115 patients (92.5%) the SAA concentrations became
markedly raised in the acute phase of viral infection: EBV (81%), CMV
(84.3%), HSN-1 (79.3%), ECHIVIRUSpool (85.4%), COSXACKIE B1-5
(84.3%), RSV (75.8%). In convalescence phase of the above infections, the
SAA concentrations were normal (<5mg/mL), also in Mycoplasma infections
and healthy controls (P¼ 0005). In 46% of the patients with acute viral
infections had raised SAA concentrations (>5mg/mL) with normal CRP
levels (<5mg/mL). In patients withM. pneumoniae the CRP levels were found
increased in 58.4%, while SAA in 56.2%.
Conclusions: (i) The increase of SAA concentrations may provide a useful
marker of viral infection in cases where the differential diagnosis may be
difﬁcult clinically. (ii) In acute viral infection the combination of SAA and
CRP could be useful to conﬁrm the diagnosis of the infection.
P595 Echovirus serotype 13 infection in children in
Lithuania
I. Narkeviciute, D. Vaiciuniene
Vilnius, LIT
Background: The morbidity of enterovirus infections has increased in
Lithuania during summer and fall in 2001.
Aim: To establish the frequency of enterovirus isolation in hospitalized
children with viral meningitis or nonspeciﬁc rashes during epidemic period.
Patients andmethods:Thirty children, aged 1.5months to 14 years, referred
to hospital during August–September in 2001 with initial diagnosis of viral
meningitis or nonspeciﬁc rashes. Information included personal and epi-
demiologic data, signs and symptoms, laboratory results, initial diagnosis. Viral
cultures from feces, throat and cerebrospinal ﬂuid (CSF) were collected.
Results: Eight (26.9%) of 30 children had positive results of viral culture.
Echovirus serotype 13 was isolated from feces (eight children) and throat (one
child), but was not detected from samples of CSF. All eight children had fever
for 2.3 days. Two patients had nonspeciﬁc rashes, 6 viral meningitis. All
children recovered.
Conclusions: In Lithuania enterovirus infection was associated with echovirus
serotype 13 during epidemic period in 2001.
P596 Signiﬁcance of the IgG titration against mumps
virus for diagnosis of the infection in vaccinated children
J. C. Sanz, M. J. Sagu¨es, M. Ferna´ndez, R. Ramı´rez, L. Garcı´a-Comas,
J. E. Echevarrı´a, F. De Ory
Madrid, E
Objectives: To evaluate the application of IgM detection and IgG titration as
diagnostic markers of mumps, according to the vaccination status.
Methods: Serum samples of 64 cases of clinical parotitis (mean age 8.1 years;
standard deviation 7.0) and of 310 asymptomatic controls (mean age 6.0 years;
standard deviation 3.3) were studied. The vaccination status (number of
administered vaccine doses and strain, Rubini ‘R’ or Jeryl Lynn ‘JL’) was
available in all cases and controls. Determinations of IgM in cases and IgG in
cases and controls were carried out by indirect ELISA (Enzygnost IgG and
IgM, Dade Behring).
Results: In 27 of the 64 cases mumps speciﬁc gM was detected (global
sensitivity 42.2%). The sensitivity of IgM in relation to the vaccination
status was: 100% in non vaccines (12/12), 42.1% in vaccines with one dose
of R (8/19), 25% in vaccines with one dose of JL (5/20), 18.2% in vaccines
with one dose of R plus 1 of JL (2/11) and 0% in vaccines with two doses of JL
(0/2). The sensitivity of different IgG cut-off titers, according to the
vaccination status (in all cases with speciﬁcity higher tan 95%) were as follows:
zero doses (IgG titer 4250) sensitivity 41.7%; one dose (R) (IgG titer 2250)
sensitivity 94.7%; one dose (JL) (IgG titer 6000) sensitivity 75%; two doses
(1Rþ 1JL) (IgG titer 10 250) sensitivity 36.4%; two doses (R) non applic-
able; two doses (JL) IgG titer 13 000 sensitivity 0%.
Conclusions: The detection of mumps speciﬁc IgM is the method of choice
for mumps diagnosis in unvaccinated patients. However, in vaccinated
children, the diagnosis based on the detection of IgM is not enough sensitive.
In these instances, the titration of IgG could be an useful complementary tool
for the diagnosis of this infection, especially in individuals vaccinated with the
Rubini strain. According to our results the deﬁnition of conﬁrmed case of
mumps must be reviewed.
P597 Tick-borne relapsing fever in Ardabil, the main
endemic area in Iran: an epidemiologic survey
S. Arshi, H. Sadeghi Bazargani, A. Majidpour, M. Asmar, D. Emdadi
Hour, R. Qassemi, S. H. Sezavar
Ardabil, Tehran, Qazvin, IR
Objectives and background:The main area of Iran affected by relapsing fever
(RF) is Ardabil province, in which Borrelia persica is the most common cause.
First presentation of B. persica and B. baltazardi to world was from Ardabil in
Iran. The aim of this study was to determine the epidemiologic characteristics
of the disease, and frequency of infection among ticks in this region.
Methods:This clinical epidemiologic and entomologic study was performed
on a total of 391 patients diagnosed tick-borne RF from 1998 to 2001. The
presence of Borrelia with any species as well as the clinical characteristics was
observed. Borreliawas searched the thick blood smears of 1421 ticks collected
from the 130 indoor human and animal shelters and 14 outdoor places
studied. The ticks were crushed and the suspension obtained was injected into
the peritoneum of mice and pigs to determine the infection rate among
collected ticks. Data including the tick spices were collected through a
questionnaire, and analyzed using Chi-square and ANOVA tests.
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Results: Forty-nine percent of cases were females and 51% were males. 84.3%
of the cases were children and those who did not work outside their homes.
The mean age of the patients was 12.111.2 years. The most frequent clinical
manifestations were fever, chills, and headache. Other ﬁndings included
nausea, vomiting, sweating abdominal pain, arthralgia, cough, photophobia,
eosinophilia, hematuria, jaundice, petechiae and scleral congestion. Chills
were 10%more frequent in females than males. Laboratory tests performed on
60 patients showed leukocytosis, high erythrocyte sedimentation rate (ESR),
and anemia. Regardless of sex, hemoglobin level was less than 11mg/dL in
34% of cases. Of the 1421 ticks collected, 45.9, 40.3 and 13.8% were of the
Ornithodorus lahorensisi, Ornithodorus tholozani and Argas persicus species,
respectively. The ticks collected from three villages were found to be infected
with Borrelia.
Conclusion: The clinical manifestations were similar to those reported in
other studies. Petechiae occurred less frequently in our study compared to
louse-borne RF. The high frequency of anemia, which was not stated in most
other reference articles, requires further investigation.
P598 Rubella epidemiology in Arkhangelsk region,
Russian Federation, in the prevaccination era
A. Tulisov, R. Buzinov
Arkhangelsk, RUS
Objectives: The main task of this study was to investigate situation with
rubella incidence in the North of the European part of the Russian Federation
before the vaccination program establishment and discover epidemiologic
peculiarities of rubella in Arkhangelsk region.
Methods:We used data on rubella reported to the State Sanitary-Epidemio-
logical Surveillance Center in Arkhangelsk region. Descriptive and statistical
methods for data proceeding were used in the investigation.
Results: The maximum rubella incidence per 100 000 population was dis-
covered in 1985 (659), 1990 (471) and 1999 (1211). School children and kids
attending kindergartens predominated. Maximum incidence was revealed at
the age from 3- to 5-year-old with gradual reduction of the ﬁgures, and the
second lower incidence peak was discovered at the age of 14–15 years old.
Most cases occurred in the winter and spring time, with the peak in April
(14.5% from the total during the year). For the observation period there were
no cases of congenital rubella documented, while there are some cases in other
regions of Russia.
Conclusions: According to the received data, rubella incidence in Arkhan-
gelsk region has a waveform character. The degree of increase during the
following peak correlate with the duration of the interpeak period. This is
caused by the cumulative growth of nonimmune individuals between epi-
demic years. Age distribution of the incidence reﬂects the picture, which is
characteristic for the behavior of this infection in other regions. Seasonal
rubella distribution is similar to the seasonality of other airborne infections.
Relative extension of high incidence period during a year is probably
connected to the more severe weather conditions in Arkhangelsk region.
A high number of rubella cases were observed in organized collectives such as
schools and kindergartens. This is probably caused by the increased possibi-
lities of airborne transmission in these crowded areas. This analysis of the
epidemiology of rubella in Arkhangelsk region was taken into the account
when planning population vaccination.
P599 Pediatric visceral leishmaniasis in Albania
G. Kuli-Lito, H. Hoxha, S. Bino
Tirana, AL
Introduction: Visceral leishmaniasis is an endemic disease in northern and
north-eastern part of Albania, but sporadic cases are seen even in the other
regions of the country. Pediatric age is the most affected by this infection
considering immunologic characteristic of this age group. The university
hospital center is the only reference hospital for all over the country
concerning this disease.
Objectives: To see the trend of pediatric visceral leishmaniasis during the
quinquennial 1995–2000. To show the epidemiologic characteristics of this
important infection.
Patients and methods:This is a retrospective study based on the analyzing of
all medical records of children with visceral leishmaniasis hospitalized at our
clinic during the 5-year period June 1995–June 2000. Epidemiologic data
included were: age, sex, place, seasonality, outcome and case mortality rate.
Results: During the study period, 457 children with visceral leishmaniasis,
aged 6month to 14-year-old were admitted to our clinic. The distribution of
the patients for each year was as follows; ﬁrst year ( June 1995–96) enrolled 70
(15.3%) patients, second year—77 (17%) patients, third year—103 (22.5%),
fourth year—121 (26.5%) and during ﬁfth year—86 (18.7%) children were
registered. An increase of cases during last 3 years was observed. The disease
was most spread in summer. Rural origin (65%) and the northern part of the
country dominated among the other regions. The age group 1–4 years was
most infected (74%), followed by the infants (14%). Children above 4 years
presented 12% of the hospitalized cases. Therewas a slight domination of male
patients (56%). Case fatality rate was 2.4%, ﬁve (1.1%) cases presented
resistance to the treatment with Meglutamine antimoniate (Glucantime)
and four (0.9%) cases progressed toward chronic hepatitis. The others had
a satisﬁed complete recovery, although during the clinic course of the disease
different complications such as bronchopneumonia, enteritis, measles were
observed.
Conclusions: Visceral leishmaniasis is an important infection for some
Albanian regions. The number of pediatric cases has an increasing trend.
Glucantime still remains an efﬁcacious treatment for this age group.
P600 Visceral leishmaniasis in Greek children, 1996–2002
A. Kostoula, M. Tzouﬁ, C. Bobogianni, A. Drimtzia, E. Economou,
A. Siamopoulou, S. Levidiotou
Ioannina, GR
Visceral leishmaniasis constitutes the most frequent form of leishmaniasis,
particularly in Mediterranean area. In Greece the precise prevalence rate
among children remains unknown. In this study 18 children <14 years (14
males4 females: 3.5/1) were included, who were diagnosed having visceral
leismmaniasis in the Pediatric Clinic of University Hospital of Ioannina,
during a 7-year period (1996–2002). The patients mean age was 4.6 years,
from which 11 (61%) were <5 years. Ten patients (55%) came from Albania
and eight from Greece, area Epirus (three from capital city and ﬁve from the
wider region) and the symptoms appeared in 61% of them, during spring and
summer. They presented with classical clinical manifestations: 17/18 with
fever and splenomegaly, 16/18 with hepatomegaly, anorexia and weakness,
8/18 with enlarged lymph nodes, vomiting, diarrhea and cough, 5/18 with
bruises and petechiae and one child with jaundice. In addition all of them
presented with hypergammaglobulinemia, 94% with anemia, 72% with
leucopenia, 66.6% with thrombocytopenia, while the 11% had pathologic
chest X-ray. In the whole group of children a control of antibodies against
leismania was done, with the methods of indirect immunoﬂuorescence (bio-
Merieux) and indirect (passive) hemagglutination (Dade-Behring) and with a
positivity rate: 1/40–1/1280 and 1/8–1/1024, respectively. Eighteen out of
18 patients were found positive with the IFA and 14/18 with the IHA. In
addition in the 15/18 patients (83%) bone marrow aspiration was done and in
the 11/15 (75%) leishmanias were found. All patients were treated with
meglumine antimonite intramuscularly for 21 days, without any clinical
relapse.
Conclusions: The children in which visceral leishmaniasis was diagnosed,
primarily by the presence of antibodies against leishmania, were usually under
ﬁve years, boys, who came mainly from agricultural regions. They presented
with classical symptoms, the majority during spring and summer and
responded very well to suitable therapy, with no clinical relapse.
P601 Presentation on admission of WHO-deﬁned severe
malaria in children aged 6–59months in two district
hospitals
A. E. Forlack, M. T. Abena Obama, M. Beyeme Owono, E. Manga,
A. Same-Ekobo, M. Ondoa Mekongo, F. Tietche, E. M. Minkoulou
Yaounde, CM
More than one century after the discovery of the Plasmodium parasite malaria
remains a major cause of morbidity and mortality in the world with 2.3 billion
people are exposed (41% of theworld’s population), there are 300–500million
clinical cases and 1.5–2.7 deaths annually. Children less than 5 years old carry
the largest part of this burden with 3000 deaths daily. Knowledge of the
various forms of severe malaria at peripheral hospitals is important in order to
better direct available resources for case-management. Hence we set out to
describe the clinical and paraclinical presentation at two peripheral hospitals in
the Central province, Cameroon; this according to the current criteria of the
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World Health Organization (WHO). From January 1 to August 31 2000, at
the Djoungolo and the Mfou district hospitals 148 children aged from 6 to
59months who presented with at least one feature of severe malaria were
recruited by consecutive sampling. The incidence of severe malaria was
21.1%. The male/female ratio was 1.06. Fever (96.6%), anorexia (62.2%)
and convulsions (54.7%) were the commonest symptoms, while prostration
(88.5%), confusion or drowsiness (70.3%), inability to feed (68.9%), pallor
(56.8%) and splenomegaly (48.0%) were the commonest signs in these
children who arrived at the hospital 4 days on average after the onset of
illness. Most (79.7%) children were said to have received antimalarial drugs
before admission and chloroquine was the most presumed drug of choice
(73.4%). The paraclinical presentation was marked by a high median para-
sitemia at 18000/mm3. This high parasitemia was not inﬂuenced by drugs
taken before admission. The commonest clinical forms of severemalaria were:
generalized convulsions (54.7%), prostration (43.2%) and severe anemia
(14.9%). We recommend reinforcement of education of parents/caretakers
on the management of malaria at home and the equipment of peripheral
referral hospitals with transfusion facilities in order to reduce the number of
referrals to the central level of transfusion-requiring cases.
P602 Evolution and outcome on case management of
severe malaria following the current WHO guidelines in
children in two district hospitals in Cameroon
A. E. Forlack, M. T. Abena Obama, M. Beyeme Owono, E. Manga,
A. Same-Ekobo, M. Ondoa Mekongo, F. Tietche, E. M. Minkoulou
Yaounde, CM
Malaria is a major endemic parasitic disease which remains the main cause of
morbidity and mortality in sub-Saharan Africa. Children less than 5 years old
carry the largest part of this burden with 3000 deaths daily. Case management
of severemalaria is a main problem inCameroon. The regime proposed by the
WHO needed to be tested in African countries to prove its effectiveness and
efﬁcacy before adoption. This is thus part of a multicenter study. Our main
aim was to describe the evolution and outcome of severe malaria on manage-
ment following the current WHO guidelines. From January 1 to August 31
2000, 148 children aged from 6 to 59months with at least one feature of severe
malaria were recruited by consecutive sampling, at the Djoungolo and the
Mfou district hospitals. Treatment according to WHO guidelines was imple-
mented and there was rigorous in-patient monitoring and the outpatient
follow-up. The incidence of severe malaria was 21.1%. The male/female ratio
was 1.06. The commonest clinical forms of severe malaria were: generalized
convulsions (54.7%), prostration (43.2%) and severe anemia (14.9%). The case
management of severe malaria was effective for, the mean fever clearance time
was 27.9 21.4 h, the mean coma recovery time was 36.0 17.0 h, the
parasitemia reduced by 96.5% 48 h after onset of treatment and the hematocrit
increased from 26.4% 6.7 initially to 33.7% 3.7 on day 28. Most children
(95.9%) were completely cured, 2.0% died and there were no neurologic
deﬁcit over 1 month follow-up. We recommend the generalization of the
protocol throughout the national territory in Cameroon and further training
of health personnel to facilitate the utilization of the protocol.
P603 Assessment of the relation between trace
elements and antioxidant status in children with protein
energy malnutrition
N. Abdelrazik, S. Abouelhassan, A. Abdelaziz, R. Abdelaziz
Mansoura, EGY
Background: Protein energy malnutrition represents one of the commonest
nutritional deﬁciencies in developing countries. Marasmus is a severe form of
protein energy malnutrition and is associated with oxidative hemolytic
anemia. The oxidative hemolysis could be associated with reduced level of
antioxidant enzymes (e.g. superoxide dismutase [SOD] and glutathione
peroxidase [GPX]) and some trace elements, which serve either cofactors
for these enzymes or integral parts of them, e.g. zinc, copper, and selenium.
Objective: The current study was performed to evaluate the level of those
antioxidant enzymes and some trace elements in different degree of marasmus
and their correlation.
Patients and methods: This study was carried on 30 patients suffering from
marasmus (14 patients with 1st degree marasmus and 16 patients with 2nd
degree marasmus). They were selected from infants and children admitted to
mansoura university children’s hospital. Twelve healthy children of matched
age and sex were included in the study as a control group. All patients and
controls were subjected to: determination of RBCs level of SOD, whole
blood level of GPX enzymes, and serum level of zinc, copper, selenium, lead,
manganese, nickel, and chromium.
Results: Signiﬁcant decrease of RBCs SOD, and whole blood GPX in the
marasmic groups compared with the control group (902.45þ 80.87,
25.87þ 3.39 for the 1st degree marasmus group, 662.14þ 135.57,
18.01þ 2.95 for the 2nd degree marasmus group and 1666.47þ 205.58,
56.04þ 11.58 for the control group, P¼ 0005. Also, there is signiﬁcant
decrease of the serum level of copper, zinc, and selenium in both groups of
marasmus compared with control group. Serum level of nickel, manganese,
and chromium show signiﬁcant increase in both groups of the marasmus
compared with control group.
Conclusions:
1. Decreased activities of antioxidant enzymes in marasmic children, which
make them liable to toxic effect of reactive oxygen species.
2. Low serum levels of some micronutrients as selenium, copper, and zinc in
marasmic children.
3. There are an existing correlation between serum levels of micronutrients
and blood levels of antioxidant enzymes which reﬂect the importance of
these trace elements in the process of tissues protection against oxidative
stress.
4. High level of lead, chromium, and nickel in both control and diseased
children may reﬂect environmental pollution.
Microbial pathogenesis
P604 Aspergillus fumigatus elicits a complement
response in a liver cell line (HepG2 cells)
M. S. Wright, H. Clausen, T. E. Mollnes, T. G. Abrahamsen
Oslo, N
Objective: Fungal infections are an increasing problem and can be fatal in
immunocompromised patients. The complement system with complement
factor 3 (C3) plays a major role in a fungal invasion. A change in C3 RNA
expression can therefore be used to monitor an impending immune response.
We have used HepG2 cells as a model system in order to see how liver cells
respond to ﬁlamentous fungi and a modulation with soluble beta-1,3-glucan,
a component of the cell wall of Aspergillus fumigatus (AF).
Methods: HepG2 cells were stimulated with various concentrations of LPS
and conidia of AF with and without beta-1,3-glucan. RNA expression was
analyzed by RT-PCR, C3 protein was measured by ELISA.
Results: Both LPS and AF elicited an increase in C3 RNA. The LPS-
dependent increase occurred faster and was more pronounced than the C3
RNA increase seen after AF stimulation. Soluble beta-1,3-glucan had a lower
effect on C3 expression during the same time period. In combination with AF
(preincubation with beta-1,3-glucan (1 h) and stimulation with AF (8 h), C3
RNA expression was clearly inhibited compared to the reverse stimulation
combination. LPS-dependent C3 secretion was nearly constant during the
stimulation period and seemed unaffected by its high RNA expression
response. In contrast, AF-dependent C3 secretion showed a bell-shaped
curve but with an inverse shape; starting and ending with a concentration
of secreted protein slightly above control, but falling to 50% of control at 18 h
of stimulation. Protein secretion after combinations of AF with soluble beta-
1,3-glucan showed again an inverse correlation, high C3 expression coin-
ciding with low protein secretion.
Conclusion: Both LPS and AF are able to elicit a substantial increase in C3
RNA expression while the increase in C3 protein secretion was less
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pronounced. Soluble beta-1,3-glucan was able to dampen an AF- dependent
C3 RNA increase. Protein secretion was different; while LPS stimulation
showed a near constant secretion pattern, independent of C3 expression, did
protein secretion after AF stimulation as well as after combination with beta-
1,3-glucan follow its C3 expression curve, but in an inverse manner.
P605 Effect of IL-1 and IL-10 on uropathogenic E. coli
adherence to human endothelial cells
A. Szkaradkiewicz, M. Wal, Z. Muszyn˜ski
Poznan˜, PL
Objectives: The polyfunctional effect of IL-1 on endothelial cells has
already been well documented. Present study aimed at analyzing of IL-1
and IL-10 effects on adherence of uropathogenic E. coli to human endothelial
cells.
Methods:The studies were performed usingE. coli strains which were isolated
from urine of adult patients. The strains were identiﬁed as belonging to E. coli
species using Api ID 32GN strip and the ATB system (bioMerieux). All the
strains were assayed by agglutination using the latex reagent for detection of
P. ﬁmbriae (P. ﬁmbriae particle agglutination test). Adherence of bacterial cells
to human umbilical vein endothelial cells (HUVEC) was studied after labeling
of bacteria with BrdU. Bacterial adherence was detected by immunoenzy-
matic assay with peroxidase-labeled monoclonal anti-BrdU antibodies.
HUVEC were preincubated for 30min in PBS containing r(h) IL-1, r(h)
IL-10 (R&D Systems) at 5, 10, 25, 50, 75 and 100 pg/mL or containing no
r(h) IL-1 and no r(h) IL-10 (control).
Results: Mean value of absorbance for the E. coli strains was 0.45 0.03. As
compared to control values, bacterial adherence to HUVEC signiﬁcantly
increased following preincubation with r(h) IL-1 in the dose range of 5–
100 pg/mL (P< 0.05). On the other hand, adherence of E. coli to HUVEC
preincubated with IL-10 (dose range of 5–100 pg/mL) did not signiﬁcantly
differ from the control.
Conclusion: IL-1 may promote bacterial adherence to endothelial cells while
IL-10 does not signiﬁcantly affect the adherence.
P606 Perinatal Listeria monocytogenes strains from
different phylogenetic lineages have the same virulence and
induce identical inﬂammatory response by cord blood
mononuclear cells
L. Mereghetti, S. Roche, P. Lanotte, S. Watt, N. Marquet-van der Mee,
P. Velge, R. Quentin
Tours, Nouzilly, F
Objectives: Listeria monocytogenes strains from phylogenetic lineage I are
involved in quite 70% of human listeriosis whereas strains from lineage II
are responsible for less than 30% and strains from lineage III for less than 1%.
The aim of our study was to determine if only some strains belonging to
lineages II and III are able to cause invasive disease in humans, whereas most
lineage I strains can, or if all strains from lineages II and III are less pathogenic
and are only able to infect the most immunocompromised people.
Methods:We compared the virulence of six L.monocytogenes perinatal strains,
selected to be representative of the three phylogenetic lineages of the species.
The virulence was evaluated by a plaque-forming assay with HT-29 cells. We
also explored the immune response of cord blood mononuclear cells after 4, 8,
12, 18 and 24 h of incubation with heat-inactivated bacteria by measuring
cytokine production. The TNF-alpha, IL-1beta, IL-6, and IL-8 production
was evaluated using enzyme-linked immunosorbent assays.
Results: All of the strains were over the 3.34 cut-off (between 4.29 and 5.97
mean log) with the HT-29 model and can therefore be considered to be
equally virulent. All strains induced the production of similar amounts of
TNF-alpha and IL-1beta, and high concentrations of IL-6 and IL-8 were
produced for the six strains. Thus, there is no difference between the strains
from the three genetic lineages in terms of virulence or cytokine response.
Conclusions: Given the epidemiologic distribution of the serotypes respon-
sible for human listeriosis and the genetic structure of the L.monocytogenes
species we suggest that all strains from lineage I, a genetically homogeneous
subpopulation, have a similar level of pathogenicity and may constitute a
highly virulent group for humans. We also propose that lineage II, which is
genetically more heterogeneous, is composed of strains with different levels of
pathogenicity. The ones responsible for invasive diseases, particularly perinatal
infections, display a similar level of pathogenicity to lineage I strains, whereas
the other lineage II strains are probably less pathogenic for humans. Thus, the
virulence of strains from lineage II seems to be strain-dependent.
P607 Study on interleukin-12 and interferon-gamma
serum and stool levels of patients in the course of
salmonellosis
M. Murdjeva
Plovdiv, BG
Objectives: To study interleukin-12 (IL-12) and interferon-gamma (IFN-
gamma) serum and stool levels of patients in the course of salmonellosis and
their correlation with the severity of the disease and bacteriologic sanation.
Methods: The study includes 37 patients with culture conﬁrmed gastro-
intestinal salmonellosis. Salmonella enteritidis was the etiologic agent in 81%,
Salmonella typhimurium in 13.51% and other Salmonella spp. were isolated in
5.49% of the cases. The patients were at the age of 18–57 years, with mild
(n¼ 12), moderate (n¼ 14) and severe (n¼ 11) clinical variants of the disease.
The control group comprised of 15 clinically healthy individuals at the same
age. Serum concentrations of the examined cytokines were detected at the
acute stage (2–4 days after admission) and reconvalescence, whereas the stool
cytokine levels were determined only at the acute stage (concomitantly with
the ﬁrst sample). ELISA (Biosource, Belgium) was used for cytokine detection.
Statistical methods involved nonparametric and Student t-tests.
Results: IL-12 and IFN-gamma serum levels were signiﬁcantly elevated at the
acute stage (Il-12: 319 13; IFN-gamma: 1.87 0.23) and at the reconva-
lescence as well (251 9; 1.04 0.19) in comparison with the healthy
controls (IL-12 : 82 12; IFN-gamma: 0.175 0.02). The values were
higher and more frequently increased in severe clinical variants and in patients
with bacteriologic sanation. Stool concentrations of cytokines did not differ
from these in healthy people.
Conclusion:Measurement of IL-12 and IFN-gamma serum levels in patients
with salmonellosis is an important prognostic factor for the course and severity
of the disease.
P608 Identiﬁcation of G-CSF producing cells in
Salmonella infection and endotoxin shock by in situ
hybridization
N. Hasiwa, L. Hareng, T. Meergans, G. Niedobitek, T. Hartung
Constance, Erlangen, D
Objectives: The granulocyte colony-stimulating factor (G-CSF) is a prime
hematopoetic growth factor and immunologic response modiﬁer with a
unique combination of antibacterial and anti-inﬂammatory effects. The
recombinant protein is in broad clinical use to treat different forms of
neutropenia and studies evaluating G-CSF for sepsis prophylaxis and for
treatment of various infections are ongoing. In order to apply exogenous G-
CSF efﬁciently, a better understanding of the endogenous formation is
necessary. We focussed on the identiﬁcation of producing cells in different
tissues by detection of G-CSF mRNA levels via in situ hybridization (ISH).
Methods: Balb/C mice were challenged intraperitoneally with 3mg/kg LPS
for induction of endotoxin shock or with 1 107CFU/kg Salmonella typhi-
murium. Tissue homogenates were controlled by G-CSF and b-actin speciﬁc
real-time PCR for their G-CSF mRNA content. Failing with commercially
available ISH kits, that provide short oligonucleotides (about 20 nt), we
prepared a 360 nt RNA probe by molecular cloning, gel extraction and
sequencing. Digoxigenin-labeling and labeling with S35 by in vitro transla-
tion was used for radiometric and antibody-based detection.
Results: Two and 4 h after challenge of the animals, an approximately 100–
1000-fold increase of the quantity of G-CSF mRNA was observed by real-
time PCR. The ISH carried out with synthetic oligonucleotides or Digox-
igenin-labeled probes resulted in unspeciﬁc signals as evaluated by comple-
mentary probes and sham animal samples as control. Using radioactive ISH,
the controls of all examined organs showed no signals. In the livers of
challenged animals, single cells were identiﬁed by the accumulation of G-
CSF ISH speciﬁc grains, located at the inner margin of blood vessels.
Furthermore, stained cells were identiﬁed in the endocardium of the heart
and kidney blood vessels. In the thymus, grained cells were located amidst the
tissue at the border between cortex and medulla, as well as in the spleen at the
border between red and white pulpa.
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Conclusion: Based on these ﬁndings, identiﬁcation of G-CSF mRNA-
positive cells was achieved solely by the radiometric approach. Due to their
location and their morphology these cells appear to be endothelial cells in the
majority of tissues investigated. Not all endothelial cells were stained within a
vessel, indicating a selective G-CSF formation in certain endothelial cells only.
P609 Analysis of CXCR1 and CXCR2 expression in
premenopausal women with recurrent urinary tract
infections
A. Smithson, J. Barcelo, J. P. Horcajada, J. Vila, J. A. Martinez, F. Lozano,
J. Mensa
Barcelona, E
Objectives: Polymorphonuclear neutrophils (PMN) play an important role in
the host defence against urinary tract infections (UTI). PMN express two cell
surface receptors (CXCR1 and CXCR2) for CXC chemokines, especially
IL-8, which has a chemotactic effect on PMN. In animal models, it has been
demonstrated that transepithelial PMN migration through the uroepithelium
is mainly CXCR1 dependent. In this study we have investigated the existence
of defects on the surface expression of CXCR1 and CXCR2 as well as of
polymorphisms at the promoter and the coding region (exons 1 and 2) of
CXCR1 in premenopausal women with recurrent urinary tract infection
(RUTI) and in a control group.
Methods: Between January 2002 and January 2003 a case control study was
performed. Cases were premenopausal women with RUTI deﬁned as 3
UTI in the previous 12months (n¼ 20). Controls were premenopausal
women without previous UTI (n¼ 30). The CXCR1 and CXCR2 expres-
sion on PMN was measured by ﬂow citometry using speciﬁc antibodies.
Polymorphisms of a 519-bp region encomprassing the exon 1 and the
promoter region and in a fragment of 1203 bp encomprassing the whole
exon 2 of the CXCR1 were studied using a sequence based typing method
with speciﬁc primers.
Results: Four out of the 20 cases (20%) had a decreased CXCR1 expression
and 1 out of the 30 controls (3.3%) had it (P¼ 0.14). Two cases had a
decreased CXCR2 expression (10%) and none of the controls had it
(P¼ 0.15). Among the nine cases with previous UTI during childhood
(n¼ 9) three (33.3%) had low expression of CXCR1 (P< 0.05) and two
(22.2%) had low expression of CXCR2 (P< 0.05). No polymorphisms were
detected neither in the promoter or in the exon 1 of CXCR1 while four
polymorphisms were detected in the exon 2 with equal frequency in both
groups.
Conclusions:The deﬁcient CXCR1 and CXCR2 expression seems to play a
pathogenic role in the UTI of premenopausic women having RUTI starting
at childhood. The low expression of CXCR1 is not related with the existence
of polymorphisms in the promoter, exon 1 and exon 2 region analyzed.
Further studies are needed in order to address whether CXCR1 deﬁcient
expression is caused either by speciﬁc gene defects or by upstream regulatory
mechanisms.
P610 Immunomodulatory effects of ﬁve Bacteroides
fragilis strains differentiated by random primer PCR
ﬁngerprinting on the mouse macrophage cell-line IC-21
R. Schaumann, K. Koch, A. C. Rodloff
Leipzig, D
Objective: To study the immunomodulatory effects of ﬁve different B. fragilis
strains on the cytokine expression in macrophages.
Methods: Five B. fragilis strains were differentiated in two groups by random
primer PCR ﬁngerprinting. The resistance patterns of these strains against
antimicrobial agents conﬁrmed the differentiation in the two groups. Macro-
phages (IC-21 cell line) were incubated with either different amounts of
B. fragilis alone or with both, B. fragilis and Escherichia coli-LPS. Negative
controls were run with untreated cells, positive controls only with LPS. After
3 and 20 h of incubation, IL-1beta- and IL-6-mRNA were determined by
qualitative PCR and semiquantitatively analyzed by HPLC. In addition, the
synthesized cytokine-proteins were determined from supernatants by ELISA.
Results: Stimulation of macrophages with E. coli-LPS resulted in signiﬁcantly
augmented mRNA as well as cytokine product. The stimulation of macro-
phages with different amounts of B. fragilis resulted in minimally augmented
cytokine levels compared to untreated cells. Co-stimulation of macrophages
with B. fragilis and E. coli-LPS increased the levels of all cytokines. However,
they did not always reach the levels of the positive control.
Conclusion: Our present study shows, that immunomodulatory effects of
B. fragilis on cytokine expression in macrophages are involved in the patho-
physiology of mixed aerobic/anaerobic infections.
P611 Variants of the R1 protein of group B streptococci
J. Maeland, R. Valsoe Lyng
Trondheim, N
Objectives: The R1 protein was expressed by approximately 10% of GBS
(APMIS 109: 842, 2001). R1 belongs to a family of ladder-forming GBS
proteins. Recently, the genes alp2 and alp3 encoding the proteins Alp2 and
Alp3 were described (Proc Natl Acad Sci USA 97: 9630, 2000). Alp2 and
Alp3 might be variants of the ‘classical’ R1 protein. We have approached this
question by PCR and antibody-based methods
Methods: PCR which detects both the alp2 and alp3 genes or alp2 and alp3
separatedly (J Clin Microbiol 40: 620, 2002) were used. Rabbit antisera
against the R1-expressing strains ATCC 12403 (alp2 positive), JM9 and 64/95
(both alp3 positive) were appropriately cross-absorbed to achieve speciﬁcity
for R1 proteins and for each of the Alp2 and Alp3 proteins. Immunoﬂuor-
escent antibody testing was used.
Results: Of 150 GBS strains of various capsular antigen types, 19 tested
positive with the anti-R1 antibodies and these isolates were alp2/alp3 PCR
positive. Three out of 19 R1 positive strains expressed Alp2 and were alp2
PCR positive, 16/19 expressed Alp3 and were alp3 PCR positive. Alp2 or
Alp3 expression was never found in alp2/alp3 PCR negative GBS.
Conclusions: The ﬁndings substantiate the notion that Alp2 and Alp3 are
variants of the classical R1 protein, and that these variants have common as
well as variant-speciﬁc epitopes. Strains expressing Alp2 were capsular type III
or type V isolates and all strains expressing Alp3 were type V isolates. These
results are of importance both in the context of GBS serotyping and vaccine
development.
P612 The effects of streptozotocin-induced diabetes on
brucellosis of rats and interaction of insulin with Brucella
melitensis
Z. Yumuk, O¨. Ku¨c¸u¨kbasmaci, O¨. Bu¨yu¨kbaba Boral, M. Ku¨c¸u¨ker Ang,
V. Du¨ndar
Kocaeli, Istanbul, TR
Objectives: Depression of the natural defenses against infection in diabetics
has long been suspected and investigated. This altered susceptibility to
infection has been ascribed to disturbance in cellular innate immunity. On
the other hand Brucella species and the disease spectrum are partially explained
by the ability of the organism to evade host defense mechanism by virtue of its
intracellular existence. The spectrum of disease depends on many factors
including the immune status of host, the presence of other underlying diseases
or conditions and the species of infecting organism. Thus, the aim of the
present study was to investigate whether the streptozotocin-induced diabetes
affects the course of B.melitensis infection in a rat model.
Methods: In the diabetic rat trial, diabetes was induced in overnight fasted rats
by intraperitoneal injection of streptozotocin 4 days prior to the B. melitensis
inoculation; 80mg/kg STZ were administrated to the rats in group A and C
for each of two consecutive days and 65mg/kg STZ to rats in group B once.
One hour prior to B.melitensis inoculation, 10mU of NPH per g of body
weight were injected intraperitoneally to the rats in group C for once.
Results: The mean of serum glucose level of diabetic rats are higher than rats
in nondiabetic control group and statistically signiﬁcant (P< 0.05, for each
comparison) differences occurred in serum glucose level between groups A,
B, C and control. The number of B.melitensis isolated (mean log10CFU/
organ weight) from spleen and liver of rats in group A, B and control was
signiﬁcantly (P< 0.05, for each comparison) different than each other. There
was a slight decrease in the number of organisms recovered from spleen of rats
in group C compared with those rats in Group A, which did not represent a
signiﬁcant (P> 0.05) difference. At a concentration of 10U of insulin per ml,
the growth rate of B. melitensiswas not affected compared with that of cultures
containing no insulin.
Conclusions: In this study, a model of B.melitensis infection was used in the
setting of STZ-induced diabetes in rats. It was found that STZ injected rats
exposed to B. melitensis infection had a signiﬁcantly (P< 0.05) greater number
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of B. melitensis in their spleen and liver than the rats in the control group. The
reason for this might be related to disturbance in innate and adaptive
immunity due to diabetic state induced by STZ injection.
P613 Bacteremia in patients with hidradenitis
suppurativa undergoing surgical treatment with CO2 laser
stripping – secondary intention technique
M. Hedberg, J. Lapins, K. Sartorius, L. Emtestam
Stockholm, S
Introduction: Hidradenitis suppurativa (HS) is a cicatrizing and persistent
disease of apocrine glandbearing areas in adults. The severity of the condition
varies from a few suppurating lesions to widespread and disabling disease. The
etiology is obscure, but suggested contributory factors include a genetic
predisposition, comedones occluding the pilosebaceous apparatus, bacterial
infection, and hormonal factors.
Objectives: The aim of the study was to investigate the amount and type of
bacteria circulating in the bloodstream in patients with HS undergoing
surgical treatment with CO2 laser stripping – secondary intention technique.
Methods: Twenty-one patients (20 females and 1 male) were included in the
study. One blood sample (8mL) was taken before surgery, one during the
operation and the last one 10min after surgery. A group of ﬁve healthy
individuals not undergoing any kind of operation was used as control. The
blood was cultured by a lysis-ﬁltration technique that earlier has been shown
to be very sensitive. As the ﬁlter catches the micoorganisms and colonies are
formed during the culturing the number of bacteria in the samples are easily
determined.
Results: In six patients all samples were negative which indicates that the
surgery method itself did not cause any spread of bacteria from the lesions.
Bacterial growth in the ﬁrst blood sample was found in nine patients, from the
second sample in 10 and from the third sample in ﬁve patients. At least 10
different bacterial species were identiﬁed. The dominating bacteria were
coagulase-negative Staphylococci (CNS), Propionibacterium sp., P. acnes and
S. aureus. A few other anaerobes and some alfa-streptococci were also
encountered. The bacterial ﬁndings in the blood samples are in agreement
with the results from a previous study in patients with deep HS-lesions. In the
ﬁve controls no microbial growth was detected.
Conclusion: The CO2 laser stripping technique used did not cause any
additional spread of bacteria in the blood stream. The evaluation of cultures
containing microorganisms from normal skin ﬂora is controversial. As the
bacteria encountered in this study are in good agreement with ﬁndings in
cultures from deep HS-lesions they seem to be relevant. The growth of
bacteria in the ﬁrst blood sample taken before surgery might indicate
that some of these patients have bacteria continuously circulating in the
blood.
P614 Evaluation of the OSIRIS system for disk diffusion
susceptibility testing
B. Hendrickx, M. Reijn
Terneuzen, NL
Objectives:OSIRIS is an automatic system for reading and interpreting disk
diffusion susceptibility tests. The aim of our study was to evaluate the system
by comparing the Osiris measured zone sizes to manually measured inhibition
zones.
Methods: Six hundred and sixty strains were tested by the disk diffusion test,
according to the NCCLS recommendations, using round 10mm Mueller-
Hinton agar plates. All strains were routine clinical isolates of diverse origins
(urine, suppurations, feces, blood, bronchial aspiration) and included 486
enterobacteriaceae, 40 nonfermenters, 73 staphylococci and 61 enterococci.
For each isolate 7–8 antimicrobials were tested: ampicillin, amoxicillin/
clavulanic acid, ceftriaxone, ciproﬂoxacin, meropenem, tobramycin, oxacillin
and cotrimoxazole. All zone diameters were read with OSIRIS and, if
necessary, corrected on screen by the operator. Since the conventional manual
reading is considered as the reference method, the inhibition zones were also
measured with an electronic caliper using the mean of 3–4 measurements as
the deﬁnite zone diameter.
Results:Essential agreement (3mm diameter differences) was obtained with
88% of the Gram negative strains (GNS). Ten percent of the GNS showed
major errors (4–10mm diameter differences) and 2% showed very major
errors (>10mm diameter differences). All GNS were easily read with
OSIRIS, except some of the Pseudomonas aeruginosa strains. The results for
ampicillin, amoxicillin-clav., meropenem, tobramycin and cotrimoxazole
were excellent, showing essential agreement in more than 90% of the strains.
The lower score for ciproﬂoxacin was due to the absence of a clear-cut
inhibition zone and therefore a less accurate reading by OSIRIS. The scores
for ceftriaxone improved signiﬁcantly by changing the position of the disc on
the plate. The results for staphylococci and enterococci were somewhat less
satisfying, with essential agreement for 73 and 59% of the strains, major errors
for 22 and 18% and very major errors for 5 and 23% of the strains, respectively.
Conclusion: The OSIRIS system is a useful method for the reading and
interpretation of inhibition zone sizes in disk diffusion susceptibility testing.
The position of antibiotic discs on the plate can improve reading perfor-
mances. On screen adjustment, especially of major discrepancies, is useful to
optimize the results but appears to be an easy task.
P615 High-level expression of the plasmid-encoded
AmpC gene, blaCMY-7 does not compromise the virulent
phenotype of a strain of Salmonella typhimurium
A. Hossain, M. D. Reisbig, N. D. Hanson
Omaha, USA
Objectives: In a previous study with a Salmonella typhimurium (St) strain
containing cloned ampC-ampR from Enterobacter cloacae, it was suggested that
ampC beta-lactamase expression must be kept at low levels by AmpR to
maintain a virulent phenotype. The purpose of this study was to determine
how these ﬁndings obtained with a laboratory model system related to a
virulent clinical isolate of St expressing the plasmid-encoded (PE) ampC
blaCMY-7.
Methods: Disk induction assays were used to determine the induction
potential of CMY-7. Conjugation was performed to transfer the plasmid
encoding blaCMY-7 to E. coli J53AzR and St strain LT2. Five-hundred base
pairs upstream of blaCMY-7 were generated for sequencing using Genome
Walker, a PCR based methodology. The copy number of the plasmid
encoding blaCMY-7 was determined using a comparative PCR-based
method. Primer extension analyses were carried out to quantify blaCMY-
7 RNA expression. Invasion potential was determined by in vitro invasion
assays using gastric carcinoma cells.
Results:Conjugation and PCR results indicated that blaCMY-7 was encoded
on a large molecular weight plasmid that was present in two copies. Induction
of AmpC b-lactamase activity was not observed using the disk induction assay.
In addition, ampR was absent in a 500 bp region upstream of the blaCMY-7
structural gene. The blaCMY-7 expression was ﬁve-fold higher than ampC
expression from a derepressed mutant ofCitrobacter freundii (Cf). Comparisons
between the clinical isolate, transconjugants of strain LT2, and strain LT2
without blaCMY-7 indicated that growth and virulence phenotypes were not
compromised in St expressing blaCMY-7.
Conclusions: Contradicting a previous report, these data demonstrate that
high-level expression of ampC in the absence of AmpR did not comprise the
virulence phenotype of a clinical isolate of St. The origin of blaCMY-7 is the
chromosome of Cf and derepressed mutants of Cf produce high levels of beta-
lactamase leading to clinical resistance. However, expression of blaCMY-7 is
5-fold higher than a derepressed mutant suggesting that PE ampC beta-
lactamases may be regulated differently in Salmonella isolates. Furthermore,
these data suggest that plasmid copy number plays a minimal role in overall
expression of blaCMY-7.
P616 Comparison of enterotoxin genes in
Staphylococcus aureus strains from patients vs. healthy
carriers
H. Lagler, C. L. Marodi, W. Graninger, F. Rozgonyi
Vienna, A; Budapest, HUN
Materials and methods: The presence of mecA-, enterotoxin (A–E and
G–Q), TSST-1 genes was detected by the PCR technique in 161 strains of
Staphylococcus aureus (SA). Strains (n¼ 137) were collected at Semmelweis
University from throats, anterior nares and hands of healthy students, and at
the Department of Pulmonology (DP) from sputum, throat, or bronchial
lavage (BAL) of patients (n¼ 24). All isolates were identiﬁed by the classical
methods. Antibiotic susceptibility was determined by microdilution (oxacil-
lin), agar plate dilution (vancomycin) and disc diffusion (others). Phage types
were determined by the standard international collection of phages.
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Results: 87.5% (21) of the isolates from DP, and 74% (101) in the students’
group harbored enterotoxin genes. In the 24 DP-strains SE-gene distribution
was as follows: SEA 25% (6), SEB 16% (4), SEC 0%, SED 12.5% (3), SEE 0%,
TSST-1 4.2% (1), SEG 62.5% (15), SEH 0%, SEI 62.5% (15), SEJ 12.5% (3),
SEK 4.2% (1), SEL 0%, SEM 62.5% (15), SEN 66.7% (16), SEO 62.5% (15),
SEP 25% (6), SEQ 12.5% (3). One strain was mecA-gene positive. In contrast,
the 137 strains from students showed the following distribution: SEA 16%
(22), SEB 11% (15), SEC 11.7% (16), SED 11% (15), SEE 1.5% (2), TSST-1
6.6% (9), SEG 34.3% (47), SEH 5.1% (7), SEI 38% (52), SEJ 11% (15), SEK
10.2% (14), SEL 11% (15), SEM 37.2% (51), SEN 38.7% (53), SEO 38% (52),
SEP 5.8% (8), SEQ 16.1% (22). No mecA-gene was detected.
Conclusion: The overall number of SE-gene positive SA were (87 vs. 73.7%)
in both groups high. Surprisingly, no MRSA was found in the students and
only one in the patients. The most frequent SE-genes in the collection are
SEG, SEI, SEM, SEN, SEO. The genes were mostly found combined and
were present almost twice as frequent in patients’ strains as in those of healthy
carriers. The ﬁve-fold higher frequency of SEP in patients’ isolates is
noteworthy.
Acknowledgement: Supported by O¨AAD-MO¨B.
P617 Virulence factors in Serratia marcescens hospital
infections
B. Ulatowska, E. Gospodarek
Bydgoszcz, PL
Objectives: The aim of this study was to analyze some of virulence factors of
S. marcescens strains isolated in the Department of Medical Microbiology
Ludwik Rydygier University School of Medical Science in Bydgoszcz over
6 years (1996–2002).
Methods:The collection of 136 S. marcescens strains was analyzed. Production
of DNAse was examined on DNAse Test Agar, proteolytic properties – on
Chemical Deﬁned Medium (CDM) containing Casein Sodium Salt or Skim
Milk Powder. Production of gelatinase was examined on solid medium with
3% gelatine. Hemolytic activity was determined on CDM containing 5%
sheep erythrocytes and CDM with 5% human erythrocytes. Cell surface
hydrophobicity (CSH) was analyzed using Salt Aggregation Test (SAT) and
Bacterial Adhesion to Hydrocarbons (BATH) test. Adhesion of S. marcescens
strains to natural human and sheep erythrocytes and tanned human and sheep
erythrocytes was determined. Adhesion to polystyrene was evaluated with
spectrophotometric method with usage of sterile, polystyrene, 96-well,
round-bottomed tissue culture plates.
Results: All analyzed strains produced extracellular DNAse. Proteases were
produced by 85.3–98.5% of S. marcescens strains. More than 70% of S. mar-
cescens strains were CSH in both SATand BATH tests. The highest percentage
of strains (19.9%) adhered to tanned sheep erythrocytes while incubated in
378C grades. Over 60% of analyzed strains adhered to polystyrene plates while
incubated 24 h in 378C grades.
Conclusions: S. marcescens strains are mostly isolated from hospital infections.
Analyzed in this work virulence factors can help them to initiate infection
process.
Pseudomonas aeruginosa
P618 Hemagglutination and adherence ability of
Pseudomonas aeruginosa strains isolated from a variety of
clinical sites
J. Vranes, V. Kruzic, B. Turkovic, M. Horonitz
Zagreb, Osijek, HR
Objectives: Pseudomonas aeruginosa is an opportunistic pathogen which rarely
causes disease in healthy individuals and is a common human saprophyte. In
most cases, the disease process begins with an alteration or a circumvention of
normal host defenses. This may involve a disruption in the integrity of
physical barriers to bacterial invasion such as the skin or mucous membranes,
or their circumvention as in the case of intravenous lines, urinary catheters or
endotracheal tubes. The ability of P. aeruginosa to adhere to the surface of
mucous membranes of the human body or to medical devices is considered
the initial step in its colonization and subsequent infection. In the present
study, we compared the hemagglutination ability (HA) and adherence ability
of wild-type P. aeruginosa strains to different cell lines and to polystyrene.
Methods: A total of 35 P. aeruginosa strain isolates from clinical specimens
(urine, bronchial secretion, and ear, throat and wound swabs) were used. HA
of strains was quantitatively determined in round-bottomed microtiter plates.
The ability of strains to adhere to three different cell lines (Buffalo green
monkey kidney, HeLa, and human fetal ﬁbroblasts) was detected by immu-
noﬂuorescence staining and the adherence of the strains to the wells of ﬂat
bottom polystyrene tissue culture plates was estimated by the spectrophoto-
metric method.
Results:Most strains (89%) adhered well to the used cell lines, and there was
no signiﬁcant difference between adherence of the strains to the three cell
lines used. The bacterial binding to the cells was almost completely blocked
when bacteria were incubated at 808C for 20min before the adherence assay
(one to ﬁve bacteria bound per 40 cells, compared with 30–110 bacteria per
cell for the untreated bacteria, depending on strain). Fourteen of the 35 strains
were positive for alginate production. The results of the spectrophotometric
assay have revealed that the optical densities of formed bioﬁlms of these 14
strains were 0.181–0.540. No statistically signiﬁcant difference was observed
in the adherence ability of isolates from different specimens to polystyrene.
HA was detected in half of the strains and was not associated with alginate
production.
Conclusions: Alginate is not involved in the hemagglutination ability and
adherence ability of P. aeruginosa to the epithelial cell lines and ﬁbroblasts.
P619 Effect of adjunctive clarithromycin on the
treatment of foreign body-related Pseudomonas aeruginosa
osteomyelitis model
O¨. Kandemir, V. O¨ztuna, A. Milcan, A. Bayramoglu, H. C¸elik, G. Aslan,
C. Bayarslan, A. Kaya
Mersin, Ankara, TR
Backgraund: Bioﬁlm formation may be the main factor of resistance to
antibiotic therapy in treatment of implant-related infections in orthopedic
surgery. Macrolide antibiotics can prevent the bioﬁlm formation as shown in
several invitro studies. In this study, bacterial bioﬁlm formation in foreign
body-related Pseudomonas aeruginosa osteomyelitis model in rats, and the effect
of clarithromycin, a macrolide, on the bioﬁlm was investigated.
Methods: Right tibia of 26 rats were infected by P. aeruginosa resistant to
clarithromycin but sensitive to ceftazidime. To verify osteomyelitis, radio-
graphic examination was performed in all rats, and the tibia of three rats were
removed, cultured, and then examined under electron microscope on the
14th day. The control group was formed by three infected rats that had no
treatment. Ten rats had ceftazidime (1500mg/kg/day) subcutaneously, and 10
rats had ceftazidime subcutaneously and clarithromycin (100mg/kg/every
12 h) orally. After a treatment period of 20 days, the rat tibias and the foreign
bodies were extracted under sterile conditions, cultured, and examined
electron microscopically.
Results: The number of microorganisms grown on the bone tissue in the
combined treatment group was signiﬁcantly lower than the other groups
(P¼ 0.034). However, therewas no signiﬁcant difference between the control
and ceftazidim-only group (P¼ 0.998). The number of microorganisms
grown on the foreign body in the only-ceftazidim treatment group was
signiﬁcantly higher than the combined treatment group (P¼ 0.019). Electron
microscopic examination revealed that the bacterial concentration on the
bone tissue in the group having combined therapy was clearly less than that on
the other groups. The bioﬁlm layer was eradicated, and the bacteria were
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apparent in the group that had combined therapy; nevertheless, it was evident
on the foreign body in the ceftazidime-only group.
Conclusion: Although clarithromycin was ineffective as a bactericidal against
Pseudomonas aeruginosa, it enhanced the activity of concomitantly used
bactericidal agents via preventing the formation of glycocalix structure on
the surface of biomaterials.
P620 Treatment of experimental sepsis by
multidrug-resistant Pseudomonas aeruginosa with the
coadministration of antimicrobials, gamma-linolenic acid
and arachidonic acid
T. Adamis, E. J. Giamarellos-Bourboulis, M. Mouktaroudi, I. Dontas,
D. Perrea, H. Giamarellou
Athens, GR
Objectives: Gamma linolenic acid (GLA) and arachidonic acid (AA) have
been shown to render invitro mulridrug resistant (MDR) Pseudomonas
aeruginosa into susceptible to ceftazidime and amikacin (Giamarellos-Bour-
boulis et al. 2000, 44: 2187). The invitro effect was tested in an experimental
model of sepsis.
Methods: Sepsis was induced by the intravenous infusion of an 8.4 log10
inoculum of one MDR isolate of P. aeruginosa by a catheter inserted in the
right jugular vein of 24 male rabbits. Thirty minutes later six animals were
treated by the intravenous coadministration of 50mg/kg of ceftazidime and
15mg/kg of amikacin by a catheter in the left jugular vein. Six animals were
treated by antimicrobials and an i.v. emulsion of 25mg/kg of GLA infused
within 10 minutes; six by antimicrobials and an i.v. emulsion of 25mg/kg of
AA infused within 10 minutes; six animals served as controls. Quantitative
blood cultures were performed at regular time intervals. Animals were
sacriﬁced 3.5 h after bacterial inoculation, and tissue samples of liver, spleen,
lung and mesenterial lymph nodes (MLN) were homogenized and quantita-
tively cultured.
Results: Median log10 changes (CFU/mL) of bacterial blood counts of
controls, of animals administered antimicrobials, of animals administered
antimicrobials and AA, and of animals administered antimicrobials and
GLA 30min after treatment were: 0.52, 1.00, 1.30, and 2.00,
respectively. Respective median values 90min after treatment were:
1.26, 1.50, 2.04, and 1.97; 120min after treatment: 0.95, 1.97,
2.04, and 1.96; and 180min after treatment: 1.08, 2.19, 2.23, and
3.12. Respective median log10 values of bacterial counts (CFU/g) of liver at
necropsy were 4.60, 5.47, 5.30, and 5.46; of spleen at necropsy 4.92, 4.90,
4.80, and 5.56; of the lower lung lobe at necropsy 4.49, 3.52, 2.44, and 3.22;
and of MLN at necropsy 4.13, 2.47, 1.35, and 2.90.
Conclusions: The intravenous coadministration of an emulsion of AA and
of GLA with ceftazidime and amikacin in experimental sepsis by MDR
P. aeruginosa results in considerable enhancement of the antimicrobial effect of
both antimicrobials in lowering blood and tissue bacterial counts. These
results merit further clinical evaluation.
P621 Effective immunomodulatory treatment of
experimental pyelonephritis by multidrug-resistant
Pseudomonas aeruginosa with intravenous clarithromycin
E. J. Giamarellos-Bourboulis, G. Laoutaris, T. Adamis, L. Sabrakos,
P. E. Karayannacos, H. Giamarellou
Athens, GR
Objectives:Clarithromycin has been shown to inhibit in vitro biosynthesis of
interleukin-8 at concentrations above 10mg/L that are not achieved in serum
after oral administration. The immunomodulatory effect of intravenously
administered clarithromycin was assessed in experimental sepsis by multidrug
resistant (MDR) Pseudomonas aeruginosa.
Methods: Sixteen male rabbits were applied: ﬁve controls (group A), ﬁve
treated with amikacin (group B), and six treated with clarithromycin and
amikacin (group C). Acute pyelonephritis was induced by ligation of the
pelvoureteral junction of the right kidney and by bacterial inoculation in the
right renal pelvis. An 8 log10 inoculum of one MDR isolate of P. aeruginosa
was applied. MIC of amikacin was 512mg/L and of clarithromycin 512mg/
L; no synergy between them was found after time-kill assay. Clarithromycin
was administered at a dose of 80mg/kg within 30min by the vein of the left
ear immediately after and 2 hours after bacterial inoculation. Amikacin was
administered as a bolus by the same route at a dose of 15mg/kg. Tumor
necrosis factor-alpha (TNFa) was estimated in blood samples by the cytotoxic
effect of serum on ﬁbrosarcoma L929 cell line. Survival was assessed by
Kaplan–Meier analysis.
Results: Mean SE of survival of group A was 3.00 0.68 days, of group B
2.00 0.29 days (pNS compared to group A) and of group C 9.75 1.14 days
(P< 0.0001 compared to both other groups). Median TNFa of serum of
groups A, B, and C were 24.0, 26.0, and <11.5 pg/mL, respectively, 1 h after
bacterial inoculation; 33.0, 35.0, and <11.5 pg/mL, respectively, 2 h after
bacterial inoculation; 19.5, 25.0, and < 11.5 pg/mL, respectively, 24 h after
bacterial inoculation; and 42.0, 55.0, and 24.0 pg/mL, respectively, 48 h after
bacterial inoculation. Inoculated bacteria were cultured from the right kidney
of all animals at necropsy.
Conclusions: The intravenous administration of clarithromycin decreases
serum TNFa signiﬁcantly and prolongs survival in experimental pyelo-
nephritis by MDR P. aeruginosa. These results appear promising in clinical
practice.
P622 Impact of gamma-linolenic acid and arachidonic
acid on tumor necrosis factor-alpha in experimental sepsis
by multidrug-resistant Pseudomonas aeruginosa
M. Mouktaroudi, T. Adamis, L. Sabrakos, P. E. Karayannacos,
H. Giamarellou, E. J. Giamarellos-Bourboulis
Athens, GR
Objectives: Polyunsaturated fatty acids like gammalinolenate (GLA) and
arachidonate (AA) are considered as potent immunomodulators in chronic
inﬂammatory states. Their effect was assessed in experimental sepsis by
multidrug resistant (MDR) P. aeruginosa.
Methods: Sepsis was induced by the intravenous infusion of an 8.4 log10
inoculum of one MDR isolate of P. aeruginosa by a catheter inserted in the
right jugular vein of 24 male rabbits. Thirty minutes later six animals were
treated by the intravenous coadministration of 50mg/kg of ceftazidime and
15mg/kg of amikacin by a catheter in the left jugular vein. Six animals were
treated by antimicrobials and an i.v. emulsion of 25mg/kg of GLA infused
within 10min; six by antimicrobials, and an i.v. emulsion of 25mg/kg of AA
infused within 10min; six animals served as controls. Systolic blood pressure
and pulse rate were continuously recorded for 3.5 h by a catheter inserted in
the right carotid and blood was sampled by a catheter in the left carotid.
Tumor necrosis factor-alpha (TNFa) was assessed by the cytotoxic effect of
serum on L929 ﬁbrosarcoma cell line.
Results:Mean SE of TNFa before treatment was 163.2 147.2 pg/mL in
controls, 152.0 75.5 pg/mL in animals administered antimicrobials,
36.0 22.94 pg/mL in animals administered antimicrobials and AA and
23.17 19.61 in animals administered antimicrobials and GLA. Respective
values 30min after treatment were 73.3 41.9, 116.7 99.7, 197.8 101.5,
and 30.0 26.2 pg/mL; 90min after treatment, 57.5 34.7, 110.0 101.8,
115.8 98.7, and 146.0 66.2 pg/mL; 120min after treatment 62.8 32.9,
110.2 74.1, 94.7 35.7, and 165.7 81.7 pg/mL; and 180min after treat-
ment 168.0 137.5, 121.0 105.3, 63.2 35.3, and 175.3 103.9 pg/mL.
Control animals and animals treated only with antimicrobials had hemody-
namic instability with increased pulse rate and ﬂuctuations in systolic pressure.
Administration of GLA and AA resulted in stable values of systolic pressure
and of pulse rate.
Conclusions: Intravenous administration of an emulsion of AA and of GLA
with antimicrobials in experimental sepsis by MDR P. aeruginosa presents with
hemodynamic beneﬁt of the animals; AA seems to achieve a decrease of serum
TNFa. These results merit further evaluation.
P623 Remodeling of sepsis by multidrug-resistant
Pseudomonas aeruginosa. What does the experimental
model propose as a target for immunomodulation?
G. Laoutaris, N. Bolanos, V. Koussoulas, A. Pantopoulou, D. Perrea,
E. J. Giamarellos-Bourboulis
Athens, GR
Objectives:To deﬁne the sequence of events leading to systemic inﬂammation
in an experimental model of sepsis by multidrug-resistant (MDR) Pseudo-
monas aeruginosa.
Methods: Seventy-ﬁve male Wistar rats were used; 20 for assessment of
survival and 55 for estimation of tumour necrosis factor-a (TNFa)
and malondialdehyde (MDA). Sepsis was induced after the intraperitoneal
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injection of an 8log10 inoculum of one MDR isolate of P. aeruginosa. Survival
was estimated by Kaplan–Meier analysis. Animals were sacriﬁced in groups at
regular time intervals, and blood was sampled by the abdominal aorta. TNFa
was assessed by EIA and MDA by the thiobarbiturate assay.
Results:Mean SE of survival was 18.60 1.84 h. All animals died after 36 h.
Mean SE of TNFa 1, 2, 3, and 4 h after bacterial inoculation was
32.5 28.8, 20.8 6.3, 37.9 9.6, and 50.5 11.1 pg/mL (pNS compared
to previous time intervals), respectively. Mean SE of MDA 1, 2, 3, and 4 h
after bacterial inoculation was 0.74 0.64, 0.40 0.13, 0.81 0.19, and
1.84 0.35M (P< 0.001 compared to previous time intervals), respectively.
Conclusions: In an experimental model of lethal sepsis by MDR P. aeruginosa,
it is shown that increases of oxidant status, as assessed by estimation of MDA,
occur earlier than the respective increases of TNFa. These results might create
a new perspective for the application of antioxidants as immunomodulators in
sepsis by MDR bacteria.
P624 Cystic ﬁbrosis antibiotic susceptibility service in
Scotland – 2002
F. M. MacKenzie, K. E. Milne, I. M. Gould
Aberdeen, UK
Objectives: Multi-resistant isolates from cystic ﬁbrosis (CF) patients are
referred to Aberdeen Royal Inﬁrmary (ARI) from all over Scotland for
extended susceptibility testing. This study describes patterns of antibiotic
resistance in these isolates in the year 2002.
Methods: During 2002, 130 Gram-negative nonfermenting bacilli isolates
from 62 different patients were submitted to ARI. MICs were established for
each isolate against a range of antibiotics including amikacin (AMIK),
gentamicin (GENT), netilmicin (NET), tobramycin (TOB), ciproﬂoxacin
(CIP), levoﬂoxacin (LEV), aztreonam (AZT), ceftazidime (CAZ), Piperacillin
(PIP), Piperacillin/tazobactam (P/TAZ), imipenem (IMP), Meropenem
(MER), colistin (COLIS), timentin (TIM), Cefpirome (CPIR), ampicil-
lin/sulbactam (AMPSUL), chloramphenicol (CHLOR), minocycline
(MINO), cotrimoxazole (COTRIM), and rifampicin (RIF). The E-test
method was used.
Results: One hundred and thirty isolates were submitted from nine Scottish
hospitals (range 2–46 isolates per hospital). The isolates were from 62 different
patients whose age range was 9months to 44 years. The 130 were broken
down to 67 Pseudomonas aeruginosa, 42 Burkholderia cepacia, nine Stenotropho-
monas maltophilia, seven Pseudomonas species and ﬁve Alcaligenes species. Up to
20 antibiotics were tested for each isolate, and a total of 3135 MICs were
carried out. The MIC-90 for the majority of antibiotics tested was above the
maximum value tested for each species. TheMIC-90 fell within range for ﬁve
antibiotics tested against Pseudomonas species; GENT (64mg/L), NET
(128mg/L), TOB (8mg/L), CIP (8mg/L), COLIS (4mg/L), for ﬁve anti-
biotics tested against S. maltophilia; LEV (6mg/L), COLIS (24mg/L),
CHLOR (24mg/L), MINO (3mg/L), RIF (48mg/L) and for only MINO
(128mg/L) when tested against B. cepacia.
Conclusions: Due to the highly resistant nature of these isolates from CF
patients, single antibiotic therapy was rarely possible, necessitating the
requirement for combination therapy.
P625 Investigation of resistance rates of
Pseudomonas aeruginosa isolates to various
antimicrobials
T. Gunduz, A. Sivrel Arisoy, U. Algun, H. Borand, B. Ozbakkaloglu
Manisa, TR
Objectives: Pseudomonas aeruginosa is frequently isolated from nosocomial
infections and has a complicated management as a result of high resistance rate.
The resistance to antibiotics varies among hospitals and even clinics.
Materials and methods: The resistance rate of Pseudomonas aeruginosa strains
isolated from 150 hospitalized or outpatients in Celal Bayar University
Hospital between December 1999 and January 2002 to various antibiotics
(ciproﬂoxacine, oﬂoxacine, norﬂoxacine, gentamicin, amikacin, netilmicin,
amoxicillin-clavulanate, ceftazidime, ceftriaxone, cefepime, cefoperazon-
sulbactam, imipenem, meropenem) were investigated. The isolated bacteria
was identiﬁed by the usage of API 20 NE (Biomerieux) system. The
susceptibility testing was performed by disk diffusion method (Oxoid)
according to NCCLS criteria.
Results: The resistance rate of Pseudomonas aeruginosa strains were found
as following; ciproﬂoxacine (8%), oﬂoxacine (26%), norﬂoxacine (10.7%),
gentamicin (39.6%), amikacin (4%), netilmicin (5.3%), amoxicillin-
clavulanate (96%), ceftazidime (13.3%), ceftriaxone (62.7), cefepime (2%),
cefoperazon-sulbactam (7.3%), imipenem (10%), meropenem (2%). The
resistance rate was found to be statistically higher in the strains which were
isolated from hospitalized patients especially from the intensive care unit.
Conclusion: In order to control the nosocomial infections, the annual
susceptibility rates of hospitals should be determined and effective antibiotic
usage policy should be performed.
P626 Invitro synergism testing of antibiotic
combinations and clinical outcomes of resistant
Pseudomonas aeruginosa
H.-J. Woo, W. Song, J. S. Kim, K. -M. Lee
Seoul, KOR
Objectives: This study was designed to determine whether synergism
occurred between beta-lactams and aminoglycosides or ﬂuoroquinolones
for Pseudomonas aeruginosa isolates that were resistant to these antimicrobial
agents and to evaluate clinical outcomes of infections by these isolates.
Methods:Using the chequerboard titration method, the activity in combina-
tion of beta-lactams, ﬂuoroquinolones and aminoglycosides was investigated
against 24 P. aeruginosa isolates resistant to these antibiotics, and the clinical
records were reviewed to evaluate the clinical outcomes.
Results: Synergy was detected with one or more antimicrobial combinations
against 15 of 24 (63%) isolates and partial synergy was detected with one or
more combinations against all 24 isolates. Twelve of 24 (50%) isolates were
considered pathogens of true infections. Only one of 12 infections was treated
by antibiotic combination with synergism. Others were treated by antibiotic
combinations without synergism. The rate of treatment failure was 8/12
(67%) in all of these infections.
Conclusions: The results of this study indicate that against P. aeruginosa,
synergy may occur between beta-lactams, ﬂuoroquinolones and aminoglyco-
sides, although the strains are resistant to the individual antibiotics. The
clinical outcomes of infections of resistant P. aeruginosa treated by antibiotic
combinations without synergism are poor.
P627 Synergistic bactericidal activity of rifampin (RF)
and colistin (CL) combination against multidrug-resistant
Pseudomonas aeruginosa, in vitro and clinical study
C. Tascini, G. Gemignani, E. Tagliaferri, A. Leonildi, G. Canale,
A. Piaggesi, F. Menichetti
Pisa, I
Background: MDR P. aeruginosa may be responsible for difﬁcult-to-treat
nosocomial infections and search for effective antimicrobial combinations
is warranted. The addition of rifampin to colistin showed to be synergistic
against some nonfermentative Gram-negative rods.
Study objective:To evaluate the activity of rifampin and colistin combination
against MDR P. aeruginosa in vitro and invivo.
Methods: Nine MDR P. aeruginosa clinical isolates were evaluated with the
checkerboard method using the combination of RF and CL. Synergism was
deﬁned using the sum of fractional inhibitory concentration (S FIC): com-
binations with S FIC< 0.5 were considered to be fully synergistic, those with
S FIC< 1 partially synergistic and those with FIC> 1 indifferent. Two strains
were tested with the time-kill curve method to show bactericidal activity of
this combination. Bactericidal activity of the antibiotic combination was
deﬁned as a 100-fold decrease in colony count by the combination
compared with that by the most active single agent. Seven patients (pts)
with deep-seated life-threatening MDR P. aeruginosa infections were treated
with this antibiotic combination: two ICU pts with VAP, two pts with
infected diabetic foot, one AIDS pt with sepsis, one lymphoma pt with
pneumonia and sepsis, one pt with common variable immunodeﬁciency and
pneumonia.
Results:All the tested strains resulted tobe resistant to rifampin (MIC:64mg/L).
The MIC in combination of rifampin decreased from four to six dilutions,
reaching the range of susceptibility. TheMIC in combinationof colistin resulted
to be in the range of susceptibility. The combination of rifampin and colistinwas
fully synergistic against four strains and partially synergistic against ﬁve tested
strains.Bactericidal activitywas showedagainst the strain testedwiththe time-kill
curve method. All the seven patients treated with RFþCL combination were
treated successfully.
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Conclusions: The addition of rifampin to colistin show invitro synergistic
bactericidal activity against MDR P. aeruginosa strains. The activity of this
combination in clinical practice seems to be effective also in difﬁcult-to-treat
severe MDR P. aeruginosa infections
P628 Effect of pyocin S2 produced by endemic
Pseudomonas aeruginosa 42 A on the growth of human
tumor and normal cell lines
A. Abdi-Ali, F. Malekzadeh, A. Deezagi, A. Kazam Nejad
Tehran, IR
Objectives: Pyocins are bacteriocins produced by Pseudomonas aeruginosa
which kill other strains from the same species. Pyocin S2 is a type of S
pyocin produced by certain strains of P. aeruginosa, with molecular weight of
74 kDa. Pyocin S2 has potential DNases similar to the E2 group colicins, also
inhibits lipid synthesis. This research investigates the cytotoxic effects of
pyocin S2 produced by endemic P. aeruginosa 42 A on the growth of cultured
human tumor and normal cell lines.
Methods:Pyocin S2 was produced by one of the endemic isolates P. aeruginosa
42 A after induced by mitomycin C (2mg/mL). Puriﬁcation of pyocin S2 was
achieved by ion exchange chromatography using CM-Sepharose CL-6B and
sodium phosphate buffer (pH 8) from an 80% ammonium sulfate precipitate
of whole cell lysates. Pyocin activity of fractions were detected by using the
Govan spot testing method. The purity of active fraction was conﬁrmed by
SDS–PAGE. Cytotoxic effects of pyocin S2 from endemic P. aeruginosa 42 A
on HepG2 (Hepatocellular Carcinoma, Human), Im9 (Lymphoblast, Immu-
noglobulin Secreting, derived from Multiple Myeloma, Human) and HFFF
(Human Fetal Foreskin Fibroblast) cell lines were studied by MTT assay
method. HepG2 and HFFF grew as monolayer, whereas Im9 grew in
suspension.
Results:Our results showed that pyocin S2 from P. aeruginosa 42 A exhibited
inhibitory effects on the growth of tumor cell lines HepG2 and Im9 after
5 days incubation. No inhibitory effect was observed on the growth of normal
cell line HFFF.
Conclusions: In summary, the observation presented here point to the
potentialities inherent in pyocin S2 as a diagnostic tool for sensitive cancer
cells suggesting that these molecules may have therapeutic value as nontoxic
inhibitors of some neoplasia.
Diagnosis of mycobacteria
P629 Improvement of the PCR diagnostic method in
patients with kidney tuberculosis suspicion
M. Koziol-Montewka, A. Kolodziejek, J. Oles, L. Janicka
Lublin, PL
Introduction:Kidney tuberculosis is an important clinical problem, especially
because of the difﬁculties in a diagnostic examination. While nonspeciﬁc
clinical presentation and variable radiographic appearance often mimic other
pathologic lesions, limited bacterium discharge to urine makes it difﬁcult to
isolate Mycobacterium tuberculosis from the urine samples.
Objectives: The aim of our study was to indicate the high value of nested
PCR method in case of kidney tuberculosis suspicion and limited myco-
bacterium discharge in urine. We also emphasized the role of blood PCR in
these patients. Since the proinﬂammatory cytokines TNF-alpha, INF-
gamma, and IL-12 are regarded to be signiﬁcant diagnostic markers in many
infectious diseases, we showed the importance of these immunologic indi-
cators in diagnosis of the extrapulmonary tuberculosis.
Materials: Thirty patients attending the urology clinic with suspicious of
kidney tuberculosis were evaluated. The main symptoms suggestive of kidney
tuberculosis were: signiﬁcant changes in urine and urographic image, weight
loss, and weakness. The PCR for M. tuberculosis was done for both blood and
urine samples obtained from all patients. The blood levels of TNF-alpha,
INF-gamma and IL-12 were quantiﬁed by ELISA test and compared with
control group.
Results: In 12 patients, presence of M. tuberculosis was detected neither in
urine nor in blood samples. In 11 patients, the product of gene ampliﬁcation
was noticeable only in urine samples, while in seven patients it was present in
both urine and blood samples. Additionally, the differences in serum cytokine
levels between patients with kidney tuberculosis and healthy people were
found. TNF-alpha concentration was about twofold higher in the positive
patients; IL-12 concentration was about fourfold higher and the differences
between IL-12 levels were statistically important (P< 0.05). However, no
signiﬁcant differences were found in INF-gamma level among all groups.
Conclusions:Owing to high sensitivity, the nested PCR is particularly useful
in paucibaciliary situations such as kidney tuberculosis. Next to urine PCR,
PCR for blood specimen is also an important diagnostic marker during the
examination for the disease. Our study also indicates that alterations in certain
cytokines levels may be helpful in differentiating the lesion.
P630 Early diagnosis of tuberculous meningitis by
polymerase chain reaction
S. Mitka, E. Chaidouli, A. Ifantidou, A. Kansouzidou
Thessaloniki, GR
Introduction: Due to inconsistent clinical ﬁndings, rarity, and the lack of a
rapid, sensitive, and speciﬁc test, tuberculous meningitis (TBM) is difﬁcult to
diagnose, although the rapid diagnosis is of vital importance for patients. The
aim of this study was the evaluation and the contribution of PCR in the early
and speciﬁc diagnosis of TBM.
Materials and methods:A total of 23 cerebrospinal ﬂuid (CSF) samples from
patients with symptoms suggestive of TBM were studied. The pellet of the
centrifuged CSF samples was examined for mycobacteria using Ziehl–
Neelsen (ZN) staining, and it was cultured onto Lowenstein–Jensen slope.
Mycobacterial DNAs from the samples were ampliﬁed using an IS6110 gene-
speciﬁc PCR (fragment 123 bp). In order to evaluate the speciﬁcity of PCR in
the diagnosis of TBM, seven CSF samples from patients with microbial
meningitis (Streptococcus pneumoniae, Neisseria meningitidis, Cryptococcus neofor-
mans, Brucella melitensis) were examined by PCR. A strain of Mycobacterium
tuberculosis isolated from a CSF sample was used as a positive-control.
Results:All the 23 CSF samples were negative by ZN staining. Seven culture-
positive samples forM. tuberculosiswere also positive by PCR. The culture was
negative in all the remaining 16 samples, while the PCR was positive in nine
and negative in seven samples. The PCR conﬁrmed the diagnosis of TBM in
16 patients while the CSF culture only in seven patients. The samples from the
microbial meningitis cases were all negative by PCR.
Conclusion: The CSF PCR is a rapid, sensitive, and speciﬁc diagnostic test
that contributes to the early diagnosis of TBM.
P631 A 4-year experience of Cobas Amplicor system use
for the rapid detection of Mycobacterium tuberculosis
complex in respiratory and nonrespiratory specimens in
Greece
S. Levidiotou, G. Vrioni, E. Galanakis, E. Gesouli, C. Pappa, D. Stefanou
Ioannina, GR
Objectives and methods: To demonstrate the experience of a clinical
microbiology laboratory on DNA ampliﬁcation assay for routine detection
of Mycobacterium tuberculosis, we performed the Cobas Amplicor MTB-PCR
test (Roche Diagnostics) in 7722 pulmonary and 1451 extrapulmonary
specimens collected from 3321 patients. The results were compared with
those of the conventional Lowenstein–Jensen medium, MB/BacT liquid
culture, and the clinical ﬁndings.
Results: Among the 254 culture-positive MTB respiratory specimens, 240
were positive with Cobas Amplicor MTB-PCR test, and among the 7300
culture-negative specimens, 45 (0.6%) were positive by the PCR. After
detailed interpretation, the overall sensitivity, speciﬁcity, positive and negative
predictive values for the Cobas Amplicor MTB-PCR test were 84.5, 99.8,
94.1, and 99.4%, respectively. The Cobas Amplicor MTB-PCR assay was
more sensitive for smear-positive respiratory specimens, exhibiting sensitiv-
ities of 97.1 for smear-positive and 48.6% for smear-negative specimens. For
the 18 culture-positive MTB (smear-negative) nonrespiratory specimens,
nine were positive by the PCR. None of the 1384 culture-negative non-
respiratory specimens was positive by the PCR. So, the overall sensitivity,
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speciﬁcity, positive and negative predictive values for the Cobas Amplicor
MTB PCR test were 50, 100, 100, and 99.4%, respectively. The inhibition
rates detected by the internal control of the test were 2.2 for respiratory and
3.4% for nonrespiratory specimens.
Conclusion: Cobas Amplicor MTB-PCR test might enable clinical micro-
biology laboratories with considerable previous experience in molecular
biology testing to perform PCR and conﬁrm TB infection immediately,
leading to a better clinical management.
P632 Evaluation of the routine use of MTD (Gen-Probe)
for the direct detection of Mycobacterium tuberculosis
complex in clinical specimens
E. Demertzi, C. Kourelis, I. Stefanou, S. Smilakou, A. Avlamis
Athens, GR
Objectives:Evaluation of sensitivity and speciﬁcity of the molecular detection
of Mycobacterium tuberculosis complex by MTD (Gen-Probe, Inc. San Diego,
CA) for diagnosis of pulmonary and extrapulmonary tuberculosis in compari-
son with culture results and clinical outcome.
Methods: We studied 2094 specimens from 1615 patients submitted to the
microbiology lab of our hospital over a 3-year period (2000–2002). Forty-
three percent of the samples were pulmonary (sputum, BALs, gastric lavage,
bronchial washing), 49% body ﬂuids and aspirates (CSF, pleural effusions,
pericardial effusions, ascitic ﬂuids, urine, others), and 8% blood and bone
marrow aspirates. The interpretation of the MTD results was done consider-
ing values <30 000 RLU as negative results according to the manufacturer.
Results of 30 000–300 000 were considered as indeterminate. All the MTD
results were compared with BACTEC culture (BACTEC9000MB, Becton
Dickinson) and culture on LJ medium, and resolution of discordant results was
accomplished by incorporating clinical data and repeated specimen analysis.
Results: After resolution of discrepant results and repeated testing of the
specimens with indeterminate results (>30 000–300 000 RLU), we had total
82 positive MTD samples. Among the 48 of them with results above 300 000,
42 samples were conﬁrmed as positive by culture or clinical outcome. Of the
other 34 positive MTD samples with results in the zone 30 000–300 000, only
11 had clinical conﬁrmation. The sensitivity, speciﬁcity and positive pre-
dictive value for respiratory specimens (n¼ 39) were 100, 99, and 80%,
respectively. With body ﬂuids and other aspirates (n¼ 23), those values were
100, 99, and 74%, respectively, when for blood and bone marrow aspirates
(n¼ 20) they were 100, 91, and 25%. By implementing an equivocal zone and
considering all the samples with results <300 000 as negatives, the overall
speciﬁcity and positive predictive values were improved (from 98.5 and 65% to
99.7 and 88%, respectively).
Conclusions:
1. Inclusion of MTD test in the routine testing algorithm of a diagnostic
laboratory when testing samples are appropriate selected, can result in the
rapid, reliable, and accurate detection of MTB in clinical specimens.
2. The number of false positive results can be limited by implementing an
equivocal zone.
3. Regarding the blood specimens, we propose the reconsideration of the
positive cut-off value.
4. Ampliﬁcation assays cannot still replace the conventional diagnostic
techniques.
P633 Rapid identiﬁcation of mycobacterial isolates by
PCR-restriction fragment length polymorphism analysis
(PCR-RFLP) of rpoB gene
F. Kontos, E. Petinaki, R. Nikolaou, Z. Gitti, S. Anagnostou,
M. Maniati, C. Kostopoulos, I. Tselentis, A. Maniatis
Larissa, Athens, Crete, GR
Objective:The purpose of this study was to evaluate the PCR-RFLP analysis
of rpoB gene for the rapid identiﬁcation of mycobacterial isolates.
Methods: Three hundred and forty-one clinical isolates (250 Mycobacterium
tuberculosis, 32 M. gordonae, 28 M. fortuitum, 9 M. chelonae, 9 M. avium, 6
M. intacellulare, 5 M. kansasii, and 2 M.malmoense) included in this study were
cultured in a liquid medium (Bactec MGIT 960 system, BBL, Becton
Dickinson Microbiology Systems) and on Lowenstein–Jensen medium.
Bacterial DNA was prepared as described by Sion et al. (Sion et al. 1999,
Eur. J. Clin. Microbiol. Infect. Dis. 18, 346–351) and a segment of the RNA
polymerase gene (rpoB) was ampliﬁed as described by Kim et al. (Kim et al.
2001, J. Clin. Microbiol. 39, 2102–2109). The ampliﬁed PCR products were
digested with four restriction enzymes (Hind II,HaeIII,MvaI, and AccII), and
the mixtures were electrophoresed on a 3% Metaphor agarose. The isolates
were identiﬁed using the PCR-RFLP algorithm (Kim et al. 2001, J. Clin.
Microbiol. 39, 2102–2109), and the results of identiﬁcation were compared
with those obtained by conventional biochemical and AccuProbe tests.
Results:The results of the PCR-RFLP analysis of rpoB gene were in excellent
concordance with that obtained by routine biochemical identiﬁcation tests.
All the 341 mycobacterial isolates included in this study have been correctly
identiﬁed. On the other hand, AccuProbe identiﬁed 302 of the 341 isolates
(90%) (250 M. tuberculosis, 32 M. gordonae, nine M. avium, six M. intacellulare,
and ﬁve M. kansasii isolates) but failed to identify the remaining 39 non-
tuberculous mycobacterial isolates (28 M. fortuitum, nine M. chelonae, two
M.malmoense).
Conclusions:The PCR-RFLPmethod is a rapid and a reliable method for the
identiﬁcation of mycobacterial isolates. It is faster than the conventional
methods, technically simple, less expensive, and can identify more myco-
bacterial species than AccuProbe tests. Therefore, we recommend the use of
this method for routine identiﬁcation of mycobacterial isolates in clinical
laboratories.
P634 Evaluation of the VIDAS PROBE MTB test:
analytical sensitivity, interference, and specimen-processing
robustness
A. Boucher, J. Kelly, B. Rice, S. Wilkins
Rockland, Durham, USA
Objectives: To evaluate the analytical sensitivity of the VIDAS PROBE1
Mycobacterium tuberculosis (MTB) Test (BioMerieux, Inc., Rockland, MA).
Additionally, interference by endogenous and exogenous substances and the
robustness of the MTB specimen processing procedure to inactivate Myco-
bacterium was assessed.
Methods: Thirty-one M. tuberculosis (MTB) strains, both sensitive and resis-
tant to current antibiotic therapies, were tested with the MTB assay in both
pure system and sediment matrix to evaluate sensitivity. Mucin, whole blood
(WB), white blood cells (WBC), albuterol, saline, and epinephrine were
tested in theMTB assay at varied concentrations in combination withMTB at
16 CFU/test to evaluate interference. The robustness of the MTB specimen-
processing procedure to inactivate Mycobacterium was performed by varying
the time and temperature of the heat step and the time of the sonication step
while processing M. tuberculosis and M. gordonnae. The processed lysates were
then cultured to determine if viable organisms were recovered.
Results: All 31 MTB strains were detected at a level of 0.5 CFU/test in both
pure system and sediment matrix. No interference was observed with mucin
and whole blood when tested at levels equal to or less than 10%. No
interference was observed with WBCs at concentrations equal to or less
than 80%. Exogenous substances did not interfere when tested at the
following concentrations: equal to or less than 20% with albuterol and saline,
and equal to or less than 8% epinephrine. No viable Mycobacterium was
recovered from lysates when the temperature of the heat step was varied
from 80 to 958C in combination with a 15min sonication step or when the
duration of the 958C heat step was varied from 10 to 20min in combination
with 0, 10, 15, and 20min sonication. Growth was observed when the heat
step was omitted, regardless of sonication time from 10 to 20min.
Conclusion: The MTB test is a sensitive method that is not inﬂuenced by
endogenous or exogenous substances at concentrations normally found in
respiratory specimens. This study clearly demonstrated the robustness of the
MTB specimen processing procedure to inactivate Mycobacterium while
showing the 958C heat step to be the critical parameter for effective
nactivation.
1This device has not been approved by the US FDA and is not commercially
available.
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P635 PCR for nasal swabs from pulmonary tuberculosis
patients
A. Raﬁ, S. Amini, J. Stanford
Tabriz, IR; London, UK
Objectives: To investigate the presence of tubercle bacilli on nasal mucosa of
pulmonary tuberculosis patients using polymerase chain reaction (PCR).
Methods:A group of 31 smear-positive pulmonary tuberculosis patients were
entered into the study, and PCR were performed for nasal swabs from them.
Swabs dipped in sputum samples from the same smear-positive patients were
used as positive controls. The method of Boom et al was used for DNA
extraction and a simple PCR forMycobacterium tuberculosis of Eisenach et al was
carried out to detect speciﬁc IS6110 DNA sequences using a set of primers
with a detection limit of fewer than 10 bacilli.
Results: Tubercle bacilli were detected in nasal swabs from 13/31 smear-
positive tuberculosis patients (42%). All of the sputum swabs were positive for
M. tuberculosis.
Conclusions: The results of this investigation reveal thatM. tuberculosis can be
found in the noses of some pulmonary tuberculosis patients. It is suggested
that more studies should be done on this matter to render more information
on the relation between nasal carriage of tubercle bacilli and pulmonary
tuberculosis.
P636 Direct detection of resistance in
Mycobacterium tuberculosis from clinical samples by
real-time PCR
M. Marı´n, D. Garcı´a de Viedma, G. Lorenzo, M.-J. Ruiz-Serrano,
E. Bouza
Madrid, E
Objectives: In recent years, several real-time PCR designs have been devel-
oped to detect resistance in Mycobacterium tuberculosis (MTB) from cultured
samples. Nevertheless, little effort has been made to detect resistance directly
from clinical samples. Our aim is to adapt a real-time PCR design, recently
developed in our laboratory, to detect resistances against rifampin and
isoniazid directly from clinical samples.
Methods:Clinical samples from patients with phenotypically resistant isolates
of MTB were retrospectively recovered from our collection. Twelve clinical
samples (11 respiratory and one lymph node, 11 acid-fast positive) were
available for study. Of these, ﬁve were isoniazid-resistant, three rifampin-
resistant and four multiresistant. Thirteen samples with susceptible MTBwere
also selected as controls. Resistance to rifampin and isoniazid was detected by
Light-cycler technology using ﬂuorescent probes (FRET) designed to detect
all mutations to rifampin and those most frequent for isoniazid in MTB.
Results: All but one of the resistant samples with mutations conﬁrmed by
DNA-sequencing were assigned as resistant by real-time PCR. For the
remaining resistant samples, no ampliﬁcation was obtained by real-time
PCR. All samples with susceptible MTB were correctly assigned by real-
time PCR. The speciﬁcity of the assay was proved by assaying different
respiratory pathogens (Streptococcus pneumoniae, Haemophilus inﬂuenzae, Myco-
bacterium avium, Enterococcus faecalis, Escherichia coli, Streptococcus aureus,Nocardia
asteroides and Pseudomonas aeruginosa) and no ﬂuorescent signal was obtained in
these cases.
Conclusions: Our design can rapidly (60min) detect resistance against
rifampin and isoniazid directly from clinical samples. This method can
contribute signiﬁcantly to optimising the treatment of tuberculosis at diag-
nosis, and it also enables us to rapidly detect resistant strains, thus limiting their
transmission. Additional efforts should be made to adapt this design to acid-
fast-negative samples.
P637 Ziehl–Neelsen staining and PCR study in
parafﬁn-embedded slides of tuberculous granulomas
A. Mert, R. Ozaras, M. Bilir, F. Tabak, H. Aki, R. Ozturk
Istanbul, TR
Objectives: In the diagnosis of tuberculosis (TB), the use of methods studying
acid-fast bacilli (AFB) and Mycobacterium tuberculosis complex DNA in biopsy
materials is also recommended. In this study, we aimed to ﬁnd the sensitivity
of these diagnostic methods.
Methods: Forty-ﬁve parafﬁn-embedded granulomatous samples taken from
patients with TBwere stained with Ziehl–Neelsen by a pathologist in order to
detect AFB. Thirty-eight out of the samples were also studied by polymerase
chain reaction (PCR) to detect M. tuberculosis complex DNA. IS 6110-
speciﬁc primers, which could amplify allM. tuberculosis complex strains, were
used for ampliﬁcation.
Results: While AFB were not seen in any (0/45), M. tuberculosis complex
DNA was detected in 14 out of 38 (37%) samples. AFB have been seen in
tuberculous granulomas in 0 to 35% in previous studies. The sensitivity of
PCR to detect M. tuberculosis complex DNA (86–88%) was reported to be
higher than that of the Ziehl–Neelsen staining to detect AFB.
Conclusion: While we could not detect AFB by Ziehl–Neelsen staining in
parafﬁn-embedded granulomatous TB tissues, PCR was positive in nearly
one-third of the same tissues.
P638 Investigation of genetic heterogeneity in insertion
sequence IS6110 among Mycobacterium tuberculosis
isolates from pulmonary and extrapulmonary patients using
DNA ﬁngerprinting for epidemiological purposes
B. Barazandeh, A. Khosravi
Ahwaz, IR
DNA ﬁngerprinting of Mycobacterium tuberculosis has been shown to be a
powerful epidemiologic tool. Restriction enzyme analysis is a ﬁngerprinting
technique which is widely used to investigate molecular epidemiology of
M. tuberculosis and other related mycobacteria. A total of 150 clinical isolates of
M. tuberculosis were collected from TB reference unit, PHLS, Ahwaz, Iran.
The PCR-REA employed uses a simple DNA extraction followed by a PCR
step involving primers based on the insertion sequence IS6110. Restriction
enzyme analysis was then performed on the ampliﬁcation products using
HaeIII enzyme. IS6110-REA produced ﬁve clusters that accounted for 78% of
the low-fragment number isolates (117 patients) and two clusters for 22% of
the high-fragment number isolates (33 patients). All the isolates from extra-
pulmonary cases had identical restriction patterns, and prisoners (three
patients) had unique pattern too. Patients within two of the clusters were
found to be epidemiologically related, while no relation was observed in
patients in the other clusters. In conclusion, PCR-REA is rapid, reproducible
and as discriminating as IS6110-RFLP analysis to investigate theM. tuberculosis
epidemic and study of genetic heterogeneity among M. tuberculosis strains.
P639 New perspectives in the diagnosis of lung
tuberculosis
S. Van den Wijngaert, A. Dediste, M. Gerard, M. Hildebrand,
O. Vandenberg, H. Vanachter, T. Lafontaine, G. Stas, R. Scheen,
G. Zissis
Brussels, B
Objectives:The aim of this study was to investigate the combined applications
of nuclear acid ampliﬁcation techniques in the detection of Mycobacterium
tuberculosis (MTB) and criteria proposed by the Belgium Centres for
Molecular Diagnosis (CMD).
Methods: During the study period, direct examination (DE), mycobacterial
culture, and PCR were performed on 477 respiratory samples of 262 patients
older than 16 years of age. The results were reviewed retrospectively for over a
period of 2 years (May 2000–May 2002). The CDM proposed to allow a
DNA ampliﬁcation only if following criteria are met: (i) the patient may not
have had an anti-MTB treatment during the last 12months; (ii) a positive DE,
or in case of a negative DE; (iii) there must be clinical signs of infection and a
positive radiography (RX or CT) and no other infectious agent may be found.
Results: Among the 262 patients, 85 presented a positive culture, giving a
recovery rate of 32%. The patients could be divided into three groups: DE-
positive group, DE-negative group complying the criteria, and DE-negative
group with drawbacks in one or more criteria. In the 46 patients with a
positive DE, the sensitivity of the PCRwas 95%. One hundred and ﬁfty-nine
of the 216 patients with a negative DE met the inclusion criteria. Thirty of
those had a positive culture for MTB (on a ﬁrst sample), which were
conﬁrmed by PCR in 20 cases (60.6%). If we used two samples per patient,
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37 patients had a positive culture conﬁrmed by PCR in 32 of those (86.5%).
The inclusion criteria were not met by 57 of the patients with a negative DE.
No positive culture was found, and PCR gave two false-positive results. 46%
of the PCR could be avoided if we looked for the results of routine cultures
made 5 days prior till 2 days after the analysis. If we also take the radiography in
consideration, we could avoid 98% of unnecessary DNA ampliﬁcation tests.
Conclusion: The results of our study plead for a new protocol for the
detection of MTB in patients suspicious for lung tuberculosis: (i) in a positive
DE sample, a nucleic acid ampliﬁcation can be used to exclude an atypical
mycobacterium; (ii) when the DE is negative, we will wait for the results of
routine cultures (5 days prior to 2 days after analysis), prior to utilisation of
expensive nucleic acid ampliﬁcation tests.
P640 Value of gastric lavage in diagnosis of pulmonary
tuberculosis
M. Rahbar, A. Samadian, M. Abbasi, A. Taghavi Hoseini
Tehran, IR
Objective: The aim of this study was to ﬁnd value of gastric lavage in the
diagnosis of pulmonary tuberculosis.
Methods: From May 1994 to February 1999, 886 gastric lavage were sent
from hospitals of Umia city to heath reference tuberculosis laboratory. Early
morning gastric lavage was collected. All specimens decontaminated and
processed according to Petrrofs method. The supernatant was removed, and
sediment were subjected to smear examination for acid-fast bacilli and culture.
Results:Of 886 patients whose gastric lavage had been sent to health reference
laboratory, 54 (6.3%) had positive results for Mycobacterim tuberculosis. The
mean age of patients was 36 years (SD 21 years), and 20 (37%) patients were
males and 34 (63%) were females. Of 54 patients, 33 had positive results for
MTB, both direct smear and culture. In 10 patients, the result of direct smear
was positive but the result of culture was negative; on contrary, 12 patients
were positive for direct acid-fast smear but the results of the culture were
negative. We expected that all positive direct smears had positive culture
results because the sensitivity of culture in comparison of direct smear is very
high. After investigation, we found that there was a long time delay between
collection of gastric lavage and sending of specimens to laboratory and there
was not any evidence of neutralization gastric aspirate by sodium bicarbonate
after collection.
Conclusion: It is concluded although gastric lavage is a valuable specimen for
diagnosis of tuberculosis but delay in sending of specimen to laboratory yields
low rate of isolation MTB as, the aspirate contains hydrochloric acid from the
stomach, which may kill MTB.
P641 Evaluation of the BACTEC 960 System and
conventional culture media for recovery of mycobacteria
from different clinical specimens
S. Saribas, Y. Bagdatli, N. Yildiz
Istanbul, TR
Objectives: A total of 3242 clinical specimens were studied in 22-month
period. BACTEC MGIT 960 system (BD, Sparks MD) is an automated
growth and detection system using an oxygen sensitive ﬂuorescent indicator
to monitor microbial respiration and automatically determines and reports
results. We compared the BACTEC MGIT 960 system with conventional
Lo¨wenstein-Jensen (LJ) medium for detection and recovary of mycobacteria
from clinical specimens.
Methods:We performed standard N-acetyl-L-cysteine-2% NaOH procedure
for decontamination for both BACTEC and solid media culture. BACTEC
MGIT 960 media were supplemented with the antibiotic mixture polymyxin
B, amphotericin B, nalidixic acid, trimethoprim and azlocillin (PANTA) and
growth supplement (Becton Dickinson). Solid media were incubated at 378C
for 8weeks and were inspected weekly or until mycobacterial colonies were
seen.
Results:We isolated 162 (4.52%)Mycobacterium tuberculosis and 10 (0.3%) non-
tuberculosis mycobacteria. One hundred and six, 27, 14, eight, two, four and
one of M. tuberculosis strains were isolated from respiratory system, abscess,
body ﬂuid, urine, thorax tube, biopsy, and stool specimens, respectively.
Eight, one, one of non-tuberculosis mycobacteria were isolated from respira-
tory system, gastric lavage, and urine, respectively. BACTEC MGIT 960
detected 162 (100%) of totalM. tuberculosis and 10 (100%) of non-tuberculosis
mycobacteria. Solid media (LJ) detected 160 (98.7) of M. tuberculosis and 10
(100%) of non-tuberculosis mycobacteria. Ninety (55.5%) specimens were
found to be positive by acid-fast stain method. Only, one lymph node was
found to be positive in acid-fast stain. We did not recover it both in BACTEC
MGIT 960 system and solid media. We found almost no difference between
MGIT 960 SYSTEM and solid media for detection of mycobateria, but we
found a big and meaning difference for recovery times of mycobacteria.
Average time needed for detection of mycobacteria was 10.5 days in BAC-
TECMGIT 960 system but it was longer in solid medium (26.5 days).We also
used antimicrobial susceptibility testing (AST) OF BACTEC MGIT 960
system. We had the test results in average of 7 days. The time needed for
susceptibility tests in solid media was 20 days or more.
Conclusions: As conclusion, We had the shortest times to detection and
susceptibility test results of mycobacteria with BACTEC MGIT 960 system
when compared with solid media for the avarege times to detection of
mycobacteria.
P642 Evaluation of the LiPA assay in clinical
Mycobacterium tuberculosis specimens
F. Zara, P. Troupioti, R. Brerra, R. Migliavacca, E. Nucleo, A. Cardillo,
E. Giacobone, M. Spalla, L. Pagani, E. Romero
Pavia, Sondalo, I
Introduction: In controlling the spread of tuberculosis (TB), rapid diagnosis of
Mycobacterium tuberculosis complex (MTC) and identiﬁcation of resistance to
rifampin (RIF), one of the most potent antituberculosis drugs, are crucial for
efﬁcient treatment and control of multidrug-resistant strains. The LiPA RIF.
TB assay (Innogenetics, Belgium) provides direct detection of MTC and the
determination of RIF resistance in respiratory specimens.
Objectives: We evaluated the performance of the LiPA RIF. TB assay in
clinical respiratory samples vs. traditional methods and the BACTET MGIT
960 system (Becton Dickinson, USA). Cultures of the samples which resulted
negative to LiPA RIF. TB were assessed by LiPA Mycobacteria for the
identiﬁcation of MOTT.
Methods: Between May and October 2002, 135 clinical respiratory speci-
mens were collected from patients suspected of TB and recovered at the A.O.
‘E. MORELLI’ of Sondalo (northern Italy), and examinated by ﬂuorescence
microscopy for acid-fast bacilli, solid (Lowenstein–Jensen, Difco Laboratories,
USA) medium and liquid culture medium (BACTETMGIT 960). A portion
of all the decontaminated samples was sent to our laboratory for the LiPA
evaluation.
Results:Among the 135 respiratory specimens, MTB bacteria were identiﬁed
by LiPA RIF. TB assay in 98 samples, of which 58 were positive by both
microscopy and LiPA assay. Ten of 98 samples wereRIF resistant. Mutations at
codon 531 were the most prevalent (8 of 10 or 80%). LiPA RIF. TB assay
showed perfect concordance with the Bactet MGIT 960 system with the
potential to reduce time of determination of RIF resistance in a range of 8–
25 days. Among the 37 specimens which resulted negative to LiPA RIF TB
assay, 16 were MOTT and were correctly identiﬁed by LiPA Mycobacteria.
Twenty-one of 37 samples which resulted negative to LiPA assay were
negative with microscopy and cultures.
Conclusions: The LiPA RIF TB assay offers a rapid and reliable molecular
approach to the detection of M. tuberculosis and determination of RIF
resistance in addition to nonmolecular systems, especially in the management
of patients with active disease.
P643 Comparison of BACTEC MGIT 960 and BACTEC 460
TB for detection of mycobacteria: a meta-analysis
M. Cruciani, C. Scarparo, M. Malena, S. Nardi, O. Bosco, C. Mengoli
Verona, Vicenza, Padua, I
Objectives:A combination of solid and liquidmedia is currently recognized as
the procedure of choice for primary isolation of mycobacteria from clinical
specimens. Recently, several nonradiometric methods have been introduced,
including the BACTEC MGIT 960 system (B960). In order to obtain an
overview of the diagnostic accuracy of B960 for the detection of mycobac-
teria, a systematic review and meta-analysis of studies reporting the com-
parative speciﬁcity and sensitivity of BACTEC 460 TB system (B460)þ solid
media (the ‘gold standard’) and B960 was performed.
Methods: An electronic and hand search was performed. Studies were
included in the analysis if the comparison between tests was performed
prospectively in a consecutive series of patients. We calculated summary
receiving operating characteristic curve, diagnostic odds ratio, pooled sensi-
tivity, and speciﬁcity.
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Results: In the 10 identiﬁed studies, a total of 1292 mycobacteria were
recovered from 15 837 clinical specimens. The B960 had a sensitivity of 82.3%
(95% CI, 80.1–84.4) and a speciﬁcity of 99.5% (95% CI, 99.4–99.6). B460
had sensitivity of 84.0% (95% CI, 81.9–86.0) and a speciﬁcity of 100% (95%
CI, 99.9–100). Speciﬁcity, but not sensitivity, was signiﬁcantly higher with the
B460 (P< 0.001). Time to detection of mycobacteria was signiﬁcantly
shorter with the B960 compared with the B460 (13.0 days vs. 15.2 days,
P¼ 0.02).
Conclusion: Compared to the well established B460, the B960 has similar
sensitivity, lower speciﬁcity, but higher rapidity in detecting mycobacteria.
P644 Evaluation of BioFM liquid medium for recovery of
Mycobacterium species from clinical specimens
C. Sa´rva´ri, C. Ko¨dmo¨n, N. Szabo´, E´. Kene´z
Budapest, Miskolc, Nyı´regyha´za, Pe´cs, HUN
Objectives: BioFM (Bio-Rad) is a liquid culture medium designed to
accelerate the growth of mycobacteria. The aim of this study is to prove
the role of BioFM liquid medium in the isolation of mycobacteria from
respiratory and nonrespiratory clinical samples of patients treated in Saint
La´szlo´ Hospital for Infectious Diseases. The chromogenic BioFM liquid
medium was evaluated and compared both with smear examination and
with the conventional Lo¨wenstein–Jensen (LJ) solid medium from all of the
samples and with the PCR-based system for the detection of Mycobacterium
tuberculosis from all respiratory samples.
Methods:A total of 50 routine clinical specimenswith the preliminary suspect
of mycobacterial infection were tested for the presence of mycobacteria.
Specimens included 28 respiratory samples (sputum, BAL, pleural, and
tracheal ﬂuid) and 22 nonrespiratory (CSF, pus, lymph node, gastric juice,
urine, bone marrow, tissues) samples. All specimens (except sterile samples)
were decontaminated by the NALC-NaOH method, examined by micro-
scopy stained by Ziehl–Neelsen and cultured on BioFM and LJ medium.
PCR testing to detect M. tuberculosis was performed from all respiratory
samples.
Results: A total of 12 mycobacterial strains were isolated from 50 clinical
samples: 8M. tuberculosis complex (including two multidrug resistantM. tuber-
culosis (MDR-TB)) and four M. avium complex (MAC) strains. In the 12
positive cases, four were smear positive, nine were positive on LJ medium and
all of the 12 mycobacterial strains were positive in BioFM medium. The
appearance of growth of Mycobacterium species in BioFM medium was 1–
6weeks earlier than on LJ medium. The isolation of the twoMDR-TB strains
was 2 weeks faster in BioFM medium than on LJ medium. Three strains
belonging to MAC were not isolated on LJ medium (two smear-negative
cerebrospinal ﬂuid and one smear-positive pus samples) but cultured in
BioFM medium. The identiﬁcation and susceptibility testing of the strains
were performed directly from BioFMmedium. In all three cases where PCR
testing was positive, the M. tuberculosis strain was cultured in BioFM medium
as well.
Conclusion: In our study, the BioFM liquid medium proved to be an effective
method to detectMycobacterium infection. Therewas a signiﬁcant difference in
the time required for the isolation of mycobacteria. The combinatination of
BioFM medium with other solid medium is an excellent culture method for
the detection of mycobacteria.
P645 Comparison of Dio-TK and Lo¨wenstein–Jensen
media for primary culture of mycobacteria: a preliminary
study for a new medium
C. Bicmen, M. Coskun, G. Senol, N. Florat, T. Kocagoz
Izmir, Istanbul, TR
Objective: To evaluate the Dio-TK Medium for primary culture of myco-
bacteria in comparison with the Lo¨wenstein–Jensen (L-J) medium.
Methods: A total of 456 samples (348 sputum, 46 bronchial aspiration, 31
pleural ﬂuid, 12 biopsies, 10 bronchoalveolar lavage, ﬁve gastric lavage, three
urine, and one intrathoracic ﬂuid) recovered from 327 patients were studied.
After standart decontamination and concentration procedure, each sample
was then cultivated in Dio-TK Medium, Dio-TK Selective, Dio-TK Med-
ium with para-nitrobenzoic acid and L-J medium in 378C. Acid-fast staining
was employed for smear preparation. Time and presence of growth on Dio-
TK Medium was monitored graphically by Incubascan software. Growth on
Dio-TKMediumwas evaluated with the color change from red to yellow due
to the indicator in the medium and presence of acid-fast bacteria on the
medium by staining. Occurrence of green color on the medium indicated
contamination. L-J cultures were checked visually twice a week and time of
growth was recorded.
Results: Among the specimens, 298 (65.4%) were smear-positive and 158
(34.6%) were smear-negative. Mycobacteria grew in 299 (65.6%) and 279
(61.2%) of the specimens on Dio-TK and L-J media, respectively. Contam-
ination ratios for Dio-TK and L-J were 3 and 4.4%, respectively. In smear-
positive samples, 8 (2.7%) samples were culture-positive on L-J and culture-
negative on Dio-TK, whereas 10 (3.4%) were culture-positive on Dio-TK
and culture-negative on L-J. In smear-negative samples, one (0.6%) sample
was culture-positive on L-J and culture-negative on Dio-TK; whereas two
(1.3%) were culture-positive on Dio-TK and culture-negative on L-J and 18
(11.4%) samples were culture-positive on both Dio-TK and L-J media. Two
atypical mycobacteria were differentiated in sputum specimens as Mycobacter-
ium avium complex and MOTT. Mean time of growth on Dio-TK and L-J
were 12.8 (min. 3, max. 30) and 25 (min. 20, max. 30) days, respectively.
Conclusion: Dio-TK is a new very useful and practical medium for rapid
primary culture of mycobacteria. Further studies may be necessary for its
standardization in the automated system.
P646 Investigation of the level of IgG, IgM and IgA
antibodies in tuberculosis patients referred to TB reference
center, PHLS, Ahwaz, Iran
A. D. Khosravi Boroujeni, R. Torabizadeh, A. Landi
Ahwaz, IR
The detection of tuberculosis, especially in its early stages is difﬁcult, the
culture and biochemical tests despite being speciﬁc, are time consuming and
laborious and the clinical features of the disease are not speciﬁc. So to eradicate
the disease, it is important to improve diagnostic techniques so that the active
disease can be treated at early stage. Since the level of antibodies is increased
during the active phase of the disease, serologic techniques such as ELISA are
of value in early diagnosis because these are among the rapid, reliable and less
costly diagnostic methods for the detection of pulmonary tuberculosis. In
present research, a total of 90 sera were enrolled in the study. This group
consisted of 45 sera belonging to patients with clinical and radiologic signs and
microscopic examination of sputum suggesting active tuberculosis, who
referred to TB reference center, PHLS, Ahwaz and 45 sera from healthy
subjects. Sera were obtained from the patients before receiving antitubercu-
losis chemotherapy. ELISA test was used to determine the IgG, IgM and IgA
antibodies activity against the A60 speciﬁc antigen of mycobacteria. The
results revealed that in general antibodies especially IgG and IgA were much
higher in tuberculosis patients compared with healthy subjects. There was no
relevance between antibody titer and gender or previous BCG vaccination,
but the relevance with age and the degree of smear positivity were signiﬁcant.
The titer of IgG and IgAwas higher in patients under 50 years old and patients
with 3þ sputum smear had signiﬁcant increased IgG titer. Besides, the
antibody titer was signiﬁcant in culture-positive patients compared with
those with a negative culture result. Present study showed that the ELISA
using A60 antigen can greatly facilitate the diagnosis of tuberculosis especially
in TB endemic area where a rapid, inexpensive, and reliable technique is most
needed.
P647 Development of serologic test of
Mycobacterium tuberculosis in humans
A. Ferna´ndez-Ra´mirez, C. Espitia-Pinzo´n, E. Rosales, R. Do¨fﬁnger,
J. Montaraz-Crespo, G. Barcenas-Morales
Edo. de Me´xico, Mexico City, MEX; Cambridge, UK
Introduction: Serologic tests for the diagnosis of infectious diseases are very
useful because they are technically straightforward and do not need isolation
and culture of the pathogen. Mycobacterium tuberculosis causing approximately
1.5 million human deaths per year worldwide. Diagnostic tests which let us
discern among individuals with active tuberculosis, infected, asymptomatic
and noninfected individuals are needed.M. tuberculosis antigens induces a great
and heterogeneous variety of antibodies. The aim of this work is to analysis
and compare the antibody production against different mycobacterial antigens
in individuals with the mentioned characteristics by the multiple antigen ﬁx
immunoassay (MAFI) test.
Methods: Employed antigens rPT-16, 38 kDa, 45/47 kDa, thioredoxin,
ESAT-6 proteins; AN-5 and RV-11 culture ﬁltrates from M. bovis and
M. tuberculosis, respectively; and puriﬁed protein derivative (PPD) from
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M. tuberculosis, M. bovis and M. avium. Ninety-nine serum samples were
collected from 22 healthy individuals, 42 individuals with different types
of tuberculosis, 30 tuberculosis suspicious individuals and ﬁve with other
nonrelated diseases. The antigens were immunoblotted on nitrocellulose
membranes and incubated with each serum sample. The membranes were
then rinsed and incubated with antihuman IgG peroxidase. The peroxidase
activity was detected with 4-chloro-1-naphtol and H2O2.
Results: 54.8% of the patients with tuberculosis recognized at least one of the
analyzed antigens. From these, 100% recognized RV-11, 91.3% PPD tuber-
culosis, 86.9% AN-5 and PPD bovis, and 56.5% rPT-16. In the group of
suspected infection individuals, 23.3% recognized at least one mycobacterial
antigen of which 100% recognized RV-11, 85.7% AN-5 and PPD tubercu-
losis, 71.42% PPD bovis, and 57.14% rPT-16. Only one serum from the
healthy individuals recognized RV-11 and PPD tuberculosis. With the
exception of one sample from the patients with tuberculosis, none of the
sera recognized PPD avium. The group of unrelated diseases did not
recognize any of the antigens used.
Conclusions: The RV-11 culture ﬁltrate, PPD tuberculosis and rPT-16
recombinant protein are promising antigens for the tuberculosis diagnosis
using theMAFI technique. Recognition of the culture ﬁltrate AN-5 and PPD
bovis might reﬂect previous vaccination of the individuals.
P648 Serologic test for the diagnosis of tuberculosis in
bovine cattle
L. Sebastia´n, E. Rosales, C. Espitia-Pinzo´n, C. Arriaga-Dı´az,
A. Romero, R. Do¨fﬁnger, J. Montaraz-Crespo, G. Barcenas-Morales
Edo. de Me´xico, Mexico City, MEX; Cambridge, UK
Introduction:Bovine tuberculosis, which is caused byMycobacterium bovis, has
a considerable negative economic impact for cattle farming and constitutes
also a major risk factor in human public health. It is important to develop
simple, fast, and inexpensive diagnostic tests, which do not need the isolation
and culture of the pathogen and specialized equipment. Serologic techniques
have the potential to fulﬁl these criteria.M. bovismay induce a highly diverse
antibody response. But to date, there is no serologic test available, capable to
distinguish healthy bovines from those having the disease; so the aim of this
investigation is to analyze and compare the antibody production against
different mycobacterial antigens in bovine cattle using the Multiple Antigen
Fix Immunoassay (MAFI) technique.
Methods: Ninety-ﬁve sera samples were collected from Holstein Friesian
bovine cattle: 22 were PPD positives (PPDþ), 37 were PPD negatives (PPD–)
and for 36 with bordeline results in the tuberculine test (PPDþ/–). The
antigens tested were 16 kDa, 38 kDa, 45/47 kDa, Thioredoxin and ESAT-6
proteins, H37Rv and AN-5 culture ﬁltrates, and puriﬁed protein derivatives
from M. tuberculosis (PPDt), M. bovis (PPDb) and M. avium (PPDa). The
antigens were immunoblotted on nylon membranes and incubated with each
serum sample. The membranes were then rinsed and incubated with anti-
bovine IgG peroxidase. The peroxidase activity was detected with 4-chloro-
1-naphtol and 0.01% H2O2 in PBS.
Results: 72.7% of PPDþ, 13.8% of PPDþ/– and 35.14% PPD– animals
recognized at least one antigen. The PPDþ animals differentially recognized
the antigens as follows: rPT16 (22.7%), RV-11 (72.7%), AN-5 (45.5%), PPDt
(59%), PPDb (22.7%) and PPDa (13.6%). The corresponding values for the
PPD – animal group were: rPT16 and 45/47 (5.4%), p-38 (2.7%), RV-11
(21.6%), AN-5 (13.5%), PPDt (21.6%), and PPDb (10.8%). The PPDþ/–
animals only recognized RV-11, PPDtub, AN-5 and PPDb in an interval of
13.8 to 2.8%.
Conclusion: The recognition of the antigens is heterogeneus for each animal
gruop. However, the percentage values of recognition were strickingly higher
for the PPDþ animal group than in the other two groups. The RV-11 and
AN-5 culture ﬁltrate, PPDtub and rPT16 recombinant protein are promising
antigens for bovine tuberculosis diagnosis by the MAFI technique.
Non-molecular diagnostics: general
P649 Constructing and testing a novel system for the
rapid identiﬁcation of bacteria using MALDI-TOF-Mass
Spectrometry
C. Keys, H. Shah, D. Dare, H. Sutton, M. Lunt, M. McDowall
London, Manchester, UK
Objectives:To assemble a mass spectral database of the ionizable components
of bacterial cell surfaces generated by Matrix Assisted Laser Desorption/
Ionization Time of Flight Mass Spectrometry (MALDI-TOF-MS) and assess
its potential for rapid identiﬁcation of unknown isolates.
Methods: Strains tested were propagated and analyzed using optimized
protocols. Data collection was carried out on the Micromass M@LDI mass
spectrometer and data processed using the MicrobeLynxTM and MassLynxTM
software (Micromass UK Ltd, Manchester). For the database, characterized
strains from the National Collection of Type Cultures (NCTC), UK,
representing clinical, environmental and food borne pathogens were used.
Entries were quality controlled and validated by comparison of like spectra
between Manchester Metropolitan University, Micromass UK Ltd and the
Molecular Identiﬁcation Services Unit, NCTC. Field isolates sent into the
PHLS for identiﬁcation were analyzed using the above system. The software
was used to locate the closest matching spectra within the database and
provided a probability score. A comparison with the identiﬁcation based upon
cellular fatty acid proﬁles and 16S rDNA sequence analysis was used to assess
the accuracy of the MALDI identiﬁcation.
Results: The MALDI-TOF-MS database (ca.1500 species) was essential for
the identiﬁcation of the test isolates and was achieved in a fraction of the time
taken using other methods. Of 149 isolates,90% were identiﬁed correctly at
genus level and 74% at species level including organisms that are typically
difﬁcult to identify. For example, nonfermentative, Gram-negative species
which are often difﬁcult to identify by most methods were readily character-
ized using MALDI-TOF-MS.
Conclusions: Identiﬁcation using MALDI-TOF-MS correlated well with
other techniques and represents a rapid and novel method for the character-
ization of microorganisms. Furthermore, sample preparation is minimal, only
a small amount of bacterial growth is required and consumable costs are
negligible. The technique should ﬁnd wide application in clinical and
reference laboratories.
P650 Evaluation of the VITEK 2 system for routine
identiﬁcation of clinical isolates in a Portuguese clinical
microbiology laboratory
M. Ramos, C. Silva, F. Carvalho, E. Martins
Oporto, P
Objectives: This study was performed to evaluate the quality of the perfor-
mance of the VITEK 2 cards used for the identiﬁcation of Gram-negative rods
(GNR), Gram-positive cocci (GPC) and yeast isolates in the routine context
of our microbiology laboratory.
Methods:A total of 250 GNR, 137 GPC and 13 yeast, composing a sample of
species that are commonly isolated in our laboratory, were tested using the
VITEK 2 ID-GNB, ID-GPC and ID-YST cards, according to the manu-
facturer’s recommendations in comparison with the API strips (API 20 E, API
20 NE, ID 32 STAPH, API 20 Strep, ID 32 C) used as the reference method.
Quality control strains were tested with each study batch. The identiﬁcation
obtained with the VITEK 2 system, were divided into four categories: correct
identiﬁcation (unambiguous correct identiﬁcation at the species level); low
level of discrimination (either identiﬁcation at the genus level or low level of
discrimination between several species, including the correct species); no
identiﬁcation (a doubtful, unacceptable, or unreliable identiﬁcation); and
misidentiﬁcation the species identiﬁed with the VITEK 2 systemwas different
from that identiﬁed by the reference method). Discrepant results were
repeated in duplicate both on VITEK 2 and the reference method, strains
with remaining discrepant results were sent to bioMe´rieux laboratory for
retesting.
Results: Overall 95.8% of all strains were correctly identiﬁed at the species
level (98.9% Enterobacteriaceae, 89.3% nonfermenters, 98.4% Staphylococci,
92.4% Streptococci, 100% Yeast). One strain of Enterobacteriaceae was not
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identiﬁed (0.25%). Misidentiﬁcations were observed for 13 strains (3.2%),
seven of these (54%) strains were nonfermenters spp., twoCitrobacter spp., two
E. faecium and two Streptococcus alfa hemolyticus. Twenty-three (5.7%) strains
were identiﬁed to the species level after additional simple tests (indol reaction,
motility and pigmentation). For 10 strains (2.5%) these additional tests did not
give an identiﬁcation at the species level, nevertheless the correct species
identiﬁcation was given among the organisms listed. Four strains were
excluded from the study because no reference identiﬁcation was obtained.
Conclusion: The VITEK 2 System demonstrates an excellent capability for
providing a rapid and reliable means for the routine identiﬁcation of clinical
bacteria.
P651 Comparison of two methods for biochemical
speciation of lactobacilli including probiotic strains
Z. Khodaii, A. M. Snelling, H. I. Dodson
Bradford, UK
Objective: Lactobacilli are important as probiotics; however, a simple stan-
dardized method for their speciation does not exist. Taxonomy of the genus is
confused with many commercial strains assigned species names that have not
been properly validated. 16S rRNA sequence analysis can be applied but does
not on its own given information about probiotic attributes. Our aim was to
determine a simple, reliable method for biochemical speciation and pre-
liminary characterization of strains.
Methods: Forty-two isolates from probiotic and dairy products were used.
Survey of the literature was used to compile a set of characters which include
growth at different temperatures, tolerance to acid and bile, production of
NH3 from arginine, aesculin hydrolysis and the fermentation proﬁle of 22
sugars to allow speciation according to accepted taxonomy. Two test formats
were compared: (1) solid media inoculated using a multipoint inoculator (2)
broth media in 96-well plates. With each, bromocresol purple (BP, read by
eye) and chlorophenol red (CR, read by eye or at 450 nm with a plate reader)
were evaluated as pH indicators. Test results were read at 2–14 days as
appropriate. Cultures were incubated anerobically, and tested in duplicate.
Results: The most discriminatory tests for speciation were growth at 15 and
45 8C and sugar fermentation tests. Both methods were amenable to high
throughput and identiﬁed Lactobacilus acidophilus, L. casei casei, L. casei rhamno-
sus in agreement with the probiotic products labeling. With method (1) there
was interference between strains, where some reacted more quickly than
others and the media in the plate was acidiﬁed. Method: (2) needed less
anaerobic incubator space and substrates, and there was no interference
between tests read at different times. With method (1) CR results were
unreadable by eye as the color change was too subtle, duplicates with BP
matched in 90% tests. Test reproducibility usingmethod (2) was 95%with CR
but 98.5% with BP.
Conclusion: The 96-well plate method with bromocresol purple indicator
allows simple, reproducible speciation of lactobacilli and quantiﬁcation of
useful probiotic characteristics such as acid and bile tolerance.
P652 Comparison of methodologies for anaerobic
organisms described in NCCLS document M40-P Quality
Control of Microbiological Transport Devices
J. Arbique, S. Campbell, M. MacFarlane, R. Davidson
Halifax, CAN
Introduction: Prior to production of NCCLS document M40-P, Quality
Control of Microbiological Transport Systems; Proposed Standard, there had
not been a recognized procedure for determining the effectiveness of trans-
port devices. Here we describe our experience using the new standard to
evaluate six commercial swab transport systems.
Methods: ATCC strains of Bacteroides fragilis, Propionibacterium acnes, Peptos-
treptococcus anaerobius, Prevotella melaninogenica, and Fusobacterium nucleatum
were inoculated to two different swab transport devices (Amies without
charcoal and liquid Stuart’s), from each of three manufacturers, Copan
Diagnostics, Starplex Scientiﬁc Inc., and Medical Wire & Equipment Co.
Swabs were held at ambient (20–258C) and refrigeration (4–8 8C) tempera-
tures for 0, 24, or 48 h, and then plated onColumbia agar containing 5% sheep
blood. Viable bacteria were counted following incubation. Growth recovery
was determined for both a roll-plate and swab elution technique. Base-line
counts were obtained from media inoculated at zero time. Performance
characteristics were compared with acceptance criteria described in
M40-P.
Results: Trends in growth recovery were similar using either the roll-plate or
swab elution techniques, irrespective of the organism, holding time or
temperature. The Copan and Starplex transport devices met acceptance
criteria for both roll-plate and swab elution techniques with B. fragilis, P. acnes,
and P. anaerobius. The Medical Wire transport devices met acceptance criteria
for B. fragilis and P. anaerobius using both techniques; however, failed to meet
acceptance criteria for P. acnes for the roll-plate technique at ambient tem-
perature. None of the transport devices tested met acceptance criteria for
F. nucleatum and P.melaninogenica by either the roll-plate or swab elution
techniques.
Conclusion: We found the new proposed NCCLS standards provide an
excellent means of evaluating swab transport systems. The roll-plate method
described in the document is well suited for most laboratories, whereas, we
found the swab elution technique to be costly and labor intensive without
yielding additional information.
P653 Comparison of two culture media to detect group
B streptococcal-colonized pregnant women
M. A. Blanco Gala´n, C. Pazos Pacheco, I. Sa´nchez Romero
Madrid, E
Objective: Comparison of direct plating on Granada agar plate and Instant
Granada Medium agar tubes for detection of GBS colonization in pregnant
women.
Methods: 517 vaginal and rectal exudates from pregnant women between 35
and 37weeks of gestation were included in this study. In 320 patients, four
separate swabs were collected in each woman, and in the other 197, two
separate swabs were also collected. Samples were inoculated on a selective
differential agar plate (Granada) and also were immersed in instant Granada
medium (after rehydratation). The plates were incubated at 37 8C anerobical
atmosphere for 24–48 h, and the tubes were incubated 24–48 h at 37 8C
aerobically. In bothmedia, the presence of intense-orange pigmented colonies
is a characteristic of GBS.
Results: In the ﬁrst group, 320 women studied with vaginal and rectum
exudates separate by, 69 (21.5%) were positive in direct plating and 46 (14.4%)
were positive in instant Granada medium. Three patients were positive in
instant Granada medium and negative in agar plates and 26 women were
negative in instant Granada medium and positive in agar plates. In the second
group (197 women), 51 (25.8%) were positive in direct plating and 33 women
(16.7%) were positive in instant Granada medium. In this group, all those
positive in instant Granada medium were also positive in direct plating.
Conclusions:
1.When vaginal and rectal specimenswere collected separate by 100% of GBS
isolates detected were recovered in Granada plates and 66.6% in instant
Granada medium.
2. When vaginal-rectal were collected together, only 64.7% of the positives
women were recovered in instant Granada medium.
3. 41 of those women positive in both media (34.35%) will be lost if only
instant Granada medium is used.
4. Granada agar plate is better for GBS detection in pregnant women than
instant Granada medium.
P654 Occurrence of invasive GBS infections with
serotype VIII in Denmark, 2001–2002
K. Ekelund, H.-C. Slotved, H. Konradsen
Copenhagen S, DK
Objectives:Group B streptococcus (GBS) (Streptococcus agalactiae) is a frequent
cause of mortality and morbidity in neonates. The GBS serotypes Ia, Ib, II, III
and V are the most prevalent among patients with invasive GBS disease in
Europe and USA, while serotype VIII predominates among GBS isolated in
Japan. Outside Japan, only a few isolates with serotype VIII have been
described. We have identiﬁed four GBS serotype VIII isolates in Denmark
in 2001–2002.
Methods: The Streptococcus Unit, Statens Serum Institute, Denmark,
receives the majority of Danish invasive GBS isolates. After determination
of the group B antigen, the isolates were serotyped by the precipitation
method described by Lanceﬁeld. The antigens were extracted using both 0.1
and 0.2N HCl. The invasive GBS isolates were from blood of patients
admitted to hospitals from January 2001 to December 2002. In addition to the
four clinical strains, two reference serotype VIII GBS strains (JM9 Prague no.
130013 and JM9 Prague no. 1330669) were analyzed by Pulsed Field Gel
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Electrophoresis (PFGE). Antibiotic susceptibility testing of the clinical and
reference strains was performed on blood agar by disc diffusion.
Results: The mean age of the four patients (two males and two females (not
pregnant)) was 62.3 years and none of them had been outside Denmark in the
last 3weeks before admission to hospital. The clinical strains were identiﬁed in
blood. One of the clinical strains shared an identical PFGE pattern with the
two reference strains, and the clinical strains were assigned into two closely
related DNA proﬁles. In addition, the susceptibility pattern showed minimal
differences between the four clinical isolates.
Conclusion:We conclude that the four clinical strains were very closely related
to each other and to the two reference strains although not completely
identical. We believe that serotyping with all the nine type antisera (Ia – VIII)
by use of different extracts (0.1 and 0.2N HCl) can reduce the proportion of
non-typable strains and result in a more complete and correct description of
the serotype distribution in GBS surveillance programs.
P655 Use of synthetic antigens Borrelia burgdorferi
sensu lato in immunoenzyme assay
A. Ivanov, A. Kolobov, I. Korshunova, V. Verbov, G. Aniskina, I. Volkov,
N. Razdolskaja
St.Petersburg, RUS
Objectives: Ixodes tick-born borreliosis (ITB) is a widespread disease in the
Russian Federation. A multiplicity of clinical manifestations of the infection
necessitates implementation of new reliable and inexpensive diagnostic
laboratory tools into practice; improvement of serodiagnositics seems to be
the most perspective trend. One of possible options could be a use of
immunoenzyme assay (IEA) based on the artiﬁcial analogs of the natural
borreliosis protein antigens.
Methods:We have studied six synthetic peptides imitating potential antigenic
determinants of the 41 kDa, regions P35 and P39, borreliosis lipoproteins
(two peptides from each region). Seventy-eight blood sera from patients with
different clinical ITB manifestations and 34 blood sera from healthy donors
were tested by IEA to study speciﬁc antibody/antigen reactions.
Results: Best results of immunochemical reactivity were obtained for the
peptide 69–90 from the P35 region and peptide 119–339 from the P39 region
(amino acid numbering according to the sequence of the natural antigen).
Conclusions: The results obtained shows a possibility to use synthetic
peptides in immunoenzyme diagnosis of ITB. Additional investigation
should be carried out to exclude possible nonspeciﬁc reactions while using
borreliosis antigens for testing material from syphilis and other spirochetoses
patients.
P656 Possibilities of immunoenzyme assay for
diagnostics of early neurosyphilis
A. Ivanov, V. Verbov, V. Klimovich, M. Kochanova, I. Telichko,
G. Ismagulova, S. Fedoseeva, I. Rose
St.Petersburg, RUS
Objectives: A total of 23 syphilis patients in different clinical periods (mean
duration of disease 2 years) were examined. On the basis of clinical and
laboratory data ﬁve of them were diagnosed to have early neurosyphilis. The
speciﬁc lesion of the central neural system was ruled out for 18 patients.
Methods: For each patient a method of immunoenzyme assay (IEA) was used
to detect antibodies to major Treponema lipoproteins with molecular weight of
15, 17, 41, and 47 kDa in blood sera and cerebrospinal ﬂuid.
Results: In the majority of patients the antibodies to all four Treponema
antigens were detected in blood sera. IgG1 and IgG3 subclasses were pre-
vailing in the pool of antitreponemous antibodies. Comparative analysis of the
level of antibodies of these subclasses did not reveal statistically signiﬁcant
difference between patient groups (P> 0.05). In cerebrospinal ﬂuid the
antibodies to the T. lipoproteins were found only in samples from the patients
with conﬁrmed diagnosis of early neurosyphilis. At the same time, all the
samples were found to be positive in IEA for IgG1 to the 17 kDa antigen
(P< 0.05). For all the patients with excluded syphilitic lesion of the central
neural system, antibodies to the 15, 17, 41, and 47 kDa antigens were not
detected in cerebrospinal ﬂuid.
Conclusions: We thus propose a method of serodiagnostics of early neuro-
syphilis. Detection of antibodies to two or more Treponema antigens in the
blood serum of the syphilis patient and detection of antibodies to 17 kDa
antigen in cerebrospinal ﬂuid only, reﬂect early syphilitic lesion of the central
neural system.
P657 Evaluation of a new cellulose sponge for
microbiological sampling
M. O¨sterblad, H. Ja¨rvinen, K. Lo¨nnqvist, J. Viljanto, H. Arvilommi,
P. Huovinen
Turku, FIN
Objective: We have developed a new type of sampling/transport swab (the
Cellswab, Cellomeda, Finland), which is made of a highly absorbent cellulose
viscose sponge material.
Methods: The survival of 14 aerobic, and 10 anaerobic and microerophilic
bacterial species in the Cellswab, two commercial swab transport systems
(Copan, Italy, and Orion Diagnostica, Finland) and one dacron swab (TSC,
UK) was evaluated. Bacteria were suspended in broth, into which the swabs
were dipped. Aerobic bacteria were stored in dry tubes, the others in transport
medium, at 4 8C and RT, for up to 14 days.
Results: The Cellswab absorbed 1.3 times more, and released 3.5 times more
ﬂuid upon plating than the other swabs. Swabs were plated at 0, 1, 2, 4, 7 and
14 days. For 10 strains the Cellswab yielded 10% of the original CFU for
longer than all the other swabs. It never performed worse than the other
swabs. The Cellswab showed no inhibitory properties.
Conclusions: The Cellswab was found to perform at least as well as ordinary
swabs. It was better at storing fastidious strains, and at keeping bacteria viable
for long storage times; it might well be a useful replacement or complement to
ordinary swabs.
P658 Evaluation results of 10th external quality
assessment of microbiology laboratories of Tehran 2002
M. Abbasi, M. Rahbar, S. Hekmat Yazdi, R. Saboorian, M. Sarami
Tehran, IR
Objective:The aim of this study was to evaluate performance of microbiology
laboratories in Tehran.
Methods: In this study we distributed 487 unknown samples each containing
two strains of bacteria between microbiology laboratories located in Tehran.
Of 487, laboratories we received answers from 437 (89.7%) laboratories. Five
species of bacteria including (1) Staphylococcus saprophyticus, (2) Citrobacte
freundii, (3) Acinetobacter baumanii, (4) Entrococcus faecalis, (5) Enterobacter
agglomerance were selected and randomly two strains of them sent to each
laboratory. We asked for identiﬁcation all of strains and susceptibility testing
for S. saprophyticus and C. freundii.
Results:Of 291 laboratories, 224 (77%) produced correct answer for S. sapro-
phyticus. Of 146 laboratories, 102 (69.85) for C. freundii. Of 114 laboratories,
34 (30%) for Acinetobater baumanii. Of 146 laboratories, 37 (25.3%) for
E. faecalis and of 177 laboratories, 63 (35.6%) for E. agglomerance. A score
of 3 points were given for correct identiﬁcation of each strain, while for
incorrect identiﬁcation score of 0 point were given. The incorrect answers for
above mentioned bacteria were 7.9, 27.3, 43.8, 26 and 52.5%, respectively.
The other laboratories obtained of 0.5–2.5 scores of points for partially
correct answers. The most laboratories were able correct performing suscept-
ibility testing. Eighty-nine percent of laboratories reported correct suscept-
ibility testing answer for S. saprophyticus and 79 for C. freundii.
Conclusion: It is concluded that most microbiology laboratories were not able
to identify correctly unknown strains of bacteria, it may be due to lack of some
reagents, culture media and experienced personnel.
P659 Predictive value of the detection of leukocytes and
erythrocytes in feces for the diagnosis of inﬂammatory
bacterial diarrhea
K. Tzanetou, A. Strouza, G. Ganteris, K. Pechlivanidis, A. Antoniou,
M. Lelekis, V. Delis, E. Malamou-Lada
Athens, GR
Objectives: To evaluate the usefulness of the detection of leukocytes and
erythrocytes in fecal wet preparation, as predictive markers for the presence of
enteropathogenic bacteria cultured in the stools of adult patients with
diarrhea.
Material and methods: During a 3-year period (from October, 1999 to
November, 2002) 1230 of unformed stool specimens (one specimen/patient)
were examined: (a) for leukocytes and erythrocytes by direct microscopy of
wet preparation and (b) for the enteric pathogens Salmonella, Campylobacter,
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Shigella, Yersinia enterocolitica and Aeromonas by the standard laboratory meth-
ods.
Results: Enteropathogenic bacteria were isolated in 174 out of the 1230
(14.15%) stool specimens examined by culture. In 156 (89.65%) and 143
(82.18%) of the 174 culture-positive specimens leukocytes (WBCs) and
combination of leukocytes and erythrocytes (WBCsþRBCs) were detected,
respectively. In 248 (23.48%) and 170 (16.09%) of the 1056 culture-negative
specimensWBCs andWBCsþRBCswere detected, respectively. Of the 248
culture-negative patients with WBCs or WBCsþRBCs (170 of them had
both) in the stools, the 179 (72.17%) had inﬂammatory bowel diseases (w2 test,
0.72 mean, 0.2845 standard error, 95% conﬁdence interval 0.6615–0.7766), 1
(0.40%) amebic dysentery and in the 68 (27.42%) patients the cause of
inﬂammatory diarrhea was not identiﬁed (most of them were considered
as having inﬂammatory bacterial enteritis based on clinical presentation). The
sensitivity, speciﬁcity, positive predictive value, negative predictive and like-
lihood ratio of the presence of WBCs and WBCsþRBCs in the feces as
predictors of a positive stool culture for enteric pathogens was estimated to
89.65, 76.51, 38.61, 97.82, 3.81% and 82.18, 83.90, 45.68, 96.61 5.10%,
respectively.
Conclusions: The detection of leukocytes or leukocytes and erythrocytes in
the stools is a simple, rapid and inexpensive method with high sensitivity and
speciﬁcity for predicting the presence of enteropathogenic bacteria in feces of
patients with diarrhea. Furthermore, the detection of WBCs or
WBCsþRBCs in stools with culture negative for enteric pathogens, highly
suggests inﬂammatory bowel disease.
P660 Utility of Binax Now(R)-rapid urinary test in a
series of 67 consecutive adult patients with bacteremic
pneumococcal pneumonia
E. Garcı´a Va´zquez, C. Font, M. A. Marcos, J. Puig, G. Francisco,
M. Almela, J. Mensa, A. Torres
Barcelona, E
Objectives: Bacteremic pneumococcal pneumonia (BPP) occurs in about
one-third of patients with community-acquired pneumonia (CAP) due to
Streptococcus pneumoniae and mortality is twice that in patients without
bacteremia. Some recent guidelines recommend ambulatory treatment of
patients in groups I and II (PORT-score). The objective of this study is to
analyze the sensitivity of Binax Now(R)-rapid urinary test in the diagnoses of
BPP.
Methods: We prospectively collected clinical and microbiological data of
patients with CAP admitted in a tertiary-level hospital from January 2000 to
December 2002. Binax Now(R)-rapid urinary test in concentrated urine
samples and blood cultures were routinely performed. Patients with HIV
infection or with severe immunosuppression due to organ transplantation,
neoplasic or hematological diseases were not included in our series.
Results: 697 patients with CAP were evaluated during the study period (188
cases (31%) were classiﬁed in Fine risk-class I–II). Pneumococcal pneumonia
was diagnosed in 193 patients (27.7%); 48 (25.5%) Fine risk-class I–II. BPP
was identiﬁed in 67 (34.5%) cases; 23 (34.3%) Fine risk-class I–II (representing
12% out of the 188 total number of cases in these Fine risk-classes). Binax
Now(R)-rapid urinary test in concentrated urine was performed in 53 out of
67 patients with BPP, being positive in 52 (98%).
Conclusions: In our series, 12% of CAP patients classiﬁed in Fine risk-class I–
II had a BPP. Binax Now(R)-rapid urinary test has a high sensitivity in
patients with BPP. A negative result of the Binax Now(R)-test in concen-
trated urine samples of patients with CAP may permit to rule out bacteremic
pneumococcal pneumonia. This information could be useful to improve the
initial decision to treat cases in Fine risk-class I–II as outpatients with oral
antibiotics.
P661 Direct susceptibility testing of urines at outpatient
clinics using system U3
A. Bolmstro¨m, J. Capelle, A. Engelhardt
Solna, S
Objective: One of the most common out patient ailments is urinary tract
infection (UTI). Since urinary pathogens are no longer uniformly susceptible
to standard empiric regimens, susceptibility test data would provide reliable
individual treatment. Directed UTI therapy will improve patient care, reduce
social and health-care costs and most importantly promote the rational use of
antibiotics in the community. Direct susceptibility testing of urine specimens
at out patient clinics will provide results within 24 h and facilitate the upfront
prescription of appropriate antibiotics.
Methods: We compared direct testing of urines using system U3, a new
susceptibility test approved by the FDA, in comparison to standardized urine
isolate testing. System U3 was used with three different Dipslide brands: MB-
Dip 2 (Madaus, Germany), DS 103 A (Oxoid, UK) and Uricult (Orion,
Finland). Direct testing was done at three out patient clinics in the Stockholm
area by nonlaboratory personnel and pure culture testing at AB BIODISK.
Dipslides set up with system U3 were also sent to AB BIODISK for a second
reading.
Results: 71 urine samples and corresponding isolates: E. coli (61), Enterobacter
spp. (1), Klebsiella spp. (4), E. faecalis (1) and Gram-positive cocci (4) were
tested with ampicillin (AM), cefalexin (CX), nitrofurantoin (NI), norﬂoxacin
(NX) and trimethoprim/sulphamethoxazole (TS). Susceptibility category
agreement for direct urine testing compared with isolate testing were 92–
100% (Dipslide Madaus), 94–100% (Dipslide Oxoid) and 92–97% (Dipslide
Orion). CX results on Cled agar on Dipslides gave lower agreement (50%) but
results on the same medium agreed at 95% level. Reader variations between
trained and non-trained personnel were low (81–100% agreement) except for
TS (70%) due to difﬁculties in reading of trailing end-points at the so-called
80% inhibition by non-laboratory personnel.
Conclusion: System U3 was found to be simple to set up and interpret and
could be reliably used by nontrained personnel at out patient clinics. Direct
testing of urine samples with system U3 on dipslides were substantially
equivalent to the standardized pure culture testing.
P662 Efﬁciency of Sysmex UF-50 Urine Flow Cytometer
in detection of urinary tract infection
O. Malminiemi, A. Penttila¨, K. Malminiemi
Tampere, FIN
Background:Diagnosis of urinary tract infection (UTI) has been based more
on clinical ﬁndings than laboratory tests: positive leukocyte ﬁeld in chemical
test strip screening has low speciﬁcity and not all bacteria produce nitrite.
Visual microscopy is rather laborious, needs special skills, and the result may
depend on the analyst. The result of bacterial culture is not available in acute
situations.
Objectives: We evaluated the efﬁciency of an automated urine ﬂow cyt-
ometer, Sysmex UF-50 (Sysmex Corporation, Japan), in detecting UTI.
Methods: The analyzer identiﬁes RBC, WBC, squamous epithelial cells,
transitional epithelial and renal tubular cells, bacteria, hyaline and inclusional
casts, yeast-like cells, crystals and spermatozoa using argon laser ﬂow cyto-
metry. Patient samples from wards and ambulatory clinics, positive for
leukocytes (>20/mL, n¼ 86) in chemical test strip screening, were analyzed
with UF-50, conventional bacterial culture acting as the reference.
Results: Bacteria were identiﬁed with a sensitivity of 88% and speciﬁcity of
72% compared with the reference method. Negative predictive value was 90%
and positive predictive value 70%.
Conclusions: Automated urinalysis with the UF-50 urine ﬂow cytometer
offers considerable savings in time and labor, and provides results with 79%
concordance with bacterial culture.
P663 Serodiagnosis of prosthetic joint infection by lipid S
ELISA
T. Worthington, P. Lambert, D. Dunlop, T. Elliott
Birmingham, UK
Objectives: Staphylococcus aureus and low virulent skin microorganisms includ-
ing coagulase negative staphylococci and Propionibacterium acnes are major
causes of prosthetic joint infection. Differentiation between these infections
and aseptic loosening of prosthetic joints is important as the diagnosis
inﬂuences the clinical management of the patient and revision procedure.
However, false positive revision cultures arising from skin contamination
make the microbiological diagnosis of prosthetic joint infection difﬁcult. The
objective of this current study was to investigate a serological approach to
facilitate the diagnosis of prosthetic joint infection due to staphylococci by
determining serum levels of IgG to lipid S, a recently described exocellular
short chain form of lipoteichoic acid, in patients with prosthetic joint
infection and controls.
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Methods: Fourteen patients with suspected prosthetic joint infection due to
staphylococci were included in the study. These patients yielded identical
microorgansisms from two or more clinical sites associated with the prosthesis
and had elevated levels of conventional markers of infection including
C-reactive protein, erythrocyte sedimentation rate and white blood cell
count. Furthermore, 23 patients undergoing elective arthroplasty and 16
patients with suspected aseptic loosening and negative microbiology were
included as controls. Serum levels of antilipid S IgG were determined by
ELISA.
Results:Ten (71%) out of 14 patients with suspected prosthetic joint infection
had elevated serum levels of antilipid S IgG whilst 21 (91%) out of 23 control
patients undergoing elective arthroplasty had negative titres (P< 0.0001).
Sixteen (100%) out of 16 patients with suspected aseptic loosening had no
detectable antilipid S IgG (P< 0.0001).
Conclusions:The lipid S ELISAmay facilitate the diagnosis of prosthetic joint
infection due to staphylococci and assist in differentiating between septic and
aseptic joint loosening.
Helicobacter pylori
P664 Molecular analysis of vacA and cagA genes of
Helicobacter pylori isolates from Turkish patients with
peptic ulcer disease and non-ulcer dyspepsia
M. Karaman, H. Abacioglu, O¨. S. Topalak, I. Simsek
Izmir, TR
Objective: In this study, we sought to determine the cagA status and the
distribution of vacA genotypes ofHelicobacter pylori (Hp) isolates from patients
with peptic ulcer disease (PUD) and non-ulcer dyspepsia (NUD).
Methods:Gastric biopsy samples taken from patients, diagnosed as either Hp-
related PUD (n¼ 13) or NUD (n¼ 16) by endoscopic and biochemical
criteria, were sent to laboratory and kept at 70 8C until use. Following the
extraction of bacterial DNA with proteinase-K and phenol–chloroform
method, PCR was utilized to amplify vacA s, m1, m2 and cagA regions
using speciﬁc oligonucleotide primer sets. A 785-bp vacA m region was also
ampliﬁed with VA6F/VA6R primer set and the resulting PCR product was
directly sequenced using Sequitherm Excel II DNA Sequencing Kit. Nucleo-
tide sequences obtained in this study and fromGenBank database were aligned
with Clustal X version 1.81 and a phylogenetic tree was constructed with
neighbor-joining method after Kimura 2 parameter correction using MEGA
version 2.1 software. Reliability of the phylogenetic tree was conﬁrmed with
bootstrap analysis (1000 sets).
Results:Distribution of the vacA s and m genotypes and the cagA status of the
isolates are shown in Table 1. PUD was signiﬁcantly correlated with vacA
s1m1 genotype (P¼ 0005) and cagA positivity (P¼ 0008). All vacA s1m1
genotype isolates were cagA positive (P¼ 0000). Clustering patterns of the
isolates in phylogenetic analysis were in accordance with the PCR-based
genotyping results.
Conclusions:Our ﬁndings suggest that cagA positivite-vacA s1m1 genotype
Hp strains are signiﬁcantly related to PUD, as described for patients from
Europe. However, as some of the patients with NUD also harbor these strains,
there may be other host or bacteria-related factors operative in the pathogen-
esis of Hp infections. Our data also suggest that PCR-based genotyping is an
accurate, rapid and inexpensive alternative to sequence-based methods and
suitable for large epidemiological studies.
P665 Differences of vacA allelic types of
Helicobacter pylori strains: the tales of the two cities
F. Kolayli, A. Karadenizli, R. Bingol, T. Schneider, M. Kist, G. Mauff,
H. Vahaboglu
Kocaeli, TR; Hamburg, Freiburg, Geesthacht, D
Objectives: In some countries, a particular geographic pattern of different
Helicobacter pylori genotypes were seen. The aim of this study was to determine
allelic differences between H. pylori strains isolated from two cities, Kocaeli
(Turkey) and Hamburg (Germany).
Methods: Each gastric biopsy was obtained from a different patient who
complaints of dispeptic symptoms. Strains were cultured on Mueller Hinton
agar supplemented with 10% sheep blood and identiﬁed by urease, catalase
and oxidase tests. Phenol–chloroform method was used for DNA isolation.
The vacA alleles were identiﬁed by a PCR method.
Results:A total of 72 H. pylori isolates 35 strains from Germany and 37 strains
from Turkey were used in this study. CagA genotypes were found 71.4%,
75.7% in Hamburg and Kocaeli, respectively. VacA alleles s1a-m1, s1a-m1a,
s1a-m2, s1b-m2 and s2-m2 were observed 8.4, 38.4, 25.7, 5.6 and 16.8% in
Hamburg strains, respectively. VacA alleles s1a-m1, s1a-m1a, s1a-m2, s2-m2
were found 8.1, 10.8, 59.5 and 21.6% in Kocaeli, respectively. It was no found
s1b-m2 allele in Turkey isolates.
Conclusion: In this study, cagA status was not found signiﬁcantly different
between the strains isolated from Hamburg and Kocaeli. As for vacA gene,
s1a-m1a allele was the most frequent in Hamburg strains, whereas s1a-m2
allele was in Kocaeli strains.
P666 Analysis of Helicobacter pylori 30 area of CagA
gene by PCR-RFLP
M. Hamid
Tehran, IR
Helicobacter pylori, (Hp) causes active chronic gastritis in the infected popula-
tion, 10% of which develop gastric and duodenal ulcers. In addition, Hp is
considered as the risk factor for gastric carcinomas and mucosa associated
lymphoid tissue (MALT) lymphomas. The most studied and presented
virulence factors for this pathogen are the cytotoxin (vacA) and its associated
gene product (cagA). The majority of strains isolated from high risk patients
(i.e. peptic ulcer or gastric cancer patients) were found to be cagA-positive.
Thus this gene has been identiﬁed as a pathogenic factor for Hp. In this study
IranianH. pylori strains were isolated from gastric biopsies by bacterial culture.
Following identity conﬁrmation, genomic DNAwas extracted and conserved
genes such as the Hp ureC gene were ampliﬁed by PCR. Furthermore, two
different segments of the cagA gene in the 30 area were PCR ampliﬁed and
categorized by restriction fragment length polymorphism, RFLP. Due to the
high frequency of Hp infection in developing countries, previous studies have
shown no association between cagA-positivity and gastrointestinal disorders.
Thus, in order to identify relevant virulence markers for the Iranian popula-
tion, the heterogeneity in the 30 region of the cagA gene was studied.
Accordingly, PCR-RFLP was performed and eight categories were identi-
ﬁed. Non-parametric statistical analysis (Chi-square) determined the associa-
tion between each of the identiﬁed RFLP proﬁles and the associated disease.
This data demonstrates that only the C proﬁle has a weak association
(P¼ 0.33). The rest had no signiﬁcant correlation. Therefore, further research
is required to identify other CagPAI markers.
P667 Real-time PCR for detection of clarithromycin
resistance in Helicobacter pylori clinical isolates and in
biopsy samples
T. Alarcon, A. Vega, J. Garcia-Campos, D. Domingo, A. Perkins,
M. Abanades, M. Lopez-Brea
Madrid, E
Background: Mutations involved in clarithromycin (CLA) resistance in
Helicobacter pylori are detected by different genotypic methods. The aim of
Table 1 Distribution of vacA s and m genotypes and cagA status of Hp strains isolated
from patients with PUD and NUD.
PUD NUD
TotalcagA(þ) cagA() cagA(þ) cagA()
s1m1 11 – 5 – 16
s1m2 1 – – 3 4
s2m1 – – – – –
s2m2 – 1 1 7 9
Total 12 1 6 10 29
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the study was to determine resistance to CLA in H. pylori clinical isolates by a
novel Real-Time PCR performed in a LightCycler (LC) and to standardize
PCR conditions to use it directly from gastric biopsies.
Material and methods: A total of 63 strains obtained from gastric biopsies
were studied. In vitro susceptibility to CLA was determined by an agar
dilution and resistance considered when MIC> 1mg/L and intermediate
when MIC¼ 0.5mg/L. 42 resistant and 21 susceptible strains were included.
DNA from the isolates was extracted by a previously described method (Ge &
Taylor) and from biopsies by a commercially available kit (Gentra). Different
conditions such as magnesium concentration, primer annealing temperature,
probes and DNA amount and storage of DNA, were tested. A 425 bp
fragment of the 23S rRNAwas ampliﬁed in a LC (Roche Diagnostics) with
two probes: ﬂuorescein-labeled anchor probe and LC-640 ﬂuorescent-
labeled sensor probe (wild type sequence) separated by two nucleotides in
the sequence (Designed by TibMolBiol, Germany). After standard ampliﬁca-
tion cycles a melting cycle was performed with continuous reading of LC-640
from 50 to 90 8C. A perfect match with a susceptible strain was indicated by a
melting temperature of 64 8C. However, when a mismatched sequence was
found, a melting peak at 56 or 60 8Cwas observed. Appropriate controls were
run in each experiment. After DNA extraction the whole process was
performed in 1 h.
Results: Among the overall 63 strains tested the distribution of MIC values
were as follows: 21 with MIC<¼ 0.25mg/L, 2 with MIC¼ 1mg/L, 4 with
MIC¼ 2mg/L, 2 with MIC¼ 4mg/L, 11 with MIC¼ 8mg/L, 10 with
MIC¼ 16mg/L, 10 with MIC¼ 32mg/L and 3 with MIC¼ 64mg/L. The
melting temperature of all susceptible strains were 64 8C. However, the
resistant strains had a melting temperature of 56 or 60 8C (34/42). In ﬁve
resistant strains heteroresistance was observed. Moreover, three strains with
MIC¼ 1 or 2mg/L showed he wild type pattern by using LC. Best results in
biopsies were found when using 2mM MgCl2, 50 8C primer annealing, 4mL
DNA in a 20-mL ﬁnal volume and 0.2mM each probe.
Conclusions: A very good correlation among the agar dilution and detection
of mutation involved in resistance to clarithromycin was found. The use of
Real-Time PCR and the LightCycler is an accurate an rapidmethod to detect
resistance.
P668 Rapid diagnosis of Clarithromycin-resistant
Helicobacter pylori infection by using a double-probe
ﬂuorescent in situ hybridization assay
Y. Moreno, A. Gonzalez, E. Medina, A. Jimenez, S. Botella,
M. Hernandez, J. Hernandez, M. A. Ferrus
Valencia, E
Objectives: We have evaluated the use of a ﬂuorescent in situ hybridization
(FISH) assay directly from biopsies to determine simultaneously Helicobacter
pylori infection and its susceptibility to clarithromycin treatment.
Methods: 26 gastric biopsies from ulcer-patients were examined. Samples
were homogenized in 2mL of selective broth, and a 500-mL aliquot was used
for FISH detection. Samples were ﬁxed with 4% paraformaldehyde solution
for 4 h and then washed with 1% PBS buffer. HPY probe, a 16S rRNA
targeted FITC-labeled oligonucleotide sequencewas used for the detection of
all H. pylori strains. CLA1-3, a set of three CY3-labelled probes, was used for
the detection of 23S rRNA mutations associated with resistance to clari-
thromycin. Hybridization was performed at 46 8C for 2 h. Results were
compared with direct PCR, culture of samples on Pylori Selective Agar and
Clarythromicin sensitivity E-test of isolated H. pylori strains.
Results: FISH allowed the detection of H. pylori in 20 out of 26 samples
analyzed. Seven of these positive biopsies showed to contain Clarithromycin-
resistant H. pylori strains. PCR detection yielded positive results for 15 sam-
ples. Strains could only be isolated from 14 biopsies. Results from E-test
showed good correlation with FISH-detected resistance to clarithromycin.
Conclusions: FISH method can be used as a rapid and accurate way of
diagnosis of H. pylori infection, and simultaneous evaluation of the optimal
treatment for its eradication.
P669 Resistance of Helicobacter pylori isolates to
metronidazole, clarithromycin, tetracycline, amoxicillin and
ceﬁxime in patients after treatment failure
Z. Samra, H. Shmuely, Y. Niv, G. Dinari, J. Bachor, J. Yahav
Petach-Tiqva, IL
Objectives:Antibiotic resistance of Helicobacter pylori isolates differs according
to geographical area. The aim of our study was to determine the resistance of
H. pylori isolates to ﬁve antimicrobial agents from patients after treatment
failure.
Methods:Sixty-six isolates ofH. pyloriwere isolated from biopsy specimens of
66 dyspeptic adults (37F/36M; median age 57 years) after treatment failure
with 2–4 commonly used antibiotics for H. pylori eradication. Susceptibility
for metronidazole (MET), clarithromycin (CLR), tetracycline (TC), amox-
icillin (AM) and ceﬁxime (CEF) was tested by E-test (AB Biodisc). Isolates
were considered as resistant if MIC for MET 8mg/mL, for TC 4mg/mL
for AM 1.5mg/mL, for CLR and CEF 2mg/mL.
Results:Resistance to METand CLR was found in 53 and 51.5% of isolates,
respectively. Dual resistance to both antibiotics was detected in 27.3% of
isolates. HighMIC value of256mg/mL for METand CLRwas observed in
37.8 and 24.2%, respectively, 97 and 91.4% of isolates resistant to CLR or
MET were recovered from patients previously treated with CLR or MET,
respectively. One isolate was found to be resistant to AM and TC and to all
other antibiotics with MIC 256mg/mL. This isolate was recovered from
patient previously treated with four antibiotics: MET, CLR, TC and AM.
Resistance to CEF was found in 4.5% of isolates.
Conclusion: High resistance to MET and CLR was found in patients
previously treated with MET and CLR, respectively. CEF which is not
currently used for treatment of H. pylori and TC are potential alternative
agents for eradication after treatment failure.
P670 Antimicrobial potential of lactobacilli against
reference and wild Helicobacter pylori strains
K. Lo˜ivukene, H. Maaroos, M. Mikelsaar
Tartu, EST
Objectives: To screen for antagonistic activity of different lactobacilli against
Helicobacter pylori wild and reference strains in vitro.
Methods: In total four lactobacilli strains from different origins were included:
Lactobacillus fermentum IV from gastric mucosa, Lactobacillus salivarius 180-2-1
from the fecal sample of healthy young Estonian children, and two reference
strains (Lactobacillus rhamnosus ATCC 53103 and Lactobacillus paracasei ssp.
paracasei DSM 20020). Nine randomly selected H. pylori isolates from gastric
samples and reference strain H. pylori NCTC 11637 were used. Antagonistic
activity was assessed by a streak line procedure on Columbia Agar Base
supplemented with 7% horse blood and 1% Vitox. A single line of lactobacilli
suspension in 0.9% saline solution by McFarland 1.0 was seeded in the middle
of the agar plate and incubated for 48 h in a 10% CO2 environment at 37 8C.
From the H. pylori culture, a suspension in Brucella broth of McFarland 3–4
was made and seeded in duplicate and perpendicular to the streak line of
lactobacilli. Following incubation for 3 days at 37 8C in a microaerobic
environment, the width of clear zone of inhibition (mm) extending from
the culture line of lactobacilli was measured.
Results: Although the tested lactobacilli strains inhibited the H. pylori strains
investigated, inhibition of the reference strain H. pylori (NCTC 11637) was
more effective than for the wild types. The inhibitory activity of the
lactobacilli was not solely related to metabolic type of the lactobacilli,
suggesting a role of strain-speciﬁc properties of lactobacilli in the suppression
of H. pylori.
Conclusions:The in vitro tests showed the contrast between the susceptibility
pattern of reference strain and wild isolates of H. pylori to distinct lactobacilli
with probiotic properties. While selection of an individual and suitable
probiotic strain is complicated, the application of some combination of
effective lactobacilli strains could be recommended (Table 1).
Table 1
Inhibition zone in mm (median/ranges)
L. salivarius
180-2-1
L. paracasei ssp.
paracasei DSM
20020
L. rhamnosus
ATCC 53103
L. fermentum
IV
NCTC 11637 19.0/15-23 18.0/15-20 19.0/18-22 17.5/16-18
HP2 21.0/20-22 13.0/12-15 18.5/17-20 8.5/8-10
HP1 12.0/12-14 6.0/5.7 7.0/6-7 0
HP6 12.0/11-13 9.0/6-10 11.0/10-12 0
HP7 7.0/6-10 6.0/5-7 0 0
HP8 6.0/5-7 7.0/6.8 0 0
HP9 13.5/13-15 7.5/6-8 8.0/8-10 0
HP3,4,5 0 0 0 0
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P671 Dental plaque and Helicobacter pylori infection in
Iran
M. Nasrolahei, I. Maleky, H. Fakhery, O. Emadian
Sari, IR
Objective: The precise mode of transmission and the natural reservior for
Helicobacter pylori are unknown. The aim of this study was to investigate the
prevalence and distribution of H. pylori in dental plaque and its correlation
with H. pylori infection of the stomach.
Methods: Samples were obtained from supragingival and subgingival dental
plaques and gastric mucosa (antrum and body) of 78 dyspeptic patients (age
range 11–90 years, 45 men, 33 women) with endoscopically active chronic
gastritis, peptic ulcer and gastroesophageal reﬂux (with normal gastric
mucosa). H. pylori infection was evaluated with rapid urease test, histology
and culture. For detection ofH. pylori in dental plaque, rapid urease test, Gram
staining, culture and histology were performed.
Results:H. pyloriwas detected in antral and body gastric mucosa specimens of
87% (68 of 78) by rapid urease test, 85% (66 of 78) by histology and 66% (52 of
78) by culture. All (100%) of 78 patients under study, were positive for
H. pylori colonization in dental plaque by rapid urease test, Gram staining and
histology. By culture 72% (56 of 78) ofH. pylori infected patients were positive
for colonization of the bacterium in dental plaque.H. pyloriwas detected in all
three locations but with differences in prevalence: 89% in the molar region,
61% in the premolars and 42% in the incisors. Dental plaques of 55.1% of
H. pylori infected patients, 5.1% of chronic gastritis who were not infected
with H. pylori and 6.4% of patients with normal gastric mucosa were positive
by rapid urease test within 10min.
Conclusions: The results of this study show that H. pylori is present in dental
plaque samples independent of the infection status of the stomach and may
belong to the normal oral microﬂora.
Bloodstream infections in immunocompromised hosts
P672 Etiology of septic episodes in children with
hematologic malignancies and solid tumors
A. Pangalis, A. Charisiadou, J. Panagiotou, A. Doudoulakakis,
A. Raftopoulou, A. Stamatiadou, S. Polychronopoulou
Athens, GR
Objectives:Bacteremia is still a common and serious complication during the
course of intensive chemotherapy for malignant diseases of hematologic
origin and solid tumors. The aim of our study was to investigate the incidence
and etiology of septic episodes during chemotherapy in the department of
Pediatric Hematology – Oncology of our hospital.
Methods:We studied 111 children (43 girls and 68 boys, aged from 6 months
to 14 years) suffering from hematologic malignancies and solid tumors, 63 and
48, respectively, during the August 2000 – July 2002 period. Among the
hematologic malignancies 45 children (40.5%) had acute lymphoblastic
leukemia, 8 (7.2%) acute myeloblastic leukemia, 9 (8.1%) lymphomas, 1
histiocytosis whereas 13 (11.7%) had different sarcomas, 12 (10.8%) neuro-
blastoma, 9 (8.1%) CNS tumors, 6 (5.4%) nephroblastoma and 8 (7.2%) other
tumors. These patients developed 43 episodes of sepsis during the courses of
intensive chemotherapy or relapse of their primary disease. Two hundred and
forty-four blood cultures were obtained using pediatric Plus F vials from
Becton-Dickinson and the Bactec 9240 blood culture monitoring system
(B–D).
Results: Seventy-one blood cultures had proven positive (29%). Gram-
positive bacteria accounted for 39.4% and Gram-negative ones for 60.6%.
Fungi were not detected. Among Gram-positive bacteria, coagulase negative
Staphylococci predominated (19/26, 8%) followed by S. aureus (6/8, 4%) and
Streptococci viridans (3/4, 2%). E. coli predominated among Gram-negative
bacteria (15/21, 1%) followed by Klebsiellae pneumoniae and oxytoca (13/18,
3%), P. aeruginosa (6/8, 4%), Acinetobacter spp. (4/5, 6%), E. cloacae (4/5, 6%)
and S. enteritidis (1). The majority of septic episodes concerned children with
hematologic malignancies (32 episodes against nine concerning solid tumors)
P¼ 0.007. All septic episodes were treated successfully.
Conclusions: Septic episodes are more frequent among children subjected to
intensive chemotherapy for hematologic malignancies than children for solid
tumors. Gram-negative bacteria exceed Gram-positive ones, while the
opposite was the case some years earlier.
P673 Infectious complications in patients with
hematological malignancies consulted by the infectious
diseases team: a retrospective cohort study
G. Sain Gu¨ven, B. C¸akir, O¨. Uzun
Ankara, TR
Background: Although there has been signiﬁcant advances in the manage-
ment of infectious complications, they are still a major cause of morbidity and
mortality in patients (pts) with hematological malignancies (HM).
Objectives: To identify the characteristics of pts with HM in the presence/
suspicion of any accompanying infectious disease and the predictors of
mortality in this group.
Methods:The hospital charts of patients with HM consulted by the Infectious
Diseases (ID) team for signs/symptoms of any infection between January 1,
1997- December 31, 2001 were retrospectively evaluated. Datawere collected
on some demographic and disease characteristics and hospital outcome of the
study participants. Uni- and bi-variate analyses were conducted for a total of
1132 episodes but multivariate analysis of predictors of mortality was limited
only to the ﬁrst episode of each participant.
Results:A total of 1132 consultations were done for 641 patients, 59.4% were
men. The mean of age was 47.87 1.36 years. The most common underlying
diseases were non-Hodgkin’s disease (30.9%) followed by acute myelogenous
leukemia (26.2%). The underlying disease was in remission in 22.5% of all pts.
Pneumoniawas the most common clinically documented infection (n¼ 173).
Bacteremia was detected in 122 episodes, 56.5% being due to Gram-negative
microorganisms. Invasive fungal infection was detected in 51 attacks, 20 of
which were pulmonary aspergillosis. A total of 163 patients died during the
infectious episode.
In logistic regression analysis, the presence of pneumonia [OR¼ 7.56
(95% CI¼ 4.84–12.486)], fungal infection [OR¼ 4.12 (95% CI¼ 1.78–
9.55)], relapse or recent diagnosis of underlying disease [OR¼ 2.82 (95%
CI¼ 1.53–5.21)] and neutropenia, [OR¼ 2.70 (95% CI¼ 1.70–4308)],
were identiﬁed as statistically signiﬁcant predictors of mortality, controlling
for age and gender.
Conclusions: Gram-negative and Gram-positive microorganisms are almost
equally responsible for bacteremia. Patients with relapsed or newly diagnosed
HM, who are neutropenic, have pneumonia or invasive fungal infection are
more likely to have a poor prognosis. Therefore, we should act more
aggressively while dealing with patients who have these risk factors.
P674 Outcome of catheter-related bloodstream
infections in adult hematology patients
R. McMullan, V. Coyle, C. Morris, P. Rooney, S. Hedderwick
Belfast, UK
Objective: To evaluate the impact of central venous catheter (CVC) removal
on outcome of catheter-related bloodstream infection (CRBSI) in adult
hematology patients.
Methods: Subjects were identiﬁed retrospectively according to diagnosis
coding of ‘sepsis’ and subsequent inclusion was dependent upon the exam-
ination of medical records conﬁrming both sepsis and a strong clinical
suspicion that the source was the CVC. Demographic and bacteriological
data as well as therapeutic measures and clinical outcomes were recorded.
Results: One hundred and three patient episodes were evaluated; the most
frequent type of CVC was the Hickman catheter and the most frequently
isolated pathogen was coagulase-negative staphylococci. Treatment failure,
deﬁned as recurrence of infection within 90 days or mortality attributed to
sepsis within 30 days, occurred signiﬁcantly more frequently in the group
managed without catheter removal (52.5 vs. 4%, P< 0.05%). Recrudescence
within 90 days occurred in 36 (35%) episodes; this accounted for 46% of the
78 whose infections were managed without catheter removal; of these 36
episodes where recurrence was noted, 26 (72%) were associated with CoNS
and 10 (28%) were associated with Gram-negative pathogens. There was no
144 Abstracts
signiﬁcant difference between the two groups in respect of measured char-
acteristics, other than CVC removal, considered as potential determinants of
outcome such as gender, presence of neutropenia pathogen isolated and
duration of antibiotic therapy.
Conclusion: More frequent CVC removal for CRBSI, in this population, is
likely to be of beneﬁt since not doing so is associated with treatment failure,
morbidity and carries signiﬁcant resource implications.
P675 An increase in methicillin-resistant S. aureus
bacteremia in neutropenic patients
F. Fitzpatrick, K. Khalib, M. Mallen, H. Humphreys, E. Smyth
Dublin, IRL
Aim: The aim of this study was to analyze the spectrum of pathogens isolated
from patients with neutropenic sepsis.
Methods: Blood cultures taken from neutropenic patients under the care of
hematology and oncology services from 1st January 1999–30th September
2002 were analyzed.
Results: 3642 cultures were taken over the study period. Six hundred and sixty-
eight were positive giving a positivity rate of 18.34%. The most common
isolates were coagulase-negative staphylococci (42%), coliforms (18%), S. aureus
(14%) and Enterococcus spp. (8%). There was no signiﬁcant shift in the spectrum
of pathogens with Gram-positive organisms predominating in each year. Fifty
percent of Candida spp. isolated were identiﬁed as C. albicans. The spectrum of
organisms observed between hematology and oncology patients was similar.
With regards to the incidence of resistant organisms: 40% of S. aureus were
methicillin resistant and 6% of enterococci were vancomycin resistant. Of the
Enterobacteriaceae isolated, 2.6% were gentamicin resistant and 4.3% cipro-
ﬂoxacin resistant. There was an increase in methicillin resistance in S. aureus
isolates over the study period from 13% in 1999, 19% in 2000, 38% in 2001 and
75% in 2002, with the opposite trend observed in coagulase-negative staphy-
lococci; 58% in 1999, 52% in 2000, 44% in 2001 and 40% in 2002.
Conclusion:Whilst recent studies have reported an increase in Gram-negative
pathogens, Gram-positive cocci remain the most prevalent organisms isolated
from blood cultures in our center. The incidence of multiresistant Gram-
negative pathogens remains low. However there is a worrying increase in the
incidence of methicillin resistance among S. aureus isolates, but all isolates to
date remain sensitive to our current empiric antibiotic regimen.
P676 Micro-organisms isolated from neutropenic
patients in a university hospital in Turkey with a special
interest in non-fermenter Gram-negative bacilli
O¨. A. Akan, E. Yildiz, H. Akan
Ankara, TR
Objectives: As early administration of appropriate antibiotics is crucial for
successful management of infections in neutropenic patients, close monitor-
ization of type and susceptibility of causative agents is mandatory both for the
decision of empirical antibiotic therapy and evaluation of new antimicrobial
drugs. This study is performed to show the microorganisms isolated in blood
cultures of neutropenic patients with hematological malignancy in our
University Hospital.
Methods:During the year 2001, we obtained 125 microorganisms from 121
febrile neutropenic episodes.
Results: Seventy-one (56.8%) of the isolates were Gram-negative bacteria
(enterobacters 44, non-fermenters 27) and 43 (34.4%) were Gram-positives
(cocci 40, coryneforms 3). The predominant bacteria were E. coli, Klebsiella
spp. and coagulase negative staphylococci. The list of the isolates are shown
in Table 1.
Conclusion: Although a shift towards Gram-positive bacteria among isolates
from neutropenic patients are observed in many countries, Gram-negative
bacilli still seem to be the major pathogens in our hospital. When compared
with a previously published data from the same hospital in 1998, the most
considerable ﬁnding is the increase of non-fermenter Gram-negative bacilli
(8.8 to 21.6%), with a marked increase in Stenotrophomonas maltophilia (0.8 to
5%) in three years time.
P677 Stenotrophomonas maltophilia bacteremia in
cancer vs. noncancer patients. Comparison of risk factors,
outcome and antimicrobial susceptibility
J. Koprnova, A. Harnicarova, E. Bilikova-Buckova, M. Kacmarikova,
V. Krcmery
Bratislava, SK
Objectives: To compare two periods of survey 1992–95 and 1996–2001 for
antimicrobial susceptibility and mortality of Gram-negative bacteremia.
Methods: A total of 61 episodes of Stenotrophomonas maltophilia bloodstream
infections in 61 patients from 8 major teaching hospitals appeared between
1991 and 1995 and 1996–2001. This multicentric study included The
National Cancer Institute, The National Institute of Heart Diseases and
The Pediatric University Hospital in Bratislava and 5 other University
Hospitals in Bratislava, Trnava, Nitra, Banska Bystrica, Kosice, Slovakia
(5.5 milion inhabitants).The following clinical characteristics were recorded:
sex, age, presence of underlying disease, previous colonization, source of
infection, antimicrobial susceptibility, number of positive blood cultures,
presence of vascular catheters, ventilatory support, dialysis, prior receipt of
antibiotics (prophylaxis or therapy), previous surgery. Complications (endo-
carditis, abscess, pneumonia), oucome and therapy were also recorded. Strains
from blood cultures were isolated through the semiautomated system Bactec
or Bact-Alert and identiﬁed with Vitek Jr. system (Bio Me´rieux).
Results: Sixty-one cases of Stenotrophomonas maltophilia bacteremia were
analyzed. Thirty occurred in 1991–95 and 30 in 1996–2001, so there was
no found of increasing occurence. Concerning risk factors there was no
difference in major risk factors, cancer as underlying disease, whereas majority
of cases in 1991–95 were from cancer patients in contrast to only 10% in
1996–2001. Relapse rate was signiﬁcant higher in 1991–95 (10 vs. 0%) and
attributable mortality, what was some what lower 3.3% in 1996–2001.
Concerning antimicrobial susceptibility, there was lower resistance to coli-
mycine and ceftazidime in 1996–2001, where susceptibility increased from
38.7% to 50% in colimycine and quinolones and 64.5% to 93.2% for
ceftazidime (P< 0.04), respectively.
Conclusion: There are less attributable deaths and complications due to
bacteremia caused by S. maltophilia and antimicrobial susceptibility improved
within last 5 years when analasing two subgroups of patients with S. maltophilia
bacteremias in 1996–2001 in comparison to 1992–95.
P678 Stenotrophomonas maltophilia infection in cancer
patients – frequency, spectrum of infection and
antimicrobial susceptibility
K. Rolston
Houston, USA
Objectives: Frequent use of empiric broad-spectrum antibiotic therapy in
cancer patients might result in the selection of some resistant organisms. Our
objectives for this study were to ascertain the current frequency of infection,
determine the spectrum of infection, and the antimicrobial susceptibility of
S. maltophilia isolated from cancer patients.
Methods: (i) Review of institutional surveillance data (1986–2002) to
determine frequency. (ii) Review of microbiological data to determine
spectrum of infection. (iii) Microtiter, broth-dilution studies to determine
in vitro susceptibilities to 22 antimicrobial agents.
Results: Surveillance data indicate that despite an overall decline in the
frequency of Gram-negative infections in our cancer patients, there was an
increasing frequency of S. maltophilia with these organisms causing 2% (22 of
851) of all Gram-negative infections in 1986; 3% (23 of 679) in 1993; 6% (45
of 758) in 1996; and 7% (61 of 903) in 2002. S. maltophilia rose from being the
9th most common Gram-negative isolate in 1986 to the 5th most common in
2002. The spectrum of infection included bacteremia (32%) colonization
(27%), simple and complicated urinary tract infection (18%), pneumonia
(12%), skin and soft tissue (4%), and other sites including disseminated
Table 1 The types of microorganisms from positive blood cultures
Bacteria n % n % n %
Gram positive 43 34.4 Gram negative 71 56.8 Candida spp. 10 8
Staphylococcus spp. 27 Enterobacteriaceae 44 35.2 C. albicans 6
S. aureus 12 E. coli 23 C. tropicalis 3
CNS

- S. epidermidis 10 Klebsiella spp. 15 C. glabrata 1
other CNS 5 Enterobacter spp. 4
Enterococcus spp. 9 Proteus mirabilis 1 Others
Streptococcus spp. 4 Pantoea spp. 1 Haemophilus spp. 1 0.8
Gr A beta hem. Strep. 1 Nonfermenters 27 21.6
S. pneumoniae 1 Acinetobacter baumannii 7
alpha hem. Strep 2 Alcaligenes spp.
Pseudomonas spp.
1
13
Coryneform bacteria 3 Stenotrophomonas maltophilia 6
CNS

: coagulase negative staphylococci.
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infection (7%). The most frequent site of colonization was from respiratory
specimens. Antimicrobial susceptibility was variable with 76% of isolates
being susceptible to clinaﬂoxacin, 72% to TMP/SMX, 68% to cefepime, 66%
each to gatiﬂoxacin, moxiﬂoxacin, and ticarcillin/clavulanate, and 64% each
to ceftazidime and trovaﬂoxacin. All other agents inhibited less than 50% of
isolates. Eight percent of isolates were resistant to all agents tested.
Conclusions: The frequency of S. maltophilia infection in cancer patients has
more than tripled in the past 16 years. The spectrum of infection ranges from
disseminated disease to local colonization. Antimicrobial susceptibility is
variable with no single agent inhibiting >76% of isolates. Some isolates
are multidrug-resistant and might require high-dose, combination therapy.
P679 Francisella philomiragia bacteremia in a patient
with chronic granulomatous disease
A. Friis-Møller, L. E. Lemming, B. Bruun
Copenhagen, DK
Objective: Francisella philomiragia is a rare pathogen in humans. It has been
found in patients with chronic granulomatous disease (CGD), near-drowning
patients and patients with malignant bone marrow diseases.We describe a fatal
case of bacteremia with this pathogen in a 24-year-old man with CGD. The
patient, who was on holiday swimming and taking mudbaths in Turkey,
developed high fever despite CGD-antimicrobial chemoprophylaxis with
cotrimoxazole. Oneweek after returning to Denmark, he was admitted to the
ICU with clinical sepsis, pneumonia, pleural effusion and abdominal pain.
Blood cultures were drawn and antimicrobial treatment was initiated with
penicillin, ciproﬂoxacin and metronidazole. Penicillin was replaced by ery-
tromycin on suspicion of Legionnaire’s disease. The patient died from
multiorgan failure and DIC on day 5. Four of ﬁve sets of blood cultures
were positive with Gram stain only revealing an amorphous Gram-negative
mass. Wet-mount microscopy showed spherical bodies with diameters of
3–5mm, with only an occasional bacilli. Conventional identiﬁcation was
hampered by difﬁculty in determining microscopic morphology and weak
and delayed phenotypic reactions. The diagnosis F. philomiragiawas conﬁrmed
by 16S rDNA sequencing. Halophilicity was not demonstrated until the
identiﬁcation was established.
Conclusion:Familiarity with F. philomiragia, a very rare and difﬁcult to identify
pathogen, is important when dealing with CGD patients because of the
organism’s ability to cause serious disease and death. CGD patients should
probably be cautioned about participation in salt water activities.
P680 Meropenem is effective and well tolerated in the
treatment of febrile episodes in elderly or renally impaired
neutropenic patients
G. Ramı´rez, G. Can˜igral, J. Zapardiel, H. Bovio, M. Tafalla and the
Spanish Meropenem Study Group
Objectives:Treatment of elderly patients, a signiﬁcant and increasing propor-
tion of the population, is often complicated by the presence of underlying
illnesses, concomitantmedication and decreased renal function. The dosage of
predominantly renally excreted drugs needs to be carefully considered prior to
the treatment of elderly patients. This study evaluated the clinical efﬁcacy and
tolerability of meropenem (MEM) in the treatment of febrile neutropenia in
patients aged >64 years (or who were aged <65 years but renally insufﬁcient
[CrCl<51mL/min]) (Group 1) compared with patients aged<65 years with
normal renal function (Group 2).
Methods: An observational, prospective and comparative, open study was
performed in 318 hospitalized, febrile neutropenic patients (aged >18 years)
from 30 Spanish hospitals. MEM (1 g i.v.) was administered every 8 h for at
least 7 days. The protocol allowed for dosage reductions in renally impaired
patients (according to the manufacturer’s guidelines). Clinical evaluations
(EORTC criteria) including hematology, biochemistry and microbiology
were performed on initiation, 72 h after, and at the end of treatment.
Results:Three hundred and eighteen patients were recruited to the study, 313
were evaluable for efﬁcacy and 318 were evaluable for safety. Discounting two
patients for whom there were no creatinine clearance values available, the
mean age of Group 1 was 70.4 years (range 20–85, n¼ 135) and of Group 2
was 45.6 years (range 15–64, n¼ 181). The mean creatinine clearance at
baseline was: Group 1, 58.7mL/min; Group 2, 102.4mL/min. 38.5% of the
patients in Group 1 and 56.9% of the patients in Group 2 received antibiotic
treatment prior to recruitment, and 54.5 and 70.1%, respectively, received
concomitant antibiotic therapy (mainly glycopeptides and aminoglycosides)
during the study. MEM was clinically and microbiologically effective in both
groups. MEM was well tolerated in both groups and the incidence of nausea
and vomiting was low. Importantly, in renally impaired or elderly patients no
cases of seizures were reported. Efﬁcacy outcomes, and incidence and types of
adverse events are given in the Table 1.
Conclusions: MEM was well tolerated and efﬁcacious in the treatment of
febrile neutropenia in the elderly and renally impaired as well as in patients
aged <65 years without renal impairment.
Table 1
Group 1
(>64 years or
renally impaired)
Group 2
(<65 years with no
renal impairment)
Clinical outcome at the end of the study (%)
Success 64.9 60.6
Failure 26.1 32.6
Non-evaluable 9.0 6.9
Microbiological outcome at the end of the study (%)
Eradication/presumed eradication 47.3 46.4
Persistence 1.5 6.0
Recurrence 1.2 1.2
Superinfection 0.8 3.0
Non-evaluable 50.4 43.5
Patients with adverse events (%) 2.2 3.3
Types of adverse events
Renal insufficiency 2
Diarrhea 1
Liver disease 1
Bronchospasm 1
Cutaneous rash 1
Nausea 1
Vomiting 1
Seizure 1
Intrahepatic choleostasis 1
Within the expected range.
Clinical infections and immunity
P681 Severe eosinophilia during the course of toxic
shock syndrome
R. Ozaras, A. Mert, F. Tabak, M. Bilir, R. Ozturk
Istanbul, TR
Objectives: Staphylococcal toxic shock syndrome (STSS) is deﬁned as the
occurrence of fever, rash, hypotension, multiple organ dysfunction, and
desquamation. It is caused by toxigenic strains of Staphylococcus aureus. The
main hematologic change is usually thrombocytopenia and leukocytosis.
Eosinophilia has been recently described ﬁrst time by our unit in 50% of
20 cases with STSS. We described a patient with non-menstrual recurrent
TSS going with severe eosinophilia.
Case report: A 16-year-old girl reported an episode of fever and rash
beginning nearly one month ago. She had presented to a dermatologist 1
week later and treated with antibiotics for 10 days. She had responded partially
to the treatment, but after discontinuation, the clinical features had appeared
1week before admission. She had presumed psoriatic lesions on scalp and
elbow for a few years and epilepsy for one year treated with carbamazepine.
Temperature was 39.28C, pulse 112 beats/min, and blood pressure 80/
50mmHg. A diffuse macular erythroderma and peeling on face, scalp, and
palms and soles were noted. WBC was 34 300/mm3 (eosinophils 62%), Hb
12.4 g/dL, platelets 205 000/mm3, urea 10mg/dL, cr 0.88mg/dL, ALT
15U/L, AST 17U/L, CK 23U/L, CRP 30.5mg/L (0–5), and sedimenta-
tion rate 20mm/h. CMV IgM, rubeola IgM, and Monotest remained (–).
Samples from scalp cultured MRSA, swabs of throat, axilla, nose, and
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umbilicus yielded MSSA. Carbamazepine was discontinued and valproate
initiated. Teicoplanin was prescribed. IgE level was normal. No parasites were
determined. Three days after the initiation of the antibiotics, her temperature
returned to normal. The rash also resolved. A very prominent desquamation
was noted on palms and soles on day 9.WBC count decreased to 15 000/mm3
(eosinophils 32%). The dose of teicoplanin was decreased to 6mg/kg/day.
However 2 days after lowering the dose, another febrile episode with rash
occurred. Repeated cultures yielded MSSA from the same sites. The treat-
ment was replaced with amoxicillin/clavulanate and fusidic acid. She
responded well in 2 days. After an afebrile period of 8 days, WBC count
decreased to 7500/mm3 (eosinophils 12%; 900/mm3), and the treatment was
discontinued. During a follow-up of 10months, she has been doing well.
Conclusion: Our patient had recurrent non-menstrual STSS most probably
facilitated by psoriatic lesions. Eosinophilia can be seen during the course of
STSS in a considerable frequency and it can be severe.
P682 Antibodies to human heat shock protein 60 and to
Chlamydia pneumoniae in abdominal aortic aneurysm
patients
J. Niedzwiadek, E. Mazur, M. A. Wolski, J. Ligieza, M. Koziol
Montewka
Lublin, PL
Objectives:Heat shock protein 60 (hsp-60) and C. pneumoniae infection have
both been associated with cardiovascular diseases, including abdominal aortic
aneurysm (AAA). We examined whether there is any association between
antibodies to human hsp-60 and anti-C. pneumoniae antibodies in AAA
patients.
Material: Fifty-two AAA patients participated in the study. Thirty control
subjects, matched for age and sex, without clinical signs and symptoms of
cardiovascular and pulmonary disease took part in our study.
Methods: IgG and IgA antibodies to human hsp-60 were detected in sera
samples using ELISA method and measured by means of internal units. In
order to evaluate the level of IgG and IgA antibodies to C. pneumoniae
microimmunoﬂuorescence method was applied. Chlamydia pneumoniae
Micro-IF test (Labsystems, Finland) was used according to manufacturer’s
instructions. The following criteria have been adopted to assess the type of
infection:
1. chronic infection: IgG 1 : 128, IgA 1 : 32;
2. exacerbation of chronic infection (active infection): IgG 1 : 512, IgA
1 : 64
3. contact with the pathogen: IgG <1 : 128, IgA 1 : 8
Results: The mean concentrations of IgG and IgA antibodies to human hsp-
60 were as follows:
IgG: AAA patients – 155.9U/mL (range: 46.99–1001.0) healthy controls –
107.24U/mL (range: 5.91–291.49)
IgA: AAA patients – 85.37U/mL (range: 14.8–467.41) healthy controls –
61.85U/mL (range: 0.0–216.78).
Percentages of AAA patients with serological markers of chronic and activeC.
pneumoniae infection or the contact with the pathogen were as follows: active
infection – 32.69%, chronic infection – 53.85%, contact with the pathogen-
13.46%. Mean concentrations of IgG and IgA antibodies to human hsp-60 in
the three groups of AAA patients were as follows: active infection group: IgG
– 238.76U/mL; IgA – 87.58U/mL; chronic infection group: IgG –
128.57U/mL; IgA – 84.69U/mL; contact with the pathogen group: IgG
– 64.0U/mL; IgA – 82.74U/mL.
Conclusions: The concentrations of antibodies to human hsp-60, both IgG
and IgA, were signiﬁcantly higher in AAA patients than in healthy controls
(P< 0.05). Strong correlation was observed between titers extent of IgG and
IgA antibodies to C. pneumoniae and the concentration of IgG antibodies to
human hsp-60 in AAA patients. There was no correlation between titers
extent of IgG and IgA anti-C. pneumoniae and the concentration of IgA
antibodies to human hsp-60 in AAA patients.
P683 Evidence of poliovirus-speciﬁc memory immunity
in seronegative elderly people
F. Abbink, A. M. Buisman, G. Doornbos, J. Woldman, T. G. Kimman,
M. A. E. Conyn-van Spaendonck
Bilthoven, Tiel, NL
Objectives:There are doubts about the poliomyelitis protection of the Dutch
born between 1925 and 1945 because of their small seroprevalences. They
were ineligible for the inactivated poliovirus vaccine (IPV) vaccination
introduced in 1957, and they may have escaped natural infections because
of reduced poliovirus circulation. Waning natural or vaccine-induced immu-
nity may be a factor. To guarantee high protection levels, we must determine
whether low or undetectable antibody levels increase susceptibility to infec-
tion or whether memory immunity provides protection.
Methods: In a Dutch study in 1999, 429 of the 1847 elderly subjects screened
for all three types of poliomyelitis antibodies were challenged with a stan-
dardized, oral dose of live-attenuated, monovalent poliovirus vaccine (type 1
or 3) and followed for 8weeks. Systemic and local immune responses and
virus excretion were compared for four groups: seronegativity for type 1 or
type 3 polio, natural immunity (seropositivity for all types and no vaccination
history), and IPV immunity (seropositivity for all types and documented
vaccinations).
Results and conclusions: In the quick antibody response and absence of IgM,
the authors see clear evidence of memory immunity in about one-third of the
elderly population without detectable antibodies against type 1 poliovirus. No
evidence of memory immunity was found for another third; and there is no
clarity for the remainder. The evidence of memory immunity for type 3
poliovirus is 5%.
P684 Prevalence of Tetanus immunity in the Kocaeli
Region, Turkey
V. Du¨ndar, Z. Yumuk, D. Ozturk-Dundar, G. Gacar
Kocaeli, TR
Objectives:To detect antibody levels against tetanus in the general population
in Kocaeli region, and its relation to age and gender.
Methods: This study has been performed in Kocaeli University Hospital.
After having received their informed consent, 5mL of blood was taken from
outpatients, ages over 20 years. Serum levels of antitetanus antibodies were
detected by an enzyme-linked immunosorbent assay system (Genzyme
Virotech GmbH, Germany). The procedure was performed as indicated
by the manufacturer. Results were expressed in units based on a standard curve
drawn by using control sera. The results were accepted as follows: <0.15 IU/
mL¼ susceptible, 0.15–1.0 IU/mL¼ basic protection, >1.0 IU/mL¼ full
protection.
Results:Overall, 25.7% of the population had full protective levels of tetanus
antibodies (>1.0 IU/mL). Full protectivity rate was dropped with increasing
age. In the age groups of 21–30, 31–40, 41–50, 51–60 and >61, full
protectivity rates were 63, 43.7, 18.2, 8.5 and 2.8%, respectively. Full
protectivity rates were similar in the male and female population (26.3,
and 25.3%, respectively). In 55.6% of all outpatients, antibody levels were
detected between 0.15 and 1.0 IU/mL accepted as basic protection level. In
the 21–30, 31–40, 41–50, 51–60 and >61 age groups, basic protectivity rates
were 32.6, 52.1, 59.1, 64.1 and 64.8, respectively. In 18.7% of all patients
antibody levels were <0.15 IU/mL accepted as susceptible and at risk. In the
21–30, 31–40, 41–50, 51–60 and >61 age groups, susceptibility rates were
4.3, 4.2, 22.6, 27.3 and 32.3%, respectively. If 0.03 IU/mL is accepted as
treshold value, all 592 tested outpatient were immune against tetanus.
Conclusions: Tetanus is a prime example of a serious preventable disease.
Effective control requires immunizing every individual by vaccination. In
Kocaeli region susceptibility to tetanus (antibody levels <0.15 IU/mL)
increases signiﬁcantly (P< 0.001) over than 41 years of age. These data
suggest that routine booster immunization should be programmed every
10 years over than 40 years of age.
P685 Placental transfer of total immunoglobulin G and
subclasses in a Turkish population
H. Akbulut, I. Celik, E. Sapmaz, A. Godekmerdan, A. Celik
Elazig, TR
Objectives:Maternal immunoglobulin G (IgG) transferred across the placenta
to the fetus during intrauterine life. It is a remarkable component for newborn
defense mechanism against infection. There are numerous publications on
IgG subclass levels in different populations. Therefore, we investigated
placental transfer of total IgG and IgG subclasses in a Turkish population.
Methods:The concentrations of total IgG and its four subclasses were studied
in 103 pairs of maternal and cord blood samples from pregnancies of various
gestational ages ranging from 32 to 42weeks. Total IgG values were studied by
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using the method of turbidimetric assay and IgG subclasses by radial immuno-
diffusion and the results were compared.
Results: The mean ratios of all IgG subclasses were positively correlated to
gestational age. Total IgG values were found at cord blood samples greater
than maternal serum samples (Table 1).
The mean values of cord/maternal concentration ratios of IgG subclasses at
32–42weeks gestational ages were as follows: IgG1 (1.19) >IgG3 (0.95) and
IgG4 (1.15) >IgG2 (0.81).
Conclusion: It was established that the transfer of IgG1 and IgG4 rates were
found to be signiﬁcantly more capable than that of IgG2 and IgG3 rates were
the least capably transferred from mother to fetus. The different results as to
placental transfer of IgG subclasses in the literature might be due to different
maternal IgG subclass serum levels in the populations studied.
P686 Serum neopterin levels in patients with brucellosis
H. Akbulut, I. Celik, A. Akbulut, P. Yuce, S. Kilic
Elazig, TR
Objectives: Brucella species are facultative intracellular pathogens capable of
surviving and replicating within phagocytes. Brucellae ingested by macro-
phages are not killed by polymorphonuclear leukocytes. Neopterin is released
from monocytes and macrophages by stimulation with viruses and intracel-
lular bacteria likeM. tuberculosis. Neopterin can be used as a sensitive marker at
cellular immunity. The purpose of this study was to evaluate the importance
of neopterin levels for diagnosis, follow up and chronicity of brucellosis.
Methods:A total of 30 patients whose clinical ﬁndings and Brucella standard
tube agglutination tests were positive were included in the study. Nineteen of
the patients were male and 11 of them were female. The control group was
composed of 30 healthy subjects (15 male, 15 female). The patients who had
any infection, malignity and major surgical attempt were not included the
study. The blood samples were collected from the patients under appropriate
conditions, and centrifuged at 2000 r.p.m. for 20min, and stored at 208C
immediately until anlyzed. Neopterin levels were measured by ELISA
according to the protocol of manufacturer by Brahms Diagnostica GmbH
(Berlin, Germany).
Results:Mean neopterin level was 54.15 33.66 nmol/L at study groups and
8.75 2.48 nmol/L at controls (P< 0.001). It was determined that the
neopterin levels measured at application time of the patients had a linear
correlation between the length of complaint (r¼ 0.560, P¼ 0.001, Spear-
man’s rank test.). While the mean neopterin level at the patients whose
complaints were more than 30 days was 79.09 34.91 nmol/L, and it was
39.71 23.41 nmol/L at the patients whose complaints fewer or equal to
30 days (P¼ 0.002). There were no correlation between neopterin levels with
Brucella standard tube agglutination test, 2-mercaptoethanol test, erythrocyte
sedimentation rate and C-reactive protein levels.
Conclusion: It was concluded that the neopterin levels are increased at patients
with brucellosis and it will be a supportive marker for diagnosis. In addition it
was thought that continuing high levels of neopterin after 30th days of the
disease could be an early marker for determining the chronicity of the
brucellosis.
P687 Anticardiolipin and Beta2-Glycoprotein I
antibodies in Greek patients with chronic hepatitis
C and B (Hbeag Negative) virus infection
A. Pavlitou-Tsiontsi, G. Germanidis, A. Giannakou, J. Xanthakis,
A. Gantzarou, V. Galanopoulou, R. Zilidou, A. Fleva, E. Pagkalos
Thessaloniki, GR
Aim of the study: To determine the prevalence of anticardiolipin (aCL)
and antibeta2-glycoprotein I (antibeta2GPI) antibodies in Greek patients
with chronic hepatitis C and chronic hepatitis B (HBeAg negative) virus
infection.
Patients and methods: Fifty-one (51) consecutive patients with biopsy
proven chronic hepatitis C and HCV RNA positive in serum were studied.
In eight patients the histological diagnosis was cirrhosis (15.7%). Forty-one
(41) patients are actually on treatment. Twenty-four (24) consecutive patients
with biopsy proven chronic hepatitis B (HBeAg negative) and HBV DNA
positive in serum were also studied. Ten (10) patients (41.7%) were cirrhotic
and 20 are actually on treatment. IgG and IgM aCL and anti beta2GPI
antibodies in serum samples before and at 6months during treatment, were
measured by ELISA. A wide spectrum of autoantibodies were also tested.
Results: In chronic hepatitis C patients, IgG-aCL antibodies were positive in
1/51 (2%). IgM antibeta2GPI antibodies were positive in another patient
1/51 (2%). ANA> 1/160 in 3/51 (6%), ASMA >1/80 in 13/51 (25%),
RF> 100 IU/mL in 6/51 (12%) and anti-TPO> 100 IU/mL in 3/51 (6%)
were also detected. In chronic hepatitis B patients, IgM-aCL antibodies were
positive in 1/24 (4%). ANA> 1/160 in 1/24 (4%), ASMA> 1/80 in 11/24
(46%), RF> 100 IU/mL in 10/24 (41.7%) were also detected. No antibody
reactivity has changed during treatment. The positive detection of aCL and
antibeta2GPI antibodies was not correlated with any clinical manifestation.
Conclusion: The prevalence of aCL and antibeta2GPI antibodies in Greek
patients with well characterized chronic hepatitis C and B is not signiﬁcant
and does not change during treatment. Their presence is not correlated with
any clinical manifestation.
P688 HLA-B27 antigen and brucellosis
E. Tanyel, G. T. Ertem, G. B. Ulkar, N. Tulek
Ankara, TR
Objectives: Osteoarticular involvement is a common complication of bru-
cellosis including arthralgia, sacroileitis, spondylitis and arthritic episodes.
Some of the symptoms resemble those associated with the reactive spondyo-
larthropathies, which are associated with an increased frequency of the
histocompatibility antigen HLA-B27. There were few conﬂicting reports
about association between osteoarticular brucellosis and HLA-B27. In this
study, we aimed to ﬁnd that whether the occurence of osteoarticular
brucellosis could be predisposed by HLA-B27 antigen or not.
Methods: Seventy-eight patients with brucellosis followed up between April
1999 and April 2002 in our department, were included in this study. The
mean of age the patients was 43 years (range: 15–73 years). Brucellosis was
diagnosed with the following criteria: (i) clinical picture compatible with
brucellosis and (ii) standard tube agglutination 1/160 titers and/or (iii)
isolation of Brucella species from blood and/or bone marrow culture. Osteoar-
ticular complications were considered to be present if there were obvious
inﬂammatory signs in any peripheral joint, or unrelieved pain at rest in any
deep joint with radiographic evidence of abnormalities. Detection of HLA-
B27 antigen made by microlymphositic cytotoxicity method in peripheric
blood. One hundred unrelated healthy individuals served as controls.
Results: Osteoarticular complications were deﬁned in 25 of 78 patients
(32.1%). The most observed complications were spondylitis (44%) and
sacroiliitis (28%). The frequency of HLA-B27 was 14.1% (11/78) in all
patients, while 8% in control group. It was 16% (4/25) in patients with
osteoarticular brucellosis. Although HLA-B27 frequency in this group was
slightly higher than those of others, there was no signiﬁcant difference
between patients with and without osteoarticular manifestations and healthy
control group (P> 0.05).
Conclusion: We could not ﬁnd any association between HLA-B27 antigen
frequency and osteoarticular brucellosis.
P689 Ciproﬂoxacin, moxiﬂoxacin and clarithromycin
alter Th cell interferon gamma and interleukin-4 expression
A. Williams, H. Galley, N. Webster
Aberdeen, UK
Objectives: Quinolone and macrolide antibiotics are routinely used for the
treatment of critically ill patients with sepsis. These antibiotics modulate
aspects of immune cell function [1,2]. Alteration in the proﬁle of T helper cell
cytokine expression will affect the Th1/Th2 proﬁle and have knock-on
effects on subsequent immune responses [3]. We examined the effect of
increasing concentrations of ciproﬂoxacin, moxiﬂoxacin and clarithromycin
on Th cell cytokine expression.
Table 1 Mean immunoglobulin levels at mother and cord blood samples and statistical
differences
IgG subgroups Maternal blood Cord blood P
IgG1 8.47 2.63 10.08 2.95 0.0001
IgG2 3.65 1.45 2.96 1.33 0.0001
IgG3 0.79 0.33 0.75 0.32 0.02
IgG4 0.45 0.37 0.52 0.44 0.004
Total IgG 11.56 4.25 12.62 4.87 0.003
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Methods: Following ethical committee approval and informed consent,
mononuclear cells were isolated from 20 healthy volunteers aged 20–48 years
using single density gradient centrifugation. Cells were incubated for 4 h with
ciproﬂoxacin (0–100 mg/mL), moxiﬂoxacin (0–50mg/mL) or clarithromycin
(0–125mg/mL) and stimulated with PMA/ionomycin in the presence of
monensin. Cells were stained with antibodies to CD3 and CD4, prior to
permeabilisation with saponin and intracellular staining with anti-IL-4 and
anti-IFNg, and ﬂow cytometric analysis. Data are expressed as median
percentage of CD3þ/CD4þ and either IL-4þ or IFNgþ cells and were
analyzed by Friedman analysis of variance with Wilcoxon signed ranks post
hoc testing.
Results: Both moxiﬂoxacin and ciproﬂoxacin dose dependently decreased
IFNg and IL-4 expression by Th cells (both P< 0.0001). Only IL-4 expres-
sion, however, was affected by clarithromycin (P¼ 0.04). There was no
signiﬁcant change in IFNg/IL-4 expression (Th1/Th2 ratio) for moxiﬂoxacin
or ciproﬂoxacin, but the Th1/Th2 ratio increased with increasing concen-
trations of clarithromycin, from a median [range] of 5.3 [13–16.0] to 9.1 [1.8–
18.8] (P¼ 0.017).
Conclusion: The quinolone antibiotics moxiﬂoxacin and ciproﬂoxacin have
pronounced effects on both Th1 and Th2 cytokine expression, without
altering Th1/Th2 ratios. However clarithromycin decreased IL-4 but not
IFNg expression such that the Th1/Th2 ratio increased. Since a predomi-
nantly Th1 proﬁle is considered favourable for resolution of acute infection,
elucidation of the immunomodulatory proﬁles of antibiotics may in the future
permit more rational antibiotic choice in critically ill patients.
Acknowledgement: We are grateful to Bayer Plc for ﬁnancial support.
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P690 Cytokines and disseminated intravascular
coagulation in sepsis
A. Lekkou, A. Mouzaki, D. Siagris, H. P. Bassaris, C. A. Gogos
Patras, GR
Objectives: To investigate the relationships between tumor necrosis factor-
alpha (TNF-alpha), interleukin (IL)-6, IL-10, transforming growth factor-
beta (TGF-beta) and disseminated intravascular coagulation (DIC) in
sepsis.
Patients: Methods: 30 patients (17 males, 13 females, mean age 69.8
8.5 years) with severe sepsis (septic SIRS plus at least one organ dysfunction)
were studied. The etiology of sepsis was: skin or joint infection (n¼ 5),
pneumonia (n¼ 10), lung abscess (n¼ 1), pyelonephritis (n¼ 6), intra-abdom-
inal infection (n¼ 8). The control group included 10 healthy subjects (sixmales,
four females, mean age 66.5 7.2 years). Serum cytokine levels were deter-
mined by using Elisa (Quantikine, R&D Systems, Minneapolis) on admission,
on days 3, 10, 13 and on discharge.
Criteria for dic were: platelets <150 000/mm3, prothrombin time >15 s,
ﬁbrinogen <160mg/dL, ﬁbrin degradation products >10mg/mL.
Results: Fifteen patients fulﬁlled the criteria for DIC. InDIC patients (group A)
TNF-alpha levels were signiﬁcantly higher than to non-DIC patients (group B)
on admission [median (m)¼ 110.90; range (r)¼ 113.16 vs. m¼ 58.09;
r¼ 105.03 pg/mL, P¼ 0.022] and on day 10 (m¼ 133.24; r¼ 87.43 vs.
m¼ 44.89; r¼ 89.27, P¼ 0.02). We also found IL-6 levels signiﬁcantly higher
in group A compared with group B on admission (m¼ 214.28; r¼ 380.94 vs.
m¼ 80.28; r¼ 240.02 pg/mL,P¼ 0.045) and on day 3 (m¼ 131.85; r¼ 371.78
vs. m¼ 64.20; r¼ 154.02, P¼ 0.028). On admission TGF-beta levels were
detected signiﬁcantly lower in DIC-group (m¼ 21116.97; r¼ 3477.46 vs.
m¼ 39 499.20; r¼ 6838.90pg/mL, P¼ 0.004). No signiﬁcant difference was
found in IL-10 levels between the two groups. Logistic regression analysis
demonstrated TNF-alpha levels on admission as sign prognostic factor for the
development of DIC (odds ratio, 1:0001; 95% conﬁdence intervals, 1.0000–
1.0002, P¼ 0.015).
Conclusion: Pro-inﬂammatory cytokines, like TNF-alpha and IL-6, seem to
be remarkable factors for development of DIC in sepsis. On the contrary
TGF-beta may acts as an anticoagulant cytokine, reducing the effect of pro-
inﬂammatory cytokines.
P691 Local and peripheral pro-inﬂammatory cytokine
concentration in otitis media; possible Mycoplasma
pneumoniae coinfection
G. Niedzielska, M. Koziol-Montewka, J. Niedzwiadek, E. Mazur,
A. Szczepanik, A. Niedzielski, W. Kusa
Lublin, PL
Background: Chronic otitis media with effusion (COME) often affects
children. The development of COME is one of the most common con-
sequences of the lack or inappropriate treatment of acute otitis media. COME
is associated with retention of inﬂammatory mediators and cells in the middle
ear cleft. Retention of effusion causes a change of an inactive mucoperiosteum
in a secretory epithelium. It is associated with ongoing inﬂammation with the
potential for pathologic changes and hearing loss. Mycoplasma pneumoniae
(M.p) and Chlamydia pneumoniae (Ch.p), common pathogens of the human
respiratory tract, have been reported to play an important role in the
pathogenensis of many respiratory diseases including otitis media.
Objective: The aims of the study were to measure levels of inﬂammatory
cytokines (IFN-g, TNF-a and IL-8) in middle ear effusions (MEE) and in
serum samples with respect to their reciprocal relations and their dependence
upon degree of hearing loss and to evaluate serological markers of M.p. and
Ch.p. infections in patients with COME.
Methods: Serum samples were obtained from 23 children (2–14 years of age)
with COME. All patients suffered from hearing loss lasting 2–24months.
Concentrations of cytokines were measured by ELISA. This method was also
used to detect IgM and IgG directed against M.p. IgG and IgA against Ch.p.
were detected by MIF test.
Results: TNF-a and IFN-g concentrations in MEE were comparable to their
levels in serum. IL-8 concentration in MEE was signiﬁcantly increased with
respect to its concentration in serum (414 pg/mL-left ear, 314.1 pg/mL-right
ear vs. 6.9 pg/mL in serum). Concentration of cytokines depending on the
degree of hearing loss was compared. In children with hearing loss >20 dB
levels of IL-8 and TNF-a in MEE were about twice higher in comparison
with samples obtained from children with hearing loss <20 dB. Antibody
titers consistent with Ch.p. infection were found in one child (4.3%). M.p.
speciﬁc antibodies were detected in nine children (39.1%). The simultaneous
presence of M.p. speciﬁc signiﬁcant levels of IgG and IgM was detected in
three children.
Conclusions: Persistently high levels of IL-8 in middle ear effusions suggest a
close connection between IL-8 concentrations and the development and
persistence of hearing loss. High incidence ofM.p. speciﬁc antibodies suggests
a possible contribution of this pathogen to the pathogenesis of COME.
P692 Do reactive nitrogen intermediates take part in
elimination of Staphylococcus aureus during chronic
staphylococcal infections of the upper respiratory tract?
E. Kosior-Jarecka, M. Koziol-Montewka, A. Sidor-Wojtowicz
Lublin, PL
Objective: Chronic staphylococcal infections of upper respiratory tract con-
stitute a common therapeutic problem and may indicate any defect in host
defense. The persistence of infection may be connected with intracellular
survival of Staphylococcus aureus. Nitric oxide and reactive nitrogen inter-
mediates are reported to be important in the protection against Staphylococcus
aureus and in host defense against intracellular pathogens. The aim of the study
was to evaluate nitric oxide concentartions in plasma of patients with chronic
staphylococcal infections of upper respiratory tract. In vitro studies were
performed to assess capacity for NO production after stimulation of patient’s
blood by stimulus which had caused the infection.
Methods: The concentrations of nitrite in blood plasma of 19 patients with
chronic staphylococcal infections of upper respiratory tract and 15 healthy
volunteers weremeasured by colorometric method using Griess reaction. The
synthesis of nitric oxide was activated in vitro in the samples of blood by
incubation with staphylococcal strain isolated from swabs of patient’s nose and
throat or with model staphylococcal strain ATCC 25923 in control group.
After induction the concentration of nitrite was measured in supernatant.
Results: Initial NO concentrations in group of patients were very varied
(mean 20.99 mmol/L), whereas in control group the concentrations were
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signiﬁcantly lower (mean 0.06 mmol/L). After stimulation by staphylococcal
strain NO concentrations have increased to small extent in group of patients,
while in control group no changes were observed.
Conclusions:During chronic staphylococcal infection occurs elevated produc-
tion of NO and increased readiness to NO production by leukocytes after
stimulation in comparison to acute inﬂammatory response. It indicates possible
participation of reactive nitrogen intermediates in organism defense during
chronic staphylococcal infections as an auxiliary mechanism of oxygen burst.
P693 Long-term primary CD4 lymphocytopenia
associated with spastic paraparesis and conjunctival
microangiopathy. A rare syndrome of unknown
pathogenesis and outcome
R. Manfredi, L. Calza, F. Chiodo
Bologna, I
Introduction: The syndrome of idiopathic CD4þ T-lymphocytopenia
(ICTL) has been classiﬁed by both CDC and WHO as a distinct nosological
feature: it was deﬁned by a CD4 count<300 cells/mL and/or<20% of T cells,
and a CD4:CD8 ratio<1, in absence of a known cause of immunodeﬁciency.
A unique case report of a patient (p) with an ICTL of 10-year duration
associated with an unexplained paraparesis and a conjunctival microangio-
pathy is reported and discussed on the ground of literature evidences.
Case report: A non-HIV-infected female p followed for a decade with an
extremely severe ICTL (as expressed by a CD4 count of 8–25 cells/mL), and
an isolated spastic paraparesis and a conjunctival ischemic microangiopathy is
described. Despite a deep and prolonged immunodeﬁciency, no opportunistic
disease (OD) occurred in a period of observation longer than ever reported.
The paraparesis was diagnosed concurrently with ICTL, while ocular com-
plication occurred 2 years later, but remained stable thereafter. Both disorders
had no relevant changes during the subsequent 8 years. Notwithstanding an
extensive workout, very limited immunologic abnormalities were detected
(besides the extremely low CD4 count), and no apparent explaination was
found for the disabling paraparesis. Repeated cranio-encephalic and lumbar
spine TC, MRI, and PET scans proved normal, while a predominantly motor
peripheral neuropathy was found. Autoimmune, endocrinologic, and col-
lagen vascular disorders, Wegener’s granulomatosis and Behc¸et disease were
carefully excluded. Chemotaxis, phagocytosis and killing of neutrophils and
macrophages did not show anomalies as well as in vitro lymphoproliferative
assays and lymphocyte apoptosis.
Discussion: ICTL, whose pathogenesis warrants careful investigation, has
been associated with a broad clinical spectrum, ranging from negligible or no
disturbances, to severe lymphoproliferative disorders, OD, and other focal
diseases, including neurological ones. Our case report of ICTL appears
signiﬁcantly different from all other literature reports. A decade follow-up
was never described, and despite a CD4 count persistingly<25 cells/mL, OD
never occurred.The prominent paraparesis was quoted one time only, while a
ICTL-associated conjunctival microangiopathy was never described. The
association of a long-lasting deep CD4 lymphocyte depletion in absence of
any OD or neoplasm, and long-term isolated and stable paraparesis and
conjunctival angiopathy, represents an absolutely exceptional ﬁnding.
P694 Pulsed-ﬁeld gel electrophoresis demonstrated
genetic diversity in a maxillary abscess
of Prevotella nigrescens
L. T. Zabel
Goeppingen, D
Objectives: Anaerobic infections like abscesses due to Prevotella nigrescens in
previously sterile environments may be the result of ecological formation in
dependence of the time. This must inevitably result in genetic rearrangements
of the species. Therefore strain diversity of various colonies of P. nigrescens from
two single infections was determined.
Methods: Pulsed ﬁeld gel electrophoresis (PFGE) was applied to strains of
P. nigrescens isolated from cultures of a patient with maxillary abscess and a
patient with an acute peritonitis. Up to seven colonies from each culture plate
were examined and compared with the typing results of arbitrarily primed
PCR (AP-PCR). Coaggregation experiments were performed with these
strains using a panel of Streptococci, including clinical strains of S. mitis and S.
bovis, and the reference strains S. parasanguinis DSM 6778, S. gordonii DSM
6777, S. sobrinus DSM 20742, S. salivarius DSM 20560, and S. mutans DSM
20523 as coaggregation partners.
Results:The patterns of single strains of the maxillary abscess differed by more
than three bands in the PFGE. These differences were not seen in the AP-
PCR. Strains isolated from the patient with acute peritonitis demonstrated no
differences in either method. Moderate coaggregation was seen between S.
parasanguinis and S. gordonae and all strains of the maxillary abscess, but only
three strains showed weak to moderate coaggregation with S. mitis. All strains
isolated from the patient with peritonitis demonstrated strong coaggregation
with S. mitis, S. parasanguinis, and with S. bovis.
Conclusions: Orofacial infections may be the result of chronic infection
allowing strains to develop single genetic events. PFGE is more discriminative
than AP-PCR to detect such events. The coaggregation may be of advantage
in colonising compartments other than the oral cavity. The coaggregation of
P. nigrescens isolated from the patient with peritonitis to S. bovis reﬂects the
adaptation of this predominantly oral species to the intestinal ﬂora.
Environmental epidemiology of fungi
P695 A survey on pathogenic fungi in potted plants
from a hospital environment – Sari, Iran
A. Mohseni Bandpay, M. T. Hedayati, S. Moradi
Sari, IR
Objectives: The aim of this study was to analyze the soil collected from the
potted plants in the hospitals for pathogenic fungi.
Methods: A total of 23 soil samples of potted plants were collected from Sari
hospitals. Each sample contained about 200 g of soil, taken from a 0–10 cm
depth. Then, samples were analyzed by two different methods: (1) About 50 g
of samples were suspended in distilled water and were shaken vigorously for
10min at room temperature, and allowed to settle for another 10min.
Supernatant was inoculated on to the Sabouraud’s dextrose agar (S) supple-
mented with chloramphenicol (SC) and chloramphenicol and cycloheximide
(SCC), and plates were incubated at room temperature for 4weeks. During
this period, the grown fungi was identiﬁed by macroscopic and microscopic
characterization. (2) The keratin-baiting technique was used for isolation of
keratinophilic fungi; therefore, approximately 50 g of each samples was placed
into empty sterile Petri dishes, mixed with sterilized hair, and cut into small
pieces. The presence of keratinophilic fungi was conﬁrmed by low-power
microscopic examination. Fragments on colonized hair were inoculated on to
see and incubate for 2weeks at room temperature.
Results: In one method, 100% of plates were positive for fungal growth and a
total of 1150 colonies with 13 different type of fungi were isolated. Penicillium
spp. (52.35%), Paecilomyces spp. (11.91%), Cladsporium spp. (3.74%), and
Aspergillus spp. (3.13%) were predominant fungi. Rhizopus spp. was the
uncommon. In this study, Microsporum gepseum, M. cookei, and Chrysosporium
spp. were identiﬁed as keratinophilic fungi.
Conclusion: The presence of pathogenic fungi such as Cladosporium, Asper-
gillus, M. gepseum, and M. cookei in hospitals that isolated from this study are
risk factor for patients.
P696 Is drinking water a potential vehicle for
community-acquired aspergillosis? A study of water-borne
Aspergillus species in the Province of Madrid
J. Guinea Ortega, T. Pela´ez, O. Cuevas, L. Alcala, P. Mun˜oz, J. Blanco,
E. Bouza
Madrid, E
Objective: The presence of conidia in bathrooms has recently been reported
as a potential vehicle of spores causing community or nosocomially acquired
invasive aspergillosis. The aim of our study was to determine the presence of
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Aspergillus spp. spores in drinking water during different seasons across the
province of Madrid (Spain).
Methods: We collected samples of drinking water from 37 taps across the
province of Madrid where water is collected from 14 water reservoirs located
in the mountains. Twelve stations treat the water and turn crude water into
drinking water. From here, drinking water is kept in 22 deposits distributed
throughout the Province, and these provide water for every dwelling in the
Province. The selected taps were as follows: 19 taps located at the private
residences (bathrooms and kitchens) of workers in our laboratory, 11 from
fountains (10 of drinking water and 1 from an ornamental fountain) located in
city squares, 5 were from the bathroom (3 located at pubs and 2 from petrol
stations), and the last 2 located in two different laboratories. Every tap was
tested twice, in August (summer) and inNovember (autumn), to obtain a total
of 74 water samples. The samples were collected after letting the water run for
5min to clean stagnant water from the pipe. We took 500mL of water per
sample, each of which was transported in sterile vacuums, and these were kept
at 48C until processing. Each sample was ﬁltered by means of Millipore ﬁlters
(Microﬁl TM V, 0.45mm diameter pore). The ﬁlters were removed from the
ﬁltration structure and put over the surface of Sabouraud-chloramphenicol
agar plates and incubated at 358C for 7 days. The plates were checked daily to
observe the growth of fungi.
Results: None of drinking water samples were positive for Aspergillus spp.
either in summer or in autumn. The only positive sample was the water
obtained from the ornamental fountain, showing growth for Aspergillus niger
and dematiaceous fungi.
Conclusions: Although water-borne Aspergillus spp. conidia transmission has
recently been reported, we did not ﬁnd any samples in drinking water, and
only one positive sample at a non-drinking water point was found. The
deposits in the Province are exposed to air (a main source of conidia), and we
did not ﬁnd the presence of spores in any selected tap. Our data did not
support the idea of the presence of conidia in drinking water as a potential
vehicle of spores causing invasive aspergillosis.
P697 Public awareness of the risks and spread of fungal
infections
A. Kimera Kyakoonye
Kampala, UG
Objectives:Control of fungal infections in women, especially young mothers
and teenagers.
Methods:A survey carried out in May 2002 by community health workers in
Uganda Makindye division indicates that 80% of women and pregnant
mothers in this area have the problem of fungal infections, especially candiasis.
Bukasa development group have gone around sensitizing women and reassur-
ing them that fungal infections are common and are not acquired through
sexual relations and that they should avoid using dirty and contaminated
toilets. We advised them to stop decieving health workers when they go to
clinics; they must tell the truth so that they can get the right medications and
doses. They should not fear to go to clinics to be checked and advised by
doctors. We teach them how to handle their underware and other clothes by
washing with soap, drying them in sunshine, and ironing them before use,
they should keep their bodies and private parts clean and dry.
Results: Women, especially young mothers and teenagers, have started
coming to our clinics and they explain their difﬁculties with conﬁdence.
This has helped the medical workers to ﬁnd out the different types of fungal
infections and how to treat them.
Conclusions: The rate of fungal infections can be decreased if many projects
come out to sensitize the community about this problem. Even local leaders
and the press should keep on advertising and encouraging the people so that
even those who are infected and are fearing to be known should come out and
get treated.
P698 Dermatophyte fungi contaminations in 16 public
bathrooms in Golpayegan, Iran
H. Novrouzi, S. Alavi, M. G. Shoar, P. Behzadi
Tehran, IR
It has been established that bathrooms contribute to the spread of derma-
tophytosis in susceptible hosts. The recent studies indicate that the infection of
dermatophytosis is increasing in different cities of Iran, but the species of the
fungal agent in each city is different. The fungal contamination of 16 indoor
public bathrooms was investigated by the method of carpet sampling. Two
hundred and twenty-four samples from the ﬂoor, slippers, dressing rooms, and
related areas of each bathroom were tested for the presence of dermatophyte
fungi in different places of the city. In this investigation, different dermato-
phytes such as Trichopyton rubrum and T.mentagrophytes were observed in very
low level, but the most common dermatophyte recovered was Microsporum
gypseum. M. gypseum is a geophilic dermatophyte and it seems that the reason
of high-level spreading of this fungus in the city is because of materials that are
used in bathroom buildings (clay and straw) and special climate conditions of
Golpayegan. The fungal contamination of these bathrooms under speciﬁc
conditions could be an alarm for induction of dermatophytosis in compro-
mised and susceptible hosts.
Nosocomial infections
P699 Vaginal colonization in patients before
gynecological procedures
A. Samet, J. Komarnicka, R. Debski, A. Spaczynski, J. Emerich,
A. Dudziak
Gdansk, Warsaw, Poznan, PL
Objective:Analysis of vaginal ﬂora in women with different diseases, without
previous antibiotics, before different gynecological operations.
Methods:We studiedmicrobiological results of vaginal swabs from 62 patients
aged 22–83 years, admitted to a three tertiary care hospitals. Samples were
collected in operating room, before performing povidone–iodine (Betadine–
Egis) antisepsis procedures. Isolation and identiﬁcation were performed by
standard methods and VITEK system (Biomerieux).
Results: We examined 62 women with: Ca corporis uteri, 8; Ca colli uteri,
14; Myomata uteri, 15; Ca ovariorum, 9; Cystis ovarii, 9; Tu vaginae,
Sterilitas, 2; Graviditas extrauterina, 1; Descensus uteri, 3. Lactobacillus sp.
was isolated in 38 cases (61% women) and S. epidermidis in 25–40%. Other
isolated microorganisms were: Escherichia coli – 32 (52%) patients, Enterococcus
faecalis – 29 (45%), Streptococcus agalactiae – 17 (27%), Gardnerella vaginalis – 13
(21%), Staphylococcus aureus – 8 (11.2%), Candida albicans – 14 (22.5%),
Ureaplasma urealyticum – 15 (24%), Mycoplasma hominis – 3, Prevotella spp. –
8, Peptostreptococcus spp. – 7, and 14 other isolates.
Conclusions: In such a group of women, the natural vaginal microﬂora is
changed, perhaps due to underlying disease. Lactobacillus sp. was present in
only 61% examined women. Other isolated bacteria should be considered as
potential causes of postoperative infections.
P700 Postoperative infections caused by mycoplasma
in patients after gynecological procedures
A. Samet, M. Kochowska-Bronk, M. Bronk, J. Emerich, L. Naumiuk
Gdansk, PL
Objectives: To characterize the infections caused by Ureaplasma urealyti-
cum (U.u.) and Mycolasma hominis (M.h.) in patients after gynecological
operations.
Methods:During 1 year, there were four patients with signs of infection after
caesarean section and negative standard aerobical, anaerobical, and mycolo-
gical cultures. Wound exudates, vaginal swabs, and urine were cultured on A7
medium and Mycoplasma IST test (Biomerieux) which detects the presence
of Mycoplasms and determines their antimicrobial susceptibility. A7 cultures
were incubated in 378C in microaeroﬁlic bags for 48 h.
Results: Both A7 and Mycoplasma IST tests were positive in four patients.
The culture results are presented below in the Table 1.
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Conclusions: M. hominis and U. urealyticum are capable of causing serious
infections in patients after gynecological procedures. In case of negative
standard cultures, the presence of mycoplasma should be suspected and
appropriate media inoculated.
P701 Immunobiological preparations in complex of
treatment and sanitary measures in obstetric practice
K. Sokolova, V. Anastasiev, I. Solovyeva, O. Milovidova
N Novgorod, RUS
Objectives: The active introduction of a new medical technology in the
obstetrical pediatric practice such as using a new forms of the immunobio-
logical preparations being developed on the basis of studying natural mechan-
isms of the human organism protection is carried out for perfecting perinatal
care for the women who are going to have babies, pregnant women, and their
neonates from the risk group of the infectional pathology.
Methods: The newly developed immunoglobulin preparation with the
monomeric form of IgG features the pronounced treatment and prophylactic
action as it permits a prolonged circulation of IgG in the blood channel to be
achieved. The selection of production-perspective bacterium strains the
representatives of the obligate human microﬂora on the basis of studying
their antagonistic activity to pathogenic and conditioned pathogenic micro-
organisms, adhesivneness, and resistence taking into account biotechnological
characteristics (rate of increasing biomass, duration of storage and, etc.)
permits a new manycomponent eubiotic from lacto- and biﬁdobacteria on
nonallergic basis to be developed.
Results: The immunoglobulin for intravenous injection has been included in
the standard complex of antibactericides for the prophylaxis of the possiblity
of infecting a women in child birth in the case of premature birth with tearing
amnion membranes at temporizing tactics and also for the prevention of
developing and generalizating the infectious pathology in premature infants
and neonates with the low birth weight. The normaﬂora preparations in
general use for the women who are going to have babies, pregnant women,
the women in childbirth, and neonates depending upon the character of
recognized disorders in their microﬂoras. Eubiotics being developed from
lactobacilli are preferable for vaginomicroﬂora disorders.
Conclusions: The use of a new form of imunobiological preparation permits
reduction of the infectious morbidity in perinatal stage to be achieved.
P702 Urinary pathogens and their in vitro
susceptibility to antibiotics
E. Chinou, A. Georgouli, N. Trombouki, E. Skouteli, P. Golemati
Piraeus, GR
Objectives:To determine the susceptibility of urinary pathogens isolated from
semiquantitative cultures toward common antibiotics.
Methods: Over 2 years, we tested the susceptibility of 1072 bacterial strains
isolated from urine specimens of inpatients to the most common antimicrobial
agents. The susceptibility test was determined by the agar disk diffusion
method.
Results: Coli forms remained the commonest pathogen, being (64.1%) of
isolates. Second most common was Enterococcus spp. (18%) and it was closely
followed by Pseudomonas spp. (12.2%). Coagulase-negative staphylococci and
Staphylococcus aureuswere the other main pathogens which remained at 3.3 and
2.2%, respectively. In terms of percentage sensitivities of E. coli to antibiotics,
ciproﬂoxacin amoxicillin/clavulanic acid and amikacin covered the highest
proportion of pathogens at 87, 80, and 87%, respectively. Enterococcus strains
were 80% sensitive to amoxicillin/clavulanic acid and 100% sensitive to
glycopeptides. Pseudomonas aeruginosa strains were sensitive to imipenem
(80%), ciproﬂoxacin (65%), and amikacin (80%).
Conclusion: E. coli was identiﬁed as the chief causative agent of urinary tract
infections. Monobacterial infection was observed in the majority of cases.
Quinolone beta lactame and aminoglycoside antibiotics remain the ﬁrst
choice of U.T.I.
P703 Monitoring of bacterial origin systemic
inﬂammatory response syndrome marker procalcitonin in
cardiac surgery with cardiopulmonary bypass
D. A. Popov, N. V. Beloborodova
Moscow, RUS
Objectives: To study the correlation between manifestation of systemic
inﬂammatory response syndrome (SIRS) symptoms and concentration of
procalcitonin (PCT) in blood plasma in perioperative period in cardiac
surgery – the analysis of results of the ﬁrst experience.
Methods: Fifteen high-risk patients with the acquired heart diseases before
and after surgery with cardiopulmonary bypass (CPB) were enrolled in the
study (mean age 50 9.8 years). Eighty-one assays of PCTwere made using
the immunoluminometric method (PCT LumiTEST BRAHMSDiagnostica
GmbH, luminometer Lumat LB 9507 Berthold Technologies GmbH). SIRS
was deﬁned according to the classiﬁcation of the Society of Critical Care
Medicine Consensus Conference, 1997.
Results:There were no cases of SIRS before surgery; PCT concentration did
not exceed 0.5 ng/mL (in average 0.32 0.05 ng/mL). Following SIRS
manifestations during the ﬁrst 24 h after surgery, the patients were divided
into two groups: group I – without SIRS, group II – with SIRS. Serial PCT
tests in early postoperative period on 2nd, 3rd, and 6th days after surgery
demonstrated faster decrease and normalization of the PCT concentration in
blood plasma of patients of group I in comparison with the group II. There
were no postoperative complications in group I. In group II PCT concen-
trations were higher and remained elevated for a longer period of time than in
group I. Three patients from group II developed lethal infectious complica-
tions in early postoperative period: two cases of multiorgan failure (MOF) and
one case of sepsis. There was no signiﬁcant difference in APACHE II scores
between the groups with and without SIRS during the ﬁrst day after surgery
(7 2 in the ﬁrst vs. 9 3 in the second group). This difference in APACHE
II scores between the two groups appeared later following the development of
postoperative complications (Table 1).
Conclusions: The ﬁrst experience of monitoring PCT concentration during
the early postoperative period has revealed the marker’s informative and
prognostic importance in cardiac surgery practice.
P704 Infections after open-heart surgery
C. Ezpeleta, E. Go´mez, C. Busto, I. Atutxa, J. Unzaga, R. Cisterna
Bilbao, E
Objective: To know the rates of NI (nosocomial infection) in patients
operated on open-heart surgery.
Patients andmethods:The 670 patients (pts) operated on open-heart surgery
in our hospital from January 2000 to November 2002 were included.
Preoperative protocol regarding infection control includes: shower with
4% clrohexidine soap the night before surgery and again repeated the day
of surgery. Hair removal immediately before surgery by clipping.
Antibiotic prophylaxis:Cefuroxime 1.5 g. IV/8 h. All the pt are prospectively
studied since the day they are operated until the end of the episode. A
computer based surveillance system INOZ is used during admission and
continued 1 years after discharge. CDC deﬁnitions of nosocomial infection
and NNIS (National Nosocomial Infection Surveillance) score are used.
Results:Age and sex: 461 (68.8%) men, mean age 66.2 years (SD 10.8). Mean
preoperative stay in the hospital 6.2 days (SD 10.4). NNIS score 0, 34 pts;
score 1, 450 pts; score 2, 181 pts, and score 3, 5 pts. Infections at admission: 40
pts (20 urinary tract, 7 respiratory, 2 skin. Nosocomial infections: 144 pts
(21.49%) acquired 197 NI, 35 of them were surgical site infections (SSI): 12
Table 1
Patient No.
Wound Vaginal swab Urine
M.h. U.u. M.h. U.u. M.h. U.u.
1 þþþ - þþ - - -
2 þþþ þþþ þþþ þþþ - -
3 þþ - þþþ - <104 -
4 þþ þþ þþþ þ >104 <104
Table 1 PCT concentration measurements (ng/mL)
Group
Postoperative
complications n Day 1 Day 2 Day 3 Day 6
I (no SIRS) No 8 0.81 0.35 0.69 0.27 0.56 0.15 0.37 0.22
MOF 2 7.52 1.43 7.89 3.87 5.80 1.19 6.35 2.5
II (SIRS) Other complications 5 8.14 7.07 5.96 5.27 6.41 7.19 0.63 0.27
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incisional superﬁcial, 10 deep incisional, and 13 organ space. NNIS score 0,
0%; 1, 4.2%; 2, 7.2%, and 3, 40%.Microorganisms in SSI: S. aureus 5, CNS 11,
polymicrobial 5, S. marcescens 1, P. aeruginosa 1, Propionibacterium 1. Urinary
tract infections (UTI): 53 pts. Etiology: E. coli (17), E. faecalis (11), C. albicans
(4), Serratia (4), and P. aeruginosa (3) were the most frequent etiological agents.
Respiratory infections: 57 pts. Pneumonia: 8 cases. Bacteremia: 17 cases: 3
catheter related, 6 primary, and 8 secondary bacteremias. Microorganisms:
E. coli (4), S. marcescens (4), S. aureus (4), P. aeruginosa (1), S. epidermidis (1),
Candida spp. (1), E. cloacae (1), and Corynebacterium spp. (1).
Conclusions: Nosocomial infections other than SSI are the most frequent
(33% respiratory and 26.9% urinary) infections. Oral clorhexidine rinses are
now being used to decrease the overall incidence of nosocomial respiratory
infections according to the CDC guideline for prevention of nosocomial
pneumonia along with an effort directed to decrease the time on mechanical
ventilation, and a preoperative urine culture to decrease UTI.
P705 The in vitro comparative activity of old and new
quinolones against bacterial isolates from surgical wounds
E. Chinou, A. Georgouli, N. Trombouki, E. Skouteli, P. Golemati
Piraeus, GR
Objectives:The aim of this study was to determine the range of pathogens in
wound swabs, to ascertain the in vitro susceptibility of the isolated bacteria,
and to assess the value of quinolones for clinical use.
Methods: Over a year, we tested the susceptibility of 502 bacterial strains
isolated from conﬁrmed wound infection specimens. For the identiﬁcation of
these bacteria the Api system was used. The susceptibility to antibiotics was
determined by the agar disc diffusion method.
Results:The Gram-negative bacterial strains, 288 (57.1%) predominated over
Gram-positive ones, 214 (42.9%).The distribution of Gram-negative into
different taxons indicates a clear prevalence of enterobacteriaceae (33%) over
Pseudomonas (17.9%) and Acinetobacter (7.5%). S. aureus (20.7%) predominated
among Gram-positive bacteria followed by coagulase-negative staphylococci
(14%) and enterococci (7.7%). The susceptibility of the most commonly
isolated bacteria to ciproﬂoxacin and moxiﬂoxacin were: E. coli (79 and 95%),
P. aeruginosa (65% and 70%), S. aureus (55 and 60%), and C.N.S. (29 and 83%),
respectively.
Conclusion:These results indicate that moxiﬂoxacin is slightly less active than
ciproﬂoxacin thus both quinolones provide superior invitro activity in wound
pathogens compared with usually employed autibiotics.
P706 Cefuroxime prophylaxis is effective in herniated
disk surgery: a double-blind, placebo-controlled study
C. Petignat, G. Zanetti, N. de Tribolet, J. G. Villemure, D. Pittet,
P. Francioli
Lausanne, Geneva, CH
Objective: To assess the efﬁcacy of one single, preoperative, 1.5 g dose of
cefuroxime in preventing surgical site infection after surgery for herniated
disk.
Methods: Patients >18 years undergoing surgery for herniated disk at two
university hospitals from April 1994 to March 2000 were included in a
double-blind, placebo-controlled trial. Surveillance of postoperative infec-
tions was conducted according to criteria derived from the Centers for
Diseases Control and Prevention (Garner et al. 1988) and from a study on
antibiotic prophylaxis in clean surgery (Platt et al. 1990). Standardized
information on signs and symptoms of infection were collected during
hospital stay and at a 6-week follow-up visit by the surgeon, and through
phone calls at 3 and 6months.
Results: Patients allocated to cefuroxime (N¼ 613) or placebo (N¼ 624)
were similar with respect to demographic characteristics, preoperative hospital
stay, number of comorbidities, and type and duration of surgery. Eight (1.3%)
patients in the cefuroxime group and 18 patients (2.9%) in the placebo group
developed a surgical site infection (adjusted OR 2.39; 95% CI: 1.02–5.58;
P¼ 0.044). A diagnosis of spondylodiscitis was made in 9 patients in the
placebo group, but in none in the cefuroxime group (P¼ 0.004). Infection
was diagnosed during hospital stay in 5 patients in the placebo group (two
spondylodiscitis, three wound infections), while all the infections in the
cefuroxime group were diagnosed after hospital discharge. Infection was
microbiologically documented in 12 patients in the 2 groups: 11 were caused
by Gram-positive organisms (S. aureus: 3; coagulase-negative staphylococci: 5;
P. acnes: 2; P. acnes, and coagulase-negative staphylococci: 1).
Conclusions: A single, preoperative dose of cefuroxime signiﬁcantly reduced
the risk for surgical site infection, most notably spondylodiscitis, occurring
after surgery for herniated disk.
P707 Incidence of the site operative infection in
orthopaedic surgery
W. Amhis, M. Mammeri, M. Azizi, M. Naim
Algiers, DZ
Objective: To evaluate the incidence of the site operative infection in two
units of the orthopedic surgery of our hospital.
Methods: All the patients admitted in the two orthopedic surgery units for a
ﬁrst operation and whom stayed more than 48 h in the hospital were recruited
for this study which duration was 3months. The operative wounds were
controled regularly. A swabbing out was done when a discharge appeared on
the wound and addressed immediately to our laboratory. The samples were
tested. The strains isolated were identiﬁed and a susceptibility test according to
NCCLS determined.
Results: Two hundred and thirty patients were hospitalized during the study
period, but only 180 patients were recruited. The sexe ratio was 6.64 in the
unit A and 3.14 in the unit B. The male patients were younger (the mean age
was 35.5 years) than the female patients (the mean age was 49.4 years). The
number of surgeries according to NRCA classiﬁcaionwas 23 (class I), 118 (II),
20 (III), 16 (IV), and 3 (V).The infection rate was equal to 0% for the classes I,
III, and Vand 3.77 and 1.53% for the class II, respectively, in the units A and B,
and 22.22 and 14.28% for the class IV, respectively, in the units A and B. Six
patients out of 180 were infected (3.33%), ﬁve were males and four were
young (<30 years old.).The sex ratio of the infected and non infected patients
was nearly the same. The preoperative hospitalization duration was 10.25 days
for the infected patients and 6.4 days for the non-infected patients.We did not
ﬁnd a signiﬁcant difference between the urgent operations (3.7%) and the
programmed operations (3.33%), but a signiﬁcant difference between the
major surgeons infection rates (3.33–4%) and the young surgeons infection
rates (6.6–16.66%). Ten specimens out of 16 tested were positive. Seven
specimens out of 10 were monomicrobial. Thirteen strains were isolated and
the main agent was Staphylococcus aureus: 91% (7 out of 13). Two S. aureus out
of three were MRSA in the unit A.
Conclusion: The incidence of the site operative infection in our study was
3.33%. It obvious that this rate is may be under the real infection rate because
of the patients with implants. These patients must be controled 1 year later.
The duration of the preoperative hospitalisation and the insufﬁscent experi-
ence of the surgeons were the two major risk factors found in our study.
S. aureus is the most frequently isolated agent in the two units. In the unit Awe
isolated 2 MRSA, so measures must be taken to limit its diffusion.
P708 Outbreak of nosocomial aspergillosis in a general
medical ward
R. Castany, A. Teixido´, I. Pujol, A. Castro, P. Sarda`
Reus, E
Background:Two outbreaks caused by Aspergillus spp. were detected recently
in our hospital. The ﬁrst one was related to renovation activities undertaken in
our hospital general medical ward consisting of ﬁxing, tiling and updating the
furniture of the inﬁrmary area in November 2001. The second one was
related to street building works taken place close to the hospital, in July 2002.
Objectives: To describe prospective data collected from February to Decem-
ber 2002, from 34 patients in whom nosocomial bronchial colonization
(NBCA) or probable nosocomial invasive pulmonary aspergillosis (PNIPA)
was diagnosed. To study control measures and results concerning aerial
contamination.
Results: During the mentioned period, 12 cases of PNIPA were diagnosed,
another 21 were classiﬁed as NBCA and one could not be determined (1.1%
of admissions to our medical ward). A. fumigatus (21), A. ﬂavus (13), and ﬁve
terreus were found. The ﬁrst outbreak originated 29 cases and 5 cases the
second. 22 of them had been admitted between November and February,
before the outbreak was detected. Another patient was in hospital while street
works were going on. Admission was due to acute respiratiry failure, infection
or pneumonia. Median age was 73.82 years. PNIPA cases median hospital stay
was 36.45 days (vs. 9.5 days for Chonic Obstructive Pulmonary Disease
patients (COPD)). All but six patients showed other bacteria or fungi growth
in their sputum. All but tree suffered from severe COPD, asthma, pulmonary
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ﬁbrosis or bronchiectasis and were on chronic corticosteroid therapy. None of
them was neutropenic. PNIPA patients were treated with amphotericin B.
Colonized patients were treated with itraconazole if discharged on oral
corticosteroid therapy. 33.3% of PNIPA and 27.7% of NBCA died. It is
difﬁcult to demonstrate that death was the result of aspergillosis but was
probably a contributing factor in some cases. Patients were moved, as soon as
possible, to another hospital facility and a thorough cleaning and repairing
procedure was undertaken. Colony counts per 1000 L of ﬁltered air varied in
patients’ rooms but were usually higher in the corresponding shower facility
and diminished to 0–2 cfu/1000 L afterwards.
Conclusion: As has been shown lately, severe COPD and corticosteroid
treatment are important risk factors for Aspergillus infection. Environmental
disturbances together with humidity and poor shower facility maintenance
were the probable source of the outbreak.
P709 Recurrent endophthalmitis due to Enterococcus
faecalis: the bacterium was localized in the capsular bag
P. Lanotte, M. L. Le Lez, S. Watt, B. Arbeille, P. J. Pisella, L. Mereghetti,
A. Goudeau
Tours, F
Introduction: Postoperative endophthalmitis is a rare, albeit serious, compli-
cation of intraocular surgery. The most frequent isolated bacteria are
coagulase-negative staphylococci, Staphylococcus aureus, streptococci, miscel-
laneous Gram-positive organisms and Gram-negative organisms.
Case: We report the case of a 85-year-old man with a history of diabetes
mellitus, who developed a recurrent endophthalmitis caused by Enterococcus
faecalis following cataract surgery. Nine days after phacoemulsiﬁcation cataract
extraction, the patient developed acute endophthalmitis. Aqueous humour
and vitreous were collected. Direct examination of the samples after Gram
staining revealed Gram-positive cocci arranged in short chains only for the
vitreous specimen. Cultures under aerobic and anaerobic conditions yielded
E. faecalis. The patient received intravitreal vancomycin and ceftazidime, and
intravenous vancomycin for 8 days followed by 10 days of piperacillin. A
second intravitreal injection of vancomycin was performed 4 days after the
ﬁrst one because there was no clinical improvement. Associated topical
treatment included ticarcillin, vancomycin and gentamicin. Four months
after the onset of the infection, the persistence of severe intraocular inﬂam-
mation led to a later enucleation. Bacterial cultures were performed on
aqueous humour, vitreous and capsular bag. Only the capsular bag was
positive for E. faecalis. Scanning and transmission electron microscopy allowed
the discovery of adherent bacteria to the posterior capsule and in intrama-
crophagic localization.
Conclusion:This case shows that adhesion factors are also important virulence
factors for E. faecalis endophthalmitis, in addition to cytolysin which is the
major virulence factor. The antibiotherapy failure is explained by the fact that
the bacterium was sequestered in the posterior capsule, escaping total
eradication and thus producing recurrent endophthalmitis. Our report also
underlines the contribution of electron microscopy (several descriptive
pictures) showing the exact localization of E. faecalis and the massive coloni-
zation of the capsular bag by the bacterium.
P710 Detection of P. carinii in sputum of asymptomatic
HIV-seronegative oncologic patients
A. Georgouli, E. Chinou, E. Skouteli, N. Trombouki, P. Golemati
Piraeus, GR
Objectives: To investigate the presence of asymptomatic carriers of P. carinii
among oncologic patients without the acquired immunodeﬁciency syn-
drome.
Methods: Induced sputum specimens from 304 consecutive oncologic
patients (130 M, 174 F, of mean age 56 years), were studied for the detection
of P. carinii cysts and trophozoites using a direct immunoﬂuorescent proce-
dure. Any specimen which contained at least two typical cysts considered
positive for the presence of P. carinii. All patients were HIV seronegative and
had no evidence of pulmonary infection. Hematologic malignancy in 176
(57.9%) and solid tumors in 128 (42.1%) of our patients were the underlying
malignancies. 225 out of the 304 patients were undergoing chemotherapy
during the last six months.
Results: P. carinii cysts and trophozoites were detected in 68 out of 304 of our
patients (22.4%). There was no signiﬁcant difference between the patients
with hematologic malignancy (23.2%) and those with solid tumors (19.5%).
All 68 of our patients with presence of P. carinii in their sputum had undergone
chemotherapy during the last six months and 58 of them (85.3%) were also
received long-term therapy with corticosteroids at the time of diagnosis
(mean duration 3months).
Conclusion: The prevalence of P. carinii colonization is quite high among
oncologic patients. It is possible that the dysfunction of the immune response
due to chemotherapy and long-term treatment with corticosteroids in these
patients provide this colonization during which the organism persists in a
latent state. This may imply a higher risk of pneumoniae in these patients due
to reactivation of the organism.
P711 Inﬂuenza outbreak on a hematological ward
A. Troelstra, T. E. M. Kamp-Hopmans, A. J. L. Weersink, A. W. Dekker,
E. M. Mascini
Utrecht, NL
Objectives andmethods:To describe an inﬂuenza outbreak on a hematology
ward. In March 2002, at the hematological ward of our hospital, virological
cultures from a patient with symptoms of respiratory infection, revealed
inﬂuenza A-virus. The patient was treated with zanamavir and respirotory
isolation precautions were implemented to prevent spread; furthermore
contact-patients were nursed in isolation. At the end of that week it became
clear that 14 health care workers from the ward were at sick-leave simulta-
neously. Ten out of these health care workers experienced symptoms of
inﬂuenza and were moderately ill. Soon, virological cultures from one of the
contact-patients was positive with inﬂuenza A-virus. As a third positive
patient was identiﬁed, an additional PCR-detection for inﬂuenza for all
respiratory samples from this ward was performed for the fastest identiﬁcation
of new positive patients. The hygienic precautions were intensiﬁed; positive
patients were nursed in cohort-isolation, contact patients were nursed in a
separate cohort and received zanamavir prophylaxis, and new patients were
nursed in protective isolation. In 3weeks, 13 patients were positive for
inﬂuenza. From these, six patients were positive in PCR and in conventional
cell culturing, four patients were detected by PCR only, for 3 patients cultures
were positive but no PCR was performed. From literature, we expected the
clinical picture of our immunocompromised patients to be more severe,
however, the clinical picture of the health care workers, whowere moderately
ill with a sick-leave of 1–2weeks, was much more severe than the patients
who merely experienced mild symptoms such as rhinitis and somewhat
elevated temperature. Possibly, the prompt administration of zanamivir
ameliorated the clinical picture in the patients.
Conclusion: In the inﬂuenza-outbreak we encountered at our hematology
ward, a causative relation with health care workers was very suggestive. A total
of 13 patients were positive, however, due to the high sensitivity of the PCR,
we identiﬁed more positive patients then before PCR detection was imple-
mented, and to our relief no major illness was encountered. Despite recom-
mendations of, i.e. the CDC and the WHO, the Dutch guidelines do not
advocate inﬂuenza vaccination of health care workers. In our hospital, the
board of directors has recently approved the vaccination of health care workers
that take care of haematological patients.
P712 Successful pre-exposure hepatitis B virus vaccine
prophylaxis for hospital personnel
S. Kashiwagi, T. Shingu, A. Ueda, N. Furusyo, J. Hayashi
Fukuoka, Miyazaki, JP
Objectives: Nosocomial infection among hospital personnel by hepatitis
viruses, especially HBV, has been well documented. The aim of this study
was to investigate the prevalence of HAV, HBV, HCVand HTLV-1 infection
among hospital personnel and to develop means to protect them from HBV
infection.
Methods: All hospital personnel of four Prefectural hospitals in Miyazaki
prefecture, Japan were screened for HBc, HBs, HCV, HAV, HTLV-1 anti-
bodies, and HBsAg in 1980, 1988, 1997, and 2002. All anti-HBs negative
personnel were vaccinated with HB vaccine. Those who lost antibody
protection again received HB vaccine at 5–8-year intervals. Each year, newly
recruited personnel were screened for the same virus markers and vaccinated
with HB vaccine.
Results: All virus markers tested decreased from 1980 to 2002. HBsAg from
3.5% to 2.0%, anti-HBc from 36.8% to 19.6%, anti-HCV from 2.3% to 0.6%,
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anti-HA from 38.7% to 10.2%, and anti-HTLV-1 from 6.3% to 3.2%. The
anti-HBs prevalence gradually increased after the initiation in 1988 of HB
vaccine, 23.3% in 1980, 34.9% in 1988, 77.3% in 1997 and 81.7% in 2002.
Acute hepatitis B was diagnosed in 4 nurses between 1980 and 1988, after
which no hepatitis B cases were found. During the observation period, one
administrative clerk developed acute hepatitis A.
Conclusion: HAV, HCV and HTLV-1 infection have decreased in recent
years, with the decreases in prevalence seen in the general population
reﬂected in lower rates of nosocomial infection. However, HBV infection
remains relatively high in the general opulation of Japan. Vaccination was
effective in preventing the spread of hepatitis B among Japanese hospital
personnel.
Epidemiology of resistance 2
P713 Species distribution and antifungal susceptibility
patterns for Candida isolates from the SENTRY Antimicrobial
Surveillance Program (Europe)
G. Prod’hom, J. Bille, R. N. Jones, Sentry Participants Group in Europe
Objectives: Susceptibility of Candida species should be monitored against
azole compounds. Candida species isolated from bloodstream infections (BSI)
during 1999–2001 were compared with potentially pathogenic strains of
Candida species isolated from other body sites (Other).
Methods: A total of 469 strains were collected by 19 tertiary care centers in
Europe (12 countries including Turkey and Israel). At the reference labora-
tory, conﬁrmation of identiﬁcation and broth microdilution susceptibility
testing were performed (NCCLSM27 for azoles and 5-ﬂucytosine, E-test for
amphotericin B).
Results: Overall, C. albicans (Ca) represented 64% of all isolates, followed by
C. glabrata (Cg) (15%), C. tropicalis (Ct) (10%), C. parapsilosis (Cp) (5%).
C. krusei represented only 1%. MIC90s (mg/L) to ﬂuconazole (Flu), itraco-
nazole (Itra), ravuconazole (Ravu), voriconazole (Vori), 5-ﬂucytosine (5FC),
and amphotericin B (AmB) are shown below:
According to published breakpoints, the percentage of resistant isolates to Flu
was 3% for Cg and 0% for Ca, Cp, and Ct; to Itra 70% for Cg, 7% for Ct, 1%
for Ca and 0% for Cp; to 5FC 18% to Ct, 2% for Ca and 0% for Cg and Cp.
Although no breakpoints are available for Ravu and Vori, a few resistant strains
(1mg/L) were isolated among nonalbicans species [Ravu: Cg(5), C. guil-
liermondii (2), C. krusei (1), Ct(3); Vori: Cg(2), C. guilliermondii (2)].
Conclusions: In 19 European medical centers, C. albicans represented 2/3 of
all clinically signiﬁcantCandida species between 1999 and 2001. Resistance to
azoles was similar for Candida species isolated from BSI compared with those
isolated from other sites. In particular, Ravu and Vori demonstrated an
excellent in vitro activity against all Candida species tested.
P714 Prevalence and resistance rates of Enterobacter
spp. in nosocomial infections, Euro-SENTRY Antimicrobial
Surveillance program, 1997–2001
H. Rodriguez-Villalobos, M. J. Struelens, R. N. Jones on behalf of the
Euro – SENTRY participants
Objective:Enterobacter spp. are reported as emergent multiresistant nosocomial
pathogens in several countries. The SENTRY program monitors antimicro-
bial resistance of nosocomial and community-acquired pathogens via an
international network of hospitals. The prevalence and antimicrobial resis-
tance rates in Enterobacter spp. isolates from European SENTRY hospitals were
analyzed for the years 1997–2001.
Material and methods: A total of 10–27 hospitals in 17 European countries
collected 32.921 isolates from bloodstream infections (BSI), lower respiratory
tract infection (LRTI), wound and urinary tract infection (UTI). Antimi-
crobial susceptibility to 28 antimicrobial agents was tested by a broth micro-
dilution NCCLS method in two central monitoring centers.
Results: Enterobacter spp. (n¼ 1587) were recovered, with E. cloacae (EC) and
E. aerogenes (EA) as predominant species (69 and 24%, respectively), and 9
other species (7%). The proportion of infections caused by Enterobacterwas 4%
of BSI per year, 5.5–9.1% of LRTI per year; 40% were from patients admitted
to intensive care units (ICU). EA isolates were signiﬁcantly more resistant than
EC isolates to cephalosporin, penicillins, aminoglycosides, and ﬂuoroquino-
lones. Resistance rates were higher in isolates from ICU patients than non-
ICU in both species. In 2001, the proportion of non-susceptible isolates were
for EA/EC, respectively: ceftazidime 31.2/15.3% (52.5/34.6% in ICU),
cefepime 0/2.2% (0/1.2% in ICU), piperacillin-tazobactam 25/15.3%
(42.5/33.3% in ICU), ciproﬂoxacin 5.1/5.1% (37.5/16% in ICU), amikacin
0/2.9% (2.5/1.2% in ICU), and gentamicin 6.2/6.6% (12.5/12.3% in ICU).
Only four nonsusceptible carbapenem strains were recovered since 1999
(three EA and one EC). Multiresistant EAwere mainly recovered from France
(23–86% of EA per year), Belgium (20–66% of EA per year) and Greece
(60–100% of EA per year).
Conclusions:The data conﬁrm the high prevalence of Enterobacter species as a
nosocomial pathogen. Higher resistance rates were observed in E. aerogenes
and in ICU patients. Susceptibility to the most potent antimicrobials (carba-
penems, cefepime and amikacin) remained stable at >90% of isolates.
P715 Carbapenem-resistance among hospitalized
patients in the Asia-Paciﬁc Region (APAC): report from the
SENTRY Antimicrobial Surveillance Program,
1998–2001
J. M. Bell, J. D. Turnidge
Adelaide, AUS
Objective:Resistance to carbapenems in Pseudomonas aeruginosa (PAER) and
Acinetobacter (ACIN) species is being described with increasing frequency in
many parts of the world. Because carbapenems are now commonly used in
hospital practice in the Asia-Paciﬁc region (APAC), we wished to determine
whether carbapenem-resistance was emerging in PAER and ACIN isolates
from hospitalized patients.
Methods: As part of the SENTRY APAC we examined PAER and ACIN
isolates from infected patients in seven countries (16 laboratory centers) since
1998. Isolates came from blood, LRTI, skin/skin structure, urine, and
intensive care specimens in hospitalized patients, and were tested by broth
microdilution against a wide range of antimicrobials including imipenem
(IMI) and meropenem (MER), over the concentration range 0.06–8 mg/mL.
Isolates were considered resistant to either of these carbapenems if their MIC
was>8mg/mL.
Results:A total of 1830 PAER and 588 ACIN isolates were collected over the
4-year period. Rates of MER resistance by country and year are shown in the
Table 1. Examination of the antibiograms of the ACIN from the two
countries where resistance was seen most frequently (Singapore and Taiwan),
indicate that clonal spread may have accounted for up to one half of all the
resistance seen. Over 90% of MER-resistant ACIN had a possible metallo-
beta-lactamase phenotype (ceftazidime- and meropenem-resistant).
Site/Species (n) Flu Itra Ravu Vori 5FC AmB
BSI (181)
Ca (112) 0.25 0.06 0.015 0.015 0.25 1.5
Cg (23) 32 2 1 0.5 0.12 4
Cp (19) 2 0.25 0.03 0.015 0.25 4
Ct (16) 2 0.5 0.12 0.06 128 2
Others (288)
Ca (187) 0.25 0.12 0.007 0.015 0.5 0.75
Cg (47) 16 2 0.5 0.25 0.12 2
Cp (6) 1 0.5 0.06 n.a. 0.12 2
Ct (29) 2 0.5 0.12 0.06 128 2
n.a.: not available.
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Conclusions: Carbapenem-resistance in ACIN was common in only two
countries in the APAC, and appears to vary signiﬁcantly from year-to-year,
perhaps related to changes in circulating clones over time. MER resistance in
PAER appears to be stable in the APAC region except for a recent (2001)
rapid rise in Japan.
P716 Antimicrobial susceptibility and epidemiology of
Australian and South African Neisseria meningitidis from
the SENTRY Asia-Paciﬁc Surveillance Program, 2001
J. M. Bell, S. Wati, J. D. Turnidge
Adelaide, AUS
Objectives: The emergence of meningococcal strains with reduced suscept-
ibility to penicillin has been reported in several countries during the past two
decades. As part of the SENTRY Asia-Paciﬁc surveillance program clinical
isolates of Neisseria meningitidis (NMEN) collected during 2001 were exam-
ined for prevalence of antibiotic resistance and epidemiological character-
istics.
Methods: Susceptibility of isolates to penicillin, ceftriaxone, ciproﬂoxacin,
rifampicin and trimethoprim-sulphamethoxazole (SXT) were determined
using Etest strips on Mueller-Hinton agar supplemented with 5% sheep
blood. All isolates were further characterized using the automated Ribo-
Printer1 system (DuPont Qualicon) with EcoRI restriction enzyme.
Results: A total of 43 isolates were tested. 95% of isolates were from blood or
CSF. One isolate from sputumwas penicillin non-susceptible (MIC, 0.25mg/
L). Over 70% were susceptible to SXTat 0.5mg/L. One strain (CSF, South
Africa) had SXT MIC of 3mg/L. All strains were highly susceptible to
ciproﬂoxacin, ceftriaxone and rifampicin. No beta-lactamase production was
detected. Over 80% of isolates from Australia were serogroup B (see Table 1).
In South Africa, however, serogroups A, B,W135 and Ywere found in similar
numbers. Over 25 different ribogroups have been detected to date, with more
than nine small clusters. A comparison with other ﬁngerprinting methods is
ongoing.
Conclusions:Reduced susceptibility to penicillin was uncommon in Australia
and South Africa. Automated ribotyping enables riboprint proﬁles to be easily
and reliably performed, which allows for timely comparison of isolates from
different geographic regions. Best discrimination was observed, however,
when a combination of typing methods were used.
P717 Evolution of an integron carrying blaVIM-2 in
Central Europe: report from the SENTRY Antimicrobial
Surveillance Program
M. Toleman, W. Hryniewicz, P. Bennett, R. Jones, T. Walsh
Bristol, UK; Warsaw, PL; Iowa, USA
Objectives: To analyze the genetic nature and context of the determinant
of imipenem resistance in a blood stram isolate of Pseudomonas aeruginosa
isolated in Poland as part of the SENTRY Antimicrobial Surveillance
Program.
Methods: The determinant of imipenem resistance was isolated from a gene
bank of P. aeruginosa strain 81–11963A prepared in the cloning vector pK18,
by plating out on media containing ceftazidime plus the serine lactase
inhibitor BRL42715. Sequencing was carried out on both strands by the
dideoxy-chain termination method with a Perkin-Elmer Biosystems 377
DNA sequencer and sequence analysis was performed using DNASTAR
software.
Results: The metallo-beta-lactamase blaVIM2 was found on a 5 kb insert of
chromosomal DNA containing the transposon gene tnpr and a Class1
integron harboring two gene cassettes (aacA4 and blaVIM2). The integron
shows high identity to the blaVIM2 containing integron In58 previously
reported in France. However, the blaVIM2 integron is novel in possessing a
gene cassette that has a 59-bp element that is only 19 bp long and is probably
fused to the downstream aacA4 gene cassette.
Conclusions:The deleted 59be is not expected to be functional which would
indicate that the blaVIM2 gene is no longer a component of a functional
blaVIM2 cassette but rather is part of a double gene cassette that also carries
the aminoglycoside resistance gene aacA4. This is the ﬁrst report of a mobile
metallo-beta-lactamase in central Europe and illustrates the continuing dis-
semination of these genes throughout the continent. The enzymes encoded
by these mobile genes can hydrolyze almost all clinically useful beta-lactams,
irrespective of class, and the fact they are resistant to the effects of serine beta-
lactamase inhibitors makes such reports particularly alarming for selection of
clinical treatments.
P718 Epidemiology of the new metallo-beta-lactamase
gene, blaSPM, in South America: report from the SENTRY
Antimicrobial Surveillance Program
M. Toleman, D. Bennett, T. Walsh, R. Jones
Bristol, UK; Iowa, USA
Objective: Recently, a new type of metallo-beta-lactamase genes, blaSPM,
was described from Sao Paolo, Brazil; however, very little is known of the
epidemiology of blaSPM. Therefore, as part of the SENTRY Antimicrobial
Surveillance Program, we genetically analyzed Acinetobacter spp. or Pseudo-
monas aeruginosa from Argentina and two centers in Brazil for the presence of
the blaSPM gene.
Methods: Phenotypic screening was carried out by the Etest MBL strip (AB
BIODISK, Solna, Sweden). Biochemical analysis utilized imipenem hydro-
lysis in the presence of EDTA (20mM) or BRL42715 (1mM). Ampliﬁcation
of the SPM gene was performed by PCR using AB-gene Expand Hi-ﬁdelity
master mix PFU/proof reading TAQ polymerase. Sequencing of PCR
amplicons was undertaken by the dideoxy-chain termination method.
Sequence analysis was performed using the Lasergene DNASTAR software.
Alignments and phylogenetic analysis was obtained using Clustal Wand PAM
250 matrix.
Results: Isolates meeting the criteria and screened were: 12 from Argentina
and 19 from Brazil. Of the 19 isolates from Brazil, 18 showed imipenem
hydrolysis inhibited by EDTA. PCR screening showed that 11 isolates carry
the blaSPM gene; 10 from same center as the index blaSPM gene and one
from a new center in Brazilia. Seven of the Brazilian are likely to carry novel,
as yet unidentiﬁed, metallo-beta-lactamases. Sequencing analysis has revealed
the blaSPM PCR products to be identical to that of blaSPM-1. Biochemical
analysis on the isolates from Argentina revealed that most possess weak
imipenem hydrolytic activity and none gave positive PCR products for
blaSPM.
Table 1
Country
ACIN PAER
1998 1999 2000 2001 1998 1999 2000 2001
Australia 0 0 0 0 3.4 2.8 5.4 4.0
Hong Kong,
China
15.4 4.2 0 0 8.3 9.5 9.3 11.8
Mainland,
China
0 8.3 – – 11.9 15.4 – –
Japan 6.3 7.7 0 7.1 8.3 8.7 8.7 26.2
Philippines 0 0 0 0 10.0 10.5 6.9 6.9
Singapore 10.5 20.0 33.3 33.3 0 16.7 3.3 9.1
South Africa 0 0 8.8 5.3 14.8 0 13.2 4.4
Taiwan 0 14.3 5.6 21.2 0 0 3.3 5.7
Table 1
Country
Serogroup
A B C W135 Y Total
Australia 16 2 1 19
South Africa 7 7 7 3 24
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Conclusions: The data from this study indicates that the blaSPM gene has
already been found in other Brazilian cities other than Sao Paolo. This data
also indicates that bacteria strains from this region carry metallo-beta-lacta-
mase genes other than the blaSPM as judged by their phenotypic proﬁle. The
data from the Argentinean centers suggest that the blaSPM gene has not spread
to that country. The ﬁndings of this study highlight the importance of large-
scale surveillance, molecular-level studies.
P719 Antimicrobial susceptibility and serotypes of
Streptococcus agalactiae clinical isolates from a Lisbon
hospital
J. Figueira-Coelho, M. Ramirez, L. Lito, M. J. Salgado, J. Melo-Cristino
Lisbon, P
Objectives: S. agalactiae is a major pathogen in neonates but can also cause
several infections in adults. This study determined the prevalence, antimi-
crobial susceptibility and serotypes of clinical isolates of S. agalactiae in the
largest Lisbon hospital over a 3-year period.
Methods: From December 1999 to November 2002 all S. agalactiae recovered
in the Laboratory of Bacteriology of Hospital de Santa Maria were studied.
Susceptibility testing was performed by disk diffusion (according to NCCLS)
and E-test. Antimicrobials tested included penicillin, cefotaxime, erythro-
mycin, clindamycin, tetracycline, chloramphenicol, oﬂoxacin, and vanco-
mycin. Serotyping was done by slide agglutination using antisera (Hemolytic
streptococcus Typing antisera for Group B, Denka Seiken, Japan) according to
the instructions of the manufacturer.
Results: A total of 252 S. agalactiae were isolated from clinical samples. The
origin of isolates was: blood (37), urine (54), sterile ﬂuids (4), vaginal swabs
(108), and other products (49). Invasive isolates were detected from (17)
neonatal infections and (24) adult infections. Resistance to antimicrobial
agents was detected against erythromycin (10.7%), clindamycin (9.9%), and
tetracycline (75.4%). All isolates were susceptible to penicillin (MIC50¼
0.064mg/L; MIC90¼ 0.094mg/L), cefotaxime, chloramphenicol, oﬂoxa-
cin, and vancomycin. Erythromycin resistant phenotypes were MLSB con-
stitutive (70.4%), MLSB inducible (22.2%), and M phenotype (7.4%).
Serotype distribution was as follows: Ia (17.9%), Ib (3.6%), II (16.6%), III
(24.2%), IV (2.0%), V (23.4%), VII (1.2%), and VIII (0.4%). A total of 10.7%
were non-typable.
Conclusion: Penicillin was active against all strains but macrolide resistance
was detected in 10.7% isolates. Overall, the most common serotypes were III,
V, Ia, and II. Within the 41 invasive isolates the serotypes ranked as follows: III
(15), Ia (10), V (7), II (3), IV (3), Ib (2), and VII (1). S. agalactiae infections are
caused by a heterogeneous group of microorganisms, according to suscept-
ibility pattern and serotype.
P720 Resistance and serotypes of Streptococcus
pneumoniae invasive isolates from Portugal
I. Serrano, M. Ramirez, J. Melo-Cristino on behalf of the Portuguese
Surveillance Group for the Study of Respiratory Pathogens
Objectives: Determine the antimicrobial susceptibility and serotype of inva-
sive isolates of Streptococcus pneumoniae recovered in Portugal during a 4-year
period.
Methods: S. pneumoniae recovered from normally sterile sites during the years
of 1999–2002 were sent to the Microbiology Laboratory of Faculdade de
Medicina de Lisboa for study. Susceptibility testing was performed by disk
diffusion (according to NCCLS guidelines) and E-test. Antimicrobials tested
included penicillin, amoxacillin/clavulanic acid (XL), cefuroxime (XM),
cefotaxime (CT), erythromycin (EM), clindamycin (CM), tetracycline
(TC), chloramphenicol (C), trimethoprim-sulfamethoxazole (SXT), levo-
ﬂoxacin (LE), moxiﬂoxacin (MX), gatiﬂoxacin (GA), linezolid (LZ), quinu-
pristin/dalfopristin (RP), and vancomycin. Serotyping was done by the
Quellung reaction using sera from the Statens Serum Institut (Copenhagen,
Denmark).
Results: The origin of the 407 isolates tested was: blood (384), CSF (13),
other sterile ﬂuids (10). Resistance to most antimicrobial agents was detected:
XL 4.9%, XM 14.5%, CT 1.5%, EM 8.4%, CM 6.1%, TC 5.6%, C 2.4%,
SXT 19.5%, LE 0.2%. Four isolates presented low-level resistance to qui-
nupristin/dalfopristin (MIC¼ 1.5mg/L). All isolates were susceptible to
moxiﬂoxacin, gatiﬂoxacin, linezolid, and vancomycin. Penicillin non-sus-
ceptibility was 19.9% (MIC50¼ 0.023mg/L; MIC90¼ 1mg/L). Low-level
resistance was observed in 63 isolates whereas high-level resistance was
restricted to 18 isolates. Multiresistance was detected in 7% of the
isolates. Six serotypes accounted for half of all isolates: 1 (11.8%), 14
(11.6%), 3 (10.8%), 4 (6.7%), 8 (6.7%), and 9V (4.9%). The rank order
and serotypes accounting for half of the isolates varied with the age group
considered.
Conclusion: Penicillin non-susceptibility was mostly (77%) associated with
serotypes 9V, 14, and 23F found in internationally disseminated clones. As
expected, multiresistance is also found mainly among these serotypes as well as
19A and 6B. Despite 20% non-susceptibility to penicillin, most strains remain
susceptible to amoxacillin/clavulanic acid (95.6%), third generation cepha-
losporins (98.5%) as well as to new antimicrobials soon to be made available or
recently introduced in Portugal – levoﬂoxacin, moxiﬂoxacin, gatiﬂoxacin,
quinupristin/dalfopristin and linezolid. Coverage of the 23-valent polysac-
charide vaccine is almost constant among all age groups and is 90% among
individuals older than 60 years of age.
P721 Antibiotic susceptibility of Edwardsiella isolates
from Antarctic penguins
M. O¨sterblad, T. Broman, J. Waldenstro¨m, J. Bonnedahl, J. Jalava,
P. Huovinen, B. Olsen
Turku, FIN; Umea˚, Lund, Fa¨rjestaden, S
Objective: The spread of antibiotic resistance is generally thought to be a
result of the use of antibiotics, but sporadically it has been suggested that
resistance can be common even in environments apparently devoid of
antibiotic exposure. Here we look at Enterobacteriaceae from such an
environment.
Methods: Fecal bacteria from cloacal swabs of gentoo penguins (Pygoscelis
papua) living on the Antarctic Peninsula were isolated from MacConkey
plates. Enterobacteriaceae were identiﬁed by biochemical tests, and in 17
cases, 16S rDNA sequencing. MICs to 17 antibiotics were determined by agar
dilution.
Results: From 14 swabs of 49, enterobacteria were found; in all 42 isolates. Of
these, 38 were Edwardsiella tarda, or closely related species (100% sequence
similarity for 10 isolates, 99–97.6% for 5 isolates sequenced). The other
isolates were one E. coli, and three unknown species. All isolates were
susceptible to all antibiotics tested. Compared with median MIC values of
susceptible Enterobacteriaceae in human fecal ﬂora, the E. tarda MICs were
three to ﬁve dilution steps lower for ampicillin, amoxiclav, piperacillin-
tazobactam, cephalothin, cefuroxime, ceftazidime, trimethoprim, and chlor-
amphenicol. Nalidixic acid, tetracycline, gentamicin, streptomycin, and
sulphamethoxazole only differed 0–2 steps. The extreme susceptibility caused
technical problems: antibiotic carryover from the highest dilutions in normal
dilution series (e.g. 0.06–128mg/L) inhibited the growth of many strains on
the control plates of the next series. Therefore, low-range series, ending at 8
or 4 mg/L had to be used.
Conclusion: In line with our previous results on Enterobacteriaceae from
vegetables and wild Finnish moose, deer and vole, no acquired resistance was
found in the fecal microbiota of Antarctic penguins. Resistance is thus
acquired and spread mainly due to antibiotic use; microbiota in pristine
environments are naturally susceptible.
P722 Molecular epidemiology of penicillin-resistant
Streptococcus pneumoniae in Turkey
M. Bic¸men, Z. Gu¨lay, D. Gu¨r, D. A. Watson, D. Musher
Izmir, Ankara, TR; Galveston, Houston, USA
Objective: To investigate the clonal relationship among penicillin-resistant
and penicillin-susceptible S. pneumoniae strains recovered from different med-
ical centers in Turkey.
Methods: A total of 110 S. pneumoniae (10 high level (PenR), 80 low-level
(PenI) penicillin-resistant and 20 penicillin-susceptible) isolates selected ran-
domly from seven centers, were studied. Penicillin (Pen) and erythromycin
(E). MICs were analyzed by E-test (AB Biodisk). Cefotaxime MICs were
determined by microdilution. Susceptibility patterns for other agents, namely
clindamycin (CC), tetracycline (Te), chloramphenicol (C), trimetophrim
sulfamethoxazole (SXT), ciproﬂoxacin and levoﬂoxacin were studied by disk
diffusion. Capsular serotypes were determined by coagglutination and quel-
lung reactions. Clonal relationship among the isolates and similarities of the
patterns with 16 penicillin-resistant clones deﬁned by the Pneumococcal
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Molecular EpidemiologyNetwork (PMEN)were investigated by BOX-PCR
using BOX-A1R primer.
Results: Most of the PenR isolates were also resistant to other antibacterial
agents but not to levoﬂoxacin. Quinolone resistance was not observed.
Serotypes 23, 14 and 9V were the most frequent serogroups among PenR
isolates. Eight, 57 and 18 unique molecular patterns were identiﬁed among
high-level PenR, low-level PenR and PenS strains, respectively. Although, six
and seven Ankara isolates showed similar BOX-PCR patterns with Spanish
23F and 6B clones, respectively, most of the Turkish isolates were different
from the PMEN clones.
Conclusions: According to BOX-PCR patterns, most of the penicillin
nonsusceptible S. pneumoniae isolated in Turkey, were diverse clonally.
P723 Epidemiological study of vancomycin-resistant
Enterococcus isolated from a single medical university
hospital in Japan
K. Ishikawa, S. Hayakawa, Y. Naide, K. Hoshinaga
Toyoake Aichi, JP
Objectives: Since 1998 more than 130 reports have described the isolation of
high-level vancomycin-resistant enterococci (VRE) in Japan. Here, we report
on our clinical isolates of VRE and an epidemiological study carried out using
chemical and genetic techniques.
Methods: VRE isolates were screened for high resistance to vancomycin
(VCM) with a cutoff value of 6mg/mL and VCM-resistant gene was
conﬁrmed by polymerase chain reaction (PCR). The epidemiological studies
used pulse-ﬁeld gel electrophoresis (PFGE) and plasmid analysis.
Results: Seven strains of VRE were isolated from seven different patients on
three wards during early 3-month period, and ﬁve strains of VRE were
isolated from ﬁve different patients on three wards during late 3-month
period. All of the isolates possessed vanA on their plasmid, and the isolates of
early group were divided into two similar groups. Furthermore, three
different patterns were deﬁned by PFGE. Although all of the asymptomatic
carriers were hospitalized for more than 3months, we were able to prevent an
outbreak of VRE in our hospital by using our guidelines for infection control,
which are stricter than those of methicillin-resistant Staphylococcus aureus.
Conclusions: From the results of this epidemiological study, we propose that
there was a possibility of contamination in this hospital, and that three of the
early seven isolates may have acquired vanA independently. In this study we
demonstrated that the infection control, according to appropriate prevention
guidelines, as well as regular surveillance for VRE, are essential for designing
interventions to prevent the further spread of VRE.
P724 Epidemiology and antibiotic susceptibility of
common bacteria causing skin and soft tissue infections in
the USA, Canada, and Europe (TSN Database 2000–2002): a
guide to empiric therapy
M. Jones, J. Karlowsky, D. C. Draghi, C. Thornsberry, R. Master,
D. Sahm, D. Nathwani
Hilversum, NL; Herndon, Franklin, USA; Dundee, UK
Objectives: In this study we report current incidence and susceptibility rates
of antimicrobials for key pathogens isolated from skin and soft tissue infections
(SSTI) as reported to physicians by clinical microbiology laboratories in
Europe (EU), Canada (Cn) and the USA.
Methods: We analyzed data (January 2000–October 2002) from The Sur-
veillance Network1 (TSN) Databases in France (Fr), Italy (It), Germany
(Gy), Spain (Sp), Cn and the USA to determine susceptibilities from routine
test results as reported to physicians. Only inpatient data from isolates taken
from SSTI (n¼ 276,739) were included in the analysis. Contemporary
NCCLS breakpoints were used, except for Fr (CA-SFM).
Results: Gram-positive organisms (S. aureus [SA]), Streptococcus spp. and
Enterococcus spp. [Esp] and Enterobacteriaceae (notably E. coli [EC]) were
the most common isolates among SSTI. Methicillin-resistant S. aureus
(MRSA) rates were USA 45.7%, It 41.0%, Fr 34.6%, Sp 34.2%, Gy 12.0%
and Cn 18.1%. Greater than >99.0% of methicillin-susceptible S. aureus
(MSSA) tested susceptible (S) to ceftriaxone (CTX) and >94.9% to tri-
methoprim-sulfamethoxazole. A total of 83.6% (Fr) to 92.7% (Gy) of MSSA
were ciproﬂoxacin-S; 71.3% (USA) to 87.9% (Sp) were erythromycin (ERY)-
S; 81.1% (It) to 99.1% (Fr) were gentamicin-S. 100% of S. agalactiae and
S. pyogenes were S to penicillin, CTX and cefotaxime (CFO). ERY-R was
11.7% (Sp) to 22.2% (USA) for S. agalactiae, 10.8% (Gy) to 25.4% (It) for
S. pyogenes and 14.1% (Gy) to 28.0% (Fr) for viridans group streptococci.
Vancomycin-R Esp were uncommon outside the USA (16.0%) and It (4.1%).
EC from all countries were 100% imipenem-S, >98.6% to amikacin (AK),
>90.4% to CTX and CFO. Putative extended-spectrum b-lactamase expres-
sion in EC remained rare, comprising 3–7% of isolates in USA, It, Sp, and Cn
and<2% in Fr and Gy. For P. aeruginosa piperacillin-tazobactam, AK, IMI and
ceftazidime were the most active compounds tested irrespective of region.
Conclusions: Among SSTI, rates of MRSA, vary signiﬁcantly between
countries. Resistance to orally available compounds was common in all
species. Surveillance data should be considered when selecting empiric
therapy for treating SSTI.
Conclusions: Among SSTI, rates of MRSA, vary signiﬁcantly between
countries. Resistance to orally available compounds was common in all
species. Surveillance data should be considered when selecting empiric
therapy for treating SSTI.
P725 Pitfalls in prompt eradication of nasal MRSA
(methicillin-resistant Staphylococcus aureus) carrier status in
health care workers
E. Kniehl, A. Becker, D. H. Forster
Karlsruhe, D
Objectives: The aim of the study was to investigate the effectiveness of
eradication treatment in nasally colonized health care workers (HCWs) and to
highlight reasons for eradication failure.
Methods: Two tertiary care hospitals (1600 beds) in South-west Germany
perform an active screening of HCWs, who had close contact to MRSA
patients. MRSA carryingHCWs are treated with local antibiotics (mupirocin,
tyrothricin) and antiseptic soap for 5 days and are advised to clean and disinfect
bath room, hygiene articles and bed linen. Screening for successful eradication
is performed for up to 3months. When eradication failed, additional screens
are performed, including the animate and inanimate home environment.
Infection control charts of patients and HCWs for a 7-year period (1995–
2001) were reviewed.
Results: From 1995 to 2001, a total of 592 patients were found to be MRSA-
carriers; 87 HCWs harbored MRSA in their noses soon after contact to these
patients. 73 of 87 (84%) of HCWs responded with prompt and deﬁnite
eradication of their carrier status. Pitfalls of this eradication strategy were
observed in 14 HCWs; all but three were tested MRSA negative shortly after
eradication treatment, but were recolonized 10–30 days thereafter. In two of
three cases where swabs did not turn negative, initial eradication had failed
because of inadequate eradication treatment; when repeated and intensiﬁed,
they turned deﬁnitely negative. In 11 of the recurrent cases, household
contacts (HC) were screened for nasal carriage; in 8 of these cases, environ-
mental samples were taken from the home environment. HC of 8 out of 11
carriers also proved to be colonized. In 7 out of 8 screened environments
MRSAwas detected although HCWs had cleaned bed and bath rooms. Two
homes were shown to be heavily contaminated, suggesting long-term carriage
by the household members. When eradication therapy was given to HC and
surfaces were cleaned and disinfected, prompt and deﬁnite eradication was
achieved in most cases within a few weeks; however, in the cases of heavily
contaminated homes, deﬁnite eradication success was achieved only by
architectural renovation/sanitation and took up to 1 year to achieve.
Conclusions:The data support the hypothesis, that attempts to eradicate long-
term carriers (patients or staff) should not be restricted on antibiotic or
antiseptic treatment, but must also include cleaning and disinfection of
household contamination.
P726 Diversity and spread of multiresistant
Acinetobacter baumannii strains in Europe
H. Van Dessel, L. Dijkshoorn, T. van der Reijden, N. Bakker, A. Paauw,
P. J. van den Broek, J. Verhoef
NL
Objectives: To explore the diversity and spread of multiresistant Acinetobacter
baumannii strains in Europe
Methods: Fifty geographically representative isolates were investigated that
had been allocated to ribogroups 1, 2 and 3 in a previous study. In that study,
400 isolates were collected from 23 European hospitals. Amongst these, 145
sitoﬂoxacin-resistant Acinetobacter isolates were recognized, 92 of which
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were allocated by automated ribotyping to three major ribogroups 1, 2 and 3
with 17, 52 and 23 isolates, respectively. Species identiﬁcation of the 50
selected strains of the present study was performed by ampliﬁed ribosomal
DNA restriction analysis (ARDRA), and by AFLP ﬁngerprinting cq cluster
analysis with ﬁngerprints of reference strains of all described (genomic) species
using a clustering level of 50% to delineate species. The diversity at strain level
was investigated by high resolution ﬁngerprinting using pulsed ﬁeld gel
electrophoresis (PFGE) and AFLP using a 90% level for strain delineation.
Results: All isolates were multiresistant and were identiﬁed as A. baumannii,
conﬁrming the predominance of this species in clinical settings. Combined
AFLP and PFGE led to the distinction of 23 genotypes within the, with PFGE
being the most discriminatory method. Cluster analysis of PFGE and AFLP
proﬁles showed a good agreement with ribogroup categorization, except for
two PGE types. Most genotypes corresponded to a single hospital, indicating
the local spread of a single strain, whereas three genotypes were found in
different geographic locations. The AFLP ﬁngerprints of these strains were
distinct from the previously described identiﬁed NW European clones 1 and
2. Isolates of these three widespread genotypes showed different antibiotic
susceptibility proﬁles in different hospitals.
Conclusions:Grouping by ribotyping seems a useful method for rough typing
of strains, whereas AFLP and/or PFGE provide reveal additional genotypes
and AFLP and/or ARDRA are more useful for strain identiﬁcation. The
combined use of the methods revealed the existence of several widespread
multiresistant strains.
P727 Urinary tract infections in Northern Greece:
bacterial etiology and susceptibility. A retrospective study
of clinical isolates
M. Chatzidimitriou, A. Bisiklis, E. Avramidou, E. Tsakiri, F. Tsapara,
S. Alexiou-Daniel
Thessaloniki, GR
Objectives:The aim of this study was to interpret the results of urine cultures
which were sent in the laboratory of the University Hospital AHEPA from
1998 until 2002 both from hospitalized and outpatients – population of
Northern Greece – so as to identify major bacterial isolates which are
responsible for urinary tract infections and to test their sensitivity to anti-
biotics.
Methods: 24259 urine samples were cultivated during the above mentioned
period. Samples were inoculated in ordinary used media: blood and McCon-
key agar. The identiﬁcation of bacterial isolates and antibiotic susceptibilities
were performed by the analyzer VITEK 60 of BIOMERIEUX.
Results: 5445 out of 24259 urine samples had positive results. More speci-
ﬁcally, bacteria in hospitalized patients – 4529 in total – were isolated as
follows: E. coli in 2291 patients (56%), Pseudomonas aeruginosa in 445 (10%),
Enterococcus spp. in 342 (7.5%), Klebsiella pn. in 309 (7%), Proteus spp. in 270
(6%). Bacteria-916 in total isolated from outpatients appeared as follows:
E. coli in 636 patients (69%), Proteus in 77 (8%), Enterococcus in 47 (5%),
Klebsiella pn. in 45 (5%), P. aeruginosa in 34(4%). The antibiotic sensitivity of
E. coli was: Amoxicillin/Clavulanic 80%, Cefuroxime 88%, Ciproﬂoxacin
92%, Norﬂoxacin 92%. Trimethoprime/Cotrimoxazole 78%, Ticarcillin/
Clavulanic 85%, Tobramycin 98%. The antibiotic sensitivity of Proteus was:
Amoxicillin/Clavulanic 83%, Cefuroxime 83%, Ciproﬂoxacin 89%, Nor-
ﬂoxacin 91%, Trimethoprime/Cotrimoxazole 70%, Ticarcillin/Clavulanic
98%, Tobramycin 92%. The antibiotic sensitivity of P. aeruginosa was: Ami-
kacin 70%, Cefepime 64%, Ceftazidime 81%, Ciproﬂoxacin 64%, Imipenem
76%, Piperacillin/Tazobactam 86%, Ticarcillin/Clavulanic 63%, Tobramycin
71%.
Conclusions:Our study indicates that (1) E. coli is the most common cause of
urinary tract infection mostly sensitive to tobramycin, ciproﬂoxacin and
norﬂoxacin. The observed decrease in susceptibility to cotrimoxazole is
worrying. (2) P. aeruginosa was mostly sensitive to piperacillin/tazobactam,
ceftazidime, tobramycin. A higher resistance of P. aeruginosa to imipenem
was observed in nosocomial infections. (3) Proteus was mostly sensitive to
Ticarcillin/Clavulanic, tobramycin and norﬂoxacin. (5) The bacteria isolated
from hospitalized patients suffering from urinary tract infection appeared
higher resistance in the used antibiotics than bacteria isolated from out-
patients.
P728 Comparison of several criteria for rejecting
multiple isolations on Pseudomonas aeruginosa
antimicrobial sensitivity estimation
J. -M. Lo´pez-Lozano, E. Sirvent, J. -C. Rodrı´guez, M. Gonza´lez,
G. Royo, A. Cabrera
Orihuela, Elche, E
Objectives: To compare several criteria for rejecting duplicate isolations and
to know its effects on the estimation of antimicrobial sensitivity of Pseudo-
monas aeruginosa during a 2-year period (2000–2001).
Methods: We applied the following criteria:
1. Time elimination criterion: We have calculated data on sensitivity by
rejecting multiple isolates from the same patient within an interval of 0 (All),
7, 15, 21 and 30 days by means of ViResiST program (vvv.viresist.org).
2. Antibiotic sensitivity criterion: By means of Wider system (Soria
Melguizo, Spain), we have calculated sensitivity data by rejecting multiple
isolates from the same patient that show the same antibiogram, regardless of
time criterion.
Results: The average isolation rate (AIR) (number of isolates tested/number
of patients tested) was 1.6, the frequency of single isolation (FSI) (number of
patients with single isolations/number of patients tested) was 0.7. The
estimated sensitivity percentage appears in Table 1.
Conclusions: Data of longest intervals suggest that it is likely that there are
more duplicate isolates when patients are infected by multiresistant micro-
organisms. The use of antibiotic sensitivity criteria detects strains that became
resistant during the course of the treatment and there fore the results show
lower percentages of sensitivity. Antibiotic sensitivity criterion is the one
which reﬂects the real situation best, but it may be inﬂuenced by methodo-
logical mistakes, for this reason sensitivity of strains that show mutations
during treatment should be conﬁrmed.
P729 Vancomycin resistance of Staphylococcus
aureus isolates from co-colonized patients with
vancomycin-resistant enterococci and Staphylococcus
aureus
S. H. Lee, C. H. Jang, D. W. Kim, J. S. Kim, S. Yu
Busan, KOR
Objectives: Transfer of vancomycin resistance determinants from vancomy-
cin-resistance enterococci to Staphylococcus aureus has been a serious concern.
It has been shown that such a transfer was possible in the laboratory. More
recently, two clinical isolates of true vancomycin-resistant S. aureus having
vanA were reported. We examined the vancomycin resistance of S. aureus
isolates from cocolonized patients with S. aureus and VRE including rectal or
perianal regions where two organisms might be encountered.
Methods: During a year (2001), swabs of the nare, axilla, perineum and
rectumwere obtained weekly to isolate S. aureus among the patients known to
be colonizedwith VRE from clinical specimens or rectal surveillance cultures.
MICs of vancomycin and oxacillin of S. aureus isolates were determined by
NCCLS broth microdilution test.
Results: A total of 228 swabs were conducted from 19 patients who were
colonized VRE. Ten of 19 patients had E. faecium or E. faecalis (vancomycin
MIC 256mg/mL and 9 patients had E. gallinarum, E. casseliﬂavus or E. avium
(vancomycinMIC 4–16mg/mL). 60 isolates of S. aureuswere collected and 58
strains (96.7%) were MRSA (24, 6, 13, 15 isolates from nare, axilla, perineum
Table 1
Time elimination criterion
Antibiotic sensitive
criterionSensitivity to
0 days
(all isolates) 7 days 15 days 21 days 30 days
Ceftazidime 91.47 92.27 92.99 92.74 93.23 90.97
Imipenem 88.42 89.77 90.65 91.57 92.02 86.46
Ciprofloxacin 80.87 80.58 81.07 82.20 83.09 78.94
Amikacin 92.92 92.27 95.09 95.55 95.65 88.90
Clinical Microbiology and Infection, Volume 9, Supplement 1, 2003 159
and rectum). Vancomycin MIC of MRSA isolates was as follows: 2, 49, 6 and
1 isolates for MIC of 0.5, 1, 2 and 4mg/mL.
Coclusions: Despite high percentage of MRSA colonization, no VRSA
strains were recovered among cocolonized patients with S. aureus and
VRE.
P730 Prevalence of extended-spectrum beta-lactamases
in a district general hospital
F. H. M’Zali, S. Quamer, A. W. Anderson, K. G. Kerr, M. Allen,
N. J. Todd
Leeds, York, Harrogate, Maidenhead, UK
Introduction: Extended-spectrum beta-lactams are commonly included in
empirical antibiotic regimens for the treatment of Gram-negative sepsis.
However, the emergence of extended-spectrum beta-lactamase (ESBL)-
producing bacteria pose a serious threat to the continued use of this family
of antibiotics.
Objectives: Following the isolation of Enterobacteriaceae producing ESBLs
from patients in the Haematology unit at York District Hospital during 2000–
2001, a study was instigated to look at the incidence of ESBL producing
isolates from blood culture taken from the general hospital population.
Material and methods: 234 selected clinical isolates of Gram-negative bacilli
obtained from blood culture taken from inpatients at York District Hospital,
York, UK between 1997 and 2001 were studied. The selected isolates were all
resistant to at least one of the following extended-spectrum beta-lactams;
ceftriaxone, ceftazidime, cefotaxime. The isolates were identiﬁed using the
API 20E system. All isolates were tested for ESBL production by the double
disc diffusion test and the MAST DD Test. The Minimum Inhibitory
Concentration of ceftriaxone, ceftazidime, cefotaxime, cefepime, cefoxitin
and imipenem were determined for all the isolates using an agar dilution
method. Speciﬁc polymerase chain reaction (PCR) was used to screen for the
presence of blaSHV, blaTEM and blaCTX-M in the ESBL-producing isolates.
Pulsed Field Gel Electrophoresis (PFGE) was used to determine the clonality
of the isolates.
Results: ESBL production was detected in 83 isolates, 62 Escherichia coli, 10
Klebsiella pneumoniae, 5 Klebsiella oxytoca, 2 Proteus mirabilis and 4 Enterobacter
cloacae. PFGE revealed the presence of multiple clones. Molecular character-
ization of the ESBLs showed that the isolates produce SHV-5, SHV-12, TEM-
52 and CTX-M ESBL.
Conclusion:To our knowledge, this is the ﬁrst report describing the presence
of organisms expressing ESBL in a District General Hospital in the UK. The
data presented here highlight the global emergence of these clinically
important resistance determinants and the importance of screening for their
presence not only in tertiary hospitals but in district hospitals as well.
P731 Teicoplanin-resistant Staphylococcus aureus from
diabetic food ulcer
S. Monecke, R. Ehricht, L. Jatzwauk, W. Witte
Dresden, Jena, Wernigerode, D
Objectives: The emergence of glycopeptide resistance in Staphylococcus aureus
(MRSA) causes major concern as therapy often relies on these compounds.
We report a case cluster of infections with Teicoplanin-resistant MRSA.
Methods: Susceptibility tests were performed using E-test strips. For the
detection of resistance genes, PCR and chip-based hybridization assays were
used. PCR assays for the coa gene were performed for preliminary typing
based on polymorphisms of that gene.
Results:AMRSAwas isolated from a diabetic food ulcer of a patient from an
outpatient department in which that drug is administered routinely. TheMIC
for Teicoplanin was 16–24/mL but the MIC for Vancomycin was 2 mg/mL.
VanA and vanB were not detectable. The isolate contained mecA, blaZ, apha3,
norA, and sat genes. It belonged to the Berlin epidemic strain. In PCR assays
for the coa gene, the resistant isolate showed the same pattern as a Teico-
planin-susceptible MRSA isolate from the same patient which was sampled
5weeks earlier. Possible transmissions to other patients are investigated after
Teicoplanin-resistant MRSAwith identical coa patterns were isolated in three
additional cases.
Conclusions: The present set of data might indicate a mutational
resistance which developed under therapy and a subsequent spread to other
patients.
P732 Characterization of macrolide and
streptogramin-resistant genes in enterococci from poultry
and human samples from Portugal
C. Novais, J. Sousa, T. Coque, L. Peixe
Porto, P; Madrid, E
Objectives: To characterize some of the genes responsible for resistance to
streptogramines andmacrolides in enterococci with decreased susceptibility to
quinupristin-dalfopristin (QD) isolated from poultry samples (PS) and faeces
of healthy volunteers (FH).
Methods: 73 PS and 46 FH were collected in Porto between 1999 and 2001.
Susceptibility to erythromycin (E) and QD was performed by the agar
dilution method and E-test, respectively. Species identiﬁcation and detection
of genes coding for resistance to QD or E (vatD, mefA, ermA, ermB and
ermC) were done by PCR.
Results: Isolates with reduced susceptibility to QD were recovered from all
samples. Enterococci resistant to E were found in 97% PS and 89% FH.
Reduced susceptibility to E was veriﬁed in 3% PS and 9% FH.N¼ 54 isolates
from PS (27 E. faecium (fc), 19 E. gallinarum, 8 Enterococcus (sp.)) and 39 from
HV (fc) with decreased susceptibility to QD (2mg/L<MIC> 32mg/L)
were included for gene characterization. vat(D) was detected only in 1 fc
isolate from PS (MIC 4mg/L). 13/22 (59%) and 31/38 (82%) E resistant
isolates from HVand PS, respectively, carried erm(B). Interestingly, ermB was
also found in isolates with intermediate susceptibility (MIC 1–2mg/L): four
fc FH isolates and one fc PS. No erm(B) was found in 11 isolates with
MIC> 32mg/L. Presence of erm(A), erm(C) or mef(A) was not detected in
any isolate.
Conclusion: Resistant isolates to QD and E are frequently found among
Portuguese PS for human consumption and HV. In agreement with other
studies, the QD resistant isolates did not contain vat(D) genes suggesting that
other unknown genetic mechanisms are responsible for QD resistance in
enterococci. Although erm(B) gene was found in most of the E resistant
isolates, it was also detected in strains with E MIC value of 1–2mg/L
suggesting that these rarely yet reported enterococci might be more wide-
spread that it was thought. Since we did not obtain positive ampliﬁcations for
mef(A), erm(A) or erm(C) genes, the presence of other genetic mechanisms
implicated in enterococcal E resistance cannot be ruled out and should be
further studied.
P733 Genotyping of Serratia marcescens strains isolated
over 5 years in two university hospitals
L. Naumiuk, B. Krawczyk, A. Baraniak, M. Gniadkowski, A. Samet,
J. Kur
Gdansk, Warsaw, PL
Objectives: Serratia marcescens (Sm) is a pathogen difﬁcult to treat and control.
Genotyping enables the better understanding of an outbreak dynamics and
endemicity. The objective of this study was to analyze Sm genotypes over long
period of time at two tertiary care hospitals.
Methods: From 1996 to 2000 we collected 527 Sm isolates, 382 of them from
362 patients were selected to MIC determination by agar dilution method.
Double-disk synergy test was used to detect ESBL production. RAPD was
used to genotype 358 isolates, 321 from hospital I (1204 beds) and 37 from
hospital II (314 beds). Fifty-six isolates selected from both hospitals were
genotyped by PFGE. ESBL producers were further investigated by isoelec-
trofocusing and PCR.
Results: The majority of isolates were from the respiratory tract (33%),
wounds (20%), urine (18%), and blood (8%). We differentiated 68 Sm
genotypes by RAPD. PFGE results for selected strains were in general
concordance with RAPD. Two most common strains A – 64 isolates, B –
126 comprised 53% isolates. Strain B was responsible for endemic situation in
both hospitals. Five other predominat genotypes included 81 isolates. 54
genotypes were isolate speciﬁc. 35% isolates from hospital II produced ESBLs.
TEM-ESBL Sm strain appeared in 1997 in hospital I but most of 67 ESBL
isolates produced CTX-M enzymes and disseminated in 1999 and 2000.
Endemic strains acquired ESBL enzymes but majority of ESBLs were detected
in special ESBL genotypes.
Conclusions:Bothmethods PFGE andRAPD gave comparable results for Sm
isolates obtained over 5 years. Once established Sm strains persisted for many
years in two hospitals. 75% isolates belonged to seven most common
genotypes. Majority of genotypes were ephemeral. CTX-M enzyme was
most often produced in our Sm ESBL strains.
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P734 Distribution of macrolide-lincosamide resistance
amongst S. pyogenes isolates from different sources, during
January 1998–September 2001
G. Chronopoulou, L. Zachariadou, N. Petropoulou, E. Petridou,
E. Alexandrou, A. Pangalis
Athens, GR
Having noticed that resistance rates to erythromycin and clindamycin of
S. pyogenes (GAS) strains, isolated from different specimen sources, differ
signiﬁcantly, we studied the sensitivity of GAS strains isolated during January
1998–September 2001. A total of 2744 GAS strains derived from throat
(2180), ear (141), nose (101), vagina (97), pus (159) and skin lesions (66), were
studied by the double-disk diffusion test, according to the NCCLS recom-
mendations using Becton Dickinson’s disks. Pharyngeal strains, during 2001,
showed an increased resistance (R: 32.08%) and an intermediate one (IR:
5.75%) to erythromycin (Ery), as well as to clindamycin (Cli) with 3.98% R
and 1.11% IR, compared with 21.05% Ery R, 3.95% Ery IR and inexisting
resistance to Cli during 1998. Skin lesion strains, also, showed an increase in
Ery resistance (1998: 10.53% R and 5.26% IR – 2001: 26.67% R and 16.66%
IR). Vagina strains revealed a noticed increase of Ery resistance (1998: 14.29%
Ery R and 0.00% IR – 2001: 38.90% R and 16.67% IR). None of the strains
isolated from skin or vagina was resistant to clindamycin. Pus strains, in
contrast, revealed a minimum resistance ﬂuctuation (1998: 19.51% Ery R,
7.32% Ery IR and 2.44% Cli R – 2001: 18.6% Ery R, 9.30% Ery IR and
2.33% Cli R). Ear and nose isolates showed the same total Ery resistance rates,
but, there was an increase in the percentage of IR strains to it, from not-
existing during 1998, to 11.76% IR and 17.65% IR, respectively, during
2001. No ear isolate detected as Cli R, but, nose strains showed an increasing
resistance (1998: 0% Cli R – 2001: 5.58% Cli R). The high resistance rates to
erythromycin of nose strains can possibly be attributed to colonization. The
increase of resistant strains totally 45% isolated from infections (pharyngo-
tonsillitis, vanginitis, skin lesions) usually treated by pediatricians, possibly by
macrolides, is of high importance.
P735 Beta-hemolytic streptococci from throat cultures
of Greek children, during 2000–2002 – S. pyogenes
resistance to erythromycin and clindamycin
N. Petropoulou, L. Zachariadou, G. Chronopoulou, K. Chrisaki,
E. Kirikou, A. Pangalis
Athens, GR
9812 throat cultures from children were studied using standard operating
procedures, sheep blood agar 5% (OXOID), 35 08C anaerobic incubation,
bacitracin 0.04U sensitivity(OXOID), serogrouping (TransLab UK kit).
Sensitivity to erythromycin (Ery) and clindamycin (Cli) was detected for
all S. pyogenes (GAS) strains by the double disk test, using the NCCLS criteria
and Becton-Dickinson’s disks. A total of 2381 strains of beta-hemolytic
streptococci were isolated during the 3-year period of study. The overall
isolation rate and the distribution of different groups were as follow:
2000: 851 isolates with 65.33% group A, 32.31% group C and 2.35%
group G.
2001: 937 isolates with 62.43% group A, 35.11% group C and 2.45%
group G.
2002: 593 isolates with 71.00% group A, 27.15% group C and 1.85%
group G.
The sensitivity test revealed decreasing tendency in the resistance of GAS to
Ery and an increasing one to Cli, as follow:
Erythromycin resistance:
30.57% R and 4.68% IR, during 2000
25.13% R and 3.76% IR, during 2001
23.54% R and 3.32% IR, during 2002
Clindamycin resistance:
1.62% R and 0.36% IR, during 2000
3.25% R and 1.54% IR, during 2001
9.26% R and 1.66% IR, during 2002
The decline of erythromycin resistance can, possibly, be explained by the self-
limitation of pediatricians in the use of macrolides these last years, as a
consequence of the high resistance rates referred at late 1990s in Greece (30–
35%). Clindamycin’s higher resistance rate (totally 10.9%) during 2002, needs
the detection of the resistance genes’ distribution among GAS strains, as there
is no signiﬁcant change in its use.
P736 Emergence of a clone of Streptococcus pyogenes
resistant to bacitracin during a prospective survey of
acute pharyngitis in France
L. Mihaila-Amrouche, J. Loubinoux, A. Bouvet
Paris, F
Objectives: A prospective survey of acute pharyngitis was conducted from
November 2000 to June 2001, in Bourgogne, a region of France, involving 20
general practitioners. The aim was to study the frequency of antimicrobial
resistance of Streptococcus pyogenes responsible for pharyngitis.
Methods: Streptococcal pharyngitis were ﬁrst diagnosed by the positivity of
the Biostar Strep A Optical Immunoassay (International Microbio). It is a
rapid test that detect the group A antigen. A second throat swab was cultured
on Columbia blood agar plate and allowed to isolate 247 strains of S. pyogenes
from 282 patients. Biotyping, T-typing and emm-typing were carried out
with the Rapid ID Strep 32 (BioMerieux), agglutination method, and
sequence analysis, respectively. Pulsed-ﬁeld gel electrophoresis was performed
on strains with similar markers. Susceptibility to 12 different antibiotics,
including bacitracin, was tested by the disk diffusion method. The minimal
inhibitory concentrations (MICs) of macrolides (erythromycin, azithromycin,
and josamycin), clindamycin, and tetracyclin were determined by the agar
dilution method according to the guidelines of the ‘Comite´ de l’Antibio-
gramme de la Socie´te´ Franc¸aise de Microbiologie’ (CA-SFM). The major
genetic determinants of macrolides resistance (ermB, ermTR andmefA) were
investigated by multiplex PCR assay.
Results: Thirty out of 247 isolates of S. pyogenes (12.1%) were found to be
resistant to bacitracin. All these strains were also resistant to high levels of
macrolides and clindamycin (MICs> 32mg/L) associated with the ermB
gene. High levels of resistance to kanamycin and streptomycin were detected
in 30 and 27 strains, respectively. Most of these multiresistant strains were of
biotype 1, serotype T28, and type emm28, and represent more than 40% of
the emm28 strains. The pulsed-ﬁeld gel electrophoresis showed an homo-
geneity among these strains.
Conclusions:These results conﬁrm the spread of a strain of S. pyogenes biotype
1, T28, emm28, characterized by an unusual resistance to bacitracin. The
spread of this clone during a 8-month period among the whole area of the
survey might have been favored by the association of high levels of resistance
to macrolides. Bacitracin resistant strains have already been isolated from
invasive infections. Therefore, the detection of S. pyogenes should not be relied
by the positivity of the bacitracin susceptibility test.
P737 Differences between MRSA and MSSA
colonization/infection in outpatients with vascular or
diabetic foot ulcers
N. Juan, M. Xercavins, N. Freixas, J. Moncunill, J. Viade´,
M. Rodriguez Carballeira, J. Garau
Barcelona, E
Objectives: To know the prevalence, epidemiology and risk factors for
MRSA colonization/infection (C/I) in outpatients with ulcers as well as
their differences with patients colonized/infected by MSSA.
Methods: We prospectively studied all patients with ulcers attending the
Outpatient Vascular Surgery and Diabetic foot Care Clinics at our Institution.
Patients were routinely cultured (nose and ulcer). A previously elaborated
questionnairewas ﬁlled at each patient’s visit. Demographics, previous contact
with Health Care facilities, previous or actual exposure to antimicrobials,
underlying disease, nature and clinical characteristics of the ulcer were
recorded. We used for the comparative study F-Fisher and Chi-square tests
for qualitative variables and t-Student for quantitative variables.
Results:One hundred patients were included. Sixty-four weremen, mean age
of 66.5 years (SD 13.8; range, 63.7–69.2), with a mean time of evolution of
the ulcers of 297 days (range, 144–449). 52/100 patients had not been
hospitalized during the previous year. 34% were taking antibiotics and
68% had been exposed to antimicrobials in the preceding 3months. 72%
of the patients were diabetics and 52% had arterial peripheral vascular disease.
Ulcer examination revealed signs of active infection in 39%; 23% had also
underlying osteitis. Six patients were colonized or infected by MRSA and 34
by MSSA; this represents an incidence of MRSA of 15% of all S. aureus
colonized/infected patients. All MRSA patients had been in contact with
Health Care facilities (hospital, ambulatory care center, etc.) prior to C/I by
MRSA. MRSA patients, as compared with MSSA colonized/infected
patients, were older [81 years (SD 9.8) vs. 66.2 years (SD 14.7), P ¼ 0.02],
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and had been exposed to antibiotics more frequently in the preceding
3months [100% vs. 52.9%, P ¼ 0.03]. MRSA strains had different resistance
phenotypes and genotyping showed identity with previously isolated strains of
nosocomial origin.
Conclusions:MRSAC/I in our community is rare (6%) and always found in
persons previously in contact with Health Care Organizations. Old age and
previous exposure to antibiotics are risk factors for MRSA in the community.
MRSA in ambulatory patients is genotypically similar to nosocomial isolates
and it is presumably acquired through contact with health care personnel and/
or colonized/infected patients.
P738 Comparison of antibiotic resistance of the most
common Gram-negative pathogens and Staphylococcus
aureus isolated from patients with urinary or respiratory
tract infections
K. Huppertz, I. Noll, B. Wiedemann and the GENARS-group
Objectives: Urinary tract infections (UTI) and respiratory tract infections
(RTI) are the most common infections in hospitalized patients. As the most
common pathogens for both kinds of infection are different, the antibiotics
commonly used are not identical, resulting in different selection pressure.
Therefore, it should be expected that antimicrobial resistance of bacterial
species isolated from both UTI and RTI should also be different. For those
species which are causing infection in both sites we compare the incidence of
resistance using the data of the German Network for Antimicrobial Resis-
tance Surveillance (GENARS).
Methods: In all laboratories involved in the GENARS-project, in the daily
routine, susceptibility is measured by MIC determination. Once a week, for
central evaluation these data are transmitted to the central ofﬁce. Selection
criteria for the query in a time frame of January 1 to November 30 in
2002 included all ﬁrst isolates of a patient for the species common in both
sites. Therefore, the data of the typical kinds of patient-material of the
respiratory tract (sputum, tracheal secretion, bronchial secretion, pleural
puncture, material from pleural biopsy, pus, bronchioalveolar lavage)
and the urinary tract (urine: mid stream, bag, catheter, puncture) were
evaluated.
Results: The number of cases evaluated with 80–2100 per species and
antibiotic is quite high. Only those species have been evaluated which are
common in both infection sites. Mainly nosocomial RTI’s are included and
not community-acquired infections which are usually caused by S. pneumoniae
andH. inﬂuenzae. Differences in the incidence of resistant strains (see Table 1)
are striking in some cases (nine-fold, Ciproﬂoxacin and E. cloacae) on a low
level but may be signiﬁcant also at a high level (three-fold, 45% vs. 15% in
S. aureus with Ciproﬂoxacin). Although these differences are signiﬁcant, they
seem not to be based on a principle.
Conclusions: Antimicrobial resistance of the same bacterial species isolated
from respiratory tract and from urinary tract of hospitalized patients in
German university hospitals differs signiﬁcantly. This might be due to the
different therapeutical action for UTI and RTI. Thus, for the calculated
therapy not only local statistics in the epidemiology of resistance has to be
considered but also the site of infection.
P739 Characterization of invasive strains of
vancomycin-resistant enterococci isolated in Italy,
2001–2002
M. Del Grosso, L. Stampone, S. Fokas, D. Boccia, F. D’Ancona,
S. Salmaso, A. Pantosti
Rome, I
Objectives: The aim of this study was to characterize recent strains of
vancomycin-resistant enterococci (VRE) isolated from patients with invasive
diseases in different areas of Italy. The strains were collected over the years
2001–2002, the majority as part of the national surveillance of antibiotic
resistance AR-ISS.
Methods:A total of 25 invasive VRE strains (24 from blood and 1 from CSF),
were isolated in 12 different laboratories and submitted to be further
characterized. Characterization included a multiplex PCR assay to detect
species-speciﬁc ligases to conﬁrm species identiﬁcation and to detect the
different vancomycin resistance genetic determinants (vanA, vanB, vanC1/2).
Susceptibilities to different antibiotics were tested by the microdilution
method using Sensititre panels. To analyze clonal relatedness among the
strains, proﬁles of total genomic DNA digested with Sma I were obtained by
pulsed-ﬁeld gel electrophoresis (PFGE). The PFGE proﬁles were interpreted
by standard criteria.
Results:The multiplex PCR analysis conﬁrmed that out of 25 invasive VRE,
21 belonged to the species E. faecium and 4 to the species E. faecalis. All of the
isolates, except one, carried the vanA gene, whereas a single E. faecium strain
carried vanB. The antibiotic susceptibility assays performed on 21 VRE
E. faecium showed that all the strains were resistant to ampicillin, the majority
were also resistant to high level streptomycin (20 strains out of 21) and
gentamycin (19 strains out of 21). A single strain, the vanB-positive E. faecium,
was susceptible to both streptomycin and gentamycin. Five strains were
resistant to tetracycline and one to quinupristin/dalphopristin. The results
of genotyping by PFGE showed that the majority of the isolates had very
similar electrophoretic proﬁles, differing by 1–3 bands only.
Conclusions: As in other European countries, in Italy the majority of VRE
belong to the species E. faecium and resistance to vancomycin is mainly
conferred by the gene cluster containing vanA. Interestingly, we found an
isolate carrying vanB, the ﬁrst such report to date in Italy. The VRE E. faecium
strains were also resistant to several other antibiotics used to treat enterococcal
infections. The PFGE analysis suggest that the invasive VRE E. faecium
circulating in different hospitals and areas of Italy have a clonal origin.
P740 Antibiotic resistance association with age and sex
in Escherichia coli
A. Delgado-Iribarren, J. Valverde, R. Barba, M. Velasco, L. Moreno,
J. Losa, A. Espinosa
Madrid, E
Background: Escherichia coli antibiotic resistance is a serious and common
health problem. Empiric therapy is based on local pattern of resistance. We
studied the resistance relationship with patient age and sex.
Methods: 1157 patients with a positive urine culture for E. coli within
February 2001 and October 2001 retrospective analysis (only one isolate
from each patient). The identiﬁcation and susceptibility tests were done with
MicroScan WalkAway. We evaluated Ampicilin (Ap), Amoxycilin-Clavula-
nate (Amc), Gentamicin (Gn), Cefotaxime (Ctx), Cotrimoxazol (Sxt) and
Ciproﬂoxacin (Cp) resistance. Results were compared by the Chi-square or
Table 1 Percentage of resistance of the same bacteria isolated from UTI and RTI
(UTI/RTI)
E.
cloacae
E.
coli
K.
pneumoniae
K.
oxytoca
P.
aeruginosa
P.
mirabilis
S.
aureus
Ampicillin R 40/49 R R R 31/39 40/40
Piperacillin 33/19 24/34 14/19 18/11 9/13 10/5 –
Oxacillin – – – – – – 31/14
Cefaclor R 8/15 12/19 16/9 R 12/22 36/28
Cefuroxime 63/52 8/12 14/19 19/9 R 7/12 –
Ciprofloxacin 9/1 9/14 4/3 3/1 13/11 5/2 45/15
Gentamicin 5/1 4/10 4/4 7/4 10/31 12/8 7/7
Doxycycline 21/8 35/34 20/24 23/5 R R –
Erythromycin – – – – – – 25/17
Bold letters indicate a difference between UTI and RTI of more than 5%.
R, natural resistance.
–, not done.
Table 1
Antibiotic
Univariate Logistic regression
%R
Sex
(P)
Age
(P)
Males
OR
IC
95%
>40 years
OR IC 95%
Ap 59.8 0.054 0.213 1.32 0.99–1.77 1.1 0.88–1.45
Amc 10.3 0.66 0.001 1.1 0.7–1.7 1.8 1.16–2.8
Ctx 1.7 0.83 0.022 0.88 0.29–2.67 2 0.67–6.1
Gn 6.1 0.05 0 1.7 1.0–2.9 4.9 2.2–10.7
Cp 21 0.006 0 1.6 1.14–2.23 4 2.76–6.04
Sxt 29.3 0.37 0 1.1 0.8–1.5 1.5 1.1–2
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Student t-test as appropriate. The association between age (being older than
40 years old) and sex with antibiotic resistance was evaluated by logistic
regression (LR) models.
Results: Median age was 52 years (0–99), 78% were female (Table 1).
By univariate analysis, antibiotic resistance was associated to being older in all
the cases except with Ap. Cp and Gm resistance were associated with sex
(27.3% males vs. 19.4% females, 8.7% males vs. 5.3% females, respectively).
We also found a strong correlation among the resistance to different anti-
biotics. The multiresistance isolates were frequent.
By LR patients older than 40 years old were four to ﬁve times more likely to
present an isolate resistant to Cp or Gn, and these isolates were more frequent
in males (OR 1.6 and 1.7).
Conclusions: There seem to be minor variations in the resistance to beta-
lactam antibiotics with respect patients sex and age, but these variations were
signiﬁcant in the resistance to Gn and Cp. This fact may reﬂect a more stable
E. coli population with resistance to beta-lactam antibiotics meanwhile
acquired resistance to Gn or Cp may increase faster by antibiotic pressure.
These variables may be useful in prediction models for empiric therapies.
P741 The short- and long-term impact of hospitalization
on the colonization of the lower gastrointestinal tract with
antibiotic-resistant bacteria
S. Zouridakis, M. Souli, K. Kanellakopoulou, J. Skiadas, T. Tsaganos,
M. Tsivra, L. Prezas, D. Katsala, H. Giamarellou
Athens, GR
Objectives: The fecal ﬂora represents an important source of potential
pathogens and a large reservoir of resistance genes, able to move to susceptible
bacteria of the same or other species. Hospitalization could alter the fecal ﬂora
due to selection and/or horizontal dissemination of resistant bacteria. The
present study was prospectively designed to (1) assess whether hospitalization
leads to the acquisition of resistant strains in the fecal ﬂora, (2) deﬁne the risk-
factors associated with colonization with resistant strains, and (3) examine
whether colonization disappears after discharge.
Methods: Study population consisted of patients admitted for any reason to a
medical ward. In our department, strict policies for the containment of
antibiotic resistance, including hand hygiene, are implemented. A stool
specimen was collected using a rectal swab (Portagerm Amies Agar, Biomer-
ieux) on admission, in 7–10 days, before discharge and at follow-up. Infor-
mation on several possible risk factors was also recorded. Swabs were plated
onto agar plates containing each (in mg/mL): ceftazidime (2 and 8), cipro-
ﬂoxacin (2), cefepime (8), imipenem (4), oxacillin (6)þ 2% NaCl and
vancomycin (6). Isolates were submitted to identiﬁcation and susceptibility
testing.
Results: Of 140 patients enrolled, 32 (22.9%) were colonized with new
resistant isolate(s) during hospitalization. A total of 36 different strains were
isolated, the most prevalent being E. coli ciproﬂoxacin and/or ceftazidime-
resistant. Fifteen patients (46.9%) received antibiotics whereas 2 (6.3%) shared
the room with another colonized patient. For seven patients a median follow-
up of 6months was available and only two retained a resistant isolate.
Conclusions: In a setting where antibiotic resistance policies were imple-
mented, fecal colonization with resistant bacteria was 22.9%, antibiotic
consumption being probably the most important risk factor. The study is
still ongoing in order to assess the long-term colonization rate.
P742 Dissemination of structurally related class I
integrons among Acinetobacter baumannii clones
A. Nemec, T. van der Reijden, L. Dijkshoorn
Prague, CZ; Leiden, NL
Objectives:To investigate the relationship between aminoglycoside resistance
genes and class 1 integrons and clonality of multiresistant A. baumannii strains
from the Czech Republic.
Methods:Seventy epidemiologically unrelated multiresistant strains ofA. bau-
mannii isolated in Czech hospitals between 1991 and 2002, 13 reference strains
of epidemic clones I and II from NW Europe (Dijkshoorn L et al. J Clin
Microbiol 1996; 34: 1519–25) and a control group of 15 susceptible Czech
strains were investigated. The strains were studied by AFLP ﬁngerprinting and
HindIII/HincII ribotyping and screened for the presence of seven aminogly-
coside resistance genes and class 1 integrons by PCR. PCRmapping was used
to study the content and order of integron-associated gene cassettes.
Results: AFLP ﬁngerprinting and ribotyping classiﬁed the Czech multi-
resistant strains into clone I (n¼ 41), clone II (n¼ 21) and a heterogeneous
group of other strains (n¼ 8). The susceptible strains had heterogeneous
genotypes distinct from those of clone I or II. Aminoglycoside resistance
genes aac(3)-Ia, aph(30)-Ia, aph(30)-VIa, ant(20 0)-Ia and ant(30 0)-Ia were
present in 13 different combinations, some of which were found in both
clones. Class 1 integrons were detected in most clones I and II strains and were
classiﬁed into two types according to size (3.0 and 2.5 kb) and structure of
their internal variable regions. The two integron types contained aac(3)-Ia
and ant(30 0)-Ia cassettes and were structurally highly related to each other as
indicated by the restriction patterns and positions of gene cassettes. The
integrons of the two types were found both in clones I and II strains including
Czech and NW European strains.
Conclusions: The Czech multiresistant A. baumannii strains belonged almost
exclusively to the two clonal lineages previously recognized in a set of strains
from NW European hospitals. Both the intraclonal diversity of aminoglyco-
side resistance genes and the presence of the same resistance genes and
integron structures in clonally distinct strains are indicative of horizontal
gene transfer. The data suggest that the structure of the integrons remains
stable over a long period of time.
In vitro susceptibility testing
P743 Accuracy of four susceptibility methods for
detection of oxacillin resistance in Staphylococcus
aureus
S. B. Ricardo, G. P. Matta-Machado, E. S. Moreira
Belo Horizonte, BR
Oxacillin-resistant Staphylococcus aureus (MRSA) is responsible for an increas-
ing number nosocomial- and, more recently, community-acquired infections.
Effective control measures for reducing the hospital reservoir of MRSA
depend, basically, on correct identiﬁcations of these strains. The most
common methods currently used for identifying oxacillin-resistance in many
clinical laboratories are susceptibility tests. The performance of these tests has
been erratic because the expression of resistance is variable and, commonly,
heterogeneous within strains. Using a set of 103 nosocomial strains of
S. aureus, four routine methods were evaluated (disk diffusion, agar dilution,
oxacillin agar screen, and Vitek GPS-101 card) by using the presence of the
mecA gene, as detected by PCR, as the ‘gold standard’. The susceptibility tests
were carried out as recommended by the NCCLS. Among all the isolates, 36
were identiﬁed as mecA-positive, and the remained 67 were identiﬁed as
mecA-negative. The results of the susceptibility tests (oxacillin-resistant/
oxacillin-susceptible) were as follows: disk diffusion, 33/70; agar dilution,
41/62; oxacillin agar screen, 34/69; and Vitek, 45/58. The percentages of
correct results (% sensitivity/% speciﬁcity) were: disk diffusion, 81/94; agar
dilution, 97/91; oxacillin agar screen, 94/100; and Vitek GPS-101 card, 97/
85. Ten isolates, negative for the mecA gene by PCR, were recognized by at
least one phenotypic method as oxacillin-resistant. Further evaluation of these
organisms reveled that only two were susceptible to amoxacillin-clavulanic
acid. Hyperproduction of beta-lactamase was considered the most likely cause
of false positive result in these two strains, and could not be determined in the
other eight. Only two strains mecA-positive were incorrectly identiﬁed as
oxacillin-negative by the oxacillin agar screen, although spot inoculation
method with a 1mL loopful of a 0.5 McFarland suspension were used to
improve sensitivity/speciﬁcity. Assay to determine the cause of this discre-
pancy were not done. As shown in this and other studies, no phenotypic
method is completely reliable for the detection of oxacillin resistance in
S. aureus. The oxacillin screen test is the most accurate test and approaches the
accuracy of PCR. It should be considered in association with other suscept-
ibility method to maximize the ability to correctly detect oxacillin-suscept-
ibility in S. aureus.
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P744 Evaluation of a novel medium for the screening of
methicillin-resistant Staphylococcus aureus among
hospitalized patients
D. Blanc, A. Wenger, J. Bille
Lausanne, CH
A novel medium, the oxacillin-resistant screening agar medium (ORSA), was
evaluated for the screening of MRSA in the hospital setting. Screening swabs
(nose, throat, perineal, and infected sites) were inoculated onto this new
ORSA medium and in an enrichment broth (Muhler-Hinton supplemented
with NaCl and oxacillin). After 24 h of incubation, the enrichment broth was
sub cultured onto one ORSA plate and one lipovitellin Chapman salt agar
plate. The sensitivity to detect MRSAwas calculated for each medium alone
or in combination. A low sensitivity (83%) was obtained when the ORSA
medium was used alone as a primary culture. Among the 414 blue colonies
observed on ORSA plates, 47% were found to be MRSA, 41% were
coagulase-negative straphylococci, 6% were Enterococcus species, and 2% were
methicillin-sensitive S. aureus. The optimal incubation time of the ORSA
plates was evaluated: on primo-culture, 38% of the blues colonies were visible
only after 48 h of incubation (not seen at 24 h of incubation), whereas 94% of
the colonies were visible already at 24 h when ORSA plates were used for
subcultures. In conclusion, the advantage of the novel ORSA medium is the
ease of recognition of mannitol-fermenting bacteria, but further identiﬁca-
tion tests are needed to conﬁrm the diagnostic of MRSA. An enrichment
broth is still needed to ensure a good sensitivity to recover MRSA, and an
incubation time of 48 h is required for the primo-culture of the ORSA
medium.
P745 Comparison of methods used for the detection of
methicillin-resistant Staphylococcus aureus
T. Atay, Z. Gu¨lay
Izmir, TR
Objective: To determine the most accurate method for the detection of
methicillin-resistant Staphylococcus aureus (MRSA).
Methods:Methicillin (oxacillin) susceptibility of 111 S. aureus isolates, which
were recovered from various clinical specimens were studied by four different
methods: (1) NCCLS disk diffusion test; (2) Susceptibility determination by
the Vitek GPS 101 cards (BioMerieux; France); (3) Direct detection of PBP2a
with MRSA-Screen (Denka Seiken; Japan) test; (4) mecA gene detection by
PCR.
Results:The number of isolates found as resistant to methicillin was 80 for the
disk diffusion test, 85 for the Vitek system, 81 for the MRSA-Screen test, and
76 for the mecA gene analysis. According to mecA gene analysis, sensitivity
and speciﬁcity of disk diffusion, Vitek, and MRSA-Screen tests are 100 and
90%, 100% and 80%; 100 and 88%, respectively. When the isolates which had
shown discrepancies with different methods were re-studied, it was observed
that all results were in complete agreement with the MRSA-Screen test.
Conclusion: NCCLS disk diffusion test and Vitek system, providing that all
recommendations were followed carefully, are suitable tests to be used in
routine laboratories to detect MRSA isolates, whereas the MRSA-Screen test
can be preferred as a veriﬁcation tool due to its being a fast, easy and
dependable method.
P746 Detection of methicillin resistance in
S. aureus – a disc with cefoxitin 30g is superior to
oxacillin 1g
R. Skov, R. Smyth, M. Clausen, A. R. Larsen, N. Frimodt-Møller,
B. Olsson-Liljequist, G. Kahlmeter
Copenhagen, DK; Va¨xjo¨, Stockholm, S
Background: Accurate phenotypic detection of methicillin resistance in
S. aureus has proven very difﬁcult, especially of strains with heterogeneous
and low-level methicillin resistance. Recently the use of a cefoxitin 30 mg disc
on Mueller Hinton agar and conﬂuent growth was shown to perform very
well. In this study we investigated the use of a cefoxitin 30mg disk on standard
IsoSensitest Agar using a semi conﬂuent inoculum and compared it to the
method recommended by the Swedish Reference Group of Antibiotics
(SRGA).
Material and methods: A total of 456 S. aureus strains comprising 181 mecA
positive S. aureus and 275 consecutive S. aureus routine isolates were inves-
tigated. A large number of MRSA phenotypes, including heterogeneously
and low-level resistant variants, were included. All strains were investigated
with a 30 mg cefoxitin disk (Oxoid, Basingstoke, UK), on standard IsoSen-
sitest Agar (Oxoid), using semi conﬂuent growth and overnight incubation in
ambient air at 35–378C as well as by a 1mg oxacillin disk (Oxoid) on Iso-
Sensitest Agar supplemented with 5% deﬁbrinated horse blood, conﬂuent
growth and full 24 h incubation in ambient air at 308C (SRGA recommended
method). Themethods were evaluated using a best-ﬁt breakpoint for cefoxitin
and the published SRGA breakpoints for oxacillin, respectively.
Results and discussion: All MRSA but only two MSSA isolates exhibited
cefoxitin zones of <29mm resulting in a sensitivity of 100% and a speciﬁcity
of >99%. The corresponding values for the SRGA recommended method
was 77 and 99%. Since there was considerable overlap between MRSA and
MSSA, changing the breakpoint for the SRGA method could not solve the
problem. Apart from the increased sensitivity and speciﬁcity of the cefoxitin
method it has the advantage of allowing the laboratory to utilize the same
plate, inoculum, incubation atmosphere and time used for susceptibility
testing of S. aureus against other antibiotics.
Conclusion: A cefoxitin 30-mg disk is highly accurate for the detection of
methicillin resistance in S. aureus. We suggest a tentative breakpoint of
R< 29mm and S 29mm on IsoSensitest Agar using semi conﬂuent growth,
overnight incubation in ambient air at 35–378C. We suggest that this method
should replace the method currently recommended by the SRGA.
P747 Evaluating different methodologies to detect
glycopeptide intermediately susceptible Staphylococcus
aureus – the Dutch experience
A. Voss, J. W. Mouton, E. P. Elzakker, M. G. Hendrix, W. Goessens,
J. A. Kluytmans, A. J. de Neeling, J. H. Sloos, R. A. Howe,
T. R. Walsh
Nijmegen, Delft, Enschede, Rotterdam, Breda, Bilthoven, Alkmaar, NL;
Bristol, UK
Background: Vancomycin resistance will have a major impact on the treat-
ment of Staphylococcus aureus infections around the world. To determine the
incidence of hGISA/GISA (and its consequent clinical impact) methods that
will reliably and reproducibly discriminate these resistant phenotypes from
normal MRSA must be deﬁned. The present study was a separate part within
and adapted from a Pan-European/American study protocol.
Objective: Aim of the study was to assess and compare the ability to
discriminate vancomycin-susceptible MRSA from hGISA/GISA phenotypes
and the intra- and interlaboratory reproducibility of agar screening plates and
the E-test method.
Methods: At total of 100 isolates (10 MRSA, 9 hGISA and 6 GISA – as
determined by PAP-AUC ratio, each strain in quadruplets) were sent to eight
Dutch study centres. Investigators were blinded with regard the isolates’
phenotype. All strains were PFGE typed to eliminate clonal duplication. Each
participant performed test for vancomycin and teicoplanin resistance by three
agar screening methods (BHIþ 6mg/mL vancomycin, MHþ 5mg/mL van-
comycin, MHþ 5mg/mL teicoplanin) and the E-test macro-method using
2.0 McFarland. All media were centrally supplied. E-test’s were interpreted as
positive when vancomycin was 8 and teicoplanin 12 or 8 (combined
results) (Table 1).
Conclusions: Independent of the phenotype of the isolates and the method
used for detection, the speciﬁcity was generally high, especially with the agar-
screening methods. More importantly, the sensitivity (looking for the true
Table 1
Results BHI-van MH-van MH-teico E-test
MRSA correctly identified (%)
MRSA 97.8 99.1 94.4 84.1
hGISA (%)
Sensitivity 3.1 0.7 64.9 80.6
Specificity 94.4 99.7 94.4 83.4
GISA (%)
Sensitivity 85.9 50.5 95.8 99.5
Specificity 98.4 99.7 94.4 83.4
Final results may differ due to the still ongoing retesting of hGISA with regard to their
stability to express this phenotype.
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positive results) varied between the different methods and especially between
the different phenotypes. BHI-vancomycin- andMH-vancomycin-screening
agars completely lacked the ability to detect hGISA. The use of MH-
teicoplanin screening agar and the teicoplanin E-test, seemed to be the most
efﬁcient methods to detect hGISA/GISA, with E-test achieving the highest
sensitivity. The intra- and interlaboratory reproducibility of all methods was
very high.
P748 BDXpertTM system: implementing NCCLS and SFM
rules in a knowledge base for interpretation of antibiotic
susceptibility testing results
D. Callihan, J. Pollitt, B. Turng, T. Wiles, J. Reuben
Sparks, USA
Objectives: The National Committee for Clinical Laboratory Standards
(NCCLS, USA) and Comite De L’Antibiogramme De La Societe Francaise
De Microbiologie (SFM, France) regularly publish standards for performance
and interpretation of antimicrobial susceptibility testing (AST) results. These
documents contain information that laboratories can use to assist clinicians in
selection of appropriate antimicrobial agents for treating bacterial infections.
Effective communication of this information is critical for providing proper
patient cares. The BDXpert System knowledge base has been developed for
use in the BD PhoenixTM Automated Microbiology System and BD Epi-
CenterTM System to enhance the interpretation of AST test results as
recommended by NCCLS or SFM. This study evaluated the functionalities
of the BDXpert System.
Methods: Statements listed in the NCCLS M100-S12 and SFM Report
2000–2001 documents were converted into expert rules. Special rules were
also constructed for the detection of the following resistant markers:
extended-spectrum beta-lactamase (ESBL), methicillin-resistance staphylo-
cocci (MRS), vancomycin resistance enterococci, high-level gentamicin
resistance and streptomycin resistance in enterococci, beta-lactamase produc-
tion in staphylococci (S-BL), and vancomycin intermediate staphylococci.
Associated actions were implemented as speciﬁed in the standard. A total of
222 Gram-negative or Gram-positive isolates with MIC results were used to
evaluate the BDXpert System.
Results: Phoenix MIC values were interpreted according to the breakpoints
listed in the standards for the appropriate organism-drug combinations and
SIR interpretations generated. BDXpert rules were applied and applicable
expert messages were displayed. When 33 isolates of ESBL were detected,
selected beta-lactams with susceptible (S) or intermediate (I) results were
changed to resistant (R) with the NCCLS as the standard.When SFM criteria
were applied to the same isolates, selected beta-lactams with S results were
changed to I. For 35 MRS isolates, all beta-lactams with S or I were changed
to R both with NCCLS and SFM. For 37 S-BL strains, all hydrolysable
penicillins were changed to R.
Conclusions:The BDXpert System has proven to be a reliable system that can
assist laboratory reporting and proper interpretation of AST results. Special
messages can be used to communicate timely and accurate information to
clinicians for proper therapy of infections.
P749 POLMICRO 2002 – national external quality
assessment scheme in microbiology
E. Mlodzinska, K. Szczypa, B. Chmylak, J. Fiett, E. Zurek,
W. Hryniewicz
Warsaw, PL
Objectives: The objective of this study was to analyze the results of Polish
National External Quality Assurance Scheme in Microbiology, POLMICRO
2002
Methods: Ten bacterial isolates representing key antimicrobial-resistance
phenotypes were distributed to 370 laboratories in Poland. Each isolate
was blind-coded and laboratories were asked to identify the strains to the
species level and test for antimicrobial susceptibility. Participants received data
collection sheet, which contained questions about routine work of the
laboratory, e.g. method used, source of media and reagents, interpretive
criteria used. The following strains were distributed: Enterococcus faecalis
(vancomycin-resistant VanB, HLAR), E. faecium (vancomycin-susceptible),
Staphylococcus aureus (methicillin-resistant), S. aureus (methicillin-susceptible),
Escherichia coli and Klebsiella pneumoniae (extended spectrum b-lactamase
producer). The organisms were tested multiple times at the Centre of Quality
Control in Microbiology by disk diffusion and agar dilution to establish the
reference MIC and disk diffusion values. In some cases PCR assays for mecA,
vanA and vanB were used to conﬁrm the resistance mechanisms.
Results: Of the 370 laboratories volunteered to participate in the study, all
(100%) completed the proﬁciency test and returned a completed data report
sheet. Almost 96% laboratories were able to identify isolates to the species
level adequately. Most of the laboratories were able to detect methicillin
resistance in S. aureus, vancomycin resistance in E. faecalis and resistance to
extended-spectrum cephalosporins in E. coli and K. pneumoniae. The most
difﬁcult phenotype to detect was high-level aminoglycoside resistance in
E. faecalis.
Conclusions: The majority of laboratories proved to be reliable and keeping
up with high standards of microbiological diagnostics, which was conﬁrmed
by their capabilities to accurately identify species and determine susceptibility
of clinically relevant strains.
P750 Investigation of the synergistic effects of
combinations of beta-lactam and ﬂuoroquinolone or
aminoglycoside against clinical isolates of Pseudomonas
spp. with E-test technology
E. Fodor, E. Hajdu´, E. Nagy
Szeged, HUN
Objective: The aim of the study was to investigate the applicability of E-test
technology for antibiotic combination testing in clinical routine work.
Methods: The E-test was used by superimposing the gradients of various
antibiotics to detect potential synergy between beta-lactam antibiotics (cef-
tazidime, piperacillin, or imipenem) and ﬂuoroquinolones (ciproﬂoxacin) or
aminoglycosides (amikacin or tobramycin) against 110 clinical isolates of
Pseudomonas spp. Interpretation of the results was based on calculation of the
fractional inhibitory concentration (FIC) index for all isolates.
Results: Synergistic, additive or indifferent effects were observed as concerns
the Pseudomonas spp., depending on the isolates; antagonism was not seen. In
10 of 30 ciproﬂoxacin-resistant or multiresistant Pseudomonas/Burkholderia
isolates (33.3%), synergy was seen between ceftazidime and ciproﬂoxacin or
piperacillin and amikacin combinations. Other combinations, such as piper-
acillin and ciproﬂoxacin (23.3%), and imipenem or ceftazidime and cipro-
ﬂoxacin (16.6%) combinations displayed synergy. Imipenem and tobramycin
were synergistic against two isolates (6.6%). For one ciproﬂoxacin-resistant
Burkholderia cepacia isolate, synergy was observed between ceftazidime and
ciproﬂoxacin and between piperacillin and amikacin.
Conclusion: The Etest is an easy and useful MIC method for clinical
laboratories to utilize for the combination testing of various antibiotics.
Calculation of the FIC indices provides an efﬁecient means of interpreting
the results.
P751 Erythromycin zone breakpoints should be changed
in susceptibility testing of Streptococcus pyogenes
H. U. Nielsen, N. Frimodt-Møller
Copenhagen, DK
Objective: Macrolide resistance in Streptococcus pyogenes (SP) is increasing
worldwide, and use of macrolides in treatment of infections where SP could
be the pathological organism has become standard in many countries. This
calls for a reliable susceptibility testing method and accurate zone breakpoints
Methods: We performed susceptibility testing with 87 macrolide resistant
(MR) and 50 susceptible SP according to three different standards: the
NCCLS, The Swedish Reference Group for Antibiotics (SRGA) and the
Rosco tablet diffusion. MIC was determined for MRSP by E-test.
Results: Susceptibility testing by disc diffusion according to NCCLS standards
on 87 MRSP found 8 isolates (9%) as intermediate susceptible. Disc diffusion
according to SRGA on 87 MRSP found 10 (11%) as intermediate susceptible
and 5 (6%) as susceptible. Tablet diffusion according to Rosco on 87 MRSP;
found 16 (18%) intermediate susceptible and two (2%) as susceptible. There
were no errors in the determination of the susceptible isolates for any of the
methods. E-test found MIC for the MRSP ranging from 2 to >256.
Conclusion: Zone breakpoints should be changed: by Rosco method resis-
tance should be deﬁned as equal or smaller than 28mm, by SRGA method
resistance should be deﬁned as equal or smaller than 24mm and by NCCLS
method resistance should be deﬁned as equal or smaller than 20mm.
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P752 Antimicrobial susceptibility testing of streptococci
and Haemophilus inﬂuenzae using a medium with
deﬁbrinated horse blood and NAD
C. Bore´n, R. Smyth, G. Kahlmeter
Va¨xjo¨, S
Objectives: Antimicrobial susceptibility testing (AST) of fastidious organisms
requires that base media such as ISA (Oxoid Ltd), PDM (AB Biodisk) or MH
(various) are supplemented with nutritionals to permit good growth. The
SRGA-M (Swedish Reference Group for Antibiotics subcommittee on
methodology) recommends the addition of deﬁbrinated horse blood for
AST of streptococci and pneumococci and of 1% hemoglobin (Oxoid)
and 1% IsoVitaleX (BBL) for AST of Haemophilus inﬂuenzae. The BSAC
(British Society of Antimicrobial Chemotherapy) working party on AST
recommends the addition of deﬁbrinated horse blood and NAD for H. inﬂu-
enzae and suggests that the same plate may be used for streptococci, pneumo-
cocci and Neisseria. The present study compared the two recommendations to
ﬁnd out if the SRGA-M recommended plate for H. inﬂuenzae could be
scrapped.
Methods: Laboratory reference strains and clinical isolates (collected during
1997–2002) were examined by the disc diffusion test. The plates were read
after 20 h incubation at 378C in 5% CO2. Bacterial growth, together with the
diameter and appearance of the inhibition zones was noted. The following
species were included in the study: H. inﬂuenzae, Moraxella catarrhalis, Strep-
tococcus agalactiae, S. pyogenes, S. pneumoniae and streptococci of Lanceﬁeld
groups C and G.
Results:With two exceptions the results on the two media were identical. For
H. inﬂuenzae the inhibition zones for phenoxymethylpencillin was smaller
(3mm) on the NAD-containing medium. For M. catarrhalis cotrimoxazole
produced pronouncedly larger zones on the NAD-medium.
Conclusion: The ISA (Oxoid) medium containing deﬁbrinated horse blood
and NAD can be used for AST of streptococci, pneumococci, H. inﬂuenzae
and M. catarrhalis. It can replace the medium with 1% hemoglobin and 1%
IsoVitaleX hitherto recommended by the SRGA-M for H. inﬂuenzae. This
simpliﬁes the production and quality control of AST media. With two
exceptions (H. inﬂuenzae and phenoxymethylpencillin and M. catarrhalis
and cotrimoxazole) no adjustments are necessary to zone diameter break-
points.
P753 Antimicrobial susceptibility testing of
beta-hemolytic and viridans group streptococci using the BD
PhoenixTM Automated Microbiology System
C. Gosnell, C. Yu, J. Sinha, V. Kennedy, D. Turner, J. Pollitt, T. Wiles,
J. Reuben
Sparks, USA
Objectives:Viridans (VS) and beta-hemolytic (BS) streptococci are important
agents of infections such as sepsis, menigitidis, and endocarditis. Increase in
frequency of penicillin resistant VS and macrolide resistant BS from clinical
isolates have been reported. Resistance testing among this important group of
organisms is difﬁcult to test in a routine laboratory using traditional overnight
broth dilution systems. The performance of the PhoenixTM Automated
Microbiology System (BD Diagnostic Systems, Sparks, MD) with the newly
developed Streptococcal AST panel was evaluated for ability to detect
resistance for 12 antibiotics in VS and BS. Results from these antibiotics;
Penicillin (P), Erythromycin (E), Cefotaxime (CTX), Ceftriaxone (CRO),
Chloramphenicol (C), Gatiﬂoxacin (GAT), Levoﬂoxacin (LVX),Meropenem
(MEM), Oﬂoxacin (OFX), Quinupristin/Dalfopristin (SYN), Tetracycline
(TE), and Vancomycin (VA) are evaluated in this study.
Methods: A total of 86 BS and 42 VS were tested, including recent clinical
isolates and previously characterized genotype and phenotype resistant strains.
All testing was performed in parallel using the Phoenix System and NCCLS
recommended standard broth microdilution (SBM) method. Phoenix and
SBMwere analyzed for essential accord (EA) and categorical agreement (CA)
based on NCCLS established breakpoints.
Results:EA for each drug was greater than or equal to 90% except CTX,GAT
and TE which are at 89, 86, and 80%, respectively. CA for each drug was
greater than or equal to 93%. Very Major Errors and Major Errors were less
than 1.5% for all drugs except for E and TE. E resulted in a VME of 4.8% due
to 2 out of 42 resistance strains and TE showed 1.6%ME based on 1 out of 63
susceptible strains. The overall average time to result (TTR) for all drugs using
the Phoenix System was 8.4 h.
Conclusions: This study indicates that the Phoenix Streptococcal AST
panel provides rapid, reliable MIC determination for VS and BS. This
important group of organisms is showing increased resistance and is typically
difﬁcult to test using traditional overnight broth dilution systems. The
Phoenix System provides a new improved method for susceptibility testing
of streptococci.
P754 Fluoroquinolone susceptibility testing of
pneumococci using the BD PhoenixTM Automated
Microbiology System
C. Yu, M. Gosnell, N. Krotkov, T. Quivers, J. Reuben
Sparks, USA
Objectives: Streptococcus pneumoniae (SP) is one of the most common causative
agent for community-acquired pneumonia and acute exacerbations of
chronic bronchitis. The increase in frequency of resistance to penicillin,
extended spectrum cephalosporins, and macrolides have made ﬂuoroquino-
lones an important choice of empiric treatment. The PhoenixTM Automated
Microbiology System (BDDiagnostic Systems, Sparks,MD)was evaluated for
its ability to detect resistance to ﬂuoroqinolones in SP.
Methods: Drugs evaluated include Levoﬂoxacin, Moxiﬂoxacin, Oﬂoxacin,
Gatiﬂoxacin, Gemiﬂoxacin, and Garenoxacin. A total of 190 SP were selected
for the evaluation. Selected strains include recent clinical isolates and phe-
notypically/genotypically characterized strains. All testing was performed in
parallel using the Phoenix System and the NCCLS recommended standard
broth microdilution (SBM) method supplemented with lysed horse blood.
Phoenix and SBM were analyzed for essential accord (EA) and categorical
agreement (CA) based on NCCLS established or manufacturer recom-
mended breakpoints.
Results: Essential accord for each drug was greater than or equal to 97%. CA
for each drug was greater than or equal to 94%. Very major errors are at 0% for
all drugs tested. Major errors are at 0% for all drugs except for Moxiﬂoxacin
(0.6%) and Garenoxacin (2.7%). The average time to result (TTR) based on
the Phoenix system for each drug ranged from 7.6 to 9.4 h.
Conclusions: This study indicates that the Phoenix System provides rapid,
reliable MIC determination for SP against a broad selection of ﬂuoroquino-
lones including the newly developed desﬂuoroquinolone, Garenoxacin.
P755 Evaluation of ID and AST with 241 strains of
Pseudomonas aeruginosa comparing the PHOENIXTM and
the VITEK (R) 2 system
A.-M. Fahr, U. Eigner, U. Wild
Heidelberg, D
Objectives: Pseudomonas aeruginosa is a very common but sometimes difﬁcult
organism for rapid automated systems to accurately identify (ID) and perform
antimicrobial susceptibility testing (AST). We compared the accuracy of two
such systems the VITEK 2 (V2) (bioMe´rieux, Marcy L’Etoile, France) with
the Phoenix (PHX) system (BD Diagnostic Systems, Sparks, USA) with 241
Pseudomonas aeruginosa strains.
Methods:A total of 241 clinical isolates of P. aeruginosawas tested, including a
signiﬁcant number of strains resistant to extended spectrum cephalosporins,
carbapenems, aminoglycosides and ﬂuoroquinolones. The isolates were
collected in the routine lab of Laboratory Group Heidelberg from various
specimens. PHX combination ID and AST panel NMIC/ID-5 were used,
and for V2 the Gram-negative ID-GNB and the AST card AST-GN09 were
used. All tests were performed following the manufactures recommended
procedures. For ID reference the ID 32GN strips (BioMe´rieux) were used.
Discrepant ID results were retested in duplicate. For AST the following
antibiotics were evaluated: gentamicin, tobramycin, amikacin, ciproﬂoxacin,
levoﬂoxacin, piperacillin, piperacillin/tazobactam, ceftazidime, cefepime, and
meropenem. The results of AST were compared with the reference broth
microdilution method (Biotest AG, Dreieich, Germany) according to
NCCLS recommendations. Discrepant results were repeated in duplicate,
data analysis was performed following the FDA guidance document.
Results: The V2 system correctly identiﬁed 99% of the species, the PHX
system 100%. With regard to AST, overall category agreement (CA) for the
V2 was 90.6%, and 90.2% for the PHX instrument (range PHX: 62.7%
(cefepime)- 98.8% (piperacillin, amikacin); range V2: 77.9% (meropenem)-
99.2% (piperacillin)). Major error rate for the V2 and PHXwere 0.4% (6), and
1.3% (20), while the very major error rate were 2.0% (12) and 1,.0% (6),
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respectively. The majority of VME for both systems were seen with Mer-
openem, 6 with V2 and 4 with PHX.
Conclusions: The V2 and the PHX systems, showed good performance
concerning ID and ASTof P. aeruginosa isolates, considering the challenging
characteristics of this species for susceptibility testing methods.
P756 A multicentre evaluation of the VITEK 2 Advance
Expert System (AES) using selected bacteria harboring
characterized mechanisms of resistance to antibiotics
Y. Glupczynski, A. Dediste, D. Govaerts, A. Mertens, M. Polet,
A.-M. Van den Abeele, L. Van Helleputte, M. Lontie
Yvoir, Brussels, Charleroi, Antwerp, Ghent, B
Objectives: To evaluate the performance of the VITEK 2 AES software for
the detection of difﬁcult resistance phenotypes in a set of well-characterized
bacterial strains.
Methods: Six laboratories tested a collection of 60 reference strains (40 Gram-
negative bacilli (32 Enterobacteriaceae, 8 Pseudomonas aeruginosa, 12 staphy-
lococci, 8 enterococci) comparatively by the VITEK 2 system and by their
own routine testing methods (disc diffusion) against 10–20 antimicrobial
agents. The strains were selected on the basis that they harbored challenging
and important resistance genotypes.
Results: Interpretive reading by the VITEK 2 AES achieved full agreement
with genotype data or identiﬁed the correct mechanisms as one or two other
possibilities in 82, 86, and 98% of the Gram-negative bacilli, staphylococci,
and enterococci strains, respectively. By contrast, the correct resistance
phenotypes were identiﬁed in only 39, 56, and 20% for the same three
groups of organisms by the investigators when using their own routine
method. The ability to recognize resistance mechanisms in the set of strains
varied widely from one centre to another. The most frequent reasons
accounting for the failure of detecting resistance by the investigators included
either inappropriate selection of the agents tested, absence of recognition of
phenotypes with low expression of resistance (e.g. vanB, hetero resistant
VISA, ESBLs, quinolone efﬂux resistance mechanisms. . .) or the absence of
interpretive reading of results. Clinically important mechanisms inferred with
>90% agreement with reference data by the VITEK 2 AES included
methicillin resistance in staphylococci, high-level aminoglycoside resistance
in Gram-positive cocci, VanA, VanB, and VanC phenotypes in enterococci,
ESBLs, AmpC cephalosporinases and various types of penicillinases in
Enterobacteriaceae and P. aeruginosa.
Conclusions:The VITEK 2 AES system appears as a reliable tool and is clearly
superior to locally used routine methods for the detection and interpretive
reading of clinically important mechanisms of resistance.
P757 Identiﬁcation and susceptibility testing of
vancomycin-resistant enterococci using automated
systems: VITEK2 and PhoenixTM
T. Schu¨lin, P. E. Verweij, A. Voss
Nijmegen, NL
Objective: Infections caused by vancomycin resistant enterococci (VRE) are
difﬁcult to treat and require infection control measures. The fact that VRE-
infections are still uncommon in The Netherlands, makes their fast and
reliable detection even more important.We evaluated the performance of two
automated systems with respect to identiﬁcation and susceptibility testing of
VRE.
Material and methods: Fifty-ﬁve isolates of molecular identiﬁed VRE (7
Enterococcus casseliﬂavus ECCA, 2 E. faecalis ECFA, 19 E. faecium ECFI, and 27
E. gallinarum ECGA) with known VAN status (17 VanA, 4 VanB, 34 VanC1/
2/3) were tested for identiﬁcation and vancomycin and teicoplanin MIC on
the VITEK2 (BioMerieux) and PhoenixTM (BectonDickinson) system.
Results: Identiﬁcation: None of the systems could differentiate between
ECCA/ECGA. Simple further tests were necessary to obtain the correct
identiﬁcation and were advised by the systems software. VITEK2 and Phoe-
nixTM correctly identiﬁed the strains as follows: ECCA 7/7 and 6/7, ECFA 2/2
and 2/2, ECFI 12/19 and 16/19, ECGA 26/27, and 27/27, respectively.
Susceptibility: Vancomycin MICs were correctly measured by both systems in
all strains (55 of 55). In 3 of 55 strains, TECMICs measured by VITEK2 were
too low, suggesting VanB resistence in VanA positive strains. The same was true
for 2 strains tested in PhoenixTM. Additionally, PhoenixTM suggested a VanA
type in one VanC strain.
Conclusion: In this study, VITEK2 and PhoenixTM both detect VRE fast and
reliable.
P758 Performance of identiﬁcation and susceptibility
testing of automated systems VITEK2 and PhoenixTM of
Pseudomonas aeruginosa from cystic ﬁbrosis patients
T. Schu¨lin, A. Voss, P. E. Verweij
Nijmegen, NL
Objective: Pseudomonas aeruginosa is the most frequent colonizing and infect-
ing pathogen in patients with cystic ﬁbrosis (CF). Identiﬁcation and suscept-
ibility testing of those isolates is time-consuming thus a fast and reliable
method would be desirable.
Material and methods: We tested 30 strains of P. aeruginosa (13 nonmucoid
(nm) and 17 mucoid (m)) isolated from CF patients. The strains were
identiﬁed by conventional methods and MICs (tobramycin (TOB), ceftazi-
dime (CAZ), meropenem (MEM), ciproﬂoxacin (CIP)) were determined by
an agar-dilution technique and interpreted according to NCCLS guidelines.
Identiﬁcation and susceptibility testing were then performed on the auto-
mated systems VITEK2 (BioMerieux) and PhoenixTM (BectonDickinson)
according to the manufacturers guidelines.
Results: Identiﬁcation: The VITEK2 system identiﬁed 19/30 (57%) strains
correctly. For 10 (4 nm, 6m) strains, further tests were necessary to obtain the
correct identiﬁcation. One strain remained unidentiﬁed (nm). The Phoe-
nixTM identiﬁed 27 strains (81%) correctly. Three strains (2 nm, 1m) were
identiﬁed only to the species level. One of these strains (m) had been
identiﬁed correctly by VITEK2. Susceptibility testing: the rate of minor,
major and very major errors for the VITEK2 and PhoenixTM were as shown
in Table 1.
Conclusion: In this study, the ability to identify of P. aeruginosa was more
reliable with PhoenixTM than with VITEK2. Major drawback with both
systems was the high number of strains for which no susceptibility testing was
done and the high number of errors when testing CIP.
P759 A multicentre comparison between the VITEK 2
and the NCCLS disk diffusion susceptibility testing
M. Lontie, A. Dediste, D. Govaerts, A. Mertens, M. Polet, A. Van den
Abeele, L. Van Helleputte, Y. Glupczynski
Leuven, Brussels, M-L-T, Antwerp, Ghent, Mont-Godinne, B
Objectives:To compare the VITEK 2, a new automated instrument for rapid
(results the same day) antimicrobial susceptibility testing, with the NCCLS
disk diffusion method with routine strains.
Methods: Six laboratories participated in this study, ﬁve hospital laboratories
and one private laboratory. Five hundred and seventy-two strains were tested
(295 Enterobacteriaceae belonging to 19 species, 69 non-fermenters belong-
ing to 2 species, 131 Staphylococcus spp., 59 Enterococcus spp., and 18 Streptococcus
pneumoniae). The strains were isolated from different clinical relevant speci-
mens and were selected at random. The number of Escherichia coli was limited
to 30 per center. The reagents and culture media (BioMe´rieux) were the same
in all the labs. A difference of one category between the two methods was
considered a minor discordance, a difference of two categories was a major
discordance.
Results: The overall degree of agreement between the two methods was
88.5% (3646 paired results on 4121). There were 8.6% minor discordances
and 2.9% major discordances between NCCLS-disk and VITEK 2. The best
score of an individual lab was 92.9% full agreement, the worst was 82.5%. The
three labs with the lowest overall agreement disagreed mainly with E. coli and
Pseudomonas aeruginosa. The antibiotics with the lowest concordance were
Table 1
VITEK2 PhoenixTM
TOB CAZ MEM CIP TOB CAZ MEM CIP
Minor 2 2 2 9 2 2 2 7
Major 0 0 0 1 0 0 0 1
Vary major 1 0 0 1 0 0 0 1
Not determined 5 5 5 5 3 4 5 4
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amoxiclav with the Enterobacteriaceae and gentamicin high level with the
enterococci.
Conclusions: The VITEK 2 seems well suited for use as a routine method of
antimicrobial susceptibility testing.
P760 Time-to-result for antimicrobial susceptibility
testing using the VITEK12 instrument in a routine
laboratory
U. Eigner, M. Kirstahler, M. Holfelder, D. Bertsch, A.-M. Turnwald-
Maschler, A.-M. Fahr
Heidelberg, D
Objectives:The basic goal of automated bacterial susceptibility test systems is
to produce reliable results in rapid time, preferably on the same workday. We
collected the time to result data of the VITEK 2 system (BioMe´rieux, Marcy
l’Etoile, France) for antimicrobial susceptibility testing (AST) in our routine
laboratory. The evaluation was performed from January 2002 to February
2002 comprising 3134 fresh clinical isolates belonging either to Gram-
positive cocci (staphylococci and enterococci) or Gram-negative rods (Enter-
obacteriaceae, and non-fermenters).
Methods: A total of 3134 fresh clinical isolates were routinely tested from
blood cultures, wound-, vaginal- and respiratory tract specimens including:
Staphylococcus aureus (336), Coagulase negative staphylococci (CNS) (481),
Enterococcus spp. (537), Enterobacteriaceae (1525), Pseudomonas aeruginosa
(200) and others (55). AST for Gram-negative rods was performed using
the VITEK 2 AST-N021 card, for staphylococci and enterococci using the
AST-P526 card, respectively. Concerning time to result the following data
were calculated: the mean values  standard deviation (SD), the ranges, and
the time when 50, 90, and 95% (T50, T90, T95) of the results were available.
Results:The mean time to result for all bacterial isolates tested was 8.1 2.3 h
(range 5.1–17.9 h) with T50, T90, and T95 of 7.4 h, 11.1, and 12.6 h,
respectively. AST for Enterobacteriacae was ﬁnished in 7.2 1.7 h (range
5.1–17.8 h) with T50, T90, and T 95 values of 6.2, 8.7, and 9.6 h. The results
for P. aeruginosa were available in 12.1 1.9 h (range 6.6–17.8 h) with T50,
T90, and T95 values of 12.1, 14.6, and 25.4 h. AST for S. aureus was
performed in 6.9 1 h, with T50, T90, T95 of 6.7, 7.4, 7.9 h. The mean
time to result for CNS was 9.5 2.3 h (range 6.6 h9.5 h). T50, T90, and
T95 were 8.2, 11.4, and 12.9 h. Enterococci were tested in 9 1.9 h (range
5.8–8.9 h), with T50, T90, and T95 of 8.8, 10.4, and 12.6 h, respectively.
Conclusion: The mean time to result for all 3134 bacterial isolates tested was
8.1 2.3 h 50% of the results were ready in 7.4 h. Especially with regard to
S. aureus 90% of the isolates were tested in one workday in 7.4 h. For
Enterobacteriaceae 50% of the isolates were available in 6.2 h and 90% in
8.7 h. With a late shift nearly 70–80% of the results for Gram-positive cocci
and Enterobacteriaceae could be reported to the clinical ward on the same
workday.
P761 Evaluation of three automated systems: BD
Phoenix system vs. Vitek (BioMe´rieux) and MicroScan
WalkAway-96 (Dade-Behring)
C. Pina-Vaz, M. J. Espinar, D. Pinheiro, S. Costa-de-Oliveira,
J. Correia da Fonseca
Porto, P
Objectives:Compare the identiﬁcation proﬁles (ID) and susceptibility testing
results (AST) of Phoenix System (BD Diagnostic Systems, USA) (PHX) with
Vitek system version 701 (BioMe´rieux, France) (Vk) and MicroScan Walk-
Away-96 system (Dade-Behring MicroScan, USA) (WA). PHX system was
also evaluated for general easiness of use in a clinical laboratory with a heavy
workﬂow.
Methods: One hundred and thirty-one clinical strains (51 Gram-negative
bacilli (GNB) and 80 Gram-positive cocci (GPC) (29 Staphylococcus, 23
Enterococcus, 28 Streptococcus) isolated in laboratory of University Hospital
were tested simultaneously with three equipments. Five type strains were used
as quality control, according the recommendations of NCCLS. ID proﬁles
and AST result obtained in the 3 systems were compared. Discrepant results
were retested; continuing discrepancy regarding ID was conﬁrmed by Crystal
identiﬁcation system (BD Diagnostic Systems, Sparks, Maryland, USA) and
API system BioMe´rieux and by Etest regarding AST. Categorical agreement
(CA) was determined for the antimicrobials to the three systems. Technical
performance and the expert system were evaluated.
Results: ID proﬁles results were similar between the different equipments:
agreement between PHX and Vk was 99.26% at the genus level and 87.5% at
the species level; agreement between PHX and WAwas at 98.7% Genus level
and 97.56%. Species level. PHX system didn’t require special reagents for the
reading of results as well as additional testing while Vk and WA required
testing in 6.7 and 1.4% of cases. 2460 AST combinations were evaluated in the
three systems. CA rate was 99.2% between PHX and Vk and 99.3% between
PHX and WA. WA was the single system that could perform AST for
S. pneumoniae, just by a visual evaluation. Results regarding detection of
extended-spectrum beta-lactamase production (ESBL) in Gram-negative
organisms and of methicillin resistant S. aureus (MRSA) were similar in
the three different systems.
Conclusions: All systems showed to be adequate showing high levels of
agreement. PHX presents the possibility of integration on the EpiCenter, a
microbiology data management system that can integrate data from other
equipment, state-of-art software components, an expert system and data
validation logic, without increasing costs. PHX represent an excellent
automated tool, easy to use for clinical laboratory personal in large
hospitals.
Acknowlegments: Luis Ribeiro, Ineˆs Moreira, Olı´via Pinto e Lu´cia
Ricardo.
P762 Correlation between broth microdilution and
E-test methods in the MIC determination of colistin in
clinical Acinetobacter baumannii strains
L. Arroyo, D. Martı´n-Lozano, A. Garcı´a-Curiel, M. Pacho´n-Iba´n˜ez,
A. Llanos, M. Ruiz, J. Aznar, J. Pacho´n
Sevilla, E
Objectives:To evaluate the correlation between MICs of colistin determined
by reference broth microdilution and E-test methods in clinical A. baumannii
isolates.
Methods: A total of 101 strains were studied; these isolates were randomly
chosen, including 14 strains from a nosocomial outbreak of colistin-resistant
A. baumannii infections. Broth microdilution: MHIIBCAwas used as growth
medium; the bacterial inoculum was 6 log10 cfu/mL and concentrations
among 0.015 and 128mg/mL were proved; the MIC was read after 24 h of
incubation at 378C. E-test: viable colonies from an overnight agar plate were
used and the inoculum was adjusted to McFarland 0.5; manufacturer instruc-
tions were followed in the inoculation and application of E-test strips; MH
agar plates were incubated 24 h at 378C and the MIC was read at the point of
intersection between the inhibition ellipse edge and E-test strip. Both
experiments were assayed in parallel. Escherichia coli ATCC 25922 was used
as quality control. MIC breakpoints of colistin were 2 and 4mg/mL to
designate susceptible and resistant strains, respectively (MENSURA 2000); an
E-test MIC of 3mg/mL was rounded up to 4 mg/mL (nearest higher two-fold
dilution). Very major (VM) errors were considered when E-test showed
susceptibility, being resistant by reference method; major (M) errors were
considered when E-test showed resistance, being susceptible by reference
method. Frequency of interpretative errors (VM and M-error classiﬁcation),
Pearson correlation coefﬁcient (r), concordance (2 dilutions) between
methods, and usefulness of E-test (sensitivity and speciﬁcity) in the detection
of resistance were evaluated.
Results: 86% was susceptible and 14% resistant to colistin by broth micro-
dilution. There was one VM error out of 14 strains resistant to colistin, and no
M error was found. Signiﬁcant positive correlation was observed between
both methods, although it was very poor (r¼ 0.61). Concordance was also
very poor, being below 80% (46%). In the detection of colistin-resistant A.
baumannii, the sensitivity and speciﬁcity of E-test method was 93 and 100%,
respectively, with a positive and negative predictive values of 100 and 99%,
respectively.
Conclusion: The E-test was an useful method in the detection of colistin-
resistant A. baumannii strains, showing high sensitivity and speciﬁcity. How-
ever, because its poor concordance, to know the exact MIC it is necessary the
use of broth microdilution method.
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P763 Ability of Spanish laboratories using automatic
susceptibility testing devices to detect and report
ESBL-producing Enterobacteriaceae. Results of a
multicenter proﬁciency study
R. Canto´n, E. Loza, M. C. Conejo, F. Baquero, L. Martı´nez-Martı´nez
on behalf of MENSURA, Spain
Objective:To determine the proﬁciency of Spanish microbiology laboratories
in detecting extended spectrum b-lactamases producing Enterobacteriaceae.
Methods: Six Enterobacteriaceae isolates harbouring ESBL were sent to 52
Spanish clinical microbiology laboratories to routinely study their antimi-
crobial susceptibility. Forty-six laboratories used automatic system (19Micro-
Scan, 13Wider, 12 Vitek, and 2 Sensititre) with NCCLS interpretive criteria,
but 15 with corrections following the Spanish Antibiogram Committee
(MENSURA Group). In addition, 27 laboratories (59%) used the double
disk synergy (n¼ 24) and/or speciﬁc E-test (n¼ 5) as ESBL conﬁrmatory
tests.
Results: The highest rate of ESBL recognition was obtained with an SHV-5
producing Klebsiella pneumoniae (74%), a TEM-27 producing Escherichia coli
(72%), a CTX-M-9 producing E. coli (63%), and an SHV-5 producing
K. pneumoniae lacking both OmpK35 and OmpK36 porins (43.4%). ESBLs
were less frequently recognized in two isogenic CTX-M Enterobacter cloacae
strains, one of them hyperproducing the AmpC enzyme (34.6% and 9.6%).
All laboratories using MENSURA interpretations detected at least one ESBL
producing E. cloacae strain. VITEK users had the highest ability to recognize
ESBL producing E. coli and K. pneumoniae, but lower in ESBL producing E.
cloacae strains compared with MicroScan and Wider users.
Conclusions: MENSURA criteria favoured the recognition of ESBL phe-
notypes. ESBLs were recognized to a higher degree in E. coli and K. pneu-
moniae strains than in E. cloacae strains, due to the lack of NCCLS
recommendations for screening and conﬁrmation of ESBL in Enterobater
spp. and to difﬁculties to discriminate between the ESBL and the AmpC
hyperproduction phenotype in this genus. The CTX-M-ESBL phenotype
was less frequently detected than TEM- or SHV-ESBL phenotype due to the
lack of cefotaxime-clavulanate combination tests in automatic susceptibility
testing systems.
P764 Isolation, characterization and antimicrobial
susceptibility testing of Salmonella species recovered
from cases of septicaemia in an endemic area
D. Nair, M. Capoor, B. Gupta, L. Srivastava, P. Aggarwal
New Delhi, IND
Objectives: (a) Isolation and identiﬁcation of Salmonella species from blood
culture specimens of patients of septicaemia. (b) Perform the antimicrobial
susceptibility testing using Kirby Bauer method. (c) Perform the agar dilution
Minimum Inhibitory Concentration (MIC) testing for Ciroﬂoxacin, Cepho-
taxime and Ceﬁpime. (d) Detection of Extended Spectrum Beta Lactamase
(ESBL) production by these isolates.
Material andmethods:One hundred and seventy-eight isolates of Salmonella
species were recovered from blood culture specimens received over a 21-
month period. These were identiﬁed using biochemical tests and serotyping
with speciﬁc antisera. The isolates were subjected to antimicrobial suscept-
ibility screening by Kirby Bauer method for the following agents: Trimetho-
prim/Sulfamethoxazole, Nalidixic acid, Ciproﬂoxacin, Crhotaxime,
Ceftriaxone, Ampicillin and Cefpirome. The MIC for Ciproﬂoxacin (178
isolates), Cephotaxime (100 isolates) and Cefepime (100 isolates) was done by
the agar dilutionmethod. Extended Spectrum Beta Lactamase productionwas
detected using the Double Disc Screening test using Cephotaxime, Ceftriax-
one and Cefoperazone along with Augmentin.
Results: The Salmonella species were mostly recovered from the community.
Only one strain of Salmonella senftenberg isolated from a nursery patient was a
hospital isolate. The most common species was Salmonella typhi followed by
Salmonella paratyphi A. One strain each of Salmonella senftenberg and Salmonella
typhimurium were also isolated from neonatal septicaemias. On Disc diffusion
testing the Salmonella typhi isolates were found to be sensitive to Ciproﬂoxacin,
Cephotaxime, Ceftriaxone and Cefpirome. Nalidixic acid resistance was
observed in over 20% of the isolates. The MIC to Ciproﬂoxacin by agar
dilution showed resistance in 3/178 (1.6%) Salmonella, MIC to Cephotaxime
showed resistance in 2/100 (2%) strains and intermediate sensitivity in 1/100
(1%) and MIC to Cefepime showed resistance in 1/100 (1%) strain.
Conclusions: Resistance to quinolones, third generation cephalosporins and
fourth generation cephalosporins is emerging amongst Salmonella species.
These ﬁndings would have important implications in the clinical management
of community acquired salmonella infections.
P765 Study to investigate the effect of media depth on
the performance of control strains by BSAC methodology
J. M. Andrews, J. P. Ashby, G. Jevons, R. Walker on behalf of the BSAC
Working Party on Sensitivity Testing
Objectives: The study was designed to conﬁrm that the depth of media
suggested by the BSAC of between 3.5 and 4.5mm was ideal for the
performance of control strains by BSAC methodology.
Methods: The ATCC and NCTC control P. aeruginosa, H. inﬂuenzae, S. aur-
eus, E. coli, S. pneumoniae, and E. faecalis strains suggested for use with the
BSAC standardized disc testingmethodwere studied. Antibiotics including b-
lactam, quinolone, macrolide and glycopeptide antibiotic discs (Oxoid) were
tested on Iso-Sensitest agar (Oxoid) (supplemented where necessary) poured
to a depth of 2, 2.5, 3, 3.5, 4, 4.5mm. Plates were stored at 4–88C and plates
were tested on four separate occasions day 1, 5, 10, and 14. Zones were
measured by an automated zone reader (Aura, Oxoid).
Data analysis: For the test performance to be acceptable BSAC recommend
that 95% of zone diameters for the control strains should be within the
published acceptable limits. Each antibiotic/control combination was ana-
lyzed to see if it met this criteria.
Results: Table 1 shows the results for discs that did not fulﬁl the criteria for
depths between 3.5 and 4.5mm. Irrespective of organism/antibiotic combi-
nation. When the percentage of tests within the acceptable limits was
combined 57, 74, 83, 83, 93, and 91% of tests were within the acceptable
limits on media depths of 2, 2.5, 3, 3.5, 4, and 4.5mm, respectively.
Conclusion: The study conﬁrms that the depth of media should be within
3.5–4.5mm for the ideal performance of the BSAC standardized disc-testing
method.
P766 Disk diffusion method for determining
susceptibility of Candida spp. to voriconazole
C. Serrano, D. Morilla, A. Valverde, R. Claro, M. Ramı´rez, S. Bernal,
E. Martı´n-Mazuelos
Seville, E
Objective:The purpose was to evaluate the disk diffusion test for determining
suceptibility of Candida spp. to voriconazole (V) in comparison with the
reference method (NCCLS M27-A2 document).
Material and methods: We studied 203 Candida spp. (168 C. albicans, 26
C. glabrata, 9 C. tropicalis) isolated from clinical specimens. Susceptibility test
was carried out by the agar diffusion method using disk with 1 mg of V
(Beckton Dickinson) on Yeast Nitrogen Base (YNB, Difco) plus 1.5% agar.
The MICs obtained by the reference broth microdilution method (NCCLS
M27-A2 document) (MDB) were deﬁned as the lowest concentration of V
that inhibited the 50% of growth. Both methods were read after 24 and 48 h of
incubation at 358C.
Results:At 24 h, 201 strains (96.5%) hadMICs values minor or equal to 2 mg/
mL, showing 188 (93,5%) of these an inhibition zone diammeter major or
equal to 18mm. Only two C. albicans strains (0.98%) showed MICs values
major to 2 mg/mL to V by MDB but none of these strains had inhibition zone
diammeter minor to 18mm by disk diffusion method. At 48 h, 144 strains
(71%) had MICs values minor or equal 2 mg/mL, showing 106 of these (3.6%)
had an inhibition zone diammeter major or equal to 18mm. Fifty-nine strains
Table 1
Control Disc (mg)
%of tests within the acceptable zone
diameter limits
2mm 2.5mm 3mm 3.5mm 4mm 4.5mm
ATCC 25922 E. coli TMP 2.5 0 0 20 3 43 65
ATCC49247 H. influenzae AMC 3 100 100 100 83 48 15
ATCC 49619 S. neumoniae RD 5 45 45 50 48 33 45
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(57 C. albicans, 2 C. glabrata) (29%) had high MICs values (major to 2 mg/mL)
by MDB (13 were resistant and 10 were sensitive dose dependent to
ﬂuconazole), 8 of these (6 C. albicans, 2 C. glabrata) (13.5%) had inhibition
zone diammeter minor to 18mm.
Conclusions:
1. Better correlation between disk diffusion and the reference brtoh micro-
dilution method at 24 h/24 h than at 48 h/48 h for strains with low MICs
values to voriconazole.
2. Reading of the inhibition zone diammeter became easier at 48 h than at
24 h.
3. The disk diffusion is a method easier to perform and easier to read than the
reference broth microdilution method and is more available to clinical
laboratories.
4. More studies are necessary with strains with high MIC values to vor-
iconazole.
P767 Detection of extended spectrum beta-lactamase
among Acinetobacter baumanii strains
F. Timurkaynak, O. Kurt Azap, H. Arslan, E. Kuru Inci, S. Karaman,
G. Yapar
Ankara, TR
Objective: To investigate extended spectrum beta-lactamase (ESBL) fre-
quency amongst Acinetobacter species isolated from nosocomial infections in
a university hospital.
Methods: Hundred nonduplicate Acinetobacter strains isolated from clinical
specimens were enrolled in the study. Double disk synergy (DDS) was used to
detect ESBL frequency. Thirty-microgram ceftazidime, cefepime, aztreonam
and ceftriaxone (Oxoid) disks were placed 25mm (center-to-center) from a
20/10microgram amoxicillin-clavulunate disk for the conventional DDS test.
A clear extension of the edge of inhibition zone of any of the antibiotics
towards the disk containing clavulanate disk was interpreted as positive for
ESBL production. The test was repeated for the strains by decreasing the
distance between the disks to 15mm.
Results: All strains were identiﬁed as Acinetobacter baumanii by BBL Crystal
(Becton-Dickinson). The strains studiedwere isolated from tracheal aspiration
(39%), blood (31%), wound (14%), urine (9%), catheter (6%), cerebrospinal
ﬂuid (1%). No ESBL producing strain was detected when strains tested
25mm, however by decreasing this distance to 15mm, 55 of the 100 isolates
were demonstrated to be ESBL producers.
Conclusion: Acinetobacter baumanii is an important pathogen in nosocomial
infections. For this microorganism there is no deﬁned appropriate method for
detecting ESBL production. Several studies used DDS method by applying
25mm distance between the disks and some others 15mm. Two steps of our
study had different results that may affect the clinicians’ antibiotic therapy
decisions.We concluded that further studies are required to improve detection
method.
P768 Rapid Light Cycler PCR for detection of
methicillin-resistant Staphylococcus aureus
A. Albers, J. Uhl, C. Aichinger, C. Knop, F. Cockerill, K. Tabiti
Penzberg, D; Rochester, USA
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) is responsible
for an increasing number of serious nosocomial and community-acquired
infections. MRSA are resistant to all penicillins, including semisynthetic
penicillinase-resistant congeners, penems, carbapenems, and cephalosporins.
The basis of this resistance is conferred by an additional gene mecA, encoding
the penicillin-binding protein, PBP-2a, which is absent in methicillin sus-
ceptible strains.
Methods:We developed a research kit for rapid real time PCR on the Light
Cycler Instrument (Roche) to identify the mecA resistance gene. For
detection of mecA S. aureus colonies are lysed and the DNA is subjected
to real time PCR using sequence speciﬁc primers and Hyb-probes. PCR
products are conﬁrmed by melting point analysis.
Results: The whole procedure, including fully automated DNA preparation,
PCR and data interpretation is done within one day. Sensitivity experiments
revealed a detection limit of 5–10 genome equivalents.
Conclusion: Thus, the MRSA kit provides a gold standard assay for fast,
reliable and sequence speciﬁc detection of methicillin resistance in Staphy-
lococcus aureus or Coagulase negative Staphylococci in research samples.
Pharmacodynamics
P769 Serum bactericidal activity of penicillin/
sulbactam, piperacillin/sulbactam and piperacillin/
tazobactam against Staphylococcus aureus and
Moraxella catarrhalis
S. Lemmen, D. Zolldann, D. Pfruender, R. Lu¨tticken, H. Ha¨fner
Aachen, Karlsruhe, D
Objectives: Conventional in vitro susceptibility tests like MIC and MBC
measure the inhibitory activity of antimicrobial agents under standard labora-
tory conditions only. The serum bacteridical activity (SBA) includes resorp-
tion and metabolization of the drug and thus delivers additional
pharmacokinetic information. The aim of the study was to compare the
SBA of the newly registered narrow-spectrum b-lactam/b-lactamase com-
bination penicillin/sulbactam (Pen/Sul) with the well established broad-
spectrum combinations piperacillin/sulbactam (Pip/Sul) and piperacillin/
tazobactam (Pip/Taz).
Methods: The study was performed according to the NCCLS guideline.
Penicillin G (10 Mega)/sulbactam (1 g), piperacillin (4 g)/sulbactam (1 g) and
piperacillin (4 g)/tazobactam (0.5 g) were administered intravenously to six
healthy volunteers. Serum concentrations were measured with HPLC. The
SBAs against 20 strains of Staphylococcus aureus and 10 strains of Moraxella
catarrhalis were determined 1 and 3 h after drug administration. MICs were
determined with the agardilution test. All strains selected were producing b-
lactamase and thus were resistant to penicillin.
Results: The MICs of Pen/Sul, Pip/Sul and Pip/Taz for S. aureus and M.
catarrhalis were 0.5 and 0.0015mg/L, respectively. With S. aureus, the
geometric means of the bactericidal titres at 1 and 3 h were: 23 and 4 for Pen/
Sul, 21 and 3 for Pip/Sul, 21 and 5 for Pip/Taz, respectively. With M.
catarrhalis, the geometric means of the bactericidal titres at 1 and 3 h were: 630
and 52 for Pen/Sul, 6208 and 1552 for Pip/Sul, 6208 and 676 for Pip/Taz,
respectively.
Conclusions:With both S. aureus and M. catarrhalis, all b-lactam/b-lactamase
combinations tested had peak SBAs beyond eight, which is considered to
correlate well with clinical cure and bacterial eradication. Against S. aureus,
which is – beside anaerobes – the main target of Pen/Sul, the narrow-
spectrum combination Pen/Sul was as efﬁcacious as the broad-spectrum
combinations Pip/Sul and Pip/Taz. WithM. catarrhalis, Pip/Sul and Pip/Taz
had higher SBAs than Pen/Sul, although the latter also proved an excellent
activity.
P770 The effect of protein binding on the activity of
Faropenem against S. aureus
C. Fuhst, A. Barger, B. Wiedemann
Bonn, D
Objectives: To predict the efﬁcacy of antibiotics many authors use pharma-
cological indices which should refer to the nonprotein bound (free) fraction of
a drug, as only the free fraction of the antibiotic is active. However, this
hypothesis has not yet been proven. To examine this hypothesis, we per-
formed killing curves of S. aureuswith Faropenem (F), a new oral penemwith
a protein binding of 94%.
Methods:The kill kinetics of S. aureus (MIC 0.125mg/L) were performed in
a batch culture with increasing constant concentrations. The area above the
killing curves (AAC) was calculated. Negative values indicate growth of the
bacteria whereas positive values indicate bacterial reduction. Furthermore, we
determined killing curves in a pharmacological in vitro model over 24 h. The
simulated kinetic refers to a 300-mg oral dose of F (tmax 0.5 h, Cmax
11.8mg/L) and was carried out with and without the addition of 40 g/L
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human serum albumin. Additionally, a calculated dosing scheme (6% of
300mg, tmax 0.5 h, Cmax 0.708mg/L) resembling the free fraction was
simulated.
Results: Figure 1 shows the antibacterial effect vs. concentration of F in a
batch culture. The curves demonstrate the effect of F: (i) no albumin is added;
(ii) 40 g/L A is added; (iii) 6% of the drug concentration is added. The
addition of albumin leads to a decreased antibacterial effect. However, this
effect is higher compared with the effect of the free fraction. This tendency
could also be seen in the in vitro model. The simulation of a 300mg dose
without albumin results in a reduction of cells of two orders of magnitude and
a regrowth after 8 h. The addition of albumin leads to a higher initial
reduction of cells but a regrowth already after 6 h. A dosing with only 6%
of 300mg (free fraction) results in a faster and higher initial reduction of cells
(2.3 orders of magnitude) than the 300mg dose without albumin, but the
bacteria regrow already after 4 h.
Conclusion:The hypothesis that only the free fraction of an antibiotic is active
cannot be proven. The binding of F to albumin results in a sort of depot. At a
concentration of 8mg/L (total concentration) the effect of protein binding
becomes negligible. The stronger reduction of cells of S. aureus with lower
dosing of F might be explained by an ‘Eagle Effect’. However, more data of
different strains and antibiotics are needed to see if the results are generalizable.
P771 Under-dosing with teicoplanin remains a
problem in the UK
A. Lovering, C. Tobin, K. Bowker, A. MacGowan, J. Sunderland
Bristol, UK
Objectives: Glycopeptide antibiotics have been the treatment of choice in
severe Gram-positive infection for many years, with teicoplanin extensively
used in both the UK and much of Europe. Soon after the introduction of
teicoplanin, concerns were raised about under dosing and the importance of a
loading dose. Although it is not appropriate to monitor teicoplanin con-
centrations in all patients, there is good agreement between pre-dose levels
and outcome. Current recommendations are that pre-dose levels should be
>10mg/L in most serious infections, >20mg/L for serious staphylococcal
infections, but<60mg/L to avoid potential toxicity. In this study, we report a
9 year review of teicoplanin concentrations.
Methods: A retrospective analysis was conducted of teicoplanin concentra-
tions in samples referred to our laboratory for assay between 1994 and 2002.
All samples were assayed by ﬂuorescence polarization immunoassay (Opus
Diagnostics Inc).
Results: Over the study period 12 085 requests, from 5720 patients and 258
hospitals across the UK were received. Although the pre-dose concentrations
increased slightly over the study period (mean values for the ﬁrst sample from
each patient increasing from 14.7 to 17.8mg/L), the proportion of patients
with acceptable concentrations did not change signiﬁcantly (P> 0.05) over
the study period. Overall, pre-dose concentrations were below 10mg/L
(subtherapeutic) in 21.6% of patients, between 10 and 20mg/L (probably
subtherapeutic) in 40.2% and above 60mg/L (potentially toxic) in only 1.6%.
The percentages varying from 23.0, 40.3 and 0.0% (1994) to 17.5, 41.7 and
1.8% (2002), respectively.
Conclusions: Overall, <40% of patients had teicoplanin concentrations
appropriate for the treatment of serious staphylococcal infection. In most
cases, concentrations were too low, with <2% of patients experiencing
concentrations that were considered too high. Although the reasons for assay
referral were not known in most cases, initial loading dose recommendations
are independent of physiological condition and adequate levels should be
achieved in all patients. We conclude that despite recommendations high-
lighting the importance of adequate loading and maintenance dosing, a
signiﬁcant proportion of patients receiving teicoplanin still have potentially
subtherapeutic levels. This situation appears to have changed little over the
past 9 years and highlights the continuing importance of therapeutic mon-
itoring for teicoplanin.
P772 The pharmacodynamics of pharmacokinetically
enhanced co-amoxiclav and co-amoxiclav 7 : 1 standard
formulation on penicillin-resistant Streptococcus
pneumoniae
A. Noel, K. Bowker, A. MacGowan
Bristol, UK
Objectives: Penicillin resistance amongst Streptococcus pneumoniae (Sp) remains
a cause of therapeutic concern in many countries. Pharmacokinetically
enhanced Co-amoxiclav (PeCo-A) produces a greater T>MIC than the
standard formulation and hencemay have activity against Sp strains with raised
Co-AMICs. In this study we used an in vitro pharmacokinetic model to assess
the antibacterial effect (ABE) of PeCo-A and amoxicillin: clavulanate 7 : 1
(Co-A 7 : 1) standard formulation against Sp with Co-A MIC greater than or
equal to 3mg/L.
Methods: An open dilutional in vitro model was used to simulate the total
serum concentrations of amoxicillin and clavulanic acid associated with oral
dosing of PeCo-A and Co-A 7 : 1. The pharmacokinetic parameters modelled
were:- PeCo-A Cmax 17.1mg/L, Tmax 1.5 h T½ 01.25 h, Co-A 7 : 1 Cmax
11.6mg/L, Tmax 1.6 h & T½ 01.25 h. Six strains of Sp were used with Co-A
MICs of 3, 4, 5, 6 (one strain each) and 8mg/L (two strains). The inoculum
used was 10eþ 6/7 cfu/mL and each experiment was performed at least in
triplicate over 24 h. ABE was measured by log reduction in viable count at
24 h (delta 24, log cfu/mL), time to reduce the viable count by 99.9% of the
inoculum (T99.9, h) and the area-under-the-bacterial-kill-curve (AUBKC,
log cfu/mLh).
Results: The ABE of the two dose simulations is shown in Table 1.
Conclusion: PeCo-A resulted in a>4 log reduction in viable counts with 5/6
strains, Co-A 7 : 1 only produced a >4 log reduction in the two strains with
MIC less than or equal to 4mg/L. PeCo-A is a more active formulation than
Co-A 7 : 1 especially with SpMIC greater than or equal to 5mg/L. This is in-
keeping with the greater T>MIC with PeCo-A of 39–51% compared with
Co-A 7 : 1 of 20–28% with these four strains.
P773 Effect of human serum on the bactericidal
activity of faropenem against representative strains of
S. pneumoniae, S. aureus and capsulate H. inﬂuenzae
K. Bowker, A. MacGowan
Bristol, UK
Objectives: Faropenem daloxate is a highly protein bound oral beta-lactam
with in vitro potency against a range of respiratory and skin and soft tissue
pathogens. Therefore it is important to establish the effect of human serum on
the antibacterial action of faropenem against H. inﬂuenzae, S. pneumoniae and
S. aureus.
Figure 1 Effect of Faropenem against S. aureus.
Table 1
Strain
MIC (mg/L) D24
PeCo-A
D24
Co-A 7 : 1
T99.9 AUBKC T99.9 AUBKC
3 4.0 2 9 4.2 6 19
4 4.1 6 16 4.4 6 23
5 4.1 6 16 0.2 7 51
6 4.1 2 15 2.2 19 44
8 3.1 6 20 þ2.2 >24 115
8 4.0 12 22 3.4 24 41
The T>MIC for 80% maximum effect in these experiments was 41–46%. The
T>MIC PeCo-A was 39–61% and Co-A 7 : 1 20–41%.
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Methods: All three strains used had faropenem MICs of 0.12–0.25mg/L. A
time-kill method was used to test all combinations of 0, 2.5, 5 and 10mg/L
faropenem with 0, 25, 50 or 75% serum. An inoculum of 10e6 cfu/mL was
used and samples were taken every 40min for viable counting up to 6 h. All
experiments were performed in triplicate. The bactericidal activity of far-
openem was calculated as the difference in area-under-the bacterial kill curve
(AUBKC); log cfu/mL/min) between curves with human serum alone and
those with serum plus faropenem.
Results: Control experiments (no faropenem) indicated serum had bacter-
icidal activity against H. inﬂuenzae; 25 and 50% serum promoted the growth
of S. pneumoniae. The area-between-the-curves summarizing the activity of
faropenem are shown below. The smaller the area, the poorer the activity
(Table 1).
Conclusion: Human serum markedly reduced the activity of faropenem
against H. inﬂuenzae but not against S. pneumoniae and S. aureus. The effect
of protein binding on the antibacterial effect for any antibiotic may vary with
bacterial species.
P774 The impact of bacterial inoculum on the
antibacterial effect of moxiﬂoxacin studied in an in
vitro model of infection
A. MacGowan, K. Bowker, A. Noel
Bristol, UK
Objectives: Little is known about the effect that inoculum may have on the
antibacterial effect of ﬂuoroquinolones (FQ) in PK in vitro models. In
particular inoculum may have an effect on the magnitude of the AUC/
MIC required to reach the required antibacterial effect (ABE) endpoint. We
studied this issue using E. coli at an inoculum of 10e6 cfu/mL and 10e8 cfu/
mL and a range of moxiﬂoxacin dose simulations.
Methods: An open dilutional PK in vitro model was used to simulate the
serum concentration associated with moxiﬂoxacin at doses of 6.25, 12.5, 25,
50, 100, 200, 400 and 800mg 24 h for 2 days. Experiments were performed in
triplicate and E. coli (MIC 0.06mg/L at inocula of 10e6 and 10e8 cfu/mL)
used to assess ABE. ABE was measured by reduction in viable counts at 24 h
(delta 24) and 48 h (delta 48) plus the area-under-the-bacterial-kill curve
(AUBKC) at 24 h (AUBKC24) and 48 h (AUBKC48). A sigmoid Emax curve
was ﬁtted to deﬁne the dose–ABE relationship.
Results: The relationship between dose and delta 24 was well described by a
sigmoid Emax model (r
2¼ 0.90, 10e8 cfu/mL inoculum; r2¼ 0.86 10e6 cfu/
mL inoculum). The EC50 dose for 10e8 cfu/mL was 23mg (CI 17–29) and
10e6 cfu/mL 30mg (CI 23–40). The dose for 90% maximum effect was
43.7mg 10e8 inoculum and 53.7mg 10e6 inoculum. Using AUBKC24 as the
ABE the EC50 (10e8 inoculum) was 20 (16–25) and EC (10e6 inoculum) 26
(20–35). Using delta 48 and AUBKC48 did not alter signiﬁcantly the dose–
ABE relationship.
Conclusion: Bacterial inoculum has little impact on the dose–ABE relation-
ship for moxiﬂoxacin vs. E. coli.
P775 The antibacterial effect of moxiﬂoxacin against
three anaerobic species studied in an in vitro
pharmacokinetic model of infection
A. Noel, K. Bowker, A. MacGowan
Bristol, UK
Objectives: Moxiﬂoxacin (moxi) has been shown to have in vitro potency
against a range of anaerobic species, this combined with its pharmacokinetic
(PK) properties would indicate likely anti anaerobic activity in pharmaco-
dynamic models. We used an in vitro PK model to explore the activity of
400mg/24 h moxiﬂoxacin against B. fragilis (B frag)C. perfringens (C perf) and
Gram positive anaerobic cocci (GPAC).
Methods: An open dilution PK model was used to simulate the free drug
concentrations associated with moxiﬂoxacin 400mg/day (Cmax 1.6mg/L,
AUC 18.1mg/L, T½ 10.5 h). Experiments were performed at least in
triplicate with an inoculum of 10eþ 6/7 cfu/mL. Three strains were used
with typical moxi MIC values: B frag, moxi MIC 0.25mg/L, C perf moxi
MIC 0.25mg/L, GPAC MIC 0.12mg/L. Antibacterial effect (ABE) was
measured by change in viable count at 12, 24 and 48 (delta 12, delta 24, delta
48, h) time to kill 99.9% inoculum (T99.9, h) and area-under-the-bacterial-
kill curve (AUBKC, mg/L/h).
Results: The in vitro PK model was able to sustain the growth of all three
species over 24 h with a 1–2 log increase in viable count over 24 h when no
moxi was added. The ABE of a single dose of moxi are shown.With all strains
a>2 log drop in viable count was observed at 24 h. Second drug exposures of
the three strains resulted in at least >3 log reduction in count at 48 h.
Conclusions: Moxi has signiﬁcant activity against B frag, C perf and GPAC
(MIC less than or equal to 0.25mg/L) in this in vitro PK model of infection
(Table 1).
P776 The pharmacodynamics of oral once a day
extended release compared with twice daily standard
formulation dosing ciproﬂoxacin using an in vitro
pharmacokinetic model
K. Bowker, A. MacGowan
Bristol, UK
Objectives: Cmax/MIC and AUC/MIC are the pharmacodynamic (PD)
parameters associated with successful clinical and microbiological outcomes
for ﬂuoroquinolones. ODXR CIP 1 g allows a higher Cmax and once a day
dosing compared with CIP 0.5 g BDSF. In this study we simulated total serum
concentrations of ciproﬂoxacin associated with 1 g oral administration as
ODXR or 0.5 g BDSF and measured the antibacterial effect measures (ABE)
for a range of common pathogens.
Methods:The following isolates were utilized; E. coli (EC) (CIPMICs 2, 0.5,
0.03mg/L), P. aeruginosa (PA) (1.5, 0.9mg/L), S. aureus (SA) (2, 0.12mg/L) at
an inoculum of 10e8 cfu/mL. A dilutional in vitro PK model was used to
simulate the dosing regimens over 24 h. All experiments were performed in
triplicate. The pharmacokinetic parameters modelled were BDSF dosing
Cmax 1.7mg/L, Tmax 1 h and ODXR dosing 2.6mg/L, 3 h for both
simulations AUC¼ 24.2mg/L and T1/2¼ 230min. Antibacterial effect
was determined by reduction in viable count at 6, 12, and 24 h; slope and
AUBKC 0–24 h.Cmax/MIC ranged from 117 to 0.9, AUC/MIC from 808 to
12. Statistical analysis was performed using the Sign Test which tests the null
Table 1
Faropenum
(mg/L)
Human
serum (%)
Area-between-curves
(log cfu/mL/min)
SaHi Sp
2.5 þ 0 839 793 781
þ 25 1059 962 832
þ 50 554 941 908
þ 75 97 790 746
5.0 þ 0 936 855 799
þ 25 1172 1021 854
þ 50 706 970 887
þ 75 152 778 730
10.0 þ 0 1008 815 854
þ 25 1351 1024 899
þ 50 740 929 906
þ 75 199 789 777
Table 1
B frag
C perf GPACMIC 1.0 MIC 0.25
D12 0.0 0.1 1.4 0.2 3.1 0.1 1.8 0.3
D24 þ0.1 0.1 2.4 0.2 3.2 0.2 2.4 0.1
T99.9 >24 >24 12 >24
AUBKC 24 95.9 1.0 63.4 3.0 32.6 2.4 57.3 3.7
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hypothesis that ODXR is equivalent to BDSF based on the direction of
differences between the datasets, and the Students t-test.
Results: Strains with an AUC/MIC< 125 showed signiﬁcantly greater killing
than strains with AUC/MIC> 125. Analysis of the ABE using the Sign Test
showed equivalence between the two regimens. No statistical differences were
observed.
Conclusion: Similar antibacterial effects were observed with both dosing
regimens. Our data suggests that oral ODXR ciproﬂoxacin (Ciproﬂoxacin
XR) is equivalent to BDSF dosing (Table 1).
P777 Antibiotic tolerance in enterococcus strains
S. Saribas, Y. Bagdatli
Istanbul, TR
Objectives: Vancomycin tolerance was investigated in the various
clinical specimens. Tolerance can be deﬁned as the ability of bacteria to
grow in the presence of high concentrations of antimicrobics, so that the
killing action of the drug is avoid but the MIC (minimal inhibitory con-
centration) remains the same. We investigated vancomycin tolerance in the
Enterococcus faecium and Enterococcus faecalis strains isolated from different
clinical specimens.
Methods: Vancomycin was obtained from Sigma Chemical Co. We studied
with the total of 100 Enterococcus strains. 56 and 44 of Enterococcus
were idendiﬁed as Enterococcus feacalis and Enterococcus faecium, respectively.
To determine MICs and MBCs (minimal bactericidal concentration),
we inoculated strains from an overnight agar culture to the MHB (Mu¨l-
ler-Hinton broth) and shaken for 4–6 h at 378C to obtain a logarithmic phase
culture. The inoculum used, was controlled by performing a colony count for
each test.
We used MBC: MIC determinations to study tolerance to vancomycin.
Vancomycin tolerance was indicated by MBC:MIC ratio 32.
Results: We identiﬁed Enterococcus strains. 56 and 44 of the Enterococcus
strains were identiﬁed as Enterococcus faecium and Enterococcus faecalis, respec-
tively. 31 E. faecium and 52 E. faecaliswere found as susceptible to vancomycin
and these susceptible strains were included in this study. The MICs of
susceptible strains ranged from 1–4mg/mL. The MBCs ranged
>512mg/mL. A tolerance was detected in 52 E. faecalis and 31 E. faecium
strain. Standard E. faecalis 21913 strain also showed tolerance by the
MBC:MIC ratio. We deﬁned the tolerant strains with the MBC:MIC
ratio 32. The MBC: MIC ratios of 82 Enterococcus strains were greater
than 32. We found a 100% percent tolerance in susceptible Enterococcus
strains.
Conclusions:One of the hypothese for tolerance is that, tolerant cells fail to
mobilize or create the autolysins needed for enlargement and division. Our
data suggests that tolerance may compromise glycopeptide theraphy of serious
Enterococcus infections. To add an aminoglycoside to the glycopeptide
theraphy unless MBCs are unavailable can be usefull in effective treatment
of Enterococcus infections.
P778 In vitro interaction of terbinaﬁne in combination
with ﬂuconazole against Candida albicans isolates
A. S. Kantarcioglu, A. Yucel
Istanbul, TR
Fluconazole (FLZ) is commonly used to threat systemic candidal infections.
However it is only fungistatic. Furthermore the isolation of FLZ-resistant
C. albicans is occuring more frequent and resistance to one azole is usually
associated with cross-resistance to other azoles. As the allylamine antimicotic
terbinaﬁne (TRB) represents a separate class of antifungals, a combination of
TRB with other classes of drugs might be a therapeutic option. In the present
study, the in vitro activity of TRB in combination with FLZwere investigated
against 31 clinical Candida albicans strains. All the strains were isolated from
deep mycosis suspected patients’ materials (sputum, bronchoalveolar lavage,
urine). 2% glucose supplementedRPMI 1640 medium buffered with 0.165 M
mops were used. Drug interactions were assessed by a checkerboard micro-
dilution method that adhered to the recommendations of the NCCLS. The
ﬁnal antifungal concentrations (micrograms per milliliters) ranged from 0.125
to 8 for TRB, from 0.125 to 64 for FLZ. MIC endpoints were determined in
combination at which the turbidity in the well was less than or equal that in
the control growth. Drug interactions were classiﬁed as synergistic, additive or
antagonistic on the basis of the fractional inhibitory concentration index. The
MIC ranges and the MICs (micrograms per milliliters) required to inhibit 50
and 90% of the test isolates (MIC50s and MIC90s, respectively) of TRB were
0.25 to higher than 8 and 8 to higher than 64; of FLZwere 0.25 to higher than
64 and 16–64. The combination of these two antifungals were additive for 18
(58%) and synergistic for 13 (42%) isolates. Antagonism was not observed.
These ﬁndings are encouraging however, in vitro correlation should be
investigated in controlled clinical studies.
P779 Bolus injection vs. 3h infusion of meropenem in
normal volunteers
S. Jaruratanasirikul, S. Sriwiriyajan
Hatyai, Songkla, TH
Over the last decade, several investigators attempted to establish the most
appropriate administration techniques to optimize bectericidal activity of the
parenteral antibiotics for the treatment of infections. For beta-lactams, it is
generally accepted that the bactericidal effect of these agents is determined by
the time that the serum concentrations of antibiotics remains above the MIC
(T>MIC) for a pathogen. Therefore, continuous infusion would be a mode
of administration to maintain such serum concentrations. Meropenem, a
beta-lactam antibiotic, is unstable when stored at room temperature in a
tropical country (32–378C) for 8 h. We proposed that 3 h infusion every 8 h
would be the appropriate mode of administration of meropenem. Thus, the
objective of this study was to compare the T>MIC of meropenem adminis-
tered by 3 h infusion and bolus injection regimens. The study was three-way
crossover study with 1week wash out period in 12 normal volunteers. Each
subject received a single dose of meropenem in three regimens: (i) bolus
injection of 1 g-meropenem; (ii) 3 h infusion of 1 g-meropenem; and (iii) 3 h
infusion of 0.5 g-meropenem. Themeropenem pharmacokinetic studies were
carried out in three regimens for 8 h. According to the pharmacokinetic
simulations with MIC for the pathogens, the results were shown in Table 1.
In conclusion, 3 h infusion of 1 g meropenem would be a mode of admin-
istration that canmaintain serum drug concentrations above theMIC for most
pathogens.
Table 1
Strain
MIC mg/L
ODXR BDSF
D24 S AUBKC D24 S AUBKC
EC 2mg/L 0.2 0.21 135 0.1 0.17 123.4
0.5 2.4 0.15 99.1 2.4 0.06 112.4
0.03 3.1 0.51 65.4 5.8 0.56 33.9
PA 1.5 0.42 0.35 106.0 0.9 0.82 97.1
0.9 1.3 0.49 77.7 4.2 0.82 64.5
SA 0.5 1.4 0.06 126.0 3.6 0.01 124.6
0.12 1.4 0.47 86.4 3.6 0.37 95.6
Table 1
1 g bolus injection 1 g 3 h infusion 0.5 g 3 h infusion
4mg/mL 2mg/mL 1 mg/mL 4 mg/mL 2mg/mL 1mg/mL 4 mg/mL 2 mg/mL 1mg/mL
% of T>MIC 42.50
6.20
54.38
7.64
67.04
8.47
59.27
7.34
71.97
8.63
86.07
9.41
47.27
5.34
69.36
6.60
71.44
8.45
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Ertapenem
P780 Invitro activities of Ertapenem and other agents
against clinical isolates of anaerobes
D. M. Citron, L. Mixson, E. C. J. Goldstein, M. Motyl, G. Woods
Santa Monica, West Point, USA
Objectives:Ertapenem, a once-a-day parenteral beta-lactam that was licensed
in Europe in April 2002, can be used as a single agent to treat several types of
community-acquired and mixed infections. Objectives of this study were to
determine the in vitro activity of ertapenem against anaerobes isolated from
patients enrolled in ertapenem clinical trials, and compare it with the activities
of other agents commonly used to treat the types of infections studied.
Methods: Three double-blind, multicenter studies—complicated intra-
abdominal (IAI), complicated skin/skin structure (SI), and pelvic (PI) infec-
tion—were conducted worldwide in adults. Patients were randomized to
receive ertapenem or piperacillin-tazobactam (PT). Appropriate specimens
were cultured for aerobes and anaerobes. Anaerobes were tested using the
NCCLS agar dilution method for susceptibility to ertapenem, PT, ceftriaxone
(CRO), ampicillin-sulbactam (AS), cefoxitin (FOX), clindamycin (CL),
ticarcillin-clavulanate (TC), chloramphenicol (CHL) and metronidazole
(MTZ) by agar dilution following NCCLS guidelines.
Results: One thousand seven hundred and eighty-nine anaerobes were
studied, including 641 (36%) Bacteroides fragilis group, 283 (16%) peptostrep-
tococci, and 227 (13%)Clostridium spp. Themost common pathogens wereB.
fragilis group in patients with IAI, and peptostreptococci in thosewith SI or PI.
Overall, ertapenem, CHL, PT, AS, and MTZ had excellent antianaerobic
activity; CRO was the least active. The rank order of activity against all
anaerobes was: ertapenem98%, CHL98%, PT97%, AS97%,
MTZ96%, TC92%, FOX83%, CL82%, CRO68%. Only 1% of
all anaerobes were ertapenem-resistant, predominantly Bilophila wadsworthia.
Isolates most often resistant to CHL were Clostridium spp.; peptostreptococci,
anaerobic Gram-positive bacilli, and B. ureolyticus/Bilophila group were most
often resistant to MTZ. The most active agents against B. fragilis group were
MTZ, CHL, and ertapenem.Only 1% of 210 B. fragilis strains were resistant to
ertapenem; none of 431 other B. fragilis group pathogens were ertapenem-
resistant. Resistance to ertapenem among Gram-positive anaerobes was rare.
Conclusions: Ertapenem had excellent in vitro activity against anaerobes in
this study, including B. fragilis and other members of the B. fragilis group,
recovered from patients with IAI, SI, or PI. Ertapenem was more active
against the anaerobes reported here than PT, AS, MTZ, TC, FOX, CL, and
CRO.
P781 Ertapenem once a day is highly effective for
treatment of generalized peritonitis
H. Teppler, A. Meibohm, G. Woods, R. Gesser
West Point, Blue Bell, USA
Objectives:Ertapenem is a once-a-day parenteral beta-lactam that can be used
as a single agent for treatment of several community-acquired and mixed
infections. In a large trial comparing ertapenem 1 g once a day and piper-
acillin-tazobactam (PT) 3.375 g Q6H for treatment of complicated intra-
abdominal infection (IAI), cure rates were 87% (176/203) for ertapenem and
81% (157/193) for PT. One marker of severe IAI is generalized peritonitis.
Objectives of this posthoc analysis were to examine the demographics of
patients (pts) with and without generalized peritonitis and assess the efﬁcacy of
ertapenem vs. PT for treatment of IAI with generalized peritonitis.
Methods: In a double-blind international trial, randomization was stratiﬁed
by primary site of infection and APACHE II score. The primary efﬁcacy
analysis was clinical and microbiological response in microbiologically evalu-
able (micro eval) pts 4–6week post-therapy (test of cure [TOC]). Infectious
process was classiﬁed as generalized peritonitis, single or multiple abscess, or
localized disease; for this analysis the latter three were combined as other.
Results: 185 of 623 (30%) treated pts had generalized peritonitis. Compared
with pts without generalized peritonitis, those with generalized peritonitis
were older (median age, 47 vs. 40.5 year), had slightly higher APACHE II
scores (median, 8 vs. 6), and had infections at sites other than appendix (65%
vs. 36%). Of pts with generalized peritonitis, 113 (61%) were micro eval, and
among them, a higher proportion in the ertapenem group were male (73% vs.
53%), Caucasian (60% vs. 45%), 65 year (23% vs. 15%), had appendiceal
infection (50% vs. 42%), and had polymicrobial infection (92% vs. 83%), and a
lower proportion had postoperative infection (7% vs. 15%). The most
common pathogens were E. coli and B. fragilis group. Median days of therapy
were seven for ertapenem and eight for PT. Ertapenem and PT cure rates in
micro eval pts were 90% (54/60) and 81% (43/53), respectively, at completion
of therapy and 83% (50/60) and 74% (39/53) at TOC. In the microbiologic
modiﬁed intent-to-treat pts, clinical cure rates were 74% (58/78) for erta-
penem and 70% (48/69) for PT. Among those who failed therapy, persistence
of a pathogen was documented in two patients in the ertapenem group and
three in the PT group.
Conclusion: In this analysis of IAI with generalized peritonitis, which is
considered a marker of severe disease, ertapenem 1 g once a day was highly
effective therapy.
P782 Ertapenem for treatment of CAP caused by
Gram-negative enteric pathogens
G. Woods, R. Isaacs, K. McCarroll, I. Friedland
West Point, USA
Objective: Ertapenem is a once-a-day parenteral beta-lactam that can be used
to treat serious CAP. In the combined analysis of two trials comparing
ertapenem and ceftriaxone (CRO) for treatment of serious CAP, efﬁcacy
was 92% for both ertapenem and CRO. GN-CAP generally is considered
among the more serious infections. Objectives of this analysis were to assess
the: (1) demographics and disease characteristics of patients with GN-CAP
and CAP due to other pathogens, and (2) efﬁcacy of ertapenem and CRO for
treatment of GN-CAP.
Methods: Two prospective, double-blind, randomized studies of CAP in
adults, comparing ertapenem, 1 g once a day, with CRO, 1 g once a day, were
conducted worldwide.
Randomization was stratiﬁed based on Pneumonia Severity Index (PSI less
than or equal to three or>3) and age (less than or equal to 65 or> 65). Switch
to oral amoxicillin-clavulanate (or other active agent) was allowed after three
or more days of parenteral therapy and clinical improvement. Sputum was
collected for culture and susceptibility testing of pathogens. The primary
efﬁcacy variable was clinical response in clinically evaluable patients 7–14 days
after completion of all (parenteral plus optional oral) therapy (test of cure
[TOC]).
Results:A pathogen was identiﬁed in 402 (47%) of the 857 treated patients; 44
(11%) had Enterobacteriaceae. No Enterobacteriaceae was resistant to erta-
penem; ﬁve (11%) were resistant to CRO. Compared with the 358 patients
with other pathogens, those with GN-CAP were older, and a lower propor-
tion were bacteremic. Of those with GN-CAP, 38 (86%) were clinically
evaluable; the proportion of patients with underlying chronic obstructive lung
disease, heart failure, and/or diabetes was similar in both treatment groups.
Among evaluable patients with GN-CAP, median days of parenteral/total
therapy were 4.5/14 for ertapenem and 7/13.5 for CRO, and 85% in the
ertapenem group and 72% in the CRO group received oral therapy. Cure rates
for ertapenem vs. CRO, respectively, in evaluable patients with GN-CAP
were: 95% (19/20) vs. 89% (16/18) at TOC. Cure rates in the modiﬁed
intent-to-treat population were 91% (21/23) for ertapenem and 90% (19/21)
for CRO.
P783 Comparative in vitro activities of Ertapenem
against fastidious aerobic bacteria from European patients
L. Mixson, D. Shungu, M. Motyl, K. Bartizal, G. Woods
West Point, USA
Objective: Ertapenem, a once-a-day parenteral beta-lactam, was licensed in
Europe in April 2002 for treatment of several community-acquired andmixed
infections. In large clinical trials, it was shown to be highly effective treatment
for intra-abdominal, skin/skin structure, urinary tract, and pelvic infections,
and community-acquired pneumonia (CAP). The purpose of this study was
to assess the in vitro activity of ertapenem against clinical isolates of fastidious
bacteria from European patients prior to its clinical use and to compare it to
piperacillin-tazobactam and ceftriaxone, the comparators used in the clinical
trials.
Methods: In 2001, fastidious bacteria recovered from clinical specimens were
tested in 13 centers (11 European countries) by using Etest strips. Interpreta-
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tion of MIC values was based on NCCLS breakpoints. Isolates included the
common respiratory pathogens – Streptococcus pneumoniae, Haemophilus inﬂu-
enzae, Haemophilus parainﬂuenzae, and Moraxella catarrhalis, and Neisseria
gonorrhoeae. In addition to study antimicrobials, susceptibility to penicillin
also was evaluated in isolates of S. pneumoniae.
Results: A total of 184 S. pneumoniae (138 penicillin-susceptible [PSSP], 32
penicillin-intermediate [PISP], 14 penicillin-resistant [PRSP]), 188 H. inﬂu-
enzae, 140 H. parainﬂuenzae, 140 M. catarrhalis and 55 N. gonorrhoeae were
tested. The ertapenem MIC range/MIC90 value (mcg/mL) were: PSSP,
0.002–0.125/0.02; PISP, 0.008–1/0.25; PRSP, 0.25–1/0.75; H. inﬂuenzae,
0.004–0.38/0.12, H. parainﬂuenzae, 0.003–0.15/0.06; M. catarrhalis, 0.002–
1.5/0.03; N. gonorrhoeae, 0.002–0.125/0.02. For these same isolates, respec-
tively, MIC90 values were 0.3, 1, 3, 0.06, 0.5, 0.05, and 0.02 for piperacillin-
tazobactam; and 0.06, 0.25, 32, 0.01, 0.02, 0.5, and 0.02 for ceftriaxone.
Based on NCCLS breakpoints, all PSSP, PISP, PRSP, H. inﬂuenzae, and H.
parainﬂuenzae were ertapenem susceptible.
Conclusions:Ertapenem had excellent in vitro activity against these isolates of
S. pneumoniae, H. inﬂuenzae, H. parainﬂuenzae, M. catarrhalis, and N. gonor-
rhoeae recovered from European patients. The data for the respiratory
pathogens plus results of the CAP trials suggest that ertapenem may be an
appropriate choice for empiric treatment of many patients with CAP.
P784 Comparative in vitro activities of Ertapenem
against aerobic and anaerobic bacteria from Europe
L. Mixson, D. Shungu, M. Motyl, K. Bartizal, G. Woods
West Point, USA
Objective: Ertapenem, a once-a-day parenteral beta-lactam licensed in
Europe in April 2002, has been shown to be highly effective for treatment
of complicated intra-abdominal, complicated skin/skin structure, compli-
cated urinary tract, and pelvic infections and community-acquired pneumo-
nia. The purpose of this study was to assess the in vitro activity of ertapenem in
Europe prior to its clinical use and to compare it to piperacillin-tazobactam,
ceftriaxone and, for urine isolates, norﬂoxacin.
Methods: In 2001, 13 centers (11 countries) in Europe tested a wide range of
Gram-positive and Gram-negative nonfastidious aerobes and anaerobes iso-
lated from clinical specimens by broth microdilution, following NCCLS
guidelines. Bacteria generally considered contaminants were excluded from
analysis.
Results:Overall 3475 isolates were included in the study. Against all Entero-
bacteriaceae (n¼ 2260), ertapenem was the most active agent tested; suscept-
ibility rates were 99% for ertapenem, 95% for ceftriaxone, and 92% for
piperacillin-tazobactam. For the subset of Enterobacteriaceae from urine
(n¼ 591) susceptibility rates were: ertapenem, 99%; ceftriaxone, 94%; piper-
acillin-tazobactam, 93%; and norﬂoxacin, 91%. Less than 1% of Enterobac-
teriaceae were ertapenem-resistant; most of these were from Austria and
Belgium. Ertapenem also was the most active agent against the 357 anaerobes:
99% were ertapenem-susceptible vs. 93% for piperacillin-tazobactam, and
48% for ceftriaxone. All agents had excellent activity against methicillin-
susceptible Staphylococus aureus (MSSA, n ¼ 198), Streptococcus pyogenes
(n¼ 169), and Streptococcus agalactiae (n¼ 133), but ertapenem was the most
potent, based on MIC90 values. Piperacillin-tazobactam was the only agent
active against Pseudomonas aeruginosa (n¼ 200), Acinetobacter (n¼ 187), and
Enterococcus faecalis (n¼ 199).
Conclusions: Ertapenem had excellent in vitro activity against Enterobacter-
iaceae, anaerobes, MSSA, S. pyogenes, and S. agalactiae in this study, and was
more potent than piperacillin-tazobactam, ceftriaxone and, for urine isolates,
norﬂoxacin. Resistance to ertapenem was not detected in MSSA, S. pyogenes,
and S. agalactiae and was rare (< 1%) in Enterobacteriaceae and anaerobes.
P785 Serious community-acquired pneumonia in
patients with chronic obstructive pulmonary disease: utility
of Ertapenem
G. Woods, R. Isaacs, K. McCarroll, I. Friedland
West Point, USA
Objective: Ertapenem (ETP) is a once-a-day parenteral beta-lactam that can
be used to treat adults with serious CAP. CAP in patients with COPD is often
more difﬁcult to treat than CAP in patients without underlying lung disease.
Objectives of this analysis were to compare: (1) the demographic and disease
characteristics of treated patients with and without COPD (2) the outcome of
evaluable patients with and without COPD, irrespective of therapy, and (3)
the efﬁcacy of ETP and ceftriaxone (CRO) for treatment of CAP in evaluable
patients with COPD.
Methods:The efﬁcacy of IV/IM ETP, 1 g once a day, was compared with IV/
IM CRO, 1 g once a day, in two prospective, double-blind, studies of CAP
conducted worldwide. Randomization was stratiﬁed based on Pneumonia
Severity Index (PSI 3 or >3) and age (65 or >65). Patients could be
switched to oral amoxicillin-clavulanate or other effective agent after3 days
of parenteral therapy and clinical improvement. Sputum and blood were
cultured; pathogens were tested for susceptibility to study drugs. The primary
efﬁcacy variable was clinical response in clinically evaluable patients 7–14 days
after completion of all (parenteral plus optional oral) therapy (test of cure
[TOC]).
Results: Two hundred and sixty-four (31%) of the 857 treated patients with
CAP had COPD. The proportions of patients who were male, were aged
65 year, had PSI scores >3, and had Haemophilus inﬂuenzae isolated at
baseline were higher in those with COPD than in those without COPD.
Streptococcus pneumoniae was the most common pathogen in patients with or
without COPD. Among evaluable patients with COPD, treatment groups
were similar with respect to age, gender, and PSI score; median days of
parenteral/total therapy were 4/11 for ETP and 5/11 for CRO; 83 and 77% of
those in the ETP and CRO groups, respectively, were switched to oral
therapy. Cure rates in evaluable patients at TOC, for the combined treatment
groups, were 90% (187/208) for those with COPD and 93% (424/456) for
those without COPD. Favorable response rates for evaluable COPD patients
at completion of parenteral therapy and at TOC, respectively, were: ETP, 95%
(114/120) and 90% (109/121); CRO, 94% (81/86) and 90% (78/87).
Conclusions: Although treatment of CAP in patients with COPD is often
difﬁcult, cure rates were only slightly lower than in those without COPD. In
this analysis, ETP 1 g once a day, with an oral switch option, was highly
effective for treatment of patients with COPD and serious CAP.
P786 Comparative in vitro activities of Ertapenem
against clinical isolates of Enterobacteriaceae
L. Gerckens, M. Motyl, L. Mixson, I. Friedland, G. Woods
West Point, USA
Objectives: Ertapenem is a once-a-day parenteral beta-lactam that was
licensed in Europe in April 2002 for treatment of several community-acquired
and mixed infections. Objectives of this study were to determine the in vitro
activity of ertapenem against Enterobacteriaceae isolated from patients
enrolled in ertapenem clinical trials, and compare it with the activities of
other agents commonly used to treat the types of infections studied.
Methods: In seven double-blind, multicenter studies, adults with intra-
abdominal (IAI), skin (SI), pelvic (PI), or urinary tract infection (UTI) or
community-acquired pneumonia (CAP) were randomized to receive erta-
penem or comparator: ceftriaxone (CRO; UTI and CAP) or piperacillin-
tazobactam (PT; IAI, SI, and PI). Appropriate specimens were cultured for
aerobes and, if indicated, anaerobes. Aerobic bacteria were shipped to Merck
Research Laboratories and tested for susceptibility to ertapenem, CRO, PT,
ampicillin-sulbactam (AS), and ciproﬂoxacin (CP) by microtiter dilution
following NCCLS guidelines. Enterobacteriaceae are the focus of this
analysis.
Results: 1768 Enterobacteriaceae were tested: 1221 E. coli (69%), 258 Kleb-
siella (15%), 103 Proteus (6%), 96 Enterobacter (5%), 61 Citrobacter (3%), 15 S.
marcescens (1%), 14 M. morganii (1%). Ertapenem was the most active agent
tested (100% susceptible); the MIC was less than or equal to 0.5mg/mL for all
but seven Enterobacter (< 1% of all isolates). Of the isolates, 97% were
susceptible to CRO, 91% to PT, 91% to CP, 61% to AS. Of the 31
CRO-resistant strains, 100%, 55%, 23%, and 6% were susceptible to ertape-
nem, CP, PT, and AS, respectively. Of the 53 isolates resistant to PT, 100%,
63%, 55%, and 0% were susceptible to ertapenem, CP, CRO, and AS,
respectively. 135 strains were CP-resistant; of these 100%, 91%, 67%, and
21% were susceptible to ertapenem, CRO, PT, and AS, respectively.
Conclusions: Ertapenem was highly active against Enterobacteriaceae recov-
ered from patients with IAI, SI, PI, UTI, or CAP, including isolates resistant to
CRO, PT, CP, or AS. Ertapenem was more active against these isolates than
CRO, PT, CP, and AS.
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P787 Phenotypic patterns of antimicrobial
cross-resistance in Pseudomonas aeruginosa: data from a
multicenter US ICU surveillance study
I. Friedland, R. Gesser, L. Stinson, M. Ikaiddi, G. Gallagher, S. Harm,
G. Woods
West Point, USA
Objectives: ISS is an ongoing surveillance study of antimicrobial resistance in
Gram-negative bacilli (GNB) isolated from ICU patients. The focus of this
analysis is P. aeruginosa. Objectives were to (1) examine resistance rates in
P. aeruginosa over time, and (2) explore phenotypic patterns of cross resistance
between antipseudomonal agents. Ertapenem, a non-pseudomonal carbape-
nem, was included to assess its relation to imipenem.
Methods: Each year, participating laboratories tested 100–200 GNB by
microdilution following NCCLS recommendations. Only initial isolates of
P. aeruginosawere analyzed. NCCLS breakpoints for P. aeruginosawere used for
antipseudomonal agents but are not deﬁned for ertapenem.
Results: 42–97 US laboratories participated each year from 1995 to 2001.
During this time, resistance to most antipseudomonal agents increased slightly
(2–5%), but resistance to ciproﬂoxacin increased from 12 to 30%. Among the
1509 isolates tested in 2001, resistance rates for the most active agents were:
amikacin, 5%; piperacillin-tazobactam (P/T), 14%; cefepime, 15%; imipe-
nem, 16%; ceftazidime (CTZ), 17%; tobramycin, 17%. Resistance to the
combination of an aminoglycoside plus a beta-lactam was lowest for amikacin
þ imipenem (1.6%). Examples of phenotypic cross-resistance in 2001 isolates
are shown in Table 1.
Imipenem resistance rates were 42% for P/T resistant isolates and 35% for
isolates resistant to ciproﬂoxacin. 80% of cefepime-resistant strains were
resistant to CTZ.
Conclusions:Resistance of P. aeruginosa to imipenem increased with increas-
ing CTZ MICs. This trend was stronger than that seen with increasing
ertapenem MICs. In contrast to the rates of cross-resistance between anti-
pseudomonal cephalosporins and between CTZ and P/T (which ranged from
62 to 80%), only one-third of P. aeruginosa isolates with an ertapenemMIC of
16 mg/mL or more were imipenem resistant, which was similar to the rates of
phenotypic cross-resistance between imipenem and CTZ as well as between
imipenem and other classes of antimicrobial agents.
P788 Health-care associated pneumonia acquired
outside the ICU: results of a randomized, double-blind study
comparing Ertapenem and Cefepime
I. Friedland, R. Isaacs, J. Moll, B. Adeyi, G. Woods, the Protocol 024/
025 Study Group
Objective: Compare efﬁcacy of ertapenem, a once-a-day parenteral beta-
lactam, with cefepime for treatment of health-care associated pneumonia
acquired outside an ICU.
Methods: A prospective, double-blind (with sponsor blinding), multicenter
study was conducted in adults who had pneumonia with onset 48 h or more
after hospitalization (outside an ICU) or in a skilled nursing facility. Rando-
mization was stratiﬁed by APACHE II score (15 or> 15). Patients were
randomized (1 : 1) to intravenous (IV) ertapenem 1 g once a day, or IV
cefepime 2 g Q12H. Those in the cefepime group could receive IV metro-
nidazole 500mg Q12H for suspected aspiration; those in the ertapenem
group received matching placebo. Switch to oral ciproﬂoxacin (or other
appropriate oral therapy) was allowed after at least 3 days of IV therapy and
well documented improvement. Clinical and microbiologic efﬁcacy were
assessed 7–14 days after IV þ optional oral therapy (test of cure [TOC]).
Results: In the 303 patients randomized, comorbidities were common and
generally evenly distributed between treatment groups: congestive heart
failure, 24%; prior cerebrovascular accident, 23%; anemia, 21%; chronic lung
disease, 21%. The most common pathogens were Enterobacteriaceae (pri-
marily K. pneumoniae and E. coli), S. pneumoniae, and S. aureus. 193 (64%)
patients were clinically evaluable, and of these, 24% and 21% in the ertapenem
and cefepime groups, respectively, had APACHE II scores > 15. Median
duration of total therapy for evaluable patients was 10 days in both treatment
groups; 59% of patients in the ertapenem group and 53% in the cefepime
group were switched to oral therapy. At TOC, clinical cure rates for clinically
evaluable patients were 87% (89/102) for ertapenem and 86% (80/93) for
cefepime; bacterial eradication rates were 84% (42/50) and 83% (44/53),
respectively, for microbiologically evaluable patients. Clinical cure rates per
pathogen for ertapenem and cefepime, respectively, were 93% (13/14) and
87% (13/15) for S. pneumoniae and 86% (24/28) and 84% (21/25) for
Enterobacteriaceae. The frequency of adverse events in this ill population
was generally similar in both treatment groups.
Conclusions: In this study, ertapenem therapy, with an oral switch option, was
highly effective for treating adults with health-care associated pneumonia
acquired outside an ICU. Ertapenem 1 g once a day was as effective as
cefepime 4 g daily (þ optional metronidazole) and had a similar overall safety
proﬁle.
Table 1
CTZ MIC
(mg/mL) N %Imipenem R % P/T – R
Ertapenem
MIC (mg/mL) N % Imipenem R
1 360 <1 1 1 124 <1
2 463 11 3 2 169 0
4 257 17 3 4 203 1
8 94 20 3 8 290 1
16 80 31 26 16 723 33
32 255 34 62
R¼ resistant.
New anti-staphylococcal drugs
P791 Invitro activities of a novel cephalosporin,
CB-181963 (CAB-175), against methicillin-resistant
Staphylococcus aureus
V. Huang, M. Rybak
Detroit, USA
Objectives:CB-181963 (CAB-175) is a novel parental investigational cepha-
losporin belonging to the Azomethines subclass of cephalosporins that has
demonstrated in vitro activity against most Gram-positive and Gram-negative
bacteria, as well as methicillin-resistant Staphylococcus aureus (MRSA). We
examined the inhibitory and bactericidal activity of CB-181963 against recent
MRSA clinical isolates.
Methods: Two hundred clinical strains of MRSA was obtained from Detroit
Medical Center and William Beaumont Hospital in Michigan between 1999
and 2002. Minimum Inhibitory Concentrations (MIC) and Minimum
Bactericidal Concentrations (MBC) were performed using NCCLS guide-
lines. The bactericidal activity of CB-181963 was also evaluated with time-
kill experiments using four randomly selected MRSA isolates.
Results: See table.
Overall, CB-181963 exhibited MIC proﬁles that were similar to linezolid.
However, MBCs and time-kill studies demonstrated that CB-181963 possessed
bactericidal activity against MRSA: CB-181963¼ vancomycin> quinupris-
> linezolid.
Conclusions:CB-181963 demonstrated signiﬁcant in vitro bactericidal activ-
ities against MRSA isolates. CB-181963may provide an alternative option for
the treatment of MRSA infections within the cephalosporin class. However,
further pharmacokinetic/pharmacodynamic and clinical investigations are
warranted.
Antimicrobials
MRSA (n¼ 200) MRSA (n¼ 4)
MIC90 (Range) MBC Range
Change in 24-h log
10
CFU/mL
CB-181963 4 (0.25–8) 1–8 3.87 0.10
Linezolid 4 (0.25–8) 0.5–64 1.68 0.45
Quinupristin/dalfopristin 1 (0.125–2) 0.25–32 2.95 0.90
Vancomycin 2 (0.25–2) 0.5–4 3.86 0.10
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P792 Dose-escalation safety and pharmacokinetics
study of a novel cephalosporin, CB-181963 (CAB-175): initial
human experience
D. Damphousse, B. Dvorchik, D. Benziger, K. Galil
Lexington, USA
Purpose: CB-181963 (CAB-175) is a new cephalosporin from the subclass
azomethines with in vitro broad-spectrum cidal activity against both Gram-
negative and Gram-positive bacteria, including methicillin-resistant S. aureus
and glycopeptide intermediately susceptible S. aureus. This ﬁrst study in man
assessed the safety and pharmacokinetics of CB-181963 at single doses of 250,
500 and 1000mg.
Methods: In a dose escalation study, a minimum of seven healthy male
volunteers was enrolled into each of three dosing groups and randomized
(3 : 1) to receive a single dose of CB-181963 (250, 500 or 1000mg) or
placebo. The treatment regimenwas intravenous infusion over 30min. Plasma
and urine samples were collected over 24 h from time of infusion and analyzed
to determine the pharmacokinetic proﬁle. Safety and laboratory data (includ-
ing special markers for monitoring effects on the kidney) were collected over
96 h from time of infusion.
Results: Preliminary results indicate that the most frequent adverse event was
headache, occurring in eight of the 22 subjects treated. No clinically
signiﬁcant drug-related changes in laboratory data (including renal markers),
ECG parameters, or vital signs were reported. The ﬁnal safety and pharma-
cokinetic results will be presented.
Conclusions: Initial safety and pharmacokinetic results from this study
indicate that further clinical evaluation of a multiple-dose CB-181963 is
warranted.
P793 Microbiological characterization of CB-181963
(CAB-175) a novel anti-MRSA cephalosporin
J. Silverman, N. Cotroneo, V. Laganas, G. Thorne, J. Alder
Lexington, USA
Objectives: CB-181963 (formerly CAB-175) is a novel cephalosporin with
potent activity against a broad range of bacterial pathogens, including
methicillin resistant Staphylococcus aureus (MRSA). The in vitro antibacterial
potency of CB-181963, including susceptibility and bactericidal activity, was
characterized against a range of Gram-positive and Gram-negative pathogens.
In addition, the potential of susceptible bacteria to develop resistance was
probed.
Methods: Minimum inhibitory concentrations (MIC) were determined by
broth microdilution according to NCCLS standards, except all cultures were
incubated at 378C. Bactericidal activity was determined by addition of CB-
181963 to exponentially growing cultures at 378C. At various timepoints,
samples were removed and diluted at least 1000-fold prior to plating on drug-
free agar to determine bacterial viability. To examine the potential develop-
ment of resistance, bacteria were grown with sub-MIC levels of CB-181963
in Mueller-Hinton broth. From the highest concentration that supported
growth, cultures were diluted 1 : 100 000 into fresh media plus CB-181963 at
two-fold dilutions; this process was repeated for 21 days.
Results: MIC50/90 values for CB-181963 and Ceftriaxone are shown in
Table 1. CB-181963 demonstrates potent activity against MRSA, coagulase-
negative Staphylococcus (including methicillin-resistant strains), S. pneumo-
niae (including macrolide, quinoline, and penicillin resistant isolates), and
vancomycin sensitive and resistant E. faecalis (VSE, VRE), as well as Gram
negative pathogens including beta-lactamase negative K. pneumoniae. CB-
181963 had no signiﬁcant activity against E. faecium or P. aeruginosa. The
activity of CB-181963 was not affected by the presence of 4% human serum
albumin., suggesting low protein binding. As shown in Table 2, CB-181963
was bactericidal (>3 log decrease) at 24 h against all strains tested, including
E. faecalis, which is typically tolerant of beta-lactams. CB-181963 MICs
increased less than ﬁve-fold during serial passage of MSSA, MRSA and
K. pneumoniae strains, suggesting low potential for development of resistance.
Conclusions: CB-181963 displays potent in vitro activity against MRSA as
well as broad spectrum activity against clinically important bacterial patho-
gens. This compound is a promising candidate for further clinical develop-
ment for broad spectrum use, as well as for treatment of MRSA.
P794 The activity of daptomycin against
linezoid-resistant Gram-positive pathogens
R. Howe, A. Noel, T. Walsh, A. MacGowan
Bristol, UK
Objectives: Antimicrobial resistance is an increasing problem among Gram-
positive pathogens. Vancomycin-resistant eneterococci (VRE) are now wide-
spread and vancomcyin (VAN) resistance has recently emerged in S. aureus.
The oxazolidinone, linezolid (LIN), was introduced into clinical practice in
the last couple of years and already there have been reports of resistance.
Daptomycin (DAP) is a lipopeptide antimicrobial with broad-spectrum
activity against Gram-positive organisms. We have studied the activity of
DAP against clinical and laboratory-derived LIN-resistant Gram-positive
pathogens.
Methods:The clinical LIN resistant isolates testedwere one S. epidermidis, two
Vancomycin sensitive enterococci (VSE), one VRE, and one Streptococcus
oralis. Other strains tested were parental strains of MRSA, VRE, and
pneumococci, and their derivatives selected for linezolid resistance. Labora-
tory selection was performed by serial daily passage in Mueller Hinton (MH)
Broth containing increasing concentrations of linezolid for 28 days. Suscept-
ibility was tested by agar dilution MIC performed by NCCLS methodology
using MH agar (supplemented with 5% blood for pneumococci). Daptomy-
cin MICs were measured on sensitivity testing medium supplemented with
50mg/L calcium. The agents tested were DAP, LIN, VAN, and Dalfopristin/
Quinupristin (D/Q).
Results: The clinical strains were all susceptible to DAP with MICs between
0.25 and 4mg/L (proposed breakpoint 4mg/L). LIN MICs for these strains
were 16–32mg/L, one enterococcus was also resistant to VAN (MIC>
128mg/L), and one enterococcus was resistant to D/Q (MIC 8mg/L). The
results for laboratory-selected strains are shown in the table. As can be seen, all
isolates were susceptible to DAP irrespective to resistance to LIN, VAN or
D/Q.
Table 1
Strain N
CB-181963 (CAB-175) Ceftriaxone
MIC50 MIC90 Range MIC50 MIC90 Range
MRSA 23 2 2 0.5–2 32 >128 8–>128
Coag.neg.Staph 23 1 4 0.25–16 4 >64 0.5–>64
Vanc S E. faecalis 45 0.25 0.5 0.125–1 >256 >256 2–>256
Vanc R E. faecalis 16 0.25 1 <0.1–1 >128 >128 4–>128
S. pneumoniae 24 0.25 0.5 <0.008–0.5 0.25 1 <0.008–1
K. pneumoniae 30 0.063 0.13 <0.008–16 0.31 0.13 <0.008–1
Table 2
Species N
Average log kill
4 h 6 h 24 h
MSSA 3 4.58 4.98 4.98
MRSA 3 1.95 2.53 3.97
GISA 2 1.73 2.56 4.11
VSEfs 3 1.26 2.13 5.63
VREfs 3 2.05 2.44 4.44
No of
strains
Geometric mean MIC (range) (mg/L)
DAP LIN VAN D/Q
MRSA (parents) 8 0.47 (0.25–0.5) 1.9 (1–2) 0.56 (0.25–2) 0.69 (0.5–1)
MRSA
(LIN selected)
8 0.56 (0.5–1) 13 (8–16) 1.0 (0.25–2) 1.3 (0.5–2)
S. pneumonia
(parents)
9 0.16 (0.12–0.25) 0.92 (0.25-1) 0.47 (0.25–0.5) 0.89 (0.5–1)
S. pneumonia
(LIN selected)
12 0.12 (0.06–0.25) 14 (4–64) 0.43 (0.12–0.5) 1.5 (0.5–2)
VRE (praents) 2
 (0.25–0.5)  (1)  (>128)  (8)
VRE
(LIN selected)
2  (0.5–1)  (32–128)  (>128)  (8–16)
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Conclusions:Daptomycin maintains activity against Gram-positive pathogens
which are resistant to other agents such as linezolid, vancomycin, or dalfo-
pristin/quinupristin.
P795 S. aureus wound isolate resistance to new
antibiotics
L. M. Tibor, S. E. Cramton, H. W. Hopf, F. Goetz, T. K. Hunt
San Francisco, USA; Tubingen, D
Objectives: Staphylococcus aureus is the most common bacterium cultured from
infected wounds. There is particular concern about its resistance to methicillin
and vancomycin. Consequently, several new antibiotics have been developed.
Linezolid and daptomycin have novel mechanisms of action in bacterial
infection. Gallidermin is a lantibiotic produced by Staphylococcus gallinarium.
The goal of this study was to determine resistance to these antibiotics in
S. aureus clinical isolates and laboratory strains. We previously demonstrated
low resistance to standard antibiotics in the same 64 laboratory and clinical
strains and we hypothesized that these strains would not be resistant to the new
antibiotics.
Methods: In total, 64 different S. aureus strains were investigated. Forty-ﬁve
strains were isolated from wound cultures, ﬁve from central venous catheters
of ICU patients, and 14 were control strains, consisting of commonly used
laboratory strains. The subject population consisted of patients treated at the
University of Tu¨bingen (Germany) hospitals and clinics. Strains were isolated
in the course of routine clinical diagnostics. Investigations consisted of PCR at
the mec (methicillin resistance) locus and assessment of antibiotic resistance at
5mg/mL, with the exception of daptomycin and linezolid, which were tested
at 2 and 4mg/mL, respectively.
Results:
Conclusions: Although there were several MRSA strains, no strain was
resistant to vancomycin, linezolid, or daptomycin. No control strains were
resistant to gallidermin, although there was gallidermin resistance in wound
and ICU isolates. This is not surprising given its potential to be encountered
in the environment. These results indicate that linezolid and daptomycin are
likely to be effective for MRSA infection. Lantibiotic development may be
useful but requires further investigation.
P796 Clinical experience with Linezolid in Greek
patients with Gram-positive infections
G. Chrysos, S. Anagnostopoulou, J. Kakatsos, M. Nezi, A. Pastelli,
A. Kamaratos, S. Antonopoulos, A. Visvikis, D. Gianneli,
C. Nikolopoulou, G. Giannoulis
Athens, GR
Objectives: To gain clinical experience in Greek patients (pts) with Gram-
positive infections, treated with Linezolid.
Methods: Patients with Gram-positive infections were studied. The duration
of linezolid treatment was min 7 days and max 28 days. The schedule of
treatment was twice daily either 600mg per os or 300mL of 2mg/mL
solution intravenously (i.v.). The patient had to make at least three visits
during the study. One visit at baseline, one at the end of treatment and one
follow up visit (approximately 15–28 days after end of treatment).
Results:Twenty adult pts (55%male, 45% female) with mean age of 56.9 years
(median 61 year, SD 18.8 year) were studied. All of themwere hospitalized for
skin/soft tissue (15 pts) or lower respiratory infections (four pts) and one case
of osteomyelitis (allergic to methicillin, clindamycin, vancomycin and tei-
coplanin). Linezolid was given i.v. or orally or switched from i.v. to oral
treatment at the discretion of the investigators. Simultaneously, four diabetic
pts received oﬂoxacin 400mg twice daily for soft tissue infections of the lower
extremities and one received rifampicin 900mg daily for osteomyelitis.
Underline conditions were hypertension, diabetes, cardiac failure, asthma,
Parkinson’s disease, peripheral vein insufﬁciency, migraine, cirrhosis, renal
insufﬁciency, gastrectomy (gastric carcinoma). Median duration of i.v. treat-
ment was 8 days and of oral treatment 6 days.Median duration of treatment for
skin and soft tissue infections was 14.0 days (SD 4.49 days), for pneumonia
9.0 days (SD 0.5 days) and for osteomyelitis 45 days. All of them were cured
and none of them discontinued therapy. Adverse events that occurred were
generally mild to moderate and resolved during continuous treatment, except
of one patient with worsening renal failure. Headache, skin rash, oral
candidiasis, fever, anemia, thrombocytopenia, increase of liver enzymes were
reported. Forty-ﬁve percent of the enrolled patients experienced the reported
adverse events.
Conclusion:Linezolid has the potential to be an alternative to vancomycin and
may ﬁnd a major role in the treatment of infections caused by Gram-positive
microorganisms and especially by MRSA or other difﬁcult-to-treat pathogens
as long as the potential for resistance is minimal. Further clinical investigation
will help determine its place in the treatment of these infections.
P797 Invitro activity of daptomycin against
Gram-positive uropathogens
K. G. Naber, F. M. E. Wagenlehner, N. Lehn
Straubing, Regensburg, D
Objectives: The incidence of nosocomial UTIs caused by Gram-positive
bacteria, resistant against current antibiotics, e.g. ﬂuoroquinolones, is increas-
ing. Daptomycin, a recently developed antibiotic, active against Gram-
positive bacteria should be tested for its antimicrobial activity against uro-
pathogens.
Methods: The antimicrobial activity of daptomycin was tested against
pathogens from three different collections: (i) Uropathogens from hospitalized
urological patients (1990/91) with complicated and/or hospital-acquired
UTIs of the Hospital St. Elisabeth, Straubing. (ii) Uropathogens from a
multicenter study (1995/96) on complicated UTI comprising 37 urological
centers throughout Germany. (iii) MRSA isolates of patients and staff (1999/
2000) within the Hospital St. Elisabeth, Straubing. Genotyping of the latter
isolates was performed by pulsed-ﬁeld-electrophoresis. The minimal inhibi-
tion concentrations (MIC) of daptomycin, were determined by an agar
(calcium supplemented isotonic sensitivity agar) dilution method using a
multipointer with an inoculum of 104 cfu per point.
Results: For all methicillin susceptible S. aureus (MSSA) (n¼ 25), for methi-
cillin resistant S. aureus (MRSA) (n¼ 49), for methicillin susceptible coagu-
lase-negative staphylococci (CNS) (MSSE) (n¼ 129), for methicillin resistant
CNS (MRSE) (n¼ 33), for E. faecalis (n¼ 289), and for E. faecium (n¼ 4) the
MICs ranged up to 2mg/L indicating that all strains were susceptible to
daptomycin.
Conclusion:According to the in vitro activity daptomycin may be considered
a promising antibacterial agent for the treatment of complicated UTI caused
by Gram-positive uropathogens. Thus, daptomycin should be evaluated in a
clinical study.
P798 Vancomycin to linezolid switch in patients with
MRSA infection
Y. Carmeli, M. Schwaber, S. Weber, M. Bolon
Boston, USA
Objectives: Linezolid is a new treatment option for resistant Gram-positive
cocci infections. Due to its favorable bioavailability it can be used as a follow-
up option for IV treatment. We describe the clinical consequences of patients
(Pts) with MRSA infections, treated initially with vancomycin (VA) and latter
switched to linezolid.
Methods:Retrospective cohort study. Thirty-eight Pts withMRSA infection
treated with VA and switched to linezolid, were included. Data were collected
on demographics, comorbidities, clinical characteristics, antibiotic treatment,
indications for switch, recurrence of MRSA infection, failure of treatment,
occurrence of thrombocytopenia, leukopenia, and renal failure. Criteria for
the likelihood of these events to be related to linezolid were set a priori.
Results: Pts mean age was 62 years (35–85), 66% were female, 50% were
surgical Pts, and 47% were in ICU before the switch. Pts were severely ill as
Table 1 Antibiotic resistance (percentage of strains showing resistance)
Controls
n¼ 5
Wound Isolates
n¼ 45
ICU Isolates
n¼ 5
Vancomycin 0 0 0
Methicillin 21 18 40
mec gene 43 44 60
Linezolid 0 0 0
Daptomycin 0 0 0
Gallidermin 0 7 20
No resistance 64 40 0
P< 0.05 by Fisher’s exact test.
P< 0.05 as compared to other antibiotics by Cochran’s Q-test.
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expressed by Charlson score of 3.7 (range 0–10). The most common
comorbidities included cardiovascular disease (71%), renal disease (45%),
and diabetes (39%). Indication for VA treatment included: bacteremia or
sepsis (40%), soft tissue infections (29%), nosocomial pneumonia, and med-
iastinitis (8% each). Treatments was switched to linezolid due to subsequent
isolation of VA resistant enterococcus (VRE), in 66%; VA associated allergy/
adverse effect 10%, VA failure 10%, and in 14% with main aim to switch to
oral antibiotics. The switched occurred after a median 7 days of VA treatment
(mean 19 days). Linezolid was prescribed for a median 5 days in the hospital
(mean 9 days); and 10 patients were discharged on oral linezolid (median
14 days). Microbiological failure (recurrence of MRSA) occurred in only one
Pt (with arterial graft infection). Hematological events during linezolid
treatment: Thrombocytopenia occurred in three Pts in only one case it
was likely related to linezolid and in other it was unlikely related to.
Leukopenia occurred in one patient, unlikely to be related to linezolid.
New renal failure occurred in one patient, unlikely to be related to linezolid.
No drug events, except the one case with thrombocytopenia required
discontinuation of linezolid.
Conclusion: Pts with MRSA infection were switched to linezolid mostly due
to coinfection with VRE, or to VA related drug effect or failure. The switch
appeared to be safe both with respect to recurrence ofMRSA infection, and in
respect to side-effects.
P799 Comparative in vitro activity of TD-6424, a
rapidly bactericidal, concentration-dependent antibiotic
with multiple mechanisms of action against Gram-positive
bacteria
A. King, I. Phillips, L. Farrington, J. Pace, K. Kaniga
London, UK; Malaga, E; South San Francisco, USA
Objectives:Unlike other glycopeptides, TD-6424 has been shown to inhibit
bacterial lipid synthesis in addition to inhibiting peptidoglycan synthesis. TD-
6424 has potent activity against Gram-positive bacteria and exhibits rapid,
concentration-dependent bactericidal activity. We compared the in vitro
activity of TD-6424 with that of vancomycin, teicoplanin, linezolid, quinu-
pristin/dalfopristin, moxiﬂoxacin and ampicillin, penicillin or oxacillin as
appropriate, by the NCCLS/EUCAST and BSAC methods.
Methods:The organisms (n¼ 401) included in the study were patient isolates
from St. Thomas’ Hospital and were selected to include representatives of the
clinically important Gram-positive aerobic species. The isolates were further
selected to include, where possible, those known to have speciﬁc resistance
mechanisms including vancomycin, methicillin and erythromycin resistance.
Susceptibility testing was performed by agar dilution methods on Mueller-
Hinton agar according to the NCCLS/EUCAST guidelines in comparison to
Isosensitest agar according to the BSAC guidelines. Bothmediawere enriched
with 5% horse blood for fastidious organisms. The minimum inhibitory
concentration was deﬁned as the lowest drug concentration that prevented
bacterial growth.
Results: TD-6424 was active against all the Gram-positive species tested and
nearly 90% of isolates included in the study had TD-6424 MICs< 1mg/L.
Vancomycin-resistant enterococci and lactobacilli isolates with vancomycin
MICs> 64mg/L had TD-6424 MIC ranges of 0.5–8 and 2–16mg/L,
respectively. There was no evidence of cross-resistance with other comparator
drugs. The results for TD-6424 for the two methods were mostly either the
same or within one doubling dilution.
Conclusions: The susceptibility breakpoints have yet to be established but it
would appear that TD-6424 has superior activity to the other tested glyco-
peptides and on aweight for weight basis displays comparable or better activity
than the other agents tested with activity against Gram-positive bacteria.
P800 Oritavancin demonstrates in vitro activity against
susceptible and resistant enterococci collected in 2000–2001
R. Blosser-Middleton, J. Karlowsky, C. Thornsberry, M. Jones, S. Porter,
J. Loutit, D. Sahm
Herndon, USA; Hilversum, NL; Brisbane, USA
Objectives: Vancomycin (VAN)-resistant (R) enterococci are commonly
encountered pathogens in the hospital setting. As antimicrobial resistance
among enterococci, especiallyEnterococcus faecium (EM), continues to increase,
the need for new agents capable of evading current resistance mechanisms
becomes greater. Oritavancin (ORI) is a semisynthetic glycopeptide anti-
microbial that has previously shown potent in vitro activity against enter-
ococci, including VAN R EM and Enterococcus faecalis (EF).
Methods:We examined the in vitro activity of ORI, VAN, and comparator
agents against 238 EM, 401 EF, and 77 Enterococcus spp. (Espp.; non-EM and
non-EF) collected from patient specimens at hospital laboratories in 15
European countries. Isolates were selected to include both susceptible (S)
and R phenotypes. All isolates were centrally tested using NCCLS broth
microdilution methodology, and MICs were interpreted using the 2002
NCCLS published breakpoints.
Results:ORI had an MIC90 of 1mg/L against all EM and showed consistent
activity against VAN S (MIC90, 1mg/L) and VAN R (MIC90, 2mg/L)
isolates. ORI had an MIC90 of 2mg/L against all EF; MIC90s were 2mg/L
against VAN S EF and 2mg/L against VANR EF. Against Espp., ORI had an
MIC90 of 1mg/L against all isolates and MIC90s of 1 and 2mg/L against
VAN S and VAN R isolates, respectively. Against vanA (n¼ 55 EM, 30 EF)
and vanB (n¼ 13 EM, 5 EF) phenotypes, ORI had MIC90s of 2 and 2mg/L,
respectively, against vanA phenotypes and 1 and 2mg/L, respectively, against
vanB phenotypes. ORI showed consistent activity against high-level strep-
tomycin (HLS; 1000mg/L) R EM (n¼ 151; MIC90, 1 mg/L) and EF
(n¼ 189; MIC90, 2mg/L) and against high-level gentamicin (HLG;
500mg/L) R EM (n¼ 137; MIC90, 1mg/L) and EF (n¼ 44; MIC90,
2mg/L). ORI had an MIC90 of 2mg/L against 21 pan R EM, deﬁned as
R to ampicillin, VAN, HLG, and HLS.
Conclusions: ORI showed consistent activity against EM and EF, including
those isolates that were R to multiple antimicrobials. Based on these data,
ORI may have potential as a therapy for R enterococcal infections.
P801 Activity of Oritavancin against susceptible and
resistant Staphylococci collected in Europe during
2000–2001
J. Karlowsky, J. Loutit, S. Porter, R. Blosser-Middleton, M. Jones,
C. Thornsberry, D. Sahm
Herndon, Brisbane, USA; Hilversum, NL
Objectives: The burden of antimicrobial resistance (R) among staphylococci
is a continuous challenge faced by physicians worldwide. Increases in the
prevalence of oxacillin (OX) R among staphylococci are often seen in
conjunction with increases in R to other antimicrobials, thereby making
the treatment of patients with staphylococcal infections more difﬁcult.
Oritavancin (ORI) is a semisynthetic glycopeptide that has shown potent
in vitro activity against Staphylococcus aureus (SA) and coagulase-negative
staphylococci (CNS).
Methods:We tested 701 SA and 303 CNS against ORI, vancomycin (VAN),
OX, and comparator agents by NCCLS broth microdilution. Isolates were
originally collected during 2000–2001 from patient specimens in 15 Eur-
opean countries and were chosen to include both susceptible (S) and R
phenotypes. MICs were interpreted using the 2002 NCCLS published
breakpoints.
Results: ORI had an MIC90 of 2mg/L against all SA and showed identical
activity against both OX S (n¼ 483; MIC90, 2mg/L) and OX R (n¼ 218;
MIC90, 2mg/L) isolates. One SA and one CNS had VAN MICs¼ 4mg/L;
the corresponding ORI MICs were 2mg/L. Against CNS, ORI showed an
MIC90 of 2mg/L with identical activity against OX S (n¼ 140; MIC90,
2mg/L) and OX R (n¼ 163; MIC90, 2mg/L) isolates. Among the isolates
tested, 190 SA and 113 CNS were multidrug-resistant (MDR), deﬁned as R
to 3 antimicrobial classes. ORI showed consistent activity against non-
MDR and MDR SA (MIC90s, 2mg/L) and CNS (MIC90s, 2mg/L),
including isolates that were resistant to ﬁve antimicrobial classes (OX,
ciproﬂoxacin, erythromycin, gentamicin, trimethoprim-sulfamethoxazole).
Conclusions:ORI showed consistent activity against SA and CNS, irrespec-
tive of R to OX or other antimicrobials. ORI is currently in Phase III clinical
trials for the treatment of Gram-positive infections and may possess potential
as a therapy for R staphylococci.
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New antibiotics – quinolones and miscellaneous
P802 Mutational studies with a new ﬂuoroquinolone,
DK-507k, against Gram-negative bacteria: comparisons with
six ﬂuoroquinolones
P. Lister, E. Smith-Moland, J. Black, T. Lockhart, L. Olson, K. Thomson
Omaha, USA
Objectives: The objectives of this study were to evaluate the selection of
mutational resistance by a new ﬂuoroquinolone (FQ), DK-507k (DK), against
three Gram-negative bacterial species and to compare with ciproﬂoxacin
(CIP), levoﬂoxacin (LEV), gatiﬂoxacin (GAT), moxiﬂoxacin (MOX), sita-
ﬂoxacin (SIT), and garenoxacin (GAR) In addition, the potency of these FQ
against the mutants selected were also compared.
Methods: Pseudomonas aeruginosa (PA), Escherichia coli (EC), and Haemophilus
inﬂuenzae (HI) were selected for this study. FQ potency was measured by agar
dilution methodology. Mutant selection studies were performed in vitro using
two methods. Gradient plate methodology was used to select mutants with
subinhibitory concentrations of FQ over seven culture passages. The second
method involved selection of single-step (SS) mutants with superinhibitory
concentrations of FQ. Changes in susceptibility to the FQ were evaluated
with the mutants selected.
Results: In studies with EC, SS mutants were selected with each FQ. SIT, DK
and CIP were the most active against these SS mutants withMICs< 0.25mg/
L. Higher levels of resistance were selected with gradient plates. Surprisingly,
LEV was most active against these mutants (MIC¼ 8mg/L) with other FQ
being two- to fourfold less active. In studies with HI, SS mutants were only
selected with DK, GAR, GAT, and CIP. All FQ still maintained MICs of
<0.12mg/L against these HI mutants. Although larger increases in MICs
were observed using gradient plates, MICs for all FQ against these mutants
remained below 1mg/L. In studies with PA, SS mutants were selected with
each FQ. MICs increased up to eightfold, with all mutants remaining
susceptible to <4mg/L of SIT and CIP, and <16mg/L of DK and LEV.
Similar to EC and HI, mutants from gradient plates exhibited much higher
levels of resistance, with MICs for all FQ being >16mg/L.
Conclusions:The potency of DK, CIP and SITagainst SS mutants of EC and
HI suggest that these drugs may be effective in slowing the emergence of
resistance in these bacterial species. With all FQ, mutational to resistance
remains a serious threat with PA. Pharmacodynamic and further mutational
studies with DK against other Gram-negative pathogens are warranted.
P803 Mutational studies with a new ﬂuoroquinolone,
DK-507k, against staphylococci and streptococci:
comparisons with 6 ﬂuoroquinolones
P. Lister, P. Wickman, K. Thomson
Omaha, USA
Objectives: The objectives of this study were to evaluate the selection of
mutational resistance by a new ﬂuoroquinolone (FQ), DK-507k (DK), from
four staphylococci (Sta) and two streptococci (Str), compared with cipro-
ﬂoxacin (CIP), levoﬂoxacin (LEV), gatiﬂoxacin (GAT), moxiﬂoxacin
(MOX), sitaﬂoxacin (SIT), and garenoxacin (GAR) In addition, the potencies
of these FQ against the mutants selected were also compared.
Methods: Two Staphylococcus aureus and two S. epidermidis (one methicillin-
susceptible and one resistant strain for each species), and one strain each of
Streptococcus pneumoniae and S. pyogenes were included in this study. FQ
potency was measured by agar dilution methodology. Mutant selection studies
were performed in vitro using two methods. Gradient plate methodology was
used to select mutants using subinhibitory concentrations of FQ over seven
culture passages. The second method involved selection of single-step (SS)
mutants with superinhibitory concentrations of FQ. Changes in susceptibility
to the FQ were evaluated with the mutants selected.
Results: DK, GAR, and SIT were the most potent FQ (MIC¼ 0.015–
0.06mg/L). Mutants with high-level resistance were readily selected with
gradient plate method. Against the Sta mutants, DK and SITwere signiﬁcantly
more potent with MICs of <2mg/L against most mutants. It was harder to
select SS Sta mutants with DK and SIT compared with other FQ. MICs for
DK, SIT, GAR, and MOX against all SS mutants were <0.5mg/L. SS
mutants were selected from both Str strains with all FQ. DK, SIT, and GAR
were signiﬁcantly more potent than other FQ against the SS pneumococcal
mutants with MICs < 0.5mg/L. Against the S. pyogenes SS mutants, DK and
SITwere also signiﬁcantly more potent with MICs < 0.06mg/L. DK, SIT,
and GAR were the most potent FQ against the mutants selected by gradient
plates. However, it was surprising that GAR actually selected mutants with
signiﬁcantly higher levels of resistance than the other FQ.
Conclusions: The Gram-positive activity of DK is a strength of this com-
pound. The potency of DK and lower propensity of DK to select less
susceptible Sta mutants is very comparable to that of SIT. These ﬁnding
suggest these two agents may be effective in slowing the emergence of FQ
resistance among Gram-positive bacteria.
P804 Post-antibiotic effect studies with a new
ﬂuoroquinolone, DK-507k, and six other ﬂuoroquinolones
P. Lister, A. Houssain
Omaha, USA
Objectives: The objectives of this study were to evaluate the postantibiotic
effects (PAEs) of a new ﬂuoroquinolone (FQ), Dk-507k (DK), against
Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, and Pseudomonas
aeruginosa, compared with ciproﬂoxacin (CIP), levoﬂoxacin (LEV), gatiﬂox-
acin (GAT), moxiﬂoxacin (MOX), sitaﬂoxacin (SIT), and garenoxacin
(GAR).
Methods: All four bacterial species were FQ-susceptible. Log-phase cultures
(106107 cfu/mL) were exposed to each FQ at a concentration 10 the MIC
and incubated at 378C. As the control, similar cultures were incubated in the
absence of FQ. After 1–2 h, dependent upon rate of killing, drug was removed
by centrifugation and 2 washing with sterile buffer, and cells were resus-
pended in fresh 378C growth media and incubated at 378C for 5 h. Viable
bacterial counts were measured at time of initial inoculation, at the end of
drug exposure, after removal of drug and resuspension in fresh media, and at
hourly intervals thereafter. PAEs were deﬁned as the time required for FQ-
exposed cultures to increase 1 log after drug removal minus the time required
for control cultures to increase 1 log after receiving the same centrifugation
and washing treatment.
Results:AgainstE. coli, DK, CIP, andMOX exhibited the longest PAEs of 3 h,
compared with 2.5 h for SIT, and 1–1.5 h for GAT, LEV, and GAR. Against
P. aeruginosa, DK, LEV, GAR, GAT, and MOX exhibited PAEs of 1.5–2 h,
compared with 0.5–1 h for CIP and SIT. Against S. aureus, only CIP exhibited
any substantial PAE (2 h). The other FQ either failed to exhibit a PAE or
exhibited a short PAE of only 0.5 h. Against S. pneumoniae, GAT, GAR, and
MOX exhibited the longest PAEs of 3.5–4 h, compared with 2 h for DK and
SIT, and 1 h for CIP and LEV.
Conclusions: DK exhibited its longest PAEs against E. coli and S. pneumoniae.
In comparison to other FQ, DK exhibited one of the longest PAEs against the
Gram-negatives. DK was similar to most FQ in its lack of PAE against
S. aureus, and exhibited a moderate PAE against S. pneumoniae compared with
the most active FQ. In general, the PAEs exhibited by DK were very
comparable to those exhibited by other FQ that are dosed once daily. Of
interest would be further studies evaluating the PAEs of DK in the presence of
subinhibitory concentrations of drug.
P805 Molecular analysis of Streptococcus pneumoniae
mutants selected by DK-507k, an investigational
ﬂuoroquinolone
P. Wickman, N. D. Hanson
Omaha, USA
Objectives: DK-507k (DK) is an investigational ﬂuoroquinolone (FQ) with
potent activity against Gram-positive pathogens. A study was designed to
determine the molecular mechanisms involved when less susceptible mutants
of Streptococcus pneumoniae (SP) were selected by DK and six comparison FQs.
Methods: The six comparison FQs were sitaﬂoxacin (SIT), ciproﬂoxacin
(CIP), levoﬂoxacin (LEV) and moxiﬂoxacin (MOX), gatiﬂoxacin (GAT) and
BMS-284756 (BMS). SP strain R6 was used for generation of mutants by
seven serial passages on gradient antibiotic plates containing increasing
concentrations of drug. Mutants selected during the ﬁrst, fourth (p4) and
seventh (p7) passage were evaluated for changes in quinolone susceptibility by
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comparing agar dilution MICs (NCCLS methodology) to those of the parent
strain. The QRDR regions of gyrA, gyrB, parC and parE, the ATP binding
region (ABR) of parE and the efﬂux associated gene pmrA of p4 and p7
mutants were ampliﬁed by PCR and directly sequenced.
Results:The p4 mutants hadMICs corresponding to reduced susceptibility to
the selecting drug and also to the comparison drugs tested while the p7
mutants had the highest MICs obtained for all drugs tested in this study. The
mutations observed in this studywere previously associatedwith FQ resistance
in S. pneumoniae. The mutations found in p4 mutants were also present in p7
mutants. The most common mutation was Ser(81)Tyr in gyrA followed by
Ser(79)Tyr in parC. Except for the p7 mutants selected by MOX and GAT
(which had one mutation), the p7 mutants selected by the other drugs had at
least two mutations. The mutation proﬁle of DK-p4 was Ser(81)Tyr in gyrA
and Ser(79)Tyr in parC while the mutation proﬁle of DK-p7 was Ser(81)Tyr,
and Glu(85)Lys in gyrA and Ser(79)Tyr in parC. Such mutations correlated
with a 32-fold (p4) and 128-fold (p7) increase in DKMICs. Only the SIT-p7
mutant had changes in three genes, gyrA, gyrB and parC. No base change was
noted in any mutants for parE, pmrA and the ABR of parE.
Conclusions: DK and the comparison FQs exhibited correlation between
mutational changes and increases in MIC. DK appears to have the character-
istics of a dual target drug that did not show any preference for gyrA or parC as
its primary target.
P806 Efﬁcacy and safety of telithromycin in two
treatments of acute sinusitis in adults
F. Diamantea, G. Koratzanis, J. Katsargiris, P. Nikolaidis, A. Psiﬁdis,
S. Moschovakis, D. Batzakakis, H. Giamarellou
Athens, Thessaloniki, GR
Objective:Telithromycin is the ﬁrst antimicrobial agent of the Ketolide group
that is in the market. It has a promising spectrum of activity against respiratory
pathogens including S. pneumoniae Pen-R strains. Forty-one Greek patients
(27 males, age range 19–65 years) were recruited in an international, multi-
centre, randomized, double-blind study, aiming to evaluate the clinical
efﬁcacy and safety of telithromycin in the treatment of acute sinusitis in adults.
Methods:All subjects had acute sinusitis, clinical and radiologically conﬁrmed
and underwent transantral needle puncture with aerobic and anaerobic culture
performed in the obtained specimens. In 20 subjects, 800mg of telithromycin
once daily was administered for 10 days (group A) and in 21 subjects for 5 days
followed by placebo for the remaining days (group B). Criteria of successful
treatment were full remission or improvement of the symptoms and signs of
acute sinusitis as well as the elimination or improvement of radiological
ﬁndings.
Results: Ten positive cultures from sinus aspirates revealed S. pneumoniae (3),
Streptococcus spp. (1), Staphylococcus CNS (2), H. inﬂuenza (1), S. aureus (3). All
strains were sensitive to telithromycin. In 18 subjects of group A and 18 of
group B therapy was considered successful. One each subject deteriorated in
both groups and one each had clinical and radiological ﬁndings that remained
unchanged. Mild adverse events were observed in two subjects. No clinically
signiﬁcant laboratory abnormalities or QTc changes were identiﬁed.
Conclusion: The 5- and 10-day treatment regimens with telithromycin were
equivalent in efﬁcacy with only minor side-effects. Treatment failures were
possibly due to domination of anaerobic species in the pathogenesis of the
infection as conﬁrmed by the subjects positive response to the administration
of additional therapy with antianaerobic activity.
P807 Antimicrobial activity of tigecycline (GAR-936)
against multiresistant Acinetobacter baumannii
D. Martı´n-Lozano, C. Pichardo, M. Pacho´n-Iba´n˜ez, M. Jime´nez-Mejı´as,
M. Rodrı´guez-Herna´ndez, A. Llanos, M. Herrero, J. Pacho´n
Seville, E
Objectives:Multiresistant A. baumannii, including resistance to carbapenems,
is a common cause of severe nosocomial infections. The objective of this study
was to determine the in vitro antimicrobial activities of a new glycylcycline,
tigecycline, and imipenem against clinical A. baumannii isolates.
Methods: Forty-nine strains from bacteremic patients were studied, belong-
ing to the two more frequent clones genotyped by REP-PCR in our hospital,
with 22 and 27 strains, respectively. Thirty-seven strains were multiresistant,
deﬁned as resistance at least to three antimicrobials: carbapenems, ceftazidime,
ciproﬂoxacin, amikacin, and/or sulbactam. The MICs and MBCs values for
each strain were determined by broth microdilution method according to
NCCLS 2000. Because there is not an approved standard for considering
A. baumannii susceptible or resistant to tigecycline, MIC breakpoints used for
this agent were those for minocycline: 4, 8, and 16 mg/mL to designate
susceptible, intermediate, or resistant isolates, respectively. Escherichia coli
ATCC 25922 and Staphylococcus aureus ATCC 29213 were used as quality
control strains. Bactericidal activity of tigecycline and imipenem was eval-
uated using time-kill curves using nine strains with different susceptibilities to
imipenem (IMP): three IMP-susceptible (S), three IMP-intermediate (I), and
three IMP-resistant (R); tigecycline or imipenem concentrations correspond-
ing to theMIC, 2MIC and 4MIC for each isolate were tested. Bactericidal
activity was deﬁned as 3 log 10 reduction compared with the initial inocu-
lum.
Results: MIC50/MIC90 of tigecycline and imipenem were 2/2 and 32/
128mg/L, with a range of 1–4 and 1–128mg/L, respectively. MBC50/
MBC90 were 8/>8 and 32/128mg/L for tigecycline and imipenem, ranging
from 2 to >8mg/L, and from 1 to 128mg/L, respectively. Percentages of
susceptible isolates were 100 and 28% for tigecycline and imipenem, respec-
tively. By time-kill studies, tigecycline was not bactericidal; imipenem was
bactericidal against seven strains (3S, 2I, and 2R).
Conclusions: (1) Tigecycline is active against multiresistant A. baumannii
strains, including those imipenem-resistant. (2) The results of the time-kill
studies show that tigecycline is bacteriostatic against these strains.
P808 Effects of S-carboxymethylcysteine on the
attachment of Streptococcus pneumoniae
M Turkoz, G. Cakan, T. Turan, K. Ahmed, T. Nagatake
Ankara, TR; Nagasaki, JP
Objectives: Respiratory infections are preceded by colonization of the
pharynx by bacteria. Therefore, inhibition of bacterial colonization in the
pharynx seems to be a useful strategy to prevent infections. S-carboxymethyl-
cysteine (S-CMC) is perhaps the most promising agent since previous studies
have shown that it signiﬁcantly reduced the number of episodes of acute
exacerbations of respiratory infections. The effects of S-CMC on Gram-
positive bacteria and bacteria with a well-deﬁned capsule have not been
investigated. The present study was designed to examine the effects of S-
CMC on the attachment of S. pneumoniae to human pharyngeal epithelial cells
(HPEC).
Methods:The following strains of S. pneumoniaewere used in this study: strain
SP-95-27 (serotype 9V); strain SP-95-19 (19F); strain SP-96-29 (6B); and
strain SP-95-36 (14). All were isolated from respiratory specimens. Assays
were done to ﬁnd out the effects of S-CMC on the attachment and
detachment of S. pneumoniae to HPEC.
Results:The attachment of strain SP-95-19 to HPEC signiﬁcantly (P< 0.05)
decreased following treatment of the cells with S-CMC at a concentration of
100, 10, 1 or 0.1mg/mL. However, at 0.01 and 0.001mg/mL, S-CMC had no
effect on the attachment. Treatment of HPEC with S-CMC at a concentra-
tion of 0.1mg/mL resulted in a signiﬁcant (P< 0.001) decrease in the
attachment of the other three strains of S. pneumoniae. For detachment assay,
HPECwith the attached S. pneumoniae strain SP-95-19were treated with 100,
10, 1 or 0.1mg/mL S-CMC. This resulted in a signiﬁcant decrease in the
number of attached bacteria. However, no such decrease was noted with 0.01
and 0.001mg/mL S-CMC. The detachment assay also showed a signiﬁcant
(P< 0.05) decrease in other three strains of S. pneumoniae, with 0.1mg/mL S-
CMC. Treatment of strain SP-95-19 with 10 or 1 mg/mL S-CMC signiﬁ-
cantly decreased the number of bacteria attached to HPEC. However, at
concentrations of 0.1 and 0.01 mg/mL, S-CMC had no signiﬁcant effect on
attachment. Treatment of the other three strains of S. pneumoniae with 10 mg/
mL of S-CMC resulted in a signiﬁcant (P< 0.001) decrease in the number of
attached bacteria.
Conclusion: S-CMC can modulate the attachment of S. pneumoniae to HPEC
by acting both on the cells and bacteria at a concentration, which is achievable
in respiratory secretion in vivo. This drug may be potentially useful for the
prevention of S. pneumoniae infections.
P809 Inhibition of endotoxin-induced cellular
activation by polymyxin B-albumin conjugate
S. Najar Peerayeh, Q. Behzadian Nejad, M. Moazenee, A. Kazam Nejad
Tehran, IR
Objective:The endotoxin fromGram-negative bacteria consists of a molecule
lipopolysaccharide (LPS), which can be shed by bacteria during antimicrobial
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therapy. The resulting syndrome, endotoxic shock, causes organ failure, shock
and death. Thus, there is great interst in the development of antiendotoxin
agents, which can reverse rather than promote sepsis. We describe here
covalent PMB-HAS conjugate, which has antiendotoxin activity.
Methods:Conjugates of PMBwith HSAwere prepared by EDAC [1-ethy-3-
(3-dimethylaminopropyl) carbodiimide]. Double immunodiffusion agar test
with immunized rabbits sera was performed. Fresh heparinised blood from
normal doners was collected to prepare peripheral blood mononuclear cells.
After incubation and washing nonadherant cells, the monocytes were sti-
mulated with LPS and various concentration of PMB-HSA conjugate.
Supernatants were collected for measurement of TNF alpha using bioassy
with L929 cells and ELISA. Peritoneal macrophages were isolated from
C57BL/6 mice, and stimulated with LPS and various concentration of
PMB-HSA conjugate. Nitric oxide formation was measured in culture
supernatants with the Griess reagent.
Results: Double immunodiffusion agar test showed that puriﬁed conjugate
contained bound PMB. The PMB bound in the conjugate retained its
endotoxin-neutralizing activity compared with that of unbound PMB as
evidenced by its dose-dependent inhibition of TNF release from human
monocytes (in vitro), and nitric oxide production from murine macrophages,
which stimulated by puriﬁed E. coli O55:B5 LPS.
Discussion: These experiments demonstrated that the PMB-HSA conjugate
retains bound yet functional PMB and may be useful for the design of drug for
treatment of Gram-negative bacterial sepsis.
P810 Antimicrobial activity of 2,40-bipyridyl
ammonium salts
P. W. J. West, B. Denny, L. Novotny, M. Blesova, J. Zamocka
Kuwait, KWT; Brno, CZ; Bratislava
Objectives: A series of novel 2,40-bipyridyl ammonium salts with varying
lengths of alkyl chains were synthesized and tested as antimicrobial agents
against Staphylococcus aureus, Acinetobacter, Escherichia coli, Stenotrophomonas
maltophilia and Pseudomonas aeruginosa.
Methods: Chemical synthesis was based on the reaction between 2,40-
bypyridyl and 1-bromoalkane. The structure of the compounds was con-
ﬁrmed by their physico-chemical characteristics, elemental analysis and UV
and IR spectra and their purity by TLC antimicrobial activity was measured
by inoculating disks with 100mg of the agents and recording the inhibition of
different bacterial strains on Mueller–Hinton agar.
Results: The compounds displayed excellent antimicrobial activity against
S. aureus. Lesser activity was observed against Acinetobacter, E. coli and S. mal-
tophilia. P. aeruginosa was completely resistant to the compounds but the
resistance could be overcome by adding membrane permeabilizing agents
such as EDTA and sodium citrate. For each species tested the antimicrobial
activity varied according to the length of the alkyl chains. The most active
compounds had alkyl chains of between 9 and 12 carbons. The parent
dipyridyl compound and the compounds with the longest alkyl chains
(C14, C16) had no appreciable activity.
Conclusions: The proposed mechanism of action is by interaction with the
cell membrane These compounds represent a promising new series of drugs
for further testing.
P811 Antirhinovirus activity of new 2-styrylchromones
C. Conti, N. Desideri
Rome, I
Human rhinoviruses (HRVs) constitute the most extensive genus of the
Picornaviridae. The more than 100 serotypes of HRVs are the major cause of
common cold, an acute infectious disease widespread in developed countries.
No licensed effective antiviral is available at the moment for the treatment of
common cold. The in vitro antipicornavirus activity of ﬂavonoids, either
synthesized by us or from natural sources, is well known. Because of the broad
spectrum of activity and of the interesting mechanism of action, we synthe-
sized new ﬂavonoid derivatives (2-styrylchromones) to improve their antiviral
effect and to better deﬁne structure–activity relationship. The antiviral
potency of new compounds has been evaluated against HRV 14 and HRV
1B infection of (Ohio) HeLa cells. HRV 14 and 1B have been selected as
representative serotypes for group A and B of HRVs, respectively, as identiﬁed
by a different susceptibility of all HRVs to a panel of antiviral compounds. The
activity has been tested in a plaque reduction assay, starting from themaximum
concentration of compound which did not affect cell viability and growth.
Results obtained from structure–activity relationship studies suggest that the
introduction of a methoxy or hydroxy substituent in third position of the
chromone ring enhances the antiviral potency against both serotypes tested;
the introduction of a chlorine substituent on the chromosome ring leads to a
reduction of activity for both 3-hydroxy- and 3-methoxy-2-styrylchomones;
among the 2,4-pentadien-1-ones, the 3-hydroxy substituted compounds
result more potent against HRV 1B and less active towards HRV 14 than
the corresponding compounds without substituent on the chain. In conclu-
sion, our data indicate that 2-styrylchromones represent a new class of
antirhinovirus ﬂavonoids, exhibiting activity against both group A and B
of HRVs.
P812 Efﬁcacy of dimerized vs. monomeric magainins
against nosocomial bacterial pathogens
M. Avison, C. Dempsey
Bristol, UK
Objectives:Magainin is a cationic peptide derived from the skin of frogs. It is
known to have antimicrobial properties due to its ability to bind to bacterial
LPS and induce spontaneous pore formation. Previously, we have synthesized
native magainin peptides and those containing a cystine residue, which can be
induced to form dimers (Dimagainin). Using Stenotrophomonas maltophilia as
the test organism, we have shown that dimerized magainin is 1000 times more
efﬁcient at killing cells than an equivalent concentration of monomeric
magainin. The reason for this is that the rate limiting factor of pore formation
by magainin is dimerisation of magainin monomers. In this study, we have
tested the range of organisms killed by monomeric and dimeric magainins.
Methods: Bacterial kill assays were performed by adding magainin or
Dimagainin (1 mm monomer equivalents) to broth cultures (500 cfu/mL)
for varying lengths of time, followed by plating serial dilutions of the resultant
cell suspension onto nutrient agar and growing overnight at 378.
Results: Consistently, when magainin was shown to reduce viable count,
dimerized magainin reduced the viable count around 100 times more at a
given time point. Monomeric magainin (1mM) was not able to reduce viable
counts to zero for any bacterial strain tested. Viable counts were reduced to
zero after 30min incubation of clinical isolates of Escherichia coli, Klebsiella
pneumoniae, Serratia marcescens, Acinetobacter baumannii and Stenotrophomonas
maltophilia with 0.5mM dimerized magainin It took 90min incubation with
0.5mM dimerized magainin to reduce the viable count to zero of Salmonella
typhimurium, Enterobacter cloacae, and Pseudomonas aeruginosa. The growth of
Gram-positive organisms, such as Staphylococcus aureus and coagulase negative
streptococci was not inhibited by either monomeric or dimeric magainins,
nor was the growth of Providencia stuartii.
Conclusions: Probably due to its more rapid killing of bacteria, 0.5mm
dimerized magainin is able to reduce the viable count of many clinically
important Gram-negative bacteria to zero, even using starting culture den-
sities of 500 cfu/mL. This adds further evidence that dimerized magainin
would make a more efﬁcacious topical antimicrobial agent than the already
clinically used monomeric form of the peptide.
P813 Tomatozid – a new perspective antiviral and
immunomodulating drug
I. Soric, P. Galetchi, V. Vorojbit, O. Andreev
Chisinau, MD
This study investigated the antiviral activity of tomatozid (a steroid glycoside
extracted from tomato seeds) against human viruses (Picornaviridae, Reovir-
idae, Herpesviridae) and its inﬂuence on the immune system. In vitro antiviral
activity was evaluated using an index of neutralization (IN, the difference
between the titre of viral replication in the absence and in the presence of
tomatozid): IN¼ Ig (CPE50)/mL (where CPE is the cytopathic effect). The
antiviral activity of tomatozid was found to increase simultaneously with its
dose. The most efﬁcient concentration was 0.05–0.1%. IN¼ 3.14–3.7
[lg(CPE50)/mL] for different virus families. For experiments in vivo, we
used mice infected with Herpes simplex virus (HSV-1). The IN was 2.56
[lg(LD50)/0.03mL] (where LD is lethal dose). In the experimental group,
95.8% of mice survived. The mean duration of life was 20.25 days (the period
of observation was 21 days). For the reference group the corresponding values
were 58.08% and 16.64 days. In a comparative study, the antiviral activity of
tomatozid was compared with the activity of a reference interferon sample
(Leukinferon, Reaferon, Realderon). The IN was 3.0 [lg(CPE50)/mL] for
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Tomatozid and 1.8–2.4 [lg(CPE50)/mL] for interferon. Immunomodulating
activity in vitro was estimated using the Lymphocyte Blast Transformation
Test. Index of stimulation (IS) of lymphocytes exposed to phytohemagglu-
tinin was IS¼ 11. Next we added to the test system different concentration of
tomatozid. At a concentration of 0.01 mg/mL tomatosid stimulated blast
transformation (IS¼ 18). Concentration of 0.1mg/mL had no evident effect
(IS¼ 12). High concentration (1.0, 10.0, 100.0 mg/mL) manifested inhibiting
action on lymphocyte transformation (IS¼ 7–0). The experiments in vivo
conﬁrmed the immunostimulating action of tomatozid. Histologic study of
lymphoid tissue in mice treated with tomatozid showed evident proliferative
changes: large lymphoid follicles with developed germinal centers and
accumulation of many blast cells. In conclusion, tomatozid has a signiﬁcant
antiviral effect upon RNA- and DNA-containing viruses. Tomatozid proves
also immunomodulating activity (low doses-stimulating action, high doses-
suppressing action). The antiviral activity degree of tomatozid does not yield
to the reference human interferon samples. The interferonogenous effect of
tomatozid has been stood out, which would clear up a possible antiviral action
mechanism of the tested substance.
Clinical fungal infections and nosocomial infections
P814 A Fusarium oxysporum strain isolated from a
case of keratitis
A. S. Kantarcioglu, A. M. Sarica, Y. Bagdatli, G. Iskeleli
Istanbul, TR
Keratomycosis is a signiﬁcant worldwide ophthalmic problem. Fusarium spp.
are common soil saprophytes and plant pathogenes which in humans are
mostly associated with superﬁcial mycosis and keratitis. We report a Fusarium
oxysporum strain isolated from a case of keratitis after corneal injury by a plant
matter. A 40-year-old female patient presented with a trauma history in
October 2002. Only one specimen obtained by swab was sent to deep mycosis
lab due to perforation risk of deteriorated epithelial layer. In direct micro-
scopic examination of the specimen stained with Ehrlich-Ziehl-Neelsen,
methylene blue, Giemsa techniques revealed several individual one-celled
fungal elements. Specimen was inoculated onto Sabouraud dextrose agar,
brain–heart infusion agar, cooked sheep’s blood agar. The plates were
incubated at 35, 30, 258C. After 4 days cultures on SDA showed whitish
mycelial growth with pale orange colored in the center. The reverse was
concentrically brownish, orange and whitish color. The fungus was isolated as
a single microorganism from specimen and was transferred onto oat meal agar,
potato dextrose agar, potato sucrose agar, Czapek Dox agar, malt extract agar
and incubated at 258C in diffuse daylight for 7–10 days. The isolate produced
whitish, ﬂoccose colonies 4–5 cm in diameter. The colony reverse of sub-
cultures was pale white on all agar media. The isolate produced numerous one
to two celled oblong microconidia in variable size on short and often
unbranched conidiophores bearing monophyalides. Macroconidia were
aboundant, having 3–5 cells, more or less curved, pointed at both ends.
The chlamydospores were mostly globose, hyaline, smooth-walled, terminal
or intercalary. The isolate was identiﬁed as F. oxysporum. Susceptibility testing
of the strain was performed against conventional antifungals according to
NCCLS M38-P guideliness. MICs (micrograms per milliliter) were found as
follows: amphotericin B 16, ﬂuconazole higher than 64, itraconazole higher
than 16, ketoconazole 16. Fungal elements could be inoculated into the
cornea by traumatic instrument such as a plant matter at the time of injury and
then the cornea is susceptible to opportunistic fungal infection. Seasonal
variation has been noted in several keratomycosis series in USA, India.
Corneal infection by hyphomycetes peaked during late spring and late
autumn. Fusarium spp. are the predominant fungi causing keratomycosis
during those months like in the present case.
P815 Clinical and epidemiologic data of 40 cases with
candidal balanitis
D. Kraja, N. Como, B. Tila
Tirana, AL
Objectives: The recognition of favorable and epidemiologic factors and
clinical features of candidal balanitis.
Methods:During the period, March 1995–August 2002, we have observed 40
patients of age 14–67years with candidal balanitis. The diagnose was proved by
microscopic examination and growing in culture of Sabouraud terrain with
chloramphenicol [we consider positive the presence of 15 and more colonies/
culture]. We analyzed the frequency according to age groups; favorable factors
[unprotected sexual contacts accompanied pathologies; immune suppressive
therapies, prepuce status] and clinical features of the disease.
Results: The epidemiologic analyses: (a) Cases related to age group were:
14–20 years 1 case, 21–30 years 11 cases, 31–40 years 16 cases, 41–50 years 6
cases; 61–67 years 3 cases. (b) Favorable factors unprotected occasionally
contacts 35 cases; diabetes mellitus 2 cases; long immune suppressive therapy
2 cases; prepuce interest and/or its constriction 20 cases. Clinical analysis: (a)
Subjective signs: dysuria 11 cases, pruritis 14 cases; painful glans or prepuce 16
cases; discomfort during coitus 34 cases. (b) Lesion location: glans 15 cases,
glans and prepuce 16 cases, glans and balano-prepucial sulcus 3 cases, glans and
frenulum 4 cases, glans and urethrael meatus 2 cases. (c) Macroscopic aspects:
small painful erythemas 3 cases, diffuse erythema 8 cases, moist papule 3 cases,
erosion-ulcer 8 cases, abrasions-rhagades 7 cases, pseudo membranous 11
cases. (d) According to course: acute forms 22 cases, prolonged forms [over
1month14months] 18 cases. (e) Complications: phymosis presence 13 cases
and urethra meatitis 2 cases.
Conclusions:The most affected age group of that candidiasis was 21–40 years,
67.5% of the cases; the most frequent favorable factor resulted unprotected
sexual contact 87.5% of the cases; more often we met balanoposthitis 40% of
the cases and balanitis 37.5% of the cases. We identiﬁed six types of
macroscopic lesions of the disease.
P816 The inﬂuence of fungal colonization in the colon
mucosa on the activity of IBD/ulcerative colitis and Crohn’s
disease
D. Trojanowska, M. Zwoliska-Wcislo, A. Budak, A. Bucka
Cracow, PL
Background: Three main interactive factors such as: host susceptibility,
enteric microﬂora and mucosal immunity play role in the pathogenesis of
IBD. The importance of presence of fungi in digestive tract remains unclear.
The aim of study was to: (1) Estimate the frequency of fungal colonization of
colon mucosa in patients with ulcerative colitis (UC) and Crohn’s disease
(CD). (2) Identify the fungal species. (3) Evaluate the differences in the
frequency of fungal colonization between groups of patients with the duration
of disease, less and more than 5 years. (4) Evaluate the inﬂuence of antifungal
treatment on the course of IBD. (5) Examine the coexistence of pathogenic
bacteria with fungi.
Material and methods:We investigated 84 patients, admitted to the Depart-
ment of Gastroenterology of University Hospital in Cracow in active phase of
UC/64 cases, 27 duration less and 33 more than 5 years/and 20 cases of CD/
12 less, 8 more than 5 years of duration/aged from 18 to 72 years. Clinical
investigations included the history of disease, colonoscopy with biopsies from
changed colon mucosa, brush smears from mucosal surface. Mycologic tests/
210 samples/included biopsies from colon mucosa, brush smears, blood and
stool samples. Quantitative and qualitative tests for the presence of fungi and
bacteria were performed. For evaluation of the activity of disease, histopathol-
ogy of colon mucosa and the level of CRP in the blood were estimated.
Results: Signiﬁcant fungal colonization, more than 105CFU/mL was found
in 35–78% of UC patients and 15–47% of CD cases with the history of disease
less -more than 5 years respectively. In three cases of UC patients and two cases
of CD patients, fungal antigen was isolated from the blood. Candida/C. albi-
cans was isolated in 92.6% and C. glabrata in 7.2% of cases. In 30%—25% of
UC–CD patients, respectively, fungal colonization coexisted with such
bacteria as: E. coli, Proteus spp., Klebsiella spp. Introduction of antifungal
therapy caused clinical remission in all positive cases.
Conclusions: (1) Fungal colonization is one of the factors inducing exacer-
bation of UC and CD. (2) C. albicans was the most important species isolated
from patients with IBD. (3) Longer duration of IBD, more than 5 years is a risk
factor of signiﬁcant fungal colonization of the colon. (4) Introduction of
antifungal treatment induced clinical remission of IBD in all positive cases.
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P817 Trichosporon asahii causing fetal septic shock in
a patient without neutropenia
A. D. Celik, A. Murtezaoglu, T. Bese, T. Utku, A. Mert, Y. Dikmen,
R. Ozturk
Istanbul, TR
Objective: Trichosporon asahii has been reported as a cause of fungemia,
especially in patients who have neutropenia and hematologic malignancy.
We describe a patient without hematologic malignancy and neutropenia
representing septicemia resulting from Trichosporon fungemia.
Case report: A 57-year-old woman was performed subtotal hysterectomy,
right oopherectomy and omental biopsy. Pathologic examination revealed
ovarian serous papillary cystadenocarcinoma. She was then initiated a che-
motherapy regimen (carboplatin and paclitaxel) in postoperative period.
During and after chemotherapy period, no neutropenia was devoleped. After
chemotherapy she was re-operated for left oopherctomy and bilateral pelvic
adenectomy. On the second day of this operation she was admitted to
intensive care unit (ICU) due to the development of acute respiratory distress
syndrome. On ICU day 2, her respiratory failure was progressed and she was
intubated and re-operated due to the intra-abdominal hemorrhage and
increased intra-abdominal pressure (abdominal compartment syndrome).
On day 8, her fever was 38.28C, culture of blood and endotracheal aspirate
samples revealed methicillin-resistant Staphylococcus aureus and a chest X-ray
revealed bilateral pulmonary inﬁltration. Teicoplanin was initiated. On day
15, her fever was 39.38C and she developed septic shock and imipenem was
added to the antibiotherapy after blood samples were withdrawn for culture.
These samples cultured T. asahii within 48 h, imipenem was discontinued and
amphotericin B started. Cultures obtained from vascular and abdominal
drainage catheters were negative for T. asahii. Throughout the patient’s
hospital stay and during cancer chemotherapy she had never neutropenia.
On the 3rd day of antifungal treatment, the patient died. The blood isolate was
identiﬁed as T. asahii morphologically and by the means of Vitek API 20 C
biochemical (BioMerieux, France) testing system.
Conclusion: Fungemia due to Trichosporon species has been an emerging state
in patients with hematologic malignancies and neutropenia. We demonstrate
here with this case presentation that Tasahii may also cause life threatening
sepsis in patients who do not have neutropenia.
P818 Disseminated cryptococcosis in an HIV-negative
patient: case report
N. Ozgunes, S. Yazici, D. Mistanoglu, F. Sargin, G. Bekler, H. Aydin,
O. S. Aydin
Istanbul, TR
A 45-year-old male patient was presented with altered consciousness, som-
nolence, headache, dizziness, vertigo, nausea, vomiting, obtundation, clumsi-
ness, weight loss. Physical ﬁndings; axiller temperature 378C, pulse rate: 100/
minute, blood pressure: 180/100mmHg. Nuchal rigidity was detected.
Laboratory studies: leukocytes13000/mL, hemoglobin 16 g/dL, hematocrit
46%, thrombocyte 146000/mL, sedimentation 10mm/h, CRP 0.6mg/dL,
HBsAg, anti-HCV, anti-HIV were all negative. Blood chemistry, chest
roentgenogram, cranial CT were normal. The cerebrospinal ﬂuid (CSF)
was clear, colorless, increased opening pressure, Pandy reaction was positive,
leukocytes 128/mL (95% lymphocyte), protein 87mg/dL, glucose 30mg/dL,
concomitant blood glucose 160mg/dL Gram and Giemsa stains of CSF
showed cells with large, white capsules. India ink preparation and culture of
CSF revealed cryptococci. Blood and urine cultures were also positive. Latex
particle agglutination antigen titers for Cryptococcus neoformans; 1 : 8000 in
CSF, 1 : 4000 in blood. Cranial MRI showed nonspeciﬁc vasculitic and
ischemic lesions without contrast enhancement. Antifungal sensitivity test
revealed ﬂuconazole and ﬂucytosin resistance and amphotericin B sensitivity.
Non-lipid amphotericin B (amp B) was started. The patient developed left
facial paralysis, chemosis in both eyes, papilledema was detected. Two weeks
later; plasma urea and creatinine levels elevated by more than 50% (127 and
2.4mg/dL, respectively). Non-lipid amp B was discontinued and liposomal
amp B treatment was planned for 8 weeks. During the fourth week of
liposomal amp B, ﬂuconazole (800mg, i.v.) was added because of slow
response and development of incomplete lost in left eye, complete visual
loss in right eye. After 8 weeks, oral ﬂuconazole maintenance therapy was
started. Further investigation; T-cells subgroups, immunoglobulin levels, C3-
C4 levels were normal. RF were negative. Ppd: 10mm. Thorax CT was
normal. Abdominal CT showed a 4.5 2.5 cm hypodens adrenal mass.
Adrenal MRI T1-T2 images conﬁrmed an iso-hypointens mass. I˙ V Gd
DTPA showed homogen contrast enhancement. Blood levels of adrenal
hormones were normal (incidental adrenal adenoma). Four months later;
while parenchymal cryptococcomas seen on ﬁrst MRI enlarged. Neurologic
ﬁndings improved completely except visual loss. Latex particle agglutination
antigen titers of CSF 1:2000, blood 1:1600. No recurrence was observed
during controls.
P819 Recurrence of cryptococcal meningoencephalitis
in a patient with idiopathic CD4þ T lymphocytopenia
D. Kofteridis, Z. Saridaki, I. Kazakou, I. Mixaki, A. Gikas
Heraklion–Crete, GR
Objectives:To report a case of relapsed cryptococcal meningoencephalitis in a
patient with idiopathic CD4þ T lymphocytopenia. A 75-year-old hetero-
sexual white male was admitted to the hospital because of severe headache,
fever, nausea, fatigue and weight loss for 4 months. There was a history of skin
and central nervous system cryptococcal infection 6 years ago, then treated
with excision of the lesion and 5-ﬂucytosine for a period of 6 weeks. A lumbar
puncture was performed and the cerebrospinal ﬂuid (CSF) revealed an
opening pressure of 12 cm H2O, a cell count of 52/mm
3 (NE 18, LY 26,
non-recognizable 8), a total protein value of 198mg/dL and a glucose level of
11mg/dL. The CSF India ink stain for fungus were negative, but the serum
and CSF cryptococcal antigen titers were positive forCryptococcus sp. at 1/128
and 1/512, respectively. In addition, Cryptococcus neoformans was isolated from
CSF cultures. The total number of patient’s WBC was within the normal
range, but a persistent lymphopenia (a systemic lymphocyte count of
approximately 500/mL) was detected in every examination. In order to
complete the investigation of the patient’s lymphopenia the immunopheno-
type of peripheral blood and bone marrow were performed. A persistent low
CD4 þ cell count of approximately 17/mm3 was present in the peripheral
blood of the patient, combined with normal CD8. The patient had no risk
factors for HIV infection and he has been repeatedly tested negative for HIV-1
and HIV-2, as well as by Quantiplex HIV RNA 3 (bDNA) technique. The
ANA, ANCA, C3, C4 and ACE tests were also negative. No pathologic
ﬁndings were detected at the CT scans of the upper and lower abdomen, as
well as at the CT and HRCT scans of the thorax. The gastroscopy and
colonoscopy examinations were also normal. The bone marrow biopsy
revealed a nonspeciﬁc slightly hypoplastic bone marrow tissue. The cytology
examination of the CSF was negative for the existence of neoplastic cells. The
therapeutic regimen followed was intravenous amphotericin B (0.5mg/kg/
day) in combination with ﬂucytosine (150mg/kg/day divided into 4 dosages)
for 2 weeks, followed by per os ﬂuconazole in a dosage of 800mg/day for 5
days and then 400mg/day until today.
Conclusions: Cryptococcal meningitis is a life threatening opportunistic
infection in patients with idiopathic CD4 lymphocytopenia. The occurrence
of relapses suggests that a chronic suppressive therapy is needed.
P820 Severe imported maduromycosis poorly
responsive to multiple antifungal treatments: a rare case
report treated with liposomal amphotericin B and
voriconazole, and literature review
R. Manfredi
Bologna, I
Introduction:Maduromycosis (M) is a chronic disease usually involving lower
limbs. An aspeciﬁc onset (papular-nodular lesions, subcutaneous abscess), has a
slowly progressive evolution borne by local edema, avascular necrosis, and
tendency to ﬁstulization and discharge of typical brown-black granules.
Coming from tropical regions, M is rarely observed in nonendemic areas,
mostly as an imported disease, so that only anecdotal reports are described. Its
correct management relies ﬁrst on the distinction between a bacterial origin
(Nocardia and Actinomyces spp.),and a fungal one (with >20 different species
involved). A 45-year-old male immigrated from Kenya 13 years before,
suffered from a severe M involving the left lower limb, already detected in
1987. Multiple complications interested bone, joints, muscle, ligaments,
tendons, and soft tissues, leading to foot deformity associated with severe
functional deﬁcits, in absence of systemic disease, despite frequent episodes of
bacterial superinfection, which contributed to worsen local ﬁbrosis, ischemia,
and ulceration. Istopathologic studies showed a granulomatous process con-
taining macrophages and giant multinuclear cells, and conﬁrmed the fungal
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etiology (PAS-positive spheric chlamydosporae, arthrosporae, and true
hyphae typical of Madurella mycetomatis). Notwithstanding multiple courses
of amphotericin B, ketoconazole, ﬂuconazole, and itraconazole (often asso-
ciated with therapy for bacterial complications), a chronic-relapsing evolution
continued, and the severe bone-joint damage (documented by X-ray and CT
scan studies), required a surgical debridement of necrotic and ﬁbrotic areas, in
association with the administration of liposomal amphotericin B, followed by
voriconazole.
Conclusion: The emerging of M as an imported disease with a disabling
course should focus attention on both diagnostic and especially treatment
features. Clinicians and microbiologists should be aware of M, when history
and epidemiologic clues may suggest it, althoughM remains a very infrequent
disease at our latitude. Differential diagnosis between bacterial and fungal
etiology is the ﬁrst key step, since its recognition may be delayed by the
cumbersome identiﬁcation of Actinomyces and Nocardia spp., and the fungal
organisms. Medical therapy of M of fungal origin remains an unresolved
problem, due to the unpredictable efﬁcacy of antimycotic therapy. Among
newer agents, voriconazole deserves attention for its potential activity against
most of fungi causing M.
P821 Colonization and infection with Candida species
in adult hematology wards
H. El-mugamar, M. F. Hanson
Edinburgh, UK
Objective: Most data on the epidemiology of Candida species are from the
United States, mainly studying the epidemiology of candidemia. European
studies have focused on speciﬁc groups of patients such as neonates, patients
with malignancies or HIV infections. Data on the epidemiology of Candida
species in adult hematology unites are scarce. The epidemiology of Candida
species in our hematology unit has not previously been studied. The aims of
the project were to describe trends in the incidence of colonization and
infection with candida species in our hematology unit during the study
period, to describe the molecular epidemiology of the isolates and to make
recommendations on surveillance and prevention of nosocomial candidal
infections.
Methods:The study was conducted for 3 months period (fromMarch toMay
2002). Isolates from routine surveillance samples, taken from patients on
admission, and weekly thereafter during their stay, were included, in addition
to any isolates from clinical samples taken at the time of suspected infection.
Samples from staff hands and environmental samples from areas of high patient
and staff hand contact were taken using transparent adhesive tapes. Identiﬁca-
tion and antifungal susceptibilities of strains were carried out using standard
laboratory methods. A randomly ampliﬁed polymorphic DNA method
(RAPD) was used for ﬁngerprinting of isolates.
Results: A total of 725 samples were taken from patients during the study
period and 112 (15.44%) were positive for Candida species. Of the 167
Candida species isolates recovered from patients during the study period 116
(70%) C. albicans, 39 (23%) C. glabrata, 8 (5%) C. tropicalis, 2 (1%) C. krusei 2
(1%) C. parapsilosis. Twelve (10%) and 9 (8%) C. albicans isolates were resistant
to ﬂuconazole and ﬂucytosine, respectively. Eight of the nine C. tropicalis
isolates had similar phenotypic and PCR ﬁngerprinting (isolates were from
two patient and the environment). In our study isolation of Candida species
from environmental and the healthcare workers samples were rare.
Conclusion:The ﬁnding of this prospective study suggests that the nosocomial
acquisition of Candida species as we found with C. tropicalis is not uncommon
and may be due to the exogenous acquisition. Further prospective studies are
needed to deﬁne more clearly the reservoirs of infection, the mode of
transmission and the optimal measures for preventing spread of Candida
species.
P822 Changing pattern of Candida spp. isolated from
neutropenic patients in a single institution
O. Guzel, E. Senol, R. Karakus, M. A. Saracli, A. Gonlum, L. Doganci,
A. Kalkanci
Ankara, TR
Background: Changing patterns of Candida species causing fungal infections
in neutropenic patients along with decreased azole susceptibility is now
reported with increasing frequency. We undertook this study to examine
the distribution of clinical isolates of Candida species from infections of
neutropenic patients.
Methods:The study was carried out in the periods of 1999–2001 and 2002–
2003 Candida isolates from all samples of febrile neutropenic patients were
identiﬁed by conventional methods, germ tube testing being the ﬁrst step
followed by morphology on cornmeal Tween 80 agar and carbohydrates
assimilation and fermentation results by using ID32C (BioMerieux, France).
Results: A total 174 of Candida spp. were isolated from 115 patients. 127 of
them recovered in the 1999–2001 period and 47 of them recovered in the
2002–2003 period. The distrubution ofCandida species fotr the ﬁrst study and
second period was as following;C. albicans for 68.8 and 48.9%,C. glabrata 14.3
and 4.2%, C. tropicalis 10.4 and 8.5%, C. krusei 3.9 and 2.1%, C. kefyr 3.9 and
27.6%.
Conclusions: Increase in the prevalance of nonalbicans Candida spp. was
obseved in the latter study period. Continuous surveys of the distrubution of
Candida spp. in an institution are warranted.
P823 Colonization of intensive care and
hemato-oncologic patients by Candida species: is there a
trend towards more frequent isolation of non-albicans
species?
A. Becker, M. Scha¨fer, D. H. Forster, E. Kniehl
Karlsruhe, D
Objectives:According to published surveillance data, the etiology of Candida
bloodstream infections has shown a signiﬁcant worldwide shift towards
nonalbicans species, at least during the late eighties and early nineties.
However, most studies were not able to detect a further increase during
the late nineties. The aim of the present study was to monitor the relative
prevalence of differentCandida species not recovered from blood cultures, but
from surveillance cultures of intensive care patients and hemato-oncologic
patients during a 5-year period (1997–2001) in a tertiary-care hospital in
South-West Germany (1500 beds).
Methods: Clinical and surveillance specimens (upper respiratory tract swabs,
lower respiratory tract specimens, gastric juice, anal swabs, urinary tract
samples and genitourinary tract swabs, etc.) were cultured on Candida-II-
agar (heipha, Heidelberg, Germany). Isolates were typed by Chromagar
Candida (Mast Diagnostica, Reinfeld, Germany) and/or ATB ID 32 C
(BioMe´rieux, Marcy-L’Etoile, France).
Results: From 1997 to 2001, after elimination of multicopy strains, a total of
8000 Candida isolates were obtained. The following signiﬁcant trends
(P< 0.01) were observed: C. glabrata increased from 14.9% of all urinary
tract isolates (1997) to 46.8% (2001). C. tropicalis increased from 3.0% of all
upper respiratory tract isolates (1997) to 7.3% (2001). There were no
differences between intensive care patients and hemato-oncologic patients.
In 2001, relative prevalences of the most prevalent species (C. albicans,
C. glabrata, C. tropicalis, C. krusei) were: upper respiratory tract 74.5, 13.9,
7.3, and 2.2%; lower respiratory tract 59.5, 32.0, 4.7, and 2.0%; gastro-
intestinal specimens 63.2, 29.1, 3.2, and 3.2%; urinary specimens 45.2, 46.8,
4.0, and 1.6%.
Conclusion: During the study period, the following signiﬁcant trends were
noted: For urinary tract specimens, a major shift to C. glabrata was detected,
now being the most prevalent species in these specimens. For upper respira-
tory tract specimens, a minor increase in the relative prevalence of C. tropicalis
was noted.
P824 Candida albicans versus Candida nonalbicans
candidemia among the critically ill patients in a tertiary
hospital, Greece
G. Dimopoulos, E. Faviou, A. Velegraki, S. Dimopoulou, P. Plantza, M.
Kompoti, S. Kanavaki, A. Rassidakis
Athens, GR
Objectives: This observentional prospective study was designed to compare
the frequencies ofCandida albicans andCandida nonalbicans candidemia cases in
Intensive Care Unit (ICU) non-immunocompromised patients, depict the
associated risk factors and appraise respective mortality rates.
Methods:Observations on 327 patients in the ICU (January 2001–December
2002), comprised data on age, sex, length of ICU stay (LOS), duration of
Mechanical Ventilation (MV), Acute Physiology and Chronic Health Evalua-
tion Score(APACHE II), on admission. Predisposing factors for candidemia,
such as diabetes, duration of antibacterial chemotherapy regimens, candiduria,
steroid treatment, total parenteral nutrition (TPN), presence of central venous
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catheter (CVC), duration of MV(>7 days), prior major surgery and admin-
istration of antifungal prophylaxis were also recorded. Candidemia was
deﬁned by at least two positive blood cultures. The point in time of
candidemia, Candida septic shock and outcome were also assessed. Statistical
analysis encompassed t-test for quantitative parameters and chi-square test
for categorical data. Probability (P )< 0.05 was considered statistical signiﬁ-
cant.
Results: Candidemia was diagnosed in 55/327 patients (16.8%). C. albicans
was responsible for 35 (63.6%) cases (Group A) whileC. nonalbicans species for
20 (36.4%) cases (Group B). In both groups no differences were detected on
age, sex, LOS, duration of MVand APACHE II score(P> 0.05). Candidemia
due to C. nonalbicans species was signiﬁcantly more frequent, in patients with
positive CVC cultures (P< 0.003), in those with candiduria episodes
(P< 0.0001)and in patients undergoing steroid therapy (P< 0.014). In these
three groups of patients the commonest bloodstream isolates were C. glabrata
8 (40%), C. parapsilosis 5 (25%) followed by C. tropicalis 4 (20%, C. krusei 2
(10%) and C. guillermondii 1 (5%). Crude mortality was higher in Group B
(P< 0.009). No difference was detected in the mortality attributed to
candidemia (Group A 10.4% vs. Group B 10%, P> 0.5).
Conclusions: CVC, candiduria and steroid treatment were the commonest
predisposing factors for C. nonalbicans candidemia. Though the crude mor-
tality was higher among patients with C. nonalbicans candidemia, the overall
candidemia mortality was not signiﬁcantly different between the two groups
of patients.
P825 Frequency, risk factors and outcome of
candidemia in critically ill patients
D. Peres-Bota, H. Rodriguez-Villalobos, G. Dimopoulos, C. Me´lot,
J. L. Vincent
Brussels, B
Objectives: Candida spp. are the most common cause of fungal infections in
critically ill patients. We conducted a prospective study to compare the
morbidity and mortality of patients infected with Candida spp. with patients
infected by other pathogens.
Methods: The study included 949 patients who stayed more than 24 h in a
mixed 31 bed Intensive Care Department (ICU) of a tertiary care hospital; 31
patients with diagnosed candidemia were compared with 249 patients with
bacterial infections. The analyzed variables included previous hospital stay,
length of ICU stay (LOS), need and duration of mechanical ventilation (MV)
and hemodialysis or hemoﬁltration, APACHE (Acute Physiologic and
Chronic Health Evaluation) II score, SOFA (Sequential Organ Failure
Assessment) score at admission, SOFA maximum score during patients
ICU stay, SOFA score on the day of infection diagnosis, antibiotic use, type
of nutritional support, association with another infection, immune response,
C-reactive protein, procalcitonin levels, number of medical devices, and
mortality.
Results: Of 280 infected patients, 31(11%) were infected with Candida spp.,
including 18 (58%) Candida albicans, and 13 (42%) Candida nonalbicans spp.
(C. glabrata in 5 cases, C. parapsilosis in 3 cases, C. krusei, C. tropicalis, C. guil-
liermondii, C. lusitaniae in 1 case, respectively). Candidemia was always asso-
ciated with other bacterial strains and among these with methicillin-resistant
Staphylococcus aureus (MRSA) in 11 (35%) patients. Both the degree of
morbidity assessed by APACHE II and SOFA scores and mortality were
higher in patients with candidemia than in other infected patients. Univariate
logistic regression revealed the degree of morbidity, LOS, antibiotic use,
duration of MV, and the number of medical devices as independent factors
associated with Candida infections (P< 0.05). Multivariate logistic regression
revealed only the LOS as independent predictor for Candida infection
(P¼ 0.03). There was a trend toward a higher mortality rate in patients with
candidemia (48% vs. 37% in bacterial infections), but it was not statistically
signiﬁcant (P¼ 0.09). Infection with Candida per se was not an independent
factor to predict mortality.
Conclusions: Bloodstream infections with Candida spp. are common in
ICU patients, they are associated with other bacterial infections and show
high mortality rates. A longer ICU stay is the best predictive factor for
candidemia.
P826 The outbreak of nosocomial fungemia caused by
Candida pelliculosa
A. N. Koc¸, T. Gu¨nes
Kayseri, TR
Objective:Candida pelliculosa is a rare cause of fungemia. Between April 1999
and December 2001, 167 cases of C. pelliculosa fungemia occurred in the
Newborn Unit. We investigated the antifungal susceptibility for these species,
and using orally nystatin for prophylaxis.
Methods:Between April 1999 andDecember 2001, BACTEC 9240 detected
184 bloods, three cerebrospinal ﬂuids, and one peritoneal ﬂuid culture
obtained from the Newborn Unit as positive. Twenty-one of 188 cultures
were isolated same patients. A Gram-strained smear of the positive bottles
revealed yeasts, which were subsequently identiﬁed as C. pelliculosa. Anti-
fungal susceptibility to amphotericin B, ﬂuconazole, ketoconazole, itraco-
nazole, and nystatin was determinate by using National Committee for
Clinical Laboratory Standards microdilution reference methods.
Results: Results of environmental cultures study including hands of person-
nel, and all areas of the Newborn Unit to which patients had potentially been
exposed were negative. After July 2000, orally nystatin was started each infant
for prophylaxis in the Newborn Unit. During follow-up ( July 2000) only six
candidemia occurred that were caused byC. pelliculosa. After December 2001,
this species was not isolated in this Unit. The minimum inhibitory concen-
trations (MICs) forC. pelliculosa species were found in 0.06–0.125mg/mL for
amphotericin B; 1–4mg/mL for ﬂuconazole; 0.03–0.25mg/mL for keto-
conazole; 0.03–0.25 for itraconazole; 0.5–2 for nystatin. Of the 167 cases, 51
were retrospective analyzed according to antifungal treatment. Systemic
antifungal agents had been used after the occurrence of candidemia in 42
cases: amphotericin B, ﬂuconazole (22), and amphotericin B subsequently
ﬂuconazole (nine). Only nine patients not received antifungal treatment.
Patients who received treatment had higher improved than did not treated
patients (62% vs. 33%). The overall crude mortality rate was 43%.
Conclusion: We conclude that C. pelliculosa should be considered in the
differential diagnosis of blood cultures and used orally nystatin for prophylaxis
in the Newborn Unit.
P827 Laboratory investigation of fungal peritonitis in
patients on continuous ambulatory peritoneal dialysis
C. P. K. Subudhi, C. B. Moore, S. J. Howard, M. Keaney,
P. R. Chadwick
Salford, UK
Objective: Fungal peritonitis is a relatively uncommon complication in
patients on continuous ambulatory peritoneal dialysis (CAPD), but accounts
for signiﬁcant morbidity and mortality. We reviewed the etiology and
antifungal susceptibility of the fungi isolated from peritoneal dialysis efﬂuent
of patients on CAPD at our hospital in the last 11 years (1992–2002).
Methods: Fungal isolates were identiﬁed using standard mycologic laboratory
methods and tested prospectively for susceptibility to ﬂuconazole (FCZ),
ﬂucytosine (5FC) and amphotericin B (AMB). MIC tests have evolved over
the 11 years reﬂecting best practice at the time of use.
Results:There were 43 episodes of fungal peritonitis in 41 patients during this
period. The fungi isolated wereCandida albicans (18),Candida parapsilosis (17),
Candida tropicalis (2), Candida guilliermondii (2), Candida kefyr (1), Candida
glabrata (1), Candida pelliculosa (1) and Saccharomyces cerevisiae (1).
Conclusions: C. albicans and C. parapsilosis were the predominant fungi iso-
lated constituting 81.4% of fungal peritonitis in our hospital. In general, both
species were susceptible to FCZ, 5FC and AMB. There was a high degree of
FCZ resistance (62.5%) among the other fungi. Current guidelines (Year
2000) from the International Society for Peritoneal Dialysis recommend
initial imidazole/triazole and ﬂucytosine without catheter removal when
fungi are identiﬁed by Gram stain or culture and use fungal sensitivities to
guide treatment for 4–6weeks. In the absence of clinical improvement,
catheter removal is warranted after 4–7 days of therapy. Therefore, identiﬁca-
tion and antifungal susceptibility testing of fungi isolated from peritoneal
efﬂuent is essential for optimal management of fungal peritonitis in patients on
CAPD.
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Bacterial infections in children
P828 Chlamydophila pneumoniae infections in infants
E. Podsiadly, B. Fracka, S. Tylewska-Wierzbanowska
Warsaw, PL
Objectives: The aim of the study was to investigate the prevalence of
Chlamydophila pneumoniae infections in infants hospitalized due to respiratory
tract diseases.
Methods: Serum samples from 158 hospitalized infants from 1 to 36 months
old-were examinated. Eighty-three children presented with clinical symp-
toms of various respiratory tract infections, 75 suffered from other diseases.
Levels of speciﬁc Chlamydophila pneumoniae serum IgM, IgG and IgA anti-
bodies were determinedwith ELISAmethod (EleganceChlamydia pneumoniae
IgG/IgA ELISA, Bioclone, Australia; Chlamydia pneumoniae IgM ELISA
Vircell, Spain). Antibodies to Mycoplasma pneumoniae were measured using
ELISA test (MRL Diagnostic, USA).
Results: Among 83 infants with respiratory tract infections, C. pneumoniae
speciﬁc IgM antibodies were detected in 12 (14.5%)(in 9 infants with
bronchitis and in 3 ones with upper airways infection). Speciﬁc IgG antibodies
were found in 2 infants (9 and 12months old) as well as in 6 ones under age of
6 months. No speciﬁc IgA antibodies were detected. Among 75 children with
other diseases, 6 (8.0%) had C. pneumoniae speciﬁc IgM antibodies and 1
(19months old) had C. pneumoniae speciﬁc IgG antibodies. Mixed C.
pneumoniae and M. pneumoniae infections were found in 8 (9.6%) of children.
Six of them suffered from bronchitis. Infants were infected withC. pneumoniae
most often in October, November and December.
Conclusions:
1. C. pneumoniae infections are seen in infants younger then three years.
2. C. pneumoniae infections are seasonal, mostly occur in autumn.
3. MixedC. pneumoniae andM. pneumoniae infections are present especially in
infants with bronchitis
P829 Urinary tract infection in boys under the age of 5
W. Amhis and M. Naim
Algiers, DZ
Objective: To determine the frequency of the urinary tract infection(UTI)
and its etiology.
Methods: 79 boys under the age of 5 years with a suspected urinary tract
infection were addressed by the pediatrists to our laboratory, during our study
period of one year (May 1997–May 1998).The strains isolated were identiﬁed
with API 20E gallery for the Gram-negative bacilli and the classical gallery for
the Gram-positive cocci. The antibiotic susceptibility was determined by the
agar diffusion method according to NCCLS. The antibiotics effective on
Gram-negative bacilli tested were: Ampicillin, Amoxicillin/clavulanic acid,
Ticarcillin, cefalotin, Cefoxitin, Cefotaxim, Gentamycin, Amikacin, Nali-
dixic acid and sulfamethoxazol.
Results:Ten boys out of 79 (12.62%) presented a bacteriuriawith pyuria and 9
boys out of 79 (11.39%) a bacteriuria without a pyuria.100 urine samples from
the 79 boys were tested of which 49 had< 1000 UFC/mL, 22 had> 100 000
UFC/mL and 29 had 1000–10000 UFC/mL(contaminated). 40% of the boys
who presented a UTI were under the age of a year. Three boys out of 4
presenting a malformative urinary tract were infected by the bacteria Proteus
mirabilis. P. mirabilis was the most frequent agent isolated in the bacteriuria
with pyuria (50%) and without pyuria (58.33%).The strains of P. mirabilis
usually susceptible were highly resistant 100% to Ampicillin, 90% to Ticar-
cillin 81.8% to pipercillin and 54.5% to cotrimoxazol.
Conclusion:The urinary tract infection is frequent in boys (24%) in our study
(19/79) and is often associated to a malformative urinary tract (4/10). P.
mirabilis is the main agent isolated and its resistance to betalactams and
cotrimoxazol increased more and more, so these antibiotic could not be
anymore the initial antibiotic therapy. The susceptibility test is needed to treat
correctly this serious infection.
P830 E. coli causing urinary tract infection in Greek
children. Resistance to antibiotics and virulence factors
T. Panagea, A. Makri, A. Lakumenta, H. Papavasileiou
Athens, GR
Background:Urinary tract infections (UTI) affect a large number of theworld
population. Uropathogenic E. coli (UPEC) is the cause of most of these
infections. Virulence factors associated with UPEC include several toxins
(hemolysin, cytotoxin necrotizing factor), capsule, a number of adhesive
organelles, etc.
Objectives:To determine the antibiotic resistance of E. coli producing UTI in
children, as well as to detect and determine the frequency of virulence factors
produced by this microorganism.
Methods: One hundred ﬁfty two E. coli isolates from urine cultures of
children with UTI, aged between 0 and 14 years, were studied in our labora-
tory, during one year’s period (1/4/2001–31/3/2002). Resistance to antibio-
tics was examined according to NCCLS instructions. All strains were further
examined for the production of hemolysin, K1 antigen (Directigen, Beckton
–Dickinson) andexpressionof pili by agglutination of humanOredblood cells.
Results:Resistance to antibiotics was as follows: ampicillin 50%, cephalothin
32.2% amoxycillin þ clavulanic acid 5.3%, cefoxitin 1.3%, cefuroxime 7.9%,
cefotaxime 5.3%, gentamicin 7.9%, netilmicin 4.6%, trimethoprim-sulfa-
methoxazole 27%, nitrofurantoin 0.6%, ciproﬂoxacin 1.3%, norﬂoxacin 1.3%.
There were no strains resistant to imipenem. Conserning virulence factors,
28.2% of strains produced hemolysin, only 16.1% carried K1 antigen and
53.2% produced HRBC agglutinating pili. In all cases, agglutination was
mannose-resistant, indicating the presence of P or Dr pili.
Conclusion: E. coli causing UTIs in children from Greece is often resistant to
ampicillin, cephalothin and trimethoprim-sulfamethoxazole. Resistance to
second and third generation cephalosporins, aminoglycosides and quinolones
remains relatively low. Careful use of antibiotics is needed to avoid further
increase of resistance. Pili is the most frequent virulence factor detected.
Detection of virulence factor genes in these strains by molecular techniques is
considered necessary. The above is being performed and will be announced at
a later date.
P831 Paediatric infective endocarditis: a review of
22 cases
M. Alam, G. Tariq, R. Munir, Jr., N. Smego, A. Akhtar
Karachi, Multan, PAK
Objectives: To evaluate the epidemiology, risk factors, clinical features,
echocardiographic and laboratory characteristics of infective endocarditis
in pediatrics age group.
Methods: A total of 22 pediatric patients diagnosed with infective endocar-
ditis between January 1996 and November 2001 at The Aga Khan University,
Karachi, Pakistan were included in this review.
Results: Of the 22 patients with infective endocarditis, male to female ratio
was 1 : 1 (Male 45.5%, Female 54.5%).
Patients: Age ranged from 1 month to 14 years with a mean age of 5.8
4.8 years. Twenty patients (91%) presented with fever and an equal number
had heart murmurs at the time of evaluation. Splenomegaly was found in only
4 patients (18%). A distant focus of infection was present in 5 (23%) patients
and pneumonia was diagnosed in two of them (9%). Underlying congenital
heart disease was present in 19 (86%) patients while only one had rheumatic
heart disease. Ten patients (45.5%) had native valve endocarditis while a VSD
was involved in 5 (23%) patients. A history of cardiac surgery was present in
3(14%). On echocardiography, vegetations were seen in 12 patients (55%).
The commonest sites involved were mitral valve (23%) and aortic valve (14%).
Ten (45.5%) patients did not show any evidence of vegetations on echocar-
diography. Blood cultures were positive in 11 (50%) patients with Strepto-
cocci (27%) and Staphylococci (9%) being the commonest organisms isolated.
Viridans group streptococci were found to be the commonest species (18%)
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responsible for infective endocarditis. Eleven (50%) patients did not grow any
organism on their blood cultures. Neurological complications were present in
6 (27%) patients and the commonest of them were cerebral embolism (9%)
and seizures (9%). Other complications included hemolysis (13%), hematuria
(9%), and renal failure (9%). Surgical interventions were required in 2 (9%)
patients. Inpatients mortality was 27.3%. Thirteen (59%) patients were alive
without the disease (mean follow-up of 53 48weeks). Lost to follow up rate
was found to be 4.5%.
Conclusions: This study demonstrates that fever and a heart murmur are
common presenting features of infective endocarditis in pediatric population.
Almost all of the patients with infective endocarditis have congenital heart
disease (VSD being the commonest). Neurological complications may be the
presenting feature of infective endocarditis in as many as one-fourth of the
cases.
P832 Relationship between Lewis antigen and other
virulence factors in pediatric Helicobacter pylori isolates
J. A. Garcı´a-Campos, T. Alarco´n, A. P. Moran, D. Domingo, J. Dı´az-
Regan˜o´n, M. J. Martinez, M. Lo´pez-Brea
Madrid, E; Galway, IRL
Aim: The aim of this study was to determine the occurrence and relationship
between the presence of Lewis antigen and other virulence factors (cagA and
vacA) in H. pylori strains obtained from pediatric patients.
Introduction:The inﬂammatory response is a primary host defence mechan-
ism against an invading pathogen. It is known that CagA þVacA þ strains of
Helicobacter pylori (Hp) are associated with enhanced inﬂammatory responses
andmucosal damage. In the other hand, Hp lipopolysaccharides (LPS), theO-
speciﬁc chain, mimics Lewis blood group antigens in structure (present in the
gastric mucosa). So the expression of Lewis antigens on the bacterial surface
may camouﬂage the bacterium and aid survival of Hp.
Methods: Fifty H. pylori strains were obtained from pediatric patients attend-
ing to the Gastroenterology Unit due to different symptomatology. Upper
endoscopy was performed and biopsy cultured following standard methodol-
ogy. Strains were conserved at 708C until used. Lipopolysaccharide (LPS)
was extracted from a 48-h culture by mini-phenol water. Detection of Lewis
antigen was determined by a standard serodot method using monoclonal anti-
LewisX, -LewisY and peroxidase-labelled secondary antibodies. DNA was
extracted from a 48-h culture and PCR performed to detect cagA gene, and
vacA s1- and s2-alleles.
Results: The frequency of H. pylori strains expressing LewisX was 34.7% and
LewisY was 55%. Of the strains tested, 28.6% expressed LewisX and LewisY
simultaneously and 38.8% no Lewis antigen. In 32.6% of strains, the expected
cagA fragment was ampliﬁed by PCR; 34.8% carried the s1-allele and 65.2%
the s2-allele. A correlation was observed between cagA positivity and the
vacA s1-allele (P< 0.01), and between the presence of LewisX and LewisY
(P< 0.01). Also, the presence of the cagA gene was associated with the
presence of LewisX (P< 0.01) and LewisY (P< 0.001).
Conclusions: Of the pediatric-originating strains tested, a lower percentage
expressed both LewisX and LewisY than previously reported in isolates from
adults. Also, a low prevalence of cagA gene and vacA s1-allele was observed in
strains from pediatric patients. Furthermore, occurrence of cagA was asso-
ciated with vacA s1-allele and to LewisX and LewisY in this population.
P833 Prevalence and resistance of bacterial
enteropathogens in children in Crete
S. Maraki, M. Bitsori, E. Galanakis, A. Georgiladakis, Y. Tselentis
Heraklion, GR
Objectives: To investigate the epidemiology and resistance rates to antibac-
terial agents of the enteropathogens responsible for bacterial gastroenteritis in
children in Crete, Greece. Population-Methods: All positive stool cultures
from hospitalized and outpatient children during the period January 1993 to
December 2001 were included.
Results: One or more pathogens were identiﬁed in 1059 stool specimens.
Salmonellae spp. were the most commonly isolated (36.6%), followed by
Campylobacter spp. (32%), enteropathogenic E. coli (EPEC) (23.7%), Yersiniae
spp. (5.3%), Shigellae spp. (1.9%) and Aeromonas spp. (0.7%). The overall
resistance rates to antibacterial agents are presented in Table 1. The resistance
rates of the pathogens to the antibiotics of choice were in general high. A
signiﬁcant drop of resistant strains of Salmonellae spp. to ampicillin was noted
from the ﬁrst to the third 3-year period of the study (40.2% vs. 15.7%;
P< 0.0001; relative risk 2.56). A similar resistance decline was noted for
Campylobacter spp. to erythromycin, although not at a signiﬁcant level (21.7%
vs. 12.9%; P¼ 0.1054; relative risk¼ 1.67).
Conclusions: In the area of the study, Salmonella spp. andCampylobacter spp. are
the leading causes of bacterial gastroenteritis in childhood. The drop of
resistance rates of Salmonella spp. and, to a lesser degree, of Campylobacter spp.
to the antibiotics of ﬁrst choice might be attributed to the more rational use of
these antibiotics through the study period, however, the overall resistance of
the enteropathogens remains high.
P834 First occurrence of sorbitol-fermenting Shiga
toxin-producing E. coli O157 in Austria
F. Allerberger, W. Radauer, A. Rettenbacher, A. W. Friedrich, H. Karch,
H. Tschaepe
Innsbruck, Salzburg, A; Munster, Wernigerode, D
Objectives: Shiga toxin-producingE. coli (STEC) have emerged worldwide as
a cause of severe human diseases such as bloody diarrhea and the hemolytic
uremic syndrome (HUS). First recognized in Germany in 1988, SF STEC
O157:H- has been isolated from patients with diarrhea or HUS in the Czech
Republic, Hungary, Finland and recently in Australia and Scotland.We report
the ﬁrst isolation of an SF STEC O157:H- in Austria.
Methods and results: A 34-month-old girl was admitted with HUS to a
hospital in Salzburg on November 2, four days after onset of bloody diarrhea.
On admission, laboratory investigation indicated anuric renal failure (plasma
creatinine 7.5mg/dL; normal range for this age 0.3–0.6mg/dL) and hemo-
lytic anemia (hemoglobin 10.9 g/dL; normal range for this age 11.5–14.0mg/
dL) with 5% fragmentocytes. The platelet count was normal (196,000/mm3;
normal range for this age 140,000–440,000/mm3). Lactic dehydrogenase was
highly elevated (1900U/L; normal range 120–340U/L). The child remained
anuric despite furosemide therapy and veno-venous hemodiaﬁltration was
initiated. A diagnostic kidney biopsy was performed on day 7 of hospitaliza-
tion just before receiving positive culture results from the national reference
laboratory. It is questionable whether diagnostic kidney biopsy should have
been performed under these circumstances. After initiation of anesthesia, just
before puncture an epileptic attack occurred, after biopsy uncontrollable
bleeding necessitated unilateral nephrectomy on day 9. Pancreatic insufﬁ-
ciency with insulin dependent diabetes mellitus and indication for hemoﬁl-
tration were still present on day 27, when the patient, who is presently on a
waiting list for kidney-transplantation, was transferred to a specialized clinic
abroad. Stool specimens gained on days 3 and 4 were tested at the local
microbiology laboratory using SMAC plates and reported as ‘no STEC
found’, but yielded tellurite sensitive and beta-glucuronidase positive SF
STEC O157:H-, indistinguishable from the so-called Bavarian outbreak
clone by PFGE and ribotyping, when tested at the national reference
laboratory using toxin ELISA and PCR based screening for stx genes.
Conclusions: Laboratories should be cautious of overly relying on visual
identiﬁcation of E. coliO157 on both sorbitol MacConkey agar (SMAC) and
ceﬁxime-tellurite (CT)-SMAC plates in patients presenting with clinical
symptoms suggestive of an STEC infection.
P835 Secondary lactase deﬁciency in Japanease infants
due to respiratory infections
H. Miyata, Y. Iwasa, K. Murakami, H. Kuwasima
Sakai, JP
The adult of Japanese can not secrete lactase, which is the primary lactase
deﬁciency, while, the infant of Japanese can secrete lactase into the intestine.
Table 1 Resistance rates of enteropathogens to usual antibacterial agents (%)
Salmonellae Campylobacter Yersiniae EPEC Shigellae Aeromonas
Ampicillin 31.1 ND 100 29 60 100
Cefotaxime 0 ND 0 0.4 0 0
Gentamicin 1.5 2.3 0 2.4 0 0
Chloramphenicol 6.2 7.9 3.5 13 45 0
Ciprofloxacin 0 42.5 0 1.6 0 0
Cotrimoxazole 3.3 69.5 1.7 17 60 40
Erythromycin ND 19.3 ND ND ND ND
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Diarrhea, however, is often observed even in infant who is suffered from
infection except for digestive tract. Secondary lactase deﬁciency is considered
as this disease state. In this study, the frequency of secondary lactase deﬁciency
was examined as a cause of the diarrhea with respiratory infection in infancy.
Materials and methods: The 82 patients, who were suffered from the
respiratory infections complicated with watery diarrhea, were included in
this study. All patients were necessary to hospitalize for the intravenous ﬂuid
therapy. All feces were examined the reducing sugar, enteropathogenic
bacteriae and antigens of Rota virus and Adeno virus.
Results and conclusions: The reducing sugar was detected in feces from 43
out of 82 patients, that is, these patients were secondary lactase deﬁciency. No
feces showed positive reaction of enteropathogenic bacteriae or of antigens of
Rota virus or Adeno virus. There was no relationship between the positive
rate of the reducing sugar in feces and the degree or the type of respiratory
infections. The reducing sugar in feces was more frequently detected in the
patients belonged in younger age group. It may be concluded that there is an
individual difference on capacity of lactase secretion even in the infant of
Japanese.
P836 Asessment of Cefepime monotherapy vs.
combined therapy with Ceftriaxone and Aminoglicosyde in
oncologic children and adolescents with febrile neutropenia
E. N. Berezin, F. J. Almeida, A. G. Santos, M. Arnoni, M. Safadi,
F. Peixoto, L. Mimica, M. Martino
Sao Paulo, BR
Objective:Assessment of cefepime monotherapy’s efﬁcacy in the treatment of
febrile neutropenia in children and adolescents, comparing with combined
therapy with ceftriaxone and aminoglicosyde (amikacin or gentamicin).
Methods: Retropective assessment of oncologic patients admitted with
neutropenia (granulocytes <500) and fever (axillar temperature higuer than
38.58C).We deﬁned as therapeutic success patients that become without fever
after 5 days. Therapeutic failure was deﬁned as clinical deterioration or grown
of resistant bacteria during treatment.
Results:We have analyzed 51 patients who were admitted for 67 episodes of
neutropenia and fever. Thirty-seven episodes (50%) had negative urine and
blood culture and 37 (50%) had a positive urine and/or blood culture, with a
total of 49 positive cultures. The most frequent isolates from blood cultures
wereKlebsiella pneumoniae (29.4%),Acinetobacter sp. (17.6%) andEnterobacter sp.
(11.7%); and from urine cultures were Pseudomonas aeruginosa (30%) and
Proteus sp. (16.6%). We analyzed the antibiotic use in 67 episodes of febrile
neutropenia. Ceftriaxone and aminoglicoside were used in 29 episodes
(43.2%) and cefepime was used in the remaining 38 episodes (56.7%). The
groups were comparable in relation to age, duration of fever and neutrophil
count. In the combined therapy group there were 18 therapeutic failures
(62%) and in the monotherapy group, 12 failures (31.5%) (P¼ 0,01).
Conclusion: In our series, cefepime monotherapy was superior to the
combination therapy with ceftriaxone and aminoglicoside in the treatment
of febrile neutropenia. Most of our isolates were Gram-negative agents
(77.5%). We observed a low rate of isolation of Gram-positive agents
(12.2%) and fungi (10.2%), even though febrile neutropenia is a important
risk factor for infections with these agents.
P837 Eosinophilic cationic protein in serum of children
with acute respiratory diseases
K. Themeli-Digalaki, E. Orcopoulou, S. Velmachou,
M. Ziva-Petropoulou, S. Papadakou-Lagoyianni, C. Koutsia-Carouzou
Athens, GR
Objective: to deﬁne the correlation between serum Eosinophilic cationic
protein (ECP) levels and the inﬂammatory procress of the respiratory tract
during infections or asthmatic reactions.
Methods: We studied 56 children (24 girls and 32 boys), aged 3 months–
13 years, with respiratory tract infections diagnosed by radiography and 15
with asthmatic reactions. Serum ECP levels were mesured at acute phase of
disease by using FEIA method. IgM or fourfold IgG antibodies titers against
respiratory viruses or Mycoplasma pneumoniae and antigen detection by using
EIA and ELFA.
Results: 24 children (42.8%) presented concetrations of ECP> 15 g/mL and
32 (57.1%) ECP< 15 g/mL. Of the children with high levels, 37.5% had
respiratory tract infection with asthmatic reaction, 29.15% asthma attack,
12.5% respiratory tract infection, 8.3% laryngitis and 12.5% broncholitis with
RSV(antigen positive). Of the children with ECP low levels 31.25% had
respiratory tract infection, 28.12% infection with asthmatic reaction, 28.12%
asthma attack, 6.25% laryngitis and 6.25% broncholitis (Antigen RSV
negative).
Conclusions: (1) High serum ECP concetrations are found in a greater
percentage of children with asthmatic reaction with or without infection
compated to chidren with respiratory tract infection (P¼ 0001). (2) The
results suggest that the inﬂammation in RSV bronchiolitis differs from that
induced by other viruses or Mycoplasma pneumoniae.
P838 Chronic mediastinitis in children after cardiac
surgery: a complication observed in developing
countries?
S. Malekzadeh Milani, K. Khaldi, H. Demanet, C. Fonteyne, H. Dessy,
A. Vergison
Brussels, B
Our hospital has a cardio-surgical activity of 300 children operated on a year,
60% of which are Algerian.We report two cases of chronic mediastinitis com-
plicating cardiac surgery in Algerian patients. The ﬁrst case is a 9-year-old girl
admitted for the cure of a retrosternal ﬁstula that had persisted during ﬁve
years after cardiac surgery performed in her country. On admission, Staphy-
lococcus aureus was grown from the ﬁstula. The child underwent several
debridements and surgical drainage of the mediastinum. She presented a
mediastinal super infection with Pseudomonas aeruginosa at the time of an
epidemic in the intensive care unit. Additionally to the surgical treatment, she
received a prolonged course of antibiotics. The second case is a girl who
underwent a former cardiac surgery at the age of two, complicated by a
sternitis that lasted for two years. At the age of seven, she was admitted for the
last stage of her cardiac correction. On the third postoperative day, she
developed sepsis and P. aeruginosa was grown from the sternal wound and
blood cultures. She was treated by surgical debridement and drainage and
antimicrobial intravenous therapy. Ten days later fever increased again and a
chest CT showed a retrosternal collection. She had a new surgery that
evidenced an aortic pseudoaneurysm. The ascending aorta was partially
replaced by a homograft aortic root. Cultures from the aorta remained
negative. She was treated with a 3-month intravenous antimicrobial
regimen followed by a prolonged oral ciproﬂoxacin treatment. These two
patients had a favourable outcome after aggressive surgical treatment com-
bined with prolonged antimicrobial therapy. Mediastinitis following cardiac
surgery are uncommon in children operated on in developed countries.
Optimal antimicrobial regimen and duration of treatment are not well
established.
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Therapeutic issues in HIV infection
P839 Modiﬁcations induced by antiretroviral therapy
on cytokine phenotype 1 and 2 during HIV infection
J. Vecchiet, M. Dalessandro, D. Racciatti, F. Travasi, K. Falasca,
A. Di Iorio, P. Zingariello, E. Di Ilio, E. Pizzigallo, R. Paganelli
Chieti Scalo, I
Objectives:Our aim was to verify possible alterations in vitro secretion of IFN-
gamma and IL-4 by mononuclear cells in the peripheral blood (PBMCs) of
HIV patients in different stage of the disease, both naive and undergoing
highly active antiretroviral therapy (HAART) to compare the results obtained
in two groups and in 12 patients after one year of antiretroviral therapy.
Methods: Fifty two HIV-positive patients (39 males and 13 females with a
mean age of 40.5 1.4 years) were enrolled in this study. All patients were
classiﬁed on the basis of treatment (therapy vs. no therapy), on the basis of the
clinical stage (A, B or C) as deﬁned by the Center for Disease Control (CDC),
and on the basis of the viro-immunological condition (lymphocyte CD4
counts and blood HIV-RNA). Brieﬂy, Th1 and Th2 cytokines (IFN-gamma
and IL-4, respectively) were detected in surnatant samples by ELISA kit
(R&DSystems,Minneapolis,MN) derivated by cell cultures incubated for 48 h
and samples were stimulated by anti-CD3, Phytohemoagglutin-P (PHA),
E. coli B04/035 Lipopolysaccharide (LPS) in all selected subjects. In 12
patients a second analysis was performed after 12months.
Results:A progressive decrease in the baseline production of IFN-gammawas
observed from patients with CD4> 500 to patients with CD4< 200. In
contrast, the IL-4 production was increased in the PHA-stimulated cultures
both in clinical and immunological progression. IL-4 secretion was lower in
the treated subjects compared with the naive ones in PHA-stimulated
cultures. Treatment caused an increase of the IFN-gamma/IL-4 ratio and
a 12-months’ follow-up study in 12 patients showed a signiﬁcant decrease of
IL-4 and an increase of IFN-gamma.
Conclusion:Our data conﬁrm the alteration of Th1/Th2 balance reported by
many authors and support the hypothesis of a cytokine switch in the
progression of HIV-1 disease and the important role of the antiretroviral
therapy in the restoring of the balance of type 1 and 2 patterns.
P840 Indinavir vs. Indinavir-boosted by Ritonavir plus
2 new NRTIs in rescue of dual NRTI regimen virological
failures
B. Santos, C. Rosenthal, R. Dietze, D. Lewi, M. Schechter, K. Patel,
M. Shivaprakash, M. Stek Jr
Porte Alegre, Sao Paulo, Vitoria, Rio de Janeiro, BR; Whitehouse Station,
USA
Background: Broad use of dual NRTI therapy has resulted in increasing
numbers of patients failing this single antiretroviral class approach. Protease
inhibitor (PI) boosted regimens, including PI-combinations such as IDV/
RTV, offer rescue options for these patients.
Methods: This prospective, open-label, 24week. study conducted in Brazil
randomized 78 patients having failed a dual NRTI regimen to group A: IDV
800mg tid (n¼ 38) or group B: IDV 800mg/RTV 100mg bid (n¼ 40). Both
previous NRTIs were replaced. Local brands of NRTIs were used as switch
agents due to reimbursement requirements. Efﬁcacy was determined by viral
load (VL) reduction and CD4 increase. Safety, tolerability, and compliance
were also assessed.
Results: The most frequent NRTI prior to switch was ZDV (A¼ 95%; B ¼
80%) followed by DDI (A¼ 61%; B¼ 48%). The most frequent replacement
was another thymidine analogue, D4T (A¼ 100%); B¼ 94%) and the second
most frequent was 3TC (A¼ 87%; B ¼ 77%). Baseline median VLs (cps/mL)
were: A¼ 18K; B ¼ 15K and median CD4 (cells/mm3) were: A ¼ 374; B ¼
411. Observed data at week 24, 42.4% of both A and B achieved VLs< 400,
median log decreases of A¼0.71 and B¼1.13 were recorded, and CD4
increases of A ¼ þ69 and B ¼ þ61. Using the criteria of VL< 400 or> 1.5
log decrease, 60.5% of A and 52.5% of B could be classiﬁed as responders. Of
those with baseline VL> 50K, 8% of A and 23% of B achieved VL< 400.
Discontinuations were slightly higher in B (18%) compared with A (11%) as
were discontinuations due to AEs in B (15%) vs. A (3%). The incidence of
nephrolithiasis was the same in both arms (11/100 pt./year.). Mean PI drug
compliance percentages were A-IDV¼ 95.9 6.0; B-IDV¼ 94.1 15.0 and
RTV¼ 91.0 20.0 at week 12 and A-IDV¼ 96.0 6.2; B-IDV¼ 95.4
12.5 and RTV¼ 92.7 17.1 at week 24.
Conclusions: Similar overall rescue results were achieved with IDV tid and
IDV/RTV bidþ 2 new NRTIs for patients having virologically failed dual
NRTI regimens. Rescuewas lower for patients with higher VLs at baseline. In
these cases, the boosted IDV regimen tended to afford greater success. Two
possible confounding issues regarding the IDV/RTV regimens were lower
RTV compliance and higher discontinuations due to AEs. Further assessments
are in progress to determine whether the PI may have been the major
contributor to regimen potency andNRTI-resistancemay have compromised
rescue.
P841 Characterization of viro-immunological
responses in a closely followed cohort of heavily pretreated
patients: evidence from the GenPheRex Study (MaSTeR
Cohort)
C. Torti, E. Quiros-Roldan, L. Scudeller, S. Lo Caputo, P. Pierotti,
F. Mazzotta, F. Castelli, G. Carosi
Brescia, I
Background:Factors associated to viro-immunological discordant trends have
been poorly investigated in cohorts of heavily pretreated patients (pts), mostly
using categorical heterogeneous viro-immunological end-points.
Methods:One hundred ﬁfty nine patients in a prospective study of real- vs.
virtual-phenotype who experienced 2 years antiretroviral therapy with 6
drugs have been studied. First, univariate and multivariate logistic regression
was used to assess risk factors for categorical discordant responses ceasing
follow-up at week 32 since more pts were on the original drug combination
after reasonable time to evaluate immune response. Second, complementary
linear regression analysis was performed over the entire 48weeks follow-up
considering CD4þ and viral load (pVL) as continuous measures. ITT-LOCF
was the primary analysis; OT analysis provided conﬁrmation.
Results: Among 101 virological non responders (<1 Log10 c/mL pVL
decrease), immunological discordance (100CD4 þ increase/mm3) was
observed in 63.5% of pts. In this group, baseline CD4þ> 200/mm3 (OR
4.71, 95%CI 1.86–11.93; P: 0.001) and> 2 drug classes in the salvage therapy
(OR 6.25, 95%CI 1.04–37.36; P: 0.045) were independently associated to the
probability of discordant responses at logistic regression analysis. Among 58
virological responders, immunological discordances (< 100CD4 þ increase/
mm3) were observed in 58.6%. In this group, the following covariates were
independently associated to discordant responses: baseline CD4þ> 200/
mm3 (OR 0.09, 95%CI 0.02–0.45; P: 0.003), randomization in the real-
phenotype arm (OR 10.09, 95%CI 2.28–44.72; P: 0.002), and 3 experi-
enced protease inhibitors (PIs) (OR 0.16, 95%CI 0.03–0.8; P: 0.026).
Multivariable linear regression over the entire 48week follow-up demon-
strated signiﬁcant correlation between absolute decrease in pVL and increase
in CD4 þ count (HR 28.06, 95%CI 35.32–20.79; P <0.001), but also PIs
in the salvage regimen (HR 36.57, 95%CI 15.45–57.68; P: 0.001),>
8months on treatment (HR 41.64, 95%CI 19.27–64.01; P <0.001) and
randomization into the virtual-phenotype arm (HR 23.70, 95%CI 43.12–
4.28; P: 0.017) correlated with better immune recovery.
Conclusions: In conclusion, these data suggest that therapy should be
continued in heavily pretreated pts possibly including PIs. Hard-to-reach
undetectability of the pVL is not essential to obtain immune recovery
however, this is strongly favoured by the degree of pVL reduction that should
be achieved.
P842 Extensive HIV-1 genotypic resistance pattern and
evolution analyzes in patients failing to
Nelﬁnavir-containing regimens
C. Torti, F. Moretti, E. Quiros-Roldan, V. Tirelli, G. Paraninfo,
L. Tomasoni, A. Beltrame, P. Nasta, G. Carosi
Brescia, I
Background: It has been suggested that nelﬁnavir (NFV) may not preclude
efﬁcacy of other PIs in the treatment sequencing however, this was mainly
based on the sole consideration of signature mutations (D30N and L90M) in
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the HIV protease gene.Moreover, it has been suggested that L90M andD30N
are mutually exclusive on NFV containing regimens.
Methods: Extensive analysis of primary and secondary mutations or poly-
morphic substitutions in the HIV protease gene has been performed in
patients (pts) who had ﬁrst resistance testing while on NFV.
Results: Among 41 pts, 18 (43.9%) were PI naı¨ve; D30N was detected from
10/41 (24.4%), L90M from 8/41 (19.5%), and D30Nþ L90M from one
(2.4%); in 22/41 (53.7%) pts neither D30N nor L90M (D30N-/L90M-) were
detected. D30N was found at higher frequency in PI naı¨ve pts (70%), in
contrast to L90M (12.5%). The unique patient with D30Nþ L90M had
previous long-term experience with failing PIs (NFV, indinavir, saquinavir).
The most frequent substitutions associated to D30N were S37N (70%), L63P
(60%), E35D (50%), M36I (50%), I13V (40%), N88D (40%), N37D (30%),
I62V (30%) and I93L (30%). All pts whose HIV carried D30N had 1
mutation common with other PIs (2/10 primary) among those listed in the
last IAS algorithm, as well as pts with D30N-/L90M- resistance pattern (2/22
primary). Among pts whose HIV did not carry any primary mutations, mean
number of secondary mutations was 1.6 (range 1–3) for pts with D30N and
1.8 (range 1–3) for pts with D30N-/L90M- pattern. In six patients who stayed
on NFV despite virological failure, sequential resistance tests showed minimal
variations in secondary mutations or polimorphisms up to 16months, except
from one patient with initial D30N-/L90M- pattern in whom L90M
eventually emerged. Pts without L90M had complete initial virological
response to alternative regimens including PIs.
Conclusions: Complete class cross-resistance through L90M in pts failing
NFV was found at 1 : 6 ratio, mainly in those who had experience for other
PIs however, secondary cross-resistant mutations were invariably present. The
association between L90M and D30N was exceptionally found in one patient
with experience for multiple PIs. Clinical cross-resistance to PIs in patients
with D30N resistance pattern whowere switched on to alternative PIs was not
demonstrated. More studies are necessary to assess the clinical impact of
secondary mutations on PI sequencing.
P843 Cessation of antiretroviral therapy in patients
who started with previous guidelines: 48weeks of
follow-up
F. Allegrini, C. Cancellieri, A. Mastroianni
Forli, I
Objectives: IAS-USAUpdatedRecommendations on Antiretroviral Therapy
(Tarv), published July 2002, write that ‘For persons who have already initiated
therapy at higher CD4 cell count thresholds (e.g. 400, 450, or 500 cells/mL)
and have had durable HIV RNA suppression and no adverse effects over
periods of months to year, it is not clear whether it is safe to discontinue
therapy.’ (JAMA. 2002; 288 : 222–235). Our objective is to evaluate clinical,
immunologic and virological course after cessation of Tarv in Patients (Ps)
who started according to previous Guidelines at earlier stage of infection.
Methods: Perspective observational cohort study. 20 Ps (around 20% of all Ps
on Tarv in our Unit) stopped Tarv; they were examined every 2 months and
should restart Tarv if recommended by actual Guidelines.
Results: We examine 16 Ps (10 men, 6 woman) after at least 48weeks of
cessation. Ps, at moment of cessation, were between stage A1 and B2 (CDC
93); 10 Ps were on Tarv with 2 NRTIs; 3 Ps with 2 NRTIsþ 1 NNRTI and 3
Ps with 2 NRTIs þ 1 IP; 9/16 Ps had HIV-RNA< 200 c/mL. No oppor-
tunistic infections or malignancies occurred during follow up, there were 3
cases of Thrush and 1 case of Thrush þ Oral hairy leukoplakia. No Ps
restarted therapy according current DHSS Guidelines. In Table 1 we show
immunologic and virological data (Table 1).
Conclusions:Our results suggest that in Ps who started therapy according to
previous Guidelines (marginal indication to therapy) is possible to stop Tarv
without relevant clinical, immunologic and virological risk; with improve of
the quality of live in our Ps; elimination of toxic effects of drugs; elimination
about risk of drug resistance (especially in Ps with sub optimal therapy and
with incomplete viral suppression); decrease of cost.
Caution: Our study was performed in a little cohort and for relatively short
follow up. We need a larger perspective trial.
P844 Effect of recombinant human growth hormone
(r-hGH) on the activity of antiretroviral agents against
wild-type and resistant human immunodeﬁciency
virus-1 (HIV-1)
M. A. Wainberg, B. G. Brenner, J. M. Gertner, S. Kenley, C. Olivier
Montreal, CAN; Rockland, USA; Geneva, CH
Objective:The objective of our study was to assess the effect of r-hGH on the
ability of approved nucleoside, nucleotide, non-nucleoside reverse transcrip-
tase inhibitors and protease inhibitors to inhibit HIV-1 wild-type and resistant
viruses in vitro.
Methods: These studies were performed by growing either wild-type or
drug-resistant, mutated variants of HIV-1 in peripheral blood mononuclear
cells (PBMC) in various concentrations of the nucleoside analogue reverse
transcriptase (RT) inhibitor (NRTI) Abacavir, the nucleotide RT inhibitor
Tenofovir, the non-nucleoside RT inhibitors (NNRTIs) Efavirenz, Delavir-
dine and Nevirapine, and the protease inhibitors (PIs) Nelﬁnavir, Amprenavir
and Lopinavir in order to determine drug concentrations that inhibit viral
replication by 50% (IC 50 values) for each compound. As a means of
evaluating the potential effect of r-hGH (Serostim) on viral replication, this
product was included in the tissue medium culture at concentrations of either
10 or 50 ng/mL.
Results: We have shown that r-hGH, at either 10 or 50 ng/mL over 48 h,
exerted insigniﬁcant effects on viral replication levels (p24 antigen) after 7 days
in regard to each one of the drug-resistant viruses that were studied.
Furthermore, the responsiveness of wild-type variants against each of the
antiviral drugs was not affected by the addition of r-hGH at either of the two
tested concentrations (10 or 50 ng/mL). Also, the presence of r-hGH did not
signiﬁcantly alter the IC 50 values of the eight compounds that were studied
using viral isolates that displayed resistance against any of NRTIs, NNRTIs,
and/or PIs. This included viruses that were multiply drug resistant (MDR).
Conclusion: The anti-HIV effects of commonly used antiretroviral drugs in
PMBC were not altered or inhibited by r-hGH. These tissue culture data
provide no evidence that the use of r-hGH in HIV-infected people who are
undergoing active antiretroviral therapy carry a risk of promoting viral
replication.
P845 High-dose chemotherapy and autologous
peripheral blood stem cell transplantation as salvage
treatment for HIV-associated lymphoma
F. Moretti, S. Casari, C. Torti, A. Re, G. Rossi, E. Quiros-Roldan,
U. Tirelli, G. Paraninfo, G. Cadeo, G. Carosi
Brescia, I
Background: Availability of effective HAART has allowed for aggressive
therapeutic approaches to be postulated for relapsing or not responder HIV-
Ly however, no data currently exist on related clinical outcome.
Methods: Patients (pts) with relapsing or refractory (< 50% debulking after 1
month of standard chemotherapy) HIV-Ly were considered for inclusion in
this salvage program consisting of ablative chemotherapy (MINE combina-
tion and/or high dose cyclophosphamide) followed by CD34þ stem cell
apheresis after G-CSF stimulation, HDCT and subsequent CD34þ trans-
plant. Patients with active mayor opportunistic infections or CSN lymphoma
were excluded from this program.
Results: Up to September 2002, 10 pts entered the program; 7 Hodgkin
Disease (HD, 3 at 1st relapse, 2 at 2nd relapse, and 2 refractory) and 3NHD (all
at 1st relapse). Median age was 40 years (range 31–56), median CD4þ count
196/cmm (101–451); disease stage as byW-F was II (n: 1), III (n: 3) and IV (n:
6); bone marrow involvement was found in 4 pts. After a median of 3 (2–3)
apheresis, a median of 5.9 (4.1–8.3) 106/kg CD34 þ cells were collected;
only 2 pts failed to mobilize enough CD34þ cells for transplant. Two pts with
advanced HD died before transplant due to disease progression. After
apheresis, the six remaining pts underwent HDCT with BEAM (BCNU
300mg/sm, melphalan 140mg/sm, vepesid 200mg/sm and ARA-C
200mg/sm) followed by CD34þ reinfusion. Prompt hematological recovery
was observed in all pts (PMN> 500/cmm after 8–10 days, PLT> 20.000/
Table 1
Ps n¼ 16 START Tarv STOP Tarv 24weeks 48weeks
CD4/mL mean
(range)
508
(351–1.207)
664
(352–1.111)
568
(363–877)
523
(350–977)
HIV-RNA
c/mL mean
(range)
31.188
(<200–208.541)
1.039
(<200–14.800)
18.951
(450–49.000)
28.707
(684–51.500)
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cmm after 11–18 days). Adverse events during HDCT included oral mucositis
(two WHO grade 1, one grade 2), one reaction to cryoprotectant DMSO;
one grade 3 cellulitis, one S. epidermidis sepsis, and one colitis due toC. difﬁcile.
HIV plasma viral load remained undetectable in 3 of 4 pts on HAART.
Opportunistic infections were diagnosed during follow-up in 3 pts after at
least 5 months from HDCT. Five pts obtained complete response after 1
month. Among these pts, 2 had relapse at month 5 and 12, respectively, while
three of them are disease free at month 5, 11, and 18.
Conclusions:These ﬁrst observations suggest that HDCT can be both feasible
and successful in selected pts with refractory or relapsing HIV-Ly. Such
intervention was believed unfeasible in the pre-HAART era.
P846 Pravastatin and Fluvastatin as pharmacological
treatment for hyperlipidaemia in HIV-infected patients
receiving HAART
R. Manfredi, L. Calza, F. Chiodo
Bologna, I
Objectives:Awide spectrum of lipid metabolism abnormalities have recently
been described in HIV-infected patients receiving a protease inhibitor-based
highly active antiretroviral therapy. Aim of our work is to evaluate the role of
pravastatin and ﬂuvastatin in the management of HIV-associated hypertrigly-
ceridaemia and hypercholesterolaemia. An open-label, randomized, prospec-
tive study about the efﬁcacy and the safety of pravastatin and ﬂuvastatin as
pharmacologic treatment for protease inhibitor-related hyperlipidemia was
performed.
Methods: Plasma lipid levels of 662 HIV-infected patients referred to our
tertiary care centre and on protease inhibitor-based antiretroviral therapy
since at least 12months have been evaluated. All patients established with HIV
viral load <50 copies/mL and presenting hypertriglyceridemia, with or
without hypercholesterolemia and lipodystrophy, of at least 6-month duration
and unresponsive to a hypolipidaemic diet and physical exercise, have been
treated with ﬁbrates or statins for 12months.
Results: One hundred and twenty of the 662 observed patients (18.1%)
received pharmacological therapy, while eight patients were excluded from
evaluation due to early drop out. With regard to the 112 evaluable subjects,
pravastatin was employed in 21 subjects and ﬂuvastatin in 19. At the close of 1-
year follow-up, pravastatin led to a reduction of 32.8% and 39.5% vs. baseline
triglyceride and total cholesterol levels, respectively (P< 0.001). At the same
time, ﬂuvastatin obtained a reduction of 30.2% and 36.6% vs. baseline
triglyceride and total cholesterol levels, respectively (P< 0.001). During
these 12months, the statins showed a favourable tolerability proﬁle (with
slight gastrointestinal symptoms reported in ﬁve patients only), plasma HIV
viral load did not present any variation, and the mean CD4þ lymphocyte
count increased as expected.
Conclusions: Pravastatin and ﬂuvastatin revealed in our study a similar
and statistically signiﬁcant efﬁcacy in the treatment of diet-resistant
hyperlipidemia, with a more favourable effect on the hypercholesterolemia.
However, further, enlarged studies seem necessary in order to establish the
most appropriate guidelines for the management of dyslipidemia associated
with highly active antiretroviral therapy.
P847 The management of accidental injuries with
retrovirus infected instruments
F. Robicsek, A. Fokin, T. Masters, J. Cook, M. Reames
Charlotte, USA
Background: About 1 million needlestick injuries are reported yearly in the
USA in health care and research environments, with an estimated daily rate of
2400 and most often involve nurses and physicians. These incidents are
observed in about 15% of surgical procedures. Accidental injuries usually
occur at the depth of the subcutaneous layer, thus the lymphatic pathway is
mainly involved. The seroconversion rate from percutaneous exposure to
HIV is about 0.3%.
Objective:To investigate the possibility of preventing seroconversion by local
intervention after simulated retrovirus inoculation thus enhancing the effec-
tiveness of systemic treatment.
Methods: In the feline model, treatment of feline leukemia (an experimental
model for HIV) after subcutaneous injury was studied. In the canine model
subcutaneous (SQ), intralymphatic and intravenous injections of 200 nm
radioactive particles equal in size to retroviral bodies were performed at
the distal part of hind limb. Blood and lymph samples were collected at the
groin and both pathways were compared using parameters such as ﬂow rates,
particle arrival time, concentration, and accumulation. Local measures such as
tourniquet application and antiviral agent injection at the site of injury were
used to prevent dissemination.
Results: After SQ introduction, 90% of the inoculum remains locally for a
prolonged time, with gradual release into the circulation, thus justifying local
treatment. Inﬁltration of the injury site with 0.2% povidone iodine prevented
viremia after needlestick if applied immediately. After SQ injection, lymph
carried 1000 times more particles than blood, but with much less speed.
Application of a tourniquet above the site of injury reduced the spread of
inoculum, especially by the lymph pathway while massage enhanced dis-
semination. Fast arrival of the particles in the blood after intralymphatic
injection conﬁrmed existence of functional lymphaticovenous communica-
tions at the peripheral level. Based on these ﬁndings operating room guide-
lines were established to prevent infection during suspected HIV cases.
Conclusions:There is a physiological basis for immediate local treatment after
accidental injuries with retrovirus contaminated instruments. Massage or
movement of the affected limb should be avoided. Tourniquet application
and inﬁltration of the injury site with an antiviral agent slows dissemination,
decreases the amount of spreading virus and makes systemic treatment more
efﬁcient.
Nosocomial bacteremia
P848 Nosocomial bacteremia among pediatric patients
in Kosova
L. Raka, G. Mulliqi-Osmani, I. Dedushaj, D. Pittet, R. Binishi,
S. Ahmeti
Pristina, YU; Geneva, CH
Objective: To describe the epidemiology of nosocomial bacteremia among
pediatric patients in Kosovo.
Design:Retrospective observational–descriptive study of bacteremia based on
positive blood cultures. Standard deﬁnitions proposed by the Centers for
Disease Control and Prevention for bacteremia were used. Blood samples
were processed in the Department of Microbiology Institute of Public Health
of Kosova, between June 1, 2000 and May 31, 2001.
Setting: Tertiary Health Care University Hospital with 2400 beds.
Participants: All newborns in Obstetrical Clinic (N¼ 13469) and all
hospitalized children in Pediatric Clinic (N¼ 4510) were included in study.
Results: A total of 714 blood cultures were processed during study period.
Totally, 34.7% of all blood extractions had signiﬁcant growth. Gram-negative
rods represented 91.7% of all isolates, whereas Gram-positive bacteria were
8.3%. Most commonly isolated microorganisms were: Klebsiella pneumoniae
with 63.3%; Citrobacter, 11.1%; and Streptococcus aureus, 7.6%. Hospitaly
acquired were 77% of registered bloodstream infections. Resistant strains
of Klebsiella species to cephalosporins were above 90%, except ceftriaxone
37.3%. The most common prescribed antibiotic was ceftriaxone received by
206 patients (52.4%). The median length of hospital stay from admission to
infection was 15 days. Nosocomial bacteremia was the most frequent (38.4%)
on children who stayedmore than 20 days in the hospital. The crudemortality
was 31.8%. First 5 days of staying were associated with highest mortality –
87.8% (36/41). 45.3% of patients with nosocomial bacteremia had respiratory
tract diseases in admission in hospital.Klebsiella species were alsomost frequent
microorganisms identiﬁed from death cases. 27.2% of patients did not receive
adequate treatment.
Conclusions: Nosocomial bacteremia among most vulnerable popu-
lation represents one of the main priorities of health care system in Kosova.
Detailed investigation should be conducted for surveillance of main noso-
comial infections and strategic projects of prevention of nosocomial infections
and antibiotic policies should be implemented in the near future.
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P849 Stenotrophomonas maltophilia pseudobacteremia
in the accident and emergency department
M. M. Doyle, M. Kelleher, B. O’Connell
Dublin, IRL
Objectives: Stenotrophomonas maltophilia was the sixth most common cause of
bacteremia in our hospital in 2001. In 2000/1999 it ranked seventeenth as a
cause of bacteremia. On examination of the patients’ records, we found that in
2001/2002, 57% of these blood cultures (BC) were taken in the emergency
department, compared with 29% in 2000/1999. The aim of this study was to
investigate the apparent increase between the two time periods, and inves-
tigate why the apparent increase took place largely in our emergency
department (AþE).
Methods: Isolates of Stenotrophomonas maltophilia from the emergency depart-
ment were sent to the PHLS in Collindale, London for typing by Pulsed Field
Gel Electrophoresis. Patients records were examined looking for any common
factors among the patients and attending medical staff. Environmental screen-
ing was carried out. We investigated the blood culture technique in 27Aþ E
staff and compared this to the technique used by 27ward staff.We cultured the
contents of blood bottles used for ESR, U þE, Coag, serum, blood culture
and blood group.
Results: All of the isolates typed by PFGE were the same, supporting our
suspicion of pseudobacteremia. There were no common factors among the
patients. Extensive environmental screening in AþE failed to show con-
tamination with Stenotrophomonas maltophilia. Examination of blood culture
technique in 27Aþ E staff, showed that 25 staff members took the BC
through an intravenous cannula along with a number of other bloods (FBC,
UþE, glucose, ESR, Coag, etc.). 41% took the blood culture ﬁrst or used a
separate site. Examination of BC technique among 27 ward staff, showed that
all 27 staff took the blood directly from the vein. 59% took blood for culture
only, the remainder, took blood for FBCþ/–UþE, at the same time. On the
wards, blood for glucose, ESR, Coag, etc. was usually taken in the morning by
the phlebotomist. We recovered Stenotrophomonas maltophilia from the culture
of the ESR bottle contents. All other blood bottles were culture negative.
Conclusions: We conclude that this cluster of cases of Stenotrophomonas
maltophilia pseudobacteremia was related to contaminated ESR bottles.
Further discussion with colleagues in the PHLS revealed that Stenotrophomonas
had been isolated from ESR bottles in the UK.
P850 Microorganisms isolated from neonatal
bloodstream infections
J. Komarnicka, A. Samet, J. Szczapa, E. Czarniak, A. Sledzinska
Gdansk, PL
Objective: Analysis of etiological agents of bacteremia in Department of
Neonatology Public Hospital no. 2 in 2002.
Methods:Neonatal Unit has 63 beds (with 8 NICU beds) and admitted 1620
patients in 2002. Blood cultures were incubated in BacT/Alert system (Bio-
Merieux). Identiﬁcation and susceptibility was performed by VITEK system
(Bio-Merieux) and disk diffusion method.
Results: We studied positive blood cultures from neonates with sepsis (6),
congenital infection (6), meningitis (1), preterm birth (9), osteomyelitis (1),
soft tissue infection (1), seizures (1), congenital toxoplasmosis (1) and suspi-
cion of infection (20). Fifty-nine (11.5%) from total 514 blood cultures
obtained from neonates in 2002 were positive (63 isolates). The predominant
pathogen was methicillin resistant Staphylococcus epidermidis (MRSE) – 35
isolates (55%). There were only 6 isolates (10%) of methicillin susceptible
S. epidermidis and one S. aureus MSSA. Enterobacteriaceae were isolated in 7
cultures: six K. pneumoniae (10%) and one mixed culture of K. pneumoniae and
Enterobacter aerogenes – all ESBL positive. From other cultures we isolated:
Enterococcus faecalis – 4, Streptococcus viridans – 2,Candida albicans – 1, Bacillus sp.
– 1, Lactobacillus sp. – 1 and Corynebacterium sp. – 1. We cultured 3 isolates of
the genus Hemophilus: one H. inﬂuenzae and two H. parainﬂuenzae from
patients with congenital infections. After analysis, 16 cultures (13 with
S. epidermidis and 3 with other bacteria: Bacillus sp., Corynebacterium sp. and
Lactobacillus sp.) were considered contamination.
Conclusions: Surprisingly we did not isolated any primary agent of neonatal
infections – Streptococcus agalactiae and Escherichia coli. It could be explained by
early proﬁlaxis with amoxicillin-clavulanic acid. The dominating pathogen
was S. epidermidisMRSE responsible mainly for catheter related infections and
multiresistant K. pneumoniae. We can conclude that in Neonatology Unit
dominated nosocomial bloodstream infections.
P851 First report on nosocomial blood-stream infection
caused by Burkholderia stabilis
F. Otag, G. Erso¨z, M. Salcioglu, C. Bal, I. Schneider, A. Bauernfeind
Mersin, Istanbul, TR; Munich, D
Objective: Analysis of the signiﬁcance of Burkholderia stabilis (B. cepacia
genomovar IV) in nosocomial blood stream infections.
Methods: Blood culture system Bactec 9050 (Becton Dickinson) was used.
Strains were grown on Burkholderia cepacia selective agar and identiﬁed by
PCR with species speciﬁc oligonucleotides using strain suspensions as
template. MICs were determined by agar-dilution technique according to
NCCLS guidelines.
Results: Between July and October 2002 B. stabilis was isolated from hemo-
cultures of seven patients presenting signs and symptoms of septicemia in the
ICU of the Mersin University Hospital, Mersin, Turkey. All patients died.
B. stabiliswas isolated from blood cultures between 1 and 8 days prior to death.
Four patients had one, two patients two and one patient four B. stabilis positive
blood cultures. The strains showed identical pattern of resistance (resistant to
amoxicillin, amoxicillin/clavulanate, cefuroxime, cefoxitin, aztreonam, gen-
tamicin, cotrimoxazole; intermediate to cefotaxime, tobramycin, sensitive to
piperacillin, ceftazidime, meropenem, imipenem, ciproﬂoxacin). B. stabilis
was cultured from washing ﬂuid of bronchoscope, bronchoalveolar lavage
ﬂuid, and water distillator and may have been transferred from there into
patients.
Conclusion: Our data indicate that B. stabilis may cause nosocomial blood
stream infections and should be regarded as an opportunistic pathogen.
P852 Evaluation of blood-stream infections in a tertiary
care hospital in Turkey
A. Erbay, K. Sayilir, A. Colpan, E. Akinci, N. Balaban, H. Bodur
Ankara, TR
Objective: To evaluate the epidemiology and risk factors of bloodstream
infections (BSI), to determine the mortality associated BSIs and identify
independent predictors of mortality.
Methods:All patients with positive blood cultures followed at ANERH from
November 2001 to April 2002 were included to the study and followed up
prospectively.
Results: 308 patients with BSI were enrolled to the study. Mean age was
48.8 21.1 years, and 189 (61.4%) were male. During study period 407
episodes occurred, of which 49.9% were nosocomial bacteremia, 23.8% were
community acquired bacteremia, 22.6% represented contamination and 3.7%
represented transient bacteremia. Gram positive microorganisms were the
most commonly isolated microorganisms (68.1%). Nosocomial BSI occurred
in 129 (42%) patients. Themost common pathogens in nosocomial BSI group
were coagulase negative Staphylococcus (28.3%), S. aureus (24.5%), E. coli
(8.9%), Acinetobacter spp. (8.4%), P. aeruginosa (6.6%) and Enterococcus spp.
(6.1%). Methicillin resistance was detected in 78% of staphylococcus isolates
in nosocomial BSI group. 22.7% of the patients died. Mortality rate associated
with bacteremia obtained as 17.8%. Mortality rate in nosocomial BSI group
obtained as 36.4%. Multivariate analysis revealed age >60 years, nosocomial
acquisition, hospital stay more than 7 days, stay in intensive care unit as factors
associated with mortality rate.
Conclusion: It is possible to eliminate factors inﬂuencing the outcome of
bacteremia especially in nosocomial bacteremia. The prevention of nosoco-
mial infections and appropriate antibiotic treatment can improve the prog-
nosis of patients.
P853 Pseudobacteremia caused by contaminated
erythrocyte sedimentation rate tubes: investigation of an
outbreak
E. P. M. van Elzakker, J. A. Severin, A. Ott, L. de Groot
Delft, Rotterdam, NL
Objectives:Contamination of blood culture bottles may occur at any stage of
inoculation and culturing. Pseudobacteremia can lead to unnecessary use of
antibiotics, a prolonged admission period and wasting of valuable resources.
Finding the source however, can be laborious and expensive. We investigated
a prolonged outbreak of pseudobacteremia with nonfermentative Gram-
negative rods in our hospital in order to ﬁnd and eliminate the source.
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Methods:The study design was case-control. All patients with contaminated
blood cultures during the year 2000 were included. Species identiﬁcation was
performed using API 20NE (BioMerieux) and Phoenix automated micro-
biology system (Becton Dickinson). Controls were randomly selected from a
group of patients with a negative blood culture, matched by date of sampling.
SPSS software was used for analysis. Data related to patients and sampling
technique were recorded. The liquid content of several commercial blood
collection tubes was cultured.
Results: Forty patients and 40 controls were included. Sex and age were
equally distributed. Cases were more likely to be admitted with fever (OR
3.61). Contaminated blood cultures were taken more often at the ER (OR
8.5), by a nurse (OR 8.3) in combination with hematological tests (OR 69.9).
Blood cultures of cases were less likely to be drawn by trained laboratory staff
(OR 0.1). Evaluation of the procedures showed that ER nurses lacked proper
instructions and took blood cultures after ﬁlling the Vacutainer collection
tubes, using the same device. Laboratory technicians used written instructions
and knew the correct order when collecting blood for culture in order to
avoid contamination. From the liquid content of the erythrocyte sedimenta-
tion rate (ESR) tubes and from the blood cultures biochemically identical
strains were identiﬁed.
Conclusion: ESR tubes were the source of an outbreak of pseudobacteremia
in our hospital. Blood cultures were most likely infected by the Vacutainer
system needle after it was contaminated by the non-sterile liquid content of
the ESR tubes. After the implementation of a protocol for drawing blood at
the ER, the problem was reduced considerably.
P854 Nosocomial bacteremia in a community hospital:
a 20-year prospective study
E. Espejo, R. M. Borrallo, E. Anoro, M. A. Morera, M. Simo´, F. Bella
Terrassa, E
Objectives: To evaluate the characteristics and prognostic factors of noso-
comial bacteremia (NB) in adult patients.
Methods: During a 20-year period (1983–2002) all episodes of NB were
studied in a 320-bed community hospital. Clinical and laboratory features of
survivors and nonsurvivors were compared using the SPSS statistical packet.
Results: 8 episodes of NB occurred in 687 patients (57% males, 43% females)
aged 65 18 year. The length of the hospital stay until the NB was
19 16 days. Malignancy (30%), diabetes (24%), chronic renal failure
(13%), and liver cirrhosis (9%) were the main underlying conditions. These
were rapidly or ultimately fatal in 43%. The most frequent sources of NB
were: intravascular catheters (23%), urinary tract (21%), intra-abdominal
(14%), respiratory tract (12%), skin and soft tissues (9%). The most frequent
isolates were: Escherichia coli (165), Streptococcus aureus (110), coagulase-nega-
tive staphylococci (99), Pseudomonas spp. (94), Klebsiella spp. (53), Enterococcus
spp. (49), Bacteroides spp. (47), Proteus spp. (30), and S. pneumoniae (29). Crude
mortality was 30% and mortality related to bacteremia was 20%. In the
multivariate analysis 9 variables were identiﬁed as independently associated
with mortality: septic shock (OR: 4.9; 95% CI: 3.0–8.0), rapidly fatal
underlying disease (OR: 6.4; 95% CI: 2.3–17.4), axillary temperature
<378C (OR: 6.1; 95% CI: 2.1–16.0), liver cirrhosis (OR: 2.8; 95% CI:
1.4–5.3), age >65 years (OR: 2.3; 95% CI: 1.4–3.5), inappropriate antibiotic
therapy (OR: 2.2; 95% CI: 1.3–3.4), previous corticosteroid therapy (OR:
2.2; 95% CI: 1.3–3.5), respiratory, gastrointestinal or unknown origin (OR:
2.2; 95% CI: 1.4–3.2), and infection due to a high risk organism (Bacteroides,
Pseudomonas or S. aureus) (OR: 1.6; 95% CI: 1.1–2.4). While in the ﬁrst
decade of the study the urinary tract was the main source of NB and E. coliwas
the predominant microorganism, in the second decade the intravascular
catheters constituted the main source and coagulase-negative staphylococci
were the predominant microorganisms.
Conclusions:
1. The main sources of NBwere: intravascular catheters, the urinary tract and
intra-abdominal.
2. E. coli, S. aureus, coagulase-negative staphylococci, and Pseudomonas spp.
were the predominant causative organisms.
3. Nine variables were signiﬁcantly related with mortality.
P855 Analysis of clinical features, risk factors and
outcomes of nosocomial bacteremia
A. Cagatay, L. Gulec, N. Ince, H. Berk, S. Kucukoglu, S. Aksoz,
H. O¨zsu¨t, H. Eraksoy, S. Calangu
Istanbul, TR
Objectives:The objective of this study was to determine clinical features, risk
factors and outcomes of nosocomial bacteremia (NB).
Methods: 414 patients with bacteremia were investigated in our hospital.
Patients who met the nosocomial infection deﬁnitions of CDCwere included
in this study. A chi-square test was used to compare categorical variables,
Student-t-test and Mann–Whitney U-test were performed for analyzing
continuous variables. Multivariate analysis was performed with logistic
regression.
Results: 414 patients with 484 bacteremic episodes were included in this
study. 277 (67%) patients survived and 137 patients (33%) died. 176 patients
(42.5%) in intensive care units (ICU) (including emergency and surgery), 238
patients (57.5%) in non-ICU clinics were enrolled. Methicillin-resistant
Staphylococcus aureus (MRSA) (n¼ 105, 21.7%), Escherichia coli (n¼ 65,
13.4%), Pseudomonas aeruginosa (n¼ 60, 12.4%), Klebsiella pneumoniae
(n¼ 59, 12.2%) were the most common causative agents in NB. In univariate
analysis, to be older than 55 years old (w2¼ 15.47, P< 0.001), hospitalization
in ICU (w2¼ 45.02, P< 0.001), increased creatinin level (>1.4mg/dL) (w2:
6.08, P< 0.014), requirement of inotropic drug on admission (w2¼ 49.3,
P< 0.001) (w2¼ 45.02, P< 0.001), bacteremic episodes more than one
bacteremia (w2: 34.34, P¼ 0.002), Gram-positive bacteremia (w2¼ 8.23,
P¼ 0.016) were determined as risk factors for mortality in patients with
NB. Themean values of AST, ALT, creatinin, leukocyte and hemoglobin level
in patients with bacteremia who survived were found signiﬁcant in relation
with mortality (P< 0.05 for all variables). Multivariate analysis revealed that
being older than 55 years old [Odds ratio (OR): 2.29, P¼ 0.001)], hospi-
talization in ICU (OR:3.38, P< 0.001), bacteremic episodes more than one
bacteremia (OR: 4.05, P< 0.001), Gram-positive bacteremia (OR: 1.76,
P< 0.026) were independent risk factors for mortality of NB.
Conclusions: MRSA and E. coli were the most common causative agents in
NB. Advanced age, hospitalization in ICU and bacteremic episodes more than
one bacteremia and Gram-positive bacteremia were independent risk factors
for mortality of NB.
P856 Etiology of septicemia in hospitalized patients
M. Wroblewska, E. Swoboda-Kopec, H. Marchel, M. Przybylski,
M. Luczak
Warsaw, PL
Objectives: Estimation of etiology of septicemia in patients hospitalized in a
tertiary care hospital from VII 1999 to XII 2001.
Methods: The study comprised 127 patients with clinically diagnosed
hospital- or community-acquired septicemia. Blood cultures were processed
in a computerized BacT/Alert system (Organon Teknika). The strains were
cultured according to standard bacteriological procedures and identiﬁed with
the use of biochemical API tests (BioMerieux). Susceptibility to antimicrobial
agents was assessed by a disk-diffusion method, according to the NCCLS
recommendations, and VITEK tests (BioMerieux).
Results: Most of the patients with hospital- or community-acquired septi-
cemiawere hospitalized in the hematology-oncology ward (82.3% and 17.7%,
respectively). In total 135 bacterial isolates have been cultured, comprising 92
clinical strains. Sixty-two of them (67.4%) were isolated from cases of
hospital-acquired septicemia. Among isolated bacteria dominated coagu-
lase-negative staphylococci (CNS) – 23 strains, including 18 resistant to
methicillin (MRCNS), S. aureus – 9 (including 4 MRSA) and E. coli – 9
strains. Thirty strains (32,6%) were cultured from patients with community-
acquired sepsis. Etiology of these cases implicated 7 strains of CNS (including
5 MRCNS), 7 strains of E. coli and 4 strains of S. aureus (including 2 MRSA).
Among fungi C. tropicalis, C. lusitaniae and C. parapsilosis were isolated from
blood cultures of patients with septicemia.
194 Abstracts
Conclusion: Methicillin-resistant staphylococci may be etiological agents of
both community- as well as hospital-acquired septicemia. There is an increase
in frequency of isolation of Candida species other than C. albicans.
P857 The inﬂuence of inappropriate empirical
antimicrobial treatment on the outcome of intensive care
bacteremias
R. Zaragoza, A. Artero, J. Camarena, S. Sancho, C. Tormo,
J. Nogueira
Valencia, E
Objectives: Inappropriate empirical antimicrobial treatment has been related
to mortality in intensive care units, but this relationship depends on the local
ﬂora and the place where the study was done. The aims of this study were to
determine the prevalence of inadequate empirical antimicrobial treatment and
to know its inﬂuence on clinical outcomes in critical ill patients with
bacteremia.
Material and methods: During a ﬁve and a half-year period, from 1996 to
2001, 215 patients admitted to a 12-bed general adult intensive care unit with
signiﬁcant bacteremia were evaluated. Inadequate antimicrobial treatment of
bloodstream infection was deﬁned as the microbiological documentation of
infection that was not being effectively treated at the time the causative
microorganism and its antibiotic susceptibility were known. Clinical and
microbiological variables were studied. A multivariate analysis was performed
to determine the inﬂuence of inappropriate treatment on mortality
Results: The prevalence of inappropriate empirical antimicrobial treatment
was 26% (n¼ 56). The proportion of nosocomial-acquired bacteremias was
signiﬁcantly higher in the group with inappropriate treatment (91%) than in
the group with appropriate treatment (77%), P¼ 0.025. None of the other
clinical variables were signiﬁcantly different between cases with inappropriate
and appropriate treatment: Years of age (mean sd 63.4 14.1 vs.
61.9 16.3), sex (m/f 36/20 vs. 100/59), septic shock (30.3% vs. 26.4%),
high risk focus (23% vs. 37.5%), ultimately fatal disease (26.7% vs. 32.7%) and
high risk microorganisms (58.9% vs. 45.2%). The principle etiologies of cases
with inappropriate treatment were: Acinetobacter baumannii (n¼ 19), CNS
(n¼ 16), Enterococcus spp. (n¼ 5), Escherichia coli (n¼ 4), Candida spp. (n¼ 4)
and Pseudomonas aeruginosa (n¼ 3). Related mortality of bacteremia was
associated with septic shock (OR 3.28, 95% CI 1.71–6.30), but not with
inappropriate treatment (OR 1.29, 95% CI 0.64–2.60).
Conclusions: Intensive care bacteremias are frequently treated with inap-
propriate empirical antibiotics. However, inappropriate empirical antibiotic
treatment was not related to mortality, probably due to characteristics of the
local organisms causing of bacteremia in our setting.
P858 Bacteremia in febrile elderly presenting to a
hospital emergency department
A. Zacharof, C. Petrogiannopoulos, C. Flevaris, G. Chartzoulakis,
G. Svoukas, D. Poulikakos, G. Vassilopoulos, L. Kandili,
K. Mpethimouti
Athens, GR
Objective: Determination of the prevalence of bacteremia in elderly pre-
senting to hospital emergency department.
Patients andmethods:We retrospectively study the records of eight hundred
and twenty-three patients (823) aged 65–85 years presenting to our Emer-
gency Department with temperature 38.58C and without speciﬁc viral
illnesses during the last 15 years. Bacteremia (deﬁned as presence of patho-
genic bacteria in a blood culture), white blood cell count (WCC), and ﬁnal
diagnosis based on clinical features and laboratory investigations.
Results: Bacteremia was identiﬁed in 28 of 823 patients (3.4%). Pathogens
isolated were Streptococcus pneumoniae (19), Neisseria meningitidis (2) and
Klebsiella pneumoniae (7). Increased WCC counts (P< 0.001) and brief
duration of fever (P< 0.001) were associated with bacteremia. Nevertheless,
clinical features, including high WCC counts (20 109/L) had <10%
predictive accuracy for bacteremia. Overall, ﬁnal diagnoses in the 823 febrile
elderly patients included nonspeciﬁc viral infections (25%), upper respiratory
tract infections (4%), infectious gastroenteritis (9%), pneumonia (37%), and
urinary tract infection (25%).
Conclusions: Most elderly patients presenting to a hospital emergency
department with temperature 38.58C without a clinical focus have a viral
infection. However, 3–4% have occult bacteremia. Neither clinical features
nor high WCC counts reliably identify these patients. As empiric antibiotics
may contribute to increasing antibiotic resistance and have not been shown to
prevent the rare complication of meningitis, we believe that close contact and
regular review of these patients is preferable to empiric antibiotic therapy.
P859 Anaerobic bacteremias
J. M. Ruiz Giardin, A. Noguerado Asensio
Madrid, E
Objective: Compare the incidence and clinical characteristics of anaerobic
bacteremias with the difference of 10 years, analyzing the number of
bacteremias during 1986–87, and 1997.
Methods:During 1985–86 (2 years), and 1997 (1 year), there were studied all
the anaerobic bacteremias (46 anaerobic bacteremias with clinical signiﬁ-
cance). There were collected clinical and analytical characteristics of all of
them by the study group prospectively, with intention to analyze if incidence
of anaerobic bacteremias is decreasing and to analyze the most common
characteristics of them.
Results: In 1985–86 about a total of 512 bacteremias, 22 (2.2%) were
anaerobic bacteremias and of them: 8 were polymicrobial, 13 were by
Bacteroides sp. (the most frequent one), and one of them by Fusobacterium
sp. In 1997 about a total of 472 bacteremias, 24 (2.4%), were anaerobic
bacteremias and of them: 6 polymicrobial bacteremias, 14 were by Bacteroides
sp. (themost frequent one), 1 by Fusobacterium sp., 2 byClostridium sp., and one
of them by Flavobacterium meningosepticum. About the evolution to death, in
the ﬁrst period 10 (45.4%) were deaths, and in the second one 9 (37.5%), died.
About the empiric treatment received before knowing the results of blood
hemocultures, in the ﬁrst period 17 (77.2%), received correct empirical
treatment. In the second one 20 (86.9%), received correct empirical treat-
ment. About the age of the patients in 1986–87, 14 (63.6%), were older than
60 years, and in 1997, 18 (75%), were older than 60 years.
Acquisition: In 1986–87, 8 (36.3%), were extrahospitalary acquisition, in
1997, 15 (62.5%) were extrahospitalary acquisition.
Origin: In 1986–87, 12 (54.5%) had an abdominal focus, 5 (22.7%) had skin or
surgery wound and 3 (3.63%), were of unknown origin. In 1997, 13
(54.16%), were of abdominal origin, 3 (12.5%) had a skin or surgery wound
focus, and 3 (12.5%), were of unknown origin.
Conclusions:Although there is a low anaerobic bacteremia incidence this one
hasn’t diminished in 10 years. Anaerobic bacteremias have a high mortality
index although the most part of empirical antibiotic treatments are correct.
The most part of patients are over 60 years, the most frequent origin of
bacteremias is abdominal, following by skin and wound surgery, and unknown
focus (similar in both periods), and the most frequent bacteria is Bacteroides sp.,
and polymicrobial bacteremias.
P860 Infection control strategies to reduce nosocomial
blood stream infections related to central venous access
devices: the use of control charts to analyze outcomes
K. L. Shaw, A. S. Ritchie, P. A. Cox
St Leonards, AUS
Objectives: To assess and interpret the effectiveness of strategies designed to
reduce nosocomial blood stream infections (BSIs), related to central venous
access devices (CVADs), using process control charts.
Methods: BSI surveillance data routinely collected at Royal North Shore
Hospital, a tertiary referral center, indicated CVADs as an increasingly
signiﬁcant source of BSIs. A multiple approach prevention program, January
2001–November 2002 included the development of an Infection Control
policy on CVADs and a hospital wide education program to enhance the
proﬁle of the risks associated with the insertion and care of these devices.
Surveillance methods and data analyzes were improved by using a database
system, ‘electronic Infection Control Analysis Technology’ (eICAT),
designed by Queensland Health. The need to limit the insertion of these
devices to accredited staff was reinforced and hospital sites for insertion of
these devices limited to Anesthetics, Radiology and Intensive Care Units.
Two process control charts, the Shewart and the exponentially weighted
moving average (EWMA) chart measured the effectiveness of the program.
Both the Shewart, which shows large changes indicating poor implementa-
tion of policies or unusual variation, and the EWMA, important for detecting
changes in average rates due to systems and process changes, have proved
useful in analyzing outcomes.
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Results:As random variation was present we used an upper 95% control limit
which is 2 standard deviations above the mean. The monthly count of BSIs
related to CVADs prior to the introduction of the program exceeded the
upper control limit for both the Shewart (U95S¼ 12.1) and the EWMA
(U95E¼ 8). Random variation has continued, however, the EWMA shows a
consistent trend towards the mean (6.1) and the data appear to remain in
statistical control. Our most recent analysis demonstrates the data to be below
the mean in November 2002.
Conclusion:The process control charts have shown a decrease in the number
of BSIs related to CVADs. We believe process control charts are a useful tool
for measuring the effectiveness of prevention programs.
P861 Bacteremia in a new Greek Hospital: a 2-year analysis
H. Moraitou, G. Georgoulias, P. Morfou, P. Hatzopoulou, D. Nikita
Athens, GR
Objectives: The aim of this study was to analyze the epidemiological and
microbiological characteristics of all positive blood cultures yielded in the
microbiology laboratory of our new hospital, which was inaugurated in 2000.
Methods: Henry Dunant Hospital is a new 355-bed tertiary hospital. The
periods (A) 01/11/00–31/10/01 (ﬁrst year of full activity) and (B) 01/11/01–
31/10/02 (second year) were studied retrospectively for all episodes registered
as true bacteremia. The blood cultures were processed and cultured auto-
matically with Bactec 9240 system.
Results: During period (A) 7346 patients were admitted to Henry Dunant
Hospital and 135 cases of bacteremia (18.4 cases/1000 admissions) were
registered. Coagulase-negative staphylococci were the commonest micro-
organisms detected (38.5%, [MRSE 78.8%]), followed by Pseudomonas aer-
uginosa (14.8%), E. coli (7.4%), Enterococcus faecalis (7.4%), Staphylococcus aureus
(5.2% [MRSA 87.5%]),Acinetobacter baumanii (5.2%), yeast (4.4%),Enterococcus
faecium (2.9%), Proteus mirabilis (2.9%), Klebsiella spp. (2.2%) and various
organisms of low incidence. Polymicrobial bacteremia was detected in one
patient. During period (B) 23 723 patients were admitted to the Hospital and
310 cases of bacteremia (13.1 cases/1000 admissions) were registered. Still
coagulase-negative staphylococci were the most prevalent organisms (27.1%,
[MRSE 85.7%]), E. coli (9.7%), yeast (8.4%), Pseudomonas aeruginosa (7.1%),
Enterococcus faecium (5.2%,[GRE 7.0%]), Klebsiella spp. (5.2%), Enterococcus
faecalis (4.8%),Acinetobacter baumanii (2.9%),Enterobacter spp. (2.6%), Salmonella
spp. (1.3%) and various organisms of low incidence. Polymicrobial bacteremia
was detected in six patients.
Conclusions:We conclude that despite the progressively increasing workload
(number of patients’ admissions, new departments’ activity) the total percen-
tage of bacteremia decreased during the second year. However, we must
notice the increasing number of serious pathogens occurring during the
second year such as GRE, yeasts, Ralstonia pickettii, Stenotrophomonas mal-
tophilia, as well as the higher incidence of polymicrobial bacteremia. This
occurrence should be attributed to the wider spectrum of clinical syndromes
admitted to our hospital during the second year and to the expansion of
certain departments such as Hematology, Oncology and ICU.
Serious systemic infections: meningitis, septicemia and endocarditis
P862 The ﬁrst French outbreak due to Neisseria
meningitidis B:15:P1,12
C. Grodet, P.-F. Dequin, S. Watt, P. Lanotte, C. de Gialluly,
M.-K. Taha, J.-M. Alonso, L. Mereghetti
Tours, Paris, F
Introduction: Neisseria meningitidis is an exclusive human pathogen respon-
sible of bacteremia and meningitis. In developed countries, most of menin-
gococcal diseases are sporadic and serogroups B, C and W135 represent the
majority of the strains isolated, as illustrated by the French situation where
more than one half of the meningococcal diseases are due to serogroup B and
quite a third to serogroup C.
Results: From November 2000 to February 2002, 13 cases of meningococcal
disease, either meningitis or meningococcemia, were recorded in the depart-
ment of Indre-et-Loire, France. Eight of the 13 cases were due toN.meningitis
B:15:P1,12. Molecular typing performed by restriction fragment length
polymorphism of the genes pilA and pilD showed that the eight
B:15:P1,12 strains harbored the same restriction patterns. Six patients were
male and two females and were 14–28 years old. Epidemiological investiga-
tion revealed that all eight patients lived in the same district of the department,
and that two of themwere closely related. For seven patients, symptomatology
was typical, but evolution was signed by septic metastasis for one patient and
by neurological sequels for ﬁve patients; the outcome of the illness was
favorable for these patients after antibiotic treatment. For one patient, overall
clinical picture was unusual atypical; death occurred before the admission to
the hospital and the N.meningitidis strain was isolated from culture of a
meningeal biopsy.
Conclusions: This is the ﬁrst time that N.meningitis B:15:P1,12 has been
isolated in Indre-et-Loire or limitrophe regions, and also the ﬁrst time that this
serogroup is implicated in an outbreak in France. The strain has spread rapidly
among the population because it was responsible of ﬁve cases over a short
period of 3weeks secondary to the ﬁrst case. Besides, the outbreak has
conduct to death in one case and in severe forms for the other cases with
subsequent neurological sequelae. Finally, none of the patients had underlying
immune defects that may confer a predisposition to invasive meningococcal or
had taken an immunosuppressive therapy. These elements may suggest that
this N.meningitis B:15:P1,12 strain may possess a high virulence.
P863 The changing epidemiology of severe infections
caused by Neisseria meningitidis over the last
7 years
E. Cercenado, O. Cuevas, N. Garcı´a-Escribano, E. Bouza
Madrid, E
Objectives: Serogroup B Neisseria meningitidis has been traditionally the most
frequent cause of severe meningococcal disease in Spain. In 1996 there was a
concern over an increase in the incidence of meningococcal infection in
Madrid due to serogroup C, and a vaccination campaign was started in 1997.
To assess the evolution of admissions caused by N.meningitidis severe infec-
tions, the evolution of the responsible serogroups and the antimicrobial
susceptibility of the isolates, we reviewed the 101 cases of N.meningitidis
which occurred at our institution from 1996 to 2002.
Methods: Ours is a large teaching institution (1800 beds) serving a
population of 640 000 inhabitants. Isolates were identiﬁed by standard
procedures and susceptibility testing was performed using the broth micro-
dilution method with 5% lyzed horse blood. Beta-lactamase production was
detected using the nitrocephin test. Serogroup, serotype and subtype
were determined at the National Reference Laboratory for Meningococci
in Spain.
Results:The evolution of new cases was as follows: 1996, 16 cases (0.32/1000
admissions); 1997, 22 cases (0.38/1000); 1998, 11 cases (0.19/1000); 1999, 12
cases (0.22/1000); 2000, 11 cases (0.19/1000); 2001, 12 cases (0.19/1000);
2002, 17 cases (0.28/1000). The evolution of serogroups C/B (percentages)
from 1996 to 2002 was: 87/13, 82/18, 45/55, 50/50, 36/64, 83/17, and 12/
88, respectively. The incidence of severe infections due to serogroup C in
children over the period of study was: 85% (6 cases), 86% (12 cases), 17% (1
case), 40% (2 cases), 36% (4 cases), 100% (2 cases), and 0% (0 cases). The
evolution of isolates non-susceptible to penicillin (MIC 0.12–0.25mg/L) from
1996 to 2002 was: 62%, 86%, 91%, 58%, 82%, 58%, and 70%, respectively.
None of the isolates produced beta-lactamase. All isolates were fully suscep-
tible to cefotaxime, rifampin and ciproﬂoxacin.
Conclusions: Our data show a decrease of severe infections caused by
serogroup C N.meningitidis that paralleled the vaccination campaign, a
changing epidemiology of serogroups over the period of study and a high
incidence of penicillin-resistant (non-susceptible) isolates.
196 Abstracts
P864 Acute bacterial meningitis in adults. A review of
31 recent episodes in an Italian hospital
M. Bonadio, G. Morelli, S. Costarelli, M. Giraldi, S. Moneta,
A. Scasso
Pisa, Lucca, I
Objectives: Bacterial meningitis has to be reviewed periodically because the
speciﬁc microorganisms responsible for the infection vary with time, geo-
graphy and patient age. Aim of this study was to evaluate clinical and
laboratory ﬁndings of acute bacterial meningitis in adults.
Methods: The charts of all patients 19 years of age or older in whom acute
bacterial meningitis was diagnosed at the Infectious Diseases Division of the
Hospital of Lucca during the 1998–2001 period were reviewed. Patients with
HIV-related immunodeﬁciency or tuberculosis infection were excluded from
this study.
Results:During the 4-year period 31 adults (16 males and 15 females, median
age 60 year, range 19–88) were treated for acute bacterial meningitis all of
which were community acquired and 17 (54.8%) occurred in elderly patients
(>65 years). Predisposing factors were present in 13 (41.9%) of the episodes.
Nineteen (61.3%) pts had the classical triad of fever, nuchal rigidity and
change in mental status. Seizures occurred in 1 (3.2%) pt. Cerebrospinal ﬂuid
pleocytosis with a neutrophilic predominance and hypoglycorrhachia and
elevated protein levels were present in 90% of the pts. A pathogen was
identiﬁed in 29 (93.5%) of the cases. The causative pathogens were Strepto-
coccus pneumoniae 14 (all strains fully sensitive to penicillin), Neisseria meningi-
tidis 5, Hemophilus inﬂuenzae 2, Staphylococcus aureus 2, Listeria monocytogenes 2,
Staphylococcus capitis 1, Leptospira 1, Enterococcus faecium 1, Bacteroides spp. 1.
Bacterial antigen was found to be of acceptable sensitivity: 72.7% in all
evaluable pts. The overall in–hospital mortality was 13.3%. Two out of 4
fatality cases of acute bacterial meningitis were caused by Staphylococcus capitis
and Bacteroides spp., respectively.
Conclusions: The causative organisms of community acquired meningitis in
adults are mainly S. pneumoniae and N.meningitidis. Invitro resistance of
S. pneumoniae to penicillin was not observed in this series. A substantial
proportion of cases due to staphylococcal microorganisms and Listeria mono-
cytogenes was observed in our geographic area.
P865 Acute bacterial meningitis in adults: a study of 186
cases in South-eastern Anatolia of Turkey
C. Ayaz, M. F. Geyik, S. Hosoglu, S. Akalin, M. K. Celen,
O. F. Kokoglu
Diyarbakir, TR
Objective: The aim of study was to assess the epidemiology, diagnosis, clinic,
and laboratory of the patients with acute bacterial meningitis (ABM).
Methods:This is a retrospective study that described all the cases of ABMwas
diagnosed in the Dicle University Hospital from June 1996 to December
2002. In 7-year period, 186 adult patients were diagnosed and treated. The
diagnosis of ABM was established on cytochemical characteristic of CSF and
positive Gram stain and/or CSF blood cultures.
Results: The mean age of the patients, 110 male, 76 female, was
30.2 15.3 years (range 14–90). Otitis media 40(21.5%) and head trauma
12(6.5%) were identiﬁed as the main predisposing factors for ABM. Etiology
was described only in 23 patients (12.4%). Streptococcus pneumoniae was the
most common identiﬁed pathogen. Antibiotic treatment before admission
was given to 61.8% of patients. On admission, symptoms of meningitis were
predominant: 92.5% headache 88.2%, fever and 80.1% had nuchal rigidity,
Twenty-nine patients (15.6%) died during hospitalization period. The sig-
niﬁcant risk factors for mortality were as follows: Elderly, comatose mental
status, low CSF/blood glucose ratio, erythrocyte sedimentation rate and
treatment of penicillin.
Conclusion: ABM still remains a serous infection. Early diagnosis and
treatment may reduce fatal outcome and improve the course of the disease.
P866 Bacterial septicemia: susceptibility of
contemporary blood isolates (2000–2002) from
hospitalized patients in Europe, Canada and the USA to
Ceftriaxone and other antibiotic compounds (TSN
Database)
M. Jones, J. Karlowsky, D. C. Draghi, C. Thornsberry, R. Master,
D. Sahm
Hilversum, NL; Herndon, Franklin, USA
Objectives: In this study we report susceptibility rates of ceftriaxone (CTX)
and other relevant antimicrobials for key pathogens isolated from blood as
reported to physicians by clinical microbiology laboratories in the USA,
Europe (EU), and Canada.
Methods: We analyzed data (January 2000-October 2002) from The Sur-
veillance Network1 (TSN) Databases in France (Fr), Italy (It), Germany
(Gy), Spain (Sp), Canada (Cn) and the USA to determine susceptibilities from
routine test results as reported to physicians. Only inpatient data from isolates
taken from blood specimen sources (n¼ 394 554) were included in the
analysis. Contemporary NCCLS breakpoints were used, except for Fr
(CA-SFM).
Results: Coagulase-negative Staphylococcus spp., S. aureus (SA), E. coli (EC),
K. pneumoniae (KP), P. aeruginosa (PA), E. faecium (EFM), E. faecalis, S. pneu-
moniae (SP), and viridans group streptococci (VGS), together comprised 80–
84% of all isolates per country. Comparatively high incidence of EFM in the
USA (4.5%) and It (2.2%) reﬂected high incidence of vancomycin resistant
[R] strains in those countries (65.1% and 12.6%, respectively). Methicillin-
resistant SA (MRSA) rates were USA 47.9%, It 40.5%, Fr 33.3%, Sp 30.5%,
Gy 13.0% and Cn 15.4%. More than 98.5% of methicillin-susceptible SA
(MSSA) (all countries) tested susceptible (S) to ceftriaxone (CTX). 89.2%
(Gy) to 93.0% (Sp) of MSSAwere ciproﬂoxacin S; 71.7% (USA) to 86.9% (It)
were erythromycin S; 93.5% (It) to 99.2% (Fr) were gentamicin S. Among SP,
penicillin resistance was 1.9% (Gy) to 17.2% (Sp). SP isolates were CTX-S
97.3% (0.8% R) USA, 99.7% S (0% R) Cn, 84.4% S (0.3% R) Fr, 100% S Gy,
97.2% S (1.1% R) It, 93.2% S (6.8% R) Sp. For all countries susceptibility of
EC and KPwas 100% to imipenem (IMI),>95% to amikacin,>90% to CTX.
Putative extended spectrum beta-lactamase expression in EC remained rare
comprising 0.7% in Gy to 3.2% in the USA. Among H. inﬂuenzae (HI),
ampicillin R ranged from 5.0% in Gy to 30.0% in the USA. Among HI, CTX
was >98.2% S in USA, Cn, and EU. Among PA, IMI-S ranged from 69.5%
(It; 22.0% R) to 87.2% (Gy; 8.4% R), ceftazidime-S 61.7% (It; 28.3% R) to
86.9% (Gy; 7.7% R), and piperacillin-tazobactam-S 79.3% (Fr; 8.5% R) to
92.8% (Gy; 4.5% R).
Conclusions: Surveillance data can help guide empiric choice. Apart from
VRE and MRSA, acquired resistance to parenteral beta-lactams and ami-
noglycosides remains low.
P867 No ESBL producing Escherichia coli strains were
observed among 210 clinical blood isolates in
Copenhagen, Denmark
A. Kjerulf, S. A. Salamon, C. Moser, N. Frimodt-Møller
Copenhagen S, DK
Objectives: Increasing resistance to antibiotics is a major problem in treatment
of serious infectious diseases. Recently, extended spectrum beta-lactamases
(ESBL) has attracted considerable attention. The aim of the present pro-
spective study was to investigate the presence of ESBL in E. coli blood isolates
during a period of six months at Herlev University Hospital in Copenhagen,
Denmark. Furthermore, the isolates were studied for the prevalence of
coupled- and multiresistance (4 different groups of antibiotics).
Methods: The disc diffusion method (Oxoid, Sweden) on agar plates was
used. The isolates were tested for resistance to amoxicillin (amx), amoxicillin
þ clavulanic acid (amc), ceftazidime (cfz), cefotaxime (ctx), aztreonam (atm),
sulphonamide (sul), trimethoprim (trm), nalidixic acid (nal) and gentamicin
(gnt). Susceptibility to the antibiotics were deﬁned using the breakpoints
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according to SRGA/RAF. The MIC’s were determined to cefuroxime and
ampicillin as control by the agar dilution method.
Results: No ESBL producing strains were observed, since no resistance to
amc, cfz, ctx and atmwas detected. The frequency of resistant isolates was amx
41% (84/204 strains), sul 43% (86/202 strains), trm 23% (48/206 strains), nal
6.3% (13/206 strains), and gnt 2.5% (5/203 strains). Resistance to amx was
coupled to sul (80%). Resistance to sul was coupled to amx (78%). Resistance
to trmwas coupled to amx (75%) and sul (90%). Resistance to nal was coupled
to amx (69%), sul (85%), and trm (62%). Resistance to gnt was coupled to amx
(100%), sul (80%), and trm (80%), however, only 5 resistant strains were
isolated. Multiresistance were registered in 13 isolates (6.2%).
Conclusions: The present study indicates that ESBL is not a problem in
clinical blood isolates in Denmark. Resistance to amoxicillin and sulphona-
mide was signiﬁcant, and highly coupled. This correlates to the widespread
use of these antibiotics in Denmark. Resistance to nalidixic acid and
gentamicin is still low in Denmark.
P868 Study of bacteremias at the emergency
department in a Spanish teaching hospital during 2002
J. Dı´az-Regan˜o´n, T. Alarco´n, S. Abanades, J. A. Garcı´a-Campos,
M. C. del Rey, M. C. de las Cuevas, M. Lo´pez-Brea
Madrid, E
Objectives: To determine the microorganism most frequently isolated from
blood cultures from the emergency department during 2002 in a University
Hospital in Madrid and the invitro susceptibility.
Methods: 1579 blood cultures were retrospectively studied during 2002 in
patients attending the emergency department with a range of age from 15 to
104. Blood culture system used was BACTEC 9240 (Becton-Dickinson).
Bacteremia was deﬁned as the isolation of Gram-positive cocci or Gram-
positive rods in two or more extractions and the rest of microorganisms in at
least one extraction. Identiﬁcation and susceptibility was performed by
conventional technology and an automatic system (MicroScan, Dade Behr-
ing).
Results: From the total of blood cultures, 281 bacteremias were identiﬁed
(17.80%). The microorganisms most commonly isolated causing bacteremia
were Escherichia coli in 98 cases (34.87% of the total because 10 of them were
included in the polymicrobial blood cultures), coagulase-negative staphylo-
cocci in 44 (15.66%), polymicrobial in 26 (9.25%), Streptococcus pneumoniae in
21 (7.47%) and Staphylococcus aureus in 11 cases (3.91%; 9 were MSSA and 2
were MRSA). The rest of bacteremias (93) were divided as follows; 28
Streptococcus spp. (9.96%), 24 enteric Gram-negative rods (8.54%), 19 Staphy-
lococcus spp. (6.41%), 10 anaerobics (3.56%), 8 non-fermentative Gram-
negative rods (2.85%) and 2 yeasts (0.71%). The susceptibility of E. coli
strains was as follows; 35.71% of the strains were susceptible to amoxicilin,
93.88% to amoxicilin-clavulanic acid, 98.98% to cefotaxime (the resistance
was due to an ESBL production), 100% to imipenem, 86.73% to ciproﬂox-
acin, 67.35% to TMP/SMX, 95.92% to gentamicin and tobramycin and
100% to amikacin.
Conclusions: Escherichia coli was the most common cause of bacteremia, with
the 34.87% of the cases, of the blood cultures reported from our emergency
department. The susceptibility pattern of this E. coli was within the expected
values.
P869 Optimization of empirical antibiotic selection in
the emergency department for suspected Gram-negative
bacteremia
S. Benenson, A. Yinnon, Y. Schlesinger, B. Rudensky, D. Raveh
Jerusalem, IL
Objectives:To identify risk factors for resistance of Gram-negative bacteria to
ﬁrst line antibiotics commonly used in the emergency department (ED)
setting.
Methods: We conducted a one-year prospective study of patients admitted
through the ED, who had positive blood cultures. Baseline data were
collected, pertaining age, residence, prior antibiotic treatment, prior hospi-
talization or medical procedures, diabetes, immunosuppression, presence of
foreign bodies, as well as current clinical data including infectious diagnoses,
pattern of microbial resistance, APACHE score and outcome. Univariate
analysis and multivariate regression analysis were carried out.
Results:A total of 246 ED-admitted patients had positive blood cultures. The
spectrum of bacteria included 131 (53%) Enterobacteriaceae, 86 (35%) Gram-
positive cocci and 29 (12%) others. We sought to determine risk factors for
resistance among the Enterobacteriaceae. Of 131 isolates of Enterobacter-
iaceae, 32 (24%) were resistant to gentamicin and 37 (28%) were resistant to
ciproﬂoxacin. Signiﬁcant risk factors for resistance to gentamicin by uni-
variate analysis were: older age, nursing home residence, prolonged recent
hospitalization, foreign body and bacterial type (P< 0.05–0.0001); only
presence of a foreign body was signiﬁcant by multivariate analysis
(P< 0.05). Signiﬁcant risk factors for resistance to ciproﬂoxacin by univariate
analysis were: male gender, older age, recent antibiotic treatment (especially
prior ciproﬂoxacin use), nursing home residence, prolonged recent admission,
foreign body and bacterial type (P< 0.05–0.00005); of which male gender,
nursing-home residence and presence of a foreign body were signiﬁcant by
multivariate analysis (P< 0.01–0.001).
Conclusions: There is signiﬁcant resistance to ciproﬂoxacin (28%) and/or
gentamicin (24%) among Enterobacteriaceae isolated from blood cultures
from patients admitted through the ED. Identifying risk factors for resistance
against these commonly prescribed antibiotics allows for optimal selection of
empiric antibiotic treatment of suspected Gram-negative infections by tailor-
ing this to the patients’ proﬁle presented here. This may lead to improved
patient outcome and more optimal use of antibiotics.
P870 Incidence of invasive pneumococcal disease in two
Italian regions
F. D’Ancona, D. Boccia, A. Pantosti, A. Barale, P. L. Lopalco,
C. Rizzo, M. Monaco, R. Camilli, M. Massari, S. Salmaso
Rome, Alessandria, Bari, I
Objectives:Estimating the incidence of invasive pneumococcal diseases (IPD)
is crucial to correctly design appropriate control strategies against these
diseases. Reported incidence rates vary widely across European countries
and USA. Determinants for the observed differences are unclear. So far no
data on incidence rates of IPD were available for Italy.
Methods:A laboratory-based surveillance network was established, including
all public microbiological laboratories (114), in 2 Italian regions (Piemonte
and Puglia), respectively, with 4 289 731 and 4 086 608 inhabitants (14% of
Italian population). IPD was deﬁned as a case with isolation of S. pneumoniae
from blood or CSF. Laboratory identiﬁed IPD in the two regions from April
2001 to March 2002 were prospectively reported and all isolates were sent to
ISS (the Italian Public Health Institute) for further characterization.Moreover
in 5 hospitals the local databases of hospital discharge records were retro-
spectively matched with the laboratory database, in order to determine the
proportion of patients undergone to blood or CSF culture, as an explanatory
variable for the observed incidence of IPD.
Results: Over the 12-month period of the prospective surveillance 129 IPD
cases were identiﬁed in Piemonte and 24 cases in Puglia. The isolates from
CSF were, respectively, 28 and 14. The incidence in children aged up to
23months was 7.6100 000 in Piemonte and 4.7100 000 in Puglia. In the
65 years or older age-group, the incidence was, respectively, 5.7100 000 and
0.2100 000 in the two regions. The total number of blood cultures per-
formed in Piemonte was 6 times higher than in Puglia (32.674 vs. 5007). In
the retrospective study, in Piemonte a blood/CSF culture had been performed
in 35% of patients with a diagnosis at discharge of pneumonia, in 40% of those
with fever of unknown origin, and in 58% of those with meningitis. In Puglia
these ﬁgures were 7%, 26% and 32%, respectively.
Conclusions:The active surveillance provided incidence rates different in the
2 regions. The population based incidence rates were lower than those
reported in USA and some other European countries. The retrospective
study showed a different attitude between the two regions in performing
blood culture especially in pneumonia cases, which may represent a large
number of IPD cases.
P872 Community-acquired bacteremias in critically ill
patients
A. Artero, J. Camarena, R. Zaragoza, S. Sancho, G. Vila, J. Nogueira
Valencia, E
Objectives:The goals of this study were to know the epidemiological, clinical
and microbiological features of community-acquired bacteremias, and their
clinical outcomes in critical ill patients, in a general intensive care unit.
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Material and methods: Prospective observational study of 41 cases of
community-acquired bacteremias in a 12-bed adult medical and surgical
intensive care unit in a teaching hospital, during a period of 5 and a half years,
from 1996 to 2001. Community-acquired bacteremia was deﬁned as the
isolation of one or more organisms from blood cultures taken before 48 h after
admission, which were not related to an invasive procedure. Epidemiological,
clinical and microbiological features were recorded from clinical charts. To
determine the clinical outcomes global and related mortality were evaluated
and compared with clinical outcomes of nosocomial bacteremias by Chi-
square test.
Results: Forty-one (19%) from a global of 215 clinical signiﬁcant bacteremias
in critical ill patients were community-acquired. Themean age of patients was
56.2 years 17.8, and the distribution by sex was 49% men and 51% women,
with the following distribution of focus of infection: respiratory 24.4%,
urinary tract 14.6%, abdominal 14.6%, endocarditis (7.3%), unknown
34.1%, and others 4.9%. Thirty-six percent of patients had an pre-existing
comorbidity classiﬁed as ultimately or quickly fatal disease according with
MacCabe classiﬁcation. The most frequently causative organisms of com-
munity-acquired bacteremia were Staphylococcus aureus (n¼ 11), Escherichia coli
(n¼ 10), Streptococcus pneumoniae (n¼ 6) and Pseudomonas aeruginosa (n¼ 4).
The frequency of severe sepsis and septic shock were 73.2% and 48.8%,
respectively. Inappropriate empirical treatment was given in 12.2% of cases.
Global mortality was lower in community-acquired bacteremias (39%) than in
nosocomial bacteremias (56.3%), P¼ 0.046, but related mortality was great in
both groups, 29.3% and 25.3%, respectively (P¼ 0.601).
Conclusions: Community-acquired bacteremias in critical ill patients had a
high global and related mortality, Classic pathogens such as Staphylococccus
aureus and Escherichia coli were the most frequently organisms isolated, but
Pseudomonas aeruginosa should be considered as an etiological agent of com-
munity-acquired bacteremias.
P873 The changing epidemiology of Staphylococcus
aureus bacteremia: a 10-year study in a community
hospital
R. Gonzalez, J. Camarena, R. Zaragoza, A. Gea, A. Artero,
J. Nogueira
Valencia, E
Objectives: To determine the episodes of signiﬁcant Staphylococcus aureus
bacteremia in a community hospital over a 10-year period, and to evaluate
methicillin-resistance of the strains (MRSA) and the origin (nosocomial or
community-acquired) of the bloodstream infections.
Methods: During a 10-year period (1993–2002) we have evaluated all
S. aureus bacteremia recovered from patients admitted to the community-
teaching hospital. Antibiotic-susceptibility of the strains by several methods
(disk diffusion assay, ETest-MICs, latex agglutination test-MRSA-Screen) and
mecA PCR-analysis for detecting methicillin-resistance were performed to
estimate the proportion of nosocomial or community-acquired MRSA
during the study period. Sensibility to glycopeptides and linezolid from all
strains were also tested.
Results: A total of 306 signiﬁcant S. aureus bacteremia cases were detected,
with a progressive increase over the years, from which the 19.6% (60 cases)
were MRSA. Considerable differences were observed when the distribution
of MRSA isolates of different origin (community or nosocomial) and period
of the study were compared. At the ﬁrst time (1993–96), with only the 19.3%
(59) of the bacteremia cases, ICU-MRSA outbreak grouped the 57.9% of the
32.2%MRSA detected in this period. The second one (1997–99) exposed the
36.2% of the cases (111), with a MRSA decrease to 12.6% located in the ICU
and internal ward. However, in the last period of the study (2000–2002), that
grouped nearly 50% of the cases, MRSA increased until 27.8% in 2002. In
difference to the two previous periods, the origin ofMRSA cases were mainly
community-acquired (44.4%), whereas no MRSA cases in ICU-surgical
wards were detected. All MRSA isolates were glycopeptides (vancomycin,
teicoplanin) and linezolid ‘in vitro’ sensible.
Conclusions: The prevalence and origin of MRSA bacteremia cases changed
during the study. The initial problemwithMRSAnosocomial-ICU-outbreak
was resolved in time, emerging in the last 3 year period the community-
acquired cases, that seems to increase substantially.
P874 Mortality associated with community-onset
Staphylococcus aureus bacteremia
J. Losa, J. Valverde, A. Delgado-Iribarren, R. Barba, A. Espinosa,
M. Velasco, I. Gonza´lez, H. Martı´n, C. Guijarro, A. Zapatero
Alcorcon (Madrid), E
Objectives: Staphylococcus aureus bacteremia (SAB) is still a serious and
common health problem. Data concerning Community-Onset SAB
(COSAB) are scant, so that we performed a study to describe the mortality
of COSAB and to analyze the factors associated with it.
Methods: Retrospective analysis of all 73 patients with a positive blood
culture for S. aureus within 48 h after hospital admission (March 1998–
October 2001). Patients on hemodialysis, or regular visits to day hospital
were excluded. Demographic and microbiologic factors, foci of infection,
underlying conditions, previous hospitalization, preadmission antibiotic use
and outcome were evaluated. Results [percentages, median (range)] were
compared by the chi square or Student t-test as appropriate. A logistic
regression (LR) model evaluated the factors independently associated with
mortality.
Results: Median age was 73 years (0–99), 52% were female and 30% were
nursing home residents. Twenty-two percent of S. aureus strains were resistant
to methicillin and 81% of the patients had an apparent focus of infection.
Median length of hospital stay was 10 days (0–82) and 30% of the patients died.
By univariate analysis, death was associated to be older (85 vs. 66 years),
nursing home resident (55% vs. 20%), dementia (50% vs. 22%), no recent
betalactamic treatment (36% vs. 0%), shorter hospital stay (8 vs. 11 days) (all
P< 0.05), and no evident focus of infection (50% vs. 25%, P¼ 0,10) but not
with sex, methicillin resistance, recent non-betalactamic antibiotic use, or
previous hospitalization. By LR, nursing home institutionalization (OR 5,02;
95% CI 1.24–20.31), identiﬁed focus of infection (OR 0.21; 95% CI 0.05–
0.94), preadmission antibiotic use (OR 0.14; 95% CI 0.02–0.96) and,
marginally, age (OR 1.03; 95% CI 0.99–1.07), were associated with death.
In contrast, methicillin resistance (OR 1.89; 95% CI 0.36–9.81) was not
associated with death.
Conclusions: COSAB has a high mortality, especially in nursing home
residents not recently treated with antibiotics with no apparent focus of
infection. However methicillin resistance was not associated with death.
P875 Blood stream infections at an infectious diseases
hospital in Ho Chi Minh City, Vietnam: 1993–2000
C. M. Parry, T. S. Diep, N. V. V. Chau, J. Wain, N. M. Duong,
N. T. T. Hoa, T. T. Hien, N. J. White, J. J. Farrar
Liverpool, UK; Ho Chi Minh City, VN; London, UK
Objective: To study the changing pattern of bacteremia and fungemia at an
infectious diseases hospital in Ho ChiMinh City, Vietnam, between 1993 and
2000.
Methods: Retrospective analysis of hospital and laboratory records.
Results:There were 31 720 blood cultures taken in 29150 patient episodes. In
4292 (14.7%) episodes an organism was isolated that was considered sig-
niﬁcant. The proportion of positive episodes in children was signiﬁcantly
greater than in adults (1371/6677 (20.5%) vs. 2918/22 473 (13.0%),
P< 0.001). Salmonella was the predominant isolate (3164 (73.8%) episodes)
and Salmonella typhi accounted for 96.1% of these isolates. S. typhi isolations
varied each year with peaks in 1995, when 90% of strains were multidrug
resistant, and in 1998, when 76% were also nalidixic acid resistant. In 2000,
41% of S. typhi strains were multidrug-resistant and 47% were nalidixic acid
resistant. Salmonella paratyphi A accounted for 2.9% of Salmonella isolates and
were rarely drug resistant. Escherichia coli, Klebsiella and Staphylococcus aureus
were the commonest other isolates. There was a signiﬁcant decline in the
susceptibility of E. coli and Klebsiella to gentamicin, oﬂoxacin and ceftriaxone,
and S. aureus to methicillin over the study period. Isolations of Cryptococus
neoformans and Penicillium marneffei increased, and this was related to the
increasing number of patients admitted with HIV infection.
Conclusion: Important changes in the etiology and antimicrobial suscept-
ibility of organisms causing blood stream infection were identiﬁed over the
8-year period.
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P876 Epidemiology and clinical characteristics of
patients with unsuspected endocarditis detected after
elective valve replacement
A. Yinnon, O. Merin, E. Rosenmann, I. Dzigivker, S. Silberman,
D. Bitran, N. Shapira
Jerusalem, IL
Background:The diagnosis of infective endocarditis (IE) is primarily based on
clinical and laboratory criteria and may be conﬁrmed by histology or cultures
of the excised valves. The presence of only an inﬂammatory inﬁltrate in
surgically removed valves is insufﬁcient to fulﬁll present (Duke University)
criteria for IE.
Objective: To determine the prevalence and signiﬁcance of inﬂammatory
changes in valves excised during operations for reasons other than IE.
Methods: The charts and histopathology of all patients undergoing valve
replacement during eight years were reviewed in order to identify those with
an unexpected valvular inﬁltrate. A total of 534 patients, 264 females and 270
males, mean age 64 17, underwent 621 valve replacement(s) during this
period; aortic valve (250, 47%), mitral valve (197, 37%), and both (87, 16%).
Eleven of these patients (2%) underwent valve surgery during the course of
diagnosed IE; these were excluded from this study. All excised valves were
cultured and examined histologically for the presence of an inﬂammatory
inﬁltrate, vegetations and microorganisms.
Results: The histopathologic examination of valves from 5 of 523 patients
(1%) who had elective valve surgery for reasons other than IE, unexpectedly
demonstrated inﬂammatory inﬁltrates suggestive of IE. There was no clinical
or laboratory evidence of endocarditis prior to surgery in any of these patients.
Blood and valve cultures, and serologic tests for Mycoplasma, Chlamydia,
Legionella, Q fever, Brucella, Rickettsiae and Bartonella were negative in all, as
was a thorough evaluation for antiphospholipin syndrome and thrombophi-
lias. The patients were treated with antibiotics for culture-negative IE. Three
patients had an uneventful recovery; one developed intramyocardial abscesses
and expired during cardiac re-operation; one had recurrent fever and
dehiscence of the aortic and mitral valve prostheses and after two cardiac
re-operations is still in severe heart failure.
Conclusions: An inﬂammatory inﬁltrate in a valve excised for indications
other than endocarditis may be present in as many as 1% of such operations.
These inﬁltrates could be clinically signiﬁcant and warrant empiric anti-
microbial therapy.
P877 IVDA endocarditis in a tertiary hospital: a 22-year
retrospective study
J. Benes, M. Kabelkova, O. Dzupova
Prague, CZ
Objectives: A study to document the characterization and evolution of
infectious endocarditis in intravenous drug addicts (IVDA) in Prague, the
capital of the Czech Republic.
Methods:A retrospective study on IVDA endocarditis patients who have been
hospitalized in the Department of Infectious Diseases since 1980. The data of
postdischarge condition of patients were collected with phone or personal
contacting the patients, their families, or GPs.
Results: In years 1980–2002, 29 episodes of endocarditis in 26 intravenous
drug addicts (14 men: 12 woman) were treated in our Department. The
patients were 18–36 years old; the average age was 26 years. The etiology was
Staphylococcus aureus in 22 episodes (76%), Streptococcus mitior (1), and
Neisseria cinerea (1). Culture negative endocarditis due to previous antibiotic
treatment was found in 5 episodes (17%). Vegetations were localized on the
tricuspid valve in 21 patients (72%), on the aortic and/or mitral valve in 5
patients (21%), and on the both left-side and right-side valves in 2 patients
(7%). Predisposing condition other than narcomania was found in 1 patients;
it was a bicuspid aortic valve. Twenty-three episodes were cured. Relapses
(>30 days and <1 years after stopping the antibiotic treatment) occurred in
four of them. The relapses began 36 days till 3months after stopping the
antibiotic cure. Six patients (21%) died. The reasons were multiple organ
failure (2), lung failure (2), congestive heart failure þ brain embolism
(1), and massive lung embolism (1).
Conclusions: The prevalence of IVDA endocarditis has been rising: There
were 4 episodes in 1980–89, 2 episodes in 1990–94, 15 episodes in 1995–99,
and 8 episodes in a 3-year period of 2000–2002. This trend correlates with the
prevalence of narcomania in the Czech Republic.
P878 The comparison of 154 infective endocarditis cases
for etiology, prognosis and treatment between two time
periods (1992–2001 and 1978–92)
M. Baskurt, B. Kocazeybek, B. Okcun, S. Altun, S. Saribas, M. Aslan,
S. Kucukoglu, H. Yuksel
Istanbul, TR
Introduction: Infective endocarditis (IE) is a major cause of mortality and
morbidity in Turkey which rheumatic hearth diseases is still a serious health
problem, against new improved techniques and treatment protocols.
Methods: The microbiological and laboratory results with the clinical ﬁnd-
ings of 66 cases (42 male and 24 female), hospitalized and treated with the
diagnosis of IE were investigated for the treatment and prognosis in Cardiol-
ogy Institute between the years of 1992–2001 (II. period) for 10-year period
in this study. The results were compared with the similar parameters of 88
cases monitored between the years of 1978–92 (I. period).
Results: Speciﬁcally decreasing rheumatic hearth disease ratios against the I.
period was an important predispozone factor in the II. period with the ratio
of 48%. The positivity of the blood cultures were detected as 53% and 54%
in the I. and II. periods, respectively. Staphylococcus epidermidis was the
common microorganism isolated as 15 and 10 cases in I. and II. period,
respectively. The second isolated microorganism was Staphylococcus aureus, as
12 and 8 cases of I. and II. period, respectively. It was found a signiﬁcant
difference for the detection of prosthetic valve endocarditis in the II. period
against the I. period. It was not found a signiﬁcant relationship between
causative pathogen and death but the death ratio was decreased from 28% to
12.5% in cases with S. epidermidis and decreased from 40% to 17% in cases with
S. aureus.
Conclusions: As conclusion, in spite of a decrease in the last 10 years, acute
rheumatic fever and rheumatic hearth diseases are still important health
problems in Turkey. Besides that, prosthetic valve endocarditis cases were
increased signiﬁcantly when compared with the previous years. It was
detected that there was no signiﬁcant difference for the known causative
patterns in both of the I. and II. period. It was concluded that, the mortality
and morbidity of IE were decreased with increasing personal hygiene,
improving medical approaches and new therapy methods.
Opportunist infections in immunocompromised hosts
P879 Opportunistic infections in patients treated with
Inﬂiximab: experience from a single institution (1999–2002)
C. Garcı´a Vidal, J. Martı´nez Lacasa, M. Esteve, F. Ferna´dez Ban˜ares,
F. Moya`, J. Pujol, J. Garau
Terrassa, E
Introduction: Inﬂiximab is a humanized monoclonal antibody against TNF-
alpha approved for the treatment of selected patients with rheumatoid arthritis
(RA), Crohn’s disease (Cd) and others. TNF-alpha is a cytokine implicated in
the initial immunologic response to infection.
Objective: To describe the epidemiology and risk factors for opportunistic
infection in patients treated with inﬂiximab in our institution.
Methods:Retrospective analysis of all patients treated with inﬂiximab in our
center between 1999 and 2002. Since 2001, PPD testing was routinely
performed in all patients prior to initiation of inﬂiximab. All PPD positive
patients had a chest X-rays; treatment of latent disease was done with isoniazid
during 9months.
Results: Sixty-four patients had been exposed to inﬂiximab (45 rheumatoid
arthritis, 6 ankilosing spondiloarthropaty, and 13 with Crohn’s disease). 47
were women, mean age was 45 years old, 52 in RA and 38 in Cd (P¼ 0.02).
RA group received more inﬂiximab dosage during more time than Cd group.
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PPD tests were positive in four patients, all in AR group, that were treated
with isoniazid. Another four patients (6.2%) developed opportunistic infec-
tion: three had tuberculosis and one visceral leishmaniasis. All tuberculosis
were extrapulmonary and/or disseminated (two cases of miliary TB and one
with gastrointestinal, hepatic and lung involvement). Previously treatment,
PPD testing and chest-X-rays were negative in all cases of diagnosed TB. One
patient had a paradoxical reaction 1month after start of treatment. All patients
responded to treatment. The patient that developed Kala Azar 4months after
inﬂiximab therapy, had an excellent response to amphotericin lipidic complex
therapy. No one in Cd group developed opportunistic infection.
Conclusions:Our data support an association between inﬂiximab and oppor-
tunistic infections as previously reported. TB was the most frequent infection,
presenting as a disseminated or extrapulmonary illness. Screening for TB
infection is needed in this population before the start of inﬂiximab therapy.
Anergy status could be a problem due to basal immunodepression and TLIT
should be considered in PPD-negative patients with known previous TB
contact. To our knowledge, leishmaniasis has not been previously described in
this setting.
P880 Mycobacterium tuberculosis in patients with
cancer and marrow transplantation (1990–2000)
A. Safdar, K. Jacobson, D. Kontoyiannis, K. Rolston, I. Raad
Houston, USA
Objective:Mycobacterium tuberculosis remains a serious cause of morbidity and
infection-associated death worldwide. Patients with defects in cellular
immune response have increased risk of reactivation and tuberculosis in this
setting may lead to systemic dissemination. Characteristics of M. tuberculosis
infection in susceptible patient population in a region of low endemicity were
studied.
Methods: Retrospective analysis during 1990–2000 was performed in
patients receiving care at The University of Texas, M.D. Anderson Cancer
Center. All patients with HIV-I, and HIV-II infection were excluded.
Results: In 30 patients, 19 (63%) had hematological malignancy; head and
neck involvement was most common (n¼ 4; 36%) among solid-organ cancer.
Eighteen (60%) were foreign-born, and 4 (13%) had received systemic
corticosteriods. Fever was present in 97%, hemoptysis (30%), and night
sweats (27%) were less common. In greater than half of pulmonary infections
(n¼ 11; 58%), lung lesions were initially mistaken for a neoplasm. No
multidrug-resistant strain was identiﬁed, and in 20% (n¼ 7 of 29) death
was attributed to tuberculous infection, 57% (n¼ 4) of these had received
high-dose systemic corticosteroids (P< 0.001).
Conclusions: Tuberculosis was uncommon in patients undergoing treatment
for cancer, and mostly occurred in persons born outside of the US. Treatment
with high-dose, systemic corticosteroids signiﬁcantly increases mortality in
cancer patients with M. tuberculosis infection.
P881 The prevalence rate of Cryptosporidium in
patients receiving immunosuppressive drugs in Amircola
Pediatrics Hospital, Iran, 2002
H. Ziaee, M. Sharif
Sari, IR
Objective: Cryptosporidiasis is one of the problems in patients receiving
immunosuppressive drugs. Considering the presence of broad range of clinical
manifestations in such patients, following secondary infections, longevity of
patients, the new methods of treatment and prevention, are continually in
change. Hence, the aim of this study was to determine cryptosporidium parvum
in 100 patients receiving immunosuppressive drugs considered as the test
group and another 100 patients with gastroenteritis but nonimmunosuppres-
sive drugs users, as the control group.
Methods: The patients under study were 100 for test and 100 for control,
which were matched for sex, age, geographic conditions of the residing places
(rural and urban areas). All the data concerning the patients such as age, sex,
the kind of disease, the kind of drug used, the doses being used, contact with
animals, the kind of drinking water, the place of living, duration of che-
motherapy and the other clinical symptoms were obtained from the ques-
tionnaire. From the test and control groups, stool samples were collected
thrice, and were stained by Ziehl–Neelsen and modiﬁed Ziehl–Neelsen
methods. The results were analyzed statistically.
Results: The results of the study indicate that the rate of infection in test and
control groups is 5 and 6%, respectively. The average infection rate was (5.5%).
There was no signiﬁcant difference in the rate of infection between test and
control groups statistically (Z¼ 0.3). The highest rate of infection was
observed in the age groups of 4–6 years and 6–8 years in the test and control
groups, respectively. There was no signiﬁcant difference between sex and the
rate of infection. The highest rate of infection was observed in patients with
acute lymphatic leukemia, and the number of drugs used had no effect on the
rate of infection.
Conclusion: The result of this study indicates that more accurate laboratory
diagnostic study of this parasite in more individuals with normal and
suppressed immune system is required.
P882 Evaluation of the etiology of infections in
patients with hematological malignancies
V. Tchebotkevitch
St-Petersburg, RUS
Objectives: To evaluate the incidence and distribution of infective agents in
patients (pts) with hematological malignancies with primary Respiratory
Syncitial viral (RSV) infection.
Methods: Retrospective analysis of all primary episodes (eps) of RSV
infections at Hematological clinic was performed. Serological and PCR tests
on viral pathogens and swabs from clinically suspect sites were taken.
Additionally blood samples were collected and tested microbiologically.
Results: Fifteen eps of RSV infection were studied. All eps were diagnosed
during the period of chemotherapy for hematological malignancies (3,
chronic leukemia; 3, multiple myeloma; 6, acute leukemia). The RSV
infection in four cases was diagnosed before eps of CMV and in one case
before herpes virus 6. In these cases the treatment with IVIG ‘Intraglobulin’
(Biotest, Germany) plus aciclovir (GlasxoSmithKline, GB) reduced the
clinical manifestations of disease. Bacteria were isolated from blood cultures
in seven eps after RSV infection. These seven isolates were found: Streptococcus
pneumoniae – four cases, Staphylococcus aureus – two cases and Klebsiella
pneumoniae – one case.
Conclusion: Complex virological and microbiological control must be per-
formed in eps of infections in pts with hematological malignancies in order to
correct therapy regimen.
P883 Fever of unknown origin caused by primary CMV
infection in a patient with Behcet syndrome
A. Mert, R. Ozaras, S. Sipahi, E. Ayata, F. Tabak, R. Ozturk
Istanbul, TR
Objectives: Fever of unknown origin (FUO) is a diagnostic challenge for the
physician and needs both knowledge and experience. We could not ﬁnd any
report of CMV infection developing in a patient with Behc¸et syndrome (BS)
and causing FUO (Medline 1966–2002). We reported such a patient pre-
sented with FUO and diagnosed as a primary CMV infection.
Case report: A 30-year-old-male was admitted with severe fever and shaking
chills of 2 days. He reported a history of Behc¸et’s disease of 2 years and use of
azathioprine and cyclosporine A for recent 4months. On examination, he
appeared moderately ill. Temperature was 40.3 8C, pulse 120 beats/min, and
blood pressure 100/60mmHg. A mild, evanescent maculopapular rash was
noted on face, neck, and dorsum. The remaining systems were normal.
Hematocrit was 36%, WBC 3000/mm3 (stab 8%, PNL 72%, and L 20%), plt
107 000/mm3, ESR 44mm/h, CRP 170mg/L (N :<5). Azathioprine and
cyclosporine treatment was discontinued. On follow-up, the fever continued,
and the rash did not persist. An infectious focus could not be found.
Leukocytes decreased to 1500/mm3 and CRP level increased to 34 times
of normal. He was as febrile neutropenic and initiated imipenem. Remitting
fever persisted despite the therapy and CRP level did not decrease. He
developed hepatosplenomegaly (3 cm each), and muscle pain. Liver enzymes
were above three times of normal and bilirubin level was high (1.6 g/dL).
ThenWBC and plt counts increased to normal. The cultures remained sterile
and the antibiotics were discontinued. Brucella tests, abdominal USG and CT
revealed hepatosplenomegaly. Doppler USG of portal vein and lower extre-
mities, echocardiography, ophthalmic examination, and chest X-ray were
normal. The fever persisted for 4weeks and efforts to ﬁnd out the etiology
lacked. Then his temperature seemed to decrease spontaneously. On 10th day,
CMV-IgM was weakly (þ) by ELISA, CMV-IgG being (–). CMV-68 kDa
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antigen in leukocytes, CMV-DNA in both plasma and leukocytes were (þ).
CMV-IgM was measured two times (1week apart) were (þ). The corre-
sponding CMV-IgG which was initially (–) measured as 2.4 ISR and 3.6 ISR
(N< 1.1). At 30th day of the fever, CMV-DNA became (–). The tempera-
ture, liver enzymes and CRP levels normalized within 4weeks. He was
discharged as healthy and 3months after, CMV-IgM was (–) and IgG was 4.6
ISR. In conclusion, CMV infection should be considered in patients with BS
receiving immunosuppressive therapy.
P884 Focal lymphatic abscess due to Salmonella
enteritidis
U¨. G. Bahar, Z. Dansuk, S. Kocatu¨rk, T. C¸akir, V. Hacioglu, A. Mert
Ankara, TR
A 45-year-old-type II diabetic woman was admitted to the hospital in
November 2002 with right sided swelling and pain of the neck for 16 days.
She had fever and difﬁculty in swallowing. The mass was ﬁrst noticed 16 days
prior to admission and became progressively larger and more tender. Except
for the diffuse mass in the right submandibular region of about 60 50mm in
size, ﬁndings from physical examination were normal (i.e. without peripheral
lymphadenopathy). Her medical history was not characteristic except for type
II diabetes mellitus (unregulated) since 1998 and a history of dental abscess
prior to the mass. Blood and urine cultures were sterile and stool culture
revealed no pathogenic microorganisms on three separate occasions. An
abscess specimen was processed using an automated monitoring system
(BACTEC 9050; Becton, Dickinson and Company, Franklin Lakes, NJ),
and it was positive for growth of a microorganism on the second day of
incubation. Subcultures were plated on 5% sheep blood agar and eosin-
methylene blue agar and incubated aerobically at 35 8C. After 24 h of
incubation, Gram-negative bacillary microorganisms were seen at Gram stain
of lactose negative colonies. Biochemical tests of the strain suggested that the
microorganism was Salmonella spp. Subtyping according to Kauffmann–
White using speciﬁc antisera (Denka-Seiken, Tokyo, Japan) deﬁned that
the isolate was S. enteritidis. Computed tomography revealed 60 50mm
conglomarate formed lymphadenopathy inferior to the right parotid adjacent
to submandibular gland. An ultrasonography of the gallbladder was normal.
Treatment consisted ciproﬂoxacin 2 2 g and metronidazole 4 1 g. Abscess
was drained spontaneously on the 10th day of antimicrobial therapy. A review
of the literature by medline found one previous report of focal suppurative
lymphatic abscess due to S. typhi. In this case the ﬁrst submandibular
suppurative lymphatic abscess caused by S. enteritidis in a diabetic woman is
reported.
P886 Prevalence of respiratory Syncytial virus infection
in cancer patients
C. Petrochilou, V. Karabassi, S. Karachalios, N. Alexandropoulos,
S. Kastellanos, C. Kontou-Castellanou
Athens, GR
Objectives: The purpose of this study was to determine in serum of cancer
patients antibodies IgA and IgG against respiratory syncytial virus (RSV).
Methods: During December 2002 was collected sera from 80 cancer in-
patients. Fifty of them had lung cancer (Group A) and the rest 30 (Group B)
other types of cancer. All the sera were tested for detection of antibodies IgA
and IgG against RSV by the micro-Elisa in plates method (Serion).
Results: Of the 80 cancer patients, 25 (31.2%) were positive for IgA RSV
antibodies and 8 (10%) for IgG RSVantibodies. Of the 50 patients with lung
cancer (Group A) 15 (30%) were positive for IgA RSVantibodies and 4 (8%)
for IgG RSVantibodies. From Group B 10 patients (33.3%) were positive for
IgA RSV antibodies and 4 (13.6%) were positive for IgG RSV antibodies.
Conclusions:Our study shows that the prevalence of RSV in cancer patients is
low (10%) but the frequency of RSVactive infection is intermediate (31.2%)
during the winter months.
P887 Prevalence of Adenovirus infection in cancer
patients
C. Petrochilou, S. Karachalios, V. Karabassi, M. Pouyouka, S. Kastellanos,
N. Strandzalis, C. Kontou-Castellanou
Athens, GR
Objectives: The purpose of this study was to determine in serum of cancer
patients antibodies IgA and IgG against Adenovirus.
Methods: During December 2002 was collected sera from 80 cancer in-
patients. Fifty of them had lung cancer (Group A) and the rest 30 (Group B)
other types of cancer. All the sera were tested for detection of antibodies IgA
and IgG against Adenovirus by the micro-Elisa in plates method (Serion).
Results:Of the 80 cancer patients were positive 72 (90%) for IgG Adenovirus
antibodies as well as 44 (55%) for IgA Adenovirus antibodies and all of them
were also positive for IgG Adenovirus antibodies. Of the 50 patients with lung
cancer (Group A) 21 (42%) were positive for IgA Adenovirus antibodies and
43 (86%) for IgG Adenovirus antibodies. From Group B 23 patients (76.6%)
were positive for IgA Adenovirus antibodies and 29 (96.6%) were positive for
IgG Adenovirus antibodies.
Conclusions: This study showed that (1) there is a high Adenovirus infection
prevalence (90%) and high frequency of Adenovirus active infection (55%).
(2) There was not signiﬁcant difference of adenovirus infection frequency
between the two groups of cancer patients.
P888 Risk factor associated with coagulase negative
Staphylococcus colonization of cancer patients
S. F. Costa, A. A. Barone, A. S. Levin, E. Anaissie
Sa˜o Paulo, BR; Arkansas, USA
Objective: To evaluate the prevalence of coagulase negative Staphylococcus
(CNS) colonization in cancer patients with positive CNS blood culture, the
most frequent site colonized and risk factor associated with CONS coloniza-
tion in cancer patients.
Methods: To assess factors associated with CNS colonization, colonized
patients were compared with noncolonized patients. Univariate statistical
analyzes were conducted using the program EPIInfo 6.04 (CDC). Chi-square
test and Student’s t-test were used for categorical variables. For the quanti-
tative variables the Kruskal–Wallis test was used. Odds Ratio (OR) and 95%
conﬁdence interval (95% CI) were calculated, the level of signiﬁcance was
P< 0.05. A multivariate model was built using the program Statistics/Data
Analysis 7.0 (STATA) 2001. Variables which had a P-value of less than 0.1 in
the univariate analysis were included in the multivariate model.
Results: Surveillance cultures (nasal swab, swab of skin on the site insertion of
central venous catheter and retal swab) were performed in 60 cancer with a
positive surveillance culture. Of these, 20 (34%) patients were classiﬁed as BSI,
14 (21%) as contaminants and 26 (45%) as possible BSI. Thirty-six patients
were male, the age ranged from 27 to 81 years old (median of 59.5) and 31
(52%) were hospitalized. The most frequent underlying diseases was multiple
myeloma (88%), 33 patients (69%) were submitted to bone marrow transplant.
Mucositis was present in (38%), graft vs. host diseases in 2% and neutropenia in
50% of patients. Sixty-one percent had received levoﬂoxacine prophylaxis and
75% were under systemic antibiotic before the collection of blood culture.
Fifty patients (83%) had a positive surveillance culture to CNS. Nose was the
site most frequently positive to CNS (62%), following by gastrointestinal (GI)
tract (32%), and skin on the insertion site of CVC (30%). Mucositis grade II
(P¼ 0.0023) was associated with colonization due CNS and neutropenia
(500/mm3) (P¼ 0.004) and severe neutropenia (100/mm3) (P¼ 0.006) were
associated with colonization of GI tract by the univariate analysis. However,
only severe neutropenia remained signiﬁcant in the multivariate analysis
(P¼ 0.0036).
Conclusion:Our results suggest that cancer patients are usually nasal colonized
by CNS and that severe neutropenia is associated with GI tract colonization by
CNS.
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P889 The effect of oral zinc supplementation on
oropharyngeal infection agents in patients receiving
radiotherapy and chemotherapy for head and neck cancer
A. Ozbek, V. Ertekin, H. Uslu, I. Karslioglu, E. Ozbek, O. Aktas
Erzurum, TR
Objectives: Oral zinc supplementation is able to reduce the frequency of
infectious diseases owing to opportunistic microorganisms. For this reason,
we aimed to investigate the effect of oral zinc supplementation on orophar-
yngeal infection agents in the immunocompromised host.
Methods: Thirty patients receiving radiotherapy and chemotherapy due to
head and neck cancer were included in this study. Patients were between 18
and 71 years old. They were divided into two groups: 15 patients were given
zinc (150mg/day¼ 3 Zinco 220 capsules per day) orally (treatment group),
and other 15 received empty capsules as placebo (control group). All patients
took the capsules everyday throughout the course of therapy and 6 more
weeks. No patients received any antibiotic chemotherapy during the term of
oral zinc supplementation. The oropharyngeal samples from the patients were
collected four times: 1 day before the ﬁrst course of radiotherapy and
chemotherapy, 1 day after the last course of radiotherapy and chemotherapy,
1 and 6 weeks after the therapy. The samples obtained by swab technique were
cultured and investigated for bacterial and fungal pathogens by usingmicrobial
diagnostic methods and the gas chromatography method (Microbial Identi-
ﬁcation System).
Results: Coagulase positive and negative staphylococci, group A beta hemo-
lytic streptococci, Streptococcus pneumonia, and Candida spp. seemed as oppor-
tunistic infection agents in both groups according to the culture results. We
found a decrease in amount of colonizedCandida spp., coagulase negative and
positive staphylococci in the treatment group in comparison with control
group. But, any difference in amounts of group A beta hemolytic streptococci
and S. pneumonia could not be seen between two groups.
Conclusions: However, oral zinc supplementation seems enough to prevent
the opportunistic infections especially from Candida spp. and coagulase
negative and positive staphylococci, we suggest low doses of antibiotics in
accordance with the antibiotic susceptibility test results for these pathogens,
along with oral zinc supplementation. Because any effect of oral zinc
supplementation on group A beta hemolytic streptococci and S. pneumonia
was not seen, it is essential to start the antimicrobial chemotherapy based on
antibiotic susceptibility test results before radiotherapy and chemotherapy
particularly in the presence of S. pneumonia.
P890 Oral cavity disinfection in prevention of
stomatitis in patients with immunosuppression during
systemic chemotherapy
W. Prejzner, E. Arlukowicz, A. Sledzinska, E. Czarniak, E.
Dziemaszkiewicz, A. Hellmann, A. Samet
Gdansk, PL
Introduction:Betadine solution is an iodide antiseptic with broad spectrum of
antimicrobial activity. Application of this agent on skin or mucosa eliminates
at least 85% microorganisms, which makes it one of the most effective
antiseptics.
Objectives: Estimation of betadine activity on microorganisms colonizing
nosopharynx of patients treated with chemotherapeutics. The main purpose
of the test was to check the level of microorganisms elimination from the
nosopharynx and to estimate of side-effects’ intensity (mucosal complications
after chemotherapy – WHO scale) in two groups.
Methods: In this work we compared two antiseptic agents in 31 patients
(Betadine and hospital pharmacy prepared solution), which demonstrated
leukopenia after chemotherapy. Those pts were treated in Hematological
Ward. 15 pts had to gargle betadine three times a day and 16 pts were a control
group (they used hospital pharmacy prepared solution). All of them had
bacteriological examinations (nosopharyngeal swab and saliva) before they
started using betadine and on 7th, 14th, 21st day of study. Samples were
identiﬁed by standard methods and disc – diffusion susceptibility testing was
done according to NCCLS.
Results:The patients were examined fromMarch 2001 to February 2002. 364
bacteriological tests were done. They included 109 nasal swabs, 107 phar-
yngeal swabs and 158 saliva samples. We noticed presence of multisusceptible
pathogens taken before the treatment in 15 cases, normal ﬂora in 16 pts. There
isolates were as followed: yeasts (49.3%), Gram-negative rods (37.7%), Gram-
positive cocci (13%). Besides we cultured multiresistant A. baumanni and
S. maltophilia in two cases (Table 1).
We did not observe correlation between gargling with antiseptic and the
number of microorganisms in nasal samples.
Conclusions: We conclude that Betadine gargled patients experienced faster
pathogen eradication and faster mucosal recovery comparing to hospital
pharmacy prepared solution.
P891 Application of N-chlorotaurine in rhinosinusitis
complicating immunosuppression following heart
transplantation
A. Neher, M. Gsto¨ttner, R. Geiger, M. Nagl, C. Pototschnig
Innsbruck, A
Objectives: Severe infections are a frequent problem complicating immu-
nosuppression following heart transplantation.N-chlorotaurine, a new endo-
genous antiseptic involved in innate immunity, is very well tolerated by
human tissue and promising in local therapy of infections.
Methods: We report about a heart-transplanted, immunosuppressed patient
suffering from bacterial sinusitis caused by Pseudomonas aeruginosa.
Results: In spite of repeated antibiotic therapy, septoplasty, conchotomy, and
fenestration of the sphenoid sinus bacterial cultures remained positive and the
infection persisted. It was ﬁnally cured by repeated irrigations using 1%
N-chlorotaurine solution for 7 days.
Conclusions: The combination of functional endonasal sinus surgery and
lavage with N-chlorotaurine proved to be an effective and well tolerated
therapy in antibiotic-resistant sinusitis during immunosuppression.
P892 Chronic Chlamydia pneumoniae infection and
risk of lung cancer
S. Konstantopoulou, S. Karachalios, A. Mourikis, E. Logothetis,
N. Strandzalis, S. Demeridou, C. Kontou-Castellanou, E. Kouskouni
Athens, GR
Objective: To evaluate the association of past infection with Chlamydia
pneumoniae (C.pn) with subsequent risk for development of lung cancer.
Methods: 80 cancer in-patients from Saints Anargyri Oncological Hospital
(44 men and 36 woman, aged 40–65 years) with histologically conﬁrmed
invasive carcinoma of lung, were prospectively examined. 45 (56.25%) cases of
cancer patients were small cell, 24 (30%) squamous cell, 5 (6,25%) adeno-
carcinoma and 6 (7.5%) large cell carcinoma. 100 healthy subjects (70men and
30 women) aged 38–62 years were included as control group. In cancer
patients and control cases 45% were smokers. In total 180 sera samples from
cancer patients and healthy subjects were examined for the presence of IgG,
IgA and IgM antibodies against C.pn. Speciﬁc antibodies against C.pn were
performed by ELISA method.
Results: In patients group the presence of speciﬁc IgG, IgA and IgM
antibodies against C.pn was 58.75, 18.75, and 0%, respectively. The percen-
tages in control group were 30, 7, and 0%, respectively.
Conclusion:Higher levels IgG and IgA antibodies against C.pn were detected
in cancer patients than in control group. In cancer patients 55-year-old-or
younger who were smokers with small cell carcinoma or squamous cell
carcinoma were diagnosed chronic C.pn infection more frequent. These
results were indicated that chronic C.pn infection is possible to play a role in
increasing the risk of lung cancer but the studies must continue with a larger
number of cases.
Table 1
Results Betadine (%) Control group (%)
Erradication 33 6
Failure 66 56
Changes of flora 0 37
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P893 Serological evaluation of antibodies against
herpes viruses CMV and EBV and Helicobacter pylori in liver
cirrhosis
S. Konstantopoulou, T. Avramidi, E. Nikitidis, C. Drakoulis,
A. Mourikis, S. Dourakis, M. Minadaki, M. Savvala
Athens, GR
Objective: The detection of IgG and IgM antibodies against herpes viruses
CMV and EBV as well as IgG and IgA antibodies against Helicobacter pylori
(H.P.) in cirrhotic patients.
Methods: 114 cirrhotic patients documented by biopsy were examined.
72 of them were men and 42 women aged 49–70 years. 100 healthy persons
(70 men and 30 women) aged 45–68 years were included as control
group. Speciﬁc IgG and IgM antibodies against CMV and EBV (VCA) as
well as IgG and IgA antibodies against H.P. were performed by ELISA
method.
Results: IgG seropositivity to CMV, EBV (VCA) andH.P. in cirrhotic patients
was 92.98, 71.92, and 59.64%, respectively. IgM seropositivity to CMV and
EBV (VCA) in patients group was 10.52 and 14.03%, respectively, while IgA
seropositivity to H.P. was 19.29%. In control group, positive IgG antibodies
against CMV, EBV (VCA) and H.P. were found 87, 70 and 43%, respectively.
Positive IgM antibodies against CMV and EBV (VCA) weren’t detected
in control group cases while IgA antibodies to H.P. were detected in
11%.
Conclusions: (1) There isn’t signiﬁcant difference in IgG seropositivity to
CMV and EBV (VCA) between cirrhotic patients and control group cases.
On the contrary a signiﬁcant difference appears for HP. (2) Various levels
of IgM antibodies to CMV and EBV were detected in patients group.
In control group weren’t detected IgM antibodies. Higher levels IgA anti-
bodies to H.P. were found in cirrhotic patients in relation with control group
cases.
P894 Detection of IgG and IgM antibodies against
herpes viruses CMV and EBV and parvo-virus B-19 in
patients with beta-thalassemia major
S. Konstantopoulou, M. Papachristodoulou-Pantou, M. Drosou-Servou,
L. Foudoulaki-Paparizou, E. Vigla, H. Lymperopoulos, A. Moschou,
M. Savvala
Athens, GR
Objective: The occurrence rate of IgG and IgM antibodies against herpes
viruses CMV and EBV and Parvovirus B-19 in polytransfused patients with
beta-thalassemia major.
Methods: 76 patients with beta-thalassemia major were prospectively exam-
ined. 28 of them were men and 48 women aged 13–48 years. 100 healthy
persons (70 men and 30 women) aged 20–45 years were included as control
group. The detection of speciﬁc IgG and IgM antibodies against CMV, EBV
and Parvovirus B-19 was performed by ELISA method.
Results: Positive IgG antibodies against CMV, EBV (VCA) and Parvovirus B-
19 were found in 69 (90.78%), 59 (77.63%) and 49 (64.5%) thalassemia-
patients, respectively, while in control cases positive IgG antibodies were
found to CMV in 85 (85%), to EBV (VCA) in 70 (70%) and to Parvovirus in
65 (65%). Positive IgM antibodies to CMV in patients group were found in 3
(3.94%), to EBV (VCA) in 4 (5.26%) and none in patients against parvovirus
B-19. Positive IgM antibodies to CMV, EBV and Parvovirus B-19 weren’t
found in anyone of the control group.
Conclusion: IgG seropositivity to CMV, EBV and Parvovirus B-19 in
thalassemia patients group was similar with control group cases as well as
IgM seropositivity to parvovirus B-19. IgM seropositivity to herpes viruses
EBV and CMV seems to be signiﬁcantly higher in patients with beta
thalassemia major than in control group cases. These results are probably
due to the large number of blood transfusion that this group of patients
undergo and/or to immunosuppression of beta-thalassemia patients.
Clinical and epidemiologic aspects of HIV infection
P895 Evaluation of HIV-related nucleic acids and
Papillomavirus DNA in cervicovaginal secretions of
HIV-positive women
F. Zara, A. Spinillo, R. Brerra, C. Bergante, E. Nucleo, B. Gardella,
R. Migliavacca, M. Spalla, L. Pagani, E. Romero
Pavia, I
Background: Human immunodeﬁciency virus (HIV)-seropositive women
represent an important population at risk for acquiring cervical cancer and
thus require frequent screening.
Objectives: To assess simultaneous HIV-related nucleic acids and human
papillomavirus (HPV)-DNA in cervicovaginal secretions of a cohort of
known HIV-seropositive women (no. 130).
Methods: Vaginal swabs were collected to diagnose infection by candida,
trichomonas, or bacterial vaginosis. Proviral HIV-DNA, cell-associated and
cell-free HIV-RNA in cervicovaginal secretions were analyzed using com-
petitive polymerase chain reaction (PCR) and reverse transcription PCR.
HPV types 6, 11, 16, 18, 31, 33, 35 and 56 were detected using PCR and
subsequent restriction fragment length polymorphism analysis of PCR
products.
Results: Proviral HIV-DNA, cell-associated and cell-free HIV-RNA were
detected in 75 of 130 (58%), 51 of 130 (39%), and 45 of 130 (35%) lavage
samples, respectively. 81 of 130 (62%) women had HPV-DNA in cervicova-
ginal secretions. The rate of HPV infection was related to severity of
cytologically diagnosed squamous intraepithelial lesions. The rate of
detection of HPV types of intermediate to high oncogenic risk was higher
in HIV-positive women who tested positive for cell-associated or cell-free
HIV-RNA in cervicovaginal secretions than negative subjects. Vaginal infec-
tion was more frequent among women who tested positive for cell-associated
or cell-free HIV-RNA in cervicovaginal secretions compared with negative
women.
Conclusions: The rate of HPV infection increases among women with high
HIV viral loads in cervicovaginal secretions.
P897 A survey of the knowledge and preventive
measures of HIV/AIDS in the New Juabeng District of
the Eastern region of Ghana
F. K. Ofei, A. Offei
Kumasi, GH
Objectives:HIV/AIDS pandemic has thrown a great challenge to the public
health services of the world. Since the pandemic began, more than 60 million
people have been infected with the virus. It is now the leading cause of death
in the Sub-Saharan Africa. At the end of the year 2001, an estimated 40
million people globally were living with HIV/AIDS. The increase in HIV/
AIDS cases, especially in the rural folks could be attributed to several social
factors including formal education. Cross-sectional study was conducted in
the New Juabeng District in the Eastern Region of Ghana to access the level
of knowledge of the people on HIV/AIDS and its preventive measures in
relation to their level of formal education and religious beliefs.
Methods: The survey instrument was an interview guide, which contained a
mixture of open ended and close-ended questions. Respondents were inter-
viewed after their house numbers had been randomly selected from a box.
Results: About 77% of the respondents were within the ages of 15–25 years
representing the sexually active group in society. All respondents with
secondary or tertiary education knew that, contact with infected needles
and blades, unprotected sex and contact with infected blood were means of
HIV transmission. About 97% of those with secondary education, 44% of
those with junior secondary school education and 42% of those with primary
or no formal education knewmother to child transmission of HIV. Signiﬁcant
population, that is, 12% of those with primary or no formal education knew
no methods of HIV transmission whilst another signiﬁcant population, that is,
4% of those with junior secondary school education did not know any
method of HIV transmission.
Conclusion: All the people had heard of the disease HIV/AIDS but the level
of formal education of the respondents markedly inﬂuenced an in-depth
knowledge of the disease. Those with higher levels of formal education are
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better informed. Religion also had an inﬂuence on the choice of preventive
methods used by the respondents in HIV prevention. An improvement in the
literacy levels of individuals as well as a modiﬁcation of their religious beliefs
would therefore greatly increase their level of knowledge on HIV/AIDS.
P899 Co-infection by hepatitis viruses in a monocentric
cohort of 248 HIV-infected patients in a suburb of Paris
during the era of HAART
O. Launay, E. Gordien, A. Guillou, P. Honore´, P. Cohen, B. Jarrousse,
N. Me´main, O. Bouchaud, L. Be´larbi, P. Deny, M. Robineau,
L. Guillevin, O. Lortholary
Bobigny, F
Objectives:To investigate the prevalence and characteristics of infections with
hepatotropic viruses in a cohort of HIV-infected patients from a University
Hospital in the suburb of Paris.
Methods: Two hundred and forty-eight consecutive HIV-infected patients
(pts) attending the outpatients clinic (May–November 2001) were prospec-
tively studied for socio-demographic, epidemiological, clinical and routine
biological data. Anti-HAV and anti-HCV IgG antibodies (Ab), HBsAg and
HbcAb were measured in all pts. HCV RNA and serotype genotype were
determined in all HCV-positive pts and HBsAb in all HBcAb-positive pts;
HbeAg, HbeAb and VHB-DNA in all HBsAg-positive pts and in case of
isolate HBcAb. Anti-HDV IgG Ab and HDV-DNA were measured in all
HBsAg-positive pts.
Results: The mean age of pts was 39.8 9.7 years; 26% were females, 28%
were intravenous drug users (IVDU) and 3% had received contaminated
blood or blood products. Thirty percent were born in Sub-Saharan Africa.
Thirty-ﬁve percent had declared AIDS. Eighty percent were ongoing current
antiretrovirals; median CD4 and HIV-RNA were 345/mm3 [2–2172] and
3750 copies/mL [<20–>500,000], respectively. The overall anti-HAV Ab
prevalence was 79%: 84% in Sub-Saharan African pts, 66% in pts born in
France and 73% in IVDU. The overall prevalence of HCV IgG was 35%: 96%
in IVDU and 11% non-IVDU. Seventy-four percent of HCVAb-positive pts
had detectable HCV-RNA (55% type 1, 21% type 3, 10% type 4, 3% type 2,
10% untypable). Fifty-two percent of HCV-Ab positive pts undergone liver
biopsy (20% hadMetavir F4) but only 23% of them had been treated for HCV
infection. Nine Sub-Saharan African pts were HCV positive (type 2, n¼ 2;
type 4, n¼ 2; untypable n¼ 2). Twelve pts (5%) had positive AgHBs (ﬁve
native from Sub-Saharan Africa) among whom two had positive AgHBe,
three had positive DNA-HBVand two DNA-HDV. Nineteen percent of all
pts had isolated positive HbcAb with no detectable DNA-HBV. Overall, 26%
of pts had no marker of HBV infection and among HCV-RNA and/or
AgHBS positive pts, 1/3 had no HAV IgG.
Conclusion: In our cohort of HIV-infected pts: (a) a high seroprevalence of
HAV is observed, particularly in Sub-Saharan African and IVDU pts, (b) high
type 1 or 4 HCV prevalence (65%) may predict a low response rate to
antivirals, (c) immunization against HBVand HAV should be proposed to 26
and 33% of them, respectively.
P900 Late diagnosis of HIV infection in Portugal
A. Ferreira, N. Ribeiro, R. Serra˜o, C. Lima-Alves, R. Abreu,
R. Marques, H. Gomes, A. Mota-Miranda
Porto, P
Introduction: HIV infection has a high incidence in Portugal. Diagnosis is
nowadays easy, and information about transmission is well spread among
population. Nevertheless, a high number of patients (pts) and doctors are still
unaware of risk behavior, which leads to late diagnosis.
Objective: To evaluate the proportion of pts in whom the diagnosis of HIV
infection and AIDS are coincident, and to compare two periods 10 years
apart.
Patients andmethods: Study of clinical records of HIV infected pts, observed
in amajor central hospital, between 2000–2002 and 1990–1992. HIV pts were
included if the diagnosis of HIV infection and AIDS were coincident.
Demographic data, risk behavior, AIDS deﬁning disease and survival where
recorded.
Results: From 2000 to 2002, 899 HIV infected pts were observed for the ﬁrst
time. In the 171 (19%) pts in whom AIDS was diagnosed at admission, age
ranged from 14 to 67 years (x¼ 38 13 years); 143 (83%) were male. Risk
behavior was IDU in 96 (56%), heterosexuality in 69 (40%) and bisexuality in
2; in 4 risk was unknown. AIDS was deﬁned by tuberculosis in 78 (46%), PCP
in 31 (18%), cryptococcosis in 14 (8%), esophageal candidiasis in 12 (7%),
cerebral toxoplasmosis in 11 (6%), NH lymphoma in 6 (4%), KS in 5 (3%);
other diagnosis in 14 pts. Death occurred in 64 (36%) pts, 0–835 days after
diagnosis; 47 (73%) fatalities were in the ﬁrst 6months. In the tables we
compare the two 3-year periods. (see Tables 1 and 2).
Conclusion: Late diagnosis of HIV infection is still common. Heterosexuals,
not aware of the risk, do not perform screening tests, and IDU’s are difﬁcult to
reach populations. Tuberculosis is common, according to the high prevalence
of M. tuberculosis infection in Portugal. High early mortality is related to the
late diagnosis. Strategies to reach these patients sooner are urged.
P901 Biologic characterization of a HIV-1 isolate
involved in a primary infection associated with severe
hemophagocytic syndrome
C. Castilletti, M. R. Capobianchi, F. Carletti, S. Calcaterra,
G. Bernardini, R. Preziosi, C. F. Perno, O. Armignacco
Rome, Viterbo, I
Background: Symptomatic primary HIV infection is generally accompanied
by more rapid clinical progression than asymptomatic infection. We per-
formed biological characterization of an HIV-1 isolate involved in a primary
infection, presented as severe hemophagocytic syndrome, and compared the
properties of the newly transmitted virus to those of the donor virus.
Methods:Virus isolates were obtained by CD8-depleted coculture. Replica-
tion kinetics of the primary isolates were assessed by p24 release in super-
natants. HIV-1 coreceptor usage was determined by growth on U87-CD4
cells expressing CCR5 or CXCR4. V3 loop region was ampliﬁed by nested
RT-PCR. The amplicon underwent clonal sequence analysis, using Big Dye
terminator method with ABI Prism 310 sequencer. Phylogenetic analysis was
performed by the PHYLIP package software; inter- and intrapatient relation-
ships were assessed by building a phylogenetic tree (neighbor-joining pro-
gram).
Results: A 27-year-old-man was admitted to hospital with fever (40 8C), a
diffuse nonpruritic morbilliform rash, generalized adenopathy and hepatos-
plenomegaly. Primary HIV infection with a life-threatening hemophagocytic
syndrome was suggested by negative serology, presence of HIV p24 antigen,
and high VL values. Clinical symptoms disappeared promptly after starting
three drugs-based HAARTand VL became undetectable. The asymptomatic
viral source was identiﬁed and the virus was isolated from PBMC and plasma
of both donor and recipient. The biologic characteristics of virus isolates from
both donor and recipient were apparently indistinguishable for replication
efﬁciency, coreceptor utilization (CCR5) and predicted phenotype (M-R5).
Both isolates carried the I93L polymorphism of the protease gene. Molecular
analysis showed the presence of a virtually homogeneous V3 quasispecies in
the recipient, while highly divergent variants were found in the donor. The
unique viral population present in the patient corresponded to a minor
population of the donor quasispecies.
Conclusions: As frequently found during the early phases of HIV infection,
circulating viral quasispecies were genetically homogeneous in the recipient,
probably as the result of the transmission bottleneck. Biologic properties of the
isolate, together with V3 region aminoacidic sequence, indicating M-R5
phenotype, did not account for the aggressive course of the infection,
although it was promptly controlled by HAART.
Table 1 Patients with AIDS and HIV infection diagnosis coincident
Nr (%) Male
Age,
mean SD IDU Hetero Homo/bis Transfused Unknown
1990–1992 50/287 (17) 39 (78%) 37 10 13 (26%) 18 (36%) 12 (24%) 6 (12%) 1 (2%)
2000–2002 171/899 (19) 143 (84%) 38 13 96 (56%) 69 (40%) 2 (1%) – 4 (2%)
Table 2 AIDS defining disease
TB PPC Cryptoc.
esof.
cand. Toxo NHL KS
6months
mortality
1990–1992 11 (22%) 14 (28%) 3 (6%) 3 (6%) 4 (8%) 1 (2%) 6 (12%) 39%
2000–2002 78 (46%) 31 (18%) 14 (8%) 12 (7%) 11 (6%) 6 (4%) 5 (3%) 73%
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P902 A case of fatal lactic acidosis triggered by
amphotericin B in an AIDS-patient with visceral
leishmaniasis
S. J. Vandecasteele, B. Rijnders, P. De Munter, E. Van Wijngaerden
Leuven, B
Introduction: Although asymptomatic hyperlactatemia is common in HIV
infected patients, lactic acidosis (LA) is rare and severe. The factors triggering
the onset of LA are not yet well understood. A case of abrupt-onset and fatal
LA coinciding with the start of amphotericin B (amphoB) treatment is
reported. Thirty-four-year-old female ex-IV-drug user was diagnosed with
AIDS (VL> 750,000 copies/mL; T4 4/mm3), cryptococcal meningitis and
chronic HCVand HBV in October 2000. She was lost to follow-up. In April
2001, pancytopenia (Hb 9 g/dL, leucocytes 900 and 56,000 platelets/mm3)
and bacterial pneumonia was diagnosed and HAART (AZT, 3TC and
nelﬁnavir) was added to cotrimoxazol and ﬂuconazol. VL became undetect-
able and T4 cells rose to 54 cells/mm3. In May 2001 she was treated with
amphoB 0.7mg/kg per day for 2weeks for relapsed cryptococcal meningitis
without problems. Pancytopenia persisted. In September 2001 AZT was
switched to d4T. InMarch 2002, visceral leishmaniasis with pancytopenia and
massive bone marrow involvement was diagnosed. Treatment with amphoB
(0.7mg/kg per day) was started. Before start, anion gap, HCO3 and CK’s were
normal, and LDH slightly elevated (1.3 times ULN). Lactate level 3 days
before start of amphoB was normal (1.46mmol/L). In the 4 days following
the start of amphoB the patient developed vomiting, severe malaise and
muscle aches. A progressive decrease in HCO3 and an increase in anion was
noticed. At day 5, patient developed hypotension, severe dyspnea and stupor.
LA was diagnosed (lactate 13.0mmol/L, HCO3 5.1mmol/L, pH 7.22).
HAART and amphoB were stopped and vitamins, ﬂuids, HCO3 and dialysis
were started. At day 12, lactate (0.9mmol/L), pH (7.44) and HCO3
(24mmol/L) were normalized and amphoB (but not HAART) was restarted.
During the following 3 days, lactate increased again (2.6, 4.3 and 6.0mmol/
L). Despite maximal therapy, lactic acidosis persisted. The patient died
5weeks after start of amphoB due to LA and multiorgan failure.
Discussion: AmphoB causes distal renal tubular acidosis type I, with a
decreased renal Hþ excretion. No case of LA is linked to amphoB in the
literature. In this patient, the start of amphoB coincided with the abrupt onset
of LA. It may be prudent to monitor patients under HAART and amphoB
closely for LA.
Viral vaccines
P903 Decay of measles maternal antibody in infancy in
Indian children
G. Arunkumar, J. Rajeev, R. Jai Prakash, B. Nalini, P. G. Shivananda
Manipal, IND
Objective: Measles continue to be an important cause of mortality and
morbidity in developing countries including India in spite of the availability
of an effective vaccine. The effectiveness of the vaccination against measles
greatly depends on the level of measles maternal antibody (MMA) in the
blood during infancy. This study was done to determine the Geometric Mean
Titer (GMT) of MMA and its decay pattern in infancy in Indian children.
Methods:Cord blood samples from 200 new born infants and blood samples
collected from 122 children below 1.5 years who neither had natural measles
nor received measles vaccination was collected. Measles neutralizing antibody
in blood was detected by a microneutralization assay using Edmonston-
Zegreb vaccine strain of Measles virus (used in India) and the results were
expressed as milli International Units/Ml (mIU/mL) with reference to the
WHO 2nd International standard 1990 Anti-measles antibody.
Results: The anti measles neutralizing antibody titer varied from 62.5 to
16,000mIU/mL. The GMTof maternal measles antibody titer in the cord
blood was 942.80 3.364mIU/mL GMT of maternal measles antibody
titer in the infants blood showed a statistically signiﬁcant reduction with
an increase in age during the early part of the infancy and touched the
lowest 79.27 1.756mIU/mL by 7th month and there after remained in the
vicinity of 125mIU/mL (Fig. 1). At all age groups and in cord blood there was
a proportion of samples showed a GMT less than 125mIU/mL and the
number of children who had low GMTwas directly proportional to increase
in age. On the contrary, few children had high GMTeven after 9months of
age.
Conclusion: This study supports the earlier ﬁndings that GMT of measles
maternal antibody in infants blood decay as age advances and reaches a low
level below 125mIU/mL by the end of 6th month. We found that few
children had below 125mIU/mL even before they reach 6months of age
while some children possess a very high level of measles antibody in their
blood even after 9months of age. These ﬁndings explain the occurrence of
measles in infants below 6months as well as vaccine failure in children
vaccinated at 9months. Hence, determination of absolute titers of Measles
neutralizing antibody in infants blood prior to vaccination may prove to be
helpful in deciding the age of vaccination to get the maximum seroconver-
sion. This strategy could go a long way in achieving eradication of measles
from the world.
P904 Prevalence of measles maternal antibody in
newborns in Udupi, South India
G. Arunkumar, K. R. Rajesh, G. B. Vallab, P. G. Shivananda
Manipal, IND
Objective:Measles is the major cause of vaccine preventable deaths in infants
in the world. The ability of maternal antibody to measles virus to interfere
with seroconversion after vaccination is well known. This study was con-
ceived to determine the absolute level of measles maternal antibody (MMA)
in the cord blood of newborns in a south Indian district Udupi and to ﬁnd out
the factors affecting the MMA level.
Materials and method:Cord blood samples from 1031 new born infants was
collected. Measles neutralizing antibody in cord blood was detected by a
microneutralization assay using Edmonston–Zegreb vaccine strain of Measles
virus (used in India) and the results were expressed as milli International
Units/mL (mIU/mL) with reference to theWHO 2nd International standard
1990 Anti-measles antibody. The association of maternal and infant related
factors with MMA level in cord blood was compared using ANOVA by a
statistical program SPSS.
Results: The antimeasles virus antibody titer in cord blood ranged from 62.5
to 16,000mIU/mL with a geometric mean titer (GMT) of 1223
3.467mIU/mL. While 99% of cord blood samples showed a titer
125mIU/mL or more, 1% of samples had a titer of 62.5mIU/mL or less.
Various maternal and infant related factors such as mother’s age, parity, mode
of delivery, mother’s HIV status, mother’s blood group, baby’s sex, birth
weight and gestational age did not show any statistically signiﬁcant association
with MMA titers in cord blood.
Conclusion: The GMTof MMA titer in cord blood was 1223 3.467mIU/
mL. Considering the titer 125mIU/mL as the minimum detectable level the
prevalence of MMA in cord blood of infants was 99%. It is interesting to note
that 1% of cord blood had a titer less than 125mIU/mL indicating their
susceptibility to natural measles well before the age of routine vaccination. On
the other hand, many samples recorded a very high level of MMA.We did notFigure 1 Decay of Neutralizing Measles Maternal antibody in infancy.
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ﬁnd any of the maternal or infant related factors signiﬁcantly inﬂuencing the
level of MMA in cord blood. Determination of absolute MMA in cord blood
may a useful predictor in deciding the schedule for measles immunization to
get maximum beneﬁt in terms of seroconversion and coverage.
P905 Seroprevalence against measles, mumps and
rubella in vaccinated children with a dose of MMR according
to the type of vaccine received
J. C. Sanz, M. Ferna´ndez, M. J. Sagu¨es, R. Ramı´rez, L. Garcı´a-Comas,
F. De Ory
Madrid, E
Objective: To evaluate the seroprevalence and immunogenicity against
measles, mumps and rubella in children vaccinated with one dose of
MMR according to the type of vaccine received.
Methods: 122 children aged between 2 and 5 years and with one conﬁrmed
dose of MMR vaccine were studied. The detection of IgG against measles,
mumps and rubella was carried out by indirect ELISA (Enzygnost, Dade
Behring GmbH,Germany). The children were grouped according to the type
of vaccine administered: Triviraten (n¼ 78), Triple Vaccine MSD (n¼ 41)
and Priorix (n¼ 3). The seroprevalence percentages and the geometric mean
antibodies concentration (GMC) against each virus were calculated with
conﬁdence intervals of 95% (CI95%).
Results: The global seroprevalence against mumps, measles and rubella was,
respectively, of 55.7%, 92.6% and 98.4%. In children vaccinated with the
Rubini strain (Triviraten), the seroprevalence (43.6%, CI95% 32.6–55.3) and
the GMC of antibodies against mumps (354, CI95% 295–426) were sig-
niﬁcantly lower (P< 0.01) regarding the children vaccinated with Jeryl Lynn
(Triple MSD) (seroprevalence 78.1%, CI 62.0–88.9; and GMC 1000, CI95%
676–1479). No differences in the seroprevalence for measles or rubella were
obtained. However, the GMC of antibodies against measles were signiﬁcantly
lower (P< 0.01) in children vaccinated with the Edmonston Zagreb strain
(Triviraten) in relation to the children receiving the Enders strain (Triple
MSD) (977; CI95% 758–1258 vs. 2089; CI95% 1412–3090). By the contrary,
the GMC of antibodies against rubella were signiﬁcantly lower in children
vaccinated with Triple MSD (33; CI95% 25–42) than in the children
vaccinated with Triviraten (89; CI95% 74–107) (both vaccines include the
Wistar RA 27/3 strain).
Conclusions: The strain of mumps vaccine administered may have important
implications in the real status of protection (less protection in children
vaccinated with the Rubini strain). The meaning of the GMC differences
for both measles and rubella viruses depending the vaccine administrated is
more difﬁcult to establish, but seems to be clinically minimum.
P906 Measles vaccination in Greece: seroprevalence
in general population
A. Voyiatzi, G. Tzanakaki, S. Katsigaraki, S. Mouratogloy, H. Iliadis,
J. Kremastinou
Athens, GR
Objectives:Measles is primarily child’s disease caused by an RNAvirus and is
the major cause of mortality in malnourished infants and of morbidity in
immunosuppressed patients (HIV-patients) The aim of the present study was
to evaluate the coverage rate of measles vaccine in order to obtain data that
could be used to determine the vaccination policy in Greece.
Materials andmethods:A total of 775 serum samples were screened for IgM
and IgG antibodies whichwere obtained from 496males and 279 females aged
from 0 to 83 years. The IgM and IgG antibody titers against measles were
measured by enzyme immunoassay method (ELISA) (EIA-PanBio). Positive
were considered the samples having values of greater or equal to 11 PanBio
units, whereas negative were considered the samples having values less than or
equal to 9 PanBio units.
Results: Measles speciﬁc IgG antibodies were found to be positive in 81%
(627/775) of the serum samples. Particularly, IgG antibodies were found in
82.5% (409/496) and 78.1% (218/279) in the male and the female groups,
respectively. Low vaccination coverage, 58.3% (7/12) was observed in
children 0–2 years of age, whereas, 80% (36/45) of the children 2–5 years
of age were shown to be covered by the vaccine. Measles speciﬁc IgM and IgG
antibodies were found in 35 serum samples (22.1%), obtained from children
aged 0–20 years. Measles speciﬁc IgM antibodies were detected only in ﬁve
serum samples (4.9%) from children 6–20 years of age, whereas, only two
samples were found to have IgG and IgM antibodies in ages >20 years old. A
total of 19% from the examined population were not immunologically
covered (IgM and IgG negative) and belonged to all age groups examined
showing a great susceptibility to the age group of 40–50 years (26%).
Conclusions:The total population immune response against measles virus was
found to be 81%. The immune response was found not to be satisfactory
especially for the age groups 0–2 years (58.3%) and 40–50 years (74%)
according to the WHO recommendations that vaccination routine coverage
of the population should be >90%.
P907 Serologic response to three doses of
recombinant hepatitis B vaccine in 2–5-year-old-population
in the Community of Madrid
L. G-Comas, R. Ramirez, R. Castan˜eda, D. Barranco, J. C. Sanz,
P. Leon, F. De Ory
Madrid, E
Objectives:To describe the serologic response to the recombinant hepatitis B
vaccine in the 2–5 years old population living in the Community of Madrid
(CM) and who were vaccinated with a three-dose regimen, starting at birth.
Methods: 174 children aged 2–5 who had received three doses of vaccine,
starting at birth, were selected among those who participated in the latest
Seroprevalence Survey carried out in the CM from September 1999 to April
2000. Antibodies to hepatitis B virus antigen (AntiHBs) were measured
through EIA (Anti-HBs VITROS1 ECI, Ortho Diagnostic Systems Inc.).
Levels of antiHBs higher than 10 IU/mL were considered as protective.
Persistence of levels in a 2–5 years interval from the last dose is analyzed.
Results: Prevalence of antiHBs was 86.2% (CI 95%; 80.2–91.0%) in the
sample studied. No decreasing trend was found within the time interval
considered.
Conclusions: The low prevalence detected could be due to the loss of
antibodies after vaccination, as other authors have already observed, especially
during the ﬁrst year. However, serologic measurements were not made
immediately after vaccination, so that the initial response cannot be known.
Therefore, these results could be caused by an inadequate administration or
conservation of vaccine.
P908 Persistence of anti-HB antibodies in healthy
Iranian children vaccinated with recombinant hepatitis B
vaccine and response to a booster dose
A. Jafarzadeh, M. A. Sajjadi
Rafsanjan, IR
Objectives: Long-term protection against hepatitis B virus (HBV)is depen-
dent on persistence of anti-HBs antibodies and/or strong immunologic
memory. The aim of this study was to evaluate the persistence of anti-
HBs antibodies in healthy Iranian children 5 years after primary vaccination
and the response to a booster dose using recombinant HB vaccine.
Methods:Originally from February to October 1995 triple 10 mg doses of a
recombinant HB vaccine (Engerix-B) were administered i.m. at 0, 1.5 and
9months of age to 81 healthy Iranian neonates. Blood samples were collected
in November 2000, 5 years after completion of primary vaccination course.
Immediately a single booster dose of the same concentration was administered
i.m. to all children and peripheral blood was taken 4weeks after booster
vaccination again. The level of anti-HBs antibodywas quantitated in serum by
sandwich ELISA.
Results: At 5 years after completion of primary vaccination course, seropro-
tection (anti-HBs> 10 IU/L) was observed in 61/81 (81.5%) of children.
After booster dose 100% vaccinees developed protective level of antibody and
geometric mean titer (GMT) rose from 206 IU/L to 1278 IU/L. The
postbooster GMTwas found to be signiﬁcantly higher in comparison with
prebooster mean concentration (P< 0.0000001). Before and after booster
vaccination both seroprotection rate and GMTwere found to be higher in
females compared with male children but differences were not statistically
signiﬁcant.
Conclusion:These results indicated the existence of an effective immunologic
memory over period of 5 years after primary vaccination with HB
vaccine.
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P909 Antibody response of an adjuvanted inﬂuenza
vaccine in COPD patients on steroid therapy
A. Marx, A. De Roux, O. Burkhardt, B. Schweiger, A. Borkowski,
H. Lode
Berlin, Marburg, D
Objectives: The currently used Inﬂuenza vaccine formulation is known to
have limited immunogenity in high-risk groups as COPD patients. The
efﬁcacy is known to range between 60 and 70%. Therefore, a new vaccine
formulation was developed combining subunit inﬂuenza antigens with a
MF59 adjuvant emulsion (Fluad1, Chiron Vaccines, Germany). The aim of
the study was to compare the antibody response after vaccination with the
new adjuvanted inﬂuenza vaccine (AIV) in three different groups of patients.
Methods: Elderly patients (>60 years) with COPD were included in the
following groups: (1) subjects without steroid therapy (control group, n¼ 44);
(2) patients on inhalative steroids (group II; n¼ 90); (3) patients on systemic
steroids (10mg prednisolone/day; group III; n¼ 40). All enrolled subjects
were vaccinated with the AIV. The vaccine contained the components of
the virus strains A/NewCaledonia/20/99 (H1N1), A/Panama/2007/99
(H3N2), B/Sichuan/379/99. Antibody titers were determined at baseline,
4weeks and 6months after vaccination. Measurements were performed by
hemagglutination inhibition assay. Nonresponders were deﬁned as subjects
with a less than twofold antibody titer increase and/or a titer level <40.
Results:Of n¼ 174 initially enrolled patients n¼ 162 (93.1%) completed the
study (male n¼ 88; female n¼ 86; mean age 71 years). We found a signiﬁcant
(P< 0.05) increase of mean geometric antibody titers for all three strains in all
groups 4weeks after vaccination. After 6 months antibody titers against
inﬂuenza A (H1N1, H2N3) fell close to baseline, only Inﬂuenza B (B/
Sichuan/379/99) antigens induced a sustained immune response. Differences
between patient groups were not signiﬁcant. We found an important rate of
nonresponders (after 4weeks: 58% (H1N1); 70% (H3N2); 51% (B); after
6months 92% (H1N1); 91% (H3N2); 48% (B)).
Conclusion: Antibody response to vaccination after 4weeks was sufﬁcient in
all groups regardless a concomitant steroid therapy. Despite this we found an
important rate of nonresponders after 4weeks and 6months.
P910 Rabies antibody response achieved by different
rabies prophlaxis methods
N. Tulek, H. Senocak, M. A. Yetkin, H. Un, O. Aylan
Ankara, TR
Introduction: Rabies is one of the most lethal infectious diseases known.
Rabies immunoglobulin (RIG) and vaccine are the only agents that can be
used for treatment or postexposure prophylaxis. Two problems, however,
have continued to exist for rabies prophylaxis. RIG is very expensive and not
readily available where it is needed.
Objective: We aimed to compare the rabies antibody titers achieved by two
different postexposure prophylaxis program; RIG and ﬁve dose standard
vaccination (on days 0, 3, 7, 14, 28) versus 2-1-1 schedule (on days 0, 7, 21).
Methods: Patients with a history of animal bite admitted to outpatient clinic
of Health Minister Ankara Training and Research Hospital, Department of
Infectious Disease and Clinical Microbiology, between September–Decem-
ber 2001, were included in the study. Patients with underlying disease and
medication history were excluded. Postexposure prophlaxis was given accord-
ing to Rabies Prophylaxis Guideline of Turkish Health Ministry which was
based on WHO and CDC recommendations. Patients with class III exposure
were treated with RIG and ﬁve dose standard vaccination. 2-1-1 vaccination
schedule was applied to patients either that RIG could not be used or
admission from low endemic area for rabies. All candidates were vaccinated
with either human diploid cell vaccine or Vero-cell culture vaccines. Blood
samples were collected on days 7 and 28 after vaccination for each patient.
Serum rabies antibodies were detected by ELISA, Platelia Rabies (Diagnostics
Pasteur). The cutoff value was 0.5 IU/mL.
Results:A total number 83 patients were divided into two groups; Therewere
43 and 40 patients in group I and group II, respectively. 2-1-1 vaccination
regimen was applied to group I and RIG and ﬁve dose standard vaccination to
the other. At day 7, seroconversion of rabies antibodies was detected in 23 of
43 (53%) patients in group I and 12 of 40 (30%) patients in group II. Although
seroconversion rate in group I was 1.76 times greater than group II, this
difference was not statistically signiﬁcant (P> 0.05). At day 28, seroconver-
sion rates were 95 and 90%, respectively (P> 0.05).
Conclusion: Postexposure rabies prophylaxis should begin as soon as possible.
As seroconversion rates of both regimens are inadequate at early period of
postexposure, prompt local treatment of all bite wounds and scratches might
be lifesaving. In the absence of RIG, applying 2-1-1 dose vaccination schedule
may be an alternative to the standard vaccination.
P911 Protection of mice against a lethal HSV-1
challenge by immunization with DNA vaccine
H. Soleimanjahi, M. Rustaee, F. Mahboodee, J. Rassaee, T. Bamdad
Tehran, IR
Objective:Nucleic acid based vaccines represent a novel approach to control
of infectious diseases. The immunogenecity and protective efﬁcacy of a DNA
vaccine encoding herpes simplex virus type 1 (HSV_1) glycoprotein D
(gD-1) under the control of CMV promoter was studied.
Methods: BALB/c mice immunized three times by intramuscular injection
with pcDNA3-gD that contains full length of HSV-1. Humoral immune
response was detected in sera taken from immunized mice.
Results: Following each dose of vaccination sera were analyzed with virus
neutralization test. The sera were shown considerable antibody titer after
second and third dose of vaccination. Immunized mice were 85% protected
against lethal challenge with a virulent HSV-1 isolated from an Iranian patient.
Conclusion: DNA vaccination does induce a protective immunity and Ab
response against HSV-1, which could be maintained by expression of gD gene
in muscle cells.
P912 Nucleic acid vaccine encoding glycoprotein B
of HSV-1 can protect mice from HSV-1 challenge
T. Bamdad, M. Rustaee, M. Sadeghizadeh, F. Mahboodi,
H. Soleimanjehi
Tehran, IR
Objective: One of the most important immunogenic proteins of HSV-1 is
glycoprotein B (gB), so it is being used in recombinant vaccines to induce
protectivity against virus.We constructed an expression vector containing gB-
1 and used it as a DNA vaccine.
Methods: A clone carrying full length of gB-1 was digested with BamH1 to
separate gB-1 gene. The gene was inserted in pcDNA3 and its ability in
expression of gB was tested by immunoﬂuorescence in COS-7 transfected
cells. BALB/cmicewere immunized with 90microgram of puriﬁed DNA for
three times. Humoral response of the immunized mice were measured with
virus neutralization test.
Results:One hundred percent of serum samples contained antibody titer and
100% of immunized mice were protected against lethal dose of HSV-1
challenge, although 25% of them showed symptoms of infectivity.
Conclusion:The results demonstrated that gB DNAvaccine is highly efﬁcient
in production of antibody and suggests that it may have potential as a
protective recombinant vaccine.
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P913 Evaluation of Burkholderia cepacia selective agar
(BCSA) for the isolation of Burkholderia cepacia from
sputum in pediatric patients with cystic ﬁbrosis
C. Ploton, A. M. Freydiere, I. Verdier, F. Vandenesch
Lyon, F
Objectives: Rapid isolation and identiﬁcation of bacteria belonging to the
Burkholderia cepacia complex is important for appropriate management of
cystic ﬁbrosis (CF) patients. Since B. cepacia isolates grow quite slowly on
conventional medium such as MacConkey, and are often mixed with rapid
growing microorganisms such as Pseudomonas spp., the use of a selective
medium is recommended to increase the recovery rate of these bacteria from
respiratory samples. The purpose of this study was to evaluate the perfor-
mance of two selective media, a recently designed medium BCSA (bioMer-
ieux, France) and a commercially available medium, PC agar (AES
Laboratoire, France) in comparison with a conventional MacConkey agar
(Oxoid, France).
Methods: A total of 175 specimens of respiratory secretions from 135
pediatric CF patients were evaluated prospectively. Aliquots of 10 mL of
sputum were streaked in parallel on BCSA, PC agar and MacConkey.
Bacterial strains were identiﬁed at species level by conventional biochemical
methods, the B. cepacia complex status was assessed by PCR-RFLP of the 16S
rDNA.
Results: B. cepacia was isolated from 7 of 175 (4%) samples examined,
representing 3 of 135 patients with CF (2.2%). The seven B. cepacia strains
were detected on BCSAwhile six were detected on PC andMacConkey agar.
On MacConkey ﬁve of the six strains were in mixed-culture with pseudo-
monads while on BCSA and PC agar, all the strains were in pure culture. A
total of 11 (8.1%), 39 (28.8%) and 163 (100%) of other microorganisms grew
on BCSA, PC and MacConkey agar, respectively. BCSA and PC agar showed
the same global performance of selectivity concerning Enterobacteriaceae and
pseudomonads. BCSA showed a better selectivity than PC agar concerning,
mainly, cocci (12 vs. 1), molds (14 vs. 3) and yeasts (4 vs. 0). The low rate
(2.2%) of colonization with Burkholderia cepacia complex, found in this study,
conﬁrms previous ﬁndings concerning pediatric CF patients.
Conclusion: The three media were, at the time of the present study, quite
similar in term of sensitivity (because of the low rate of colonization in our
pediatric patient). We are currently extending our population studied to adult
CF patients from other centres in an attempt to further discriminate the
sensitivity rate of the three media. However, concerning the speciﬁcity, our
present data revealed that BCSA offers a real advantage toward the other
media in term of easiness for the detection of Burkholderia.
P914 Evaluation of a new GVPC medium for the
detection of Legionella in clinical and environmental
samples
M. Reyrolle, S. Jarraud, J. Freney, J. Etienne
Lyon, F
Background: Community acquired or epidemic legionellosis often leads to
severe pneumopathy with a possible mortality rate of 30% in case of
nosocomial infections. The isolation of the strains from clinical samples
allows the diagnostic and also the determination of the origin of the
contamination by comparing the clinical and environmental strains with
epidemiologic markers. The Legionella culture is therefore essential in clinical
and environmental contexts. The GVPCmedium from bioMerieux (LB) was
evaluated in comparison with the GVPCmedium fromOxoid (LO) routinely
used in our laboratory.
Methods: The detection of Legionella was performed on 100 clinical samples
(CS) and 104 water samples (WS). The detection of the Legionella in CS was
performed using culture in our laboratory according to the GBEA protocol
(French recommendations, MO LE 019). The waters were analyzed accord-
ing to the technique described in the ISO 11-731 norm. The two media have
been tested in parallel for all the samples allowing a comparison of speciﬁcity
and selectivity.
Results:Among the 100 analyzedCS, 3 Legionella positive cultures were found
on both media. The number of colonies was more important on the LB
medium, with less contaminants than the LO medium: 50/60. Among the
104 testedWS, 55 were positive for Legionella pneumophila for the LB medium
and 52 for the LO medium. At day 10 (end of the analysis) the Legionella
enumeration was equivalent. However, L. anisawas better detected on the LB
medium 16/8 with a more important colony number 12/2. Contaminants
such as Gram-negative bacilli, Gram-positive bacilli and cocci were in smaller
numbers on the LB medium: 12/14. Less moulds were found on the LO
medium: 41/8.
Conclusion: For the WS, the LB medium showed better performance than
the LO medium except for mold contamination at 10 days. For the CS, the
LB medium was more selective, with less contaminants. The culture of
Legionella from clinical samples is difﬁcult. It is therefore important to be able
to detect the Legionella colonies as soon as possible with few contaminants
since they may mask the speciﬁc colonies of Legionella growing in 3 days.
Moreover, as L. anisa is responsible for clinical cases, it is helpful to be able to
detect this bacteria on the LB medium.
P915 Rapid identiﬁcation of Legionella pneumophila
serogroups by latex agglutination
M. Reyrolle, C. Ratat, M. Leportier, S. Jarraud, J. Freney, J. Etienne
Lyon, Marcy l’Etoile, F
The sanitary hot water networks are often colonized up to 60% by Legionella
belonging to all species. Among the isolated strains, a large number of
Legionella pneumophila (Lp) remains unidentiﬁed due to cross-reactions with
the direct ﬂuorescent assay (DFA) which are the identiﬁcation techniques
used. Moreover, there is a lack of commercialized reagents for the identiﬁca-
tion of Legionella. We have developed a new reagent for a fast identiﬁcation of
Lp strains as well as clinical and environmental ones. At the French Reference
Center, about 150 Legionella clinical strains have been identiﬁed each year
(95% of Legionella pneumophila strains) and more than 3000 environmental
strains of which 66% are Lp. We developed the following latex reagents: 1
monovalent Lp serogroup 1, 1 polyvalent Lp 2-14 and a monovalent reagent
for each serogroup from Lp 2 to Lp 15. The evaluation of these reagents has
been done using 16 reference strains and 367 other strains (27 clinical and 340
environmental strains). Using the latex reagents, 19 Legionella nonpneumophila
strains produced no agglutination with Lp 1 and Lp 2-14 reagents. Three
hundred and forty-eight Lp strains have been identiﬁed (78 Lp 1, 71 Lp 6, 65
Lp 3 and 64 Lp 8) as well as 4 Lp 2, 7 Lp 4, 10 Lp 5, 1 Lp 7, 5 Lp 9, 2 Lp 10, 4
Lp 12, 2 Lp 14 and 4 Lp 15, which were never found before (Table). In
conclusion, the different latex reagents used have allowed us to identify 95% of
Lp strains. The agglutination latex test takes 5min while the DFA techniques
requires 3 h. Among the strains isolated from water, the most frequent
serogroups are Lp 1, Lp 6, Lp 3 and Lp 8, that corresponds to the clinical chart.
P916 Comparison of indirect ﬂuorescent antibody
assay and culture method
S. Eshraghi, A. Sarrafnejad, H. Taheri Roudsari, M. H. Shirazi
Tehran, IR
Objectives: Pulmonary nocardiosis is an acute or suppurative chronic disease,
caused by a soil-borne aerobic actinomycete called Nocardia. The bacterium
is an opportunistic pathogen in immunocompromised hosts. The present
investigation was planned to detect nocardiosis in immunocompromised
patients who had been conﬁned in Shariati Training Hospital (Tehran), using
indirect immunoﬂuorescence assay (IFA) and bacterial culture methods.
Comparison of the two methods and correlation between the antibody titer
with the statistical and epidemiological data was also investigated.
Table 1 Comparative study of the identification by DFA and latex reagent
Identification DFA (%) Latex (%)
Lp ser 1 92 98
Lp 2–15 9 94
Lp 1–15 27 95
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Methods: One hundred and one patients with advanced symptomatic
pulmonary infection were studied during a period of 10months. All the
patients were tested for their sputum, bronchoalveolar lavage (BAL) and blood
sera. From each sample three thin smears were prepared for microscopic
observations. The samples were cultured in Sabouraud dextrose, blood and
parafﬁn agar. The detection of antibody against Nocardia asteroides was
performed in all study groups, using IFA assay. Medical histories of patients
were also recorded in questionnaires for further data analysis.
Results:Nocardia asteroides was isolated from only one patient suffering from
Wegner vasculitis with an antibody titer of 1/512 in serum. Among the 41
patients suspected for nocardiosis with an antibody titer of at least 1/64 in sera
detected by IFA, there were 26 men (63.4%) and 15 women (14.8%). The age
of the patients varied from 7 to 80 years. Those who had reasonable antibody
titers included 15 housewives (36.5%) and 9 workers (21.9%). Furthermore,
in vitro investigation for differentiation of the isolate was performed and
conﬁrmed that the organism that grew on primary media was Nocardia
asteroids complex.
Conclusion: Our results revealed that the bronchopulmonary infections
which occur in high risk patients (T-cell deﬁciencies, long-term corticoster-
oid therapy, immunocompromised hosts, HIV infection, organ transplanta-
tion, etc.), was an important index for primary diagnosis of nocardiosis. As the
important ﬁnding of the research, antibody at a titer of 1/64 could be
proposed as a criterion for the diagnosis of the infection. The probability
of nocardiosis was proposed, when antibody titer was less or more than 1/64.
P917 An indirect ﬂuorescent antibody assay against
Nocardia complex
S. Eshraghi, A. Sarrafnejad, S. Mazdeh, N. Asasi
Tehran, IR
Objective:Nocardiosis is an acute or suppurative chronic disease caused by a
soil-borne actinomycete called Nocardia. Species of Nocardia are aerobic,
Gram-positive, partially acid fast bacilli. Nocardia asteroides which is the
dangerous and most frequently pathogen, infects humans through the
respiratory tract. The bacterium is primarily an opportunistic pathogen that
causes the infection in patients with underlying immunodeﬁciencies.
Methods: The present investigation is a cross-sectional study conducted on a
population consisted of 300 subjects including 200 hospitalized individuals’
patients, nurses and healthcare workers from Imam Khomeini hospital, and
100 health adult blood donors. None of the patients had already been
diagnosed to be affected by Nocardia. The main purpose of the study was
to detect antibody against Nocardia in all study groups, using indirect
immunoﬂuorescent assay (IFA). Correlation between the antibody titer
against Nocardia with age, sex, occupation, chronic pulmonary infection,
and corticosteroid therapy was also investigated.
Results: Our results demonstrated four patients suffering from different
infections, including TB, mycetoma, chronic pulmonary and chronic
obstructive pulmonary diseases were IFA positive. None of the high risk
hospital personnel who were working in close proximity to the areas infected
with Nocardia, were found to be IFA positive. Meanwhile there was no
positive result in a group of patients (n¼ 34) who were under corticosteroid
therapy.
Conclusion:Finally, considering the small sample size of the IFA positive cases
no signiﬁcant association between the IFA results and age, sex, occupation and
clinical conditions of the subjects could be established.
P918 Rapid antigen assay for the diagnosis of severe
pneumococcal disease in patients from a university
hospital
J. I. Garcı´a-Cı´a, M. V. Torres, F. Santos-O’Connor, A. Ortiz, J. Esteban,
R. Ferna´ndez-Roblas, I. Gadea
Madrid, E
Study objective: To evaluate the usefulness of a Streptococcus pneumoniae
antigen urinary detection assay for the diagnosis of severe pneumococcal
disease.
Methods: We retrospectively reviewed the records from the Microbiology
laboratory for patients who had pneumococcal antigen assay (Binax NOW,
USA) performed between January 1, 2000, and October 22, 2002. We
selected for analysis those patients who had also blood cultures taken during
an interval of 10 days before or after urinary antigen was performed. We
reviewed clinical charts from patients with positive blood cultures, positive
urine test, or both, to determine the clinical syndrome of the patients.
Results: Six hundred and nineteen patients had a urinary antigen test
performed during the study period. Three hundred and thirty patients had
also blood cultures taken and were evaluated in further analyzes. The assay
gave a positive result in 14 of 16 patients with pneumococcal bacteremia,
yielding a sensitivity of 87.5%. The test result was negative in 276 of 314
patients with negative blood cultures (speciﬁcity 87.9%). Patients with a
positive test and negative blood cultures had pneumonia (35 cases), and upper
respiratory tract infection (3 cases). Both patients with a positive blood culture
for S. pneumoniae but antigen test negative had pneumonia. Patients with both
tests positive had pneumonia (12 cases) and pneumococcal meningitis (2 cases,
both with positive CSF cultures for S. pneumoniae).
Conclusion: The S. pneumoniae antigen detection assay is useful for the
diagnosis of severe pneumococcal disease in the deﬁned population.
P919 Isolation and identiﬁcation of Moraxella
(Branhamella) catarrhalis in a routine laboratory from
expectorated sputum samples within 48h
E. H. Al-Rikabi
Ibb, YE
Objectives: To set economic, practical, rapid and nonlaborious laboratory
procedures for the isolation and identiﬁcation of M. (B.) catarrhalis from
sputum and other samples.
Methods: Using selective cellular criteria and a Gram-stain directed culture
method for selection of noncontaminated and representative sputum samples.
Predominant Gram-negative diplococci on microscopy and predominant
growth of typical colonies on 5% human blood agar after 24 h of aerobic
incubation at 37 8C, initially noted. Conﬁrmation achieved by positive rapid
oxidase test (rubbing colonies on oxidase impregnated ﬁlter paper pieces), and
by positive DNase test (growth carrying needle stabbed into microtiter wells
containing toluidine O-DNase agar) within less than 24 h of incubation.
Results: Using the above method, 26 clinically signiﬁcant isolates of M. (B.)
catarrhaliswere isolated and identiﬁed from 300 adults with productive cough,
within 48 h of sputum samples receipt. The laboratory results were constant
and the tests were reliable for all the isolates. No need to do carbohydrate
fermentation tests or to test growth on nutrient agar at room temperature or
on modiﬁed Thayer–Martin medium.
Conclusions: We recommend using the selective policy for sputum samples
acceptance, Gram-stain directed culture method for proper isolation, and
economically prepared rapid oxidase and DNase tests for ﬁnal identiﬁcation.
This is most important in developing countries.
P920 New cytological criteria for the microbiological
diagnosis of acute exacerbation of chronic bronchitis
H. Stetzelberg, M. Fischer, W. Fischer, A. Roth, S. Wagner, H. Mauch
Berlin, D
Objectives: Re-evaluation of the validity of macroscopic and microscopic
examination of sputum specimens from patients with acute exacerbation of
chronic bronchitis (AECB) and development of new cytologic criteria for
quality assessment of specimens.
Methods: Two hundred and ﬁfty-two sputa from patients with AECB were
inspected macroscopically (purulent, slightly purulent, mucoid) and exam-
ined by microscopy (cytology, Gram) and quantitative culture. Two methods
for interpretation of specimen adequacy were applied: (i) Bartlett criteria
(<25 squamous epthelial cells (SC) and >25 neutrophils (PMN) per low-
power ﬁeld) and (ii) Heckeshorn criteria developed by our group which rely
on the ratio between SC and PMN: a sputum is considered of high quality,
when it shows <20% SC and simultaneously >50% PMN per ﬁeld.
Results: As expected, positive culture was most frequently associated with
purulent exacerbations (47 of 70, 67%). However, slightly purulent and
mucoid specimens revealed an unexpected high isolation rate of pathogens, 52
and 25%, respectively. With respect to the cytological Bartlett criteria 76% of
purulent (53 of 70), 42% of slightly purulent (18 of 42) and still 28% of mucoid
(39 of 140) sputa could be considered as acceptable specimens. Using the new
criteria, we were able to classify an additional 26% of sputa as acceptable. Of
110 acceptable specimens according to the Bartlett criteria 65 yielded growth
of bacterial pathogens in high concentrations (>105 cfu/mL). This ﬁgure
could be increased by 20% by using the new method which involves ratios of
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SC and PMN. Microscopy of Gram stains was highly reliable in diagnosing
either H. inﬂuenzae (microscopy 22, culture 20) or M. catarrhalis (microscopy
14, culture 14). The Heckeshorn criteria were clearly superior to the Bartlett
criteria in predicting signiﬁcant cultural results (84 vs. 65).
Conclusions: Purulent sputum can be considered to be the specimen with
highest adequacy for the diagnosis of AECB, but nevertheless nearly a quarter
of nonpurulent sputa could be evaluated as well. The new cytological criteria
based on ratios and relative cell counts in percentage increased the number of
potential pathogens which could be interpreted as causative agents of the
acute exacerbation by an additional 30%. Since the Bartlett criteria failed to
identify a considerable portion of patients which could otherwise be treated
speciﬁcally, we conclude that the Heckeshorn criteria are superior to the
Bartlett criteria and will improve the diagnosis of AECB.
P921 Rate of false negative blood cultures in BACTEC
9000
U. Eigner, A. Fahr, P. Shah
Heidelberg, Frankfurt am Main, D
Objective: In 2000 Klaerner et al. (1) fromMunich reported that BacT/Alert
failed to detect nonfermentative Gram-negative bacteria. We performed a
two center prospective study to evaluate the rate of false-negative blood
cultures (not detected by BACTEC but positive on terminal subculture) in
two routine laboratories.
Material and methods: One hospital based laboratory and one laboratory
servicing a number of hospitals planned to prospectively study 1000 pairs of
blood cultures each. Among other data, information on time of inoculation,
entry into system, antimicrobial treatment and time to detection by BACTEC
9000 were recorded and analyzed.
Results: (see table below):
27 bottles were classiﬁed as false negative, 7 of these had a positive cohort
bottle [S. aureus (N¼ anaerobic), E. cloacae (A¼ aerobic), E. faecalis (N),
C. albicans (N), B. cepacia (N)] and two strains of P. aeruginosa (N), 4 of these
7 were not expected to grow in these media. One C. glabrata (N) without a
positive cohort bottle was also not expected to grow in this media. 15/27 were
from patients on antimicrobial therapy. Four were contaminants. Fifteen of
the false negative bottles had a transport time of >48 h. Only one true
signiﬁcant false negative (polymicrobial: H. alvei, E. faecium, C. perfringens)
occurred in the study.
Summary: The rate of clinically relevant false negative blood cultures
(pathogen not detected in cohort bottle) in bottles that were entered into
BACTEC 9000 within 48 h after inoculation is 0.03%. All efforts need to be
directed to prompt transportation of material to the microbiology laboratory.
Reference
1. H.-G. Klaerner, U. Eschenbach, K. Kamereck, N. Lehn, H. Wagner, T. Miethke. Failure of an
automated blood culture system to detect nonfermentative Gram-negative bacteria. J Clin Microbiol
2000; 38 (3): 1036–41.
P922 A comparison of commercial DNA extraction kits
for the extraction of bacterial genomic DNA from whole
blood samples
K. Smith, M. A. Diggle, S. C. Clarke
Glasgow, UK
Objectives: A rapid diagnosis of the causative organism is crucial to the
treatment and recovery of individuals suffering from bacterial septicemia or
meningitis. Advances in molecular biology have promoted the routine use of
techniques such as PCR and DNA sequencing for the improved diagnosis and
surveillance of microbial disease. Bacterial DNA can be extracted from the
body ﬂuids of patients with suspected bacterial disease and then ampliﬁed by
PCR and sequenced to enable detection and identiﬁcation of the bacteria
responsible. The success of these reactions depends upon an efﬁcient method
of DNA extraction that produces pure, high quality DNA. Automation of the
extraction process would also allow a more rapid throughput of clinical
samples. In this study, ﬁve commercially available kits were compared for the
extraction of bacterial genomic DNA from whole blood samples.
Methods: The ﬁve kits operate by 96-well binding plate, 96-well ﬁlter plate
or metallic bead formats. Tests were carried out to determine the sensitivity
and speciﬁcity of each kit. All kits were automated on the MWG Biotech
Roboseq 4200PE liquid handling robot, and the ease of use and automation
was compared. The PicoGreen assay was used to quantify the level of DNA in
each extracted sample.
Results: All kits were used successfully and were fully automated. Overall
efﬁciency was determined by the sensitivity, speciﬁcity, DNA yield, and
throughput time for sample processing for each kit. The Bilatest DNA 2 kit
and the Promega Wizard SV96 kit were most sensitive with the ability to
detect down to 1–2 genome copy units per 100mL sample. These kits also
produced the highest yield of DNA and were the easiest to automate.
Conclusion:The Promega Wizard SV96 binding plate system and the Bilatest
DNA2 metallic bead kit are both highly sensitive and produced good quality
bacterial DNA at a desirable concentration for use in PCR and sequencing
reactions. Furthermore, both kits are easily automated, and simple to use.
They are capable of processing 96 samples in a short time scale without the
need for manual intervention. This is highly beneﬁcial to the patient as it
allows labor to be concentrated in other areas and leads to a more rapid
diagnosis of disease.
P923 Controlled clinical comparison of BacT/ALERT
pediatric PF vs. adult FA bottles for culturing blood from
pediatric patients
S. Mirrett, M. Joyce, R. Addison, L. Reller
Durham, USA
Objectives: The pediatric BacT/ALERT PF medium (PF) (bioMerieux,
Durham, NC, USA) is a nonvented aerobic culture medium designed to
detect bacteria from the blood of pediatric patients. To determine whether a
pediatric medium is necessary, we compared the performance of PF to the
adult BacT/ALERT aerobic FA medium (FA) for the recovery of micro-
organisms as well as the time to detection of growth in samples of blood
obtained for culture from children.
Methods:Activated charcoal is present in both PF (8.5%, w/v) and FA (6.5%,
w/v) media. All bottles were weighed before inoculation and upon receipt;
only bottles ﬁlled with similar volumes of blood were compared.
Results: Of 5221 bottle pairs received, 3667 (70.2%) contained comparable
volumes of blood. Of 203 clinically signiﬁcant (based on previously published
criteria) isolates, 142 were detected in both bottles, 32 only in PF, and 29 only
in FA (P¼NS). No organism group was detected signiﬁcantly more fre-
quently in one medium vs. the other. Of 140 sets that were positive in both
bottles within 3 days, the mean time to detection of pathogens from pediatric
patients was 20.5 h in PF and 19.5 h in FA bottles. False-positive instrument
signals were detected in 5 of 3667 (0.1%) PF bottles and 6 of 3667 (0.2%) FA
bottles.
Parameter Center 1 Center 2 Total
Patients (n) 467 876 1343
Cultures (n) 990 889 1879
Bottles (n) 1984 1923 3907
Average transport time (h)
All 21.5 21.3 21.4
True positives 19.3 21.6 20.7
False positives 2.0 30.2 21.0
True negatives 21.2 21.1 21.2
False negatives 71.8 30.9 55.1
Time to detection (h) 27.7 16.3 20.7
True positives (%) 9.1 14.1 11.6
False positives (%) 0.1 0.2 0.2
True negatives (%) 90.0 85.1 87.6
False negatives (%) 0.8 0.6 0.7
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Conclusions: We conclude that BacT/ALERT PF and FA bottles are
comparable for recovery of microorganisms from pediatric patients and that
any potential advantage of the pediatric formulation was not detected in this
study.
P924 Controlled comparison of two BacT/ALERT
aerobic FA bottles vs. the combination of an aerobic and
anaerobic FA bottle for the culture of equal volumes of
blood from adults
S. Mirrett, M. Joyce, L. Reller
Durham, USA
Objectives:Optimal distribution of a given volume of blood between media
and different atmospheres of incubation for detection of bloodstream infec-
tions remains uncertain. To assess the overall yield and yield by microorganism
group, we compared 20mL of blood inoculated into two aerobic FA bottles
(8–12mL each) (FA/FA) vs. the same volume split between one aerobic FA
bottle and one anaerobic FA bottle (FA/FN) (bioMerieux Inc., Durham,NC,
USA).
Methods: At the bedside, 30-mL samples of blood from patients with
suspected sepsis were inoculated equally into two FA bottles and one FN
bottle. Only culture sets that had all three bottles ﬁlled with 8–12mL of blood
each were included in the study.
Results:Overall yield from 3841 three-bottle blood culture sets that included
360 positive cultures of clinical importance favored the FA/FN combination.
Staphylococcus aureus (P< 0.005) and anaerobic Gram-positive and Gram-
negative bacilli (P< 0.025) were detected more frequently in FA/FN, but
yeasts (P< 0.005) were detected more frequently in FA/FA. For 171 pairs of
FA and FN bottles in which both bottles were positive, the mean time to
detection within 72 h was 18.3 h in FA and 18.0 h in FN. Of 151 contaminant
isolates detected, there was no difference in contamination rates between the
two systems. False-positive instrument signals were detected in 10, 9, and 11
(0.3%) of 3841 FA, FA, and FN bottles, respectively.
Conclusion:We conclude that the BacT/ALERT FA/FN bottle combination
with 20-mL samples of blood yields better results than FA/FA for the
detection of bacterial bloodstream infection in adults.
P925 Determination of serum procalcytonine and
presence of bacteria in blood cultures in patients in a
tertiary care hospital, Gdansk, Poland in 2002
E. Arlukowicz, K. Hryckiewicz, E. Czarniak, A. Sledzinska, J. Juszczyk,
A. Samet
Gdansk, Poznan, PL
Objectives: To analyze serum procalcytonine (PCT) level and blood cultures
in febrile patients hospitalized in Tertiary Care Hospital in Gdansk in 2002.
Methods: In the year 2002 we examined PCT level in 77 patients (pts). All of
them were febrile (above 380C). We analyzed serum PCT level and blood
cultures taken on the same day. We performed PCT analysis using the test
PCT-Q (Brahms Diagnostica GMBH). Blood cultures were incubated in
BacT/Alert system (bioMerieux). Microorganisms were identiﬁed by stan-
dard methods and disc-diffusion susceptibility testing was done according to
NCCLS.
Results:We divided pts into four groups depending on their PCT level. In the
ﬁrst group (PCT level 10 ng/mL) 58.3% blood samples were positive, we
isolated mostly Staphylococcus aureus (SA) and Pseudomonas aeruginosa (PA) from
blood cultures. In the second group (PCT level 2 ng/mL) 53.8% blood
samples were positive, we isolated most often Escherichia coli, PA and Strepto-
coccus pyogenes. In the third group (PCT level 0.5 ng/mL) 23.1% blood
samples were positive, we isolated mostly PA and Enterococcus sp. In the fourth
group (PCT level <0.5 ng/mL) only 17.9% blood samples were positive, we
often isolated Enterococcus sp. and S. epidermidis.
Conclusions:We can conclude that the correlation between serum PCT level
and isolation of pathogens from blood cultures exists. We could not conﬁrm
correlation between serum PCT level and prevalence of Gram-positive or
Gram-negative bacteremia.
P926 Bioﬁlm production by Staphylococcus
epidermidis at 37 and 32 8C
M. Svabic-Vlahovic, I. Dakic, D. Vukovic, S. Stepanovic
Belgrade, YU
Objectives: Staphylococcus epidermidis, the most prominent causative agent of
catheter related bloodstream infections, enters the bloodstream from the skin
insertion site or through the hub of catheter device. The ability of the
organism to produce bioﬁlm at 37 8C, which corresponds to the inner
temperature of human body, has been well established. However, the super-
ﬁcial temperature of human organism is lower and is roughly averaged at
32 8C. The present study compared bioﬁlm-producing capacity of S. epider-
midis and bioﬁlm formation by other staphylococcal species after incubation at
37 and 32 8C.
Methods: Quantiﬁcation of bioﬁlm formation by eight S. epidermidis, eight
S. aureus, eight S. sciuri and six S. haemolyticus strains was performed by the
modiﬁed microtiter-plate test. After overnight incubation in brain heart
infusion broth poured in 96-well ﬂat-bottomed plastic microplates, bacterial
ﬁlm was ﬁxed with methanol and stained with crystal violet. The bound dye
was released with 33% glacial acetic acid, and optical density was measured at
570 nm by using an automated microtiter-plate reader.
Results:Among S. epidermidis strains tested, six (75%) produced more bioﬁlm
when incubated at 32 than at 37 8C. On the other hand, only two (35%)
S. aureus strains and one (16.7%) S. haemolyticus strain produced more bioﬁlm
when incubated at 32 than at 37 8C. All S. sciuri strains tested produced more
bioﬁlm when incubated at 37 8C.
Conclusion: In contrast to other staphylococcal species tested, S. epidermidis
showed more abundant production of bioﬁlm after incubation at lower
temperature, which corresponds to the superﬁcial temperature of human
organism, than after incubation at 37 8C. The obtained results indicate that
the capacity of S. epidermidis to produce bioﬁlm at the temperature lower than
37 8C, should also be considered as a factor contributing to its marked ability
to cause catheter related bloodstream infections.
P927 Optimalization of conditions for bioﬁlm growth
of Staphylococcus epidermidis, ica-operon positive and
negative, on polystyrene surface
V. Hola, F. Ruzicka, M. Votava, R. Horva´th
Brno, CZ
Objectives: The aims of the study were to evaluate the applicability of
different surface treatments for bioﬁlm formation on hardened polystyrene
material in different culture media and to evaluate the applicability for
assessment of minimum bioﬁlm eradication concentration of antibiotics
(MBEC) in routine laboratory conditions.
Methods: The S. epidermidis strains isolated from hemocultures were used in
this study. Isolates were grouped on the basis of presence of ica-operon,
determined by PCR reaction, into two groups, ica-operon positive (20) and
negative (20). All isolates were examined phenotypically by two methods – by
Christensen’s method and by the typical growth on agar with CongoRed. For
the growth evaluation, the plates of polystyrene with 96 pegs that ﬁt into
standard microtiter-plates were used. The pegged plates were assigned for the
microtiter assay ofMBEC. The growth of bioﬁlmwas observed in six different
variants – on unadapted pegs, on pegs adapted with abrasion by means of
acetone and on pegs adapted with sulfonation by means of sulfuric acid, all in
Tryptic Soya Broth and Brain Heart Infusion, respectively. The General
LinearModels and Dunnett analysis were used for the data evaluation. All tests
were examined at the 95% probability level.
Results: From 20 ica-positive strains 14 (70%) were positive with CRA
method, 2 (10%) and 12 (60%) with Christensen’s method, 0 and 10 (50%)
with unadapted pegs, 0 and 12 (60%) with pegs adapted by abrasion, 3 (15%)
and 14 (70%) with sulfonated pegs, all in TSB and BHI, respectively. From 20
ica-negative strains 17 (85%) were negative with CRA method, 18 (90%) and
20 (100%) Christensen’s method, 20 (100%) and 15 (75%) with unadapted
pegs 19 (95%) and 17 (85%) with pegs adapted by abrasion, 19 (95%) and 16
(70%) with sulfonated pegs, all in TSB and BHI, respectively.
Conclusions:Stronger bioﬁlm formationwas observable on pegs with adapted
surface, where the sulfonation proved to be better than the chemical abrasion.
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For the slime formation the nutrition-rich medium (BHI) proved to be more
appropriate. Staphylococci form there a more vigorous slime layer. Despite
the bioﬁlm formation on the pegs, the layer was neither homogenous nor well
adhered. For the routine laboratory use of the pegged plate it would be good
to consider application of other materials.
Acknowledgement:The study was supported by the grant IGA 6818-3 from
MZ CR and by the fund Nadani J., M. a Z. Hlavkovych, CR.
P928 Evaluation of S. aureus ID: a new chromogenic
agar for the isolation and identiﬁcation of Staphylococcus
aureus
A. Nicholson, J. D. Perry, L. A. Butterworth, F. K. Gould
Newcastle upon Tyne, UK
Objectives: S. aureus ID medium (bioMerieux) is a new chromogenic agar
designed for the enhanced isolation of staphylococci and the speciﬁc identi-
ﬁcation of Staphylococcus aureus. The medium contains selective agents for the
inhibition of nonstaphylococci and a chromogenic substrate for alpha glu-
cosidase produced by strains of S. aureuswhich are visualized as green colonies.
The aim of this study was to evaluate the diagnostic utility of this mediumwith
clinical samples for the isolation of S. aureus.
Methods: A total of 147 wound swabs were cultured onto blood agar (BA),
aztreonam blood agar (ABA) and S. aureus ID medium (SAID) using a
standardized inoculum. All culture plates were incubated for a total of
48 h at 37 8C and interpreted after both 18 and 48 h. The number of colonies
of each organism type was recorded on each medium and all strains were
identiﬁed by standard methods. Colonies of staphylococci were tested with
latex reagent for the identiﬁcation of S. aureus.
Results:After 18 h of incubation a total of 109 strains of S. aureuswere isolated
on any of the three media. Ninety-eight percent of these strains were isolated
as green colonies on SAID medium compared with 75% isolated on BA and
92% on ABA. One further strain of S. aureus presented as cream colonies on
SAID after 18 h of incubation and required 48 h of incubation for generation
of pale green colonies. No further strains of S. aureus were isolated after
extended incubation on BA or ABA.Only two non-S. aureus strains presented
as green colonies and both strains were conﬁrmed as Micrococcus luteus. After
18 h of incubation a total of 63 strains of coagulase-negative staphylococci
were isolated on any of the three media. Ninety-seven percent of these strains
were isolated on SAIDmedium compared with 51% on BA and 67% on ABA.
SAID medium was more selective than ABA. No Gram-negative bacteria
were recovered on SAID medium and most strains (94%) of enterococci were
inhibited.
Conclusions: S. aureus ID medium was a useful diagnostic tool for the
enhanced isolation of staphylococci from clinical samples. This was due to
its high selectivity against enterococci and Gram-negative bacteria and its
ability to differentiate S. aureus from coagulase-negative staphylococci based
on colony color. It also allowed for the identiﬁcation of S. aureus with high
speciﬁcity.
P929 S. aureus ID: A new chromogenic medium for
isolation of staphylococci and identiﬁcation of
Staphylococcus aureus
C. Cotte, N. Fanjat, S. Orenga, C. Roger-Dalbert, D. Robichon
La Balme-Les-Grottes, F
Objectives: S. aureus ID (bioMerieux, Marcy l’Etoile, France) is a new, ready-
to-use, chromogenic and selective medium designed for isolation of staphy-
lococci and identiﬁcation of Staphylococcus aureus. On S. aureus ID, identiﬁca-
tion of Staphylococcus aureus is based on the expression of alpha and beta-
glucosidase, revealed by green-colored and pink-colored colonies. The
detection of these two activities enables discrimination between S. aureus
and other species. On this medium, S. aureus expresses alpha-glucosidase
activity only, while other species express both activities, beta-glucosidase
activity only or neither of them. Subsequently, S. aureus colonies are green
whereas colonies of other Staphylococcus are purple/violet, pink or white. The
aim of this study was to evaluate the performance of S. aureus ID medium in
terms of fertility, selectivity, sensitivity and speciﬁcity in comparison with
Mannitol Salt (MS, Chapman) medium.
Methods: S. aureus ID was compared with Mannitol Salt agar using a total of
350 bacterial and yeast strains, including clinical isolates but also strains from
species rarely encountered in clinical samples or with particular phenotypes.
Results: The fertility of S. aureus ID was better than that of MS: colonies of
S. aureus and coagulase-negative strains were larger and appeared earlier. In
terms of selectivity, results for both media were similar with a slight advantage
for S. aureus ID after 48 h of incubation at 37 8C (62.7% of inhibition vs.
53.6% for MS). The sensitivity of Staphylococcus aureus identiﬁcation was
higher on S. aureus ID medium with 90 and 100%, respectively, after 24 and
48 h, against only 12 and 84% with MS. There were more false positive results
on Mannitol Salt; the speciﬁcity was in fact 77% after 48 h at 37 8C against
93.1% on S. aureus ID.
Conclusion: In conclusion, S. aureus ID medium enables the rapid and
accurate identiﬁcation of S. aureus, and this will help in early detection of
MRSA strains.
Non-molecular diagnostics: gastro-intestinal infections
P930 The LOUIS test: a rapid biochemical based
protocol for the screening of lactose nonfermenting
colonies for the presence of Salmonella and Shigella
G. Wilson
Stirling, UK
Objectives: Identiﬁcation of suspect Salmonella and Shigella colonies from
primary isolation media is highly non-speciﬁc. The aim of this study was to
develop a rapid screening test that would reduce the need for unnecessary
biochemical identiﬁcations. This led to the formation of a protocol based on
four rapid tests, lysine decarboxylase (LDC), o-nitrophenyl-beta-D-galacto-
pyranoside (ONPG), urease production (URE), and indole (IND) (to be
known as the LOUIS test).
Methods: Suspect oxidase negative colonies from DCLS and MacConkey
agar primary isolation plates (Oxoid, England) were inoculated to 1mL of
sterile saline to give a suspension equivalent to at least McFarland no. 4.
Suspensions were dispensed (0.2mL) in to three test tubes, a nutrient agar
slope (Oxoid, England) and a CLED (Oxoid, England) purity plate. Indi-
vidual reagent tablets (Rosco, Denmark) were then added to the tubes and
incubated at 3788C/3h. Results were compared with Table 1 for identiﬁca-
tion. The API rapid 20E gallery (bioMerieux, France) was used for full
biochemical conﬁrmation. Polyvalent and group speciﬁc sera (Murex,
England) were used for serological identiﬁcation. During a 6-month period
2500 stools were examined giving rise to 265 suspect organisms for testing. In
addition 140 known stock organisms (119 Salmonella and 21 Shigella species)
were tested. Biochemical reactions were controlled with Salmonella typhimur-
ium ACTC 14028, Proteus mirabilis ACTC 14153 and Escherichia coli ACTC
10536.
Table 1 LOUIS test algorithm
LDC ONPG URE IND
Possible
identification Step 1 Step 2
þ þ  þ E. coli Discard
þ   þ
  þ þ Proteus spp. or Discard
  þ  Morganella morgani
þ    Salmonella Confirm
by serology
(O and H
antigens)
Positive: API
rapid 20E plus
sensitivity
Negative
serology.
Discard
    Shigella spp.
(possible
LDC negative
Salmonella)
API rapid
20E (4 h)
Confirm
with serology
plus sensitivity
Negative
serology.
Discard
   þ Shigella spp. API rapid
20E (4 h)
Confirm
with serology
plus sensitivity
Negative
serology.
Discard
 þ   Shigella sonnei
or Sh. dysenteriae 1
Confirm
with serology
Positive: API
rapid 20E
plus sensitivity
Negative
serology.
Discard
þDiscard any other recombination of reactions.
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Results: Step 1 discarded 175 organisms (66%) as non-signiﬁcant and correctly
suggested 49 out of 50 Salmonella isolates (sensitivity 98%, speciﬁcity 98.6%).
Step 2 discarded a further 29 organisms leaving 12 organisms for full
biochemical identiﬁcation (excluding the 49 serologically conﬁrmed Salmo-
nella isolates). Of these 12 identiﬁcations, only 2 were signiﬁcant isolates (1
LDC negative Salmonella and 1 Shigella). Overall the LOUIS test showed a
sensitivity of 100% and a speciﬁcity of 94%. Stock organisms were all correctly
identiﬁed by the 2-step LOUIS test protocol. Two Salmonella isolates were
LDC negative giving a sensitivity of 98%. Negative reports were conﬁrmed
after examination of the CLED purity plates (24 h).
Conclusion: Early presumptive reporting of Salmonella can be achieved with a
positive LDC proﬁle with conﬁrmatory serology 3 h after isolation on
primary media. This would be of real value in outbreak situations both
nosocomial and in the community.
P931 The comparison of Cary-Blair and selenit
containing Dio-transportswab-SST transport media
H. Erdogan, N. Inan, N. Gurler
Istanbul, TR
Objectives: Cary-Blair is a classic transport medium which enhances the
survival of enteric bacterial pathogens like Salmonella and Shigella. Dio-
transportswab-SST (Diomed) is a newly developed transport medium with
properties of Cary-Blair in addition to containing selenium salts to suppress
the growth of enteric bacterial ﬂora and facilitate the isolation of enteric
pathogens like Salmonella. In this study, to detect the suitability of SST, the two
transport media were compared.
Methods:The turbidities of Salmonella typhiATCC14028 and Shigella sonnei
ATCC 25931 suspensions were adjusted to that of 0.5 McFarland standard
(1.5 108CFU/mL) and diluted 1:10 (1.5 107CFU/mL) with saline.
100mL from these dilutions were added to each transport medium, reaching
a ﬁnal inoculum of 106CFU/mL. Transport media were incubated at room
temperature and þ4 8C. Serial dilutions (1:10, 1:100, 1:1000) were prepared
from both transports and 100mL from each dilution were double plated at 0, 6,
24 and 48 h. Bacterial count was measured by taking the average of the two
plates. For detection of the clinical efﬁcacy of the SST medium, 300 stool
samples of diarrheal patients were examined. Each stool samplewas taken both
into Cary-Blair and SST. While samples from SSTwere plated directly onto
McConkey agar, those fromCary-Blair were plated ontoMcConkey agar and
to selenit F broth. After 8–12 h of incubation, selenit F broth was subcultured
again onto McConkey. Lactose non-fermenting suspect colonies were
screened biochemically and serologically for Salmonella and Shigella.
Results:The culture results of SSTand Cary-Blair transport mediawere found
similar. In addition, there were no differences between 24 and 48 h culture
results of SST but keeping SST at room temperature seemed to be more
appropriate. According to stool culture results; six Salmonella and nine Shigella
spp. were isolated from both transport media. One Salmonellawas isolated only
from SST and another only from Cary-Blair.
Conclusion: For carrying Salmonella and Shigella, SST transport medium was
found as effective as Cary-Blair. For SST, there is no need to use selenit F
broth and extra incubation; it is easier, faster and more cost effective for both
transport and culturing of fecal specimens.
P932 Comparison of three methods: agglutination
test, Dot ELISA and culture of feces for diagnosis of
inapparent infection of Salmonella in calves
T. Zahraei Salehi, M. Nadalian, Y. Faghih Habibi
Tehran, IR
Objective: Diagnosis of Salmonella carrier calves by using feces culture,
Agglutination test and dot ELISA.
Procedure: 216 sera and feces samples were obtained from calves in farms
around Tehran. The feces samples were cultured in enrichment and selec-
tive media and then isolated Salmonella were serotyped by O and H antisera.
The sera samples were tested for O and H agglutinins by Widal and dot Elisa
tests.
Results: In this study two serotypes including: Salmonella typhimurium (four
cases) and Salmonella dublin (two cases) were isolated from feces. In serological
tests 5 and 15 sera samples were positive in Widal and Elisa tests, respectively.
Discussion: The results of this study showed that dot Elisa method is very
sensitive in diagnosis of Salmonella carrier calves than other tests especially fecal
culture.
P933 SM ID2, a new chromogenic medium for
isolation, detection and presumptive identiﬁcation of
Salmonella: comparison with SM ID, Hektoen and four
commercially available chromogenic media
S. Delorme, A. Senta-Loy¨s, V. Sauvonnet, S. Orenga, D. Robichon,
C. Roger-Dalbert
La Balme-les-Grottes, F
Objectives: SM ID2 (bioMe´rieux) is a new, ready-to-use chromogenic
medium for selective isolation and differentiation of Salmonella in human
stools. Detection of Salmonella is based on the expression of esterase activity
revealed by pink-colored colonies. Non-Salmonella species produce blue,
green or colorless colonies. The purpose of this study was to compare the
performance of SM ID2 to that of SM ID, Hektoen and four commercially
available chromogenic media.
Methods: SM ID2 was compared with SM ID, CHROMagar Salmonella
(Becton Dickinson), ASAP (A.E.S Laboratoire), OSCM (Oxoid) and Ram-
bach agar (Merck), and to the conventional Hektoen medium. A comparison
was made using a collection of 126 strains: 50 Salmonella, including some
atypical strains, and 76 microorganisms frequently encountered in stool
specimens.
Results: After 24 h of incubation, fertility of Salmonella was higher with SM
ID2, SM ID and Rambach agar (100%) than with Hektoen (98%), OSCM
(96%), ASAP (88%) or CHROMagar Salmonella (84%). As for all the
chromogenic media tested, the selectivity of SM ID2 against yeasts, Gram-
positive strains and non-fermenting bacilli was high, whereas selectivity
against Enterobacteriaceae was low. Sensitivity after 24 and 48 h of incubation
was 84 and 86% with SM ID2, 86 and 92% with OSCM, 82 and 90% with
Hektoen, 80 and 80% with SM ID, 76 and 60% with Rambach agar, 74 and
90% with ASAP, and 56 and 78% with CHROMagar Salmonella, respectively.
The speciﬁcity after 24 and 48 h of incubation of all chromogenic media was
greater than 84%, except for OSCM which showed 80 and 67%, respectively
(72.4 and 67.1% with Hektoen). Out of all the highly speciﬁc chromogenic
media (speciﬁcity greater than 92%), SM ID2 was the most sensitive medium.
Conclusion: The high speciﬁcity and sensitivity of SM ID2, after 24 h of
incubation, makes it a chromogenic medium of choice for the detection and
presumptive identiﬁcation of Salmonella in stool samples.
P934 DIO-Salmonella selective medium, a novel
medium for speciﬁc isolation of Salmonella spp.
S. Kocago¨z, F. Budak, F. Kirca, D. Gur, T. Kocago¨z
Istanbul, Kocaeli, Ankara, TR
Objectives:DIO-SSM (Diomed, Turkey), is a new chromogenic medium for
the isolation and presumptive identiﬁcation of Salmonella spp. It is a clear pale
yellow liquid medium that turns black when Salmonella grows in it. No other
species tested so far including Proteus spp. has this effect. They either do not
grow or create turbidity without color change.
Methods: DIO-SSM was evaluated with a total of 192 strains of Salmonella
and standard strains, consisting of 13 reference strains and 179 clinical isolates
which were previously all identiﬁed biochemically and veriﬁed serologically.
Results:All Salmonella strains changed the color of the medium from yellow to
black, others either did not grow or just turned it to turbid.
Conclusions:Compared with SSmedium (Salmonella Shigellamedium), DiO-
SSM is a more speciﬁc medium in isolation of Salmonella spp. since the
colonies of other bacterial species like Proteus spp. may also appear black on SS
medium. DiO-SSM is a very practical, speciﬁc medium for isolating Salmo-
nella from various samples
P935 The potential diagnostic value of clinical and
laboratory ﬁndings in typhoid fever
S. Hosoglu, M. F. Geyik, S. Akalin, C. Ayaz, O. Kokoglu
Diyarbakir, Kahraman Maras, TR
Objectives:To evaluate the predictive value of various clinical and laboratory
features in cases with culture-proven typhoid fever.
Methods: A retrospective analysis was done on hospital charts of culture-
proven typhoid fever cases. The important associated features with typhoid
fever as constipation, diarrhea, hepatomegaly, splenomegaly, discordance
between pulse and fever, Widal test, leukopenia and an elevated aspartate
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aminotransferase (AST) more than 1.5 times were evaluated for diagnostic
predictive value on admission. A simple model to predict diagnosis of typhoid
fever was built by using four features the most frequent associated.
Results: A total of 129 blood culture proven typhoid fever cases were
evaluated using clinical and laboratory features. There were 66 males and
63 females. Average age was 23.7 10.5 years. The mean preadmission
duration of fever interval was 11.7 8.8 days. The most frequent associated
features with typhoid fever were discordance in 100 cases (77.5%), high AST
in 95 (73.6%), Widal test in 66, leukopenia in 56 (43.4%), diarrhea in 44
(34.1%), splenomegaly in 37 (27.7%), hepatomegaly in 20 (15.5%) and
constipation in 15 cases (11.6%). At least two of the most frequent associated
features (discordance, high AST,Widal test, leukopenia) was found positive in
121 cases (93.8%). Two features were found positive in 50 cases (38.8%), three
features in 50 cases (40.3%) and four features in 19 cases (14.7%).
Conclusions: The predictive value of these features for diagnosis of typhoid
fever is found very high. The association of two or more features among
discordance, high AST, Widal test and leukopenia may be used for early
diagnose of suspecious typhoid fever cases.
P936 Characterization of anti-Salmonella monoclonal
antibody (3D11)
M. Taravati, W. Stimson
Orumiye, IR; Glasgow, UK
Background: The genus Salmonella is a member of Enterobacteriaceae and is
composed of phenotypically and genotypically related bacteria. Salmonella are
Gram-negative facultative anerobic rods. It causes many diseases in man e.g.
typhoid fever, gasteroenteritis and food poisoning. For rapid and direct
detection of bacteria 3D11 monoclonal antibody was developed against heat
killed Salmonella strains in the Department of Immunology, Strathclyde
University, Glasgow. The aim of this study was characterization of the anti-
body enable to be used as a diagnostic and therapeutic agent in clinical ﬁelds.
Material and methods:More than two hundred Salmonella, E. coli and other
Gram-negative and gram positive bacteria were purchased from NCTC
colindale, UK and many bacterial strains kindly donated by Stobhil Hospital,
Glasgow. LPS, lipid A, outer membrane proteins, ﬂagellar antigens, Ra
mutant LPS were extracted from salmonella. The reactivity of antibody
was assessed with all extracted materials using ELISA, SDS–PAGE, and
Western blotting and dot blotting techniques.
Results:The antibody was reactive with only heat killed Salmonella strains. It is
strongly reactive with polysaccharide, smooth LPS, and not reactive with
polypeptide, phospholipids and ﬂagellar antigens. More characterization and
epitope mapping showed the antibody was developed against outer core of
LPS.
Discussion: The results were indicated the epitope is not accessible to the
antibody in live bacteria and when heated a strong positive reaction was
observed. The heat treatment destroys the integrity of the outermembrane in
bacterial strains. The results were indicated the outer core of LPS is conserved
in all Salmonella strains and trissacharides are immunodominant sugars in all
salmonellae strains. This antibody should be used as a diagnostic and
therapeutic purposes.
P937 Evaluation of jackbean meal as a control for
rapid urease tests and introduction of a new room
temperature stable rapid urease test for diagnosis of
Helicobacter pylori
Sa. Das, Sr. Das
Kolkata, IND
Objectives: To determine whether jackbean meal which contains urease can
be used as a positive control for rapid urease tests and also to ﬁnd out whether a
paper-strip rapid urease test (RUTP) containing urea, phenol red and acidic
salt which is stable at room temperature was reliable when compared with
histology in the diagnosis of Helicobacter pylori infection.
Methods:Prospective consecutive sampling were done of 83 selected patients
who underwent outpatient esophagogastroduodenoscopy and antral biopsies
were taken. CLO test, RUTP, and histology examinations were done on
obtained specimens. Sensitivity, speciﬁcity, positive predictive value, negative
predictive value and accuracy of the RUTP were calculated and compared.
For standardization of RUTP, biopsy samples of another 179 patients were
studied and analyzed. Jackbean meal was used as control for all CLO and
RUTP tests.
Results: Amongst 83 patients, the sensitivity, speciﬁcity, positive and negative
predictive values and accuracy of RUTP were 91, 100, 100, 100, and 95%
which appeared very signiﬁcant. RUTP was stable for more than 6months at
room temperature. Jackbean meal was also stable at room temperature and it
was found as an ideal control for rapid urease tests.
Conclusions: RUTP is an inexpensive test stable at room temperature with
good sensitivity and speciﬁcity for H. pylori infection and jackbean meal is an
ideal control which may be used in all rapid urease test kits as there is no
control in all presently available rapid urease test kits.
P938 Western blot analysis for the serological
detection of CagA and VacA status in Helicobacter pylori
seropositive children
G. Antonaki, K. Kallergi, E. Lebessi, G. Stamos, S. Ioannidou,
M. Foustoukou
Athens, GR
Objectives: The assessment of CagA and VacA seropositivity in children by
the Western blot technique.
Methods: 59 dyspeptic children (M: 26, F: 33) aged 4–14 years, grouped by
the presence of anti-H. pylori (HP) IgG or IgA antibodies (ELISA), were
studied. Group I included 33 children IgG positives and IgA negatives, Group
II 19 children IgG and IgA positives and group III 7 children IgA positives and
IgG negatives. All groups were tested for CagA and VacA speciﬁc IgG or IgA
antibodies with Western blot analysis.
Results: In the ﬁrst group, 36.4 and 24.2% of the children presented reactivity
against the CagA and the VacA band, respectively. In the third group, 28.6% of
the children were CagA positives, but none VacA positive. In the second
group, IgG antibodies against CagA and VacA antigen observed in 100 and
94.1% of the children, and IgA antibodies in 68.4 and 52.6%. IgG antibody
response to CagA and to VacA was expressed in 56.9 and 47.1% of the IgG
seropositive children (Groups I and II) and IgA response in 57.7 and 38.5% of
the IgA seropositive children (Groups II and III). We found that CagA or
VacA seropositivity was associated with statistically signiﬁcant (P< 0.05)
higher anti-HP ELISA titers.
Conclusions:Detection of speciﬁc antibodies against CagA and VacA antigen
by Western blot, may be useful in the screening of severe H. pylori infection.
P939 Simultaneous assessment of H. Pylori (by means
of cultural and rapid urease test) using a newly developed
transport medium
M. Zanetti, R. Vendramin, O. Pieramico
Merano, I
Background: Culture is one of the most important diagnostic tools for
assessment of H. pylori infection before and after therapy.
Obiective: To evaluate the diagnostic value of new vials (Pyloriset(R) urease,
Orion Diagnostica) for rapid assessment of HP infection and culture in
comparison with rapid urease test (CP test) and standard culture technique.
Materials and methods:Gastric biopsies from a total number of 115 patients
who underwent gastroscopy for dyspeptic symptoms, were taken. All subjects
had not received antibiotics during the last three months before endoscopy.
During gastroscopy, ﬁve biopsies were taken from antrum (three biopsies) and
corpus (two biopsies) and used (one biopsy) for rapid urease test (CP test),
standard culture with refrigerated NaCl 0.9% as transport medium (two
biopsies), and two biopsies were put in the new vials containing newmedium
(Pyloriset(R) urease) for rapid HP diagnosis and subsequent culture. Results
from culture perfomed from biopsies transported with the standardmedium in
NaCl 0.9% were compared with results of CP test at 30 and 120min, with
rapid HP test from biopsies put into Pyloriset(R) vials, and with culture with
Pyloriset(R) urease as transport medium.
Results: See Table 1.
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Conclusions: (1) Cultures performed from vials containing Pyloriset(R)
urease shown high rates of sensibility and speciﬁcity and are therefore
comparable with standard culture technique; (2) The result of the rapid
HP test using the new vials are similar to those obtained with CP test; (3)
Sensibility of Pyloriset(R) rapid urease test was already high at 30min and
similar to the one at 120min; (4) Bioptic assessment of HP by means of rapid
test and culture with Pyloriset(R) urease represents therefore a promising
technical advance.
P940 Determination of the levels of procalcitonin and
C-reactive protein in the diagnosis of H.pylori infections and
the value of these markers in the post-treatment follow-up
of H.pylori eradication
B. Kocazeybek, S. Saribas, Y. Seyhun, S. Altun, M. Aslan,
N. Memisoglu
Istanbul, TR
Objectives:To determine, the levels of PCTand CRP inHelicobacter pylori (þ)
cases diagnosed as duodenal and gastric ulcer and to evaluate the correlation of
PCT and CRP with other invasive and noninvasive methods in H. pylori
eradication in the post-treatment follow-up.
Methods: Forty patients with dyspepsia were included in this study. 5mL
serum samples were collected in admission and after 24 h. One week
antimicrobial therapy (omeprazol, amoxicillin and clarithromycin) was given
to the HP(þ) patients with the result of only culture or ureaseþ pathology.
5mL serum samples were collected again and culture, urease, pathology
investigations were performed for endoscopic samples after one month. PCT
andCRP levels weremeasured in the collected blood samples. 35 HP(þ) cases
with peptic ulcer and 38 cases with bacteremia and 38 healthy blood donors
were included in this study as control groups.
Results: The mean of PCT and levels (minimum-median-maximum), were
found as 1.39 (0.25–0.73–6.75), 0.35 (0.12–0.35–0.71), 7.45 (0.68–4.51–
51.5), 0.40 (0.12–0.41–0.71) for the groups of HP (þ), HP (–), bacteremia
and healthy donors, respectively. The mean of CRP levels were found as 1.00
(<0.5–<0.5–8.11), 0.62 (<0.5–<0.5–3.2), 11.5 (3.2–7.77–43.5), 0.63
(<0.5–<0.5–5.46) for the same groups. Between HR (þ) cases and three
other groups, it was found statistically difference for PCT levels in admission
(P< 0.05). It was observed a statistically decrease in PCT levels between the
admission and post-treatment period (P< 0.05).
Conclusion: HP(þ) cases were found to have lesser PCT levels than bacter-
emia cases in admission. A statistically signiﬁcant decrease was observed in
PCT levels after the post-treatment period against the PCT levels in admis-
sion. In contrast to this observation CRP levels were found in similar range,
both in admission and after the post-treatment period. Sensitivity of PCTwas
found higher but speciﬁcity of PCT was found lower against CRP in
admission. PCT and CRP, were found to have similar sensitivity and
speciﬁcity levels after treatment.
P941 Serum anti-CagA antibodies in patients with
different clinical symptoms of Helicobacter pylori infection
E. Andrzejewska, A. Szkaradkiewicz, A. Jopek, H. Klincewicz
Poznan˜, PL
Objectives: To estimate the frequenty of anti-CagA antobodies in the serum
of patients with H. pylori infection and having different symptons of diseases.
Methods: The studies were performed on 78 serums obtained from adult
patients (mean age 48 years).
More speciﬁcally: Thirty-nine serums came from patients with duodenal
ulcer, 22 with gastritis, 3 with gastric cancer and 14with rosaceae. Serum anti-
CagA antibodies of IgG and IgA classes were detected by Helicobacter p120
(CagA) ELISA test (VIVA Diagnostica). The presence of H. pylori in gastric
biopsies was detected by culture method, using Columbia-agar with 7% sheep
blood and antibiotics. The samples were incubated under microaerophilic
conditions for 4–10 days.
Results: Thirty-ﬁve (90%) patients with duodenal ulcer demonstrated the
presence of anti-CagA antibodies of IgG class and 29 (74%) of IgA class. All
patients with gastric cancer showed the presence of anti-CagA antibodies of
IgG class only. In the group of patients with rosaceae—6 of them (43%) had
anti-CagA antibodies, of both IgG and IgA class. Only four patients (18%)
with gastritis demonstrated the presence of anti-CagA antibodies of IgG class
and three of them (13%) of IgA class.
Conclusion: Our results indicate a relationship between anti-CagA seropo-
sitivity and an increasing risk for the development of more than dangerous
clinical forms of H. pylori infection.
P942 3-Polymerase chain reaction assay for the
detection of Helicobacter pylori in gastric tumor specimens:
comparison with histopathologic studies
N. Abu-Khadr
Alexandria, EGY
Helicobacter pylori, particularly the cag A positive strain, has been associated
with gastric tumors. The aim of the present study was to evaluate the
frequency of cag A positive strain of H. pylori in cases of gastric tumors by
PCR assay, and to correlate between H. pylori and the patients’ age, sex and
tumor istologic subtypes and grades. Thirty gastric tumor patients (male to
female ratio: 2:1 mean age: 55.5 years; age range: 28–75 years) and 20 control
cases were studied. The presence of the ure C gene which is indicative of
H. pylori infection, and the cag A genotypewere determined by PCR assay. ure
C gene was detected in 70 and 40% of the gastric tumor and control cases,
respectively. cag A gene was detected in 63.3 and 20% of the gastric tumor and
control cases, respectively. 90.5% of H. pylori strains detected in gastric tumor
patients were cag A positive compared with 50% in the control group. In
conclusion, there is a signiﬁcant association between H. pylori cag A positive
type infection and gastric tumors.
P943 Helicobacter pylori antigen investigation in stool
specimens with ELISA method
Y. Bagdatli, S. Kisioglu, S. Saribas, K. Bal, B. Baysal
Istanbul, TR
Objectives:Many invasive and non-invasive methods are used in the diagnosis
of Helicobacter pylori infections. All of the tests have speciﬁc properties, but a
test with high sensitivity and speciﬁcity to be easily applicable and also
economic was not deﬁned yet. Recently, a new non-invasive test was
improved for the detection of H. pylori antigen with ELISA method in stool
specimens. In this study, the applicability of H. pylori antigen test (Genesis
Diagnostics Ltd., United Kingdom) for H. pylori infections was evaluated by
using sensitivity and speciﬁcity, positive predictive values(PPV) and negative
predictive values(NPV).
Methods: A total of 62 patients (age average: 42.6) 33 of male and 29 of
women who had gastrointestinal system endoscopy with the complaint of
dyspepsia were included in this study. While selecting these patients, anti-
microbial therapy, proton pumb inhibitors (PPI) and bismute compounds
were not taken into consideration. A total of four biopsy specimens, one from
corpus and three from the antrum of the stomach were obtained during the
gastrointestinal system endoscopy from all of the patients. Biopsy specimens
were investigated for rapid urease test, culture and histopathologic examina-
tion. H. pylori antigens were investigated from the the simultaneously col-
lected stool specimens from all of the patients with the ELISA method.
Results: Patients were deﬁned as H. pylori positive when histopathologic
examination and urease test or only culture were positive. The other patients’
test result were classiﬁed asH. pylori negative. 43 (69.4%) and 19 (30.6%) of 62
patients were found as H. pylori positive and H. pylori negative, respectively.
We compared the results of H. pylori positive and H. pylori negative patients
with the test results of H. pylori antigen test. We found the sensitivity and
speciﬁcity, PPV, NPV, of H. pylori antigen test as 83.7, 52.6, 80 and 58.8%,
respectively, with our test results.
Conclusions: H. pylori antigen test is not found sufﬁcient only in the light of
our ﬁndings for the diagnosis of H. pylori infection.
Table 1
Test
Sensibility
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
Concordance
(%)
Culture Orion 93 100 100 85 95
CP 30 85 85 93 71 80
CP 120 86 85 93 73 83
Orion 30 88 80 90 76 79
Orion 120 88 80 90 76 79
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P944 Evaluation of two commercial culture media for
the isolation of toxigenic Clostridium difﬁcile from fecal
samples
L. Alcala´, T. Pela´ez, P. Catala´n, A. Ferna´ndez-Chico, V. Garcı´a-Arias,
E. Bouza
Madrid, E
Background: Clostridium difﬁcile-associated diarrhea is a very common noso-
comial infection that contributes signiﬁcantly to patient morbidity and
mortality as well as to the cost of hospitalization. Diagnosis of C. difﬁcile-
associated diarrhea is based in the toxin detection by a tissue culture cytotoxin
assay. Isolation ofC. difﬁcile is performed in certain institutions with diagnostic
and epidemiologic purposes.
Objectives:To evaluate two commercial culture media, one containing blood
(C. difﬁcile agar, CDA, bioMerieux1) and the other without blood (CCFA,
Difco1), for the isolation of C. difﬁcile in human fecal samples for patients
suspected of having C. difﬁcile-associated diarrhea.
Methods: A total of 96 consecutive fecal specimens were cultured in both
culture media and processed by the tissue culture assay. For comparison
purposes, the combination of the two culture media and the tissue culture
assay performed directly from the feces or from the isolate (‘second look’) was
considered the gold standard. The sensitivity value of both types of culture
media was compared using the exact binomial test for paired samples.
Results: Overall, 23 specimens (24%) yielded toxigenic C. difﬁcile isolates
(TCD), and only one (1%) yielded a nontoxigenic isolates (NTCD). CDA
media recovered all the 23 TCD and the NTCD, while CCFA only recovered
17 CDT. In four of the 22 samples, the direct tissue culture assay showed false
negative results giving a positive result only when the ‘second look’ was
performed. Moreover, the sensitivity values for CDA and CCFA media were,
respectively, 100 versus 73.9 (P¼ 0.03).
Conclusions: Our ﬁndings show that CDA media was signiﬁcantly more
sensitive than CCFA media for the isolation of C. difﬁcile. Combination of a
sensitive culture media with the tissue culture assay increases the diagnostic
yield of C. difﬁcile-associated diarrhea.
P945 Heat-stable Enterotoxin producing
Enterobacteriacae isolated from diarrheal children in Iran
N. Amir Mozaffari, S. Shahsavan, H. Forohesh, M. Aleyasin
Tehran, IR
Objectives: Certain members of Enterobacteriacae elaborate heat-stable
enterotoxins (ST) which contribute to their virulence. Diarrheal diseases
are a major cause of morbidity and mortality of infants and children in
developing countries. In Iran, they constitute a major public health concern.
Methods: To survey the prevalence of ST secreting enteric bacteria in
diarrheal children, 250 stool samples from infants and kids suffering from
watery diarrhea as well as, 50 stool samples from nondiarrheal children as a
control group with the same relative age, sex, and family socio-economic
status were studied. Following stool culture and isolation of the presumed
pathogenic bacteria, their ability to secrete ST was examined by suckling
mouse assay.
Results: From a total of 148 bacterial strains isolated from the diarrheal
samples (Escherichia, Citrobacter, Klebsiella, Yersinia, and Enterobacter spp.), 35 of
themwere able to produce detectable levels of ST (14.3%).Whereas, only one
strain from the control group (an E. coli isolate) was ST positive (2%). Most ST
producing bacteria were isolated from children with less than 3 years of age.
Conclusion: The statistically signiﬁcant difference in the prevalence of ST
positive bacteria in the diarrheal versus control group establishes a clear
involvement of the enterotoxin in the etiology of watery diarrhea.
Fungal infection: clinical epidemiology
P946 Epidemiology and susceptibility of
Candida isolates from high and low risk patients in Denmark
to eight antifungal compounds
M. Arendrup, N. Frimodt-Møller, I. M. Jensen, J. S. Andersen,
J. D. Knudsen
Copenhagen, DK
Objectives: An expected consequence of the increase in number and use of
antifungal compounds is a selection of fungal isolates with decreased suscept-
ibility. We conducted a study of the susceptibility of Candida isolates obtained
from patients under low and high selective pressure, respectively.
Methods:A total of 233Candida isolates were studied. 185 were blood stream
isolates collected in the period 1994–2001 from the Copenhagen County.
The remaining isolates were from patients at an intensive care unit in 2002.
MIC’s of eight antifungal agents were determined following the NCCLS
microbroth-dilution method.
Results: The annual incidence of candidemia increased from 1.8 to 4.9 per
100 000 of the population in the observation period. All isolates were
susceptible to amphotericin B (MIC’s 1mg/mL) and caspofungin
(MIC’s 2mg/mL). Combined ﬂuconazole, ketoconazole, itraconazole
and voriconazole resistance was observed for 3/37C. albicans isolates obtained
from high-risk patients while no such isolates were found from the low-risk
patients. Also a difference in MIC50 and MIC90 for ﬂuconazole was
demonstrated among low and high-risk patients: MIC50 0.5 versus 1 and
MIC90 1 versus 8 mg/mL, respectively (P¼ 0.018). C. glabrata and C. krusei
isolates were all voriconazole susceptible (MIC’s of 2mg/mL). With the
exception of C. parapsilosis isolates the MIC50 of terbinaﬁne was 16 for all
species. Resistance to ﬂucytocinewas demonstrated among allCandida species
with the exception of C. glabrata and C. parapsilosis. In conclusion, isolates
from patients under high selective pressure were found to be more azole
resistant than isolates from low risk area. This resistance included voriconazole
although the drug has not yet been introduced in Denmark.
P947 Recovery of Candida dubliniensis
from nonhuman immunodeﬁciency virus-infected patients in
Kuwait and its rapid identiﬁcation using seminested PCR
ampliﬁcation of rDNA
S. Ahmad, Z. Khan, E. Mokaddas, Z. Khan
Safat, KWT
Objective: Candida dubliniensis is an emerging pathogen capable of causing
oropharyngeal, vaginal and bloodstream infections. The aim of this study was
to isolate C. dubliniensis from clinical specimens and to develop a rapid
molecular identiﬁcation method by exploiting its genotypic differences with
C. albicans.
Methods: Four clinical isolates of C. dubliniensis were recovered from
immunosuppressed patients attending various hospitals in Kuwait. The
molecular test to identify C. dubliniensis was based on ampliﬁcation of high
copy rDNA. The universal fungal outer primers ampliﬁed the 30 end of 5.8S
and 50end of 28S rDNA including the internally transcribed spacer 2 (ITS2).
The species-speciﬁc primer was derived from ITS2 sequence ofC. dubliniensis
and was used together with outer universal reverse primer in the re-ampli-
ﬁcation step of the snPCR.
Results:We describe the ﬁrst four isolations ofC. dubliniensis from Kuwait, all
originating from nonhuman immunodeﬁciency virus (HIV)-infected
patients. The isolates were initially identiﬁed by Vitek 2 yeast identiﬁcation
system and subsequently conﬁrmed by positive germ tube test, production of
chlamydospores on Staib agar, and by their inability to assimilate xylose and a-
methyl-D-glucoside. The species-speciﬁc primer corresponding to unique
sequences within ITS2 of C. dubliniensis, together with universal fungal
primer ampliﬁed DNA from C. dubliniensis reference strain only and not
from C. albicans or other Candida species in the re-ampliﬁcation step of the
snPCR. The snPCR identiﬁed all the four clinical isolates as C. dubliniensis.
The identity of our clinical isolates was conﬁrmed by further molecular
characterization and direct DNA sequencing of ITS2.
Clinical Microbiology and Infection, Volume 9, Supplement 1, 2003 217
Conclusions: The isolation of C. dubliniensis from four non-HIV-infected
patients from Kuwait reinforces the existing view that this novel yeast species
has a worldwide distribution and its occurrence is not restricted to any
particular immunocompromised population. The snPCR developed in this
study is rapid, speciﬁc and more sensitive than biochemical methods and other
PCR-based methods for detecting and differentiating C. dubliniensis from
C. albicans in clinical specimens.
Supported by Research Administration projects grants MI 118, Kuwait
University.
P948 Identiﬁcation, clinical and epidemiologic
aspects in candidiasis
M. Junie, D. Tatulescu, C. Costache, A. Radulescu, H. Colosi
Cluj Napoca, RO
Background:Fungal infection remains a common health problem. The aim of
this study has been to determine the incidence and species distribution of
infectious agents for 228 hospitalized patients for clinical assumption of fungal
infection.
Methods: The laboratory diagnosis has been established by bacteriologic
and mycologic examinations: direct microscopic examination of patient
samples in a drop of lactic blue or 30% potassium hydroxide, culture on
Sabouraud’s agar and identiﬁcation of the isolated Candida strains by bio-
chemical tests.
Results: Candida spp. has been isolated from patient’s samples. The most
common isolated species have been C. albicans (65%) followed by C. krusei
(21%), C. glabrata (14%). Mucosal candidiasis prevailed (73.1%) followed by
cutaneous candidiasis (25.2%) and candidemia (1.8%). The prevalent mucosal
candidiasis included: enterocolitis (43.5%), vaginitis (13.6%), oral candidiasis
(12.4%). The prevalent cutaneous candidiasis included eczema (14.2%) and
onychomycosis (2.4%). Prolonged antibiotic therapy favored the occurrence
of glossitis, enterocolitis and vaginitis. Diabetes mellitus represented a pre-
disposing factor for cutaneous, vaginal and urethral candidiasis while preg-
nancy represented a predisposing factor for vaginitis. Candidiasis occurred
both in children (50.3%) and in adults (49.7%) but there have been differences
in location. In children the most common were enteritis and colitis (54.7%),
followed by glossitis (18.8%), intertrigo (17.6%), cystitis and urethritis
(5.09%), candidemia (2.9%). In adults we found similar proportions of
enterocolitis (32.1%), cutaneous candidiasis (32.7%) and urogenital candidiasis
(28.6%) followed by less frequent glossitis (6%) and candidemia (0.6%).
Candidiasis had a slightly higher incidence in women (55.1%) then in
men (44.9%), vaginal (79.5%) and oral (60%) candidiasis being prevalent.
Conclusions:Knowledge of clinical manifestations and predisposing factors is
proﬁtable due to correlations that can be made between different candidiasis
and Candida spp., patient state, age and sex, in order to establish the proper
prophylaxis and treatment. An important issue in therapy of fungal infections
is the occurrence of resistant strains, both to common antifungal drugs and to
newly discovered ones. It is important to study the susceptibility of Candida
spp. to antifungal drugs in order to effectively ﬁght these infections.
P949 Species distribution and antifungal susceptibility
of yeasts and molds isolated at Cerrahpasa Medical Faculty
Department of Microbiology and Clinical Microbiology Deep
Mycoses Laboratory between 02 January and 27 December
2002
A. S. Kantarcioglu, Y. Bagdatli
Istanbul, TR
The aim of this study is to characterize the species distribution and antifungal
susceptibility patterns of yeast and mold strains isolated at a Turkish University
Hospital deep mycoses laboratory. Totally 300 specimens belonging to various
body sites (10 CSF, 4 corneal, 4 ear, 9 nose, 2 nasopharinx, 72 sputum, 3 ETA,
89 BAL, 8 pleural, 13 oral, 6 gastric aspiration, 2 feces, 13 urea, 2 vaginal, 1
pericardium, 2 hemoculture, 28 blood, 1 articular ﬂuid, 7 pus, 4 bonemarrow,
16 tissue biopsy specimens) submitted from different units of the hospital were
studied. Yeast and mold strains isolated were identiﬁed according to classical
mycologic methods. Antifungal susceptibility pattern of the clinically sig-
niﬁcant yeast and mold isolates recovered from deep mycoses suspected
patients’ specimens over 1-year period determined against conventional
agents using the US National Committee for Clinical Laboratory Standards
M27-A and M38-P reference methods. A total of 54 yeasts and 11 molds
strains were isolated. Candida albicans strains were 14.8% (8/54), nonalbicans
Candida species were 81.5% (44/54), Trichosporon sp. 1.9% (1/54), and
Cryptococcus neoformans 1.9% (1/54). The molds isolated were Aspergillus
spp. 57.1% (8/14), Paecilomyces spp. 21.4% (3/14), Fusarium oxysporum
7.1% (1/14) and 2 hyphomicetes fungi 14.3% (2/14) (identiﬁcation is
continuing). No growth was observed in two antifungal receiving patients’
materials inspite of direct microscopical positivity of fungal elements. In a case
with aspergillosis clinical diagnosis due to the symptoms and radiological
ﬁndings, Paecilomyces sp. was recovered from BAL specimen and Aspergillus
latex agglutination test was found negative. F. oxysporum was isolated from a
case of keratitis. In vitro resistance to ﬂuconazole (MIC higher than or equal to
64 micrograms per milliliters) as per NCCLS criteria was observed in 2
C. albicans (25%), 13 nonalbicans Candida strains (29.5%), resistance to
itraconazole (MIC higher than or equal to 16 micrograms per mililiters)
in 1 Candida (12.5%), 9 nonalbicans Candida (20.5%). All Aspergillus niger
strains showed high MIC values to both azoles. F. oxysporum isolate was found
in vitro resistant to all antifungals tested. We observed that nonalbicans
Candida spp. and Aspergillus tend to show again high prevalence along with
the presence of rare opportunistic molds other than Aspergillus as were in the
past three years ﬁndings of our deep mycosis laboratory.
P950 Oral candidosis, new perspective: mixtures
of Candida spp. and antifungal therapy
F. Alecu, C. Defta, D. Alecu, S. Dumitriu
Bucharest, Tulcea, RO
Objectives: The purpose of this study was to prospect for mixed cultures of
Candida spp. in 53 oral samples and to assess their antifungal susceptibilities
with respect to a possible relapse of infection due to proliferation of the
coexistent species usually not considered in routine laboratory practice.
Materials and methods: 53 oropharyngeal samples were included in the
study. For identiﬁcation, the colony appearance on Chromagar Candida
medium, chlamidospores production and substrate assimilation proﬁles with
API 20 C aux system were used. The ﬂuconazole (FL) susceptibility assess-
ment was conducted using E-test method and ATB Fungus (BioMe´rieux,
France), was used to assess for susceptibility to six antifungals: nistatine (NIS),
miconazole (MIC), econazole (ECO), ketoconazole (KET), amphotericine B
(AMB) and 5-ﬂucitosyne (5FC).
Results: 8 from 53 samples (15%) represented mixed cultures (4 double, 4
triple). Colony numbering on primary isolation plate was used to consider the
species causing the infection and coexistent species as well. In these samples
the dominant species were Candida albicans in 7 cases and Candida glabrata in 1
case. In 50% of samples, the coexistent species (C. krusei, C. norvegensis,
C. lusitaniae) were more resistant to antifungal agents than C. albicans. By
chance, in one sample, we recovered two different strains of C. albicanswhich
were identiﬁed by means of susceptibility patterns for antifungals.
All 20 isolates presented distinct susceptibility patterns for the 7 antifungal
agents tested.
Conclusions:
1. Two different strains of C. albicans with major susceptibility patterns
discrepancies could coexist in one sample.
2. C. albicans is not always the main species in a mixture of yeasts from oral
samples; it could play a secondary role.
3. Species of Candida less susceptible could be easily selected after antifungal
treatment if the coexisting species are not considered.
4. Antifungal therapy, according to susceptibility patterns of all Candida
isolates in one sample could be the key for increasing incidence of non
albicans species of Candida.
5. In the light of our results, the use of higher doses of Fluconazole could
avoid the selection problem.
P951 The prevalence of vulvovaginal candidosis,
bacterial vaginosis and Trichomonas vaginalis infection in
patients with vulvovaginitis
S. Keceli, G. Yucesoy, G. Sonmez Tamer, V. Du¨dar, A. Willke
Kocaeli, TR
Objective: The purpose of this study was to detect the prevalence of
vulvovaginal candidosisTrichomonas vaginalis and bacterial vaginosis in patients
with diagnosis of vulvovaginitis.
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Material and methods: A total of 100 nonpregnant, nondiabetic patients,
ages between 25 and 35, applied to Obstetrics and Gynecology Clinic of
Kocaeli University were enrolled to this study. Vaginal secretions from patients
with clinical ﬁndings were investigated by direct and gram stained micro-
scobic examination. All specimens were cultured into Sabouraud agar.
Isolated Candida species were identiﬁed by germ tube test, morphological
characteristics on cornmeal Tween 80 agar and carbohydrate fermentation
tests. Bacterial vaginosis (BV) was diagnosed evaluating gram stained pre-
parations according toNugent’s criteria, i.e. scores of 7 or higher was accepted
as BV. T. vaginalis infection was diagnosed investigating direct and gram
stained preparations. All patients were questioned about antibiotic or corti-
costeroid treatment, type of contraceptive method used, history of sexually
transmitted diseases and the frequency of coitus.
Results: Totally 28 Candida species were isolated. They were identiﬁed as
C. albicans (21, 82.1%),C. glabrata (4, 14.2%)C. tropicalis (2, 7.1%) andC. krusei
(1, 3.4%). Only 84 preparation could be examined, and BVwas detected in 32
patients (35.6%). In 11 patients (35.7%) with vulvovaginal candidosis (VVC),
BVwas also present.T. vaginaliswas detected in 9 (10.6%) patients and none of
them had accompanying candidosis. Demographic data of patients were
evaluated for only patients with VVC. Two (7.1%) and three (10.7%) of
them were using antibiotics and corticosteroids, respectively. Contraceptive
methods used and the number of patients were as follows: IUD and condom
(4, 14.2%), oral contraceptive and tube ligation (2; 7.1%), injection (1, 3.5%)
and coitus interruptus (9, 30.2%). The frequency of coitus was once or twice a
week (24, 80.5%) and once or twice a month (4, 14.2%). and two (7.1%)
patients had history of previous VVC.
Conclusions: The most common pathogen causing VVC was detected as
C. albicans. Since the high prevalence of BV in those patients was determined,
patients with BV should be followed carefully and regularly for the possible
presence of VVC, and vice versa. The high frequency of coitus could be
related with VVC.
P952 Prevalence and sensitivity proﬁle to 5 antifungal
agents of yeast species causing onychomycosis and
vaginitis
R. Migliavacca, E. Nucleo, F. Zara, S. Asticcioli, M. Spalla, R. Daturi,
A. Spinillo, M. L. Guglielminetti, L. Pagani
Pavia, I
Objectives: The present study was undertaken to investigate the yeast species
most involved in onychomycosis and vaginitis and their in vitro sensitivity
against amphotericin-B (AMP), 5-ﬂucytosine (FLC), ketoconazole (KET),
ﬂuconazole (FLU) and itraconazole (ITRA).
Methods: Yeasts were collected from specimens obtained from 25 patients
suffering from onychomycosis and 59 afﬂicted by vaginitis. Clinical samples
were cultured on Chromalbicans Agar (Biolife). The fungal isolates were
identiﬁed by using the YBC card (Vitek System bioMe´rieux) and conﬁrmed
by a commercial yeast identiﬁcation kit API-Candida (bioMe´rieux). To
evaluate the antifungal susceptibility, the broth microdilution test YeastOne
(Sensititre) and the E-test (AB Biodisk) on RPMI 1640 glucose agar plate
were used.
Results: The identiﬁcation of isolates revealed the prevalence in vaginitis of
C. albicans (52.3%), followed by C. glabrata (24.6%), C. krusei (4.6%), C. para-
psilosis and S. cerevisiae (4.6%), while in onychomycosis the most frequent
specie was C. parapsilosis (44%) followed by C. albicans (32%), C. guilliermondii,
C. lusitaniae,C. rugosa andC. terreus. In vitro testing showed that the sensibility
against FLU resulted high in vaginitis (75.4% of isolates) especially for
C. albicans (91%); while the nonalbicans species were mostly sensible to
AMP and to FLC, but showed higher levels of resistance to FLU. Indeed
the 6.25% of C. glabrata isolates resulted resistant to this agent. In onycho-
mycosis we observed intermediate levels of resistance to ITRA and KET in
two C. parapsilosis, one C. guilliermondii and one C. lusitaniae strains. One
C. albicans strain was resistant to AMP.
Conclusions: The results demonstrate an higher frequency of C. parapsilosis
isolation compared with C. albicans in onychomycosis instead of in vaginitis.
However, C. glabrata and other nonalbicans species characterized by broad
resistance to antifungal agents are emerging as important causes of vaginitis.
Thus, further studies are required to establish the possible role of these species
in recurrent vaginal candidiasis.
P953 Causative agents of fungal nail infections in
Russia: new species and implications for therapy
A. Sergeev, N. Savchenko, Y. Sergeev, V. Malikov
Moscow, RUS
Background: Little concordance is observed in modern views on etiology of
fungal nail infection (onychomycosis). While some authors claim signiﬁcant
role of nondermatophyte molds and yeasts, others totally reject the right of
nondermatophytes to cause infection.
Objectives: To examine current etiologic composition of onychomycosis in
Russia, by prevalent genera and species, and also by major etiology groups.
Methods: Laboratory protocols (mycology unit of Central clinical hospital
under Presidential medical center) for 1997–2001 years were analyzed. Pri-
mary material was collected from 5 hospitals and 2 clinics of Moscow region.
During this period, there were cultured 3075 fungal isolates from 12617
samples.
Results:Dermatophytes (Trichophyton, Epidermophyton orMicrosporum species)
were isolated in 73.3%; Candida species in 9.6% and molds in 16.9%. Among
fungi identiﬁed by genus and/or species T. rubrum was the leader (71.06%),
followed by Candida spp. (8.8%) and T. mentagrophytes var. interdigitale (4.6%).
Occurrence of different species changed from time to time. Among derma-
tophytes, T. rubrum took 93.3% and T.mentagrophyteswas isolated 15 times less
frequent with prominent variability in time. We have isolated 5 cultures of
T.mentagrophytes from ﬁngernails (1.8%).M. canis, T. tonsurans and T. violaceum
onychomycosis was sporadic (12 cases total). Fungi were isolated from toenails
4–15 times more frequent, but positive ﬁngerail cultures were increasing in
number since 1997. Among ﬁngernail isolates, proportion of dermatophytes
was 38.4%, Candida spp. – 44.8% and molds – 16.5%. Among toenail isolates,
proportion of dermatophytes was 79.9%, Candida spp. – 14.3%, molds –
14.3%. Among nondermatophyte mold fungi Aspergillus spp. and Scopular-
iopsis brevicaulis shared the same proportion of 38.3% each. Other species, such
as Acremonium, Alternaria and Fusarium spp. had unique occurrence (although
the majority of mold isolates except Aspergillus and Scopulariosis was not
identiﬁed). We have described also two cases of onychomycosis caused by
relatively rare Aspergillus species: Aspergillus ustus and Aspergillus clavatus.
Conclusions: In certain clinical patterns of onychomycoses various fungi may
become a causative agent. This should point the clinician towards selective
usage of antifungals of known spectrum or perform susceptibility testing.
P954 The incidence of opportunistic fungi in patients
suspected of tuberculosis
M. Chadeganipour, S. Shadzi, J. Bijary
Isfahan, IR
Objectives: Opportunistic fungal infections are one of the major mortality
and morbidity in the debilitated patients. The patients affected with tuber-
culosis are among the immunocompromised hosts predispose to opportunistic
fungal infections. In addition, pulmonary fungal infections manifest clinical
syndromes which mimic tuberculosis. The objective of this study is to
examine the incidence of opportunistic fungi in bronchoalveolar lavage
(BAL) specimens of patients suspected of tuberculosis and to evaluate the
signiﬁcance of the ﬁndings.
Methods: The BAL specimens from 200 patients suspected of tuberculosis
were collected by standard bronchoscopic procedure and examined by direct
and culture methods for both tubercle bacilli and fungi.
Results: From 200 patients 36 yeasts (18%) and seven ﬁlamentous fungi (3.5%)
were isolated and identiﬁed as follows: Candida albicans (26), C. glabrata (3),
C. tropicalis (3), C. pseudotropicalis (2), C. krusei (1), Rhodotorula rubra (1),
Aspergillus fumigatus (4), A. ﬂavus (2), A. niger (1) and Streptomyces griseus
one case. Out of 200 cases, 16 patients were affected with deﬁnite tuberculosis
and 11 of these cases had pulmonary fungal infection in addition to tubercu-
losis.
Conclusion: From this study we can conclude that the yeasts had the highest
frequencies and among ﬁlamentous fungi A. fumigatus was more frequently
responsible for chronic pulmonary infections in patients suspected of tuber-
culosis in Iran. Therefore, attention should be paid to the recognition of
opportunistic fungi isolated from patients presumed to have tuberculosis and
that any organism should be considered a potential agent of infection in
debilitated patients.
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P955 Molecular epidemiology of Candida spp.
isolated from urine at an intensive care unit, Turkey
M. C. Ergon, Z. Gu¨lay
Izmir, TR
Objective:Candida spp. has been the leading microorganism isolated from the
urine specimens of patients hospitalized at the Anesthesiology and Reanima-
tion Intensive Care Unit (ICU) of Dokuz Eylul University Hospital, Izmir
since 1998. This study was undertaken to investigate the clonal relationship of
Candida urine isolates in order to ﬁnd the mode of spread among the patients.
Methods: Epidemiologic surveillance of 38 C. albicans, 15 C. tropicalis and 10
C. glabrata recovered from the urine specimens of patients who were hospi-
talized in the ICU between June 11th 2000 and October 15th 2001 was done
by antifungal susceptibility testing and randomly ampliﬁed polymorphic
DNA (RAPD) analysis. Two short primers [Cnd3 (50-CCAGATGCAC-
30) and Cnd4 (50-ACGGTACACT-30)] were used for RAPD.
Results: None of the isolates were resistant to amphotericin B with MIC50
values of 0.5mg/mL, 0.5mg/mL and 0.125mg/mL for C. albicans, C. tropicalis
and C. glabrata isolates, respectively. On the other hand, three C. glabrata
isolates were resistant and one C. albicans and ﬁve C. glabrata isolates were
dose-dependent susceptible to ﬂuconazole. Among C. albicans isolates 22 and
24 patterns were detected with primers Cnd3 and Cnd4, respectively. Primer
Cnd3 yielded four and primer Cnd4 yielded two patterns for C. tropicalis
isolates. Among C. glabrata isolates four and ﬁve patterns were observed with
the two primers.
Conclusion: Our results suggest that the source of C. albicans isolates were
mostly endogenous. On the other hand, cross transmission among patients was
considered for C. tropicalis and C. glabrata, as isolates that were clonally related
were recovered from different patients hospitalized at the same time interval.
P956 The identiﬁcation of Candida spp. isolated from
different clinical samples and investigation of their
susceptibility to antifungals
G. Sengoz, S. Elmi, F. Yildirim, Y. Bilgin, O. Nazlican
Istanbul, TR
Objective:At Haseki Education and Research Hospital microbiology labora-
tory, the identiﬁcation and antifungal susceptibilities ofCandida spp. isolated as
an infectious agent from specimens were investigated.
Methods: 53 Candida spp. were isolated from urine, blood, sputum, abscess,
ear discharge and vaginal secretions. These strains were identiﬁed according to
their microscopic morphology, germ tube test and with API ID32C (bio-
Me´rieux, France). Their antifungal susceptibilities were detected by API ATB
Fungus (bioMe´rieux, France).
Result: 25 strains were isolated from urine, 13 from blood, 8 from sputum and
7 from the others. If the strains are distributed according to their species,
C. albicanswas the majority (40). and it follows as C. krusei (5), C. utilis (3) and
the others. Antifungal resistance was15% to ﬂucytosine, 41.5% to amphoter-
icin B, 39.6% to nystatin, 33.9% to miconazole, econazole and ketoconazole.
Conclusion:The resistance of C. albicans strains to ketoconazole was found to
be 40%whereas it was found to be 19% in a study of ours in the year 1999. The
identiﬁcation ofCandida spp. and to determine their antifungal susceptibilities
will be a guide to the appropriate treatment of Candida infections.
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P957 Rapid and speciﬁc detection of secreted aspartyl
proteinases (SAP) genes of Candida albicans by
LightCycler PCR
M. M. Lopes, L. Monteiro, R. Barros, I. Peres, G. Freitas
Lisbon, P
Objectives: Saps are putative virulence factors in Candida infections. It is
reported the sequences of 10 members of a SAP gene family in Candida
albicans (SAP1–SAP10). The conventional PCR protocols for detection these
genes are time- and labor-intensive. The LightCyclerTM (Roche) combines
rapid ampliﬁcation of nucleic acids in glass capillaries with melting curve
analysis based on ﬂuorescence resonance energy transfer (FRET) for the
sequence-speciﬁc detection of the amplicons. Based on an established PCR
protocol for the sensitive and speciﬁc detection of SAP genes, the present
study describes the development and evaluation of that methodology for the
detection of these genes.
Methods: 20 cultured strains were screened (10 C. albicans, 5 C. parapsilosis, 5
C. tropicalis), isolated from pediatric patients, and a reference strain, C. albicans
SC5314, for the presence of deﬁned amplicons by comparing conventional
cycling with a LightCycler assay. One primer pair each for SAP1, SAP2,
SAP3, SAP4, SAP6, SAP7, and SAP8, was chosen. After LightCycler run, gel
electrophoresis was performed to have an independent validation check of the
presence of an amplicon.
Results:All fragments from the reference and the otherC. albicans strains were
ampliﬁed and detected, whereas none of the fragments from other Candida
species examined were recognized. The curves generated by the LightCycler
software allowed for a clear discrimination between positive and negative
samples. The identity of the PCR product from the unknowns was conﬁrmed
by comparing its speciﬁc melting temperature (Tm) with the Tm of the
product from the positive control. Gel electrophoresis conﬁrmed the authen-
ticity of all amplicons; a single band was obtained for each fragment ampliﬁed.
All LightCycler-based assays were performed in duplicate and showed
identical results, indicating an high reproducibility of the assay. The Light-
Cycler reduced the time taken to achieve results from PCR reactions and
simpliﬁed the laboratory workﬂow by automation and by reducing the
possibility of product contaminations. The results of the LightCycler-based
analysis corresponded to the results found by conventional cycling (100% of
agreement).
Conclusions: The LightCycler offers a standardized, fast, sensitive, and
reproducible tool for in vitro ampliﬁcation and sensitive-speciﬁc detection
of the PCR products of SAP genes by melting curve analysis in C. albicans.
P958 Semi-quantitative detection of
Aspergillus fumigatus in BAL ﬂuids from patients with
invasive pulmonary aspergillosis with a real-time PCR
K. Rantakokko-Jalava, S. Laaksonen, J. Issakainen, J. Vauras,
J. Nikoskelainen, J. Salonen
Turku, FIN
Objectives: To develop a quantitative or semiquantitative real-time PCR
method for detection of Aspergillus fumigatus in BAL ﬂuids and evaluate its
value in the microbiologic diagnosis of invasive pulmonary aspergillosis (IPA),
especially in differentiating between invasive disease and colonization of
respiratory tract.
Methods:Ampliﬁcation of aspergillus mitochondrial DNAwas monitored by
a pair of ﬂuorescing probes in the LightCycler instrument. The analytical
sensitivity of the assay was 100 A. fumigatus conidia per milliliter of BAL ﬂuid
(one conidium per reaction), and the assay was linear over four orders of
magnitude above the detection limit. The reproducibility of the test was good,
the coefﬁciency of variation (including DNA isolation, intra-assay and
interassay variation) ranging between 1.0 and 2.7%. BAL ﬂuids from 66
patients at risk of IPA and 33 immunocompetent controls were analyzed and
the results were related to the clinical diagnosis established according to the
recently published consensus criteria. Of the patients at risk, the diagnosis of
IPA was proven in six (9%), probable in four (6%), and possible in ﬁve (8%).
Results: Ampliﬁcation of aspergillus DNAwas detected in 16/81 (20%) BAL
ﬂuid specimens from patients at risk and in 1/33 (3%) samples from
immunocompetent controls. PCR was positive in 5/6, 2/4, and 4/5 of
the patients with proven, probable and possible IPA, respectively, as well as in
ﬁve patients in risk, but with no other evidence of IPA. Three patients with
proven or probable IPA were positive in galactomannan antigen testing but
negative in PCR, and two, positive in PCR but negative in antigen testing.
With qualitative detection, the sensitivity of PCR per patient was 73%,
speciﬁcity, 92%, and predictive values of positive (PPV) and negative (NPV)
results, 73 and 95%, respectively. Using the threshold cycle <35 as a limit for
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positive PCR, the speciﬁcity and PPV of PCR in the diagnosis of invasive
aspergillosis in immunocompromised patients were 100%, but the sensitivity
was only 45%, and NPV, 92%.
Conclusion: Semi-quantitative detection ofA. fumigatusmtDNA in BAL ﬂuid
may be helpful in the diagnosis of IPA (in combination with galactomannan
antigen), but the sensitivity of our assay was lower than expected on the basis
of previous literature. The possibilities to improve the sensitivity are under
evaluation.
P959 Identiﬁcation of dematophyte species by 28S
rDNA sequencing using a commercial kit
B. Ninet, I. Jan, O. Bontems, B. Lechenne, O. Jousson, R. Panizzon,
D. Lew, M. Monod
Geneva, Lausanne, CH
Background: Dermatophytes are usually identiﬁed on the basis of macro-
scopic characters and microscopic examination of the cultures. However,
identiﬁcation of dermatophytes often remains difﬁcult or uncertain because
there are variations from one isolate to another.
Objective:To develop a method for rapid identiﬁcation of the dermatophytes
with high speciﬁcity and sensitivity on the basis of the DNA sequence of the
genes encoding 28S rDNA.
Material andmethods:DNAwas extracted from fresh dermatophyte cultures
on Sabouraud’s agar medium. A part of the large ribosomal subunit RNA
(28S rRNA) was sequenced after PCR ampliﬁcation using the primers and
the PCR mix included in the commercial MicroSeq D2 LSU rRNA Fungal
Sequencing kit (Applied Biosystems).
Results: The selected sequence was unique and species-speciﬁc for all isolates
of Trichophyton rubrum, T. tonsurans, T. soudanense,Microsporum canis,M. audoui-
nii, M. gypseum, Epidermophyton ﬂoccosum and T.mentagrophytes var mentagro-
phytes. Two different sequence types were detected for T.mentagrophytes var.
interdigitale. The differences between the species were generally due to single
nucleotide polymorphisms.
Conclusions:The dermatophyte species could be easily, rapidly and routinely
identiﬁed on the basis of a DNA sequence encoding a part of the 28S
rRNA.
P960 Semi-nested PCR ampliﬁcation of rDNA in the
diagnosis of candidemia: comparison of amplicon
detection by agarose gels with enzyme immunoassay
S. Ahmad, A. Al-Rifaiy, Z. Khan, A. Mustafa, Z. Khan
Safat, KWT
Objective: To rapidly detect and identify four most commonly encountered
Candida species viz. C. albicans, C. tropicalis, C. parapsilosis and C. glabrata in
clinical specimens by speciﬁc ampliﬁcation of rDNA and to compare the
sensitivity of amplicon detection by enzyme immunoassay with visual detec-
tion of ampliﬁed product in agarose gels.
Methods: The target for ampliﬁcation was high copy rDNA. The universal
outer primers ampliﬁed the 30-end of 5.8S and 50-end of 28S rDNA including
the internally transcribed spacer 2 (ITS2) generating 317–423 bp fragments
from the four commonly encountered Candida species. The species-speciﬁc
primers derived from ITS2 and labeled with biotin, together with outer
reverse primer labeled with digoxigenin ampliﬁed species-speciﬁc DNA in
the re-ampliﬁcation step of the snPCR.
Results: The snPCR employing both the detection methods was positive for
genomic DNA recovered from 0.06 Candida cells in culture and 1 organism/
mL in spiked serum specimens. Evaluation of snPCR product detection by
both the methods for speciﬁc identiﬁcation ofCandida species with 26 clinical
Candida isolates showed 100% concordant results with Vitek and ID32C yeast
identiﬁcation systems. Further evaluation of snPCR amplicon detection by
both the methods for detection of Candida species in sera from culture proven
(n¼ 6), suspected (n¼ 10) and healthy subjects (n¼ 10) showed concordant
results.
Conclusions: The comparable sensitivity of amplicon detection by enzyme
immunoassay and agarose gel electrophoresis implies that that the re-ampli-
ﬁcation step introduced before the amplicon is detected has resulted in
maximum sensitivity of the protocol and that the incorporation of a more
sensitive method of detection did not improve the sensitivity further. The
agarose gel detection of the amplicons also reveals the size of the ampliﬁed
product, is cheaper and more suitable for most of the laboratories in the
developing countries for the detection of infecting Candida species in clinical
specimens.
Supported by Research Administration projects grants MI 118, Kuwait
University.
P961 A multiplex PCR using universal and
species-speciﬁc primers to rapidly identify eight yeast
species in positive blood cultures
Y. L. Li, S. N. Leaw, H. C. Chang, J. H. Chen, T. C. Chang
Tainan, TW
Objectives:The aim of this study was to evaluate a multiplex PCRmethod in
a single reaction to directly identify eight yeast species in positive blood
cultures. Three species are Candida glabrata, Cryptococcus neoformans, C. krusei,
C. albicans, C. guilliermondii, C. tropicalis, C. parapsilosis, and C. lusitaniae.
Methods: The principle for designing primers for multiplex PCR was to
select a consensus region within each species and to generate amplicons with
difference sizes that can be separated by electrophoresis. Eight forward species-
speciﬁc primers – CL, CP, CT, CGU, CA, CK, CN, and CGL – were
designed based on sequences of the internal transcribed spacer (ITS) regions 1
and 2 determined in this study and on comparison of the sequences in the
GenBank database to speciﬁcally amplify C. glabrata, C. neoformans, C. krusei,
C. albicans, C. guilliermondii, C. tropicalis, C. parapsilosis, and C. lusitaniae,
respectively. The ITS4 was used as a universal reverse primer. PCR ampli-
ﬁcation conditions were 3min of denaturation at 94 8C, followed by 30 cycles
of 94 8C for 1 min, 60 8C for 1 min, and 72 8C for 1 min. To determine the
lengths of PCR products, the amplicons were sequenced with an ABI Prism
377 automated system (Applied Biosystems). A total of 234 positive blood
cultures containing yeasts were analyzed in this study. The blood yeasts
isolated on subculture plates were identiﬁed by the conventional procedures
based on phenotypic and biochemical reactions.
Results: The amplicon sizes were as follows: C. glabrata (631 632 bp), C. neo-
formans (516 bp), C. krusei (475 bp), C. albicans (402 bp), C. guilliermondii
(185 bp), C. tropicalis (149 bp), C. parapsilosis (126 bp), and C. lusitaniae
(116 bp). The method was used to analyze 234 positive blood cultures
(237 isolates) from which the following species (strain number) were isolated:
C. albicans (121), C. tropicalis (50), C. glabrata (29), C. parapsilosis (20), Crypto-
coccus neoformans (6), C. krusei (4), C. guilliermondii (3), C. lusitaniae (1), and
other minor species (3). All isolates of the eight target species were identiﬁed
by the multiplex PCR, resulting a test sensitivity of 98.7% (234/237).
Conclusions:The present method is simple, rapid, and approximately 99% of
yeasts in positive blood cultures could be identiﬁed within 6 h.
P962 Karyotyping of Turkish environmental
Cryptococcus neoformans variety neoformans isolates by
pulsed-ﬁeld gel electrophoresis
M. A. Saracli, S. T. Yildiran, K. Sener, A. Gonlum, L. Doganci
Ankara, TR
Objective: Importance of opportunistic fungal infections has increased gra-
dually in recent years due to expansion of immunocompromised situations.
Cryptococcus neoformans has emerged as an important pathogen due to its
virulence factors especially in cases of Acquired Immunodeﬁciency Syn-
drome. The most important ecological source of C. neoformans var. neofor-
mans which is one of the two varieties of C. neoformans species is pigeon
droppings. There are approximately 10 studies about isolation ofC. neoformans
from pigeon droppings in Turkey, however, this project is the ﬁrst study
deﬁning genotypic characteristics of the isolates. In this project which is
supported by the Scientiﬁc and Technical Research Council of Turkey,
genotyping of national and environmental C. neoformans var. neoformans
strains is aimed.
Methods: A total of 28 environmental C. neoformans var. neoformans strains
isolated from 634 pigeon droppings from 54 different provinces of Turkey
between years of 1996 and 1997 were enrolled in this project. Pulsed Field Gel
Electrophoresis technique was applied as genotyping method.
Results: It was determined that the 28 strains constituted 26 different PFGE
patterns.
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Conclusion:Typing methods are indispensable components of epidemiologic
investigations. Phenotypic methods such as antibiotyping, sugar assimilation,
nitrate reduction and urease production might be insufﬁcient sometimes as it
is observed for these isolates (data not shown). PFGE as one of the most
popular genotyping method was well enough to show genomic differences
among cryptoccoccal strains as stated in previous reports and this study for
epidemiologic purposes. The determined great heterogeneity indicates that a
certain clonal population was not dominated in Turkey.
Fungi: pathogenesis/mechanisms/immunology
P963 Identiﬁcation of new antifungal targets by
comparative genomics and proteomics
C. Alberti-Segui, A. Morales, Q. Zeng, G. Cottarel, M. Kessler
Waltham, USA
We used a comparative genomic approach to identify new antifungal targets.
We ﬁrst screened the Saccharomyces cerevisiae genome for small open reading
frames (named smORFs) that have been overlooked in the previous annota-
tion of the yeast genome. These smORFs were then searched against a
comprehensive fungal protein sequence database to identify those that are
conserved in other fungi. We further conﬁrmed the existence of a subset of
these small genes in S. cerevisiae by showing that they are expressed and are
transcribed from the expected DNA strand using RT-PCR. From the list of
expressed smORFs, we focused on those with homologs in both Candida and
Aspergillus species and further tested these smORFs for essentiality. One of
these genes, smORF 57, was essential in both S. cerevisiae and C. albicans. We
searched for proteins interacting with smORF57 using the yeast two-hybrid
system and identiﬁed three binding partners that are known to be part of the
fungal mitotic apparatus. We additionally showed that the Candida gene
CasmORF57 interacts with two of the respective C. albicans homologs. All
three genes were found to be essential. The impact of this study on the
identiﬁcation of new essential, broad-spectrum, fungal speciﬁc targets is
considerable. These results demonstrate that the smORF population provides
an additional pool of potential therapeutic targets, both directly and through
interactions with partner proteins.
P964 Expression of coagulase and hemolytic activity
among Candida species
C. Pina-Vaz, A. G. Rodrigues, S. Costa-de-Oliveira, C. B. Tavares,
J. Ramon, D. Mendonc¸a
Porto, P
Introduction: Candida species have the ability to produce enzymes that are
known to mediate pathogenesis, particularly by facilitating hyphal invasion.
Coagulase is an enzyme produced by different microorganisms that causes clot
formation when in contact with plasma. Hemolysins are another example of
microbial enzymes conferring pathogenic potential.
Objective: To evaluate the production of coagulase and the expression
hemolytic activity by clinical strains of Candida.
Material and methods: A total of 144 Candida strains representing six
different species (C. albicans: 70; C. tropicalis: 12; C. glabrata: 25; C. parapsilosis:
23; C. krusei: 11, C. guilliermondii: 3) isolated from clinical samples were
selected. Two type strains from the American Type Culture Collection
(ATCC) (C. albicans 90028 and C. parapsilosis 22019) were also included in
the study. Tube coagulase test was prepared and analyzed at 4 h and whenever
negative observed again following 24 h of incubation. The Pasteurex latex test
is considered a speciﬁc test for the detection of S. aureus coagulase.We decided
to evaluate its speciﬁcity by assaying the agglutination of its reagent with the
same Candida strains (S. aureus ATCC 25923 and S. epidermidis ATCC 14990
were used as controls). Hemolysin productionwas evaluated using the method
described by Luo et al. (1).
Results: The results regarding production of coagulase in the test tube, the
agglutination of Pasturex reagent and production of hemolysis are detailed in
Table 1.
Conclusion: Several species of Candida can produce coagulase, a known
mechanism of pathogenicity. Many of them react unspeciﬁcally with the
reagent to detect S. aureus coagulase, particularlyC. albicans, as well as strains of
C. tropicalis and a few of C. parapsilosis, probably due to similitude of antigens.
Such a fact may cause mistakes in clinical laboratories. C. krusei does not
produce coagulase. Despite the conﬂicting results of Luo et al. none of the
tested strains was able to produce hemolise, independently from the site of
isolation.
Reference:
1. Luo G., Samaranayake L.P., Yau J.Y.Y. Candida species exhibit differential in vitro hemolytic
activities. J Clin Microbiol 2001; 39: 2971–4.
P965 Immunoblotting analysis of sera from patients
with acute and chronic candidal and noncandidal vaginitis
for IgE and IgG antibodies to Candida albicans
M. T. Hedayati, H. Badali, F. Vasheghani, R. Aghili,
R. A. Mohammadpour
Sari, IR
Objectives: The purpose of this study was determination of IgE and IgG
antibodies to Candida albicans in sera from patients with acute and chronic
candidal and noncandidal vaginitis.
Methods: In this study, Candida albicans (C. albicans) was grown on medium.
Then yeast cells were carefully harvested from the surface of the solid medium.
After disruption of yeast cells, samples were centrifuged (25,000 rpm). Super-
natants were collected and were used as a crude extract. Protein components
in crude extracts of C. albicans were separated by sodium dodecylsulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) and transferred to nitrocel-
lulose ﬁlter. The components were detected by sera from patients with acute
and chronic candidal and noncandidal vaginitis (n¼ 80, 20 patients from each
of groups) and visualized by enzyme-labeled antihuman IgE and IgG anti-
bodies in chromogenic substrate.
Results: In SDS–PAGE a total of 15 different protein bands (13–75 kDa) was
observed in crude extract of C. albicans and in immunoblotting none of
protein bands gave response with IgE antibodies. On the contrary, protein
bands with molecular weight of 25, 47 and 52 kDa gave strong response with
IgG antibodies in 100% of sera from chronic candidal vaginitis patients.
Whereas, chronic noncandidal vaginitis patients were not reacted with any
protein bands. Hundred percent of sera from acute candidal vaginitis patients
gave strong response only with 47 kDa protein bands and 63.8% of chronic
noncandidal vaginitis patients gave weak response with 47 kDa protein bands.
Conclusion: Our results showed that anti-Candida IgG to 25 and 52 kDa
protein bands was strongly related with chronic course of candidal vaginitis.
P966 Antifungal activity of oregano oils (Lippia
graveolens and Origanum virens) on dermatophyte species
E. Pinto, A. Palmeira, L. Salgueiro, C. Cavaleiro, M. J. Gonc¸alves,
C. Pina-Vaz, A. G. Rodrigues, S. Costa-de-Oliveira, C. B. Tavares,
J. Martinez-de-Oliveira
Porto, Coimbra, P
Dermatomycoses caused by dermatophytes are common superﬁcial infec-
tions. The increasing resistance to antifungal compounds and the reduced
number of available drugs urged the search for therapeutic alternatives.
Previous research of our team demonstrated the antifungal activity of some
thymus essential oils against dermatophyte species (1).
Objectives: Evaluate the antifungal activity of the essential oils of Lippia
graveolens andOriganum virens (oregano oils) used in folk medicine in order to
support their use as antifungal agents.
Table 1
Tube coagulase
test
Pasteurex latex
test Hemolysis
C. albicans 88.5% 68.9% 0
C. tropicalis 66.7% 33.3 0
C. glabrata 20% 0 0
C. parapsilosis 41.7% 8.3% 0
C. krusei 0 0 0
C. guilliermondii 33.3% 0 0
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Material and methods: The composition of the oils was investigated by gas-
chromatography and gas-chromatography/mass spectroscopy (2). The Mini-
mal Inhibitory Concentration (MIC), determined according to the NCCLS
protocol M 38-P, and theMinimal Lethal Concentration (MLC) were used to
evaluate the antifungal activity against dermatophyte clinical strains (Micro-
sporum canis, M. gypseum, Trichophyton rubrum, T.mentagrophytes and Epidermo-
phyton ﬂoccosum). The antifungal activity of their major components
(carvacrol, gama-terpinene, p-cymene and thymol) was also evaluated.
Results:Both oils showed similar antifungal activity for all tested strains. MIC
and MLC values are similar, ranging from 0.08 to 0.16 mm/mL. This is
probably due to their chemical composition, mainly composed (over 70%)
by carvacrol/gama-terpinene (O. virens) and carvacrol/p-cymene/thymol
(L. graveolens).
Conclusions: This study showed the antifungal activity of these essential oils
on dermatophyte species, supporting future therapeutical trials on dermato-
phytoses.
Acknowledgements: FCT, POCTI and FEDER (POCTI/40167/ESP/
2001) for ﬁnancial support; Prof. Dr. Armando Ca´ceres (CYTED-RIPRO-
FITO) for providing Lippia graveolens.
References:
1. Pinto E., et al. In: Proceedings of the 33rd International Symposium on Essential Oils, 2002,
p. 120.
2. Cavaleiro C., et al. Biochem Syst Ecol 2001; 29: 1175–83.
P967 The effects of UVB-irradiation on dermatophyte
fungi
P. Behzadi, S. Rezaie, M. Emami
Tehran, IR
The effects of UVB-irradiation on the various microorganisms have been
investigated previously. However, little knowledge is available in the case of
dermatophyte fungi. In this study, we tried to ﬁnd out the morphologic and
genetic changes following the UVB-irradiation on these fungi and analyze the
obtained results by molecular methods. The following species of dermato-
phytes (Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton ﬂoc-
cosum and Microsporum canis) have been isolated from patients and selected for
investigation in this project. Equal amounts of dermatophyte species were
cultured on Petri dishes contained Sabouraud Dextrose Broth (SDB), Sabour-
aud Dextrose Agar (SDA) and Sabouraud Dextrose Agar with cyclohexamide
and chloramphenicol (Scc). Also some slidecultures were prepared from these
species. The cultured plates and slidecultures were then irradiated by UVB-
light at the wavelength of 302 nm. The irradiated plates were kept in a dark
room at room temperature. The effects of the irradiation on colonies have
been studied based onmacroscopical andmicroscopical methods in all species.
For determining the possible molecular changes in dermatophytes due to
UVB-irradiation, we next isolated high molecular weight DNA from non-
irradiated as well as irradiated T. rubrum and compared them by gel-electro-
phoresis. The result of study indicated the inhibition of growth in irradiated
colonies cultured all media. The longer irradiation time caused slower rates of
growth in these fungi. Besides, the changes in shape of colonies and
pigmentation was observed in some cases. The microscopic studies of
irradiated colonies indicate deformation of hyphae and changes in size and
shape of macroconidia in all species. Besides, changes in number of micro-
conidia in some species were determined. The investigation of isolated DNAs
from T. rubrum showed no differences in DNA banding patterns. These results
indicate the susceptibility of dermatophyte fungi to UVB-irradiation. As we
did not ﬁnd any DNA changes due to irradiation, it can be concluded that the
observed changes in growth-rate and deformation of mycelial and conidial
bodies, may occur due to protein miss-folding or other changes in cell
metabolisms.
P968 Propofol promotes Aspergillus fumigatus hyphal
growth
R. Araujo, A. Rodrigues, C. Pina-Vaz
Porto, P
Aspergillus is a growing agent of disseminated fungal infections, particularly
among neutropenic and transplant patients admitted in ICU units. Mycelium
formation plays a crucial role in virulence, namely by promoting adherence to
host cells and tissue invasion. Propofol, administered in a lipid emulsion, is a
sedative drug widely used in critical care patients.
Objectives: To evaluate the promotional effect of propofol upon hyphal
extension by Aspergillus.
Materials and methods: Five day old spores of clinical isolates of A. fumigatus
(ﬁve strains) and A. ﬂavus (four strains) were incubated with serial dilutions of
propofol in RPMI 1640 medium (Sigma), at 37 8C. Samples (200 cells) were
hourly checked for germination and hyphal extension (elongation), up to
24 h.
Results: Propofol-induced germination and hyphal formation by Aspergillus,
noticeable soon after 5–6 h and particularly with A. fumigatus. The extending
hypha usually shows embedding in a lipid layer, particularly at the hyphal tip.
Conclusions: Propofol is potentially associated to a promoted risk of noso-
comial fungemia due its high potential of contamination, even when infused
shortly after its use. The lipid layer around the hypha may, apart from
promoting growth, prevent the antifungal activity of drugs and/or host
defense mechanisms. Therefore, propofol seriously enhances the invasiveness
and pathogenesis by Aspergillus organisms, promoting deep-seated fungal
infections.
P969 Inhibitory effect of local anesthetics on
germination and mycelium formation by Aspergillus
A. Rodrigues, R. Araujo, C. Pina-Vaz
Porto, P
Germination of spores and hypha formation is a crucial step in the pathogen-
esis of infection by Aspergillus. Local anesthetics possess a potent antifungal
activity, namely uponCandida spp. (1, 2). It would be of interest to assess such
effect on other emerging fungal pathogens.
Objectives: To evaluate the effect of lidocaine and bupivacaine on germina-
tion and mycelium formation of pathogenic species of Aspergillus.
Materials and methods: Five days old spores of 12 clinical isolates of
A. fumigatus (six strains), A. ﬂavus (three strains) and A. niger (three strains)
were assayed for germination and mycelium formation in the presence of
serial concentrations of lidocaine (0.06–0.25%) and bupivacaine hydrochlor-
ide (0.03–0.125%) (pure salts, free of preservatives, Sigma, USA), in RPMI
1640 medium (Sigma) at 37 8C. Germination and hyphal extension was
hourly assessed by observation of 200 spores in a Neubauer’s chamber, up to
48 h, in triplicate. Controls were prepared in plain RPMI medium.
Results: A signiﬁcant, dose-dependent, pH-independent, inhibition of ger-
mination and hypha formation was observed in presence of lidocaine and
bupivacaine, soon after 6 h of incubation, in all tested strains of A. fumigatus,
A. ﬂavus and A. niger. Germination of A. ﬂavus and A. niger spores was
completely abolished with 0.125% lidocaine. In the case of A. fumigatus,
0.25% lidocaine completely prevented mycelium formation by A. fumigatus,
an effect that lasted up to 48 h. Bupivacaine reproduced this inhibitory effect
but much lower concentrations than lidocaine.
Conclusions: Lidocaine and bupivacaine produced a potent inhibition of
germination and hypha formation by Aspergillus species. Therefore, this
antifungal activity should be better characterized in order to evaluate its role
in future preventive or therapeutic attitudes to be taken in patients at risk of
developing Aspergillus infections.
References:
1. Rodrigues A., Pina-Vaz C., Mardh P.A., et al. Inhibition of germ tube formation by Candida
albicans by local anesthetics: an effect related to ionic channel blockade. Curr. Microbiol. 2000; 40:
145–8.
2. Pina-Vaz C., Rodrigues A., Sansoretty F., et al. Antifungal activity of local anesthetics against
Candida species. Infectious Dis. Obstet. Gynecol. 2000; 8: 124–37.
P970 Inhibition of germination and mycelium
formation by Aspergillus by local anesthetics: an effect
related to ionic channel blockade
R. Araujo, A. Rodrigues, C. Pina-Vaz
Porto, P
Formation of mycelium following the germination of spores has been
assumed an important virulence factor among fungal pathogens.
Local anesthetics (LAs), e.g. lidocaine and bupivacaine, are known to exhibit a
potent antifungal activity, namely upon pathogenic species of Aspergillus.
Objectives: To determine if ionic channel blockade by means of selective
calcium blockers could mimic the inhibitory effect of LAs on germination and
hyphal extension by Aspergillus.
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Materials andmethods: Five days old spores of clinical isolates ofA. fumigatus
(three strains), A. ﬂavus (two strains) and A. niger (two strains) were assayed for
germination and mycelium formation in the presence of serial concentrations
of selective calcium blockers, i.e. verapamil (0.5–1.5mg/mL) and nifedipine
(1–6mg/mL) (Sigma), and a general blocker of ionic channels, i.e. lanthanum
(0.25–2mg/mL) (Sigma), in RPMI 1640 medium (Sigma), at 37 8C. Ger-
mination and hyphal extension was hourly assessed by observation of 200
spores in a Neubauer’s chamber, up to 48 h, in triplicate. Controls were
prepared in plain RPMI medium.
Results: A dose-dependent, pH-independent, inhibitory effect of germina-
tion and hyphal formation was obtained with the different blockers assayed,
particularly with the selective blockers of calcium channels.
Conclusions:We conclude by the dependence of the inhibitory effect of LAs
of blockade of ionic channel, particularly calcium channels. Our results
stress the importance of calcium ion on morphology and pathogenesis of
Aspergillus.
P971 Microscopic pathology of the kidney in rats fed
Fusarium graminearum-inoculated diet
E. Ozbek, A. Ozbek, H. Uslu
Erzurum, TR
Objective: Recently, Fusarium species have emerged as opportunistic patho-
gens in the immunocompromised human host. These fungi are frequently
isolated from cereal grains, and produce some mycotoxins causing toxic
disorders in mammals. In this study, we aimed to examine possible renal
pathology in rats fed Fusarium graminearum-inoculated diet.
Methods:Twelve young adult Sprague–Dawley rats were randomly allocated
into two groups: six animals fed F. graminearum-inoculated rice medium for
14 days (treatment group), and six animals fed noninoculated diet (control
group). At the end of the 14-day interval, all rats were applied the technetium
(99mTc)-labeled immunoglobulin G (IgG) scintigraphic imaging method for
detection of foci of infection and inﬂammation, and then sacriﬁced. Subse-
quently, their kidneys were removed, and ﬁxed in 10% neutral buffered
formalin, and embedded in parafﬁn for light microscopic examination.
Sections were stained with H-E.
Results: Increased uptake of 99mTc-labeled IgG was observed in the kidneys
of treatment group rats. By light microscopy, the renal changes in the
treatment group were characterized by the following ﬁndings: patch-like
mononuclear cell inﬁltrations in cortex; many foci of necrosis and cellular
debris; ﬁbrosis in the necrotic areas; prominent atrophy of distal tubules;
pleomorphism, karyoreksis, cytoplasmic vacuolation, apoptosis, and mitotic
ﬁgures in the epithelial cells of proximal tubules.
Conclusions: It was concluded that dietary F. graminearum caused a chronic
inﬂammation and great tubular damage to the rat kidney.
P972 Origins of relapses and resistance in recurrent
vaginal candidosis
T. Romanovskaya, A. Sergeev, Y. Sergeev
Moscow, RUS
Background: The cause of frequent relapses in chronic vulvovaginal candi-
dosis (CVC) is still unknown. Microbiologic resistance is considered some
times, but no proof still exists. Immunologic abnormalities may play a role in
such patients.
Objectives: To study the possible microbial resistance and immunologic
features in CVC with frequent relapses and treatment failures.
Methods: Study group included 53 female patients with CVC. Species
identiﬁcation was conducted using BBL Mycotube kit. Antifungal suscept-
ibility testing was performed with ATB Fungus panel, complying with
NCCLS standards. Immunological features and sensitization were examined
with a set of speciﬁc methods.
Results: No variability was observed with causative species of Candida,
regardless of disease duration and relapse frequency. Candida albicans was
the only causative agent. No microbiologic resistance was observed for all
azole antifungals. In this group, examination of immunologic status revealed
signiﬁcant decrease in CD4þ lymphocyte counts (CI with P< 0.01 vs. 94
donor controls) with non-signiﬁcant decrease in IgA levels. Later we exam-
ined proﬁles of sensitization to standardC. albicans antigens in a set of ﬁve tests,
allowing to reveal four types of hypersensitivity reactions (IgE, IgG-speciﬁc
antibodies, bound IgG in neutrophil damage test, delayed hypersensitivity
with lymphocyte IL-2 stimulation test) with control group of 22 healthy
women. Speciﬁc IgE antibodies were found in 28/53 (52%) of CVC group
and IgG neutrophil damage test (antibody-dependent cellular toxicity) was
positive in 41 (77.3%), with signiﬁcant difference from controls. Type III
reactions (Candida-speciﬁc IgG) were signiﬁcantly less frequent than in age-
matching control group. Delayed type anti-Candida hypersensitivity was more
frequent than in controls and more prominent after beginning of antifungal
treatment.
Conclusions: A possibility of underlying immune deviation in CVC exists.
This could better explain relapses and failures, rather than true microbial
resistance that was not revealed in study group.
Antimicrobial susceptibility
P973 Antibiotic resistance of Gram-negative bacteria
isolated from drinking water of South-western Greece
D. Venieri, A. Vantarakis, E. Kouskouni, M. Papapetropoulou
Patras, Athens, GR
Objectives:Determination of antibiotic resistance of Gram-negative bacteria
isolated from drinking water samples.
Methods: Water samples were collected from 15 different regions of SW
Greece. 105 water samples were analyzed for the presence of Gram-negative
bacteria. Isolation of bacteria was performed by the ﬁltration method.
Identiﬁcation of the bacteria was performed using API system method.
The antibiotic resistance of all the isolates was assessed, applying antibiotic
disk diffusion method. 13 antibiotics were used: Amoxicilline, Ampicilline,
Cephalotine, Norﬂoxacine, Nalidixic acid, Chloramphenicol, Gentamycine,
Amikacine, Neomycine, Nitrofurantoin, Tetracycline, Oxytetracycline,
Sulfathiazole.
Results: Twelve different Gram-negative bacteria were isolated (Aeromonas
hydrophila, Citrobacter freundii, Enterobacter aerogenes, E. cloacae, E. sakazakii,
Klebsiella oxytoca, K. pneumoniae, Morganella morganii, Salmonella arizonae,
Serratia fonticola, Serratia marcescens, Escerichia coli). 18.19% ofE. coliwas resistant
to one or two antibiotics, 28.41% to three or four antibiotics, 3.41% to ﬁve or
six antibiotics. E. coli showed 100% susceptibility to norﬂoxacine, chloram-
phenicol, gentamycine, amikacine. 80% ofA. hydrophilawere resistant to three
antibiotics used. 75% of C. freundii isolated were resistant to three antibiotics
and 25% were resistant to one antibiotic. E. aerogenes was resistant to four
antibiotics whereas 50% of the E. cloacaewere resistant to three antibiotics and
50% to four antibiotics. E. sakazakii was resistant to one antibiotic. Klebsiella
species were resistant to two antibiotics. S. arizonae isolated showed suscept-
ibility to all antibiotics used whereas M.morganii and Serratia species were
resistant to four antibiotics.
Conclusions: Gram-negative bacteria isolates showed different antibiotic
patterns. No statistical relationship was established between the antibiotic
resistance pattern and the area of water sampling and the species of the
bacteria. However, E. coli isolated from three distant regions showed different
and characteristic antibiotic patterns. This is probably due to the different use
of these antibiotics in each geographic area. The antibiotic resistance genes
can naturally be transferred to other antibiotic sensitive bacteria via conjuga-
tion. These mechanisms of gene transfer aids in the horizontal transfer of
antibiotic resistance and could pose a potential public health hazard by serving
as a reservoir of antibiotic resistance genes.
P974 Bacterial isolates of intensive care and therapy
units of a hospital in Kolkata and their meropenem
sensitivity patterns
Satadal Das
Kolkata, IND
Objectives: To ﬁnd out common bacterial isolates in intensive care and
therapy units and to observe sensitivity patterns of the newly introduced
antimicrobial agent meropenem in our hospital in Kolkata.
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Methods: The prevalence of different bacterial isolates was observed sepa-
rately in different units within a span of 6months from April to September
2002 and the prevalence rates of different bacterial isolates were compared.
The sensitivity pattern of meropenem was determined according to NCCLS
guidelines.
Results: Mainly three bacterial isolates were found highly prevalent in
different units. These are Klebsiella sp. (K), Pseudomonas sp. (P) and E. coli
(E). The prevalence rates in different units were quite different. In general
ITU (K 15.0%, P 35.0%, E 25.0%) and in neurology ITU (K 22.2%, P 33.3%,
E 30.6%), Pseudomonas sp. isolates were more while in neonatal ITU (K
58.8%, P 23.5%, E 14.7%) and in ICCU (K 35.7%, P 25.7%, E 18.7%)
Klebsiella sp. Isolates were much more in number. The reason of increased
Klebsiella sp. isolates may be due to the high prevalence of these organisms in
environment of the City, which we observed earlier. Among all isolates
96.25% isolates were meropenem sensitive and the meropenem resistant
isolates were mainly found in neonatal ITU.
Conclusions:Klebsiella sp., Pseudomonas sp. and E. coliwere the main isolates of
intensive care and therapy units of our hospital in Kolkata. Increased Klebsiella
sp. isolates in these units may be due to high prevalence of these organisms in
environment of the City. Meropenem sensitivity of the isolates was signiﬁ-
cantly high.
P975 In vitro antimicrobial sensitivity proﬁle of the
most common organisms isolated by a reference
bacteriology laboratory in a prospective study, 1999–2002
A. Nanetti, R. Manfredi, S. Morelli, M. Ferri, R. Valentini, L. Calza,
F. Chiodo
Bologna, I
Objective: To evaluate the antimicrobial susceptibility pattern of the most
common bacteria isolated at a reference Hospital.
Methods: A 4-year prospective survey was conducted to assess the micro-
biologic proﬁle of all pathogens isolated from inpatients and outpatients
referring to our center.
Results: From January 1999 to June 2002, over 100 different bacterial species
were identiﬁed from clinical specimens, with Staphylococcus aureus (9961
strains, 3254 in the year 1999) and Pseudomonas aeruginosa (9670 isolates,
3202 in the year 2000), as the most prominent organisms, also borne by
therapeutic problems. Throughout the 42-month study period, S. aureus
strains remained completely sensitive to teicoplanin, vancomycin, rifampicin,
chloramphenicol, and cotrimoxazole, while susceptibility of coamoxyclav
ranged from 0 to 40.4% of tested strains, that of cefotaxime from 0 to 42.8%,
clindamycin from 0 to 41.5%, erythromycin from 0 to 37%, gentamycin from
0 to 46.4%, and penicillin proved always ineffective; methicillin resistance
ranged from 31.5% (year 2001) to 100% (year 2002). When analyzing the
temporal trend, a signiﬁcantly increased resistance was found for methicillin,
coamoxyclav, cefotaxime, and gentamycin (P< 0.001, 2002 vs. 1999). P. aer-
uginosa proved sensitive over the entire 4-year period to ceftazidime, piper-
acillin-tazobactam, and imipenem, followed by tobramycin (74.8–100% of
strains), amikacin (73.8–100%), aztreonam (70.2–100%), ciproﬂoxacin (68.5–
100%), gentamycin (62.9–100%), ticarcillin-clavulanate (61.1–100%), piper-
acillin (68–72.6%), and mezlocillin (44–59.4%). A signiﬁcantly increased
resistance rate was found for gentamycin and ticarcillin-clavulanate
(P< 0.001, 2002 vs. 1999).
Conclusion: A permanent survey plays a key role in the monitoring of
epidemiology and resistance pattern of bacterial pathogens isolated in every
geographic context. Empiric treatment and prophylaxis should be guided by
local surveillance programs. S. aureus and P. aeruginosa were the most repre-
sentative Gram-positive and Gram-negative bacterial pathogens in our 4-year
prospective survey. In vitro assays conducted on nearly 10 000 isolates of each
bacterial species showed an elevate effectiveness of glycopeptides, and also
rifampicin, cotrimoxazole and chloramphenicol for S. aureus, and a fully
reliable activity of ceftazidime, piperacillin-tazobactam and imipenem for
P. aeruginosa, while the sensitivity of a broad spectrum of other tested anti-
microbial agents was unpredictable, so that in vitro studies are strongly needed
when such infections are of concern.
P976 In vitro antimicrobial susceptibility trends in
clinically signiﬁcant bacteria isolated in a general hospital
during a 6-year period
E. Vogiatzakis, D. Hatzaki, G. Antonakos, E. Tombrou, E. Mastrokalou,
G. Kostogianni, A. Vatopoulos
Athens, GR
Objective: To investigate the resistance trends in certain antibiotics during a
6-year period in our Hospital, which does not have ICU.
Methods: From 1997 to 2002, 5,471 hospital and community-acquired
bacterial stains were studied. The majority of the clinical specimens tested
was urine (85.5%), and the rest (14.5%) included: pus, wounds, catheter tips,
sputum, blood cultures, bile, prostatic secretions, etc. The identiﬁcation of the
isolates to the species level and the susceptibility testing to antimicrobials was
performed by the API system (BioMerieux). The antibiotics included in our
study were: ciproﬂoxacin (CIP), imipenem (IMP), nalidixic acid (NAL),
ceftazidime (CAZ), gentamicin (GEN), oxacillin (OXA), vancomycin (VA)
and teicoplanin (TEI).
Results: The majority of the isolates were obtained from urine specimens
(69.2%). The predominant pathogen isolated was E. coli (44.7%), followed by
E. faecalis (8.8%), P. aeruginosa (7.5%), K. pneumonia (6.3%), P. mirabilis (5.4%),
S. aureus (3.7%) and other pathogens (23.6%). The resistance rates (%) of the
most frequent pathogens for the years 1997–2002 for each of the antibiotics
included in the study were as follows: E. coli 5.1–4.7–5.91–6.7–6.8–9.1 for
CIP, 0 for all the years for IMP, 7.7–12.7–9.6–11.3–14.4–13.8 for NAL, and
2.3–3.2–3.6–4.6–4.83–6.1 for CAZ. K.Pneumoniae 8.5–8.3–6.8–7.8–9.6–
10.6 for CIP, 0 for all the years for IMP, 29.7–27.9–21.3–19.3–13.5–16.3
for NAL and 10.6–11.6–12.2–8.3–10.7–13.2 for CAZ P. aeruginosa 34–38.5–
29.1–29.5–41.3–47.1 for CIP, 6–12.9–9.3–11.6–12.3–19.1 for IMP and 6–
17.9–16.6–17.9–16–19.1 for CAZ. S. aureus 22.2–25–31.5–33.3–21.4–48.2
for GEN and 22.2–25–44.7–30–27.8–53.5 for OXA. As for E. faecalis, we
found 7.4 (5/67) VA resistant and 13 (9/67) TEI resistant strains in 1997, 1.4
(1/71) VA resistant strains in 2001 and 2 (1/50) VA resistant strains in 2002.
Conclusions:We observed an upward trend of the resistance rates of E. coli for
CIP, NAL and CAZ. The K. pneumoniae strains showed a reduction of the
resistance rates for NAL and P. aeruginosa strains showed an upward trend of
the resistance rates for CIP, IMP and CAZ. The S. aureus strains also showed a
signiﬁcant increase of the resistance rates for GEN and OXA. We should
notify that IMP kept a high effectiveness (100% sensitivity) for E. coli and
K. pneumoniae.
P977 Activity of antibiotics against
periodontopathogenic bacteria within epithelial cells
S. Eick, C. Puschmann, M. Richter, W. Pﬁster
Jena, D
Objectives: Periodontopathogenic bacteria are able to invade epithelial cells
and to survive there. This might be a cause for chronicity of periodontitis. The
purpose of this study was to determine the activity of different antibiotics
against intracellular bacteria.
Methods:KB cells as a permanent epithelial cell line were infected by each of
the following strains: Actinobacillus actinomycetemcomitans (A.a.) NCTC 9710,
Porphyromonas gingivalis (P.g.) ATCC 33277 and JH16-1, and Streptococcus
constellatus (S.c.) J012-2. P.g. JH16-1 and S.c. J012-2 were clinical isolates
obtained from patients with severe recurrent periodontitis. After infection of
the cell line extracellular bacteria were killed by addition of 10mg penicillin/
mL cell cultivation media. The effect of the antibiotics clindamycin, dox-
ycyclin, metronidazole and moxiﬂoxacin on the intracellular bacteria was
tested after 2, 4 and 12 h. The concentrations used were the 1-, 10-, 50- and
100-fold MIC, which had been determined with planctonic, extracellular
bacteria.
Results: The bacterial strains differed markedly in their ability to invade
epithelial cells: 1.08 105 of intracellular P.g. ATCC 33277 were enumerated
after 2 h, but only 0.5 103 up to 2 103 cfu were found for the other strains
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at the same time. The 10-foldMIC of clindamycin reduced the number of S.c.
after 4 and 12 h and the number of viable bacteria of the two P.g. strains were
lower after addition of the 100-fold MIC. The 10-fold MIC of doxycyclin
killed all A.a. after 4 h, whereas only little effects on the other strains were
observed. Metronidazole showed only a reducing effect on the P.g. strains up
to the 100-foldMIC.Moxiﬂoxacin in the 10-foldMIC killed all A.a. The 50-
fold MIC was able to eliminate all S.c. and the 100-fold MIC killed all
intracellular P.g. ATCC 33277. The P.g. JH16-1 strain was not completely
eliminated. The combination of metronidazole and moxiﬂoxacin eliminated
the ATCC strain by the 50-fold MIC and the JH16-1 strain by the 100-fold
MIC for both antibiotics.
Conclusions: The results of this in vitro-study showed that moxiﬂoxacin was
the most active of the antibiotics against intracellular bacteria. But high MIC
values were necessary for eliminating periodontopathogenic bacteria. Con-
sidering these results a possible application of this antibiotic in periodontitis
patients should rather be a local than a systemic one and the efﬁcacy has to be
proven in clinical controlled trials.
P978 Interaction of aminoglycosides with the other
antibiotic, combined in multiantibiotic drugs, analyzed by
checkerboard and E-test methods
W. Grzybowska, S. Tyski, M. Banaszczyk
Warsaw, PL
Objective: Aminoglycosides with other antibiotics combined in some com-
posed pharmaceutical preparations existing on Polish market. Combined
antibiotic therapy has been used mainly to broaden the antibacterial spectrum
and prevent the development of resistance. Checkerboard method is the most
widely used technique to analyze antimicrobial interactions. The aim of this
study was to compare above method with E-test assay for analysis of
aminoglycosides (gentamicin, kanamycin, streptomycin and dihydrostrepto-
mycin) interaction with other antibiotics (lincomycin, benzylpenicillin,
amoxycillin, cephalexin, spectinomycin and erythromycin) combination
on selected clinical bacterial strains.
Methods: Using checkerboard technique, serial dilutions of two antibiotics
were prepared and combinations of six concentrations proportional to MIC
value (from 1/4MIC to 2MIC) of both drugs were analyzed. Fractional
Inhibitory Concentration (FIC) indexes were calculated from the checker-
board data. The strips of E-tests were placed on agar in a cross formation, with
a 908 angle at the intersection between scales at their respective MICs. If only
one antibioticE-test was available, the second agent was added to agar. Strains:
bacterial strains of: Salmonella sp., S. enteritidis, K. pneumoniae, P. aeruginosa,
E. coli, E. cloacae, MRSA and MSSA isolated from clinical sources were under
investigation.
Results: Checkerboard results of all analyzed strains demonstrated synergism
in 8% of combinations. However, additive effect was the predominant (65%).
Neutral effect was obtained in 12.5% of combinations. In three cases (2 strains
of E. coli and one E. cloacae isolate) in gentamicin combination with amox-
icillin, inhibition effect was noticed. The checkerboard and E-test results
corresponded in 55%. Twenty-one percentage of results obtained by both
methods showed some discrepancies. These results concerned additive or
neutral effects. Some investigators declare indexes, from over 0.5 up to 4, for
neutral effects. Sharing this point of view, above 21% of discrepancy results can
be counted as corresponded. In this situation, deﬁnite disagreement was
observed only in 8% of obtained results.
P979 Antimicrobial susceptibility of bacteria causing
complicated intra-abdominal infections
O. U. Stetsiouk, D. V. Galkin, E. L. Ryabkova, O. I. Kretchikova,
L. S. Stratchounski
Smolensk, RUS
Objective:To study antimicrobial susceptibility (AS) of the complicated intra-
abdominal infections (CIAI) pathogens.
Methods:AS testing of the aerobic CIAI pathogens was performed by E-tests
on Muller–Hinton II agar, of the anaerobes by broth microdilution. AS data
were interpreted according to NCCLS (2001) recommendations and ana-
lyzed with WHONET software.
Results: 135 strains (55 aerobes and 80 anaerobes) isolated from 18 patients
with CIAI in Smolensk were evaluated. Predominant bacteria were Gram-
negative non-sporeforming anaerobes (NSA, N ¼ 50) – Bacteroides spp. (37),
Prevotella spp. (8), Porphyromonas spp. (3), Dialister pneumosintes (2); Enter-
obacteriaceae (N¼ 35) – E. coli (18), K. pneumoniae (6), Proteus spp. (5);
Clostridium spp. (N¼ 16); less common bacteria were Enterococcus spp. (13);
nonfermenters (N¼ 9): P. aeruginosa (5) and Acinetobacter spp. (3); Eubacterium
spp. (N¼ 5); Peptostreptococcus spp. (N¼ 4). Most potent antimicrobials against
Enterobacteriaceae were cefepime, imipenem and ertapenem (100% suscep-
tible strains), ceftazidime and amikacin (97%), piperacillin/tazobactam, cefo-
taxime, ceftriaxone and ciproﬂoxacin (91%). High resistance was noted to
ampicillin (71%) and gentamicin (43%). Most active against NSA were
piperacillin/tazobactam, imipenem, ertapenem, metronidazole and chloram-
phenicol (98% susceptible strains), poor activity was noted for clindamycin
(60% susceptible strains) and cefoxitine (68%). Similar susceptibility patterns
were revealed in Clostridium spp. (imipenem, ertapenem and metronidazole –
100%, piperacillin/tazobactam and chloramphenicol – 88%, clindamycin –
62%, cefoxitine – 69%).
Conclusion: From the microbiologic point of view monotherapy with
imipenem or ertapenem is appropriate for CIAI. Combination of piperacillin
with tazobactam; cephalosporins III–IVor ciproﬂoxacin with metronidazole
may be applied according to the in vitro AS data.
P980 Frequency of occurrence and antimicrobial
susceptibility of bacterial pathogens from intensive care
units in Latin American medical centers: report from the
SENTRY Antimicrobial Surveillance Program
H. S. Sader, A. C. Gales, R. E. Mendes, R. N. Jones on behalf of the
SENTRY Group – Latin America
Objectives:Resistance rates are usually higher in intensive care units (ICUs)
due to a more focused antimicrobial selective pressure. This study assessed the
antimicrobial susceptibility of bacterial isolates collected in ICUs from Latin
American (LA) countries.
Methods:The isolates were collected in 10 medical centers (ﬁve countries) as
part of the SENTRY Antimicrobial Surveillance Program. Beginning in
January 2001, each participant center collected 50 consecutive and clinically
relevant bacterial isolates from patients hospitalized in the ICU. The isolates
were tested by reference broth microdilution methods (NCCLS) against a
large number of antimicrobial agents.
Results:A total of 470 isolates were evaluated. The 10most frequently isolated
species were (n/%): S. aureus (SA – 102/21.7%), P. aeruginosa (PSA – 85/
18.1%), E. coli (55/11.7%),Klebsiella spp. (43/9.1%),Acinetobacter spp. (ACB –
39/8.3%), Enterobacter spp. (38/8.1%), Enterococcus spp. (29/6.2%), coagulase-
negative staphylococci (CoNS – 16/3.4%), Serratia spp. (16/3.4%), and
S. maltophilia (13/2.8%). Resistance to oxacillin was detected in 54.9% of
SA. Carbapenem resistance was detected in 42.4% of PSA and 28.2% of ACB.
Polymyxin B (98.8% susceptibility [S]), piperacillin/tazobactam (64.7% S) and
amikacin (63.5% S) were the most active compounds against PSA. Polymyxin
B resistance (MIC> 4mg/L) was also detected among ACB (97.4% S).
ESBL-producing phenotypes occurred in 12.7% of E. coli and 54.5% of
Klebsiella spp.; and 36.8% of Enterobacter spp. showed resistance to third-
generation cephalosporins (AmpC hyperproduction). Only 82.8% of enter-
ococci were vancomycin-S.
Conclusions:Resistance rates were extremely high among isolates from ICU
patients in Latin American (LA) hospitals, especially among Gram-negative
bacilli. The most alarming problems detected were imipenem and merope-
nem resistance among PSA and ACB, and ESBL mediated beta-lactam
resistance and/or chromosomally based beta-lactamase (AmpC) among
Enterobacteriaceae. Vancomycin resistance has clearly emerged among enter-
ococci as a serious ICU problem in the LA region.
P981 Folic acid casei medium as a trimethoprim
susceptibility test medium of Lactobacillus paracasei,
L. rhamnosus, and L. plantarum
M. Danielsen, H. S. Andersen, A. Wind
Hoersholm, DK
Objectives: Documentation of probiotic bacteria often includes MICs.
Lactobacilli have been reported to have intrinsic resistance to sulphonamides
and trimethoprim. The ability of lactobacilli to use exogenous preformed
folates and thymidine might explain the observed resistance. The suscept-
ibility of lactobacilli to sulfadiazine and trimethoprim on different media
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without thymidine was investigated in order to search for a phenotypic test
method that could indicate the presence of resistance genes.
Methods: Etest susceptibility tests on MRS with thymidine phosphorylase,
Deﬁned Medium 1, and folic acid casei medium was compared. Strains
included in the study were Lactobacillus rhamnosus, L. paracasei, L. acidophilus,
and L. plantarum. Enterococcus faecalis ATCC 29212 was included as a tri-
methoprim sensitive control strain.
Results: L. paracasei, L. rhamnosus, and L. plantarum could be tested for tri-
methoprim resistance with Etests on folic acid casei medium. The MICs for
the tested strains were 0.125–0.19mg/mL for L. paracasei, 0.25–3mg/mL for
L. rhamnosus and 0.064–0.19mg/mL for L. plantarum. L. acidophilus did not
grow well on folic acid casei medium and could not be trimethoprim
susceptibility tested. All lactobacilli had MICs of sulfadiazine >256mg/
mL on all media indicating intrinsic resistance.
Conclusion: The results show that L. rhamnosus, L. paracasei, and L. plantarum
do not have intrinsic resistance to trimethoprim. However, an intrinsic
phenotype could be observed on MRS medium. A total of 18 strains were
susceptibility tested and the results indicate that none of the strains harbour a
trimethoprim resistance gene. Trimethoprim susceptibility testing of some
Lactobacillus species is possible with the use of folic acid casei medium.
P982 Comparative in vitro cytotoxic effects of
Ornidazole, Metronidazole and Ciproﬂoxacin against
Trichomonas vaginalis trophozoites
T. Inceboz, U¨. Inceboz, S. O¨ztu¨rk
Izmir, Manisa, TR
Objective: To compare in vitro effects of Ornidazole, Metronidazole and
Ciproﬂoxacin on Trichomonas vaginalis trophozoites in terms of minimal
inhibition concentrations (MICs) and minimal lethal concentrations (MLCs).
Methods: A strain of T. vaginalis, isolated from a patient complaining vaginal
discharge, was incubated in Trypticase-yeast extract-maltose (TYM) media at
37 8C. Then, T. vaginalis was cultivated in RPMI 1640 with 10% FCS under
sterile conditions at 37 8C. To determine MICs and MLCs, drugs (Ornida-
zole, Metronidazole and Ciproﬂoxacin) at different concentrations were
added into the culture plates. T. vaginalis trophozoites 25 104/mL in
1mL of RPMI 1640 with 10% FCS were served as control. The numbers
of T. vaginalis were counted by using Thoma counting chamber at 12, 24, 48
and 72 h.
Results: In this in vitro antitrichomonial experiment, at 12 h, although lesser
effect was observed with 50 mg/mL, Ornidazole was effective at all doses,
whereas Metronidazole was partially effective, and Ciproﬂoxacin was inef-
fective. MIC levels at 24 h for Ornidazole, Metronidazole and Ciproﬂoxacin
were 50, 50, and 750mg/mL. Corresponding MLC levels were the same.
Conclusions: In this in vitro study Ornidazole was found the most effective
drug among three drugs tested against T. vaginalis in terms of MIC and MLC
levels. It is interesting to note that Ciproﬂoxacin, although was not as effective
as others, did have some cytotoxic effect on T. vaginalis trophozoites. Future in
vivo studies may shed new light on this.
P983 Phenotypic antibiotic resistance of some
enterobacterial strains adhered to an inert substratum. In
vitro models for bioﬁlm formation in liquid and solid media
V. Lazar, M. Balotescu, R. Cernat, D. Bulai, G. Nitu, L. Ilina
Bucharest, RO
While planktonic bacteria causing acute disseminated bacterial infections can
be controlled by conventional doses of antibiotics, adhered bacteria, respon-
sible for chronic infections are resistant to antibiotherapy, due to their
phenotypic antibioresistance, one of the most important consequence of
the adhesion process. It was demonstrated that the currently used MICs are
not active on bacterial bioﬁlms. The purpose of this study was to determine
the sensitivity levels of some opportunistic enterobacterial strains adhered to
inert surfaces placed in 24-multiwell plates in liquid media and included in
solid media, respectively, to subinhibitory concentrations, MICs, MBCs. In
the experimental model in liquid medium the bacterial suspensions, pre-
incubated with silicon-covered catheter sections (to promote the bacterial
adherence and bioﬁlm forming) were further incubated for 3 h in the presence
of antibiotics and thereafter cultivated in fresh medium. The bacterial culture
density, considered as indicator for the adherence capacity to the inert
substratum and for bacterial recalcitrance to the usual doses of antibiotics,
was assayed by spectrophotometer. The most interesting ﬁndings concern the
chloramphenicol which was not active on adherent bacteria even in MBC,
despite their sensitivity to chloramphenicol in planktonic phase. In the second
model, we imagined an in vitro model for the bioﬁlm polysaccharide matrix,
represented by agar medium distributed in Petri plates in which the bacterial
cells were embedded. The plates were further ﬂooded with MICs, SICs,
BMCs antibiotic solutions and the bacterial grow inhibition zones compared
with those revealed by the classical disc diffusion method. Our study
demonstrated that the bacterial strains sensitive to antibiotics in planktonic
phase became resistant to the same doses of antibiotics when preincubated in
the presence of the inert substratum, due to the bioﬁlm formation that
protects bacteria from the antibiotics action, by blocking the antibiotics
diffusion. The bacterial cells included in agar medium exhibited decreased
sensitivity to antibiotics. Phenotypic resistance exhibited by bacterial cells
adherent to a substratum or included in bioﬁlms ampliﬁes the better known
and recognized genotypic resistance phenomenon. These experimental
models could be very useful for the appropriate testing of susceptibility
and for an efﬁcient treatment of medical devices associated infections.
P984 Bacterial conjunctivitis in primary care: causing
agents and their susceptibility
R. P. Rietveld, J. H. Sloos, H. C. P. M. van Weert, P. J. E. Bindels
Amsterdam, Alkmaar, NL
Objectives: Bacterial conjunctivitis is often diagnosed and treated by the
general practitioner. In the Netherlands it is not common practice to conﬁrm
the diagnosis by culture, and therefore the infection is empirically treated by
application of a topical antimicrobial agent. In the literature, data of the
causing agents and their susceptibility to antibiotics are scarce. The aim of the
study was to identify the bacterial cause and their susceptibility to antibiotics
of conjunctivitis in general practice.
Methods: In 176 patients from 10 general practices with clinically suspected
bacterial conjunctivitis using strict criteria, cultures were taken from the
conjunctiva of both eyes by the general practitioner. Cultures were send to the
laboratory for microbiology and performed according to the American
Society for Microbiology. MICs from several topical antibiotics were deter-
mined using Etest. Critical MICs were used according to Dutch National
Standards.
Results: Of the most affected eye, 58/176 cultures were positive with
pathogenic bacteria, including Streptococcus pneumoniae (n¼ 26), Staphylococcus
aureus (n¼ 11), and Haemophilus inﬂuenzae (n¼ 11). Of S. pneumoniae, four
isolates were resistant against fusidin acid (MIC 3–16mg/L), 4 against
trimethoprim (MIC 8–32mg/L), three against gentamicin (MIC 6–8mg/
L), and one against chloramphenicol (MIC 12mg/L). Of H. inﬂuenzae, four
isolates were resistant against fusidin acid (MIC 3–48mg/L), two against
trimethoprim (MIC 6–256mg/L), and one against gentamicin (MIC 8 mg/
L). Of S. aureus, six isolates were resistant against fusidin acid (MIC 12–
256mg/L), three against trimethoprim (MIC 8–32mg/L), and one against
gentamicin (MIC 8mg/L). None of the isolates tested were resistant to
Ciproﬂoxacin.
Conclusions:
1. The sensitivity of strict clinical criteria for bacterial conjunctivitis in
general practice is low, when the culture is used as the golden standard.
2. From a bacteriologic point of view, only one-quarter of cases of clinically
suspected bacterial conjunctivitis can be empirically treated effectively
using local application of antibiotics.
3. In case of culture conﬁrmed bacterial conjunctivitis, resistance against
common topical antibiotics is relatively high.
4. General practitioners should be withholding in prescribing antibiotics for
the empirical treatment of clinically suspected bacterial conjunctivitis.
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P985 Comparison of length of stay between linezolid
and vancomycin for the treatment of complicated skin
and soft tissue infections from suspected or proven
Methicillin-resistant Staphylococcus species: results from
two randomized trials
H. Glick, J. Li, B. Tadesse, R. Willke, B. Rittenhouse, T. Tang
Philadelphia, Kalamazoo, Peapack, USA
Objectives: In a randomized trial (Trial A), linezolid was shown to result in
shorter duration of intravenous (IV) antibiotic treatment and length of stay
(LOS) and higher proportion of ﬁrst-week discharges among patients with
complicated skin and soft tissue infections (CSSTI) from suspected/proven
methicillin-resistant Staphylococcus species (MRSS) when compared with van-
comycin (Pharmacotherapy 2001, 21: 263–74; IJTAHC 2002, 18: 540–54).
A second trial (Trial B) showed a similar trend (2002 IDSA, 562). This study
aims at conﬁrming linezolid’s effect by combining data from these trials.
Methods: Data were from two phase III trials (Trials A and B) that demon-
strated equivalent efﬁcacy between linezolid and vancomycin. The trials
differed slightly in enrollment by geographic region but had same inclusion
criteria and treatment regimens for CSSTI patients, who received up to
4weeks of linezolid (IV or oral) or vancomycin (IV only), followed by up to
4weeks of observation. The primary endpoint for the current analysis is LOS,
which was estimated using Kaplan–Meier survival functions (KM). Results
are presented as KM adjusted LOS means and medians, as well as proportions
of patients discharged by the end of weeks 1–4. Arithmetic means for IV
antibiotic treatment durations are also reported. Between-treatment differ-
ences in the KM functions of LOS, proportion of discharges and mean IV
antibiotic treatment durations were tested with Wilcoxon test, Chi-square
test, and Student’s t-test, respectively.
Results:The combined sample showed that linezolid treatment was associated
with a statistically signiﬁcant shorter mean (1.7 days) and median (3 days)
LOS, and approximately double the proportion of ﬁrst-week discharges,
possibly due to the linezolid group’s shorter IV antibiotic treatment duration
(see Table 1).
Conclusion: Data from two prospective randomized trials conﬁrm that
linezolid use leads to shorter LOS, higher proportion of early hospital
discharges, and reduced IV antibiotic treatment in CSSTI patients.
P986 Treatment with telithromycin leads to lower
overall healthcare costs than clarithromycin in patients with
community-acquired pneumonia: results from two
independent, randomized, double-blind studies
J. R. Chang, P. G. Davey, J. Stewart, C. V. Asche, R. B. Nieman
Bridgewater, USA; Dundee, UK; Quebec, CAN
Objectives: To compare the clinical efﬁcacy and economic impact of treat-
ment with oral telithromycin (TEL) and clarithromycin (CLA) in adult
outpatients with community-acquired pneumonia (CAP).
Methods: In two independent, randomized, double-blind, multicenter clin-
ical studies, adult outpatients (Study 1, n¼ 448; Study 2, n¼ 575) with CAP
received TEL 800mg once daily for 10 days (Study 1) or 5/7 days (Study 2), or
CLA 500mg twice daily for 10 days (comparator regimen Study 1/2). Clinical
and economic outcomes were followed over a 1-month period. The primary
statistical hypothesis was equivalence of clinical efﬁcacy in the per-protocol
populations. Economic outcomes in the intent to treat populations were
assessed by nonprotocol-driven CAP-related resource use. Unit costs were
assigned as follows: additional antibiotics/medications using 1999/2000
(Study 1/2) Redbook prices; physician visits/tests/procedures based on
Medicare’s Resource Based Relative Value Scale; and hospitalizations using
1999/2000 (Study 1/2) American Hospital Association national average daily
rates for short-term hospitalization.
Results:Equivalence in clinical efﬁcacy of TEL and CLAwas demonstrated in
both studies – Study 1: 88.3% (143/162) vs. 88.5% (138/156) for 10-day TEL
vs. CLA, respectively; Study 2: 5- and 7-day TEL, 89.3% (142/159) and
88.8% (143/161), respectively, vs. 10-day CLA, 91.8% (134/146). In Study 1,
there were 16 CAP-related hospitalizations: 8 for TEL vs. 8 (with 2 ICU
admissions) for CLA. In Study 2, there were 12 CAP-related hospitalizations:
4 and 1 (with 1 ICU admission) for 5- and 7-day TEL vs. 7 for 10-day CLA,
respectively. TEL treatment resulted in a shorter total length of stay vs. CLA –
Study 1: 42 vs. 64 days for 10-day TEL vs. CLA, respectively; Study 2: 47 and
14 days for 5- and 7-day TEL vs. 75 days for 10-day CLA, respectively. The
mean per-patient cost of additional resource use for TEL was considerably less
than that for CLA in both studies – Study 1: $382 vs. $666 for 10-day TEL and
CLA, respectively; Study 2: $385 and $151 for 5- and 7-day TEL vs. $570 for
10-day CLA, respectively. Treatment with TEL resulted in mean per-patient
savings of $284 vs. 10-day CLA (Study 1, 10-day), $185 vs. 10-day CLA
(Study 2, 5-day), and $419 vs. 10-day CLA (Study 2, 7-day).
Conclusions: Two independent, randomized, double-blind studies conﬁrm
that TEL is an effective therapy for outpatients with CAP and is associated
with lower overall healthcare costs than CLA.
P987 Total therapy cost for the preparation and
administration of intravenous antibiotics: a single daily
administration therapy vs. therapies requiring multiple daily
administrations
E. De Troy, J. Damiaans, J. Huygh
Hasselt, B
Objectives: To compare the costs of different antibiotics-based therapies
having a comparable spectrum. To ascertain what cost-savings may be
obtained by a therapy requiring a single daily i.v. administration as against
therapies requiring multiple daily i.v. administrations.
Methods:The study was conducted in a large peripheral hospital in Belgium.
The i.v. antibiotics were prepared centrally in the CIVA service dispensary.
The entire process of preparation and administration of i.v. antibiotics was ﬁrst
analyzed. Each separate motion necessary for preparation and administration
was timed. A total of 100 measurements were taken in the dispensary and on
the wards. Additional data were then collected on staff salaries, the cost of
materials and other costs making up the total cost of the therapy. An i.v.
therapy with ertapenem 1 g, once daily (case 1), was compared with the
following therapies with multiple daily i.v. administrations:
1. Piperacillin/tazobactam 4 g, four times daily (case 2).
2. Cefotaxime 2 g, three times daily in combination with metronidazole
500mg RTU, three times daily (case 3).
The average cost per therapy was calculated for all three cases. Variable costs,
ﬁxed costs and overheads were included in the cost calculation. Variable costs
are costs that increase as the number of preparations and administrations
increases. They include a labor cost and a material cost. The ﬁxed costs, by
contrast, are independent of the number of preparations. In these ﬁxed costs a
distinction was made between a ﬁxed labor cost, a ﬁxed material cost, the
investments and the maintenance of the investments. Finally, the overheads
allocated to the clean room were also included in the calculation. The cost of
the active products was disregarded.
Results: The time measurement results were as follows: the average prepara-
tion times for the three cases were, respectively, 5.62, 10.22 and 8.74min. The
average administration times for the three cases were, respectively, 1.38, 3.03
and 4.97min. These working times were then converted into labor costs. Cost
analysis produced the result set out in the table below.
Table 1
Study
sample
Study
antibiotic N
IV days
(mean)
LOS
(days, KM estimate)
 % patients discharged by
the end of
Mean
Median
(25–75
percentile)
Week
1
Week
2
Week
3
Week
4
Trial A Linezolid 122 5.8 17.2 9 (5-26) 36 54 62 75
Vancomycin 108 12.6 19.4 14 (8-24) 17 46 65 76
P-value – <0.0001 0.052 0.001 0.24 0.69 0.93
Trial B Linezolid 163 6.0 16.4 11 (5-21) 29 56 71 80
Vancomycin 161 11.8 18.1 13 (7-22) 17 49 69 76
P-value – <0.0001 0.10 0.015 0.22 0.75 0.39
Both trials
combined
Linezolid 285 5.9 26.9 11 (5-24) 32 55 67 78
Vancomycin 269 12.1 18.6 14 (7-23) 17 48 67 76
P-value – <0.0001 0.01 <0.001 0.09 0.95 0.57
The P-values for LOS are based on tests of the differences between the Kaplan–Meier
survival functions for the two treatments from which the mean and median LOS are
estimated.
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Conclusions: Our analysis reveals the main cost drivers to be the labor costs
involved in preparation and administration and the cost of material. An i.v.
antibiotic therapy requiring only one daily administration delivers a con-
siderable cost-saving compared with therapies that require multiple daily
administrations.
P988 Economic evaluation demonstrates that
moxiﬂoxacin IV/PO monotherapy is cost-effective to the UK
National Health Service when compared with IV/PO
amoxicillin/clavanulate  clarithromycin in the treatment of
community-acquired pneumonia
M. Drummond, J. Chancellor, M. Hux, D. Becker, I. Duprat-Lomon,
P.-P. Sagnier
York, High Wycombe, UK; Burlington, CAN; Puteaux, F; Slough, UK
Objectives: Community-acquired pneumonia (CAP) is associated with sub-
stantial morbidity, mortality, and ﬁnancial cost. Improved treatments have
potential to reduce these burdens on health care systems. A cost-
effectiveness analysis was conducted from the UK National Health Service
(NHS) perspective, comparing sequential IV/PO moxiﬂoxacin (MXF)
monotherapy to standard comparators in patients admitted to hospital with
CAP.
Methods: Costs and consequences over 21 days were evaluated based on
clinical cure rates 5–7 days post-treatment (test-of-cure (TOC) visit) and
resource use reported for the TARGET multinational, randomized, open-
label trial. Sequential IV/PO monotherapy with MXF 400mg OD was
compared with IV/PO amoxicillin/clavulanate (AMC) (1.2 g IV/625mg PO
TID) þ clarithromycin (CLA) (500mg BID) for 7–14 days in hospitalized
patients with CAP. Since treatment effect on resource use (hospital days)
was similar across countries, resource data (antimicrobial treatment, hospi-
talization, and out-of-hospital care) from all centers were pooled and valued
using UK unit prices to estimate CAP-related cost per patient to the
NHS.
Results: Clinical efﬁcacy analyzes for ITT and PP populations, respectively,
found 8.3% (95%CI: 3.1, 13.6) and 8.1% (95%CI: 2.9, 13.2) higher cure rates
in the MXF group at TOC. Clinical outcomes were consistent with micro-
biological results in the trial. For economic evaluation, patients with inde-
terminate or missing outcome at TOC were conservatively assumed to be
clinical failures, resulting in higher cure rates in the MXF group of 5.3% (95%
CI 1.2%, 11.8%). Statistically signiﬁcantly increased speed of response (ﬁrst
return to apyrexia 1 day sooner; P¼ 0.008) and reduction in hospital stay by
0.81 days (95% CI: 1.63, 0.01%) were observed in the MXF group.
Treatment with MXF resulted in projected savings to the NHS of £230/
patient, primarily due to shorter hospital stay. A cost-effectiveness accept-
ability curve demonstrated the probability of MXF being cost saving was 87%,
and the probability of MXF being cost-effective relative to AMCCLA
reached 92% at acceptability thresholds up to £1300 per additional patient
cured.
Conclusions: MXF IV/PO monotherapy shows superior clinical outcomes
and is cost-effective from a UK NHS perspective when compared with
IV/PO AMCCLA in the treatment of CAP.
P989 Potential economic impact of an outpatient and
home parenteral antibiotic therapy (OHPAT) programme for
managing community-acquired skin and soft tissue
infections (comSSTI’s) in Scotland
D. Nathwani, J. Morrison, K. Gray, G. Barlow, A. France, P. Davey
Dundee, Scotland, UK
Objective: ComSSTIs (cellulitis and erysipelas) remain a signiﬁcant cause of
morbidity and hospitalization. The predominant pathogens remain MSSA
and S. pyogenes. Intravenous therapy with high dose ﬂucloxacillin (1 g qds) or
oxacillin and benzylpenicillin, respectively, remains the established standard of
care in most European hospitals. Administration of ambulatory IV therapy,
usually with a single daily bolus injection of 1 g IV CEFTRIAXONE,
remains an effective clinical and economic option. There is no evidence
that this regimen in the ambulatory setting is associated with greater occur-
rence of resistance or adverse reactions. This study aimed to examine the
economic impact of OHAPT in treating comSSTIs in Scotland.
Methods: Retrospectively review using the SMR1O inpatient discharge
diagnosis data from Information Statistics Division Scotland (ISD) (http://
www.show.scot.nhs.uk/isd) and the Dundee Infectious Diseases Units
(DIDU) Outcomes Registry Database. The key diagnosis (ICD 10 codes)
groups considered were cellulitis (LO30, 31, 32, 33, 38, 39) and erysipelas
(A46X) over four consecutive years (1997–2001).
Results: Table.
Conclusions: OHPAT was implemented in the (DIDU) in 1997/98. Data
from the Dundee outcomes registry revealed a mean reduction in length of
hospitalization from 6.1 days (1996/1997) to 2.9 in 1999/2000 – a reduction
of 48%. If this is applied to Scotland then OHPATwould reduce hospital stay
roughly by half with a resultant annual reduction in cost of about GBP 3.8m.
If IV therapy is to remain a standard of care for more severe comSSTIs then
OHPAT should be considered as an important clinical and cost effective
option. These data would be applicable to European practice.
P990 The (direct) cost-efﬁcacy of managing severe
malaria in children aged 6–59months following the WHO
guidelines in two district hospitals in Cameroon
E. A. Forlack, M. T. Abena Obama, M. Beyeme Owono, E. Manga,
A. Same-Ekobo, M. Ondoa Mekongo, F. Tietche, E. M. Minkoulou
Yaounde, CM
Since efforts to eradicate malaria failed in the 1970s, Sub-Saharan African
countries have learned to live with malaria, which remains the main cause of
morbidity and mortality in children less than 5 years old. There is increasing
concern about the cost of health care, especially as health insurance policies
Total cost Case 1 Case 2 Case 3
Variable costs
Labour cost, preparation, variable 2.723 4.639 4.021
Labour costs, administration, variable 0.578 1.268 2.076
Material cost 2.144 7.028 5.804
Fixed costs
Labour cost, fixed 0.066 0.263 0.197
Material cost, fixed 0.087 0.348 0.261
Investments in material 0.121 0.484 0.363
Maintenance of material 0.118 0.471 0.353
Overhead costs 0.507 2.029 1.521
General total (Euro) 6.344 16.528 14.596
1997–1998 1998–1999 1999–2000 2000–2001
Total no. of annual impatient
admissions in Scotland with
above ICD 10 diagnosis
4434 4756 4997 5573
Total no. of
episodes¼
19,760
Mean duration of
hospitalization (day)
5.33 5.69 4.7 4.91
Mean duration of hospitalization
over four years (day)
5.16
Mean cost per day of infection
in Scottish ID unit
(1999/2000)
GBP 279
Estimated annual cost to
Scottish health Service
for all hospitalized comSSTI
1440 19,760 divided by 4¼GBP 7.1 million
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have been proliferating. Our main aim was to determine the direct cost and
efﬁcacy of case-management of severe malaria following the current WHO
guidelines in children aged 6–59months. From January 1 to August 31, 2000,
148 children (aged 6–59months, and who presented with at least one feature
of severe malaria) were recruited by consecutive sampling, at the Djoungolo
and the Mfou District Hospitals. Treatment according to WHO guidelines
was implemented and there was rigorous in-patient monitoring and the
outpatient follow-up. There were 72 girls and 76 boys; the mean age was
23.1 13.1months and the commonest clinical forms of severe malaria were:
generalized convulsions (54.7%), prostration (43.2%) and severe anemia
(14.9%). Most children (95.9%) were completely cured, 2.0% died and there
were no neurological deﬁcits over 1month follow-up.We estimate the cost of
hospital management of each episode of severe malaria at 26,000–36,000F
CFA and the overall direct costs (before and during hospitalization) at 27,000–
39,000F CFA.We conclude that the currentWHO guidelines are efﬁcacious,
but expensive as compared with the standard of living in Cameroon.
P991 Potential impact of IV-Oral switch on length of
stay in Gram-positive infection
S. Jones, K. B. Bamford, B. Dean, A. Jacklin, A. Holmes
London, UK
Objectives:To prospectively evaluate the potential impact that switching from
a glycopeptide to an equally effective oral agent to treat resistant Gram-
positive infections would have on IV line use and length of stay (LOS) in a
London Teaching Hospital Trust.
Methods: Patients on glycopeptides for 5 days or more were reviewed by a
pharmacistþMedical Microbiologist or ID physician. Patient demographics,
antibiotic prescribing indications, monitoring, comorbidities, laboratory
investigations and clinical course were recorded. Standardized IV-oral switch
(previously piloted and implemented) and discharge on oral therapy criteria
were applied to each patient. The difference between actual and potential
resource utilization was recorded. Statistical analysis was carried out using
SPSS.
Results: Two hundred and eleven patients received glycopeptides for over 5
days, 183 (87%) vancomycin, 20 (13%) teicoplanin, and 8 (4%) both (at
different times), 176 (83%) had a positive microbiology result of which 122
(69%) were MRSA, 60 (28%) patients were prescribed glycopeptides within
4 days of admission. Sixty-two (29%) patients could have had a reduced LOS
potentially saving 649 bed days over 6months. A further 15% could have
beneﬁted from reduced time on IV therapy. Reduced LOS was signiﬁcantly
associated with site of infection (skin and soft tissue), specialty (orthopedics
or plastics), organism (MRSA) and number of other antibiotics (P less than
0.01–0.001, chi-square or logistic regression as appropriate). Importantly
whether a patient could switch from IV-oral therapy and LOS could be
reduced would have been successfully predicted in 76% cases in patients with
skin/soft tissue infection, were managed in orthopedics or plastic surgery
specialties, were on less than ﬁve antibiotics and did not have speciﬁc
comorbidities.
Conclusions:There is signiﬁcant potential to reduce IV line use and LOS in at
least a quarter of patients with resistant Gram-positive infections by using an
equally effective oral agent. This would have a considerable impact on bed use
in some specialties. IV-oral switch programmes should be evaluated further.
P992 Association between inappropriate initial empiric
antibiotic therapy and healthcare resource use among
patients undergoing surgery for community-acquired
intra-abdominal infections in Spain
G. Nocea, O. Geling, P. Mavros, S. Sen for the Ciais study group, Spain
Objective: To assess the association between inappropriate initial empiric
antibiotic therapy and healthcare resource use among patients undergoing
surgery for community-acquired intra-abdominal infections (IAI) in Spain.
Methods: Records of patients who underwent surgery for community-
acquired IAI from 10/1998 to 08/2002 in hospitals in Spain were reviewed.
Initial empiric antibiotic therapy was classiﬁed as inappropriate if at least one
pathogen was resistant to all antibiotics in initial regimen in case of positive
culture, while in case of negative/missing culture, the Surgical Infection
Society guideline (Bohnen 1992) was used for classifying appropriateness of
initial empiric therapy. Healthcare resource use was measured as hospital
length of stay in days (LOS) and days on IVantibiotic therapy. Semi-log least
square regression analyses were performed to assess associations between
inappropriate therapy and healthcare resource use measures, after adjusting for
patients’demographic and comorbid characteristics and site/type of infection.
Results: Four hundred and twenty-ﬁve patients were included of whom
40.5% were female. Mean (SD) age of these patients was 53.2 (20.7) years. Of
these patients, 387 (91%) received appropriate initial empiric therapy while
the rest were on inappropriate therapy. Most common sites/type of IAI were
appendicitis with peritonitis (31.5%) and appendicitis with peritoneal abscess
(17.2%). Mean LOS (SD) was 12.4 (10.5) and 16.3 (14.0) days among patients
with appropriate and inappropriate therapy, respectively (P¼ 0.24). Mean
(SD) days on IV antibiotic therapy was 8.6 (6.9) for patients on appropriate
initial therapy while 12.5 (10.1) days for patients on inappropriate therapy
(P¼ 0.02). Multivariate analyses showed that after adjusting for type/site of
infection and patients’ characteristics, inappropriate therapy was associated
with almost 18% increase in LOS (P< 0.05) and 28% in IVantibiotic days as
compared with appropriate therapy (P< 0.05). Conﬁning the analysis only to
patients with positive culture (n¼ 199), showed that inappropriate therapy
was associated with 57% increase in LOS and 35% increase in IV antibiotic
days as compared with appropriate therapy after controlling for other factors.
Conclusion: Among patients undergoing surgery for community-acquired
IAI, inappropriate initial empiric antibiotic therapy was associated with
increased healthcare resource use through increase in length of hospital stay
and length on IV antibiotic therapy.
P993 National programme for antibiotic policy: the
Bulgarian experience
E. Keuleyan
Soﬁa, BG
Objectives: A national program for antibiotic policy (NPAP) was developed
for both appropriate antibiotic treatment of patients and containment of
antimicrobial resistance (AR). The aim of this work is to share our experience
and some difﬁculties in implementation, which may be common with other
Eastern European countries.
Methods: It was developed by an expert multidisciplinary committee and
following wide discussions, was approved by theMinistry of Health in 2001. It
included: (A) Quality Control (QC) in the Clinical Microbiology Laboratory
(CML) and AR surveillance, (B) rational antibiotic treatment and prophylaxis,
(C) control of infection (CI), (D) education. A reference CML was created to
perform QC and AR surveillance. National consumption of antibiotics was
registered by the Bulgarian Drug Agency. Hospital committees developed
institutional guidelines on AP and CI. Medical education was enforced.
Results: NPs for Good Clinical Practice and CI are at early stage of
preparation. Problems encountered were (1) over the counter sale of anti-
biotics is not controlled, (2) no good coordination between the institutions
involved, (3) funding is not sufﬁcient: sometimes patients have to buy more
expensive antibiotics by themselves, (4) resources for CML are 10–20-fold less
than in EC countries.
Conclusion:Reality is more complex than theory: to create a working NPAP,
world-wide and European recommendations should be considered together
with the particular socio-economic, political and healthcare status of the
country involved. Awareness and responsibility of medical societies should be
combined with coordinated actions of the institutions and funds from
government, health Insurance and international authorities.
P994 Antimicrobial misuse in patients with bacteraemia
B. Roca, C. Lapuebla, A. Garcia del Busto, J. M. Gatell
Castellon, Barcelona, E
Background: Studies have shown that antimicrobials are not always properly
used in clinical practice. Misuse of such drugs may be harmful for patients and
may produce unnecessary expenses. Research is needed to clarify the
magnitude of the problem and to know its determinants.
Methods: The medical charts of all patients with bacteremia, detected from
January to April 2001 in the Hospital General of Castellon, were reviewed by
two Infectious Disease physicians. They assessed (1) if blood cultures repre-
sented true infection or contamination and (2) if antimicrobials were pre-
scribed according with current recommendations [Med Lett 2001; 43 : 69;
Sanford Guide 2002]; when both physicians disagreed, they jointly discussed
the case and reached a consensus. The possible association of age, sex,
department, ward, length of hospitalization, cultured microorganism, number
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of predisposing factors of infection, true infection or contamination, source of
bacteremia, and mortality, with appropriate or inappropriate prescription of
antimicrobials was appraised with a logistic regression. The approximate cost
of improperly employed drugs was estimated.
Results: A total of 190 patients were included. The median of age was
58 years; 116 (61%) weremale. The agreement between both physicians about
the clinical signiﬁcance of blood cultures and about the appropriateness of
antimicrobial prescriptions were good (Kappa 0.897 and 0.876, respectively,
both P¼ 0.000); 68 cultures (36%) were classiﬁed as true infections; 28
patients (13%) received antimicrobials that were considered inappropriate.
Staphylococcus spp. other than S. aureus represented 97 isolates (51%) and E. coli
19 (10%). An association was found between inappropriate antimicrobial
prescription and: longer hospitalization (P¼ 0.011), true infection
(P¼ 0.011) and known source of infection (P¼ 0.001). The estimated cost
of unnecessarily employed antimicrobials was s11,000.
Conclusion: Nonadherence with recommendations on antimicrobial pre-
scription was common and widespread among physicians of all departments,
and provoked substantial unnecessary expenses.
Epidemiology of parasite infection
P995 An epidemiological study of cutaneous
leishmaniasis in a central focus of the disease in Iran
A. A. Hanaﬁ-Bojd, M. R. Yaghoobi-Ershadi, R. Jafari
Yazd, Tehran, IR
Objectives: In the past decade cutaneous leishmaniasis had a high outbreak in
Yazd province, central Iran. The aim of this study was to determine the
epidemiological situation of the disease for designing and suggestion a control
program.
Methods:The study was carried out in 3 villages around the Ardakan county,
Yazd province. Total population were visited and examined for scar(s) or
sore(s). A questionnaire was completed for any family by asking them about
age, sex, history of previous infection, etc. Smears were prepared from every
case with acute lesion. The RAPD-PCR test was used to detection the
parasite species.
Results:More than 3000 persons were visited and examined. From them 747
cases had acute lesion(s) and in 920 cases we found scar(s). The infection was
observed in all age groups. The prevalence of the diseases was evaluated
24.7%. Results of the parasitology examination showed that Leishmania major
is the agent of cutaneous leishmaniasis in this area.
Conclusion: The ﬁndings showed that an epidemic of zoonotic cutaneous
leishmaniasis (ZCL) was happened in this focus. L.major was isolated for the
ﬁrst time in the area, in this study. Because of the epidemiological aspects of
ZCL, we suggest the reservoir hosts (gerbils) be controled with toxic bait in a
radius of 500m around the villages.
P996 Occurrence of Plasmodium spp. among the
suspected cases in Diyarbakir, Turkey
A. Suay, M. Mete, A. Gargili, B. Kocazeybek, N. Kaya, S. Tekin,
S. Altun, S. Saribas
Diyarbakir, Istanbul, TR
Objectives: The aim of this study was to outline the total number of
Plasmodium positive blood samples in Diyarbakir in the last 6 years according
to the data of Malaria Eradication Chamber. Also, to evaluate the types of
malaria seen in the region, the data of blood donors and to compare the
situation of Diyarbakir which has priority for malaria, with the other parts of
the country.
Methods:Blood samples of 751 312 people were evaluated for the presence of
Plasmodium parasites between 1995 and 2000. These samples were collected
for the aim of active or passive surveillance studies and check studies. Among
the samples, 80,330 were found positive for Plasmodium spp. Thin and thick
blood smears and direct microscopy technique were used to detect the
parasites.
Results: Numbers of Plasmodium positive donors varied between 2581 and
26 912 during 1995–2000 period. Percentages of male patients varied
between 52.6 and 58.0% and of female patients between 42.0 and 47.4%.
Infection occurred most predominantly in 15–44 years of age. According to
the monthly data of all examined years, malaria infection was seen intensively
between may and September. Plasmodium vivax was identiﬁed as the causative
agent in the positive blood smears.
Conclusions: Malaria infection is still important in Diyarbakir and districts.
According to the inspected data in this study, 31.5–35.6% of the annual
malaria cases of Turkey were seen in Diyarbakir between 1995–2000.
Infection rates are higher in males than females and in 15–44 years of age
group than the rest of the ages.
P997 Is Strongyloides stercoralis endemic in Greece?
K. Tzanetou, I. Geros, E. Kalogeropoulou, A. Karathanasis,
G. Tsoufakis, P. Ziroyiannis, E. Malamou-Lada
Athens, GR
The aim of this study was: (a) the detection of an endemic area of Strongyloides
stercoralis in our country (b) the investigation of existent forms of the parasite in
the environment, the infectivity of the strains which encounter in the soil and
the transmission frequency of the infection in the general population. The
detection of ova and rhabditiform/L1 larvae in the urine sediment of a patient
with nephrotic syndrome under immunosuppressive therapy, the repeatedly
negative fecal examination for ova and parasites and the excellent clinical
condition of the patient, created the suspicion of urine contamination from
the soil. The culture of the urine sediment with Harada-Mori tube ﬁlter paper
method showed all the stages of the indirect or heterogenic cycle (free living
male and female worms, ova and rhabditiform/L1 larvae) except for the
infective ﬁlariform/L3 larvae. Testing a large quantity of soil from and around
the area where the urine selection pot was kept, with the Baerman method,
revealed Rhabditiform/L1 larvae. Despite the detection of S. stercoralis ende-
mic area in our country, the autochthonous human infection is extremely rare,
since during the last 16 years among a large number of patients examined in
our laboratory only one case of asymptomatic enteric strongyloidiasis was
diagnosed. The fecal culture (using the same method) of two patients from
Egypt with enteric strongyloidiasis, showed only infective ﬁlariform/L3
larvae (direct or homogenic cycle).
Conclusions: (a) This restricted epidemiological study provides evidence for
the endemicity of S. stercoralis in Greece. (b) The autochthonous human
infection in our country is rare, probably because of the existence of strains
adapted to complete the indirect cycle in the environment without giving
infective ﬁlariform/L3 larvae. On the contrary, strains of S. stercoralis
Rhabditiform/L1 larvae detected in feces of patients with strongyloidiasis
yielded only infective ﬁlariform/L3 larvae.
P998 Prevalence of microﬁlaria infection in a 12-month
period in Spanish hospital
R. De Julian, A. Morente, S. Puente, M. Lago, M. Baquero, M. Subirats
Madrid, E
Objective:To ﬁnd out the frequency of imported microﬁlaries in travelers and
immigrants coming from endemic areas.
Methods: All samples were collected in Hospital Carlos III from January to
December 2002. The analysis was based on the microbiology laboratory data.
Research for microﬁlaries in blood and skin were done in laboratory
according to standard techniques. The identiﬁcation were performed by
an expertized parasitologist.
Results:A total of 1017 samples were analyzed. 663 were collected from blood
and 354 from skin (169 from gluteus, 158 from scapula, and 27 from other
localization). We found 44 positive samples in blood (6.64%), and 20 in skin
(5.65%). In the positive blood samples, 31 were Mansonella persans (70.45%),
12 Loa-Loa (27.27%). One case had bothM. persans and Loa-loa (2.27%). The
patients came from Equatorial Guinea (30 cases of M. persans and 12 cases of
Loa-loa) and Congo (1 case withM. persans and Loa-loa). All the positive skin
samples were caused byOncocerca volvulus, 12 were obtained from gluteus, and
8 from scapula. The patients came from Equatorial Guinea (18 cases) andMali
(2 cases).
Conclusions: In the last few years, we have observed in our hospital a growth
in the number of cases of microﬁlaria infection due to the increasing arrival of
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immigrants coming from endemic areas. We suggest clinicians should be
aware of this kind of infections.
P999 Seasonal variation in bacterial pathogens isolated
from stool samples in Karachi, Pakistan
M. Alam, Y. N. Akhtar, S. S. Ali, M. Ahmed, M. Atiq, H. Bashir,
F. A. Chaudhry, M. A. Bangash, A. Awais, A. S. Husain, S. F. Hasnain,
A. Zafar
Karachi, PAK
Objectives: Diarrheal diseases contribute signiﬁcantly to morbidity and
mortality in the developing countries. Although a few publications have
been cited in literature from Pakistan on diarrheal diseases, none of the
investigators have ventured into describing the seasonal variation of the
commonly found bacterial pathogens in our setting. We wanted to describe
the seasonal variation of various enteric pathogens found in an urban setting in
Pakistan.
Methods:We planned a retrospective descriptive study of all the stool samples
submitted from within Karachi to the Aga Khan University Hospital Labora-
tory over a period of 5 years (January 1997–December 2001) in order to
determine the commonly isolated bacterial pathogens and to predict their
seasonal variation.
Results:A total of 16,379 stool samples were included in this review. Bacterial
isolates were found in 6670 stool samples (culture detection rate¼ 40.7%).
The mean age at the time of culture of each subgroup was under 1 years group
(6.58 3.1months), 1–5 years (2.13 0.94 years), 5–14 years (8.3 2.6 years)
and adults (43.2 18.5 years). Male:female ratio was 1.2:1. Vibrio cholera 01
Ogawa (32.8%),Campylobacter jejuni (17.3%), EnteropathogenicEscherichia coli
(9.9%), Salmonella paratyphi b (6.6%) and Shigella ﬂexneri (6.2%) were the most
common organisms isolated. These organisms show a distinct seasonal
variation with summer predilection (Fig. 1).
Conclusions: In contrast to the previous studies from South Asia which have
identiﬁed E. coli, followed by V. cholerae as the most common enteric isolates,
we found V. cholera 01 Ogawa followed by Campylobacter jejuni as the most
common enteric pathogens isolated in an urban setting. It is important to
consider seasonal variation when empirically treating diarrheal diseases in our
setting.
Parasitology: basic science
P1000 Characterization of a divalent metal ion
transporter in adult schistosomes
E. Hacker, D. Smyth, G. Anderson, D. McManus, M. Jones
Herston, AUS
Objectives: Schistosomes are parasites of the portal veins of humans, where
they derive nutrition by digesting host erythrocytes. The parasites have a high
requirement for iron and store iron in two isoforms of ferritin, Fer1 and Fer2.
Fer1 is highly expressed in females and is most likely associated with ferritin
complexes observed in vitelline cells by electron microscopy. It would appear
therefore that schistosomes have a strong requirement for iron in embryo-
genesis, but the mechanisms for iron regulation and transport in the parasite
have been entirely unexplored. We are investigating key iron transporter
proteins in schistosomes to determine whether the parasites have an iron
regulatory system homologous to that of their human hosts. Here we describe
studies on a schistosome homologue of a mammalian divalent ion transporter
(DMT-1), which, in mammals is involved in uptake of iron from the gut by
enterocytes.
Methods: We used nested PCR using degenerate primers based on con-
sensus regions of DMT-1 genes to amplify schistosome sequences from
adult Schistosoma mansoni cDNA. Ampliﬁed products were cloned into
vectors and sequenced. Further characterization of the gene and product
was carried out using Southern and Western blotting, as well as immuno-
ﬂuorescence microscopy using heterologous antisera raised against mouse
DMT-1.
Results: We found that S. mansoni expresses a protein with signiﬁcant
homology to DMT-1 of mammals and other organisms. Western blot analysis
showed the native protein to be approximately 110 kDa. The molecule was
encoded by a single gene. Immunoﬂuorescencemicroscopy suggested that the
schistosome protein is expressed in the tegument and vitelline cells of females.
Conclusions: Schistosomes express a molecule with signiﬁcant homology to
mammalian DMT-1. The function of the schistosome protein has yet to be
determined, but from its localization pattern, it is tempting to speculate that
the molecule is involved in cellular uptake of iron. We are currently
investigating whether other homologues of the mammalian iron regulatory
molecules are also expressed in these parasites. Iron appears to play an
important role in egg formation in schistosomes. In view of the importance
of the eggs in the pathology of schistosome infections, a better understanding
of the role of iron in embryogenesis and its regulation in adult worms may
open new avenues for future control of schistosomes.
P1001 In vitro activities of telithromicin (HMR 3647) and
primethamine on Toxoplasma gondii in cell culture
M. Kilinc, M. Hokelek, M. Erturk
Samsun, TR
Objectives: Toxoplasmosis is an infection disease caused by the obligate
intracellular parasite Toxoplasma gondii, and receives upmost attention because
of its potential to cause congenital infection. The infection is also severe and
can be life threatening in immunodeﬁcient or immunocompromised indi-
viduals. Drugs currently used for the treatment of toxoplasmosis are not
always effective and/or may be deleterious for pregnant women and immu-
nocompromised patients with acute toxoplasmosis, and for those with the
ocular disease. The search for more effective and less-toxic drugs and
therapeutic approaches have been continuing. The aim of this study was
to investigate the therapeutic activities of telithromycin (HMR 3647) and
pyrimethamine in vitro using HeLa cell cultures maintained intracellularly
infected with T. gondii RH strain.
Methods: Monolayer HeLa cells in 96-well tissue culture plates were ﬁrst
infected with the tachyzoites obtained from peritoneal ﬂuid of mice infected
withT. gondii. The drugs were then added and their therapeutic activities were
assessed after 24, 48 or 72 h postinfection by detecting the amount of T. gondii
antigens in methanol ﬁxed cells by using ELISA employing antitoxoplasma
antibodies. The toxicities of drugs and the tachyzoites for HeLa cells were also
determined by dye uptake assay.
Results: The signiﬁcant inhibition of replication of the tachyzoites even at
48 h postinfection was obtained with telithromycin at 0.5 mg/mL (P< 0.01),
and after 72 h of incubation even a concentration as low as 0.05mg/mL
(P< 0.05) was effective. The 50% inhibitory concentrations (IC50) of
telithromycin and pyrimethamine at 72 h postinfection were estimated
0.81 and 0.16mg/mL, respectively. None of the tested concentrations of
both drugs demonstrated toxicity for HeLa cells even after 72 h of incubation.
Conclusions: Our results showed that telithromycin (HMR 3647) signiﬁ-
cantly inhibited intracellular replication of the tachyzoites of T. gondii RH
Figure 1 Seasonal variation of three most common bacterial isolates (1997).
232 Abstracts
strain as did pyrimethamine, and that further studies with regard to use of
telithromycin in combination with other drugs in animal models of toxo-
plasmosis may be of help for designing new treatment regimens for toxo-
plasmosis in humans.
P1002 Tissue cysts of the RH strain of Toxoplasma
gondii induced by treatment of murine infection with
atovaquone combined with pyrrolidine dithiocarbamate
O. Djurkovic-Djakovic, A. Nikolic, B. Bobic, I. Klun
Belgrade, YU
Objectives:During evaluation of the efﬁcacy of atovaquone (ATO) combined
with pyrrolidine dithiocarbamate (PDTC) in murine Toxoplasma gondii
infection induced with tachyzoites of the mouse-virulent RH strain, brain
cysts were observed in some survivors. Since this strain is considered to have
lost its cyst-forming capacity, and conversion of RH tachyzoites into cysts in
mice has previously been shown exclusively following treatment with sul-
phadiazine, this new protocol for in vivo development of RH strain cysts is
described.
Methods: Groups of 12 Swiss Webster mice infected intraperitoneally with
102 tachyzoites each were treated with ATO at 5, 25 and 100mg/kg/day
alone and combined with PDTC at 250mg/kg/day administered in food
from day 1 post infection (p.i.) for 14 days. Six weeks p.i., the euthanized
survivors were examined for residual infection. Virulence of the recovered
cysts was examined by subinoculation into fresh mice.
Results: Whereas the survival of all treated mice was prolonged in a dose-
dependent manner, 1, 2, and 4 mice treated with PDTC combined with 5, 25
and 100mg/kg ATO/day (8, 17 and 33%), respectively, survived the 6-week
observation period. However, 2 of these showed clinical toxoplasmic ence-
phalitis only days before its end, and each was found to have harbored >3000
brain cysts. In addition, in brain homogenates of another 2 survivors without
clinical signs, 107 and 267 cysts, respectively, were revealed, giving a total of
57% (4/7) cyst-harboring survivors. These ﬁndings were associated with
highly positive T. gondii serology. Peroral inoculation of these cysts into fresh
mice (10 cysts/mouse) produced acute lethal toxoplasmosis in one instance,
and the recovered tachyzoites showed normal infectivity.
Conclusions: Early treatment of murine T. gondii RH strain infection with
ATO and PDTC induces conversion of tachyzoites into tissue cysts, which in
addition to showing therapeutic potential, provides a model for studying the
mechanisms of stage conversion.
P1003 Investigation of congenital toxoplasmosis in
Rattus rattus
M. Saleh, Z. Saleh, F. Taheri
Tehran, IR
Background: Toxoplasma gondii is a coccidian parasite of felides and has, as
intermediate hosts, many warm-blooded animals, including mammals and
birds. Congenital toxoplasmosis is one of the most important infectious
disease seen in fetuses and infants born from mothers infected with T. gondii
during pregnancy. Congenital infections, which may occur of a mother is
infected for the ﬁrst time during pregnancy, is often serious, resulting in
abortion or severe neurological and ophthalmological disorder. Information
on human cases of neonatal toxoplasmosis makes it unquestionable that
toxoplasma crosses the placenta and invades the fetus in utero.
Objective andmethods:T. gondii infection in newborn rat litter was detected
by a bioassay in mice. Rat’s litter were killed and their tissues were separately
hemogenized in normal saline or PBS and inoculated intraperitonealy in to 3
mice. The tissues used for bioassays were brain, hearts, lungs, livers, and spleen
of pups, which were killed on the day of birth. In a study of congenital
toxoplasmosis in rats during the acute stage of toxoplasma infection, three
trails were performed, and the day of gestation at the time of T. gondii
inoculation ranged from 6 to 18 (day 6, 12, and 18 of pregnancy).
Results:The results demonstrated that toxoplasma infection of rats on day 12 of
pregnancy is the most effective time to cause congenital toxoplasmosis (with
62.5%), but the incidence of congenital toxoplasmosis in 18th dayof pregnancy
is 37.5%, and none of the 105 litters from 6th day of pregnancy indicate
infections. Data on the occurrence of congenital transmission from chronically
infected mother rats given similarly graded inoculums of the RH Strain
(1 1065 106) are presented that none of the 36 pups was infected with
T. gondii. Theoccurrence of congenital transmission in ratswhichwere reinfec-
tedwith toxoplasma shows that none of the 14 pupswas infectedwithT. gondii.
Conclusions: Thus, this study demonstrates that Rattus chronically infected
with T. gondii, have immunity capable of protecting their embryos from
congenital infection, even if they are reinfected during pregnancy.
Macrolides
P1004 Activity of telithromycin against
macrolide-resistant Streptococcus pyogenes isolated from
pediatrics: PROTEKT Year 1 vs. 2
G. Russo, E. Bouza, D. J. Farrell
Catania, I; Madrid, E; London, UK
Background: Increasing erythromycin resistance (ERY-R; MIC 1mg/L)
among Streptococcus pyogenes is causing concern, particularly as macrolides are
the main option for penicillin-allergic patients in the treatment of RTIs. Data
from the PROTEKT study were analyzed to assess the prevalence of ERY-R
among S. pyogenes isolated from pediatrics during the winters of 1999–2000
(Y1) and 2000–2001 (Y2) and to assess the activity of telithromycin (TEL)
against such isolates.
Methods: S. pyogenes isolates were collected worldwide from children aged
14 years with community-acquired RTIs from 53 centers in Y1 and 58
centers in Y2. Antibacterial susceptibility of the isolates was assessed using
NCCLS guidelines. Macrolide resistance mechanisms were determined by
PCR in ERY-R isolates.
Results:A total of 676 (Y1) and 713 (Y2) isolates of S. pyogeneswere collected
from pediatric patients. The prevalence of ERY-R isolates was 10.2% (n¼ 69)
in Y1 and 9.3% (n¼ 66) in Y2, with high cross-resistance to clarithromycin
(66/69, 95.7% Y1; 63/66, 95.5% Y2) and azithromycin (69/69, 100% Y1;
66/66, 100% Y2). Mef(A) followed by erm(B) was the principal macrolide
resistance mechanism in both years. TEL was highly active (MIC90
0.03mg/L) in both years. At 1mg/L, TEL inhibited 96% (Y1) and 98%
(Y2) of all isolates, including, for both years, all strains harboring mef(A) or
erm(TR). Isolates harboring the erm(B) gene had a telithromycin MIC range
of 0.015 to >32mg/L (Y1) and 0.06–16mg/L (Y2).
Conclusions: mef(A)-mediated macrolide resistance among S. pyogenes from
pediatrics is more prevalent worldwide than other macrolide resistance
mechanisms. Telithromycin exhibits excellent activity against S. pyogenes,
including most macrolide-resistant and all mef(A) isolates. Telithromycin
activity is not reduced by mef(A) and hence it offers considerable potential
for clinical utility in areas of macrolide resistance.
Country
No. of isolates
Y1 Y2
All ERY-R
mef
(A)
erm
(B)
erm
(TR) Neg All ERY-R
mef
(A)
erm
(B)
erm
(TR) Neg
Italy 30 11 1 10 0 0 51 6 2 4 0 0
Japan 59 12 10 1 1 0 84 2 1 1 0 0
Portugal 34 10 3 7 0 0 2 1 0 1 0 0
Spain 0 – – – – – 80 22 18 2 1 1
Worldwide 676 69 37 28 4 0 713 66 38 18 8 2
Countries with 10 ERY-R isolates in either year.
Negative for resistance mechanisms tested.
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P1005 In vitro activity of telithromycin against
Streptococcus pneumoniae isolated in Europe, Africa,
Middle East and Asia during 2001
D. Felmingham, C. Janus on behalf of the E-BASKETT Study Group
Objective: Surveillance of antimicrobial susceptibility is fundamentally
important as an aid for informed choice in the empirical therapy of infectious
diseases. E-BASKETT, an international prospective study, determines the
susceptibility of Streptococcus pneumoniae isolated from patients with commu-
nity-acquired respiratory tract infections to established antimicrobial classes
and to the new ketolide, telithromycin.
Methods: 1563 isolates of S. pneumoniae were collected in 23 countries from
March 2001 and January 2002. The in vitro susceptibility of isolates to various
antibacterials was determined by a disk diffusion method at the participating
laboratories and by MIC determination following NCCLS guidelines at a
central laboratory.
Results: The prevalence of penicillin G resistance (resistant [PEN G R] –
MIC 2mg/mL)anderythromycinAresistance(ERYAR–MIC 1mg/mL)
were as per table:
Overall, 99.3% of the isolates of S. pneumoniae were inhibited by 0.5mg/L
and 99.9% by 1mg/L telithromycin (MIC50, MIC90, MIC range; 0.008,
0.12, 0.004–4mg/L, respectively).
Conclusions: S. pneumoniae isolates from different geographical regions all
showed a high overall susceptibility to telithromycin. In penicillin and
erythromycin resistant strains of S. pneumoniae, telithromycin showed signiﬁ-
cant activity.
P1006 Accuracy in determining telithromycin MIC
values against Streptococcus pneumoniae: E-test vs.
microbroth dilution
D. H. Hoban, S. K. Bouchillon, J. L. Johnson, T. Stevens
Schaumburg, USA
Objectives: Streptococcus pneumoniae (SP) is a common cause of outpatient
respiratory tract infections routinely treated with oral agents including
macrolides and the new ketolide telithromycin. Macrolide-resistant SP are
increasingly common while telithromycin resistance is exceptionally rare in
SP. Accurate susceptibility testing is essential to document SP telithromycin
activity. This study documents the effects of CO2 on telithromycin MICs
when determined by E-test methodology.
Methods: A total of 75 SP, 22 (29%) azithromycin susceptible and 53 (71%)
azithromycin-resistant were selected from recent international surveillance
trials. All E-test values were determined after incubation in 5% CO2 while
microbroth dilution panels were tested under ambient air conditions follow-
ing NCCLS guidelines. Both microbroth dilution panels and E-test plates
were inoculated using the same broth inoculum. Random colony counts
conﬁrmed inocula.
Results:E-test and broth dilution telithromycin geometric mean (GM)MICs
and fold GM increases for ALL, macrolide sensitive and macrolide resistant SP
were: All [0.108/0.037, 2.9], macrolide sensitive [0.022/0.006, 3.7] and
macrolide resistant [0.228/0.079, 2.9]. Telithromycin E-test MIC90s for
ALL isolates increases 4-fold compared with microbroth dilution SPMIC90s.
However no susceptible to resistant categorical interpretative changes were
documented.
Conclusions: E-test is a valuable diagnostic tool but when testing SP against
telithromycin in a CO2 environment, MICs increase. The data suggest
caution when interpreting telithromycin MICs when using telithromycin
E-test strips in a CO2 environment.
P1007 Three-year surveillance of resistance to
beta-lactam antibiotics and telithromycin among bacterial
pathogens associated with community-acquired respiratory
tract infections in Japan
S. Kohno, Y. Hirakata, M. Inoue
Nagasaki, Kanagawa, JP
Objectives: Japan has a high usage of beta-lactam (BL) antibiotics, which has
led to increasing BL resistance. This has been monitored for 3 years in
community-acquired respiratory tract infections (CARTIs) in Japan, as part
of the PROTEKT global surveillance study.
Methods: During 1999/2000, 2000/1 and 2001/2, isolates (n/year) of
Streptococcus pneumoniae (308, 627, 816), S. pyogenes (120, 161, 182), Haemo-
philus inﬂuenzae (281, 442, 545) andMoraxella catarrhalis (122, 186, 248) were
collected from patients in Japan with CARTIs and their susceptibilities
determined using NCCLS breakpoints (bpt) to the standard PROTEKT
panel of antibiotics plus cefditoren, cefdinir and cefcapene.
Results: Each year, susceptibility of S. pneumoniae to penicillin, cefuroxime,
ceﬁxime, cefaclor, cefpodoxime and cefdinir was <50%. Cefcapene (no bpt)
exhibited similar low activity to cefpodoxime (MIC90 4mg/L). Cefditoren
(MIC90 1mg/L, no bpt) and amoxicillin-clavulanate (AMC, MIC90 2mg/L,
>96% S each year) were the most potent BLs, but both were >4-fold less
active than telithromycin (MIC90 0.25mg/L, 99.6% S). All S. pyogenes
were susceptible to all BLs (all MIC90 0.5mg/L). The prevalence of BLþ
and BLNAR (BL–, ampicillin-resistant [MIC 2mg/L])H. inﬂuenzaewas 9,
10 and 4, 7, 10%, respectively, over the 3 years. Cefditoren (MIC90
0.12mg/L, no bpt) was the most active BL. Each year, >82% of isolates
were susceptible to cefdinir and 99% isolates were susceptible to cefpodox-
ime and AMC. BLþM. catarrhalis exceeded 94% each year, decreasing
susceptibility to cefuroxime (92, 87, 83%), cefprozil (75, 72, 71%) and
cefaclor (89, 84, 74%). Cefditoren (MIC90 0.03–0.06, no bpt) was the most
active BL and all isolates were susceptible to AMC (MIC90 0.25mg/L) and
cefdinir (MIC90 0.5mg/L). Each year,99% of S. pneumoniae (MIC90
0.25mg/L) and H. inﬂuenzae (MIC90 2mg/L) were susceptible to telithro-
mycin. All M. catarrhalis and >97% of S. pyogenes (all MIC90 0.25mg/L)
were inhibited by telithromycin at 1mg/L.
Conclusions: Japan has high levels of BL resistance among S. pneumoniae and
rising levels of resistance among H. inﬂuenzae and M. catarrhalis. Cefditoren
exhibits low MIC90s against these pathogens. Cefdinir and cefcapene exhibit
weaknesses in their spectrums of activity. Telithromycin, the ﬁrst ketolide
antibiotic, may offer an alternative to BLs for CARTI therapy in Japan because
of its potent activity even against BL-resistant strains.
P1008 In vitro activity of the ketolides telithromycin
and ABT 773 against Staphylococcus aureus and their
potential to select for resistant mutants
S. Besier, K.-P. Hunfeld, I. Giesser, V. Scha¨fer, V. Brade,
T. A. Wichelhaus
Frankfurt/Main, D
Macrolides are widely used in the treatment of respiratory tract and soft tissue
infections where Staphylococcus aureus is considered to be one of the major
pathogens. The rising incidence of infections caused by erythromycin-
resistant S. aureus strains is a growing problem that is leading worldwide to
an increasing need for new agents. The ketolides telithromycin and ABT 773
represent a new class of antimicrobial agents and could possibly be of great
value in the treatment of infections caused by pathogens such as S. aureus.
Country n PEN G-R (%) ERY A-R (%)
Austria 187 3.2 9.6
Finland 90 4.4 14.4
Greece 72 41.7 48.6
Netherlands 63 0 3.2
Spain 108 28.7 37.0
Switzerland 99 2.0 7.1
Czech Republic 160 4.4 3.7
Hungary 46 21.7 39.1
Poland 108 9.3 15.7
Slovakia 49 28.6 34.7
Turkey 41 14.6 7.3
Algeria 39 25.6 28.2
Ivory Coast 12 0 8.3
Lebanon 47 19.1 21.3
Morocco 13 0 0
Senegal 3 0 0
South Africa 196 50.0 57.7
Tunisia 44 29.5 38.6
South Korea 28 57.1 89.3
Philippines 26 0 0
Taiwan 87 72.4 94.3
Thailand 24 50.0 66.7
India 21 0 0
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Objectives: The aim of the present study was to determine the in vitro
activities of telithromycin and ABT 773 against S. aureus and to examine the
potential of these two ketolides to select for resistant mutants.
Methods: 100 clinical S. aureus isolates were analyzed including 20 erythro-
mycin-susceptible, 40 erythromycin-inducible-resistant, and 40 erythromy-
cin-constitutive-resistant strains. The MICs of telithromycin and ABT 773
were determined by the agar dilution method and compared with those of
clindamycin, clarithromycin, azithromycin, and quinopristin/dalfopristin.
Additionally, the ability of telithromycin and ABT 773 to select for resistant
mutants was investigated by subculturing three erythromycin-susceptible and
three erythromycin-inducible-resistant S. aureus isolates in the presence of
subinhibitory concentrations of these two ketolides.
Results: In vitro, telithromycin and ABT 773 showed high activity against
erythromycin-susceptible and erythromycin-inducible-resistant S. aureus
strains, with MIC90 values ranging between 0.125 and 0.25mg/L. The
subculturing experiment, however, revealed that telithromycin and ABT 773
easily select constitutive-resistant mutants in macrolide-inducible-resistant
isolates. The MICs increased to >128mg/L already within 2 days of sub-
culturing and were stable after 10 days of antibiotic-free passages.
Conclusions: The results of the present study show that a cautious and
judicious use of telithromycin and ABT 773 is strongly recommended in
order to maintain the valuable status of this class of antimicrobial. As ketolide-
resistant mutants can be easily selected overnight by the exposure of inducible-
resistant isolates to telithromycin and ABT 773, ketolides should not be
deployed for the treatment of infections caused by staphylococci of this
phenotype.
P1009 Comparative in vitro activity of Telithromycin
(KETEK), macrolides, quinolones and beta-lactams against
S. aureus, S. pneumoniae and H. inﬂuenzae
J. Dubois, C. St-Pierre
Sherbrooke, CAN
Background: Telithromycin, a semisynthetic new ketolide, was compared
with erythromycin A, azithromycin, clarithromycin, ciproﬂoxacin, oﬂoxacin,
levoﬂoxacin, gatiﬂoxacin, moxiﬂoxacin, cefaclor, cefuroxime, amoxicillin and
amoxicillin/acid clavulanate against more than 1000 recent clinical isolates.
Methods: MIC’s were determined by agar dilution (NCCLS).
Results: Against S. aureus methi.-resistant (MecA), telithro. (MIC90 0.06mg/
L) was more active than macrolides tested (MIC90 8mg/L), oﬂox. and
ciproﬂox. (MIC90 2mg/L). A decreased activity (MIC 4mg/L) was observed
with telithro. against erythro.-resistant or MLSb-resistant S. aureus strains.
Against S. aureus ciproﬂox.-resistant pathogens, telithro. (MIC90 0.006mg/L)
was the most active compounds tested, followed by gatiﬂox., moxiﬂox.
(MIC90 2mg/L) and cefurox. (MIC90 4mg/L). Telithro. (MIC90 0.5mg/
L) was superior to oﬂox. (MIC90 2mg/L), claritho. (MIC90 256mg/L) and
cefurox. (MIC90 0.5mg/L) against S. pneumoniae peni.-resistant or peni.-
intermediate strains. Against S. pneumoniae erythro.-resistant (ermB), telithro.
(MIC90 0.01mg/L) was the most active agents tested. Against S. pneumoniae
erythro.-resistant (mefE), telithro. moxiﬂox. and gatiﬂox. (MIC90 0.5mg/L)
were the most active agents tested. Against H. inﬂuenzae Beta-lactamase- or
erythro.-resistant strains, telithro. (MIC90 4mg/L) was more active than
clarithro. and Beta-lactams tested.
Conclusion: Telithromycin (KETEK) could be a valuable compound for the
treatment of respiratory pathogens, including those resistant to usual oral
therapy.
P1010 In vitro activity of Telithromycin (KETEK) vs.
macrolides, quinolones and beta-lactams against
S. pneumoniae, H. inﬂuenzae and M. catarrhalis isolated
from adults and children specimens
J. Dubois, C. St-Pierre
Sherbrooke, CAN
Background: Telithromycin, a new ketolide, was compared with clarithro-
mycin, azithromycin, erythromycin A, gatiﬂoxacin, levoﬂoxacin, oﬂoxacin,
ciproﬂoxacin, cefotaxime, ceﬁxime, cefpodoxime, cefaclor, cefuroxime,
amoxicillin and amoxicillin/acid clavulanate against recent S. pneumoniae,
H. inﬂuenzae and M. catarrhalis strains isolated from adults (18 years old) and
three age groups of children (1–6, 7–12, 13–17 years old).
Methods: MIC’s were determined by agar dilution (NCCLS).
Results: H. inﬂuenzae and M. catarrhalis strains isolated from adults or from
children showed similar activity with all tested antibiotics. With S. pneumoniae
strains, most macrolides and cephalosporins tested were more active against
strains isolated from children than against strains isolated from adults. Telithro.
(MIC90 0.5mg/L) was superior to macrolides tested (MIC90 16mg/L)
against S. pneumoniae peni.-resistant strains isolated from adults. In children
group, S. pneumoniae peni.-resistant strains were more susceptible to telithro.
(MIC90 0.06mg/L). Against S. pneumoniae (ermB genotype) isolated from
adults, telithro. (MIC90 0.01mg/L) was the most active agents followed by
moxiﬂox. (MIC90 0.25mg/L) and gatiﬂox. (MIC90 0.5mg/L). Against
S. pneumoniae (mefE genotype) isolated in children (1–6), telithro. (MIC90
0.25mg/L), moxiﬂox. (MIC90 0.25mg/L) and gatiﬂox. (MIC90 0.5mg/L)
were the most active agents followed by levoﬂox. and cefotaxime (MIC90
1mg/L). Against H. inﬂuenzae b-lactamase-positive or ery-resistant strains
isolated in both group, telithro. (CMI90 4mg/L) was more active than
clarithro. and more active than b-lactams tested. Against M. catarrhalis
b-lactamase positive strains isolated in both group, telithro. (MIC90
0.06mg/L) was comparable to moxiﬂox., levoﬂox., oﬂox. and ciproﬂox.
Against M. catarrhalis ery-resistant, telithro. and azithro. showed a similar
activity (MIC90 2mg/L).
Conclusion: Combined with favorable pharmacokinetics in human, telithro.
could be a valuable oral compound for the treatment of S. pneumoniae and
M. catarrhalis isolated from adults or children, including resistant strains to
usual oral therapy.
P1011 Comparative in vitro activity determination of
ketolides, macrolides, and azalides against the spirochete
Borrelia burgdorferi
K.-P. Hunfeld, T. A. Wichelhaus, P. Kraiczy, R. Ro¨del, V. Brade
Frankfurt, D
Objectives: So far, ketolides belonging to a new class of antimicrobial agents,
have not been tested in vitro against larger numbers of the B. burgdorferi
complex derived from different clinical sources and geographic origin. Here
we analyzed the in vitro activity of new ketolides, ABT-773 and telithro-
mycin, in comparison to that of four classical macrolides, one azalide
derivative, apramycin, and ceftriaxone against borreliae.
Methods: Seventeen isolates of the B. burgdorferi sensu lato (s.l.) complex in
addition to one Borrelia valaisiana and one Borrelia bissettii tick isolate were
tested. Minimal inhibitory concentrations (MICs) and minimal borreliacidal
concentrations (MBCs) providing 100% killing of the ﬁnal inoculum were
determined by a standardized colorimetric test methodology and conven-
tional subculture. In addition, time-kill studies and electron microscope
analysis were performed on borreliae exposed to increasing drug concentra-
tions.
Results:The rank order of potency on a mg/mL basis for the substances tested
against B. burgdorferi was ABT-773 (MIC90: 0.002mg/mL, MBC90: 0.12mg/
mL)> telithromycin (MIC90: 0.007mg/mL, MBC90: 0.25mg/mL)>
azithromycin (MIC90: 0.01mg/mL, MBC90: 0.5mg/mL)> clarithromycin
(MIC90: 0.03mg/mL, MBC90:> 0.5mg/mL)> ceftriaxone (MIC90: 0.03
mg/mL, MBC90: 2mg/mL)> roxythromycin (MIC90: 0.06mg/mL, MBC90:
> 0.5mg/mL), erythromycin (MIC90: 0.06mg/mL, MBC90:> 0.5 mg/
mL)> apramycin (MIC90:> 64mg/mL, MBC90:> 64mg/mL). Results of
electron microscope analysis and time-kill studies clearly support enhanced
in vitro activity of the ketolides on borreliae.
Conclusions: Our ﬁndings emphasize superior in vitro effectiveness of the
new ketolide antibiotics ABT-773 and telithromycin in comparison to
classical macrolides against B. burgdorferi under strictly standardized test con-
ditions and hence the possible suitability of these substances for clinical trials
on their performance in the treatment of Lyme disease.
P1012 Agar dilution and E-test MIC values of
azithromycin, chlarithromycin and erythromycin among
Haemophilus inﬂuenzae isolates
P. Ka¨rpa¨noja, J. Jalava, H. Sarkkinen
Lahti, Turku, FIN
Objectives:To study the suitability of E-test for the quantitative susceptibility
testing of H. inﬂuenzae for three antibiotics from the macrolide and azalide
groups: azithromycin, chlarithromycin and erythromycin. As a reference
method agar dilution was used instead of the broth microdilution method
recommended by the NCCLS-standard (2000). Since quality control limits
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have been deﬁned by the NCCLS for only one of the macrolides; azithro-
mycin, the novel ketolide, telithromycin was included. Telithromycin E-tests
were not performed while the strips are not yet available.
Methods: 374 consecutive clinical H. inﬂuenzae isolates from seven clinical
microbiology laboratories in Finland were tested according to the guidelines
of the NCCLS-standard (agar dilution method for nonfastidious bacteria) and
the manufacturer of the E-test method (Biodisk Ab). HTM-agar was used for
both methods. H. inﬂuenzae ATCC 49247 was used as a quality control for
both tests. The results were analyzed using the WHONET5.1-computer
program.
Results and conclusions: Acceptable quality control limits for H. inﬂuenzae
ATCC 49247 have been deﬁned by NCCLS for azithromycin and telithro-
mycin. The QC-results of these antibiotics using the agar dilution method
indicate that it can be used as a reference method for the MIC ofH. inﬂuenzae
isolates instead of the broth dilution (NCCLS recommendation). The results
fell, with one exception, within the acceptable QC-limits for the broth
dilution method. Consequently, agar dilution was used as a comparative
method for chlarithromycin and erythromycin, as well. The E-test method
showed also QC-results for azithromycin within the accepted range given by
the NCCLS. The MIC50-values of the clinical isolates for erythromycin and
chlarithromycin were lower with the E-test compared with agar dilution but
the corresponding values for azithromycin were identical. The MIC90-values
and geometric means of the MIC-values were lower with the E-test method
for all three antibiotics. Interpretive categorization errors (classiﬁed as very
major, if a resistant strain was classiﬁed as susceptible) with the E-test were as
follows: azithromycin very major errors 19/374 (5.1%), total errors 23/374
(6.2%); chlarithromycin very major errors 8/374 (2.1%), total errors 111/374
(30.2%); erythromycin very major errors 1/374 (0.3%), total errors 237/374
(63.4%). The possible causes for these observations will be discussed.
P1013 Time-kill kinetics of clarithromycin,
roxithromycin, and azithromycin against selected
Streptococcus pneumoniae isolates compared with
those of penicillin and moxiﬂoxacin
S. Bagel, J. Brauers, M. Kresken
Bonn, D
Objectives:Macrolides are supposed to exert marginal concentration-depen-
dent killing. Time-kill kinetics are observed for 6 h (h) and 24 h according to
the German DIN and NCCLS criteria, respectively. This study aimed at
investigating the kill kinetics of three macrolides, penicillin (PEN), and
moxiﬂoxacin (MOX) against S. pneumoniae (Sp) applying both the DIN
and the NCCLS criteria.
Methods: Time-kill kinetics of clarithromycin (CLA), azithromycin (AZI),
roxithromycin (ROX), PEN, and MOX were determined for 4 Sp strains
(PEN- and CLA-susceptible (S) (Sp1), PEN-intermediate (Sp2), PEN-resis-
tant (R) (Sp3), and CLA-R (SP4)). MICs (mg/L) were: CLA, 0.015–2; AZI,
0.06–4; ROX, 0.03–8; PEN, 0.004–2; MOX, 0.125. Antibiotics were tested
at 1MIC, 2MIC and 4MIC. Colony forming units were counted at 0,
2, 4, 6, 8, and 24 h. A bactericidal effect was deﬁned as a decrease of the
inoculum by 99.9% (3 log 10).
Results: Applying NCCLS criteria all antibiotics exhibited bactericidal
activity at 4 MIC against all Sp strains. At 2 MIC only CLA and
MOX showed a bactericidal effect against all Sp strains. Applying DIN
criteria, bactericidal activity was achieved for all antibiotics against Sp1 but
only for CLA and PEN against Sp2, Sp3, and Sp4. Among the macrolides the
rate and/or extent of killing against Sp strains was highest for CLA.
Conclusions: All antibiotics exhibited bactericidal activity against S. pneumo-
niae according to NCCLS, but according to DIN criteria only CLA and PEN
were bactericidal. Bactericidal effect of CLA against Sp strains was stronger
than that of AZI and ROX and comparable to that of PEN and MOX.
P1014 Different susceptibilities of implant-associated
bacteria against azithromycin and b-lactam antibiotics in
mixed and pure culture
J. Karbach, A. Callaway, B. Willershausen, B. Al-Nawas
Mainz, D
Objectives: Reduced susceptibility to b-lactam antibiotics in mixed culture
has been described for abdominal pathogens. For the oral situation a symbiosis
between Veillionellae and Lactobacilli is recognized. However no data is
available regarding antimicrobial resistance.
Methods: During routine follow up microbial specimens were drawn from
the periimplant pocket of 19 patients using sterile paper tips. The samples
were diluted in sterile saline and cultivated under anaerobic conditions on
BHI and Schaedler agar for 7 days. After cultivation, the mixed cultures were
resuspended again in saline and mixed with soft agar of the respective medium
as top agars. E-test strips containing azithromycin (AZI), ampicillin (AMP),
ampicillinþ sulbactam (AMP-SUL) and penicillin G (PEN) were placed on
the top agar and the plates were incubated for >24 h under anaerobic
conditions. After reading the E-test, resistant strains were picked and puriﬁed
and the E-test was repeated with the pure isolate.
Results: Mean values of the MIC (mg/mL) of the mixed cultures (BHI and
Schaedler) and of the respective isolates are given:
Conclusion: No relevant difference of the MIC values of periimplant
pathogens in mixed culture was found using different culture media. How-
ever, after isolation lower MIC values were found for all antibiotics. Regard-
ing the clinical situation of perimplantitis, he polymicrobial infection with its
possible implications for antimicrobial therapy should be further elucidated.
Alternative agents
P1015 Activities of crude extracts of Thai medicinal
plants on methicillin-resistant Staphylococcus aureus
S. Voravuthikunchai, L. Kitpipit
Hatyai, TH
Objectives: Over recent years, there has been a global increase in the
prevalence of antibiotic-resistant Staphylococcus aureus. The aim of our study
was to screen for effective medicinal plants, widely used in Thai traditional
medicine for the treatment of this organism.
Methods: Sixteen preparations of aqueous and ethanolic extracts of 10 kinds
of Thai herbs includingAcacia catechu,Garcinia mangostana, Impatiens balsamina,
Peltophorum pterocarpum, Psidium guajava, Punica granatum, Quercus infectoria,
Tamarindus indica, Uncaria gambir, and Walsura robusta were tested for their
antibacterial activity against 35 hospital strains of methicillin-resistant S. aureus
(MRSA) and S. aureus ATCC 25922. Inhibition of growth was preliminarily
tested by the paper disc agar diffusion method. Antibiotic susceptibility discs
were used as control. Minimum inhibitory concentration (MIC) and mini-
mum bactericidal concentration (MBC) were determined by the agar dilution
method in Petri dishes with millipore ﬁlter.
Results: Nearly all extracts, except of T. indica, showed some antibacterial
activity against all strains of MRSA and S. aureus. P. granatum and Q. infectoria
showed the greatest inhibition zones, ranging from 13 to 23mm. Among the
plants tested, aqueous and ethanolic extracts of Q. infectoria and ethanolic
extract of P. granatum andG.mangostanawere demonstrated to be signiﬁcantly
effective with the MIC values of 0.05–0.4, 0.05–0.1, 0.2–0.4mg/mL and the
MBC values of 0.1–0.4, 0.1–0.4, 0.4–3.2mg/mL, respectively.
Conclusions:As both aqueous and ethanolic extracts ofQ. infectoriawere very
effective against all strains of MRSA, this plant should be further investigated
for alternative treatment of this antibiotic-resistant organism.
AZI AMP AMP-SUL PEN
BHI mixed (n¼ 19) 230 167 174 24
Schaelder mixed (n¼ 19) 206 249 212 30
Isolates (n¼ 103) 68 13 76 12
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P1016 Investigation into the antibacterial and
immunomodulating effects of Lingzhi (Ganoderma lucidum)
L. Yuen, J. Yuen, M. V. Boost, I. F. F. Benzie, S. Wachtel-Galor
Kowloon, HK
Introduction: Lingzhi (Ganoderma lucidum) is widely used in traditional
Chinese medicine in the treatment of infections. There have been limited
reports of its antimicrobial properties, though several authors have shown it to
have modulating effects on the immune system.
Objectives: To investigate the antibacterial properties and effects on lym-
phocyte levels of Lingzhi extract.
Methods: A hot water extract from certiﬁed Lingzhi and a solution of a
commercial source of Lingzhi were tested for their antimicrobial properties
against a range of Gram-positive and Gram-negative organisms by means of
broth dilution. Several strains of each organism including antibiotic sensitive
and resistant strains were tested. Ten subjects were given three capsules of a
commercial extract of Lingzhi or a placebo for 28 days. The treatment was
followed by a 21-day wash out period and then subjects were crossed over to
receive the alternative treatment. Fasting blood was collected on days 1 and 29
of each treatment period. Levels of CD3þ, CD4þ and CD8þ cells were
determined by ﬂow cytometry.
Results: Lingzhi was found to have no antibacterial effect on Staphylococcus
aureus, Enterococcus, E. coli, Klebsiella oxytoca, Klebsiella pneumoniae, Salmonella
enteritidis, Salmonella typhi, Shigella, Serratia marcescens, Pseudomonas aeruginosa
or Proteus mirabilis even at a concentration of 16mg/mL. Both penicillin
sensitive and penicillin resistant Streptococcus pneumoniae were inhibited at
16mg/mL. CD4þ and absolute CD4þ cells were signiﬁcantly increased, 12%
(P< 0.05) and 37% (P< 0.01), respectively. The increase in CD4þ cells led to
a 25% increase in the CD4/CD8 ratio (P< 0.05).
Conclusions: Lingzhi appears to exert in vivo immunomodulatory effects
resulting in an increase in CD4þ lymphocytes. This increase in CD4þ cells
may indicate enhancement of CD4 receptors on T cells by MHC class II
molecules on antigen presenting cells, which may help to further amplify cell-
mediated response to exogenous pathogens. In contrast to a previous report,
Lingzhi did not appear to demonstrate antibacterial activity in vitro, except at
high concentration for S. pneumoniae. The success of Lingzhi in the treatment
of infection is likely to be due to its immune regulating function rather than its
speciﬁc antibacterial effects.
P1017 The antimicrobial properties of the essential oil
of Melaleuca alternifolia (tea tree oil) and its individual
components
T. Stark, J. Rattray, A. Leanord
Lanarkshire, Glasgow, UK
Objectives: To examine the antimicrobial properties of tea tree oil and
identify those components that possess antimicrobial activity by testing against
a range of organisms.
Methods: Clinical isolates of methicillin-resistant Staphylococcus aureus
(MRSA), vancomycin-resistant Enterococcus faecium (VRE), Acinetobacter junii
andCandida albicanswere tested against tea tree oil and eight of its components
using time kill curves. The components tested were alpha-terpinene, gamma-
terpinene, terpinolene, cymene, linalool, alpha-terpineol, terpinen-4-ol and
1,8-cineole at various concentrations.
Results: All the microorganisms tested proved susceptible to tea tree oil.
C. albicanswas the most susceptible, and VRE was the least susceptible. Of the
tea tree oil components tested, alpha-terpinene, gamma-terpinene, terpino-
lene and cymene showed no or negligible antimicrobial activity. 1,8-cineole
showed antifungal activity against C. albicans, and antibacterial activity against
A. junii, but no antibacterial activity against MRSA or VRE. Linalool, alpha-
terpineol and terpinen-4-ol showed antimicrobial activity against all the
organisms tested, with alpha-terpineol shown to possess slightly greater
antimicrobial activity against VRE and MRSA than terpinen-4-ol (the main
antimicrobial component in tea tree oil).
Conclusion: Alpha-terpineol could be considered as an alternative to tea tree
oil and conventional antimicrobials in the topical treatment of infection. The
use of individual components of tea tree oil may eliminate the potential for
allergic reactions often associated with tea tree oil.
P1018 Time kill curves of tea tree oil and sweet
marjoram against MRSA and E. coli
A. Leanord, N. Brown, L. Macham
Lanarkshire, Glasgow, UK
Objective: There have been minimal studies carried out on the rate of
bacterial cell growth or death in the presence of essential oils (EOs). It
was, therefore, decided to carry out time kill curves on tea tree oil and sweet
marjoram which have both shown antimicrobial activity
Methods: The bacteria, Escherichia coli (E. coli) and methicillin-resistant
S. aureus (MRSA) used in the following experiments were obtained from
clinical isolates. The EOs studied included Melaleuca alternifolia (tea tree) and
Origanum majorana (sweet marjoram). Tea tree oil (TTO) and sweet marjoram
were doubly diluted in nutrient broth to a ﬁnal concentration ranging from 10
to 0.08% (v/v). Time kill curves were then carried out on 0.30 and 0.08%
TTO and sweet marjoram against MRSA and E. coli.
Results: At 0.30% EO sweet marjoram reduced bacterial numbers to zero
within 30min whilst a similar reduction in bacterial numbers required 8 h
with TTO. At the lower concentration of 0.08% both EOs were not
bactericidal to either MRSA or E. coli after 8 h incubation
Conclusions: Although the majority of research has centered on the anti-
bacterial properties of TTO and its uses against MRSA, the present experi-
ments have shown that Sweet marjoram has greater antibacterial properties
than TTO against MRSA and E. coli. Sweet marjoram is less irritant to skin
when applied topically at concentrations of 1–30% and has lower oral toxicity
when compared with TTO. This could be used as a viable alternative to TTO
in the eradication of MRSA.
P1019 Antibacterial efﬁcacy of commercially
manufactured disinfectant substances against Salmonella
enterica serovar Enteritidis
L. Majta´nova´, V. Majta´n
Bratislava, SK
Objectives: To evaluate the antimicrobial efﬁcacy and effect on the biosyn-
thetic processes as well as on the endogenous respiration of 19 commercially
manufactured disinfectants on Salmonella enterica serovar Enteritidis.
Methods: The antimicrobial efﬁcacy was characterized by inﬂuencing the
growth of bacterial cells expressed by MIC and ED50 values as well as by the
inhibition of the incorporation rate of [14C]adenine and [14C]leucine into
TCA-insoluble fractions of cells. The endogenous respiration was determined
polarographically with a Clark type oxygen electrode.
Results:The disinfectant substances represented eight quaternary ammonium
salts (QAS) and 11 combinatedQASwith other ingredients. These substances
were divided into three groups according to their efﬁcacy. The ﬁrst group
comprised the substances with a strong inhibitory effect (MIC 0.006–
0.045 mg/mL) such as Diesin forte, Hexaquart plus, Neoquat S, Triquart,
Almyrol, Hexaquart S, ID212, ID213 and Microbac forte. The second group
represented substances with a good antibacterial efﬁcacy (MIC 0.09–0.78mg/
mL) and in the third group were substances with MIC values up to 0.78–
3.12mg/mL. Cetrimide had a very low activity (MIC 3.12–6.25mg/mL). The
effect of disinfectants on the biosynthetic processes expressed by R-values
(IC50Ade:IC50Leu) showed that these values were 1 (except for six sub-
stances), which suggested interference of these substances with cellular energy
metabolism. All substances except 5Pplus caused an inhibition of the endo-
genous respiration of Salmonella cells.
Conclusions: The results suggest that these techniques can be used for
evaluation of antibacterial efﬁcacy and demonstrate the mechanism of action
of disinfectant substances.
P1020 The effect of human lactoferrin on the antibiotic
susceptibilities of Stenotrophomonas maltophilia isolated
from cystic ﬁbrosis patients
I. Alshami, M. M. Alkawash, A. O. Qamruddin
Manchester, UK
Objectives: The presence of lactoferrin at the high concentration (0.9mg/
mL) found in the respiratory secretions of cystic ﬁbrosis (CF) patients has
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effects on bacterial growth and may affect the susceptibility of CF pathogens.
The effect of lactoferrin at this high concentration on the susceptibility of
Rifampicin, Gentamicin, chloramphenicol, erythromycin, Ceftazidime and
Trimethoprim against Stenotrophomonas maltophilia obtained from CF patients
were investigated.
Methods: MICs for the clinical isolates of S. maltophilia in the presence and
absence of lactoferrin (0.9mg/mL), were tested by a microtiter broth dilution
method. MBCs were also determined. For each clinical isolate, eight replicate
MIC and MBC determinations were performed per antibiotic. MICs and
MBCs quoted are median values.
Results: The presence of lactoferrin lowered the MICs and MBCs of rifam-
picin by 2–16-fold for clinical isolates of S. maltophilia. There were no changes
in the susceptibility of the other antibiotics when lactoferrin was added.
Conclusions:These ﬁndings may be of relevance to the treatment respiratory
tract infections in CF patients, in whom the presence of lactoferrin in vivo
may enhance the activity of antibiotics, an effect that would not be predicted
by standard antibiotic testing methods. In this setting it may be useful to
incorporate lactoferrin in antibiotic sensitivity testing methodology.
P1021 In vitro activity evaluation of some antibiotics
included in a hydrogel
T. Oita, I. Oita, M. I. Lazar, D. Grigore, O. Tanase, P. Fiterman
Iasi, RO
Background: Latest years revealed the beneﬁts of local therapy in dermato-
logical infectious affections. Good local tolerance of tested hydrogel encour-
aged us to elaborate four formulations containing well known antibiotics,
used in dermatology.
Objectives:We intended to evaluate in vitro activity and stability of antibiotics
included in our hydrogel.
Material and methods: We used a bentonite hydrogel prepared after an
original method which met the European Pharmacopoeia’s quality condi-
tions. We included in hydrogel sodium benzylpenicillin, chloramphenicol,
tetracycline hydrochloride and neomicine sulfate. The products were char-
acterized physic-chemically. The antibiotic activity was evaluated using
difusimetric methods. As test microorganisms we used Staphylococcus aureus
6538 P and Escherichia coli ATCC 10536.
Results:The hydrogel pH is 7.0, and the pH of antibiotic containing hydrogel
varies with each antibiotic. Benzylpenicillin hydrogel had the lowest stability,
but the chloramphenicol hydrogel and neomicine sulfate hydrogel maintained
the activity throughout the study time (98 days). Benzylpenicillin hydrogel
had a mild activity decrease after 19 days (82%) and only 48% of initial activity
after 30 days. Tetracycline hydrochloride hydrogel maintained the initial
activity 30 days, but only after 48 days the activity become 95% of initial
one, and remained so until the end of study. Moreover we studied the
inﬂuence of surfactants on antibiotic release from hydrogel.
Conclusions: E. coli was more sensitive to the tested antibiotics than S. aureus.
Benzylpenicillin hydrogel had the lowest stability. Surfactants use increased
the antibiotic stability included in hydrogel.
P1022 ‘Ex vivo’ synergism: a method to optimize
antimicrobial combinations for difﬁcult-to-treat
endocarditis
C. Tascini, G. Gemignani, A. Leonildi, F. Menichetti
Pisa, I
We describe a method to evaluate synergism between the antibacterial activity
of patient serum taken during a given antibiotic combination added in vitro
with further antibiotic. A 63-year-old male patient was admitted to cardiac
unit with a mitral valve endocarditis due to E. faecalis. The blood isolate
resulted susceptible but tolerant to penicillin, ampicillin, teicoplanin and
vancomycin; highly resistant to gentamycin, tobramycin, and streptomycin
and susceptible to netilmicin. No beta-lactamases production was found. The
patient was treated with penicillin (24MU/day) and netilmicin (150mg
t.i.d.), a combination resulted fully synergistic with the checkerboard method
(SFICI: 0.2). After 4 days of therapy, peak and through serum bactericidal
activity (SBA) were both 1:16 and blood cultures were still positive for
E. faecalis. Therefore, we tested synergism between patient serum and teico-
planin with the checkerboard method. The combination of the peak serum
with teicoplanin gave a SFICI of 0.02 indicating fully synergism. Teicoplanin
was therefore added to the current patient treatment. After 4 days peak and
through SBA resulted 1:128 and 1:32, respectively. Blood cultures became
negative on day 8 and endocarditis was cured after 4weeks of the three drugs
combination therapy. Ex vivo synergism between the patient serum during
antibiotic therapy and further antibiotics might be an useful method to
optimize the antibiotic therapy in difﬁcult-to-treat infections.
Does antibiotic policy affect usage?
P1023 Is community antibiotic prescribing
consequence-free?
J. T. Magee, J. L. Bell, M. L. Heginbothom, A. J. Howard – Welsh
Antibiotic Study Group
Objectives: To elucidate factors associated with antibiotic resistance in
community infection as a guide to rational intervention.
Methods:Retrospective resistance data on community isolates and antibiotic
prescribing data for 1996–2001 were collected for Wales. Analyzes were
performed in Excel and SPSS.
Results: During the study, overall prescribing decreased by c. 40% in Wales.
Antibiotic prescribing varied markedly between practices, with a minority
prescribing up to four to ﬁve times the mean. Similarly, resistance levels
varied, sometimes markedly between practices. For Staphylococcus aureus and
urinary coliforms there was a clear association between high practice pre-
scribing of an antibiotic and high levels of resistance to that antibiotic. There
was also an association between resistance and social deprivation exceeding
that expected from high prescribing in deprived areas. The proportion of
resistant infections appeared to be highest in the young (<10 years) and the
aged (>70 years). This was a generalized rule across awide variety of infections
(urinary, respiratory and wound) and pathogens (urinary coliforms, H. inﬂu-
enzae, MSSA, MRSA, pneumococci and group A streptococci). Community
methicillin resistance in S. aureus rose linearly from age 25, and showed a more
rapid increase beyond age 70. The age-resistance distributions for pooled data
from practices in the highest quartile of prescribing generally showed curves
parallel to those for pooled data from the lowest quartile, with signiﬁcantly
higher resistance throughout the age range. For some infections and some
antibiotics, resistance was signiﬁcantly greater in males.
Conclusions: Antibiotic usage appears to have consequences on resistance
levels in community infection at practice level. The statistical link between
practice usage and practice resistance documented previously for urinary
coliforms has been conﬁrmed and extended to infections for another
pathogen with distinct pathology and epidemiology – S. aureus. This associa-
tion also appears to operate throughout the age range of underlying pathol-
ogies involved in coliform urinary tract infections. Other factors associated
with increased resistance were patient age and gender. Possible mutual
associations between age, prescribing and resistance deserve further investiga-
tion.
P1024 Statistics and resistance: is guessing really easier
than this?
F. D. J. Dunstan, M. L. Heginbothom, J. T. Magee, J. L. Bell,
A. J. Howard – Welsh Antibiotic Study Group
Objectives: To develop methods for preliminary analysis of an all-Wales
survey of community antibiotic resistance (c. 350 000 isolates). Automated
methods were needed to show the level of uncertainty for individual
resistance estimates (REs) and in trend and scatter graphs, and to compare
large numbers of REs objectively.
Methods: The conﬁdence interval is regarded as essential in presentation of
numerical data by many medical journals. The CI indicates the plausible range
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of values for the true level consistent with the data, taking into account
variation from random sampling effects (e.g. a RE of 0.1% based upon 1000
isolates has an uncertainty from c. 0.02 to 0.56%; the single resistant isolate
might represent chance inclusion of rare strain, or chance exclusion of more
common strains in the sample). For REs, approximation CI formula found in
books for nonstatisticians are not generally valid as they assume resistance not
close to 0 or 100% and large samples. Formula allowing rigorous calculation of
CIs for REs, and for comparisons between REs were written in Excel
spreadsheets and utilized in preliminary analysis of data from the All-Wales
survey. Detailed methods for incorporation of these formula into Excel
spreadsheets and production of graphical representations that include error
bars will be available.
Results:Microbiologists’ intuitive estimates of uncertainty were often grossly
optimistic. The small effort of incorporating the formule into a general-
purpose pro-forma analysis spreadsheet aided interpretation. Ready visuali-
zation of the range for estimates facilitated interpretation of trend and scatter
plots, and where sample sizes were widely variant, e.g. for interpractice and
interlaboratory comparisons. In one analysis, CIs of REs for 13 antibiotics
against six species at 14 laboratories were calculated and compared with all-
Wales REs. Excel sorting of the comparison CIs listed laboratories in order of
statistical deviation from the all-Wales estimate. This ideal presentation of data
in analysis priority order took less than 10min to achieve.
Conclusions: The Excel formule are convenient and allow much more
rigorous interpretation of resistance data than normally occurs. They are
not a panacea for all statistical problems – advice from an experienced
statistician should always be sought. CIs are a vital adjunct to interpretation
of susceptibility data, and essential in published papers.
P1025 Audit of linezolid use within a large teaching
NHS trust
A. K. Morris, A. P. Gibb, R. Morgan, C. Philip, F. Sloan
Edinburgh, UK
Objectives: We wished to audit the frequency, distribution, and indications
for linezolid use within Lothian University Hospitals, NHS Trust for the
12months from the 1st November 2001 to the 31st October 2002.
Methods: The Trust covers three major hospital sites and includes tertiary
referral centers. A protocol for use of Linezolid was agreed and put into place
in November 2001. The protocol stated that linezolid was only prescribed
with the approval of a consultant microbiologist or infectious disease phy-
sician for one of four indications: (1) organisms resistant to conventional
antibiotics, (2) patient intolerant to vancomycin, (3) intolerance of other oral
therapy for MRSA, and (4) failed glycopeptide therapy. The pharmacist for
each clinical area was asked to complete an audit form for each course of
therapy. Pharmacia kindly provide monthly data on the amount of linezolid
purchased by the Trust.
Results: Audit forms were completed for a total of 48 patients. The forms
stated that 26 patients (54%) were prescribed linezolid for failed glycopeptide
treatment, 8 because of intolerance of other oral therapy, and 16 because of
infections resistant to conventional therapy. 23 had infection withMRSA, and
12 with VRE. The length of treatment was recorded for 29 patients, and
ranged from 2 to 42 days with an average of 10 days. The cost of linezolid
accounted for by the audit was £37 706, assuming and average course of
10 days for all patients. The total expenditure on linezolid over the same
period was £74 369.
Conclusions: Large amounts of money are being expended on linezolid. Our
audit data accounts for only about half of all the linezolid purchased. The use
on ‘hard’ indications (VRE, glycopeptide intolerance, and intolerance of oral
MRSA regimens) has been roughly as we had anticipated, but the expenditure
on the ‘soft’ indication of glycopeptide failure has been greater than expected
and seems to be increasing. There is a need to develop better audit processes if
we are to understand and manage the use of this valuable drug.
P1026 Audit of usage of i.v. antibiotics in an Irish
hospital, Dublin for a 4-week period
O. Flynn, S. Hopkins, L. Rajan, E. Mc Namara, C. Bergin
Dublin, IRL
Introduction: In keeping with the Strategy to Control Antimicrobial Resis-
tance in Ireland, empiric antibiotic guidelines were developed and launched
in St. James’s Hospital (SJH) in November 2001. 9months post introduction
of the guidelines an audit of acceptance of these guidelines was undertaken.
Methods:Data was collected within 24 h of i.v. antibiotic commencement for
a 4-week period. Parameters recorded included patient speciﬁc data, indica-
tion for antibiotic, antibiotic-speciﬁc data, microbiology data and interven-
tion data.
Results: The patient cohort consisted of 200 patients (45% females, 55%
males; 58%medical and 42% surgical patients). Empiric antibiotic therapy was
prescribed for 91% of patients. For some conditions such as febrile neutro-
penia (n¼ 7), bacterial meningitis (n¼ 2) and skin and soft tissue infection
(n¼ 41), acceptance of the SJH empiric antibiotic guidelines was excellent
(90–100%). For other clinical conditions such as community acquired pneu-
monia (n¼ 52) and abdominal infection (n¼ 23), acceptance of institutional
guidelines was considered good (60–90%). However, poor guideline accep-
tance (<60%) was seen in conditions such as hospital acquired pneumonia
(n¼ 25) and bacteremias (n¼ 2). Microbiological data indicated that 27.5% of
all patients prescribed i.v. antibiotics had no specimens taken. Of the speci-
mens taken, 70% of patients yielded positive microbiological data and these
patients received appropriate tailored antibiotic therapy. Despite the sugges-
tion of interventions by combined Infectious Diseases, Clinical Microbiology
and Clinical Pharmacy services for 48% of patients, 31% of interventions were
rejected. Rejections consisted of using antibiotics with over-lapping spectra in
the absence of microbiological data and poor understanding of the switch
from intravenous to oral administration.
Conclusion: The audit has highlighted areas (disease and specialty-speciﬁc)
where concordance of prescribing with the EAG has been almost universal.
However, some speciﬁc areas were identiﬁed where antibiotic prescribing was
signiﬁcantly at odds to the EAG, usually in the setting where minimal
microbiological work-up was undertaken. The primary reasons for rejection
of multidisciplinary suggested interventions related more to educational
aspects of anti-infectives rather than to the EAG themselves. This further
highlights the need for the establishment of continued educational programs
focusing on appropriate antimicrobial prescribing.
P1027 Trends and errors of antimicrobial usage in a
tertiary hospital
D. Voutsinas, T. Peppas, E. Petratou, K. Bata, A. Alexandratou,
E. Kontela, A. Moschou, E. Lyberopoulos, N. Zachos, M. Savvala,
N. Galanakis
Piraeus, GR
Objective: Aiming intervention for proper antimicrobial (A) usage in our
hospital, during a nationwide nosocomial prevalence study (04/06/2002) we
also recorded antimicrobial usage to database
Methods: Prevalence recording study. As restricted Awe deﬁne the ones that
require a predeﬁned application sheet to be ﬁlled. The A administration was
considered justiﬁed if the recording physician was convinced by patient
records or discussion with the attending physician/surgeon. Statistical analysis
by nonparametric methods.
Results: On the day of recording, in our hospital departments of adults,
excluding ICUs, a total of 357 patients, 145 (40.6%) medical and 212 (59,4%)
surgical, were present. On A regimen were 177/357 (49.6%) patients, namely
66/145 medical (45.5%) and 111/212 surgical patients (52.4%) Restricted A
had been prescribed to 58 (32.8%), 26 (39.4%) medical and 32 (28.8%)
surgical (P¼NS). On more than one A were 66 (37.3%) patients, 31.8% of
medical and 40.5% of surgical ones (P¼NS). Finally, the A administration
was considered justiﬁed in 85 (48%) patients, 44 (66.7%) medical and 41
(36.9%) surgical (chi-square ¼ 13.93567, P< 0.01) ones. The main reason of
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improper usage in surgical patients was a loosely termed ‘chemoprophylaxis’,
not deemed by choice or duration, while the medical increased percentage
was attributed to a sole department administering A, as a ‘diagnostic criterion.’
There were considerable differences among departments regarding the stu-
died parameters.
Conclusions:This recording pinpoints the problem and allowed us to under-
stand the points that must be targeted to achieve a more rational usage of
antimicrobials in our hospital.
P1028 Bugs in the data 1: effects of testing policies and
sampling on antibiotic resistance estimates
M. L. Heginbothom, J. T. Magee, J. L. Bell, A. J. Howard – Welsh
Antibiotic Study Group
Objectives: To elucidate the effects of laboratory antimicrobial susceptibility
testing (AST) policies and sample submission behavior on estimates of
community antibiotic resistance.
Methods: Retrospective resistance data on routine community isolates for
1996–2001, specimen submission rates and practice list sizes were collected for
Wales. Analyzes were performed in Excel and SPSS.
Results: Selective testing policies were often associated with resistance
estimates markedly higher than those from laboratories that tested all isolates.
These differences were often larger (in one case, 62% resistance compared
with 2% resistance in nonselective testing) than might reasonably be explained
by geographical variation. The effects were particularly marked where
antibiotics were selectively tested as second-line agents on resistant isolates,
or only when noted on the request form as being current therapy. Smaller (but
often signiﬁcant) effects were seen for site-speciﬁc testing. The majority of
marked effects occurred where the laboratory performed AST on less than
20% of isolates of a species for an antibiotic. Comparison of practice resistance
estimates with urine specimen submission rates per 1000 registered patients
showed little correlation, despite wide variation in submission rates.
Conclusions: Selective laboratory AST policies can produce heavily biased
resistance estimates. Most of this bias can be eliminated by removal of data
where less than 20% of isolates for a speciﬁc antibiotic/species combination
are tested by a laboratory. Bias due to variation in specimen submission
policies seems to be consistent between practices, with no trend to increased
resistance for practices with low specimen submission rates that might indicate
selective sampling in, e.g. treatment failure. This consistency suggests that
resistance prevalence estimates might be derived from routine data by
application of correction factors deduced from regular sentinel studies.
Our investigations of putative biasing effects suggest that, where bias can
be detected, it is generally towards over-estimation of resistance. It may be
possible to produce sets of rules and correction factors to remove these biases.
In the interim, we regard resistance estimates from routine data as useful in
comparative analyses of, e.g. variation in time or between practices, rather
than prevalence ﬁgures. Nonetheless, these comparative analyses can be
powerful tools in studies of resistance epidemiology.
P1029 Bugs in the data 2: effects of identiﬁcation,
repeat and screening isolates on resistance estimates
M. L. Heginbothom, J. T. Magee, J. L. Bell, A. J. Howard – Welsh
Antibiotic Study Group
Objectives: To elucidate the effects of species identiﬁcation policies for
urinary coliforms, repeat isolates, and screening isolates on estimates of
community antibiotic resistance from routine data.
Methods: Retrospective resistance data on routine diagnostic community
isolates for 1996–2001 were collected for Wales and analyzed in Excel and
SPSS.
Results:Laboratory policy on identiﬁcation of urinary coliform isolates varied
between the 14 participating laboratories. Isolates identiﬁed biochemically
(minimum of indole test and lactose fermentation) as Escherichia coli were
signiﬁcantly less resistant than those identiﬁed as E. coli by colony morphol-
ogy, and both were signiﬁcantly less resistant than urinary coliforms with no
species identiﬁcation. For all species investigated, exclusion of repeat isolates
(same patient, same susceptibility pattern ignoring mismatches for inter-
mediate or not-tested results) produced negligible differences in resistance
estimates. Exclusion of MRSA isolates from specimens overtly submitted as
carriage screens, and from sites normally associated with carriage rather than
infection, produced negligible differences in susceptibility estimates for
MRSA.However, exclusion of repeat and screening isolates affected estimates
of incidence, and MRSA screening isolates affected estimates of methicillin
resistance in Staphylococcus aureus.
Conclusions: Species identiﬁcation policies for urinary coliforms affect
resistance surveillance. The identiﬁcation requirements of the BSAC meth-
odology; the implications of non-E. coli urinary infection on the underlying
pathology for individual patients, and these surveillance effects may justify
routine discrimination of E. coli from other urinary coliforms. Repeat and
screening isolates have little effect on community resistance estimates, but
inclusion of screening isolates of MRSA affects both methicillin-resistance
estimates for S. aureus, and community MRSA prevalence estimates. It
appears unnecessary to remove duplicate isolates for community resistance
surveillance, and simple rules based upon specimen site can be used to
eliminate screening isolates, removing this source of bias.
P1030 Microbiological consequences of a
community-acquired pneumonia prophylaxis with
azithromycin in military conscripts
I. Gouchev, G. Ivanitca, O. Klochkov, on behalf of the ‘DIANA’ Study
Group
Background: Community-acquired pneumonia is a common cause of mor-
bidity (230%) in Russian military training camps. Prophylaxis with azithro-
mycin is an effective method of outbreak control. But it’s commonly accepted
that high level of macrolide consumption correlates with macrolide and,
sometimes, clindamycin and streptogramin B resistance of Streptococcus pneu-
moniae
Aims: To assess the carriage of macrolide-resistant pneumococci after azi-
thromycin prophylaxis of CAP outbreak in military conscripts we conducted
this prospective study.
Materials and methods: Two prophylaxis schemes with azithromycin vs.
control (group 3) were evaluated: 8-week consumption of 500mg/w (group
1), and once-though sanation with 1500mg (group 2). Nasopharyngeal
carriage of S. pneumoniae and its susceptibility to erythromycin, azithromycin,
miocamycin, clin-damycin, penicillin, amoxicillin, cefotaxime, tetracycline
and cotrimoxazol evaluated trice by broth microdilution: before treatment
and after treatment on weeks 9 and 20.
Results: S. pneumoniae carriage rate at visit 0 was 34–43%; onweek 9 in groups
1, 2, and 3 – 75, 66 and 50% (P< 0.05); on week 20 – 69, 57, and 36% in the
same groups (P< 0.05). At visit 0 no macrolide resistance were detected in all
40 strains tested. But background level of intermediate penicillin resistance
estimated in 0–14% of strains. Dramatic growth of macrolide resistance had
been detected on 9th week. In the 1st group – 95.7% (44 resistant strains, 37%
of them were moderately resistant to clindamycin and azithromycin) and in
the 2nd group – 89.5% (n¼ 34, 11.9% moderately resistant to clindamycin
and azithromycin). As for penicillin, we didn’t ﬁnd unfavorable resistance
shift. By week 20th resistance rate in group 1 decreased up to 40% (n¼ 16,
10%) and up to 22.6% (n¼ 7, 5.4%) in group 2.
Conclusion: Prophylactic courses of azithromycin correlates with carriage of
pneumococci and macrolide-resistant pneumococci. It is not revealed inﬂu-
ences of both regimens on penicillin resistance. It is, therefore, important to
continue to monitor macrolide resistance rates on a national level so that if
prevalence rates begin to increase signiﬁcantly, attempts to control their use
should be made.
P1031 Macrolide-resistant Streptococcus pneumoniae in
Canada: correlation with azithromycin use
R. J. Davidson, C. C. K. Chan, G. Doern, G. G. Zhanel
Halifax, Toronto, CAN; Iowa City, USA; Winnipeg, CAN
Objectives: Several investigators have suggested that the pharmacokinetic
(long half-life, low and prolonged concentrations in serum, epithelial lining
ﬂuid and middle ear ﬂuid), and pharmacodynamic (poor killing of macrolide-
resistant Streptococcus pneumoniae [Sp] possessing the efﬂux phenotype), proper-
ties of azithromycin result in the preferential selection of macrolide-resistant
Sp comparedwith macrolides such as clarithromycin and erythromycin. Here,
we correlate regional differences in macrolide resistance in Sp from Canada
with the use of azithromycin, clarithromycin and erythromycin.
Methods: Sp were collected from all provinces across Canada through
national surveillance programs from both respiratory and sterile sites. Suscept-
ibility testing was performed using NCCLS approved microbroth dilution
techniques. Macrolide-resistant Sp were further characterized phenotypically
and genotypically using a double disk diffusion technique and PCR for the
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mef and erm genes. Provincial macrolide usage data was collected through
IMS Canada and normalized for population.
Results: Macrolide resistance in Sp varied considerably in Canada in 2002,
although three distinct trends were found. The coastal provinces demon-
strated low rates of resistance (5%), similar to rates previously described in
1995. The prairie provinces andOntario demonstrate rates varying between 9
and 14%, while Quebec and the maritime provinces have rates exceeding
20%. The consumption of azithromycin in the coastal provinces remains the
lowest in Canada accounting for <20% of prescribed macrolides. In contrast,
azithromycin accounts for>44% of all macrolides in the three provinces with
the highest rates of resistance. Use of azithromycin accounts for between 25
and 32% of total macrolide use in the prairie provinces. No correlation was
found between total consumption of macrolides and the regional differences
in resistance.
Conclusions: The prevalence of macrolide-resistant Sp varies considerably in
Canada from, 5 to >20%. Regions with the lowest rates of resistance use
signiﬁcantly less azithromycin vs. other macrolides while regions with the
highest rates of resistance use more azithromycin vs. other macrolides. Our
data suggest that azithromycin may have a greater propensity to select for
macrolide-resistant Sp, compared with either clarithromycin or erythromy-
cin.
P1032 Clinical audit in surgical units of a tertiary care
hospital: antibiotic resistance proﬁles and commonly
prescribed antibiotics. It’s time for routine ESBL testing
A. Guleri, G. D. Corcoran, S. Samavedam, A. B. J. Speekenbrink
Glasgow, UK
Introduction:Nosocomial infections with multiply antibiotic resistant organ-
isms cause signiﬁcant morbidity and mortality. Extended spectrum beta
lactamase (ESBL) producing aerobic Gram-negative rods (AGNR) are
resistant to second and third generation cephalosporins and monobactams,
and may show simultaneous resistance to quinolones and aminoglycosides.
They are known to have caused hospital outbreaks and are an important
nosocomial infection issue. A clinical audit was carried out in the surgical
units of Western Inﬁrmary and Gartnavel General Hospital, Glasgow.
Objective: The aim was to establish the degree of correlation between
commonly prescribed antibiotics in these surgical units and the antibiotic
resistance proﬁle (ARP) of AGNR isolates from clinical specimens. It is a base
line study to examine the feasibility of routine testing for ESBL production.
Methods: Data over a period of 6months (April–September 2002) on
approximately 100 AGNR isolates from blood cultures, pus and wound
specimens and their ARP to the commonly prescribed antibiotics in surgical
units were audited. ESBL testing was performed on selected clinical isolates of
AGNR resistant to cefotaxime (CTX) or ceftazidime (CAZ) by the NCCLS
method of susceptibility testing. ESBL testing was done by the NCCLS
method using combination discs.
Results: The overall ARP was co-amoxyclav (58%), cefuroxime (54%),
cefotaxime (22%), ciproﬂoxacin (11%), piptazobactam (9%), gentamicin
(6%) and carbapenem (2%). Most of the AGNB isolates resistant to CTX
or CAZ were positive for ESBL. Distribution and correlation of data to be
presented.
Conclusion: A signiﬁcant proportion of AGNR show resistance to the most
commonly used beta lactam antibiotics in the surgical units. ESBL elaborating
AGNB isolates are not uncommon. The ARP may justify routine testing for
ESBLs in clinical isolates and use of a carbapenem in an acute clinical scenario
when ESBL producing AGNR is the infective agent. Strict hand hygiene and
infection control practices should be in place and may play an important role
in controlling spread of multiply antibiotic resistant organisms.
P1033 Antimicrobial drug use and imipenem resistance
of Pseudomonas aeruginosa and Acinetobacter spp. strains
isolates from nosocomial infections
S. Metallidis, A. Tsona, P. Kollaras, E. Koumentaki,
M. Chatzidimitriou, P. Nikolaidis
Thessaloniki, GR
Objective: An increase of Pseudomonas aeruginosa’s and Acinetobacter spp.’s
resistance to imipenem was observed during the 1999–2001 period in
our hospital. We compared the consumption of antibiotics and the resistance
of P. aeruginosa and Acinetobacter spp. to imipenem in nosocomial isolates of
a Greek university hospital during 1999–2001 in order to evaluate the
relationship between antibiotic use and resistance prevalence in nosocomial
infections.
Methods: AHEPA is 463-bed university hospital with an infectious diseases
department that monitors nosocomial infections continuously. Resistance
data for imipenem was collected on 1999–2001 about all P. aeruginosa and
Acinetobacter spp. strains isolated from nosocomial infections. Antibiotic
consumption was recorded by the pharmacy. The ATC/DDD 2000 metho-
dology was used. The data are expressed as Deﬁned Daily Dose (DDDs) per
100 bed days. There is a restriction policy for third generation cephalosporins,
ureidopenicillins and carbapenems in our hospital. Linear regression analysis
(SPSS 10) was used to assess relationship between antibiotic use and resistance.
Results: There was not statistical difference in the number of patients or the
total bed days during the 3-year period. There was an increase of P. aeruginosa’s
resistance to imipenem from 4% in year 1999 to 29% in year 2001 and for
Acinetobacter spp.’s from 1 to 18%, respectively. During the study period there
was an increase in the consumption of almost all antibiotics (total antibiotic
use DDDs from 47.52 to 50.62, second generation cephalosporins from 10.13
to 12.99, third generation cephalosporins from 3.32 to 3.41 DDDs, ureido-
penicillins from 5.47 to 6.42 and carbapenems from 2.73 to 3.36). For
Acinetobacter spp.’s resistance to imipenem the only correlation found was
for carbapenems (r2¼ 0.9, P¼ 0.01). For P. aeruginosa correlation was found
between carbapenems (r2¼ 0.96, P¼ 0.002) and second generation cepha-
losporins (r2¼ 1, P¼ 0.009).
Conclusion: Although the total amount of restricted antibiotics is not
signiﬁcantly high, it led to the higher level of P. aeruginosa’s and Acinetobacter’s
resistance to imipenem. The great misuse of second generation cephalospor-
ins should also be monitored, since it affects the resistance trend. Close
monitoring of antibiotic use and resistance can have a positive impact on
infection control measures.
P1034 Antibiotic prescription rate in hospitalized
patients: a multicenter prevalence study
G. Usluer, I. Ozgunes, H. Leblebicioglu
Eskisehir, Samsun, TR
Accurate information about prescribing patterns in hospitals is valuable in
improving the quality of antibiotic prescriptions. Only very limited data on
the use of antibiotics in Turkey is available. Data on the use of antimicrobial
agents in 18 tertiary care hospitals were collected on March 20, 2002. In this
ﬁrst 1 day point prevalence study the total bed capacities, number of hospi-
talized patients, the type and number of antibiotic prescriptions, the main
diagnosis which the prescription was made, clinical and microbiological
evidences for treatment were recorded. One or more antibiotics were ordered
in 2900 (30.6%) of 9471 hospitalized patients. The reasons of hospitalization
of the patients receiving antibiotics were medical treatment (42.5%), elective
surgery (39.6%), treatment of infectious disease (17.1%) and emergent surgical
procedures (10.4%). The highest consumption rates were found in surgical
(81.6%) and medical (55.2%) intensive care units. The 48.8% of antibiotics
were given for treatment and 44.2% for prophylactic use. The most common
reasons for treatment were found as lower respiratory tract, urinary tract,
surgical wound infections and febril neutropenia. It was impossible to ﬁnd a
reason in 168 (5.8%) patients’ records. Antibiotics were ordered empirically in
78.4% of patients. The proven infection rate was found as 30.7%. The 56.4
and 13.4% of orders were evaluated as clinically and microbiologically
appropriate, respectively. The most common prescribed antibiotics were
cefazolin, ampicillin-sulbactam, ceftriaxone, ciproﬂoxacin, amikacin, genta-
micin, ornidazole, cefuroxime, meropenem and vancomycin.We determined
that 67.44% of the patients were in ofﬁcial health insurance systems and 19.7%
of them were in ofﬁcial social assistance system. These results suggest that
antibiotic prescription and empirical treatment rates were high at inpatient
groups.
P1035 Relationships between susceptibility of
Enterobacter spp. and hospital- and patient-speciﬁc
variables. Report from the Antimicrobial Resistance Rate
Epidemiology Study Team (ARREST Program)
S. M. Bhavnani, J. P. Hammel, A. Forrest, P. G. Ambrose, R. N. Jones
Buffalo, North Liberty, USA
Introduction: Identiﬁcation of patients with infection associated with anti-
biotic-resistant pathogens remains a serious challenge for the study of drug
regimens to treat such infections. The ARREST Program was established as a
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multidisciplinary, collaborative effort to use surveillance data and analytic
techniques to better understand factors associated with antimicrobial resis-
tance. The analyzes presented herein were conducted to identify factors
predictive of decreased susceptibility of Enterobacter spp. in hospitalized
patients.
Methods: 5 years (1997–2001) of North American SENTRY Program data
were analyzed. MICs for cefepime (CPM), ciproﬂoxacin (CIP) and piper-
acillin/tazobactam (P/T) vs. patient-speciﬁc (e.g. age, duration of hospital stay
prior to isolate collection (hospital duration), infection source, infection risk
factors) and hospital-speciﬁc (e.g. bed count, geographical region, study year)
variables were analyzed using multivariable general linear modeling (GLM)
for censored data with backwards stepwise elimination (at P> 0.1).
Results: MIC50, MIC range and percentage nonsusceptible for isolates
(n¼ 356, 96% blood, from 30 hospitals) were 0.12,< ¼0.12 to >16,
0.6 for CPM;0.25,< ¼0.015 to > 2, 4.8 for CIP; and 2, 0.5 to > 64, 22
for P/T. Highly signiﬁcant variables identiﬁed from the GLM models
included bed count (P 0.001) and hospital duration (P 0.008). The
proportion of explained MIC variability ranged from 20 to 33%. This range
increased to 33–43% when hospital was included as a variable in these models.
Higher predicted MICs resulted from combinations of these and other
signiﬁcant variables in the models. Observed MIC50 (% non-susceptible)
for each agent was compared in selected patient cohorts possessing combina-
tions of variables identiﬁed from these models (see Table 1).
Conclusions: This approach may be used to predict factors associated with
decreased susceptibility. Though GLM models explained a moderate propor-
tion of MIC variability, the higher observed MIC50 values among certain
patient cohorts compared with the entire population were clinically relevant.
Increased variability in MIC may be further explained by additional factors
(including antibiotic use). Collection of these additional data remain an on-
going focus of the ARREST Program. Irrespective of this limitation, it
appears that in patient cohorts at risk for infection with less susceptible
Enterobacter spp., CPM was more active than CIP or P/T.
P1036 Relationships between susceptibility of
Streptococcus pneumoniae and hospital- and
patient-speciﬁc variables: Report from the Antimicrobial
Resistance Rate Epidemiology Study Team (ARREST
Program)
S. M. Bhavnani, J. P. Hammel, A. Forrest, P. G. Ambrose, R. N. Jones
Buffalo, North Liberty, USA
Introduction: S. pneumoniae remains a leading cause of morbidity and mor-
tality worldwide. The ARREST Program was established as a multidisci-
plinary, collaborative effort to use surveillance data and analytic techniques to
better understand factors associated with antimicrobial resistance. The ana-
lyses presented herein were conducted to identify factors predictive of
decreased susceptibility of pneumococci in hospitalized patients.
Methods: 5 years (1997–2001) of North American SENTRY Program data
were analyzed. MICs for amoxicillin-clavulanate (A-C), azithromycin
(AZM), cefepime (CPM), ceftazidime (CTZ), ceftriaxone (CTX), clarithro-
mycin (CLAR), erythromycin (ERY), and levoﬂoxacin (LEV) vs. patient-
speciﬁc variables (e.g. age, specimen type) and hospital-speciﬁc variables (e.g.
bed count, geographical region, study year) were analyzed using multivariable
general linear modeling (GLM) for censored data with backwards stepwise
elimination (at P> 0.1), yielding one model for each of these eight agents.
Results: Of the 483 blood isolates from 29 hospitals, a range of 41–100% of
MIC values were available for individual agents. Signiﬁcant and frequently
identiﬁed factors included geographical region (6/8 models) and age (4/8
models). High predicted MICs resulted from combinations of these and other
variables identiﬁed. Based on the model for CPM, factors predictive of high
MICs were the following: geographical region ¼ South-west or South-east,
age18 years, and specimen type ¼ lower respiratory. The observed percen-
tage non-susceptible (NS) and MIC90 are compared for all agents for cohorts
of patients with 2–3 vs. those patients with 0–1 of these variables (see Table 1).
The percentage NSwas at least three times higher for patients with 2–3 vs. 0–1
variables for 6/8 models (Table 1).
Conclusions: This approach may be used to predict factors associated with
decreased susceptibility. GLM models explained a moderate proportion of
MIC variability and the higher observed percentage NS among certain patient
cohorts compared with the entire population of isolates is clinically relevant.
Further explanation of the variability in MIC will require identiﬁcation of
additional variables (including antibiotic use). Collection of these additional
data remains an on-going focus of the ARREST Program. Finally, in patients
with higher observed MICs, CPM, CTX and LEV, in contrast to other agents
studied, may be more appropriate empiric choices when pneumococci is
suspected.
P1037 Relationships between susceptibility of
Pseudomonas aeruginosa and hospital- and patient-speciﬁc
variables: Report from the Antimicrobial Resistance Rate
Epidemiology Study Team (ARREST Program)
S. M. Bhavnani, J. P. Hammel, P. G. Ambrose, A. Forrest,
C. M. Rubino, R. N. Jones
Buffalo, North Liberty, USA
Introduction: Identiﬁcation of patients with infection associated with anti-
biotic-resistant pathogens remains a serious challenge for the study of drug
regimens to treat such infections. The ARREST Program was established as a
multidisciplinary, collaborative effort to use surveillance data and analytic
techniques to better understand factors associated with antimicrobial resis-
tance. The analyzes presented herein were conducted to identify factors
predictive of decreased susceptibility of Pseudomonas aeruginosa in hospitalized
patients.
Methods: Five years (1997–2001) of North American SENTRY Program
data were analyzed. MIC for cefepime (CPM), ciproﬂoxacin (CIP) and
piperacillin/tazobactam (P/T) vs. patient-speciﬁc (e.g. age, hospital stay prior
to isolate collection (hospital duration), infection source, specimen, primary
diagnosis) and hospital-speciﬁc (e.g. bed count, geographical region, study
year) variables were analyzed using multivariable general linear modeling
(GLM) for censored data with backwards stepwise elimination (at P> 0.1).
Results:MIC50, MIC range and percentage resistant (R) for isolates (n¼ 487,
93% blood, from 33 hospitals) were: 2, 0.5 to >16, 5.3 for CPM; 0.25,
0.25 to >2, 12 for CIP; and 4, 0.5 to >64, 11 for P/T. Highly signiﬁcant
variables and interactions between variables identiﬁed from GLM models
included hospital duration (P¼ 0.008) and specimen (P¼ 0.003) for CPM;
specimen (P< 0.0001) for CIP; and hospital duration primary diagnosis
Table 1
Patient cohorts
Observed MIC50 (% non-susceptible)
CPM CIP P/T
All patients 0.12 (0.6) 0.25 (4.8) 2 (22)
Bed count <400 0.12 (0) 0.25 (2.6) 4 (29)
Bed count <400 and age 41–60 years 0.25 (0) 0.25 (11) 4 (28)
Bed count <400 and hospital duration
11–20 or >30 days
1 (0) 0.25 (19) 64 (56)
Age 41–60 years and hospital duration
11–20 or >30 days
0.5 (0) 0.25 (6.7) 64 (67)
Bed count <400 and hospital duration
11–20 or >30 days and age 41–60 years
1 (0) 0.25 (25) 64 (75)
Table 1
Patient cohorts
Observed % non-susceptible (MIC90)
CPM A-C AZM CTZ CTX CLAR ERY LEV
All patients 1.9 (0.5) 3.7 (2.0) 11 (1.0) 19 (8.0) 3.5 (0.5) 9.9 (0.25) 13 (2.0) 0.5 (1.0)
2 or 3 variables 9.8 (1.0) 19 (4.0) 26 (4.0) 50 (16) 13 (2.0) 26 (2.0) 36 (4.0) 0 (2.0)
0 or 1 variables 1.1 (0.5) 2.3 (2.0) 9.5 (0.12) 15 (4.0) 2.3 (0.5) 8.7 (0.25) 11 (1.0) 0.6 (1.0)
Table 1
Patient cohorts
Observed MIC50 (% resistant)
CPM CIP P/T
All patients 2 (5.3) 0.25 (12) 4 (11)
Hospital duration >5 days and primary
diagnosis¼ immunocompromized
4 (8.2) 0.25 (10) 8 (20)
Hospital duration >10 days and
infection source¼ lower respiratory
2 (4.6) 0.25 (9.1) 4 (32)
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(P 0.008) for P/T, with higher MICs resulting from combinations of these
and other variables. ObservedMIC50 (%R) were compared in selected patient
cohorts with combinations of variables identiﬁed from these models (see
table). Among the two patient cohorts shown, MIC50 remained stable for
each agent while percentage R increased markedly for P/T (Table 1).
Conclusions: Data such as these may be used to predict variables likely for
decreased MICs. Though GLM models explained a moderate proportion of
MIC variability, the higher observed percentage R among certain patient
cohorts compared with the entire populationwas clinically relevant. Increased
variability in MIC may be further explained by additional factors (i.e.
antibiotic use). Collection of these additional data remains an on-going focus
of the ARREST Program. Irrespective of this limitation, it appears that in
patient cohorts at risk for infection with less susceptible P. aeruginosa, CPM
and CIP were more active than P/T.
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P1038 Intra-abdominal infections: a 2-year analysis
from the MYSTIC program in Italy (2001–2002)
G. Bonﬁglio, G. Russo, G. Nicoletti
Catania, I
Objective: The MYSTIC (Meropenem Yearly Susceptibility Test Informa-
tion Collection) Program is a longitudinal antimicrobial surveillance study
that collects isolates from patients in intensive care units, neutropenia units,
cystic ﬁbrosis and general wards (intra-abdominal and lower respiratory tract
infections), where meropenem (MEM) is prescribed. Here are reported 2001
and 2002 data from isolated collected in intra-abdominal infections.
Methods: Organisms were tested using National Committee for Clinical
Laboratory Standards (NCCLS) methodology. Minimum inhibitory concen-
tration (MIC) values and percentage susceptibilities at NCCLS breakpoints
(%S) were obtained for MEM and a range of comparators including:
imipenem (IPM), ceftazidime (CAZ), piperacillin þ tazobactam (TAZ),
ciproﬂoxacin (CIP), gentamicin (GM), and tobramicin (TOB).
Results: A total of (101 and 96 Gram-negative and 44 and 27 Gram-positive
isolates were collected between 2001 and 2002, respectively. E. coli (26.2 and
38.2%) was the most common isolate in both year, followed by K. pneumoniae
(9.6 and 17.1%), P. aeruginosa (7.6 and 13.0%) and S. aureus (9.6 and 10.6%). In
general, the carbapenems (MEM and IPM) were the most active antimicrobial
agents tested against the common organisms. The percentages of MEM was
the same as or higher than IPM against every organism tested. Like MEM,
TAZ also showed good invitro activity against P. aeruginosawhereas lower was
the activity of the other antibiotics. All the antibiotics tested demonstrated a
high potency against E. coli, with the exception of CIP in both years of study
(92.1 and 85.1%, respectively). K. pneumoniae was 100% susceptible to MEM
and IPM throughout the study period while the activity of the other agents
was considerably lower (CAZ 78.6 and 80.9%, TAZ 85.7 and 80.9%, CIP and
78.6 and 76.2%).
Conclusion: The carbapenems, in particular meropenem, remain the most
active antimicrobials against the range of Gram-negative and Gram-positive
bacteria isolated from intra-abdominal infections in Italy. There was no
apparent increase in resistance to meropenem over the 2-year surveillance
period.
P1039 Antimicrobial usage and resistance trend
comparisons from the MYSTIC program in North America
(1999–2001)
A. Mutnick, P. Rhomberg, R. Jones
North Liberty, USA
Objectives: The MYSTIC Program is a global, longitudinal antimicrobial
surveillance network of hospitals or speciﬁc units that utilize carbapenems. A
deﬁning aspect of the program is the ability to capture antimicrobial con-
sumption data from participating institutions to evaluate usage patterns,
individually or in aggregate, compared with emerging resistance. This report
evaluates these relationships for enteric Gram-negative bacilli (EGNB) and
P. aeruginosa (PSA) over the initial 3-year period.
Methods: Between 10 and 16 medical centers participated during 1999–
2001, each submitting up to 200 isolates/year (>7000 overall). Antimicrobial
usage for each year plus hospital bed capacity, occupancy rates and number of
ICU beds were obtained. Usage was evaluated for several parenteral agents
including: ceftazidime, cefepime, imipenem, meropenem, gentamicin, cipro-
ﬂoxacin, and beta-lactamase inhibitor combinations. The parameter of drug
usage was deﬁned daily dose (DDD)/100 patient days calculated from total
grams administered (WHO deﬁnitions). NCCLS susceptibility testing meth-
ods and interpretations were followed to assess resistance.
Results: Resistance among EGNB did not signiﬁcantly change for beta-
lactams, but tended to increase for gentamicin (þ1.2%) and ciproﬂoxacin
(þ3.1%). PSA resistance rates for gentamicin (þ9.0%) and ciproﬂoxacin
(þ10.2%) increased in contrast to signiﬁcantly decreased resistance rates
for carbapenems (8.4%). PSA cross-resistance analysis noted direct correla-
tions of ciproﬂoxacin resistance and resistance to all other classes, lowest
degree of correlation was with meropenem. Formulary use changes were
noted: increased meropenem and ciproﬂoxacin use and decreased imipenem,
aminoglycosides and cephalosporin use. Changes in ciproﬂoxacin DDD/100
rates (þ4.9) were directly related to EGNB and PSA resistance, while among
PSA, usage and resistance were inversely correlated for meropenem (þ0.5
DDD/100; 7.7% resistant) and gentamicin (3.8 DDD/100; þ9.0%
resistant).
Conclusions: Important trends were identiﬁed: (i) relationship between
increased ciproﬂoxacin use and higher resistance among EGNB and PSA;
(ii) correlation between ciproﬂoxacin resistance and resistance to other classes
in PSA; and (iii) an inverse relationship between increased use of carbapenems
(meropenem> imipenem) and resistance. This illustrates the value of linking
usage data to resistance rates as part of global, longitudinal surveillance
programs.
P1040 Comparative antimicrobial potency and spectrum
of activity for meropenem and nine comparator agents:
report from the United States MYSTIC program surveillance
study in 2002
P. Rhomberg, A. Mutnick, R. Jones
North Liberty, USA
Objective:To monitor meropenem (MEM) activity in 15 US medical centers
actively prescribing MEM through the MYSTIC program, a longitudinal
resistance surveillance study.
Methods: In 2002, the centers submitted 3047 isolates from the following:
Citrobacter spp., Enterobacter spp., E. coli, Klebsiella spp., P.mirabilis, Serratia spp.,
S. aureus, coagulase-negative staphylococci, enterococci, Streptococcus spp.,
P. aeruginosa and Acinetobacter spp. The antimicrobial activity of MEM, imi-
penem (IPM), ceftriaxone (CTX), ceftazidime (CAZ), cefepime (CPE),
aztreonam (AZT), piperacillin/tazobactam (TAZ), gentamicin (GM), tobra-
mycin (TOB), and ciproﬂoxacin (CIP) was assessed. NCCLS reference broth
microdilution methods and interpretative criteria were applied. Extended
spectrum beta-lactamase phenotypes were conﬁrmed (clavulanate inhibition)
for isolates, with CTX or CAZ or AZT MICs at 2mg/L.
Results: The MEM MIC90 values were 0.03mg/L for E. coli and Klebsiella
spp., 0.06mg/L for Citrobacter spp., P. mirabilis, and Serratia spp., and 0.12mg/
L for Enterobacter spp. These potencies were 4–32-fold greater than for IPM.
MEM demonstrated the highest susceptibility (S) and lowest resistance (R)
rates against Enterobacteriaceae (99.8% S, 0.1% R)¼ IPM (99.8, 0.2)>CPE
(99.5, 0.4). Against P. aeruginosa, the rank order based on S, R was MEM
(93.1%, 4.4%)>TOB (92.2, 6.9)>TAZ (91.5, 8.4). IPM was slightly more
active than MEM (MIC90, 16 vs. 32mg/L) against Acinetobacter spp. CIP
showed highest R (11.0%, range 2.0–40.6%) followed by aminoglycosides
(AMG; 5.2–6.5%) for all Gram-negative isolates. Among methicillin-S-sta-
phylococci, only CIP (6.1–15.6% R) and AMG (1.3–5.5%) showed signiﬁcant
R. MEM, IPM, CTX, and CPE inhibited94.5% of Streptococcus spp. (88% of
tested strains were pneumococci and beta-hemolytic streptococci).
Conclusions: As reported for previous years (1999–2001), the MYSTIC
Program recorded no signiﬁcant decline in MEM activity, the widest spec-
trum agent tested. In contrast, CIP and aminoglycoside resistancewas elevated
and apparently increasing. Continued R surveillance is warranted in these
institutions with high broad-spectrum antimicrobial use, where possible
continued with quantitative drug utilization statistics.
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P1041 No evidence of decreasing susceptibility of
Proteus mirabilis to meropenem despite >8 years’ licensed
usage: comparison of recent susceptibility data from the
MYSTIC program (1997–2002) with data from the
preregistration period (1989–1993)
P. J. Turner
Alderley Park, UK
Objectives: Species such as Proteus mirabilis have recently emerged as ther-
apeutic problems due to mutations that compromise quinolone, cephalos-
porin and aminoglycoside use. Carbapenem susceptibility data for P.mirabilis
isolates have been monitored as part of the ongoing Meropenem Yearly
Susceptibility Test Information Collection (MYSTIC) Program. MYSTIC is
a global, longitudinal surveillance program providing invitro activity data for
major nosocomial bacterial pathogens in centres using meropenem (MEM)
including intensive care units, cystic ﬁbrosis units, neutropenia wards and
general wards. To ascertain the effect of MEM usage on susceptibility of
P.mirabilis, in vitro activity data from the MYSTIC Program to date (1997–
2002) were compared with those obtained during the MEM clinical trial
program prior to registration of MEM (1989–93).
Methods: MICs (mg/L) of MEM and imipenem (IPM) against 4110 P. mir-
abilis isolates (1507 isolates collected from MYSTIC centers in Europe, N.
America, S. America and Asia from 1997 to 2002; 2603 isolates collected from
Europe, N. America and S. America from 1989 to 1993) were determined
using the agar dilution method as recommended by the National Committee
for Clinical Laboratory Standards (NCCLS). Percentage susceptibilities (%S)
were interpreted using the NCCLS 2001 susceptibility breakpoint of 4mg/L
for MEM and IPM.
Results: The susceptibility (%S) of MEM remained consistently high
throughout the preregistration period and the duration of the MYSTIC
study: 99.9% during 1989–93 and 99.4% during 1997–2002. However, there
was a decrease in IPM percentageS from 98.9% for 1989–1993 to 92.8% for
1997–2002. MIC90 values for MEM and IPM were 0.25 and 2 mg/L,
respectively, for 1989–1993 and 0.5 and 4mg/L, respectively, for 1997–2002.
Conclusions: Comparison of MEM pre- and postregistration susceptibility
data found no decrease in susceptibility ofMEMdespite increased usage of this
agent. In contrast, an overall decrease in susceptibility of P.mirabilis to IPM
over the same time period was noted. Continued surveillance of all classes is
warranted to monitor future trends in resistance and focus effective treatment
regimens (such as MEM) for infections caused by P. mirabilis (Fig. 1).
P1042 Worldwide trends in ESBL producing
Klebsiella pneumoniae – results from the MYSTIC program
1997–2001
P. J. Turner
Alderley Park, UK
Objectives: Extended spectrum beta-lactamase (ESBL)-producing bacteria
are of increasing concern and represent a major challenge to future
antimicrobial therapy. ESBLs are most prevalent in Klebsiella spp., especially
in intensive care and other specialized units. The Meropenem Yearly Sus-
ceptibility Test Information Collection (MYSTIC) Program is a global,
longitudinal surveillance study monitoring resistance trends in units where
meropenem (MEM) is used. The objective of this analysis of MYSTIC data
was to determine the incidence of ESBL producing Klebsiella pneumoniae and
regional trends in frequency and resistance.
Methods: K. pneumoniae isolates were collected from MYSTIC Program
centres in Europe, N. America, S. America and Asia. Isolates were tested
using standard NCCLS methodology against MEM, imipenem (IPM),
ceftazidime, piperacillin þ tazobactam, gentamicin, and ciproﬂoxacin.
Results: A total of 2677 isolates were tested overall which included K. pneu-
moniae from Europe (n¼ 1688), S. America (n¼ 276) Asia (n¼ 103), and N.
America (n¼ 610). The carbapenems demonstrated the highest activity with
MEM IPM in every region except for N. America (99.1% vs. 99.3%,
respectively). All the antimicrobial agents tested were more active against
K. pneumoniae isolates from N. America than from other regions. The percen-
tage of K.pneumoniae producing ESBLs was higher in Asia (32.0%) > Europe
(30.3%)> S. America (27.2%), and the incidence in all of these regions was
considerably higher than that identiﬁed in N. America (7.1%). With the
exception of the carbapenems, the activity of all antimicrobial agents tested
was reduced in ESBL producers compared with non-ESBL-producing isolates.
Conclusion:The carbapenems remain the agent of choice for the treatment of
serious infections caused by ESBL-producing K. pneumoniae.
P1043 Worldwide susceptibility patterns to
Enterobacter cloacae from the MYSTIC Surveillance Program
1997–2001
P. J. Turner, C. Mendes, A. Hsiung
Alderley Park, UK; Sa˜o Paulo, BR
Objectives: To monitor the susceptibility patterns of E. cloacae to commonly
prescribed antimicrobial agents as part of the ongoing multinational MYSTIC
Surveillance Program.
Methods: In vitro activities of meropenem (MEM), imipenem (IPM),
ceftazidime (CAZ), piperacillin/tazobactam (TAZ), ciproﬂoxacin (CIP)
and gentamicin (GM) against 1916 E. cloacae isolates (N. America,
n¼ 330; S. America, n¼ 163; Europe, n¼ 1328; Asia, n¼ 95) collected
from 1997 to 2001 were analyzed and interpreted according to NCCLS
2002 criteria.
Results:Overall, the carbapenems were the most active agents, inhibiting all
isolates from S. America and Asia. Moreover, MEM and IPM inhibited
99.4% and 98.8%, respectively, of isolates from N. America and Europe.
Some degree of resistance to IPM (n¼ 14) andMEM (n¼ 6) was reported in a
few N. American and European isolates. Isolates from N. America demon-
strated higher susceptibility than those from other regions to CAZ (77.3% vs.
62.1–69.3%) and TAZ (81.5% vs. 65.3–76.1%). Susceptibility to GM (96.3%)
was much higher in N. American isolates compared with those from S.
America (68.7%), Asia (73.7%) or Europe (88.7%). Asian strains were 100%
susceptible to CIP, while susceptibility in other regions was<¼ 93.6%. A
susceptibility pattern characteristic of AmpC hyperproducers was found in
29.6, 21.0, 14.0 and 3.9% of isolates from Europe, Asia, S. America and N.
America, respectively. Coexistence of other mechanisms of resistance (e.g.
extended-spectrum beta-lactamases) was found in a total of 38 AmpC
hyperproducers (27 European, 3 Asian, 8 S. American isolates).
Conclusions: Carbapenems remain the most active antimicrobial agents
against E. cloacae. Continued surveillance is warranted to monitor future
resistance trends and guide empiric therapy.
P1044 Lower-respiratory tract infections: a 2-year
analysis from the MYSTIC program in Italy (2001–2002)
G. Russo, G. Bonﬁglio, G. Nicoletti
Catania, I
Objective: The MYSTIC (Meropenem Yearly Susceptibility Test Informa-
tion Collection) Program is a longitudinal antimicrobial surveillance study
that collects isolates from patients in intensive care units, neutropenia units,
cystic ﬁbrosis and general wards (intra-abdominal and lower respiratory tract
infections), where meropenem (MEM) is prescribed. Here are reported 2001
and 2002 data from isolated collected from lower respiratory tract infections.
Methods: Organisms were tested using National Committee for Clini-
cal Laboratory Standards (NCCLS) methodology. Minimum inhibitory
Figure 1
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concentration (MIC) values and percentage susceptibilities at NCCLS break-
points (%S) were obtained for MEM and a range of comparators including:
imipenem (IPM), ceftazidime (CAZ), piperacillin þ tazobactam (TAZ),
ciproﬂoxacin (CIP), gentamicin (GM), and tobramicin (TOB).
Results: A total of 39 and 48 Gram-negative and 16 and 29 Gram-positive
isolates were collected between 2001 and 2002, respectively. P. aeruginosa (16.4
and 23.4%) was the most isolated microorganism followed by S. aureus (10.9
and 24.7%) and K. pneumoniae (10.9 and 20.8%). In general, the carbapenems
(MEM and IPM) were the most active antimicrobial agents tested against the
common organisms. The percentages of MEMwas the same as or higher than
IPM against every organism tested. MEM showed excellent invitro activity
against P. aeruginosa. K. pneumoniae was 100% susceptible to MEM and IPM
throughout the study period while the activity of the other agents was
considerably lower in both years of study (CAZ and 83.3 and 68.8%,
TAZ and 83.3 and 68.8%, CIP 83.3 and 75.0%).
Conclusion: The carbapenems, in particular meropenem, remain the most
active antimicrobials against the range of Gram-negative and Gram-positive
bacteria isolated from lower respiratory tract infections in Italy. There was no
apparent increase in resistance to meropenem over the 2 year surveillance
period.
P1045 Emergence of multiresistant Enterobacteriaceae
in Eastern Romania
I. Schneider, A. Poiata, C. Tuchilus, R. Filip, I. Badicut, D. Buiuc,
A. Bauernfeind
Munich, D; Iasi, Galati, RO
Objectives: Clariﬁcation of the mechanisms of resistance of oxyiminocepha-
losporin and cefoxitin resistant Enterobacteriaceae.
Methods: Strains of E. coli (n¼ 2) and K. pneumoniae (n¼ 6) isolated from
patients of the Galati County Hospital, Galati, Romania between 2000 and
2001 with positive ESBL test were investigated. MICs were determined by an
agar dilution technique according to NCCLS guidelines. Analysis of trans-
ferrability of plasmids and isoelectric focusing of crude homogenates were
performed by standard procedures. The type of beta-lactamase was identiﬁed
by PCR using beta-lactamase group speciﬁc oligonucleotides. The ampliﬁed
beta-lactamase genes were sequenced.
Results:The strains were resistant to oxyiminocephalosporins, aztreonam and
cefoxitin. Beta-lactam resistance was transmissible except resistance to cefox-
itin. The pIs were either 8.2 or above 9.0 indicating SHV- and CTX-M-type
enzymes. PCRs with SHV- and CTX-M-group speciﬁc primers were run.
By comparison of the amino acid sequence of the ampliﬁed beta-lactamase
genes with published sequences the enzymes were identiﬁed as SHV-12 and
CTX-M-15. Resistance to cefoxitin was not reduced by Ro48–1220, an
AmpC beta-lactamase inhibitor, suggesting a nonenzymatic mechanism.
Conclusion: In Moldavia region a rather unique combination of resistance
mechanisms namely of CTX-M-15 or SHV-12 production plus reduced
permeability evolved among Enterobacteriaceae conferring resistance to all
beta-lactams except carbapenems.
P1046 Emergence of metallo beta-lactamase-mediated
resistance to Imipenem in enterobacterial isolates in
Australia
L. Poirel, J. Pham, L. Cabanne, S. Bell, B. Gatus, P. Nordmann
Le K. Bicetre, F; Randwick, AUS
A multiresistant strain of Escherichia coli and another of Klebsiella pneumoniae
were isolated from two patients with urinary tract infections in a hospital in
Melbourne, Australia. The E. coli isolate was resistant to all beta-lactam
antibiotics except imipenem to which it showed reduced susceptibility and
no synergy was found with the double-disk synergy test using any beta-lactam
and clavulanic acid. The K. pneumoniae isolate was resistant to all beta-lactam
antibiotics including imipenem and synergy was found only between aztreo-
nam and clavulanic acid with the double-disk synergy test. Besides the
expanded-spectrum beta-lactamase (ESBL) demonstrated by the double-disk
synergy test in the K. pneumoniae isolate, preliminary hydrolysis experiments
with crude culture extracts revealed that both isolates had carbapenem-
hydrolyzing beta-lactamase activity. PCR experiments with whole-cell
DNA of each isolate as template and speciﬁc primers for blaIMP and blaVIM
revealed that these strains had a blaIMP-like beta-lactamase gene. Sequencing
identiﬁed metallo-enzyme IMP-4 previously found in Citrobacter youngae and
Acinetobacter baumannii isolates from Main China. This beta-lactamase gene
was part of a class 1 integron. Conjugation experiments identiﬁed a similar
plasmid carrying the blaIMP-4 gene in the two isolates. This is the ﬁrst report
of acquired class Bmetallo-beta-lactamase in Australia. Additionally, this work
underlines that these expanded-spectrum beta-lactamase genes may spread
not only in Pseudomonas spp. but also to the Enterobacteriaceae.
P1047 VIM-1 or VIM-1þVIM-2
metallo-lactamase-producing Pseudomonas aeruginosa
isolated from hospitalized children in Poland
(1997–2002)
J. Patzer, M. Toleman, W. Kaminska, D. Dzierzanowska, R. Jones,
T. Walsh
Warsaw, PL; Bristol, UK; North Liberty, USA
Objectives: To screen imipenem-resistant P. aeruginosa clinical isolates for the
presence of metallo-beta-lactamases (MBL) and to characterize MBL-produ-
cing strains.
Methods: Minimum inhibitory concentrations (MICs) were determined
using the NCCLS agar dilution method. Phenotypic screening involved
the MBL Etest strip (AB BIODISK, Solna, Sweden). Biochemical analysis
used crude cell extracts examining imipenem (IMP) hydrolysis preincubated
with EDTA. Genotyping to determine epidemiologic relatedness was done
using pulsed-ﬁeld gel electrophoresis (PFGE). PCR analysis was undertaken
using oligonucleotides based on the conserved regions of imp and vim DNA
sequences. Sequencing was determined using DuPont Automated systems
and analyzed using DNAstar.
Results: In the period 1998–2002 12 P. aeruginosa isolates producing MBL
were detected. The Etest produced positive results: IMP MIC at >256mg/L
and IMP/EDTA at 1–1.5mg/L. Isolates were resistant to aminoglycosides, all
beta-lactams (except of aztreonam), and susceptible to ciproﬂoxacin. PFGE
pattern indicated that they were clonally related. Crude extracts showed
hydrolysis of IMP, which was inhibited (over 90%) on addition of EDTA.
PCR analysis of genomic DNA, in contrast to plasmid DNA, gave a positive
result for the presence of vim MBL gene. Sequencing of these products
indicated a 100% match with the vim-1 MBL in all tested strains, and seven
additionally contained a vim-2 MBL.
Conclusions:This is the ﬁrst report in Europe concerning isolation of multiple
MBL-producing P. aeruginosa strains from one hospital in a 5-year period. Seven
of 12 isolates produced simultaneously a VIM-1 and VIM-2 MBL.
P1048 Drug resistance pattern of Pseudomonas
aeruginosa strains isolated from burn infections in Iran
R. Abiri, N. Badami, F. Shahcheraghi, M. M. Feizabadi
Tehran, IR
Background:One of the most important complications of burned patients is
burn infection, particularly infections with Pseudomonas aeruginosa that occurs
after one week of hospitalization. This organism is highly resistant to the
antibacterial agents.
Objective:The aim of this survey was the study of antibacterial resistance and
Beta lactamase production of P. aeruginosa isolated from burn infections.
Therefore, 150 isolates of Pseudomonas strains were cultured from burned
patients at a burn and accident center in Iran.
Methods:All strains were screened for their susceptibilities to antibiotics such
as: ciproﬂoxazine, amikacin, gentamicine, tobramycine, tetracyclin, carbeni-
cilin, ceftazidime, cefteriaxone and cotrimoxazole using disk diffusion
method. Beta lactamase production was checked by iodometric method.
Results:The rate of resistance of the strains to ciproﬂoxazine was less than the
other antibiotics: 119 resistance strains¼ 80%. The results of the resistance to
other antibiotics are as follow: ceftazidime¼ 96.6%, gentamicin¼ 93.3%,
amikacin¼ 89.3%, tobramycin and kanamycin¼ 97.2%, carbenicillin, cef-
triaxone and cefotaxime¼ 98.6%, tetracyclin and cotrimoxazol¼ 100%.
Using the iodometric method, we found that 87 strains out of 127 produced
Beta lactamase.
Conclusions: Considering the obtained results and high prevalence of multi-
drug-resistant strains in the hospital environment, it is obviously necessary
to detect and follow up the sources of nosocomial infections. This is
particularly important for P. aeruginosa infections at Burn and Accident
Centers to prevent the spreading of drug resistant strains and its transmission.
Using the correct drug susceptibility result, would help the better manage-
ment of such cases.
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P1049 Evolution of the antibiotic resistance in
Acinetobacter baumannii isolates from a hospital in
Northern Spain
G. Ramos, I. Rojo, B. Arrugaeta, M. Canduela, F. Calvo, L. Gallego
Leioa, E
Objectives: The study of the evolution of the resistance and the detection of
class 1 integrons from 1999 to the year 2002 among Acinetobacter baumannii
clinical isolates.
Methods: Minimum inhibitory concentration to ceftazidime, cefotaxime,
imipenem, meropenem, amikacin and gentamicin was determined following
the NCCLS protocol. Isolates tested were all A. baumannii isolated at the
Microbiology Service of Hospital de Sta. Marina (Northern Spain) during the
years 1999 and 2002. Detection of class 1 integrons was done by PCR
experiments with the primers 50CS and 30CS.
Results: The most active antibiotic was amikacin during 1999 but imipenem
during 2002. Cefotaxime and gentamicin were the lest active during 1999 and
also the same during 2002. The resistance to ceftazidime, imipenem, mer-
openem and amikacin increased being most important to meropenem (from
60.8% to 76.8%) and amikacin (32.3% to 76.8%). The evolution of the
integrons was towards the combination of the different individual bands
identiﬁed during 1999. The majority of isolates from 2002 bored combina-
tions of the 1200 bp, 760 bp and 550 bp integrons.
Conclusions: The resistance of A. baumannii to antibiotics increased from
1999 to 2002, specially to meropenem and amikacin. This could be due to the
acquisition of multiple class 1 integrons.
P1050 Detection of the ermTR gene among
erythromycin-resistant Streptococcus pneumoniae strains
circulating in Italy
L. Gualco, E. A. Debbia, G. C. Schito, A. Marchese
Genoa, I
Objectives: Macrolide-resistance in pneumococci has been ascribed to two
different genes: ermB conferring constitutive or inducible cross-resistance to
MLSB antibiotics and mefA. Strains harbouring this latter gene are resistant
only to 14- and 15-membered ring macrolides. At present, the ermTR gene,
which is widely diffused in S. pyogenes, has been found in only four S. pneu-
moniae strains isolated from pediatric throat swabs in Greece, in two Australian
and in one Spanish isolates whose origins have not been described. In this
study 336 erythromycin-resistant pneumococci have been characterized for
their macrolide-resistant genotype.
Methods: Erythromycin-resistant S. pneumoniae (336) isolated from various
clinical specimens during 1996–2000 in Italy have been studied. Minimal
inhibitory concentrations were determined by the microdilution method as
suggested by the NCCLS (2002). Macrolide resistance phenotypes were
assessed by the double disk test. The ermB, mefA and ermTR genes were
ampliﬁed by PCR using speciﬁc primers and conditions described by other
Authors (Syrogiannopolus et al. AAC, 2001).
Results: The great majority of the strains (90.5%) possessed the ermB gene,
while all M-type pneumococci (9.2%) carried the mefA determinant. Only
one strain (0.3%) originating from a pediatric throat swab belonging to
serotype 11A, the same displayed by the Greek isolates, was characterized by
an inducible phenotype. TheMICs for erythromycin and clindamycin were 1
and<0.06mg/L, respectively. PCR studies revealed that this strain harboured
the aermTR gene.
Conclusions: This is the ﬁrst study showing the presence of the ermTR gene
among pneumococci circulating in Italy. The rare occurrence of this genetic
element in S. pneumoniae is therefore conﬁrmed.
P1051 Beta-lactamases in Enterobacteriaceae from
pediatric patients in Iasi, Romania
R. Filip, G. Coman, J. Silva-Sanchez
Iasi, RO; Cuernavaca, MEX
Objectives: To determine the mechanism of beta-lactam resistance in Enter-
obacteriaceae causing pediatric infections and to increase the level of aware-
ness of clinical laboratory about the detection of beta-lactamases.
Material and methods: During January–June 1999, E. coli (n¼ 8), Klebsiella
pneumoniae (n¼ 1), Enterobacter cloacae (n¼ 1) isolated from urine and pus in
children hospitalized in ‘Sf. Maria’ Pediatric Hospital from Iasi, Romania,
were selected by their resistance phenotype, suggesting a beta-lactamase
production. Identiﬁcation and sensitivity testing was done by Dade Micro-
Scan system with NegCombo 20E panel. Isoelectric focusing was done in
preformed minigels and Ceftazidime (0. 25 mg/mL) was used for bioassay.
Results: The strains resistant to Ceftazidime (4/10) showed association of pIs:
5.4þ 7.6 or 5.4þ 8.2 suggesting the production of extended spectrum beta-
lactamases (ESBLs). This was conﬁrmed by bioassay method with bacterial
growth (due to hydrolysis of CAZ) at pIs of 7.6 and 8.2 indicating ESBLs of the
SHV type. The beta- lactamases of theCAZ sensitive strains (6/10) focused at pI
of 5.4 which corresponds to the production of TEM-1 beta-lactamase.
Conclusion: Results show the emergence of ESBL (most likely of the SHV
type) in strains isolated from infections in children hospitalized in a large
clinical pediatric hospital. Association of ESBL plus TEM type beta-lacta-
mases (40% of the isolates) impairs the options for treatment of infections
caused by these strains. The routine diagnosis clinical laboratory should detect
these enzymes, by simple and cheap methods, as showed above. Part of this
work was performed at the Bacterial Genetics Department in Cuernavaca,
Morelos, Mexico.
P1052 First detection of Klebsiella pneumoniae and
Enterobacter cloacae clinical isolates producing the VIM-1
metallo-beta-lactamase
F. Luzzaro, J. D. Docquier, C. Colinon, A. Endimiani, G. Amicosante,
G. M. Rossolini, A. Toniolo
Varese, Siena, L’Aquila, I
Objectives:Multidrug resistance among clinical isolates of Enterobacteriaceae
represents an increasing problem. The recently discovered acquired metallo-
beta-lactamases (MBLs) of the VIM-type, mostly found in nonfermenting
Gram-negative bacteria, are able to efﬁciently hydrolyze nearly all beta-lactam
antibiotics, including carbapenems, and are encoded by mobile genetic
elements, thus representing a challenging threat for beta-lactam-based che-
motherapy. To-date, in Europe, production of VIM-type enzymes in Enter-
obacteriaceae has been reported only in one isolate of Escherichia coli from
Greece. In this study, we report on the detection of the VIM-1 enzyme in
Klebsiella pneumoniae and Enterobacter cloacae isolates from Italy, and on results
concerning the molecular characterization of these isolates.
Methods: Antimicrobial susceptibility testing was performed and interpreted
according to the NCCLS criteria. The presence and nature of a metallo-beta-
lactamase determinant was determined by molecular methodologies (RFLP-
multiplex PCR) and enzymatic assay. The genetic background of the MBL-
determinant was investigated by conjugation and Southern blot hybridization
experiments.
Results: On June 2002, one K. pneumoniae and one E. cloacae exhibiting
resistance to several beta-lactams and reduced susceptibility to carbapenems
were isolated from an inpatient at the ICU of the Ospedale di Circolo of
Varese, Italy. Both isolates produced EDTA-inhibitable carbapenemase activ-
ity. Results of the RFLP-multiplex PCR for the detection of MBL genes
indicated the presence of a blaVIM-1 determinant. In either isolate the MBL
determinant was carried by an apparently identical plasmid, that was success-
fully transferred to E. coli by conjugation.
Conclusions: The emergence of MBL determinants carried by conjugative
plasmids among clinically relevant species of Enterobacteriaceae, especially
K. pneumoniae, is particularly alarming and underlines the need of a contin-
uous surveillance program of these worrisome determinants.
P1053 The EOLO Project: an epidemiological study of
community-acquired lower respiratory tract infections (LRTI)
in Italy (2001–2002)
S. Mannelli, G. Corrao, F. De Benedetto, C.F. Donner,
M. Ochan Kilama, G. Nicoletti, C.M. Sanguinetti,
M. Scatigna, G. Sevieri,
G.C. Schito – Eolo Project Group
Objectives: An epidemiological evaluation of bacterial pathogens responsible
for community-acquired lower respiratory tract infections (LRTI) and the
corresponding resistance patterns to the commonly used antimicrobial drugs.
Methods: This Italian national survey involved 360 general practitioners
divided in groups of 12, each group coordinated by a pneumologist with a
reference microbiology center.
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Results: A total of 860 patients were recruited of which 449 (92%) diagnosed
as acute exacerbation of chronic bronchitis (AECB) and 39 (8%) community
acquired pneumonia (CAP). Sputum samples were collected from 727
(88,0%) patients of which 515 (70,8%) had samples valid according to Bartlett
criteria and were further analyzed and cultured. These 515 patients (67.4%
males and 32.6% females) included in the microbiological analysis had mean
age of 69.1 years for males and 65.6 years for females. Etiology of AECB
varied from area to area but overall 6.5% of cases had a polymicrobial aetiology
and pathogens with the highest incidences were: S. pneumoniae (12.9%),
H. inﬂuenzae (19.5%),H. parainﬂuenzae (17.9%),M. catarrhalis (9.6%), S. aureus
(15.2%), followed by Enterobacteria and Gram-negative non-fermenting rods.
Resistance rate of S. pneumoniae to penicillin was 13% (6.5% high level, 6.5%
low-level), whereas the resistance to macrolides was 35.7%. One pneumo-
coccal strain only was reported as resistant to moxiﬂoxacin. Beta-lactamases
production in H. inﬂuenzae was 33% and even higher beta-lactamase produc-
tion rates were expressed by H. parainﬂuenzae andM. catarrhalis. S. pneumoniae
was 14.8% of all strains isolated in CAP,H. inﬂuenzae 22.2%,H. parainﬂuenzae
18.5%, and S. aureus 29.6%.
Conclusions:This epidemiological survey conﬁrmed the causative role of the
main pathogens also in Italy as reported elsewhere regards the etiology of
AECB and CAP. The incidence of bacterial resistance observed is in agree-
ment with data from previous Italian studies. Moxiﬂoxacin was one of the
most active compounds and showed greater activity than the beta-lactams and
macrolides tested.
P1054 Occurrence of extended-spectrum
b-lactamase-producing Klebsiella pneumoniae strains in a
neonatal intensive care unit, Budapest
D. Szabo, K. Kristof, A´. Harmath, G. Hazai, F. Rozgonyi
Budapest, HUN
Objectives:The present study was designed to determine the occurrence and
the antimicrobial resistance of the extended-spectrum beta-lactamase produ-
cing of Klebsiella pneumoniae (ESBL-Kp) strains isolated from the Neonatal
Intensive Care Unit of 1st Department of Obsetricology and Gynecology,
Semmelweis University.
Methods:The strains were identiﬁed in the automatic ATB system using trips
with biochemical tests. ESBL-producing strains were detected with double
disk diffusion test and it was conﬁrmed by ESBL screening (ceftazidime/
ceftazidime þ clavulanic acid) E-test. MICs for different b-lactams and
aminoglycosides and ciproﬂoxacin were determined according to the
NCCLS guidelines. BlaTEM and blaSHV and blaCTX-M primers were
used to amplify the b-lactamase gene. To assess the relatedness between the
ESBL-Kp isolates AP-PCR were performed with ERIC2 primers.
Results: From 2001 April to 2002 April 74% of the K. pneumoniae strains
produced ESBL. Colonization/infection with the ESBL-Kp isolate was
detected in 21 patients. Two patients were infected ﬁrst with ESBL-Kp,
and subsequently with ESBL-producing Serratia marcescens. The risk factors for
infection with ESBL-Kp were the low maturity (delivery at an average of 30
gestations weeks), the low birth weight (average: 1560 g), the prolonged
hospital stay, the mechanical ventilation (100%), and previous broad spectrum
antibiotic prophylaxis. Out of the 21 strains eight strains harbored the TEM
gene, all had the SHV gene, and two strains had the CTX gene. Based on the
AP-PCR 10 different genotypes could be distinguished. The susceptibility
proﬁles (range MICs, mg/L) of the ESBL-Kp isolates were as follows:
cefotaxime: 2->32, cefoperazone: 6->256, ceftriaxone: 1.5->32, imipe-
nem: 0.125–4, meropenem: 0.023–0.25, piperacillin/tazobactam: 2->256,
amikacin: 2–48, tobramycin:6–24, netilmicin: 8->256, ciproﬂoxacin: 0.047–
0.25. All isolates were susceptible to imipenem,meropenem and ciproﬂoxacin
and showed low resistance rate to amikacin (10%). Higher and signiﬁcant
resistance rates of ESBL-Kp was observed to cefotaxime, ceftriaxone, cefo-
perazone, piperacillin/tazobactam (67%) and netilmicin (67%), tobramycin
(71%).
Conclusions: This study strongly suggests that ESBL production of K. pneu-
moniae isolates have been highly disseminated among patients in neonatal
intensive care unit. There was a high resistance to antimicrobials, and
multiresistance rates were increased in the strains producing ESBLs.
P1055 High prevalence of multiresistant
penicillin-intermediate Streptococcus pneumoniae due to
clonal spread in Germany, winter 2000/01
B. Henrichfreise, B. Wiedemann, S. Bagel, J. Brauers, M. Kresken
Bonn, D
Objectives: In Germany, penicillin-nonsusceptible S. pneumoniae (PNSP) are
relatively uncommon, occurring at a rate of about 7% (6% intermediate and
1% resistant). The aims of this surveillance study were to assess the
prevalence of PNSP recovered from outpatients with RTIs in the winter
season 2000/01 and to examine the clonal relationship between PNSP.
Methods: We performed two multicenter studies comprising a total of 17
laboratories. MICs were determined in a central laboratory with a broth
microdilution procedure according to NCCLS. Among the antibiotics tested
were penicillin (PEN), several other beta-lactams, erythromycin (ERY),
tetracycline (TET) and cotrimoxazole (SXT). Fourty-two PNSP were
studied using pbp2b restriction fragment length polymorphism (RFLP)
and pulsed-ﬁeld gel electrophoresis (PFGE).
Results:Of the 595 isolates included, 107 (18%) proved PNSP. For those, the
PEN MICs were 0.125–0.5mg/L. None were resistant to PEN. Among the
107 PNSP 84 (78.5%) were of the same phenotype. The most frequent
phenotype (pt I) was cross-resistant to TET (98.8%) and had reduced
susceptibility to SXT (100%). Sixteen isolates (15%) were addionally resistant
to ERY (pt II). The rate of PNSP varied by region ranging from 0% to>40%.
Twenty PNSP of pt I and all 16 PNSP of pt II were genetically characterized.
Four PFGE types (types 1–4) and 2 different pbp2b RFLP patterns were
found among the 20 isolates of pt I. Seventeen of these isolates belonged to
PFGE type 1 representing a unique RFLP pattern. They were detected at 7
centers. All 16 isolates of pt II belonged to the same PFGE type (type 5) and
represented a different unique RFLP pattern. These isolates were recovered at
3 centers in Eastern Germany. The MICs of two beta-lactams (cefaclor and
ceﬁxime) for PNSP exceeded the PK/PD breakpoints.
Conclusions: The rate of PNSP in this surveillance study was higher than
reported in previous studies in Germany. There is evidence that this difference
is mainly due to the epidemic spread of two clones. Both clones were
nonsusceptible to PEN, SXT, and TET, and one was additionally resistant
to ERY. The observed regional differences in the prevalence of PNSP is
attributed to the spread of these two clones. Regional resistance rates must not
be predicted from overall resistance data in a country. The use of standard
antibiotics like TET, SXT, ERYand some oral cephalosporins like cefaclor or
ceﬁxime contribute to the selection of multiresistance in S. pneumoniae.
P1056 Detection of CTX-M-15 extended-spectrum
beta-lactamase (ESBL) in the UK
S. Mushtaq, N. Woodford, N. Potz, D. Livermore
London, UK
Objectives:To investigate for the presence of CTX-M type beta-lactamases in
isolates of Enterobacteriaceae collected in a survey of bacteria from hospi-
talized patients in the British Isles.
Methods: Twenty-six hospitals in the UK and Ireland collected up to 200
consecutive clinically signiﬁcant isolates from separate in-patients in 2001.
Disc testing was performed at the hospital laboratories, and isolates with key
resistances, including to third-generation cephalosporins, were sent to
ARMRL for MIC determinations by the BSAC agar dilution method.
Isolates of Enterobacteriaceae (except Serratia spp.) with cefotaxime MICs
at least 8-fold higher than ceftazidime MICs were screened for blaCTX-M
genes by PCR using universal primers. PCR products were sequenced on
both strands to determine CTX-M subtype, and group-speciﬁc primers were
then used to amplify and sequence the entire gene. CTX-M-positive isolates
were compared by pulsed-ﬁeld gel electrophoresis (PFGE) of XbaI-digested
DNA.
Results: 122 cephalosporin-resistant Enterobacteriaceae were collected. For 7
of these the cefotaxime MIC was at least 8-fold greater than that of
ceftazidime. Three of these isolates yielded amplicons with universal
CTX-M primers, as did one isolate highly resistant to both ceftazidime
and cefotaxime. These 4 isolates were all Escherichia coli, and were isolated from
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3 hospitals; the isolates from different hospitals were unrelated by PFGE.
Sequencing of one representative from each site revealed a CTX-M-1-group
enzyme, identiﬁed by further sequencing as the CTX-M-15 variant. CTX-
M-15 is one of the CTX-M types with relatively greatest activity against
ceftazidime, perhaps explaining why the isolates were clearly resistant to this
drug as well as cefotaxime. Nevertheless the high level resistance to cefta-
zidime of the Newcastle isolate suggests the presence of other mechanisms in
addition to CTX-M-15.
Conclusions:CTX-M-15 beta-lactamase has emerged at multiple sites in the
UK (Table 1).
P1057 Group A Streptococcus: evaluation of
antimicrobial susceptibility
R. Bandettini, L. Pescetto, S. Lualdi, M. A. Barretta
Genoa, I
Objectives:The purpose of this study was to evaluate the antibiotic resistance
pattern of Group A Streptococcus (GAS) strains isolated from children.
Methods:Between September andDecember 2002, a total of 120 GAS strains
were collected from cultures of throat swabs from pediatric patients affected by
tonsillitis. Multiple isolates from the same patient were avoided. Strain
identiﬁcation was conﬁrmed with bacitracin disks and by a latex agglutination
assay. The susceptibilities tests (penicillin, erythromycin, rokitamycin, clin-
damycin, tetracycline, ciproﬂoxacin, vancomycin) were determined by the
disk diffusion method on Mueller–Hinton agar supplemented with 5% sheep
blood and the macrolide resistance phenotypes were evaluated using the
erythromycin-clindamycin double-disk test.
Results:Our ﬁndings are showed below: all Group A Streptococcus strains
were susceptible to penicillin and vancomycin; 71 of 120 strains (59.1%)
were susceptible to all antibiotics tested; 35 (29.1%) strains were resistant to
erythromycin; 13 (10.8%) were resistant to rokitamycin; 18 (15%) were
clindamycin-resistant; 17 (14.1%) were tetracycline-resistant; 10 (8.3%)
were ciproﬂoxacin-resistant. The macrolide resistance phenotypes test
gave the following results: 52.2% of erythromycin-resistant strains were
constitutive phenotype; 39.1% M-resistance phenotype; 8.7% inducible
phenotype.
Conclusions: This analysis shows that penicillin is still the most effective
antibiotic against GAS probably because of the absence of selectable variants
carrying mechanisms of beta-lactam resistance. Regarding the prevalence of
macrolide-resistance, erythromycin performance is worse than rokitamycin
and unlike data reported in literature we have a larger prevalence of
constitutive phenotype while inducible phenotype is only 8.7%. Regarding
ciproﬂoxacin, the resistance-prevalence was 8.3% without any association
with macrolide resistance (only one strain was constitutive phenotype). This
could be a warning signal for a future increase in resistance considering that
children are not usually given ﬂuorquinolones.
P1058 Occurrence and spread of extended-spectrum
beta-lactamase producing Klebsiella pneumoniae isolates in
Curac¸ao
M. Van Westreenen, A. Paauw, A. C. Fluit, S. Brisse, W. Van Dijk,
J. Verhoef
Utrecht, NL
Objective: In recent years, the growing incidence of ESBLs, in particular
produced by Klebsiella pneumoniae isolates in nosocomial infections, also
became evident in Curacao. To get insight into the evolution of ESBLs
and to identify a possible source for the increase of these multidrug resistant
strains on this island, K. pneumoniae clinical isolates were genotypically
characterized.
Methods: Sixty-ﬁve ESBL producing K. pneumoniae of patients from the St.
Elisabeth Hospital were collected from November 1999 until June 2002.
Identiﬁcation and susceptibility testing were done by Vitek and conﬁrmed
by additional double-disc synergy tests. Twelve strains were collected between
November 1999 until December 2000. Fourteen isolates were collected during
a NICU outbreak in 2001, 13 strains were collected outside the NICU during
the same year. Twenty-six strains were collected in the ﬁrst half year of 2002.
Microbial strain delineation by ribotyping with EcoR1 has been performed to
study clonal spread of the strains. All strains were analyzed for plasmid-encoded
SHV type b-lactamase by SHV-speciﬁc PCR and SHV-NheIRFLP. To test the
possible transfer of this plasmid to an E. coli recipient strain, conjugation
experiments were performed by liquid mating. Isoelectric Focusing (IEF)
was done to identify the b-lactamase proﬁles of these multidrug resistant strains.
Results: The results showed that most of the 65 ESBL-producing K. pneu-
moniae strains contain plasmid encoded SHV-type b-lactamases. SHV-type b-
lactamase of the NICU isolates could be transfered by conjugation. However,
with the majority of non-NICU strains no SHV ESBL transconjugants were
observed. This may be explained by poor mobilization of the ESBL carrying
plasmid. Most of these strains demonstrated a variety of IEF patterns; 38 of the
51 isolates showed a pI 8.3 suggestive of an AmpC-type b-lactamase.
Ribotype analysis revealed 22 unique types. However, one type was increas-
ingly present. This was not the same type as observed in the NICU outbreak
of 2001.
Conclusions:Our data suggest that in Curac¸ao there is an ongoing outbreak of
ESBL-producingK. pneumoniae, only in a small part due to horizontal transfer
of plasmid-encoded SHV genes. There is a prevalent clone, but it remains to
be seen if strains of this type all harboring the same ESBL genes. Character-
ization of ESBL genes other than SHV will be studied.
P1059 Macrolide-resistance phenotypes in S. pyogenes
St. Fokas, Sp. Fokas, F. Markatou, K. Papakostas, M. Kalkani,
M. Dionisopoulou
Sparta, GR
Objectives: The aim of this study was the assessment of macrolide-resistance
rate in S. pyogenes isolates and the evaluation of their phenotypic character-
ization of resistance in Lakonia region, Greece.
Methods: A total of 231 strains of S. pyogenes were isolated in 2-year period
(2000–2001) from symptomatic patients, children (174 strains) and adults (57
strains). Most strains were isolated from throat swab cultures (212 strains) and
the rest from other clinical specimens. The strains were identiﬁed as S. pyogenes
using standard procedures: (i) negative catalase test, (ii) Gram stain, (iii) beta-
hemolytic pattern, (iv) colony size, (v) bacitracin sensitivity, and (vi) group A
latex agglutination. Susceptibility to penicillin–erythromycin–clindamycin
was determined by the disk diffusion method (NCCLS 1999). The strains
were examined phenotypically for resistance to macrolides and lincosamides
by the double disk method using disks of erythromycin (15mg) and clin-
damycin (2mg).
Results: All strains were found to be susceptible to penicillin. The overall
resistance rate to erythromycin was 20.8% (48 isolates). Resistance to
clindamycin was observed in 15 strains (6.5%) and this resistancewas inducible
in 14 and constitutive in 1 strain. The M-phenotype (efﬂux resistance
mechanism) was found to be predominant among the erythromycin-resis-
tance strains as it was expressed in 33 strains (69%). Fourteen strains (29%)
were assigned to the inducible macrolide, lincosamide, streptogramin B
resistance phenotype (iMLSB) and only 1 strain (2%) revealed the constitutive
cMLSB phenotype.
Conclusions: S. pyogenes remains fully susceptible to penicillin. Due to the
signiﬁcantly high rate of resistance to macrolides, susceptibility tests to
macrolides and lincosamides should be performed simultaneously in the
clinical microbiology laboratories, particularly in areas with high rates of
macrolides resistance. Continuous epidemiological surveillance of the anti-
biotic resistance of this species to macrolides is also needed. The high
prevalence rate of the M phenotype in our region makes clindamycin a
good alternative choice in patients allergic to penicillin.
P1060 Uropathogens causing community-acquired
urinary tract infections
Sp. Fokas, St. Fokas, F. Markatou, E. Lauranou, M. Kalkani,
M. Dionisopoulou
Sparta, GR
Objectives: To assess the frequency and antimicrobial resistance of urinary
pathogens isolated from patients with community-acquired urinary tract
infections (UTI).
Table 1
Strain Species CTZ MIC CTX MIC
London (two isolates) E. coli 32 >256
Newcastle E. coli >128 >256
Belfast E. coli 32 256
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Methods: This was a retrospective study using the results of 1510 urine
cultures considered as potentially signiﬁcant. The urine samples were col-
lected over a 3-year period (1999–2001). The criteria to consider a
positive urine culture as signiﬁcant were: (a) symptoms suggestive for
UTI, (b) bacterial growth counts >10000 CFU/mL with pyuria >15
WBC/hpf. The identiﬁcation of the bacteria to the species level was achieved
using the API system (BioMerieux) and the susceptibility tests were per-
formed by the disk diffusion method following the NCCLS (1998) recom-
mendations.
Results: During the study period a total of 1529 isolates were collected. The
most common uropathogen was E. coli (72.7%) followed in decreasing order
by: Klebsiella spp. (7.3%), Proteus spp. (6.3%), Enterococcus spp. (3.2%), S. sapro-
phyticus (2.1%), P. aeruginosa (2%) and others (6.4%). The resistance rates (%)
for E. coli, Klebsiella spp., and Proteus spp. to antimicrobial agents were as
follows: ampicillin 34.8/100/46.4 amoxicillin/clavulanate 16.5/23/18.5;
cefuroxime 2.3/5.3/12.3; cotrimoxazole 17/28.5/26.8; ciproﬂoxacin 2.1/
1.8/4.1; ceftriaxone 0.4/1.7/0; gentamicin 2/0.9/3. ESBL producers were
found among E. coli isolates (0.26%) and among Klebsiella spp. (1.7%).
Ampicillin resistance in Enterococcus spp. was detected in 12% of the isolates;
ciproﬂoxacin resistance occurred in 41% and none of the isolates was
vancomycin-resistant.
Conclusions: Enterobacteriaceae were the most commonly isolated uro-
pathogens and E. coli was the predominant bacterium. In our region multiple
drug resistant strains have not occurred in signiﬁcant rates but we isolated
ESBL producers strains. The antimicrobial susceptibility results must taken
account by the clinicians for a rational use of antibiotics in order to avoid the
emergence and spread of multiresistant strains.
P1061 Antimicrobial Resistance Surveillance in Italy:
results of AR-ISS project
St. Fokas, D. Boccia, A. Pantosti, F. D’Ancona, S. Gianitelli, S. Lana,
F. D’Ambrosio, S. Salmaso – AR-ISS working group
Objectives: To monitor the antimicrobial resistance of bacteria of particular
interest and clinically relevant by means of a sentinel surneillance laboratory-
based network coordinate by the ISS, the Italian Public Health Institute.
Results on the ﬁrst year of activity are presented.
Methods: Since June 2001, ISS collected data on antibiotic resistance related
to strains of Staphylococcus aureus, Enterococcus fecalis/fecium, Klebsiella pneumo-
niae/oxytoca, Escherichia coli isolated from blood and of Streptococcus pneumoniae
from blood and cerebrospinal ﬂuid. 61 clinical microbiology laboratories
collecting samples from 71 hospitals participated, using their routine lab
methods, sending data on standard paper forms or electronically (17 labs). The
data analysis was performed on antimicrobial susceptibility results provided by
labs.
Results: From June 2001 to May 2002, we received a total of 3989 non
duplicate isolates including: S. aureus: 1858 isolates-100% were susceptible to
vancomycin., MRSA ¼ 41.5%; multiresistance in MRSA strains: 78% S.
pneumoniae 396 isolates-10.8% non susceptible to penicillin (2.8 resistant),
37.6% resistant to erythromycin. Enterococcus fecalis/fecium: 742 isolates-1.5%
of E. fecalis and 19.9% of E. fecium resistant to vancomycin (VRE). Multi-
resistance in VRE strains: 57.1% of E. fecalis and 72.9% of E. fecium. Klebsiella
pneumoniae/oxytoca: 743 isolates-15.2% reported as ESBL positive, 8% multi-
resistant. E. coli 534 isolates-44.8% resistant to aminopenicillins, 19.7% non
susceptible to ciproﬂoxacin, 3% multiresistant.
Conclusions: According to previous studies, antimicrobial resistance of
S. aureus and S. pneumoniae seems to be stable. The AR-ISS surveillance
provided the ﬁrst national data about antimicrobial resistance of E. fecalis/
fecium and Gram negative. The level of vancomycin resistance of E. feciumwas
higher than expected and resulted one of the highest in Europe. Aminope-
nicillin resistance was high both among E. coli and K. pneumoniae/oxytoca
strains. Resistance to amicoglicosides and cephalosporines in E. coli is still
low, but high compared with what reported in other European countries.
The level of K. pneumoniae/oxytoca ESBL producing strains need to be
conﬁrmed.
P1062 Effects of clarithromycin on oropharyngeal and
nasal ﬂora: a double-blind placebo controlled study
H. F. Berg, J. H. T. Tjhie, E. E. Stobberingh, M. F. Peeters, P. H. J. van
Keulen, J. A. J. W. Kluytmans
Tilburg, Veldhoven, Maastricht, Breda, NL
Objectives: The use of antimicrobial agents is associated with the emergence
of resistance to these drugs in almost all human pathogens. Whether this also
accounts for clarithromycin, as a relatively new macrolide antibioticum, has
not yet been evaluated. Therefore, a prospective, placebo-controlled, rando-
mized, double blind study was performed to investigate the effect of clari-
thromycin slow-release on colonization and resistance in oropharyngeal and
nasal ﬂora.
Methods: 296 patients with documented coronary artery disease were
randomized to receive a daily dose of clarithromycin 500mg slow release
(CL) or placebo tablets (PB) until the day of surgery, during the preoperative
period. Nose- and throat swabs were taken before initiating therapy and after.
Minimal Inhibitory Concentration (MIC) was determined for oral Hemo-
philus species and nasal Staphylococcus (S) aureus. Throat swabs were also
cultured for genotypic macrolides, lincosamides, and streptogramins b
(MLS) cross-resistance detection in indigenous ﬂora.
Results: Basic patient characteristics were comparable in the two treatment
groups. The average number of used tablets was 15 (SD¼ 6.4). Orophar-
yngeal carriage of Hemophilus species was not inﬂuenced in either of the
treatment groups (79.1% before treatment in both groups, and 70.3% after CL
vs. 74.3% after PB). Nasal carriage of S. aureus however, decreased signiﬁ-
cantly from 34.7% before treatment, to 4.9% after CL treatment (compared
with PB: 32.4% before and 30.1% after; RR¼ 13.2). The resistance for
clarithromycin was signiﬁcantly increased in Hemophilus species (P¼ 0.0002;
RR¼ 1.9; 95% Conﬁdence Interval: 1.4–2.7). The MLS resistant bacteria
accounted for 37% of the total indigenous ﬂora. Directly after therapy and 8
weeks after therapy, the percentage of MLS resistant bacteria increased
signiﬁcantly in patients who received clarithromycin (77% in CL group
vs. 30% in PL group directly after, and 53% (CL) vs. 27% (PL) 8weeks after).
Conclusion: These results show a rapid effect of clarithromycin slow-release
on resistance, and suggest the capability of transfer of MLS resistance genes
from indigenous ﬂora to pathogenic ﬂora.
P1063 Staphylococcus spp. resistance to macrolides and
lincosamides
M. Tsivitanidou, C. Kleisiari, D. Soﬁanou
Thessaloniki, GR
Clindamycin, a derivative of lincomycin, is active against Staphylococcus spp.
when the microorganism is susceptible to this antimicrobial agent. A sig-
niﬁcant number of staphylococci though, are susceptible to clindamycin (ClS)
and resistant to erythromycin (ErR). The most common mechanism of
resistance to macrolides-lincosamides-streptogramins B (MLSB) is the mod-
iﬁcation of the antimicrobial binding site due to the methylation of 23S
rRNA at the 50S ribosomal subunit. The expression of this resistance can be
constitutive or inducible and is related to the acquisition of the erm gene. This
study was performed aiming to the determination of the frequency of the
Staphylococcus spp. that are ErR/ClS at Hippokrateio General Hospital,
Greece. In total, 2364 non-repetitive clinical strains of Staphylococcus aureus
and coagulase-negative staphylococci (CoNS) that were isolated from various
pathological samples during the period of 1998 and 2002 were studied. 257
(23.66%) out of the 1086 clinical strains of S. aureus were resistant to both
antibiotics, while 80 (7.34%) strains were resistant to erythromycin and
sensitive to clindamycin. 93.75% of these strains were oxacillin sensitive
(MSSA) and only 6.25% were oxacillin resistant. Among CoNS strains,
527/1278 (41.24%) was resistant to erythromycin and clindamycin, while
286 (22.38%) exhibited the ErR/ClS phenotype. Most of this phenotype
strains were oxacillin resistant (66.43%) and 33.57% were oxacillin sensitive.
According to these results, the ErR/ClS phenotype is observed mainly to
MSSA strains in contrast to CoNS where it is most frequently observed to
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oxacillin resistant isolates. The presence of inducible resistance to clindamycin
was determined by the double disk test in 18 S. aureus and 16 CoNS strains.
Inducible resistance to clindamycin was observed to 18/18 (100%) of S. aureus
and 8/16 (50%) CoNS isolates, demonstrating a large number of ErR/ClS
Staphylococcus strains possessing the erm gene and therefore the emergence of
constitutively resistant mutants during treatment is likely to occur. In con-
clusion, patients infected with staphylococci exhibiting inducible resistance,
should not be treated with clindamycin or should be under continuous
surveillance because the selection of resistant isolates to all MLSB during
therapy is a risk. Furthermore clinical studies are necessary to evaluate in vivo
whether clindamycin should be used and when.
P1064 Activity of vancomycin, teicoplanin and linezolid
against coagulase-negative staphylococci
D. Kotulova, A. Longauerova, L. Slobodnikova
Bratislava, SK
Objectives: To follow the antimicrobial susceptibility of coagulase-negative
staphylococci (CoNS), isolated from wounds of patients of the 1st surgical
clinic, from wounds and hip prostheses infections of patients of the 1st
orthopedic clinic, and from hemocultures of all patients from the Faculty
Hospital.
Methods: In the period from 2000 to 2002, staphylococci were isolated from
the blood and swabs from deep wounds after cultivation on blood agar, were
identiﬁed by plasmacoagulase production and biochemical tests. MIC to
vancomycin, teicoplanin, linezolid, quinupristin/dalfopristin, ciproﬂoxacin,
clindamycin, gentamicin, and rifampin was determined by colorimetric
method. Resistance to methicillin/oxacillin was determined by the disk-
diffusion test according to the NCCLS and veriﬁed by the PBP2a detection;
resistance to vancomycin was conﬁrmed by the E-test.
Results: 692 strains of CoNS were tested, of which 504 showed methicillin
resistance (72.8%). Highest percentage of methicillin-resistant CoNS was
isolated from hemocultures (76.1%) and from wounds of patients of the 1st
orthopedic clinic (73.7%). Out of 692 strains, 132 (19.1%) were resistant to
gentamicin, and 261 (37.7%) to ciproﬂoxacin. Co-resistance in the methi-
cillin-resistant strains was found to gentamicin in 121 cases (24.0%), and to
ciproﬂoxacin in 238 cases (47.2%). 15 strains (2.2%), out of 692 strains,
showed teicoplanin resistance. Only 8 strains (1.2%) were resistant and 9
strains (1.3%) intermediately susceptible to linezolid. Resistance to this drug
did not exceed 1% in methicillin-resistant strains. All 692 investigated CoNS
strains were vancomycin susceptible.
Conclusion: In vitro tests showed that vancomycin can be applied in the
therapy of all cases of severe wound infections and sepses, caused by coagulase-
negative staphylococci. Teicoplanin and linezolid were ineffective in less than
2.2 and 1.2% of the total number of isolated coagulase-negative staphylococci,
respectively.
P1065 Targeted recombinant b-lactamase (Trbl)
prevents emergence of ampicillin induced resistance in
Enterobacteria
S. Mentula, J. Harmoinen, K. Lindevall, E. Westermarck, M. Rautio,
H. Jousimies-Somer
Helsinki, Espoo, FIN
Objectives: Ampicillin induces changes in the gut microﬂora composition,
concentrations and antibiotic resistance patterns of coliforms. The aim of the
study was to determine whether targeted recombinant b-lactamase (TRBL)
could overcome the adverse effects of ampicillin by degrading intestinal
ampicillin with oral, in time and pH controlled form released, TRBL
supplementation.
Methods: 18 male laboratory beagles were randomized in 3 treatment groups
(ampicillin þ placebo, ampicillin þ TRBL or only placebo). Stool samples
were cultured before (0 days), during (4, 10, 14 days) and 2weeks after
(28 days) the supplementation period. A total of 860 fecal coliform isolates
were collected and tested against ampicillin and 8 other antimicrobial agents.
Results: In ampicillin group all dogs became carriers of ampicillin resistant
coliforms and the proportion of ampicillin resistant strains of all isolated
coliforms increased dramatically (2%!98%) replacing practically all sensitive
strains. On contrary, in TRBL group no new dog became a carrier during the
intervention and the proportion of ampicillin resistant strains increased only
mildly (20%!36%). In addition, the recovery to baseline-like distribution of
ampicillin resistance among coliforms after the supplementation period
occurred more intensely in TRBL than in ampicillin group. In placebo
group the proportion of fecal ampicillin resistant strains increased steadily
from 16% on day 0–50% on day 28. The acquisition of the resistant strains in
placebo group has most likely happened via ingestion of resistant ﬂora, as the
dogs were not totally isolated from each other.
Conclusion: These results indicate that oral b-lactamase administration
(TRBL) can prevent the increase of ampicillin resistance among coliforms
in gut microbiota.
P1066 Low prevalence of reduced susceptibility to
glycopeptide in methicillin-resistant Staphylococcus aureus
from Belgian hospitals, 2001
C. Nonhoff, O. Denis, M. Struelens
Brussels, B
Objectives: To determine the prevalence of methicillin resistant S. aureus
(MRSA) with reduced susceptibility to glycopeptide in a national survey
conducted in 2001 in Belgian hospitals.
Methods: In 2001, 455 MRSA clinical isolates from various body sites were
collected from 98 acute-care hospitals. Glycopeptide susceptibility was
screened by MIC agar dilution method, vancomycin screen agar
(BHIþ 6mg/L) and synergy/antagonism test with aztreonam/cefazolin on
Mu3 agar (BHIþ 3mg/L vancomycin) and conﬁrmed by population analysis
and broth microdilution.
Results: By dilution, vancomycin MIC50 and MIC90 were 1 and 2mg/L,
respectively (ranging from 0.25 to 4mg/L) and teicoplaninMIC50 andMIC90
were 0.5 and 2 mg/L (ranging from 0.06 to 8mg/L). Only four isolates grew
on vancomycin screen agar (1–2 colonies) but were vancomycin susceptible
by the agar dilution method (MIC equal or less than 2 mg/mL). OnMu3 agar,
31 MRSA strains grew with inhibition around cefazolin disk and enhanced
growth around aztreonam disk (putative GISA phenotype). Thirty-six strains
that either had vancomycinMICs of 4mg/L (n¼ 6) and/or teicoplaninMICs
ranging from 4 to 8mg/L (n¼ 9) or grew on vancomycin screen and/or Mu3
agar were submitted to population analysis and microdilution broth. Hetero-
geneous vancomycin intermediate S. aureus (hetero-VISA) with equal or
more than 1/100 000 subpopulation growth at 4mg/mL was found in one
(0.2%) isolate. By pulsed-ﬁeld gel electrophoresis, this hetero-VISA isolate
belonged to gentamicin-resistant genotype A4 which is increasingly less
frequent in Belgium.
Conclusions: No vancomycin intermediate or resistant S. aureus were found
and hetero-VISAwere very infrequently encountered among Belgian MRSA
strains in 2001. Mu3 agar screening showed insufﬁcient speciﬁcity for GISA
detection in this setting.
P1067 A Spanish national surveillance study among
uropathogens that cause community-acquired urinary tract
infection
A. Andreu, I. Alo´s, M. de la Rosa, J. A. Garcı´a-Rodrı´guez – The
Spanish Surveillance Group for Uninary Pathogens
Objectives: To assess the etiology and rates of antimicrobial susceptibility
among uropathogens recovered from outpatients with urinary tract infections
(UTIs), mainly lower UTIs, in both national and regional settings in Spain.
Methods:A prospective, multicenter study was performed between April and
July 2002. Fifteen microbiology laboratories located in 9 regions were
enrolled. All urine samples were obtained from outpatients. Culture proce-
dures, biochemical identiﬁcations and antimicrobial susceptibility testing
were performed by each participant laboratory using their usual standard
methods.
Results: A total of 2674 patients were included, 80.3% women and 19.7%
men. The mean age was 53.8 years (10.4% <20 years, 20.9% 21–40 years,
21.3% 41–60 years, 35.2% 61–80 years, and 12.2% >81 years). Patients that
suffered their ﬁrst episode of UTI acount for 52.5% and those with uncom-
plicated UTI accounts for 45.5%. A total of 2724 isolates were recovered:
Escherichia coli 73%, Proteus spp. 7.4%, Klebsiella spp. 6.5%, Pseudomonas
aeruginosa 1.3%, Enterococcus spp. 4.8%, Streptococcus agalactiae 1.7% and Sta-
phylococcus saprophyticus 0.7%. The overall antimicrobial susceptibilities of
E. coli isolates were as follows: fosfomycin 97.9%, cefexime 95.8%, nitrofur-
antoin 94.3%, amoxicillin-clavulanate 90.8%, cefuroxime 90.7%, norﬂoxacin
77.3%, ciproﬂoxacin 77.2%, TMP-SMZ 66.1%, and ampicillin 41.3%.
Resistance of E. coli to ﬂuoroquinolones was signiﬁcant higher in men
(28.9% vs. 19% in women), aged patients (7.1% in <20–40 years, 15% in
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41–60 years, 29.2% in 61–80 years, and 33.7% in >81 years), complicated
UTI (24.8% vs. 13.7% in uncomplicated UTI) and in some regions (9.2% in
Galicia and Asturias, 24.8% in Valencia, and 33.3% in Aragon).
Conclusions: In outpatients, E. coli accounts for more than two-thirds of the
microorganisms causing lower UTIs. Almost all E. coli isolates were suscep-
tible to fosfomycin, cefexime and nitrofurantoin, and 90,8% to amoxicillin-
clavulanate. Rates of ﬂuoroquinolones resistance are globally near 22%, but
vary signiﬁcantly according with sex, age, type of UTI, and geographic
region. This information needs to be considered when empirical therapy has
to be recommended or instaured in Spain.
Non-molecular diagnostics: viral, parasites, fungal and clinical
P1068 Intrathoracic lymphadenopathy in adults: a
review of 30 cases
A. Mert, R. Ozaras, M. Bilir, F. Tabak, R. Ozturk
Istanbul, TR
Objectives: Intrathoracic (hilar and/or mediastinal) lymphadenopathy (LAP)
is caused by several disorders such as tuberculosis, sarcoidosis, lymphoma, and
metastasis. The rate of these disorders vary according to the clinics and
geographic areas. In this study, we aimed to determine (i) clinical ﬁndings, (ii)
radiographic features, (iii) diagnostic methods, (iv) etiologic distribution of
the patients with intrathoracic LAP followed during last 10 years (1993–
2002).
Methods: For diagnosis, beside compatible clinical and radiographic features,
microbiological and/or histopathologic features are used. Broncoscopic
(bronchoalveolar lavage and/or transbronchial biopsy) and/or mediastino-
scopic methods were used for obtaining clinical samples.
Results: The etiologic distribution was as follows: mediastinal TB lympha-
denitis (n¼ 10), primary TB (9), sarcoidosis (9), and lymphoma (2). In TB
cases, thoracic imaging (chest X-ray and CT) revealed hilar and/or mediast-
inal LAP in all, and additionally parenhcymal involvement in six of the
patients with primary TB. Bilateral hilar LAP (BHL) was seen in eight of
sarcoidosis patients, two of primary TB patients and none of the remaining.
All of primary TB patients and six of sarcoidosis patients had presented with
erythema nodosum (EN), but none of mediastinal LAP and lymphoma had
EN. Tuberculin skin test was positive 17 out of 19 (90%) TB patients, but 2
out of 9 sarcoidosis patients.
Conclusion: TB is the leading etiology of intrathoracic LAP in our country
where TB is endemic. On the other hand, sarcoidosis should be considered in
patients admitted with BHL and EN and with a positive tuberculin skin
test.
P1069 Diagnostic laparotomy in the diagnosis of fever
of unknown origin
R. Ozaras, A. D. Celik, K. Zengin, A. Mert, R. Ozturk, F. Tabak
Istanbul, TR
Objectives: Fever of unknown origin (FUO) was ﬁrstly deﬁned in 1961 by
Petersdorf and Beeson as following: Fever greater than 38 8C in several times
and lasting longer than 3weeks and diagnosis is obscure after examination for
1week in the hospital. Detailed medical history, physical examination,
noninvasive laboratory tests and radiological examinations constitute the ﬁrst
level in approach of the diagnosis. Excisional biopsy, ﬁne needle biopsy, and
ﬁnally laparotomy are among the invasive methods that could be applied in
diagnosis of cases in whom the above methods are insufﬁcient.
Methods: In this study we aimed to evaluate the place and contribution of
laparotomy in the diagnostic approach of FUO. Of 126 cases with FUO
followed up in our clinic between January 1984 and March 2001, 17 cases in
whom laparotomy was performed were enrolled in this study. The diagnostic
rate of laparotomy and etiology of the FUO by this intervention were
identiﬁed.
Results: The diagnostic rate of laparotomy was found as 88%. Tissue samples
were taken from spleen, liver, mesenteric lymph nodes during operation. As a
result of pathologic examination of these tissue samples; miliary tuberculosis
(n¼ 4), non-Hodgkin’s lymphoma (3), Hodgkin’s lymphoma (3), liver tumor
(1), hairy cell leukemia (1), adult-onset Still’s disease (2), and peritonitis
carcinomatosa (1) were diagnosed. No diagnosis could be reached in two
cases.
Conclusion: After rapid evolution of diagnostic methods especially those of
imaging modalities, laparotomy is less frequently used. However, it con-
tributes to the diagnosis in a considerable extent. In selected FUO cases, this
invasive intervention will identify the etiology of FUO.
P1070 Interphase tensiometry of cerebrospinal ﬂuid in
patients with meningitis
I. A. Zaitsev, I. G. Gerasimov, V. B. Finerman, E. A. Chebalina,
V. N. Zhidkikh, N. A. Malik
Donetsk, UKR
Objectives: It is surveyed 40 patients withmaningitis (20 with purulent and 20
with a serous inﬂammation of meninges).
Materials andmethods: Superﬁcial tension (ST) of cerebrospinal ﬂuid (CSF)
investigated methods of the maximal pressure in vesicle (Tensiometer MPT2
the ﬁrm-manufacturer LAUDA, Germany) and a hanging drop (Tensiometer
PAT1, Sintech, Germany) in a time of interval from 0.001 up to 10,000 s.
Determined value of ST (s) at the initial moment of time t¼ 0(s1), at
t¼ 0.01 s (s2), t¼ 100 s (s3), t¼ 1200 s (s4). Expected a tangent of a corner
of an inclination of tensiogramm (l) in coordinates time of life of a surface –
STat t¼ 0(l1), and at restoration of the initial form of vesicle after his stressful
relaxation 2, registering at this time of a relaxation (oˆ) and calculating module
binding elasticity E by that formula:
" ¼ ADs
DA
where A is the area of a surface of a drop, Ds growth of ST, caused by
spasmodic change of the area of a drop DA.
Results: We reveal moderate positive correlation between concentration of
electrolytes and STof CSF (with concentration of sodium –r¼ 0.42, P¼ 0.14,
potassium –r¼ 0.51, P¼ 0.30 and chlorine –r¼ 0.68, P¼ 0.04). In process of
increase life duration of a surface correlation connection between electrolytes
and ST becomes negative (coefﬁcients of correlation between s3, sodium,
potassium and ions of chlorine are equal, accordingly r¼ 0.134, P¼ 0.70,
r¼ 0.41, P¼ 0.22, r¼ 0.29, P¼ 0.38. On our data, correlation between ST
and concentration of glucose in CSF also varies in process of increase of life
duration of a surface (coefﬁcients of correlation with s1 r¼0.42, P¼ 0.31;
s3 r¼ 0.40, P¼ 0.03). ST of CSF is determined mainly by increase of the
correlation between glucose and protein of CSF r¼0.61, P< 0001). The
high contents of protein in CSF assumes high values of the module binding
elasticity (r¼ 0.68, P< 0.05) and small time of a relaxation of a surface
(r¼0.61, P< 0.05). A corner of an inclination l characterizes size of
adsorption and the contents of protein. In this connection the revealed close
correlation between the contents of protein l1 (r¼ 0.42, P< 0.05) and l2
(r¼ 0.76, P< 0.05) is represented.
Conclusions:Distinctions in size of STof CSF in the ﬁeld of short times of life
of a surface are caused by the maintenance in its electrolytes. Concentration of
the last is inversely proportional to the contents of protein in liquor. The basic
distinctions in size of STof CSF, irrespective of time of life of a surface, ﬁnally
are caused by the contents of protein.
P1071 The impact of a sore throat score in streptococcal
pharyngitis
C. S. Stingu, T. Turcu, S. Dimitriu, D. Dimitriu
Iasi, RO
Objective:To establish the validity of a clinical sore throat score (proposed by
CDC) in Infectious Disease Hospital from Iasi, Romania. and to ﬁnd out if
this score will reduce the number of antibiotic prescriptions for upper
respiratory tract infectious.
Methods: This study included 168 patients hospitalized between January 1
and November 1, 2002 in Infectious Disease Hospital from Iasi, Romania.
The sore throat score had ﬁve criteria: age (3–15, 15–45, >45), temperature
higher than 38 8C, absence of cough, tender anterior cervical nodes, tonsillar
swelling or exudate. The score range is 1 to 5. Pharyngeal swabs were
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collected from each patient for throat culture (considered gold standard).
Culture was done on blood agar, plates were incubated aerobically for 48 h. In
this study we included only patients with no antibiotic therapy prior
examination and without other infectious diseases.
Results:Of the 168 patients, 53 (31.5%) had a positive culture result for beta
hemolitical streptococci. Most of the patients 106 (63%) was between 15 and
44 years of age. Temperature higher than 38 8C was present in 81 (48.2%)
patients, absence of cough in 79 (47.1%), tender anterior cervical nodes in 20
(11.9%) and tonsillar swelling or exudate in 125 (74.4%). Antibiotics were
prescribed in 158 (94.04%) cases. Compared with throat culture a score of 3 or
higher than 3 has a sensitivity of 62.26%, a speciﬁcity of 78.26%, a positive
predictive value of 56.7% and a negative predictive value of 81.81%. Efﬁ-
ciency of this score is 73.21%.
Conclusions: All the patients with score 0 should be excluded from culture
with no antibiotic therapy. Although several other studies extend this con-
clusion to patients with score 1 in our study from 31 patients with score 1, 4
(2.3%) had a positive culture for beta hemolitical streptococci so they should
not be excluded from culture or a rapid antigenic test (if it is available). Using
this score the prescription of antibiotics would have been reduced in our study
with 28.5%.
P1072 Value of the naproxen test in the differential
diagnosis of prolonged febrile illnesses
S. Vanderschueren, D. Knockaert, W. Peetermans, H. Bobbaers
Leuven, B
Objectives: Several studies in oncological patients have suggested that the
antipyretic response to naproxen is sufﬁciently speciﬁc to distinguish tumor-
related fever from infectious fever. We sought to determine the sensitivity and
speciﬁcity of the ‘naproxen test’ in unselected patients presenting with a
prolonged febrile illness of unknown etiology.
Methods: From a prospectively collected cohort of 290 patients admitted to a
single university center with a prolonged unexplained feverish illness, we
reviewed the charts of a group of 77 patients who received a non-steroidal
anti-inﬂammatory drug (NSAID), mainly naproxen, during the diagnostic
work-up. A complete reponse to the NSAID (‘positive naproxen test’) was
deﬁned as a decrease of maximal body temperature to below 37.2 8C. The
ﬁnal diagnosis was established at the time of discharge from the hospital or
during follow-up and the response to the NSAID was compared in the
different diagnostic categories.
Results: A complete antipyretic response to the NSAID occurred in 6 of 11
(54.5%) patients with neoplastic fever vs. in 25 of 66 (37.9%) patients with
nonneoplastic fever (P¼ 0.48). The sensitivity, speciﬁcity, and accuracy of the
naproxen test for neoplastic fever were 55, 62, and 61%, respectively.
Conclusion: The naproxen test is not speciﬁc for tumor-related fever and has
no differential diagnostic role in the work-up of a patient with prolonged
unexplained fever.
P1073 Routine use of the new commercial test,
GLABRATA RTT for the rapid identiﬁcation of Candida
glabrata in six laboratories
A.-M. Tortorano, O. Faure, A. Nicholson, B. Willinger, P. Verweij,
J. Peman, A. M. Freydiere, G. Land
Milan, I; Grenoble, F; Newcastle, UK; Vienna, A; Nijmegen, NL; Valencia,
E; Lyon, F; Houston, USA
GLABRATARTT (Fumouze Diagnostics, France) is the ﬁrst commercial test
based on the ability of C. glabrata to hydrolyze trehalose but not maltose,
within 20min. It uses a glucose-oxidase reaction to detect glucose, and
requires only 4–6 colonies.
Objectives: To assess the performance of this test in the real clinical setting of
six laboratories from six countries.
Methods: A total of 275 freshly isolated yeasts including 191 C. glabrata and 84
non-C. glabrata strains were tested. These strains were isolated either on Candida
ID from BioMerieux (50 strains in Laboratory A), or CHROMagar Candida
fromBectonDickinson (60 strains either in Lab. B, or in Lab. C) or Albicans ID2
from BioMerieux (45 strains in Lab. D) or Sabouraud 4% dextrose from Biolife
(86 strains in Lab. E) or SabouraudChloramphenicol 4%Dextrose fromBBL (29
strains in Lab. F). All the strains were fully identiﬁed using standard methods.
Results:Using Candida ID medium (Lab. A), the GLABRATA test showed a
sensitivity and a speciﬁcity of 100%. Using CHROMagar Candida (Lab.
Bþ Lab. C), the sensitivity and speciﬁcity were 93.3 and 100%, respectively.
Using Albicans ID2 (Lab. D), the sensitivity and speciﬁcity were 100 and 92%,
respectively. Using Sabouraud Dextrose from Biolife (Lab. E) the sensitivity
was 94.2%. Using Sabouraud Chloramphenicol 4% Dextrose from BBL (Lab.
F) the sensitivity and speciﬁcity of the test were 42.8 and 100%, respectively.
Overall, the GLABRATA test allowed the identiﬁcation of 175 of 191
C. glabrata strains (sensitivity 91.6%) and only 2 of 84 isolates of other yeast
species yielded a false-positive result (speciﬁcity 97.6%). If the data from Lab.
F, where 8 of the 14 C. glabrata strains gave an uninterpretable result were
excluded, the sensitivity increased to 94% and for the ﬁve other laboratories
sensitivity and speciﬁcity were consistent from one laboratory to another. In
Lab. E, the 5 C. glabrata strains yielding a false-negative result gave a positive
result after a second testing. On the three chromogenic media which allow a
good discrimination of the colonies, in 93.1% of cases, the test could be
performed directly from the primary isolationmedium thus reducing the time
for the instauration of an efﬁcient treatment.
Conclusion: The rapid and easy to perform GLABRATA test proved to be
highly reliable for the identiﬁcation of C. glabrata in routine use of clinical
laboratories.
P1074 Fungi isolated from bile of patients undergoing
bile duct surgery
M. Wroblewska, E. Swoboda-Kopec, A. Rokosz, G. Nurzynska,
A. Bednarska, M. Przybylski, M. Luczak
Warsaw, PL
Objectives: The study comprised the patients undergoing surgery in the
tertiary care hospital in Warsaw (1200 beds) during 2 years (2000–2001) due
to the gallbladder and bile ducts pathology.
Methods: Fungal strains were cultured from the following clinical specimens:
bile and swabs from the drains of the bile ducts, taken before and after the
operation. The culture was done according to the standard mycological
procedures and commercially available tests (BioMerieux, Sanoﬁ Diagnostics
Pasteur). Susceptibility to antifungal agents was tested using an E-test system
(AB BIODISK, Sweden).
Results: In total 62 specimens were cultured (in 2000–2023; in 2001–2039).
Out of them 62 strains of yeast-like fungi were isolated. C. albicans was the
most commonly isolated species – 38 strains (61.3%), followed byC. glabrata –
7 strains (11.3%) and C. inconspicua – 7 strains (11.3%), C. tropicalis – 4
(6.5%), C. parapsilosis – 3 (4.8%), C. krusei – 1 (1.6%), C. valida – 1 (1.6%) and
C. guilliermondi – 1 (1.6%). C. albicans strains were sensitive to amphotericin B
and ﬂuconazole. All strains of C. inconspicuawere susceptible to amphotericin
B and itraconazole.
Conclusion: C. albicans was the fungal species most frequently isolated from
the bile of surgical patients. Strains of C. inconspicuawere characterized by the
highest frequency of resistance to antifungal drugs.
P1075 Evaluation of Candida ID 2, a new chromogenic
medium for yeasts
J. M. Roche, F. Villeval, V. Mula
Craponne, F
Objective: Candida ID 2 chromogenic medium (BioMe´rieux, France) is an
evolution of Candida ID for the isolation of yeasts, the identiﬁcation of
Candida albicans (blue colonies) and differentiation of other species belonging
to the C. tropicalis, C. guilliermondii, C. kefyr and C. lusitaniae group (pink
colonies). This medium includes a novel patented speciﬁc inhibitor of the
C. tropicalis hexosaminidase enzyme. The other species of yeast give white
colonies.
Methods: One hundred and ﬁfty-eight yeast strains (158) and 61 bacterial
were isolated onAlbicans ID 2 (ALB),Candida ID (CAND), andCandida ID 2
(CAN2) in order to study fertility and selectivity of these media. Growth, size
and coloration of the colonies were monitored after 24 h of incubation at
35 8C. Results obtained with collection and clinical strains have shown that
selectivity for bacteria is superior on CAN2 especially for strains from clinical
specimens. Data showed that 97% of the strains tested were inhibited on
CAN2 against 82% on CAND. Growth, size of colonies and sensitivity
on CAN2 have been improved; 41% of the strains grow in larger colonies
size on CAN2 compared with CAND and ALB. The intensity of coloration
with CAN2 has been improved for 83% of C. albicans strains allowing a better
reliability. No false negative results was seen on CAN2 whereas one strain of
C. albicans was colorless on CAND and 2 strains on ALB. In addition no false
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positive results were given for C. tropicalis strains on CAN2. According to
these results, detection of mixed cultures should be easier than ever with three
perfectly distinct colony colors for this new chromogenic medium.
Conclusion: Candida ID 2 shows a signiﬁcant increase in sensitivity and
speciﬁcity of identiﬁcation of C. albicans; no C. albicans false-negative results
were found. It enables the identiﬁcation of C. albicans as well as the dis-
crimination between Candida glabrata and C. krusei (white colonies) and the
C. tropicalis, C. guilliermondii, C. kefyr and C. lusitaniae group. Complete iden-
tiﬁcation of the main yeast species in clinical specimens were mainly obtained
in 24 h with possible conﬁrmation at 48 h.
P1076 Performance of Chromagar Candida and BIGGY
Agar for presumptive identiﬁcation of yeasts
M. Yucesoy, S. Marol
Izmir, TR
Objectives:The importance of identifying the pathogen as quickly as possible
has encouraged the development of differential media for the identiﬁcation of
yeasts. In this study two differential media, CHROMagar Candida (CHRO-
Magar, French) and BIGGY agar (Nickersen agar) (Oxoid, England) were
evaluated for the presumptive identiﬁcation of yeast species.
Methods: A total number of 270 yeast strains including 169 Candida albicans,
33C. tropicalis, 24C. glabrata, 18C. parapsilosis, 12C. krusei, 5Trichosporon spp.,
4 C. kefyr, 2 C. lusitaniae, 1 Saccharomyces cerevisiae and 1 Geotrichum candidum
were included. The strains were ﬁrst identiﬁed by germ tube test, morpho-
logical characteristics on cornmeal Tween 80 agar and Vitek 32/API 20 C
AUX systems. In parallel, they were also streaked onto CHROMagarCandida
and BIGGYagar plates which were prepared according to the manufacturers’
recommendations. The results were read according to the color, morphology
of the colonies and the existence of halo around them after 48 and 72 h of
incubation at 370 8C in the dark.
Results:All the strains did grow and the properties of the colonies were clearly
distinguished after 48 h of incubation. The sensitivity and speciﬁcity values for
C. albicans strains were found to be 99.4, 100% for CHROMagarCandida and
87.0, 75.2% for BIGGYagar, respectively. The sensitivity values for CHRO-
MagarCandida changed between 90.9 and 100%while the speciﬁcity rate was
100% for other Candida species. The sensitivity rates for BIGGY agar were
between 66.6 and 100% while the speciﬁcity values changed between 95.4
and 100% for other Candida species.
Conclusion: It can be concluded that the use of CHROMagar Candida is an
easy and reliable method for the presumptive identiﬁcation of most com-
monly isolated Candida species especiallyC. albicans, C. tropicalis, C. krusei and
C. glabrata. On the other hand, BIGGY agar can also be used for the
identiﬁcation of Candida species however; its sensitivity and speciﬁcity values
are lower for the most isolated species such as C. albicans and C. tropicalis.
P1077 Improving medical outcomes, service outcomes
and cost outcomes: implementation of Rapid Respiratory
Viral Direct Fluorescent Testing (the Raving Fans
Generating Test Process)
J. A. Daly, K. Gerber, H. Castillo, C. L. Byington
Salt Lake City, USA
Objectives: ‘Between the health care we have and the care we could have lies
not just a gap, but a chasm.’ Intermountain Health Care (IHC) is an inter-
nationally recognized leader in closing this quality chasm. For more than
15 years, we have studied care processes and the consistent delivery of healthcare
according to best practice standards. Our objective in this evaluation is to
determine if the availability of a sensitive, rapid diagnostic test for respiratory
viruseswould affect length of stay (LOS)and antibiotic use in a children’s hospital.
Methods: A study was performed at Primary Children’s Medical Center
(PCMC) to determine the adequacy of direct ﬂuorescent assay (DFA) in rapid
detection of viral respiratory pathogens. Acquired fundamental knowledge
was applied to improve the process using outcomes research techniques. Each
nasal wash sample was prepared by cytospin and tested by the following
methods: (1) SimulFluor Respiratory Screen (Chemicon International,
Temecula CA), followed by SimuFluor FluA/FluB and SimuFluor Para
1,2,3/Adeno stains if warranted, (2) viral respiratory culture using four shell
vials with 72 h and 10 day exit stains.
Results: A true positive was deﬁned as any nasal wash specimen that was
positive by DFA and by viral culture. Of the 6225 adequate samples, 2177
were true positive for an overall positivity rate of 34.9%. Viral distribution was
Respiratory Syncytial Virus (N¼ 1433), para inﬂuenza virus (N¼ 269),
adenovirus (N¼ 146) inﬂuenza A (N¼ 275) and inﬂuenza B (N¼ 54).
Overall sensitivity and speciﬁcity was 86.7 and 93.8%, respectively. Average
turn-around-time was approximately 9 h.
Conclusions:With each positive DFA diagnosis, medical outcomes improved
by shortening LOS by 1.5 days and administration of less IVantibiotics by 18%
(P¼ 0.008) and administration of less oral antibiotics at discharge by 15%
(P¼ 0.02). Service outcomes improved by providing a diagnosis within 9 h
(vs. 4–5 days) and cost outcomes improved by providing a savings of US
$4,000.00 per positive DFA diagnosis.
P1078 Evaluation of a new chemiluminescent assay for
the detection of Epstein-Barr virus antibodies
I. Solino, C. Freyre, E. Palacios, A. Dominguez, S. Garcia-Valdivia,
M. Hernandez, M. Rodriguez-Iglesias
Puerto Real, E
Objectives: Epstein-Barr virus (EBV) infects and persists for life in the
majority of the human population which is developed in several levels, from
the acute infectious mononucleosis to reactuvation of the latent virus. We
have evaluated a new chemiluminiscent assay for to determine the proﬁle
anti-EBV antibodies and the EBV infection status.
Methods: Two hundred and forty-eight sera were selected from several
situations deﬁned by clinical and analytical criteria: not infection (27), acute
infection (56), past infection (79) and reactivation (86). Anti-EBVantibodies
(VCA IgG, EBV IgM, EBNA IgG, EA IgG) were quantitatively determined
by a automation chemiluminiscent assay (Liaison, Diasorin).
Results: From 27 EBV(–) patients, 21 were negative markers and 6 were
EBNA IgG close to cutoff. In samples corresponding to acute mononucleosis,
51 were EBV IgM (91.0% sensitivity and 90.9% speciﬁcity) with negative
detection of anti-EBV IgG (VCA, EBNAor EA). For the detection of present
or past EBV infection, sensitivity, speciﬁcity, and positive and negative
predictive value were 100, 77.7, 97.3 and 100, respectively. EBV reactivation
was a close relationship with the quantitative value of anti-EBNA because
over 600 IU/mL the positive predictive value was 88.6, falling to 69.3 and
61.8 when over 200 and 100 IU/mL, respectively, were detected. From 55
sera with past infection studied, only 2 positive and 6 in gray zone EA IgG
were detected, corresponding tocases of subacute infection, with EBV IgM
negative and ENBA IgG low or negative value.
Conclusions: The detection of EBVantibodies by chemoluminiscent Liaison
assay is a new automatedmethod very useful for to know EBV infection status.
Their advantages are speed, automation, simplicity, quantitative measure, run
high workload and good sensitivity to detect acute infection. As disadvantages
we found very difﬁcult to detect EBV reactivation however, is possible to
demonstrate past reactivation when EBNA IgG titer s very high. The
implementation of avidity test for to VCA IgG can be to improve the
discrimination between subacute or past infection, when EA IgG shows
unﬁnished result.
P1079 Chlamydia pneumoniae pediatric serology:
comparison between two assays
A. Micillo, V. Formicola, A. De Rosa
Naples, I
Objectives: Serological analysis represents the current routine method for the
diagnosis of C. pneumoniae infections because the direct research by PCR is
difﬁcult. The microimmunoﬂuorescence assay (MIF), which requires exper-
tise to perform, was considered, for a long time, the ‘gold standard method’.
Now, automated enzyme-linked immunosorbent assays (ELISAs), which are
more standardized and for which the reading of results is less subjective, have
been developed for routine diagnosis. The aim of our study was a comparison
between two assay methods (ELISA and MIF), for the determination of anti-
C. pneumoniae antibodies in paediatrics.
Methods: We selected serum samples from children (2–14 years) during
normal laboratory routine: 104 children with high or low respiratory tract
infections that showed high serum level C. pneumoniae-speciﬁc IgM and/or
IgG antibodies in MIF (SeroFia, Savyon, IL), and 114 sera from apparently
healthy children without antibodies (according toMIF) againstC. pneumoniae,
C. trachomatis, C. psittaci which were used as a control group. C. pneumoniae-
speciﬁc IgM and IgG antibodies were also determined in these two groups of
serum samples by a commercial ELISA test (Cp-Eurospital, I). The tests were
performed and analyzed as recommended by the manufacturer.
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Results: Results show the speciﬁc concordance of the presence of anti-
C. pneumoniae IgM and IgG antibodies in different patient groups determined
by two assays. Therewas a very high concordance (98%) between the results of
the two different methods.
Conclusions: The results obtained by ELISA overlap those obtained by a
traditional MIF assay and show that the ELISA test is highly reliable. In
addition, the rapidity, the ease of use, the possible automation as well as the
easy analytical interpretation independent of the subjective evaluation of the
operator, are important advantages.
P1080 Tau- and S100B-protein but not phospho-tau
in the cerebrospinal ﬂuid are higher in bacterial than in
viral infections of the central nervous system
H. Schmidt, B. Ciesielczyk, J. Gerber, R. Nau, M. Otto
Goettingen, D
Objectives: In patients presenting with fever and meningism, the differentia-
tion of bacterial from viral central nervous system infections often remains
clinically uncertain, despite of additional and widely accessible laboratory
parameters. S100B, tau and phospho-tau (ptau) all are proteins being released
in various kinds of brain damage. The concentrations of the glial protein
S100B in the serum and cerebrospinal ﬂuid (CSF) predict the outcome after
hypoxic brain damage. The neuronal proteins tau and ptau help in the
differential diagnosis of dementia. This pilot study aims to evaluate the pattern
of S100B, tau and ptau release in infections of the nervous systems and their
potential value in the differential diagnosis algorithm of viral and bacterial
infections.
Methods: CSF of patients with clinically suspected CNS-infection was
collected consecutively over 3months whenever material was left from
routine diagnostics. After the diagnostic workup had been ﬁnished, we
excluded CSF of fungal-, borrelia- and HIV-infected patients. A total of
29 specimens remained, n¼ 12 viral and n¼ 17 bacterial infections, respec-
tively, for analysis. S100B, tau- and ptau were measured using commercially
available ELISA-kits.
Results:Both S100B and tau-protein were higher in the CSF of patients with
bacterial than in those with viral infections (P< 0.05). In contrast, the release
of ptau in both groups did not differ.
Conclusion: This preliminary study shows that S100B- and tau-protein, but
not ptau protein could be helpful candidates for the differentiation of bacterial
from viral central nervous system infections.
P1081 Comparison of TestPack RSV and Directigen RSV
with direct immunoﬂuorescence assay
G. Antonaki, K. Kallergi, A. Zaﬁropoulou, C. Malliou, M. Psatha,
M. Foustoukou
Athens, GR
Objectives: In the present study, we compared two rapid diagnostic techni-
ques, Testpack RSV and Directigen RSV with direct immunoﬂuorescence
assay (DFA), for Respiratory Syncytial Virus (RSV) detection.
Methods: Fifty nasopharyngeal aspirates collected from children aged
<2 years, with acute lower respiratory tract infection, were evaluated by
Testpack RSVand Directigen RSV, for RSV detection. Thirty-six specimens
were found to be RSV positives and 14 RSV negatives, when tested with
DFA. The number of ﬂuorescing cells per optical ﬁeld (fc/pof) was counted
for the RSV positive specimens, in order to discriminate low (0–2), medium
(2–4) and high (> 5) positives. After DFA testing, all specimens were kept
frozen at – 8 8C for up to 3months before evaluation.
Results: No false positive results were accounted by Test pack RSV and
DirectigenRSV. The speciﬁcity and positive predictive value for both Tests vs.
DFA for RSV detection, was 100%, but their sensitivity ranged from 56 to
80% and 100% when low, medium or high RSV positivity specimens were
tested.
Conclusions: Negative results by Test pack RSV or Directigen RSV should
be retested with a more sensitive method, such as, PCR, cell culture, or
IFA, which are more expensive, time consuming or require experienced
personel.
P1082 A rapid modiﬁed antibody-capture
enzyme-linked immunosorbent assay for detection
of HSV-1 primary infection in humans
M. Ravanshad, M. Roostaee, A. Mostafaee, F. Sabahi
Tehran, Kermanshah, IR
Objective: Development and application of an enzyme-linked immunosor-
bent assay (ELISA) for detection and measurement of IgM antibody to herpes
simplex virus type 1 (HSV-1) in human sera.
Methods: An antibody-capture ELISA based on the reaction between
antihuman IgM, prepared in rabbits, and IgM of serum samples and HSV-
1 conjugated with horesradish peroxidase was developed and applied. Five
hundred sera from healthy persons and 26 sera from persons with primary
HSV-1 infection were tested for the presence of IgM antibody against HSV-1.
The speciﬁcity and sensitivity of the test were compared with a commercial
test kit, and was acceptable.
Results:Based on the results obtained from this method, it was shown that this
method is suitable to detect IgM to HSV-1. Seven point three percent of
healthy sera were positive for IgM. The sensitivity and speciﬁcity of the test
was measured and were 94.4 and 93.91%, respectively.
Conclusion: Detection of HSV-1 IgM provides a sensitive, rapid and eco-
nomic method for the diagnosis of HSV-1 primary infection. The ELISA test
developed in this study had acceptable sensitivity and is a suitable method for
the detection of HSV-1 primary infection.
P1083 IgG avidity for toxoplasmosis detection by the
Liaison system
J. R. Hernandez, M. V. Borobio, E. Perea
Seville, E
Objectives: To evaluate the usefulness of IgG avidity detection with an
automatic system for toxoplasmosis diagnosis and to diferentiate between
acute and past infection.
Methods: Eighty-nine serum samples collected between 1999 and 2002 from
20 patients diagnosed with probable toxoplasmosis, in whom IgM detection
was positive in a number of the sera were selected retrospectively. ELISA IgG
detection and capture ELISA IgM detection were determined by the access
system. Positive results for IgM were conﬁrmed by the Vidas system (inmu-
nocapture). IgG avidity was determined by the Liaison system.
Results:Nine out of the 20 patients with IgM positive (40 sera) had high IgG
avidity in all sera, indicating a past infection. Three patients (10 sera) showed
an IgG and IgM seroconversion and their IgG avidity changed from low to
high. In three patients (17 sera) IgG avidity remained low during few months
(between 5 and 10months).
Conclusions: IgG avidity test has demonstrated its usefulness to rule out an
acute toxoplasmosis. Long standing of low avidity IgG in sera of some patients
diminish its value to differentiate between acute and past toxoplasmosis, being
necessary complementary detections.
P1084 Performance and clinical use of stage-speciﬁc
toxoplasma antigens investigated with the new DPC
Western blot assay
V. Luyasu, C. Debauche, A. Mostaert, J. Frans, N. D’Hont,
A. Courcelles, N. Bilem
Ottignies, Brussels, Dinant, Bonheiden, Tournai, B
We evaluated the performance of the new DPC Western blot for toxoplas-
mosis on 123 sera from 103 adults and on 12 samples from 7 newborns
presumed to be congenitally infected. Clinical aspects and immune status in
the adults were supported by a panel of seven methods focusing on the
combination of isotypes IgG, IgM and IgA with avidity. The relative
speciﬁcity, in terms of absence of infection, was 100% (30/30) in individuals
with negative IgG and negative IgM antibodies, 100% (4/4) for reactivation
and 96% (28/29) for past immunity. The relative sensitivity was 100% (46/46)
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in the infected group. The seropositivity criteria for the binding of IgG were
P30 and P35 for both early seroconversion (n¼ 2) and recent infection
<3months (n¼ 36); P30, P35, P20, P24, P63 with P55 for acute infection
>3months (n¼ 8) and without P55 for past immunity (n¼ 29). P30 IgMwas
the major criterion within the infected group, whereas the group with past
immunity did not show any IgM reactivity. Following seroconversion during
pregnancy, the comparative mother–infant immunological proﬁles revealed
newly synthesized IgG antibody at birth in one child and at 3months in
another child. In contrast, IgM and IgA immunocapture remained negative in
both cases. We thus recommend the DPC Western blot as a ﬁrst line-
assay for early diagnosis of postnatal congenital toxoplasmosis and as a
second-line conﬁrmatory assay for past immunity vs. infection in adults,
in particular, when an IgM antibody has been detected by the conventional
techniques.
P1085 A rapid, simple and inexpensive Fluorescent In
Situ Hybridization (FISH) assay for direct detection of
Babesia microti on a blood smear
J. S. Shah, N. S. Harris
Palo Alto, USA
Babesiosis is a tick-borne disease caused by an intraerythrocytic parasite. At
present, four species of Babesia, Babesia microti, Babesia divergens, Babesia MOI
and Babesia-WA1 are known to infect man. B. microti, B. MOI, and Babesia-
WA1 are present in the US. B. divergens and B. microti are present in Europe.
The Giemsa-staining of a whole blood smear is the method of choice for
diagnosing Babesiosis. However, it is neither sensitive nor speciﬁc. The
introduction of PCR to the ﬁeld has resulted in greater speciﬁcity and
sensitivity, but the time and cost requirements are still not optimal. Therefore,
we have developed a highly speciﬁc, inexpensive and simple ﬂuorescent in situ
hybridization (FISH) test for detection of B. microti directly on an air-dried
blood smear. The assay can be performed in less than 1 h. An added advantage
is that the assay provides parasite morphological information. The ribosomal
RNA of B.microti, within the ﬁxed blood smear (on a glass slide), is hybridized
to a ﬂuorescent-labeled oligomer probe that is highly speciﬁc for B.microti.
The excess probe is washed off. The processed smear is counterstained and
viewed at 40 under UV microscope using ﬂuorescent speciﬁc ﬁlter set. The
B.microti parasites if present ﬂuoresce apple-green within the red blood cells.
Over the past 2 years we received 25 blinded blood samples from patients with
Babesiosis-like symptoms from theNewYork StateDepartment (NYS). Smears
prepared from EDTAwhole blood of 21of the 25 patients, were tested by the
FISH assay. NYS conﬁrmed all 21 samples by Giemsa staining and PCR. Seven
were B. microti positive and 14 were B.microti negative. Of the 14 B.microti
negative samples, 3 were fromPlasmodium falciparum positive patients and 2were
from Trypanosoma cruzi positive patients. All 14 B. microti negative samples were
negative by the FISH assay. Of the 7 positives, 6 were correctly identiﬁed by the
FISHassay. The one sample thatwasmissed by the FISH assaywas from a patient
whose blood was at 4 8C for more than 5months before the smear was made.
Thus, the FISH assay had a speciﬁcity of 100% and sensitivity of 86%.
Molecular diagnosis and characterization of Gram-negative bacteria
P1086 A combined AFLP – multiplex PCR assay for
molecular typing of Escherichia coli strains using
variable bacterial interspersed mosaic elements
(BIMEs)
M. Dendis, R. Horva´th, M. Grijalva, J. Schlegelova´, F. Ruzicka,
J. Benedı´k
Brno, CZ
Objective: The original method for molecular typing of E. coli strains was
developed using the polymorphisms in chromosomal sequences of bacterial
interspersed mosaic elements (BIMEs) detected by multiplex polymerase
chain reaction (PCR) and analyzed by ampliﬁcation fragment length poly-
morphism (AFLP) assay.
Methods:The method was based on detection of the patterns obtained by the
combinations of three different ampliﬁcation products of variable sequences
localized between the genes for mtlA and mtlD, lamb and malM, araA and
araD. The three primer pairs were targeted to the conserved sequences of 30
and 50 ends of these genes to amplify variable intergenic sequences. The
lengths of these amplicons were variable due to strain-speciﬁc arrangements of
noncoding intergenic sequences BIMEs and boxCs, which are located
between relatively conserved genes. The applicability of the method as an
epidemiological tool was tested on the group of 350 E. coli strains cultured
from beef meat, milk and milk products and on 174 E. coli strains cultured
from human feces and urine.
Results: The observed fragment lengths varied from 170 to 554 bp and were
combined producing 18 genotypes (A–S) from which some were preferen-
tially detected in certain materials (genotype J in human urine, genotype C in
human feces and in cow milk). Signiﬁcant differences were found in the
frequencies of these genotypes among various groups of different origins
(milk farms 1 and 2).
Conclusion: From the data here presented we could conclude that this
method can reliably detect and recognize various E. coli genotypes. The
presented method when tested on bigger groups of epidemiologically dif-
ferent sources could be promising tool for simple, rapid, robust and repro-
ducible molecular epidemiology of E. coli.
P1087 Use of real-time PCR for rapid detection of
Salmonella spp.
C. Palomares, M. J. Torres, J. Aznar, J. C. Palomares
Seville, E
Objectives:The development of a rapid and reliable real time PCR assay, that
uses a single-tube ampliﬁcation, for the detection and quantiﬁcation of
Salmonella organisms and its application for the rapid detection of Salmonella
spp. in mayonnaise samples.
Methods: A pair of primers were used to amplify a 457-bp fragment that
overlaps the junction between the invE and invA genes, and for detection we
used either Sybrgreen I or two speciﬁc labeled probes that hybridize with
adjacent sequences in the amplicon when present in the reaction mixture.
Ninety-two strains of 35 different Salmonella serovars and 77 strains belonging
to 34 non-Salmonella species were studied.
Results: The sensitivities of both assays were higher than those of previously
described PCR protocols; 5 fg of DNA/PCR for the Sybrgreen method and
10 fg of DNA/PCR were detected for the hybridization method. The
speciﬁcities were 100% for both systems. We were also able to detect 1 cell
in 25 g of food product after 7 h of preenrichment in buffered peptone water
(BPW), with both LC Sybrgreen and LC FRET PCR.
Conclusions:The capillaries tubes do not have to be reopened for post-PCR
analysis, the risk of carryover contamination is minimized. With the Light-
Cycler methods, all the strains were correctly identiﬁed within 30min
without the need of any post-PCR sample manipulation. Overall, this pilot
study has revealed that the LightCycler technology is an extremely rapid and
economical method for the detection of Salmonella organisms.
P1088 Rapid and highly sensitive detection of
Pseudomonas aeruginosa by real-time, on-line PCR
using the LightCycler instrument
B. Panzinger, T. Emrich
Penzberg, D
Objectives: Pseudomonas aeruginosa is an opportunistic pathogen that causes a
variety of localized infections, e.g. of the urinary tract, respiratory system, soft
tissue, endocarditis, and a variety of systemic infections, particularly in burn
patients and immunosuppressed patients. P. aeruginosa has emerged as one of
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the most important nosocomial pathogens causing more than 10% of all
nosocomial infections, as this organisms is inherently resistant to common
antibiotics and even survives in antiseptics.
Methods: We have developed a real-time, on-line PCR-based assay to
speciﬁcally detect P. aeruginosa in nucleic acid preparations from bacterial
cultures, blood cultures and biological samples for research use.
Results: Using the LightCycler Instrument for ampliﬁcation and simulta-
neous detection of the target DNAwe were able to detect P. aeruginosa over a
seven log 10 dynamic range with an analytical sensitivity of less than 10
genome equivalents per reaction (Probit analysis; 95% cut-off value). Spe-
ciﬁcity of the assay for P. aeruginosa was demonstrated by analysis of 90
P. aeruginosa isolates and 100 other Pseudomonads or unrelated organisms.
Inclusion of an internal control that is ampliﬁed/detected simultaneously in
the same PCR reaction prevents misinterpretation of false negative results
caused by PCR inhibitors or due to inefﬁcient nucleic acid extraction. In
addition, the closed-tube homogenous detection format eliminates the
necessity of post-PCR analysis and the risk of carry-over contamination.
Conclusions:The assay provides a new research tool for rapid, highly speciﬁc
and sensitive detection of P. aeruginosaDNA. The assay is especially adapted to
the PCRWorkﬂow System (MagNA Pure LC and LightCycler Instrument)
thus enabling automation of the complete isolation/detection process from
the sample to the result under standardized conditions.
P1089 Comparison of phenotypic and molecular
methods to identify multiresistant bacteria from cystic
ﬁbrosis patients
F. M. MacKenzie, S. V. Smith, K. E. Milne, I. M. Gould
Aberdeen, UK
Objectives: It is essential to accurately identify Gram-negative non-ferment-
ing bacilli in cystic ﬁbrosis (CF) patients as both their clinical signiﬁcance and
interpretation of susceptibility test results differs. The aim of this study was to
compare routinely performed phenotypic identiﬁcation with molecular
identiﬁcation methods.
Methods: 90 Gram-negative non-fermenting bacilli were identiﬁed by API
and other phenotypic methods as well as by species speciﬁc PCR. Previously
described primers were used to identify the 23S rRNA gene in Stenotropho-
monas maltophilia, the 16S rRNA gene in Alcaligenes xylosoxidans and Pseudo-
monas aeruginosa and the recA gene in the Burkholderia cepacia complex.
Results: The majority of the isolates (59) originally identiﬁed phenotypically
as P. aeruginosa. Of these 91.5% conﬁrmed by PCR. The remainder were
identiﬁed using PCR as either A. xylosoxidans (3 isolates) or S. maltophilia (2
isolates). Of the 19 isolates which were phenotypically identiﬁed as B. cepacia,
10 were conﬁrmed by PCR. The remainder were identiﬁed by PCR as
S. maltophilia (6 isolates),A. xylosoxidans (1) or P. aeruginosa (1) with one isolate
remaining unidentiﬁed. All three of the isolates identiﬁed phenotypically as
A. xylosoxidans were conﬁrmed by PCR. All nine of the isolates identiﬁed
phenotypically as S. maltophilia were conﬁrmed by PCR.
Conclusions: 84.4% of the isolates were identiﬁed as the same species by both
phenotypic and PCR-based methods. Of the 14 isolates incorrectly identiﬁed
by phenotypic means, 57% were identiﬁed as S. maltophilia and 29% identiﬁed
as A. xylosoxidans by PCR.
P1090 Genetic diversity of Burkholderia cepacia strains
isolated from cystic ﬁbrosis patients in Torino (North-
west Italy)
T. Allice, S. Bianco, M. G. Chirillo, V. De Rose, D. Savoia
Orbassano, I
Objectives: Forty-one Burkholderia cepacia strains, among which 33 isolated
from cystic ﬁbrosis patients (children and adults) in Torino (Italy) and 8
reference strains (obtained from different sources) were assessed to evaluate
their: (i) genetic characteristics (using PCR, PFGE and RAPD techniques);
(ii) transmissibility (by detection of the cblA and BCESM genes) and (iii)
antibiotic susceptibility.
Methods: The strains were biochemically identiﬁed (Vitek auto microbic
system and API 20NE). By PCR with speciﬁc primers, their genomovar
status and the presence of genes responsible for the expression of
epidemic markers were tested. Two genomic typing systems, PFGE and
RAPD, were used to further discriminate the genotypes. The antibiotic
susceptibility was analyzed using the Vitek AMS System and the disc diffusion
method.
Results: Among the isolated B. cepacia strains, 23 (70%) were characterized as
genomovar III-A and 3 (9%) as genomovar VII. No strains belonging to
genomovars I, II, III-B, IV, V and VI were identiﬁed, and 7 strains were
grouped in other not yet identiﬁed genomovars. Only one of the isolates,
belonging to the genomovar VII, was positive for the epidemic gene cblA,
whereas 15 (5 from children, 10 from adults, all genomovar III-A) were
positive for the epidemic marker BCESM. Analyzing the chromosomal DNA
with PFGE and RAPD techniques combined, 6 genotypes were differen-
tiated; only two of these were found both in children and adults. The isolates
belonging to the genomovar III-Awere distinguished in 3 genotypes and two
of these presented the BCESM gene. In all isolates we revealed a marked
resistance to the aminoglycosides amikacin and tobramicin, to the beta-
lactams carbenicillin, piperacillin and ceftazidime. In particular, in 8 of the 12
strains resistant to all these antibiotics the gene BCESM was demonstrated.
Conclusion:Themajor part of the B. cepacia strains isolated from cystic ﬁbrosis
patients belonged to the genomovar III-A (70%) and were positive for the
BCESM gene (45%). Using PFGE and RAPD, we demonstrated that these
were grouped into three peculiar types that differ from strains isolated in other
countries. Moreover, there appears to be a link between the presence of the
BCESM gene and resistance to antibiotics, suggesting a transmission of
genetic virulence factors.
P1091 Combined analysis of AFLP- and REP-PCR
patterns to determine episodes of potential transmission
with P. aeruginosa in ﬁve intensive care units
K. Weist, S. Ba¨rwolff, P. Gastmeier, H. Grundmann, H. Ru¨den
Berlin, Hanover, D; Nottingham, UK
Background: Standardized PCR-based methods are missing to genotype
numerous isolates of nosocomial pathogens. Easy-to-use methods like RAPD
techniques do not offer a high enough reproducibility. Sequence-based
procedures require a high laboratory expertise and are not fully evaluated
for the microepidemiological setting.
Objective: To evaluate a combined analysis of Ampliﬁed Fragment Length
Polymorphism (AFLP)- and Repetitive Element PCR (REP PCR)-method
determining episodes of potential transmission (EPT) with P. aeruginosa (P.a.).
Methods: A prospective study was performed in ﬁve ICUs of a university
hospital over a period of 18months with surveillance of all nosocomial
infections. All clinical P.a. isolates were collected from patients having had
more than 48 h stay in the ICU. Community acquired P.a. isolates detected in
patients from the same region were also typed. REP-PCR with ERIC2
primers and an AFLP protocol with restriction enzymes EcoRI andMseI were
used. Automated laser ﬂuorescence analysis of the PCR products was
generated in a DNA sequencer (ALF II). Cluster analysis was performed
with Gel Compar II using UPGMA and the Pearson coefﬁcient. Isolates were
assigned to the same strain if the percent genetic similarity exceeded 80% in
both PCR methods. One n isolates from different patients of the one clone
yielded in nminus 1 EPTs. For these patients their ICU stay had to overlap or
not exceed 9 days between discharge of the one patient and admission of the
other patient.
Results: A total of 1769 different patients with 28 498 patient days were
included. 184 P.a. isolates were genotyped. The genetic similarity of all type
and reference strains in different gel runs exceeded the threshold. After
exclusion of copy strains from different sites of the same patient 134 P.a.
isolates remained. 10–39 different P.a. strains were detected in the ﬁve ICUs.
84 community acquired isolates (68 strains) were genotyped. The genetic
diversity of the P.a. isolates from both sources did not differ signiﬁcantly. 18
EPTwere detected. 34 nosocomial infections due to P.a. were identiﬁed and 5
were associated with EPT.
Conclusion: Isolates of P.a. had a high clonal diversity, detection of identical
strains in different patients is possibly due to transmission. 14.7% of noso-
comial P.a. infections were associated with EPT. A combined analysis of
AFLP- and REP-PCR method may be a useful tool to determine transmis-
sion with P. aeruginosa.
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P1092 Molecular typing using arbitrarily primed
polymerase chain reaction: establishing an
epidemiological relationship between nonfermentative
Gram-negative rods involved in an outbreak of
pseudobacteremia
J. A. Severin, A. Molijn, R. Bax, E. P. M. van Elzakker
Rotterdam, Delft, NL
Objectives: A case–control study performed previously in our hospital
indicated potential contamination of blood culture (BC) bottles by non-
fermentative Gram-negative rods originating from the liquid content of the
erythrocyte sedimentation rate (ESR) tubes. The purpose of the study was to
investigate the epidemiological relatedness of these strains by arbitrarily
primed polymerase chain reaction (AP-PCR).
Methods: Fifty isolates from BC bottles and seven from ESR tubes were
collected during the year 2000. In addition 16 epidemiologically unrelated
strains were examined. Study isolates were identiﬁed by Phoenix automated
microbiology system (Becton Dickinson) and API 20 NE (BioMerieux). For
AP-PCR the following three primer sets were used: M13 core, DAF4 and
ERIC1R/ERIC2R.
Results:Based on AP-PCR ﬁve clonal groups (I–V) could be identiﬁed, with
isolates displaying similar ﬁngerprints within each group. The predominating
species in these groups were as follows: I and II Ochrobactrum anthropi, III
Stenotrophomonas maltophilia, IV Pseudomonas stutzeri and V Chryseobacterium
meningosepticum. In three of these ﬁve groups identical isolates from ESR tubes
and BC bottles were identiﬁed. All 16 unrelated strains showed different
ﬁngerprints, suggesting a high discriminatory power. Typeability was best for
primer sets DAF4 (98.6%) and M13 core (97.3%).
Conclusion: The results are consistent with our hypothesis that ESR tubes
were the source of the pseudobacteraemias. AP-PCR with primer sets DAF4
and M13 core can be used as a rapid and simple typing method for
nonfermentative Gram-negative rods.
P1094 Detection of E. coli O157:H7 stx1 and stx2 genes
by oligochromatography of PCR amplicons
P. Mertens, I. Renuart, D. Pie´rard, T. Leclipteux
Gembloux, Brussels, B
Enterohemorrhagic Escherichia coli (EHEC) produces different protein exo-
toxins that play an important role in the pathogenesis of diarrheal diseases.
Infection by Shiga-like toxin (ST)-producing E. coli may result in hemor-
rhagic colitis with the possible development of hemolytic uremic syndrome.
STEC strains are difﬁcult to distinguish by cultivation methods, except for
E. coli 0157:H7. They are more reliably identiﬁed through the detection of
their toxin genes. Several methods for the simultaneous PCR detection of
these genes have been described; analysis of the amplicons were primarily
done by gel electrophoresis that differentiates the amplicons on their lengths.
This method cannot exclude false-positives with similar lengths as one of
those expected. Speciﬁc detection requires effort and time-consuming
hybridizations with an internal probe either by blotting or hybridization-
coupled immunoassays. More recently, real-time ampliﬁcation techniques
enabled to detect speciﬁcally different genes, but with the use of expensive
equipment. In order to perform easy and speciﬁc detection of multiplex
PCR-ampliﬁed stx genes encoding the E. coli STs, we set up and tested a new
detection method that we call oligochromatography which is similar to
immunochromatography. SLT-I and II gene ampliﬁcation was performed
by PCR with one hapten-labeled primer for each gene. Biotin was used for
stx1 andDIG for stx2. For each amplicon, an internal probewas conjugated to
colloidal gold particles. Oligochromatography is performed by placing a stick
in the PCR product. While migrating, the amplicon reacts with the dried
conjugated probe and then accumulates on a line where an antihapten
antibody is coated, giving rise to a red line in less than 5min for high
positives. Oligochromatography was compared with agarose gel with ethi-
dium bromide staining for detection of PCR ampliﬁed stx genes from EHEC
strains. Oligochromatography was shown to be more sensitive and quicker
than agarose gel. Results are observed in less than 10min following the end of
ampliﬁcation. Oligochromatography could be regarded as a good alternative
to current methods since it gives rise to rapid and speciﬁc detection of
ampliﬁed products without the need of extra material.
P1095 Assessment of interlaboratory reproducibility of
genomic ﬁngerprints of Acinetobacter baumannii by the
Acinetobacter Working Group of the ENEMTI network
funded by ESF
L. Dijkshoorn, L. Dolzani, H. Heersma, M. Vaneechoutte, H. Seifert
Leiden, NL; Trieste, I; Bilthoven, NL; Ghent, B; Cologne, D
Objectives: To validate methods for electronic exchange of Acinetobacter
genomic ﬁngerprints for establishment of an Internet-based database to study
the geographic spread of clinically important strains.
Methods:Three methods were explored, RAPD-ﬁngerprinting, pulsed-ﬁeld
gel electrophoresis (PFGE), and AFLP high resolution genomic ﬁngerprint-
ing. Twenty-seven Acinetobacter baumannii strains were used including out-
break and sporadic strains. Results of the participating laboratories were
centrally analyzed using the BioNumerics software package (Applied Maths,
Sint-Martens-Latem, Belgium).
Results: RAPD proﬁles of a training set of 6 strains generated with DAF4 as
primer, Ready-to-Go RAPD beads and separation in 2% agarose gels were
not compatible between laboratories. PFGE ﬁngerprints of the 27 strains were
generated in 3 participating laboratories with ApaI as restriction enzyme,
followed by fragment separation in 1% Seakem Gold agarose for 19 h with
pulses ranging from 5 to 20 s. Central analysis with lambda ladder standard for
normalization showed 100% matching of strains, but the tolerance setting was
relatively high due to the limited set of marker lanes and the low number of
bands in the fragment size zone used. Results of multiple samples of one
Acinetobacter strain (RUH2034) indicated that use of this strain as standard
for normalizationmay allow a tolerance setting of 1.5%. Comparison of AFLP
results between two participating laboratories with different fragment separa-
tion systems indicated that interlaboratory data exchange was not possible.
Conclusion: Pulsed ﬁeld gel electrophoretic ﬁngerprints of A. baumannii
strains generated according to the used protocol have the potential to be
used for electronic data exchange and establishment of an Internet-based
database.
PCR diagnosis of difﬁcult to grow organisms
P1096 DNA ampliﬁcation of Leptospira spp. by
polymerase chain reaction in the diagnosis of leptospirosis
C. Fonseca, V. Freitas, E. Romero, E. Camargo, C. Spinosa, M. Teixeira,
M. Silva, M. Shikanai-Yasuda
Sa˜o Paulo, BR
Objectives: This study is aimed to compare PCR sensitivity between two
pairs of primers (G1/G2, Gravekamp et al., 1993 and LP1/LP2, SunHo et al.,
1994) in blood and urine samples from patients with leptospirosis; to study
PCR speciﬁcity in samples in healthy individuals and patients with other
diseases; to compare PCR results with the microagglutination (SAM), IgM
ELISA and the macroagglutination test (SAT).
Methods: Among the 60 patients screened, 33 had conﬁrmed diagnosis of
leptospirosis with seroconversion through microagglutination test and/or
positive hemoculture and 27 patients with antibodies titers  at 800,
according to WHO (Faine, 1994). The control group was constituted by
44 healthy individuals with nonreactive microagglutination test and 20
patients with other diseases, conﬁrmed by microbiologic, parasitologic
and/or immunologic tests. The following tests were applied for statistical
analyses: w2 test with Yates correction, Fisher exact test if necessary and
McNemar test for evaluation of response between two dicotomic variables
with the signiﬁcance level of 5% (P¼ 0.05).
Results: Sensitivity with both primers was 10 pg in agarose gel and 1 pg by
hybridization. In blood and/or urine samples these primers were able to
amplify DNA in 39 out of 60 patients with leptospirosis (65%). Use of primers
Clinical Microbiology and Infection, Volume 9, Supplement 1, 2003 257
G1/G2 (60%) proved to be more sensitive in comparison to LP1/LP2
(30%)(P¼ 0016). Urine samples presented greater sensitivity (45.8%) with
primers G1/G2 in relation to blood samples (31.7%) in patients with leptos-
pirosis. However, greater sensitivity was observed in blood samples (21.7%)
with primers LP1/LP2 than in urine samples (12.5%). The PCR with each of
the primers proved to be speciﬁc, not amplifying DNA of other bacteria, from
healthy individuals, or from patients with other diseases. Comparing serologic
tests and PCR on patient’s admittance (ﬁrst sampling) the IgM ELISA test was
the most sensitive, followed by macroagglutination and microagglutination test
and PCR. The speciﬁcity of the tests was in decreasing order microagglutina-
tion, PCR, macroagglutination and IgM ELISA.
Conclusion: In conclusion, PCR is an useful and speciﬁc technique for the
diagnosis of leptospirosis and was the only technique able to conﬁrm this
diagnosis in the initial stage of the disease in 4 out of 11 patients presenting
negative results for all serologic tests. Supported by: FAPESP and Laboratory
of Immunology (LIM 48), Clinic Hospital, School of Medicine, Sa˜o Paulo
University.
P1097 Polymerase chain reaction assay speciﬁc for
pathogenic Leptospira based on the gene encoding the
hemolysis-associated protein (Hap1): identiﬁcation of the
primers Adia 217 and 2181
C. Branger, B. Blanchard, C. Fillonneau, F. Aviat, B. Chevalier,
G. Andre-Fontaine
Nantes, Saint Brieuc, F
Objectives: Leptospirosis is a spirochetal disease with multiorgan involve-
ment. The clinical presentation is often a diagnostic challenge because of its
manifestation and varying severity. As pathogenic leptospires are very tedious
in culture, PCR is a more useful tool for the diagnosis of leptospirosis. Lep1-
Lep2 primers (Merien) are often used in clinical samples and are genus
speciﬁc. As animal samples would be often contaminated, it would be
interesting to differentiate the pathogenic from the saprophytic species
belonging to Leptospira genus. Two primers named Adia217 and Adia218
were selected from the gene hap1 (AF366366) of the Hemolysin-Associated
Protein (designated as LipL32 by Haake). The presence of hap1 gene were
analyzed by DNA/DNA hybridation (SB) and PCRwas performed either on
Leptospira spp. cultures either on clinical and water samples.
Methods: DNA was extracted by Qiagen process from 17 cultures of
pathogenic, saprophytic and intermediate strains of leptospires. Blood, urine
samples and kidneys were collected from dogs with leptospirosis and sub-
mitted to culture and PCR with Adia217-Adia218 after DNA extraction.
PCR analysis of concentrated water samples was performed by both primers
lep1-lep2 and Adia217-Adia218 too.
Results: Cultures of L. interrogans ss serovars pomona and icterohemorrhagiae,
L. kirschneri serovar grippotyphosa, L. borgpetersenii serovar javanica, L. noguchii
serovar panama, L. inadai serovar lyme gave a positive signal in PCR conﬁrmed
by SB whereas cultures of L. fainei serovar hurstbridge, L.meyeri serovars
semaranga and ranarum, L. wolbachii serovar codice, L. biﬂexa ss serovar patoc,
genomospecies 5 serovar sao paulo and L. illini gave a negative signal in PCR
conﬁrmed by SB. The results are discussed in term of sensitivity of culture
compared with the threshold of PCR.
Conclusions: PCRwith Adia17-Adia18 primers can be useful to differentiate
pathogenic from saprophytic leptospires. This rapid speciﬁc test has a potential
clinical and prophylaxis applications especially with surveillance of recrea-
tional water.
P1098 PCR technique for detection of Treponema
pallidum ssp. pallidum
J. Kremen, J. Strı´brna´, E. Pavlik, M. Knappova´, H. Za´koucka´
Prague, CZ
Objectives: Treponema pallidum ssp. pallidum is major human pathogen.
Emerging increase of syphilis incidence in some european countries, espe-
cially of adnate form, requires improvement of routine diagnostic techniques.
As detailed map of T. pallidum already exists, nucleic acid detection-based
methods are very promising. So far, only a few results were achieved on this
ﬁeld. Our aim was to develop sensitive, speciﬁc and user friendly PCR-based
laboratory technique for routine diagnostics of syphilis.
Methods: PCR format using DIG-labelled nucleotides and anti-DIG ELISA
detection system was chosen because of standardised commercial reagents.
Sets of primers and biotin-labelled capture-probes for three genes (polA(I),
47-kDa and bmp) were tested. For test calibration and as positive controls
T. pallidum strain Nichols—freshly cultured and freeze-dried was used. As
negative control served human DNA extracted from lymphocytes. Different
systems for sample collection and DNA isolation have been proven for lesion,
whole blood, serum/plasma and CSF specimens.
Results: Amplicor STD Specimen Collection Kit (Roche) provided optimal
conditions for DNA stability and integrity of Tp from lesions. Isolation results
from whole blood samples were equal, using Wizard DNA Isolation Kit
(Promega) or Amplicor Whole Blood Preparation Kit (Roche). Amplicor kit
seemed to be more user-friendly. Ampliﬁcation proﬁle and Mg2þ concen-
tration have been optimized for PCR reaction. Systems for 47-kDa and
polA(I) genes were more effective than bmp one. Fresh Nichols strain
functioned best as positive control. Co-ampliﬁcation-based internal control
using system for tpA or beta-actine gene sequences was added to avoid false
negative results due to polymerase inhibition. Test sensitivity limit for whole
blood was 50 T. pallidum cells/mL.
Conclusions: PCR technique was optimised for routine detection of Trepo-
nema pallidum DNA in lesion and whole blood samples. Standardised sample
collection, preparation, ampliﬁcation and detection reagents and coampliﬁ-
cation-based internal control were implemented. Test is rapid, sensitive and
user-friendly.
P1099 PCR in Lyme neuroborreliosis—post-treatment
progress
D. Pı´cha, L. Moravcova´, S. La´sikova´, E. Zda´rsky´, V. Maresova´
Prague, CZ
Objectives:High diagnostic value of PCR in neuroborreliosis (NB) is caused
by the direct way of spirochete detection. Elimination of DNA after acute NB
is poor documented. Prospective study on this topic is being held and the latest
results are presented.
Methods: Three sets of primers in nested PCR were used: one for plasmide
gene encoding OspC protein and two for chromosomal gene – 16S rDNA
and ﬂagellin. So far 57 patients with clinically manifested involvement in NB
were enrolled into the prospective study. Patients were included according to
main criterions: positive CSF/serum antibody index (in 48 patients) and PCR
positivity in CSF (in nine patients). Patients were examined by neurologist
and samples of CSF, plasma and urine were taken before treatment and after
treatment was urine examined in periods as followed: (1) after treatment
(3weeks of benzylpenicilin) (2) after 3months (3) after 6months. The most
frequent clinical diagnosis was Bannwarth’s syndrome (31), acute encephalitis
(14) and poly(radiculo)neuritis (12).
Results:Before treatment were 20 patients PCR positive in CSF, 16 in plasma,
and 28 in urine. Five were parallel positive in all three body ﬂuids. Urine after
treatment was positive in 17 cases (30%), after 3months was positive in 8
patients (15%) and after 6months in 1 (2%).
Conclusions: In themost of patients DNAhas been eliminated up to 3months
from urine. The frequency of PCR positivity in urine and CSF is very similar
in the period before treatment. The PCR has got relative high sensitivity
(46%), but does not reach the sensitivity of antibody index. Supported by
grant MZCR 6244; 111300003.
P1100 PCR in whole blood in diagnosis of syphilis
D. Shakhmatov, T. Chakova, O. Strelchenko
Novosibirsk, RUS
Objectives:The diagnosis of false-positive or false-negative results of serologic
tests in syphilis continues to pose a difﬁcult clinical challenge. Because the
serodiagnosis of syphilis has signiﬁcant limitation, the direct detection of
Treponema pallidum in suspect blood may serve as an alternate diagnostic
strategy. The aims of the present study were to develop polymerase chain
reaction (PCR) with use of whole blood for the diagnosis of syphilis and to
estimate its sensitivity and speciﬁcity.
Methods: The study persons (186 patients, f/m—82/104, mean age 29 7)
included: the patients receiving treatment for syphilis in venereologic clinic;
the patients independently addressed to venereologic clinic for examination
related to syphilis; the persons directed from other therapeutic and surgical
hospitals, at which routine serologic examination revealed doubtful results.
Control group consisted of pregnant women (16), patients with chronic
infectious and skin diseases (27), drug abuse (14) and 42 healthy donors (f/
m—19/23, mean age 23 5). A polymerase chain reaction was carried out
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with nested primer pairs based on the DNA sequence of the 47–1 and 47–
2 kDa gene of T. pallidum. PCR was utilized with 1 milliliter of whole blood.
To prevent inhibiting inﬂuence of hemoglobin a pretreatment of blood
samples by the lysing buffer was performed. A complex of serologic tests:
FTA-abs and T. pallidum immobilization test (TIT) was used as the ‘gold
standard’. As a results the sensitivity of PCR was 62.5% and speciﬁcity was
93.4%. PCR at 21 patients was carried out simultaneously both with serum
and with a whole blood. The comparison of received results has shown that
the sensitivity of a method at use of serum is reduced practically twice. It
allows assuming an opportunity of a sedimentation T. pallidum with a deposit
at a centrifugation of a whole blood and validity of its use for reaction. In
conclusion results of PCR in whole blood application in syphilis detection
revealed its high sensitivity and speciﬁcity; possibility to obtain rapid results in
unclear cases. Other advantage of PCR is opportunity to discriminate
between false-positive and false-negative results of serologic tests in immu-
nologically compromised patients. The purpose of the following researches to
evaluate the opportunities of PCR application in differential diagnosis of
asymptomatic, latent syphilis and false-positive results of serologic tests.
P1101 Rapid diagnosis of Bartonella infections using
automated DNA extraction and real-time PCR
B. Duim, E. van de Maas, R. Boom, D. van der Riet, M. D. de Jong
Amsterdam, NL
Objectives: Several Bartonella species are important human pathogens that
cause a variety of clinical syndromes. Diagnosis of infections by Bartonella
species is seriously hampered by their fastidious growth characteristics. We
have developed a real-time PCR assay for rapid diagnosis of clinically relevant
Bartonella species.
Methods:TheMagNaPure LC for automated DNA isolation in combination
with LightCycler PCR and DNA sequence analysis was used. DNA was
extracted from B. henselae, B. quintana and B. elizabethae cultures. Before using
the MagNa Pure Bacterial DNA isolation kit III were cells lysed with
Proteinase K. PCR primers targeting the 16S-23S rRNA intergenic region
of the genus Bartonella were used for PCR ampliﬁcation. Amplicons were
detected with meltingcurve analysis and biprobe hybridisation. A Bartonella
generic biprobe, labeled with the ﬂuorophore Cy5 was used.When this probe
binds to complementary sequences the Cy5 is excited by the energy transfer
from Sybr Green I. After a positive probe result the amplicon is sequenced for
determination of the Bartonella species.
Results:With serial dilutions of bacteria the sensitivity of real-time detection
using Sybr Green I, was determined at 1.7CFU of B. henselae, 0.7 CFU of
B. quintana and 0.2CFU of B. elizabethae. Meltingcurve analysis enabled
differentiation of the three species. The probe assay was developed as the
primers were found to amplify human DNA from clinical samples. The
sensitivity of the probes was identical to the Sybr Green I detection. The probe
assay detected B. henselae in a lymph node from a patient with cat scratch
disease. The MagnaPure isolation in combination with the probe assay is now
being evaluated in a large number of clinical specimens.
Conclusions: Automated DNA isolation and biprobe LightCycler PCR
allowed rapid and sensitive detection of Bartonella species and, in combination
with DNA sequencing is a promising and accurate method for identiﬁcation
of Bartonella infections.
P1102 Tropheryma whipplei and gastroenteritis:
frequency of positive results in stool samples by
polymerase chain reaction
K. Horn, H.-M. van de Loo
Schwa¨bisch Gmu¨nd, D
Objectives: The leading symptoms of the Whipple’s disease are weight loss,
diarrhea and arthropathy. In the past years a rod shaped bacterium has been
associated with this disease. The causative organism was named T. whipplei and
can be detected in stool samples by PCR. The aim of this study was to
investigate the frequency of T. whipplei-PCR positive results in stool samples,
which were sent to the laboratory physician’s private ofﬁce for routine
diagnostics with the alleged clinical symptoms of diarrhea.
Methods:FromMay 2002 until November 2002, 1086 stool samples with the
suspician of enteritis pathogens were also analyzed for T. whipplei by an in
house PCR (in cooperation with IMD, Zu¨rich, Switzerland). The samples
were sent from South-west-Germany: Ostalbkreis, Stuttgart and adjacent
Bavarian Franken.
Results: T. whipplei-PCR was positive for 7.2% of the stool samples, whereas
only 4.3% Salmonellae were found. Other pathogens such as Campylobacter,
VTEC (verocytotoxin-producing E. coli), EPEC (enteropathogenic E. coli),
ETEC (enterotoxigenic E. coli), EIEC (enteroinvasive E. coli) and Norwalk (–
like) virus were found to a lesser percentage.
Conclusion: T. whipplei is a frequent agent of diarrhea. Physicians should
always consider it in their differential diagnosis since its clinical presentation
may be so variable and since it may be lethal for the patient.
P1103 Molecular diagnosis of Actinomycotic infections
A. Smith, K. Bonnelie, A. Lennon, M. Riggio, J. Hood
Glasgow, UK
Objectives: Actinomycosis is a chronic disease characterised by abscess
formation, tissue ﬁbrosis and draining sinuses. It is caused by nonspore
forming species of the genus Actinomyces. Identiﬁcation of Actinomyces spp.
is notoriously difﬁcult, time consuming and unreliable, yet clinically impor-
tant. Identiﬁcation in clinical laboratories is based solely upon a limited range
of conventional biochemical tests. The aim of this study was to develop more
reliable diagnostic methods for identiﬁcation of Actinomyces spp.
Methods: A total of 49 clinical Actinomyces isolates, taken from different
anatomic sites of infection were examined. A PCR-RFLP method was
developed for the identiﬁcation of Actinomyces clinical isolates.
Results: Analysis of the Actinomyces clinical isolates with routine laboratory
methods identiﬁed 45 A. israelii, 2 unidentiﬁed Actinomyces species, 1
A.meyerii and 1 Biﬁdobacerium spp. Analysis of the RFLP patterns resulted
in the classiﬁcation of 17 A. israellii, 16 A. gerencseriae, 13 A. voscosus, 2
A. naeslundii and 1 A. bovis isolate.
Conclusions: The PCR-RFLP method identiﬁed a greater species diversity
within the panel of isolates tested when compared with current laboratory
tests. Many infections caused by Actinomyces species are probably misidenti-
ﬁed, the use of PCR-RFLP technology should improve the diagnosis and
treatment of Actinomycotic infections and our understanding of this chronic
disease.
Anaerobic bacteria
P1105 Lactobacilli prevent antibiotic-associated
disturbances in the intestinal tract
A˚. Sullivan, L. Barkholt, C. E. Nord
Stockholm, S
Objectives:To compare the effects of clindamycin on the intestinal microﬂora
in subjects ingesting yoghurt with added probiotic microorganisms with the
microﬂora in subjects ingesting placebo yoghurt.
Methods: Twenty-four healthy subjects were included in the study. None of
them had taken any antimicrobial drugs during the three months preceding
the study. All subjects received 150mg clindamycin q.i.d. for 7 days and
250mL yoghurt b.i.d. for 14 days. The subjects were randomized into two
groups in a double-blind fashion. Twelve subjects received yoghurt containing
108 cfu/mL of each of the strains L. acidophilusNCFB 1748, B. lactis Bb12 and
Lactobacillus F19 while individuals in the placebo group received yoghurt
with no additions. Stool specimens were collected before the start of
administration (days 3 and 0), during the clindamycin administration (days
2, 5 and 7) and after the administration (days 10, 14 and 21). The specimens
were diluted 10-fold in reduced media and inoculated on selective and
nonselective media. The plates were incubated aerobically and anerobically.
All morphologically different isolates were identiﬁed to genus level. The
clindamycin inhibitory concentrations (MIC) for strains of Bacteroides spp.
collected on days 0, 7 and 21 were determined by the agar dilution method.
Results: In the aerobic intestinal microﬂora the numbers of enterococci
increased after treatment in both groups while other Gram-positive micro-
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organisms decreased. In both groups the numbers of E. coli also decreased
while there was a concomitant increase of other Gram-negative rods, mainly
Klebsiella spp. In the anerobic microﬂora in the active group the numbers of
lactobacilli and bacteroides remained stable while the numbers decreased in
the placebo group. Numbers of biﬁdobacteria decreased in both groups.
Smaller decreases were observed in the numbers of eubacteria, clostridia and
veillonella. In both groups there was an increase in MIC values for bacteroides
on day 7 that remained on day 21.
Conclusions: The probiotic microorganisms tested in this study prevented
ecologic disturbances in the dominating intestinal microﬂora during clin-
damycin administration.
P1106 The susceptibility patterns of bacteroides species
isolated in two different hospitals
M. Yucesoy, E. Mutlu, R. Brown, I. Poxton
Izmir, TR; Edinburgh, UK
Objectives: Bacteroides species are the most clinically important anerobic
pathogens due to the facts that they are the most frequently isolated anerobic
bacteria and they have the widest range of antibiotic resistance. The objective
of this study was to analyze the susceptibility proﬁles of Bacteroides species
isolated in two hospitals located in different countries and compare the results.
At the same time the results may help for the decision of empirical therapy.
Methods: A total of 36 Bacteroides strains (6 B. uniformis, 3 B. fragilis, 2
B. ovatus, 2 B. ureolyticus, 1 B. vulgatus, 1 B. caccae, 1 B. eggerthii from Izmir,
Turkey; 20 B. fragilis from Edinburgh, Scotland) isolated from clinical speci-
mens in two hospitals were included in this study. The susceptibilities of these
bacteria against imipenem, clindamycin, amoxycillin clavulanate, cefoxitin,
metronidazole and ciproﬂoxacin were determined by E-test using Brucella
agar supplemented with horse blood, vitamin K and hemin. NCCLS break-
points were used for susceptibility categorization.
Results:TheMIC ranges obtained for B. fragilis isolates from Edinburgh were
<0.002–0.5, 0.016 to >256, <0.016–32, 0.023–64, 0.023–0.38 and 1.5 to
>32 mg/mL for imipenem, clindamycin, amoxycillin clavulanate, cefoxitin,
metronidazole and ciproﬂoxacin, respectively. These values were 0.064–1.5,
0.064–0.38, 0.19–2, 2–32, 0.064–0.19, 0.25–24mg/mL for B. uniformis strains
and 0.064–0.125, 0.094–0.25, 0.19–0.25, 2–8, 0.064–0.47, 0.75–32mg/mL
for B. fragilis strains isolated in Izmir. Of the Edinburgh strains 2, 2, 1 and 16
were determined to be resistant to clindamycin, amoxycillin clavulanate,
cefoxitin, ciproﬂoxacin, respectively. Four strains were intermediate for
ciproﬂoxacin. Of the Izmir strains 2 and 10 were detected to be resistant
to clindamycin and ciproﬂoxacin, respectively. Two isolates were intermediate
for both cefoxitin and ciproﬂoxacin. None of the isolates showed resistance to
metronidazole and imipenem.
Conclusion: In conclusion, we can say that the resistance patterns of two
hospitals were similar; metronidazole and imipenem are good empirical
therapy choices of a suspected anerobic infection in these two hospitals while
clindamycin, amoxycillin clavulanate and cefoxitin should be used carefully
and ciproﬂoxacin does not seem to be an alternative drug for anerobic
infections.
P1107 Comparison of susceptibility of Bacteroides
fragilis group by MIC potency and pharmacokinetic-
pharmacokinetic (PK-PD) proﬁles
K. Aldridge, C. Ho
New Orleans, USA
Objectives: The objectives were to compare in vitro potency of selected
antimicrobials alone using in vitro parameters and to combine these values
with PK-PD values to determine percentage of the dosing interval the drug
level was over each MIC parameter (%T>MIC).
Methods: Over 400 Bfg clinical isolates were tested for susceptibility to
piperacillin-tazobactam (PT), ampicillin-sulbactam (AS), imipenem (IM),
meropenem (ME), and ertapenem (ER). MIC values (potency) were deter-
mined by NCCLS broth microdilution. Cumulative potency was compared
using the mode MIC, MIC90, and MIC99 values. Percent susceptibility (S)
was determined using NCCLS breakpoints. PK-PD values from previous
human trials using single or multiple dose area-under-curve values integrated
with MIC parameters to determine percentage T>MIC (CID 27:10, 1998).
A percentage T>MIC 50% was considered a positive endpoint.
Results: Percent S for PT, AS, IM, ME, and ER were 100, 89, 99.8, 99, and
99%, respectively. Mode MICs showed equal in vitro potency for P-T, IM,
ME, and ER and was 8-fold > activity than AS. Calculated percentage
T>MIC for PT (3.375 and 4.5 g dosing), IM (500mg q 8 h), and ER (1 g q d)
had comparable values of 115% whereas, AS (3 g of 6–8 h) had values 86–
115%. MIC90 and MIC99s indicated that IM was 4–8-fold more potent than
ME and ERwhereas PTwas 4–8-fold more potent than AS. UsingMIC90 and
MIC99 values percentage T>MIC for PTand AS (3 g q 6) was 57–76 and 15–
48%, respectively; for IM, ME, and ER the percentage T>MIC ranged from
71 to 96%, 42–92%, and 66–116%, respectively.
Conclusions: These data indicate variation in the in vitro potency of the
broad-spectrum agents tested against the Bfg although using NCCLS break-
points the susceptibility was virtually identical with the exception of AS.
Using a predictive value of 50% integration of MIC parameters with PK/PD
parameters percentage T>MIC values indicate dose dependent variation
with PT, IM, ME, and ER showing positive predictive values against the Bfg
isolates.
Bacterial vaccines
P1108 Proliferative responses in preimmunized mice
lymphocytes by Bordetella pertussis outer membrane
complex
A. Mohabbati Mobarez, R. Hosseini Doust
Tehran, IR
Objectives: Bordetella pertussis is the main etiologic agent of whooping cough.
The nature of the immunity against B. pertussis infection and disease is poorly
understood. Research on protection has traditionally been focused on the role
of humoral pertssis speciﬁc antibodies. The aim of this study was to investigate
pertussis cell mediated immunity in mice immunized with Outer membrane
complex.
Methods: A group of mice immunized with OMC and OMP of B. pertussis.
During a period of 7weeks following the immunization, lymphocyte were
isolated from lymph nodes of immunized mice. Cell proliferation was assayed
by using 1E6 cells/mL in predetermined optimal dose of OMC and OMP.
DNA synthesis was evaluated by counting H3 Thymidine incorporation.
Results: The blastogenic response of lymph nodes to 15 mg of OMP and
OMC, and 10mg of PHAwas analyzed in preimmunized mice. At 30 days of
postimmunization a signiﬁcant increase in response to OMP and OMC was
observed, but a small decrease in the level of response was evident against
OMP and OMC at 60, 120 days of post immunization. But the response was
still higher than observed at day 0.
Conclusion: Current ﬁndings evidently prove the capability of outer mem-
brane complexes of B. pertussis in inducing the cell mediated immunity.
P1109 Pertussus toxin mimics effects of whole-cell
pertussis vaccine upon hematopoiesis in mice
A. V. Sanin, O. Y. Sosnovskaya, T. N. Kozhevnikova,
A. A. Zavadovskaya, I. A. Lapaeva
Moscow, RUS
Earlier we found that whole-cell pertussis vaccine (WPV) exerted complex
and pronounced inﬂuence upon lympho-hematopoietic system in mice.
Marked proliferation of hematopoietic stem cells (HSC) was observed in
the bone marrow, followed by efﬂux of HSC from the bone marrow into
peripheral blood. Also, a sharp rise in the numbers of endogenous spleen
colonies was seen. Meanwhile, in thymus of WPV-treated mice an increase in
numbers of suppressor T cells was found capable of suppressing antibody-
forming cells activity as well as graft-versus-cell reaction, and proliferation of
syngeneic HSC. Here we attempted to make a comparison of the effects
mentioned above exerted by WPV in parallel with pertussus toxin (PT), or
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lymphocytosis-promoting factor of B. pertussis—unique toxin responsible for
most systemic reactions induced by WPV. PT isolated from B. pertussis, strain
475, was further puriﬁed using chromatography on hydroxilapatitis and
lentilectin-Sepharose 4B columns, with phosphate buffer gradient and step
elution at 48C. PT consisted of four subunits with molecular weight 28.4,
24.3, 21.8, and 15.2 kDa, was found to possess speciﬁc lymphocytosis-
promoting activity (0.2mg per mouse increased leukocyte numbers 3-fold),
and histamine-sensitizing activity. PT injected into CBA mice at a dose
0.2mg/mouse was found to give a sharp rise in endogenous hematopoietic
spleen colonies number in mice irradiated at a sublethal dose, to induce a
pronounced proliferation of bone marrow HSC, revealed by hydroxyurea
‘suicide’ assay. It was also shown to induce a severe depletion of thymus cells,
reaching its peak at day 4. Thymocytes obtained on day 2 or 3 after the
injection of PT produced a suppressive effect on endogenous colony forma-
tion and GVHR. At day 1 following PTa sharp (20-fold) rise in HSC number
was seen in the peripheral blood. Taken together, these data testify that PT
mimics all effect of WPV upon lympho-hematopoietic system that were
established earlier. As many of these reactions could be regarded as harmful
side-effects, it means that the contents of PT in acellular pertussis vaccine
preparations should be carefully controled.
P1110 Curently circulating Bordetella pertussis strains
isolated from clinical material compared with strains in the
DTP pertussis vaccine used in Poland since 1960
A. Gzyl, E. Augustynowicz, G. Dulny, J. Slusarczyk
Warsaw, PL
Objectives: Although immunization with DTP in Poland has been con-
tinuously performed from 1960, an unexpected increase of pertussis cases has
been notiﬁed in recent years. Different alleles of genes encoding S1 subunit of
pertussis toxin (ptxS1) and pertactin (prn) in currently isolated strains in
comparison with strains used in the locally produced DTP vaccine has
previously been found. The aim of the study was to evaluate an inﬂuence
of changes in pertussis vaccine strains compositions (VSC) in Poland taking
place since 1960, in respect to sequences of ptxS1 and prn genes allelic
variation seen currently. Additionally, a potential of locally produced DTP
vaccine in elimination of strains harboring different genes alleles in animal
model has been tested.
Methods: Alleles of ptxS1 and prn genes in VSC used for production within
1960–67, 1967–69, 1969–71, 1971–77, and 1978–2002 and in additional 20
currently isolated strains were determined by cycle sequencing. In animal
model, groups of BALB/C mice (40 per vaccine and 40 per control) were
immunized i.p. with 1/4 of DTP human dose twice in 2-week periods. After,
mice were nasaly challenged with B. pertussis strains harboring ptxS1B/prn1,
ptxS1A/prn1, and ptxS1A/prn2 allele combinations. The outcome of chal-
lenge was followed by performing CFU counts on lung homogenates from
individual mice (5 per time point) sacriﬁced 2 h and 3, 7, 10, 14, 17, 20,
28 days after a challenge.
Results: Within 1960–1977, strains of ptxS1B/prn1, ptxS1D/prn1, and
ptxS1A/prn1 allele combinations were used for vaccine production, and
within 1978–2002, ptxS1B/prn1 was the only one combination found in the
VSC. Two allele combinations: ptxS1A/prn1 (70%) and ptxS1A/prn2 (30%)
were characteristic for strains isolated from pertussis cases within 1995–2001.
Animal model study conﬁrmed lower potential of DTP vaccination in
elimination rates for strains harboring ptxS1A/prn2 and then pxS1A/prn1
in comparison with ptxS1B/prn1 allele combinations.
Conclusions:Our study indicates that possibility of vaccine immunity escape
mutants appearance in Poland might took place in case of pertactin and not in
case of pertussis toxin subunit S1, as not-vaccine variant (prn2) was not found
in any VSC within decades and ptxS1A has been found in VSC within 1960–
78. The results of the study suggest that a change in VSC in DTP in respect to
prn proﬁle might improve vaccine potential to eliminate currently circulating
strains.
P1111 Persistent speciﬁc T-cell memory in adults after
vaccination with acellular pertussis vaccine
C. U. Meyer, M. Knuf, F. Zepp, K. M. Edwards, M. Decker, S. Yoder,
J. Ward, D. L. Klein
Mainz, D; Nashville, Torrance, Bethesda, USA
Objectives: In the absence of well-deﬁned serologic correlates of protection
in pertussis, the importance of cell-mediated immunity (CMI) has been
acknowledged. We compared CMI responses in a subset of vaccinees in the
NIH-funded Adult Acellular Pertussis Vaccine Efﬁcacy Trial (APERT) and
compared them with responses in control recipients.
Methods: 2781 subjects were randomized to receive either aP or control
vaccine (hepatitis A). Lymphocytes from a subset (n¼ 86) enroled at one site
were tested for pertussis-speciﬁc CMI responses before, 1month and 1 year
after vaccination. Proliferation and cytokine secretion (IFNg and IL-5) from
lymphocytes cultured in the presence of speciﬁc pertussis antigens (PT, FHA,
PRN) were measured.
Results:One month and one year after vaccination the aP recipients (n¼ 66)
showed signiﬁcant increases in lymphocyte stimulation indices (LSI). One
year after vaccination PT LSI decreased by 0.69-fold, but remained signiﬁ-
cantly higher than prevaccination levels. Control vaccinees (n¼ 9) showed no
pertussis-speciﬁc CMI responses. Both IFNg and IL-5 were secreted by
pertussis antigen stimulated lymphocytes, with higher levels of IFNg.
Conclusions: aP vaccines induced strong CMI response in adults that persisted
for one year. Cytokine secretion patterns suggested a balanced Th1/Th2
immune response, comparable to those seen in animal models and in children
after acellular pertussis vaccine. The duration of CMI responses should
continue to be evaluated.
P1112 The possibility of using live-attenuated
recombinant Salmonella strain as vaccine with rectal
application
M. Boitchenko, M. Donin, A. Vorobiev, A. Ilytchev, L. Karpenko,
T. Veremeyko
Moscow, Novosibirsk, RUS
Objectives: Chronic hepatitis B is associated with serious complications
including cirrosis of the liver. T-cell mediated immunity removes infected
hepatocytes. Activation of T-cell mediated immunity is provided HBc-ag.
Thus, live-attenuated Salmonella expressing HBc-ag can be used as therapeutic
vaccine.
Methods: Attenuated cya (lack of adenylatecyclase)-supressor (CRP) mutant
of Salmonella s/t Enteritidis was used as vehicle for plasmid pkHBc expressing
HBc-ag of Hepatitis B virus. The experimental suppositories for mice
containing recombinant Salmonella in concentration 100 000 cells were
prepared. Mice were single immunizied per rectum. Releasing of Salmonella
with feces, its multiplication in spleen and ability to induce T-cell mediated
immune response were examined.
Results and conclusions: The recombinant attenuated Salmonella strain did
not release with feces and contaminate environment. The strain possessed
ability to multiply in spleen after rectal inoculation during more then 35 days
forming speciﬁc T-cell mediated immune response to HBc-ag. Thus, atte-
nuated cya-supressive mutant of Salmonella s/t Enteritidis could be used as a
deliver for HBc-ag in suppositories.
P1113 Immunologic evaluation of O-speciﬁc side chain
of Salmonella typhimurium LPS conjugated with Tetanus
toxoid
N. Hosseinijazani, Q. Behzadian Nejad, Z. Mohamad Hasan,
B. Tabaraii, S. Shahabi, A. Kazem Nejad
Tehran, IR
Objectives: Salmonella typhimurium can cause serious infections in young
children and in individuals with immunodeﬁcencies. However, there is no
vaccine against S. typhimurium licensed for human use. The O-speciﬁc
polysaccharide (O-SP)of S. typhimurium is both a virulence factor and a
protective antigen. Serum antibodies to the O-SP and phagocytosis of the
bacteria are the main defense mechanisms against this bacterium. O-SP is not
immunogenic enough, so in this study we conjugated puriﬁed O-SP with
Table 1 Fold change in proliferation for aP vaccinees/controls (N¼ 66/N¼ 9)
(comparison of mean SI)
Interval post vacc. PT FHA PRN
Pre to 1 month post 4.75/1.21 5.18/1.36 2.95/0.97
1 month to 1 year 0.69/1.21 0.96/0.63 1.023/1.10
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tetanus toxoid (TT) and investigated its effects on induction of protective
immune responses in mouse model.
Methods: O-SP was puriﬁed and conjugated with TT by carbodiimide-
mediated amidation method. For obtaining of serum samples, BALB/c mice
were injected with either conjugate, puriﬁed O-SP, or heat killed S. typhi-
murium, on days 0, 14 and 28. Animals were bled 2weeks after last injection
and serum samples were collected. Immunodiffusion was performed in
agarose gel and standard ELISA method were used for measuring of speciﬁc
antidodies against either O-SP or TT in serum samples. LD-50 was deter-
mined by the Reed and Muench method. Chemiluminescence was measured
in a liquid scintillation spectrometer. In vitro phagocytic responses were
studied by the Tomita method.
Results: High efﬁcacy was realized with conjugation of the O-SP with TT.
The immunodiffusion showed that conjugate reacted with both TT and
S. typhimuriumwhole cell antiserums.O-SP did not elicit antibodies in mouse,
however, either conjugate or heat killed S. typhimurium can elicit high levels of
IgG in mouse after third injection. Efﬁcient chemiluminescence emission was
observed in the presence of either alive or heat killed S. typhimurium or O-SP-
TT conjugate but not in the presence of O-SP alone, from mouse peritoneal
macrophages. The mean number of ingested bacteria/cell in the presence of
sera from immunized mice with puriﬁed O-SP, conjugate, heat killed bacteria
and negative control were 6.96, 14.24, 15.96 and 6.67, respectively.
Conclusions: A conjugate that induces protective immune responses were
developed and this conjugate also protects mice against challenge with
pathogenic S. typhimurium.
P1114 Persistence of Francisella tularensis in the bone
marrow of mice
A. V. Sanin, O. Y. Sosnovskaya, T. N. Kozhevnikova, T. A. Golovanova,
R. A. Savelieva
Moscow, RUS
Studied were effects of live Francisella tularensis vaccine upon hematopoietic
system in mice. Injection of bacteria at a dose 1 and 5 microbes per mouse
induced a dose-dependent increase in the numbers of endogenous hemato-
poietic spleen colonies in mice irradiated at a sublethal dose. Further increase
of inoculating number of bacteria to 10 microbe bodies per mouse resulted in
a toxic death of irradiated mice. Also, a dose-dependent rise in proliferation of
late bone marrow hematopoietic precursor cells (7-day CFUs) was observed
using hydroxyurea ‘suicide’ technique. Proportion of CFUs in the S-phase of
cell cycle increased 3–4-fold compared with controls. In order to study
persistence of F. tularensis in the bone marrow of mice, a sensitive assay was
developed enabling to reveal not only target cells for F. tularensis in hema-
topoietic tissues, but duration of the bacteria persistence in the bone marrow
in the association with particular cells, as well. In brief, the assay involved
incubation of bone marrow cells of infected mice either with speciﬁc rabbit
anti F. tularensis antiserum that had previously been absorbed with normal
bone marrow cells of syngeneic mice for 45min at 37 8C, or with normal
rabbit serum (absorbed as above to avoid possible cytotoxicity). The suspen-
sions were then incubated at 48C for 60min. At the end of that time 0.5mL of
fresh guinea pig complement (1:5) was added and the suspensions were further
incubated 30min at 37 8C. Then suspensions of both the antiserum-treated
and control cells were injected i.v. into syngeneic mice irradiated 2 h
previously at a lethal dose. Seven days later these recipients were sacriﬁced
and their spleens removed and ﬁxed in Bouin’s solution. The spleen colonies
formed by 7-day CFUs were counted, and a comparison between the cells
treated with antiserum and those with normal serum made. Thus, we
established that live F. tularensis are able to persist for at least 4months in
the bone marrow of mice in the direct association with 7-day CFUs. Other
explanation could be that some antiserum-recognized antigens of the microbe
was expressed at a surface of CFUs, thus making them susceptible to the lysis
with complement. The proportion of CFUs affected in this manner ﬂuctuated
from 18 to 40%.
P1115 Production and characterization of monoclonal
antibodies against Brucella abortus S(99) surface antigens
S. Farshad, M. J. Mehrabanpour, M. M. Namavari, A. Ghaderi,
A. Alborzi, S. M. H. Hosseini, A. Tavakoli
Shiraz, Isfahan, IR
Objectives: Considering the problems in speciﬁc and accurate diagnosis of
Brucellosis, recently Monoclonal antibodies (MAb) have been used for
identiﬁcation and characterization of antigenic determinants of the Brucella.
Methods: In this research myeloma cells(Ag8.653) were fused with spleen
cells of Balb/c mice immunized against Brucella abortus S (99) using poly-
ethylene glycol. After screening by ELISA, hybridomas producing antibody
were cloned by Limiting Dilution method. Double diffusion/Ouchterlony
(DDO) method was used to identify the isotypes of produced MAbs. To
determine the speciﬁcity of the anti-Brucella MAbs, Western immunoblot-
ting was performed with cell extract (CE) of B. abortus S (99) separated by
SDS–PAGE.
Results: In this study, six clones Ba-1, Ba-2, Ba-3, Ba-4, Ba-5 and Ba-6
producing antibody against B. abortus S(99) were obtained.MAbs of Ba-1, Ba-
3, Ba-5 and Ba-6 were identiﬁed as IgG1 and Ba-2 and Ba-4 were identiﬁed as
IgG2b. Only MAbs Ba-1 and Ba-2 cross reacted with B.melitensis 16 M and
B. suis. Western blots of CE indicated that MAbs Ba-1, Ba-2 and Ba-3 mybe
speciﬁc for S-LPS and Ba-4 and Ba-5 were reactive with major outer
membrane protein (OMP) 25–27 kDa and Ba-6 was reactive with major
OMP 36–38 kDa. All MAbs except Ba-6 have better reactivity with CE Ag.
Conclusion:With considering different patterns of the epitopes recognized by
each antibody on the surface of bacterium, application of these antibodies in
diagnosis, classiﬁcation, epidemiology and immunology of this bacterium is
considerable. The recognized bacterial antigens can be used as vaccine
production and diagnostic agents.
P1116 Vaccine cold chain monitoring on the territory of
the Republic of Serbia
D. Dimitrijevic, Z. Vukovic
Belgrade, YU
Objectives: Evaluation of vaccine cold chain quality during transportation
and storage of DTP, OPVand BCG vaccines on the territory of the Republic
of Serbia.
Methods: Monitoring was performed with the help of Vaccine Cold Chain
Monitors (CCMs) made by Berlinger, Switzerland and Freeze Watch (FW)
made by 3M, USA. Within the period of March–June 2002, 529 CCMs and
165 FWaccompanied the procurement of DTP, OPVand BCG vaccines from
the central warehouse in Institute Torlak, through all levels for vaccine supply
up to the end users in vaccine points. On the territory of Serbia, monitoring
encompassed 19 regions, including 86 vaccine points, which were chosen at
random. The supervision of monitoring was done by the control of refrig-
erators in 40 vaccine points. Closed monitor cards were sent back to Institute
Torlak, where the changes on CCMs and FW were analyzed.
Results:Up to the ﬁrst level of supply of Regional Institutes for PublicHealth,
165 CCMswith FWwere accompanied by 76180 doses of DTP vaccines, 196
CCMs were accompanied by 127220 doses of OPV and 168 CCMs were
accompanied by 44800 doses of BCG vaccines. Out of this number, 128
(78%) monitor cards for DTP, 156 (80%) monitor cards for OPV vaccine and
123 (73%) monitor cards for BCGwere sent back to the manufacturer. On the
ﬁrst level of supply, minimal exposure to temperature higher than allowed was
registered in 50% CCMs for DTP, 40% for OPVand 45% for BCG vaccine.
One percent of CCMs for OPV was exposed to the risk, that is, to
temperature that endangers the vaccine. On the second level of supply, there
was no exposure of vaccines to the risk. On the third level of supply, minimal
exposure to temperature was registered in 84% CCMs for DTP, 73% for OPV
and 100% for BCG vaccine. Exposure to the risk was registered in 2% CCMs
for OPV vaccine. By the control of refrigerators during supervision visits, the
high risk from freezing of vaccines wasn’t noted, so that the high percent of
FW cracking (64%), can be attributed to faults in monitors handling than to
the real risk from freezing.
Conclusion:The cold chain plays the basic role in the success of immunization
programme. These results will enable the correction of weaknesses that were
registered in the cold chain system on the territory of Serbia.
P1117 Immunization safety—Serbian experience
evaluation
Z. Vukovic, D. Dimitrijevic
Belgrade, YU
Aim: Quality evaluation of immunization practice.
Methods: Twenty-four immunization practice quality indicators were
checked during supervision visits of 33, out of total 78, preschool children
vaccination checkpoints, covered by the cold chain vaccine monitoring.
During these visits, personnel (51 nurse and 37 physicians) voluntarily ﬁlled
out the anonymous knowledge tests.
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Results: Vaccine purchase evidence exists at 61% of checkpoints, tem-
perature surveillance in refrigerators exists at 41% of checkpoints, and cold
chain monitoring cards were correctly marked and positioned at 58% of
checkpoints. Vaccine distribution in refrigerators and vaccine duration period
were correct at 100% of checkpoints, while at 94% of checkpoints the opened
vial policy was adequately conducted. Personnel accepted and now uses the
AD syringes at 30% of checkpoints. Although a disposable syringes are
exclusively being used for the immunization, all safe injecting procedures
were observed only at 27% of checkpoints. The used material is being
destroyed by incineration at 55% of checkpoints. On the question about
the immunization needle recommended length, nurses gave correct answers
in 39% of cases, there were 29% of incorrect answers, and 32% failed to
answer. The correct application place for certain vaccines was marked in 46%
of answers, and to the question on the cold chain vaccines there were 61% of
correct answers. The most sufﬁcient was the knowledge on the duration
period of opened vials of DTP, OPV, MMR and BCG vaccines: 80% of
answers were correct, 3% were incorrect, and 17% failed to answer. On the
questions on contraindications, physicians answered: correctly in 68% of cases,
incorrectly in 27% of cases, and 5% failed to answer. On the question on time-
laps between the prescribed amounts of vaccines application: there were 45%
of correct answers, 29% of incorrect answers and in 26% of cases the answer
was omitted. By the education on the safe immunization strategy, at 66% of
vaccination checkpoints, not one single member of the vaccination teams was
encompassed.
Conclusion: The continuing education and training of the personnel which
conducts immunization, along with the supervision of the adopted knowl-
edge and skills, are the prerequisites for the safe immunization practice
improvement in Serbia.
Respiratory tract infections
P1118 An evaluation of the best indicator set for
predicting bacterial infection in patients presenting with an
acute exacerbation of chronic bronchitis
C. J. Burley
Bourne End, UK
Objectives: In clinical trials of antibiotics, the identiﬁcation of patients with
an acute bacterial exacerbation of chronic bronchitis can be problematic as
many exacerbations are not bacterial and this is difﬁcult to ascertain in the
initial consultation. This study aimes to examine the efﬁciency of: (i) patient
symptoms (from Anthonison1); (ii) microscopic examination of sputum
purulence; and (iii) Gram stain microscopy of organism types, in identifying
patients with a bacterial infection.
Methods: Sputum samples were collected from patients with a history of
chronic bronchitis, presenting with an acute exacerbation. Patients were
required to have a worsening of at least two symptoms from: dyspnea, sputum
volume and sputum purulence, and not have previously received an antibiotic
for this episode. All centers were in Scotland and sputum samples were sent to
the local accredited hospital laboratory for analysis (purulence by appearance
and microscopy [>25WBCs and <10 epithelial cells per100 ﬁeld], pre-
dominant cell types on Gram stain and culture). All patients gave informed
consent.
Results:A total of 73 sputum samples were evaluated. There were 30 samples
from males (41%) and 43 from females (59%). The mean age of the patients
was 62.8 years (range 39–84 years). The four ineligible patients who were
enrolled with one symptom were excluded from the analysis. The efﬁciency
of symptoms, microscopic purulence and Gram stain in identifying patients
with a bacterial infection are shown below.
Conclusion: There is no simple method of identifying patients with an acute
exacerbation of chronic bronchitis and symptoms alone are a poor indicator of
bacterial infection. For the purpose of clinical trials of antibiotics, a combina-
tion of two to three symptoms and microscopic conﬁrmation of sputum
purulence appears to be the best indicator of bacterial infection and can be
expected to correctly identify bacterial infection in around 74% of patients.
Reference:
1. Anthonison NR et al. Ann Int Med 1987; 106: 196–204.
P1119 The character of infectious process in chronic
obstructive pulmonary disease exacerbation
E. Bukreeva, S. Nesterovich, E. Dementieva, T. Melnik, L. Gudkova,
G. Seitova
Tomsk, RUS
Methods: 103 patients with COPD exacerbation were inspected, the age is
25–80 years old, mean age is 52.5 years old. The clinical inspection, spirografy,
bronchoﬁbroscopy, Gram bacterioscopy of sputum smears, quantitative bac-
teriological sputum research with deﬁnition of germ concentration in 1mL of
sputum, deﬁnition of Chlamidia pneumoniae and Mycoplasma pneumoniae
antigens in the sputum by PCR method and IgG, IgM levels to them by
immuno assay method were made. The reliability of differences was veriﬁed
by Fisher exast test.
Results: In the whole patients group (n¼ 103) infectional character of COPD
exaserbaton was reliable more often then noninfectional character (70 and
30% accordingly, P< 0.01); monoinfection was prevailed over mixt-infection
(47 and 24% accordingly, P< 0.01), Streptococcus pneumoniae (18%), M. pneu-
moniae (14%), C. pneumoniae (6%), Heamophilus inﬂuenzae (5%), Enterobacter
spp. (3%), Moraxella catarrhalis (1%) were revealed as main pathogens. Myco-
plasma pneumoniae infection was more often revealed then Chlamidia pneu-
moniae infection as monoinfection (30 and 13% accordingly, P< 0.05),
whereas C. pneumoniae infection was more often revealed as mixt-infection
(44 and 4% accordingly, P< 0.01). Noninfectional character of COPD
exacerbation was more often revealed in smokers and in patients with
professional pollutants in anamnesis (39 and 14% accordingly, P¼ 0007;
41 and 13% accordingly, P< 0.01). Infectional character of COPD exacer-
bation in the form of S. pneumoniae monoinfection was revealed in non-
smokers and in patients with absence of professional pollutants in anamnesis
(78 and 18% accordingly, P< 0.01). We analyzed bronchial obstruction
degree according to GOLD, WHO, 2001. At stage I of COPD (FEV< 80%
of predicted, FEV1/FVC< 70%) infectional character of COPD exacerba-
tion was reliable more often then noninfectional character (74 and 26%
accordingly, P¼ 0.03), monoinfection was prevailed (51 and 22% accordingly,
P< 0.05). At more high bronchial obstruction degree, the reliable differences
between infectional and noninfectional character of COPD exacerbation rates
and monoinfection and mixed-infection rates were not revealed.
Concluson: In 70% of COPD patients, the exacerbations are associated with
infection, whereas smoking and professional pollutants inﬂuence on COPD
exacerbation etiology. The infectional process features in different stages of
COPD are required futher investigations.
P1120 Importance of Moraxella (Branhamella) catarrhalis
broncho-pulmonary infections in Iraqi elderly patients with
underlying chronic cardio-pulmonary disorders
E. H. Al-Rikabi
Ibb, YE
Objectives: To assess rate of infection, clinical data of the patients, orophar-
yngeal carrier rate in elderly patientswithunderlying chronic cardio-pulmonary
disorders, beta-lactamase production and antibiotic resistance patterns.
Criteria
Total Culture-positive Culture-negative
No. % No. % No. %
Sputum samples 73 43 58.9 30 41.1
All 3 symptoms 49 67.1 25 51.0 24 49.0
2 out of 3 symptoms 24 32.9 18 75.0 6 25.0
Microscopically purulent 34 46.6 25 73.5 9 26.5
Non-microscopically purulent 39 53.4 18 46.2 21 53.8
Organisms on Gram stain 66 90.4 41 62.1 25 37.9
No organisms on Gram stain 7 9.6 2 28.6 5 71.4
2 or 3 symptoms
þmicroscopicaly purulent
34 46.6 25 73.5 9 26.5
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Methods: Study group, 300 adults having broncho-pulmonary infections.
Carriers group, 200 randomly selected adults (79 controls and 121 with risk
factors; having an underlying chronic cardio-pulmonary disorder, immuno-
suppressive factor and/or use antibiotics). The study period was from
November 1995 to April 1996. Sputum samples of the study group selected
by cellular criteria and Gram-stain directed culture method and Zieh–Nielsen
stain. Isolated B. catarrhalis and other bacterial pathogens identiﬁed from
microscopic and colonic features and proper differential tests. Swabs inocu-
lated on Branhamella selective agar. Beta-lactamase production of B. catarrhalis
isolates tested using rapid iodometric method. Single-disc diffusion method
used for antibiograms.
Results: Branhamella. catarrhalis was isolated from 26/205 (12.68%), ranking
third after S. pneumoniae and Haemophilus spp. in the criteria selected patients
(205/300). Most affected patients were >50 years of age with signiﬁcant
difference from other pathogens (t of difference¼ 3.1447 and P< 0.05). The
majority of affected patients had an underlying chronic cardio-pulmonary
disorder (96.1%) more than other pathogens (Chi square ¼ 4.856 and
P< 0.005), and Beta-lactamase producing B. catarrhalis were found in 84%
of them. The commonest presentation was acute exacerbation of underlying
disorder (84.6%). Oropharyngeal carrier rate of B.catarrhalis in the study
group adults was 4.5% (9/200), being higher in the risk (5.79%) than the
control group (2.53%). Most B. catarrhalis isolates were beta-lactamase
producers (29/35; 82.86%). All were resistant to penicillins.
Conclusions: It is important to include B. catarrhalis in the differential
diagnosis of broncho-pulmonary infections in adults, especially in the elderly
with an underlying chronic cardio-pulmonary disorder. Consider high rates
of penicillin resistance in initial treatment.
P1121 Factors predicting bacterial etiology in acute
exacerbation of COPD
M. Allewelt, S. Balk, A. de Roux, H. Lode
Berlin, D
Background: Bacterial infection is a frequent cause of acute exacerbation in
COPD (AECB). Risk factors for bacterial etiology were evaluated.
Methods: Outpatients and patients hospitalized for acute exacerbation of
COPDwere studied prospectively. Severity of exacerbation was rated accord-
ing to Winnipeg criteria (I–III). The extent of underlying airﬂow-limitation
was measured during stable disease, and was categorized according to the
criteria of the ATS. Sputum samples were obtained from all patients prior to
antibacterial therapy.
Results:Out of 272 individuals, 193 patients fulﬁlled the criteria of inclusion.
In 114 subjects potential pathogenic bacteria were isolated, includingH. inﬂu-
enzae (n¼ 31), S. pneumoniae (n¼ 22), Moraxella catarrhalis (n¼ 19), P. aerugi-
nosa (n¼ 12) and Gram-negative enteric bacteria (GNEB) (n¼ 19). Univarate
analysis identiﬁed severe airﬂow-limitation (FEV1< 35% predicted), emphy-
sema, hypercapnia, use of systemic steroids, a high lifetime dose in cigarette
smoking, as well as prior antibacterial treatment as signiﬁcant predictors of
infection with GNEB and P. aeruginosa. Current smoking and the use of topic
steroids were signiﬁcantly associated with isolation of H. inﬂuenzae, M.
catarrhalis and Gram-positive bacteria. In multivariate analysis severe air-
way-obstruction (P¼ 0.017) and the use of systemic steroids (P¼ 0.017)
were independent predictors of infection with GNEB and P. aeruginosa. An
absolute FEV1 of <1.1 L (sensitivity 85%, speciﬁcity 66%) or an FEV1 of
<37.2% of the predicted (sensitivity 82%, speciﬁcity 74%) were the most
accurate discriminators in the risk of infection with GNEB and P. aeruginosa as
compared with H. inﬂuenzae, M. catarrhalis and Gram-positive bacteria.
Conclusions: H. inﬂuenzae, M. catarrhalis, and S. pneumoniae were the most
frequent pathogens in bacterial infection in AECB. Several easyly accessible
factors, however, predict infection with GNEB and P. aeruginosa and may
therefore be helpful tools in directing antibiotic therapy in acute exacerbation.
P1122 Inﬂuence of levoﬂoxacin compared with
clarithromycin on the infection-free interval in patients with
chronic bronchitis
H. Lode, H. Mauch, V. Scha¨fer, J. Eller, A. Linnhoff on behalf of the
ETIC-Study group
Background:Purulent exacerbation of chronic bronchitis in different severity
stages is a continuous therapeutic challenge. The results of previous studies
with ﬂuorquinolones gave reasonable evidence for a prolonged time interval
until the subsequent exacerbation episode.
Methods: In this randomized, multicentre, double-blind clinical study,
levoﬂoxacin (LFX) was compared with claritromycin (CLA) in patients with
acute bacterial exacerbation of chronic bronchitis (ABECB) graded GOLD II
and Winnipeg I/II. The main outcome variable for establishing clinical
efﬁcacy was the time interval between two consecutive episodes of exacer-
bation within an observation period of one year. The patients were randomly
allocated to either receiving LFX (500mg od for 7 days) or CLA (250mg bid,
for 10 days). A total of 504 patients (female 45%, male 55%, mean age
59.7 11.1 years) with mean FEV1 of 58.1–12.1% measured in the infec-
tion-free interval prior to the acute episode were included in the intention-
to-treat analysis. Demographic and baseline characteristics were comparable
amongst both groups.
Results: Satisfactory clinical outcome was observed in 82.8% of the LFX-
group and 79.6% of the CLA-group (P¼ 0.474). However, the microbio-
logical eradication rates were higher (P< 0.001) for the LFX-group (96.0%)
than for the CLA-group (81.9%). Patients with a conﬁrmed bacterial
exacerbation before treatment could be evaluated for the main objective.
The mean infection-free interval was 117 days for the LFX-group compared
with 107 days for the CLA-group (P¼ 0.378). Due to the low number of
patients with proven bacterial etiology (n¼ 100) signiﬁcance level could not
be reached.
Conclusion: The treatment of ABECB with 7 days LFX (od) revealed a
tendency towards better clinical results than with 10 days CLA (bid), although
not statistically signiﬁcant. However, the bacterial eradication rate was
signiﬁcantly higher for the LFX-group and a meaningful trend to a longer
infection-free interval could be observed.
P1123 Levoﬂoxacin vs. ceftriaxone/azithromycin in the
treatment of community-acquired pneumonia: a length of
stay comparison
S. Rai, B. Farag, Y. Mifune, N. Chandan, A. Gupta
Allentown, Kankakee, USA
Objectives: Recently, there has been increased use of the ﬂuoroquinolone,
levoﬂoxacin as ﬁrst line treatment in community-acquired pneumonia (CAP),
possibly because of its lower acquisition cost relative to other recommended
regimens such as a cephalosporin/macrolide combination. Currently, there
are no data analyzing hospital length of stay (LOS) in patients treated with
levoﬂoxacin vs. other regimens, despite the fact that LOS can signiﬁcantly
impact the total cost of CAP treatment. This retrospective study was designed
to compare LOS data for CAP patients treated with single-agent levoﬂoxacin
vs. those treated with ceftriaxone/azithromycin (CX/AZ).
Methods: In a retrospective chart review conducted at two community
teaching hospitals, inpatient data from 434 CAP patients were reviewed
for LOS, clinical outcomes and need for additional antibiotic therapy. Patients
treated with levoﬂoxacin were carefully matched to patients receiving CX/
AZ or other single-agent antibiotic therapy according to Fine risk classiﬁca-
tion. The primary comparison was length of stay.
Results: At baseline, mean Fine scores were lower (indicating lower severity)
in the levoﬂoxacin group (91) compared with the CX/AZ group (98)
(P< 0.001). Despite this, mean LOS was longer in the levoﬂoxacin group
(6.8 days) than in the CX/AZ group (4.4 days) (P< 0.001). Nineteen patients
in the levoﬂoxacin group had a LOS> 13 days; a separate analysis excluding
these patients produced similar results. Risk class by itself also had a signiﬁcant
effect on LOS (P< 0.001). In the levoﬂoxacin group, 36% of patients required
additional antibiotics, compared with 8% of CX/AZ patients.
Conclusions:Despite lower Fine risk scores, levoﬂoxacin was associated with
longer hospital stays and more supplemental antibiotic usage compared with
CX/AZ, both factors that could translate into signiﬁcant cost savings for the
hospital. Treatment cost/beneﬁt analysis must take into account total clinical
outcome with ﬁrst line therapy rather than simply the pricing of an individual
drug.
P1124 Levoﬂoxacin in the treatment of
community-acquired bacteremic pneumococcal pneumonia
J. Kahn, A. Tennenberg, B. Wiesinger
Raritan, USA
Objectives: To report on the cumulative clinical trial experience of levo-
ﬂoxacin in the treatment of patients with community-acquired pneumonia
(CAP)-related pneumococcal bacteremia.
Methods:Retrospective review of all Robert Wood Johnson Pharmaceutical
Research Institute/Ortho-McNeil Pharmaceutical trials to identify those
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patients with CAP-associated pneumococcal bacteremia. Results available to-
date reﬂect the efﬁcacy of the 500mg i.v. and/or PO once daily for 7–14 days
regimen. Data from recently completed CAP trials utilizing a regimen of
750mg i.v. and/or PO once daily for 5 days will also be included along with
calculated drug exposure rates based on the kinetics of the two doses and
recent national surveillance data.
Results (data available to-date): Ninety-ﬁve microbiologically evaluable
patients were treated with levoﬂoxacin for CAP who had at least one blood
culture positive for Streptococcus pneumoniae (SP). Eleven cases were due to
penicillin nonsusceptible strains of SP: ﬁve with high-level (MIC 2mg/mL)
and six with intermediate-level penicillin resistance (MIC¼ 0.1mg/mL).
Thirteen percent (11/82) of the tested bacteremic isolates were macrolide-
resistant. Ninety-two (96.8%) PB patients were considered clinical successes
(including all cases due to penicillin nonsusceptible SP) at the test-of-cure
evaluation; 91 (95.8%) SP isolates were eradicated or presumed eradicated.
Conclusion: Levoﬂoxacin is effective in the treatment of CAP-associated
pneumococcal bacteremia, including disease due to penicillin- and macrolide-
resistant strains.
P1125 First postmarketing data on treatment of
community-acquired pneumonia with moxiﬂoxacin i.v. – an
interim analysis
K. Stauch, H. Landen
Leverkusen, D
Objectives: This postmarketing surveillance study is being conducted to
investigate the efﬁcacy and tolerability of moxiﬂoxacin i.v. therapy in com-
munity acquired pneumonia under general hospital conditions.
Methods: This open, prospective, noncontrolled, nonrandomized multi-
center study is currently on-going in German hospitals. Patients with docu-
mented community acquired pneumonia (CAP) treated with moxiﬂoxacin
(MXF) i.v. or with MXF sequential therapy (i.v. and switch to oral) are
enrolled. The exclusion criteria are the contraindications mentioned in the
summary of product characteristics. Documentation includes demography,
anamnesis, prior antibiotic treatment, concomitant diseases and medications,
daily recording of MXF therapy and symptom status, overall assessment of
therapy with moxiﬂoxacin i.v. and reporting of all adverse events observed
within the treatment period.
Results: 308 patients with CAP treated with 400mg MXF once daily were
documented until January 2003, 52.6% males and 47.4% females, mean age
65.6 (SD¼ 16.2) years. Duration of MXF therapy was up to 4 days in 10.4%
of patients, 5–7 days in 49.4%, 8–10 days in 29.9% and >10 days in 10.4% of
patients. In case of sequential therapy (80.5% of patients), MXF i.v. was given
for 1 day in 11.3% of patients, 2 days in 26.2%, 3 days in 29.4%, 4 days in
18.2% and more than 4 days in 14.9% of patients. Improvement of clinical
symptoms is shown in Fig. 1. Improvement was reported in 59.1% of patients
at day 3, 85.4% at day 5 and 90.6% at day 7. An overall improvement of CAP
was reached after a mean of 3.2 days, cure after a mean of 6.7 days. Efﬁcacy of
MXF i.v. therapy was rated by the physicians as very good or good in 87.6% of
all cases. Tolerability was rated in 97.7% of patients as very good or good. For
18 patients (5.8%) adverse events were recorded, but only in two of these
patients (0.65%) events were considered related to the MXF therapy.
Conclusions: The new moxiﬂoxacin i.v. formulation is safe and highly
effective in general hospital practice. Due to the rapid symptom relief,
Moxiﬂoxacin allows for an early change from the i.v. to oral application in
patients with CAP treated in hospital.
P1126 Daily practice treatment of bacterial respiratory
tract infections with moxiﬂoxacin
K. Stauch, H. Landen
Leverkusen, D
Objectives: This postmarketing surveillance study was conducted to evaluate
efﬁcacy and tolerability of moxiﬂoxacin (MXF) in the treatment of bacterial
respiratory tract infections under daily-life conditions.
Methods: This open, prospective, noncontrolled, multicenter study was
carried out in general practice settings throughout Germany. Patients with
documented acute exacerbation of chronic bronchitis (AECB), community-
acquired pneumonia (CAP) or acute sinusitis were enrolled. Exclusion criteria
were the contraindications mentioned in the summary of product character-
istics. Documentation included demography, prior antibiotic treatment,
concomitant diseases andmedication, onset of symptoms, duration and overall
assessment of the MXF therapy and reported adverse events.
Results: A total of 9036 patients (4328 AECB, 1467 CAP, 2405 sinusitis, 836
other) treated with 400mg MXF once daily were documented by 1575
physicians. Gender distribution was comparable with a mean age of
50.8 17.0 years. Duration of MXF therapy was 5 days for 42.4% of patients,
7 days for 38.9%, 10 days for 17.5%, less than 5 days for 0.9% and more than
10 days for 0.2%. Clinical cure rates for single symptoms (all indications) were
59.3–96.7% at the last visit. The results of the three different diagnoses are
shown in Fig. 1. Overall improvement rate after 3 days was 54.2% for CAP,
61.8% for AECB and 71.6% for sinusitis. After 7 days, these rates were 97.1,
97.4, and 99.0%, respectively. The assessment ‘very good’ or ‘good’ was given
by the physicians for overall efﬁcacy of MXF therapy in 95.4%, for overall
tolerability in 96.8%, and for patient acceptance in 97.2% of all cases. In 72
patients (0.8%), there were adverse drug reactions recorded, the majority
being gastrointestinal disorders followed by nervous system disorders.
Conclusions:MXF used under normal daily practice conditions has excellent
efﬁcacy and safety and should be considered to be a ﬁrst line antibiotic in the
treatment of AECB, CAP and acute sinusitis.
P1127 Telithromycin is highly effective against
macrolide-resistant Streptococcus pneumoniae: a pooled
analysis of 11 multicenter clinical trials
C. Carbon, K. Roos, M. Rangaraju, R. Nusrat
Lausanne, CH; Gothenborg, S; Romainville, F; Bridgewater, USA
Objectives:The increasing worldwide prevalence of macrolide (erythromycin
A [ERY]) resistance among Streptococcus pneumoniae may complicate the
choice of treatment regimen for respiratory tract infections (RTIs) including
community-acquired pneumonia (CAP) and acute maxillary sinusitis (AMS).
Telithromycin (TEL), the ﬁrst ketolide to be approved for clinical use,
demonstrates excellent rates of clinical and bacteriological efﬁcacy in the
treatment of RTIs caused by common bacterial pathogens, including resistant
strains, as well as atypical/intracellular respiratory pathogens. We report here
the efﬁcacy of TEL in patients with CAP or AMS caused by strains of
S. pneumoniae resistant to ERY (ERSP).
Methods: Pathogens causative for infection were isolated from adult patients
enrolled in one of 11 multicenter studies and who had received 5–10 days’
treatment with TEL 800mg once daily. Clinical and bacteriological outcomes
were determined at the post-therapy/test-of-cure visit (Days 17–21). A total
of 409 isolates of S. pneumoniae (318 from CAP patients and 91 from AMS
patients) were tested for susceptibility to ERY at a central laboratory using
NCCLS broth microdilution procedures. Resistant strains (MIC 1mg/L)
were genotyped by PCR.
Figure 1 Improvement of clinical symptoms over 10 days of MXF treatment.
Figure 1 Cure rates of single symptoms at least visit for the different diagnoses AECB,
CAP and sinusitis.
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Results: In the TEL-treated per-protocol population, ERSP were isolated
from 50/409 (12.2%) patients. Clinical cure and bacteriological eradication
(documented or presumed) rates were high (both 86.0% [43/50]), and
comparable with the rates obtained for the overall patient population with
pneumococcal isolates (clinical cure, 93.4% [382/409]; bacteriological era-
dication, 94.9% [388/409]). Isolates from 29 patients with ERSP had ERY
MICs 16mg/L at baseline, and 26 (89.7%) of these patients, including 9/9
(100%) with MICs of 512mg/L, achieved clinical cure with bacteriological
eradication following treatment with TEL. The majority of ERSP isolates
with MICs< 16mg/L were genotyped as mef(E) positive (17/21), whereas
for those with ERYMICs 16mg/L, 19/29 were erm(B) positive. TEL was
well tolerated with the majority of treatment-emergent adverse events
(TEAEs) reported as mild to moderate and self-limiting. The most common
TEAEs were diarrhea, nausea and headache.
Conclusions: TEL displays high clinical and bacteriological efﬁcacy against
ERSP isolates from patients with CAPor AMS, including those with elevated
MICs to ERY, irrespective of the resistance genotype.
P1128 Potent activity of telithromycin in the treatment
of key respiratory pathogens associated with
community-acquired upper and lower respiratory
tract infections
D. Low, D. Felmingham, M. Rangaraju, R. Nusrat
Toronto, CAN; London, UK; Romainville, F; Bridgewater, USA
Objectives: To evaluate the clinical and bacteriological efﬁcacy of telithro-
mycin (TEL) in the treatment of key bacterial pathogens associated with
community-acquired RTIs.
Methods: Data were pooled from 14 Phase III/IV studies of TEL in the
treatment of community-acquired pneumonia, acute exacerbation of chronic
bronchitis and acute sinusitis. Key causative RTI pathogens (Streptococcus
pneumoniae, Haemophilus inﬂuenzae, Moraxella catarrhalis and Staphylococcus
aureus) were isolated at entry from respiratory and blood samples and tested
for their in vitro susceptibility to TEL, penicillin G (PEN) and erythromycin A
(ERY). Clinical and bacteriological efﬁcacy of TEL at the post-therapy/test-
of-cure visit (Days 17–24) was examined in patients with a microbiologically
evaluable pathogen isolated at entry.
Results: The majority (99.4%, 1530/1540) of key RTI pathogens identiﬁed
from the bacteriologically evaluable modiﬁed intent-to-treat population
(bmITT), including PEN- and ERY-resistant strains of S. pneumoniae (PRSP
and ERSP, respectively), were inhibited by TEL: 1466/1540 strains were
inhibited at TEL concentrations of 1.0mg/L (streptococci and staphylo-
cocci),4.0mg/L (H. inﬂuenzae) or0.12mg/L (M. catarrhalis), and 64/
1540 strains at TEL concentrations of 2.0mg/L (streptococci and staphylo-
cocci), 8.0mg/L (H. inﬂuenzae) or1.0mg/L (M. catarrhalis). Treatment with
TEL 800mg once daily for 5, 7 or 7–10 days resulted in high overall rates of
clinical cure (88.1%; 1593/1808) and satisfactory bacteriological outcome
(89.0%; 1593/1789), similar to those seen with comparator antibacterials
(clinically evaluable bmITT). Excellent clinical cure and bacterial eradication
rates were achieved for the following key RTI pathogens: S. pneumoniae 92.7,
94.3%; PRSP 82.3, 82.3%; ERSP 84.6, 84.6%;H. inﬂuenzae 87.0, 85.6%;M.
catarrhalis 89.7%, 89.7%; S. aureus 84.9, 87.7%, respectively (clinically evalu-
able per-protocol populations). TEL was well tolerated, diarrhoea, nausea and
headache were the most frequent adverse events, and the majority were of
mild-to-moderate intensity.
Conclusion:TEL provides potent activity against key RTI pathogens, includ-
ing drug-resistant S. pneumoniae, with high rates of clinical cure and bacterial
eradication. This targeted spectrum of activity, combined with a short
treatment regimen, makes TEL an effective option for the ﬁrst-line therapy
of community-acquired RTIs.
P1129 Five- to 10-day therapy with telithromycin is
highly effective in outpatients with pneumococcal
bacteremia associated with community-acquired
pneumonia
C. Carbon, D. van Rensburg, L. Hagberg, C. Fogarty, M. Rangaraju,
R. Nusrat
Lausanne, CH; Witbank, ZA; Gothenborg, S; Spartanburg, USA;
Romainville, F; Bridgewater, USA
Objectives: The progression of community-acquired pneumonia (CAP) to
bacteremia is one of the most serious complications of this disease, and has
been associated with an increased risk of mortality. The objectives of this
analysis were to determine the clinical and bacteriological efﬁcacy of teli-
thromycin (TEL) — the ﬁrst ketolide antibacterial – in the treatment of
outpatients with pneumococcal bacteremia associated with CAP.
Methods: A total of 2991 patients (13 years) with radiologically conﬁrmed
CAP participated in eight Phase III/IV multicenter studies (four comparative
and four open-label studies). Overall, 2289 patients were treated with TEL
800mg once daily for 5–10 days (one study comprised 5- or 7-day TEL), and
702 received a comparator antibacterial for 7–10 days (amoxicillin, clarithro-
mycin or trovaﬂoxacin). The incidence of pneumococcal bacteremia was
determined from blood samples taken upon study entry. Clinical and bacter-
iological outcomes were determined at the post-therapy/test-of-cure (TOC)
visit (Days 17–21).
Results: Of the 2289 TEL-treated patients, 94 had documented pneumo-
coccal bacteremia, and 82 of these patients were evaluable in the per-protocol
(PP) population. Infection severity at baseline was comparable between the
TEL-treated CAP patients and the subset of patients with bacteremia (15.5%
and 17.0% had Fine scores III, respectively). Clinical cure rates for the
TEL-treated patients with bacteremia were high (74/82 [90.2%]), and
comparable with the total CAP PP population (1755/1925 [91.2%]). Bacter-
iological eradication (documented or presumed) of S. pneumoniae was
achieved in 77/82 (93.9%) TEL-treated bacteremic patients vs. 305/318
(95.9%) patients in the overall CAP population. The clinical and bacterio-
logical efﬁcacy observed with pooled comparator antibacterials in bacteremic
patients was 15/19 (78.9%). Clinical cure was also high among TEL-treated
patients infected with strains of S. pneumoniae resistant to either penicillin G
(5/7), or erythromycin A (8/10). TEL treatment was well tolerated; the
majority of treatment-emergent adverse events were of mild to moderate
intensity, the most common of these being diarrhea, nausea, headache and
vomiting.
Conclusions:Oral TEL therapy is an effective, ﬁrst-line treatment for patients
with mild to moderate CAP, including those with pneumococcal bacteremia,
providing high levels of clinical cure and bacteriological efﬁcacy.
P1130 A 4-year prospective microbiological surveillance
study of conﬁrmed respiratory infection in a university
hospital in northern Italy
R. Manfredi, A. Nanetti, R. Valentini, S. Morelli, M. Ferri, L. Calza,
F. Chiodo
Bologna, I
Objective: To assess the frequency and microbiological features of lower
respiratory tract infection in patients followed at a tertiary care hospital in Italy.
Methods:Only reliable specimens (tracheobronchial aspirate (TBA), bronch-
oalveolar lavage ﬂuid (BAL), and bronchial brushing (BB)), submitted for
microbiological evaluation were prospectively considered, 1999 to June 2002.
Results: In the 42-month study period, 8376 specimens were submitted,
mostly represented by TBA (7623 : 91%), followed by BAL (698), and BB (55
cases). The great majority of samples came from intensive care units (ICU),
which accounted for 6649 TBA of 7623 (87.2%), 353 BAL of 698 (50.6%),
and 29 BB of 55 (52.7%). Medical departments (D) accounted for 772
specimens, surgical D for 218, pediatric D for 124, cardiology D for 114
samples, and hematology D for 33. When evaluating the temporal trend of
submission, 2543 samples were examined in the year 2000, followed by 2001
(2291), and 1999 (2156). When considering overall respiratory secretions, a
positive yield was obtained in 3277 materials of 8476 (38.7%), with higher
frequency for BAL (44.6%), followed by TBA (38.8%),and BB (16.4%), in
absence of signiﬁcant variations in the 4-year study period, but a peak BAL
positivity rate in the year 2001 (57.3%). Focusing on specimens coming from
ICU, TBA had a positivity index ranging from 35.1% (year 2002) to 40.5%
(year 1999), BAL positivity varied from 46.9% in 1999 to 65.6% in 2001,
while BB proved positive in 11.1% of cases in 2001, up to 33.3% in 2002.
Among the 26 different identiﬁed organisms, Pseudomonas aeruginosa ranked
ﬁrst (1176 isolations on the whole, 372 in the year 1999), followed by S. aureus
(1103 episodes, 379 in the year 1999), and Candida albicans (1009 312 in the
year 2001), regardless of submitted material. All other 23 bacterial and fungal
organisms were isolated in <10% of cases, with Stenotrophomonas maltophilia,
Serratia marcescens, Alcaligenes xylosoxidans,Klebsiella pneumoniae, Escherichia coli,
and Enterobacter cloacae as the most frequent bacteria. Mycobacterium tuber-
culosis was isolated in 37 cases (24 from BAL,13 from TBA), and Candida spp.
was the only organism who had a signiﬁcantly increased yield over time
(P< 0.01 in 2002 vs. 1999).
Conclusion:A permanent monitoring of microbiological features of the most
common infectious diseases, such as conﬁrmed lower respiratory tract
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infection, is a cornerstone for understanding their epidemiology, and planning
diagnostic, therapeutic, and prophylactic measures.
P1131 Comparative antibacterial activity of 12
antibiotics against invasive Streptococcus pneumoniae
strains, isolated in Romania from January 1996 to September
2002
M. Pana, M. Ghita, I. Rebedea, S. Iacob, O. Dorobat, V. Ungureanu,
G. Bancescu, M. Andrei, R. Popovici, N. Popescu, R. Papagheorghe,
I. Nistor, M. Gheorghe, S. Botea
Bucharest, RO
Objectives: to study the antibiotic resistance in pneumococci isolated in
Romania between January 1996 and September 2002.
Methods: The strains of S. pneumoniae collected at the National Reference
Center for Streptococcus between January 1996 to September 2002
(N¼ 1217) coming from sputum or tracheal aspirate (N¼ 570), blood and
CSF (N¼ 492) and others (N¼ 155): ear and eye ﬂuid, sinus, synovial ﬂuid
were serotyped and tested for susceptibility (MICs) to 12 antibiotics. The
isolates were analyzed for susceptibility to the following antibiotics:penicillin
(Pc), erythromycin (Em), cephalothin (Kf), cefuroxim (Cef), cefotaxim (Ctx),
cotrimoxazole (Sxt), chloramphenicol (Cm), oﬂoxacin (Ofx), amoxicillin
(Amx), amoxicillin/clavulanic acid (Amc), tetracycline (Te), vancomycin (Va)
by standard agar dilution MIC testing.
Results: Interpretative criteria were used according to NCCLS 1999. During
the study period, penicillin-resistant strains of S. pneumoniae were noted as
follows: 40% (MIC 50 : 0.06mg/L, MIC 90 : 2mg/L) in sputum and tracheal
aspirate, in blood and CSF 28% (MIC 50 : 0.015mg/L, MIC 90 : 0.5mg/L)
and in others 67% (MIC 50 : 0.5mg/L, MIC 90 : 4mg/L). During the study
period the resistance revealed the following aspects:a) strains from sputum and
tracheal aspirate: Em 28%, Te 28%, Kf 35%, Cef 20%, Ctx 4%, Amx 11%, Sxt
25%, Ofx 1%; (b) strains from blood and CSF: Em 10%, Te 24%, Kf 24%, Cef
18%, Ctx 12%, Amx 10%, Sxt 16%; (c) other strains: Em 54%, Te 39%, Kf
51%, Cef 39%, Ctx 18%, Amx 27%, Sxt 62%, Ofx4%. No resistant strain to
vancomycin was found. The following serotypes were resistant to penicillin:
23 (34%), 6 (29.7%), 19 (25.3%), 14 (11%).
Conclusions: An alarming increase of the resistant pneumococci to Pc, Em,
Sxt, and Kf was noted in the last years in Romania. There is an urgent need to
implement a network in Romania for the surveillance, prevention and control
of antibiotic-resistant pneumococci and antimicrobial usage in hospitals and
to enhance the use of an efﬁcient pneumococcal vaccine.
P1132 Antimicrobial resistance patterns of respiratory
pathogens: a local report from Turkey
P. Zarakolu, G. Soyletir, D. Gur, S. Unal
Ankara, Istanbul, TR
Objectives: Commonly used antimicrobials for respiratory tract infections
(RTI) were tested against 142 Streptococcus pneumoniae, 79 Haemophilus inﬂu-
enzae and 18Moraxella catarrhalis strains isolated from patients with community
acquired infections.
Methods: Strains were isolated both from adult (n¼ 104) and children
(n¼ 135) patients between 1999 and 2000. The specimens included sputum
(n¼ 123), bronchioalveoler lavage (n¼ 38), blood (n¼ 26), deep tracheal
aspirate (n¼ 17), cerebrospinal ﬂuid (n¼ 3), ear aspirate (n¼ 11) and con-
junctival smears (n¼ 21). Antimicrobial susceptibility testing was performed
by Etest strips (AB Biodisk, Solna, Sweden) and the results were evaluated
according to the NCCLS criteria.
Results: Intermediate-level penicillin resistance was observed in 38.7% of
S. pneumoniae isolates and there was only one isolate being highly resistant to
penicillin. Resistance to clarithromycin and trimethoprim-sulfamethoxazole
was 13.3% and 64.0%, respectively. All pneumococci were susceptible to
ceftriaxone and levoﬂoxacin. Of the H. inﬂuenzae strains tested, 3.8% were
beta-lactamase positive whereas resistance to clarithromycin and trimetho-
prim-sulfamethoxazole was 7.5% and 31.6%, respectively. Of the 18M. catar-
rhalis isolates tested, 8 of them were producing beta-lactamase. There was no
resistance against ampicillin-sulbactam, cefuroxime, ceftriaxone, ciproﬂox-
acin and levoﬂoxacin among H. inﬂuenzae and M. catarrhalis strains.
Conclusion:As several factors may have an impact on the pattern of resistance,
there might be geographic variation in antimicrobial resistance. Therefore,
local/national surveillance data is of crucial value for empiric treatment.
P1133 Antimicrobial resistance among respiratory tract
pathogens of Streptococcus pneumoniae and Haemophilus
inﬂuenzae in Sao Paulo Brazil from 1996 to 2000
L. M. Koeth, D. Felmingham, M. R. Jacobs, F. Rossi
Westlake, USA; London, UK; Cleveland, USA; Sao Paulo, BR
Background: As part of the Alexander Project, this study was undertaken to
assess the in vitro activity of several antimicrobial agents against Streptococcus
pneumoniae and Haemophilus inﬂuenzae from Sao Paolo Brazil in 1996–2000,
including penicillin, amoxicillin/clavulanic acid (A/C), ampicillin, amoxi-
cillin, cefaclor, cefdinir, ceﬁxime, cefprozil, ceftriaxone, cefuroxime, azithro-
mycin, clarithromycin, erythromycin, ciproﬂoxacin, levoﬂoxacin, oﬂoxacin,
chloramphenicol, clindamycin, doxycycline, and trimethoprim/sulfa-
methoxazole (T/S).
Methods: MICs were determined by the National Committee for Clinical
Laboratory Standards (NCCLS) method by a central laboratory and inter-
preted with NCCLS and PK/PD breakpoints.
Results: Overall, 79.0% of S. pneumoniae were penicillin susceptible, 19.0%
intermediate and 2.0% resistant and rates were fairly consistent through out
the ﬁve years of testing (ranging from 69.7 to 85.9% susceptible, 14.1–29.0%
intermediate and 0–3.4% resistant). The most active agents against S. pneu-
moniaewere amoxicillin, A/C, ceftriaxone and levoﬂoxacin; T/S was the least
active agent (the percentage of nonsusceptible strains ranged from a low of
35.8% in 1996 to 78.9% in 1999). Macrolide, chloramphenicol and clin-
damycin resistance rates were less than 6%. The prevalence of doxycycline
resistance among S. pneumoniae was 26.4%. b-lactamase was produced by
13.7% of H. inﬂuenzae. One hunhred per cent were susceptible to A/C,
cefdinir, ceﬁxime, ceftriaxone, and quinolones. The prevalence of chlor-
amphenicol resistance among H. inﬂuenzae was 8.6%. The least active agents
against H. inﬂuenzae were T/S (the percentage of nonsusceptible strains
ranged from 27.0% in 1996 to 73.2% in 1999) and the macrolides (overall
less than 2.6% were susceptible to azithromycin based on PK/PD break-
points).
Conclusions:With the exception of trimethoprim/sulfamethoxazole against
both pathogens and chloramphenicol vs. H. inﬂuenzae, the prevalence of
resistance in Sao Paulo remains relatively low and stable in comparison to
other parts of the world.
P1134 Improving the management of
community-acquired pneumonia: barriers to high-quality
care in a UK teaching hospital
G. D. Barlow, D. Nathwani, P. Davey
Dundee, UK
Objectives: Community-acquired pneumonia (CAP) requiring hospital care
is associated with considerable mortality (30-day¼ 19%) and resource use
(median hospital stay¼ 7 days) in Tayside, UK. We have previously identiﬁed
suboptimal processes of care for CAP [Clin Infect Dis 2001; 32 : 728–41]. As
part of an ongoing quality improvement programme, we have investigated
why CAP is suboptimally managed by combining quantitative and qualitative
methodology.
Methods:
1. Structured survey of hospital doctors (n¼ 83) using ordinal scales (e.g. 1¼
very poor, 5 ¼ excellent), open questions and clinical scenarios analysis.
2. Semi-structured in-depth interviews (n¼ 8) analyzed using ‘framework’
methodology.
3. Field-note analysis of patients (n¼ 22) receiving delayed (>4-h post-
admission) and/or inappropriate antibiotics.
Results:
1. Structured survey: previous training experiences (median ¼ three out of
ﬁve), self-reported familiarity with the British Thoracic Society (BTS)
guideline (median ¼ 1) and the acute medical admissions ward environ-
ment (median ¼ 3) were found to be potential barriers to high-quality
CAP care. Only 4% could correctly state the four core BTS severity
criteria and 43% could not state a BTS adherent antibiotic regimen for
severe CAP.
2. Barriers emerging from in-depth interviews include: previous CAP
training, clinical experience, awareness/familiarity with guidance, difﬁ-
culty in diagnosing CAP, conﬁdence and the perception of ones ability to
manage CAP, work intensity, ward organisation, staff communication,
priority status of CAP and guideline usability. Important relationships
between themes were: (a) the link between clinical experience/knowl-
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edge, clinician conﬁdence/perception and the likelihood of using available
guidance and (b) high work intensity and low priority status of CAP
resulting in delayed diagnosis and management.
3. Six barriers (occurring on 34 occasions) were identiﬁed in the 22 patients
who received delayed and/or inappropriate antibiotic therapy. The three
most important were: (a) failure to prescribe a one-off (‘stat’) dose (50%);
(b) inappropriate antibiotics according to severity assessment (41%); and (c)
wrong initial diagnosis (27%).
Conclusions: The combined results demonstrate the complex and multiple
barriers to high-quality CAP care that exist in a UK teaching hospital.
Improving the process (quality) of CAP care is likely to require a multifaceted
intervention addressing these barriers.
P1135 Rising incidence of Legionnaire’s disease in
Switzerland from ‘99 to ‘02
P. E. Hohl, S. Graf, P. Helbling, E. Altpeter, P.-A. Reber
Basel, Bern, CH
Objectives:Determination of the incidence of LD in CH from 1999 to 2002
by means of an epidemiological surveillance system originally instituted in
1987
Methods:LD is notiﬁable in CH. In response to mandatory notiﬁcations (Ns)
by laboratories (positive cultures, IFA, DFA, urinary antigen (UA)), physicians
are legally required to ﬁll in a questionnaire (Q) on every patient. Laboratory
Ns and Qs are entered into a data base on a case by case basis. Case deﬁnitions
of the European Working Group for Legionella Infections (EWGLI) apply,
and conﬁrmed and probable cases are evaluated, analyzed routinely, and
tabulated. Ns are updated weekly on the internet (http://www.bag.admin.ch)
and include preliminary unconﬁrmed reports.
Results: Between 1999 and 2001 the SFOPH received 302 Ns of which 261
were retained while 25 possible and 16 doubtful cases were excluded. The case
fatality rate was 10%. Most cases were sporadic. No major outbreak was
identiﬁed. A total of 211 cases were UA-positive (serogroup (sg) unknown;
speciﬁc kits for sg 1 are most used in (CH). Only 34 cases were conﬁrmed by
culture (more than 80% Legionella pneumophila sg 1). Nosocomial infections
made up 10%, LD due to professional exposure 2%, and travel-associated LD
20% of all 261 conﬁrmed and probable cases of LD. The median delay
between Ns and the Qs was 4 weeks. The 180 preliminary Ns received to date
for 2002 represent a more than twofold increase from 1999 to 2002 which is of
concern.
Conclusions: The annual incidence in CH of about two notiﬁed cases of LD
per 100 000 population is among the highest in Europe despite high sanitary
technical standards and good implementation thereof. Guidelines published in
1999 and media attention to domestic cases and outbreaks abroad have
resulted in increased public and physician awareness of LD, possibly leading
to improved reporting. The scarcity of positive cultures which parallels the
growing use of the UA test renders the tracking and linking of cases and their
environmental source(s) increasingly difﬁcult. The role of lowering hot water
temperatures (to save energy) in the rising incidence of notiﬁed LD remains
conjectural. The reporting system is presently too slow to detect outbreaks in
time for appropriate preventive interventions.
P1136 Legionella pneumophila disease in Bilbao, Spain
J. L. Barrios, M. J. Unzaga, P. Velasco, C. Pe´rez, B. Amezua, C. Ezpeleta,
R. Cisterna
Bilbao, E
Objectives: The aim of this study was to know the epidemiological and
clinical features of L. pneumophila in our hospital.
Methods: The study was a retrospective clinical investigation. We reviewed
the clinical records of all patients with urine L. pneumophila antigen detection
test positive (Binax Now0m) and/or a culture positive at the Basurto Hospital
during the period 10/1998–10/2002.
Results:During the 4-year study period were diagnosticated 73 patients with
L. pneumophila pneumonia: 3 HIV positive (4.1%) and 70 HIV negative
patients with male predominance 4/1and a mean age 57.31 (range, 25–
74 years). There were 29 patients older than 65 years (39.7%). The distribu-
tion was along the year but there were 52 patients hospitalized during August–
November. The predisposing factors were an elevated intake of alcohol 28
(45.2%), history of smoking 33 (45.2%) and chronic diseases in 30 (41.1%).
Two were receiving inmunossupresor treatment. High fever (86.3%) was a
main symptom, also were headache 19 (26%), and myalgia 15 (20.5%). The
respiratory symptoms were cough nonproductive 14 (19.2%), cough and
expectoration 22 (30.1%), dyspnea 9 (12.3%), chills 12 (16.4%) and chest pain
11 (15.1%). Gastrointestinal symptoms were diarrhea in 12 (16.4%) and vomit
in 9 (12.3%) patients. Hiponatremia was present in 39 patients. Mental status
alterations were presents in 22 (30.1%) patients. Twenty-one (28.8%) patients
were admitted in the intensive care unit. The death rate was 8.2% patients.
Chest X-rays showed inﬁltrate. The predominant pulmonary presentation
was unilateral and so in upper as lower lobes. Leucopenia was present in 21
(28.8%) patients. The most frequent treatment established was a ﬂuoroqui-
nolone (levoﬂoxacin) alone or in combination with a macrolide agent.
Patients older than 65 years and younger than 65 years did not differ
signiﬁcantly in the clinical presentation and in the outcome. L. pneumophila
was recovered by culture in 9 (32.1%) patients and only one of them the Binax
Now antigen detection was negative because of the serogroup of the isolated
was no. 1.
Conclusions: L. pneumophila has been increasingly as community-acquired
pathogen since our laboratory is performing urinary antigen detection. The
disease occurs mostly during the summer to autumn. The death rate was
elevated. Levoﬂoxacin is the ﬁrst line treatment instaurated in our hospital.
P1137 Abstract withdrawn
P1138 Clinical study of acute respiratory infections
caused by Streptococcus milleri group in the elderly
E. Sugihara, T. Koyanagi, N. Ono, H. Koga, T. Rikimaru, H. Aizawa
Chikugo, Fukuoka, Kurume, JP
Objective: Streptcococcus milleri group (SMG) is increasingly being recog-
nized as an important pulmonary pathogen. Therefore, we investigated the
clinical features of patients with acute respiratory infections associated with
SMG.
Methods: Fourteen cases were identiﬁed as pulmonary infections caused by
SMG. Those clinical and laboratory data from case records were analyzed.
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The microbiological diagnosis was based on the results of quantative sputum
culture and other invasive procedures, including transthoracic needle aspira-
tion or bronchoscopic examinations.
Results: There were 10 cases of pneumonia, two with both pneumonia and
pleuritis, one pulmonary abscess, and one empyema. Nine were men and ﬁve
were women. Patients’ ages were ranging from 65 to 91. The most common
symptons at presentation were shortness of breath, cough, sputum and weight
loss. An underlying diseases existed in 10 cases. However, four cases had no
underlying diseases in the elderly.
Conclusion: We concluded that SMG was more important pulmonary
infections than has previously been recognized in the elderly, even if they
had no underlying diseases.
P1139 Efﬁcacy and safety of levoﬂoxacin in the
treatment of acute sinusitis with high risk of complications
(frontal, ethmoid, sphenoid or pansinusitis)
P. Gehanno, J. J. Pessey, E. Serrano, F. Goldstein
Paris, Toulouse, F
Objectives: The primary objective was to assess the clinical efﬁcacy of
levoﬂoxacin (L) 500mg once daily, 7–14 days after the end of a 10-day-
treatment in acute sinusitis with high risk of complications (SRC) and
bacteriologically documented.
Methods: A prospective, international, multicenter, open, non comparative
study was conducted from February 2001 to May 2002 by 51 ENT specialists.
The intent-to-treat analysis (ITT) has been performed on 174 patients (P)
with a diagnosis of SRC conﬁrmed by independent experts on the X-ray/CT
scan (frontal: 81%, sphenoid: 9.2%, pansinusitis: 7.5%, ethmoı¨do-sphenoid:
2.3%). Pre-therapy swab sampling was systematically performed before
treatment under the middle meatus (or at the posterior oropharyngeal wall
in case of sphenoid sinusitis). The per protocol analysis (PP) was performed on
a subgroup of 101 SRC (58.0%), with a presumed bacterial infection at
inclusion (presence of leukocytes/bacteria at the direct microscopic exam-
ination of the pus) and without major violations of the protocol.
Results: In the ITT population, the mean age was 39.9 13.2 years [range:
18–74 years] with a sex ratio of 1. One-third of the P had1 episode of
sinusitis in the year prior to inclusion. In the PP population, cultures were
positive in 76 P and among the 102 isolated organisms, the most frequent ones
were S. pneumoniae (26.5%), Enterobacteriaceae (20.6%), H. inﬂuenzae
(15.7%) and S. aureus (13.7%). In this population, clinical success, 7–14 days
post-therapy, was observed in 94.1% (95/101) with a 95% conﬁdence interval
of [89.5–98.7]. No difference was observed according to the sinus involved:
frontal ¼ 77/82 (93.9%), sphenoid ¼ 8/8, pansinusitis ¼ 8/9 (88.9%),
ethmoı¨do-sphenoid ¼ 2/2. The clinical response at the follow-up visit, 3–
5weeks after the end of therapy, was successful in 85.2% (86/101) and 82.8%
(144/174) of the PP and the ITT populations, respectively. The clinical safety
was satisfactory in 97% of P: a premature discontinuation of L was observed in
six cases, mainly for digestive disorders.
Conclusions:The efﬁcacy and safety of L 500mg once daily was conﬁrmed in
this group of P with acute SRC.
P1140 Epidemiologic studies on the nasopharyngeal
carriage of nontypable Haemophilus inﬂuenzae among
healthly children attending day-care centers
E. Augustynowicz, A. Gzyl, L. Szenborn, D. Banys, A. Nowaczek,
J. Slusarczyk
Warsaw, Wroclaw, PL
Objectives: Implementation of vaccination against H. inﬂuenzae type b
reduced both morbidity and rates of carriage. It is suspected that in the
future it might result in growing importance of carriage and the diseases
induced by the NTHI and H. inﬂuenzae of other capsular types. Thus, studies
allowing to recognize relationships in the circulated strains population
structure might allow to monitor frequency and turn-over.
Methods: In this study, 112H. inﬂuenzae strains from nasopharynx of healthy,
not-vaccinated 1–5-year-old-children (and their teachers) attending 11 day-
care centers in western part of Poland were isolated during Jan–May 2002.
DNA extracted by use of QIAamp Mini Kit (Qiagen) was used for RAPD
typing with commercially available RAPDAnalysis Beads (Amersham Phar-
macia Biotech). DNA extracted by phenol–chlorophorm method was used
for AFLP typing with use HindIII/TaqI restriction of the DNA, ligation of
restriction products with speciﬁc adaptors, and then ampliﬁcation with
primers speciﬁc to adaptor/restriction sites with one selective basis. Patterns
generated through RAPD and AFLP metods were analyzed with GelCompar
Software (Applied Math).
Results:New-designed tool for monitoring of H. inﬂuenzae genetic diversity
by AFLP technique showed higher level of discriminatory power and
reproducibility in comparison to RAPD. Intra/intergel reproducibility found
for RAPD and AFLP reached 97%/96% and 96%/94% values. The overall
genetic similarity deﬁnied by the Pearson product-moment correlation
coefﬁcient chieved 58 and 35% for RAPD and AFLP, respectively. All
encapsulated isolates typed by RAPD were found in a single clade of
dendrogram with similarity level of 94%, and in AFLP typing there were
found in a single group of nontypeable isolates. In RAPD and AFLP at the
similarity level of the 70 and 60%, six clusters were found by both methods
used. Similarity level of dendrograms constructed for strains isolated from
individual child-care centers achieved higher values in CCC1 (35%) in
comparison with CCC6 (74%) in analyzed institutions.
Conclusions: We designed much more sensitive and reproducible system
for genetic typing of NTHI strains than found in case of RAPD typing.
AFLP tool has potential to monitor turn-over of NTHI strains among
individuals.
Infections in transplant patients
P1141 Is Aspergillus precipitins testing before lung
transplantation of clinical beneﬁt?
A. Krause, J. S. Harwood, P. A. Corris, J. H. Dark, F. K. Gould
Newcastle upon Tyne, UK
Background:Aspergillus fumigatus precipitins are found in a high proportion of
patients with pulmonary aspergillosis, especially in patients with aspergilloma
or allergic bronchopulmonary aspergillosis. These patients might only grow
the fungus sporadically pre transplantation but are at risk of developing severe
infection post transplantation. Targeted antifungal prophylaxis pre operatively
might be required.
Objective: To establish whether precipitins testing is useful in predicting
which patients might develop Aspergillus infection post transplantation.
Methods:We surveyed the results of Aspergillus precipitins tests performed on
115 patients who underwent lung transplantation between October 1997 and
October 2001.
Results:Nine of 115 lung transplant (LTx) recipients wereAspergillus fumigatus
precipitins positive, 106 patients were negative. Four of the nine precipitins
positive recipients grew Aspergillus post transplantation from respiratory
specimens: all received systemic antifungals when the cultures became
positive, but one patient nevertheless died of invasive aspergillosis. All four
grew Aspergillus from sputum at some time prior to transplantation. Seven of
the 106 Aspergillus fumigatus precipitins negative recipients grew Aspergillus
post transplantation: all were treated and no fatality occurred.
Conclusion: Re-isolation of Aspergillus from respiratory specimens in the
post transplant period appears more likely in AFP positive patients who
havegrownAspergillusatanytimeprelungtransplantation.Theserecipientsmight
beneﬁtfromantifungalprophylaxisatthetimeoftransplantationandwetherefore
recommend Aspergillus precipitins testing in these patients.
P1142 Infectious complications in hematopoietic stem
cell transplant recipient: experience in a general hospital,
Pisa, Italy
M. Bonadio, G. Morelli, S. Mori, R. Riccioni, F. Papineschi, M. Petrini
Pisa, I
Objectives: To evaluate the incidence, clinical and bacteriologic features of
documented infections in Hematopoietic Stem Cell Trasplant (HSCT)
recipients.
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Methods: The frequency of infectious complications was analyzed in 42 pts
with hematologic malignancies who received HSCT from January 2001 to
December 2001 at Pisa General Hospital. The median age was 53.3 years
(range 27–66). There were 24 males and 18 females. Thirty-three pts
underwent autologous HSCT and 9 allogenic HSCT. All pts were received
acyclovir, ﬂuconazole and ﬂuoroquinolones as prophylaptic regimen.
Results:A total of 38 infectious episodes were recognized in 22 pts during the
early post-HSCT period (n¼ 27), and in intermediate or late period post-
HSCT (n¼ 11). Twelve episodes of febrile neutropenia remained with
unknown etiology. As expected, in the late post-HSCT period, the incidence
of infectious episodes was higher in allogeneic HSCT recipients than in
autologous ones; Infectious complications rate correlated positively with the
deepness and length of neutropenia in the early period. There were 21 sepsis
(11 coagulase negative staphylococci, 3 Pseudomonas aeruginosa, 2 Serratia
marcescens, 2 Stenotrophomonas maltophilia, 2 Escherichia coli), 2 pneumonias
and 1 vertebral osteomyelitis. All staphylococcus strains were in vitro resistant
to oxacillin and ciproﬂoxacin and 8 out of 15 Gram negative rods were
resistant to ciproﬂoxacin. Most of the infectious complications were
cured with appropriated antimicrobial therapy and/or with the engraftment
and, in 4 cases, with central venous catheter removal. One patient developed a
positive CMV antigenemia; a precore mutant form of HBV reactivation
was diagnosed in another patient. No cases of invasive fungal infections
were recognized. Five pts died, but only one by infective cause (septic
shock). Pneumonia was a coexisting cause of death in 2 pts in the late
period.
Conclusions: Most of infective complications, occurred in the early period
post-HSCT, were due to coagulase negative staphylococci and Gram negative
rods resistant to ciproﬂoxacin. For this reason the uselfuness of ﬂuoro-
quinolone prophylaxis in HSCT recipients should be re-evaluated.
P1143 Necrotizing fasciitis caused by Cryptococcus
neoformans in a renal transplant recipient
F. Timurkaynak, H. Arslan, E. Kuru Inci, N. Haberal, G. Moray,
M. Haberal
Ankara, TR
Case:A 31-year-old man was admitted to our hospital complaining gradually
increasing pain, swelling and erythema in his left leg. He received kidney
transplantation from a living related donor six years ago. Post-transplantation
immunosuppression consisted of tacrolimus (10mg/day), mycophenolate
mofetil (2 g/day) and prednisone (5mg/day). On physical examination he
had tender, indurated erythematous lesion (25 cm 8 cm) on the left leg and
erythematous induration (3 cm 2 cm) on anterolateral aspect of right thigh.
His laboratory results were as follows;WBC: 15400/mm3 (95% granulocytes),
ESR: 52mm/h, CRP: 50mg/dL, creatinine: 2.5mg/dL. Treatment con-
sisting of penicillin G (6 3MU/day) and clindamycin (1800mg/day) was
initiated with a presumed diagnosis of NF. Surgical debridement was carried
out to remove necrotic tissue in both legs. Surgery revealed that all soft tissue
layers were involved with the exception of underlying muscle. Since the
histological examination disclosed neutrophilic inﬁltration throughout the
reticular dermis and subcutaneous adipose tissue with necrosis and PAS-
positive budding yeast like organisms, which were concordant with Crypto-
coccus, antibacterial therapy was replaced by liposomal Amphotericin B
5mg/kg on the 2nd day of hospitalization. On the 5th day of hospitalization
culture of tissue revealed C. neoformans. Cranium and thorax CTs were
unremarkable for cryptococcal infection. Lack of evidence of pulmonary
infection or meningitis proposed that the present infection was a localized
cryptococcosis. Itraconazole (400mg/day) was substituted for amphotericin
B after 15 days of therapy. On the 17th day of the therapy, the patient
underwent skin grafting to involved areas. Itraconozole therapy was stopped
at 6th week. At 1-year follow-up, the wounds were completely healed and
renal function was normal.
Conclusion: Presence of C. neoformans has been described in invasive soft
tissue infection very rarely. This case is interesting in many ways. Although it’s
accepted that cutaneous involvement is a marker of disseminated cryptococ-
cosis, any other infection site and fungemia have not been detected in this
case. It has been reported that tacrolimus has a temperature-dependent
inhibition onC. neoformans that may prevent CNS infection but allow growth
of fungus at cooler body sites such as skin. It may explain why this case has only
cutaneous involvement. Itraconozole therapy, used in this case, has limited
clinical experience in transplant recipients.
P1144 Isolates of 1997–2002 from transplant patients
and their antibiotic susceptibilities
Y. Gu¨rol, Z. Aktas, M. Salcioglu, M. Buluc, C. Bal
Istanbul, TR
Objective: To evaluate infectious complications and antibiotic use in renal
transplant recipients.
Methods: The strains were isolated from the urinary and respiratory tracts of
the renal transplant recipients in the transplantation unit at our hospital from
1997 to 2002. The resistance to various antimicrobial agents in a six-year
period was searched by disk diffusion according to the NCCLS.
Results: 324 Gram-negative rods, 291 nonfermentative Gram-negative rods,
164 staphylococci and 211 enterococci strains were evaluated in this study.
Full susceptibility was observed against vancomycin and teicoplanin in
enterococci and staphylococci, and against imipenem and meropenem in
Enterobacteriaceae. Trimethoprim-sulfamethoxazole resistance in Entero-
bacteriaceae; penicillin resistance in staphylococci; piperacillin, gentamicin
and netilmicin resistance in nonfermentative Gram-negative rods were higher
than the other antimicrobials routinely used in these strains.
Conclusions: The transplant patients are assigned ampiric antibiotics for
postop prophylaxis and these antibiotics should be chosen according to the
previous susceptibility data.
P1145 Evaluation of diarrhea episodes in renal
transplantation patients
H. Arslan, F. Timurkaynak, O. Kurt Azap, G. Yapar, G. Moray,
M. Haberal
Ankara, TR
Objective: To review the etiology, clinical features diagnostic procedures and
outcome of diarrhea episodes developed in renal transplantation (tx) patients.
Methods and results: Between 2000 and 2002, 42 episodes of diarrhea in 38
renal tx patients (13 female, 25 male) were evaluated for causative agents,
diagnostic procedures and outcome retrospectively. The mean age of the
patients were 31.8 years, 33 of them received the graft from living donor. The
recipient’s immunosuppressive protocols included various combinations of
prednisolone, cyclosporine, mycophenolate-mofetil, azathioprine and tacro-
limus. On initial admission diarrhea was accompanied by fever in 11 episodes
and vomiting-nausea in ﬁve. Median time for development of diarrhea was
35.5months after transplantation (3 days14 years), 35 of the episodes devel-
oped late post transplant period (beyond 6months). Seventy stool samples of
42 episodes were examined for bacterial (Salmonella, Shigella, Campylobacter,
Yersinia, Vibrio, Clostridium difﬁcile) and protozoal agents (Cyriptosporidium,
Entomoeba, Giardia) by using microscopic examination, cultivation and toxin
screening methods. Colonoscopic examination and biopsy was also per-
formed in 16 episodes of diarrhea. The etiology was identiﬁed in 22
(52.3%) episodes whereas the other cases remained as self limited with
unknown etiology. Among in 22 episodes 12 caused by infectious etiology,
5 immunosuppressive drugs and 5 by other causes (FMF, amyloidosis and
colitis) For seven episodes deﬁnitive diagnosis were performed bymicroscopic
examination of stool, for two by culture and for six by colonoscopic
examination and/or histopathological examination of biopsy specimen.
The etiology and diagnostic procedures are shown in Table 1.
Table 1 Etiology and diagnostic procedure of diarrhea episodes
Etiology Number (n¼ 42) Diagnostic procedure
Infectious 12 (28.6%)
Giardia lamblia 3 Stool microscopy
Cryptosporidium 4 Stool microscopy
(AFB staining)
S. sonnei 1 Culture
Campylobacter jejuni 1 Culture
Entomoeba histolytica 1 Colonoscopy
CMV 1 Coloscopy and Bx
Clostridium difficile 1 Toxin A/B
Non- infectious 10 (23.8%)
Drug related 5 Exclusion
Others (FMF, amyloid,
colitis)
5 Coloscopy and Bx
Undetermined 20 (47.6%)
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In this study we concluded that routine diagnostic procedures have limited
values to determine the etiology of diarrhea in renal transplant patients. But
colonoscopy may help the diagnosis in these group especially for the etiology
other than infectious and drug related causes.
P1146 Detection of Trichomonas tenax in renal allograft
recipients by PCR-RFLP
M. Turkowicz, J. Juskowa, D. Cielecka
Warsaw, PL
Objectives:Renal allograft recipients (RARs) have problems with their gums
and teeth. The aim of the study was to identify parasitic trichomonad in oral
cavity of these patients. Because of the insufﬁciency of conventional tech-
niques (cultivation and microscopic observation) molecular technique (PCR-
RFLP) was applied.
Methods: 50 patients (20–70 years old) were investigated: 21 females and 29
males. Thematerial used for PCR-RFLPwas saliva and smears taken from the
oral cavity. A pair of primers was designed to amplify ITS 1–5.8SrRNA–ITS 2
region and a product of PCRwas digested with two restriction enzymes:DdeI
and MspI.
Results: 12% of patients were positive for oral trichomonad infection: 4
females and 2 males. The PCR product was 393 bp long and after digestion it
showed restriction fragments: 136, 125, 50 and 82 bp (DdeI cleaving); 198 and
190 bp (MspI cleaving). The size of the product and of the restriction
fragments was characteristic for Trichomonas tenax – the most frequent
trichomonad species occurring in human oral cavity.
Conclusions: The infection of RARs with Trichomonas tenax was 12%. Sex-
dependent trichomonad infection was noticed: twice as more females were
infected than males. Oral trichomonosis in healthy humans is 10–12%. Our
results suggest that the infection caused byT. tenax in these immunosuppressed
recipients is on a similar level as in healthy humans.
P1147 A randomized dose de-escalation study of
meropenem in febrile patients with severe neutropenia
N. Basara, L. Kraut, M. Bischoff, M. Kiehl, A. Fauser
Idar-Oberstein, D
Objective: This prospective randomized study was designed to compare the
safety and efﬁcacy of meropenem 0.5 g t.i.d. vs. meropenem 1.0 g t.i.d. after
an initial successful treatment with meropenem 1.0 g t.i.d. for 72 h in febrile
patients (pts) with severe neutropenia.
Methods: 101 neutropenic patients with different hematological or onco-
logical diseases undergoing allogeneic (90 pts) or autologous (5 pts) hema-
topoietic stem cell transplantation or chemotherapy (6 pts) received initial
meropenemmonotherapy (1.0 g t.i.d.) after onset of fever. In case of successful
initial treatment (decline of fever, improved signs of infection, bacterial
susceptibility to meropenem, respectively) after 72 h without modiﬁcation
of the antibacterial regimen, patients were randomized to receive either a
deescalated dose of meropenem (0.5 g t.i.d.) or to continue with the initial
dose. Meropenem was administered until the febrile episode resolved or
antibiotic treatment was modiﬁed according to the clinical condition or
results of bacterial diagnostics. A glycopeptide was allowed to be added to the
regimen if meropenem-resistant bacteria were detected.
Results: Most patients (86%) presented with fever of unknown origin, and
14% presented with bacteremia, pneumonia or urinary tract infection,
respectively. Sixty-six pts (65%) showed an initial response to meropenem
monotherapy, and 34 of them were randomized to receive the deescalated
dose of meropenem (group 1) for a median time of 9 days (range: 5–23 days),
whereas 32 continued with the initial regimen (group 2) for a median of
10 days (range: 5–26 days). The overall clinical response rate at the end of
meropenem therapy was 71% in group 1 and 75% in group 2 (P¼ n.s.). A
glycopeptide was administered in 56% (group 1) and 66% (group 2) of
randomized pts. Most documented isolates consisted of enterococci and
coagulase-negative staphylococci. With regard to safety, no serious adverse
effects to meropenem therapy were observed in both groups.
Conclusion: Meropenem monotherapy (1.0 g t.i.d.) is an effective and well
tolerated monotherapy in febrile patients with severe neutropenia. Dose
deescalation with meropenem 0.5 g t.i.d. after 72 h is considered to be as
effective and safe and more cost effective than the recommended standard
dose.
P1148 Postoperative infections caused by Mycoplasma
hominis and Ureaplasma urealyticum in patients after renal
transplantation
A. Samet, M. Kochowska-Bronk, M. Bronk, B. Rutkowski,
L. Naumiuk
Gdansk, PL
Objectives: To characterize the infections caused by U. urealyticum and
M. hominis in patients with renal transplants.
Methods:From three patients standard aerobical, anaerobical andmycological
cultures were negative despite clinical signs of infection. Wound exudates and
abdominal ﬂuid were therefore cultured on A7 medium and Mycoplasma IST
test (Biomerieux) which detects the presence of mycoplasmas and determines
their antimicrobial susceptibility. A7 cultures were incubated in 378C in
microaerophilic bags for 48 h.
Results: Both A7 and Mycoplasma IST test were positive in 3 patients. In the
ﬁrst case M. hominis was isolated from wound exudate. In patient 2 the
abdominal ﬂuid was positive forM. hominis.U. urealyticum andM. hominiswere
isolated from wound exudate and abdominal ﬂuid obtained from the third
patient.
Conclusions: M. hominis and U. urealyticum are capable of causing serious
infections in renal transplant patients. In case of negative standard cultures
the presence of mycoplasma should be suspected and appropriate media
inoculated.
P1149 De Novo tumor in a pediatric liver recipient
associated with Epstein-Barr virus
C. Nogueira, G. Rocha, G. Marra˜o, C. Veiga, I. Gonc¸alves,
A. Oliveira, A. Domingos, A. C. Magalha˜es Sant’Ana
Coimbra, P
Introduction:An increased risk of neoplasia is a well-recognised complication
of organ transplantation. Epstein-Barr virus (EBV) infection is associated with
signiﬁcant morbidity in allograft recipients including post-transplant lym-
phoproliferative disorder (PTLD) but others tumors seems also to be asso-
ciated with EBV. Leiomyosarcoma is a rare tumor in children with only 4 cases
described in pediatric LTrecipients. De Novo tumors in LT children are most
often drive by EBV infection.
Case report: We describe one case of pediatric transplant recipient who
developed neoplasia after transplantation. The ﬁrst case is a 5-year-old girl
who received a liver graft at age of two due to biliary atresia. Two years after
transplant developed six hepatic nodules. The histomorphological features
were consistent with liver leiomyosarcoma. Blood and biopsy EBV DNA
PCR were positives. Reducing immunosuppression and initiating acyclovir
therapy was associated with no detection of the EBV DNA in blood by PCR
and one year after the liver nodules disappeared.
Conclusion: Pediatric transplant patients have increased risk for EBV-related
disease because many are ﬁrst exposed to EBV after transplantation in the
context of potent immunosuppression. EBV serology has a decreased useful-
ness in the diagnosis. EBV PCR is the most important tool for close
monitoring EBV infection and EBV-related tumors.
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Urinary tract infections
P1150 Etiologic structure and antibiotic resistance of
Gram-negative rods isolated in patients with bacteremia
and urinary tract infections in Latvia
R. Paberza, A. Zilevica, M. Paberzs, L. Luzbinska, S. Hromova,
A. Majore, B. Rozentale
Riga, LV
Objectives: To establish etiologic structure and antibiotic resistance of
hospital-acquired and community-acquired infections of Gram-negative rods
isolated from blood and urine samples.
Methods:Between January 2001 andNovember 2002 993Gram-negative rods
from blood and urine samples from hospitalized patients in Latvian Infectology
Center, Children Hospital ‘Gailezers’, Hospital of Traumathology and Ortho-
pedics were collected and also urine isolates of community-acquired patients.
Strains were identiﬁed in BBL SCEPTOR panels and antimicrobial suscept-
ibility were tested by: disk diffusion method (NCCLS), minimal inhibitory
concentration (MIC) of an antimicrobial agent in SCEPTOR panels, extented
spectrum b-lactamase (ESBL) testing by E-test ESBL (BioDisk).
Results: 993 strains were identiﬁed as 24 species: 536 Escherichia coli, 80
Klebsiella pneumoniae, 51 Klebsiella oxytoca, 31 Enterobacter cloacae, 5 Enterobacter
aerogenes, 4 Enterobacter agglomerans, 30 Serratia marcescens, 2 Serratia liquefaciens,
32 Proteus mirabilis, 18 Proteus vulgaris, 10 Morganella morganii, 3 Providencia
rettgeri, 3 Salmonella enteritidis, 2 Yersinia enterocolitica, 1 Shigella ﬂexneri, 86
Pseudomonas aeruginosa, 10 Pseudomonas putida, 6 Pseudomonas alcaligenes, 1
Pseudomonas cepacia, 29 Acinetobacter baumanii, 21 Acinetobacter lwofﬁ, 1 Steno-
trophmonas maltophila, 2 Moraxella osloensis, 2 Bordetella bronchiseptica. The 350
(35.2%) isolated strains were multidrug resistant: 40.2% of hospitalized
patients and 14.7% of community patients. In hospitalized patients isolated
strains polyresistance was mainly registered of genus Pseudomonas—83.0%,
Citrobacter—58.3%, Klebsiella–Enterobacter–Serratia (KES) group—53.1%. In
community UTI patients isolated strains multidrug resistance prevailed in
genus Pseudomonas—85.7% and Acinetobacter—42.9%.
Conclusions: The most common pathogen isolates from urine and blood
Gram-negative cultures were E. coli, genus Klebsiella and Pseudomonas. Multi-
drug resistant strains of Gram-negative rods in Hospitals were highest than in
community. In hospitalized patients polyresistant strains prevailed in genus
Pseudomonas, Citrobacter and KES group, in community patients—in genus
Pseudomonas and Acinetobacter.
P1151 Resistance to beta-lactam antibiotics and to
cephalosporins of strains isolated from urine
M. Junie, A. Ferke, D. Vancea, D. Tatulescu, I. Colosi
Cluj Napoca, RO; Rhodes, GR
Background:One of the most difﬁcult problems in hospitals is the appearance
of resistant bacteria strains to antimicrobial agents. The objective of our study
is to describe the antimicrobial susceptibility to frequently used drugs for
treatment of urinary tract infections.
Methods: Bacteria were isolated and tested for antibiotic resistance using a
panel of 23 beta lactamines and cephalosporins. Antimicrobial susceptibility
testing of isolates was determined by disk diffusion method as recommended
by NCCLS.
Results: The pathogens identiﬁed from urine culture were Pseudomonas sp.,
E. coli, Klebsiella oxytoca, Proteus sp., Acinetobacter, Morganella morganii. P. aeru-
ginosa, ﬂuorescens, E. coli, Enterobacter, Acinetobacter strains showed a high
resistance to most of beta lactamic antibiotics but were still susceptible to
carbapemens and some broad spectrum penicillin’s: ureidopenicillin, ureido-
penicillin and beta lactamase inhibitors (E. coli, P. ﬂuorescens, Enterobacter
Acinetobacter), Carbenicillin (P. aeruginosa, P. ﬂuorescens, E. coli), Ticarcillin/
CA (Acinetobacter calloaceticus), Aztreonam (E. coli, Enterobacter). Proteus mir-
abilis, Klebsiella oxytoca and Morganella strains showed 50% resistances to
Ampicilin, Amoxicilin/CA, Klebsiella to Piperacilin and Ticarcillin but all
three bacteria were susceptible to all other beta lactamics. P. aeruginosa showed
a high resistance to Cefpodoxime, Ceﬁxime, Cefazolin, Cephalotin, Cefur-
oxime, Cefoxitin, Cefotaxime, beeing susceptible only to Carbapenems,
Ceftazidime and Cefepime. P. ﬂuorescens strains were resistant to Cefpodox-
ime, Ceﬁxime, Cefotaxime and susceptible to other cephalosporins. Enter-
obacter and Acinetobacter were resistant 25–50% to ﬁrst and second-generation
cephalosporins, but susceptible to Cefpodoxime, Ceftriaxone and Cefepime.
Klebsiella, Proteus andMorganella did not show resistance to second and third
generation cephalosporins.
Conclusions: Only a limited number of beta lactamic antibiotics and cepha-
losporins show sufﬁcient activity against uro-pathogen Gram-negative bacilli.
Resistance to third generation’s cephalosporins is very important. Recom-
mended drugs are broad-spectrum penicillins (Carbenicillin), carbapenems
(ImipenemMeropenem) and cephalosporins like Ceftazidime and Cefepime.
Carbapenems and Cefpirome are effective against all Gram-negative bacilli
(P. aeruginosa included) producing extended spectrum beta-lactamases and are
recommended for therapy of urinary infections.
P1152 A comparative study of the frequency and the
antimicrobial susceptibility of causative agents between
hospital and community-acquired urinary tract infections
D. Hatzaki, G. Antonakos, A. Alevra, G. Kostogianni,
A. Konstantinou, E. Mastrokalou, A. Vatopoulos,
E. Vogiatzakis
Athens, GR
Objective: To compare the prevalence of the causative agents between
hospital and community-acquired urinary tract infections (UTI) and evaluate
the differences in antimicrobial susceptibility of the most frequently isolated
bacterial strains (E. coli, E. faecalis).
Methods:Between January 1997 and November 2002, a total of 22.123 urine
specimens from hospitalized patients as well as from patients with community-
acquired UTI were tested in our laboratory. The cultures were performed by
conventional methods. The identiﬁcation of the organisms to the species level
and their susceptibility testing to antimicrobials was performed by the API
system (BioMerieux).
Results: A total of 3.785 bacterial stains were isolated. The majority of the
isolates came from hospitalized patients. The frequency of the most common
isolates in hospitalized patients was: E. coli 50%, P. aeruginosa 11%, E. faecalis
10%, K. pneumoniae 8%, P. mirabililis 5% and in the community-aquired UTI
this was: E. coli 68%, E. faecalis 8%, P.mirabilis 7%, K. pneumoniae 6% and
P. aeruginosa 4%. The in vitro resistance rates of the most frequently isolated
bacterial strains (E. coli, E. faecalis) are shown in the table.
Conclusions: The community-acquired E. coli strains had lower in vitro
resistance rates for all of the antibiotics tested. As for E. faecalis, we observed
higher resistance rates for Pen. Entero., Amp. Entero., Tetracyclines and
E. coli E. faecalis
H (%) C-A (%) H (%) C-A (%)
Amoxicillin 44 36
Piperacillin 13 11 4 4
Amox/Clav. 6 3
Ticarcillim 37 33
Ticar/Clav.
Cefulothin 16 10
Cefoxicin 8 2
Cefritaxime 3 3
Ceflazidime 5 3
Aztreodani 5 3
Imipenem 0 0
Gomtamicin 4 3 20 7
Amicacin 2 1
Nalidixic acid 16 7
Ciprofloxacin 10 4 51 35
Co-trimoxazole 23 16
Nitrofurantoin 4 3 9 8
Vanomycin 3 0
Telcoplanin 2 1
Pen Entero (8mg/L) 7 12
Amp. Entero (8mg/L) 6 9
Tetracyclines 64 67
Erythromycin 44 48
In vitro resistance rates
H: Hospital strains
C-A: Community-Acquired strains
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Erythromycin the community-aquired strains, which may show high con-
sumption of these antibiotics in the community.
P1153 Antibiotic resistance in outpatient urinary
isolates: interim results from the North American Urinary
Tract Infection Collaborative Alliance (NAUTICA)
G. G. Zhanel, T. L. Hisanaga, M. R. DeCorby, N. M. Laing,
K. A. Nichol, L. P. Palatnick, J. Johnson, D. J. Hoban
on behalf of the NAUTICA Group
Objectives: Outpatient urinary tract infections (UTI) are common and are
managed empirically. However, antibiotic resistance is increasing to com-
monly prescribed antibiotics including penicillins, cephalosporins and sulfo-
namides. The purpose of this study was to assess the prevalence of antibiotic
resistance in outpatient urinary isolates from North America.
Methods: Thirty medical centers representing all geographic regions of the
United States (US) Bureau of the Census and 10 medical centers from all
regions of Canada submitted up to 50 consecutive outpatient urinary isolates
to the coordinating reference lab (Health Sciences Centre, Winnipeg,
Canada). NCCLS-speciﬁed MIC microbroth dilution testing was performed
against ampicillin (Amp), trimethoprim/sulfamethoxazole (TMP/SMX),
nitrofurantoin (Nitro) and levoﬂoxacin (Levo).
Results: Species prevalence of 1658 of 2000 isolates received to date included:
E. coli 57.6%, Klebsiella pneumoniae 12.7%, Proteus mirabilis 5.5%, Enterococcus
spp. 4.9%, and Pseudomonas aeruginosa 2.9%. No difference in bacteriology was
reported between the US and Canadian centres. Antibiotic resistance rates (%)
among all isolates tested to date (n¼ 959) and E. coli only (n¼ 552), respec-
tively, were Amp 41.0 and 36.7%, TMP/SMX 20.5 and 22.3%, Nitro 11.5
and 1.9%, and Levo 8.7 and 6.3%.
Conclusions:Antibiotic resistance in outpatient urinary isolates obtained from
medical centres in the US and Canada against all isolates and E. coli only,
respectively, was Amp 41.0 and 36.7%, TMP/SMX 20.5 and 22.3%, Nitro
11.5 and 1.9%, and Levo 8.7 and 6.3%.
P1154 Incidence and susceptibility of staphylococci in
urinary tract infections
E. Ikonomopoulou, I. Katsarou, K. Papadopoulos, K. Kottara,
H. Koumoundourou, P. Hamakioti, A. Reggli
Patras, Zante, GR
Objectives: To carry out the incidence of coagulase-negative staphylococci
(CoNS) and S. aureus in urinary tract infections and also to carry out the
susceptibility of staphylococci in urinary tract infections.
Methods: During a 2-year period (2001–2002), 312 (8.47%) CoNS strains
and 31 (0.84%) S. aurus strains were collected from 3684 positive urine
cultures. The identiﬁcation of CoNS strains was carried out by ID 32 Staph
and of S. aureus by conventional methods. The susceptibility test was per-
formed either by the breakpoint system: mini API or the VITEK system
(Biomerieux).
Results: 184 (58.97%) of CoNS strains were isolated from women’s urine
cultures while 128 (41.02%) CoNS were isolated from men’s urine cultures.
167 (53.52%) CoNS strains were obtained from outpatients’ cultures while
145 (46.47%) were from inpatients’ cultures. 18 S. aureus strains were isolated
from outpatients’ cultures and 13 S. aureus strains were isolated from inpa-
tients’ cultures while 21 S. aureus strains were obtained from women’s cultures
and 10 were obtained from men’s cultures. The susceptibility of CoNS was
100% to vancomycin and teicoplanin, 52.6% to oxacillin, 60% to norﬂoxacin,
86.5% to nitrofurantoin, 85% to netilmicin, 60.3% to gentamicin, 70.5% to
trimethoprim/sulfamethoxazole, 57% to tetracycline, 50% to clindamycin
and 33.7% to erythromycin. The susceptibility of S. aureus was 100% to
vancomycin and teicoplanin (28/31) to nitrofurantoin (26/31) to trimetho-
prim/sulfamethoxazole (23/31) to oxacillin, norﬂoxacin and gentamicin (25/
31) to netilmicin, (22/31) to clindamycin (20/31) to tetracycline and (19/31)
to erythromycin.
Conclusions:CoNS are often responsible (8.47%) for urinary tract infections
in women, specially in outpatients. S. aureus is rarely responsible (0.84%)
for a urinary tract infection. Susceptibility to vancomycin and teicoplanin
was absolute for CoNS and S. aureus and variable to the other antimicrobial
agents.
P1155 E. coli recurrent urinary tract infection in children:
relapse or reinfection?
K. Truusalu, I. Vainuma¨e, T. Talvik, M. Mikelsaar
Tartu, EST
Background: In childhood urinary tract infection (UTI) is one of the most
frequent bacterial infections and almost half of the patients have a recurrence
following the initial infection. The recurrences are either relapses or reinfec-
tions and in most cases due to E. coli. The objective of this study was to assess
the potential for differentiating episodes of relapse and reinfection in children
with recurrent urinary tract infection (RUTI) during an 1-year follow-up by
applying pheno- and genotyping to compare index and consecutive E. coli
strains. Furthermore, we attempted to estimate whether clinically sympto-
matic UTI episodes and patients with vesicoureteric reﬂux (VUR) are more
prone to relapse than reinfection.
Materials andmethods:Altogether 77 E. coli strains isolated from 26 children
with RUTI were examined in this study. We applied antibiotic susceptibility
tests utilising six commonly used antibiotics for paediatric UTI treatment in
order to phenotype strains. Using the antibiotic susceptibility pattern we
could not detect cases of relapses. To detect genotypic similarity a random
ampliﬁed polymorphic DNA polymerase chain reaction (RAPD-PCR) was
used with two different primers applied.
Results:We found that the persistence of genotypically deﬁned E. coli strains
occur in only one-quarter of RUTI episodes in children. The clinical
manifestation of RUTI and the presence of VUR could not predict the
persistence of a deﬁned genotype of E. coli.
Conclusion: Genotyping of consecutive E. coli strains enables to differentiate
cases of relapse and reinfection, which may be important in choosing an
appropriate intervention strategy for children suffering from RUTI.
P1156 Urinary tract infection in community-based
patients. Most frequent bacterial pathogens and
susceptibility patterns. Results from a Brazilian study
C. Mendes, E. Carmo, C. Oplustil, L. Kudo, A. Hsiung, J. Sampaio
Sao Paulo, BR
Objectives: The goal of this study was to assess the most frequent pathogens
responsible of urinary tract infections (UTI) in community patients and the
pattern of antimicrobial resistance in Sao Paulo, Brazil.
Methods: A 2-year period (January 2000 to December 2001), 142 502 urine
cultures from community-based patients were analyzed. All positive cultures
that presented one single pathogen with counts of equal or above
100 000CFU/mL were considered for the analysis. Positive cultures from
the same patient were only taken into account if the cultures were performed
at least 30 days apart. Based on these criteria, 18 298 (12.8%) positive cultures
were analyzed in this survey of which 88.3% belonged to females and 11.7%
were from male patients.
Results: Among the 18 298 positive cultures analyzed, 88.5% presented
growth of Enterobacteriaceae followed by 7.7% of Gram-positive cocci.
Among Enterobacteriaceae, E. coli (72%) was the most frequently isolated
followed by K. pneumoniae (6.1%) and P.mirabilis (6.0%). Among Gram-
positives, E. faecalis was the most frequent (4.7%). In males it was detected
a higher incidence of UTI in infants (26.1% below 4 years old) and in the
elderly (19.3% above 60 years old). By analyzing the susceptibility proﬁle, we
observed an important resistance in E. coli towards ampicillin (43.1%) and
cotrimoxazole (33.5%). It was also noticed a signiﬁcant variation of resistance
to cotrimoxazole between ages (29.5–53.0%). Concerning norﬂoxacin, it was
observed a higher resistance in males (19.9%) than in females (9.4%). In
E. faecalis isolates, 14.9% were found to be resistant to ciproﬂoxacin, 62.1% to
tetracycline, and 1.1% to nitrofurantoin. A higher resistance to all antimi-
crobials tested against E. faecalis strains was observed in patients above 60 years
old.
Conclusions: Apart from analyzing the most frequent UTI pathogens,
differences in resistance proﬁle among isolates of different age intervals
and genders were also noticed, reinforcing the hypothesis that empiric
treatment of patients with symptoms of UTI may contribute in the selection
of resistant strains.
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P1157 Uropathogens and their antibiotic resistance in
outpatients in a general hospital, Greece
E. Vagiakou-Voudris, I. Geros, G. Ganderis, P. Karabogia-Karaﬁllides,
A. Strouza, D. Mylona-Petropoulou, E. Malamou-Lada
Athens, GR
Objectives: To study the etiology of urinary tract infections (UTI) and the
antibiotic resistance of uropathogens isolated from outpatients.
Methods: During 1-year period (1/11/01–1/11/02), 2150 urine samples
were obtained from outpatients with clinical symptoms of acute cystitis in a
tertiary General Hospital of Athens. Urine cultures were performed according
to standard techniques. Urinary isolates were identiﬁed using API and Crystal
ID systems, while the susceptibility of them was tested by Kirby-Bauer
method.
Results: 714 out of 2150 urine cultures (33%) fulﬁlled the criteria for
signiﬁcant bacteriuria. (Pure growth of >100000 cfu/mL urine for bacteria
and >1000 cfu/mL for Candida sp.) There were four groups of causatives
agents: (1) Gram-negative rods: the family Enterobacteriaceae 590 (82.6%),
from themE. coli 464 (64.8%),Klebsiella sp. 44 (6.1%),Enterobacter sp. 8 (1.1%),
Serratia sp. 2 (0.28%), Proteus mirabilis 72 (10%). (2) Gram-positive cocci 76
(10.6%), from them E. faecalis 30 (4.2%), E. faecium 2 (0.2%), St. epidermidis 28
(3.9%), St. saprophyticus 4 (0.5%), St. aureus 12 (1.6%). (3) Gram-negative
nonfermenters 36 (5%), from them: Ps. aeruginosa 32 (4.4%),Acin. baummanii 4
(0.5%). (4)Candida sp. 12 (1%). The resistance of isolated strains to antibiotics
was as following: E. coli and Klebsiella sp. were resistant to ampicillin (24.1–
100%), amoxicillin-clavulanicacid (3.4–15.9%), cephalothin (6–18.1%),
nitrofurantoin (1.7–22.2%), cotrimoxazole (8.6–22.7%) quinolones (1.7–
13.6%) retrospectively. The resistance of Ps. aeruginosa to imipenem was
12.5%, ceftazidime 18.7%, meropenem 9%, quinolones 46% and aminoglyco-
sides 34%. The resistance of coagulase-negative Staphylococci (CoNS), to
oxacillin was 37.5%, gentamycin 6.2%, cotrimoxazole 29%, quinolones
21.8%. Enterococcus sp. was resistant to ampicillin 6.2%, gentamycin H-L
12.5%, quinolones 21.8%. There was no resistance to glycopeptides for
CoNS, as well as Enterococcus sp.
Conclusion: E. coli, Proteus mirabilis, Klebsiella sp. and E. faecalis were the most
common uropathogens isolated from outpatient samples. About 24% of
isolates ofE. coliwere resistant to ampicillin while the resistance to quinolones,
furans, cotrimoxazole was ranged between 1.7 and 8.6%.
P1158 Epidemiology of community-acquired urinary
tract infections in the Zenica-Doboj Canton, Bosnia and
Herzegovina
S. Uzunovic-Kamberovic
Zenica, BIH
Objectives: The aim of this study was to investigate the epidemiology of
antimicrobial resistance of community-acquired urinary tract infections
(UTIs) in the Zenica-Doboj Canton, regarding the age, gender, microorgan-
isms identiﬁed, repeating of isolates and some other factors, and to propose
empiric therapy.
Methods: It was analyzed for 54.638 consecutive urine samples by standard
procedures in 1998–2001 period. Antimicrobial susceptibility was performed
by disc-diffusion method to 11 antimicrobials.
Results:A total number of 11.012 E. coli and other coliforms were isolated, of
which 5149 (46.8%) were potentially repeated ones. Male/Female incidences
were 1.0 and 4.3/1000/year, respectively; the highest were in the youngest
age group, 7.7/1000/year. The most isolates obtained from patients under
20 years, 74.7% in male and 66.1% in female. The differences in susceptibility
rates calculated including or excluding repeat isolates were about 1.0%.
Inclusion of coliforms other than E. coli (25.6%) have increased baseline
estimates of resistance in all tested antibiotics except ampicillin and cotri-
moxasole (Sxt), for which it was almost equally high in both group tested
(70.0 and 50.0%). E. coli resistance rate was markedly higher in males than in
females, except in the case of ampicillin and Sxt, for which, again, equally
highest in both groups. Resistance rate patterns according the age were similar
for male/female and E. coli/other coliform subsets, lowest for ﬂuoroquino-
lones, and highest in 20–64 and under 65 age groups.
Conclusions:The high ampicillin (74%) and Sxt (49.3%) resistance rates for all
subsets analyzed (E. coli/other coliforms, male/female) brings ﬂuoroquinol-
ones on the top of empiric therapy list. Empiric therapy with Sxt in our region
seems inadequate even in low-risk population category, and should be left.
Nitrofurantoin also should be considered as the ﬁrst-line therapy especially in
children. The ease of procuring antibiotics in this region after thewar without a
prescription could result inuncontrolled self-medication. It can explain decreas-
ing trend in ampicillin- and Sxt- resistance rates and increasing in ﬂuoroquino-
lones in this, after the war period. It is important for physicians to know
susceptibility data of UTIs and when empiric treatment should start.
Chlamydia and other sexually transmitted infections
P1159 The effects of lipopolysaccharide on human
spermatozoa
A. Eley, H. Hakimi, S. Hosseinzadeh, I. Geary, A. Pacey
Shefﬁeld, UK
Objectives: The spermicidal activity of bacterial endotoxin (LPS) has been
reported by different researchers. LPS essentially consists of lipid A, a core
polysaccharide (Kdo) and O antigen. The expression of the LPS coreceptor
CD14 was previously shown on spermatozoa to be a functional component.
Previous work in our group showed that chlamydial LPS revealed a more
potent spermicidal effect than that from E. coli. That chlamydial LPS was
spermicidal was demonstrated by the use of polymyxin B to inhibit its effects.
As such, we have extended our initial studies to expand our understanding of
the interaction between LPS and human spermatozoa in vitro.
Methods: Semen samples that were identiﬁed to be normozoospermic by
WHO criteria were obtained from donors attending the Andrology Labora-
tory, Jessop Wing, Royal Hallamshire Hospital. From each sample, a highly
motile suspension of spermatozoa was obtained. Extraction of LPS from
C. trachomatis serovars E and LGV was performed, other LPS and constituents
were obtained commercially. Spermatozoa were adjusted to 5 106 million/
mL and incubated for 6 h at 378C/5% CO2 with 0.1mg/mL of chlamydial
LPS or 50 mg/mL of E. coli LPS, lipid A or Kdo. The effects of antihuman
CD14 antibody on the combinations of LPS/sperm were investigated. More-
over, the mechanism of death in sperm was studied by ﬂow cytometry.
Results: The toxic effects of E. coli LPS were blocked by antihuman CD14
antibody. Percent values of killing for sperm incubated with LPS alone or
sperm treated with anti-CD14 antibody for 30min and incubated with LPS,
were 27 and 12%, respectively. When sperm were incubated with 50mg/mL
of synthetic Kdo, some spermicidal activity was shown. Sperm death at 6 h
when compared with the control was 20 and 10%, respectively. Lipid A was
also shown to have a similar spermicidal activity. The level of apoptosis in the
control sperm was 5%. This value changed to 27 and 22% when sperm were
incubated with the LPS extracted from C. trachomatis serovars E and LGV,
respectively.
Conclusions: In conclusion, these data provide a further understanding of the
mechanisms of death in human spermatozoa when induced by LPS. There
were comparable effects on sperm of both lipid A and Kdo. The spermicidal
activity of LPS from E. coli was blocked by anti-CD14. Flow cytometry
showed that LPS was responsible for the induction of apoptosis in sperma-
tozoa and that this was a prime cause of death.
P1160 Potential adhesins of Chlamydia trachomatis
A. Eley, S. Fadel
Shefﬁeld, UK
Objectives: A number of adherence mechanisms in C. trachomatis were
examined, including outer membrane proteins, lipopolysaccharide (LPS)
and heparan sulfate (HS). Our aim was to shed further light on possible
C. trachomatis–host interactions.
Methods: Two C. trachomatis serovars LGV1 and E64 were examined using
two cell lines, HeLa and Hec1B. A number of approaches were used which
included inhibition of sulfation by growing the cells in the presence of various
concentrations of sodium chlorate. To investigate whether HS was present on
the chlamydia or not, the effect of chlorate on the EBs was examined. For the
reversal of the sulfation inhibition, chlorate treated cells were supplemented
with sodium sulfate. To explore the surface proteins, chlamydiae were assayed
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for infectivity after treatment with various concentrations of trypsin. A
polyclonal anti-MOMP was used to examine the possible role of MOMP.
Finally, we used polymyxin B (PmB) as an inhibitor of LPS.
Results: For the LGV1 serovar, infectivity decreased with increasing chlorate
concentration. Using 70mM chlorate, minimum infectivity was obtained in
both cell lines. Infectivity of E64 was essentially unaffected in the presence of
chlorate. Growing chlamydia in the presence of up to 70mM chlorate did not
seem to have an inhibitory effect on the infectivity of any of the tested
serovars. Supplementing sodium chlorate-treated cells with sodium sulfate led
to partial restoration of the infectivity. Serovar LGV was sensitive to trypsin
even at very low concentrations; whilst serovar E was less sensitive. Use of
anti-MOMP antibody resulted in a greater decrease in infectivity of LGV1
than E64. Growing chlamydia in the presence of 100mg/mL PmB led to a
signiﬁcant decrease in infectivity of both serovars.
Conclusions:Chlorate inhibition of infectivity on the cell lines rather than on
chlamydia itself suggested that HS is present on the host cells rather than
C. trachomatis. Serovar LGV1 was also affected by trypsin treatment more than
serovar E. Interestingly, the same pattern of results was seen when an anti-
MOMP antibody was tested. This suggests that MOMP may play a role in
infectivity. Finally, polymyxin B also showed a marked reduction in infectivity
of both serovars, suggesting that LPS might be important. Our ﬁndings
suggest that serovar LGV rather than E is perhaps more dependant on
the infectivity factors we investigated. Moreover, several factors may be
implicated.
P1161 Clinical evaluation of VIDAS PROBE Chlamydia
trachomatis test from endocervical swab specimens in
screening high and low prevalence populations
D. Fuller, L. Jasper, M. Milish, P. Lineback, R. Buckner, T. Davis
Indianapolis, USA
Objectives: Genital C. trachomatis infection, a substantial public health pro-
blem, is the most common sexually transmitted disease (STD) in many
countries and may cause serious reproductive and ocular complications.
Due to the often asymptomatic nature of chlamydial infections, it is important
to target screening that includes rapid and accurate diagnosis in order to
decrease disease prevalence. This study assessed the clinical performance of the
VIDAS PROBE C. trachomatis (CT) test as compared with Gen-Probe
AMPLIFIED Chlamydia trachomatis Assay (AMP-CT) and the BD ProbeTec
(PT) CT assay for detection of chlamydial infections from endocervical swab
specimens.
Methods: Two patient populations were screened. ‘Wishard 1’ consisted of
patient who presented at a 24H emergent OB-GYN facility that doubles as an
STD screening clinic. ‘Wishard 2’ consisted of patients who presented to their
primary care clinician for routine annual or prenatal visits. Three separate
randomized endocervical swabs were collected from study subjects (>13 years
of age) and transported to the laboratory where each assay was performed
according to manufacturer’s recommendations. Patient infectivity status was
based upon endocervical swab results from PT and AMP-T.
Results:A total of 310 subjects were screened at ‘Wishard 1’ with 44 classiﬁed
as asymptomatic and 266 symptomatic. The prevalence rate in the asympto-
matic population was 15.91% while the prevalence in the symptomatic
population was 8.65% and the overall prevalence was 9.7% (30/310). The
VIDAS PROBE exhibited 100% sensitivity (30/30) and 100% sensitivity
(278/278) in both asymptomatic and symptomatic subjects. The negative and
positive predictive values were also 100%. A total of 297 subjects were
screened at ‘Wishard 2’ with 125 classiﬁed as asymptomatic and 172 sympto-
matic. The prevalence rate in the asymptomatic population was 2.4% while
the prevalence rate for the symptomatic population was 5.23%. The VIDAS
PROBE exhibited 100% (12/12) sensitivity and 100% speciﬁcity (284/284) in
both asymptomatic and symptomatic subjects. The negative and positive
predictive values were also 100%.
Conclusions: Results from this study suggest the VIDAS PROBE CT is a
sensitive and speciﬁc test for the detection of CT infections and can be used as
a screening test in both high and low prevalence patient populations.
This product has not been cleared by the US FDA and is not yet available for
commercial use.
P1162 Detection of Chlamydia trachomatis and
Neisseria gonorrheae from CyTyc PreservCyt ThinPrep Pap
smear collection kits using the Gen-Probe APTIMA Combo 2
Assay
D. Fuller, L. Jasper, M. Milish, C. Brunnemer, M. Short, T. Davis,
C. Filomena
Indianapolis, USA
Objectives: To determine the feasibility of utilizing a single collection device
that can be used for Pap smear preparations and to screen for sexually
transmitted diseases. The CyTyc PreservCyt ThinPrep (TP) liquid Pap smear
media is used to collect and transport cervical tissue used in Pap smear
preparation and testing for cervical cancer. The cervix is also a site of infection
for Chlamydia trachomatis (CT) and Neisseria gonorrheae (GC) in women. If
undiagnosed or untreated, women may acquire cervicitis, urethritis, salpin-
gitis, proctitis, and endometriosis leading to pelvic inﬂammatory disease
(PID), which is a contributor to infertility. These organisms can be trans-
mitted in the birth canal, potentially resulting in conjunctivitis and/or
pneumonia in newborns.
Methods:This study evaluated the performance of APTIMACombo 2 Assay
(AC2)(Gen-Probe, Inc., San Diego, CA) for detection of CT and GC from
aliquots of the TP solution as compared with detection of these pathogens
from routine cervical swab and urine specimens. AC2 is an ampliﬁed nucleic
acid test that utilizes target capture specimen processing followed by tran-
scription-mediated ampliﬁcation and dual kinetic assay detection. 159 female
subjects have been tested to date. Prior to examination and collection of
cervical specimens, subjects collected 10–30mL of urine. Clinicians obtained
subsequent TP and cervical swab specimens during the pelvic examination.
The AC2 assay was performed on all swab and urine specimens according to
manufacturer’s recommendations. Additionally, the AC2 assay was performed
on a 1-mL aliquot from the TP solution. Discordant specimens, all positive
and an equal number of negative specimenswere also tested using the COBAS
Amplicor assay (CA) for CT and GC (Roche Diagnostics, Indianapolis, IN).
Results: In this low prevalence population, 11 patients were positive for CT
and 1 for GC in both cervical and urine AC2 testing. The corresponding TP
aliquot showed complete agreement (100% sensitivity) with no false positive
TP results for the remaining patients with AC2 negative swab and urine
specimens (100% speciﬁcity). The CA assay also showed complete agreement
(there were no discordant specimens to test).
Conclusions: Preliminary results from this study indicate the CyTyc Pre-
servCyt ThinPrep medium is compatible with the APTIMA Combo 2 assay,
making possible the pairing of highly accurate CTand GC detection with Pap
smear testing from a single sample.
P1163 Chlamydia trachomatis, Mycoplasma hominis and
Ureaplasma urealyticum infections in patients with
nongonococcal urethritis
D. Kese, D. Golubovski, M. Potocnik, M. Maticic
Ljubljana, SVN
Objectives:Chlamydia trachomatis and genital mycoplasmas are known patho-
gens causing nongonococcal urethritis (NGU).Our objective was to study the
distribution of infections with Chlamydia trachomatis, Mycoplasma hominis and
Ureaplasma urealyticum in male with NGU and their respective female partners
The study enrolled 926 male patients and 512 female between January 1999
and December 2001 according to the age group.
Methods: Amplicor polymerase chain reaction and direct immunoﬂuores-
cence assay were used for detection C. trachomatis on urethral or/and cervical
swab specimens. Presence of genital mycoplasmas in patients’ specimens were
diagnosed by culture screening.
Results: The overall prevalence of C. trachomatis was found in 18.5% (266) of
cases of urethral discharge: in 21.0% (195/926) of male with NGU and in
13.8% (71/512) of female partners, respectively. The highest prevalence was
determined in the age group of 15–30 years (P< 0.05). For urogenital
mycoplasma infections it was screened 891 male with NGU and 377 female.
Among them genital mycoplasmas were present in 290 (22.8%) of patients,
namely in 17.3% of men and in 39.8% of female. Ureaplasma urealyticum was
Clinical Microbiology and Infection, Volume 9, Supplement 1, 2003 275
detected in 22.9% of patients with NGU while M. hominis was found in only
1.1%. Multiple infections with genital mycoplasma and C. trachomatis were
also observed in 4.9% of patients.
Conclusion: C. trachomatis and U. urealyticum infections are common among
patients with NGU in our population. M. hominis was identiﬁed very rarely.
P1164 Incidence of infection by Chlamydia trachomatis
in female commercial sex workers in Kampala, Uganda
Y. Taidhi, B. Nabirye, S. Kapere
Iganga, UG
Objectives:To determine the incidence of cervical varginal infections caused
byC. trachomatis (CT) in female commercial sex workers (FCSWs), associated
factors and practices as well as other sexual transmitted infections.
Methods: Blood and cervicovagina samples were taken from 750 FCSWs
attending an STD/STI detection clinic in Kampala city from January 2001 to
July 2002. Structured questionnaires with social demographic data, history
STI, sexual practices and condom use was applied. Genital exam in all cases
and the following STIs detection:condylomatosis (clinical), Chlamydia tracho-
matis infection (direct immunoﬂurescence), gonorrhea (thayer-martin cul-
ture), bacterial vaginosis, trichomoniasis and candidiasis (smear/KOH/
Gram).
Results: 750 FCSWswere studied. Mean age 21 years old (range 19–45 years),
age starting sexual activity 19, in completely elementary schools 65%, average
clients per a week 60 and unstable couples. 54.2% (164) reported condom use
with their clients, 18% (57) with stable couples and 17% (51) reported
condom use in the French way (same condom for oral and genital sex with
more than one woman) Endocervical sample were positive for CT in 23%
(207) from which 31% (97) reported no clinical manifestation, 15.8% have
mucopurulent cervicitis. 51% reported previous STIs, more frequently
bacterial vaginosis and trichomoniasis.
Conclusion: CT infections among FCSWs is high, event with no clinical
manifestation. This can increase the risk of HIV transmission as well as other
STIs: regardless the cost of this test, incorporation of this type of studies for
risky practices, population is very important in order to give early treatment to
avoid complications.
P1165 Study of urethral Chlamydia infection in men
with nongonococcal urethritis in Tehran, Iran
N. Badami, A. Khamesipour, F. Amin Harati
Tehran, IR
Objectives: The objective of this study was to determine the rate of Non-
gonococcal Urethritis (NGU) caused by Chlamydia trachomatis in males
referred to the Tehran University of Medical Sciences afﬁliated hospitals.
Methods: The present study is designed to deﬁne the incidence rate of
urethral infections with NGU caused by Chlamydia trachomatis in patients
referred to Tehran University of Medical Sciences afﬁliated hospitals during
April 1999 to August 2000. In this period 310 males aged 20–50 years old,
with NGU were included in this study. The patients were referred to the
laboratory by the physicians for further microbiological examination. The
enrolled patients were interviewed by a physician, and if they agreed to
participate in the study an endo-urethral swab and a blood sample were taken
from each patient. Blood samples from 200 healthy blood donors were used as
control. The endo-urethral swab was transported into a 2SPmedia and shaken
well. Then the 2SP medium containing the swabs were transferred to the
School of Public Health Chlamydia laboroatory. The media was then cultured
in two conﬂuent McCoy cell monolayers treated with cyclohexamide. After 3
days one of the McCoy cell monolayer was stained by Giemsa technique. If
there was no growth ofChlamydia then the next passaged for two times. Blood
samples were used to check the presence of anti-Chlamydia antibodies (IgM
and IgG) by indirect immunoﬂurecent technique (micro-IF).
Results: The results indicated that Chlamydia was isolated from 36 out of 310
(11.6%) of patients. The IgM speciﬁc antiChlamydia antibodies were detected
in a titer of 1/8 in 10 patients (3.2%). The IgG speciﬁc anti Chlamydia
antibodies were detected in a titer of 1/32 and above in 68 patients (21.9%).
No IgM antiChlamydia antibody was detected in any of the sample taken from
the control group. The IgG anti Chlamydia antibodies were detected in a titer
of 1/32 and above in 4 (2.0%) of the control group.
Conclusions:All the patients except one with a positive culture resultsshowed
a positive titer of IgG. Three of the patients with positive titer of IgM showed a
positive culture. were positive. In Western countries most of the NGU cases
are caused by Chlamydia trachomatis but in this study based on the culture
results a smaller portion of NGU cases are caused by Chlamydia trachomatis in
Iranian society.
P1166 Detection of Chlamydia trachomatis DNA and
human papillomavirus DNA in cervical samples with regard
to vaginal colonization with lactobacilli
A. Szkaradkiewicz, A. Kuch, P. Pieˆta, M. Wal,
G. H. Breˆborowicz
Poznan˜, PL
Objectives: The studies aimed at evaluating the risk of Chlamydia trachomatis
and human papillomavirus (HPV) infections in patients with vaginal ﬂora.
Methods: The studies were performed on 97 women, aged 25–43 years.
Vaginal ﬂora was examined by Gram’s stain score on basis of standardized
criteria (Nugent’s score). A score equal and more than 4 was used to to deﬁne
abnormal vaginal ﬂora. In addition, presence of lactobacilli was conﬁrmed by
culture. Chlamydia trachomatis DNA was detected in cervical samples using
PCR ampliﬁcation assay (ampliﬁcation of DNA fragment which encoded
omp-1 gene). HPV DNA oncogenic types: 16, 18, 31, 33, 35, 39, 45, 51, 52,
56 and 58 were detected in cervical samples using PCR-ELISA assay (Sharp
Signal System, Digene).
Results:On the basis of vaginal ﬂora evaluation, to subgroups of the women
were distinguished. Subgroup 1 included 37 patients with normal vaginal ﬂora
characterized by domination of vaginal lactobacilli (score <4). Subgroup 2
included 60 patients with abnormal vaginal ﬂora characterized by the presence
of individual lactobacilli or by their absence (score equal and more than 4). In
the subgroup 1, Chlamydia trachomatis DNAwas detected in 9 patients, HPV
DNA in 2 patients while in the subgroup 2 Chlamydia trachomatis DNA was
seen in 3 patients, HPV DNA in 13 patients.
Conclusion: The obtained results may indicate that vaginal colonisation with
lactobacilli does not protect the patients from Chlamydia trachomatis infection,
but reduce the risk of HPV infection.
P1167 Role of Chlamydia trachomatis and Mycoplasma
spp. in rheumatologic disorders and related syndromes
D. Racciatti, J. Vecchiet, M. Dalessandro, A. D’Alonzo, F. Lattanzio,
S. Gioia, R. Faricelli, E. Pizzigallo
Chieti Scalo, I
Objectives: To identify the potential etiologic role of Chlamydia trachomatis
and Mycoplasma in precipitating rheumatological-like disorders.
Methods: At the Clinic of Infectious Diseases of Chieti University 119
patients (82 F and 37M; mean age: 37.5 10 year) complaining of localized
or diffuse arthralgias associated to fever and/or myalgias and/or prolonged
fatigue were examined. All subjects underwent routine laboratory and
rheumatologic investigations, determination of antibodies towards hepatitis
B and C viruses, HIV,C. trachomatis andMycoplasma spp., and an urethral swab
to search for C. trachomatis, U. urealyticum and M. hominis.
Results: The diagnosis formulated for the 119 patients was: chronic fatigue
syndrome (CDC, 1994) in 33 cases (27.7%), fever of unknowned origin in 44
cases (37.0%), idiopathic chronic fatigue (CDC, 1994)in 7 cases (5.9%), HCV
or HIV infection in 12 cases (10.1%), reactive arthritis in 13 cases (10.9%) and
ﬁbromyalgia syndrome in 10 cases (8.4%). In 64 of the 119 patients (53.8%) an
urogenital infection was identiﬁed and due to C. trachomatis in 19 cases
(29.7%), M. hominis in 5 cases (7.8%) and U. urealyticum in 40 cases
(62.5%). All 64 patients underwent an antibiotic therapy (doxycycline or
azythromicin). The urethral swab repeated after such therapy showed an
eradication of the infectious agent inmost of the patients (85.9%). In 9 patients
(14.1%), however, a complete resolution of the infection was reached after a
second cycle of antibiotic therapy (azythromicin or chlarythromicin in only
one case). Furthermore, 23 of the 64 patients (35.9%) showed a clinical beneﬁt
from the treatment with a complete remission of the symptomatology they
complained of.
Conclusion: Our ﬁndings suggest that the determination of sexually trans-
mitted infectious agents must be included in the diagnostic protocol of
patients complaining of rheumatologic-like disorders. In fact Chlamydia
trachomatis and Mycoplasma spp. often induce extragenital manifestations in
the absence of a local symptomatology. So it is important to identify and treat
such silent sexually transmitted infections to prevent potential severe com-
plications (e.g. PID, infertility, etc.) as well as to reach a better understanding
of pathophysiologic mechanisms involved in the onset of rheumatologic
disorders and related syndromes (e.g. chronic fatigue syndrome, etc.).
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P1168 Chlamydia trachomatis in rheumatologic
patients
I. Choroszy-Kro´l, J. Ruczkowska, J. Swierkot, D. Teryks-Wolyniec
Wroclaw, PL
Objectives:Reactive arthritis (RA) triggered by sexually trasmitted infections
is referred to as sexually acquired reactive arthritis (SARA). There is no gold
standard for the diagnosis of SARA.None of the tests or the clinical symptoms
alone are strong enough to make a deﬁnite diagnosis of SARA. Tests to
identify Chlamydia trachomatis together with typical clinical symptoms may be
helpful in making the ﬁnal diagnosis of RA.
Methods: Our study comprised 87 patients, aged 19–78 (58 women, 29
men), hospitalized in one of the rheumathological ward in Wroclaw from 1
May 2000–30 April 2002. The control group consisted of 30 individuals, aged
27–70, without any arthritis complaints. Altogether 117 specimens from
urethra were tested by direct immunoﬂuorescence – DIF (IF test, Medac,
Germany) as well as 117 serum samples were examined by immunoenzymatic
method – ELISA (Viro-Immun Labor – Diagnostika, GmbH) for speciﬁc
anti-Chlamydia trachomatis IgG and IgA antibodies.
Results: Positive DIF results were found in 42 (48%) of the 87 patients, while
speciﬁc IgG in 56 (64%) and IgA in 16 (18%) of them. Bacteriological and
serological ﬁndings together with clinical data allowed to diagnose 38 (43.7%)
patients as having RA, 5 (5.7%) cases as suspected of having RA (according to
Fendler’s criteria) and in 44 cases to excludeRA. In the control group (n¼ 30)
there were 3 (10%) DIF (þ), 8 (26.6%) IgG (þ) and 4 (13.3%) IgA (þ).
Correlation of positive results of 3 tests (DIF, IgG and IgA) was observed in 7,
and of negative results in 22 patients. Correlation of positive results of 2 tests
(DIF and IgG) was noticed in 29 out of 87 cases. Laboratory positive tests for
Chlamydia trachomatis allowed to change initial diagnosis in 23 patients from
rheumatoid arthritis (n¼ 9), osteoarthritis (n¼ 5), connective tissue disorders
(n¼ 4), gout (n¼ 1) and ankylosing spondylitis (n¼ 4) for RA as a ﬁnal
diagnosis. Basing on negative results in 2 cases there was a change from
reactive arthritis to reumatoid arthritis.
Conclusions: (i) Positive results of testing for Chlamydia trachomatis allowed to
diagnose RA in nearly a half (49.4%) of tested rheumathological patients. (ii)
High percentage of positive Chlamydia trachomatis results in the control group
may be connected with a relatively high frequency of chlamydial infections in
Lower Silesia Region of Poland.
P1169 Microbiologic characteristics of 25 Neisseria
gonorrheae strains isolated in a 10-year period
I. Go´mez De Argila, E. Cuchı´ Burgos, C. Garcı´a Vidal, J. Garau
Alemany
Terrassa, E
Objectives: To describe microbiological characteristics of Neisseria gonorrheae
isolated between 1991 and 2002. Half of the cases belongs to the calendar year
2002; differences between these strains and those of preceding years were
compared.
Methods: We included 25 N. gonorrheae isolates obtained during the period
January 1991–December 2002. We studied beta lactamase production, sus-
ceptibility (broth dilution) to penicillin, cefoxitin, ceftriaxone, ciproﬂoxacin,
tetracycline and spectinomycin, and serogroup by monoclonal antibodies
technique.
Results: A total of 25 N. gonorrheae strains were isolated. In the period 1991–
2001, 13 strains (10 from men urethral samples and 3 from women endo-
cervical samples); in 2002 11 strains were isolated frommen (urethral samples)
and 1 from a woman (endocervical). The mean age was 33 (1991–2001) and
35 (2002), respectively. The serogroup distribution was IA 5 cases, IB 8 cases
(1991–2001) and IA 2 cases, IB 8 cases (2002). Beta lactamase production was
found in 4 cases in the ﬁrst period and in one strain in 2002. In 1991–2001
penicillin MIC were>1 in 5 cases,<0.06 in 2, and the rest of strains between
these values; in 2002 all the strains had MIC values between 0.06 and 2. In the
ﬁrst period, ciproﬂoxacin was tested only in three cases: one was resistant and
two susceptible; in 2002, all the strains were susceptible (MIC< 0.06). 7
strains were tetracycline resistant (MIC> 1) in the ﬁrst period, and in 2002 2
of 10 strains tested were resistant. All the strains in both periods were
susceptible to cefoxitin, ceftriaxone and spectinomycin.
Conclusions: We detected a progressive rise in the number of N. gonorrheae
isolates, especially in the last year: we found no differences between the strain
characteristics studied in both periods. Beta lactamase production is not very
important, but penicillin susceptibility is decrease, probably by other resistance
mechanisms. The other classic antibiotic, tetracycline, is also not very effective
in vitro. The MIC for the CDC recommended antibiotics (cephalosporins
and quinolones) are still below the resistance cut-off.
P1170 Spontaneous peritonitis caused by Neisseria
gonorrheae: a case report
N. Charalambakis, Z. Salem, M. Nepka, C. Pappas, N. Syllas,
A. Christopoulou, E. Trikka-Graphakos
Athens, GR
Gonorrhea is one of the oldest human sexually transmitted diseases. The
incidence of the infection is now declining rapidly in industrialized countries.
Up to 90% of women with gororrhea may be asyptomatic although some-
times endocervicitis, vulvovaginitis, urethritis, inﬂammation of Bartholin’s
glands and even rarely disseminated gonococcal peritonitis may appear. We
describe a case of Spontaneous peritonitis in a sexually active woman caused by
Nesseria gonorrheae. A 23-year-old woman was admitted to the emergency
department with clinical signs of acute abdomen and increased body tem-
perature, started 2 days before. No infectious focus was reported. During
physical examination fever, tachycardia and rebound tenderness of the
abdominal wall were present while bowel sounds were absent. On admission,
white blood cell count was increased with a shift to the left, CRP was
elevated, while the abdominal X-ray was compatible with peritonitis. The
patient was taken to the operating theatre for exploratory laparotomy where
lavage of the purulent exudate with saline solution and removal of both
fallopian tubes took place. Purulent exudate cultures obtained intraopera-
tively, revealed heavy growth of N. gonorrheae while repeated blood cultures
were negative. She was treated with metronidazole 500mg IV, every 8 h, in
combination with ceftriaxone IV, 1 g every 12 h. The patient was discharged
after 15 days of hospitalization. In conclusion, Spontaneous peritonitis is a rare
complication of gonococcal infection that provides highly suggestive evidence
of transfallopian route of transmission, mainly in previously asymptomatic
patients. It is important therefore to consider this route of infection in a
sexually active woman with clinical and laboratory features of bacterial
peritonitis and include culture media appropriate for N. gonorrheae before
initiating empirical antibiotic therapy.
P1171 Case ﬁnding strategies in a syphilis outbreak
S. Hopkins, L. Thornton, M. Fitzgerald, C. Merry, C. Bergin,
F. Mulcahy, on behalf of the Syphilis Outbreak Control Team
Introduction: Between January 2000 and September 2002, 526 cases of
syphilis have been notiﬁed to the National Disease Surveillance Centre
through enhanced surveillance of syphilis in Ireland. These cases occurred
predominantly in MSM (79%) and were diagnosed principally in the sexually
transmitted infection (STI) clinics in the Eastern Regional Health Authority
(ERHA)(89%).
Methods: The Director of Public Health in the ERHA established an
outbreak control team in October 2000. The number and duration of STI
clinics were increased and an additional health advisor was appointed for
contact tracing. Community involvement through specialized outreach work,
on-site serological testing for syphilis and education was implemented.
Results: STI services were extended in St. James’s Hospital and in the Gay
Men’s Health Project (community clinic). Between 2000 and 2001, the
GMHP saw a 41% increase in attendees at clinics. A designated health advisor
for intensive contact tracing, education and health promotion was employed.
20.7% of patients diagnosed with syphilis at St. James’s Hospital attended as a
result of contact tracing. Serological testing for syphilis was performed in gay
venues (bars, saunas, clubs, community events and Gay PRIDE). 896 men
tested for syphilis in these venues. 54 new diagnosis of syphilis were conﬁrmed
through this method. (75% were diagnosed with early infectious syphilis with
a clinical history of primary or secondary syphilis or contact with a known
syphilis case) 24% of these men were codiagnosed with at least one other STI;
two men were diagnosed with 5 infections (HIV, HBV, N. gonorrhoea,
C. trachomatis, condyloma acuminata). A poster and information campaign
targeted at gay men that included images of ‘drag queens and kings’ was
implemented. Peer outreach workers highlighted important syphilis facts in
face-to-face interviews with community members.
Conclusion: Intervention measures have proven successful for case ﬁnding in
the context of this outbreak. The links developed during this outbreak have
fostered trust between the gay and bisexual community and health services
providing the basis for further collaboration in the future.
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PCR and sexually transmitted diseases
P1172 Performance of the APTIMA CT assay for the
detection of Chlamydia trachomatis
M. Dubucq, M. Mauricio, M. Bott, M. Shih, J. Spidle, C. Eng,
R. Johnson
San Diego, USA
Objectives:The APTIMACTassay has been developed to qualitatively detect
Chlamydia trachomatis rRNA from male urethral, endocervical, and vaginal
swab specimens and male and female urine specimens. A target
capture method is used to purify the CT nucleic acid away from both
nontarget nucleic acids and the ampliﬁcation inhibitors found in clinical
specimens. Following Transcription-Mediated Ampliﬁcation (TMA), the
products of the ampliﬁcation reaction are then detected by the Hybridization
Protection Assay (HPA). The assay was designed to be used as both a
conﬁrmatory assay for the CT portion of APTIMA Combo 2 as well as a
direct test for CT.
Methods:A panel of 154 bacteria, fungi, parasites and viruses was tested with
the APTIMA CT assay to demonstrate analytical speciﬁcity, and 15 CT
serovars were tested to show analytical sensitivity. E. coli and G. vaginalis
(1 108 cells/assay) were added to specimens containing the CT rRNA
equivalent of 1 CT IFU/assay to test the impact of nontarget organisms.
Naturally occurring and exogeneously derived materials were tested for assay
interference and impact on background in the presence and absence of CTat
the rRNA equivalent of 1 CT IFU/assay. Negative swab and urine specimens
were tested for inhibition by the addition of CT rRNA at the limit of
detection.
Results: The panel of 154 bacteria, fungi, parasites and viruses produced all
negative results, thereby demonstrating analytical speciﬁcity. The testing of
the 15 CT serovars showed analytical sensitivity to be as low as 0.01 CT IFU/
assay for all 15 serovars. None of the naturally occurring or exogenously
derived materials interfered with APTIMACT performance at all the normal
and excessive levels tested, including those known to interfere with other
ampliﬁed assays. No interference with signal recovery was observed from the
nontarget organisms tested. No inhibitory results for any of the patient swab
and urine specimens tested or for any of the urine specimens tested from
patients with conﬁrmed urinary tract infections (0/200 swabs; 0/285 urine
specimens) were observed.
Conclusions: Target capture is effective in removing endogenous and exo-
genous specimen inhibitors and TMA combined with HPA yields highly
sensitive and speciﬁc detection of CT rRNA. The APTIMA CT assay is
currently under development.
P1173 Ability of the APTIMA Combo 2 assay to detect
Chlamydia trachomatis and Neisseria gonorrhoeae in liquid
PAP samples
D. Jang, J. Patel, S. Chong, J. Kapala, M. Chernesky
Hamilton, Brampton, CAN
Objectives: Nucleic acid ampliﬁcation (NAA) screening for Chlamydia
trachomatis (CT) and Neisseria gonorrhoeae (GC) at the time of PAP testing
is a proposed strategy for controlling these sexually transmitted infections. Our
objectives were to determine the sensitivity of the APTIMACombo 2 assay to
detect CT and GC in fresh and stored liquid PAP samples.
Methods: Varying dilutions of CT and GC rRNA were spiked into Gen-
Probe specimen transport media (STM) and two liquid PAP systems: Pre-
servCyt (CyTyc) and Autocyte (TriPath); then assayed for detection sensitivity
immediately and after storage. Liquid-prep samples containing only CTor GC
were mixed in varying concentrations to determine the ability of the dual
detection assay to identify single or dual infections. Cervical swabs were
collected fromwomen immediately after an Autocyte samplewas collected for
a PAP test and both samples were assayed for CTandGC after the PAP test was
performed.
Results: The APTIMA Combo 2 CT and GC assay sensitivity curves for
organism rRNA diluted in STM, PreservCyt and Autocyte were parallel to
one another and became negative between 8 and 9 log dilutions. Bacterial
rRNA was detected in both liquid PAP systems when only CT or GC was
present or when both were mixed together either in equal concentrations or
when one was in 1000-fold concentration greater than the other. In a limited
number of patients enrolled to this point, concordance for the detection of
CT in STM and Autocyte media have been identical and this clinical
component is ongoing.
Conclusion:The APTIMACombo 2 assay detected low levels of CTand GC
from both PreservCyt and Autocyte media with equal efﬁciency to the assay’s
STM. Detection was still possible after 3weeks storage of the specimens. CT
was detected in equal numbers of clinical samples of Autocyte or STM
collections.
P1174 Simultaneous detection of Chlamydia
trachomatis and Neisseria gonorrhoeae in the APTIMA
Combo 2 assay by testing cervical swabs previously tested
by LCx or ProbeTec assays
M. Chernesky, D. Jang, J. Patel, S. Castriciano, S. Chong, J. Kapala
Hamilton, Brampton, CAN
Objectives: Laboratories changing from one commercial test to another
require assay-speciﬁc collection kits to be replaced in clinics serviced.
Equivocal results in one assay may beneﬁt from repeat testing in another.
The objective of the study was to test by the APTIMACombo 2 assay residual
cervical swab material left over from LCx and ProbeTec-speciﬁc collection
tubes; then to calculate the concordance of the assay results for Chlamydia
trachomatis. Neisseria gonorrhoeae nucleic acids were simultaneously assayed in
the APTIMA Combo 2 assay.
Methods: Swabs previously tested by the ProbeTec CT assay (Becton Dick-
inson) (n¼ 150) or LCx CT test (Abbott) (n¼ 156) were retrieved after
storage (2weeks refrigerated or frozen) and tested in the APTIMACombo 2
assay (Gen-Probe Incorporated) for CTand GC simultaneously. The original
swab and 200 mL of the remaining transport media were added to the
APTIMA Combo 2 tube before processing.
Results: The APTIMA Combo 2 CT assay results were concordant with the
LCx results in 91.4% (32/35) of the positives, 100% (121/121) of the negatives
and 98.1% (153/156) overall. APTIMA Combo 2 CT results were concor-
dant with 95.2% (40/42) of positives, 99.1% (107/108) of negatives and 98%
(147/150) overall with the ProbeTec CTresults. Six patients were found to be
dually infected with CTand GC in the APTIMACombo 2 test. Examination
of patient charts revealed that ﬁve of the six had been cultured for GC and
were positive.
Conclusions: Residual cervical swab material from the LCx and ProbeTec
transport systems provided simultaneous NAA testing for CT and GC by
APTIMA Combo 2 and identiﬁed 93.5% (72/77) of women who had been
C. trachomatis positive in the other assays. GC-positive patients were also
identiﬁed.
P1175 Speciﬁc detection of Neisseria gonorrhoeae
by the APTIMA GC assay
M. Dubucq, M. Mauricio, M. Bott, M. Shih, J. Spidle,
C. Eng, R. Johnson
San Diego, USA
Objectives: The APTIMA GC assay has been developed to allow for the
speciﬁc capture of Neisseria gonorrhoeae rRNA from male urethral, endocer-
vical, and vaginal swab specimens and male and female urine specimens onto
magnetic particles as a sample processing method that effectively removes
inhibitors of nucleic acid ampliﬁcation (target capture). GC rRNA is
qualitatively detected via Transcription-Mediated Ampliﬁcation (TMA)
and by the Hybridization Protection Assay (HPA). This assay may be used
as both a conﬁrmatory assay and as a stand-alone diagnostic assay.
Methods: The analytical performance characteristics of the APTIMA GC
assay were evaluated by testing potentially interfering substances such as
blood, white blood cells, gynecologic products, and nontarget organisms in
endocervical swab specimens and female urine specimens for assay inter-
ference and impact on background. Additionally, naturally occurring sub-
stances such as protein, glucose, ketones, bilirubin, leukocytes, and nitrite, as
well as exogeneously derived materials such as vitamins, minerals, and over-
the-counter painkillers were tested in normal urine. To test the impact of
nontarget organisms on the assay, E. coli and G. vaginalis (1 108 cells/assay)
were added to specimens containing the GC rRNA equivalent of 50
cells/assay. The frequency of specimen inhibition was determined by the
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addition of GC rRNA at the limit of detection to negative swab and urine
specimens.
Results: No signal recovery or background interference from any of the
naturally occurring or exogeneously derived substances was observed at all the
normal and excessive levels tested, including those known to interfere with
other ampliﬁed assays. As well, no interference with assay performance was
observed by the tested nontarget organisms. No inhibitory results for any of
the patient swab and urine specimens tested for specimen inhibition or for any
of the urine specimens tested from patients with conﬁrmed urinary tract
infections (0/200 swabs; 0/285 urine specimens) were found.
Conclusions: The APTIMA GC assay is a sensitive and speciﬁc assay for
detecting GC and target capture effectively removes potentially inhibitory
substances. The APTIMA GC assay is currently under development.
P1176 Evaluation of the VIDAS PROBE NG Test
for the detection of Neisseria gonorrhoeae in female
endocervical and vaginal swab and urine specimens
A. Zuniga, K. Kacena, C. Collum, C. Lenderman, C. Hill, J. Orlov,
S. Mableton, C. Aycock, M. Hunter, S. Hentschel, E. Hook III
Rockland, Birmingham, USA
Objectives: The VIDAS PROBE Neisseria gonorrhoeae Test (VPNG,
BioMe´rieux, Rockland, MA) was evaluated against patient infection status,
determined by conﬁrmed endocervical swab culture and APTIMACombo 2
(AC2, Gen-Probe, Incorporated, San Diego, CA). Specimen types tested
included endocervical swabs, self-collected vaginal swabs, and urines.
Methods: A total of 224 patients were evaluated. Testing was performed on
224 endocervical swabs, 223 vaginal swabs, and 214 urines. Specimens were
processed for the VPNG and AC2 assays per manufacturers’ instructions.
VPNG processed specimens were added to the VIDAS PROBE NG strip,
ampliﬁed on the AMPstation, and detected on the VIDAS. AC2 processed
specimens were ampliﬁed in a water bath and detected by the LEADER
detection instrument. Swabs were plated for N. gonorrhoeae detection by
culture. A patient was considered positive if conﬁrmed culture or both
AC2 swab and urine specimens were positive.
Results: The sensitivity and speciﬁcity of the VIDAS PROBE NG Test in
endocervical swabs were 100% (28/28) and 97% (188/194), respectively. In
vaginal swabs, the sensitivity and speciﬁcity were 96% (27/28) and 95% (177/
186), respectively. In urines, the sensitivity and speciﬁcity were 88% (23/26)
and 100% (178/178), respectively. Eight patients were excluded due to
negative culture and discordant AC2 results (6 AC2 swab positives and 2
AC2 urine positives). Internal control invalid rates were 0.9% (2/224) for
endocervical swabs, 3.1% (7/223) for vaginal swabs, and 4.2% (9/214) for
urines. Equivocal rates were 1.3% (3/224) for endocervical swabs, 3.1% (7/
223) for vaginal swabs, and 0.5% (1/214) for urines.
Conclusions:The VIDAS PROBENGTest is sensitive and speciﬁc compared
with patient infection status in endocervical swabs, vaginal swabs, and urines.
The use of an internal control reliably predicts the ability of each assay to
amplify target. Low invalid and equivocal rates minimize retests and recollec-
tion of samples.
This product has not been approved by the United States FDA and is not commercially
available.
P1177 Evaluation of the VIDAS PROBE NG Test for the
detection of Neisseria gonorrhoeae in male swab and urine
specimens
K. Kacena, A. Zuniga, C. Collum, C. Lenderman, W. Lauzier,
S. Mableton, C. Aycock, D. Lovern, S. Hentschel, E. Hook III
Rockland, Birmingham, USA
Objectives: The VIDAS PROBE Neisseria gonorrhoeae Test (VPNG,
BioMe´rieux, Rockland, MA) was evaluated against patient infection status,
determined by conﬁrmed urethral swab culture and APTIMA Combo 2
(AC2, Gen-Probe, Incorporated, San Diego, CA). Specimen types tested
included urethral swabs and urines.
Methods: A total of 159 patients were evaluated. Testing was performed on
158 urethral swabs and 156 urines. Specimens were processed for the VPNG
and AC2 assays per manufacturers’ instructions. VPNG processed specimens
were added to the VIDAS PROBE NG strip, ampliﬁed on the AMPstation,
and detected on the VIDAS. AC2 processed specimens were ampliﬁed in a
water bath, and detected by the LEADER detection instrument. Swabs were
plated for N. gonorrhoeae detection by culture. A patient was considered
positive if conﬁrmed culture or both AC2 swab and urine specimens were
positive.
Results: The sensitivity and speciﬁcity of the VIDAS PROBE NG Test in
urethral swabs were 98% (39/40) and 99% (116/117), respectively. In urines,
the sensitivity and speciﬁcity were 97% (38/39) and 100% (115/115),
respectively. Internal control invalid rates were 0.6% (1/158) for urethral
swabs and 1.3% (2/156) for urines. Equivocal rates were 2.5% (4/158) for
urethral swabs and 2.6% (4/156) for urines.
Conclusion: The VIDAS PROBE NG Test is sensitive and speciﬁc com-
pared with patient infection status in urethral swabs and urines. No
difference in assay performance was observed between swabs and urines.
The use of an internal control reliably predicts the ability of each assay to
amplify target. Low invalid and equivocal rates minimize retests and
recollection of samples.
This product has not been approved by the United States FDA and is not commercially
available.
Clinical and epidemiologic aspects of hepatitis C infection
P1178 The prevalence of hepatic granulomas in chronic
hepatitis C
R. Ozaras, V. Tahan, A. Mert, F. Tabak, E. Avsar, G. Ozbay,
C. A. Celikel, N. Tozun, H. Senturk
Istanbul, TR
Objectives: Hepatic granulomas (HGs) are chronic inﬂammatory lesions
composed of modiﬁed macrophages – epitheloid cells – that are usually
surrounded by lymphocytes. The common etiologies include sarcoidosis and
tuberculosis worldwide. Formation of HG is a very rare complication of
chronic hepatitis C (CHC) infection. Data about the prevalence of HG in
CHC is very limited. The correlation of hepatic granulomas to the response to
therapy is controversial. In this study, we aimed to determine the prevalence of
HG in CHC, and the relation of HG with interferon treatment.
Patients and methods: All patients with chronic hepatitis C (CHC) in two
university hospitals of Istanbul were included into the study. All biopsy reports
of the patients were reviewed. The ones which reveal HGs were further
studied. Before ascribing hepatic granulomas to CHC, the other causes were
excluded: a careful history including a detailed drug questioning, physical
examination, biochemistry, tuberculin skin test, VDRL test, Brucella agglu-
tination tests, and thorax CT.
Results: Liver biopsies of 459 patients with CHC were reviewed. Eight
patients were found to have hepatic granulomas (8/459, 1.7%). Four patients
had control biopsies following a treatment of interferon: hepatic granulomas
persisted in all although two had sustained response.
Conclusion:Hepatic granulomas are rarely seen in liver biopsies of the patients
with CHC. Data from limited number of patients revealed that HG seems to
persist whether the patient responded or not.
P1179 Anti-HBc alone, associated with hepatitis C virus
coinfection
M. Pouyiouka, V. Karabassi, C. Petrochilou, E. Kandri, A. Karﬁ,
N. Alexandropoulos, C. Kontou-Castellanou
Athens, GR
Objectives: Subjects with antibodies against hepatitis B core antigen as the
only serologic marker for hepatitis B virus (HBV) infection were found to be
often infected with hepatitis C virus (HCV) ( Jild et al. Individuals with
antibodies against hepatitis B core antigen as the only serological marker for
hepatitis B infection: high percentage of carriers of hepatitis B and C virus.
J Hepatol 1995; 23: 14–20). The aim of this study was to examine this
correlation and to assess the impact of HCV infection on aHBs level.
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Methods: In a period of 18months we examined 4711 samples for hepatitis B
markers and anti-HCV antibodies by enzyme immunoassay (EIA) (AxSym,
Abbott).
Results: Of the 4711 samples, 1870 (39.7%) were positive for anti HBc
antibodies. Of the 1870 samples positive for aHBc, 1031 (55%) had anti-HBs
antibodies, 408 (21.8%) were chronic carriers of HBs antigen, while 268
(14.3%) were aHBc-alone-positive subjects. Anti-HBc carriers who also
possess anti-HBs or HbsAg found HCV-positive in a number of 85 (5%)
while aHBc-alone-positive had anti-HCV antibodies in a number of 24
(14.3%).
Conclusions: We proved that aHBc-alone-positive subjects are more often
seropositive for HCV than anti-HBc carriers who also possess anti-HBs or
HbsAg. Moreover, HCV-positive subjects with anti-HBs had a lower level of
aHBs than HCV-negative subjects.
P1180 Low hepatitis C virus transmission to children in
hepatitis C virus and human immunodeﬁciency virus
coinfected mothers on antiretroviral therapy
E. Minola, G. Quinzan, G. Gregis, F. Suter
Bergamo, I
Background:HIV has been reported to increase the risk of vertical transmis-
sion of HCV in women coinfected. However, an aggressive antiretroviral
treatment could be implicated as a factor reducing the rate of HCV transmis-
sion.
Objectives: To compare the rate of HCV vertical transmission from mothers
with and without concomitant HIV infection and to evaluate the possibly risk
factors.
Methods: A total of 642 HCV-reactive (EIA III) mothers has been pro-
spectically observed; 413 were HCV-RNA positive (RT-PCR) with different
genotype (genotype 1a, 1b, 2, 3a, 4 and indeterminate in 82, 129, 101, 81, 18
and two patients, respectively) and, of this group, 45 were HIV coinfected
on antiretroviral therapy (18 on double regimen, 27 on triple regimen). The
rate of HCV transmission and the related risk factors were evaluated in this
HIVþ/HCVþ coinfected women and compared with the 368 viremic
HCVþ/HIV– mothers. AST, ALT, anti-HCV Ab, HCV-RNA, anti-HIV
Ab (EIA), and HIV-RNA (RT-PCR) of infants were obtained at birth and
during the 24months follow-up. HCV genotyping were determined by
Genedia KIT.
Results: One case of HCV infection and one case of HIV infection were
observed in infants born to coinfected mothers vs. 14 cases of HCV infected
infants born to anti HCVþ/HIV– mothers: no difference in the risk of
vertical HCV transmission has been observed in the two groups of child-
bearing women (Fischer exact: two-tailed P-value 1.0). Difference was
observed in the distribution of the HCV genotypes (1a in 18 and 64, 1b in
13 and 116, 2 in three and 98, 3a in eight and 73, 4 in one and 17, respectively),
reﬂecting the high proportion of intravenous heroin addicts in the HIVþ
women. The maternal HCV-RNA titer was similar (2 466 090 SD
1 098 900 copies/mL vs. 2 051 000 SD 1 121 000 copies/mL, respectively).
Delivery was by means of Cesarean section in 35 (78%) of the HIV positive
women vs. 93 (25%) of the HCVþ/HIV– mothers. Among the HCVþ/
HIVþ coinfected mothers the HIV-RNA level was below the limit of
detection in 33 cases and low in the remaining 12. No HIV-positive women
were breast feeding.
Conclusion: An effective antiretroviral therapy could prevent HCV mothers
to child transmission in HCV viremic HIV coinfected women, possibly via a
control of the HIV viral load and the consequent immunoriconstitution. Type
of delivery could be a cofactor in preventing vertical HCV infection.
P1181 Risk factors in mother-to-child hepatitis C virus
transmission
L. Mendizabal, M. Basaras, J. Bilbao, J. Aristegui, R. Cisterna
Bilbao, E
Background: Vertical transmission of hepatitis C virus (HCV) has been
estimated to be low (0–5%) in women with HCV alone and 5–15% in
women coinfected with human immunodeﬁciency virus (HIV). The aim of
this study was to evaluate a cohort of children born to HCV infected women
with particular emphasis on the role of risk factors in parents and HCV
serologic progress in children.
Subjects andmethods:The study included 67 children born to mothers with
HCV infection. Screening for HCV antibody was carried out on the serum
samples using a third-generation enzyme-linked immunoassay and conﬁrmed
by a third-generation line immunoblot assay. The detection of serum HCV-
RNAwas done by using reverse transcription polymerase chain reaction with
primers from the 50 noncoding region of the viral genome. For statistical
analysis, chi test was used, being P< 0.05 statistically signiﬁcant.
Results: The risk factors for HCV infection in the progenitors were:
unknown in 33 cases (49.25%), past or current intravenous drug user in
33 cases (49.25%) and past blood transfusion in one case (1.49%). HBsAg was
detected in six progenitors, anti-HIV in 23, HBVand HIV coinfection in ﬁve
and there was no coinfection in 33 cases. With respect to mothers treatment,
43 were not treated at the time of pregnancy, ﬁve mothers with HIV
coinfection were treated with zidovudine, eight intravenous drug users were
treated with methadone and 11 were treated with interferon. Forty-four
children were no coinfected with other viruses and 23 (34.23%) were
coinfected, principally with HIV (19 of them). At birth, there were 24
(35.82%) anti-HCV positive and HCV-RNA positive and 43 (64.17%)
children anti-HCV positive and HCV-RNA negative. During the time,
there was a seroreversion and at 12months, there were 44 (75.86%) children
anti-HCV positive and HCV-RNA negative and 14 (24.13%) anti-HCV
positive and HCV-RNA positive.
Conclusion: There was a strong interaction between intravenous drug user
and delivery of HCV infection. However, when the progenitors were
intravenous drug users there was a strong interaction between progenitors
risk factors for HCV infection and child coinfection with other viruses, in
particular HIV. On the other hand, mothers treatments did not interfere in the
child infection progress. There was no association in children between birth
analysis and progress of HCV antibodies.
P1182 Genotype distribution in chronic hepatitis C
patients in Luxembourg
T. Staub-Schmidt, E. Fontaine, K. Hawotte, A. Fischer, I. Robert,
J. Weber, V. Arendt, R. Hemmer, J.-C. Schmit
Luxembourg, LUX
Objectives: HCV genotype is associated with response to treatment. The
HCV genotype distribution was studied in chronic hepatitis C patients in
Luxembourg. Possible associations with age, gender and ways of contamina-
tion were investigated.
Methods: The genotype and subtype were determined in RNA-positive
EDTA samples from 234HCV infected patients by direct sequencing of the 50
NC gene fragment (TruGene HCV 50 NC genotyping kit, Bayer).
Results: One hundred and twenty-nine patients were men (62%) and 125
patients were older than 40 years (53%). Of the 234 samples, 75 (32%) could
only be characterized to the genotype level (no unambiguous subtype
determination). Genotype 1, subtypes a and b in equal proportions, was
present in 135 patients (58%) with no difference between gender. Genotype 3,
mainly subtype a, was present in 63 patients (27%), 45 men (32%) and 18
women (20%). Genotype 2 and 4 were less common, with 18 cases of genotype
4 (8%), mostly with undetermined subtype and 15 cases of genotype 2 (6%),
subtypes a and b. Three samples of genotype 5 were also found. Genotype 3 was
more frequent in patients younger than 40 years (32%) compared with older
patients (22%) but without reaching signiﬁcance (P¼ 0.09). Information
about possible ways of contamination was available for 143 patients. Genotype
3 was signiﬁcantly (P< 0001) more prevalent among IVDU (39/94¼ 41.5%)
compared with other risk groups (7/49¼ 14.3%).
Conclusions: Genotypes 1 and 3 represent together 85% of chronic hepatitis
C patients in Luxembourg. Genotype 3 was especially prevalent in IVDU,
pointing to a possible epidemiologic link in these patients. Genotype 3
patients tended also to be younger and were more often men. Genotype 1
and 4, associated with a poorer treatment response, represent two-thirds of all
patients.
P1183 Prevalence of hepatitis C virus infection in cancer
patients. A 3-year study
C. Kontou-Castellanou, S. Kastellanos, C. Petrohilou, B. Karabasi,
S. Konstantopoulou, T. Biniari, S. Karahalios
Athens, GR
Objectives:The aim of our study was to investigate the prevalence of hepatitis
C virus (HCV) infection in cancer patients, since they constitute a high risk
group.
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Methods: During the 3-year period (2000–2002) serum samples were taken
from 1579 hospitalized patients with cancer and were evaluated for the
presence of the antibody against HCV. The detection of the antibody to
HCV in the serum of cancer patients was made by the ELISA method
(Microparticle Enzyme Immunoassay MEIA-AXSYM, ABBOTT).
Results:Of the 1579 cancer patients 48 (3.04%) were positive for the antibody
against HCV. The prevalence of HCV infection per year for 2000, 2001 and
2002 was 3.1% (18 out of 580 patients), 3.09% (17 out of 549 patients) and
2.88% (13 out of 450 patients), respectively.
Conclusions:Our study shows that the frequency of the antibody to HCV in
the serum of cancer patients during the years 2000–2002 was 3.04% and that
the prevalence of HCV infection in cancer patients was signiﬁcant and
remained roughly the same per year.
P1184 Evaluation of total HCV core antigen detection in
follow-up of children born to HCV positive mothers
M. A. Lievre, F. Albano, L. Balbo, E. Taricco, G. Ferrio, D. Mediate,
M. F. Rostagno
Turin, I
Objectives: To propose an immunoenzymatic antigenic detection test for
early diagnosis of mother–fetus HCV infection transmission.
Methods: The work was carried out on the born to HCV positive mothers
group, followed-up by means of the Track-C experimental test (Ortho
Clinical Diagnostic) on scheduled blood samples collected between birth
and 18months, in the period January 1, 2001–December 31, 2002. One
hundred and thirteen sera belonging to 80 children born to HCV positive
mothers with different antibody titers, were tested. The routine follow-upwas
carried out by means of a qualitative HCV PCR and HCV antibodies
quantitative test at birth, 6th week, 3rd, 6th, 9th, 12th and 18th months
(when in most cases maternal antibodies disappear) according to little patients
availability. Track-C-test was performed on frozen selected sera already tested
with an immunometric technique (Ortho Vitros ECi) for HCV antibodies
and Roche Cobas Amplicor for qualitative PCR.
Results:One hundred and ﬁve sera belonging to 75 children were negative for
HCV core antigen with 100% agreement with PCR. Eight consecutive
samples of ﬁve children were positive for HCV core antigen and all were then
conﬁrmed by PCR test. Consecutive PCR test were performed on sera of
HCV antigen negative children and gave negative results.
Conclusions:The speciﬁcity of HCV core antigen can be estimated as 100%;
the diagnostic sensitivity is probably good but cannot be quantitatively assessed
yet. This test certainly does not need special equipment and facilities, is easy to
perform and cheaper than molecular test. Furthermore this antigenic detec-
tion test shown to be useful in early diagnosis of HCV infection in our study
group.
P1185 Analysis of peripheral T-lymphocyte subsets and
antibody responses in patients with chronic HCV-infection
T. Kobryn, D. Telehin
Lviv, UKR
Objectives: The aim of this study was to investigate the peripheral blood
lymphocyte phenotypes (T-cells population) and quantitative antibody
response (general anti-HCV and anti-HCV response to structural (core)
and nonstructural (NS3, NS4, NS5) hepatitis C viral proteins) in patients
with different stages and different activity of chronic HCV-infection (chronic
hepatitis C, HCV-RNAþ/–, HCV-liver cirrhosis).
Methods: Blood lymphocytes counts were determined in 36 patients with
chronic hepatitis C (CHC) and 16 patients with liver cirrhosis (LC). Flow
cytometry (‘Becton Dickinson’, USA) was used to measure proportion of T
cells (CD3þ, CD4þ, CD8þ, CD16þ/56þ, CD3/16þ). Anti-HCV anti-
bodies investigated by third-generation enzyme linked immunosorbent assay,
HCV-RNA presence in serum was determined by using PCR. Relative
intensity (RI) of antibody titer for each patient was calculated comparatively
with normal (lower limit of the assay) in every series of the researches.
Results:The peripheral blood lymphocytes of patients with CHC contained a
greater proportion of CD8þ (28.11 3.61 vs. 22.28 2.8, P< 0.01) lym-
phocytes than patients with HCV-LC. In individuals with liver cirrhosis
signiﬁcantly higher median antibody responses to core (12.41 RI vs. 8.27 RI,
P¼ 0012) were found comparatively to chronic hepatitis C patients. Sig-
niﬁcantly higher proportion of CD16/56þ (NK) cells (12.73 3.99% vs.
7.17 2.85%, P< 0.05) were found in the individuals with persistent viremia
(HCV-RNAþ) than in those with apparent resolution of HCVRNA (HCV-
RNA) in the blood. In the group of patients with elevated ALTactivity higher
median antibody titer to core protein (9.26 4.98 RI vs. 13.73 5.76 RI)
and decrease of median NS3, NS4, NS5 antibody titers (3.69 2.39 vs.
7.0 3.63) were detected comparatively to patients with normal ALT level,
but this difference was not signiﬁcant (P> 0.05) in both cases. Inverse
correlation was estimated between the percentage of CD16/56þ cells and
RI of HCV-antibody response (Spearman range correlation¼0.669,
P< 0.01).
Conclusions: Increased percentage of CD16/56þ (NK) cells was associated
with HCV-RNA viremia and could be a marker of virus persistention in
patients with chronic hepatitis C. The antibody response to core protein was
higher in patients with advanced liver disease and patients group with elevated
ALT activity.
P1186 Seroprevalence of antibodies to hepatitis C virus
among hemodialysis patients
M. Dimitrovska, E. Dimitrovska, P. Janakievska, D. Ristevska,
R. Dimitrovski
Bitola, Skopje, MK
Introduction: Chronic liver disease represents one of the most important
causes of morbidity and mortality among hemodialysis patients, hepatitis C
viral infection being mainly responsible for these affections.
Objectives and methods: The aim of our study is to evaluate the prevalence
of hepatitis C infection (ELISA-Abbot anti HCVantibodies test) in 52 patients
with chronic renal failure treated in the hemodialysis department of our
hospital. We have also analyzed the relationship between hepatitis C infection
and blood transfusion history among these patients. The age of patients was
between 23 and 70 years. According to sex, 31 patients were male, and the
other 21 were female.
Results: Antibodies against hepatitis C virus were detected in 10 patients
(prevalence 19%), six male, and four female. Among the positive patients, four
had received blood transfusion. Among the other 42 patients, 19 had a blood
transfusion history (45%), but they were not infected by the hepatitis C virus.
The prevalence of virus C infection in patients without a blood transfusion
history (10.55%) is greater then among those who had received blood
transfusion (4.5%). We have analyzed the relationship between virus C
infection and previous blood transfusion and we have not found signiﬁcant
statistical differences between the groups of our patients.
Conclusions: The prevalence obtained among our hemodialysis patients is
similar to prevalence described in other hemodialysis populations. We have
not found blood transfusion history as an only risk factor of virus C infection
among our hemodialysis patients.
P1187 Hepatitis C in rheumatoid arthritis patients
M. J. Ehsani Ardakani, S. J. Mirhassani Moghaddam, N. Mohammad
Zadeh, H. Gorji
Tehran, IR
Objectives: Hepatitis C virus (HCV) infection has been explained as some-
times presenting with rheumatic manifestations indistinguishable from rheu-
matoid arthritis. In some studies hepatitis C virus is supposed to be able to
trigger rheumatoid arthritis. So this study has been performed to evaluate the
frequency of hepatitis C virus infection in a group of patients with rheumatoid
arthritis.
Methods: In this study the serum of one hundred consecutive patients with
rheumatoid arthritis from all afﬁliated hospitals of Shaheed Beheshti Uni-
versity of Medical Sciences during 1 year (2000) were examined for anti-HCV
antibody by ELISA and HCV-RNA by RT-PCR method. Using a ques-
tionnaire, the frequency of HCV infection, the age and the sex distribution,
duration of rheumatoid arthritis, associated immune mediated disorders and
risk factors for hepatitis C virus infection were deﬁned.
Results: A total of 100 patients (M/F¼ 1) who were mainly in the age group
of 31–50 years was studied. The frequency of HCVwas found to be 2%. All of
the infected persons have had a low risk occupation in terms of exposure to
the virus and none of them had HCV risk factors. No associated immune
mediated disorder was found in HCV infected patients.
Conclusions:This study does not support any contribution of HCV infection
in the pathogenesis of rheumatoid arthritis.
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P1188 Virological features in adult beta-thalassemic
patients with chronic HCV infection
D. Siagris, N. Giannakoulas, M. Christoﬁdou, A. Lekkou, A. Kourakli,
K. Thomopoulos, C. Labropoulou-Karatza
Patras, GR
Objectives: To compare viral load and genotype distribution of adult beta-
thalassemic patients to those of nonthalassemic HCV-infected patients.
Methods: Sixty-seven adult beta-thalassemic patients (27 males, 40 females,
mean age 30.5 7.3 years) and 49 otherwise normal patients (33 males, 16
females, mean age 31.4 7.4 years) with chronic HCV infection were
evaluated. All the patients were HCVAb (þ) by MEIA HCV 3.0 (Axsym-
Abbott) and by the conﬁrmatory linked immunoassay (Sorin). The patients
were tested for HCV RNA by RT-PCR (Amplicor HCV PCR test).
Quantiﬁcation of serum HCV RNA was performed by the branched
DNA method (Bayer HCV RNA 3.0 Assay). HCV genotyping was per-
formed by a second generation, line probe assay (INNO-LiPA HCV II,
Innogenetics).
Results: HCV RNA was detected in 41/67 (61.2%) beta-thalassemic and in
41/49 (83.7%) nonthalassemic patients (P¼ 0.009). SerumHCVRNA levels,
were lower in the thalassemic group (median¼ 0.364Meq/mL, range
¼ 15.297Meq/mL) than in the nonthalassemic group (median¼
2.900Meq/mL, range¼ 54.780Meq/mL, P¼ 0.009). The distribution of
HCV genotypes was different in the two groups (P¼ 0.001). In beta-
thalassemic patients the most prevalent HCV genotype was 4 (11/34¼
32.4%) while in nonthalassemic patients it was 3a (25/41¼ 61%).
Conclusions: These data indicate that (1) thalassemias have a higher rate of
elimination of the virus, probably because of acquiring the infection during
the childhood, (2) HCV viral load is lower in adult beta-thalassemic patients
compared with that of nonthalassemic patients with chronic hepatitis C, and
(3) the most prevalent genotype in Greek adult beta-thalassemic patients is
genotype 4 while in nonthalassemic patients of similar age it is genotype 3a.
This difference is probably attributable to the different way of virus transmis-
sion in the two populations of patients.
P1189 Prevalence of cryoglobulinemia in adult
beta-thalassemic patients with chronic HCV infection
D. Siagris, M. Christoﬁdou, N. Giannakoulas, A. Lekkou,
M. Tiniakou, K. Thomopoulos, C. Labropoulou-Karatza
Patras, GR
Objectives: To determine the prevalence of cryoglobulinemia in adult beta-
thalassemic Greek patients with chronic HCV infection.
Methods: Thirty-one HCVAb(þ) adult beta-thalassemic patients (11 males,
20 females, mean age 31.4 6.8 years) and 49 otherwise normal patients (33
males, 16 females, mean age 31.4 7.4 years) with chronic HCV infection
were evaluated. Serum HCV RNAwas detected by RT-PCR. The presence
of cryoglobulins was assayed, by collection and coagulation of blood at 37 8C,
centrifugation and incubation of serum at 4 8C for 7 days. Rheumatoid factor
(RF) and antinuclear (ANA) were also detected in serum.
Results: Cryoglobulins were detected in 2/29 (6.5%) beta-thalassemic and
in 10/39 (20.4%) nonthalassemic patients (P¼ 0.089, NS). HCV RNA was
detected in 20/31 (64.5%) beta-thalassemic and in 41/49 (83.7%) nontha-
lassemic patients (P¼ 0.05). When we compared the prevalence of cryoglo-
bulinemia between thalassemic and nonthalassemic HCV RNA(þ) patients,
the difference was also not found signiﬁcant (2/20¼ 10% vs. 10/41¼ 24.4%,
NS). Positivity rate for rheumatoid factor was found lower in the
beta-thalassemic group (2/31¼ 6.5%) than in the nonthalassemic group
(15/49¼ 30.6%, P¼ 0.01). ANAs were found with equal frequency in
the two groups (4/31¼ 12.9% vs. 3/49¼ 6.1%, NS). There was no
association between the presence of cryoglobulins and patients’ age or
sex.
Conclusion: Prevalence of cryoglobulinemia was found low (6.5%) in beta-
thalassemic HCV-infected patients although not signiﬁcantly different from
that found in nonthalassemic patients. This low prevalence can be attributed
to: (1) the lower rate of HCVRNA positivity that was found in these patients
and (2) the immunosupression that is induced by multiple transfusions in beta-
thalassemic patients.
Herpesvirus
P1190 Possible risk factors for the triggering of the
human herpesvirus 8 in two non-HIV patients
E. Magira, T. Gounaris, S. Papandreou, A. Arsenoglou,
A. Abouhanditzi, D. Rontogianni, E. Sioula
Athens, GR
We report our experience originated from two patients with Kaposi’s
sarcoma, although they were human immunodeﬁciency virus negative.
The ﬁrst patient was a 70-year-old-heterosexual man who referred to our
clinic with painful disseminated skin lesions on the limbs, face and abdomen.
Dermatological examination revealed painful hard nodules and inﬁltrates that
were red violent to brown without tendency to ulceration. Later similar
lesions on the both upper and lower eyelid margin developed. Extensive and
multiple laboratory tests, computed tomograghy of the chest and abdomen
rule out infection or neoplastic diseases but did not elucidate the patient’s
illness. According to the past medical history, 5months ago due to the patient’s
chest radiographic features were very consistent with interstitial lung disease
possibly due to collagen vascular disorder he was placed on methylpredni-
zolone 16mg twice daily for almost 4months. Biopsy excision of the skin
lesions was performed and the histopathological picture suggested Kaposi’s
sarcoma. Peripheral blood mononuclear cells were tested positive for Human
Herpesvirus 8 (HHV 8) by PCR and immunohistochemistry of the tissue.
The second patient was a 26-year-old heterosexual woman who presented to
our hospital with lesions that ﬁrst appeared on the left feet and on the right
knee. Several violaceous lesions were later observed on the arms, hands and
face. Severe bilateral lymphedema of the legs with a reddish papules nodules
and tumors from 0.5 to 7 cm in diameter on the soles, toes and calves was also
observed. The patient among the other laboratory and radiographic test
underwent thoracic CT scan, which demonstrated mediastinal well deﬁned
soft tissue inﬁltration associated with mediastinitis and a well deﬁned mass in
the left paratracheal region. The mass biopsy revealed squamous cell carci-
noma of the esophagus. Peripheral blood mononuclear cells were tested
positive for HHV 8 by PCR. Immunosuppression induced by either
corticosteroid or carcinoma is a risk factor for the triggering of the HHV
8 and the development of KS, probably in genetically susceptible patients.
Review of the literature revealed that these are almost two very rare cases of
Kaposi’s sarcoma induced from corticosteroid (reported about 10 cases) or
induced from a carcinoma (reported about four cases).
P1191 Cytomegalovirus congenital infection: evaluation
of different diagnostic procedures
A. Sensini, R. Castronari, N. Zarneshan, G. Burnelli, F. Bistoni
Perugia, I
Objectives:Human cytomegalovirus (HCMV) represents the most dangerous
microorganism for the newborn. The virus can be transmitted to the fetus,
causing severe consequences on his development. Different approaches are
observed in the management of this situation. The aim of this study was to
evaluate the different diagnostic procedures performed in order to detect
primary infection in pregnant woman and congenital infection in fetus and
newborn.
Methods: Fifty-two pregnant women and their newborns were evaluated
from 1996 to 2002 for suspected HCMV infection. Speciﬁc IgG, IgM and
IgG avidity were detected in maternal serum samples at different times during
pregnancy and in the newborns at birth. A total of 22 amniotic ﬂuids, 12
placentas, 24 maternal and 34 neonatal blood samples, 37 urine and 32 saliva
samples from neonates were assayed by nested PCR for detection of viral
DNA.
Results: Ten newborns with congenital infection were identiﬁed, seven
asymptomatic at birth and three symptomatic (thrombocytopenia, anemia
and cerebral calciﬁcations with viral DNA in cerebrospinal ﬂuid, respec-
tively). Twenty two seroconversions were documented: 10 in the ﬁrst, 10 in
the second and two in the third trimester of pregnancy, but the IgG avidity test
could identify 32 acute primary infection. Eight out of 10 congenital
infections occurred in presence of low avidity IgG at serologic screening
and in the other two in absence of data about the serological pattern during the
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course of pregnancy. Prenatal diagnosis showed viral DNA at different amount
in three amniotic ﬂuid samples (one asymptomatic congenital infection, one
pregnancy interrupted and one still in course). One false negative result was
reported. Two placentas contained HCMV-DNA: the newborns were
infected. Maternal blood resulted PCR positive in only one woman, who
had spontaneous abortion. Urine and saliva samples provided viral DNA in all
congenital infections.
Conclusions:HCMV is the leading cause of congenital infection, but, despite
the availability of several serologic and molecular tools, the diagnosis in
pregnant women is still difﬁcult. Furthermore, maternal and fetal prognostic
markers of infection and disease are still unidentiﬁed. Interdisciplinary
collaboration should be encouraged to promote standardized guidelines for
an optimal management of this relevant public health problem.
P1192 Epstein-Barr virus PCR in serum is not sufﬁcient
to detect early acute infection
D. Burki, C. Noppen, M. Omeyer, A. Ankelin, L. Matter, C. Schaefer
Basel, CH
Objectives: In acute Epstein-Barr virus (EBV) infection, serology may not be
conclusive if samples are obtained at an early stage. The aim was to determine
whether EBV-PCR can detect early EBV infection when serology is incon-
clusive.
Methods: One hundred and thirteen sera were classiﬁed as early acute (46),
late acute (36), and past infection (29) on the basis of EA IgG, EA IgM, and
EBNA-1 IgG by EIA (Biotest, D-Dreieich) and on recombinant IgG and IgM
immunoblot (EA p54/p138, VCAp18/p23, EBNA1; Mikrogen, D-Martins-
ried), heterophile antibodies, white blood count, and transaminases where
available. Following extraction of DNAby theMagnaPure Total Nucleic Acid
Isolation protocol, PCR was performed on the LightCycler system using the
Epstein-Barr Virus Kit (Roche, CH-Rotkreuz). The limit of detection was
10 viral genome equivalents per PCR.
Results:Nineteen of 46 (41.3%) early acute, 12 of 36 (33.3%) late acute, and
one of 29 (3.4%) past infection were PCR-positive.
Conclusions:With a sensitivity of only 37.8% (CI95 28.1–48.6) in acute stages
of EBV infection, PCR from serum samples was not helpful for diagnosis. The
reason may be the close cellular association of the virus which may result in
low numbers of freely circulating viral DNA. As only one of 29 cases of past
infection was PCR-positive (speciﬁcity 96.6%; CI95 82.8–99.8), latent EBV
infection did not interfere. Thus, serum PCR for EBV does not allow for
reliable detection of early acute infection when serology is still inconclusive.
Further studies are required to assess the diagnostic value of EBV-PCR in
leucocytes from full blood samples.
P1193 Development of a quantitative LightCycler assay
for the detection of Epstein-Barr virus DNA
M. Auer, M. Espy, U. Oberlaender, G. Haberhausen
Penzberg, D; Rochester, USA
Background:Epstein-Barr virus (EBV), one of the eight human herpesviruses
(HHV4), is a double-stranded DNA virus of ubiquitous spread. The virus is
transmitted by salivary contact and most often individuals become infected
during their young childhood. In these cases primary infections are mostly
asymptomatic or reveal only mild unspeciﬁc symptoms. When infection with
EBV occurs during adolescence or young adulthood, it causes infectious
mononucleosis in up to 50% of all cases, an illness associated with fever and
swollen lymph glands. In some cases EBV is described as the causative agent in
chronic fatigue syndrome. Worldwide, EBV has a prevalence of about 90%.
Once acquired, the virus establishes a lifelong latent infection and remains in
epithelial cells of the throat and in B-lymphocytes. There and in very rare
events, EBV can cause severe complications like Burkitt’s lymphoma or
nasopharyngeal carcinoma mainly known from Africans or Asians, respec-
tively. Normally, EBV is under the control of T cells, which prevent their
outgrow in healthy individuals. Serious complicationmay occur after organ or
bone marrow transplantations in patients under immunosuppressive therapy.
There, EBV can be re-activated leading to a severe post-transplant lympho-
proliferative disorder (PTLD) which can have a fatal progression if not
diagnosed early.
Methods: Here, we describe the development of a highly sensitive and
quantitative PCR assay for research use based on the LightCycler instrument.
Results:This PCR test directly measure the viral DNA load in either plasma,
whole blood or CSF. The LightCycler EBV Quantiﬁcation Kit has been
proven as a fast and reliable tool. It offers a sensitivity of less than 10 copies/
reaction and gives a linear ampliﬁcation of at least 5 logs (102–106). The
reliability of the complete Nucleic Acid Detection System is granted by the
coampliﬁcation of an internal control, to exclude false negative results by
inhibition. The assay is fully compatible with the PCRWorkﬂow System
(MagNA Pure LC Instrument and LightCycler instrument), so enabling
complete automation of EBV quantiﬁcation.
Conclusions: The described EBV assay has a high sensitivity and speciﬁcity.
Thewide dynamic range of the assay make it perfectly suited for awide variety
of research applications.
P1194 Lymphotropic herpesviruses infection in
atherosclerotic coronary arteries tissue
J. Siennicka, P. Krajewski, A. Zuk, A. Trzcinska, I. Binduga-Gajewska,
B. Litwinska
Warsaw, PL
Objectives:To investigate the association of CMV, HHV-6, HHV-7, EBVand
HHV-8 with atherosclerosis.
Methods: The presence of beta- and gamma-herpesviruses DNA was inves-
tigated by nested PCR in atherosclerotic lesion and unchanged site of vessel
taken postmortem from the same person. Also the level of anti-CMV IgG
antibodies in serum samples was evaluated.
Results: Atherosclerotic changes evaluated by postmortem examination with
5 point scale were observed in 37 out of 43 investigated persons. Intensity of
changes was correlated with age. Antibodies for CMVat different level (from
0.528 to 14.042 IU/mL) were detected in 81.1% cases. CMV DNA in vessels
was found in 27.9% persons with atherosclerotic changes, but was not in
arterial walls of patients without atherosclerosis (grade 0). Prevalence of HHV-
6 and HHV-7 DNAwas even higher: 81.4 and 51.2%, respectively, but while
the presence of CMVDNAwas connected with grade of changes in arteries it
seems that HHV-6 and -7 distribution was not dependent on range of
atherosclerosis. Distribution of EBVand HHV-8 was lower than other tested
herpesviruses.
Conclusions: It will be suggested that high prevalence of different herpes-
viruses in wall of coronary arteries may be related with the pathologic process
of the atherosclerosis.
P1195 Quantitative analysis of Epstein-Barr virus DNA
in patients with breast carcinoma
G. Marra˜o, S. Faﬁ, P. Morand, C. Oliveira, A. Paiva, A. Magalha˜es
Sant’Ana, J. Seigneurin, E. Drouet
Coimbra, P; Grenoble, F
Background: EBV has been linked with a number of human malignancies,
including African Burkitt’s lymphoma, classical Hodgkin’s disease, post-
transplant and acquired immune deﬁciency syndrome-associated lympho-
proliferative disorders, sinonasal NK/T cell lymphoma, nasopharyngeal
carcinoma and gastric carcinoma. In recent years, it has been questioned
whether EBV may play a role in the development of breast carcinoma (BC),
which is the most common malignant tumor and the leading cause of cancer
in women in Western countries.
Methods: In an attempt to resolve this question, we studied the incidence of
EBV infection in 76 cases of invasive breast carcinoma by using a real-time
quantitative PCR assay for EBVDNA (Brengel-Pesce et al. J Med Virol 2002)
in order to analyze the viral burden both in peripheral blood mononuclear
cells (PBMC) and in tumor cells from BC patients. Immunochemistry using
anti-LMP-1 and anti-ZEBRA monoclonal antibodies was also evaluated.
Finally, we performed the titration of anti-ZEBRA antibodies in serum to
measure the level of EBV replication.
Results: EBV DNA was detected in tumor from 16/33 patients with breast
carcinoma and among positive samples the level ranged from 9 to 280
copies per mg DNA. EBV content in PBMC samples ranged from 6 to
250 copies per mg DNA but no correlation was found between the viral
burden in PBMC and that in tumor. No EBV genomes were found in the
serum but there was a positive correlation between the EBV load in PBMC
and increased IgG anti-ZEBRA titers, indicating that a high viral replication
occurred in blood.
Conclusion: Overall, our results strength the idea of an association between
breast carcinoma and EBV. The lack of EBV detection in serum the absence of
correlation between EBV loads in blood and those in tumor might suggest a
peculiar role of this oncogenic virus in the pathological process.
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Resistant nosocomial pathogens
P1196 Clinical outcome of the vancomycin-resistant
Enterococcus bacteremia in neutropenic patients with
hematologic malignancies – analysis of 22 cases
W. Prejzner, M. Bronk, M. Szarejko-Kaska, E. Arlukowicz,
E. Czarniak, A. Hellmann, A. Samet
Gdansk, PL
Introduction: Infection remains the most frequent cause of morbidity and
mortality in neutropenic patients with hematologic malignancies. Bacteremia
due to vancomycin-resistant enterococci (VRE) has been characterized as a
disease of severely debilitated patients, but it is not sure weather vancomycin
resistance is an independent predictor of death. We analyzed 22 patients with
hematologic malignancies to assess the clinical pattern of VRE bacteremia in
neutropenic patients.
Methods:We conducted a retrospective study of patients diagnosed as having
VRE bacteremia, treated at the Department of Hematology. We identiﬁed all
patients from whom at least two blood culture were positive. We analyzed
cases from 2000 to 2002. Antibiotic susceptibility of isolates from blood was
determined by disk diffusion method and with reference to standard break-
points. The primary outcome measure was the in hospital mortality. Poly-
microbial infection was deﬁned by isolation of a second bacterial species in a
blood culture on the index date.
Results: Among all 22 patients, 1 day positive blood culture for VRE was
found in 14 patients, in eight patients a positive blood culture was present at
least for 2 days (mean 3 days, min. 2 days, max. 5 days). All patients with VRE
bacteremia developed sepsis or SIRS (one patient), however, mortality rate
was 9%. We observed 25% polymicrobial blood cultures. All patients were in
neutropenia at the time of VRE bacteremia. All patients were treated with
imipenem plus aminoglycoside and/or vancomycin. Only three cases were
treated with linezolid or quinupristine/dalfopristine (Q/D). We did not
observe death in the group of patients treated with Q/D or linezolid. In
the group of the patients without linezolid or Q/D treatment, symptoms of
sepsis decreased when number of neutrophiles increased.
Conclusions: VRE bacteremia in neutropenic patients is not often associated
with severe outcome, mortality rate was about 9%. Good outcome of the
neutropenic patients could be improved by new antibiotics, active against
VRE, such as linezolid or Q/D.
P1197 Linezolid resistance in clinical isolates of
enterococci: risk factors, outcomes, and mechanism
K. Ruggero, A. Mankin, P. Schreckenberger, K. Rodvold, J. Quinn
Chicago, USA
Objectives: Present an update of our ongoing study to determine risk factors,
outcomes and mechanisms associated with linezolid resistance in clinical
isolates of enterococci in a tertiary medical center.
Methods: We performed a retrospective chart review of patients receiving
linezolid for 72 h or longer for enterococcal infection. All enterococcal
isolates were tested for linezolid susceptibility using E-test (AB Biodisk).
Chromosomal DNA from linezolid-resistant isolates underwent PFGE, and
the mechanism of resistance was studied by sequencing ribosomal RNA by a
PCR-based method.
Results: Among 88 patients receiving linezolid for more than 72 h for VRE
infections, resistant organisms were recovered from 13 (14.8%); 11 were
E. faecium and two E. faecalis. Many of these were associated with treatment
failure. Most patients (80%) were in an ICU. In the ﬁrst 34 patient charts that
have been reviewed in detail, duration of therapy (38 days for resistant
organisms) was the major risk factor for development of resistance (Pai
et al. Clin Infect Dis 2002; 35: 1269). PFGE showed that most isolates
emerged during therapy, as only two isolates were identical, which is
consistent with nosocomial spread. Sequencing of ribosomal RNA in the
ﬁrst seven resistant isolates revealed the characteristic G2576Umutation in all.
Some isolates demonstrated a stepwise increase in MIC, which correlated
with the number of ribosomal copies mutated. Linezolid-resistant organisms
were cross-resistant to other investigational oxazolidinones but susceptible to
quinopristin-dalfopristin, daptomycin, and oritavancin.
Conclusions: Emergence of resistance to linezolid during therapy of enter-
ococcal infections occurs relatively frequently in critically ill patients in our
center and is often associatedwith treatment failure. The duration of therapy is
the major risk factor in these patients. Most cases represent true emergence of
resistance during therapy. All isolates tested to date have the G2676U
mutation. Serial increases in MIC are due to a gene dosage effect. These
organisms are resistant to the class of oxazolidinones but susceptible to other
newer gram positive agents.
P1198 Analysis of carbapenem-resistant Pseudomonas
aeruginosa, Acinetobacter baumanii and Klebsiella
pneumoniae for the production of metallo-beta-lactamases
A. Xanthaki, A. Tsiringa, V. Skandami, M. Toutouza,
C. Kontou-Castellanou
Athens, GR
Objective: Carbapenemases are beta-lactamases able to hydrolyze carbape-
nems. Most of them also attack other beta-lactam antibiotics. Metallo-beta-
lactamases are acquired carbapenemases with signiﬁcantly increased clinical
relevance during the last few years. The aim of this retrospective study was to
examine whether Gram(–) bacteria carrying these metalloenzymes had spread
in our hospital.
Methods: Between May 2000 and December 2002 a total of 50 clinical
isolates of imipenem-resistant P. aeruginosa (32), imipenem-resistant A. bau-
manii (12) and imipenem-resistant K. pneumoniae (six) were collected from
patients either infected or colonized in our hospital. All these isolates were
identiﬁed by the API20E System (Biomerieux, France). Antibiotic suscept-
ibility testing was performed by the Kirby–Bauer method according to
NCCLS guidelines. Imipenem MICs and detection of production of
metallo-beta-lactamases were determined by the E-test MBL (AB-Biodisk,
Solna, Sweden).
Results:The great majority of all isolates were moderate to high level resistant
to imipenem (imipenemMICs ranged from 24 to 256mg/mL). The majority
of imipenem-resistant P. aeruginosa and all imipenem-resistant A. baumanii and
K. pneumoniaewere multiresistant as shown by antibiotic susceptibility testing.
Nine of 32 imipenem-resistant P. aeruginosa, 7/12 imipenem-resistant A. bau-
manii and 6/6 imipenem-resistant K. pneumoniae were found to be MBL
producers. All MBLþ isolates were also multidrug resistant. MBLþ P. aer-
uginosa were isolated from patients in different wards in contrast with
MBLþA. baumanii and K. pneumoniae who were isolated from patients in
the ICU.
Conclusions: Our ﬁndings indicate that MBL producers are a fact in the
hospital environment. MBLþA. baumanii andMBLþK. pneumoniae seem to
still be conﬁned in the ICU environment. Increased awareness of clinicians
and laboratory personnel is critical for the control of this resistant pathogen.
P1199 Vancomycin-resistant Enterococcus
faecium isolated from clinical specimens during
a 5-year period
M. Bronk, A. Samet, M. Kochowska-Bronk, L. Naumiuk, E. Czarniak
Gdansk, PL
Objectives:To present the isolation and resistance phenotypes of vancomycin-
resistant Enterococcus faecium (VREM) isolated from patients hospitalized in
Public Hospital No. 1 in Gdansk (Poland) during a 5-year period (1997–
2001). Vancomycin-resistant enterococci (VRE) have emerged as important
nosocomial pathogens. A signiﬁcant risk factor associated with acquisition of
VRE is the use of cephalosporins and glicopeptides.
Methods: Clinical specimens obtained from hospitalized patients were
inoculated on appropriate media. Enterococci were identiﬁed by conven-
tional methods (Gram stain, catalase, growth in the presence of 40% bile and
6.5% NaCl, esculin hydrolysis) and by automated system Vitek (bioMe´rieux).
The susceptibility to antibiotics was determined by the disk diffusion method
according to the NCCLS guidelines. MICs were determined by E-test (AB
BIODISK).
Results:During a 5-year period (1997–2001), 253 clinical isolates of VREM
were collected from hospitalized patients. Strains were isolated from stool 156
(61.9%), blood 46 (18.2%), urine 16 (6.3%), pus 8 (3.1%) and other specimens
26 (10.3%). Most of the patients with VREM colonization and/or infection
were hospitalized in the Hematology Unit. All VREM strains had
MIC> 256mg/L to vancomycin and MIC> 16mg/L to teicoplanin, which
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characterizes phenotype VanA. All VREMwere sensitive to chloramphenicol
and quinupristin/dalfopristin.
Conclusions: Vancomycin-resistant Enterococcus faecium have become an
increasing problem in our patients. Further studies to investigate the epidemi-
ology and the resistance of VREM strains in our hospital are warranted.
P1200 MRSA epidemiology in Scotland (1997–2002) – a
reference laboratory perspective
B. P. Cosgrove, G. F. S. Edwards, D. Morrison, C. G. Gemmell
Glasgow, UK
Background: The Scottish MRSA Reference Laboratory (SMRSARL) was
established in April 1997. Since then, over 40 000 MRSA isolates have been
referred to the SMRSARL from 35 laboratories throughout Scotland.
Referrals increased from 4078 in 1997 to a high of 9622 in 2000, decreasing
to 8004 in 2002.
Methods: All MRSA referred between 1997 and 2001 were typed by a
combination of phenotype, biotype and phage typing. Phage typing was
replaced with a molecular PCR-ribotyping technique. Pulsed Field Gel
Electrophoresis is carried out on 32% of referrals (18% in 1997). A mutiplex
PCR (nuc and mecA gene) is carried out for MRSA conﬁrmation.
Results: Although EMRSA-15 (Sequence Type (ST) 22) still predominates
(75% in 1997, 70% in 2002), the percentage of EMRSA-16 (ST 36) isolates
has increased (15% in 1997, 25% in 2002). 30 other PFGE deﬁned MRSA
clones have been recognized in Scotland, two of which predominate
(SMRSA-105 (ST5) and SMRSA-108 (MLST Clonal Complex 8)). Nearly
all EMRSA-15 and EMRSA-16 were ciproﬂoxacin-resistant and most
EMRSA-16 were kanamycin-resistant. An increase in EMRSA-15 with
gentamicin resistance has been noted in the past 18 months. Also in 2002
an increase of EMRSA-16 with gentamicin and high-level mupirocin
resistance emerged. All referrals are screened for intermediate resistant to
vancomycin (VISA). Of 10 000 isolates screened for vancomycin intermediate
resistance 233 (2%) were positive on ﬁrst screen. However, only one isolate
was positive on a repeat screen. To date, three VISA have been detected; two
in 1999 and one in 2002.
Conclusion:The need tomonitor the constant evolution ofMRSA is evident.
Further acquisition of resistance has been reported in 2002: high level
resistance to vancomycin (vanA gene) was reported in the USA and resistance
to Linezolid was reported in the UK. In addition clones with increased
virulence are being detected: reports of ‘Community-MRSA’ which carry
the Panton-Valentine Leukocidin toxin are increasing worldwide.
P1201 Evolution from 1991 to 2001 of oxacillin
susceptibility testing methods for Staphylococcus aureus in
Belgian laboratories
L. Sourdeau, O. Denis, M. Struelens, B. Jans, E. Hendrickx,
C. Suetens
Brussels, B
Objective:To assess the laboratory methods used for detection of methicillin-
resistant S. aureus (MRSA) in Belgian acute-care hospitals.
Methods: In 1991, 1995, 1997 and in 2001, a questionnaire about oxacillin
susceptibility testing methods was mailed to all hospital labs (n¼ 198).
Results: The response rate was 59% (n¼ 116) in 1991, 43% (n¼ 85) in 1995,
58% (n¼ 114) in 1997 and 46% (n¼ 92) in 2001. The use of disk diffusion
decreased from 91% in 1991 to 64% in 2001 while the use of oxacillin screen
agar increased from 9 to 49%. Automatedmethodswere used by 8% of the labs
in 1991 compared with 24% in 2001. In 2001, the other methods were mecA
gene detection by PCR (n¼ 6), MIC determination by E-test (n¼ 3) or latex
agglutination of PBP2a (n¼ 11). The combination of methods increased
strongly from 9 to 55% (P< 0.001). In 2001, 45, 9 and 1% of the labs used,
respectively, two, three or four methods. In 2001, only 14 of 54 labs (24%)
using disk diffusion and 20 of 47 labs (43%) using oxacillin agar screen strictly
adhered to NCCLS guidelines. Discrepancies mainly concerned incubation
time and temperatures. Of 41 labs using only one method in 2001, 20 (49%),
11 (27%) and 10 (24%) used, respectively, disk diffusion, oxacillin screen agar
or automated methods. In the 42 labs using two methods in 2001, 12 different
combinations have been observed. Combinations can be classiﬁed as follows:
	 Disk diffusion with oxacillin screen agar (44%);
	 Disk diffusion with automated or other method (32%);
	 Oxacillin screen agar with automated or other method (18%);
	 Association of two automated or other methods (6%).
The 10 labs using more than two techniques in 2001 have chosen disk
diffusion and oxacillin-agar screen associated with automated or other
methods.
Conclusions: The enhanced use of agar screen, automated methods and
combination of different techniques enhanced the global accuracy for MRSA
detection in Belgian laboratories. More standardization remains necessary and
would allow a more accurate estimation of the overall sensitivity and
speciﬁcity in Belgium based on test validity data from international scientiﬁc
literature.
P1202 ESBL-producing nosocomial uropathogens
A. Sawicka-Grzelak, A. Rokosz, J. Meszaros, M. Luczak
Warsaw, PL
Objectives:To isolate, identify and determine susceptibility of ESBL-positive
uropathogens to antimicrobial agents.
Methods: Four thousand urine samples from hospitalized patients were
examined in 2001. Seven hundred and thirty strains of Gram-negative rods
were cultured. Identiﬁcation and susceptibility were performed with auto-
matic ATB Expression system (bioMe´rieux, France) using ID 32 E, ID 32GN
and ATBUR5 strips. ESBL-producing strains were detected with double disc
synergy test (DDST according to Jarlier et al. 1988) or a novel method of
ESBL detection (DD, diagnostic disc) according to Appleton (1999). Two
discs were applied in this test: CPD (cefpodoxime) and CD 01 (cefpodoxime/
clavulanic acid) (Oxoid, UK).
Results: Six hundred and thirteen strains (84%) of enteric rods, 115 (15.7%) of
nonfermenting rods and two (0.3%) of Aeromonas spp. were isolated. A
hundred ESBL-producing strains (13.7% of all) were detected. Cultured
ESBL strains included E. coli (30%), K. pneumoniae (18%), E.Cloacae (17%),
C. freundii (15%), K. oxytoca (8%), other species of enteric rods (10%) and two
strains of nonfermenting rods. Seventy-two percent of ESBL-positive uro-
pathogens were susceptible to nitrofurantoin, 71% to fosfomycin and 67% to
ciproﬂoxacin/norﬂoxacin. Ninety-nine percentage of strains were susceptible
to carbapenems – imipenem and meropenem.
Conclusion: Nosocomial urinary tract infections were caused exclusively by
Gram-negatives. ESBL-positive strains were detected most often among
enteric rods. The most active drugs against examined uropathogens were
carbapenems and nitrofurantoin.
P1203 Multi-resistant Klebsiella pneumoniae
in pediatric intensive care unit
E. Sepp, P. Naaber, S. Ko˜ljalg, K. Truusalu, M. Allik, T. Metsvaht,
M. Mikelsaar
Tartu, EST
Introduction:Klebsiella is one of the most frequent causative agents of hospital
infection in children. Bacteria may originate from the environment and/or
from the patients’ mucosal surfaces. In the hospital the reservoirs for Klebsiella
are the patients’ gastrointestinal tract and the hands of hospital personnel.
Hospital infections caused by multiresistant strains, especially extended-
spectrum beta-lactamase (ESBL) producing Klebsiella pneumoniae pose a
problem in intensive care wards. The aim of our study was to estimate
epidemiology of ESBL producing Klebsiella (ESBL-K) isolated from pediatric
intensive care unit (PICU) patients, personnel and environment applying
phenotypic and genotypic methods.
Material and methods: ESBL-K strains were isolated from children hospi-
talized during 28months in Tartu PICU, from personnel and environment of
the same ward. In order to detect the phenotype of ESBL-K strains the
antibiotic susceptibility pattern and biotype (API E20) were tested. Genotype
ﬁngerprints were compared by pulsed-ﬁeld gel electrophoresis (PFGE).
Results: In Tartu PICU 583 children were hospitalized in the period of
January 2000 till April 2002. ESBL-K strains were isolated in 55 patients. No
ESBL-K strains were isolated from the personnel (n¼ 40) and environment
(n¼ 192). The 166 ESBL-K strains isolated from the patients were resistant to
penicillins, cephalosporins and gentamicin but susceptible to carbapenems,
tobramycin, amikacin and quinolones. Applying API E20 K. pneumoniae was
detected in 64 strains out of 67 isolated from 26 patients. Using PFGE we
found four different ESBL producing K. pneumoniae clones (A-D). The
prevalent clone A was detected in 17 children out of 22.
Conclusions:During 28months in 10% of patients hospitalized to PICU the
ESBL-K was detected. The putative reason of circulating hospital infection
was the most frequently isolated ESBL producing K. pneumoniae clone A.
Unfortunately the transmission of the agent was not detected and needs
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further investigation. We suggest the change of antibiotic use in the ward
following the microbial susceptibility pattern.
P1204 Characterization of methicillin-resistant
Staphylococcus aureus in a Portuguese hospital by
multiple genotyping methods
M. L. Amorim, M. Aires-de-Sousa, I. Santos-Sanches, R. Sa-leao,
J. M. Cabeda, J. M. Amorim, H. de-Lencastre
Porto, Lisbon, P; New York, USA
Objectives: To evaluate the clonal proﬁles of methicillin-resistant Staphylo-
coccus aureus (MRSA) isolates recovered from a Portuguese hospital during two
periods of surveillance (1992–1993 and 1996–2000).
Methods: A combination of molecular typing techniques: hybridization of
ClaI digests with mecA and Tn554 probes and pulsed-ﬁeld gel electrophoresis
(PFGE) was used to identify the clonal types (mecA::Tn554::PFGE) of a total
of 119 clinical MRSA isolates. Representative isolates of the different clonal
types were further analyzed by spaA typing, multilocus sequence typing
(MLST), and identiﬁcation of the speciﬁc Staphylococcal Chromosomal
Cassette (SCCmec) types.
Results: Two major MRSA clones were found: in 1992–1993, the inter-
nationally disseminated Iberian clone, I::E::A and related clonal types (ST247-
SCCmecI), included the majority (77%) of the isolates. In 1996–2000 this
clonal type decreased to 19% while a second internationally disseminated
clone, XI::B::B (Brazilian) and related clonal types (ST239-SCCmecIIIA),
emerged as dominant (69%). Nine sporadic/minor clonal types (representing
14% of the total of strains) were identiﬁed by mecA::Tn554::PFGE. However
all but one of the selected representative isolates of these sporadic isolates
revealed a spaA type, sequence type (ST), and SCCmec type identical to those
of the major MRSA pandemic clones previously described namely the
Iberian, Brazilian, and Pediatric (ST5-SCCmecIV). The unique and novel
clone, ST79-IV, was a single locus variant of ST22 characteristic of the
EMRSA-15 epidemic clone in UK hospitals and in other countries of
Northern Europe.
Conclusions: Our ﬁndings document major shifts in the endemic MRSA
background in this hospital since 1992 and reﬂects the Portuguese hospitals
picture with the decline of the Iberian clone in the early 1990s in parallel with
the increase of the Brazilian clone since 1995, suggesting a selective advantage
of the Brazilian relatively to the Iberian clone. Interestingly the minor/
sporadic clones in this hospital had been previously identiﬁed as epidemic in
other countries including Portugal.
P1205 ESBL carriage among patients in a pediatrics
public hospital in Gdansk, Poland
B. Rybak, A. Samet, E. Czarniak, L. Naumiuk, M. Bronk
Gdansk, PL
Objective: The aim of this study was to analyze occurrence of ESBL
producing Enterobacteriaceae in patients of outpatient clinics and wards of
the Institute of Pediatrics (IP) in our hospital.
Methods and materials: We analyzed records of clinical materials received
from IP patients in 2002. Strains were identiﬁed by classical method and
GNIþVITEK cards (BioMe´rieux). Production of ESBL was detected by
double disk method. ESBL colonization was determined by a positive stool/
rectal swab culture or throat swab.
Results: In the studied period 3129 patients were hospitalized in IP.
ESBLþ isolates were recovered from 153 patients, 99 of them were inpatients
and 54 outpatients. 59 inpatients were infected and 40 colonized, outpatients
41 and 13, respectively. Among outpatients only eight were earlier hospita-
lized in IP. Others previously attended different hospitals in our region.
Klebsiella pneumoniae was most often isolated (249 isolates from 101 patients)
then E. coli (102 isolates from 52 patients) and K. oxytoca (30 isolates from 16
patients), we infrequently cultured E. cloacae and C. freundii (three and two
strains from four different patients, respectively). Isolates were most often
recovered from urine (40%), stools and rectal swabs (31.8%), intravenous
catheter tips (9.4%), respiratory tract (8.2%), soft tissues (2.4%), and blood
(1.2%). 64.5% patients were admitted to IP units with ESBL. 35.5% patients
acquired ESBLs during hospitalization. 28% patients received cephalosporins,
19% cotrimoxazole, 17% nitrofurantoin and 51% were not given any anti-
biotic c. 49% ESBL strains were detected in patients with urinary tract
infections, 9% with diarrhea, and 4% with suspected sepsis. All strains were
susceptible to carbapenems, about 90% to ﬂuoroquinolones and about 50%
urine isolates to nitrofurantoin.
Conclusions: Patients with ESBLs in outpatient clinics acquired them during
hospitalization. Pediatric patients in our region should be screened for ESBL
bacteria before discharge. High percentage of ESBL carriage among children
complicates infection control and treatment of common urinary tract infec-
tion.
P1206 Abstract withdrawn
P1207 Antimicrobial resistance of nosocomial strains
of Enterococcus spp. in Russia
A. Dekhnich, I. Edelstain, A. Narezkina, L. Stratchounski
Smolensk, RUS
Objectives: The aim of this study was to determine the rates of antimicrobial
resistance in nosocomial strains of Enterococcus spp. in Russia.
Methods: A total of 362 clinical strains of Enterococcus spp. isolated in 2000–
2001 from patients hospitalized in 15 hospitals in different parts of Russia –
four in Central region (Moscow, Ryazan, Smolensk), two in North-West
region (St. Petersburg), two in South region (Krasnodar), two in Volga region
(N. Novgorod, Kasan), two in Ural region (Ekaterinburg), three in Siberian
Region (Krasnoyarsk, Novosibirsk, Tomsk), were included in the study.
Antimicrobials tested included ampicillin (AMP), gentamicin (GEN), strep-
tomycin (STR), vancomycin (VAN), teicoplanin (TEI), linezolid (LNZ),
tetracycline (TET), chloramphenicol (CHL), ciproﬂoxacin (CIP), levoﬂox-
acin (LEV), moxiﬂoxacin (MOX), quinupristin/dalfopristin (QD). Antimi-
crobial susceptibility testing was performed by agar dilution method. The
susceptibility testing and interpretation of the results were performed accord-
ing to the NCCLS guidelines.
Results: Among 362 strains 75.4% were E. faecalis, 16.3% – E. faecium, 8.3 –
Enterococcus spp. (E. durans, E. rafﬁnosus, E. gallinarum, E. avium). Results of
susceptibility testing are presented in the Table 1.
Conclusions: (1) The most active antimicrobials to which no resistance
has been found were linezolid and glycopeptides. (2) The most
important problems determined were the high frequencies of resistance
to ampicillin in E. faecium and to aminoglycosides in both E. faecalis and
E. faecium.
P1208 Multiplex LightCycler real time PCR assay for the
detection of vancomycin-resistant enterococci
K. Andreas, L. Sloan, C. Knop, C. Aichinger, F. Cockerill, K. Tabiti
Penzberg, D; Rochester, USA
Objectives: In the United States, vancomycin resistant enterococci (VRE)
have become common nosocomial pathogens. They account for 14% of
enterococcal bacteremias in intensive care patients, exhibiting a mortality of
30–46%. Rapid identiﬁcation of VRE is essential for the implementation of
appropriate control measures to prevent the spread of VRE.
Methods: We developed a research kit for rapid real time PCR on the
LightCycler Instrument (Roche) to identify the two main vancomycin
resistance alleles in enterococci, vanA and vanB. The kit is based on multiplex
Table 1
Antimicrobial IþR (%) MIC50/MIC90 MIC range
AMP 18.5 2/64 0.5–128
GEN 49.4 256/4096 8–4096
STR 54.1 4096/8912 32–8192
VAN 0 1/2 0.5–8
TEI 0 0.5/1 0.125–2
LNZ 0 2/2 1–2
QD 78.2 8/16 0.25–16
TET 68 64/128 0.5–128
CHL 55.8 16/64 2–128
CIP 72.7 2/32 0.5–128
LEV 17.4 2/8 0.5–64
MOX N/A 0.5/8 0.125–32
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PCR employing speciﬁc primers and Hyb-probes for the detection of vanA,
and vanB.
Results: Interestingly vanB speciﬁc PCR could detect an additional variant of
the vanB allele called vanB2/3. All three alleles can be differentiated by
melting point analysis. Thewhole procedure, including fully automated DNA
preparation, PCR and data interpretation takes only 3 h. Sensitivity experi-
ments revealed a detection limit of 5–10 genome equivalents.
Conclusion: Together, fast performance, sequence speciﬁcity and a very
low detection limit makes the VRE kit a premium tool for detection of
vancomycin-resistant Enterococci in research samples.
P1209 Nosocomial infections and misuse of antibiotics
in a Golestan Province Hospital, north of Iran
Z. Youseﬁ, M. Younesian, K. Rezaie
Sari, IR
Objectives:Nosocomial infection surveillance is not common in the Iran but
few hospitals use it. The incidence of nosocomial infection and prevalence of
antibiotic misuse were studied in a 70-bed community hospital in Iran.
Methods: All pathogenic strains were tested for their susceptibility to anti-
microbial agents using the standardized agar disc diffusion test. Mueller–
Hinton agar andMast antibiotic discs (Mast Diagnostics Ltd., Bootle, Mersey-
side, UK) were used. Different panels of antibiotics were employed for Gram-
positive and Gram-negative organisms and also for urinary isolates. Suscepti-
bility or resistance was determined on the basis of the size of the diameter of
the zone of growth inhibition, according to the chart of interpretive standards.
Results: 45% of patients admitted developed nosocomial infection. The rates
were highest for nursery (32%), intensive care (21%), gynecological (15.5%)
and surgical (9.8%) patients. Urinary tract (39%), wound (24%) and blood
(11.2%) infections accounted for more than 70% of the infections. Staphy-
lococcus aureus (24.9%) and Pseudomonas aeruginosa (14.7%), caused more than
90% of the infections. The most frequent pathogens were S. aureus, P. aeru-
ginosa, other Gram-negative aerobes and Candida spp. Some microorganisms
such as Klebsiella, E. coliwere resistance to ﬁve antibiotics. Coccobacill Gram-
negative was resistance to three antibiotics. Some Gram-negative bacteria
showed resistance to six antibiotics. The majority of the bacterial pathogens
(75%) were multidrug resistant.
Conclusions: Overall, nosocomial infections were associated with an
increased risk of antibiotics resistance. The results emphasize the need for
effective measures to reduce both the high infection rates and widespread
antibiotic misusage in the hospital. Such measures should include institution
of an effective infection control committee and a hospital antibiotic policy. It
is also necessary to introduce urgent measures for control of antibiotic misuse
and restriction of the spread of P. aeruginosa and S. aureus.
P1210 Prevalence and molecular epidemiology of PER-1
beta-lactamase in Gram-negative bacteria
B. Erac¸, Z. Gu¨lay
Izmir, TR
Objectives: To investigate the prevalence of PER-1 beta-lactamase among
Gram-negative bacteria (GNB) isolated at a tertiary care hospital in Izmir,
Turkey and to analyze the clonal relationship of PER-1 producers.
Methods: PER-1 beta-lactamase production was sought in 155 ceftazidime
resistant GNB (53 Pseudomonas aeruginosa, 52 Acinetobacter baumannii, 25
Escherichia coli, 25 Klebsiella pneumoniae) isolated between January 1999 and
September 2002. blaPER-1 presence was determined by PCR and clonal
relationship of PER-1 producers was analyzed by ERIC PCR.
Results: Fifteen (28.3%) P. aeruginosa and 20 (38.5%) A. baumannii isolates
were found to possess blaPER-1. On the other hand, all Enterobacteriaceae
except one K. pneumoniae (4%) were blaPER-1 negative. Two main clusters
were detected both among P. aeruginosa and A. baumannii isolates. Although
most of the strains with identical ERIC PCR patterns were isolated from the
intensive care units (ICUs),A. baumannii that exhibited the same pattern were
isolated from different hospital wards.
Conclusions: PER-1 enzyme producers have been well established in our
hospital especially in the ICUs. Our results suggest that dissemination of
endemic clones was responsible for the high prevalence of PER-1 production
among nonfermentative bacteria.
P1211 Nosocomial infections caused by Pseudomonas
aeruginosa with acquired blaVIM metallo-beta-lactamase
genes in a hospital in Northern Italy
R. Migliavacca, J.-D. Docquier, M. Spalla, L. Pallecchi, E. Nucleo,
E. Giacobone, F. Zara, R. Brerra, G. M. Rossolini, L. Pagani
Pavia, Siena, I
Objectives: To investigate the diffusion of strains producing metallo-beta-
lactamases (MBLs) among carbapenem-resistant Pseudomonas aeruginosa iso-
lated from nosocomial infections in a hospital of northern Italy where MBL
producers were ﬁrst detected in 1998.
Methods: Seventy-six nonreplicate carbapenem-resistant P. aeruginosa isolated
at the University Hospital of Pavia since 1998 were included in the study.
Susceptibility testing was carried out by a broth microdilution method. The
EPI microdilution test, in which MICs of imipenem (IMI) are determined
with and without the presence of a mixture of chelators, was used for
screening of MBL production. Carbapenemase activity was estimated by
spectrophotometry. The presence of blaVIM- and blaIMP-type genes was
investigated by multiplex PCR, and the nature of the determinant was
identiﬁed by the restriction proﬁle of the ampliﬁcation products. Pulsed-
ﬁeld gel electrophoresis (PFGE) proﬁles of genomic DNA digested with SpeI
were analyzed using the Bio-Rad Gene Path Procedure.
Results: Six of the 76 (7.8%) P. aeruginosa isolates exhibited a positive result in
the EPI test. Photometric assays showed that crude beta-lactamase extracts
exhibited a comparable carbapenemase activity. Molecular analysis revealed
the presence of blaVIM determinants (5 blaVIM-1 and 1 blaVIM-2) in the six
isolates. All but one exhibited IMI MICs> 64mg/L. VIM producers were
isolated during the period 1998–2002, from four different wards, and from
different types of nosocomial infections (urinary tract, decubitus ulcer,
respiratory tract). Only in some cases they were epidemiologically and
clonally related.
Conclusion: These results indicated a low but persistent prevalence of
nosocomial infections caused by P. aeruginosa producing VIM-type
MBLs at this hospital. These strains exhibit a low ability to cause nos-
ocomial outbreaks. The EPI test was successful for rapid detection of
MBL producers.
P1212 Epidemiology and frequency of antimicrobial
resistances among pathogens causing surgical site
infections: report from the SENTRY Antimicrobial
Surveillance Program in the United States, Canada and
Europe
D. Mathai, D. Biedenbach, R. Jones
Vellore, Tamilnadu, IND; Iowa, USA
Objective: Surgical site infections (SSIs) cause considerable morbidity,
increase hospital length of stay, add to healthcare costs, and are largely
preventable via good infection control practice and appropriate use of
prophylactic antimicrobials. We addressed SSI in the SENTRY Program in
1999.
Methods: We collected between July and December over 600 isolates (20
consecutive isolates/center) from surgical patients hospitalized in 40 medical
centers (US, 26; Canada, ﬁve; and EU, nine [ﬁve nations]). At the monitoring
center (Iowa), isolates were further processed using standardized testing and
NCCLS susceptibility criteria (25 antimicrobials). Molecular epidemiologic
typing of selected strains was also performed.
Results: Overall, 512 isolates were evaluable as causing SSI and patient
demographics included: mean age, 56 years (range 1 month95 years); males
55.8%; median duration of hospital stay was 11 days; and average onset of
infection at 7 days (82% within 30 days). One-third of the specimens (com-
monly swabs 60.3%, aspirate 18.9%, tissue 11.3%) were obtained from patients
located in the surgical ICU and operating rooms. Body sites included
abdomen (34.3%), limb (24.4%), chest (17.2%) and cranio-spinal areas
(8.9%). Procedures included coronary artery bypass (7.7%), appendectomy
(5.3%), and mastectomy (3.5%). Over 30 preoperative antimicrobials were
utilized with ceftazidime in 25% of cases and one-half of the patients received
more than one drug class. Rank order of pathogen occurrence was: S. aureus
(SA; 34.5%)> P. aeruginosa (PSA; 13.5%)>E. coli (EC; 12.7%)> enterococcus
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(E)>Enterobacter spp.>Klebsiella spp. Regional variations were noted in
pathogen prevalence (example P. aeruginosa was the most often isolated species
in EU). Polymicrobial infection was observed in less than 5% of cases. Overall,
methicillin resistance among SAwas highest in EU (43.8%), and vancomycin-
resistant-E (14.3%) in the US. ESBL phenotype rates among Klebsiella spp.
(8.4%) and EC (7.1%) were modest, but least in the US (0–3.3%). In the US,
imipenem was most active agent against PSA (97.3%)> piperacillin/tazobac-
tam> gentamicin> cefepime> ceftazidime.
Conclusion: Resistance rates among nosocomial strains causing SSI vary
widely in different geographical regions. Global and local surveillance must
continue as a tool to limit the emergence and better deﬁne prophylactic
antimicrobial choices appropriate for surgical procedures.
Pharmacokinetics
P1213 Effect of rifampicin on the pharmacokinetics of
dapsone and its metabolite, monoacetyldapsone in
HIV-infected patients
S. Jaruratanasirikul, S. Sriwiriyajan
Hatyai Songkla, TH
The dual pulmonary infections with both Mycobacterium tuberculosis and
Pneumocystis carinii in AIDS patients have been found more common than
previously report. Dapsone has been increasing use as an alternative agent for
PCP prophylaxis and the CYP3A4 system is responsible for its metabolism.
Rifampicin is still one of the most valuable drugs for the standard treatment of
tuberculosis and known to be a potent inducer of hepatic cytochrome P450
enzymes. The objective of this study was to investigate the effects of
rifampicin on the pharmacokinetics of dapsone and monoacetyldapsone.
Our study was conducted in 12 HIV-infected patients. All patients received
100mg of oral dapsone once daily in the morning from day 1–7 and day 11–
17 and 600mg of oral rifampicin once daily in the morning from day 11–20.
Dapsone and monoacetyldapsone pharmacokinetic studies were carried out
on day 7–10 and day 17–20 (96 h). The results showed that dapsone and
monoacetyldapsone concentrations were lower when dapsone was adminis-
tered with rifampicin than when it was administered alone. The mean
AUC0–24, Cmax and Cmin of dapsone were decreased by 76.08, 48.21 and
88.23%, respectively, and the mean AUC0–24 and Cmax of monoacetyldap-
sone were decreased by 83 and 61.95%, respectively, and the mean Cmin of
monoacetyldapsone was undetectable. Thus, we conclude that rifampicin has
an inducing effect on the metabolism of dapsone and its metabolite, mono-
acetyldapsone.
P1214 Pharmacokinetic disposition and serum
bactericidal activity following IV infusion of single and
multiple ascending doses of TD-6424 in healthy male
subjects
S. Barriere, J. Shaw, J. Seroogy, K. Kaniga, J. Pace, K. Judice, T. Mant
South San Francisco, USA; London, UK
Introduction: TD-6424 (TD) is a new antibiotic that exerts rapid, concen-
tration-dependent bactericidal activity against clinically signiﬁcant Gram-
positive bacteria, including methicillin-resistant S. aureus (MRSA) and peni-
cillin-resistant pneumococci (PRSP). TD inhibits bacterial lipid synthesis in
addition to peptidoglycan synthesis.
Objectives: To determine the pharmacokinetics (PK) of TD in healthy males
and quantify serum bactericidal activity (SBA) against MRSA and PRSP.
Methods: Fifty-four subjects received single [SD] (N¼ 27) or multiple [MD]
doses (N¼ 27) of TD or placebo in this double blind, randomized, placebo-
controlled study. At each SD level, six subjects received TD and two received
placebo. At eachMD level, seven subjects received placebo and seven received
TD. SD ranged from 0.25 to 15mg/kg, andMD ranged from 7.5 to 15mg/kg
given q24hr by 30min IV infusion for 7 days. Blood and urine samples were
taken at regular intervals to evaluate PK and SBA (at peak and trough). Plasma
samples were analyzed with a validated LC/MS assay, and PK parameters were
derived using nonlinear methods. SBA titers were assessed vs. one strain each
of MRSA (ATCC 33591) and PRSP (clinical isolate), using standard NCCLS
methods, including addition of human serum.
Results: Following SD, TD exhibited approximately linear PK. Following
MD, AUC,Cmax, and T½ were not signiﬁcantly different from those observed
at Day 1. Little accumulation was observed and only Cmin was slightly
increased. Steady state was achieved by Day 3. Following Day 7 dosing,
the PK results for TD at the dose range proposed for clinical use (7.5–15
mg/kg) were as follows: peak plasma concentrations and AUCss for 7.5, 12.5
and 15mg/kg doses were 97, 151 and 203mg/L, and 700, 1033, and 1165
mg h/L, respectively. T½ and Vss were approximately 9 h and 0.1 L/kg,
respectively. Median peak/trough SBA titers for the three doses vs. MRSA
were 256/16 512/24, and 512/32, respectively; and vs. PRSP were
512/128, 512/256, and 512/512, respectively.
Conclusions: The PK of TD following SD in healthy volunteers appeared to
be largely independent of dose. Cmax and AUC values of TD demonstrate
approximate dose proportionality. Following MD, the PK of TD was similar
to that following SD, and no signiﬁcant accumulation was observed. Excellent
SBA persisting for 24 h was observed against the strains of PRSP and MRSA.
These results are suggestive of potential efﬁcacy in the treatment of Gram-
positive infections.
P1215 Application of microdialysis to corticocancellous
bone tissue for the evaluation of gentamicin: an
experimental study
L. B. Stolle, M. Arpi, P. Holmberg Joergensen, P. Riegels-Nielsen,
J. Keller
Aarhus N, Aarhus C, Esbjerg, DK
Objectives: Most antimicrobial agents exert their effect inside the interstitial
space, which is the site of many infections. For the evaluation of antimicrobial
agents in bone tissue, mainly studies of bone specimens have been performed.
Microdialysis is a new technique that allows dynamic and continuous in vivo
sampling. The principle is to introduce a membrane into the tissue and perfuse
it with a liquid that equilibrates with the ﬂuid outside of the membrane by
diffusion, thus enabling dynamic measurements to be made. The aim of this
investigation was to introduce microdialysis to corticocancellous bone tissue
for the evaluation of gentamicin and compare it to values obtained from bone
specimens.
Methods: Eight pigs (46.4 0.7 kg, creatinin 144.3 7.9mM) were included
into the study and underwent surgery in general anesthesia. All animals
received an intravenous injection of 240mg gentamicin. Concentrations of
gentamicin were measured in serum and by the technique of microdialysis on
an Abbott Drug Analyzer. A direct agar diffusion technique was used to
evaluate bone specimen gentamicin using S. epiderminis ATCC 12228. Data
presented are means SEM. A P-value below 0.05 was considered signiﬁ-
cant. The pharmacokinetic measure used was the area under the curve from 0
to 6 h (AUC 6h). All surgical procedures were performed under the approval
and guidelines of the Danish Ministry of Justice, Animal Experimentation
Inspectorate.
Results: The peak concentrations of the two microdialysates and bone
specimens were 6.73 0.8mg/L, 6.52 1.09mg/L and 5.49 1.02mg/L.
Similar the area under the curve from 0 to 6 h (AUC6 h) were
1569 198mg/min/L, 1721 248mg/min/L and 1390 121mg/min/L
(ANOVA, P¼ 0.5). Serum gentamicin peaked at 33.31 2.66mg/L. Repro-
ducibility of the measurement from the microdialysates was evaluated from
the mean AUC6h/catheter no. 1/AUC6h/catheter no. 2 ratio. This ratiowas
1.02 0.17.
Conclusion: The evaluation of bone specimens is a difﬁcult task and frequent
sampling on the same individual is often not possible due to ethical con-
siderations. It seems that microdialysis is a suitable, relative noninvasive and
reproducible technique for dynamic and quantitative measurements of gen-
tamicin in corticocancellous bone tissue.
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P1216 Urinary concentration-vs.-time proﬁle of
levoﬂoxacin 500mg bid in ICU patients treated for
ventilator associated pneumonia
F. Pea, F. Pavan, E. Di Qual, L. Brollo, E. Nascimben, M. Baldassarre,
M. Furlanut
Udine, Treviso, I
Objectives: The aim of our study was to assess the urinary pharmacokinetics
of LFX by collecting urine samples at appropriate intervals in ICU patients
treated with LFX 500mg b.i.d. i.v. because of a ventilator associated
pneumonia (VAP).
Methods: In steady-state condition, urine samples were collected during a
dosing interval (at 0–2, 2–4, 4–8 and 8–12h), and urinary concentrations of LFX
were assayed by HPLC. The study involved 12 patients (6M, 6F; age,
57 19 years; weight, 71 11 kg) presenting with a normal renal function
(estimated creatinine clearance, 1.87 0.66mL/min/kg; diuresis, 1825.4
575.3mL/24h).
Results: Mean ( standard deviation) of LFX urinary concentrations were
358.2 169.9mg/L, 392.7 154.7mg/L, 241.1 85.9mg/L and 139.9
71.9mg/L at 0–2, 2–4, 4–8 and 8–12h, respectively. Fractional urinary excre-
tions of LFX were 20.0 8.9%, 17.0 3.0%, 26.1 5.3%, 15.5 3.6% at 0–2,
2–4, 4–8 and 8–12h, respectively, with a total cumulative excretion of
78.7 12.9% in the overall dosing interval.
Conclusions:Our ﬁndings show that LFX 500mg bid iv enables to maintain
high urinary concentrations during the overall dosing interval in patients with
normal renal function, and conﬁrm that LFX is excreted mainly as unchanged
drug by the renal route. Mean urinary concentrations were 50–175-fold
higher than the breakpoint for sensitive bacteria during the overall dosing
interval. Considering that a peak level (Cmax) to minimum inhibitory
concentration (MIC) ratio higher than 12.2 (Cmax/MIC> 12.2) was shown
to be one of the main pharmacodynamic determinant for the concentration-
dependent bactericidal activity of LFX, we can conclude that the urinary
pharmacokinetics of LFX enables an optimal exposure for the treatment of
UTIs not only against sensitive microrganisms, but probably also whenever
microrganisms usually considered as moderate sensitive or resistant to LFX if
localized in other infection sites may be involved.
P1217 Evaluation of the effect of age, weight, race and
gender on the plasma concentrations of posaconazole in
HIV-infected patients with oropharyngeal or esophageal
candidiasis
R. Courtney, M. Martinho, J. Lim, P. Statkevich, C. Hardalo
Kenilworth, USA
Background: Posaconazole (POS) is a triazole antifungal in clinical devel-
opment for the treatment of refractory oropharyngeal (OPC) and esophageal
candidiasis (EC) and invasive fungal infections. The pharmacokinetics (PK)of
some antifungal agents are affected by covariates such as age, gender, and race.
This analysis was performed to assess whether individual patient plasma levels
at steady state (Css avg) were altered in patients who varied with respect to age,
weight, race, and gender.
Methods:A total of 199 subjects were enrolled in an open-label, multicenter,
noncomparative efﬁcacy and safety study of POS for the treatment of azole-
refractory OPC or EC. POS oral suspension (400mg/10mL) b.i.d. with food
was used for 4weeks as acute treatment. Of these treated subjects, 46 were
randomly chosen from the data set for examination of serum POS concen-
trations. A total of 70 samples of venous blood (one or two per subject) were
collected per protocol prior to dosing on Days 8 and 28. POS levels were
analyzed using liquid chromatography with tandem mass spectrometric
detection. Graphical correlations with regression analyses were performed
to determine if a trend between the various covariates and the plasma
concentrations was observed.
Results: A mean Css avg of 577 ng/mL was observed across the entire
population, with a mean time of 11.2 h between dosing and sampling. There
were no correlations observed between the individual patient POS Css avg
values and the four demographic factors evaluated. Mean Css avg values were
not associated with differences in age (25–54 years) or weight (37–94 kg)
between patients; linear regressions yielded R2 values of 0.012 and 0.038,
respectively. The 90% conﬁdence intervals for the mean Css avg values
overlapped in samples taken from whites (n¼ 43), blacks (n¼ 23), and
Hispanics (n¼ 4), indicating that there was no effect of race on the plasma
concentrations of POS. Although the number of samples available from
women (n¼ 9) compared with men (n¼ 61) was small, mean Css avg values
between the genders were statistically equivalent.
Conclusions: Age, weight, race, and gender had no effect on POS plasma
concentrations at steady state in HIV-infected patients with OPC or EC.
Correlation of PK parameters and clinical and mycologic responses are
ongoing as part of the larger data analysis in this study. Larger studies and
a population analysis assessing the role of these covariates on the PK of POS
are currently ongoing.
P1218 Relative oral bioavailability of three formulations
of posaconazole in healthy volunteers: basis for clinical
development of the suspension
R. Courtney, A. Sansone, E. Radwanski, D. Wexler, J. Lim,
M. Laughlin
Kenilworth, USA
Objectives: Posaconazole (POS) is a new triazole antifungal that has activity
against a wide variety of pathogens including Aspergillus spp. and Zygomycetes.
Two Phase I pharmacokinetic (PK) studies were conducted to determine the
relative oral bioavailability of a suspension, capsule, and tablet formulation of
POS under fed conditions in healthy male volunteers.
Methods: Both studies employed randomized, open-label, single-dose
designs. In Study 1, 20 subjects received either a single 200-mg dose of
the POS oral suspension (5mL) or POS tablets (2 100mg) after a high-fat
breakfast (>50% of calories from fat) in a crossover manner. In Study 2, 24
subjects received either POS tablets or capsules (both 2 100mg) after a
high-fat breakfast. There was a 1-week washout between treatment periods in
both studies. Venous blood was collected predose and up to 72 h postdose for
determination of POS concentrations. PK parameters were calculated using
model-independent methods.
Results: The balanced mean POS PK parameters are shown in Table 1.
The POS AUC(0–inf) values were5 and 46% greater for the oral suspension
vs. the capsule and tablet formulations, respectively. The increase in exposure
(AUC(0–inf ) andCmax) of the suspension relative to the tablet was statistically
signiﬁcant (P 0.041). The AUC and Cmax values of the capsule and tablet
did not differ signiﬁcantly (P 0.089). In these two independent studies
where POS was administered as a tablet, similar PK parameters of POS were
observed between studies, indicating there were no signiﬁcant interstudy
differences in the PK of POS.
Conclusions: The POS suspension had greater relative oral bioavailability
than the tablet and capsule formulations. Based on these results, the clinical
development of POS has progressed using the suspension in order to deliver
optimal drug exposure in severely ill patients. In addition, POS suspension
may allow easier administration and improved tolerability in patients with
mucositis or receiving medications via a feeding tube. The suspension may
also provide an additional topical antifungal effect in patients with orophar-
yngeal candidiasis.
P1219 The effects of food and fat content on the
relative oral bioavailability of two formulations of
posaconazole
R. Courtney, A. Sansone, E. Radwanski, D. Wexler, J. Lim,
M. Laughlin
Kenilworth, USA
Objectives: Posaconazole (POS) is a potent new triazole antifungal in Phase
III clinical development for the treatment and prophylaxis of serious fungal
Table 1
Parameter
AUC(0–inf)
(ng h/mL)
Cmax
(ng/mL) Tmax (h) t1/2 (h)
Study 1
Suspension (n¼ 20) 15059,a 512,b 4.8 23.0
Tablets (n¼ 20) 10304 413 5.5 21.0
Study 2
Capsules (n¼ 21) 14293c 531d 5.1 26.1
Tablets (n¼ 21) 12505 432 6.2 25.5
n¼15.
aP¼ 0.001 vs. tablets; bP¼ 0.041 vs. tablets; cP ¼ 0.089 vs. tablets; dP ¼ 0.103 vs.
tablets.
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infections. Two studies were conducted to determine the role of food and fat
content on the systemic exposure of the suspension and tablet formulations of
POS.
Methods: Both studies were randomized, single-dose, open-label and cross-
over in design and were conducted in healthy male volunteers. In Study 1, 20
subjects received a single 200-mg dose of POS oral suspension (5mL) after a
10-h fast, with a nonfat breakfast, or a high-fat breakfast (>50% of calories
from fat); or POS tablets (2 100mg) with a high-fat breakfast. In Study 2, 12
subjects received a single POS tablet (1 200mg) after a 10-h fast or with a
high-fat breakfast. In both studies, there was a 1-week washout between
treatments. Venous blood was collected predose and up to 72 h postdose for
the determination of POS concentrations. Pharmacokinetic (PK) parameters
were calculated using model-independent methods.
Results: Balanced mean PK parameters are shown in Table 1.
Systemic exposure (AUC(tf)) of POSwas4-fold greater after a high-fat meal
than after a 10-h fast (P 0.001) and was independent of formulation
administered. The intake of food had a greater inﬂuence on the relative oral
bioavailability of POS than the fat content of the meal. Compared with the
fasted state, administration of a nonfat meal resulted in a 167% increase in POS
systemic exposure (9511 ng h/mL vs. 3553 ng h/mL), while the addition of fat
calories only increased exposure by an additional 46% (13 885 ng h/mL vs.
9511 ng h/mL). In these two studies in which POS was administered as a
tablet with a high-fat meal, similar PK parameters of POS were observed
between studies, indicating there were no signiﬁcant interstudy differences in
the PK of POS.
Conclusions: Food increased the relative oral bioavailability of POS; this
increase was independent of the formulation administered. In addition, food
containing fat calories further enhanced the relative oral bioavailability of
POS.
P1220 Therapeutic drug monitoring of cotrimoxazole: a
9-year review of levels from a UK clinical antibiotic assay
service
J. Sunderland, A. M. Lovering, C. M. Tobin, K. E. Bowker,
A. P. MacGowan
Bristol, UK
Objectives: Co-trimoxazole (SMZ–TMP) is a mixture of trimethoprim
(TMP) and sulfamethoxazole (SMZ) in the proportions 1:5 TMP:SMZ
and is the drug of choice in Pneumocystis carnii pneumonia (PCP) where high
dose treatment is given (20mg/kg/day). Therapeutic monitoring is useful in
treatment for PCP, particularly in patients with renal failure in order to
achieve both therapeutic serum levels and avoid risk of toxicity. Normal serum
levels are usually in the ratio of 20:1 (SMZ:TMP), with guide-line levels of pre
dose SMZ< 100mg/L; TMP 5–7mg/L but < 20mg/L and post dose SMZ
120–150 but <200mg/L; TMP 5–10 but <20mg/L. Achievement of
optimum levels of TMP can result in toxic levels of SMZ and conversely
impaired renal function can reduce the renal excretion of TMP resulting in
accumulation whilst the SMZ is still metabolized. We reviewed 9 years of
SMZ–TMP levels from our antibiotic assay service and present our ﬁndings.
Methods: SMZ and TMP were assayed simultaneously by HPLC. Data was
collected retrospectively from the hospital Laboratory Information Manage-
ment System.
Results: From January1994–October 2002 there were 593 sets of patient sera
for SMZ–TMP assay; a total of 279 individual patients from 93 different
requester locations. Of the 303 pre dose levels requested 47.5%were above the
SMZ guideline level of 100mg/L and of the 310 post doses assayed 21.9%
were above the potentially toxic SMZ level of 200mg/L. 6.3% of pre dose
TMP samples and 13.9% of post dose TMP samples were above the toxic
concentration of 20mg/L. 16.8% of TMP post dose levels were below the
optimum therapeutic level of 5mg/L. Of the paired pre and post dose SMZ–
TMP serum samples (n¼ 274), 36.9% of TMP post dose levels were in the
normal range when SMZ pre or post levels were potentially toxic with 16.1%
having an inadequate TMP post dose level when the SMZ levels were within
normal range. In only 5.1% were the concentrations of both the agents in the
optimum range.
Conclusions: A signiﬁcant proportion of samples assayed for SMZ–TMP are
at potentially toxic levels as a result of elevated SMZ levels. Coupled with the
knowledge that greater than 1 in 6 post dose TMP levels are potentially
therapeutically inadequate (<5mg/L), dose adjustment involving a reduction
in the dose of SMZ–TMP with an additional TMP only supplement and
vigilant monitoring of serum levels may improve achievement of optimum
therapeutic levels with a reduced risk of SMZ toxicity problems.
P1221 The pharmacokinetics of 800mg teicoplanin (T)
given once every 48h
E. S. R. Darley, A. P. MacGowan
Bristol, UK
Objectives: T is extensively used for outpatient intravenous therapy in the
UK and Europe as it can be given as a once-daily dose of 400mg. The
pharmacokinetics of Tare best described using a three-compartmental model
which indicates a terminal half-life of up to 182 h. Alternate day dosing has
been used to treat patients with home i.v. therapy. The pharmacokinetics of
800mg Tover 48 h were therefore determined in inpatients with orthopedic
infection.
Methods: Seven consenting inpatients (six male, one female) with normal
renal function were studied; mean age 67 years (range 35–73), mean weight
93 kg (range 65–114). 800mg Twas administered in 100mL saline as a 10–
20min infusion. Bloodwas collected at times; 0.08, 0.5, 0.75, 1, 1.5, 2, 4, 6, 8,
12, 24, 36, 48 h after start of infusion. T serum concentrations were assayed by
Polarization Fluorescent Immunoassay (FLX Abbott). Data were analyzed
using WinNonlin.
Results: Best ﬁt was obtained using a three-compartment model. Mean con-
centration observed 20–30min after the start of infusion was 132.0mg/L
(range 107.4–148.8) and mean 48 h concentration was 3.6mg/L (range 2.5–
5.0mg/L). 12 h after the end of infusion the mean serum concentration was
8.8mg/L (95% CI 7.1–10.5). Mean AUMC was 17 127mg h/L (95% CI
10 957–23 297). Half-lives of the alpha and beta phases were 00.17 h (95% CI
0.13–0.21) and 01.68 h (95% CI 1.24–2.12), respectively, which are compar-
able to those reported following single doses of 200 and 400mg. The mean
terminal half life, 23.8 h (95% CI 19.4–28.14), VdistributionSS 0.37 L/kg
(95% CI 30.16–36.12) are lower than previously reported, this is consistent
with our very short sampling period (48 h).
Conclusion: T 800mg pharmacokinetics when administered 48 h is best
described using three-compartment modeling and the pharmacokinetic
parameters are in keeping with those for 400mg 24 h allowing for the short
sampling period. However, without prior loading doses 800mg 48 h is
insufﬁcient to reliably achieve trough concentrations of >10mg/L.
P1222 Anidulafungin dosage adjustments are not
required for patients with hepatic and/or renal impairment
J. Dowell, M. Stogniew, D. Krause
King of Prussia, USA
Objectives: Anidulafungin, an echinocandin, is being developed for the
treatment of serious fungal infections. Anidulafungin is not metabolized
by hepatocytes or CYP450 enzymes, but is nonenzymatically degraded.
The drug and degradation products are excreted in bile/feces and not in
urine. In anticipation of treating patients with hepatic impairment (HI) or
renal impairment (RI), studies were conducted to evaluate whether dosage
adjustments are necessary.
Methods: Two studies were conducted to examine the safety and pharmaco-
kinetics (PK) of anidulafungin in subjects with either HI or RI vs. subjects with
normal function. PK were obtained from six subjects/group: normal hepatic
function andmild,moderate, or severeHI (Child–Pugh classes A, B, andC).RI
was deﬁned by creatinine clearance (mL/min): mild¼ 51–79, moderate¼ 31–
50, and severe<30. PKwere obtained from 8 subjects/group for normal renal
function and mild RI and 6 subjects/group for moderate, severe, and end-stage
(on dialysis) RI. Subjects were given a single 50mg i.v. dose of anidulafungin,
Table 1
Parameter
Cmax
(ng/mL) Tmax (h)
AUC(tf)
(ng h/mL) t1/2 (h)
CL/F
(mL/min) Vd/F (L)
Suspension (Study 1)
Fasted (n¼ 20) 132 5.0 3553 23.5 858 1743
Nonfat meal (n¼ 20) 378 4.1 9511 22.2 350 676
High-fat meal (n¼ 20) 512 4.8 13885 23.0 234 454
Tablets (Study 2)
Fasted (n¼ 12) 92.5 9.0 2718 19.0 1062 1709
High-fat meal (n¼ 12) 366 7.6 10220 18.3 323 526
High-fat meal
(n¼ 20; Study 1)
413 5.5 10304 21.0 362 648
n¼ 15 (Study 1); n¼ 7 (Study 2).
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and plasma samples for PK analysis collected for 6 days postdose. Safety was
assessed by physical exam and adverse event/laboratory monitoring.
Results: PK in subjects with normal hepatic function and those with mild/
moderate HI were similar. In subjects with severeHI, decreases were observed
in the maximum concentrations (Cmax) and area under the concentration–
time curve (AUC) and increases in drug clearance and volume of distribution;
these are changes that are likely secondary to ascites and edema. PK in subjects
with normal renal function and those with RI were similar. Additionally,
there were no measurable amounts of anidulafungin found in dialysate. The
drug was well-tolerated. No dose-limiting toxicities or serious adverse events
occurred. The mean PK parameters are shown in Table 1.
Conclusions: The PK of anidulafungin were not affected in any clinically
relevant way by either HI or RI. The drug can be administered to patients
withHI or RI, without dosing adjustments, or without regard to the timing of
hemodialysis.
P1223 Anidulafungin biotransformation in humans is by
degradation not metabolism
M. Stogniew, F. Pu, T. Henkel, J. Dowell
King of Prussia, USA
Objectives: Anidulafungin (ANID), an echinocandin, is being developed for
the treatment of serious fungal infections. Studies were conducted to support
clinical development by studying the pharmacokinetics (PK) of the drug in
animals and humans and to determine the extent and mechanism of meta-
bolism and drug elimination.
Methods: PK studies were performed in rats receiving an i.v. infusion of
5mg/kg of ANID. A mass-balance study, using [C-14]-ANIDwas performed
in rats and in human volunteers (100mg/100mCi). In vitro studies were
performed with incubations in buffer, plasma, and media containing micro-
somes or isolated hepatocytes.
Results: Following administration of [C-14]-ANID in rats and humans, drug-
derived radioactivity persists longer than ANID. In humans, the half-lives of
ANID and drug-derived radioactivity are 28 and 119 h, respectively. These
results would suggest extensive metabolism of the drug, however, in vitro
studies show the drug is not metabolized when incubated in primary human
hepatocytes, nor is it a substrate for CYP450 enzymes. ANIDwas found to be
degraded in human plasma, with a kinetic half-life (1 day) that is similar in
buffer (pH 7.4, 37 8C), in vitro plasma (37 8C), animal PK studies, and human
PK studies. The fact that the in vitro degradation rate in buffer is similar to the
degradation rate in plasma indicates ANID in vivo degradation is non-
enzymatic. The primary degradation product is a linear peptide that is further
enzymatically degraded to tertiary products. Drug and labeled degradation
products are not found in urine. The majority of drug is degraded, with
tertiary degradation products eliminated in the feces via bile. A small amount
of intact drug (<10%) is also eliminated in feces. ANID has a volume of
distribution of approximately whole body ﬂuid; the volume of distribution in
the rat and human is 1.7 L/kg and 37 L, respectively.
Conclusions: ANID is eliminated in the body through biotransformation by
nonenzymatic degradation that is time, pH, and temperature-dependent. The
lack of hepatic metabolism and urinary excretion may explain previously
reported studies showing ANID concentrations are not increased due to
hepatic or renal impairment, unlike another echinocandin. Additionally, these
results indicate that ANID has a low potential for drug interactions.
P1224 Dalbavancin dosage adjustments not required
for patients with mild renal impairment
J. Dowell, E. Seltzer, M. Stogniew, M. B. Dorr, S. Fayocavitz,
D. Krause
King of Prussia, USA
Objectives: Dalbavancin is a novel semisynthetic glycopeptide in phase 3
clinical development, that has activity against Gram(þ) organisms, including
resistant strains. Weekly doses have been shown to be effective in deep skin
and soft tissue infections. The drug’s half-life supports once-weekly dosing,
and it is eliminated through both renal and nonrenal routes. Because patients
with renal impairment (RI) are likely to receive dalbavancin, clinical studies
were done to determine the need for dose adjustments in subjects with mild
RI.
Methods: Subjects enrolled in the clinical studies received dalbavancin as a
single i.v. infusion (70 or 1000mg). All subjects had mild RI as deﬁned by
creatinine clearance (CrCL) of 50–80mL/min. Plasma samples were collected
through at least 14 days after the dose. Dalbavancin was assayed using validated
LC-MS/MS methods. Pharmacokinetic (PK) data were analyzed using
noncompartmental methods. PK of subjects with mild RI were compared
with normal subjects (CrCL> 80mL/min) from a previous study.
Results: Seven subjects with mild RI were enrolled and received one dose of
either 70 or 1000mg of dalbavancin. Six subjects with normal renal function
were enrolled in a separate study and were used for comparison. Table 1
summarizes the mean (SD) of PK parameters from these studies. Dalbavancin
PK parameters, including maximum concentration (Cmax) and the area under
the concentration–time curve through 14 days (AUC0–14), and concentra-
tion–time proﬁles were similar between subjects withmild RI receiving either
the 70 or 1000mg dose and subjects with normal renal function Table 1.
Conclusion: Dalbavanicin does not require a dosage adjustment for patients
with mild RI. These results are consistent with previous clinical and non-
clinical PK studies showing that dalbavancin, unlike currently marketed
glycopeptides, has dual (both renal and nonrenal) routes of elimination.
Studies are ongoing to determine if dosage adjustments of dalbavancin will
be required for subjects with moderate, severe, or end-stage (on dialysis) RI.
P1225 Attributes of dalbavancin: well distributed,
weekly dosing, and completely eliminated
M. Stogniew, F. Pu, J. Dowell
King of Prussia, USA
Objectives: Dalbavancin is a novel semisynthetic glycopeptide in phase 3
clinical development, that has activity against Gram(þ) organisms, including
resistant strains. Weekly doses have been shown to be effective in deep skin
and soft tissue infections. Studies were performed to support the clinical
development of dalbavancin by investigating drug distribution and excretion.
Methods: Two studies were performed in rats administered a single i.v.
infusion of 20mg/kg [H-3]-dalbavancin. Excreta and more than 40 different
tissues were collected through 70 days, and the distribution and kinetics of
drug-derived radioactivity were examined. Results from animal studies were
compared with humans using pharmacokinetic data from volunteers that were
administered an i.v. infusion of 1000mg dalbavancin.
Results: In rats, approximately two-thirds of the excreted drug was found in
urine, and one-third was observed in feces. Approximately 25% of the dose is
eliminated after 1 day and almost 60% after 1week. This is consistent with a
plasma t1/2 of approximately 1week. The majority of fecal drug elimination is
via excretion in bile. Blood to plasma ratio remained relatively constant over
Table 1
Cmax (mg/L) AUC (mg h/L)
Hepatic function
Normal 2.9 70.0
Mild HI 2.2 56.0
Moderate HI 2.3 68.6
Severe HI 1.8 46.6
Rural function
Normal 2.1 51.1
Mild RI 2.2 52.5
Moderate RI 2.7 61.4
Severe RI 2.3 54.2
End-stage 2.2 52.7
Table 1
N
Cmax
(mg/L) Cmax/Dose
AUC0–14
(mg h/L)
AUC0–14/
Dose
Mild renal impairment
70mg 3 22 (6) 0.32 1299 (312) 18.6
1000mg 4 276 (107) 0.28 15910 (996) 15.9
Normal renal function
1000mg 6 301 (65) 0.30 16772 (3193) 16.8
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time and <1. Concentrations and half-lives of radioactivity in tissues were
comparable to that observed in plasma. Concentrations in skin were compar-
able to or higher than values observed in plasma, while concentrations
remained relatively low in the CNS in this healthy animal model. At 12 h
postdose, all tissues had quantiﬁable concentrations of radioactivity with peak
concentrations attained within 24 h after the dose. Less than 5% of the dose
was found in any one tissue 5 days following the dose. By 10weeks after the
dose, less than 5% of the dose remained in the carcass. The entire dose was
accounted for through-out the study. Elimination of dalbavancin in humans
was similar to rat; the plasma t1/2 was 9–12 days and approximately 40% of
intact drug was excreted in urine.
Conclusions: These results support the use of dalbavancin as a once-weekly
regimen, show the drug to be well distributed including good penetration
into skin, and have both renal and nonrenal routes of elimination. Dual routes
of elimination may be a desirable attribute for patients with renal or hepatic
impairment, and other special populations. The drug does not accumulate
into any one tissue, compartment, or organ.
P1226 Modulation of the cellular accumulation of
garenoxacin (BMS284756) and levoﬂoxacin in J774
macrophages
C. Seral, P. M. Tulkens, F. Van Bambeke
Brussels, B
Objectives:Ciproﬂoxacin accumulates in J774 macrophages and is subject to
active efﬂux through multidrug resistance related protein (MRP). Inhibition
of this transporter increases, indeed, its accumulation to 300% of control
values (Michot et al. ICAAC 2000, A662). We have examined the kinetics of
accumulation and efﬂux of garenoxacin (GAR) and levoﬂoxacin (LEV) and
their modulation byMRP and P-gp efﬂux pumps, two transporters energized
by ATP hydrolysis.
Methods:Accumulation in J774 macrophages at different times up to 2 h and
efﬂux were examined at 37 8C in control cells, in ATP-depleted cells and in
cells incubated with GAR or LEV in the presence of MRP inhibitors
(probenecid (PRB; inhibitor of organic anions transporters) and MK-571
(preferential inhibitor of MRP)) or P-gp inhibitors (verapamil (VRP; non-
speciﬁc inhibitor) and GF120918 (preferential inhibitor of P-gp)).
Results: Both antibiotics accumulated rapidly, reaching a plateau value after
5min (cellular to extracellular ratios: GAR, 6.3 0.3; LEV 3.5 0.2) and
their efﬂux was very rapid (t1/2 ¼ 1.64min for GAR and 2.14min for LEV).
The table shows the effect of ATP depletion and pump inhibitors on
accumulation at equilibrium (2 h). PRB also decreased the rate of efﬂux
of GAR and LEV (t1/2¼ 2.78min and 3.28min vs. 1.64 and 2.14min in
controls, respectively) (Table 1).
Conclusions: GAR accumulates to a larger extent than LEV in J774 macro-
phages. Its accumulation is less affected than that of LEV by ATP depletion,
MRP or P-gp inhibitors. Since the effect of inhibitors remains quite low for
both drugs, their rapid accumulation and efﬂux is probably primarily
mediated by their diffusion through the membrane.
P1227 In vitro release of teicoplanin from a new type
calcium phosphate bone cement (Norian)
K. Athanassiou, K. Kanellakopoulou, P. Greka, I. Lazarettos,
Z. Chrisouli, H. Giamarellou
Athens, GR
Objectives: Norian Skeletal Repair System (NSRS) is an injectable calcium
phosphate cement suitable for the structural augmentation of regions of
cancellous bone cement after fractures. The aim of the study is the evaluation
of the in vitro release of teicoplanin from NSRS as a means of surgical
prophylaxis.
Methods: Five grams of NSRS were mixed by 100:3 ratio to teicoplanin at a
room temperature under sterile conditions. The solidication of the mixture
took place in the bottom of a cylindrical vial. Five samples were prepared.
One mL of Mueller Hinton broth was added over the free surface of the
mixture and at 37 8C temperature. Broth was replaced daily for 7weeks (Days
1–49). Concentration of teicoplanin in broth was determined by the micro-
biological method using B. subtilis 6633 as an indicator strain.
Results: Mean concentrations of teicoplanin of ﬁve vials after 1 h was
150.8 mg/mL; after 1 day 53mg/mL. The concentration ranged between
7.6 and 24 mg/mL on days 2–20 and 8.9mg/mL and 24.8mg/mL on days
21–49. Highest concentrations were detected on days 1 (53mg/mL) and 18
(24.8 g/mL), respectively.
Conclusions: The slow release of teicoplanin (until the 49th day) from the
NSRS resulted in concentrations adequately above the MICs (0.5mg/mL) of
the expected Gram-positive cocci implicated in bone infections. Supple-
mentation of NSRS with teicoplanin should be tested in in vivo models of
surgical prophylaxis.
P1228 Population PK (PopPK) characterization of the
new extended-release ciproﬂoxacin (CIP) formulation in
comparison to the immediate-release (IR) standard tablet
F.-P. Theil, M. Frede, H. Stass
Wuppertal, D
Introduction: The PopPK of a novel extended release formulation for once
daily (od) administration of CIP (Cipro(R) (XR)was evaluated in comparison
to the previously marketed IR formulation, which is generally given b.i.d.
The dissolution proﬁle of the XR tablet with 35% immediate release followed
by sustained release of the remaining dose allows it to be administered od for
urinary tract infections (UTI) with the commonly known compliance
beneﬁts of a once daily treatment.
Methods: For the PK evaluation, plasma and urine concentrations from two
cross-over studies in healthy male volunteers (n¼ 19 for each study) were
obtained after oral intake of either a 500 and 1000mg XR tablet or a 250 and
500mg IR tablet bid (5 days, fasting conditions, washout period of 1week).
PopPK evaluation was performed using nonlinear mixed effect modeling
(NONMEM). Two main effect compartments (urine and prostate tissue)
were simulated to illustrate the target concentration exposure.
Results:The plasma PKof CIP IR andXR formulations were described by an
oral two-compartment model. For ka, tlag and central volume, a random day-
to-day effect (interoccasion variability) was incorporated to account for the
PK complexities especially in the case of the IR tablet. The PK of the XR
tablet showed lower variability between the different study/dosing occasions
compared with the standard tablet. This resulted in a reduced variability of the
overall PK of the CIP XR dosage form, which could be described by a ﬁrst
order oral two compartment model. The ﬁnal model for CIP IR still showed
some systemic deviations (bias) due to the higher complexity of absorption.
The simulated urine concentration–time proﬁles were in good accord with
the measured data indicating that the extended release proﬁle translates into a
sustained urine concentration–time proﬁle exceeding the MICs of relevant
UTI pathogens during the entire dosing interval. Additionally, it can be
assumed that the altered plasma PK of the XR tablet will translate into
similarly altered tissue PK proﬁles as illustrated by target tissue simulations
(prostate).
Conclusions: The new XR formulation demonstrated an improved PK
variability. Together with the extended release characteristics the optimized
exposure–time pattern is beneﬁcial for compliance and might be of advantage
for the PK–PD relationship of CIP XR.
P1229 Teicoplanin therapeutic drug monitoring –
is the thrice weekly regimen adequate for treating
bone and joint infections (BJIs)?
D. Nathwani, J. Morrison, C. Roberts, H. Aboud, K. Gray, P. Davey
Dundee, UK
Background: For patients with osteomyelitis, there is evidence of a relation-
ship between teicoplanin (TEIC) trough serum concentrations of 10mg/L
and a favorable clinical outcome. These levels are achieved by a thrice weekly
Table 1
Increase in accumulation (% of controls)
Garenoxacin Levofloxacin
ATP depletion 122.2 2.1 137.7 7.2
PRB (5 nM) 126.9 5.9 148.0 8.7
MK-571 (100 mM) 133.4 6.4 163.9 8.4
VRP (100 mM) 102.7 5.1ns 123.2 8.5
GF120918 (2 mM) 102.5 4.7ns 110.2 6.5ns
ns: nonsignificant; P< 0.05; P< 0.01; P< 0.001.
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regimen of 15mg/kg after an initial dosing regimen (15mg/kg daily) of once
daily TEIC for 3–10 days.
Objective: We have retrospectively reviewed the TEIC therapeutic drug
monitoring (TDM) and clinical outcomes of 33 patients with predominantly
bone and joint sepsis to assess the relationship between levels achieved by
using this thrice weekly regimen with or without loading doses.
Results: Thirty-three patients, mean age 66; 18 had prosthetic infection, ﬁve
had osteomyelitis, three had wound infections or complicated skin and soft
tissue structure infections, six had line infections (two with bacteremia) and
one a deep diabetic foot ulcer infection. 25/33 (75%) of all infections were
due to MRSA (21/25) and MRSE (4/25). One infection was due to MSSA
and in seven no pathogens were identiﬁed. Group a n¼ 14; all received the
loading doses of 15mg/kg for 3 days followed by 15mg/kg thrice weekly. 13/
14 has at least one trough level performed at a mean of 14 days after the start of
treatment. The mean and median levels were 26.8 and 28.2mg/L, respec-
tively. Group b n¼ 18, all received 15mg/kg thrice weekly without a loading
dose. 18/18 has at least one trough level performed at a mean of 11 days after
the start of treatment. The mean and median levels were lower at 24 and
21mg/L, respectively. Only one 40-year-old patient had a level below 10mg/
L (8.1mg/L) taken on day 5 and improved to >10mg/L on two subsequent
levels on day 14 and 23. In all but one patient the baseline and serial serum
creatinine was within the normal range. 28/33 patients had a good outcome,
in two patients there was no change or worsening and in two patients teico-
planin was stopped because of a rash or worsening renal function. In this
patient the serum creatinine went up to 237mmol/L (55–100) transiently with
an associated trough level of 68.8mg/L. This resolved after stopping the TEIC.
Conclusions: Thrice weekly TEIC with or without a prior loading regimen
appears to achieve adequate serum trough levels in patients with mainly BJIs.
The levels appear to be well above 10mgL; therefore, consideration should be
given to reducing the TEIC dose or loading may be unnecessary. This would
further improve the cost-effectiveness of these regimens without compromis-
ing clinical outcomes.
Infection control
P1230 Would you prefer to perform endoscopy with a
clean endoscope? Very good effect of a quality control
program for cleaning and disinfection of endoscopes
T. Slotsbjerg, J. O. Jarløv, B. Lundgren, H. Westh
Hvidovre, Herlev, DK
Introduction: Flush water from the water channel was used to evaluate a
quality control program for cleaning and disinfection of ﬂexible gastrointesti-
nal endoscopes (FE). A clean endoscope has less than 20CFU per ml ﬂush
water and a risk endoscope has more than 250CFU per ml. A recent
international publication found 39–49% of endoscopes ready for use con-
taminated at high rate (1).
Materials and methods: Three endoscopy units from three hospitals in
Copenhagen Country (KAS) and six units from ﬁve hospitals in Copenhagen
Hospital Corporation (H:S) participated in the program. At least 100 baseline
samples were obtained immediately before an endoscopy from the different
endoscopy units. Risk factors were identiﬁed, procedures for cleaning and
disinfection of the endoscopes were revised and products unsuitable for
cleaning and disinfection of FE were phased out. A continuous quality
control program was established and included sampling before all endoscopies
on a single day per month corresponding to 5–6% of all endoscopies were
performed. Monthly cumulated written performance reports. Interventions
when control limits were exceeded.
Results: Microorganisms isolated from risk FE were found to be either
environmental/staff-related (0.3–0.74% per year) or patient-related (0.0–
0.74% per year). Risk FE decreased from 1.48% in 2001 to 0.4% in 2002
(P¼ 0.01).
Conclusion:
	 High quality manual cleaning is single most important factor.
	 Lack of routine maintenance of washer-disinfectors leads to quality pro-
gram failure.
	 Ineffective disinfectants and detergents have been removed from use.
	 Highest success rates were observed with energetic staff involvement.
Reference:
1. Z. Gastrointerol 2002; 40(3): 157.
P1231 Importance of biomaterial contamination
duration with Staphylococcus epidermidis clinical isolates:
pre- and post-treatment effect of hydrogen peroxide
A. P. Fonseca, R. Lima, P. J. Miranda, A. F. Fonseca, J. A. Nogueira
Porto, P
Introduction: Bacterial bioﬁlms are commonly resistant to antimicrobial
agents. The prevention of bioﬁlm formation involves avoiding the initial
step—adhesion. Hydrogen peroxide (3%) is not toxic to the human organism
and should be tested as a surface treatment to prevent adhesion and growth of
strains isolated from indwelling medical devices associated infections.
Objectives: to study the inﬂuence of biomaterial contamination duration
with S. epidermidis and to assess in a pretreatment and post-treatment approach
the effect of hydrogen peroxide 3%.
Materials andmethods:Ninety-six-well microtiter plates were contaminated
with different strains of Staphylococcus epidermidis (108 cells/mL) – RP62A,
M187 (reference PS/A, þ) RP62Asn, M187sn (PS/A, –) and four clinical
isolates. The contamination was done over 2 and 6 h at 37 8C in saline solution
(0.9%) (1). After contamination, 96-well microtiter plates were rinsed with
saline solution to remove nonadherent bacteria. A modiﬁed microtiter-plate
assay was used as a direct measure of adherence (2). A pre- and post-treatment
with a saline solution and hydrogen peroxide was also assayed.
Results: (Figure 1) A pretreatment with saline (0.9%) solution, when con-
tamination period was 2 h, reduced bacterial adhesion but no reduction was
found with 6 h. In contrast, 3% hydrogen peroxide was always effective,
irrespective of the duration of contamination.
Conclusions:The biomaterials contamination duration signiﬁcantly increases
adhesion values mainly in PS/þstrains. Hydrogen peroxide was more efﬁcient
in prophylactic effect than saline solution after a 2-h contamination. The
effect of saline solution and 3% hydrogen peroxide on adhesion was identical
in all S. epidermidis strains. In post treatment, saline (0.9%) solution had a
visible effect on bacteria disattachment after a 2 and 6 h contamination period,
but its effect was more evident after 2 h contamination, where adhesion values
were almost identical to the values obtained with hydrogen peroxide. The
effectiveness of saline solution was reduced when the contamination period
was prolonged to 6 h. Hydrogen peroxide (3%) was always effective, after 2
and 6 h, like in pretreatment.
Acknowledgement: This study was supported by a research grant from
Fundac¸a˜o Calouste Gulbenkian.
References:
1. Alt et al. Ann. Thorac. Surg. 1999; 68: 2123–8.
2. O’Toole et al. Mol. Microbiol. 2000; 30: 285–93.
Figure 1
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P1232 Relevance of interval between biomaterial
treatment with hydrogen peroxide and contamination with
different strains of Staphylococcus epidermidis
A. P. Fonseca, P. J. Miranda, R. Lima, A. F. Fonseca, J. A. Nogueira
Porto, P
Introduction: Bacterial bioﬁlms are sessile communities to the ability to resist
antimicrobial agents. Prevention of such communities involves avoiding the
ﬁrst step, which is adhesion. Hydrogen peroxide in 3% is not toxic to the
human organism and should be tested in strains isolated from indwelling
medical devices associated infections.
Objectives: To study the inﬂuence of the sequence of disinfection and
contamination as well as of the persistence of hydrogen peroxide effects
on the prevention of bioﬁlm formation.
Materials and methods: 96-well microtiter plates were contaminated with
strains of S. epidermidis (108 cells/mL), RP62A, RP62Asn, M187, M187sn—
that were used like controls—and four clinical isolates. The contaminations
were done over 2 and 6 h at 37 8C in saline (0.9%) solution. After contam-
ination, 96-well plates were rinsed saline solution to remove nonadherent
bacteria. A modiﬁed microtiter-plate assay was used as a direct measure of
adherence (1). The interval between washing with saline (0.9% NaCl)
solution and 3% hydrogen peroxide was prolonged to 16 h (2). In order to
achieve this aim, a wash procedure with saline and hydrogen peroxide solution
was effectuated 16 h before a 2-h/6-h contamination.
Results: There was no protective effect of saline solution for contaminations
longer than 16 h after treatment. There was a diminution on adhesion values,
when the interval between treatment and contamination was null, for a 2-h
contamination period, but it was not valid when the gap becomes 16 h. In
contrast, pretreatment with 3% hydrogen peroxide had diminished adhesion
of all different strains used. Adhesion values were very close to those ones
observed to a null interval between washing and contamination.
Conclusions:Hydrogen peroxide (3%) is effective as a prophylactic treatment
in order to avoid bacterial growth after contamination. Randomized, pro-
spective clinical studies are required to substantiate the importance of in vitro
ﬁndings, as far as these particular clinical S. epidermidis strains of nosocomial
origin are concerned.
Acknowledgement: This study was supported by a research grant from
Fundac¸a˜o Calouste Gulbenkian.
References:
1. O’Toole et al. Mol. Microbiol. 2000; 30: 285–93.
2. Alt et al. Ann. Thorac. Surg. 1999; 68: 2123–8.
P1233 Study of Salmonella contamination of foods in
Isfahan, Iran
M. Jalali, H. Kalantari, K. Gokasian, S. Zia Kashani
Isfahan, IR
Objective: To determine the prevalence of Salmonella on raw and cooked
foods from selected university restaurant.
Methods:Two hundred and sixteen food samples were obtained randomly in
Isfahan University of Medical Sciences between April and June 2002. All were
tested for the presence of Salmonella using enrichment method (Iranian
standard method of isolation of salmonella no. 1081).
Results: Salmonella detected in 21 and 7% of raw and cooked poultry samples,
respectively. On the samples of redmeats 12.5 and 2.7%were contaminated by
Salmonella, respectively. Nine percentage of vegetable were found to be
contaminated by Salmonella. All samples taken from ﬁsh and milk products
were free of Salmonella.
Conclusions: Salmonella spp. are present in a small proportion of cooked foods
and are not killed during cooking process or the contamination may occur
after thermal treatment. These ﬁnding have clear implication for public health
and indicating the needs for improvement of hygienic condition in food
processing centers.
P1234 Evaluation of anti-Toxoplasma gondii antibodies
(IgG and IgM) in sera among the women before marriage in
Urmia city, Iran
M. Taravati, F. Sadegkhalili
Urmia, IR
Introduction: Toxoplasmosis is a zoonosis caused by Toxoplasma gondii, and
obligate intracellular parasite. It is primary host are cats and in man infection
occurs mainly by ingestion of raw or underdone meats and vegetables. The
most signiﬁcant infections in humans are congenital and during ﬁrst semester
of pregnancy cause abortion. Immunologic methods are the most common
way to establish the diagnosis. The aim of this study was to determine the
incidence of IgG and IgM anti-Toxoplasma antibodies in women before
marriage in Urmia city Iran.
Material and methods: Blood of 300 women from urban and rural areas
before marriage were collected. Anti-Toxoplasma IgG and IgM antibodies
were determined from sera by using ELISA and IFA techniques.
Results: Anti-Toxoplasma IgG antibodies were found positive in 98 (32.8%)
and anti-Toxoplasma IgM antibodies were found positive in 12 (4%) of these
samples by ELISA method. The same samples were examined by using
indirect IFA technique. The IgG titer in 65 samples was 1/400, 13 samples
1/800, 12 samples 1/1600 and four samples 1/3200 and four samples showed
negative results.
Discussion: The positive results were indicated 4% of these women suffer
from acute Toxoplasmosis and 28.8% of women suffer from subacute or
chronic Toxoplasmosis. There were not statistical signiﬁcant differences
between those from rural and urban areas. As a result, the control of disease
in both area is recommended. The details will be discussed at the con-
ference.
P1235 Immunology, epidemiology and prognosis of
tetanus: a retrospective study
M. Parlak, M. Ertek
Erzurum, TR
Objectives: Tetanus is a toxi-infectious disease which can be prevented by
vaccination, having high mortality, and the follow-up and treatment of which
requires hard work. The aim of this study is to investigated retrospectively in
view of epidemiologic features, immunization history, clinical features,
prognosis and treatment.
Methods: Forty-seven patients, 46 generalized and one localized, who were
followed-up and treated with the diagnosis of tetanus between January 1985
and December 2002 in Infectious Diseases Clinic, Faculty of Medicine,
Atatu¨rk University, were investigated retrospectively. The data concerning
the patients were obtained through the investigation of the ﬁles. The places
where the patients lived, their occupations, age, set, immunization history,
infection site and the type of injury, the prophylactic approach after injury,
incubation period of the disease, clinical features, prognosis and treatment
applications were recorded.
Results: Forty-four (94%) of the cases, 31 male and 16 female were from rural
areas. The rate of men (66%) was approximately twofold than the rate of
woman. Fifty-four percentage were over 50 years old. Fifty-four had minor
injuries. Appropriate tetanus prophylaxis had not been given to nine of the
cases who applied to health centers after injury. Average incubation period
was 11.1 days, and the most common symptom and ﬁnding was difﬁculty in
swallowing and trismus. Mortality was 40.4%, and the most features that
affected prognosis were age and incubation period. The difference of
mortality between men and woman was not signiﬁcant (z¼ 0.27, P¼ 0.39).
Conclusions: The result showed that adult immunization against tetanus was
not adequate in the east of Turkey, especially in rural areas, and health
personnel do not perform adequate immunization after tetanus-prone inju-
ries. We believe that application of adult immunization programme and
training of health personnel in applying adequate prophylaxis protocols will
decrease tetanus incidence.
P1236 Etiology and incidence of halitosis in Latvia
D. Rostoka, J. Kroica, V. Kuznecova, R. Treimane, A. Reinis
Riga, LV
Objectives: Oral bacteria hydrolyze proteins and further degrade the amino
acids, which leads to halitosis, commonly referred to as bad breath. Halitosis is
a frequent problem in Latvia. The goal of our investigation was to state
etiology, diagnostic and treatment methods of halitosis.
Methods:The recent investigation began in 1997 and included 578 patients of
dental multidisciplinary outpatient department. A detailed patient’s ques-
tionnaire was prepared. It covered questions about the use of antibiotics and
other medicine, affecting the quality and quantity of saliva, as well as questions
concerning smoking, the use of alcohol, etc. The oral odor or bad breath was
conﬁrmed by the measurements made by the halimeter (Interscan Corpora-
tion, Model RH-17E USA). The halimeter quantiﬁes breath measurements
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in parts per billion (p.p.b.) of volatile sulfur compounds (VSC). The obtained
results were compared with dental (DMF index) and periodontal (PMA,
CPITN indexes) conditions.
Results: The measurements of the halimeter correlated with the clinical
assessment of breath odor, the degree of tongue coating and the depth of the
gingival pockets. 578 patients were examined. It was determined that the
main cause of halitosis is oral pathology (89%). From which 53% were
observed due to the tongue coating. It was concluded from the patient’s
questionnaire that increased level of tongue coating is due to a short-term or
frequent use of antibiotics. 39% of oral pathology derives from periodontal
diseases (severe periodontal diseases—periodontitis, 31% and gingivitis, 8%.).
In remaining 8%, a complex oral pathologies were diagnosed—tongue
coating and gingivitis, tongue coating and periodontitis. The halimetric
measurements of patients of this group showed a higher amount of VSC,
in addition, the duration of the preceding therapy of these patients was longer.
Conclusions: The results of the recent examination leads to following
conclusions: halitosis in Latvia is mainly connected with oral pathology;
halitosis can be diagnosed using different methods (especially halimetric
examinations) and can be treated successfully; protein degradation in oral
cavity and increased amount of VSC is closely connected with the changes of
oral microﬂora (with a prevalence of oral anerobes), this leads to different
periodontal diseases, which are rather common in Latvia.
Antituberculosis chemotherapy and susceptibility testing
P1237 Determination of Mycobacterium tuberculosis
drug sensitivity in Mazandaran province health center in
2002
M. Ahanjan, M. Nasrolahei, M. Vahedi
Sari, IR
Objectives: Tuberculosis (TB) is one of the most important infectious disease
and the main cause of mortality in the developing countries. There have been
educational program in order to prevent it, not only has not been eradicated in
the recent years, but also has an increasing rate in the HIV patients. Drug
resistant leads to failure in treatment which is followed by unaffordable
expenses. Hence, study on the drug sensitivity of such organism provides
guideline on the pattern of epidemiology study, as a result help reduce the
episode of drug resistant species in the society.
Materials and methods: Sputums from the individuals referring to health
center suspected of having TB were collected in sterile containers, decontam-
inated by PETROPH method and contracted, then inoculated on to the
Levenson jansons medium and incubated at 37 8C for 4weeks. Smears were
prepared from the collected samples zeihl neelson staining was performed and
looked for the presence of mycobacterium. Culture media were observed for
the growth ofMycobacterium tuberculosis (TB). The culture positive plates were
sent toMasih daneshvari TB center in Tehran, to be conﬁrmed for the growth
of TB and doing antibiogram.
Results: In this study, on 45 TB growth cultures, drug sensitivity was done for
four essential drugs that is isoniazid (INH), refampin (Ref), ethambotol (Eth)
and stereptomycin (ST) which are used against TB. The pattern of sensitivity
from 45 samples are as follows: Eth 44 samples sensitive and 1 sample resistant
(2.2%), INH 40 samples sensitive and 5 resistant (11%), Ref 43 samples
sensitive and 2 resistant (4.4%), ST 31 samples sensitive and 14 resistant (31%)
and was separately 4 to 1, and combined resistant to two drugs that is INH and
ST 2 samples and to three drugs that is to INH and Eth and ST 1 sample.
Conclusion:The results of this study indicate that, resistant to Eth, INH, Ref
and ST is 2.2, 11, 4.4 and 31%, respectively, which reveals an increasing
pattern of TB drug resistant. Hence, increase in educational training of the
physicians and paramedical personals for the proper short course treatment and
implementation of directly observed treatment short course (Dots) strategy
considered as prior issue is proposed. Also determining of drug sensitivity
which is not common in our country is recommended in order to prevent the
recurrent of the disease and failure of treatment.
P1238 Investigation of susceptibilities to primer
antituberculous agents of Mycobacterium tuberculosis
complex strains isolated in Manisa, Turkey
S. Surucuoglu, N. Ozkutuk, S. Kurutepe, K. Degerli, H. Gazi,
B. Ozbakkaloglu
Manisa, TR
Objective: In this study, we aimed to investigate the susceptibilities of
Mycobacterium tuberculosis complex isolates in Manisa region to isoniazid,
rifampicin, streptomycin and ethambutol.
Methods: One hundred and twenty-nine strains which were isolated from
respiratory system specimens between 1997 and 2002 were evaluated in Celal
Bayar University Faculty of Medicine, Mycobacteriology Laboratory. BAC-
TEC radiometric method and indirect proportional method in Lowenstein
Jensen medium were used for testing the susceptibilities.
Results: Eighty-eight strains (68.2%) were susceptible to all tested agents, and
the resistance rates of streptomycin, isoniazid, rifampicin and ethambutol
were found as 20.2, 17.1, 12.4 and 7%, respectively. The strains which were
resistant to at least one agent, two agents and three agents were determined as
17.8, 6.2 and 4.7%, respectively. The rate of resistance to all agents was also
3.1%. Multiple drug resistance was found in 11 strains (8.5%). Although it was
not found to be statistically signiﬁcant, it was determined that the frequency of
rate rifampicin resistance and multiple drug resistance was increasing by years.
There was an increasing rate of rifampicin and multidrug resistance year by
year, although not statistically signiﬁcant.
Conclusions: The determination of increased rate of rifampicin and multiple
drug resistance should led us to use reliable and rapid methods in evaluating
the susceptibility rates of antituberculous agents.
P1239 Early bactericidal activity and efﬁcacy of
moxiﬂoxacin vs. isoniazid in the treatment of acute
pulmonary tuberculosis—a prospective, randomized study
M. W. R. Pletz, A. De Roux, A. Roth, K. Neumann, H. Mauch,
H. Lode
Berlin, D
Objective: In several in vitro studies Moxiﬂoxacin was demonstrated to be the
currently most active ﬂuorquinolone against Mycobacterium tuberculosis (Mtb).
However, data about the efﬁcacy in patients are not yet available. The decrease
of colony-forming units (cfu) of Mtb in sputum and the early bactericidal
activity (EBA) of Moxiﬂoxacin were compared with those of INH in a
prospective, open, randomised, monocentric study.
Methods: Fourteen adult, not immunocompromised patients with an active,
smear positive, pulmonary tuberculosis were treated with either Moxiﬂoxacin
(400mg/day; MOX, n¼ 7) or Isoniazid (5mg/kg body weight; INH, n¼ 7)
for 5 days and followed by a standard therapeutic regimen. EBAwas deﬁned as
the fall in log counts cfu/mL sputum/24 h during the ﬁrst 2 days.
Results: After 5 days a signiﬁcant decrease of median values of CFU/mL was
detected in both groups (INH: day 1¼ 9.9 106/mL, day 6¼ 0.58 106/
mL, P¼ 0.043; MOX: day 1¼ 8.2 106/mL, day 6¼ 0.60 106/mL,
P¼ 0.046). There was no signiﬁcant difference between both groups regard-
ing the EBA (MOX¼ 0.453, INH¼ 0.598). The overall tolerance of study
medication in both groups was good.
Conclusion:According to the limited data of our study Moxiﬂoxacin exhibits
an in vivo efﬁcacy that is almost comparable to that of INH.
P1240 Evaluation of second-line antitubercular drugs
for Mycobacterium tuberculosis using the BacT Alert 3D
system
D. Nair, S. Verma, L. Srivastava, N. Mohanty, S. Nagarajan, P. Aggarwal
New Delhi, IND
Objectives: (a) Isolate and identify isolates of Mycobacterium tuberculosis from
pulmonary and extra pulmonary specimens using routine culture media and
the BacT Alert 3D System. (b) Perform antimicrobial susceptibility testing
using ﬁrst and second line antitubercular drugs.
Material and methods: One hundred isolates of M. tuberculosis recovered
from pulmonary and extra pulmonary specimens were studied. These were
subjected to antibiotic susceptibility testing using the BacT Alert 3D System
(bioMerieux, France); the results were reconﬁrmed using the E-strip method.
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The following antimicrobials were tested: First Line: streptomycin, isoniazid,
rifampcin, ethambutol, pyrazinamide. Second line: ethionamide, ciproﬂox-
acin, oﬂoxacin, amikacin, capreomycin and kanamycin.
Results:Combined resistance to isoniazid and rifampicin (Multi Drug Resis-
tance) was observed in 11 (11%) isolates. Single drug resistance was seen in 63
(63%) of the Mycobacteria. Isoniazid resistance was observed to be the
commonest, followed by ethambutol, streptomycin, rifampcin and pyrazi-
namide. Quinolones and amikacin were found to be the most effective agents,
followed by kanamycin and capreomycin. The tubercle bacilli recovered from
extra pulmonary sites were found to be more sensitive than the pulmonary
isolates.
Conclusions: (i) It was observed that multi drug resistant strains are being
increasingly isolated from lesser developed nations, especially from the urban
areas. (ii) The isolates are showing resistance to the commonly employed
second line antitubercular drugs. Resistance to second line drugs has not been
well documented previously. With the raging triple epidemic of HIV, STD
and TB, this fact could have far reaching consequences.
P1241 Determination of the susceptibilities to
major antituberculous drugs by E-test method of
45 Mycobacterium tuberculosis isolated from
cerebrospinal ﬂuid
F. Yildirim, G. Sengoz, D. Berzeg, S. Elmi, O. Nazlican
Istanbul, TR
Objective: Tuberculosis keeps its importance since it has an increasing
frequency in the society besides its increasing resistance rates. Tuberculous
meningitis is one of the most serious forms of this disease. In this study, we
aimed to examine the susceptibility of Mycobacterium tuberculosis strains,
isolated from cerebrospinal ﬂuids of patients with tuberculous meningitis,
to four major drugs.
Methods: 1515 CSF specimens were sent to our laboratory through the years
1992–2002. 142 of them had a growth on Lowenstein-Jensen medium. For
the detection of the species; niacin test, nitrite test, catalase test, catalase test
after heating to 68 8C had been held. TheMICs of 45M tuberculosis strains for
isoniazid (INH), rifampicin (RIF), ethambutol (ETB) and streptomycin (SM)
were determined by E-test method.
Result:TheMIC values of the examined strains reﬂect that the resistance rates
are very low. The MIC 90 values for INH, RF, ETB and SM were detected as
0.016, 0.016, 0.023 and 0.125mg/mL, respectively. In one case, resistance to
four antituberculous drugs has been detected. There was no other resistant
strain.
Conclusion:Although the resistance rates isolated from CSF have been found
to be low, since tuberculosis meningitis is threatening public health and the
resistance rates are increasing in years, antibiotic susceptibility tests should be
studied for all strains.
P1242 A general view for resistance problem: the MIC
values of 215 Mycobacterium spp. against major
antituberculous agents by E-test
G. Sengoz, F. Yildirim, O. Nazlican
Istanbul, TR
Objective: Among the materials that were sent to Istanbul Haseki Education
and Research Hospital microbiology laboratory, 215 acid-fast bacilli isolated
from Lowenstein-Jensen medium were deﬁned as Mycobacterium tuberculosis
and were investigated for their antituberculous sensitivity.
Methods: Sputum, cerebrospinal ﬂuid and abscess constituted most of the
materials. Abscess had the highest growth rate with a percentage of 16%.MIC
values were examined with E-test method for isoniazid, rifampicin, etham-
butol and streptomycin in Middle Brook medium.
Result: The resistance ratios for the species were found to be very low. The
MIC 90 ratios for isoniazid, rifampicin, ethambutol and streptomycin were
found to be 0.016, 0.016, 0.032 and 0.064mg/mL, respectively, implying
sensitivity. The resistance rates for isoniazid and ethambutol were found
2.33% whereas for rifampicin and streptomycin were 1.86%. The resistant
strains were mostly isolated from sputum and CSF. The resistance for the all
four antituberculous drugs were found in only two patients.
Conclusion: Resistance researches have to be carried out for all species to
continue the ﬁght against tuberculosis that still threatens the public health
seriously even in today’s world.
P1243 Comparison of Dio-TK and Lo¨wenstein-Jensen
media in antimycobacterial susceptibility testing for
Mycobacterium tuberculosis by using the proportion
method
C. Bicmen, G. Senol, M. Coskun, N. Florat, T. Kocagoz
Izmir, Istanbul, TR
Objective: To evaluate Dio-TK Medium in antimycobacterial drug suscep-
tibility testing forM. tuberculosis strains in comparison with Lo¨wenstein-Jensen
(L-J) medium.
Methods: A total of 78 M. tuberculosis recovered from the positive cultures
of 69 patients were taken into the study. Bacterial suspension(100 mL) was
inoculated in Dio-TK Medium, Dio-TK INH (Isoniazid 0.2 and 1mg/mL),
Dio-TK RIF (Rifampicin 1 mg/mL), Dio-TK ETB (Ethambutol 15 mg/mL)
and Dio-TK STR (Streptomycin 2 mg/mL). Growth and resistance on
Dio-TK Medium was monitored and evaluated with the color change from
red to yellow due to the indicator in the medium by the automated incubator
reader Dio-TK Scan and presence of acid-fast bacteria on the medium by
staining. 10–2 dilutions of suspension were inoculated into L-J medium and
L-J media with drugs (INH 0.2 and 1 mg/mL, RIF 40 mg/mL, ETB 2 mg/mL,
STR 4 mg/mL). If the ratio of growth (cfu) in the media including drug to the
growth in the media without drug was higher than 1%, the strain was accepted
as resistant.
Results:Resistance ratios for INH, RIF, ETB, STR in Dio-TKmediumwere
24.6, 22.6, 22.9 and 21%, whereas; ratios in L-J medium were 18.3, 15.6, 11
and 16.6%, respectively. Contamination ratios of Dio-TK with INH, RIF,
ETB and STR were 5, 3.8, 5 and 3.8%; whereas ratios in L-J were 16.6, 11.5,
11.5 and 12.8%, respectively. All the isolates susceptible to four drugs in Dio-
TK were also susceptible in L-J. Five of the specimens from patients did not
grow in L-J medium, therefore drug susceptibilities of those only were studied
in Dio-TKMedium. Two of these isolates were resistant to all four drugs, one
was susceptible to all drugs and the other two were resistant to RIF and ETB
together. Mean time of growth for Dio-TK and L-J were 10.6 (minimum 4,
maximum 20) and 20 (min.15, max. 25) days, respectively.
Conclusions: Dio-TK Medium is a rapid and practical medium and may be
very beneﬁcial in obtaining antimycobacterial susceptibility testing results
early. The concentration of some antituberculosis drugs may require mod-
iﬁcations for a better concordance with classical tests.
P1244 Susceptibility patterns of Mycobacterium spp.
isolated in a teaching hospital in Madrid during a 3-year
period (2000–2002)
M. Abanades, D. Domingo, J. Garcia, J. Diaz-Regan˜on, E. Escudero,
M. Serrano, M. Lopez-Brea
Madrid, E
Objective: The aim of this work was to study the susceptibility patterns of
Mycobacterium spp. to the antimicrobials most frequently used in their treat-
ment, isolated in the Hospital Universitario de La Princesa in the period of
2000–2002.
Methods: A total of 146 clinical isolates were included in this study: 130
M. tuberculosis (105 from respiratory samples and 25 from non respiratory), 4
M. avium complex (MAC), 9 rapidly growing mycobacteria (4 M. fortuitum,
4M. chelonae, and 1M. abscessus) and 3M. kansasii. Identiﬁcation was obtained
by a DNA probe (Accuprobe, Gen Probe) forM. tuberculosis andMAC and the
rest were identiﬁed in a Reference Mycobacterial Laboratory. Susceptibility
testing was performed by SIRE (Becton Dickinson), a ﬂuorescent, non
radiometric mycobacterial broth system in the case of M. tuberculosis, Radio-
metric BACTEC TB 460 (Becton Dickinson) for MAC and M. kansasii and
broth microdilution for rapidly growing mycobacteria. Antimicrobial agents
studied were: streptomycin, isoniazid, rifampin, ethambutol and pyracina-
mide for M. tuberculosis and M. kansasii, macrolides, quinolones, aminoglico-
sides and tetracycline for rapidly growing mycobacteria and rifabutin was
added for MAC.
Results: Those related to M. tuberculosis were as follows: 16 (12.3%), 7
(5.38%), 3 (2.3%) and 5 (3.8%) were resistant to streptomycin, isoniazid,
rifampin and ethambutol, respectively. All the isolates tested (21) were
susceptible to pyracinamide. Three (2.3%) strains were resistant to both
streptomycin and isoniazid, 2 (1.5%) to isoniazid plus rifampin, 1 (0.7%)
to streptomycin plus ethambutol and 1 (0.7%) isolate was resistant to all drugs.
3 out of 4 (75%) MAC strains were resistant to oﬂoxacin and clarithromycin
and 2 (50%) were resistant to both. All of them were susceptible to rifabutin.
296 Abstracts
Rapidly growing mycobacteria showed the following susceptibility pattern:
55.5% resistance to ciproﬂoxacin, 33.3% to clarithromycin, 78% to doxici-
cline and 12.5 to amikacin. All M. kansasii were susceptible to rifampin and
ethambutol and resistant to streptomycin and isoniazid.
Conclusion:We did not ﬁnd an important number of multidrugM. tuberculosis
strains. According to the variability in the susceptibility pattern of rapidly
growing mycobacteria, susceptibility test should be performed when these
mycobacteria are related with clinical signiﬁcance.
P1245 Susceptibility testing of Mycobacterium
tuberculosis by ﬂow cytometry
S. Costa-de-Oliveira, C. Pina-Vaz, A. G. Rodrigues, C. B. Tavares,
T. Carvalho
Porto, P
Background: Mycobacterium tuberculosis is a re-emerging agent and represents
an important cause of human disease. The detection of multidrug resistance in
clinical strains urged the effort to develop rapid tests to detect susceptibility
patterns. Cytometric methods show great potentialities in the area of Micro-
biology, by giving faster and accurate results than classical susceptibility
methods.
Objective: To determine the susceptibility of Mycobacterium using the ﬂuor-
escent probe SYTO 16 and ﬂow cytometry, comparing to culture with BD
BACTEC MGIT 960 system protocol (Becton Dickinson Company, Mary-
land, USA).
Material and methods: Eight strains of M. tuberculosis belonging to a Portu-
guese multicentric quality control program were studied using BD BACTEC
MGIT 960 protocol. They were classiﬁed as sensitive, intermediate and
resistant to four drugs: ethambutol, isoniazid, rifampicin and streptomycin
(SIRE). In this study, we performed incubation of the strains in MGIT tubes,
using SIRE kits (BD), in duplicate. One set was incubated during 72 h at
37 8Cwhile the other followed the BACTECMGIT protocol (10–14 days of
incubation). Following incubation, both sets of MGIT tubes were autoclaved,
to assume microbiologic safety of the cytometric study, and stained with
10 mMof SYTO 16 (molecular probes), a ﬂuorescent nucleic acid stain during
30min. A ratio between the number of microbial cells with ﬂuorescence and
the control (cells not exposed to drug) was calculated. Sensitivity represents a
strain showing a ratio <1 (meaning a reduction of cells on drug tube in
comparison with control). Intermediate strains present a ratio 1 at the
highest concentration of the drug and <1 at the lowest concentration.
Resistant strains show a ratio 1, both with low and high concentrations.
A control of contamination was performed by staining the cells in each tube
with propidium iodide (PI) 1 mg/mL, for 30min (Sigma).
Results:The results of the cytometric methodwere equivalent, both after 72 h
or 10–14 days incubation. The agreement between cytometric methods and
BACTEC 960 protocol was 100%. The extent of contamination was similar
in both methods, being revealed in cytometry by the fact that only microbial
cells, other than Mycobacterium stained by PI.
Conclusion: The ﬂow cytometric assay described is a safe, fast, simple and
reproducible assay to be used in sensitivity testing of M. tuberculosis.
P1246 Real-time PCR assay for detection of MDR
Mycobacterium tuberculosis
F. Meacci, G. Orru, S. Vicidomini, M. R. Oggioni, G. Pozzi
Siena, I
Background: The emergence of multidrug resistant strains of Mycobacterium
tuberculosis (MDR-TB) strengthens the need for routine determination of
drug susceptibility of clinical isolates in order to establish an efﬁcient thera-
peutic treatment of the patient. The traditional methods for susceptibility
testing in mycobacteria rely on culture-based techniques, which are extremely
time consuming due to the low growth rate of the microrganism.
Objectives: To set up a molecular assay able to rapidly detect the mutations
most frequently associated to the drug resistance to isoniazid and rifampin in
M. tuberculosis.
Methods: Hybridization Probes were designed to differentiate wild type
codons from mutated ones, in real time PCR. Two different PCR assays were
set up, one for the detection of Isoniazid resistance and the other one for
rifampin resistance. Target genes were katG and rpoB. Probes were designed
on those codons shown to be mutated in a molecular epidemiology study on
Italian MDR-TB isolates. Probes were validated on a collection of 53 Italian
MDR-TB isolates.
Results: The association of both PCR reactions allows us to identify resistant
alleles in 94.2% of MDR-TB strains (49/53).
Conclusion:Real-time PCR based on the hybridization probes is a rapid and
reliable system to perform a molecular antibiogram in M. tuberculosis MDR
strains. The source for the susceptibility test may be either a smear positive
specimen or a positive primary culture. This molecular assay permits to obtain
a preliminary and essential information on drug susceptibility of the isolate
within few hours from the specimen collection, while about 4–6weeks are
necessary for culture based determination of resistance.
P1247 A 10-year monitoring of in vitro antimicrobial
susceptibility levels of Mycobacterium xenopi as an agent of
HIV-associated vs. non-HIV-associated disease
R. Manfredi, A. Nanetti, S. Morelli, M. Ferri, R. Valentini, L. Calza,
F. Chiodo
Bologna, I
Objective: Aim of our study is to assess the epidemiology and in vitro
susceptibility of 35 consecutive Mycobacterium xenopi strains responsible for
conﬁrmed disease at a reference centre in the decade 1993–2002, and to
identify differences between the in vitro sensitivity of the 17 strains isolated
from 14 patients with HIV disease, and the 18 isolates cultured from 18 non-
HIV-infected patients.
Results: Compared with non-HIV-infected patients, HIVþ patients had a
lower mean age (P< 0.0001) and a tendency to develop long-term relapses
(P¼ 0.06). Gender distribution and M. xenopi disease site did not show
differences between the two study groups. Lower airways accounted for
88.6% of cases, but a prominent inﬂammatory reaction recently emerged in
HIV-infected patients favorably treated with HAART, raising the role of the
rapid immune recovery in the pathomorphism of this opportunistic disease.
The greatest in vitro sensitivity rate was registered by capreomycin and
protionamide (100% of strains), followed by kanamicin (96.6%), while
susceptibility rates for the usual 1st-line compounds like ethambutol, isoniazid
and rifampicin were slightly lower (86–91%). No temporal variation in
susceptibility was seen over the study decade, while non-HIV-infected
patients had a higher frequency ofM. xenopi isolates resistant to>1 compound
(P< 0.03), versus HIV-associated episodes, despite the heavy and prolonged
exposure of HIV-infected patients to antimicrobials, including agents acting
on mycobacteria. When considering the different antimycobacterial com-
pounds, resistance proved slightly more frequent among non-HIV-infected
patients. Only oneHIV-positive patient became rifampicin-resistant in his 3rd
relapse.
Conclusion: Diagnostic difﬁculties due to late identiﬁcation and concurrent
opportunism, add to therapeutic problems due to a unpredictable sensitivity
pattern of atypical mycobacteria, such as M. xenopi. Surprisingly, 2nd-line
antimycobacterial compounds (capreomycin, protionamide and kanamicin),
demonstrated a slightly greater activity than 1st-line drugs recommended for
M. xenopi infection (ethambutol, isoniazid, rifampicin-rifabutin, and strep-
tomycin). A rapid identiﬁcation, a reliable differentiation between coloniza-
tion and disease, and treatment choice for atypical mycobacteriosis, are still
unresolved issues for clinicians and bacteriologists treating immunocompro-
mised patients. The emerging resistance to traditional antimycobacterial
agents warrants extensive studies with promising agents (macrolides, quino-
lones), while also older drugs may act favorably.
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Streptococcus pneumoniae
P1248 Comparative activities of beta-lactam antibiotics
and quinolones for invasive Streptococcus pneumoniae
isolates
S. O¨ncu¨, M. Punar, H. Eraksoy
Aydin, Istanbul, TR
Objectives: Streptococcus pneumoniae is a leading pathogen causing pneumonia,
meningitis, otitis media, bacteremia, sinusitis and a signiﬁcant cause of
morbidity and mortality. The rapid emergence of penicillin nonsusceptible
and multidrug resistance strains of S. pneumoniae has encouraged the devel-
opment of new antimicrobial agents such as quinolones with increased activity
against S. pneumoniae. In this study, we examined in vitro activities of ﬁve
quinolones in comparison with other antibiotics for 85 invasive pneumo-
coccal isolates (derived from bacteremia, pneumoniae and meningitis cases
between January 2000 and December 2001) collected in the hospital of
Istanbul Medical Faculty.
Methods: MICs of penicillin G, cefuroxime, azithromycin, clarithromycin,
trimethoprim-sulfamethoxazole (SXT), ciproﬂoxacin, oﬂoxacin, levoﬂoxa-
cin, trovaﬂoxacin and gemiﬂoxacin were determined by the NCCLS recom-
meded broth microdilution testing method in Mueller-Hinton broth
supplemented with 2% freeze-thaw lysed horse blood with an inoculum
of approximately 105 cfu/mL.
Results: The overall rates of resistance to penicillin (46%), cefuroxime (20%),
azithromycin (20%), clarithromycin (18%) and SXT (46%) were considerable.
Among all of the isolates, nine isolates (11%) were highly resistant (MIC, ‘’d
2mg/L) and 30 isolates (35%) had intermediate resistance (MIC, 0.12–1.0mg/
L). Of the ﬂuoroquinolones investigated for their activity against S. pneumoniae,
gemiﬂoxacin (MIC90¼ 0.12mg/L) and trovaﬂoxacin (MIC90¼ 0.12mg/L)
had the highest activity. These values were three dilutions lower than those
obtained with levoﬂoxacin (MIC90¼ 1mg/L), four dilutions lower than those
obtained with oﬂoxacin (MIC90¼ 2mg/L) and ciproﬂoxacin (MIC90¼
2mg/L). Status of penicillin resistance apparently did not have any affect in
the quinolone resistance of the isolates.
Conclusion: The new ﬂuoroquinolones show great potential for treating
infections caused by penicillin-resistant pneumococci. Resistance to macro-
lides and to another beta-lactam antibiotic, cefuroxime, was more often found
among penicillin-resistant isolates. This observation limits the value of these
antibiotics for empirical treatment of pneumococcal infections in geographic
areas where penicillin-resistant S. pneumoniae are widespread. The broad-
spectrum antimicrobial activity of these new quinolones indicates these
compounds may be useful in the empirical treatment of pneumococcal
infections.
P1249 Penicillin-nonsusceptible Streptococcus
pneumoniae in Europe and worldwide: susceptibility
to amoxicillin/clavulanic acid, including a new
pharmacokinetically enhanced formulation, in 2001.
The Alexander Project
D. Felmingham, M. Jacobs, P. Appelbaum
London, UK; Cleveland, Hershey, USA
Objectives: The Alexander Project is a prospective surveillance study of
antimicrobial susceptibility. Susceptibility of penicillin-nonsusceptible Strepto-
coccus pneumoniae (PNSP) to amoxicillin/clavulanic acid (AMX/CA) at the
NCCLS breakpoint (2mg/L, susceptible) was assessed. A susceptible phar-
macokinetic/pharmacodynamic (PK/PD)-based breakpoint of 4mg/L for a
new, pharmacokinetically enhanced formulation of AMX/CA (2000/125mg
BID) has been proposed; susceptibility at this breakpoint was also determined.
Methods: Respiratory isolates were collected from centres worldwide in
2001. MICs and susceptibility to AMX/CA for isolates of S. pneumoniae
determined to be penicillin-nonsusceptible (penicillin MICs 0.12mg/L)
were determined according to NCCLS methodology and breakpoint
(AMX/CA susceptible breakpoint 2mg/L). Susceptibility to AMX/CA
2000/125mg BID was also determined at a PK/PD-based breakpoint of
4mg/L.
Results: Percentage susceptibility for isolates collected in Europe and world-
wide is given in the table.
Susceptibility to AMX/CA at a breakpoint of2mg/L (conventional formu-
lations) among isolates of PNSP was below 90.0% in Europe and worldwide
in 2001. Using the proposed PK/PD-based breakpoint of 4mg/L for the
new formulation, however, susceptibility was above 93.0% in Europe and
worldwide.
Conclusions:The new pharmacokinetically enhanced formulation of AMX/
CA has an extended time above MIC, which supports the use of the proposed
breakpoint of 4mg/L, and may therefore be a useful option for empiric
treatment of respiratory infection in areas where PNSP are prevalent, and
where susceptibility to conventional AMX/CA has decreased.
P1250 Decreasing Streptococcus pneumoniae
susceptibility tomacrolides in ﬁve European
countries: the Alexander Project
D. Felmingham
London, UK
Objectives: The Alexander Project is a prospective surveillance study of
respiratory pathogen susceptibility to antimicrobials. Trends in Streptococcus
pneumoniae susceptibility to macrolides over 10 years in ﬁve European coun-
tries were analyzed.
Methods: Isolates were collected from centers in France, Germany, Italy,
Spain and the UK annually in 1992–2001. S. pneumoniae MICs and suscep-
tibility to erythromycin (ERY), clarithromycin (CLA) and azithromycin
(AZI) were determined using NCCLS methods (ERY, CLA susceptible
breakpoint 0.25mg/L; AZI susceptible breakpoint 0.5mg/L).
Results: Percentage susceptibility to ERY for each year and country are given
in the table.
All ﬁve countries showed a decrease in S. pneumoniae susceptibility to all
macrolides tested over the 10-year period. In 1992, only France hadmacrolide
susceptibility rates below 90%. By 2001, macrolide susceptibility in all
countries but Germany had fallen below 90%, with the greatest decrease
in susceptibility seen in Italy. Of isolates that were resistant to erythromycin in
2001, 94.6% (88/93) (France), 81.8% (9/11) (Germany), 75.7% (28/37)
(Italy), 100% (28/28) (Spain) and 50% (5/10) (UK) were also resistant to
clindamycin.
Conclusions: In all ﬁve European countries studied, there was a trend towards
decreased susceptibility of S. pneumoniae to all macrolides tested from 1992 to
2001. ERY cross-resistance with clindamycin seen in 2001 indicates that the
majority of isolates possess the MLS(B) phenotype. Combined with a down-
ward trend in susceptibility, this suggests that the effectiveness of macrolides in
the clinical setting may be limited, and this should be taken into account when
making prescribing decisions to optimize treatment outcomes. Continuing
surveillance is needed to monitor further changes in respiratory pathogen
susceptibility.
%PNSP susceptible to AMX/CA in 2001 (n/N)
Europe Worldwide
2mg/L 4mg/L 2mg/L 4mg/L
88.5 (246/278) 93.5 (260/278) 88.4 (733/829) 94.3 (782/829)
Country
% susceptible
1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
France 74.0 65.3 56.1 60.9 59.4 54.1 57.1 43.9 41.4 43.6
Germany 99.0 100 93.9 97.3 97.3 93.5 94.3 93.7 91.7 91.2
Italy 98.6 95.1 84.8 81.0 75.9 70.2 58.0 68.6 67.6 64.1
Spain 90.0 87.1 74.8 74.0 80.9 67.4 80.6 64.8 71.3 73.6
UK 97.6 96.7 98.0 94.4 86.4 92.8 82.4 90.7 88.7 88.5
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P1251 Trends in single or multiple antimicrobial
resistance phenotypes among Streptococcus pneumoniae
collected worldwide: 1999–2002
M. Jones, R. Blosser-Middleton, J. Karlowsky, C. Thornsberry, D. Sahm
Hilversum, NL; Herndon, USA
Objectives: Multidrug-resistant (MDR) S. pneumoniae (SP) are associated
with increased patient and hospital costs, higher patient mortality rates,
and fewer therapeutic choices for physicians. MDR phenotypes are becoming
more prevalent, and continued surveillance is necessary to monitor changes in
MDR as they occur.
Methods: In 1999–2000 (n¼ 4951) and 2001–2002 (n¼ 5742), SP were
isolated at hospitals in 12 countries and tested by broth microdilution against
penicillin (PEN), levoﬂoxacin (LEV), azithromycin (AZI), ceftriaxone, tri-
methoprim-sulfamethoxazole (TMP-SMX), and comparator agents.
Results:Globally, there was no signiﬁcant change (0.4% decrease; P¼ 0.608)
in the prevalence of single drug resistance between 1999 and 2000 and 2000–
2001. There were signiﬁcant changes in the prevalences of pan-susceptibility
(3.0% increase; P¼ 0.002) and 2 drug resistance (DR) (2.2% decrease;
P< 0.001). MDR was present in 618 (10.8%) SP collected during 2001–
2002 and 552 (11.1%) SP collected in 1999–2000 (0.4% decrease; P¼ 0.523).
LEV R was present in 4.7% of the MDR isolates compared with 4.2% in
1999–2000 (P¼ 0.764). AZI R as a component of MDR increased between
1999 and 2000 (90.3%) and 2001–2002 (94.6%), although not signiﬁcantly
(P¼ 0.599). TMP-SMX R as a component of MDR decreased 1.1%
(P¼ 0.400) between 1999 and 2000 (100%) and 2001–2002 (98.9%). By
country, the prevalence of MDR SP ranged from 0.4% in Germany to 50.9%
in South Korea. The largest increase in MDR (23.2%) from 1999 to 2000
occurred in Hong Kong, due to an increase in AZI R. In Thailand, the
prevalence of 2 DR and MDR both showed an increase (2.7 and 8.5%,
respectively), also attributed to increased AZI R. South Korea showed a
decrease in both 2 DR and MDR (4.3 and 7.2%, respectively) due to a
decrease in TMP-SMX R.
Conclusion: Despite an increase in the number of pan-susceptible isolates,
MDR continued to be a signiﬁcant problem in some countries, exceeding
20%. LEV susceptibility, as a marker for other respiratory ﬂuoroquinolones,
remained high and least associated with MDR SP compared with other
antimicrobial classes.
P1252 Correlations in antimicrobial resistance among
Streptococcus pneumoniae and Haemophilus inﬂuenzae:
2001–2002 international surveillance
R. Blosser-Middleton, C. Thornsberry, J. Karlowsky, D. Sahm, M. Jones
Herndon, USA; Hilversum, NL
Objectives: Antimicrobial resistance (R) rates to commonly prescribed agents
such as beta-lactams, macrolides and trimethoprim-sulfamethoxazole (TMP-
SMX) forStreptococcus pneumoniae (SP) andH. inﬂuenzae (HI) canvary by region.
We analyzed correlations in R among SP and HI from different countries to
determine if R rates to selected agents varied in unison for the two species.
Methods: During 2001–2002, 5926 SP and 5319 HI were collected from
patient specimens at 80 hospital laboratories in 13 countries in Africa, Asia,
Europe, and North and South America. Isolates were centrally tested by broth
microdilution against penicillin (PEN; SP only), ampicillin (AMP; HI only),
amoxicillin-clavulanate (AC), cefuroxime (FUR), clarithromycin (CLR),
levoﬂoxacin (LEV), and TMP-SMX. MICs were interpreted using 2002
NCCLS breakpoints. Relationships between SP and HI to individual agents
between countries were tested by measuring the correlation coefﬁcient (r) of
percent R in each species using a t-test analysis.
Results: R to beta-lactams, CLR and TMP-SMX among SP and HI varied
considerably between countries, with the highest R rates generally being
reported in Asia. LEV R among SP was 1.5% in all countries except South
Korea (2.1%) and Hong Kong (8.5%) and was undetected in HI. Statistical
tests showed a highly signiﬁcant relationship (r¼ 0.886; P< 0.001) between
PEN R in SP and AMP R in HI. Similarly, a signiﬁcant relationship was
observed for TMP-SMX R for these species between countries (r¼ 0.609;
P¼ 0.05). No signiﬁcant correlation was detected for FUR or CLR.
Correlations in R rates to AC or LEV among SP and HI could not be
determined due to low R (0% in many countries) to the two agents among
HI. However, a high incidence of ACR among SP (16.6%) andHI (1.2%) was
recorded in South Korea.
Conclusions: Beta-lactam R and TMP-SMX R in SP and HI arise from
separate mechanisms in each species. Thus, the correlations in R between the
species may indicate a response to a common selective pressure, most likely
antimicrobial consumption. Examination of antimicrobial consumption
coupled with annual surveillance will provide further understanding of these
relationships.
P1253 A longitudinal assessment of antimicrobial
resistance among Haemophilus inﬂuenzae and
Moraxella catarrhalis collected worldwide during
1999–2002
R. Blosser-Middleton, J. Karlowsky, C. Thornsberry, D. Sahm, M. Jones
Herndon, USA; Hilversum, NL
Objectives: Haemophilus inﬂuenzae (HI) and Moraxella catarrhalis (MC) are
common respiratory pathogens worldwide. In some countries, high rates
of beta-lactamase (BL) production and resistance (R) to trimethoprim-
sulfamethoxazole (TMP-SMX) have challenged the empiric treatment of
HI and MC. Fluoroquinolones such as levoﬂoxacin (LEV) have provided an
alternative therapy for these infections. Currently, LEV R is extremely rare,
however, the continued monitoring of R rates is necessary to track any
changes in R, should they occur.
Methods: During 1999–2000 and 2001–2002, HI (1999–2000, n¼ 4640;
2001–2002, n¼ 5138) and MC (1999–2000, n¼ 556; 2001–2002, n¼ 1014)
were collected from patient specimens in hospital laboratories in 12 countries.
Isolates were tested by NCCLS broth microdilution against ampicillin (AMP),
azithromycin (AZI), LEV, TMP-SMX, and comparator agents. MICs were
interpreted using the 2002 NCCLS published breakpoints.
Results: Overall, BL production in HI decreased 1.5% between 1999 and
2000 (19.0%) and 2001–2002 (17.5%). This decrease was accompanied by a
0.9% decrease in AMP R (1999–2000, 18.4%; 2001–2002, 17.5%). The
largest increase in BL production (7.3%) and AMP R (7.1%) was detected in
China. Seven AZI nonsusceptible (NS)HI (Germany, 1; Italy, 1; South Africa,
2; Spain, 3) were collected in 2001–2002 compared with none in 1999–2000.
Overall TMP-SMX R decreased 4.6% from 1999 to 2000 (28.2%) to 2001–
2002 (23.6%). Mexico showed the largest decrease (10.8%) in TMP-SMX R
between 1999 and 2000 (35.8%) and 2001–2002 (25.0%). The largest increase
(12.3%) was detected in South Korea (1999–2000, 44.4%; 2001–2002,
56.7%). No LEVNSHI were collected in either year. Overall, BL production
among MC increased 3.1% from 93.5% in 1999-2000, 96.6% in 2001–2002.
MIC90s for AMP and AZI increased one doubling dilution from 4 to 8mg/L
and0.03–0.06mg/L, respectively, between 1999 and 2000 and 2001–2002.
Based on MIC90, LEV (0.06mg/L) was the most active agent tested against
MC in 2001–2002, unchanged since 1999–2000.
Conclusions: The high prevalence of beta-lactam R and TMP-SMX R
among HI and MC in some countries highlights the need for alternative
therapies such as LEV to treat respiratory infections. Continued surveillance
on a worldwide scale will provide insights into changing dynamics of
antimicrobial R among HI and MC.
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Skin and soft tissue
P1254 Panton-Valentine leukocidin associated epidemic
of soft tissue infections in the San Francisco community
B. A. Diep, G. F. Sensabaugh, N. Somboona, H. Carleton,
F. Perdreau-Remington
Berkeley, San Francisco, USA
Objective: To describe the prevalence of Panton-Valentine leukocidin (PVL)
producing S. aureus strains in patients with nosocomially and community-
acquired infections in the Community Health Network of San Francisco
(CHN), to identify the genotypes of these isolates and determine the
Staphylococcal Chromosomal Cassette (SCC) mec type conferring their
resistance to methicillin.
Methods: The PVL -carrying genes (lukS-PV and lukF-PV) and SSCmec
types were determined by PCR. Genotyping consisted of pulsed ﬁeld gel
electrophoresis following SmaI digestion (PFGE) and multilocus restriction
fragment typing (MLRFT).
Results: In a survey of 197 S aureus strains recovered from patients in the CHN
between August 1999 and April 2000, we identiﬁed 32 (16.2%) isolates that
carried the lukS-PVand lukF-PV genes. As deﬁned by PFGE andMLRFT, 27
(84.4%) of these belonged to a single clonal lineage: SF13. Twenty-four (89%)
of the 27 PVLþ SF13 isolates also carried the SCC mec typeIV. Moreover,
PVLþ isolates were more likely to have been recovered from abscess/wound
sites than sterile sites (37.5 and 6%, P¼<0.0001). To assess the geographic
spread of PVLþ SF13 isolates, we examined 47 random MRSA collected
between January 2000 and July 2001 from a public adjacent county. Fourteen
(29.8%) of them carried the PVL genes; of these, 10 (71.4%) belonged to the
SF13 clonal lineage and carried SCC mec type IV. In view of the increased
prevalence of community-acquired soft tissue infections in San Francisco, we
analyzed 65 consecutiveMRSA isolates collected between July 1 andOctober
15, 2000 from abscess/wound cultures, in a prospective study in patients
receiving surgical treatment at the Integrated Soft-tissue Infections Services at
San FranciscoGeneral Hospital (as part of CHN).Of these, 44 (67.7%) carried
the PVL genes and 34 of the 44 (77.3%) belonged to the SF13 clonal lineage
and carried the SCC mec type i.v. element.
Conclusion:A Panton-Valentine leukocidin-associated epidemic of soft-tissue
infections is due to a single methicillin-resistant S. aureus clone carrying the
SCC mec type i.v. element in the San Francisco community.
P1255 Community-acquired cutaneous infections
due to different methicillin-resistant Staphylococcus
aureus strains
N. Liassine, M. Bes, M. C. Descombes, J. Etienne
Geneva, CH; Lyon, F
Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA)
infections have recently been reported in patients from different countries,
without known risk factors for acquisition of nosocomial bacteria. Some
strains present speciﬁc virulence factors, as the Panton-Valentine toxin that is
associated with skin infections and more rarely necrotizing pneumonia with a
high mortality. Our purpose was to characterize CA-MRSA identiﬁed by our
laboratory during the year 2002. From January to December 2002, 12 isolates
of CA-MRSA have been isolated from 10 patients with cutaneous infections.
None of them was at risk to acquired nosocomial infections. There were six
patients, four children and two adults from three different families, who
presented furonculosis. Three other children presented non bullous impetigo
and one adult a folliculitis. Identiﬁcation of Staphylococcus aureus was obtained
by a positive coagulase tube test. All the isolates were resistant to methicillin,
conﬁrmed by the presence of the mecA gene. Isolates were also resistant to
kanamycin (n¼ 9), fusidic acid (n¼ 10), tetracyclines (n¼ 12), erythromycin
(n¼ 3) and cotrimoxazole (n¼ 2). Toxinotyping was performed by PCR.
Pulsed Field Gel Electrophoresis (PFGE) of genomic DNA was made after
digestion by SmaI. All the isolates had the LukE-Lu kDa leukotoxin genes.
The eight isolates obtained from patients with furonculosis had the Panton-
Valentine toxin genes, an agr3 allele and showed the same pattern by PFGE.
From the three patients with impetigo, two have isolates characterized by the
presence of exfoliative A toxin gene, an agr3 allele and a similar PFGE pattern.
The third strain isolated from a patient with impetigo had the Panton-
Valentine toxin genes, enterotoxin (enterotoxins M and O) genes and an agr2
allele. The isolate from folliculitis did not have Panton-Valentine toxin neither
exfoliative toxin genes and had an agr3 allele. These results emphasize the
emergence of community-acquired cutaneous infections due to different
strains of CA-MRSA. MRSA Panton-Valentine producing isolates linked to
furonculosis represent an emerging clonal group, which is the same that the
one described recently in France. MRSA exfoliative A producing isolates
represent a different clone. Both practitioners and microbiologists should be
aware of this new type of MRSA infections.
P1256 Community-acquired methicillin-resistant
Staphylococcus aureus in Greek children
J. Dotis, D. Soﬁanou, E. Roilides
Thessaloniki, GR
Objective: Historically, infections due to MRSA have been considered a
nosocomial problem. More recently, serious MRSA infections have been
acquired in the community. We aimed to deﬁne the frequency of MRSA in
pediatric patients of a tertiary care hospital and estimate the proportion of
community-acquired MRSA (CA-MRSA).
Methods: All cases of pediatric patients from whom S. aureus including
MRSA was isolated between January 1999 and December 2001 were
reviewed. CA-MRSA was deﬁned as a MRSA isolated from a culture
obtained at or within 2 days after hospital admission from a patient not
hospitalized during the previous 6 months. Chi square test was used for
comparison of proportions.
Results: S. aureus was isolated from 123 children and MRSA was responsible
for 45 (36.6%) cases. In 19 of these 45 patients (42.2%), MRSA was nasal
colonizer. The children with MRSA were aged 1 d to 17 year. In general,
MRSA tended to be isolated from boys and infants younger than 45 d more
frequently than girls and older children, respectively (P¼ 0.07) (Table).
Trends of differences among the years are not signiﬁcant. Forty-one MRSA
isolates (91.1%) were susceptible to clindamycin.
Conclusions: (i) More than one-third of MRSA’s isolated from pediatric
patients in our hospital are community-acquired. Frequencies of both MRSA
and CA-MRSA tend to remain constant through the study period. (ii)
Clindamycin is active against almost all MRSA strains and thus valuable
for empirical treatment of serious staphylococcal infections. (iii) Control of
MRSA requires surveillance for MRSA and appropriate use of antibiotics not
only in the hospital but also in the community.
P1257 A community outbreak of methicillin-resistant
Staphylococcus aureus
Y. Tveten, A. Jenkins, B.-E. Kristiansen
Skien, N
Objectives: In Norway, the prevalence of methicillin-resistant Staphylococcus
aureus (MRSA) has been increasing from 21 in 1995 to 122 in 2001. MRSA
has hereto largely been conﬁned to hospitals and long-term care facilities, and
known risk factors have been prior antibiotic usage, admission to ICU,
surgery and exposure to other MRSA-colonized patients. However, during
the last years the relative frequency of community-acquired MRSA has
increased. In 2001, 57% of the 122 registered MRSA in Norway were from
patients outside hospital. It is not known whether these community-acquired
isolates are bacteria escaping and spreading from hospitals, or if this isolates
have arisen as a consequence of horizontal transfer of genes conferring
methicillin-resistance into a formerly susceptible S. aureus population. In a
small urban community in Telemark, Norway, there has been an outbreak
with MRSA including eight patients during a 15-month period starting in
July 2001 and ending in October 2002. All patients presented with abscesses.
Year S. aureus MRSA CA-MRSA
1999 39 15 (38.5%) 5/15 (33.5%)
2000 49 21 (42.9%) 8/21 (38.1%)
2001 35 9 (25.7%) 4/9 (44.4%)
Total 123 45 (36.5%) 17/45 (37.8%)
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Methods: Susceptibility testing, pulsed-ﬁeld gel electrophoresis, patient
screening and interview.
Results: The eight isolates of MRSA were only resistant to beta-lactam
antibiotics and fusidic acid, and showed identical PFGE patterns. By com-
parison with PFGE patterns of strains in the Swedish MRSA database, this
Norwegian outbreak strain was found to be indistinguishable from the strain
DK E97-1, a strain that was ﬁrst isolated and characterized in Denmark, but
which origin is in the Eastern Mediterranean area. It was found that the ﬁrst
patient had been treated at a Greek hospital during a holiday prior to the
identiﬁcation of MRSA in July 2001. The following seven patients were
relatives or close social contacts.
Conclusion: Norway has guidelines for preventing MRSA from entering
hospitals which includes screening of patients and health care workers from
endemic areas. Guidelines should also include recommendations for how to
take care of patients with MRSA outside hospitals.
P1258 Nontyphoidal salmonella abscess in an
immunocompetent adult: case report
H. Moraitou, S. Davris, D. Nikita
Athens, GR
The clinical spectrum of extra-intestinal salmonella infection includes enteric
fever (typhoid and paratyphoid) and invasive infections due to nontyphoidal
salmonellae, such as osteomyelitis, septic arthritis, meningitis, arterial infec-
tions and bacteremia. A number of host factors can predispose to extra-
intestinal Salmonella infections, although a number of cases in otherwise
healthy individuals have been reported. A 58-year-old-man was admitted to
Henry Dunant Hospital for a 3-day history of fever, malaise and a painful
swelling of the right parotid. For 2 days before his admission he had being
taken amoxicillin and metronidazole as this was thought to be related to dental
infection, by his general practitioner. As the symptoms did not seem to
withdraw, the patient was referred to the hospital’s ENT department for
evaluation. His white blood count was 9250/mm3 (69.7% neutrophils, 17.2%
lymphocytes and 6.8% monocytes), hematocrit 48.5%, hemoglobin level
16.1 g/dL, platelet count 267 000/mm3, C-reactive protein 8.3mg/dL and
erythrocyte sedimentation rate 70mmHg. No evidence of palpable lymph
nodes was noted and the chest X-ray ﬁlm showed no abnormalities. CT scan
revealed an abscess of the right parotid, with no evidence of malignancy. The
patient did not suffer from any immune or endocrine disease, nor taken any
other medication in the past. He did not remember to suffer from diarrhea or
any other syndrome for the last months. The patient underwent ﬁne-needle
aspiration of the abscess under U/S guidance and the pus aspirated was sent to
our microbiology laboratory for culture. After 24-h incubation, Salmonella
enteritidis was isolated from the sample. The stool, urine and blood cultures
were negative. The patient was treated with ciproﬂoxacin 400mg p.o. q12 h
for 15 days, with complete remission of symptoms. He was revised 20 days
later and he showed complete resolution of the infection. The last decade,
Salmonella enteritidis is the most frequent of nontyphoidal Salmonellae causing
extra-intestinal infections. However, focal soft tissue infections due to Sal-
monellae are still rare and diverse underlying conditions are present in the
majority of patients. In our case, the patient was an otherwise completely
immunocompetent individual, with no risk factors predisposing to this
infection.
P1259 Recurrent intradermal abscesses caused by
Citrobacter freundii in an immunocompetent host
G. Parruti, A. Consorte, G. Calella, P. Fazii, L. Alterio, P. Marani Toro,
V. Graziani, G. Agostinone, G. Marani Toro
Pescara, Avezzano, I
Objective: Citrobacter species in the family Enterobacteriaceae are infrequent
human pathogens associated with urinary tract infections and bacteremias in
hospitalized or immunocompromised patients, as well as with sepsis, menin-
gitis and brain abscesses in newborns. C. freundii has also been reported to
cause endocarditis, spondylodiscitis and toxic gastroenteritis in healthy hosts.
Here we report on a healthy young woman with recurrent intradermal
abscesses following a cat scratch.
Methods: A 20-year-old woman was hospitalized because of the 5th recur-
rence of a intradermal abscess of her left forearm. Abscesses had appeared lined
in close sequence towards the arm root, each a month after the other, with
fever, malaise, tenderness and swelling of the whole arm. In spite of short
courses of oral amoxicillin/clavulanate, they resolved only after surgical
drainage. Blood and pus samples were cultured on admission, and i.v.
ceftriaxone and ciproﬂoxacin administered for 2weeks with apparent resolu-
tion. Three weeks later she came back with another intradermal abscess on
her left ﬂank. Clindamycin and ciproﬂoxacin were started i.v. after blood and
pus sampling. Culture isolates were identiﬁed with an automated VIDEK
system (bioMerieux) and stored for strain collection.
Results: Pus cultures grew C. freundii as the only isolate on both occasions,
blood cultures remaining sterile. Isolates from both abscesses shared resistance
to amox/clav, whereas those from the 2nd one showed decreased sensitivity to
ciproﬂoxacin. Thorough immunologic workup of the patient failed to reveal
any signiﬁcant immune deﬁcit. Histology of lesions was unremarkable.
Conclusions:To our knowledge this is the ﬁrst report of intradermal abscesses
caused by C. freundii in a immunocompetent host, likely infected through an
unusual pathway. Infection was hard to control, as indicated by recurrence by a
selected ciproﬂoxacin-resistant strain, adding to the knowledge that this
unusual pathogen may represent a relevant therapeutic challenge.
P1260 Multiple splenic abscesses due to Bartonella
henselae
C. Garzoni, V. Jacomella, R. Gayer, G. Mombelli
Locarno, CH
Introduction: Cat scratch disease (CSD) is usually characterized by a self-
limited regional lymphadenopathy but systemic manifestations has been
described, with ocular, neurological and visceral organ involvement. Less
recognized is the picture of multiple splenic abscesses, whose differentiation
from pyogenic abscesses, infarctions, lymphomas and systemic diseases could
be difﬁcult. A previously healthy 37-year-old patient was admitted with a 14-
day history of spiking fever to 40.08C with chills and epigastric pain. On
admission he was febrile at 39.78C and showed normal hemodynamic
parameters. Physical examination was unremarkable except for a weak
epigastric pain. Laboratory investigations showed slight inﬂammatory
response and elevated liver enzymes. A CT scan of the abdomen revealed
a hepatomegaly, enlarged portal lymph nodes, and multiple hypodense lesions
up to 2.5 cm in the spleen. Broad spectrum antibiotic therapy was started with
Imipenem (1 g i.v. tid). Clarithromicin was added (500mg i.v. bid) because
the history of a cat scratch raised the suspicion of a Bartonella infection.
Multiple blood cultures were negative and a transesophageal echocardiogra-
phy was unremarkable. The fever disappeared after 10 days of treatment. A
serology conﬁrmed the diagnosis of Bartonella henselae infection with a IgG
titer of 1 : 4096 (n< 50)
Discussion: Multiple splenic hypodense lesions in a high febrile patient
require both extensive diagnostic work-up and rapid therapeutic action.
The clinical presentation in our patient was not suggestive for a neoplastic
disease. In the immunologically competent host, splenic abscesses are uncom-
mon and frequently the consequence of bacteremic infections (mostly
endocarditis but also urinary, abdominal or respiratory tract infections). Most
are caused by aerobic or anerobic bacteria but very rarely unusual pathogens
such as fungi or mycobacteria are involved. Atypical presentations of B. hen-
selae infections include the so-called hepatosplenic CSD. The radiologic
aspect ranges from diffuse small granulomas in the liver and/or spleen to
larger abscesses with or without lymphadenopathies. A high index of
suspicious and a prompt diagnosis is required to avoid a splenectomy, which
is usually indicated if splenic abscesses are due to pyogenic pathogens.
P1261 Natural history and complications of deep
venous thrombosis in intravenous drug users
N. E. Jenkins, F. Syed, M. B. Beadsworth, F. J. Nye, N. J. Beeching
Liverpool, UK
Objectives: We hoped to document the nature of infective complications in
i.v. drug users (IVDU) with deep venous thrombosis (DVT).
Methods: A case note audit of all DVTadmissions in adults under 40 years of
age over a 5-years. A questionnaire was used to extract data concerning i.v.
drug use, investigation, nature and complications of DVT. In addition we
looked at all previous an subsequent DVTs in these patients.
Results: (see Tables 1–3).
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Therewere 98 IVDU (all groin injectors) and 83 non-IVDUpatients admitted
with proven DVT during the study period. From the case notes we were able
to document 134 additional admissions for possible DVT in IVDUs and 17 for
non-IVDUs. IVDUs had longer hospital stays with proven or possible DVTs.
IVDUsweremore likely to be an inpatient on the IDUnit (P< 0.001). For all
admissions, IVDUs had a high rate of self discharge. The majority of IVDU
patients had proximal DVT (16.9% of non-IVDUs). There was no difference
in the incidence of pulmonary embolism between the two groups but septic
pulmonary emboli were common in IVDU patients. Infective complications
rare in non-IVDU but occurred in nearly half of IVDUs. Of a total of 232
admissions with DVT in i.v. drug users, blood cultures were taken on 101
occasions. There were 43 positive cultures, of which 33 occurred in patients
with conﬁrmed DVT. There were no known HIV positive patients. IVDUs
needed signiﬁcantly more additional admissions to exclude a possible DVT.
The risk of recurrence in the 3 and 6-month period after discharge was
signiﬁcantly higher for IVDUs (P< 0.001). The number of days until
recurrence was not associated with the length of time anticoagulated (Pearson
correlation). IVDUs seen on the ID Unit had a longer hospital stay (MW,
P¼ 0.028), were less likely to be offered warfarin therapy (Chi, P¼ 0.002)
and received longer anticoagulation (MW, P¼ 0.039). Patients admitted to
the ID unit were more likely to have had blood cultures taken. Interpretation:
This study conﬁrms the importance of i.v. drug use as a risk factor for DVTof
the lower limb (54.1% associated with IVDU). We describe DVT in i.v. drug
users as a signiﬁcantly different disease process commonly presenting to
Infectious Diseases physicians. Treatment regimes differ between medical
wards. Such patients commonly presenting with septic complications, require
particular treatment and pose distinct problems regarding their hospital stay
and follow-up.
Epidemiology of resistance 4
P1262 Telithromycin is highly active against
Streptococcus pneumoniae isolates, including resistant
strains, from pediatric patients: PROTEKT Year 1 vs. Year 2
D. Felmingham, R. R. Reinert, D. J. Farrell
London, UK; Aachen, D
Background: Treatment of Streptococcus pneumoniae infections in pediatric
patients is often complicated by high local prevalences of resistance to beta-
lactams and macrolides. As part of the PROTEKT surveillance study, the
activity of the ﬁrst ketolide telithromycin (TEL) was investigated against
S. pneumoniae isolated from pediatric patients in 1999–2000 (Y1) and 2000–
2001 (Y2).
Methods: S. pneumoniae (Y1, n¼ 802; Y2, n¼ 1164) were isolated from
children aged 14 years with community-acquired RTIs in 20 countries
worldwide. Isolates were tested against a panel of antibacterials, including
penicillin (PEN), erythromycin (ERY) and TEL, according to NCCLS
guidelines. Macrolide resistance mechanisms were determined, using PCR,
in ERY-R (MIC 1mg/L) isolates.
Results: The prevalence of PEN-I (MIC 0.12–1mg/L), PEN-R
(MIC 2mg/L) and ERY-R varied globally but was particularly high in
several countries, notably Japan and South Korea in both years (Table).
Preliminary genotype analysis indicates similar prevalence of macrolide
resistance genes among ERY-R isolates for both years: Y1: erm(B) 51%,
mef(A) 38%, erm(B)þmef(A) 11%; Y2: erm(B) 61%, mef(A) 35%,
erm(B)þmef(A) 4%. TEL (NCCLS proposed susceptibility breakpoint
1mg/L) inhibited 100% of isolates (MIC90 0.25mg/L) in Y1 and 1162
(99.8%) of isolates (MIC90 0.12mg/L) in Y2.
Conclusions: These data conﬁrm the continuing high worldwide prevalence
of PEN and ERY resistance among S. pneumoniae isolated from pediatric
patients in several countries. Telithromycin exhibits excellent activity against
S. pneumoniae from pediatric patients, including PEN-I, PEN-R and ERY-R
isolates.
Table 1
Risk factor Number total¼181
IVDU 98 (54.1%)
Smoker 131(72.4%)
Previous DVT 50 (27.6%)
Family history 18 (9.9%)
Thrombophilia 19 (10.4%)
Recent surgery 9 (5.0%)
Other immobility 18 (9.9%)
Cancer 3 (1.65%)
Female contraceptive 6 of 72 (8.3%)
SLE 0
Chronic inflammation 16 (8.8%)
Obesity 2 (1.1%)
Steroid 3 (1.65%)
Alcoholism 27 (14.9%)
Table 2
Result of blood culture
Number of patients with possible
DVT (in brackets)
Staphylococcus aureus 23 (17)
Enterococcus faecalis 2 (2)
Enterococcus faecalis and Staphylococcus aureus 1 (0)
Moraxella oslensis 3 (2)
Streptococcus viridans 2 (2)
Group B Streptococcus 2 (0)
Group B Streptococcus and Staphylococcus aureus 1 (1)
Group A Streptococcus, Group B Streptococcus and
Staphylococcus aureus
1 (0)
Group A Streptococcus 1 (1)
Group C Streptococcus 1 (1)
Group A Streptococcus, Group B Streptococcus and
Staphylococcus aureus
1(1)
Staphylococcus aureus and Streptococcus oralis 1 (1)
Streptococcus milleri and a Gram negative rod 1 (1)
Streptococcus milleri 1 (1)
Proteus mirabilis 1 (1)
Total 43 (33)
Table 3
IVDU (n¼ 98) Non-IVDU (n¼ 83)
Type of DVT
Proximal 66 (67.3%) 14 (16.9%) P< 0.001
Distal 32 (32.7%) 69 (83.9%)
Associated problems
Cellulitis 47 (48.2%) 2 (2.4%) P< 0.001
Other STI 46 (46.9%) 1 (1.2%) P< 0.001
Septacemia 24 (24.5%) 0 P< 0.001
PE 9 (9.2%) 7 (8.4%) NS
Septic emboli 15 (15.3%) 0 P< 0.001
Country
1999–2000 (Y1) 2001–01 (Y2)
% of isolates % of isolates
Total no.
of isolates PEN-I PEN-R ERY-R
Total no.
of isolates PEN-I PEN-R ERY-R
France 28 21 46 71 11 27 36 55
Hungary 24 46 17 63 45 9 31 31
Japan 114 21 51 81 291 23 40 79
S. Korea 31 10 81 97 34 24 71 94
Worldwide 802 18 25 36 1164 15 23 40
Countries with high prevalence of resistance and >10 S. pneumoniae isolates.
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P1263 High prevalence of antibacterial resistance
among Streptococcus pneumoniae collected from patients
with community-acquired respiratory tract infections in
Japan: three years of PROTEKT data
K. Yamaguchi, T. Matsumoto, M. Inoue, D. J. Farrell
Tokyo, Kanagawa, JP; London, UK
Objectives: Japan has high levels of antibacterial resistance, including multi-
drug resistance, among S. pneumoniae. PROTEKT provides annual surveil-
lance of resistance among community-acquired respiratory tract infections
(RTIs) pathogens. International antimicrobial surveillance studies play a
critical role in deﬁning the nature and extent of this problem as well as in
guiding prescribing.
Methods: S. pneumoniae were collected from Japanese patients with
community-acquired RTIs during the 1999/00 (Y1), 2000/01 (Y2) and
2001/02 (Y3) seasons. Susceptibilities (NCCLS methodology) and macrolide
resistance genotypes were determined at a central laboratory.
Results:Centres in Japan submitted a total of 308, 627 and 816 pneumococcal
isolates in Y1, Y2 and Y3, respectively. There was no marked change in the
MIC90 of the antibacterial agents over the three years. The frequencies of the
resistant isolates of S. pneumoniae to the major antibiotics are shown in Table 1.
High levels of resistance to penicillin, erythromycin, clindamycin and tetra-
cycline continued over the 3 years. Resistance to ﬂuoroquinolones has
remained at a low level (despite high levels in neighboring Hong Kong).
The MIC90 of telithromycin has stayed low over the 3 years (0.25, 0.12,
0.12mg/L, respectively), and>99.5% of isolates each year were susceptible to
telithromycin at 1mg/L. Over the 3 years, erm(B)-(Y1 52.7, Y2 63.4, Y3
59.4%) continued to be more prevalent than mef(A)-mediated (Y1 42.7, Y2
34.1, Y3 37.0%) macrolide resistance. The prevalence of isolates with
mef(A)þ erm(B) remained low (Y1 3.4, Y2 1.9, Y3 3.4%).
Conclusion: Japan, in common with other Asian countries, has high levels of
antimicrobial resistance to many ﬁrst-line antibiotics. Telithromycin, the ﬁrst
ketolide antibiotic, exhibits high potency against S. pneumoniae including
multiresistant strains.
P1264 Demography and antimicrobial susceptibility of
community-acquired respiratory tract infection pathogens
in Year 2 vs. Year 1 of the PROTEKT Surveillance
Program
D. Hoban, D. Felmingham, I. Harding
Winnipeg, CAN; London, Ely, UK
Objectives: PROTEKT is a global longitudinal surveillance study of anti-
microbial susceptibility among community-acquired respiratory tract infec-
tions (CARTI) pathogens. Data from the ﬁrst 2 years (Y1: 1999–2000; Y2:
2000–01) are presented.
Methods: Isolates of S. pneumoniae (SPN), H. inﬂuenzae (HI), M. catarrhalis
(MC), S. pyogenes (SPY) and S. aureus (SA) from patients with CARTIs in 25
(Y1) and 22 (Y2) countries were tested at a central laboratory for antimicrobial
susceptibility (NCCLS).
Results: Demographic data are shown in Table 1.
Rates of resistance to penicillin (PEN-R) and erythromycin (ERY-R) in SPN
were similar across the three age groups in both years (PEN-R: Y1, 19–25%,
Y2 15–23%; ERY-R: Y1 29–36%, Y2 29–40%).Overall, PEN-R and ERY-R
in both years were highest in the Far East (Y1: n¼ 515; 53 and 80%; Y2:
n¼ 718; 34 and 77%, respectively) and France (Y1: n¼ 184; 46 and 58%; Y2:
n¼ 191; 39 and 54%, respectively). Beta-lactamase (BL) production in HI was
highest in South Korea (Y1: 33/51, 65%; Y2: 31/55, 56%). Among MC, BL
production was>90% in most countries for both years. Worldwide, ERY-R
remained constant for SPY (Y1 9%; Y2 10%) and for methicillin-susceptible
SA (MSSA; Y1: 246/1239, 20%; Y2: 219/1183, 19%). Telithromycin (TEL)
was highly active against all pathogens, with the same MIC90 values for both
years for SPN 0.12mg/L, HI 2mg/L, MC 0.12mg/L and SPY 0.015mg/L;
MIC90 for MSSAwere: Y1 0.12mg/L, Y2 0.06mg/L. At 1mg/L in both
years, TEL inhibited 99.9, 97.6 and 95.3% of SPN, SPY and MSSA,
respectively. At4mg/L, telithromycin inhibited99.6% of HI and 100% of
MC in both years. TEL susceptibilities were not markedly affected by patient
demography or resistance to other antimicrobial agents.
Conclusion: Antimicrobial resistance continues to be a global problem. TEL,
the ﬁrst ketolide to be approved for clinical use, has excellent in vitro activity
against the CARTI pathogens studied, including antimicrobial-resistant SPN,
regardless of demographic factors.
P1265 Hot spots of antibacterial resistance among
community-acquired respiratory tract infection
pathogens in Europe: 2 years of data from the
PROTEKT study
G. Russo, E. Bouza, E. Cercenado, I. Harding, D. Felmingham
Catania, I; Madrid, E; Ely, London, UK
Objectives: Patterns of antibacterial resistance among community-acquired
respiratory tract infections (CARTIs) pathogens vary between European
countries. In some countries, the prevalence of resistance to penicillins
and macrolides approaches the high levels seen in the Far East. PROTEKT
is a global surveillance study monitoring antibacterial resistance among
CARTI pathogens. We report here the major changes in resistance patterns
observed in European countries during the ﬁrst 2 years of PROTEKT.
Methods:Clinical isolates of S. pneumoniae (SPN),Haemophilus inﬂuenzae (HI)
and Moraxella catarrhalis (MC) from respiratory samples were submitted from
European centers during the winters of 1999/2000 (Y1) and 2000/2001 (Y2).
MICs and susceptibilities were determined according to NCCLS guidelines.
Results: In Y1 and Y2 a total of 1521 and 2331 SPN, 1288 and 1609 HI, and
527 and 619MCwere collected, respectively. Increases in resistance rates were
seen in Portugal (penicillin, cotrimoxazole) and Hungary (penicillin, cotri-
moxazole). Conversely, falls in resistance rates were seen in Poland and Eire
(penicillin, erythromycin, cotrimoxazole, tetracycline), in Spain (penicillin)
and Hungary (erythromycin, tetracycline). Beta-lactamase production in HI
fell in Spain from 26.8 to 10.9%, and rose in Ireland from 7.9 to 26.0%. MC
beta-lactamase production was >80% in all countries. In Y1 and Y2,
telithromycin at 1mg/L inhibited >99.5% of SPN, >99.5% of HI and
100% of MC.
Table 1
Antibacterial agent
Resistant isolates (%)
Y1 Y2 Y3a
Penicillinb 64.3 54.8 64.0
Erythromycin 77.9 77.2 79.9
Clindamycin 44.8 50.6 49.4
Levofloxacin 1.3 1.1 1.1
Tetracycline 78.6 79.9 83.6
Co-trimoxazole 10.7 8.1 7.4
aProvisional data.
bintermediate þ resistant (MIC 0.12mg/L).
Table 1
Demography
% of isolates for which demographic data were provided
a
Y1 Y2
SPN,
n¼ 3362
HI,
n¼ 2948
MC,
n¼ 1131
SPY,
n¼ 1485
SA,
n¼ 1547
SPN,
n¼ 4256
HI,
n¼ 3133
MC,
n¼ 1156
SPY,
n¼ 1364
SA,
n¼ 1493
Age group
0–14 24 23 28 46 13 27 26 28 52 14
15–64 36 35 33 32 46 37 36 31 33 47
65 25 24 30 4 24 26 28 33 4 31
Source
Sputum 44 54 60 5 32 42 55 59 4 37
Blood 15 2 2 3 13 16 1 1 3 18
NAP 7 9 12 3 8 11 11 13 4 11
BAL 8 9 8 1 10 9 10 7 1 10
Other 13 10 10 71
b
21 14 14 12 85
b
18
NAP: nasopharygeal swab/aspirate BAL: bronchoalveolar lavage,
a
data not available for all isolates,
b
mainly troat swabs
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Conclusion: Resistance to several ﬁrst line antibacterials is a continuing
problem in Europe. The ﬁrst 2 years of PROTEKT indicate changing
patterns of resistance to several antibacterial agents in individual countries.
Telithromycin exhibited excellent in vitro activity against the principal
CARTI pathogens, including strains resistant to other agents.
P1266 Antimicrobial resistance surveillance of
Staphylococcus aureus isolates in a pediatric population
(1998–2002)
G. Stamos, E. Lebessi, S. Ioannidou, P. Sanida, K. Malliou,
M. Foustoukou
Athens, GR
Objectives:To study the incidence of methicillin resistant Staphylococcus aureus
(MRSA), the main resistance phenotypes and to identify trends in anti-
microbial resistance throughout a 5-year period (1998–2002).
Methods:We retrospectively analyzed the antimicrobial susceptibility of 1796
nonduplicate S. aureus isolates, recovered from various clinical specimens
(infection or colonization sites), from children 0–14 years old, treated at a
Tertiary Care Children’s Hospital in Athens. The standard disk diffusion
method was used routinely to determine antimicrobial resistance (NCCLS
recommendations). The Penicillin Binding Protein Latex Agglutination test
(OXOID) was used to evaluate marginal resistance to methicillin or to obtain
a quick result in serious infections.
Results: Overall, 93.4% of the isolates were resistant to penicillin (PEN),
16.9% to oxacillin (OXA), 4.3% to gentamicin (GEN), 5.0% to tobramycin
(TOB), 11.3% to kanamycin (KAN), 13.6% to tetracycline (TET), 16.6% to
erythromycin (ERY), 2.7% to clindamycin (CLI) and 1.6% to cotrimoxazole,
while all were susceptible to glycopeptides. Annual oxacillin resistance rates of
18.8, 10.6, 18.4, 15.7 and 20.3% were noted for the years 1998–2002,
respectively. The incidence of resistance was signiﬁcantly higher among
the oxacillin resistant isolates than the sensitive ones for GEN (15.8 vs.
1.9%), TOB (17.8 vs. 2.4%), KAN (45.0 vs. 4.1%), TET (29.0 vs. 10.1%),
ERY (20.1 vs. 15.4%) and CLI (9.3 vs. 1.4%). The main resistance patterns
were PEN (1316), PEN-OXA (179), PEN-OXA-GEN-TOB-KAN (40),
PEN-GEN-TOB-KAN (26), PEN-OXA-KAN (43) and PEN-KAN (13).
The incidence of oxacillin resistance was relatively higher among the isolates
from blood (20.4%), from surgical specimens (18.8%), orthopedic specimens
(18.0%) and from Special Care Units (20.7%) than the isolates from Nephrol-
ogy Unit patients (11.1%) and children treated as outpatients or admitted in
other Pediatric Wards (14.2%).
Conclusions:Methicillin resistance was found in about one-ﬁfth of pediatric
S. aureus isolates, with no steadily increasing or decreasing trends during the
recent years. MRSA isolates were more frequently concomitantly resistant to
other antimicrobials than methicillin sensitive ones. The monitoring of
S. aureus resistance is required to help in therapeutic decisions for empirical
therapy, which must be accompanied by appropriate cultures for isolation and
antimicrobial testing of the S. aureus strains.
P1267 Antimicrobial resistance of pathogens isolated
from aural infections in a Greek pediatric hospital
S. Tsiplakou, G. Stamos, T. Goulioti, S. Ioannidou, M. Tsirepa,
N. Paleologou, A. Zaﬁropoulou, M. Foustoukou
Athens, GR
Objectives:This study records and analyzes the pathogens recovered from ear
ﬂuid cultures and their susceptibility to antibiotics during the period 2000–
2001.
Methods:A total of 1764 samples of otic exudates from children aged 23 days
to 14 years were studied. The subjects were either examined at the outpatient
department of ‘P. & A. Kyriakou’ Children’s Hospital or were admitted for
hospitalization. The antibiotic susceptibility of the isolated pathogens was
determined by the disk diffusion method and the MIC of Streptococcus
pneumoniae strains to selected b-lactams was determined by the E-test method
according to the NCCLS guidelines.
Results: A total of 1288 cultures were positive. More than one pathogen was
isolated from 131 cultures. 1481 isolates were examined; these included 319
Streptococcus pneumoniae isolates, 305 Pseudomonas aeruginosa, 297 Staphylococcus
aureus, 236 Haemophilus inﬂuenzae, 176 Streptococcus pyogenes, 34 Moraxella
catarrhalis, a total of 72 fungal isolates of theAspergillus andCandida species and
a small percentage of other bacteria. The S. pneumoniae strains isolated in the
year 2000 exhibited high level resistance to penicillin at 5.7% and intermediate
resistance at 31.4%; in the year 2001 the percentage of highly resistant isolates
increased to 9.6% and the percentage of intermediately resistant strains rose to
39.5%. The S. pneumoniae erythromycin-resistant strains increased from 31.2%
in 2000 to 41.3% in 2001; similarly, the sulphamethoxazole/trimethoprim-
resistant strains increased from 24.3% in 2000 to 32.8% in 2001. Differences
were also noted inH. inﬂuenzae resistance to sulfamethoxazole/trimethoprim,
which increased from 7% in 2000 to 16.2% in 2001. The rest of the
isolated pathogens did not show any signiﬁcant difference in resistance, as
expected.
Conclusions: No signiﬁcant differences in the incidence of the main otic
pathogens were found. A signiﬁcant increase in sulfamethoxazole/trimetho-
prim resistance was noted in H. inﬂuenzae isolates. S. pneumoniae displayed
signiﬁcant increase in resistance to suggested antibiotics (penicillin, erythro-
mycin, sulfamethoxazole/trimethoprim).
P1268 Antimicrobial susceptibility of enteric bacteria
from chickens in Europe: results of the European
Antimicrobial Susceptibility Surveillance in Animals (EASSA)
program (1999–2001)
A. de Jong, M. McConville, R. J. Bywater, H. Marion and the EASSA
participants
Leverkusen, D; Tranent, Clungunford, UK; Brussels, B
Objectives: Antimicrobial resistance in enteric bacteria of food animals and
the potential for transfer of resistance into the human population is a cause of
concern. National surveillances of susceptibility in foodborne bacteria are
common but international surveys are rare. EASSA is the ﬁrst program to
study the in vitro antimicrobial susceptibility of zoonotic and commensal
bacteria of healthy animals (poultry, pigs, cattle) at slaughter across Europe.
The survey included identical sampling and bacterial isolation procedures in
eight countries, and MIC determination to panels of human antimicrobials.
Here, the ﬁndings for chickens are reported.
Methods: Cecal samples were randomly collected by meat inspectors at four
abattoirs per country in four countries. Each ﬂock was sampled only once.
Samples (usually 200 per country) were sent to national laboratories for
isolation of Campylobacter spp., Salmonella spp. and E. coli. Isolates were sent to
a central laboratory for agar dilutionMIC testing (NCCLS, 1999). Resistance
was based on NCCLS breakpoints, and was calculated for each drug and each
country.
Results:The total number of strains isolated were 802, 120 and 546 for E. coli,
Salmonella and Campylobacter, resp. The range in percentage resistance among
the countries tested for E. coli to ampicillin (A), cefepime (CP), cefotaxime
(CT), ciproﬂoxacin (C), chloramphenicol (CA), gentamicin (G), streptomy-
cin (S), tetracycline (TE), and trimethoprim (TR) were 5–51, 0, 0, 0–4,
Resistance (%) among isolates of SPN
n Penicillin Erythromycin CO-trimoxazole Tetracycline
Y1 Y2 Y1 Y2 Y1 Y2 Y1 Y2 Y1 Y2
France 184 191 46.2 38.7 57.6 53.9 43.1 30.4 44.0 47.1
Germany 325 693 2.2 2.4 15.7 15.9 8.3 7.4 11.7 14.0
Hungary 54 60 13.0 33.3 55.6 31.7 44.4 53.3 63.0 40.0
Ireland 53 57 34.0 26.3 26.4 17.5 37.7 24.6 30.2 10.5
Italy 119 284 10.0 6.3 42.9 34.9 23.5 26.8 25.2 21.5
Poland 68 77 13.2 6.5 23.5 2.6 26.5 9.1 45.6 18.2
Portugal 106 93 10.4 26.9 16.0 12.9 21.7 35.5 19.8 14.0
Spain 133 422 42.1 30.1 28.6 35.3 48.9 46.4 36.1 37.6
Turkey 77 101 14.3 11.9 15.6 13.9 35.1 31.7 24.7 19.8
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0.5–16.6, 0–4.5, 7–51, 6.5–85.4, and 2–49.7%, respectively. For Salmonella
the resistance percentages were 0–54.7 (A), 0 (CP), 0 (CT), 0 (C), 0–14 (CA),
0–5.3 (G), 14–52 (S), 0–52 (TE), and 24–50 (TR), respectively. For Campy-
lobacter the ranges were 0–35 (nalidixic acid), 0–34 (C), 0–3 (erythromycin), 0
(G), and 0–58 (TE)%. For E. coli Sweden had the lowest and France the
highest levels of resistance (except for S). For Salmonella the low prevalence
precluded a valid comparison among the countries; forCampylobacter, Sweden
had 0% resistance; France and The Netherlands had similarly higher values.
Conclusions: This survey, based on identical methods across the EU, shows
that the levels of resistance among enteric bacteria in chickens differ markedly
geographically. This may reﬂect differences in antibiotic policies in individual
countries. The results also suggest that there is a low level of resistance to
antibiotics that are commonly used to treat foodborne disease in humans.
P1269 Epidemiology and erythromycin resistance of
group A streptococci isolated from elementary school
children and acute pharyngitis in Jinju, Korea
S. Kim, N. Y. Lee
Jinju, Seoul, KOR
Objectives:Group A streptococci (GAS), themost common cause of bacterial
pharyngitis, has become more resistant to erythromycin (EM) or clindamycin
(CC), as these antibiotics are widely used. The degree of resistance and its
mechanism is not well known for these isolates in Korea.
Methods: Throat cultures were taken from 581 healthy elementary school
children in 2002 and from 246 children of acute pharyngitis at a local clinic in
the winter of 2001 and in the spring of 2002. T typing and emm genotyping
was performed. Antibiotic sensitivity with disk diffusion, phenotypic dis-
tribution and resistance genes of EM resistance were investigated for the
isolates.
Results: The isolation rate of GAS was 17% in the carriers and 50% in the
acute pharyngitis. Although T12 is most common, 27.6% in the carriers and
37.4% in acute pharyngitis. Emm12 (33.7%), emm18 (9.2%), emm22 (8.2%)
and emm1 (7.1%) were common in the carriers, while emm12 (28%), emm75
(18.4%), emm22 (12.8%) and emm2 (12%) were frequent in the pharyngitis.
Resistance to EM and CC were 50 and 34%, respectively, in the carriers,
compared with 46 and 20% in the acute pharyngitis. Constitutive resistance
(CR) and M phenotype were 65 and 33% in the carriers, compared with 42
and 58% in the pharyngitis. The strains showing CR and M phenotypes were
positive for ermB and mefA gene, respectively. Inducible resistance phenotype
was rarely seen, being only 2% in the carriers. Eighty eight percent of emm12
contained ermB gene in the carriers and 60% of emm12 in the pharyngitis.
Conclusions: GAS is very common in school children and in acute phar-
yngitis. Emm12 is most common and it has high resistance to EM and
CC. The antimicrobial resistance of GAS has become a signiﬁcant problem
in our community, which is higher in the carriers than in the pharyngitis.
Precise diagnosis and adequate treatment for acute bacterial pharyngitis is
needed.
P1270 Detection of CTX-M beta-lactamases in
Escherichia coli strains from a hospital in Northern Italy
R. Migliavacca, E. Dell’Amico, E. Nucleo, M. Spalla, S. Asticcioli,
M. D’Andrea, C. Matti, E. Romero, G. M. Rossolini, L. Pagani
Pavia, Siena, I
Objectives: To investigate the presence of CTX-M-related enzymes in
Escherichia coli clinical isolates producing extended-spectrum beta-lactamases
(ESBLs), at the Pavia University Hospital.
Methods: Twenty-eight nonreplicate E. coli isolates with an ESBL-positive
phenotype, collected from inpatients of the S.Matteo I.R.C.C.S. Hospital of
Pavia (northern Italy) in the period January–November 2002, were inves-
tigated. MICs for cefotaxime (CTX), ceftazidime (CAZ), cefepime (FEP) and
aztreonam (ATM) were determined by a microdilution test as recommended
by NCCLS (Approved Standard M7-A4). ESBL production was detected by
the application of BD-Phoenix ESBL screen ﬂow, and by a double-disk
synergy test between clavulanate or tazobactam and CTX, FEP, CAZ and
ATM. Conjugal transfer of resistance determinants was tested in liquid
medium. Beta-lactamases, separated by analytical isoelectric focussing
(IEF), were detected using nitroceﬁn; their activity against CTX, CAZ,
FEP and ATM was tested by a bioassay. PCR ampliﬁcation of blaCTX-M
alleles was carried out with primers designed on highly conserved gene
regions. The nature of the gene was determined by amplicon sequencing.
Pulsed-ﬁeld gel electrophoresis (PFGE) proﬁles of genomic DNA digested
with NotI were analyzed using the Bio-Rad Gene Path Procedure.
Results: Fifteen isolates were characterized by higher levels of resistance to
cefotaxime than to ceftazidime. IEF of crude extracts of the 15 isolates
revealed multiple beta-lactamase bands including a pI 8.4 band that, in a
bioassay, was active on CTX, FEP and ATM. PCR screening for blaCTX-M
determinants was positive in 12 isolates. Sequencing revealed the presence of
blaCTX-M-1. The ESBL determinants were transferable by conjugation.
Comparison of the PFGE proﬁles of CTX-M producers revealed clonal
heterogeneity.
Conclusion: CTX-M-type ESBLs are emerging also in Italy, where they can
contribute to beta-lactam resistance in nosocomial isolates of E. coli. Plasmid
dissemination seems to be a major mechanism for the spread of these
resistance determinants among nosocomial strains.
P1271 Epidemiology of bacteremic urinary tract
infections and antimicrobial resistance from a French
hospital network in 2001
A. Boisivon, D. Barraud, M. Bingen-Bidois, M. Cheron,
M. C. Demachy, F. Faibis, B. Ferre´, B. Hacquard, F. Richardin,
A. Scanvic, Y. Pe´an, Ile de France Microbiologist Group
Objectives: To update antimicrobial guidelines based upon bacteremic urin-
ary tract infections (BUTI) epidemiology and antimicrobial resistance.
Methods: A prospective survey was conducted in eight general nonteaching
hospitals from Paris and area during 2001. BUTI was deﬁned as bacteremia
with a documented UTI origin, community and nosocomial acquired were
differentiated based on historical data. Administrative data, characteristics of
patients, clinical information, microorganism and their antimicrobial resis-
tance (according to ‘Comite´ de l’Antibiogramme de la Socie´te´ Franc¸aise de
Microbiologie’, http://www.sfm.asso.fr) were collected.
Results: Among 1777 bacteremia, 526 (30%) were BUTI. The BUTI yearly
incidence was 0,37 per 100 admissions and 0.68 per 1000 days of hospitaliza-
tion. Patients: (female: 62%) were admitted to the medicine wards (54%),
surgery (17%), ICU (9%), emergency (7%), obstetric and pediatric (6%).
BUTI were community-acquired (74% CA) or nosocomial (26%N). Patients
ages (years) were:0–15:2%, 16–30: 7%, 31–45: 11%, 46–60 : 16%, 61–75: 26%
and>75: 37%. Patients had a urinary catheter in 7% of CA BUTI and in 41%
of N BUTI. Bacteria (n¼ 528) most frequently isolated were 402 E. coli
(76%), 23 P.mirabilis (4%), 25 Klebsiella sp. (4%), 23 S. aureus (4%), 17 E. fecalis
(3%). The resistance rates were as follows: Amk¼Amikacin, Amx¼ Amox-
icillin, Amc¼Amxþ clavulanic acid, BLSE¼ expanded spectrum beta lac-
tamase Cip¼Ciproﬂoxacin, Ctx¼Cefotaxime, Gm¼Gentamicin, Nal¼
Nalidixic acid, Tic¼Ticarcillin. Among S. aureus, eight (35%) were methi-
cillin R (4/9 N and 4/14 CA). No glycopeptide resistant enterococci or
staphylococci were notiﬁed.
Conclusion: Guidelines for N BUTI must consider the increased ﬂuoroqui-
nolones re´sistance rates. 3rd generation ce´phalosporins and aminosides remain
the most active compounds for CA and N BUTI.
P1272 Epidemiologic evaluation of high-level
gentamicin resistant (HLGR) among blood isolates of
enterococci in the south-east of Sweden during 1994–2001
B. Saeedi, B. Isaksson, J. Jonasson, A. Ha¨llgren, L. E. Nilsson,
H. Hanberger
Linko¨ping, S
Objectives: To investigate the epidemiology of HLGR among blood isolates
of enterococci collected from patients admitted to three hospitals in the south-
east of Sweden.
% Amx Tic Amc Ctx (BLSEþ) Gm Amk NaI Cip
E. coli (n¼ 402)
CA (n¼ 362) 49 46 38 1 (0) 0 0 9 5
N (n¼ 71) 51 50 45 4 (3) 4 0 17 12
Enterobacteria (n¼ 471)
CA (n¼ 362) 55 51 43 1 (0) 3 1 10 5
N (n¼ 109) 61 55 42 6 (3) 3 2 22 15
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Methods: Three hundred and ﬁfty-two (352) initial blood isolates of enter-
ococci were collected from patients admitted to three hospitals in the south-
east of Sweden between April 1994 and December 2001. No zone around a
gentamicin 30-mg disc was deﬁned as HLGR according to a disk diffusion
method recommended by the Swedish Reference Group of Antibiotics
(SRGA) (http://www.srga.se). Isolates with HLGR as well as 33 isolates
To study similarity of the PFGE patterns between HLGR and no HLGR
strains, 33 strains of E. faecaliswith no HLGR, matched by year and unit with
the HLGR E. faecalis isolates, were selected for detection of genetic related-
ness. Detection of related clones was performed using pulsed-ﬁeld gel
electrophoresis of SmaI DNA macrorestriction fragments. The isolates with
HLGR were included for PCR detection of the aac(6 0)Ie-aph(2 0 0)Ia gene.
E. faecalis ATCC 51299 was included as positive control and E. faecalis ATCC
29212 as negative control.
Results: Of the isolates, 246 (70%) were E. faecalis and 106 (30%) E. faecium.
Thirty-three (13%) of the E. faecalis isolates and four (3.8%) of the E. faecium
isolates were HLGR. Of the E. faecaliswith HLGR 22 (67%) belonged to the
same clone. All the four E. faecium with HLGR had unique PFGE patterns. It
was no similarity in any of the PFGE patterns between the E. faecalis with
HLGR and the 33 tested strains of E. faecaliswith no HLGR. All isolates with
HLGR and the positive control (E. faecalis ATCC 51299) carried the
aac(6 0)Ie-aph(2 0 0)Ia gene and the gene was not present in the negative control
(E. faecalis ATCC 29212).
Conclusion:The results show genetic relatedness among 67% of the E. faecalis
isolates with HLGR indicating a clonal spread in the three hospitals in south-
east of Sweden.
P1273 Antimicrobial susceptibility and the molecular
epidemiologic characteristics of Neisseria gonorrhoeae
isolates in Korea
D. Yong, T. S. Kim, K. Lee, Y. Chong, J. W. Tapsall
Seoul, KOR; Sydney, AUS
Objectives: The prevalence of penicillinase-producing or ﬂuoroquinolone
(FQU)-resistant Neisseria gonorrhoeae varies greatly depending on countries.
There are only few reports on the resistance mechanisms and molecular
epidemiologic studies on Korean isolates. The aims of this study were (i) to
determine the antimicrobial susceptibilities, (ii) to determine the mutations of
the quinolone resistance-determining region (QRDR) of gyrA and parC of
FQU-nonsusceptible isolates, and (iii) to conduct a molecular epidemiolo-
gical analysis on the strains isolated from Korea and other countries.
Methods:The susceptibility of 453 Korean isolates ofN. gonorrhoeaewas tested
by the NCCLS disk diffusion test and MICs for 49 isolates were tested by the
agar dilution method. The PCR-products of QRDRs of gyrA and parC were
used to detect presence of mutation by direct sequencing. Nhe I-digested
genomic DNA of isolates from Korea and Western Paciﬁc countries was
separated by PFGE and the patterns were analyzed.
Results: Disk diffusion test showed none of the Korean isolates were
susceptible to penicillin G and to tetracycline. Among the isolates, 63% were
penicillinase-producing N. gonorrhoeae (PPNG). A marked rise in ciproﬂox-
acin (CIP)-resistance rate was noted, from 16% in 1999 to 40% in 2001. The
MIC50 of CIP, 0.5mg/mL in this study, was an increase of 32- and 4-fold
compared with those for isolates in 1993 and 1996, respectively. The MIC
range of CIP was 0.008–32mg/L for the non-PPNG strains, but was
0.008–0.5mg/L for the PPNG strains, suggesting both resistances do not
coexist. None were resistant to ceftriaxone and spectinomycin. However, the
MIC of ceftriaxone ranged 0.008–0.12mg/L. The MIC50 and MIC90
were, 0.03, and 0.06, respectively, which were 2-fold increase compared with
the previous studies. The strains with a high-level CIP-resistance mostly
carried a double amino acid substitution in gyrA and a single substitution in
parC. CIP-resistant strains isolated from Korea and other Western Paciﬁc
countries showed different PFGE proﬁles, suggesting FQU-resistant strains
emerged from the domestic clones.
Conclusions: In Korea, FQU-resistant N. gonorrhoeae isolates increased sig-
niﬁcantly, while PPNG remained prevalent. The existence of strains with
decreased susceptibility to ceftriaxone and the high prevalence of strains
resistant to FQU, indicate oral cephalosporins and FQU are no more suitable
for empiric treatment of gonorrhea in Korea.
P1274 PER-1 ESBL production in a urinary isolate of
Providencia rettgeri
U¨. G. Bahar, Z. Gu¨lay, A. Mert
Ankara, Izmir, TR
Objectives: There are a few number of extended-spectrum beta-lactamases
(ESBLs) that are not closely related to TEM or SHV beta-lactamases. The
PER-1 beta-lactamase, which is one of these, was ﬁrst discovered in strains of
Pseudomonas aeruginosa isolated from patients in Turkey. Later it was also found
among isolates of Acinetobacter baumanni and some other Enterobacteri-
aceae taxa. Here we report PER-1 production in a urinary isolate of
Providencia rettgeri strain.
Methods: A P. rettgeri strain was isolated from the urine of an elderly patient,
with benign prosthatic hypertrophy, hospitalized at the Urology Clinic.
Biochemical identiﬁcation of the strain was made by API-20E (bioMerieux,
Marcy I’Etoile, France). The susceptibility of the isolate was determined by
the Kirby-Bauer disk diffusion assay and interpreted according to NCCLS.
The presence of an ESBL was investigated by means of a double-disk synergy
test agar, of the combined disk method and of E-test.
Results: Antimicrobial susceptibility testing of the strain revealed a high
resistance to extended spectrum beta-lactams and intermediate resistance to
aztreonam. The presence of an ESBL was suggested by observation of a
synergy between the amoxicillin clavulanic acid disk and third generation
cephalosporins and aztreonam. As PER-1 is widespread in Turkey, and
besides P. aeruginosa and A. baumanni strains, is also found in Enterobacter-
iaceae like Proteus mirabilis andAlcaligenes faecalis, the strain was suspected to be
harboring PER-1. PER PCR is performed, and blaPER is detected in the
strain.
Conclusions:Wedescribe for the ﬁrst time the presence of PER-1 in P. rettgeri,
an enzymewhich is usually widespread amongA. baumanni and P. aeruginosa in
Turkey. To the best of our knowledge this report is the second description of
an ESBL and ﬁrst description of PER-1 production by P. rettgeri. Although
P. rettgeri is usually susceptible to extended spectrum cephalosporins such as
cefotaxime and ceftazidime, this strain warns us about the rapidly spreading
ESBLs (including PER-1) amongst these strains.
P1275 Epidemiologic analysis of methicillin-resistant
Staphylococci clones identiﬁed at a surgical hospital
A. Zilevica, T. Tracevska, I. Vingre, R. Paberza
Riga, LV
Objectives:To evaluate the prevalence and relatedness of clinical methicillin-
resistant staphylococci (MRS) clones collected at a surgical hospital, using
phenotypic and genotypic methods.
Methods: A total of 117 clones of MRS collected from clinical specimens of
different inpatients within 1998–2002 were analyzed. All clones were char-
acterized by conventional methods, according to the antimicrobial suscep-
tibility patterns and genotypic proﬁles deﬁned by hybridization with the mec
A gene in PCR. For typing of S. haemolyticus and S. aureus, the macro
restriction analysis of pulsed ﬁeld gel electrophoresis (PFGE) and analysis
of the PCR products of the coa gene were employed, respectively. Molecular
typing was performed at the Robert Koch Institute, Wernigerode, Germany.
Results: From 117 MRS clones, 25 were coagulase-positive S. aureus and 92
coagulase-negative Staphylococci, including 64 cultures of S. epidermidis (sensu
stricto), 17 – S. haemolyticus, 9 – S. hominis, 2 – S. warneri. All cultures were
positive for the mec A gene. In the study of 10 strains of S. hemolyticus using
SmaI macro restriction and PFGE, 2 clusters of completely identical strains
were found. Each cluster consisted of two strains. The remaining strains were
heterogeneous. The typing of the PCR products of the coa gene from 21
isolates of S. aureus revealed that 16 (80%) had similar patterns, while 2 and 1
isolates were different from this pattern. No correlation with the antibiograms
of the clones in a cluster was registered.
Conclusion: Both phenotypic and genotypic methods are necessary for
detection of the relatedness of clinical isolates.
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P1276 Analysis of genetic background in
Staphylococcus aureus isolates from North America
producing toxic shock syndrome toxin 1
R. V. Goering, C. Davis, J. Seymour, J. Parsonnet
Omaha, Cincinnati, Lebanon, USA
Objectives: S. aureus producing toxic shock syndrome toxin 1 (TSST-1) are
known to be the major cause of menstrually associated toxic shock syndrome.
Nevertheless, important questions remain regarding the genomic diversity of
these organisms, which appear to exhibit differences associated with global
geographic origin and location. This issue was approached by an examination
of TSST-1 producing S. aureus isolates from a variety of North American (U.S.
and Canada) locations.
Methods: TSST-1 producing S. aureus isolates were obtained as part of a
prevalence study culturing various body sites (i.e. nasal, anal, and vaginal) of
women in ﬁve different North American locations (4 US. and 1 Canada). A
total of 204 isolates were examined by macro-restriction (SmaI) analysis using
pulsed ﬁeld gel electrophoresis (PFGE). The isolates were additionally
examined for methicillin resistance by agar disc diffusion using standard
methods and by PCR and Southern hybridization analysis using mecA-
speciﬁc primers and probes.
Results:Multiple isolates from the same individual generally exhibited highly
related or identical PFGE patterns although there were exceptions. Common
PFGE patterns were observed which were independent of geographic loca-
tion or cultured body site. None of the isolates tested were identiﬁed as
methicillin-resistant by disc diffusion and/or PCR-Southern hybridization
analysis.
Conclusions:While signiﬁcant genomic diversity occurs in North American
TSST-1 producing S. aureus isolates, common geographically independent
subtypes are present which are not associated with methicillin resistance.
These data further reinforce previous reports regarding the tendency toward
‘clonality’ in TSST-1 producing S. aureus populations. In addition, the results
aid in clarifying the infrequent association of methicillin resistance with
menstrual TSS in North America which is in contrast to the situation
reported in Europe and Japan.
P1277 Antimicrobial susceptibility patterns of
Gram-negative bacteria in Swedish intensive care units
L. E. Nilsson, M. Nilsson, H. Hanberger Swedish Study Group
Objective: To investigate the antibiotic susceptibility among Gram-negative
isolates in Swedish intensive care units (ICUs).
Methods: During 2002 629 initial isolates of Gram-negative bacteria from
505 patients admitted to ICUs were collected at eight Swedish hospitals and
minimal inhibitory concentration (MIC) determinations of ceftazidime
(CAZ), ceftriaxone (CRO), cefuroxime (CXM), cefepime (CPM), cipro-
ﬂoxacin (CIP), cotrimoxazole (TSU), gentamicin (GTM), imipenem (IPM),
piperacillin (PIP), piperacillin/tazobactam (PTZ) were performed with E-test
(AB Biodisk). An antibiotic to which >90% of isolates were susceptible
according the breakpoints of the National Committee for Clinical Laboratory
Standards (NCCLS) was deﬁned as an treatment alternative (TA90) for
empiric therapy.
Results: The sources of the isolates were respiratory tract (36%), urine (22%),
gastrointestinal tract (17%), blood (10%) and skin and soft tissue (9%). The
most frequently bacterial isolates were: Escherichia coli (27%), Enterobacter spp.
(13%), Klebsiella spp. (12%), Pseudomonas aeruginosa (11%), Haemophilus spp.
(6%), Stenotrophomonas maltophilia (5%), Proteus spp. (4%), Acinetobacter spp.
(3%), Citrobacter freundii (2%) and Morganella morganii (2%). The number of
TA90s were low (2) for S. maltophilia (CPM, TSU), higher (5–7) for Enter-
obacter spp./C. freundii (CPM, CIP, GTM, IPM, TSU), P. aeruginosa (CAZ,
CPM, GTM, PIP, PTZ), K. oxytoca (CTZ, CPM, CIP, GTM, IPM, TSU),
Acinetobacter spp. (CTZ, CPM, CIP, GTM, IPM, PTZ, TSU) and highest (8–
10) for K. pneumoniae (CTZ, CPM, CRO, CIP, GTM, IPM, PTZ, TSU),
E. coli (CTZ, CPM, CRO, CXM, CIP, GTM, IPM, PTZ), M. morganii
(CTZ, CPM, CRO, CIP, GTM, IPM, PT, PTZ, TSU) and Proteus spp.
(CTZ, CPM, CRO, CXM, CIP, GTM, IPM, PT, PTZ, TSU). When all
isolates were pooled the TA90s were six (CTZ, CPM, CIP, GTM, IPM,
PTZ).
Conclusions:Rather high frequencies of decreased susceptibility were seen to
CRO, CXM, PIP and TSU. Higher number of isolates of E. coli and Klebsiella
spp. with MIC> 1mg/L to one or more 3rd generation cefalosporins suggest
an increase in prevalence of extended spectrum beta-lactamases (ESBLs) than
seen in earlier Swedish studies. This study also shows higher number of isolates
of P. aeruginosawith decreased susceptibility to CIP (10%) and IMP (19%) than
seen earlier in Sweden.
P1278 Macrolide-resistant pneumococci in Finland
M. Pihlajama¨ki, J. Jalava, P. Kotilainen, P. Huovinen on behalf of
the FiRe-group
Objectives: Macrolide resistance is an increasing problem among pneumo-
cocci. We have studied prevalence of macrolide-resistant pneumococci
(MRP), the connection between outpatient macrolide consumption and
resistance, and macrolide resistance mechanisms.
Methods: FiRe (Finnish Study Group for Antimicrobial Resistance) data was
used to determine the overall macrolide resistance rate and for determining
the connection between macrolide use and resistance in Central Hospital
Districts. The ﬁgures of the drug use were obtained from theNational Agency
of Medicines. Among the material of 2500 invasive/penicillin nonsusceptible
(PNS) pneumococci, macrolide resistance was studied and resistance mechan-
isms were determined. Serotyping was performed in Oulu.
Results:Macrolide use in 1995–96 correlated highly signiﬁcantly (P¼ 0.007)
with macrolide resistance in 1997 among Finnish Central Hospital Districts.
In 1997, macrolide resistance was 7% and in 2000, 11%. Among invasive
pneumococci, 6% were MRP in 1998–2001, and macrolide resistance was
most common resistance-type. Among the PNSP, macrolide resistance
increased from 29 to 61% during 1996–2000. In the invasive material, mef(A)
(M-phenotype) was the most common resistance gene and among PNSP,
erm(B) (MLSB phenotype) was the most common. In a few percent of the
MRP, a novel MS phenotype was seen. Among those, mutations in 23S
rRNA or ribosomal proteins L4 and L22 were detected. Serotype 23 was the
most common among the MRP.
Conclusions: Due to the high-quality resistance surveillance in Finland, we
were able to study the relation between the regional drug use and resistance.
The positive correlation gives more evidence for the common hypothesis that
the spread of resistance can partly be controlled by the drug use. Macrolide
resistance is not common among the invasive pneumococci, but still the
commonest. For infections caused by the PNSP, macrolides should not be
used, as among those, macrolide resistance reached 61% in 2000. Also,
macrolide resistance among those is of high-grade, as it is often mediated
by methylase gene.
P1279 Antimicrobial resistance of Staphylococcus in
Spain: ﬁve nationwide prevalence studies
O. Cuevas, E. Cercenado, J. V. Guinea, M. Sa´nchez-Conde, M. Sa´nchez-
Somolinos, E. Bouza
Madrid, E
Objectives: Data regarding the evolution of Staphylococcus resistance in a
whole country have a deﬁnite inﬂuence in the design of empirical treatment
regimens. However, incidence studies over long periods of time are expensive
an very difﬁcult to carry out. In order to ascertain the present situation of the
antimicrobial resistance of Staphylococcus in our country and the evolution of
the resistance, we performed ﬁve point prevalence studies over a 17-year
period.
Methods: From 1986 to 2002 we carried out ﬁve point prevalence studies in a
large group of Spanish hospitals (from 68 institutions in 1986 to 143 in 2002)
collecting all Staphylococcus isolates in a single day. All microorganisms were
identiﬁed in the ﬁve studies at the same laboratory, and antimicrobial
susceptibility testing was performed against 15 antimicrobial agents using
and automated microdilution method (MicroScan).
Results: The evolution in time of percentages of resistance against selected
antimicrobials is summarized in Table 1 (PEN¼ penicilin, OXA¼ oxacillin,
Table 1 Percentage of resistance of S. aureus/coagulase negative staphylococci (CNS)
to selected antimicrobials
Year PEN OXA ERY GEN RIF T/S CIP VAN TEI
1986 95/86 1.5/32 7/41 5/25 1/4 – 0.6/1 0/0 0/0
1991 97/91 11/25 24/45 14/40 5/8 – 16/21 0/0 0/0
1994 92/77 17/34 34/58 19/49 8/9 0.5/22 20/24 0/0 0/0
1996 92/86 18/51 24/54 16/40 7/9 1/31 20/33 0/0 0/1
2002 88/79 30/63 33/64 18/35 2/7 2/22 37/50 0/0 0/0
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ERY¼erythromycin, GEN¼ gentamicin, RIF¼ rifampin, T/S¼ trimetho-
prim/sulfamethoxazole, CIP¼ ciproﬂoxacin, VAN¼ vancomycin, TEI¼
teicoplanin).
Conclusions:Over the period of study there was an overall resistance increase
to most antimicrobials, mainly of S. aureus to oxacillin; resistance of S. aureus to
T/S was anecdotal. In general all the isolates were uniformly susceptible to
glycopeptides. Periodical performance of prevalence studies is an useful,
unexpensive and easy tool to know the nationwide situation of a micro-
organism and its resistance to antimicrobials, provides important information
about the changing spectrum and regional variation of antimicrobial resis-
tance, and assists in the design of appropriate measures for controlling the
emergence and spread of antimicrobial resistance.
P1280 Serotype distribution and evolution of antibiotic
resistance among Salmonella isolates in a Greek hospital
S. Maraki, A. Georgiladakis, Y. Tselentis
Heraklion, GR
Objective: To determine the serotype distribution and to analyze the evolu-
tion of the antimicrobial resistance of Salmonella strains isolated from diarrheal
patients in Crete, Greece, during the last three years (2000–2002).
Methods:A total of 251 Salmonella strains isolated from stool specimens were
studied. Identiﬁcation was made according to standard microbiological
procedures and serotyping was performed with commercial antisera by the
slide agglutination method. Antimicrobial susceptibility testing to seven
antibiotics was checked by the disk diffusion method following the recom-
mendations of the NCCLS.
Results:Two hundred and ﬁfty-one Salmonella strains were isolated during the
3-year study period, which corresponded to 16 serotypes. Salmonella enterica
serotype enteritidis was the most frequent (164 strains) accounting for 65.3%
of the Salmonella isolated. Salmonella enterica serotype typhimurium (38 strains)
constituted 15.1%, while the remaining 14 serotypes were rare, constituting
19.6% of the strains. Eleven percent of the isolates were resistant to ampicillin.
There was a marked decrease in the resistance to this antibiotic during the
study period. Between 2000 and 2001 ampicillin resistance decreased from
19.6 to 12.8%, while during 2002 only 5% of the isolates were resistant to this
antibiotic. Eight percent were resistant to chloramphenicol (17.8% during
2000, 8.5% during 2001 and 2% during 2002), 20.3% to tetracycline (44.6%
during 2000, 23.4% during 2001 and 4% during 2002). Four percent of the
isolates were resistant to cotrimoxazole (7.1% during 2000, 4.2% during 2001
and 1% during 2002), 1.6% to gentamicin (5.3% during 2000, 0% during 2001
and 1% during 2002). Only three isolates were resistant to norﬂoxacin and one
to ciproﬂoxacin.
Conclusions:
1. Salmonella enterica serotype enteritidis continuous to be the predominant
Salmonella serotype in our region.
2. Resistance of Salmonella enterica to antimicrobial agents decreased the last
3 years, probably due to the more prudent use of the antibiotics.
P1281 In vitro activities of 17 antimicrobials against 200
clinical strains of Streptococcus pneumoniae isolated in
Crete, Greece
S. Maraki, Y. Tselentis
Heraklion, GR
Objective:To study the in vitro activity of 17 antibiotics against 200 strains of
Streptococcus pneumoniae isolated from clinical specimens in the University
Hospital of Crete, Greece.
Material and methods: Susceptibility tests were done by the E-test method
according to NCCLS guidelines. The following antibiotics were tested:
penicillin G, cefuroxime, cefotaxime, ceftriaxone, cefepime, imipenem,
meropenem, erythromycin, clarithromycin, ciproﬂoxacin, levoﬂoxacin, spar-
ﬂoxacin, moxiﬂoxacin, chloramphenicol, tetracycline, trimethoprim/sulfa-
methoxazole, and vancomycin.
Results: The MIC90 (mg/L) and percentage of resistance (%) were as follow:
penicillin G 0.023 (38%; 16.5% resistant and 21.5% intermediate), cefuroxime
three (25.5% resistant and 5% intermediate), cefotaxime 0.75 (3.5% resistant
and 14% intermediate), ceftriaxone 0.75 (2.5% resistant and 9% intermediate),
cefepime 1.5 (12% resistant and 13.5% intermediate), imipenem 0.25 (1.5%
resistant and 20.5% intermediate), meropenem 0.25 (1% resistant and 9%
intermediate), erythromycin 32 (36%), clarithromycin 32 (36%) chloram-
phenicol 3 (4.5% resistant and 1% intermediate), tetracycline 16 (27.5%
resistant and 2.5% intermediate), trimethoprim/sulfamethoxazole 12 (18.5%
resistant and 16% intermediate), ciproﬂoxacin 2 (1%), levoﬂoxacin 1.5 (0%),
sparﬂoxacin 0.5 (1% resistant and 3.5% intermediate), moxiﬂoxacin 0.125
(0.5%), and vancomycin 0.5 (0%). Multiple resistance was observed for 61
strains.
Conclusion: The high incidence of antibiotic-resistant pneumococci in our
region underline the need for continuous surveillance of antimicrobial
resistance proﬁles of S. pneumoniae.
P1282 The use of amoxicillin as selection pressure for
trimethoprim resistance
A. Eastaway, R. Gillespie, B. Weinhardt
Paisley, UK
Objectives: To determine the impact of other antibiotic usage on the
persistence of trimethoprim resistance in urinary tract isolates.
Methods: Antibiotic resistance proﬁles for urinary isolates of Lactose Fer-
menting Coliforms were reviewed to establish linked resistance patterns.
GP prescribing data were analyzed and the impact of different classes of
antibiotics on trimethoprim resistance was assessed using logistic regression
(minitab). Gp prescribing habits were assessed using a questionnaire survey.
Results:
	 57% of questionnaires were returned. 80% of respondents use trimetho-
prim as ﬁrst line treatment for urinary tract infection.
	 75% of respondents use amoxicillin as ﬁrst line treatment for respiratory
tract infections.
	 57% of all lactose fermenting coliform isolates from urine samples were
resistant to trimethoprim.
	 25% of these isolates were resistant to both amoxicillin and trimethoprim
(sometimes with other classes as well).
The commonest resistance pattern being amoxicillin and trimethoprim at
15%. Logistic regression showed an association between amoxicillin usage and
percentage of isolates resistant to trimethoprim.
Conclusions:There is pressure to reduce the amount of antibiotic prescribing
in general practice and to move away from agents with high levels of
resistance. With an expectation that resistance will reduce over time. When
developing a prescribing policy for general practitioners it is essential that
associated resistance determinants are identiﬁed so that other factors associated
with persisting resistance can be considered and modiﬁed at the same time. In
this example reducing trimethoprim prescribing alone will not signiﬁcantly
impact on the level of trimethoprim resistance. Levels of amoxicillin pre-
scribing will also have to be addressed.
P1283 Lack of evolution of resistance to teicoplanin or
vancomycin of S. epidermidis: strains isolated in Nantes
from 1990 to 2001
H. Drugeon, M. Juvin, C. Janus
Nantes, Beaucouze, Paris, F
Objectives: Following concerns about the potential development of resistance
to teicoplanin and vancomycin in Staphylococcus epidermidis, this study was
performed to track the possible evolution of resistance of strains isolated over a
11-year period in Nantes. A comparison was also made of results obtained
with two different Mueller-Hinton (MH) liquid sensitivity test media.
Methods:50 strains, randomly selected from all S. epidermidis strains isolated in
Nantes over each 2-year period between 1990 and 2000, and 246 strains
isolated in 2001 were tested for Minimum Inhibitory Concentrations (MIC)
using both Difco and Bio-Rad MH broths. NCCLS methodology was used
with the following breakpoints applied for teicoplanin: S8mg/L,
I¼ 16mg/L, and R 32mg/L and vancomycin: S4mg/L, I¼ 8–
16mg/L, and R32mg/L.
Results: All isolates tested were deemed fully sensitive to vancomycin using
both media. Teicoplanin summary results are shown in Table 1.
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The number of S. epidermidis strains resistant to teicoplanin can be seen to have
not increased signiﬁcantly over the last 11 years, and there were actually fewer
isolated in 2001 than in 1990. Bio-Rad liquid MHmedium gave consistently
higher MICs to both vancomycin and teicoplanin, although the latter was
more greatly affected.With Difco media, the number of strains that were fully
sensitive to teicoplanin ranged from 92 to 100%, whereas with Bio-Rad the
range was 68–90%.
Conclusions:There is no evidence for an increase in resistance to teicoplanin
or vancomycin of S. epidermidis since 1990. MICs of teicoplanin are more
greatly affected by the media used than those of vancomycin. Bio-Rad MH
broth gave consistently higher MICs than those with Difco MH broth.
Depending on the media used, it is likely that teicoplanin MICs will vary;
without this necessarily being the result of development of resistance.
P1284 ypdI gene involved in exopolysaccharide
production in Escherichia coli K-12CM2555 mutant
J. Potrykus, G. Wegrzyn
Gdansk, PL
Objectives: We are well aware of the increasing microbial resistance to
antibacterial agents such as antibiotics and biocides. A signiﬁcant issue in
the phenomenon of resistance is the presence of bioﬁlms. By forming such
sessile, multiorganism communities, the pathogens are better equipped to
counteract the action of commonly used antibacterial agents than when living
in a planktonic state. Exopolysaccharides comprise an important component
of bioﬁlms. Although not always essential in the early stages of bioﬁlm
formation, they are imminent in sustaining the bioﬁlm architecture, being
amatrix in which the bacteria are embedded and which, in part, protects them
from the action of caustic agents. Escherichia coli K-12 is a commonly
researched model bacterium, a useful tool in elucidating many metabolic
processes. Although E. coli exopolysaccharide production has been exten-
sively examined, many issues still remain unclear. Under standard laboratory
conditions, E. coli strains produce only basic levels of the main exopolysac-
charide colanic acid. In our laboratory, we have observed that an E. coli
mutant, strain CM2555, formed mucoid colonies when bearing a multicopy
plasmid pJPA2.5 carrying a 3.6-kb fragment of E. coli chromosome. The aim
of this work was to map gene(s) responsible for the unusual mucoid colony
formation and to investigate the nature of the slime.
Methods: To reach our objectives we used a genetic mapping approach,
including DNA cloning techniques and polymerase chain reaction. In order
to investigate the nature of the slime, we analyzed bacterial protein proﬁles by
polyacrylamide gel electrophoresis. Gas chromatography in conjunction with
mass spectrometry was performed.
Results: As a result of systematic mapping of the gene(s) responsible for
mucoid colony formation of E. coli CM2555 strain we discovered that the
phenotype was due to an increased copy number of ypdI gene. This gene’s
functions have not been heretofore experimentally examined. The slime
accompanying mucoid colony formation is not associated with signiﬁcant
changes of bacterial protein proﬁle. The mucoidy results from elevated
production of extracellular polysaccharide colanic acid.
Conclusions:This work shows for the ﬁrst time that the ypdI gene is involved
in colanic acid synthesis in E. coli. However, this effect seems to be genetic
background speciﬁc since none other common E. coli wild-types tested
displayed changed colony morphology after introducing ypdI on a multicopy
plasmid.
P1285 Molecular ﬁngerprinting of multidrug-resistant
isolates of Mycobacterium tuberculosis from Chest Diseases
Hospital in Kuwait
S. Ahmad, E. Mokaddas, A. Abal
Safat, KWT
Objectives: To perform molecular ﬁngerprinting on 21 consecutive multi-
drug-resistantMycobacterium tuberculosis strains isolated from tuberculosis (TB)
patients at the Chest Diseases Hospital, Kuwait, during 1998–2001.
Methods: The genotyping was performed by touchdown double-repetitive-
element-PCR (DRE-PCR). The genotypic relationships among isolates
exhibiting cluster pattern was further studied by determining the presence
of distinct mutations in rifampin-resistance-determining region (RRDR) of
the rpoB gene, the presence of R463 or L463 polymorphism at codon 463 in
the katG gene and the presence or absence of S315T mutation (the most
common genetic alteration causing resistance to isoniazid) in the katG gene.
Results: The isolates exhibited 13 distinct patterns in DRE-PCR with more
than half of the isolates (12 of 21) exhibiting unique patterns. All the isolates
(12 of 12) yielding two or more DNA fragments in DRE-PCR were unique
strains. The remaining 9 isolates yielded a single DNA fragment of the same
size in DRE-PCR. The data on the presence of distinct mutations in RRDR
of the rpoB gene, the presence of R463 or L463 polymorphism at codon 463
in the katG gene and the presence or absence of S315T mutation in the katG
gene showed that 6 of 9 cluster pattern isolates were genotypically distinct
strains.
Conclusions: The data suggest that most expatriate patients were infected
with a unique strain ofM. tuberculosis and that the apparent grouping of some
cluster pattern isolates was most likely due to low copy number of IS6110
rather than any speciﬁc relationship among these isolates. The results may also
have implications for tuberculosis control measures in low incidence countries
with large immigrant populations.
Acknowledgement: Supported by Kuwait University Research Administra-
tion grant MDI 301 and MI 116.
P1286 Antimicrobial resistance among Campylobacter
jejuni/coli strains acquired in Sweden and abroad
A. O¨sterlund, M. Hermann, G. Kahlmeter
Va¨xjo¨, S
Objectives:The objective of this study was to ﬁnd out whether there has been
a difference in antibiotic resistance among C. jejuni/coli strains acquired
outside Sweden and domestically during the period 1990–2002.
Methods:
1. Quantitative data from susceptibility tests of C. jejuni/coli were obtained
from the database in the department of Clinical Microbiology, Va¨xjo¨,
Sweden.
2. Breakpoints, distinguishing wild type populations from those not fully
susceptible, were determined from zone histogram analysis.
3. Information about the countries, where the C. jejuni/coli strains most
probably were contracted, was obtained from the notiﬁcations sent to the
department of Communicable Disease Control and Prevention, Va¨xjo¨,
Sweden.
Results: Data on antibiotic susceptibility and country where the strains were
contracted was obtained from 1419 of 1545 C. jejuni/coli cases (92%). In 575
of the 1419 cases the strains were contracted in Sweden and in 844 cases in
countries outside Sweden. During the study period, a steady trend towards
increasing resistance to tetracycline (from 20 to 50%) and ciproﬂoxacin (from
0 to 60%) was seen in C. jejuni/coli contracted outside Sweden. No signiﬁcant
resistance to tetracycline or ciproﬂoxacin was seen in the domestically
acquired strains. No signiﬁcant resistance to erythromycin was seen either
in domestically acquiredC. jejuni/coli strains or strains acquired abroad, during
the study period.
Conclusions: A clear trend over a 13-year period of increasing ciproﬂoxacin
and tetracycline resistance, among C. jejuni/coli strains acquired abroad, was
evident. This trend was not seen for erythromycin or in domestically acquired
strains.
Table 1
% of strains, D¼Difco, B¼Bio-Rad
1990 1992 1994 1996 1998 2000 2001
Teicoplanin
sensitivity D B D B D B D B D B D B D B
S 96 90 96 74 92 86 92 70 100 88 98 68 96 85
I 2 8 2 20 4 4 6 22 0 12 2 26 4 14
R 2 2 2 6 4 10 2 8 0 0 0 6 0 1
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P1287 Enterococcus spp. organisms isolated in a
teaching hospital. A 2-year bacteriologic survey
R. Manfredi, A. Nanetti, S. Morelli, M. Ferri, R. Valentini, L. Calza,
F. Chiodo
Bologna, I
Objective: To assess the epidemiology and resistance features of enterococci
(E) cultured in a 2-year period, with attention on the difference between
E. faecalis and E. faecium, and the role of novel antibiotics targeted on multi-
resistant Gram-positive cocci: dalfopristin-quinupristin (DQ), linezolid and
ﬂuoroquinolones.
Methods: Results: 4628 E. faecalis strains and 648 E. faecium isolates were
examined. An increase of E. faecium vs. E. faecalis was observed in the year
2001 (P< 0.0001), with growing involvement of cardiovascular (P< 0.0001),
intrabdominal (P< 0.0001), and genital tract (P< 0.003). E. faecalis showed a
higher in vitro sensitivity than E. faecium against penicillin, ampicillin,
nitrofurantoin, levoﬂoxacin and streptomycin (P< 0.0001). On the other
hand, E. faecium was more susceptible to gentamycin and DQ (P< 0.0001).
The activity of tetracyclines (30% of strains), linezolid (99%) and glycopep-
tides did not show signiﬁcant differences between E. faecalis and E. faecium.
Glycopeptides and linezolid proved the most effective drugs on E, since only 2
E. faecalis strains tested resistant, while all the 648 E. faecium strains were
sensitive. When comparing the susceptibility pattern of the year 2001 vs.
2000, no signiﬁcant difference was found for both E, which showed a slightly
increased sensitivity to penicillin, semisynthetic penicillins, gentamycin,
streptomycin, nitrofurantoin and linezolid for E. faecalis, and penicillin,
tetracyclines and linezolid for E. faecium.
Conclusion: Susceptibility levels of E show broad variations according to
literature studies, due to the large spectrum of involved variables. In our
experience based on>5000 E strains, a temporal increase of isolations, and an
increasing role of E. faecium were noticed. The in vitro studies conﬁrmed a
different proﬁle of E. faecalis vs. E. faecium. Penicillin G and semisynthetic
penicillins are still highly active on E. faecalis, but it is not true for E. faecium.
The continued in vitro efﬁcacy of nitrofurantoin, gentamycin and strepto-
mycin is of interest. Among recently introduced compounds, linezolid is
effective on 99% of strains and maintains a very high activity on the emerging
E. faecium.DQ and levoﬂoxacin are characterized by a greater activity on E.
faecium and E. faecalis, respectively. Glycopeptides showed resistance levels
lower vs. those observed in most literature surveys, and remain the reference
molecules for all E. The emerging of resistances against recent molecules
suggests a prudent use of all available therapeutic resources.
Staphylococci
P1288 Antimicrobial in vitro activity of
quinupristin/dalfopristin against staphylococci and
comparison to other antimicrobial agents
E. Ikonomopoulou, K. Papadopoulos, K. Kottara, H. Koumoundourou,
P. Hamakioti, A. Reggli
Patras, GR
Objectives: To survey the current in vitro resistance of quinupristin/dalfo-
pristin (Synercid: SYN) against coagulase negative staphylococci (CoNS) and
S. aureus and also to compare the resistance of SYN to the resistance of
oxacillin (OX), erythromycin (ER), clindamycin (CL) and norﬂoxacin
(NOR).
Methods:During 2002, 690 clinical isolates of CoNS and 66 clinical isolates
of S. aureuswere collected in our hospital. Cons strains were isolated: 162 from
urine cultures, 183 from blood cultures and 345 from wound infections.
S. aureus strains were isolated: 6 from urine cultures, 15 from blood cultures
and 45 from wound infections. Identiﬁcation was carried out by ID 32 Staph
for CoNS and by conventional methods for S. aureus. Resistance was deter-
mined by the breakpoint system: mini API (bioMerieux).
Results: All CoNS and S. aureus strains were susceptible to vancomycin. Ten
percent (69/690) of CoNS and 9% (6/66) of S. aureus strains were resistant to
quinupristin/dalfopristin. The resistance of CoNS strains to other antimi-
crobial agents was: 64% (444/690) to oxacillin, 60% (414/690) to clindamy-
cin, 73% (507/690) to erythromycin and 43% (300/690) to norﬂoxacin. The
resistance of S. aureus strains to other antimicrobial agents was: 27% (18/66) to
oxacillin and norﬂoxacin, 32% (21/66) to clindamycin, 59% (39/66) to
erythromycin.
Conclusions: In vitro activity of SYN against CoNS (susceptibility: 90%) and
S. aureus (susceptibility: 91%) is indicative that SYN is an effective antibiotic to
staphylococcal infections and its superiority against OX, ER, CL and NOR
makes it an alternative therapy in staphylococcal infections.
P1289 Antibiotic-induced stress and the expression of
cell wall components by strains of Staphylococcus aureus
displaying increased resistance to vancomycin (VISA)
C. G. Gemmell, L. M. Everett
Glasgow, UK
Background: Some antibiotics are known to alter bacterial structure at
subgrowth inhibitory concentrations (sub-MIC) and in so doing alter their
susceptibility to phagocytosis. Vancomycin intermediate resistant S. aureus
(VISA) display thickened cell walls and reduced levels of protein A.
Objective: To examine the effect of sub-MIC linezolid (LZD), synercid
(SYN) and daptomycin (DAP) on surface topography of VISA.
Methods: Six strains of VISA were grown for up to 16 h in the presence or
absence of sub-MIC antibiotic, examined using transmission electron micro-
scopy for cell wall thickness and measured by ELISA for protein A content.
Susceptibility of antibiotic-exposed bacteria to phagocytosis by isolated
human neutrophils was examined in relation to surface changes in the
bacteria.
Results: VISA exposed to sub-MIC LZD and SYN had thickened cell walls
(increased by >50%) as compared with no-drug controls whereas DAP-
treated cells were thinner (decreased by >30%). Most VISA elaborated little
or no protein A but in those that did, levels were reduced signiﬁcantly
(<10 ng/100 million cells) in LZD- and SYN-exposed bacteria. For some
strains, LZD- and SYN-staphylococci were more susceptible to opsonopha-
gocytosis. There was no difference between antibiotic-exposed VISA and
VISA grown in the absence of any antibiotic in terms of their ability to induce
neutrophil respiratory burst.
Conclusion:Whereas exposure to several antibiotics at sub-MIC levels altered
the surface appearance of VISA, the changes were not translated uniformly
into altered susceptibility to phagocytosis; there was no common pattern
among the six strains of VISA tested.
P1290 A study of the effects of media and methodology
for sensitivity testing of 116 strains of apparently
teicoplanin-resistant staphylococci from South Africa
A. Brink, J. van den Ende, M. Juvin, H. Drugeon, C. Janus
Pretoria, ZA; Beaucouze, Nantes, Paris, F
Objectives:One hundred and sixteen strains of Staphylococcus spp. from South
Africa were deemed teicoplanin-resistant using brain heart agar media con-
taining 12mg/L of teicoplanin. This study determined the sensitivity of these
strains when tested using different methodologies and batches of Mueller-
Hinton (MH) media.
Methods: Identities of strains were conﬁrmed and methicillin-resistance
determined by disk agar diffusion. Teicoplanin (30mg) and vancomycin
(5mg) disk sensitivities were performed along with other relevant antibiotic
disk sensitivities. Agar and broth dilution MICs to teicoplanin and vanco-
mycin were determined using MH agar from two sources: Difco and Bio-
Rad, and MH broth from Difco. Sensitivity test methods were as recom-
mended by the National Committee for Clinical Laboratory Standards
(NCCLS) with ATCC strains as controls. Doubling dilutions ranged from
0.016mg/L to 64mg/L, and inoculum was 5 103–104 cfu. Results were
read after incubation at 358C for 20–24 h. NCCLS breakpoints for teico-
planin, for MIC and disk diameter, respectively, are: sensitive, <8mg/L and
>14mm, intermediate, 16mg/L and 11–13mm, and resistant, >32mg/L
and <10mm.
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Results:One hundred and seven out of 116 strains were methicillin-resistant
and 101/107 also had kanamycin, tobramycin, gentamicin and rifampicin
resistance phenotypes. Inhibition zones for disk testing against teicoplanin and
vancomycin were >16mm and >18mm, respectively, for all except ﬁve
strains of S. haemolyticus (all>14mm for teicoplanin). MIC50/90 s are shown
in the table.
Intermediate or resistant MICs to teicoplanin were obtained with 36 strains
(only one S. aureus) using Bio-Rad MH agar, compared with only eight (two
S. epidermidis, six S. hemolyticus) using Difco broth.
Conclusions: All these strains were considered to be resistant to teicoplanin
when tested in South Africa. However, when retested none of the staphy-
lococci were resistant to teicoplanin using Difco broth, as recommended by
the NCCLS, whereas seven strains (one Sepidermidis, six Shaemolyticus) were
determined as resistant with Bio-Rad MH agar. As the table shows, the
variation in results with different media demonstrates that careful adherence to
standardized methods is required.
P1291 Sensitivity testing of teicoplanin against
S. epidermidis: the impact of different media on MICs
H. Drugeon, M. Juvin, C. Janus
Nantes, Beaucouze, Paris, F
Objectives: Following the introduction of the VITEK 2 for susceptibility
testing in our laboratory, some strains of S. epidermidis were determined as
having higher than expected MICs to teicoplanin, even though by disk
diffusion they appeared fully sensitive. This study aimed to see if ‘resistance’
was affected by the method used to deﬁne MIC.
Methods: Two hundred and forty-six S. epidermidis strains isolated in Nantes
in 2001 and for which MICs to teicoplanin and vancomycin had been
estimated using VITEK 2 were retested in Mueller-Hinton (MH) agar media
from Difco, Oxoid, Becton Dickinson, bioMe´rieux and Bio-Rad and also in
liquid MH media from Difco, Oxoid, Becton Dickinson and Bio-Rad.
NCCLS methodology was used with the following breakpoints applied
for teicoplanin: S 8mg/L, I¼ 16mg/L, and R 32mg/L and vancomy-
cin: S 4mg/L, I¼ 8–16mg/L, and R 32mg/L.
Results: The strains were analyzed separately according to methicillin sensi-
tivity: 52 strains were methicillin-sensitive (MSSE) and 194 resistant (MRSE).
All MSSE and 99–100% (depending on media) of MRSE were fully sensitive
to vancomycin. The table gives teicoplanin sensitivity test results.
Tests performed with MH agar from Difco, Oxoid, bioMe´rieux and MH
broth from Difco, BD and Oxoid, all resulted in 90–100% of strains being
considered sensitive. Vitek, BD agar and Bio-Rad agar and broth all gave
higher MICs. In general, 98–100% MSSE were sensitive and 89–99% of
MRSE were sensitive, except when tested with Bio-Rad agar and broth (66
and 82%, respectively). VITEK 2 gave MICs in the higher range but which
were closer in values to most of the other media used.
Conclusions: The variety of test media gave a range of results where the
percentage of strains of S. epidermidis considered resistant to teicoplanin ranged
from 0 to 3%, while those evaluated as intermediate ranged from 0 to 10% for
MSSE and 1–31% for MRSE, which clearly indicates that great caution
should be used with some test media. VITEK 2 gaveMICs on the slightly high
side and Bio-Rad MH agar and broth would appear to be giving results that
do not concur with other MH media.
P1292 In vitro activity of linezolid in comparison with
vancomycin, quinopristin/dalfopristin, levoﬂoxacin, and
moxiﬂoxacin to clinical isolates of staphylococci
W. Pﬁster, H. Weisser, S. Eick, E. Straube
Jena, D
Objectives: Antimicrobial resistance among Gram-positive bacteria has
increased and new antibiotics have been introduced during the last years.
The aim of the study was therefore to evaluate the in vitro activities
of linezolid (LIZ) in comparison with vancomycin (VAN), quinopristin/
dalfopristin (SYN), levoﬂoxacin (LFX), and moxiﬂoxacin (MOX) to
staphylococci.
Methods: A total of 7245 clinical isolates of patients of a university hospital
were investigated in a prospective study over a time period of 24months. The
isolates had been identiﬁed as pathogens, not as part of the normal ﬂora. They
included 2072 methicillin-susceptible S. aureus (MSSA), 212 methicillin-
resistant S. aureus (MRSA), 868 methicillin-susceptible S. epidermidis (MSSE),
1015 methicillin-resistant S. epidermidis (MRSE), 198 methicillin-susceptible
S. haemolyticus (MSSH), 439methicillin-resistant S. haemolyticus (MRSH), 304
methicillin-susceptible strains of other coagulase-negative staphylococci
(MSCoNS), and 137 methicillin-resistant strains of other coagulase-negative
staphylococci (MRCoNS). The MIC-values were determined by broth
microdilution assay (MICRONAUT-S-GENARS, Merlin, Bornheim-
Hersel, Germany.
Results: MIC50 and MIC90 (mg/L) were:
	 Liz: 1/2 (MSSA), 1/2 (MRSA), 0.5/1 (MSSE), 0.5/1 (MRSE), 0.5/1
(MSSH), 0.5/1 (MRSH), 0.5/1 (MSCoNS), 0.5/1 (MRCoNS)
	 Van: 1/1 (MSSA), 1/1 (MRSA), 1/1 (MSSE), 1/2 (MRSE), 0.5/1
(MSSH), 1/2 (MRSH), 0.5/1 (MSCoNS), 1/2 (MRCoNS)
	 Syn: 0.5/1 (MSSA), 1/1 (MRSA), 0.5/0.5 (MSSE), 0.5/0.5 (MRSE),
0.5/1 (MSSH), 0.5/1 (MRSH), 0.5/1 (MSCoNS), 0.5/1 (MRCoNS)
	 Lfx: 0.125/2 (MSSA), 4/16 (MRSA), 0.25/8 (MSSE), 4/8 (MRSE),
0.125/8 (MSSH), 4/16 (MRSH), 0.25/1 (MSCoNS), 4/16 (MRCoNS)
	 Mox: 0.063/1 (MSSA), 2/4 (MRSA), 0.125/2 (MSSE), 1/2 (MRSE),
0.125/2 (MSSH), 1/4 (MRSH), 0.125/0.5 (MSCoNS), 1/4
(MRCoNS).
Conclusions: Apart from some elevated MIC-values, espicially of LFX and
MOX, the antimicrobials tested exhibited good activities to methicillin-
susceptible as well as methicillin-resistant staphylococci. No resistance to LIZ
could be detected.
P1293 In vitro activity of six novel antimicrobial agents
against staphylococci using the PhoenixTM Automated
Microbiology System
W. Brasso, D. Turner, S. Halvis, J. Douglass, S. Wulff, C. Yu, J. Reuben
Sparks, USA
Objectives: Staphylococcal resistance to existing antimicrobial agents has led
to the need for increased surveillance methods, strict control measures and the
development of new antimicrobics to combat this escalating trend. In this
study, six new antimicrobics, Linezolid (LZD), Daptomycin (DAP), Gar-
enoxacin (GRN), Gemiﬂoxacin (GEM), Ertapenem (ETP) and Telithromy-
cin (TEL), were evaluated for in vitro activity in the Phoenix TM Automated
Microbiology System against Staphylococcus species.
Methods:One hundred and ninety ﬁve staphylococcal strains (103 S. aureus,
42 S. epidermidis and 50 other coagulase-negative Staphylococcus species)
of clinical or stock origin were evaluated in Phoenix and the NCCLS-
recommended standard broth microdilution (SBM) reference method.
Eighty-eight methicillin-resistant Staphylococcus species were included in
the test set. Inocula were prepared simultaneously for each test strain in
Phoenix and the SBM using an inoculum density equivalent to the NCCLS-
recommended 5 105 cfu/mL. Dilution ranges for each antimicrobic tested
were equivalent in the two systems. Once inoculated, all Phoenix panels were
incubated and read automatically in the Phoenix instrument. SBM panels
were incubated in ambient air at 358C for 18–20 h and read manually.
Interpretive breakpoints used to determine categorical agreement (CA) were
Species
Teicoplanin
Vancomycin MIC
50/90 (mg/L)
Difco
broth
Difco
agar
Bio
Rad agar
Difco
broth
Difco
agar
Bio
Rad agar
S. aureus (n¼ 40) 2/4 4/4 8/8 ½ 2/2 4/4
S. epidermidis (n¼ 34) 4/8 4/8 8/16 2/2 2/2 2/2
S. haemolyticus (n¼ 39) 4/16 4/16 16/32 ½ 2/2 2/4
Staph. spp (n¼ 3) All
MICs<4
All
MICs <4
All
MICs < 16
All
MICs 2
All
MICs2
All
MICs 2
Teico
test
result
Sensitivity test medium (A¼agar, B¼broth) (% of strains, MSSE/MRSE)
Difco
A
Oxoid
A
BD
A
bioM
A
BioRad
A
Difco
B
Oxoid
B
BD
B
Bio
Rad B Vitek
S 100/99 100/97 98/89 100/96 90/66 100/99 100/95 100/99 94/82 98/90
I 0/1 0/2 0/9 0/4 10/31 0/1 0/40 0/1 6/16 2/9
R 0/0 0/1 2/2 0/0 0/3 0/0 0/1 0/0 0/2 0/1
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provided by NCCLS for LZD and ETP, CA-SFM for TEL and the individual
drug manufacturer for DAP, GEM and GRN.
Results: Essential agreement of the Phoenix and reference results overall was
equal to or greater than 98% for DAP, GRN, GEM and ETP, 94% for LZD
and 88% for TEL. CAwas between 99 and 100% for LZD, DAP and ETP, and
between 92 and 96% for GEM, GRN and TEL. No very major errors (VME)
between Phoenix and the reference system were detected with the six
antimicrobics tested. Major errors (ME) were encountered only with
GEM (two isolates) and TEL (four isolates).
Conclusions:The Phoenix System is effective for use in determining accurate
in vitro susceptibility results for the new antimicrobics LZD, DAP, GRN,
GEM, ETP and TEL with staphylococci.
P1294 The in vitro analysis of a model antimicrobial
system targeted to MRSA
H. Fairhead, S. Pollerman, D. Kirke, K. Herbert
Cambridge, UK
Objectives: The design, production and preliminary in vitro microbiologic
analysis of a Bacterial Inhibitory Protein System (BIP System) with narrow
spectrum antimicrobial activity.
Methods and results: A model antimicrobial system has been developed
which allows speciﬁc targeting to a wide range of individual bacterial species:
a gene encoding a Small Acid-Soluble Spore Protein (SASP) is delivered to
chosen bacterial cells by means of a modiﬁed bacteriophage vector. SASP
expressed within vegetative bacterial cells demonstrates a strong antibacterial
effect. SASP binds in a nonsequence speciﬁc manner to bacterial DNA and
alters its conformation from the normal B-like to A-like. This results in
inhibition of DNA replication and to some extent transcription. The
utilization of bacteriophages as delivery vectors gives the system speciﬁcity
and a model BIP System has been developed to speciﬁcally target Staphylo-
coccus aureus, including MRSA. An S. aureus-speciﬁc bacteriophage has been
modiﬁed so that its genome contains a SASP gene (sspC) in place of the native
phage holin gene. The absence of the holin gene results in phage that are
prevented from lysing the infected bacterial cells. This has a beneﬁcial impact
by inhibiting the release of inﬂammatory bacterial cell wall components and
reducing the bioavailability to other bacteria of free bacterial DNA (chro-
mosomal, plasmid or transposon) which may contain toxin and/or antibiotic
resistance genes. The modiﬁed S. aureus phage (designated HHBC-11) has
been used in in vitro susceptibility studies whereby a range of S. aureus
(including MRSA) strains have been infected with HHBC-11 and bacterial
cell viability monitored. Addition of HHBC-11 phage (1010 pfu) to S. aureus
cultures ranging from 103 to 108 cfu/mL results in up to a 6-log drop in
bacterial viability within 30min.
Conclusion: The BIP System is a promising antimicrobial agent that can be
targeted to speciﬁc bacterial species, including S. aureus and, in particular,
MRSA strains.
Streptococci and Gram-positive bacteria
P1295 Susceptibility to glycopeptides of multiresistant
coryneform bacteria
A. Mikucka, E. Gospodarek
Bydgoszcz, PL
Introduction: Coryneform bacteria are the heterogenic group of Gram-
positive rods, which comprises 15 genera. Many species, mostly from
Corynebacterium genus belong to the human natural skin ﬂora and mucous
membranes. More and more often coryneform are isolated from clinical
specimens and examined as etiologic factors of hospital infections.
Objectives: To assess the susceptibility of clinical isolates of multiresistant
coryneform bacteria to glycopeptides by MIC.
Methods: The subject of the examination were 88 of multiresistant coryne-
form bacteria strains. The strains were identiﬁed with the help of API Coryne,
API ZYM (bioMe´rieux) and modiﬁed of CDC’s scheme set. Antibiotic-
susceptibility was evaluated according to E-test, according to the NCCLS
recommendations. Staphylococcus aureus ATCC 25923 was used as control
strain. Method for comparing two frequencies was used for statistical analysis.
Results: Resistance to many antibiotics was characteristic mainly for Cor-
ynebacterium urealyticum, C. amycolatum, C. afermentans ssp. lipophilum species
which were isolated species which were isolated from urine (37.2%), wound
swabs (30.2%) and drain (16.2%) from patients treated in surgery unit (30.2%),
urology unit (22.1%), and intensive care unit (16.3%).
MIC range 0.125–0.50mg/mL of vancomycin – 14 strains, of teicoplanin –
20 strains.
MIC range 0.75mg/mL of vancomycin – 42 strains, of teicoplanin – 32
strains.
MIC range 1.00mg/mL of vancomycin and teicoplanin – 30 strains.
MIC range 1.50–2.00mg/mL of vancomycin – 2 strains, of teicoplanin – 6
strains.
The differences in percentage of strains with deﬁned MIC values are not
statistically signiﬁcant.
Conclusions: Lipophilic species and C. amycolatum strains were in most cases
multidrug resistant. All isolated strains were susceptible to glycopeptides,
however, it was noticed higher percentage of strains with MICs of glycopep-
tides in range 0.75–1.00mg/mL.
P1296 Effect of inoculum conditions on antimicrobial
susceptibility testing of Bacillus anthracis
R. Rennie, C. Brosnikoff, P. Kastner, G. Tifﬁn, L. Turnbull
Edmonton, Lethbridge, CAN
Objective:Anthrax is a zoonotic infectious disease. Antimicrobial therapy and
prophylaxis have become important issues because of recent world events.
The purpose of this study was to conﬁrm the results of NCCLS antimicrobial
susceptibility testing (AST) methods for B. anthracis and to further study issues
around inoculum conditions that might affect AST results.
Methods: Twenty-ﬁve strains of B. anthracis isolated from animals from 1964
to 2001 were tested. There were 18 isolates from cattle, 4 from bison and one
each frommoose, black bear and a goat hide. B. anthracis ATCC 4229 was also
used. The strains were tested from direct and logarithmic phase suspensions.
ASTwas performed in cation-adjusted Mueller-Hinton (MH) broth or MH
agar. The tests were incubated for 18–24 h at 35 8C in ambient air. Spore
counts and vegetative cells were estimated by heat shocking for 30min at
60 8C and performing colony counts. Six of these strains were then tested at
different inoculum concentrations (0.5 and 2.0 McFarland standards), and by
growing the primary inocula in 0.25% Tween 80, 0.25% Triton X-100 and by
disrupting clumps of cells with glass beads prior to susceptibility testing. The
agents tested were amoxicillin, amoxicillin-clavulanate, penicillin, merope-
nem, clarithromycin, doxycycline, tetracycline, ciproﬂoxacin and levoﬂox-
acin.
Results: All 25 strains were susceptible to each of the agents. The range of
MICs was marginally narrower with the direct suspension tests. The MIC90
of the log phase cultures were one dilution higher than the direct suspension
tests. Disk zone sizes were comparable and consistent with susceptible strains
of Bacillus species. The percentage of spores in the inocula of 7 strains tested
varied from 0 to 15%. MICs and disk zones did not differ when the
concentration of organisms was increased from a 0.5 to a 2.0 McFarland,
and preparing the inoculum in Tween 80 or vortexing with glass beads did not
alter MICs. Triton X-100 was inhibitory.
Conclusions: These strains of B. anthracis isolated over a long period of time
remain highly susceptible to the antimicrobial agents tested. Despite the fact
that this species readily form chains and clumps in various media, the AST
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method is robust. There was no quantitative difference in MIC or disk
susceptibility with several inoculum variations. This data supports the ﬁndings
of the NCCLS method development group for broth dilution MICs.
P1297 The susceptibility of B. anthracis to 18 different
antibiotics
A. Athamana, M. Massalha, M. Athamna, A. Nura, B. Medlej, I. Ofek,
E. Rubinstein
Kfar Quaraa, Tel-Aviv, Tel-Hashomer, IL
Objectives:To determine the antimicrobial activity (MIC) and the rate of kill
of 18 different antibiotics belonging to different antibiotic groups on two
strains of B. anthracis.
Methods: Determination of minimum inhibitory concentrations (MICs):
B. anthracis (Sterne & STI strains) were grown on brain heart agar (BHA) at
370 8C for 24 h. One colony was inoculated into brain heart infusion broth
(BHI-B) and was grown overnight at 37 8C. 10 mL containing 105CFU were
added to two-fold dilution of various antibiotics diluted in BHI-B in wells of
ﬂat bottom microtiter plates. Growth inhibition was determined following
18 h incubation at 37 8C in ambient air. The MICs were recorded as the
lowest concentration of an antibiotic that inhibited visible bacterial growth.
Determination of bacterial kill: an overnight culture of B. antharacis was
diluted 1:1000 with BHI-B in ﬁnal volumes of 2mL. Antibiotic solutions
in concentrations of 5 MICs and 10 MICs (of each strain tested) were
added and incubated at 370 8C, samples were obtained at: 0, 0.5, 2, 4, 6, 10, 12
and 24 h for bacterial count.
Results: The ﬂuoroquinolones are ciproﬂoxacin, oﬂoxacin, levoﬂoxacin and
moxiﬂoxacin. The beta-lactams: penicillin G and amoxicillin. The macrolides
clarithromycin and erythromycin. The ketolide telithromycin. Clindamycin,
rifampin and quinupristin-dalfopristin (Q/D) hadMICs in the range of 0.03–
0.25mg/mL. Ciproﬂoxacin and penicillin G being the most active with aMIC
of 0.03mg/mL. Erythromycin, vancomycin and the oxazolidinone linezolid
were less active (MIC 0.5–2.5mg/mL). Ceftriaxonewas the least active having
a MIC of 9.8mg/mL and chloramphenicol was inactive MIC> 250 mg/mL.
Moxiﬂoxacin, Q/D and rifampin showed the most rapid bacterial killing
achieving a complete kill (4 log) within 2–4 h at both concentrations. The
beta-lactams and vancomycin, demonstrated a 2–4 log reduction within 4–
6 h. Ceftriaxone had a similar effect to penicillin G and to amoxycillin. The
macrolides, tetracyclines and linezolid demonstrated a slower kill rate while
chloramphenicol failed to kill.
Conclusions: The data expands the spectrum of agents presently recom-
mended for the treatment of anthrax (ciproﬂoxacin, penicillin G and tetra-
cyclines) and adds new options such as other ﬂuoroquinolones, amoxycillin,
rifampin and Q/D as potential agents.
P1298 The resistance of Gram-positive bacteria isolated
in catheter-associated infections to glycopeptides, in an
emergency hospital, Bucharest, Romania, between 2001 and
2002
A. M. Andrei, M. Pana, Am. Petrescu, M. Valcu, E. Truta
Bucharest, RO
Objective: To study the resistance of Gram-positive bacteria to glycopeptides
isolated in catheter-associated infections between 2001 and 2002.
Methods: Pathogens were isolated according to Maki method. The resistance
to glycopeptides of 152 bacteria isolated from catheter infections was
investigated by MIC – ‘Microscan Walkaway – Dade Behring’, to 6 anti-
biotics: oxacillin (ox), amikacin (ak), claritromocin (clr), vancomycin (va),
teicoplanon (tec), penicillin (p).
Results: The microorganisms most commonly responsible for central venous
catheter were Staphylococcus aureus 45.35, S. epidermidis 20.3%, followed by
Gram-negative rods: Klebsiella neumoniae 9.2%, E. coli 6.5%, Serratia marcescens
and Proteus mirabilis 4.6%, Pseudomonas aeruginosa 3.2%, Citrobacter freundii
1.9%. Enterococcus faecium and faecaliswere only 2.6 and 1.3%, respectively. For
S. aureus 71% isolates were resistant to ox (MRSA) 47.4% to ak, 55.4% to cip,
18.5% to clr, 0% to va, 0% to tec. For S. epidermidis the resistance was: ox
69.9%, ak 37.1%, cip 52.5%, va 0%, tec 0%. For E. faecium: p 83.3%, cip 50%,
va 0%, tec 0%, for E. faecalis: p 5%, cip 100%, va 0%, tec 0%.
Conclusions: In contrast to another study S. aureus was the most frequent
isolated. A high incidence of MRSA and MRSE was observed. A good
susceptibility to glycopeptides was noted also.
P1299 An in vitro model to evaluate continuous
antibiotic lock technique to sterilize ports
A. Aguinaga, J. L. del Pozo, M. Soler, M. Rubio, A. I. Rodrı´guez,
J. Leiva, R. Dı´az
Pamplona, E
Objectives: Surgically placed venous access ports are used to facilitate long-
term intravenous therapy. Bacteria that adhere to these implanted medical
devices can become the cause of persistent infections. Treatment of such
infections is often difﬁcult due to the existing bioﬁlms on the port inner
surface; in this bioﬁlms, bacteria are less vulnerable to antimicrobial agents. A
port-associated infection in vitro model was designed to evaluate the efﬁcacy
of 16 antibiotic solutions (potentially useful for the antibiotic lock therapy in
vivo) to reduce or eliminate intraluminal S. aureus port colonization.
Methods:A clinical isolate of a slime-producing Staphylococcus aureuswas used.
Two different concentrations (2 and 10mg/mL) of vancomycin, cefazolin,
fosfomycin and teicoplanin were used alone or in combination with heparin
(V2, C2, F2, T2, V10, C10, F10, T10, VH2, CH2, FH2, TH2, VH10,
CH10, FH10 and TH10 lock, respectively). Twenty-four hours S. aureus
bioﬁlms were developed inside the port by static incubation. Then, the ports
were drained and ﬁlled with the different lock solutions simulating clinical
conditions. After different incubation times (1, 3, 5, 7 and 10 days) ports were
drained, ﬁlled with fresh broth and sonicated. Several dilutions of the ﬁnal
solutions were collected and inoculated on blood agar.
Results: We observed higher reductions in bacterial counts with cefazolin–
heparin, fosfomycin–heparin or teicoplanin–heparin locks than with cefa-
zolin, fosfomycin or teicoplanin locks; however, vancomycin–heparin locks
appeared to be less effective than vancomycin locks. Catheter intraluminal
colonization was eliminated after instillation of V10 as early as day 3.
Colonization was eliminated from the port inner surface by day 5 after being
treated with FH10, T10 or TH10, by day 7 after being treated with V2, CH2,
C10, CH10, T2 or TH2, and by day 10 with VH2, C2 or F10. F2 and FH2
failed to sterilize the port by day 10.
Conclusions:Results of this study demonstrate that prolonged contact with a
concentrated antibiotic solution within the port lumen may be effective in
eliminating slime-producing S. aureus. Cefazolin and fosfomycin were shown
to be as effective in removing surface colonization as the most costly
glycopeptides. There may be stability problems with vancomycin if heparin
is added to the solution locks.
P1300 Resistance and in vitro activity of newer
antibiotic agents against Viridans group streptococci blood
stream isolates from patients with immunosuppression and
endocarditis
E. Presterl, A. Hirschl, A. Georgopoulos, W. Graninger
Vienna, A
Objectives: Viridans group streptococci (VGS) are a frequent cause of
bacterial endocarditis and bacteremia with associated multiorgan failure in
patients with neutropenia requiring hospital admittance and intravenous
treatment. This analysis examines the in vitro activity of established and
new antimicrobials against VGS blood stream isolates.
Methods: During the years 1998–2000 43 blood stream isolates (in 2 blood
cultures) were collected at the University Hospital of Vienna, 18 from patients
with endocarditis and 26 from immunosuppressed patients. The MICs were
tested using NCCLS standards.
Results: MIC50 (MIC range) for penicillin, gentamicin, vancomycin, tei-
coplanin, amoxicillin/clavulanic acid, quinopristin/dalfupristin, moxiﬂoxacin
and linezolid were 0.06 (0.001–1), 4 (0.5–32), 0.5 (0.25–2), 0.06 (0.001–
0.25), 0.06 (0.06–0.25), 1 (0.25–4), 0.25 (0.001–1) and 1 (0.06–2), respec-
tively. Drug interaction studies showed indifference for the combinations of
vancomycin plus gentamicin, moxiﬂoxacin plus gentamicin and linezolid plus
gentamicin. Additionally, MICs were performed in a static bioﬁlm model. In
strains which formed a bioﬁlm, the MIC of vancomycin increased 2 times
compared with the planctonic MIC whereas MICs of linezolid and moxi-
ﬂoxacin were unchanged.
Conclusion: The in vitro efﬁcacy and low resistance rates of the newer
antibiotics linezolid and moxiﬂoxacin suggest their use in a sequential oral
treatment of severe VGS infections like endocarditis to shorten hospitalization
and thus reduce hospital costs.
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P1301 Susceptibility to penicillin, amoxicillin,
erythromycin, clindamycin, telithromycin, oﬂoxacin,
levoﬂoxacin and moxiﬂoxacin in recent Belgian viridans
streptococci, isolated from the upper respiratory tract
A. Piette, A. Martel, G. Claeys, F. Haesebrouck, G. Verschraegen
Ghent, B
Objectives: Because resistance to commonly used antimicrobials is increasing
in the viridans group streptococci (VGS), we studied the in vitro activities of
b-lactam antibiotics, macrolides, ketolides and ﬂuoroquinolones against a
collection of recent strains, isolated from the upper respiratory tract.
Methods: VGS were isolated from 92 consecutive throat and sputa samples.
MIC testing was performed by E-test strips on Mueller–Hinton agar sup-
plemented with 5% sheep blood. Plates were incubated for 24 h, at 37 8C, in
CO2. S. pneumoniae ATCC 49619 was used as control strain. NCCLS MIC
interpretive standards were used for penicillin (PEN), oﬂoxacin (OFLO),
levoﬂoxacin (LEVO), erythromycin (ERY) and clindamycin (CLI). For
moxiﬂoxacin (MOXY) and amoxicillin (AMO) we followed the S. pneumo-
niae criteria, for telithromycin (TEL) the breakpoint recommendations of the
manufacturer.
Results: The range, the MIC50, the MIC90 and the percentage of resistant
(R), intermediate resistant (I) and susceptible (S) strains are noted in the table.
24% of the ERY-S strains and 61% of the ERY-R strains were penicillin
nonsusceptible. 27% of the ERY-R strains showed resistance to CLI. Only
21% of all strains were S to all tested antimicrobials. In both the ERY-R and
the ERY-S group the MIC50 (and MIC90) of TEL were lower than the
MIC50 (and MIC90) of ERY; in the ERY-R group, the MIC50 for TEL and
ERY were, respectively, 0.25 and 6, in the ERY-S group 0.016 and 0.032.
Conclusion:The new ketolide, TEL, and ﬂuoroquinolones, especially LEVO
and MOXY, have a good in vitro activity. The MIC90 of LEVO however, is
already 1mg/L. Only 50% of the strains is susceptible to PEN. AMO has a
better activity than PEN. The susceptibility rate of ERY is very low. The
higher susceptibility to CLI suggest the macrolide resistance is mainly due to
an efﬂux mechanism.
P1302 In vitro susceptibility of viridans streptococci
isolated from oral and maxillofacial infections
G. Bancescu, S. Dumitriu, A. Bancescu, C. Defta, M. Pana, D. Ionescu,
S. Alecu, N. Skaug
Bucharest, RO; Bergen, N
Objectives: To investigate the antimicrobial susceptibility of 100 strains of
viridans streptococci isolated from pus samples collected from Romanian
patients with oral and maxillofacial (OMF) infections. These streptococci
strains were found either in association with other bacteria or in pure culture.
Methods: The isolates were identiﬁed at species level using the Rapid ID 32
STREP system (bioMe´rieux). The standardized disk diffusion method (per-
formed with BBL Sensi-Discs, Becton Dickinson) and the E-test (AB
Biodisk) were used for susceptibility testing of the isolates to: penicillin G
(PG), ampicillin (AM), cefotaxime (CT), erythromycin (EM) and clindamy-
cin (CM).
Results: The isolates were identiﬁed as: S. oralis (58 strains), S. anginosus (31
strains), S. mitis (4 strains), S. sanguis (4 strains) and S. constellatus (3 strains).
Both antimicrobial susceptibility techniques assigned similar results regarding
the susceptibility of the strains. The MICs (mg/L) ranges were: PG 0.008–
0.75 (86% Susceptible, 14% Intermediate), AM 0.016–0.5 (98% Susceptible,
2% Intermediate), CT 0.023–0.38 (100% Susceptible), EM 0.016–4 (91%
Susceptible, 2% Intermediate and 7% Resistant) and CM 0.016–0.047 (100%
Susceptible). The isolates with intermediate susceptibility to PG or to both
PG and AMbelonged to the species: S. sanguis, S. mitis and S. oralis. Resistance
to EM was found among all species except for S. constellatus.
Conclusions: (1) Reduced susceptibility to beta-lactam antibiotics was
detected only among the mitis group isolates. (2) Resistance to EM was less
than 10%, but CM was fully active. (3) The results recommend CM as an
alternative for antimicrobial therapy of OMF infections, which are usually
mixed infections, involving strictly anaerobic bacteria (frequently beta-
lactamase producers) and aerobic microorganisms, especially oral streptococci.
P1303 Group B Streptococcus in a tertiary hospital,
Greece (1998–2002)
M. Kanellopoulou, M. Martsoukou, N. Skarmoutsou, A. Vergaki,
A. Nasis, I. Fotopoulou, E. Papafrangas
Athens, GR
Objectives: To detect the isolation rate and the sensitivity of Group B
Streptococcus (GBS) to common antibiotics during a period of 4 years
(1998–2002).
Methods:A total number of 890 vaginal secretions of non-pregnant women,
478 prostatic ﬂuids, 1886 bronchial secretions, 2392 pus mainly from decu-
bitus ulcers, 23 982 urines were cultured in appropriate media. The suscept-
ibility to antibiotics were tested by microdilution method according to
NCCLS recommendations. The strains S. aureus ATCC 29213 and S. aureus
ATCC 25923 were used as controls.
Results: GBS was isolated from 5.2% vaginal secretions, 1.4% pus (one from
bartholinian abscess), 1.5% prostatic ﬂuids, 0.63% bronchial secretions and
0.36% urines. Seventeen patients (19.5%) had clinical evidence of urinary
tract infections (UTI), three had prostatitis, one had bartholinitis with diabetes
mellitus as underlying disease. In all cases GBS was concomitant isolate with
other microorganisms in vaginal secretions and pus. All strains were sensitive
to penicillin, erythromycin, clindamycin, vancomycin, ciproﬂoxacin and
linezolid.
Conclusions: (1) GBS seems to be a potential uropathogenic microorganism.
(2) GBS contribute to decubitus ulcers and represent potential pathogen in
invasive GBS diseases. (3) GBS remain sensitive to the most common
antibacterial agents used in Gram-positive infections.
P1304 Infections and antimicrobial susceptibility of
Streptococcus group B in nonpregnant adults
E. Ikonomopoulou, K. Papadopoulos, H. Koumoundourou, K. Kottara,
P. Hamakioti, A. Reggli
Patras, GR
Background:Group B streptococci (GBS) are an important cause of neonatal
sepsis and meningitis, and maternal infection. GBS are also responsible for
infections in nonpregnant adults.
Objectives: To survey the GBS infections and the registration of GBS
susceptibility to antimicrobial agents in nonpregnant adults.
Methods: 99 GBS strains were isolated from adults’ infections during the
period 01/01/2001–30/12/2002. The identiﬁcation was made by conven-
tional methods (the detection of B Ag according to Lanceﬁeld was made by
slidex strepto kit – bioMe´rieux) and the antimicrobial susceptibility was
determined by the breakpoint system: mini API (bioMe´rieux).
Results: 99 GBS strains were isolated from 99 patients (88 women and 11
men). Fifty-two patients were treated as inpatients and 47 as outpatients.
Classiﬁcation of isolates by specimen type and sex was: urine 51 (43 women
and 8 men), blood 1 (man), vaginal ﬂuid 42 (women) and wound infections 5
(3 women and 2 men). Wound infections were: 3 diabetic foot and 2 burns. In
one case (1 man) GBS was isolated from diabetic foot and blood culture
simultaneously. The susceptibility of GBS strains to the antimicrobial agents
was: 85.8% to penicillin, 96% to vancomycin, 91.9% to ampicillin, 86.9%
to cefuroxime, 77.7% to ciproﬂoxacin, 68.7% to clindamycin, 65.6% to
erythromycin, 52.5% to trimethoprim-sulfamethoxazole, and 33.3% to
tetracyclines.
Conclusions: GBS was found to be the causative agent to considerable
number of urinary tract infections mainly in women. Ampicillin proved to
be the most active antimicrobial agent against GBS in vitro.
Range
(mg/L)
MIC50
(mg/L)
MIC90
(mg/L)
R
(%)
I
(%)
S
(%)
PEN 0.012 to >32 0.16 32 23.9 25.0 51.1
AMO <0.016–48 0.16 8 16.3 7.6 76.1
ERY <0.016 to >256 3 256 67.4 0.0 32.6
CLI 0.016 to >256 0.064 256 18.5 3.3 78.3
TEL 0.004–3 0.125 0.75 1.1 4.3 94.6
OFLO 0.38 to>32 1.5 3 1.1 18.5 80.4
LEVO 0.125–8 0.5 1 1.1 0.0 98.9
MOXY 0.032–3 0.094 0.19 0.0 1.1 98.9
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P1305 In vitro activity of 7 antimicrobial agents against
Streptococcus agalactiae clinical isolates
A. Perkins, M. Serrano, E. Garcia-Pen˜uela, E. Aznar, C. De las Cuevas,
T. Alarcon, M. Lopez-Brea
Madrid, E
Objective: The aim of this study was to evaluate the in vitro activity of
penicillin, cefotaxime, vancomycin, linezolid, erythromycin, clindamycin
and moxiﬂoxacin against Streptococcus agalactiae isolated from clinical samples
in our Hospital.
Materials and methods: The following 32 samples were studied: 21 (65.6%)
from female genital tract infection, 6 (18.7%) from patients with urethritis, 4
(12.5%) from infected wounds and 1 (3.1%) from blood culture. Antimicro-
bial activity was determined by an agar dilution method using 5% blood plates,
according to NCCLS recommendations. ATCC-29213 Staphylococcus aureus
was used as control strain.
Results: The following MIC values were obtained for all organisms tested:
MIC50 andMIC90were 0.03 and 0.12mg/L for penicillin, 0.016 and 4mg/L
for erythromycin, 0.5 and 0.5mg/L for vancomycin, 1 and 1mg/L for
linezolid, 0.03 and 4mg/L for clindamycin, 0.06 and 0.12mg/L for clin-
damycin, 0.06 and 0.12mg/L for moxiﬂoxacin and 0.03 and 0.12mg/L for
cefotaxime. All strains showed susceptibility to penicillin, cefotaxime, van-
comycin and linezolid. 28.5% were resistant to erythromycin and 26.1%
resistant to clindamycin. Not susceptibility breakpoints exists for moxiﬂox-
acin, however, all strains were inhibited at a concentration of 0.12mg/L or
lower.
Conclusions: In our study, most strains showed susceptibility to classical
antibiotics. Linezolid could be a good alternative to vancomycin in treatment
of infections due to S. agalactiae. Moxiﬂoxacin showed a very good activity
against the strains tested.
P1306 Characterization of antimicrobial susceptibility
patterns among community-acquired isolates of
beta-hemolytic streptococci in Latin America: results from
the SENTRY Antimicrobial Surveillance Program (2001)
A. C. Gales, H. S. Sader, M. Castanheira, R. N. Jones on behalf of the
SENTRY Group – Latin America
Objectives: Recently, beta-hemolytic streptrococci (BHS) have been recog-
nized as an increasing cause of sepsis and soft tissue infections in adults with
chronic illnesses. The main objective of this study was to determine the level
of emerging resistances (R) among BHS isolates collected in the LA region
monitored by the SENTRY Program.
Methods:A total of 198 BHS clinical specimens were collected from patients
with community-acquired infections in 10 LA sites between January and
March 2001. The susceptibility (S) to penicillin (PEN) and other antimicro-
bials was evaluated by broth microdilution method (NCCLS). Quality control
was performed using ATCC strains.
Results:PEN (MIC50, 0.015mg/L) was the most potent agent with only one
isolate of group A streptococci from a Chilean site having slightly reduced
susceptibility (0.25mg/L). Although azithromycin (MIC50, 0.06mg/L) had
shown to be the second most potent drug against GBS, only 88.9% of isolates
were S to this agent. Interestingly, the R phenotype of MLSB was present in
less than 3% of BHS isolates. Quinupristin/dalfopristin, linezolid, vancomy-
cin, and gatiﬂoxacin inhibited the growth of all GBS isolates at concentrations
of 1, 2, 1, and 0.5mg/L, respectively. Tetracycline showed the lowest S rate
(53.5%) with greatest R among group B streptococci.
Conclusions:Our results indicated that BHS isolates were highly susceptible
to beta-lactam antimicrobial agents. It conﬁrms that PEN remains the best
therapeutic option for treatment of BHS infections in Latin America.
However, continuing surveillance will be warranted to detect any decrease
in the susceptibility such as those noted for macrolides.
P1307 Rising penicillin minimum inhibitory
concentration (MIC) – a cause for concern in group A
beta-hemolytic streptococci
D. Nair, A. Safaya, M. Capoor, N. Chaudhry, L. Srivastava, P. Aggarwal
New Delhi, IND
Objectives: (a) Evaluate the occurrence of recurrent bacterial pharyngitis
caused by Group A beta-hemolytic streptococci (GABHS). (b) Study the
incidence of macrolide resistance in these isolates. (c) Identify the type of
macrolide resistance. (d) Detect the minimum inhibitory concentration to
penicillin in these isolates.
Material andmethods: Eighty-eight patients of recurrent pharyngitis attend-
ing the ENT clinics formed the Medical group and 28 patients undergoing
adenoido-tonsillectomy formed the Surgical group. Twenty normal healthy
volunteers formed the Control group. Two to four throat swabs were
collected from each patient and the control subjects. In addition, tonsils/
adenoids recovered at surgery were studied. The throat swabs, tonsils and
adenoids recovered from patients were subjected to microscopy, culture,
biochemical tests and conﬁrmation using group speciﬁc antisera. Antimicro-
bial susceptibility testing was performed by disc diffusion using Kirby Bauer
method. The minimum inhibitory concentration (MIC) was done using E-
strips for penicillin and erythromycin. Double disc diffusion test was per-
formed with clindamycin and erythromycin to detect the type of macrolide
resistance.
Results: A total of 108 throat swabs and 28 tonsils were studied. Twenty
percent of the patients in the medical group and 23% of the patients in the
surgical category had GABHS. None of the samples from the control group
grew GABHS. Macrolide resistance was observed in 30% of the isolates by the
Kirby Bauer method and 16.7% of them showed resistance to erythromycin by
E-strip test. The MIC values for penicillin ranged from 0.032 to 0.250mg/mL.
Conclusions: (a) Macrolide resistance is found to be higher than in previous
reports. (b) The type of resistance seen in our strains is the M type. (c)
Increasing levels of penicillin MIC were observed in the streptococci with a
strain having MIC value outside the sensitive range as given by the NCCLS
(0.250mg/mL). As with Streptococcus pneumoniae, GABHS is also showing a
rising trend in terms of macrolide resistance. TheMIC values for penicillin are
also edging towards the intermediate levels.
P1308 Patterns and phenotypes of resistance in
streptococci
N. Hakime, Z. Daoud
Beirut, LBN
Introduction: Three mechanisms of resistance to macrolides are actually
known: target modiﬁcation, inactivation, and drug efﬂux. The target mod-
iﬁcation, occurring in the ribosome, through the production of methylase
codiﬁed by the gene erm, leads to the development of resistance to the
majority of macrolides, lincosamides and streptogramines B (MLSB resis-
tance). While the resistance by inactivation was never observed in strepto-
cocci, the mechanism of active reﬂux was described in S. pyogenes and less
frequently in S. pneumoniae as leading to the phenotype M (resistance to
macrolides, but susceptible to lincosamides and streptogramines B).
Objective: The objective of this study was to analyze the phenotype of
resistance to in S. pyogenes, S. pneumoniae and S. milleri of all the isolates at the
Saint George University Hospital.
Material and methods: A total number of 195 isolates (including 65
S. pyogenes, 76 S. pneumoniae, and 54 S. milleri) coming from the clinical
specimens of the Saint George University Hospital – SGH Laboratory
between 1-1-2000 and 1-1-2002 were included in the study. The identiﬁca-
tion and antibiotic susceptibility testing were done as recommended by the
NCCLS. Phenotypic characterization of resistance to erythromycin was
realized using the double disc method described by Sepala and cols; the
phenotypesMLSB (I and C) andMwere differentiated based on the diameters
of inhibition as well as the presence of blunting around the clindamycin and
erythromycin discs.
Results and discussion: In our study, no resistance to penicillin was found in
S. pyogenes or S. milleri. 47.4% of the isolates of S. pneumococcuswere resistant to
penicillin. This ﬁnding is consistent with data coming from EARSS 2001
where ‘’the highest average of penicillin nonsusceptibility in Pneumococcus is
found for the Mediterranean countries. Resistance in general to Erythro and
Clinda varied between 7 and 24%. As per the phenotypes of resistance, 46.7%
of S. pyogenes and 20% of S. pneumoniae showed the phenotype M. This
phenotype was detected in 2 isolates (out of 6) of S. milleri resistant to erythro,
the majority showed the Phenotype MLS. Table 1 shoes the percentages of
resistance to the different antibiotics used.
Table 1
S. pyogens
Nb (%R)
S. pneumoniae
Nb (%R)
S. milleri
Nb (%R)
Penicillin 0 (0) 36 (47.4) 0 (0)
Erythromycin 15 (23.1) 10 (13.2) 6 (11.1)
Clindamycin 8 (12.3) 8 (10.5) 4 (7.4)
Clinical Microbiology and Infection, Volume 9, Supplement 1, 2003 315
Enterococci
P1309 Linezolid susceptibility of
glycopeptide-intermediately susceptible Staphylococcus
aureus (GISA) – the Dutch experience
A. Voss, J. W. Mouton, E. P. Elzakker, M. G. Hendrix, R. A. Howe, W.
Goessens, J. A. Kluytmans, A. J. de Neeling, J. H. Sloos, T. R. Walsh
Nijmegen, Delft, Enschede, NL; Bristol, UK; Rotterdam, Breda, Bilthoven,
Alkmaar, NL
Introduction: The occurrence of glycopeptide-intermediate-susceptible Sta-
phylococcus aureus (GISA) warrants alternative treatment. One of the alternative
antimicrobial agents used to treat GISA infections is linezolid, a new
oxazolidinone.
Objective: Aim of the study was to assess the intra- and interlaboratory
reproducibility of the E-test macromethod for testing linezolid.
Methods: At total of 100 isolates (10 MRSA, 9 hGISA and 6 GISA – as
determined by PAP-AUC ratio, each strain in quadruplets) were sent to 8
Dutch study centers. Investigators were totally unaware as to the isolates’s
phenotype. All strains were PFGE typed to eliminate clonal duplication. E-test
MICs were determined using an inoculum density of 0.5McFarland turbidity.
200mL of the inoculum suspension was delivered onto a 90-mm MH agar
plate and streaked out evenly. After drying E-test strips (AB BIODISK, Solna,
Sweden) for linezolid (0.016–256mg/mL) were applied, all plates were
incubated at 358C for 24 h, and read by two independent technicians. Three
laboratories read the plates at 80% inhibition (as recommended by the
company) others at 100% as recommended for, e.g. glycopeptides.
Results: The results are shown in the table.
Conclusions: Linezolid MICs ranged between 0.8 and 2.8mg/L and 0.44–
2mg/Lwhen read at 100 and 80% inhibition, respectively. Surprisingly, MICs
were generally lower in GISA/hGISA strains than in glycopeptide-susceptible
MRSA strains. Furthermore, the average range when comparing the inter-
laboratory reproducibility was wider in theMRSA strains and in those centers
reading at 80% inhibition. The difference was less evident when testing
hGISA/GISA. The intralaboratory reproducibility was generally excellent.
All strains were considered being susceptible according to the prescribing
information.
P1310 Comparison of linezolid and daptomycin activity
against resistant Gram-positive bacterial isolates in cancer
patients
B. Booker, B. Botzer, P. Kelchlin, P. Smith
Buffalo, USA
Objectives: The increasing incidence of multidrug resistant Gram-positive
(Gþ) bacterial infections provides a signiﬁcant challenge in treating immu-
nocompromised hosts, with few therapeutic options. The activity of linezolid
(LZD) and daptomycin (DAP), an investigational lipopeptide, was evaluated
against clinical Gþ isolates in cancer patients.
Methods: Single blood isolates from hospitalized cancer patients were
collected; LZD and DAP MICs were determined in duplicate by macrobroth
dilution according to NCCLS guidelines. Calcium supplementation of
Mueller-Hinton broth was used for DAP to achieve a ﬁnal concentration
of 50mg/L.
Results:For all Gþ isolates (N¼ 257), theMIC50,90 (range) for LZDwas 2.4
(0.125–64)mg/mL and 1,4 (0.03–8)mg/mL for DAP, respectively. Of 119
Enterococcus, the LZD and DAP MIC50, 90 (range) was: for 26 E. casseliﬂavus
(24 VRE) 2.4(1–4) and 4.8(4–8); 52 E. faecium (48 VRE) 2.4 (0.5–4) and 2.4
(1–8); 24 E. faecalis (2 VRE) 4.4 (2–64) and 2.4 (0.5–4). The LZD and DAP
MIC50, 90 (range) against 128 Staphylococcuswas 2.4 (1–8) and 0.5.1 (0.25–2),
comprised of 29 MSSA, 8 MRSA, 12 MSSE, and 59 MRSE. DAP retained
activity against 3 organisms with reduced LZD susceptibility (one MSSA, and
two VS E. faecalis, LZD MIC¼ 8, 32, 64; DAP MIC¼ 1, 1, 2).
Conclusions: LZD and DAP demonstrated activity against many of the MDR
Gþ bacteria that frequently cause infections in cancer pts., however, several
LZD-resistant isolates were identiﬁed. LZD and DAP may have a potential
role for in the treatment of infections in cancer patients, including febrile
neutropenia.
P1311 In vitro antimicrobial susceptibility of linezolid
against Gram-positive cocci in suspensions, bioﬁlms and
resuspended bioﬁlms
C. Spiker, P. Arakere, A. Mushtaq, N. Khardori
Springﬁeld, USA
Objective: Diagnostic microbiology laboratories test the susceptibilities of
bacteria in suspension (planktonic bacteria). However, infections related to
indwelling medical devices are difﬁcult to treat due to the bioﬁlm mode of
bacterial growth. Bioﬁlms often dislodge and enter the bloodstream, causing
systemic infections. The objective was to compare the invitro activity of
linezolid against bacteria in suspension, in bioﬁlm and in dislodged bioﬁlm
modes of growth.
Methods:We tested the susceptibilities of linezolid, against 77 clinical isolates
of MRSA, 43 MSSA, and 46 S. epidermidis using a broth microdilution
technique (NCCLS M7-A5). The MIC90 for linezolid against MSSA,
MRSA, and S. epidermidis in was 4, 1, and 1mg/mL, respectively. To form
bioﬁlms the organisms were grown in 96-well microtiter plates by culturing
1–2 106 cfu/mL in 200mL of TSB for 24 h. Plates were then washed twice
with PBS and 100mL of TSB was added. Duplicate plates were used to
dislodge the adherent growth in order to form resuspended (dislodged)
bioﬁlms. 100mL of the antimicrobial agent were added at concentrations
of MIC90, 50, 500, and 1000mg/mL. The microtiter plates were incubated
for 24 h to allow interaction between the antimicrobial agents and the
bacteria. Colony counts on serial dilutions before and after the addition of
linezolid were used to calculate percent viability.
Results: The results are shown in Table 1.
Conclusion:Our conclusions are that routine susceptibility testing on bacter-
ial suspensions (planktonic mode of growth) does not predict the suscep-
tibilities of bacteria in the bioﬁlm (sessile mode of growth).
P1312 In vitro activity of glycopeptides/erythromycin
resistant Enterococcus faecium to linezolid from a Greek
tertiary hospital (1998–2002)
M. Kanellopoulou, S. Pournaras, N. Skarmoutsou, M. Martsoukou,
M. Kamberogianni, A. Maniatis, E. Papafrangas
Athens, Larisa, GR
Objectives: The aim of this study was to examine the sensitivity of the new
antimicrobial drug linezolid (L) against glycopeptides/erythromycin resistant
E. faecium isolates during 1998–2002.
Material and methods: Forty-six glycopeptides/erythromycin resistant
strains isolated from urine: 16, pus: 15, blood: 4, catheters: 2, bronchial
secretions: 4 and stool: 5 were examined. They belonged to patients admitted
to ICU; 29, Surgical department: 10 and Internal Medical Department: 7. All
strains carried the vanA and ermB genes without lactamase production and
N
MIC low MIC high Average MIC Average range
100% 80% 100% 80% 100% 80% 100% 80%
MRSA 10 1.35 0.44 2.8 2 2.31 1.38 0.56 0.64
hGISA 9 0.8 0.5 2.2 1375 1.4 0.88 0.27 0.27
GISA 6 0.8 0.5 1.7 1.25 1.38 0.88 0.28 0.35
Table 1
% viability
Biofilm Resuspended biofilm
Organism
MIC90
(mg/mL)
MBC90
(mg/mL) MIC90
50
mg/mL
500
mg/mL
1000
mg/mL MIC90
50
mg/mL
500
mg/mL
1000
mg/mL
S. aureus (MSSA) 4 >64 98.5 38.7 37.2 37.1 89.1 29.1 32.2 36.8
S. aureus (MRSA) 1 >64 96.0 18.4 5.1 4.7 89.9 4.9 2.9 4.72
S. epidermidis 1 32 83.9 46.7 31.8 43.3 77.9 41.1 23.7 42.6
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exhibited 13 distinct chromosomal macrorestriction genotypes. The sensi-
tivity to (L) was tested by microdilution method according to NCCLS
recommendations and E-test (AB BIODISK, Solna Sweden) according to
the manufacture’s instructions.
Results: Linezolid MIC 50 – >1.5mg/mL, MIC 90 – >2mg/mL (range 0.25
– >32 mg/mL).
Conclusion: Linezolid seems to provide a remarkable advantage in the
management of glycopeptides/erythromycin resistant E. faecium infections.
Resistance to linezolid however, has been observed, although the new drug is
prescribed only the last year in our country.
P1313 In vitro effect of linezolid against
vancomycin-resistant enterococci
H. Yazgi, M. Ertek, A. Ayyildiz, Z. Ozkurt, M. A. Tasyaran
Erzurum, TR
Objectives: Vancomycin-resistant enterococci (VRE) have emerged as
important pathogens. The reported incidence of infections with VRE is
increasing dramatically and becoming endemic in many hospitals throughout
the world. Although these bacteria are still relatively rare in Turkey, the
incidence seems to be increasing. Most VRE are also resistant to multiple
other drugs which have been used for treating VRE infections. So treatment
options and effective antimicrobial agents for VRE are often limited. Line-
zolid is the ﬁrst oxazolidinone that has been introduced to therapy in the early
2001. It has a bacteriostatic effect against gram positive bacteria including
VRE. This drug inhibits bacterial protein synthesis via binding to the 50S
ribosomal subunit to prevent translation. The drug lacks cross-resistance with
other antimicrobials. The aim of this study was to investigate the in vitro
susceptibility of VRE strains isolated in our hospital to linezolid, and to
compare this with those of to ampicillin, erythromycin, tetracycline and
moxiﬂoxacin.
Methods: The study was performed in a 600 bed University Hospital during
the period of 8months in 2001. The enterococci were isolated from rectal
swab samples of 163 hospitalized patients and identiﬁed to the species level by
conventional methods and API 20 Strep System (bioMe´rieux, France).
Isolated 116 enterococci strains were then tested for vancomycin resistance
by screening method using BHI agar containing 6 mg/mL vancomycin. This
test yielded 13 VRE strains. The susceptibility pattern of the 13 VRE strains
against ﬁve antibiotics mentioned above were determined by disk diffusion
method. Results were interpreted according to the criteria by ‘The Swedish
Reference Group for Antibiotics’ for linezolid, by recommendation of Barry
and coworkers for moxiﬂoxacin, and by NCCLS for other antibiotics.
Results: Of the 13 VRE strains (3 were E. faecalis, and 10 were E. faecium)
none was resistant to linezolid, 9 (1 E. faecalis, 8 E. faecium) were resistant to
ampicillin, 8 (2 E. faecalis, 6 E. faecium) to erythromycin, 9 (2 E. faecalis, 7
E. faecium) to tetracyclin, and 10 (2 E. faecalis, 8 E. faecium) to moxiﬂoxacin.
Conclusion: Overall, the in vitro data demonstrated that, linezolid was very
active against VRE. So this drug will be a viable alternative in treatment of
VRE infections that are becoming increasingly intractable.
P1314 Susceptibility patterns of enterococci causing
infections
S. O¨ncu¨, M. Punar, H. Eraksoy
Aydin, Istanbul, TR
Objectives: Enterococci are among the common organisms associated with
hospital-acquired infections. The emergence of enterococci as signiﬁcant
pathogens is a matter of concern because these organisms are inherently
resistant to a number of antimicrobial agents. In this study, we examined in
vitro activities of different antibiotics to 103 enterococcal isolates (derived
from bloodstream infection, urinary tract infection, surgical site infection and
central nervous system infection between January 2000 and December 2001)
collected in the hospital of Istanbul Medical Faculty.
Methods:MICs of penicillin G, ampicillin, gentamicin, ciproﬂoxacin, oﬂox-
acin, levoﬂoxacin, grepaﬂoxacin, trovaﬂoxacin and gemiﬂoxacin were deter-
mined by the NCCLS recommended broth microdilution testing method.
MIC of vancomycin was determined by the E-test (AB Biodisk, Solna,
Sweden) on Brain-Heart Infusion agar (Oxoid, Hampshire, UK). High-level
disks of 120 mg gentamicin (Oxoid, Hampshire, UK) and 300mg streptomycin
(Oxoid, Hampshire, UK) were used to screen for high-level aminoglycoside
resistance (HLAR). Production of beta-lactamase was tested with nitroceﬁn-
based beta-lactamase test (Oxoid, Hampshire, UK).
Results: Amongst the 103 strains of Enterococcus spp. 71 (69%) were identiﬁed
as E. faecalis and 32 (31%) as E. faecium. While over 75% of E. faecium isolates
were resistant to penicillin and ampicillin, approximately 25% of E. faecalis
isolates were resistant to penicillin and ampicillin. None of the E. faecalis and
E. faecium isolates were resistant to vancomycin. While 17 (52%) of E. faecium
isolates exhibited high-level gentamicin resistance (HLGR), high level strep-
tomycin resistance (HLSR) was detected in 24 (74%) of the isolates. In
contrast HLGR and HLSR rates for E. faecalis were 14 (20%) and 22 (31%),
respectively. Both HLGR and HLSRwere detected with higher frequency in
ampicillin resistant isolates. Among quinolones gemiﬂoxacin and trovaﬂox-
acin were the most potent antibiotics tested forE. faecalis andE. faecium isolates
followed by grepaﬂoxacin, levoﬂoxacin, ciproﬂoxacin and oﬂoxacin. There
was no increase in MIC90 values of the quinolones in ampicillin resistant
isolates in comparison with ampicillin susceptible isolates.
Conclusion: Our data suggests newer quinolones would be good alternative
agents to use especially for combination drug therapy where enterococci with
ampicillin resistance and HLAR are prevalent.
P1315 Vancomycin susceptibility still prevails in
Norwegian enterococcal bacteremias
D. O. Dahle, K. R. Aasen, A. Axelsen, P. Gaustad
Oslo, N
Objectives: The vancomycin-resistant enterococcus (VRE) was ﬁrst discov-
ered in Europe in 1986 and has from 1995 become endemic in many hospitals
in the USA, primarily infecting immunocompromised and severely ill
patients. In Europe hospital outbreaks have been controlled, but carriage
of VRE is endemic among healthy people and animal husbandry. At present
only one hospital outbreak of VRE has occurred in Norway and carriage of
VRE among hospitalized patients is near absent, but VRE is found in poultry
farms previously exposed to avoparcin, a glycopeptide growth promoter. We
wanted to see if any unrecognized VRE could be found among blood culture
isolates (BCIs) from a tertiary care hospital (The National Hospital) in
Norway, and also test other relevant antimicrobials against these enterococcal
isolates.
Methods:BCIs were identiﬁed using the Rapid ID 32 STREP (bioMe´rieux,
France). Enterococcal isolates from 11.06.1997 to 15.05.2001 were included
and tested against 10 antibiotics using the E-test (AB biodisk, Sweden).
Norwegian breakpoints were applied. Isolates with vancomycin MIC
8mg/L were tested further by polymerase chain reaction (PCR) using
primers speciﬁc for the vanA, vanB and vanC vancomycin-resistance genes
and electrophoresis.
Results:One hundred and eleven enterococcal isolates (6,9% of all BCIs) were
included. The species distribution was 68% E. faecalis, 23% E. faecium, 6%
E. gallinarum, 1% E. hirae and 1% E. avium. Among all enterococcal isolates we
identiﬁed phenotypical resistance against ampicillin in 17% and imipenem in
23% (both essentially due to E. faecium), erythromycin in 22%, tetracycline in
55%, linezolid in 0%, quinupristin/dalfopristin in 59% (only E. faecalis),
vancomycin 0% and teicoplanin in 0%.We found high-level resistance against
streptomycin in 33% and against gentamicin in 17% (the latter in E. faecalis
only). We identiﬁed no vanA or vanB resistance genes among the 17 isolates
with MIC for vancomycin 8mg/L, while all E. gallinarum contained the
vanC resistance gene.
Conclusion:We found no VanA or VanB resistance, 6% of isolates contained
the intrinsic nontransferable VanC resistance. Quinopristin/dalfopristin is
very seldom used in Norway, resistance in E. faecalis reﬂects the already known
low activity against this species. The glycopeptides and linezolid are still
alternative treatments in Norwegian enterococcal bacteremias when initial
treatment with ampicillin and gentamicin fails.
P1316 In vitro activities of seven antimicrobial agents
against clinical isolates of enterococci
M. Georgieva-Sredkova, D. Chankova
Pleven, Soﬁa, BG
Objectives: To evaluate the in vitro activities of seven antimicrobial agents
against enterococci, isolated from clinical specimens obtained from hospita-
lized patients.
Methods: A total of 301 enterococcal isolates (266 E. faecalis, 22 E. faecium 8
E. gallinarum, 1 E. hirae, and 1 E. rafﬁnosus) were tested. Specimens included
in the study were pus swabs (152), blood cultures (18), and urine (131).
The MICs of penicillin, ampicillin, vancomycin, gentamicin, streptomycin,
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ciproﬂoxacin, and rifampin were determined by an agar dilution method
according to NCCLS recommendations. All isolates exhibiting resistance to
penicillin or ampicillin (MIC> 16mg/L) were examined for beta-lactamase
production with the nitroceﬁn disk test.
Results: The MIC90s for E. faecalis isolates were determined to be 4mg/L
for penicillin, 2mg/L for ampicillin and vancomycin, >2048mg/L for
both aminogyicosides, 1mg/L for ciproﬂoxacin, and 8mg/L for rifampin.
E. faecium isolates were more resistant to both penicillins and rifampin with
MIC90s¼ 32mg/L. High-level resistance to gentamicin (>500mg/L) and
streptomycin (>2000mg/L) was detected in 38.0 and 41.0% of E. faecalis
isolates, and in 31.8 and 45.4% of E. faecium isolates, respectively. All isolates
tested were susceptible to vancomycin. Beta-lactamase activity was not
detected in two E. faecalis and four E. faecium isolates with MICs for penicillin
of 32mg/L or 64mg/L
Conclusions: The results of this study show high level of resistance to
penicillins aminoglycosides and rifampin in E. faecium isolates. Resistance
to penicillin in E. faecalis isolates is low.
P1317 Experience with two in vitro methods for
detecting antibiotic synergy against streptococcal and
enterococcal isolates in patients with infective endocarditis
O. Perovic, H. Koornhof, T. Capper, J. Galpin, A. Duse
Johannesburg, ZA
Introduction:Combinations of antimicrobial agents, which have been shown
to be synergistic in vitro, by the time-kill method have been associated with a
favorable clinical outcome in the treatment of enterococcal and viridans
streptococcal endocarditis.
Objectives: (i) To assess the performance of the time-kill method against drug
combinations known to be synergistic. (ii) To compare the E-test method for
synergy prediction with the time-kill method.
Methods: Eight isolates from patients with infective endocarditis that met
Duke’s criteria admitted during 2002 at Johannesburg Hospital were studied.
We performed synergy tests using time-kill, and E-tests methods with the
penicillin and gentamicin combinations on ﬁve streptococcal, three enter-
ococcal, and vancomycin and gentamicin on two enterococcal isolates.
Results: Synergy was presented in the table. Three patients (37.5%) died, two
without treatment andHIV positive, and a third after 6weeks of treatment. All
three E. faecalis isolates were susceptible to penicillin and vancomycin and
conﬁrmed withMIC results; one S. mitis and one S. sanguiswere intermediate
susceptible (MIC¼ 1 for both). The time-kill method showed synergy with 9
out of 10 isolates tested with known synergistic combinations. The E-test
method showed synergy with four isolates, three of which also showed
synergy with the time-kill method. The other isolates showed either an
indifference or antagonism.
Conclusions:
(1) The time-kill method performed well in predicting synergy in the case of
combinations expected to be synergistic.
(2) The E-test correctly predicted synergy with four out of ﬁve streptococcal
isolates. Indifferent and antagonistic results occurred with the four
isolates. Further investigations are required to conﬁrm this trend.
Helminth infection: clinical aspects
P1318 Comparison study between surgical treatment of
hydatid and medical treatment with albendazole
F. M. Mahdi
Ebb, YE
Aim of study: Iraq is an area of heavy infestation with an Echinococcus
Granulosus and the disease called hydatid cyst is still a major health hazard in
this country, so our aim in this study is to compare between right and left lobes
involvement from the point of rate of occurrence, clinical presentations,
intraoperative ﬁndings, post operative complications, effect of albendazole
and sex distributions. So we hope by this study to reach for the best method
for the diagnosis and treatment.
Patients andmethods:BetweenOctober 1993 andOctober1997, 75 patients
presented with hydatid disease of the liver were admitted to our general
surgical department in medical city teaching hospital. A retrospective study of
surgical and medical treated patients was planned. A full history was obtained
from every patients emphasizing on certain points including age, sex,
occupation, residency, contact with pet animals, family history. Each point
was thoroughly examined. All patients were diagnose by ultrasound and fewof
them by serology. Sowe compare between the right and left lobes hydatid and
comparison with albendazole therapy.
Results: Seventy-ﬁve patients with hydatid cyst of liver are surgically treated,
60% of patient were females and 40% were males with f/m 1.5:1, the age
range from 10 to 60 years, 33.3% were from rural population and the others
from urban districts, 78.7% with hydatid of right lobe and 12% in left lobe and
9.3% bilateral, 20% of the patients we gave them albendazole tablet for
6months compared with those undergoes surgery only, some of them (4%)
complain from reoccurrence compared with those taking albendazole therapy
in which neither of them reoccurrence.
Conclusion: (1) Hydatid disease of the liver is still very common in Iraq (it is a
malignant disease of Iraq). (2) Irradications started from the education of the
patient about the disease. (3) Surgery is the treatment of choice, but
albendazole therapy has its place in treatment of hydatid especially the
disseminated disease and it is used as asynergestic therapy with surgery or
is used alone especially in those they have contraindications for surgery.
P1319 Primary renal hydatid cyst
E. Mendrinou, A. Regli, T. Podimatas, A. Kolotouros,
C. Koumoundourou, A. Kouzelis, P. Grammenou, C. Frangides
Patras, GR
Objective: A case of an unusual renal hydatid cyst is reported. Detection of
antiechinococcal antibodies by indirect hemagglutination (IHA) contributed
to the diagnosis.
Material and methods: A 72-year-old man admitted to our hospital because
of intense pain in the right renal region and heamaturia. He also mentioned
elimination of ‘crashed grape like forms’ during urination. This material was
collected and examined histopathologically. The laboratory analysis included
blood examination, abdomen ultrasound, CT scan of chest and abdomen and
detection of antiechinococcal antibodies by indirect hemagglutination (IHA).
Results: Laboratory studies showed anemia (Ht¼ 29%) and leukocytosis
(WBC¼ 17 000/mm3 with 8% eosinophils). Anti-echinococcal antibodies
were presented in a title of 1:1280. Chest X-ray was normal, while the
abdomen X-ray revealed a round calciﬁed shadow in the right kidney.
Ultrasound examination revealed a cystic formation with peripheral calciﬁca-
tion. No other cystic formation were noted. On CT scan a cystic formation
without uptake of the sciagraphic was noted. Finally, histologic examination
of the eliminated in the urine cysts revealed that the cystic formation was an
echinococcal daughter cyst. Successively, right nephrectomy was performed.
Intraoperatively there was some difﬁculty in dissecting the right kidney
because of the solid adhesion to the peritoneum. Histologic examination
of the kidney conﬁrmed the initial histologic diagnosis.
Organism
Drug
combination
E-test
FIC index
Time
kill 4 h
Time
kill 8 h B/C
Enterococcus faecalis Pen-genta 2.27 (A) S S 7
Vanco-enta 1.33 (I) S S
Enterococcus faecalis Pen-genta 1.25 (I) S S 7
Vanco-genta 1.75 (I) S S
Streptococcus mitiz Pen-genta 0.065 (S) S S 
Streptococcus sanguis Pen-genta 0.44 (S) I I 3
Enterococcus faecalis Pen-genta 1.67 (I) S S 
Streptococcus mitiz Pen-genta 3 (A) I S 
Streptococcus mitiz Pen-genta 0.058 (S) I S 3
Streptococcus.constellatic Pen-genta 0.07 (S) I S Unknown
S, synergy; I, indifference; A, antagonism; FIC, (fractional inhibitory index): synergy
FIC 0.5, indifference FIC >1 and <2, antagonism FIC 2; B/C, days of negative
blood culture; died without treatment, died after 6 weeks of treatment.
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Conclusions: Renal echinococcosis that represents 4% of all cases of echi-
nococcosis is rare in Greece. The typical elimination of ‘crashed grape like
forms’ after acute urinary pain is almost pathognomonic. Serologic test of
IHA is sensitive and speciﬁc for the diagnosis of echinococcosis.
P1320 Hydatid cyst of the left ventricle
E. Mendrinou, K. Niarchos, A. Regli, C. Koumoundourou, A. Kouzelis,
P. Grammenou, C. Frangides
Patras, GR
Objective: We report a case of isolated hydatid cyst of the left ventricle, an
unusual localization, that manifested symptoms of left heart failure. Detection
of antiechinococcal antibodies by indirect hemagglutination (IHA) contrib-
uted to the diagnosis.
Material and methods: A 41-year-old man admitted to our hospital because
of an incident of loosing consciousness. The patient mentioned symptoms of
intense dizziness, tachycardia accompanied by arrhythmia, easy fatigue and
dyspnea. Laboratory examination included ultrasound and CT scan as well as
detection of antiechinococcal antibodies by indirect hemagglutination (IHA).
Results: ECG showed strain of the left ventricle, the chest X-ray showed
augmentation of the cardiothoracic index. Cardiac echography revealed
dilatation of the left ventricle with elevation of end diastolic diameter
(7.8 cm), functional decrease with ejection fraction 41% and a cystic forma-
tion, sized 4.9 cm 5.2 cm, containing daughter cysts. CT scan of the chest
conﬁrmed the existence and the size of the cystic formation. Blood analysis
revealed anemia, leukocytosis and eosinophilia. Anti-echinococcal antibodies
were detected in a title of 1:5120. The cyst was removed surgically. The
histological examination conﬁrmed the diagnosis of Echinococcus granulosus
accompanied by daughter cysts. The patient recovered completely without
any sequela.
Conclusions:The localization of the hydatid cyst in the heart is extremely rare
(0.5–2%) relatively to the incidence of echinococcosis. Imaging (U/S and CT
scan) and immunodiagnostic techniques (IHA and ELISA) contribute to
diagnosis of the disease. Surgical treatment results to full recovery. In regions
where hydatosis is endemic, cardiologists should be considered the disease in
the differential diagnosis of heart failure and thoracic pain, in order to
minimize the severity and prevent complications of the disease.
P1321 A recurrence hydatid cyst case after surgical
intervention
P. Demir, S. Cesur, H. Kurt, E. Tekeli
Ankara, TR
Hydatid cyst (echinococcosis), a zoonotic disease commonly seen in some
regions of world and Turkey. Musculoskeletal system involvement rarely
occurs in hydatid cyst. Surgical removal of hydatid cysts are frequently
complicated by cysts rupture, spillage of contents, and secondary recurrences.
In this paper a 48-year-old male, whose cyst with vertebral involvement
recurred after surgical intervention is presented. Diagnosis was conﬁrmed by
histopathological examination of surgical material, radiological imaging and
positive serology. Albendazole was started to the patient and continued for
3months. In conclusion, patients with vertebral lesions of cystic structure
should be evaluated by physicians respect of the hydatid cyst especially in areas
where echinococcosis is endemic.
P1322 Incidental detection of microﬁlariae in a renal
transplant patient
T. Baptista-Fernandes, A. Lopes, A. Pires, A. Weigert, D. Machado,
T. Marques
Carnaxide, P
Objectives:We intend to call attention to the incidence of tropical diseases in
patients we attend in our European Transplant Units, and to the need of
screening these patients before they received any kind of immunosuppression.
Methods:We used a protocol follow-up for detection of CMVantigenemia
by imunocytochemical detection of an early structural protein (pp65) of the
virus in peripheral blood leucocytes.
Results: By accident we detected high density of microﬁlariaemia, identiﬁed
as Mansonella perstans, based in its morphologic characteristics and epi-
demiology.
Conclusions: No clinical signs or symptoms called attention to ﬁlariasis.
Presumable due to the steroid therapy, eosinophilia was not present. In non
immunocompromised patients, ﬁlariasis is often a benign situation, with no
need for special therapy. Due to impaired immunity caused by triple
immunosuppression, the patient was treated with mebendazole. We could
not ﬁnd any published report of ﬁlariasis in transplanted patients and we must
be alert to tropical pathology in any patient, even asymptomatic, who came
from endemic areas.
P1323 Hepatic capillariasis: an emerging zoonosis in
Kolkata, India
U. K. Chattopadhyay
Kolkata, IND
Objectives:Hepatic capillariasis caused by C. hepatica is an anthropozoonosis.
Rodents are the main reservoirs of infection. The disease in man and animals
manifests as hepatosplenomegaly and eosinophilia. The ﬁrst authentic case of
human capillariasis had been described by McArthur in 1924 from India
following postmortem examination. Since then no case has been reported so
far from India although cases have been reported from various parts of the
world. Unlike other parasitic infections the disease cannot be diagnosed by
conventional parasitologic stool examination. The only mode of diagnosis is
liver biopsy which is not feasible always. The present study was undertaken on
development of suitable serologic tests in animal models and its application in
human beings suffering from hepatosplenomegaly and eosinophilia.
Methods: 102 black rats were examined macroscopically for the presence of
hepatic and splenic lesions. Ova of C. hepatica had been collected and antigen
had been prepared using standard technique. Co-agglutination (CoA) and
passive hemagglutination (PHA) tests had been developed and standardized
with the macroscopically positive and negative rodents. Twenty-four human
sera had been collected from the patients suffering from hepatosplenomegaly
and eosinophilia and CoA & PHA were applied to these sera.
Results: Ninety (88.2%) out of 102 black rats examined showed direct
evidence of hepatic lesions (100%) and splenic lesions (16.6%). PHA appeared
to be better than CoA for serodiagnosis when tested in rodents. Three (12.5%)
out of 24 human samples tested showed antibody titre more than 1:160 and
1:256, respectively, following CoA and PHA test.
Conclusions:Tropical eosinophilia (TE) is very common in India particularly
in the East and Southern parts of India and TE is one of the manifestations of
hepatic capillariasis. Often patients with TE do not respond to antiﬁlarial
drugs also. This necessitated a serological study on hepatic capillariasis.
Domestic black rodents is a very common association in both rural and
urban India. This study highlighted that 12.5% human cases harbored high
titre of antibody in their blood. Although this is a preliminary one, but this
study indicates emergence of undetected cases of hepatic capillariasis in
human beings if a suitable diagnostic method is developed.
P1324 Treatment of hydatid cyst with albendazole and
praziquatel
M. Jamshidi, M. Mohraz, M. Zangeneh
Bandar Abbas, Tehran, IR
Objectives:The standard therapy of hydatid cyst is surgery but in nonoperable
patients and multiple organ involvement medical therapy may be more useful
efﬁcacy of drugs especially in short duration in treatment of hydatid cyst is
unknown. This study was carried out to evaluate the effect of combination
therapy with albendazole and praziquantel in treatment of hydatid diseases.
Methods: In a nonrandomized clinical trial nine hydatid cyst patients with
multiple organ involvement or postsurgical recurrence were treated with
albendazole and praziquentel for 4 periods of 4weeks duration with 2weeks
interval between them. The average follow up was 18months response to
treatment was assessed through the observation of the symptoms, radiologic
(CT scan, sonography, conventional X-ray) and histologic study.
Results: Symptoms disappeared in 7 (77%) patients and improved partially in 2
(23%) patients. Radiologic assessment showed signiﬁcant improvement in 5
(55%) and partial improvement in 4 (45%) patients. Histologic study was
carried out on 2 patients and showed disappearance of the germinal layer.
Conclusion: Combination therapy with albendazole and praziquentel is
effective in treatment of hydatid cyst and can be used as an alternative to
surgery in disseminated and nonoperable cases.
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P1325 The efﬁcacy of niclosamide, mebendazole and
praziquantel on 50 cases with Taenia saginata taeniasis and
Taenia solium taeniasis
D. Kraja, B. Tila, N. Como
Tirana, AL
Objectives:The recognition of the real efﬁcacy of those drugs on treatment of
taeniasis in our clinic.
Methods: We have treated during the period of 1982–2002, 50 patients, 29
males and 21 females of age 14–64-year-old with taeniasis (32 cases affected by
Taenia saginata and 18 cases by Taenia solium) coming from 20 districts of our
country. The diagnose was proved through coproparasitologic examination.
As treatment we used niclosamide 25 cases (2 doses of 1 g within an interval of
2 h chewed thoroughly the drug before meal); praziquantel 12 cases (a single
dose of 10mg/kg) and mebendazole 13 cases (200mg 2/die for 3 days) at
the end of treatment we have recommended 50–100 g magnesium sulfuric.
Cases have been observed al least for 6months having additional copropar-
asitologic examination 2–3 and 5–6months after treatment as well.
Results:Niclosamide: the ﬁrst cycle cured 16 out of 25 cases, 64%; the second
cycle cured 4 out of 9 cases, 44.44% and the third cycle cured 1 out of 3 cases,
33.33% when the second cycle failed. The 2 cases when the second cycle
failed and 2 cases when the third cycle failed with niclosamide, were cured
using a cycle of praziquantel. Mebendazole: ﬁrst cycle cured 7 out of 13 cases,
53.84%; second cycle cured 2 out of 5 cases, 40%. From 3 cases remained, 1
case was cured with a cycle of praziquantel and 2 cases with a cycle of
niclosamide. Praziquantel: ﬁrst cycle were cured 9 out of 12 cases, 75%;
second cycle were cured 2 out of 3 cases when the ﬁrst cycle failed, 66.66%.
The remained case from the second cycle was cured through a niclosamide
cycle.
Conclusions: None of the drugs has been acted 100% during the case
treatment. Praziquantel and niclosamide resulted the ﬁrst choice for treat-
ment. Being twice failed with the same drug the substitution would be an
efﬁcient solution.
Brucella infections
P1326 Human Brucella abortus infection in Northern
Ireland; the ongoing epidemic
D. Orr, B. Smyth, S. Hedderwick
Belfast, UK
Objectives: A rise in cattle brucellosis has been mirrored by an epidemic of
human brucellosis in Northern Ireland. Since 1998 50 cases of human
brucellosis have been reported. Herein we describe the clinical features
and outcomes of 20 of these patients (pts) who have been seen in the regional
adult infectious diseases unit in Northern Ireland.
Methods: A retrospective review of 20 pts presenting with a history of acute
brucellosis.
Results: There were 18 male pts and the mean age was 39.2 years. All pts
acquired their infections through occupational exposure. Diagnosis occurred
after screening at work in four pts. At diagnosis the commonest complaints
were lethargy (95%), fever (85%), sweats (85%), and arthralgia (60%). Of
these, four pts had focal disease including sacroiliitis (three pts), endocarditis
(one pt), and orchitis (one pt). Of those with relevant investigations per-
formed at diagnosis, 57, 29, 21 and O% had one or more abnormal liver
function tests, a high C reactive protein, an ESR> 20mm/h and an abnormal
full blood count, respectively. Symptomatic pts received at least doxycycline
200mg daily plus rifampicin 600–900mg daily for 5–6weeks. After initial
appropriate treatment nine, six and ﬁve pts achieved complete cure, sero-
logical cure but ongoing symptoms, and relapse, respectively. Ten pts received
more than one course of antibiotics. However, 50% of these had little
evidence of ongoing infection.
Conclusion: Signiﬁcant human morbidity with Brucella abortus infection has
occurred concurrent with the rise in bovine brucellosis since 1998 and is
ongoing. Many pts receive multiple antibiotic courses since sensitive diag-
nostic tests are unavailable. PCR tests are in development, which may
differentiate between patients with active disease requiring additional anti-
biotics and those without.
P1327 A case of familiar brucellosis in Greece
F. Kamaria, E. Sidopoulos, V. Papadopoulou, D. Chrisagis,
A. Kansouzidou, L. Sidiropoulos
Thessaloniki, GR
Objective: Brucellosis is a common disease in Greece, especially among
persons with occupational animal relation. None the less, the appearance of
the disease in many members of a family simultaneously, especially without
occupational exposure, is rare. We describe an outbreak of brucellosis
occurring in a family that had nothing to do with animals.
Patients: Four patients of a ﬁve-member family visited the Infectious Disease
Hospital within a 10-days period with symptoms of brucellosis (fever,
arthralgias, exhaustion, sweats). The father was 47 years old, the mother
41, the son 18 and the daughter 4 years old. All of them mentioned the
consumption of unpasteurized goat cheese 2months before. The second son
of the family who remained healthy does not like cheese.
Results: Brucellosis was diagnosed by standard agglutination test, which was
1/1600 for the father, 1/400 for the mother, 1/320 for the daughter and
1/320 for the son. Brucella melitensis was isolated by blood cultures from the
three members of the family; only the son had negative blood culture. The
daughter had arthritis of the left elbow and hepatitis (SGPT¼ 833,
SGOT¼ 479). The father and the son had slightly elevated transaminases
(SGPT¼ 69 and SGOT¼ 44 the former, and SGPT¼ 71 and SGOT¼ 58
the latter). The mother had normal transaminases. The adult patients were
treated with 1 g streptomycin for 21 days, 900mg rifampicin and 200mg
doxocycline for 2months. The child was treated with 20mg/kg streptomycin
for 15 days and 4mg/kg doxocycline for 3weeks.
Conclusion: The consumpion of unpasteurized dairy products is a common
reason for brucellosis which can rarely cause a familiar outbreak.
P1328 Familial brucellosis: a report of four patients
O. Ural, D. Findik, N. Dikici, U. Arslan
Konya, TR
Objective: Brucellosis is a common infection in Turkey and we describe an
outbreak of brucellosis occuring in a family in Konya in Turkey.
Results: Four cases of brucellosis in a 52-year-old-man, his 43-year-old wife,
his 24-year-old and 16-year-old sons within 1month. All of the cases
admitted to the hospital with a history of pain and fever. All of the cases
were diagnosed by brucella agglutination tests. Their test results were positive
at 1/320, 1/320, 1/640 and 1/160 titers, respectively. Brucella melitensis was
isolated from the blood cultures of the mother. Family brucellosis is attributed
to cheese that they had eaten but the cultures from the cheese were negative
and the family claimed that hey had kept the cheese in salt for more than
1month. The mother and her 16 years-old-son were treated for 3weeks with
streptomycin and for 6weeks with doxycycline and the boy recovered
successfully but the mother relapsed after 45 days. The second therapy was
made for 3weeks with streptomycin, for 8weeks with doxycycline and
rifampin. The father and his 24-year-old son were treated for 6weeks with
doxycycline and ripampin combination. On the controls after 1 year all of
them were healthy.
Conclusion: As brucellosis is very frequent in our area the animals must be
vaccinated, milk and milk products must be under control and the people
must be educated about this subject.
P1329 Brucella spondylitis
H. Bodur, A. Erbay, A. Colpan, E. Akinci
Ankara, TR
Objective:To evaluate the clinical and laboratory ﬁndings, diagnostic evalua-
tions and treatment of patients with brucella spondylitis.
Methods: Patients who had brucellosis followed between February-2001 to
June-2002 were included to the study and evaluated for osteoarticular
involvement prospectively.
Results: Eighty-six patients with brucellosis were included to the study. Mean
age was 44.2 17.7 (16–79) and 33 (38%) of the patients were female.
Spondylitis was diagnosed in 26 (30%) of the patients. The mean age of
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spondylitis cases were 57.3 13 (24–74) and 11 (42%) of them were female.
Patients with spondylitis were older than patients who did not have spondylitis
(P< 0.001). The sexes affected equally. By the time from onset of symptoms,
12 (46%) patients were classiﬁed as acute and 13 (50%) were subacute
brucellosis in the group with spondylitis; whereas 45 (75%) patients were
acute and 14 (23%) patients were subacute in nonspondylitis group
(P¼ 0.016) Spondylitis cases had higher ESRs compared with nonspondylitis
cases (P< 0.001). Brucella melitensiswere isolated from blood cultures from 10
(38%) of 26 patients with spondylitis. In MRI, two patients had cervical, one
had thoracic, one had dorso-lumbar, 18 had lumbar, 3 had lumbosacral and
one had sacral involvement. Additionally 14 (53.8%) patients had discitis and 6
(23%) patient had abscess. Four patients had epidural abscess and two patients
had paravertebral abscess. In patients with cervical involvement, medullar
compression was observed due to fragmentation in a patient and granuloma in
the other patient. Both of these patients underwent surgical treatment. All
patients received combined antibiotic therapy for 4–12months.
Conclusion: Our study showed that; MRI evaluation has an important
diagnostic value in brucellar spondylitis; surgical treatment may be needed
in addition to medical treatment in cervical spondylitis as medullar and root
compression is seen more often; the duration of antibiotic treatment has to be
longer in spondylitis than systemic brucellosis without spondylitis.
P1330 Skeletal complications of brucellosis among
children and adults in Babol, Iran 1998–2001
M. R. Hasanjani Roushan, S. Smailnejad Gangi, M. Hajiahmadi
Babol, IR
Objectives: Skeletal complications are more common in brucellosis. Diag-
nosis of these complications may prevent surgical procedures. The aim of this
study was to evaluate the skeletal complications of brucellsis in Babol, Iran.
Methods: This prospective study was conducted on patients with brucellosis
in department of infectious diseases in Babol from 1998 to 2001. Skeletal
complications and laboratory test results were noted. Data were analyzed by
SPSS and proportions were compared with chi-square and Fisher’s exact tests.
Results: 161 (37.6%) out of 431 subjects, had skeletal complications (94 male
and 67 female). Mean age SD, for adults and children cases were 34 17.6
and 9.5 4.2 years, respectively. Among 127 adult cases, 79 (62%) had
peripheral arthritis which was monoarthritis in 48 (37.8%) cases. Peripheral
arthritis was seen in 32 (94%) of 34 cases of children, which was monoarthritis
in 26 (76.5%) cases. Peripheral arthritis, and hip involvement were more
common in children (P< 0.05), but spondylitis was more common in adult
cases (P< 0.05). Diagnosis of brucellosis was performed in 14 (8.7%) cases
after surgery. Normal ESR and positivity of Rheumatoid factor were seen in
80.7 and 15.5% cases, respectively.
Conclusions: Skeletal complications of brucellosis are similar with septic
arthritis and rheumatologic disorders. Monoarthritis is the most common
form of this complications. We recommend that in endemic regions, bru-
cellois must be consider in differential diagnosis of all cases of monoarthritis.
P1331 Treatment of brucella spondylitis: a 3-year
experience on the appropriate duration of therapy
E. Giannitsioti, A. Balaska, G. Koratzanis, K. Kanellakopoulou,
H. Giamarellou
Athens, GR
Objectives:To evaluate the efﬁcacy of the treatment of vertebral osteomyelitis
caused by Brucella spp.
Methods:We analyzed retrospectively 15 cases of brucella spondylitis which
were diagnosed and treated in our Department from 1999 to 2002. Informa-
tion on the age, sex and profession were included in the study. The diagnosis
was based on the clinical signs and symptoms, the serological tests and the
radiological ﬁndings, while in three cases Brucella spp. was isolated from the
blood. In all cases an MRI of the vertebra was performed at the time of
diagnosis and at least at the end of the treatment. In three cases, ﬁne needle
aspiration of the bone lesions was performed. The patients were given
antimicrobial treatment with both rifampicin and doxycycline plus cotri-
moxazole or oﬂoxacin.
Results:The total duration of treatment varies from 6 to 12months. Cure was
observed in 10 cases, relapse in one case while in four cases treatment is still on
going. Cure was precised mainly clinically and secondary radiologically and
serologically. In most cases, radiological ﬁndings were ameliorated by the end
of treatment but did not disappear. No change in response rates was observed
on patients given antibiotics for 6months rather than 12months. A long –
term follow up is scheduled for these patients.
Conclusion: The optimal duration of brucella spondylitis treatment is dis-
cussed. Experience on diagnostic and therapeutic approach of a widely
predominating, in the Mediterranean areas, disease involving the bones, is
of value in order to deﬁne the appropriate length of therapy.
P1332 Brucella spondylodiscitis: serological diagnosis in
patients with backache
K. Themeli-Digalaki, J. Capsali-Deli, E. Orcopoulou, S. Velmachou,
S. Galani, C. Koutsia-Carouzou
Athens, GR
Objectives: Brucellosis is a pleomorphic zoonotic infection. Spondylodiscitis
is one of frequent osteoarticular complications of Brucella infection in adults.
The disease is a worldwide puplic health problem in many Mediterranean
countries. The aim of this study is to present brucella infection as causative
agent of spondylodiscitis.
Methods: We studied 72 patients with low backache in period 14months
(September-2001–November-2002). All patients were adults, satisﬁed the
inclusion and exclusion criteria designed to exclude radiologically detectable
congenital or degenerative causes of backache. The ﬁnal diagnosis of Brucella
was established by the history, radiographic ﬁndings and the detection of IgM
and IgG to Brucella antibodies. Rose bengal test, Agglutination tube test and
Immunoenzyme-assay were used.
Results: Six out of 72 patients (4males and 2females) were seropositive for
brucellosis. All six patients had a history of animal contact or ingestion of raw
milk or milk products. Mean age was 40 12.2. The lumbar region was the
commonly affected site. Neurological involvement in four patients was
present, on admission. The most frequent constitutional complaints was
arthralgia, fever and fatigue in all cases. Physical ﬁndings were diagnosed
as follow: tenderness (4/6), hepatomegaly (2/6), splenomegaly (2/6) and
arthritis (5/6). Abnormal laboratory ﬁndings were ESR> 50mm/h, increasd
CRP in all patients, though blood cultures were negative. Rose bengal test
was positive in all patients. The tube agglutination test in higher titers than 1/
640 was determined. The detection of speciﬁc IgM and IgG antibodies to
brucella was the conﬁrmatory tests for diagnosis of brucella infection. IgG in
all patients were detected. IgM were positive in four patients. In two cases
with negative IgM four-fold of IgG antibodies titers were found.
Conclusions: Low backache may be the only symptom in brucella of adults.
Therefore bacteriological examination and especially the serological tests are
necessary to establish the etiological diagnosis and determine the speciﬁc
antimicrobial treatment.
P1333 Osteoarticular complications of Brucella
infection. An 11-year retrospective
M. Tsironi, P. Andriopoulos, M. Perdiki, M. Kalkani,
G. Asimakopoulos
Sparta, GR
Objectives: Brucella infection is endemic in Greece and in our state Lakonia
in particular. We describe here the osteoarticular involvement of the infection
in the hospitalized patients.
Methods: Between the year 1990 and 2000, 122 patients with brucella
infection were admitted to our hospital. Ninety-three percent presented
with acute infection diagnosed clinically and conﬁrmed by the microbiology
laboratory. Fifty-seven percent of the patients had localized infection.
Results: From the patients with localized infection 70% had osteoarticular
involvement: 47% had low back pain, 8% sarcoilitis 28.5% asymmetric
polyarthritis of large joints (hips, knees, sternoclavicular joins and shoulders)
and 17.5 monoarthritis. The diagnosis was conﬁrmedwith serological test and
cultures of synovial ﬂuid. Blood cultures were positive up to 79% and the
patients were treated with prolonged combined therapy with streptomycin –
doxycyclin.
Conclusions: Osteoarticular involvement is by far the most common focal
complication of brucella infection. The early suspicion together with the
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proper diagnostic tests and prolonged treatment is crucial to the outcome of
the infection in order to avoid relapses
P1334 Human mammary abscess caused by
Brucella melitensis. A case report
M. Tsironi, P. Andriopoulos, M. Kalkani, M. Dionisopoulou,
G. Asimakopoulos
Sparta, GR
Objective: Soft tissue localized infections due to Brucella Spp. are uncommon
in human. We describe a woman with a unilateral mammary abscess due to
Brucella melitensis.
Method and Results: A 77-year-old woman was referred to hospital because
of diffuse arthralgias, swelling and pain in her left breast. She was living in a
rural area breeding animals. She was febrile with dry cough for 5 days, 3weeks
before admission, and was given a second-generation cephalosporin per os. In
admission, she had a temperature of 37.58C. The physical examination
revealed hepatosplenomegaly with normal pulmonary ﬁndings. No lymph
nodes were detected. There was a painful abscess at her left breast, which was
initially thought to be an inﬂaming tumor, because of recurrent mastitis
history. Blood tests revealed mild neutropenia (3250/mm3 leukocytes, 40
polymorphonuclear, 45% lymphocytes), elevated transaminase levels, Wright
agglutination test positive 1/320, ESR 70mm/h. IgM and IgG antibodies for
Brucella spp. were indicative of acute infection. Markers for breast and
gastrointestinal tumors were normal. The breast ultrasound revealed thicken-
ing of the subcutaneous tissues and multiple abscess formations. An U/S
guided FNA was performed, which yielded inﬂammatory cells, necrotic
tissues but no cancerous cells. The biopsy material grew Brucella spp. and
blood cultures were positive for Brucella spp. that were both identiﬁed as
Brucella melitensis. The patient received doxycycline 100mg twice a day per os
for 8weeks and streptomycin 1 g per day intramuscularly for 3weeks. One
week later the abscess had clinically disappeared and the control U/S revealed
considerable decrease of the lesions. The patient received a 2-month treat-
ment, and remained free of symptoms in clinical and laboratory follow up, for
8months later.
Conclusions:Mastitis due to brucella is rarely reported in human. Usually the
soft tissue locations are related to an injury, but in our case there was no history
of trauma. The patient was probably exposed to the aspiration of infected
aerosol. This could also explain the cough as a relevant symptom. The unusual
location could be explained by the history of underlying pathology with
recurrent episodes of acute mastitis. This case illustrate that since Brucella spp.
is a slow growing organism in cultures the occupational history of people
living in endemic areas, along with the standard tube agglutination tests may
lead to early suspicion, diagnosis and appropriate choice of therapy.
P1335 An unusual cause of spontaneous bacterial
peritonitis: Brucella melitensis
N. Tulek, C. A. Hatipoglu, M. A. Yetkin
Ankara, TR
Background: Spontaneous bacterial peritonitis is a serious complication in
patients with chronic liver disease. The incidence of spontaneous peritonitis in
cirrhotic patients is 15–20%. Ecsherichia coli and Klebsiella pneumoniae are the
most frequently recovered pathogens. We present spontaneous peritonitis
caused by an unusual pathogen, Brucella melitensis, in two patients with chronic
hepatitis B and C, respectively. Abdominal distension, leg swelling and fever
were the main complaints of the patients. Paracentesis was performed in both
them. On examination of ascitic ﬂuid, the ﬁndings were; leukocytes 400/
mm3 and 1000/mm3 (%90 lymphocytes), protein 0.7 g/dL and 0.9 g/dL,
LDH 46U/L and 163U/mL, respectively. Nomicroorganismwas detected in
Gram’s stain of the ascitic ﬂuid. Brucella agglutination test was positive at a
dilution of 1/2560 in both cases and it was also positive in ascitic ﬂuid at a
dilution of 1/32 and 1/320, respectively. In both cases Brucella melitensis were
isolated from blood and ascitic ﬂuid cultures. One of the patients treated with
tetracycline and TMP-SXT, and the other, with streptomycin and TMP-
SXT. With the treatment, both patients’ condition improved.
Conclusion: In areas where brucellosis is endemic, in patients with lympho-
cytic ascitis brucellosis should be considered and appropriate microbiological
and serological tests should be performed to conﬁrm the diagnosis.
P1336 Neurobrucellosis: experience with 10 cases
F. Kamaria, A. Ioannidis, E. Sidopoulos, P. Mamasi, A. Kansouzidou,
L. Sidiropoulos
Thessaloniki, GR
Objective: Brucellosis in Greece was and still remains a serious medical
problem.Neurobrucellosis is a rare manifestation of the disease that, according
to various studies, occurs in 2–10% of patients with brucellosis. Very few cases
of neurobrucellosis have been reported in our country. The aim of this study is
the presentation of the cases of neurobrucellosis in Infectious Diseases
Hospital, where patients from all Northern Greece are attended.
Patients:We studied retrospectively 298 adult cases of brucellosis hospitalized
in the adult department of the hospital during the years 1991–2002.
Results: Ten patients (3,3%) with neurobrucellosis were observed, eight men
and two women, aged from 19 to 69 years. All men had occupational animal
exposure and the twowomenmentioned consumption of unpasteurized dairy
products. The patients had symptoms attributed to brucellosis for periods
ranging from 15 days to 1 year. Three patients presented with symptoms of
meningitis, ﬁve of meningoencephalitis and two of encephalomyelitis. All
patients had CSF abnormalities. They had lymphocytic pleocytosis with 18–
240 cells/mm3, increased protein (75–571mg/dL), reduced CSF/plasma
glucose ratio (24–40%) and increased lactate (18–95mg/dL). All patients
had serum antibrucellar antibodies (standard agglutination and/or Coombs
test positive in titers 1/60). Eight of 10 patients had CSF antibrucellar
antibodies (standard agglutination and/or Coombs test positive in titers 1/
40, and/or Elisa test positive). Brucella was isolated from blood in three of 10
patients and from CSF in two of 10 patients, respectively. All patients were
treated with a combination of three antibrucellar drugs (streptomycin,
doxocycline and rifampicin or cotrimoxazole) for two to 6months. The
outcome was perfect in all patients with meningitis and meningoencephalitis,
but in the two patients with myelitis there was residual motor disability.
Conclusion:Neurobrucellosis is a rare but serious complication of brucellosis
and a diagnostic delay can enhance residual disturbances.
P1337 Forty-six Brucellosis cases in which 70% of blood
cultures are positive
G. Sengoz, S. Gulduren, F. Yildirim, D. Berzeg, O. Nazlican
Istanbul, TR
Objective: Forty-six patients are followed up with the diagnosis brucellosis at
Haseki Education and Research Hospital.
Methods: The patients were diagnosed according to serological and cultural
methods and also their clinical symptoms. In 70% of the patients the blood
culture (BACTEC 9050 Becton Dickinson) were positive. Twenty-nine of
the patients were followed up as inpatients. The most frequent symptom fever
was seen in 31 cases. The other frequent symptoms were sweating and
backache. One quarter of the patients have the history of ingestion of
unpasteurized diary products, which is an important route of transmission.
Sixty percent of the patients had these complaints lasting over 1month before
they were diagnosed. In nine cases leucopenia, seven cases spondilodiscitis,
four cases pancytopoeniawere seen. In one case, Brucella spp. was isolated from
the cerebrospinal ﬂuid and blood. The most of the cases were treated by
doxycycline and rifampin. No relapses were seen in the treated cases.
Result: The diagnosis of brucellosis is difﬁcult since it is a long-lasting and
silent disease and it has important complications. It should be remembered
that brucellosis is one of the most frequent causes of fever of unknown origin
in our country. The mean growth period of Brucella spp. in automatized blood
culture systems, was found to be 3.3 days.
Conclusion: The length of the time interval between the symptoms and the
diagnosis shows brucellosis is hard to be diagnosed. Automatized blood
culture systems are very useful which provide a high ratio of growth for
Brucella spp.
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P1338 Comparison of diagnostic value of Standard Tube
Agglutination Test with the ELISA Ig G and Ig M in patients
with brucellosis
M. Ertek, H. Yazgi, Z. Ozkurt, A. Ayyildiz, M. Parlak
Erzurum, TR
Objectives: Brucellosis is one of the major zoonotic diseases in many parts of
the world, especially in Mediterranean and Middle East countries. It is also
endemic in Turkey. Since it affects many organs and the symptoms are
nonspeciﬁc, the diagnosis by clinic ﬁndings is difﬁcult and may be easily
missed. However, positive blood cultures occur in 10–70% of suspected
infections, serological tests play a major role in diagnosis when the disease can
not be detected by blood culture.Many serological tests have been used for the
diagnosis of human brucellosis. The most commonly used tests are the
standard tube brucella agglutination test (SAT), the Rose Bengal test,
complement ﬁxation test and ELISA. The aim of this study was to compare
the diagnostic value of the brucella SAT, with ELISA (brucella speciﬁc IgG
and IgM) tests in patients with brucella bacteremia.
Methods: The study was done on 32 patients with brucellosis who had
positive blood and/or bone-marrow cultures for Brucella species, and 20
healthy individuals as control. Fifty-two serum samples from both groups
were tested for brucella speciﬁc IgG and IgM antibodies by ELISA using
commercial kit (Novum, Germany). Same samples were also tested by SAT
Results: In the patients group, 30 of 32 samples gave positive result by SAT
(titer >1/160). Of the same group, IgG and IgM antibodies by ELISA were
positive in 26 and 32 patients, respectively. In 24 of the patients both IgG and
IgM antibodies were detected. From 20 control sera, all were negative (titer
<1/80) in SAT, 1 in ELISA IgG and 3 in ELISA IgM were positive. Positive
predictive value of SATwas calculated as 100.0% and the negative value was as
90.9%. Positive and negative predictive values for ELISA IgG were 96.3 and
76.0%, and for ELISA IgM were 90.9 and 89.5%, respectively. Sensitivity and
speciﬁcity rates of SAT, ELISA IgG and ELISA IgM tests were found as 93.7,
100.0, 81.3, 95.0, 93.8 and 85.0%, respectively.
Conclusion: The overall data showed that the sensitivity of SAT and ELISA
IgM tests were nearly equal, but the sensitivity of ELISA IgG was lower than
the other two. On the other hand the speciﬁcity of SATwas higher than that of
both ELISA IgG and IgM. According to the results of this study, SAT can be
preferred to ELISA because it is cheap and easy applicable.
P1339 Evaluation of growth time in Brucella spp.
H. Aydogan, M. Baysallar, A. Kilic, A. Kucukkaraaslan, Z. Senses,
L. Doganci
Ankara, TR
Objectives: The isolation of Brucella species from blood may be achieved by
using classic culture techniques but detection of the organism is difﬁcult due
to its slow growth. The detection time of brucella can take up to 30 days by
using Castaneda blood culture method. Automated blood culture systems
have reduced the growth time of brucella. In this report, we would like to
contribute our experience on detection time in the isolation of Brucella species
from blood, by use of Bact/ALERT and BACTEC 9240 blood culture
systems.
Methods and results: Thirty Brucella spp. were isolated from 35039 blood
culture sets between 1995 and 2002. Blood cultures were recovered between
1.8 and 3.7 days in BacT-Alert blood culture system, while 2.1–3.8 days in
BACTEC 9240 system.
Conclusion: Brucella spp. can be recovered minimum at 7 days in traditional
procedures while the maximum time is 3.8 day for automated blood culture
system. We concluded that automated blood culture systems could isolate
Brucella spp. in rapid and efﬁcient way.
P1340 The role of adenosine deaminase activity and
soluble interleukin 2 receptor levels in the discrimination
of acute and chronic brucellosis
A. Karadenizli, S. Helvaci, G. Goral, F. Gokirmak, H. Vahaboglu
Kocaeli, Bursa, TR
Objectives: We aimed to investigate the role of adenosin deaminase (ADA)
activity and soluble interleukin-2 receptor (sIL-2R) levels in the differentia-
tion of acute from chronic brucellosis.
Methods: ADA levels were measured in the sera of 17 acute brucellosis, 12
chronic and 11 healthy volunteers. sIL2R levels were measured in the sera of
15 acute brucellosis, 12 chronic and 10 healthy volunteers. ADA activity was
assayed according to the method of Giusti. Measurement of sIL-2R was made
using immuno enzymometric kit by Immunotech International.
Results: In acute brucellosis group (AB), ADA activity and sIL-2R level were
71.24 29.48 and 126.20 92.43, respectively. ADA activity was found as
51.16 35.85 and sIL-2R level was 144.38 103.28 in chronic brucellosis
group (CB). In healthy controls ADA activity was 12.46 2.06 and sIL-2R
level was 116.88 24.16. ADA activity was found higher in both groups than
controls (P< 0001). However, There was no statistically difference in differ-
ential diagnosis between acute and chronic brucellosis (P> 0.05). sIL2R levels
in sera were not signiﬁcantly different among acute, chronic brucellosis and
controls (P> 0.05).
Conclusion: This study showed that both ADA activity and sIL-2R level are
not informative in the discrimination of acute and chronic brucellosis.
P1341 The role of adenosine deaminase activity
and soluble interleukin 2 receptor levels in cerebrospinal
ﬂuid in differentiation tuberculous meningitis from
bacterial and viral meningitis
A. Karadenizli, S. Helvaci, G. Goral, F. Gokirmak, H. Vahaboglu
Kocaeli, Bursa, TR
Objectives:Tuberculous meningitis is difﬁcult to be distinguished from onset
of viral and bacterial meningitis with low cell-count in cerebrospinal ﬂuid. In
this study, it was investigated the role of adenosin deaminase (ADA) activity
and soluble interleukin-2 receptor (sIL-2R) levels in the differentiation
meningitis especially of tuberculous from bacterial and viral meningitis.
Methods: ADA and sIL-2R levels were measured in the CSF samples of 16
tuberculous meningitis, 37 bacterial meningitis, 18 viral meningitis and, and
35 CSF samples without any inﬂammation as controls. ADA activity was
assayed according to the method of Giusti. Measurement of sIL-2R was made
using immuno enzymometric kit by Immunotech International.
Results: In tuberculous meningitis group (TBM), cerebrospinal ﬂuid ADA
activity and sIL-2R level were 29.00 7.11U/L and 1509.10 1029.12U/
mL, respectively. ADA activity was found as 14.02 10.91U/L and sIL-2R
level was 273.68 366.94U/mL in acute bacterial meningitis group (BM). In
viral meningitis group (VM), CSFADA activity was 2.84 1.77U/L and sIL-
2R level was 40.03 36.18U/mL. In control group, ADA activity was found
to be 1.44 0.78U/L and sIL-2R level was 9.56 1.68U/mL. The mean
CSFADA activity and sIL-2R level were signiﬁcantly elevated in TBM group
as compared with BM and VM and control groups (P< 0.001). In differ-
entiation TB from other meningitis, by using 9U/L as a cut-off value of ADA
activity we showed that the test had 100% sensitivity, 75.6% speciﬁcity and
42.1% positive predictive value (PPV). When cut-off value was taken as above
500U/mL for sIL-2R, we determined the sensitivity, speciﬁcity and PPV as
91.7, 96.3 and 78.6%, respectively.
Conclusion:This study is showed that both ADA activity and sIL-2R level are
useful in the differential diagnosis of TBM from BM and VM.
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Organism carriage, prevalence, and incidence
P1342 MRSA awareness and nasal carrier rate among
newly recruited staff nurses in a new tertiary care specialist
hospital at Taif, Saudi Arabia
B. V. Navaneeth, A. S. Asghar, A. R. Al Gurashy, A. M. Amer
Taif, SA
Objectives: To evaluate the awareness of MRSA among newly recruited staff
nurses. To know the nasal carrier status of S. aureus and MRSA among them.
To record the base line antibiotic susceptibility pattern of S. aureus among the
isolates from the carriers.
Methods:This study was designed as a part of education on infection control
to newly recruited staff nurses (216) in King Abdul Aziz Specialist Hospital,
Taif. A written questionnaire was responded by staff nurses relating to the
problem, source, method of spread, suspect of an outbreak and measures to be
taken to prevent and control MRSA in a newly commissioned hospital. Nasal
swab was taken from each staff nurse and inoculated on to mannitol salt agar
and blood agar. S. aureus was identiﬁed by conventional and latex agglutina-
tion methods. Oxacillin (1 mg disc) resistance was taken as less than 10mm
screening and beta-lactamase test was done by disc diffusion method and
cephalosporin disc method, respectively. Staff nurses were educated in terms
of source, spread and suspicion of an outbreak and preventive measures to be
taken in such eventuality.
Results: Respondents had difﬁculty in suspecting an outbreak. Of 216 nasal
swabs, 43 (19.9%) showed S. aureus. All 43 isolates were susceptible to oxacillin
(MSSA), vancomycin, amoxy-clavulanic acid, gentamicin, cotrimoxazole and
rifampicin. Thirty-eight (88.3%) isolates were penicillin resistant and was due
to beta-lactamase production. Two isolates showed inducible erythromycin
resistance and one constitutive resistance.
Conclusions: S. aureus nasal colonization among staff nurses was 19.9%. None
revealed MRSA colonization. Education in suspecting outbreak needs to be
highlighted.
P1343 Prevalence of MRSA in European hospital
populations: implications for empiric therapy
M. Jones, R. Blosser-Middleton, C. Thornsberry, J. Karlowsky, D. Sahm
Hilversum, NL; Herndon, USA
Objectives: The prevalence of Staphylococcus aureus (SA) and methicillin-
resistant SA (MRSA) can vary between regions and patient groups. If the
incidence of MRSA is high, nonanti-MRSA empiric therapies could have
serious consequences for infected patients.
Methods: Data derived from the TSN Database, an electronic surveillance
system that collects routine susceptibility test results from hospital laboratories
in France (Fr; 63 sites), Germany (Gy; 169 sites), Italy (It; 48 sites), and Spain
(Sp; 21 sites) were used in this analysis. Data from 1 January 2000–31 August
2002 were used to deﬁne the overall incidence of SA and MRSA by patient
location (inpatient, ICU, surgical), age group (<18, 18–64, >64 years), and
site of infection (blood or lower respiratory tract [LRTI]), as a proportion of
all nonrepeat bacteria isolated and susceptibility tested. Contemporary
NCCLS breakpoints were used for all countries except Fr, in which CA-
SFM breakpoints were used.
Results:The incidence of SAvaried little by age and location comprising 7.5–
21.5% of all isolates. The incidence of SA was higher in LRTI comprising
19.1–24.8% of isolates in Fr and 19.2–29.1% of isolates in It, depending on
patient location. The overall incidence of MRSA in each country was Fr
(40.2%), Gy (16.5%), Italy (48.2%), and Spain (38.5%). For all patient
locations in each country, the incidence of MRSA increased with age.
The highest levels reported were in patients >64 years in It (52.9–67.6%
of SA), Fr (39.1–48.0% of SA), and Sp (24.4–44.7% of SA). By patient
location, 39.9–57.5% of SA from LRTI in Sp and It were MRSA, compared
with 35.5–42.8% in Fr and 8.0–16.4% in Gr. The highest levels of MRSA as a
proportion of all bacteria isolated were recorded in It, comprising 10.8, 15.4,
and 14.7% in inpatient, ICU, and surgical patients, respectively.
Conclusions: The variation in MRSA rates suggests that empiric antimicro-
bial therapy must be tailored to account for patient age, hospital location, and
site of infection. In particular, in patients >64 years and for LRTI, the high
prevalence ofMRSA suggest that coveringMRSAwhen choosing an empiric
therapy could be prudent. Studies are required to test whether such antibiotic
policies would positively impact patient outcomes and costs.
P1344 The ﬁrst molecular survey on mycoplasma
infections in inﬂammatory vs. noninﬂammatory arthritis in
Iran
B. Bakhshi, M. R. Khorramizadeh, N. Badami, F. Gharibdoost
Tehran, IR
Background:Mycoplasma have been debated to be associated with acute and
chronic arthritic diseases.
Aim: We devised a survey based on a statistical sample to determine the
signiﬁcance of mycoplasma in inﬂammatory vs. noninﬂammatory arthritis in
Iranian patients.
Methods: Synovial ﬂuid samples were collected from knees of 99 patients
with arthritis, all of which fulﬁlled the standard criteria for diagnosis. Patients
were categorized as inﬂammatory (59) and noninﬂammatory (40) subjects. An
aliquot of each synovial ﬂuid was placed in lysing buffer, followed by DNA
extraction. An optimized PCR protocol was then performed to detect a 280-
bp 16S rDNA speciﬁc for Mycoplasma genus. After conﬁrmatory restriction
digestion of PCR product, the densitometric data of visualized bands were
analyzed statistically and the P-values lower than 0.05 considered signiﬁcant.
Results: From the 99 patients under study, mycoplasma DNAwas detected in
5 (8.5%) of 59 samples from inﬂammatory arthritis patients, and in 6 (15%) of
40 samples from noninﬂammatory arthritis patients. Epidemiological para-
meters including sex, age, previous antibiotic therapy and smoking did not
showed signiﬁcant correlation with PCR results.
Conclusions: This study advocates the association of mycoplasma infections
with arthritis, either inﬂammatory or noninﬂammatory. However, more
studies are required on determining comparative frequencies of mycoplasma
vs. other possible bacteria.
P1345 Evaluation of anti-Chlamidia antibodies in
patients with coronary artery disease
A. Jafarzadeh, A. Esmaeili Nadimi, A. Khodadady
Rafsenjan, IR
Objectives: Atherosclerosis (AS) is important laying cause of coronary artery
disease (CAD). Common risk factors only contain almost half of patients with
AS. A potential relationship between infectious factors and AS has been
suggested recently, and some seroepidemiological evidences have suggested
the role of Chlamidia pneumonia (CP) bacteria in the etiology of AS.
Methods:This study has performed as retrospective case-control on the blood
sample from 56 cases that they were referred to Ali Ebn Abitaleb hospital, that
group (1) including 29 cases with acute myocardial infarction, and group (2)
29 cases with chronic stable angina. Control group includes 29 healthy
matched individuals (group 3).The case and control groups matched from
sex, age and major coronary risk factors. After assembling of samples, IgG
antibody concentration against CP measured in sera by ELISA. Serum
antibody ranges higher than or equal of 5 unit/mL carried as positive and
lower ranges as negative. Data analyzed by INSTAT soft ware and parametrical
Kruscal–Wallis test, w2-test and Dunns multiple comparison test. Statistical
signiﬁcant level was P< 0.05.
Results: In the group (1) positivity of anti CP antibody concentration became
100%, group (2) 65.6% and in control group 31%. The difference between
these results became signiﬁcant with P< 0.0001. Also median concentration
of antibody in these groups accounted as 34.7, 11.4 and 3.6mM/mL,
respectively, that difference between these medians were signiﬁcant with
P< 0.0001.
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Conclusions:These results show that there is anti CP antibody in considerable
percent of patients with CAD especially in patients with acute myocardial
infarction. Therefore it can be supposed that there is a relationship between
CP and CAD or its complications, and expected that can decrease in
incidence of out come of CAD by antibiotic drug therapy against CP.
P1346 Positive association between essential
hypertension and Chlamydia pneumoniae but not
Epstein–Barr antibodies
V. Pitiriga, E. Zagotzidou, C. Papanagiotou, M. Alexandrou,
V. Petrocheilou-Paschou, N. Zakopoulos
Athens, GR
Objectives:Conﬂicting data exist regarding the association between essential
hypertension and C. pneumoniae seropositivity. In our study, C. pneumoniae
IgA and IgG antibody titers were measured in 306 hypertensive patients and
45 normotensives (control group). Epstein–Barr virus antibodies were also
estimated in order to clarify whether a possible relationship between hyper-
tension and C. pneumoniae is speciﬁc or not.
Methods: C. pneumoniae IgA and IgG antibody titers were measured by
microimmunoﬂuorescence method (MIF). Elementary bodies of C. pneumo-
niae TW 183 strain, were used as antigen. IgA 40 and IgG 80 were
deﬁned as elevated titers. Epstein–Barr antibodies (VCA-IgG, VCA-IgM,
EA, EBNA) were measured by the ELISA technique. All subjects underwent
casual blood pressure readings by sphygmomanometer and 24 h ambulatory
blood pressure monitoring. The participants by selection were free of any
cardiovascular disease evidence. Smoking status, age, and gender were
recorded in each patient. Serum cholesterol, triglyceride, and glucose were
determined.
Results: There was no statistically signiﬁcant difference between the two
groups in age, smoking status, cholesterol, triglyceride and glucose serum
levels. A total of 172 hypertensives (56.2%) and 6 normotensives (13.3%) had
IgA titers40 (crosstabs P< 0.005). A total of 218 hypertensives (71.2%) and
20 normotensives (44.4%) had IgG titers 80 (crosstabs P< 0.001). No
difference in Epstein–Barr antibody levels was found between hypertensives
and normotensives.
Conclusions: A positive association between C. pneumoniae seropositivity and
essential hypertension was found suggesting high frequency of chronic
C. pneumoniae infection in hypertensives.
P1347 Association between Chlamydia pneumoniae
antibodies and Crp levels in hypertensive patients
V. Pitiriga, E. Zagotzidou, C. Papanagiotou, M. Alexandrou,
V. Petrocheilou, N. Zakopoulos
Athens, GR
Objectives: Controversy exists concerning the involvement of C. pneumoniae
in atherosclerosis via a chronic inﬂammatory process. The aim of the present
study was to investigate the association between C-reactive protein levels as an
inﬂammatory marker and C. pneumoniae antibody titers in a selected popula-
tion of hypertensive patients.
Methods: C. pneumoniae IgG antibodies were evaluated in 348 hypertensives
by the microimmunoﬂuoresence method (MIF). Elementary bodies of
C. pneumoniae TW 183 strain, were used as antigen. IgG 80 were deﬁned
as elevated titers. All subjects underwent casual blood pressure readings by
sphygmomanometer and 24 h ambulatory blood pressure monitoring. Smok-
ing status and age were recorded in each patient. Hypertensives having clinical
or laboratory evidence of previous or present infection and cardiovascular
disease were excluded from the study.
Results:C. pneumoniae seropositive and -negative patients did not differ in age
and smoking status. In IgG seropositive hypertensives (IgG 80) the average
of CRP was 0.68 1.14mg/dL whilst in IgG seronegatives was 0.48
0.34mg/dL (P< 0.02).
Conclusions: A positive association was found between elevated C. pneumo-
niae IgG titers and CRP levels in hypertensives. This association adds to the
body of evidence that the possible underlying pathophysiological mechanism
of C. pneumoniae microorganism is inﬂammation.
P1348 Identiﬁcation and biotyping of Brucella spp.
isolated from humans in central Anatolia
N. Tulek, H. Simsek, S. Erdenlig, B. Oral
Ankara, TR
Objectives:Brucellosis is a very widespread zoonotic diseases in some regions
of Turkey. Prevention of brucellosis in man is dependent on the control and
eradication of the disease in animals. In this study, we identiﬁed and biotypes
of Brucella spp. isolated from the patients admitted to our department from
various regions of central Anatolia, we aimed to determine clinical variations
according to the biotypes and to get some epidemiological data of our region.
Methods: Brucella spp. were isolated from either blood, bone marrow or
cerebrospinal ﬂuid cultures of patients by using BACTEC 9050 system.
Isolates were evaluated on the basis of requirement of CO2 for growth,
production of H2S, sensitivity to thionin and basic fuchsin dies. Tbilisi phage
typing was also used to determine the species. Biotyping was performed by
agglutination method by using A–M monospeciﬁc antiserums. Identiﬁcation
and biotyping of Brucella species were performed at Brucella Laboratory of
Pendik Veterinary Control and Research Institute.
Results: A total number of 70 Brucella spp. isolated from different patients
were included in the study. All Brucella isolates were identiﬁed as B.melitensis.
It was found that 65 of the isolates (92.8%) were B.melitensis biovar 3, and 5
isolates (7.1%) were B. melitentis biovar 1. Because of the number of other
biovars accept than biovar 3 were too low, we could not compare the clinical
variation.
Discussion:B. melitensis biovar 3 was the most frequently found biotype in our
region. Biotyping of Brucella species will give us important data for national
control and eradication programs of brucellosis In order to evaluate the
clinical importance of different biotypes of Brucella more studies will be
needed.
P1349 Detection of anti-Brucella antibodies in the
sera of slaughterhouse and veterinary farm staff by the
Wright and ELISA methods
F. Sadegkhalili, M. Taravati
Oromiyeh, IR
Introduction: Brucellosis is an important public health problem that occurs
worldwide. It causes economic losses among domesticated animals used as a
sources of meat and dairy products and is frequently transmitted from animals
to man in areas where the disease is enzootic. Direct contact with con-
taminated tissues of cattle presumably responsible for a majority of cases
among livestock producers, livestock market employees and veterinarians.
Brucellae are facultative intracellular bacilli. For seroepidemiological studies
the standard tube agglutination test widely used. The main goal of this study is
seroepidemiological studies of anti-Brucella antibodies in the sera of butchers
and veterinary farm employees.
Material and methods: Questioners were prepared and 305 blood samples
were obtained from employees by random. Anti-Brucella antibodies were
measured from the sera by the standard agglutination test (Wright test). For
determination of the class of antibodies and for identiﬁcation of false negative
results ELISA, 2-ME Wright and Coombs Wright tests were carried out.
Results: In 305 samples, 36 (12%) samples the Wright agglutination test were
positive and the titer was >1/160 and in 43 (14%) samples the titer was 1/80,
in the 15 (5%) samples the titer was 1/40 and at the rest of cases no
agglutination was observed. The ELISA and 2-ME results were indicated
that anti-Brucella IgM antibodies were found in 12 (4%) and anti-Brucella IgG
antibodies were found in 24 (8%) of positive samples (from 36 samples noted
above).
Discussion: The results were indicated 36 (12%) employee due to their
occupation potentially exposed with contaminated materials. The positive
results were indicated at least 12 (4%) persons suffer from acute brucellosis and
24 (12%) persons suffer from subacute or chronic brucellosis. It was recom-
mended for prevention of disease adherence to biosafety and precautions
should be noticed and in high risk personnel vaccine should be designed and
used. More details will be discussed in conference.
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P1350 Epidemiology of Campylobacter jejuni/coli
infections in the Zenica-Doboj Canton, Bosnia and
Herzegovina
S. Uzunovic-Kamberovic
Zenica, BIH
Objective: It has previously reported by this author about some interesting
epidemiological features of Campylobacter jejuni/coli infections after the war in
this region. This prompted us to carry out a survey to determine in its
prevalence, distribution by demographic features and antimicrobial resistance
in the 1999–2001 period.
Methods: It was examined 5426 consecutive human stool samples for the
presence of Campylobacter spp. during 1999–2001. The strains were identiﬁed
using the standard microbiological methods and were tested by disc diffusion
method to eight antimicrobials according to NCCLS.
Results: A total number of 40 (75.5%) C. jejuni and 13 (24.5%) C. coli
nonrepeated isolates were analyzed. More than half of isolates, 30 (56.6%)
were from urban dwellers, resulting in a rate of 6.7 cases/100 000/year in
urban population compared with 4.2 in rural one. Campylobacter isolates
mainly obtained from children under 6 years of age, 42 (79.2%), resulting in
far off highest rate of 41.4/100 000/year in this age group. M/F ratio was
1.1 : 1, but gender-speciﬁc incidence was higher in male, 8.3/100 000/year
vs. 3.8. Infections mostly appeared in autumn, 71.7% (38 isolates). The
frequencies of resistance for all tested antibiotics were doubled in 2001,
comparing 1999. The resistance rate to ciproﬂoxacin in children under 6 years
of age was 27.3%. There was high erythromycin-resistance (>30%) in all
subset analyzed and higher in C. coli isolates (46.2% vs. 26.3%).
Conclusions: Although Campylobacter isolation rate was low, as in developed
countries, the high proportion of infections in children under 6 years of age in
urban zone is an epidemiological features similar to that of developing
countries. It might be a consequence of recent war in this region. The
frequency of resistance to ciproﬂoxacin in the youngest for which quinolone
use is not recommended was surpassingly high. Also, there was persisted high
erythromycin- resistance, although this drug participates with only 2.2% in
antibiotic usage in this region. Thus, overuse of theses drugs in humans
probably did not the reason for such high frequencies of resistance. Campy-
lobacteriosis in this region is a public health concern, but not in the terms of
the numbers reported cases, but of distinctive epidemiological features. Thus,
research is required to identify the reservoir of Campylobacter spp. in the
environment.
P1351 Prevalence of certain infectious diseases among
economical immigrants in Greece
E. Vogiatzakis, G. Antonakos, D. Hatzaki, E. Tomprou, G. Demertzidis,
G. Kostogianni, A. Alevra, E. Mastrokalou
Athens, GR
Objective: To estimate the seroprevalence of certain infectious diseases in a
large cohort of economical immigrants that visited our hospital.
Methods: During a 5-year period (1998–2002), 3.215 consecutive immi-
grants visited our hospital and they were submitted to laboratory testing for
certain infectious diseases, according to provisions in Greek legislation. For
purpose of analysis, we divided the studied population into three groups,
according to their geographical origin: 771 (24%) of them were Albanians,
675 (21%) came fromAsia or Africa and 1769 (55%) came from East European
Countries. Beyond the tests for certain infectious diseases, required by Greek
legislation, for issuance of a health certiﬁcate (Hbs Ag, stool examination for
parasites, thorax radiography), we did a further anonymous testing of the
serum samples for hepatitis markers, as well as for antibodies against HIV I/II
and HTLV I/II. For all the serological testing, we used a commercial enzyme
immunoassay (EIA, Roche Diagnostics, Mannheim, Germany). All the
positive samples were examined twice.
Results:No one of the serums tested was found to be positive for antibodies
against HTLV I/II, whereas two of the serums tested, coming from the group
of Asian-Africans were positive for antibodies against HIV I/II, something
that we conﬁrmed by theWestern Blot method. The testing for HCVmarkers
showed that 5.4% of the East Europeans, 2.6% of the Albanians and 2.9% of
the Asian-Africans were positive for antibodies against HCV. We also found
that 17.6% of the Albanians, 4.9% of the Asian- Africans and 5.3% of the East
Europeans were Hbs Ag(þ). The prevalence of HbsAg as well as of HCV
infection for the Greek population is about 2.5–3%. The results of our study
are similar to those of other studies that took place in hospitals of other areas in
Greece.
Conclusions:The prevalence of HCVandHBV infection in the population of
economical immigrants in our country is higher than that of the Greek
population. We also notify the high prevalence of HbsAg among the
Albanians.
P1352 Occupational exposure of health care workers to
blood and body ﬂuids
S. Erol, Z. Ozkurt, M. Ertek, A. Kadanali, M. A. Tasyaran
Erzurum, TR
Objective: To determine the frequency and the epidemiological character-
istics of occupational exposure incidents among healthcare workers (HCWs).
Methods: A survey was conducted in Ataturk University Medical School
Hospital using a questionnaire form. Each questionnaire was completed
during an interview with the HCW. For statistical analysis, categorical
variables were compared using the chi-square or Fisher’s Exact Test.
Results:A total of 386HCWs (217medical doctors, 124 nurses, 45 laboratory
technicians) were included in the study. Mean ages and working periods were
as follows for doctors, nurses and laboratory technicians, respectively:
38.2 11.0 and 9.3 6.5 years, 35.5 12 and 8.9 5.8 years, 38.0 8.0
and 9.9 7.3 years. A total of 313 (81.1%) of HCWs reported one or more
exposure incidents (78.3% of doctors, 91.1% of nurses, and 66.7% of
laboratory technicians, P¼ 0.000). Blood and blood products were involved
in 84.5% of exposure incidents; body ﬂuids, excrement and other substances
accounted for 3.9, 2.4, 9.2% of cases, respectively. The most common route of
exposure was sharp and needle-stick injury, 46.6% of all HCWs, followed by
contact to open skin break (24.4%) and splash to mucous membranes (19.2%).
The ﬁrst two was apparently more frequent among the nurses, P¼ 0.000 and
P¼ 0.001, respectively. Of the 313 exposed HCWs, 12.8% had one exposure
history, while 17.6% had two, 15.0% had three and 54.6% had four or more.
Only 58.2% of the HCWs were vaccinated against hepatitis B virus (HBV),
17.9% were unaware of their own serological status to HBV, 17.4% reported
that theywere immune because of past HBV infection, 1.6%were carriers and
4.9% were still seronegative. For HCVand HIV, 37.6% were unaware of their
own serological status, 62.2% were seronegative, and 0.3% had chronic HCV
infection. No HCWs serpositive for HIVor exposure to HIV positive blood
and body ﬂuids were recorded. Of the exposed HCWs, 3.8% had been
infected with HBV and 0.03% with HCV, related to the exposure. The
doctors on surgical wards were more exposed (88.5%) than the doctors on
medical wards (69.0%), P¼ 0.001. However, the rates of doctors seropositive
for HBV were similar (15.0% vs. 18.3%, P> 0.05) in these wards.
Conclusion:This results indicate the need to educate of HCWs about the risk
of occupational exposures, preventive strategies and accurate post exposure
follow up, in addition to pre-employment screening for blood-borne patho-
gens and vaccination against HBV.
P1353 HIV infection among women who immigrated to
Italy from outside the European Union (EU):
epidemiological, clinical, and therapeutic features,
compared with a population of male immigrants
R. Manfredi, L. Calza, F. Chiodo
Bologna, I
Objective: To assess the frequency and epidemiological, clinical and ther-
apeutic features of HIV infection in women immigrated from outside the EU
vs. a comparable population of male immigrants followed during years 2001–
2002.
Methods:Among the 1027 HIV-infected patients (p) followed during the last
2 years, 74 (7.2%) come from outside the EU. Adherence to prescribed
medication was estimated by questionnaires, and a monthly direct drug
accountability.
Results: Compared with all remaining HIV-infected p of our cohort,
immigrants include a greater percentage of women, an increased frequency
of heterosexual and perinatal transmission, and a shorter period of known
seropositivity. Opposed to male p, female immigrants were more frequent (39
vs. 35 p), signiﬁcantly younger (mean age 30 vs. 34 years; P< 0.001), more
frequently exposed to sexual transmission vs. drug addiction (P< 0.04), but
they detected HIV infection more frequently after migration, since HIV was
acquired and/or discovered in our country (P< 0.04). The shorter history of
HIV disease led to a lower incidence of AIDS (8 vs. 15 p; P< 0.04).
Compared with male immigrants, an effective access to anti-HIV therapy,
characterized by an earlier initiation, a better compliance, and a lower
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frequency of discontinuation due to untoward events (P< 0.05,P< 0.01, and
P< 0.05, respectively), leads to the present higher mean CD4þ count (373 vs.
311; P< 0.03) and lower mean viremia (3.4 0.4 vs. 3.9 0.8 Log10;
P< 0.001) among women, besides a more frequent suppression of HIV
replication (71.8% among female vs. 54.3% of males).
Discussion:Migration to Italy is a recent occurrence and involves p coming
from areas endemic for HIV infection or p exposed toHIVafter their arrival in
the EU because of their economic, social and sanitary situation. A timely
management of HIV disease is an emerging issue among recently immigrated
p, due to epidemiological reasons (extra-EU p are> 7% of HIV-infected p at
our center), and the socioeconomic and psycho-cultural features which
accompany the migration project and the detection of an infectious, chronic
and life-threatening disease, needing life-long therapy and controls. Although
immigrants are expected to show a clinical-immunologic course of HIV
disease matching that of Italian p, prevention projects need to stress the need of
timely screening and therapy of HIV infection, and an adequate counseling
especially when female p are involved because of their predominant sexual
exposure and childbearing potential.
P1354 The screening of throat, conjunctiva and faces
carrier stage among nursery children
G. Sengoz, N. Sur, F. Yildirim, D. Berzeg, O. Nazlican
Istanbul, TR
Objective: 52 children who are attending at a nursery school serving only for
the workers of the Haseki Education and Research Hospital are examined for
their throat, conjunctiva and faces carrier stage.
Methods:For throat cultures, blood agar and chocolate agar media were used.
Whereas for conjunctiva cultures, chocolate agar medium and thioglycollate
broth were used. From the throat cultures we identiﬁed 23 coagulase-negative
Staphylococcus, 21 S. aureus, 12 beta-hemolytic Streptococcus, 10 Haemophilus
haemolyticus, 5 Haemophilus inﬂuenzae. From the conjunctiva cultures, we
identiﬁed coagulase-negative staphylococci and S. aureus. The stool specimens
were inoculated Endo, Salmonella–Shigella agar media and Selenite F broth in
order to screen Salmonella and Shigella spp. This study covered 22 children
who were aged between 1 and 3 years, whereas 28 were older than 3 years.
Result: In only one case, ampicillin/sulbactam resistant Salmonella spp. was
detected. This casewas 2.5 years old, attending at the nursery school for 1 year.
N.meningitidiswas identiﬁed from the throat culture of one case. This case was
5-year-old and attending at the nursery school for 1 year. With this study we
have screened the carrier stages of the children and necessary treatment were
given.
Conclusion: In public places, some bacteria can easily cause severe outbreaks,
therefore screenings sometimes should be enlarged including all the family
members.
P1355 Nasopharyngeal carriage of Streptococcus
pneumoniae in infants and young children in three different
settings in Warsaw
A. Sulikowska, P. Grzesiowski, W. Hryniewicz
Warsaw, PL
Objectives: The aim of the study was to analyze the risk factors of nasophar-
yngeal carriage of S. pneumoniae in selected settings of children under the age
of 5. It was also to determine the most prevalent serotypes among pneumo-
cocci isolated from asymptomatic children and to characterize the penicillin-
resistant isolates (PRP).
Methods: A total of 223 children were examined between November 2000
and April 2002 in selected settings in Warsaw: day care center (DCC, n¼ 58),
orphanage (OR, n¼ 107), and the family children (FC, n¼ 58). Clinical data,
including information on the antibiotic treatment within the 3-month period
before the beginning of the study, were collected with the use of a speciﬁc
questionnaire. Nasopharyngeal swabs were processed and S. pneumoniae was
identiﬁed by conventional microbiological methods. The MICs of antimi-
crobials were determined by broth microdilution method according to the
NCCLS guidelines. Serotypes of the isolates were determined by the Quel-
lung reaction. PRP isolates were typed by pulsed-ﬁeld gel electrophoresis
(PFGE).
Results:Altogether 114 S. pneumoniae isolates were identiﬁed; 36 from DCC,
65 from OR, and 13 from FC. Thus, the carrier rate of the organism was 62,
61, and 22%, respectively. The most frequent serotype in DCCwas 6B (49%),
followed by 19F (31%). The 6B serotype was also highly prevalent in OR
(52%), however, in this setting it was followed by 23F (31%). Isolates from FC
belonged to various serotypes, represented mostly by 1–2 isolates each. Nine
of the isolates were resistant to penicillin (one isolate in DCC, eight strains in
OR), and all these belonged to serotype 23F. All the children colonized by
PRP had been treated with b-lactams shortly before the study. The PRP
isolates from OR revealed a signiﬁcant similarity of PFGE patterns and they
belonged to the multiresistant pneumococcal clone Poland 23F-16. The
single PRP isolate from FC represented another PFGE type.
Conclusions:
1. The carriage rate in DCC and OR was deﬁnitely higher than in FC;
2. The prior treatment with b-lactams correlated well with the nasophar-
yngeal carriage by PRP;
3. Around 80% of the isolates identiﬁed in DCC and OR belonged to the
serotypes which are represented in the heptavalent pneumococcal con-
jugate vaccine;
4. Small closed communities, such as OR, create a high risk of the ‘silent’
clonal spread of pneumococcal strains with dangerous characteristics.
P1356 Streptococcus pneumoniae colonization in the
pharyngeal ﬂora of the elderly residents of a
retirement-home in Ankara, Turkey
P. Zarakolu, B. Dogan, G. Kaya, O. Koska, T. Ocak, F. Vural, E. Esen,
B. Burunsuzoglu, S. Unal, O. Uzun
Ankara, TR
Objectives: To determine the colonization rate of Streptococcus pneumoniae in
the pharyngeal ﬂora of institutionalized elderly people.
Methods: This descriptive study was held in one of the biggest retirement-
homes in Ankara, Turkey in June 2002. We aimed to include all the elderly
residents (N¼ 207) in that institution but due to some constraints 146 (70.5%)
were reached. The data about demographic characteristics were gathered via a
questionnaire implemented face-to-face interview by intern doctors; medical
examinations were done and throat swab specimens were collected. The
specimens were inoculated on 5% sheep blood agar. After incubation at 378C
in a candle jar for 48 h, alpha-hemolytic colonies were then subcultured on 5%
blood agar and identiﬁed as S. pneumoniae if they were catalase negative,
susceptible to optochin and soluble in bile salts.
Results: 62.3% of the study group was >75 years of age, 50.7% was female,
and 68.5% was illiterate, literate or primary school graduate. More than two-
thirds were widowed. Current smokers consisted 28.1% of the group. The
most commonly stated complaints were artralgia, rheumatism, extremity pain,
dyspnea, and dizziness. 13.6% stated that they had experienced fever within
the last 2months, and 13.1% within the last week. One-third of the elderly
peoplewas on cardiovascular medications and almost all of them indicated that
they frequently used antibiotics. We could not detect a single strain of
S. pneumoniae in the pharyngeal ﬂora of the elderly people.
Conclusion: On the contrary of the expectations, no S. pneumoniae was
detected in the study group. The season the study was performed and/or
the low number of the people involved could explain this ﬁnding. The
superﬂuous use of antibiotics could be another reason. Since the rate of
colonization is seasonal and increases in mid-winter, it would be informative
to repeat this study in winter. Although we could not detect pneumococci in
the pharyngeal ﬂora of the elderly people living in this closed society,
vaccination of people older than 60-year-old could be accepted as one of
the most important preventive measures as a public health policy with the fact
of increasing emergence of penicillin-resistant pneumococci (30–40% inter-
mediate resistance) in Turkey.
P1357 From prolonged febrile illness to fever of
unknown origin: the challenge continues
S. Vanderschueren, D. Knockaert, T. Adriaenssens, W. Demey,
A. Durnez, D. Blockmans, H. Bobbaers
Leuven, B
Objectives: Epidemiological changes and the ongoing expansion of the
diagnostic armamentarium warrant a regular update of the spectrum of
diseases that present as prolonged febrile illnesses.
Methods: We prospectively collected a series of 290 immunocompetent
patients with a febrile illness (temperature>38.38C) of uncertain etiology of
>3weeks duration, referred to our university hospital between 1990 and
1999. Patients were categorized in four groups according to the timing of
diagnosis: early diagnosis (within three in-hospital days of three outpatient
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visits), intermediate diagnosis (from day 4–7), late diagnosis (after day 7), and
no diagnosis during index contact or follow-up.
Results: A ﬁnal diagnosis was established early in 67 patients (23.1%),
intermediate in 38 (13.1%), and late in 87 (30.0%). In the remaining 98
(33.8%), no diagnosis was made. The etiology of the fever remained obscure
in 50 of 105 (47.6%) patients with episodic fever vs. in 48 of 185 (25.9%)
patients with continuous fever (P< 0.0005). Among the 192 patients with a
ﬁnal diagnosis, noninfectious inﬂammatory diseases represented the most
prevalent diagnostic category (35.4%), surpassing infections (29.7%), mis-
cellaneous causes (19.8%), and malignancies (15.1%). Fourteen disorders
(endocarditis, tuberculosis, Epstein–Barr or cytomegalovirus infectious
mononucleosis, lymphoma, leukemia, adult-onset Still’s disease, systemic
lupus erythematosus, polymyalgia rheumatica/giant cell arthritis, sarcoidosis,
Crohn’s disease, subacute thyroiditis, habitual hyperthermia, and drug fever)
accounted for over 59% of diagnoses, whether diagnosis was reached early,
intermediate or late. Hematological malignancies made up 11.5% of diag-
noses, but were responsible for 14 of the 24 (58.3%) fatalities related to the
febrile illness. Three of the 80 patients discharged alive without diagnosis and
for whom follow-up was available, died but the deaths were considered to be
unrelated to the feverish illness.
Conclusions: Prolonged febrile illnesses remain a diagnostic challenge.
Despite the technological progress of the late 20th century the origin of
the fever remains elusive in many patients, especially in those with episodic
fever. Noninfectious inﬂammatory diseases emerge as the most prevalent
diagnostic category.
P1358 Rubella immunity status in pregnant women in
Kuala Lumpur, Malaysia
Z. Sekawi, I. Isahak, M. Mohd Najib, A. Jamil Yassin
UPM Serdang, Kuala Lumpur, MY
Background: In many developed countries, the incidence of rubella and
congenital rubella syndrome (CRS) is considered to be negligible due to the
availability of an effective vaccine. However, in Malaysia, CRS cases are
occasionally seen every year. This will question the effectiveness of rubella
vaccination programme incorporated in Malaysia’s Expanded Programme on
Immunisation (EPI). Currently, Malaysia practices Selective Rubella Immu-
nisation Programme by vaccinating 12-year-old schoolgirls routinely since
1988 and unscheduled vaccinations for other women of childbearing age.
Based on this, the eldest age for women who have undergone the routine
rubella vaccination is 26 years old. Determining rubella immunity status
among women of childbearing age is a good method to estimate the
seriousness of rubella problem in Malaysia.
Objective: To determine the percentage of rubella immunity status among
pregnant women attending antenatal clinics in National University of Malay-
sia Hospital in Kuala Lumpur, Malaysia.
Methods: The hospital database on rubella immunity was assessed retro-
spectively from August 2001 to June 2002. A prospective study of interviewed
method as well as determination of rubella immunity by laboratory tests were
carried out to pregnant women attending antenatal clinics in July 2002. Past
history of rubella vaccination was speciﬁcally asked.
Results: A total of 414 women were included, of whom 134 women were
interviewed. The rubella immunity status was 92.3% with highest percentage
in the 15–26 age group (92.7%) and lowest in the 27–34 age group (88.9%).
Among the interviewed women, 61.9% gave history of rubella vaccination
(Group 1) and 23.8% were without history of vaccination (Group 2). Six
percent of Group 1 and 9.3% of Group 2 did not have protective rubella
antibodies. The antibody levels in immune women in Group 2 are signiﬁ-
cantly higher than immune women in Group 1 indicating the possibility of
natural rubella immunity.
Conclusions: The high percentage of immune women in Group 2 may
indicate high infection rate of rubella in nonimmune individuals in the general
population. This may explain the sporadic incidence of CRS cases in
Malaysia. A small percentage of nonimmune women in the 15–26 age
group may indicate primary or secondary vaccine failure, which is not
looked into seriously. This can also contribute to the incidence of CRS in
Malaysia.
P1359 Increased incidence of tick-borne encephalitis in
the 1990s in Central and Eastern Europe
B. Kriz, M. Daniel, V. Danielova
Prague, CZ
Objectives: Epidemiological analysis of tick-borne encephalitis (TBE) occur-
rence in Europe and an attempt to elucidate this phenomenon.
Methods: Collection and evaluation of epidemiological, socioeconomic,
parasitological, zoological and meteorological data.
Results:A sharp increase of TBE incidence occurred in nineties in 11 Central
and Eastern European countries. In 10 of them, maximum incidence was
recorded in years 1993–1997 and has remained high since, with some slight
ﬂuctuations. The situation is attributable to more abundant occurrence of
TBE virus vector Ixodes ricinus tick. High density of tick populations is due to
modiﬁed climatic conditions in the last decade namely in autumn resulting in
their longer host-seeking activity period – up to November and subsequent
high occurrence of ticks in following season. Mild winter seasons in the
nineties have facilitated a more successful wintering of animal hosts, mainly
small terrestrial mammals. Favorable climate conditions in early spring time
(in the year 2002 the ticks were active at the end of February in the Czech
Republic) resulted in longer period of tick activity a resulted in ﬁrst cases of
TBE disease in March. This extension of TBE incidence in early spring and
late autumn was observed throughout that period. Shift of I. ricinus distribu-
tion to higher altitude was found Czech mountain areas. Simultaneously the
shift of the tick I. ricinus and TBE into higher geographic latitudes was
described by Swedish and Danish authors. Behavioral and socioeconomic
aspects don’t play any role in described increase of TBE incidence.
Conclusions: Increased TBE incidence in nineties is attributable to climate
changes causing longer period of I. ricinus activity and favorable conditions for
wintering of this tick species.
Acknowledgement:This study was supported by the project Climate change
and Adaptation Strategies for HumanHealth (cCASHh), Contract Nr.EVK2-
2000–00670.
P1360 Surveillance study of the incidence of
tuberculosis and hepatitis B in a high-risk group of
slum-dwelling female rag pickers in Jaipur, India
M. Singh
Jaipur, IND
Introduction: Rag pickers constitute the lowest socioeconomic group and
women in a male dominating social structure are further disadvantaged.
Fifteen percent of the municipal solid waste is lifted by rag pickers; mostly
from rubbish dumps located near hospitals and include biomedical waste.
Hazards of occupation, overcrowded slum dwellings, poor nutrition, neglect
of health and hygiene, and lack of medical makes them a high-risk target for
infectious diseases.
Objective: Surveillance study to establish the incidence of hepatitis B and
tuberculosis in this high-risk target group of slum-dwelling female rag pickers
in the city of Jaipur and using this base line data to permit Jaipur Municipal
Corporation to consider executive policy changes in the welfare of rag
pickers.
Methods: A total of 1500 slum dwelling female rag pickers in the age group
18–60 years were identiﬁed as the target group from the list provided by the
JaipurMunicipal Corporation. They were screened over a period of 6 months
for tuberculosis using Ziehl–Nielsen staining (ZN) of sputum for acid–alcohol
fast bacilli (AAFB) and hepatitis B using a strip ELISA method on serum to
detect HBsAg.
Results: Sputum and serum samples from 1500 women were screened. Sputa
from 12 women (0.8%) were found positive (1þ) for AAFB while 82 (5.46%)
sera tested positive for hepatitis B (HBsAg by strip ELISA).
Conclusion: Scavenging through biomedical waste dumped near hospitals and
possibility of sharp injuries from disposed needles are possible risk factors for
hepatitis B and to a lesser extent for HIV. Poor socio-economic conditions of
living, overcrowding, lack of adequate hygiene, nutrition, and medical care
328 Abstracts
predisposes the rag pickers to tuberculosis and other infectious diseases. Data
from this study provided a yardstick for JaipurMunicipal Corporation to bring
about major policy changes in the welfare of this high-risk group, which is
discussed.
P1361 Rickettsioses: the analysis of 42 cases diagnosed
over 14years
G. Sengoz, S. Gulduren, F. Yildirim, Y. Bilgin, O. Nazlican
Istanbul, TR
Objective: The causative agent of Marseille fever which is an endemic
rickettsiosis for our country is R. conorii. Forty-two rickettsioses cases which
were hospitalized at Haseki Education and Research Hospital during the
period 1989–2002 have been examined according to their epidemiological,
clinical and laboratory properties.
Methods: The patients who applied to the hospital with fever and rash had
been diagnosed according to the patient’s history, the property of the rash and
Weil–Felix test. The Weil–Felix test which was studied by OX-2 and OX-19
antigens was found to be positive at 1/80 and 1/160 titers. Almost in all the
patients ‘tache noire’ was detected. Twenty patients were female and 22 were
male. Their ages ranged between 20 and 70 and the average was 40. When the
application date is observed, it has a peak in August for female patients and
males were hospitalized through July, August, and September.
Result: The hospitalization duration ranged between 1 and 38 days and the
mean was 5–10 days. Doxycycline had been used for therapy for 7–10 days.
The patient who was hospitalized for 38 days died, all the others recovered.
Conclusion: Although the incidence of rickettsioses in our country is low, it
must be remembered for the differential diagnosis, especially in patients who
may contact with ticks and who apply with fever and rash.
P1362 The problem of group A beta-hemolytic
streptococcal infections and complications in ambulatory
outpatient clinics in Yemen
E. H. Al-Rikabi, A. J. Kadhim
Ibb, YE
Objectives: To show the increasing rates of streptococcal and poststrepto-
coccal medical problems in the daily outpatient practice in a hospital in
Yemen. To show the rates of cardiac and articular involvement. To reveal the
level of ampicillin resistance.
Methods: Study group of 394 patients of various age groups interviewed in an
outpatient clinic in a period of 8 months (April to November 2002). Selection
made on clinical basis (complaining of arthralgia, arthritis, fever, having
tonsillitis or tonsillar enlargement, and/or cardiac complaints). All the study
patients were investigated for Anti-Streptolysin O titer, throat swab culture
and sensitivity test, C-reactive protein, erythrocyte sedimentation rate and
total leukocyte count. Patients with cardiac complaint also had electrocardio-
grams, chest X-rays and echocardiograms.
Results: Evidence of group A beta-hemolytic streptococcal infection was
found in the study group in 69.04% (272/394) by elevated ASO titers and in
51.27% (202/394) by positive throat swabs. This was more marked during
cold months November (ASO 75.86% and cultures 56.32%) and October
(69.35% and 59.68%). Rates of cardiac complications were high (37.82%).
Arthralgia found in 75.13% and arthritis in 42.64%. High rates of ampicillin
resistance noticed in streptococcal isolates (64.36%).
Conclusions: Group A beta-hemolytic streptococcal infections and postin-
fection complications forms a major medical problem in Yemeni population.
It causes a great morbidity and poses a big challenge to the national and
international health programs. This is especially important due to the devel-
opment of antibiotic resistance resulting from antibiotic abuse, and neglect of
early and adequate treatment and prophylaxis of affected children and
adolescents.
P1363 Whipple disease: diagnosed 22years after
symptom onset
E. Magira, T. Gounaris, S. Papandreou, T. Kalloniatis, T. Kalli, A.
Krikela, E. Sioula
Athens, GR
A 58-year-old man was admitted to our hospital due to anemia, weight loss,
migratory polyarthralgias with inﬂammatory sings and diarrhea of various
years of evolution with hyperpigmentation of skin. The patient had been
known to have multiple episodes of athralgias, intermittent fever and bowel
disturbances along with multiple admissions to the hospital dating back almost
22 years. His past medical history was consistent with febrile migratory
polyarthralgias 22 years ago, hemorrhagic inﬂammatory bowel disease
18 years ago, seronegative arthritis 5 years ago due to he had received steroid
therapy. Physical examination of the patient revealed hyperpigmented, dry
skin, the liver and spleen were moderately enlarged and excessive weight loss.
Laboratory tests revealed a hemoglobin concentration of 9.7 g/dL (MCV73 fL)
with normal leukocyte and platelet counts. Computed tomography of the
abdomen and chest showed no abnormal lesions. Gastroduodenoscopy dis-
closed slight edema in the second portion of the duodenum. Biopsy specimens
from the distal duodenum revealed histopathologic features of Whipple
disease, including periodic acid Schiff (PAS)-positive macrophages. The
patient was placed on antibiotic therapy with vibramycin and follow-up after
3months the patient reported less fatigue. We report this case in which the
diagnosis was made 22 years after his initial symptom. According to literature,
there is another one case in whom the diagnosis was made 36 years later.
Whipple disease is a very rare multisystem disorder caused by T. whippeli. It is
difﬁcult to diagnose unless there is a high index of suspicion. Key to the
deﬁnitive diagnosis of Whipple disease is mucosal biopsy specimens from the
distal duodenum and jejunum and the diagnosis of Whipple disease averaged
2–9 years after onset of symptoms.
PCR and parasites
P1364 Detection of Pentatrichomonas hominis DNA by
PCR in biological specimens
T. Crucitti, S. Abdellati, D. Ross, E. Van Dyck, A. Buve´
Antwerp, B; London, UK
Objectives: Pentatrichomonas hominis is an human trichomonad that inhabits
the digestive tract. It is not a pathogen in the intestinal tract but has been
associated with liver abscesses and a case of pulmonary trichomoniasis has
been described. P. hominis and T. vaginalis do grow in the same culture media
and are indistinguishable by light microscopy. To differentiate these two
human trichomonads we aimed to develop a Polymerase Chain Reaction
(PCR) assay for detection of P. hominis in biological specimens.
Methods: Two primer pairs, Th3/Th5 and Th4/Th5, were used to amplify,
respectively, 339 bp and 785 bp from an unique region of the 16S-like
ribosomale RNA gene of P. hominis. DNA was extracted with the use of
the QIAamp DNA Mini Kit (Qiagen). The target DNA was ampliﬁed in a
Perkin-Elmer, Gene Amp 9600 thermal cycler. The ampliﬁed PCR product
was detected by examination of ethidium-bromide stained agarose gel.
Presence of DNA and PCR inhibition was checked for the human specimens
by the parallel ampliﬁcation of human beta-2microglobulin and/orEscherichia
coli DNA.
Results: The results obtained with the Th3/Th5 and the Th4/Th5 primer
pair were identical. No ampliﬁcation was obtained with DNA extracts of pure
cultures of G. vaginalis, N. gonorrhoeae, N. lactamica, S. aureus, E. faecalis, Escher-
ichia coli, C. albicans, T. vaginalis, T. gallinae, T. foetus, T. gallinarum, T. tenax,
D. fragilis, and G. lamblia. Reproducible ampliﬁcations of DNA from 3
P. hominis reference strains were obtained. DNA diluted samples with a ﬁnal
concentration of 1 P. hominis organism were ampliﬁed, and gave positive
results. A total of 113 feces extracts were ampliﬁed, no positive results were
obtained. The following pathogens were detected in the feces specimens
using microscopy and bacteria culture: Entamoeba coli, E. histolytica/dispar,
E. nana, I. butschlii, T. trichuria, Campylobacter jejuni, Ancylostomatoidae, S. man-
soni. Thousand vaginal specimens were tested by PCR for T. vaginalis and
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P. hominis. DNA targets of P. hominiswere ampliﬁed by both primer sets in two
vaginal specimens, while two PCR assays with different DNA targets for
T. vaginalis gave no PCR product.
Conclusion: We developed a highly sensitive and speciﬁc PCR assay for the
detection of P. hominis. P. hominis DNA targets were detected by PCR in two
vaginal specimens. The presence of P. hominis in vaginal specimens has so far
not been described in the literature and needs to be further explored.
P1365 Ocular toxoplasmosis – two case reports
F. Henriques, R. Loureiro, S. Freire, G. Marra˜o, A. Oliveira,
A. Domingos, C. Nogueira, A. Magalha˜es Sant’Ana, R. Vieira
Coimbra, P
Goals: Describe two clinical cases of ocular toxoplasmosis in order to
understand and emphasize the importance of polymerase chain reaction
(PCR) in the management of ophthalmologic patients.
Case reports: The ﬁrst clinical case refers to a 69-year-old man, with no
relevant clinical history, with sudden onset of blurred vision and photophobia,
preceded 1week before by bilateral red eye with spontaneous resolution. The
patient presented with right eye visual acuity of 40/200 and left eye (LE) visual
acuity of 140/200, LE defect, no biomicroscopic abnormalities, normal
intraocular pressure, localized cotton-wool spots obscuring retinal vessels
and diffuse vitritis at fundoscopy in both eyes. The second clinical case refers
to a 23-year-old man, with no relevant clinical history, with sudden onset of
blurred vision and photophobia of the LE. The patient presented with right
eye visual acuity of 200/200 and LE VA of 20/200, no abnormal pupillary
reﬂexes or biomicroscopic abnormalities, normal intraocular pressure and
localized cotton-wool spots obscuring retinal vessels at fundoscopy in the LE.
Methods: Both patients underwent complete ophthalmologic study, includ-
ing campimetry, ﬂuorescein angiography, color vision tests and complete
serologic analysis. In the ﬁrst case, a lumbar punction was performed. In the
second patient we performed anterior chamber punction as well as vitreous
punction. The samples were also tested for Toxoplasma gondii DNA using
primers from the B1 gene in a PCR.
Results: The angiogram revealed active lesions of retinochoroiditis with
associated arteritis. The liquor polymerase chain reaction was positive for
T. gondii DNA in the ﬁrst patient. In the second patient the vitreous poly-
merase chain reaction was also positive for T. gondiiDNA. Flow citometry was
normal in both cases, revealing immunocompetency.
Conclusion:The patients underwent triple drug therapy with pyrimethamine,
sulfadiazine and prednisone for 6weeks. Anatomical and functional improve-
ment ocurred with resolution of diffuse vitritis. Prednisone was discontinued
2weeks before antitoxoplasmic agents. Although traditionally based on
clinical history, fundus examination and serologic evidences, modern diag-
nosis methods are getting increasingly more important for the correct
management of ophthalmological patients. Nevertheless, PCR is only capable
of detectingT. gondiiDNA in aqueous or vitreous samples in only one third of
patients with ocular toxoplasmosis.
P1366 Development of a multiplex real-time PCR assay
to detect the four species of human Plasmodium in blood
M. Rougemont, R. Sahli, J. Bille, H.-P. Hinrikson, M. Van Saanen,
K. Jaton
Lausanne, CH
Objective:These last decades, tourism and population migrations have caused
an increase of malaria cases reported in immigrants and travelers. Although
microscopic examination of blood smears remains the gold standard in
diagnosis, this method as well as antigen detection suffers from insufﬁcient
sensitivity in case of low parasitemia. In order to improve diagnosis, we have
developed a rapid and user-friendly multiplex real-time PCR.
Materials and methods:One set of generic primers was designed in a highly
conserved region of the 18S rRNA gene of Plasmodium genus, internally
polymorphic enough to allow selection of four species-speciﬁc probes for
P. falciparum, P. vivax, P.malariae, P. ovale. Positive controls and standard curves
were generated with four plasmids, containing each cloned species-speciﬁc
ampliﬁed sequence. Moreover, a Plasmodium genus-speciﬁc probe was
designed for screening purpose. So far a retrospective evaluation of this
real-time PCRwas carried out blindly on 43 clinical samples (43 patients). For
PCR, DNA from 200 mL of EDTA-treated blood stored at 208C was
puriﬁed with the MagnaPure system (Roche). Five microliter DNAwas used
in a 25mL reaction containing primers, probe and real-time PCR master mix
(ABI).
Results: Real-time PCR with species-speciﬁc probes was able to detect 1
plasmid copy of P. falciparum, vivax, malariae and ovale in a highly speciﬁc
manner. The same sensitivity was achieved for all species using real-time PCR
with the Plasmodium genus probe. Microscopy (mi), antigen detection (ag)
and real-time PCR (PCR) for the 43 blood samples had an overall agreement
of 86%. Fifteen samples were positive and 22 were negative with the 3 tests.
Six specimens (3mi–/agþ/PCRþ 1miþ/ag–/PCRþ 2miþ/ag–/PCR–)
were discordant and are being reevaluated on the basis of clinical, molecular
and sequencing data to assess their true value. However, meanwhile these six
specimens are considered true positive/negative when at least two out of three
tests results are positive/negative, resulting in an overall PCR sensitivity and
speciﬁcity of 100%.
Conclusion: Real-time PCR is a rapid and sensitive method for detecting
human Plasmodium. With sensitivity of microscopy being about 500–50
parasites per microliter (thick blood ﬁlm), real-time PCR is potentially 100-
fold superior to microscopy. Further validation on patient samples is
needed to assess the clinical settings which will beneﬁt from this diagnostic
method.
P1367 A screening for oral trichomonad infection in HIV
patients by PCR-RFLP
M. Turkowicz, D. Tomaszewska, D. Cielecka
Warsaw, PL
Objectives:Oral lesions, advanced caries and other oral manifestations often
occur in HIV patients. The aim of the study was searching for oral tricho-
monads in these patients. PCR-RFLP was performed for detection and
species differentiation of oral parasites.
Methods: Fifty-four homeless HIV patients (18 females and 36 males at the
age of 20–54) were examined. All of them were addicted to intravenous drugs
for at least 6 years. Thirty-eight patients were treated with antibiotics and
antifungals. The materials taken from the patients were: saliva, smears and
spittle. For PCR ampliﬁcation a pair of primers speciﬁc for ITS 1–5.8SrRNA
– ITS 2 region was designed; for restriction analysis two endonucleases: Dde I
and Msp I were used.
Results: Three patients (males at the age of 25, 27 and 44) were infected with
oral trichomonads. The identiﬁcation of species by PCR and digestion with
Dde I and Msp I showed the trichomonads belonged to Trichomonas tenax
(conﬁrmed by sequencing).
Conclusions: The infection of healthy humans with Trichomonas tenax is 10–
12%, but in patients with periodontitis or gingivitis – about 50%. Only 5.5%
HIV patients were infected with Trichomonas tenax. Infection with T. tenax in
two young patients is unusual in comparison with HIV negative persons.
Rapid diagnosis of respiratory pathogens
P1368 Detection of Mycoplasma pneumoniae in
respiratory samples by real-time PCR using an inhibition control
D. Ursi, K. Dirven, K. Loens, M. Ieven, H. Goossens
Edegem, Wilrijk, B
Objectives: To evaluate a real-time PCR assay using two adjacent ﬂuores-
cent probes in a Lightcycler instrument (Roche diagnostics, Belgium) for
detection of theMycoplasma pneumoniae P1 gene, using an internal control that
can be ampliﬁed by the same primers but detected by different probes to
monitor inhibition in each sample.
Methods: Primers were chosen complementary to part of the M. pneumoniae
P1 gene. An internal control that can be ampliﬁed by the same primer pair was
constructed to monitor inhibition in each reaction. Two sets of adjacent
ﬂuorescent probes were chosen complementary to the M. pneumoniae target
and to the internal control target for real-time detection in the Lightcycler.
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The use of different labels for the probe sets allows their simultaneous
detection by dual colour detection. After speciﬁcity and sensitivity testing
of the assay, DNA isolated from 115 respiratory samples from patients enrolled
in a study on lower respiratory tract infections (n¼ 80) or community
acquired pneumonia (n¼ 35) was analyzed with the Lightcycler assay. The
samples had previously been tested with an in house PCR assay targeting the
same part of the P1 gene.
Results:The Lightcycler assay proved to be highly speciﬁc, reacting only with
DNA extracted from M. pneumoniae. The assay could detect puriﬁed DNA
extracted from as little as 500 colour changing units (ccu) ofM. pneumoniae per
ml (1 ccu is estimated to correspond to 10–100 organisms). Upon analysis of
the 115 respiratory specimens, there was 100% agreement between the real-
time and the conventional assays (86 specimens were negative, 29 were
positive), but the real-time PCR proved to be highly superior in speed with
a much lower risk of false positives by laboratory contamination. Two of the
86M. pneumoniae negative specimens showed no ampliﬁcation of the internal
control. Upon 1/5 dilution of the samples the inhibition was eliminated.
Conclusions:The Lightcycler assay forM. pneumoniae detection proved to be a
very sensitive and speciﬁc diagnostic tool, allowing detection of M. pneumo-
niaeDNA in respiratory samples within two hours after receipt of the sample.
Moreover, the use of an internal control ampliﬁed by the same primers but
detected by different probes, proved to be useful to avoid false negative results.
P1369 Development of conventional NASBA for the
detection of Bordetella pertussis in respiratory specimens
K. Loens, T. Beck, P. Sillekens, M. Overdijk, D. Ursi, M. Ieven,
H. Goossens
Wilrijk, B; Boxtel, NL
Introduction:Bordetella pertussis is a major etiologic agent of prolonged cough
during childhood in unvaccinated populations. During the past 10 years,
resurgence of pertussis has been seen in several countries with high vaccina-
tion coverage. Therefore, rapid diagnosis is crucial to eradicate the source of
infection and to treatment of each contact early, particularly nonvaccinated
infants in whom pertussis might present as a life-threatening disease.
Objectives: The aim of the study was to develop a NASBA assay for the
detection of B. pertussis in respiratory specimens based on NASBA ampliﬁca-
tion of a 16S rRNA target sequence using the NucliSens Basic Kit1
(bioMe´rieux).
Methods: Oligonucleotide primers were derived from the B. pertussis 16S
rRNA. The assay was developed using the NucliSens Basic Kit, that includes
standardized reagents for nucleic acid extraction, RNA ampliﬁcation and
electrochemiluminescence (ECL) detection. Speciﬁcity was established on a
panel of bacterial strains. The analytical sensitivity of the assay was determined
through testing dilutions of different B. pertussis strains. Serial dilutions of B.
pertussis were added to pools of respiratory specimens and treated with
protease before extraction. Subsequently, a limited number of B. pertussis
positive and negative clinical specimens were analyzed.
Results: Using the B. pertussis 16S rRNA NASBA primers in combination
with the generic NucliSens Basic Kit ECL probe and a biotin capture probe,
positive results were obtained with nucleic acid extracts from B. pertussis
strains, B. parapertussis strains, B. bronchiseptica strains and with a B. holmesii
strain but with none of the other organisms. The primers enabled detection of
as little as 1–10 B. pertussis CFU. Applied on clinical specimens spiked with
B. pertussis, the sensitivity varied between 10 and 100.000CFU depending on
the kind of respiratory specimen. Four out of six clinical specimens found to
be B. pertussis positive by the Belgian Bordetella Reference Centre were also
positive in the NASBA assay. In the other two samples RNA degradation had
occurred. None of 100 B. pertussis culture negative clinical specimens were
positive by real time PCR. However, two specimens were found to be
Bordetella positive by NASBA.
Conclusions:The NucliSens Basic Kit1 could become a fast, useful and user-
friendly device for the development of diagnostic tools like the NASBA-based
assay for the detection of Bordetella species in respiratory specimens.
P1370 Detection of Mycoplasma pneumoniae in
respiratory specimens using real-time NASBA
K. Loens, T. Beck, P. Sillekens, M. Overdijk, D. Ursi, M. Ieven,
H. Goossens
Wilrijk, B; Boxtel, NL
Introduction:Mycoplasma pneumoniae is a common etiologic agent of respira-
tory tract infections in humans, responsible for 15–20% of all cases of
pneumonia and a wide range of mild to serious extrapulmonary complica-
tions. In the past, diagnosis of infection by this organism was frequently based
on serology because culture is slow and insensitive. Therefore, real-time
NASBA (nucleic acid sequence-based ampliﬁcation) might offer an alter-
native.
Objectives:The aim of the study was to develop a real-time NASBA assay for
the detection of M. pneumoniae in respiratory specimens based on real time
NASBA ampliﬁcation of a 16S rRNA target sequence using the NucliSens
Basic Kit1 (bioMe´rieux).
Methods: Oligonucleotide primers were derived from the M. pneumoniae
16S rRNA. The assay was developed using the NucliSens Basic Kit, including
standardised reagents for nucleic acid extraction, RNA ampliﬁcation and
electrochemiluminescence (ECL) detection. For real-time detection, a mole-
cular beacon was used. Speciﬁcity was established on a panel of bacterial
strains. The analytical sensitivity of the assay was determined through testing
of dilutions of a M. pneumoniae reference strain, PI1428. Serial dilutions of
M. pneumoniae PI1428 were added to pools of respiratory specimens and
treated with protease before extraction. Subsequently, a limited number of
M. pneumoniae positive and negative clinical specimens were analyzed. The
results obtained with the real time M. pneumoniae 16S rRNA assay were
compared with the results obtained by conventional NASBAwith ECL end-
point detection.
Results: Speciﬁc detection of the 16S rRNA-derived amplicons was
achieved: all M. pneumoniae strains tested positive, whereas other bacterial
strains tested negative. The sensitivity of the NASBA assay was ﬁve colour
changing units (CCU) of M. pneumoniae. In spiked throat swabs, nasophar-
yngeal aspirates, bronchoalveolar lavages and sputum, the sensitivity of the
NASBA assay was 5–50 CCU of M. pneumoniae. The sensitivity of the real
time NASBA assay was comparable to that of conventional NASBA. Seven-
teen clinical specimens positive forM. pneumoniae by PCR, were also positive
by conventional NASBA but one specimen was negative by real time
NASBA.
Conclusions: The NucliSens Basic Kit combined with real-time detection
appeared to be a fast, useful and user-friendly diagnostic tool for the
development of a NASBA-based assay for the detection of M. pneumoniae
in respiratory specimens.
P1371 Development of a PCR assay and typing method
for invasive pneumococcal disease based on the detection of
the pneumolysin gene
S. M. McChlery, J. A. Kerrigan, S. C. Clarke
Glasgow, UK
Objectives: Pneumococcal disease is a leading cause of mortality and mor-
bidity worldwide. It is primarily caused by Streptococcus pneumoniae. S. pneu-
moniae produces pneumolysin (ply) as a virulence factor which exerts its effect
on human host cells. A PCR assay has been developed for the detection of the
ply gene and nonculture laboratory conformation of invasive pneumococcal
disease. It has been reported that the ply gene varies between different
serotypes of S. pneumoniae. Thus the ply genes from the 23 serotypes most
commonly causing invasive disease were sequenced to explore a potential
sequence-based typing method.
Methods:A nested PCR test was developed, as the concentration of DNA in
clinical samples can be low. Primers were designed to amplify the 1.6 kb ply
gene. Clinical samples were tested for the presence of the ply gene using the
nested PCR. Sensitivity and speciﬁcity were determined. The ply gene from
23 most common serotypes was sequenced and analyzed.
Results: Five hundred and twenty clinical samples were used to evaluate the
PCR method (208 CSF, 247 serum, 65 whole blood). Seventeen of the
clinical samples were conﬁrmed pneumococcal antigen positive, 12 of these
were positive using this PCR test. In total, 15 PCR positives were detected
that had not previously been tested for pneumococcal infection. Speciﬁcity
was assessed using organisms that may be found in the serum and CSF
(n¼ 48), of these organisms 4 were positive (S. parasangnis, S. oralis and two
Neisseria lactamica). The initial PCR detected conﬂuent growth, adding the
nested stage increased sensitivity 10-fold (158 cfu detected). A consensus
sequence for each serotype was prepared using the sequence data. The 23
consensus sequences were aligned to show sequence variation. There was
insigniﬁcant variation between the consensus serotypes, thus it was not
possible to design oligonucleotide primers that would speciﬁcally amplify
individual serotypes of S. pneumoniae.
Conclusion: The PCR developed will detect the ply gene in clinical samples
although, as sensitivity is low, it may not detect all positive samples. This study
demonstrated there are no signiﬁcant differences between ply genes from
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different pneumococcal serotypes and therefore it is not possible to develop a
serotype speciﬁc assay for the detection of ply in clinical samples.
P1372 Detection of macrolide resistance genes in
Streptococcus pneumoniae using a rapid method
L. Gualco, J. McDermott, E. A. Debbia, G. C. Schito, A. Marchese
Genoa, I
Objectives:Macrolide resistance in streptococci occurs predominantly by two
mechanisms: target modiﬁcation or efﬂux. The ﬁrst results in coresistance to
macrolide, lincosamide and streptogramin B (MLSB phenotype) and it is
mediated by two classes of methylase genes, the conventional ermAM (ermB)
determinant and the recently described ermTR determinant. The second,
conferring low macrolide MICs and retain susceptibility to clindamycin (M
phenotype), is mediated by mefA gene. The aim of this study was to develop a
rapid large-scale screening of macrolide-resistant genotypes in isolates of
S. pneumoniae.
Methods: Fifty strains of clinical isolates of erythromycin-resistant (40
belonging to MLSB phenotype and 10 belonging to M phenotype) and
10 erythromycin-susceptible S. pneumoniae strains have been tested. MICs for
erythromycin and clindamycin were determined by the microdilution
method as suggested by the NCCLS (2002). The genes were ampliﬁed by
a multiplex rapid cycle PCR, using biotinilated primers. The products were
added to streptoavidin-coated microwell and were incubated with ﬂuoresci-
nated probes, speciﬁc for genes ermB,mefA and ermTR. Detection of ampliﬁed
products was carried out using a modiﬁcation of the method described by
Farrell et al. JAC, 2001. The products were incubated with antiﬂuorescin
antibody conjugated with peroxidase and then o-phenylenediamine (OPD)
was added to each well. Absorbances (450 nm) were read by spectrophot-
ometer.
Results: The method proved to be very rapid, results were obtained within
4 hours. As we expected, according to MIC phenotypes, 40 S. pneumoniae
isolates characterized by MLSB phenotype were positive for ermB. The
remaining 10 strains showing an M phenotype reacted with the mefA probe.
All macrolide-susceptible isolates tested were negative for the mechanisms
under investigation. Strains having dual mechanisms of macrolide resistance
(ermBþmefA) were not found. Using this method, concordance between
MIC phenotypes and genotypes was 100%.
Conclusions: The method reported in this study allows to standardize testing
of large number of isolates and to discriminate within different genotypes with
an only multiplex PCR reaction. It allows the analysis of a large number of
specimens (96 for each microwell) within in short time. In addition, the use of
an oligonucleotide probe adds speciﬁcity to the detection, which increases the
reliability of the results.
P1373 Comparison of magnetic and conventional Boom
RNA extraction using respiratory samples
K. Loens, T. Beck, P. Van Deursen, D. Ursi, P. Sillekens, M. Ieven,
H. Goossens
Wilrijk, B; Boxtel, NL
Introduction: The use of nucleic acid ampliﬁcation techniques for the
detection of infectious agents in clinical specimens continues to expand,
and these techniques promise to play an increasing role in the diagnostic
laboratory. While a great deal has been published on ampliﬁcation protocols,
less information is available addressing specimen processing for optimal RNA
recovery prior to ampliﬁcation.
Objectives: A new sample preparation system that combines the advantages of
the Boom method for RNA extraction from clinical samples with the con-
venience of the magnetic bead technology was evaluated and compared with
conventional RNA extraction using the NucliSens Basic Kit1 (bioMe´rieux).
Methods: Sputum samples were pretreated with protease, aliquoted and the
appropriate lysis buffer was added. Conventional RNA extraction was done
using the NucliSens Basic Kit according to the instructions of the manu-
facturer. For magnetic RNA extraction, the samples were ﬁrst incubated for
10min at 608C and then centrifuged for 15min at 13000 rpm. Then the
supernatants was added to the magnetic silica, centrifuged, washed twice with
wash buffer 1, wash buffer 2, followed by elution of the nucleic acids. U1A
mRNA was ampliﬁed by NASBA and the amplicons were detected by
electrochemiluminescence (NucliSens Basic Kit). Finally, a limited number
of L. pneumophila, M. pneumoniae and B. pertussis specimens were analyzed by
both extraction methods. The results obtained with both extraction proce-
dures were compared with each other.
Results: Conventional Boom extraction resulted in 12/20U1A mRNA
positive samples whereas magnetic extraction yielded 15/20 positive samples.
On the undiluted extracts all 15, and only 8/20 positive results were obtained
after magnetic and conventional extraction, respectively. Usually, at least 4-
fold higher ECL-counts were found for extracts obtained by magnetic
extraction. Five L. pneumophila positive lung biopsy specimens, 1 B. pertussis
and 1 M. pneumoniae positive sputum, 1 M. pneumoniae positive gargle speci-
men, and 1 M. pneumoniae throat swab were positive by both extraction
methods. Again, higher ECL counts were generally found for extracts
obtained by magnetic extraction.
Conclusions: The NucliSens Basic Kit1 combined with magnetic RNA
extraction could become a fast, useful and user-friendly diagnostic tool for a
NASBA-based assay for the detection of respiratory pathogens in clinical
specimens.
P1374 PCR for diagnosis of Chlamydophila pneumoniae
from respiratory specimens
K. Topping, A. Leanord, T. Paget, C. L. Williams
Hull, Airdrie, Glasgow, UK
Objectives:Chlamydophila pneumoniae is an important respiratory pathogen in
both adults, with and without COPD, and children and has recently been
associated with atherosclerosis and several other chronic diseases. The organ-
ism can be detected by antibody detection methods or by using PCR.
Published detection rates of C. pneumoniae in respiratory diseases are incon-
sistent and vary from 5–33% in chronic obstructive pulmonary disease
(COPD). We have used standardized PCR assays, using three previously
described primers, to examine an unselected group of 750 sputa submitted
sequentially to a routine diagnostic laboratory to determine in two stages
ﬁrstly the prevalence ofC. pneumoniaeDNA in a sample of sputa submitted for
examination to laboratories in the UK andwhether the rate of positivity varies
between different clinical groups and secondly is the amount of chlamydial
DNA independent of the number of White blood cells in the sputum.
Methods: Chlamydophila pneumoniae was detected by DNA Ampliﬁcation of
the 16S rRNA Gene and quantitation of the amount of C. pneumoniae DNA
in the sputum measured using the ﬂuorescent dye-labeled TaqMan probe-
based system and oligonucleotide primers and probes designed to target two
variable domains of the ompA gene, VD2 and VD4.
Results: Using DNA extracted from sputa we have found that 28% of this
unselected population are positive for C. pnemoniae by routine PCR.We have
compared these results with two real-time PCR assays speciﬁc for C. pneu-
moniae and will present data on:
1. The correlation of real time and standard PCR methodologies
2. The quantitation of C. pneumoniae DNA.
3. The correlation of PCR, bacterial culture and clinical features of infection.
Conclusion: C. pneumoniae DNA is found in 28% of all sputa submitted to a
routine diagnostic laboratory. Further work is required to ascertain the
signiﬁcance of this in different clinical conditions.
P1375 Detection of Chlamydia pneumoniae in
respiratory tract specimens by PCR: evaluation of
methodology
D. Houhoula, E. Balis, J. Papaparaskevas, N. Legakis, L. Zerva
Athens, GR
Objective: Infection of the respiratory tract with C. pneumoniae is reported
with increasing frequency. Gold standard for diagnosis of this infection is the
microimmunoﬂuorescence (MIF) assay, an expensive method with long
turnaround time. This study evaluated three DNA extraction methods and
a PCR assay using respiratory tract specimens from patients with acute lower
respiratory tract infection (ALRTI).
Materials and methods: Sputum or BAL specimens and acute and con-
valescent serum samples from 95 hospitalized patients with ALRTI were
tested retrospectively. A species-speciﬁc MIF assay (MRL, USA) was used for
serological diagnosis. Respiratory samples were subdivided in three parts and
DNAwas extracted by proteinase K treatment, NucliSens (Organon Teknika,
Belgium) and IsoQuick (Orca Research, USA). PCR testing was
performed with a nested protocol amplifying part of the ompA gene. Inter-
and intra-assay PCR reproducibility was assessed by repeat testing of PCR-
positive samples.
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Results: By MIF testing, 56 patients demonstrated acute infection with
C. pneumoniae (1 IgG seroconversion, 3 a four-fold increase of IgG titers,
5 IgM positivity and 47 a signiﬁcant IgG titer (1/512)) and 39 were MIF-
negative. PCR sensitivity by any extraction method was 46%: 26 out of 56
respiratory samples originating from MIF-positive patients were PCR-posi-
tive. Twenty-ﬁve samples were positive by proteinase K treatment, 5 by
IsoQuick and 2 by NucliSens (sensitivities 45, 10 and 4%, respectively).
Twenty samples were positive only after proteinase K treatment. None of the
39 samples obtained from MIF-negative patients was PCR-positive by any
extraction method (speciﬁcity 100%). Twenty-three PCR positive samples
(extracted by proteinase K) were tested repeatedly (3–5 times) on different
days. Overall, 57 out of 81 PCR tests revealed a positive result (PCR interassay
reproducibility 70%). Only 10 samples (44%) consistently reproduced a
positive result. Ten PCR-positive samples (extracted by proteinase K) were
retested, each sample four times within the same PCR run. There were 26
PCR-positive results out of 40 expected (PCR intra-assay reproducibility
65%).
Conclusions: PCR assay sensitivity differs greatly between DNA extraction
methods; best results are achieved with proteinase K. Although its speciﬁcity is
excellent, PCR testing lacks interassay and intra-assay reproducibility. Diag-
nosis of respiratory infection with C. pneumoniae by PCR is problematic.
P1376 Development and application of a multiplex
real-time PCR for diagnosis of Mycoplasma pneumoniae,
Chlamydia pneumoniae and Bordetella pertussis
K. Templeton, S. Scheltinga, H. Goossens, E. Claas
Leiden, NL; Antwerp, B
Objectives: To develop a multiplex real-time PCR for clinical diagnosis of
Mycoplasma pneumoniae (MP), Chlamydia pneumonia (CP) and Bordetella per-
tussis (BP) with an internal control.
Methods:Monoplex real-time PCR assays using molecular beacons as probes
were developed for each pathogen. The molecular beacons were labelled with
FAM (MP), HEX (CP), Texas RED (BP) so that discrimination in a single
tube could be determined in one multiplex. All assays were ﬁrst optimised in
the monoplex assays and thereafter into one 4-target-multiplex reaction. The
multiplex included an internal control reaction (phocine herpes virus) which
was also detected by a labeled probe (Cy5). Standards of the bacteria were
obtained by achieving a titer by colour changing units (CCU)/mL, inclusion
forming units (IFU)/mL andMcfarland turbimetric standards for MP, CP and
BP, respectively. The assay was evaluated using samples from 93 patients with
respiratory symptoms requesting investigation for at least one of the patho-
gens. All samples were tested by both the conventional diagnostic methods
(serology or culture) and by means of the multiplex reaction. Positive results
by real-time PCR only were conﬁrmed by an alternate conventional PCR.
Results: The same limit of sensitivity was seen in the monoplex reactions and
multiplex reaction, in that 50CCU/mL, 0.049 IFU/mL, 100CFU/mL was
detected for MP, CP and BP, respectively. The speciﬁcity of the monoplex and
multiplex was also the same. No other respiratory pathogens were detected by
the assays except that BP assay also detected B. holmesii in both monoplex and
multiplex formats. In the clinical testing 9/93, 0/93 and 6/93 were detected
by conventional methods and 12/93, 0/93 and 15/93 were detected by the
multiplex PCR for MP, CP and BP, respectively. Of these two extra positives
were obtained which were not suspected by the clinician.
Conclusion: The Multiplex real-time PCR for MP, CP and BP provides
sensitive and speciﬁc diagnosis of these respiratory pathogens, which are
difﬁcult to culture. The multiplex assay is suitable for diagnostic use and may
improve patient diagnosis and management.
P1377 Qualitative and quantitative detection of
Chlamydia pneumoniae DNA in cerebrospinal ﬂuid
Y. Tang, S. Sriram, H. Li, S. Yao, S. Meng, W. Mitchell, C. Stratton
Nashville, USA
Objectives: A diagnostic test for the detection and quantitation of Chlamydia
pneumoniae DNA in cerebrospinal ﬂuid (CFS) is needed because of the
association of C. pneumoniae with a number of neurological disorders includ-
ing multiple sclerosis (MS).
Methods: We developed and validated a qualitative colorimetric microtiter
plate-based PCR-enzyme linked ampliﬁcation and hybridization assay
(MTP-PCR) and a real-time quantitative PCR assay (TaqMan) for detection
ofC. pneumoniaeDNA in CSF specimens fromMS patients and controls. The
two methods were evaluated in comparison to a touchdown nested PCR (n-
PCR) assay on a total of 137 CSF specimens.
Results: The sensitivity, speciﬁcity, and concordance of the MTP-PCR assay
were 88.5, 93.2, and 90.5%, respectively. MTP-PCR presented a signiﬁcantly
higher sensitivity in MS patients (P¼ 0.008) and a higher speciﬁcity in other
neurological diseases (P¼ 0.018). Test reproducibility of the MTP-PCR assay
was statistically related to the volumes of extract DNA included in the test
(P¼ 0.033); a high volume, which was equivalent to 0.1mL of CSF per
reaction, yielded a concordance of 96.8% between two medical technologists
running the test at different times. The TaqMan quantitative PCR assay
detected 26 of 59 (44.1%) CSF specimens that tested positive by both MTP-
PCR and n-PCR qualitative assays. None of the CSF specimens that were
negative by the two qualitative PCR methods were detected by the TaqMan
quantitative PCR. MTP-PCR assay detected a minimum of 25 copies/mL
C. pneumoniae DNA in plasmid-spiked CSF, which was at least 10 times more
sensitive than TaqMan.
Conclusion: These data indicated that the MTP-PCR assay possessed an
equivalent sensitivity to nested procedures for the detection of C. pneumoniae
DNA in CSF. Due to the lowC. pneumoniae copies that existed in the majority
of CSF specimens fromMS patients, the TaqMan system may not be sensitive
enough for diagnostic purposes, but may be useful as a marker in prospectively
following neurological diseases such as MS.
P1378 Use of near patient testing kits for
microbiological and epidemiological characterization of
group A streptococci
A. Tanna, R. C. George, A. Efstratiou
London, UK
Objectives:The purpose of this study was to evaluate near patient testing kits
(NPTs) for the rapid detection and molecular characterization of group A
streptococci (GAS directly from throat swabs, in particular, to determine their
use for surveillance of type distributions and macrolide resistance.
Methods: Six commercially available NPTs were evaluated for their sensi-
tivity, speciﬁcity and efﬁcacy in the recovery of chromosomal DNA directly
from simulated throat cultures. PCR ampliﬁcation of emm genes was under-
taken directly from the kit components and detection of emm types was
determined by a PCR ELISA and/or sequencing.
Results: Recovery of GAS speciﬁc DNA was possible with some of the kits
and the most user friendly kit (ICON Fx Strep kit) had a detection limit of
10E5 organisms/mL. DNA was extracted more efﬁciently from the primary
lysate of the swab material after exposure to the NPT kit system(s) and was
used in the PCR emm capture ELISA. The emm typing data correlated with
the results obtained by conventional methods.
Conclusions:The ICON Fx Strep Kit was the most effective and sensitive kit
for recovery of DNA. Typing results were available within 24 h of throat
sampling and the presence of normal throat ﬂora did not effect the result. This
is a novel approach to typing that could also be utilised for detection of a
repertoire of virulence genes, in particular those used for antimicrobial
resistance.
P1379 Detection of Chlamydia pneumoniae in
respiratory specimens using real-time NASBA
K. Loens, T. Beck, P. Sillekens, M. Overdijk, D. Ursi, M. Ieven,
H. Goossens
Wilrijk, B; Boxtel, NL
Introduction: Chlamydia pneumoniae is an etiologic agent of respiratory tract
infections in humans. In the past, diagnosis of infection by this organism was
based on serology and culture. Real-time nucleic acid sequence-based
ampliﬁcation (NASBA) might offer an alternative.
Objectives:The aim of the study was to develop a real-time NASBA assay for
the detection of C. pneumoniae in respiratory specimens based on NASBA
ampliﬁcation of a 16S rRNA target sequence using the NucliSens Basic Kit1
(bioMe´rieux).
Methods:Oligonucleotide primers were derived from the C. pneumoniae 16S
rRNA. The assay was developed using the NucliSens Basic Kit, that includes
standardised reagents for nucleic acid extraction, RNA ampliﬁcation and
electrochemiluminescence (ECL) detection. For real-time detection, a mole-
cular beacon was used. Speciﬁcity was established on a panel of bacterial
strains. The analytical sensitivity of the assays was determined by testing
dilutions of a C. pneumoniae reference strain. Serial dilutions of C. pneumoniae
were added to pools of respiratory specimens and treated with protease before
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extraction. Subsequently, a number of C. pneumoniae positive and negative
clinical specimens were analyzed. The results obtained with the real-time
C. pneumoniae 16S rRNA assay were compared with those obtained by
conventional end-point detection using ECL.
Results: Speciﬁc detection of the 16S rRNA-derived amplicons was
achieved. The real time NASBA assay enabled detection of as little as 0.1
IFU of C. pneumoniae. In spiked respiratory specimens, the sensitivity of the
C. pneumoniae NASBA assay varied between 0.1 and 10 IFU/100mL sample
depending on the nature of the matrix. There was no difference in sensitivity
between both detection methods. Finally, 4 PCR positive specimens were
positive by both conventional and real time NASBA. None of 100 PCR
C. pneumoniae negative specimens was positive by both assays.
Conclusions: The NucliSens Basic Kit1 combined with real-time detection
proved to be a fast, useful and user-friendly diagnostic tool for a NASBA-
based assay for the development of a NASBA-based assay for the detection of
C. pneumoniae in respiratory specimens.
P1380 Serotyping pneumococci by Multiplex PCR
D. A. Brito, M. Ramirez, H. de Lencastre
Oeiras, P
Objectives: To develop a multiplex PCR-based method for the detection of
epidemiologically important pneumococcal serotypes without using immu-
nological techniques.
Methods: Three classes of primers were designed to target capsular poly-
saccharide (cps) genes: (i) the internal control (included in all reactions) (ii) the
type-speciﬁc, for the detection of serotypes 1, 3, 4, 6B, 14, 18C, 19F, 19A, and
23F; and (iii) the common primers, targeted at conserved cps genes. The
primers were assembled into two types of multiplex reactions: (i) the group-
reaction (GR) with primers common to several serotypes, and (ii) six speciﬁc-
reactions (SR) with the type-speciﬁc primers. Pneumococci were initially
screened by the GR that groups sets of serotypes based on common genes. To
distinguish between related serotypes within each set and according to the
proﬁle obtained in the GR, one of the SR was done. A simple procedure was
used for template preparation – a colony was picked with a sterile tip followed
by immersion in the multiplex reaction mix. The analysis of the ampliﬁcation
products was done by agarose gel electrophoresis and visual inspection of the
patterns obtained.
Results:Out of 446 pneumococci isolated from the nasopharynx of asympto-
matic children all were correctly typed by PCR. A total of 294 were identiﬁed
to the type-level and the remaining 152 presented GR patterns in agreement
with the serotype determined by the capsular reaction test. Primers designed
to detect serotypes 1, 3, 4, 14, 19F, 19A, and 23F proved to be type-speciﬁc,
whereas those designed to detect serotypes 6B and 18C were serogroup-
speciﬁc.
Conclusions: Multiplex PCR showed to be efﬁcient in the detection of the
most frequent serotypes colonizing children, while reducing the number of
strains that have to be serotyped by conventional immunological techniques.
Moreover, it was simple, expeditious (96 samples/day/technician), cost
effective and reliable (no specialized expertise is needed) when compared
with the capsular reaction test, making it suitable for the analysis of large
number of isolates. Preliminary results also show that this method can be used
to analyze heterogeneous bacterial samples.
Fungal infections: diagnostics
P1381 PCR-detection of Candidia albicans in blood
using a new primer pair to diagnose systemic candidiasis
H. Mirhendi, P. Kordbacheh, G. Hassanpour, K. Makimura
Tehran, IR; Tokyo, JP
The opportunistic pathogenC. albicans is able to cause disseminated infections
in immunocompromised patients. Microbiological methods for the diagnosis
of invasive candidiasis have many problem including low sensitivity, require-
ment to invasive clinical samples such as biopsies or multiple blood cultures
and need to expertised laboratory stuff. Since PCR has proven to be a
powerful tool in the early diagnosis of several infectious diseases, we applied
this approach to a rapid and sensitive detection of C. albicans cell in blood
samples, for establishment a clinically useful method in diagnosing systemic
candidiasis. DNA were extracted from blood samples seeded by serially
diluted C. albicans cells, by lysing WBC and RBC followed by enzymatic
breaking of fungal cell wall and phenol – chlorophorm extraction and alcohol
precipitation of DNA, A new primer pair was designed to PCR-ampliﬁcation
of a part of ribosomal RNA gene. The primer set was able to amplify all
medically importantCandida species. When PCRwas performed for puriﬁed
DNA, the sensitivity of the method was 1 pg fungal DNA, whereas the
sensitivity for detection of C. albicans blastospores inoculated in blood was as
few as 10 cells per 0.1mL of blood. This method could be sensitive and useful
for early and rapid diagnosis of systemic Candida infections and to simulta-
neous detection and speciation of Candida species by PCR-RFLP method.
P1382 Rapid detection of pathogenic fungi from clinical
specimens using real time PCR
A. Imhof, C. Schaer, D. Schaer, G. Schoedon, R. Walter, A. Schaffner,
M. Schneemann
Seattle, USA; Zurich, CH
Objectives: Fungal infections are a major cause of infection-related mortality
in immunocompromised patients and require early initiation of therapy for
successful treatment. However, conventional diagnosis of fungal infections
lacks sensitivity and is time-consuming. Since PCR technology holds great
promise for the early identiﬁcation of medically important pathogens, real
time PCRwas used for diagnosis of fungal infections in clinical tissue samples.
Methods and results: Seven specimens were investigated from six patients
with suspected or proven invasive fungal infections. All samples were positive
in a panfungal PCR assay. In four samples, Aspergillus fumigatus was detected
both by a species-speciﬁc hybridization assay as well as by sequencing of
ampliﬁcation products. In addition, panfungal PCR detected and subsequent
sequencing identiﬁed Candida albicans in a culture-negative liverbiopsy,
Histoplasma capsulatum in a bone marrow sample, and Conidiobulus coronatus
in a facial soft tissue specimen.
Conclusion: Real time PCR appears promising as a means to diagnose
invasive fungal infections in human tissue samples. It offers rapid analysis,
high speciﬁcity and increased sensitivity.
P1383 Comparison of E-test method with the proposed
procedure for antifungal susceptibility testing of the
European Committee on Antibiotic Susceptibility Testing
M. Cuenca-Estrella, E. Mellado, L. Alcazar, A. Monzon, V. Parra,
J. L. Rodriguez-Tudela
Majadahonda, Madrid, E
Objectives: We have analyzed the correlation between the procedure for
antifungal susceptibility testing (AFST) of the European Committee on
Antibiotic Susceptibility Testing (EUCAST) and the commercial method
E-test, a agar diffusion-based procedure for in vitro testing of amphotericin B
(AB), ﬂuconazole (FLZ), itraconazole (ITZ), ketoconazole (KTZ), vorico-
nazole (VZ) and ﬂucytosine (FC). The EUCAST has developed a proposed
standard for AFSTof yeasts based on reference procedure of NCCLSM27-A,
but incorporating modiﬁcations (RPMI-2% glucose, inoculum size of
105CFU/mL, spectrophotometrical reading) in order to get an automated
AFST and to shorten from 48 to 24 h the incubation period for MIC
determination.
Methods:A total of 60Candida spp. clinical isolates (10 eachC. albicans (CA),
C. tropicalis (CT), C. parapsilosis (CP), C. glabrata (CG), C. krusei (CK), C.
lusitaniae (CL)) were tested. CA ATCC90028, CK ATCC6258 and CP
334 Abstracts
ATCC22019 were included as QC strains. Triplicate testing on three separate
days was performed.
Analysis: (i) Correlation: intraclass correlation coefﬁcient (ICC), over a
maximum value of 1.
Results:Overall, the correlation was high with ICC of 0.89 (P< 0.01). The
lowest ICC values were obtained for CL isolates which exhibited a correlation
of 0.7, value with statistical signiﬁcance. By antifungal agents, the lowest
correlation values were obtained for AB, with ICC of 0.73 (P< 0.01). The
MICs obtained by E-test method for azole resistant isolates were as follow:
FLZ: >32mg/L, ITZ: >0.75mg/L, and VZ: >0.12mg/L.
Conclusions: (i) The correlation between EUCAST procedure and E-test
method is high with average correlation values of 0.89. (ii) The method are
comparable for all Candida species and antifungal agents. (iii) E-test method
detects azole resistant strains.
P1384 Evaluation of media to enhance conidial
production of dermatophytes
K. Heinlaid, P. Naaber, H. Ja¨rv
Tartu, EST
Objectives: Scattered reports about clinical and microbiologic resistance
among dermatophytes to antifungals have pointed out need for a reference
method for testing the antifungal susceptibility of dermatophytes. Selection of
appropriate medium for conidial formation is essential to inoculum prepara-
tion for susceptibility testing because dermatophytes are known to demon-
strate poor conidial production. The aim of the study was to compare ﬁve
different agar media by their ability to support conidial formation.
Methods: A total of 33 Trichophyton rubrum, 15 T. mentagrophytes and eight T.
tonsurans strains were tested. The ﬁve media evaluated were Poor Base
Medium (developed by Aho, 1980), Difco oatmeal agar, in-house oatmeal
agar, in-house rice-ﬂour agar and Difco rice extract. Dermatophytes were
cultivated at þ308C for up to 14 days. The production of conidia was
calculated on days 3, 5, 8, 14 using cello-tape preparation. For each isolate
the number of conidia was counted in ﬁve viewing ﬁelds (1000).
Results: In-house rice-ﬂour agar showed signiﬁcantly better conidial produc-
tion on day 8 and on day 14 for all species tested than other media (medians
300; P< 0.01). A total of 93% of T. mentagrophytes, 88% of T. tonsurans and
70% of T. rubrum isolates gave conidial production >100 conidia per ﬁeld on
this medium on day 8. The other media supported less than 50% T. rubrum
isolates to form >100 conidia per ﬁeld on day 8. More than 85% of T.
mentagrophytes isolates produced >100 conidia per ﬁeld on in-house oatmeal
and on Poor Base Medium (day 8). The Poor Base Medium gave conidial
production >100 conidia per ﬁeld on day 5 for 86% of T. mentagrophytes
strains. The conidial formation of 57% and less than 50% of T. mentagrophytes
isolates was supported by Difco rice extract agar and Difco oatmeal agar,
respectively. More than 85% of T. tonsurans isolates produced >100 conidia
per ﬁeld on in-house oatmeal and on Difco oatmeal agar. Less than 50% of the
conidial growth (>100 conidia per ﬁeld) of T. tonsurans isolates was supported
on Poor Base Medium and Difco rice extract agar.
Conclusion:Home-made rice-ﬂour agar was identiﬁed as suitable medium to
enhance the production of conidia of T. rubrum, T. mentagrophytes and T.
tonsurans to ensure appropriate inoculum concentration for susceptibility
testing. We suggest the Poor Base Medium for T. mentagrophytes conidial
formation with minimum time.
P1385 Improvement and limitations of conventional
mycologic diagnosis in superﬁcial mycoses
A. Sergeev, N. Zharikova, Y. Sergeev, P. Bogush
Moscow, RUS
Background: Low rates of positive cultures from skin and especially the nail
samples often impede the mycological diagnosis in superﬁcial fungal infection.
No generally accepted guideline exists for interpretation of nondermatophyte
positive nail cultures.
Objectives: To analyze results of use of conventional methods for laboratory
diagnosis in superﬁcial fungal infections. To ﬁnd their sensitivity and speci-
ﬁcity, and causes of their changes.
Methods: For 5-year-period 1997–2001, 21256 samples from 17 757 patients
were processed in mycology unit of Central clinical hospital under Presi-
dential medical center. Nail samples consisted 68%. A total of 3072 positive
cultures (14.4%) was obtained, 4210 (19.8%) positive microscopy and 1486
(7%) culture-only positive samples. Performing culture was mandatory for all
suspected cases of fungal infections inside that healthcare system.
Results: Sensitivity of microscopy and/or culture was drawn from relation of
its positive values to all positive values obtained by either method. The
assumption was based on a fact that positive result of either method alone
conﬁrms diagnosis of onychomycosis. According to these design, mean
sensitivity of microscopy was found as 87.8% and culture as 50%. An increase
in culture sensitivity was observed through 5 years. Analyzing the causes of
sensitivity improvement, we outline two measures: (i) better sampling by
dermatologists, with respect to clinical presentation of onychomycosis, and
(ii) paired cultures on a medium with and without cyclohexemide. Total
sensitivity increase since 1994 approximated 2.5 times. For more strict
distinction between pathogens and contaminants/saprophytes in onychomy-
cosis, we have separately assessed cultures, obtained with concomitant positive
microscopy. We have found that with ﬁngernail cultures, proportion of
dermatophytes increased from 38.5% to 56.4%, with decrease of Candida
spp. and molds. Toenail cultures showed similar tendency, with dermatophyte
share increased to 86.9%.
Conclusions: Although this fact may reﬂect the nondermatophyte contam-
ination of the samples, more studies may be needed to differentiate between
true and false/mixed nondermatophyte infections. Direct PCR probes for
prevalent dermatophytes may help to establish the true rates of yeast and mold
nail infections.
P1386 Screening for circulating galactomannan as a
marker for invasive aspergillosis in patients with
hematologic disease
M. Walberg, M. Boevre, P. Gaustad, A. Bjoerneklett, L. Brinch
Oslo, N
Objectives: The sensitivity of a sandwich enzyme-linked immunosorbent
assay (ELISA, Platelia Aspergillus kit, BioRad, France) for the detection of
Aspergillus galactomannan was evaluated in a one year prospective study in a
hematological ward with previously low incidence of invasive aspergillosis.
Methods: Eighty-six patients with acute leukemia, aplastic anemia, and
patients receiving autologous BMTwere tested until the granulocyte count
was stable and above 1.0 109 cells/L or until the patient no longer had signs
of clinical infection. Patients receiving allogeneic BMT were tested for a
minimum of 8weeks, patients receiving steroid treatment for GvHD were
tested until cessation of steroid treatment and clinical stability. 680 plasma
specimens were collected from patients in the study biweekly for investigation
of galactomannan levels.
Results:During the testing period no patients died of proven aspergillosis, one
patient died of probable aspergillosis. This patient tested galactomannan
positive (index value 5.816) 4 days prior to death. One day after the positive
galactomannan testing,A. fumigatus grew from sputum, tracheal and bronchial
secretions. Two patients tested falsely positive (index value 1.973 and 1.606),
one of these died of autopsy-veriﬁed invasive Candida 3 days after positive
galactomannan testing. None of the galactomannan positive patients showed
positive gray-zone values at any point during the testing. Thirteen patients
showed positive gray sone values (index value¼ 0.8–1.5) without any signs of
infection. 640 samples tested negative.
Conclusion: Due to the low number of patients testing galactomannan
positive and to the lack of gray zone values in this single patient, and to
the high number of falsely positive gray zone values, the galactomannan test
was not introduced as standard test for the hematological patients in our
hospital.
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P1387 IgG avidity test for acute toxoplasmosis in
pregnant women in County of Istria
M. Vranic-Ladavac, R. Ladavac, L. Radolovic, L. Lazaric, D. Pfeifer
Pula, Zagreb, HR
Objectives: It is of great importance to conﬁrm particular antibody classes
using a combination of suitable serological tests for exclusion of recent
primary infection with toxoplasma in pregnant women. Toxoplasmosis testing
should be done in early pregnancy, using ELISA or IFA to detect speciﬁc
classes of IgM and IgG antibodies. When necessary further IgA antibody and
Western blotting testing can be applied. Determination of precise date of
seroconversion is often difﬁcult because of persistence of IgM and high IgG
titter. This leads to difﬁculties in distinguishing reactivation, reinfection,
polyclonal stimulation, presence of residual or nonspeciﬁc IgM, and subse-
quently leads to unnecessary treatments, amniocentesis and even abortion.
Methods: Toxoplasma gondii imuno-globulin G (IgG) avidity enzyme-linked
ﬂuorescent assay is based on measurement of avidity (binding strength)-
speciﬁc IgG antibody to antigen in presence of urea buffer. Characteristic for
early phase of infection is dissociation of low-avidity IgG antibodies from
antigen. Representative of prior infection is increase of IgG antibody and
antigen binding afﬁnity (high avidity), and the absence of dissociation in urea
buffer. Avidity assay results are generally expressed as an avidity index (AI). In
combination with other serological tests enables rapid timing of primary
infection or differentiation of primary or secondary (persistent or reactivated)
infection. From a resident population of 200.000, during one year 960 sera
samples from 937 pregnant women were analyzed for presence of Toxoplasma
gondii-speciﬁc IgM and -IgG antibodies.
Results: IFA and ELISA test were performed and 32% of samples were
positive for presence of T. gondii IgG antibodies (hence remaining 68% are
susceptible for primary infection during pregnancy). In seven pregnant
women (0.74%) IgM and IgG antibodies both were identiﬁed. IgG avidity
test indicated high avidity in four women, thereby excluding the acute
primary infection. In the other three with low IgG avidity artiﬁcial abortion
was performed in one, and spiramycin therapy initiated in remaining two
pregnancies with diagnosed acute infection (All assays BioMe´rieux, France).
Conclusion:T. gondii IgG avidity test enables acute infection exclusion in IgM
positive pregnant women and potentially reducing unnecessary treatments by
at least 50%.
P1388 Toxoplasmosis in Kuwait: improved diagnosis
based on quantitative immuno-assay
J. Iqbal, P. R. Hira, N. Khalid
Kuwait, KWT
Introduction: Toxoplasma gondii, is an opportunistic intracellular coccidian
pathogen that causes a benign infection in immunocompetent individuals but
has emerged as a major opportunistic pathogen immunocompromised
patients. The main objective of this study was to determine the seroprevalence
rate among healthy adults and pregnant women in Kuwait by a rapid and
speciﬁc diagnostic assay to detect Toxoplasma-speciﬁc IgG antibodies.
Study Groups and methods: (1) Control groups:
(1.1) Positive for Toxoplasma IgG antibodies: 50.
(1.2) Negative for Toxoplasma IgG antibodies: 50.
(1.3) Randomly selected negative sera: 150.
(2) Adult Healthy Individuals: 1475. All major ethnic and foreign national
groups living in Kuwait were included.
(3) Pregnant women: 225 (75 each in 1st, 2nd and 3rd trimester).
Screening Assays for Speciﬁc Toxoplasma antibodies: The following screening
assaying were used: I. VIDAS IgG/IgM (bioMerieux Vitek, MO, USA). II.
Mercia Toxo Enzyme Immunoassay (Syva, Palo Alto, USA). III. Toxolatex
Immunoassay (Fumouze Labs, Le Malesherbes, France). All equivovcal results
were conﬁrmed by indirect ﬂuorescent antibody assay (Virgo, Pharmacia
Diagnostics, NJ, USA).
Results: The performance of the three immunologic assays to detect anti-
bodies to T. gondii was determined by screening the control group. VIDAS
detected 53 positive cases and Mercia EIA detected 51 cases, and 4 cases were
equivocal. VIDAS assay had the highest sensitivity (9603%) and speciﬁcity
(99.5%) of the three assays. The seroprevalence rate of antibodies to tox-
oplasma parasites in our study population ranged from 25% in Philippinos to
69.3% in Arab nomads. 42% of the urban Kuwaiti population showed
signiﬁcant level of antibodies to T. gondii. 45.7% of the pregnant women
had signiﬁcant levels of Toxoplasma IgG antibodies. Incidence during different
trimesters was approximately the same, i.e. 30%. Further, comparative data
analysis is also presented with other studies conducted in the Gulf region.
Conclusion:
1. VIDAS immunoassay had the highest sensitivity (96.3%) and speciﬁcity
(99.5%).
2. The seroprevalence rate of antibodies to toxoplasma parasites in various
study populations ranged from 25% to 69.3%.
3. 42% of the urban Kuwaiti population showed signiﬁcant level of antibodies
to T. gondii that is higher than that in Saudi Arabia and UAE (31%).
4. The seroprevalence rate in pregnant women was 45.7%.
P1389 Evaluation of two enzyme-linked
immunosorbent assays and one immunochromatographic
rapid assay for the detection of Giardia lamblia-speciﬁc
antigens in fecal specimens of patients with giardiasis
K. Tzanetou, E. Dolapsaki, C. Kakari, A. Sideri, A. Blachaki,
E. Michaelidou, A. Tsouknida, A. Tsantes, V. Papaioanou,
E. Malamou-Lada
Athens, GR
Objectives: The estimation of sensitivity and speciﬁcity of two enzyme
immunoassays (Alexon-Trend ProSpecT Giardia Microplate Assay and
Cypress Diagnostics Giardiasis Ag ELISA) and one immunochromatographic
assay (Becton Dickinson ColorPAC Giardia/Cryptosporidium Rapid Assay)
in comparison with microscopic detection ofGiardia cysts and trophozoites in
patient fecal specimens, in order to evaluate their usefulness as alternative
methods for diagnosing giardiasis.
Methods: During the last 2.5 years, 5800 fecal specimens were examined by
the conventional microscopic examination (direct wet preparation and after
concentration) for ova and parasites. All the positive fecal specimens for cysts
and/or trophozoites of Giardia using the ova and parasite examination were
stored fresh (unpreserved) at 708C. These fecal specimens were retro-
spectively examined for the presence of Giardia-speciﬁc antigens with the
three methods mentioned above using the manufacturer’s recommended
procedure. Also 52 fecal specimens negative for Giardia by ova and parasite
examination were simultaneously tested.
Results: Sixty-one fecal specimens (29 from Greek people and 32 from
immigrants) of the 5800 examined were found positive for Giardia by
microscopic examination (1.05%). Giardia-speciﬁc antigen 65 (GSA 65)
was detected in all the 61 positive fecal specimens tested by Alexon ProSpecT
Giardia Microplate Assay (sensitivity 100%). Two fecal specimens of the 61
(with the lowest absorptions in the Alexon-Trend assay) were found negative
tested by the immunochromatographic assay (sensitivity 96.72%), and one of
them by the Cypress diagnostic kit as well (sensitivity 98.36%). The 52
negative samples were found negative in all diagnostic kits (speciﬁcity 100%).
Conclusions: (i) ProSpecT Giardia Microplate Assay, which is as sensitive and
speciﬁc as the microscopic detection of the parasite and secondly Giardiasis Ag
ELISA (Cypress Diagnostics) could offer alternative and complementary
methods to routine ova and parasite examination, especially in chronic
diarrhea or clinical suspicion of giardiasis, when the ﬁrst microscopic exam-
ination of the stool is negative. (ii) The ColorPAC Giardia/Cryptosporidium
Rapid Assay could be applied as a rapid screening test, though a negative result
does not ﬁrmly exclude the infection.
P1390 Utilization of ﬂow cytometry in diagnosis of
microﬁlaria infection
M. Martinez Padial, M. Subirats, S. Puente, M. Lago, S. Crespo,
G. Palacios, M. Baquero
Madrid, E
Introduction: Some authors have recently proposed automated light depo-
larization analysis of whole blood as a useful tool for diagnosing malaria
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infection. During our study we observed abnormal patterns in samples from
patients with other parasite infections.
Aim of study: We try to establish a relation between these patterns and
microﬁlaria infection during ordinary hematologic study of samples.
Material and methods: Tests were made on 401 peripheral blood samples
collected in tubes containing EDTA using the Cell-Dyn 4000 analyzer
(ABBOTT-diagnostics). The analytical principles are the same as those upon
which ﬂow citometry is based. The leukocyte differentiation is obtained by
measuring the amount of laser light dispersed by a cell at different angles.
Microﬁlaria infection was diagnosed by ‘Knott Concentration Method’
followed by parasite visualization under light microscope.
Results: A total of 22 samples were proved positive for infection by micro-
ﬁlaria. Nineteen out of them corresponded toM. perstans, two to Loa–loa and
one mixed infection. Observing the graphs from ﬂow citometry of these
samples, the main abnormal patterns were found when green-coded events
fell outside and parallel to the normal eosinophil ‘footprint’ (also green).
Other abnormal events were also present in the ‘size vs. granularity’ graph.
These abnormal populations could represent microﬁlaria fragments able to
disperse and depolarize laser light.
Conclusion: We suggest the utilization of ﬂow citometry as a useful com-
plementary tool in diagnosis of microﬁlaria infection, specially in those
nonendemic areas where there is little awareness of these infections and
could be misdiagnosed.
P1391 Examination of feces for the detection of
parasites: a comparison of two methods
N. Fallah, E. Nasiry Shahraky
Tehran, IR
Background:The diagnosis of intestinal parasitic infection is conﬁrmed by the
recovery of helminth larvae and eggs, protozoan Trophozoites and cysts.
Objective:A comparison was made between twomethods for the detection of
protozoa cysts in human fecal sediments of formalin–ether and formalin–
gasoline technique.
Material and methods: A total of 400 fecal samples were examined by two
methods, in order to compare the value of two techniques. 342 different
parasites were identiﬁed by both techniques. Forty-four parasites were found
only by formalin–ether technique and 15 parasites were found only by the
formalin–gasoline method.
Result: The sensitivity, false negative and negative predictive value of these
techniques were determined.
Conclusions: The results of this study show that formalin–gasoline method
can be as sensitive as formalin–ether technique. However, it can be, less
dangerous, and cost beneﬁt than formalin–ether technique.
P1392 Evaluation of new commercialized systems for
the concentration and staining of intestinal parasites in fecal
specimens under routine laboratory conditions
O. Vandenberg, S. Van den Wijngaert, A. Dediste, A. Peltier, Y. Van
Laethem, P. Retore, G. Zissis
Brussels, B
Objectives:Because, intestinal parasites are intermittent shaded and vegetative
stages of protozoa are fragile, the routine diagnosis of enteric parasites
infection is complex and confusing. The development of the new commer-
cialized systems for the concentration and staining of parasite could resolve
many problems met in the diagnosis of intestinal parasites. The purpose of this
study is to compare the recovery and identiﬁcation of intestinal parasites in
fecal specimens, using new commercialized systems for the concentration
(Parasep 145600 and SpinCon) and staining (EcoStain), vs. our routine
methods consisting in Triple-Feces test (TFT) recently developed in Holland.
Methods: Fecal specimen collected from 250 patients suspected to have
parasitologic diarrhea were examined according to our speciﬁc TFT protocol.
TFT consists in three samples collected on 3 consecutive days (two with SAF
preservative and one fresh specimen) which are examined with and without
concentration techniques and a permanent staining (Chlorazol Black).
Results obtained with the two commercialized concentration systems (Para-
sep 145600 and SpinCon) were compared with our conventional ether–
sedimentation procedure. Permanent stained smears systematically prepared
from the stool specimens were assessed for morphology, clarity of nuclear and
cytoplasmic detail.
Results: Over the 250 patients examined, 37% were found positive for
potentially pathogenic parasites after the examination of the complete
TFT test, whereas the technical performance using one of the 3 concentration
procedures were comparable (P> 0.05) and allow us to recover parasites in
only 11% of patients. Moreover, no signiﬁcant differences were found in the
numbers and morphology of organisms seen in the concentration sediment
regardless the technique used. Few clinical relevant differences was seen
between EcoStain and Chlorazol Black staining. The same organisms were
usually identiﬁed in both staining, with the exception of situations in which
organism numbers were characterized as rare.
Conclusion: The use of TFT protocol allowed us to increase the recovery of
intestinal parasite when we compared with the concentration method only.
Our study suggests that commercialized concentration (Parasep and SpinCon)
and permanent staining (EcoStain) systems are reliable and easy to use for
diagnosis of intestinal parasites in routine clinical practice.
P1393 A quality control survey on malaria microscopy in
State and private laboratories in Ardabil province: Iranian
border with Republic of Azerbaijan
S. H. Arshi, H. Sadeghi, M. Mohebali, G. H. Edrissian, V. Sepehram,
S. H. Sezavar
Ardabil, Tehran, IR
Background & objectives: Quality control of microscopic diagnosis has an
important role in evaluating the Malaria control programs. We studied the
quality of simple microscopic diagnosis of Malaria in Ardabil province north-
western Iran.
Methods:We re-examined 389 blood smears examined for malaria by clinical
laboratories of Ardabil province in 1999. All positive cases and a threefold
number of negative reported smears were randomly selected to be reexamined
by expert microscopists in parasitology laboratory of public health faculty,
Tehran University. The results were considered as standard test and sensitivity
and speciﬁcity of microscopic diagnosis in personal laboratories and special
malaria state laboratories of Ardabil province were calculated.
Results: From 389 blood smears reexamined during survey 119 found to be
positive and 270 negative for malaria. 20 (16.8%) out of 119 cases of malaria
were not diagnosed and were reported negative by local laboratories. sensi-
tivity and speciﬁcity was calculated to be 87.3 and 98.5, respectively, for local
diagnosis. Sensitivity of tests was 87.3 and 78.5% for personal and state
laboratories, respectively. Speciﬁcity was 97.9 and 100%, respectively, for
personal and state laboratories. We noticed that personal laboratories did not
examine thick blood ﬁlm and state laboratories did not examine thin blood
ﬁlm. We were obliged to reexamine the smears as was examined by source
laboratories. We followed up retrospectively the people who with positive
smear for malaria that local laboratories had not diagnosed their disease and
found that most of them had later been diagnosed for malaria during the next
coming year after the date of false negative report for smears. But some lived
without any later diagnosis of malaria.
Conclusion: Although the personnel in state laboratories had a long time
experience in malaria microscopy, Sensitivity of microscopic diagnosis of
malaria was very low and unacceptable. Considering the exclusive use of thin
blood ﬁlms in personal laboratories, the real sensitivity of microscopic
diagnosis of malaria is estimated to be much lower than the value calculated
for this sector, which could not be acceptable either.
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P1394 A 5-year retrospective study of yeast and fungi
isolated from PICU patients and the role of antifungal
prophylaxis
K. Harvey-Wood, A. McIntyre, C. L. Williams
Glasgow, UK
Objectives:Patients in pediatric intensive care units (PICU) are a known to be
at a high of acquiring Candida infection with antibiotic use, catheterization
and length of stay being recognized as risk factors. In order to reduce the
incidence of systemicCandida infection targeted prophylaxis with ﬂuconazole
was introduced at the end of 1999. This study was undertaken to examine the
effectiveness of targeted ﬂuconazole prophylaxis in PICU patients.
Methods: Patients who were prescribed more than two antibiotics, colonized
with Candida spp. at more than one site or who had been in PICU for more
than 2weeks and were thought to be at risk of developing a fungal infection,
were given a prophylactic dose of ﬂuconazole, 2–4mg/kg/day. Blood and
surveillance cultures were taken on clinical grounds and there was no change
in sampling regimens after the introduction of ﬂuconazole prophylaxis. Data
for the study was obtained retrospectively from the microbiology department
computer system.
Results: A total of 1230 isolates of Candida spp. and other fungi were isolated
from 335 PICU patients during the ﬁve year period 1997–2001. The most
common species isolated was C. albicans (n¼ 1014; 82%). Of the nonalbicans
Candida species isolated the next most common were C. parapsilosis (n¼ 97;
8%) andC. glabrata (n¼ 47; 4%). The remaining 6% of non – albicansCandida
species weremade up ofC. lusitaniae,C. krusei, C. topicalis, unidentiﬁed yeasts
and ﬁlamentous fungi. In 1997–1999, 20, 5 and 13%, respectively, of all blood
culture isolates were due to Candida spp. or other fungi. In 2000 and 2001
there were no Candida spp. or other fungi isolated in blood cultures on the
PICU.
Conclusions: Our results, however, have shown that the use of ﬂuconazole
prophylaxis signiﬁcantly reduces the risk of bloodstream infection with
Candida spp. In addition, there has not been a signiﬁcant increase in non
albicans Candida infection or colonization.
P1395 Sepsis in the neonatal surgery unit
C. Lucas, L. Coombs, D. Khrishna, Cl Williams, R. Carachi
Glasgow, UK
Objectives: Bacterial infection in neonatal surgical units remains a major
problem. Neonatal sepsis can arise from a variety of causes, one of which may
be bacterial translocation, that is the passage of bacteria from the gastro-
intestinal tract to extra-intestinal sites, typically across the lamina propria to
the mesenteric lymph nodes and hence to the blood. It is possible, in the
neonatal setting, that overgrowth of bacteria in the proximal gut is associated
with increased bacterial translocation and hence sepsis. We aimed to deter-
mine ﬁrstly which organisms are the major causes of sepsis in a neonatal
surgical unit and secondly whether there was an association between bacterial
colonization of the proximal bowel and the subsequent development of sepsis.
Methods: A retrospective analysis of blood cultures and gastric aspirates was
undertaken for all cultures received from the neonatal surgical unit between
1999 and 2002. The time of gastric aspirate sampling in relation to a positive
blood culture and the bacteria found in the gastric aspirates were recorded.
Standard methods for culture and identiﬁcation of bacteria were used.
Results: Overall, 1258 blood cultures were collected from 291 patients and
1464 gastric aspirates from 264 patients. The commonest organisms isolated
from blood culture were coagulase negative staphylococci (41%) and various
aerobic gram negative rods (53%). 68% of patients with positive blood culture
had a positive gastric aspirate, compared with 48% of those with negative
blood cultures. Of those patients with a positive blood culture 17% had the
same organism in both gastric aspirate and blood culture.
Conclusion: In certain patients, positive gastric aspirate culture predicts
subsequent bacteremia. In addition, certain organisms are more frequently
found synchronously in gastric aspirates and blood cultures. Further, work is
needed to relate bacteriological ﬁndings with clinical conditions to increase
the predictive power of surveillance cultures.
P1396 Nosocomial bloodstream infections in a national
pediatric burn center in Hungary
K. Havasi
Budapest, HUN
Objectives: The purpose of this study was to determine the microbial
pathogens causing nosocomial bloodstream infections in pediatric burn
patients.
Methods:A retrospective survey of medical records was performed. Children
treated and consecutively hospitalized in the burn center between 1 Novem-
ber 2001 and 30November 2002 who had nosocomial bloodstream infections
were identiﬁed. A review of causative microbial agents, age, gender and
percentage of total body surface area burned was done.
Results: Over a 13-month period from a total of 59 burn patients seven
(11.8%) had one or more episodes of nosocomial bloodstream infections. All
seven children (ﬁve males, two females), ages 9–103months, had experienced
thermal injury covering at least 32% of their body surface (range¼ 32–75%,
mean¼ 52.7%). Themost usual bacterial pathogenwas Pseudomonas aeruginosa
followed by Staphylococcus aureus, coagulase-negative Staphylococcus and
Klebsiella pneumoniae. Two persons had fungal infections. Two of the 59
patients died, both of Pseudomonas aeruginosa sepsis.
Conclusions: Pseudomonas aeruginosa was the leading cause of nosocomial
bloodstream infections and the only cause of mortality in pediatric burn
patients in one center over a 13-month period.
P1397 Early- and late-onset sepsis at neonates. Clinical
and microbiological characteristics
E. Kenesei, G. Dunai, M. Szabo´, T. Machay
Budapest, HUN
Objective of the study:To determine the rate of early and late-onset sepsis of
newborns treated in the NICU of Department of Paediatrics, Semmelweis
University, Budapest, Hungary.
Patients and methods: 1008 newborns were transmitted to our unit in a tree
years long period of time (2000–2002). 719 of their required long-term
respiratory therapy. The number of newborns with very low birth weight
(<1500 g) was 220. All newborns had a sepsis screen immediately or later if
the clinical signs indicated it.
Results: 108 newborns had such a sepsis which was evidenced by positive
blood culture, 44 of 220 newborns with very low birth weight (Group I.) and
64 of 788 other prematures and term babies (Group II.). The incidence of
early onst sepsis in the Group I. was 3/44 (7%), and this was in the Group II.
24/64 (38%). The distribution of the pathogens at early onset sepsis was the
following: Gram-positive organisms 87.5%, Gram-negative organisms 12.5%.
This at late-onset sepsis: Gram-positive organisms 63%, Gram-negative
organisms 44% and fungi 8.6%. Mortality: 1/27 at newborns with early
onset sepsis and 10/81 (12%) at newborns with late-onset sepsis.
Conclusions:
1. The rate of early onset sepsis at newborns with very low birth weight is rare.
2. The most frequent pathogens at early onset sepsis are Gram-positive
organisms.
3. Prematures with very low birth weight has a high risk for late-onset sepsis.
4. The incidence of Gram-negative organisms at late-onset sepsis is high.
5. The late-onset sepsis is connected with higher mortality rate as the early
onset one.
P1398 Evolution of group B streptococcal early neonatal
sepsis rates during 6 years in a university hospital (Madrid,
Spain)
M. A. Blanco Gala´n, C. Pazos Pacheco, I. Sa´nchez Romero
Madrid, E
Objective: The aim of this study was to know the rates of group B
streptococcal early neonatal sepsis (SGBENS) in our hospital from 1995 to
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2000, and to evaluate the impact of the implementation of the CDC’s
guidelines (1995–1997) and after Society of ClinicalMicrobiology ofMadrid’s
(SMMC) guidelines.
Methods:We study all the neonates in our hospital between 1995 and 2000:
1995, 2439; 1996, 2283; 1997, 2236; 1998, 2228; 1999, 2819; and 2000,
3039. During 1995–1996, the universal prenatal screening for detection
vaginal and rectal group B Streptococcus (GBS) colonization in our area
(area 2), between 24 and 28weeks’ gestation, began. Ampicillin was used
when the intrapartun antibiotic prophylaxis was necessary (2 g at least 4 h
before the labor, and 1 g/4 h). In 1998, we started to attend the labors of area
1, where there was no universal prenatal screening for GBS. In 1999, they
began the universal prenatal screening for GBS (SMMC’s guidelines: swab-
bing both the lower vagina and rectum were inoculated on a selective agar
plate and also were immersed in Todd-Hewitt. Early neonatal sepsis was
considered when the neonate had GBS bacteriemia and signs and or
symptoms of infection.
Results: The GBS colonization rates were: 1996, 15%; 1997, 20.8%; 1998,
19.6%; 1999, 18.8%; and 2000, 20%. The number of culture that were
positive for GBS is: 1995, 6%; 1996, 2%; 1997, 1%; 1998, 7%; 1999, 5%;
and 2000, 4% live births. The evolution of early neonatal sepsis rates were:
1995, 2.4%; 1996, 0.8%; 1997, 0.4%; 1998, 3.14%; 1999, 1.7% and 2000,
0.9% live births.
Conclusions:
1. The interanual rate of GBSENS in our hospital is 1.66% live births.
2. In 1995 coinciding with the beginning in our area (area 2) of the
implementation of the CDC’s guidelines, the incidence of early onset
disease declined: (2.4 in 1995 to 0.4% live births in 1997).
3. The start in our hospital of the labors from area 1 (without universal
screening for GBS) was associated with an increase of the GBSENS rates
(from 0.4 to 3.14% live births).
4. Coinciding with active prevention efforts in 1999–2000 in both areas (area
1 and 2), the incidence of early onset disease declined to 0.9% live births in
our hospital.
P1399 Coagulase negative Staphylococci with reduced
susceptibility to teicoplanin in bloodstream infections of
neonates in a neonatal intensive care unit
P. Kotopouli, E. Papanagiotou, I. Marinou, A. Bourtsi, A. Voyiatzi
Athens, GR
Objectives: The purpose of this study was to characterize the species
distribution of nosocomial CNS isolates, recovered from blood cultures in
the NICU and to determine their susceptibility to antimicrobial agents for the
emergence of reduced susceptibility to glycopeptides.
Material:Methods: A total of 6.238 blood cultures were screened for aerobic,
anaerobic microorganism and fungi for a 2 years period (2000–2002). Species
identiﬁcation was performedwith an automated system (PASCO-DIFCO) and
conﬁrmed by the Api Staph. System (Bio-Merieux, France). Susceptibility to
antibiotics was detected by the diffusion method according to the NCCLS
guidelines. Minimal inhibitory concentrations (MICs) were determined by
broth microdilution technique (PASCO-DIFCO) and E-test method. (AB
BIODISK, Solna Sweden). E-test was used as the method of choice for
detection of CNS strains with reduced susceptibility to glycopeptides.
Results: Bacteremia was diagnosed in 411 cases (6.7%) of the hospitalized
neonates. of the 248 isolated Gram positive cocci, 214 (86.2%) proved to be
CNS. The species distribution was as follows: S. epidermidis 92.5%, S. warneri
3.7%, S. simulans 2.3%, S. haemolyticus 1% and one isolate (0.46%) for the
species S. hominis S. xylosus and S. saprophyticus. All CNS isolates were
susceptible to vancomycin. Most of the S. epidermidis isolates were resistant
to oxacillin (76.1%), macrolides (50.5%), clindamycin (18%), gentamicin
(52%), ﬂuoroquinolones (7%) and teicoplanin (2% – MICs> 32–128mg/
mL). Two S. epidermidis strains resistant to oxacillin (MICs> 128–256mg/mL)
and teicoplanin (MICs 32–64mg/mL) showed a borderline susceptibility to
vancomycin (MIC 6mg/mL). Finally an intermediate resistance to teicoplanin
(MICs 16–24mg/mL) was detected in 12 CNS C. methicillin resistant strains.
1. S. epidermidis strains (92.5%) are the predominant Gram positive causative
agents of NICU acquired infections.
2. The emergence of CNS isolates with reduced susceptibility to teicoplanin
emphasize the need for glycopeptide resistance surveillance especially in
hospitals with high rates of oxacillin resistant staphylococci.
P1400 Stenotrophomonas maltophilia in a neonatal
intensive care unit
K. Kristof, D. Szabo, A´. Harmath, F. Rozgonyi
Budapest, HUN
Objectives: To determine the prevalence, the susceptibility to antimicrobials
and genotypic relationship of clinical isolates of Stenotrophomonas maltophilia in
a neonatal intensive care unit.
Methods: S. maltophilia strains were isolated from different samples (blood
culture, respiratory tract and urine) of neonates treated in the neonatal
intensive care unit between January 2001 and December 2002. The strains
were identiﬁed using the ATB and Vitek systems (bioMe´rieux) and geno-
typed with AP-PCR (ERIC-2). Susceptibility to antibiotics were evaluated
by disk diffusion method and by E-test strip.
Results:A total of 45 S. maltophiliawere isolated from colonized or infected 31
neonates, which represented 8% of the total of Gram-negatives recovered over
the study period and 30% of the total of nonfermenters. There was no
considerable difference in clinical severity between patients infected or
colonized with S. maltophilia and those of noninfected ones. The risk factors
for bloodstream-, and respiratory tract infection or colonization were the low
maturity (delivery at an average of 28.8 gestation weeks), the low birth weight
(average: 1281.4 g), the prolonged hospital stay, the mechanical ventilation
(100%), the different indwelling catheters (100%) and previous broad spec-
trum antibiotic prophylaxis (carbapenems). The incidence of resistance to
aminoglycosides, ceftazidime, ciproﬂoxacin and moxiﬂoxacin was 100, 34, 76
and 0%. No resistance strain to cotrimoxasole was found. Based on the results
of AP-PCR the strains could be divided 10 different clones.
Conclusion: S. maltophilia strains seems to be the leading causes of nosocomial
infections nowadays, especially in intensive care units. Management of
S. maltophilia infections may be difﬁcult due to the inherent multidrug
resistance of starins. The newer ﬂuoroquinolones could be considered as
good option for the treatment of such infections. AP-PCR is a useful tool
for evaluating nosocomial infections caused by S. maltophilia. The high
genetic diversity among the isolates probably means, that the multiple
independent environmental sources are more relevant than the cross-trans-
mission in nosocomial infections, therefore the independent infection are
more probable.
P1401 Prognostic factors in neonatal infections:
experience from 246 neonates at a single neonatal
referral center
J. Koprnova, I. Svetlansky, J. Korcova, M. Mrazova, E. Grey,
R. Babela, V. Krcmery
Bratislava, SK
Objectives: To assess prognostic and risk factors of neonatal infections in
neonates.
Methods: We investigated prognostic factors for inferior outcome in 246
neonates from a National Referral Clinic of Neonatology, hospitalized in
years (1999–2000) in Slovakia (5.5 million inhabitants). We detected risk
factors, mother’s risk factors, and types of isolates, etiology, diagnostic
indicators, localization of infection site, therapy and prognosis.
Results: Of 246 patients, 16 had inferior prognosis, which was deﬁned as:
death of infections, death of underlying diseases with infections, intraven-
tricular hemorrhage, and periventricular leukomalacia. Risk factors for
inferior outcome were: very low body weight (<1000 g) (43.75% vs.
0.43%, P< 0.0001), <28weeks gestation (37.5% vs. 0.87%, P< 0.0001),
respiratory distress syndrome (25% vs. 3.04%, P< 0.003), total parenteral
nutrition (31.25% vs. 10.87%, P< 0.03), cerclage in mothers (imminent
premature delivery or mother with history of abortion) (25% vs. 5.22%,
P< 0.01). Bacteremia (positive blood culture) was predictor for inferior
outcome (31.25% vs. 8.7%, P< 0.014) as well as meningitis (12.5% vs.
0.43%, P< 0.011). High procalcitonin levels (31.25% vs. 5.22%,
P< 0.002) were signiﬁcant predictors of inferior outcome as well as septic
score> 2 points (25% vs. 6.52%, P< 0.025).
Conclusion: Bad prognostic factors in neonates associated to risk neonate’s
factors and several neonatal infections, what showed high procalcitonin level
and septic score as diagnostic indicators.
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P1402 Infections of neonatal age in very low birth
weight neonates are not associated with higher attributable
mortality
M. Mrazova, M. Kacmarikova, J. Koprnova, J. Korcova, V. Krcmery
Bratislava, SK
Methods: We analyzed risk factors and outcome of infections, appearing in
very low birth weight (VLBW) neonates to other neonates, within all
infectious episodes, appearing in 2 years in tertiary referral neonatal center:
246 cases within 01/01/1999 to 01/01/2001were analyzed. We used a
univariate analysis, to assess risk factors for neonatal infections according
to the birth weight.
Results: Among 246 cases, 36 patients had very low birth weight <1500 g
(VLBW) and 210 patients had birthweight>1500g (non-VLBW).Risk factors,
which included: ventilatory support (P< 0.01), total parenteral nutrition
(P< 0.0001), central vascular catheter (P< 0.01), percutaneous arterial catheter
(P< 0.0017) and respiratory distress syndrome (P< 0.012), were signiﬁcantly
more frequently observed in VLBW newborns in comparison to non-VLBW
infants. In a univariate analysis of risk factors related tomother, previous cerclage
was more frequently observed (P< 0.0005) in VLBW newborns. Positive blood
cultures and/or catheter tips showed, that the rate of bacteremia/sepsis in
<1500g birth weight newborn infants (41.67% vs. 7.62%, P< 0.0001) was
higher than in those with >1500g birth weight. From etiology, Klebsiella/
Enterobacter was more frequently in VLBW newborns (69.44% vs. 40.95,
P< 0.0027). Concerning diagnosis of infection, positive procalcitonin (PCT)
test (22.22%, P< 0.0009), leukocyte count >30000 (P< 0.028), and septic
score >2 points (P< 0.00037) were more signiﬁcantly related to VLBW
neonates. Mortality on underlying disease was higher in VLBW neonates than
non-VLBW (8.33% vs. 0.00%, P< 0.0029). Also periventricular leukomalacia
(PVL) (P< 0.02), and intraventricular hemorrhage (IVH III./IV.) (P< 0.0099)
were signiﬁcantly more frequently observed in VLBW neonates.
Conclusion: Attributable (infection related) mortality was similar in both
groups. The most important factor, why infection has not contributing to
death is strict infection control strategies at the Neonatal intensive care clinic
implanted after 1996.
P1403 Hemolytic activity of Staphylococcus cohnii
M. Ro´zalska, E. Waldon, T. Nowak, E. M. Szewczyk
Lodz, PL
Objectives:To study hemolytic activity of 297 strains of S. cohnii isolated from
the environment and skin swabs from personnel and patients – premature
infants in the intensive care unit of a pediatric hospital. Staphylococcal
hemolysins are important virulence factors of these bacteria. S. aureus pro-
duces alpha, beta, gamma and delta hemolysin. Coagulase-negative staphy-
lococci synthesise alpha and beta toxins rarely, however, delta-hemolysin in
these bacteria was found very often. S. cohnii show hemolytic activity.
Methods:Hemolytic activity was checked on TSA plate with sheep, rabbit or
human erythrocytes. CAMP test was used to detect delta-hemolysin.
CAMP test with Streptococcus agalactiae was used to study the production of
beta-hemolysin. Alpha-hemolysin production was checked with the use
of the antiserum. Hemolytic activity was quantiﬁed at 541 nm. Proteins from
the culture supernatants of the two strongly hemolytic strains were fractio-
nated by precipitation with ammonium sulfate and separated in native-PAGE.
Alpha-hemolysin was identiﬁed on nitrocellulose with speciﬁc antiserum.
Molecular weight of hemolysins was estimated by SDS PAGE and native
PAGE.
Results: S. cohnii strains used in this study hemolyzed all types of red cells.
CAMP test was positive for 92% strains of S. cohnii ssp. cohnii and 75% of S.
cohnii ssp. urealyticus. The activity of beta-hemolysin was not found. Inhibi-
tion test of hemolysis with rabbit antiserum against alpha-hemolysin and
native-PAGE/Western blot proved alpha-hemolysin absence. Hemolytic
activity was associated with proteins precipitating between 30 and 60%
saturation of ammonium sulphate. These proteins were positive in CAMP
test, which suggested the presence of delta-hemolysin. Native-PAGE showed
high heterogeneity of hemolysins of both subspecies of S. cohnii studied. These
hemolysins maintained biological activity after SDS PAGE separation and had
low molecular weight. S. cohnii hemolysins were found to be stable in high
temperatures and could be lyophilized without loss of activity and stored in
PBS solution at room temperature for several days.
Conclusion: The results of our preliminary study can be summarized as
follows: hemolytic activity of S. cohnii ssp. cohnii and S. cohnii ssp. urealyticus
strains is connected with the production of proteins similar to delta-like
hemolysin found in other coagulase-negative staphylococci. The study of
hemolytic activity of S. cohnii will be continued.
P1404 Cell surface characteristics of Staphylococcus
cohnii
E. Waldon, E. M. Szewczyk
Lodz, PL
Objectives: Adhesion is one of the most important stages in the pathogenesis
of microbial infection. Numerous multiresistant Staphylococcus cohnii isolates
were found in the ICU of a pediatric hospital. The strains of this species are
characterized by strong hydrophobicity and also the ability to form slime.
Methods:The research has been performed on three strains of S. cohniiwhich
showed various ability of slime production, hydrophobicity in SAT and
MATH test, and also rough type of growth. The bacterial cells were
fractionated to obtain cell surface glycoproteins. The slime of S. cohnii was
isolated after inoculating a staphylococci over a dialysis membrane of CRA
plates. Bacterial cells were treated by a gentle sonication as long as the cluster
cells were disengaged and then lioﬁlizate was analyzed. Cell surface proteins
were isolated using disintegrator and lysostaphin. The glycoproteins were
analyzed by SDS-PAGE.
Results: Two of the investigated isolates originated from the ICU environ-
ment (ZMF264 and ZMF325) and one from the skin swab of a hospitalized
infant (ZMF138). The two last ones produced slime. Isolates ZMF264 and
ZMF138, but not ZMF325, formed conglomerates when cultured in TSB
medium and were hydrophobic in the SAT test. However, MATH test for
hydrophobicity estimation showed that all strains were hydrophobic. The
lowest afﬁnity to hexadecan was presented by ZMF138. All strains showed the
ability to be transferred to organic phase in acidic pH. All strains, indepen-
dently of the origin, slime, and cell surface hydrophobicity, ﬁrmly adhered to
PCV. SDS-PAGE analysis of extracellular proteins separated on dialysis
membrane revealed that strains able to produce slime showed additional thick
bands close in weight, but not identical (about 100 kDa) for both producers of
slime. The substance responsible for conglomerate forming (SRCF) released
from rough strains, separated in SDS-PAGE, formed several bands 14–94 kDa
in size. The presence of polysaccharides components in the investigated
glycoproteins was conﬁrmed. Small differences in cell wall proteins composi-
tion were also observed.
Conclusions: The cell surface of S. cohnii is a complex structure, which
consists of many glycoproteins. These substances had been implied in the
initial adhesion stage. This concerns also, although to a different degree,
adherence to surface and clusters formation, which may be stimulated by
increase ionic strength of the environment.
P1405 Screening of environmental microorganisms in
the premature newborn hospitalization unit and in surgical
rooms
A. Spiliopoulou, D. Garantziotou, I. Konstantinopoulou, G. Karioris,
G. Krokidas
Patras, GR
Purpose: The screening and study of the environmental microorganisms in a
unit for the hospitalization of premature newborns and in the surgical rooms
of a pediatric hospital.
Material andmethods:The study was carried out in two time periods, with a
gap of two months and concerned: (i) premature unit: samples for cultures
were taken at the same time from the interior of incubators, the baby weighing
machine, the changing bench and the air conditioners. (ii) Operating room:
surgical table, tool table, anesthesiology machine, sterilization bench, chan-
ging table, sink, sterilization paddle-steamer. Sampling was carried out with
the special nutritional count-tact plates (tryptone-soya agar), the incubation of
the plates was done in CO2 and air, respectively, for 24–48 h and the
identiﬁcation of isolates (biochemical and phenotypic) to species level, with
the conventional techniques. It was evaluated the isolation of over 24 colonies
of the same microorganism per plate.
Results: (i) Premature unit: From the total number of 18 samples, 15 produced
no growth (negative cultures). At the sample taken from the baby weighing
machine they were isolated coagulase-negative staphylococci and Gram-
negative, oxidase positive bacilli (Pseudomonas). From the layer of the
incubator they were isolated fungi and from the changing layer of the
newborns they were isolated co (–) staph. and Gram (–) bacteria. (ii) Surgery
room: from the total number of 20 samples (at the ﬁrst screening), 12 of the
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samples were negative. Eight of the samples regarded the one surgical table,
the anesthesiology machine, the tool table and the sink were positive [they
were isolated: co (–) staph, fungi, pseudomonas and pasteurella]. During the
second sampling and following the intensiﬁcation of the cleaning methods of
the surgery room, including the changing of the used antiseptics, we had all 20
relevant samplings negative.
Conclusions:There were minimal differences between the amount of growth
and the identiﬁcation of organisms in the premature unit and the surgical
room. No correlation was observed between the above-mentioned envir-
onmental strains and the potential isolated organisms from cultures (blood or
swabs) taken from operated children or premature newborns hospitalized in
the unit. We note the beneﬁcial results of the careful cleansing policies and
the choice of the appropriate special antiseptics in the area of the surgery
room.
P1406 Device-associated infection rate in the neonatal
care unit
E. Hajdu´, K. Ma´der, M. Katona, K. Nagy, S. Tu´ri, E. Nagy
Szeged, HUN
Objectives: To investigate the frequency and outcome of new-borned babies
with devices related hospital acquired infections in a tertiary neonatal
intensive care unit in South of Hungary.
Methods:The number of central line-days, umbilical line and ventilator days
were collected prospectively in the Neonatal Intensive Care Unit of Pediatric
Department from University of Szeged between 01 February 2000 and 30
June 2000. Relevant microbiological sampling were used to determine the
infecting agents. CDC criteria were applied to deﬁne infections. Survival rate,
blood stream infections (BSI) and ventilator associated pneumonia (VAP)
were analyzed. Device-associated infection rate: number of the device
associated infection 1000/number of device used days.
Results: During the investigated period 95 newborn babies were treated.
Results are presented in the following table:
Conclusion: Survival in the very low birth weight categories (<1500 g) was
73.8% and the device-associated infection rate was high. In the higher birth
weight categories the survival was 90,5% and no device-associated infections
were detected.
P1407 A multiple-resistant and rare cause of neonatal
pneumonia due to Aerococcus viridans
N. Yu¨cel, B. Ilikkan, B. Kocazeybek, M. Vural, Y. Perk, M. Samasti
Istanbul, TR
Aerococcus viridans is an aerobic, alpha-hemolytic, Gram-positive cocci with a
strong tendency to form tetrads. This organism was frequently found on
objects in the delivery room, recovery room, nursery, intensive care unit,
patients wards, and delivery suite. It has been isolated from patients with
urinary tract infections, endocarditis, bacteremia, and pneumonia. We report
a case of Aerococcus viridans pneumonia in a newborn who was receiving
prophylactic ampicillin and netilmicin treatment for minimally respiratuar
distress syndrome. Since respiratory functions were also aggraveted, the
quantitative culture of endotracheal aspirate ﬂuid revealed 105 cfu/mL alpha
hemolytic streptococcus. This microorganism was resistant to all penicillin
MIC values and highly resistant to clarithromycin (MIC values 2mg/mL)
and cefotaxime (MIC values 32mg/mL) and intermediate resistant to
meropenem (MIC values 2mg/mL). It was suspectible to clindamycin
(MIC values 0,16mg/mL) and vancomycin (MIC values 1mg/mL). To
our knowledge, this is the third reported case of infection due to a penicillin
resistant strain, and the reported case of infection due to a ﬁrst multiresistant
strain. This case was treated with teicoplanin successfully.
P1408 Plasmids proﬁles and high-level resistance to
mupirocin in Staphylococcus cohnii ssp. cohnii isolated in
the ICU of a pediatric hospital
T. Nowak, M. Ro´zalska, E. Waldon, E. M. Szewczyk
Lodz, PL
Objectives: S. cohnii ssp. cohnii is known as forming small and transient
populations on human skin. However, this species has also been isolated
from different kinds of opportunistic infections. Numerous multiresistant
isolates were found in the ICU of a pediatric hospital. Among 235 investigated
strains 46% presented high level of resistance to mupirocin when tested by the
Mup200 discs method. The objective to this study was to characterise
plasmids proﬁles of mupirocin resistant isolates of S. cohnii ssp. cohnii.
Materials and methods: Isolation of plasmids was performed according to
the modiﬁed method of Parisi and Hecht. The number and size of
plasmids were established by gel agarose analysis of extrachromosomal
DNA. The broth dilution method was used to determine MICs, as recom-
mended by the National Committee for Clinical Laboratory Standards
(NCCLS).
Results: MIC values for mupirocin were established for 33 isolates from
our collection. Sixteen of the isolates were susceptible (MIC< 4mg/mL), 15
possessed high level mupirocin resistance (MIC> 1024mg/mL) and
two showed low level of resistance (MIC¼ 8mg/mL and MIC¼ 128 mg/
mL). Plasmid proﬁles for these isolates were determined. All of the inves-
tigated strains carried plasmids. An average number of plasmids was ﬁve, but
no less than two plasmids were found. In the high level resistant group
there were four isolates carrying small and medium plasmids of size
less than 20 kb. Each of the other investigated isolates carried at least one
plasmid bigger than 20 kb. The investigated isolates of S. cohnii had plasmids
varying in size – from 1 to 50 kb. Most of them possessed plasmids of about 7
and/or 4.5 kb but this character did not correlate with the resistance to
mupirocin.
Conclusion:Our results show diversity of plasmid proﬁles of the investigated
isolates of S. cohnii resistant to mupirocin. In their cells big plasmids about
40 kb can often be found. In S. aureus, high resistance to mupirocin genes are
located in plasmids of this size. In S. cohnii such big plasmids are present in both
resistant and susceptible to mupirocin strains.
Nosocomial, abdominal, and gastro-intestinal infections
P1409 More clinical failure and costs due to
inappropriate empiric treatment of secondary
intra-abdominal infections
M. C. J. M. Sturkenboom, W. Goettsch, G. Picelli, B. in’t Veld, D. Yin,
P. Mnyh Go, R. Herings
Rotterdam, Utrecht, NL; Desio, I; Leiden, NL; Whitehouse Station, USA;
Nieuwegein, NL
Objective: To better understand the incidence and empiric antibiotic treat-
ment of secondary intra-abdominal infections (IAI) and to assess whether
initial empirical antibiotic therapy affects patient outcomes we conducted a
population-based retrospective cohort study in the Netherlands.
Methods: Within the PHARMO record-linkage database, we identiﬁed all
patients hospitalized for secondary IAI between 1995 and 1998. In-hospital
antibiotic drug use was obtained from the computerized inpatient pharmacy
ﬁles. Inspected outcomes were appropriateness of initial empirical antibiotic
therapy, clinical failure (second line treatment, re-operation, death), length of
stay and costs of hospitalization. Associations between outcomes and treat-
ment were estimated using multivariate logistic and linear regression models.
Results: In the source population of 228 000 persons, 175 cases were classiﬁed
as secondary IAI (mean age 49.3 24.5, 50.9%male) resulting in an incidence
Birth weight
category
Number
of case
Survival
(%) Daycares
BSI
rate
VAP
rate
<1000 g 17 8/17 (47.0) 493 22.2 9.7
1001–1500 g 25 23/25 (92.0) 525 8.3 7.7
1501–2500 g 22 21/22 (95.4) 384 0 0
>2500 g 31 27/31 (87.0) 327 0 0
All 95 79/95 (83.1) 1729 13.1 7.7
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of 2.3/10 000 person-years (95% CI: 2.0–2.7). Initial antibiotic treatment was
appropriate for 84% of the cases. The risk of clinical failure was 17.1%.
Inappropriate initial antibiotic treatment increased the risk of clinical failure
3.4-fold (95% CI: 1.3–9.1). The median length of stay was 10 days (IQR: 1–
19) and the median cost of hospitalization was s 4131. The length of stay and
cost were signiﬁcantly greater for persons with clinical failure.
Conclusion:This study demonstrates that clinical failure of initial inappropri-
ate antibiotic therapy in secondary IAI patients is substantial and leads to
increased length of stay and costs of hospitalization. Inappropriate initial
antibiotic therapy is an important independent determinant of clinical failure
and should be avoided. Adequate antibiotic treatment should be directed
against the polymicrobial nature of secondary IAI.
Acknowledgement: This study was supported by an unconditional grant
from Merck & Co, NJ, USA.
P1410 Association between inappropriate initial empiric
antibiotic therapy and clinical outcome among patients
undergoing surgery for community-acquired
intra-abdominal infections in Spain
S. Sen, O. Geling, T. Caloto Gonzalez, G. Nocea for the Ciais study
group
Objective: To assess the association between inappropriate initial empiric
antibiotic therapy and the clinical outcomes among patients undergoing
surgery for community-acquired intra-abdominal infections (IAI) in Spain.
Methods: Records of patients who underwent surgery for community-
acquired IAI between the period of 10/1998 and 08/2002 in hospitals in
Spain, were reviewed. Initial empiric antibiotic therapy was classiﬁed as
inappropriate if at least one pathogen was resistant to all antibiotics in initial
regimen in case of positive culture, while in case of negative/missing culture, a
guideline by Bohnen (1992) was used for classifying appropriateness of initial
empiric therapy. Therapy was classiﬁed as successful if IAI was resolved with
initial therapy or with decrease from initial therapy; as unsuccessful otherwise.
Logistic regression analyses were performed to assess associations between
appropriateness of therapy and clinical outcomes, after adjusting for patients’
characteristics and site/type of infection.
Results: A total of 425 patients were included. Of these patients, 387 (91%)
received appropriate initial empiric therapy while rest was on inappropriate
therapy. Compared with patients on appropriate therapy, patients on inap-
propriate therapy were less likely to have success with their initial empiric
therapy (79% vs. 26%, P< 0.01) and more likely to require additional
antibiotic therapy (40% vs. 7%; P< 0.01) or being re-hospitalized within
30 days of discharge (18% vs. 3%, P< 0.01). Multiple logistic regression after
controlling for other factors showed that patients on inappropriate therapy
were 10 times less likely to have success in their therapy (OR¼ 0.096, 95%
CI: 0.045–0.206). Also patients on inappropriate initial empiric therapy, were
more likely to experience death (OR¼ 1.2, 95% CI: 0.2–6.0), re-operation
(OR¼ 3.0, 95% CI: 1.3–7.1), or re-hospitalization within 30 days of dis-
charge (OR¼ 7.1, 95% CI: 2.6–19.2). Conﬁning the analysis only to patients
with positive culture (n¼ 199) showed similar results, patients on inappropri-
ate initial empiric therapy were less likely to have success in their therapy
(OR¼ 0.15, 95% CI: 0.06–0.37).
Conclusion: Among patients undergoing surgery for community-acquired
IAI, inappropriate initial antibiotic therapy was associated with signiﬁcantly
higher risk of unsuccessful clinical outcomes including death, re-operation,
re-hospitalization or requirement for additional parental antibiotic.
P1411 Microbiologic features of nonpostoperative
nosocomial intra-abdominal infections
P. Montravers, R. Gauzit, A. Lepape, C. Martin, A. Chalﬁne
Bondy, Pierre Benite, Marseille, Paris, F
Objectives: Microbiologic characteristics of nosocomial nonpostoperative
intra-abdominal infections (NIA) have never been clearly assessed. In clinical
trials, this group of patients is often assimilated to postoperative infections.
The aim of this study was to clarify this issue in a representative cohort.
Methods:A multicenter prospective evaluation was performed over a period
of 6months (06/2000–01/2001). All pts who underwent surgery for NIA
were included. Clinical and microbiological characteristics were recorded.
Results:Among the 247 included pts (complicated appendicitis (6%) or biliary
tract infection (28%) or peritonitis (64%)), samples were taken in 203 pts
(82%). At least one organism was cultured in 193 pts. A total of 262 organisms
were isolated including 146 (56%) Gram-negative bacilli (GNB), 70 (27%)
Gram-positive cocci (GPC), 27 (10%) anaerobes and 16 yeasts (6%). GNB
were mostly Enterobacterieaceae (E. coli (n¼ 86, 42%)) and the group
Klebsiella spp., Enterobacter spp., Serratia spp. (n¼ 29, 14%)) and non ferment-
ing GNB (P. aeruginosa, n¼ 11, 5%). GPC were mostly staphylococci (n¼ 10,
5%), streptococci (n¼ 25, 12%) enterococci (n¼ 31, 15%). Polymicrobial
infections (70% of the cases) were mostly due to combinations of GNB and
GPC (n¼ 135), or GNB and anaerobes (n¼ 15). Bacteremia was reported in
30 pts (12%) recovering 34 organisms (includingE. coli (n¼ 13), staphylococci
(n¼ 6) and bacteroides (n¼ 6)). In 40 pts (20%), at least one organism was
resistant to the administered regimen (>2 bacteria in 3 pts), including E. coli
(n¼ 13), Enterobacter spp. (n¼ 4), Pseudomonas spp. (n¼ 3), enterococci (ﬁve
Enterococcus faecium) and yeasts (n¼ 3).
Conclusion: Our results give a probably good reﬂect of microbiological
features of NIA. Their assimilation in bacteriological terms to postoperative
infections is probably inadequate. Interestingly, proportion of resistant strains
toward the administered treatments seems to be low when compared with
published reports. In view of our results, antibiotic recommendations elu-
cidated for community-acquired infections could probably be applied to
patients with NIA infections.
P1412 Antibiotic therapy in severe acute pancreatitis
R. Vatseba, S. Chooklin, A. Perejaslov
Lviv, UKR
Objectives: Contamination of necrotic foci and peripancreatic ﬂuid collec-
tions obvious deteriorate the clinical course of necrotizing pancreatitis and in
most patients determine the insufﬁcient outcome of acute pancreatitis. The
purulent-septic complications are the main cause of the lethal outcome of the
late phase of acute pancreatitis. The rationale antibiotic therapy is the necessity
part of the complex management in patients with severe pancreatitis.
Methods and results: Purulent-septic complications were noted in 61
(32.4%) and were the cause of death in 27 (14.4%) patients with necrotizing
pancreatitis (188 patients). The following germs determined the puriﬁcation:
Escherichia coli, Proteus vulgaris, Enterobacter spp., Pseudomonas aerogenosa, Sta-
phylococcus spp., Streptobacillus moniliformis, Moraxella lacunata, Pneumococcus,
Candida, and Bacteroides fragilis. The monoculture was noted in 49 patients,
in 12 – the association of microorganisms. Development of purulent-septic
complications was noted in 33.3%, when the monotherapy with cephalos-
porins of the ﬁrst generation were applied and only in 16.7% – when the
cephalosporins of the third generation were used. Quinolones were applied
with combination of metronidazole and in only 16%, this therapy was
ineffective.
Conclusion:Thus, the cephalosporins of the third generation and quinolones
with metronidazole are effective in the prevention of the purulent complica-
tions in patients with necrotizing pancreatitis. Applying of these groups of
antibiotics permit to decrease the number of necrosis puriﬁcation from 37.9–
25.9%.
P1413 Etiology of infectious peritonitis in patients
undergoing continuos ambulatory peritoneal dialysis
(1987–2001)
A. Becker, D. H. Frostier, E. Kneehole
Karlsruhe, D
Objectives: According to the literature, patients undergoing continuous
ambulatory peritoneal dialysis (CAPD) have 0.4–0.6 episodes of peritonitis
every 12month. During a 15-year period, patient and laboratory charts of
patients undergoing CAPDwere reviewed and looked for episodes of CAPD-
associated peritonitis. The objective of the present study was to determine the
relative prevalence of different infectious agents recovered from peritoneal
ﬂuids during such episodes.
Methods: During the study period (1987–2001), sediments of ﬂuids from
dialysis bags sent in for microbiological investigation were cultured on routine
media directly and after resuspension with aqua dest. for cell lysis. In addition,
ﬁltrates of 100mL of ﬂuids (until 1995) or 10mL of ﬂuids inoculated in blood
culture bottles (since 1996) were cultured.
Results: A total of 1410 dialysis ﬂuids were investigated because of suspected
peritonitis. Bacteria and/or yeast could be recovered from 572 (40.6%)
peritoneal ﬂuid specimens collected from 216 patientswith 341 culture-positive
infectious episodes. The most prevalent species were S. aureus (30%) and
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coagulase-negative staphylococci (CNS) (28%). In total, Gram-positive bacteria
were found in 76%, Gram-negative bacteria in 24%, anaerobic bacteria in 0.6%
and yeast in 7% of culture-positive episodes. 6.5% of culture-positive episodes
were polymicrobial. Approximately 80% of protracted infections (duration:
more than 2 months) occurring in 7% of patients were caused by S. aureus.
Conclusions: In contrast to other studies, S. aureus was found to be most
prevalent species in culture-positive CAPD-related peritonitis, outnumbering
CNS.
P1414 Stenotrophomonas maltophilia peritonitis in
CAPD patients: susceptibility to antibiotics and outcome
of the treatment
K. Tzanetou, G. Triantaphillis, D. Tsoutsos, D. Petropoulou,
G. Ganteris, P. Ziroyiannis, E. Malamou-Lada
Athens, GR
S.maltophilia is an environmental Gram-negative bacillus, which has been
associated with expanding spectrum of clinical syndrome, particularly in
hospitalized and immunocompromised patients. Only a few cases of S. mal-
tophilia peritonitis have been reported in patients undergoing continuous
ambulatory peritoneal dialysis. We report on four patients with S. maltophilia
peritonitis during the last 4 years and comment on the susceptibility of the
isolated strains to antimicrobial agents, the antibiotic combination adminis-
tered and therapeutic outcome. All the isolated strains were susceptible to
trimethoprim–sulfamethoxazole and to ticarcillin–clavulanate. The three of
the four patients responded well to antibiotic treatment and only one of them
did not respond to the double antibiotic combination, which necessitated the
catheter removal. Risk factors, except the chronic renal failure and the
presence of indwelling catheter were not identiﬁed. None of the patients
developed secondary bacterial or fungal peritonitis due to prolonged anti-
biotic use. Conclusively, we believe that the early administration of the
appropriate antibiotic combination could lead to successful treatment of
S. maltophilia peritonitis, without removal of the catheter. The replacement
of the catheter should be conﬁned only to treatment-resistant cases.
P1415 Activity of selected antimicrobials against
obligate anaerobes
K. Kot, A. Rokosz, A. Sawicka-Grzelak, D. Kawecki, J. Meszaros,
M. Luczak
Warsaw, PL
Objectives: The aim of this study was to determine susceptibility of strictly
anaerobic strains isolated in clinical laboratory in 2001 to selected antimi-
crobials.
Methods: Two hundred and twenty-ﬁve clinical strains of obligate anaerobes
were identiﬁed with biochemical tests API 20 A (bioMe´rieux, France).
Susceptibility to antimicrobial agents was determined using ATB ANA strips.
CCCA medium was applied for isolation of C. difﬁcile strains from fecal
samples. Toxins A/B were detected with immunoenzymatic test (TechLab,
USA).
Results: A hundred and seventy-one strains of Gram-positive anaerobic
bacteria (with dominance of Peptostreptococcus genus) and 55 of Gram-negative
anaerobes (with prevalence of B. fragilis species) were cultured from clinical
specimens.C. difﬁcile toxins A/B were detected in 39 stool samples (out of 99)
and 28 C. difﬁcile strains were isolated. Drugs with highest in vitro activity
against Gram-positive anaerobic strains were b-lactam antibiotics combined
with b-lactamase inhibitors and imipenem. Gram-negative clinical strains
were susceptible to imipenem, metronidazole, ticarcillin/clavulanic acid and
piperacillin/tazobactam.
Conclusions: Imipenem and b-lactams combined with b-lactamase inhibitors
are still highly active against strictly anaerobic bacteria and should be used in
empirical treatment of anaerobic infections.
P1416 Comparison of variant Clostridium difﬁcile
strains found in different hospitals
M. Rupnik, B. Geric, S. Johnson, H. Pituch, H. Kato
Ljubljana, SI; Maywood, IL, USA; Warsaw, PL; Tokyo, JP
Clostridium difﬁcile is the most important infectious cause of nosocomial
diarrhea. Virulent strains can produce different combinations of three toxins,
TcdA (toxin A), TcdB (toxin B) and binary toxin (CDT). TcdA and TcdB are
recognized as the main virulence factors. Binary toxin producing strains were
ﬁrst described about 10 years ago, but their prevalence and the role of toxin
CDT in the pathogenesis are not well known. Variant C. difﬁcile strains have
altered toxin genes (tcdA and tcdB), coding for toxins TcdA and TcdB, when
compared with the reference strain VPI 10463. They can be divided into 20
groups called toxinotypes (I–XX). Variant strains can produce both TcdA and
TcdB (AþBþ strains; I–VII, IX, XII–XV, XVIII–XX), only TcdB (A-Bþ
strains; VIII, X, XVI, XVII) or neither TcdA nor TcdB, yet still have parts of
toxin genes present (A-B– strains; XI). Most of the data on variant strains
come from studies of two large European C. difﬁcile collections from Brussels
and Cardiff. Here, we compare variant C. difﬁcile strains found in hospitals
from different countries. Altogether eight hospitals from three countries were
included; Japan (six hospitals), USA (1) and Poland (1). Variant strains were
detected with RFLP–PCR-based screening of tcdA and tcdB and another
PCR reaction was used for detection of binary toxin gene cdtB. Variant strains
were found in all eight hospitals and belonged to nine previously described
toxinotypes and to two new toxinotypes. Our results show that A–Bþ strains
from toxinotype VIII are the most prevalent group of variantC. difﬁcile strains,
followed by toxinotypes III and IV. However, in a given hospital we found
from one to nine different toxinotypes. Variant C. difﬁcile strains in these
collections are a good indicator for the prevalence of such strains in general,
but types and number of variant strains can vary substantially among the
hospitals and within a single hospital over different time periods.
P1417 Prevalence of Clostridium difﬁcile: diarrhea in
university hospital in Warsaw
H. Pituch, P. Obuch-Woszczatynski, B. Lazinska, D. Glinka,
F. Meisel-Mikolajczyk, M. Luczak
Warsaw, PL
Clostridium difﬁcile is the main agent responsible for nosocomial diarrhea
worldwide. C. difﬁcile infection, as a complication of antibiotic treatment
appears especially in adults: elderly patients, hospitalized for longer periods
and immunocompromised patients. However,C. difﬁcilemay be an etiological
agents diarrhea in a pediatric units. The aim of our study was to examine the
frequency of C. difﬁcile and its toxins in fecal samples from patients suffering
from antibiotic associated diarrhea (AAD). From 1 January 2002 through 31
December 2002 310 patients adults as well as children were diagnosed in
direction ofC. difﬁcile. Patients were hospitalized: 128 in transplantology unit,
43 in surgery unit, 31 in internal unit, 15 in orthopedic unit, 8 in intensive
care unit, 13 in another units (urology, dermatology) and 72 in pediatric units
(hematology and gastroenterology). The immunoenzymatic C. difﬁcile TOX
A/B-test (TechLab Inc., Blacksburg, USA) was used to detection a both
toxins: toxin A and toxin B. All fecal samples were plates on selective medium
(CCCA) and incubated under anaerobic conditions. From 310 fecal samples
under investigation 183 (59%) of these samples were positive for C. difﬁcile
toxins by EIA test (TOX A/B). From all samples 77 C. difﬁcile strains were
isolated. Surgical (40%), transplanological (50%) and pediatric (60%) cases
exhibited C. difﬁcile diarrhea most frequently.
P1418 Toxigenicity and clindamycin resistance among
Clostridium difﬁcile strains isolated from patients with
antibiotic associated diarrhea in Poland
H. Pituch, P. Obuch-Woszczatynski, D. Glinka, F. Meisel-Mikolajczyk,
M. Luczak
Warsaw, PL
Objective:The toxigenicity and clindamycin resistance of 90 C. difﬁcile strains
isolated from fecal samples of patients adults and children with associated
diarrhea (AAD) was tested.
Methods:Toxin production was investigated in 90C. difﬁcile strains isolated in
our laboratory. Toxin A was tested by means a rapid slide immunoassay
C. difﬁcile A test, Clearview (Basingstoke, Oxoid, UK) and toxins A and B
were detected by means of immunoezymatic test C. difﬁcile TOX A/B-test
(TechLab, Blacksburg, USA) and conﬁrmed by PCR with speciﬁc primer
pairs. Cytotoxicity assay was used to detect toxin B. Antimicrobial suscept-
ibility was tested by means E-test to clindamycin, erythromycin, imipenem,
metronidazole and vancomycin. The ermB gene was detected using PCR.
Results: Sixty-six (63%) C. difﬁcile strains from all strains under investigation
were shown to be toxin A positive by slide immunoassay and 24 (27%) of all
strains were negative. The same 66 strains as well as 24A-negative strains were
positive in C. difﬁcile Tox A/B-test. All strains were positive in cytotoxicity
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assay. From all strains 52 (58%) were highly resistant to imipenem and 36
(40%) were sensitive. All strains were sensitive to metronidazole and vanco-
mycin. In our observations all 24 A-negative B-positive clinical C. difﬁcile
strains were highly resistant to clindamycin and erythromycin and harbor ermB
gene.
P1419 Detection of Clostridium difﬁcile and its toxin a
(TcdA) in stool specimens from hospitalized patients
M. Wroblewska, E. Swoboda-Kopec, A. Rokosz, G. Nurzynska,
A. Bednarska, M. Przybylski, M. Luczak
Warsaw, PL
Objectives:To evaluate the frequency of C. difﬁcile recovery in culture and to
determine the frequency of C. difﬁcile toxin A detection in stool specimens of
patients with nosocomial diarrhea, hospitalized in a tertiary care hospital in
Warsaw (1200 beds).
Methods: The study comprised stool samples collected (1998–2002) from
adult patients suspected of antibiotic associated diarrhea (AAD), colitis (AAC)
or pseudomembranous colitis (PMC), hospitalized in different wards. The
identiﬁcation of cultured C. difﬁcile strains was conﬁrmed with a latex
agglutination test for C. difﬁcile antigen (Becton Dickinson, USA). The
presence of C. difﬁcile toxin A was assayed using a commercial immunoassay
(Oxoid, England).
Results: In total 4435 samples collected during ﬁve years (1998–568; 1999–
707; 2000–801; 2001–1067; 2002–1292). Out of them 1308 (29.5%) have
been culture-positive for C. difﬁcile (1998–14.6%; 1999–29.3%; 2000–33.8%;
2001–31.2%; 2002–32.0%). The testing for C. difﬁcile toxin A revealed 847
(19.1%) positive samples (1998–28.5%, 1999–17.4%; 2000–23.2%; 2001–
17.1%; 2002–15.0%).
Conclusion:We observed an increase in the number of stool samples tested for
C. difﬁcile and in the number of C. difﬁcile culture-positive samples over 5
years. A decrease in the number of C. difﬁcile toxin A-positive fecal samples is
noted during last two years. This phenomenon may be due to an improved
antibiotic policy.
P1420 Value of toxin detection and stool culture of
Clostridium difﬁcile during an outbreak of CDAD on a
geriatric ward
G. Ackermann, S. Thomalla, F. Ackermann, A. C. Rodloff, B. R. Ruf
Leipzig, D
Objectives: Clostridium difﬁcile-associated diarrhea (CDAD) remains the
leading cause of nosocomial-acquired diarrhea. Prolonged hospital stay and
diagnostic and therapeutic procedures due to CDAD cause additional costs.
Methods: From June to December of 2002 62 cases of diarrhea were reported
from a geriatric ward of a clinic for Internal Medicine. C. difﬁcile and
Clostridium perfringens -Toxin ELISA and culture for C. difﬁcile, C. perfringens
and Staphylococcus aureuswere done on all stool samples. In-vitro susceptibility
ofC. difﬁcilewas tested for vancomycin, metronidazole, linezolid, fusidic acid,
and tetracycline.
Results: Twenty stools were positive for C. difﬁcile toxin using ELISA. All 62
stools were cultured and from 29 samples grew C. difﬁcile. C. difﬁcile was
isolated out of 15 ELISA negative stools. Six ELISA positive samples were
negative using culture. Additionally, in 15 stools S. aureus and/orC. perfringens
could be islolated. Four samples contained only S. aureus and C. perfringens,
respectively. Twenty-three stools were negative in all tests. All C. difﬁcile
isolates were susceptible to vancomycin and metronidazole.
Conclusion: Stool culture for C. difﬁcile was shown to be more sensitive than
toxin ELISA in this study. Culturing the organisms is the prerequisite for
susceptibility testing and epidemiological investigations.
P1421 Parasites in nosocomial diarrhea: are they
underestimated?
E. Hakko, G. Aygun, H. Yasar, M. Yilmaz, E. Polat, K. Midilli,
M. Aslan, A. Mert, R. Ozturk, K. Altas
Istanbul, TR
Objectives: To validate the role possible pathogens in nosocomial diarrhea
including parasites and to develop guidelines for our hospital use of stool
cultures.
Methods: We evaluated stool samples of hospitalized patients sent to our
laboratory during a 16-month period (2001–2002). The samples were ﬁrst
examined macroscopically and then the patients were questioned and con-
ﬁrmed about the ‘3-day rule’. A total of 226 samples qualifying all these
speciﬁcations were ﬁrst examined by direct wet mount and by addition of a
drop of iodine and then inoculated to MacConkey and Salmonella–Shigella
agar to improve recovery of Salmonella, Shigella and Aeromonas species. Part of
the sample was concentrated by sedimentation techniques for the recovery of
protozoa, eggs, and larvae. A total of 126 concentrated samples were evaluated
for Cryptosporidium by Kinyoun’s modiﬁed acid fast stain and direct ﬂuores-
cence assay with monoclonal antibody. ELISA was used for detection of
Clostridium difﬁcile toxin A þB. Samples with heavy yeast colonizations were
evaluated to be suspicious for fungal infections.
Results:We did not recover Salmonella, Shigella, or Aeromonas from any of the
samples studied. Eleven (4.87%) samples yielded positive for C. difﬁcile toxin
AþB whileGiardia cysts and/or trophozoites were diagnosed in 10 (4.42%),
Blastocytis hominis in 9 (3.98%) and Cryptosporidium in 1 (0.79%), heavy yeast
colonization in 8 (3.54%) samples. The distribution of patients are given in
Table 1.
Conclusions: Examination of nosocomial diarrhea samples for ova and
parasites is not a part of routine stool evaluation. Our study revealed that
in 12.38% of the cases, protozoon were the only relevant agents causing
nosocomial diarrhea. We found Cryptosporidium oocysts in one case with
nosocomial diarrhea. In conclusion, the yield of in-hospital stool cultures for
enteropathogenic bacteria other than C. difﬁcile performed less than 72 h after
admission is low. On the other hand, stool specimens of nosocomial diarrhea
cases should be examined for parasites in endemic areas.
P1422 Current trends in perioperative antibiotic
prophylaxis in colorectal surgery in Russian hospitals
A. V. Bedenkov, V. G. Pleshkov, V. A. Larchenko, A. S. Bazarov,
L. S. Stratchounski
Smolensk, Moscow, RUS
Objectives:To evaluate the prescribing patterns of surgeons for perioperative
antibiotic prophylaxis (PAP) in colorectal surgery (CS) in Russian hospitals.
Methods: The multicenter retrospective study of PAP in CS in Russian
hospitals was carried out in 16 centers where case histories of patients who
underwent CS in 1999 were analyzed. In all centers 50 consecutive case
histories were evaluated. Collected data included demographic information;
operation issues; dosage, route and course duration for prescribed antibiotics
(pre- and postoperation antibiotic therapy, PAP); surgical site infections (SSI);
duration of stay.
Results: Altogether 643 case histories of patients were included in the ﬁnal
analyzes (49% males and 51% females, mean age 50.0 17.4 years). The most
common operations were: hemicolectomy – 21%, rectum resection – 19.3%,
sigmoid resection – 16.6% and colostomy 13.1%. Overall, PAP was used in
65.5% of all colorectal operations. Cefazolin, gentamicin, cefuroxime, cefo-
taxime, amoxicillin/clavulanate, metronidazole were the most commonly
prescribed antibiotics (18.8, 18.3, 17.7, 8.6, 7, and 5.9% of total prescriptions,
respectively). Antibiotics in postoperative period were prescribed in 95% of
patients and course was 7 3.3 days. Gentamicin (28.8%), metronidazole
(11.9%), cefazolin (11.4%), and ampicillin (11.25) were prescribed mostly.
Overall rate of SSI for CS was 13.9%, and it varies from 8.9% after colostomy
to 20.2% after rectum resection.
Conclusions: Rate of PAP in CS is low. Antibiotics used for PAP are often
inconsistent with recent recommendations. Despite of SSI presence or
absence and PAP, antibiotic therapy in postoperative period is common.
The guidelines for PAP in CS should be implemented and more education on
the subject is necessary.
Table 1 Epidemiological data of the patients
Mean age (years) 43.042 22.378
Median age (years) 42 (0–87)
Sex (F/M) 35/59
Hematology–oncology 24 patients
Surgical units 22 patients
Medical units 41 patients
Intensive care units 7 patients
Prior antibiotic use 90 (95.7%)
History of recent surgery 29 (30.8%)
Immunosuppressive treatment 41 (43.6)
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P1423 BIVEMOX: a Belgian in-vitro evaluation of
moxiﬂoxacin
J. Verhaegen, M. Struelens, H. Goossens, Y. Glupczynski, P. De Mol,
S. Lauwers, G. Verschraegen, G. Mascart, D. Govaerts, A. Bousse
Leuven, Brussels, Antwerp, Lige, Ghent, Montigny-Le-Tilleul, B
Objectives: The three most isolated bacteria in community-acquired pneu-
monia (CAP) and acute exacerbation of chronic bronchitis (AECB) are
S. pneumonia (SP), H. inﬂuenzae (HI) and M. catarrhalis (MC). A study was
performed in Belgium to assess the in-vitro activity of moxiﬂoxacin on clinical
isolates of these bacteria in respiratory tract infections including CAP and
AECB from ambulatory and hospitalized patients by determination of the
MICs using the E-test and to compare these results against nine other
antimicrobial agents. Additionally, the microdilution method was used to
evaluate the susceptibility of SP to moxiﬂoxacin and levoﬂoxacin.
Material and methods: Nine Belgian university and nonuniversity medical
microbiology laboratories participated during one winter period (2000–2001
or 2001–2002) in a multicenter in-vitro evaluation of moxiﬂoxacin. Only the
Belgian reference center for SP (J. Verhaegen, Leuven) participated during
two consecutive winter periods. Each laboratory included strains of SP, HI
and MC. The total number of evaluable strains was 1172.
Susceptibility testing: E-test: susceptibility testing was performed in the
participating centers by using the E-test. The antibiotics tested were peni-
cillin, ampicillin, amoxi/clav., doxycycline, clarithromycin, cefuroxime, cef-
triaxone, ciproﬂoxacin, levoﬂoxacin and moxiﬂoxacin. SP (all antibiotics):
Mueller–Hinton 5% blood; 0.5 Mc Farland 24 h, HI (all antibiotics): HTM
agar; 0.5Mc Farland 24 h,MC (all antibiotics):Mueller–Hinton 7% blood; 0.5
Mc Farland 24 h. Incubation was done for 24 h in 5% CO2. Microdilution
method: according the NCCLS guidelines, with 5% lysed horse blood.
Quality control: SP ATCC 49619; HI ATCC 49766.
Results: see Table 1.
Conclusion: This Belgian multicenter study demonstrated the excellent in-
vitro potency of moxiﬂoxacin against clinical isolates of SP, HI and MC.
Moxiﬂoxacin showed in-vitro with the E-test to be 4-fold more active against
SP than levoﬂoxacin and demonstrated an equal in-vitro activity against other
bacteria. No resistant strains against moxiﬂoxacin were found. The micro-
dilution method conﬁrms the better in-vitro activity of moxiﬂoxacin vs.
levoﬂoxacin for SP. Follow-up surveys will be needed to monitor the
ecological impact of increased ﬂuoroquinolone usage in respiratory tract
infections in Belgium on the susceptibility to moxiﬂoxacin in the coming
years.
P1424 Pharmacodynamics of moxiﬂoxacin and
levoﬂoxacin against Streptococcus pneumonia
S. Schubert, A. Dalhoff, U. Ullmann
Kiel, D
Objectives: To compare the bactericidal activity of moxiﬂoxacin (MXF) and
levoﬂoxacin (LEV) against S. pneumonia (Spn) at the focal concentrations of
MXF and LEV in the respiratory tree in parallel to serum.
Methods: MFX and LEV concentrations in serum (S, Cmax 3.3/6.6mg/L),
bronchial mucosa (BM,Cmax 5.5/8.3mg/L), epithelial lining ﬂuid (ELF,Cmax
24.4/10.9mg/L), and alveolar macrophages (AM, Cmax 62.0/52.9mg/L)
following a single oral dose of 400 and 500mg, respectively, were simulated in
a one compartment in vitro pharmacokinetic model. The colony-forming
units (cfu) were determined immediately after inoculation (106 cfu/mL) and
after incubation for 1–24 h at 378C. Three Spn strains were used: pen. sens.
(4241), pen. res./cip. sens. (PP62), and a lab. generated pen. res., 1st step quin.
res. strain (19397).
Results: Times to achieve a 99.9% kill are summarized in the table:
Conclusions:MXFwas rapidly bactericidal against all test strains including the
ﬁrst step quinolone resistant strain and exhibited enhanced pharmacody-
namics compared with levoﬂoxacin.
P1425 Comparative bactericidal activity of moxiﬂoxacin,
gatiﬂoxacin, and levoﬂoxacin using simulated ELF
concentrations
H. Musgrave, M. MacFarlane, S. Campbell, D. Bast, J. de Azavedo,
D. Low, R. Davidson
Halifax, Toronto, CAN
Objectives: The ﬂuoroquinolones are bactericidal agents frequently used in
the treatment of respiratory tract infections. In this study, we compared the
killing kinetics of moxiﬂoxacin (MXF), gatiﬂoxacin (GAT), and levoﬂoxacin
(LEV), against ﬂuoroquinolone susceptible and resistant Streptococcus pneumo-
nia (Sp) at concentrations typically reached in the epithelial lining ﬂuid (ELF).
Methods: Six strains of Sp., two ﬂuoroquinolone susceptible, two parC
mutants, and two parC/gyrA mutants were tested using Mueller–Hinton
broth supplemented with 5% lysed horse blood. Cultures were inoculated at a
density of 1 106 cfu/mL, incubated aerobically at 358C, and tested for viable
growth at 0, 1, 2, 4, 6, 12, and 24 h. Simulated ELF concentrations of MXF
(400mg), GAT (400mg), LEV (500mg), and LEV (750mg), adjusted for
protein binding, were 12, 5.6, 7.4, and 14 mg/mL, respectively. Protein
binding of MFX, GAT, and LEV were taken to be 50, 20, and 30%,
respectively.
Results: All agents were rapidly bactericidal against the susceptible strains of
Sp. A 3-log drop in cfu was observed within 2–4 h for all agents. MXF
achieved complete eradication within 6 h, while GAT and LEV achieved
complete eradication within 12 h. For the parC mutants (strains #9177 and
#9427),MXF achieved a 3-log kill at 3 h, GATand LEV (750) at 4 h, and LEV
(500) at 7 h. Complete eradication with MXF was seen at 6 h with strain
#9177 and 12 h in strain #9427. Both GATand LEV (750) eradicated strain #
9177 at 12 h, however, re-growth was observed in the culture treated with
LEV (500) between 12 and 24 h. Repeat susceptibility testing of this isolate
demonstrated a 4-fold increase in the LEV MIC. Both GAT and LEV
eradicated strain #9427 at 24 h. Complete eradication was not observed
with any agent in the parC/gyrA mutants. Only MXF demonstrated a 3-log
cfu decrease. GAT and LEV (750) were bacteriostatic over 24 h, while LEV
(500) had growth kinetics similar to the growth control.
Conclusions:All the ﬂuoroquinolones are extremely active against susceptible
Sp. Superior killing kinetics were observed with the 8-methoxy ﬂuoroqui-
nolones (MXF and GAT), compared with LEV against low level ﬂuoroqui-
nolone resistant Sp. Only MXF maintained its bactericidal activity against
high level ﬂuoroquinolone resistant strains of Sp.
Table 1 MICs (mg/L)
Antibiotic
S. pneumonia H. influenzae M. catarrhalis
MIC50 MIC90 MIC50 MIC90 MIC50 MIC90
Penicillin 0.03 0.5 0.25 64 32 64
Ampicillin 0.008 1 0.25 32 2 16
Amox/clav. 0.008 0.5 0.5 1 0.12 0.25
Cefuroxime 0.03 1 1 2 1 2
Ceftriaxone 0.015 0.25 0.008 0.015 0.25 1
Doxycycline 0.12 8 1 1 0.25 0.5
Clarithromycin 0.12 256 16 32 0.12 0.5
Ciprofloxacin 0.5 1 0.015 0.03 0.03 0.06
Levofloxacin 0.5 1 0.03 0.03 0.06 0.06
Moxifloxacin 0.12 0.25 0.03 0.06 0.06 0.06
Strain no. Drug S BM ELF AM
4241 MXF 6.00 6.00 6.25 6.00
LEV 6.75 6.00 6.00 6.00
PP62 MXF 2.91 2.64 1.11 3.06
LEV 4.03 2.64 5.14 4.58
19397 MXF >24 5.28 5.55 5.14
LEV >24 >24 >24 9.17
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P1426 In vitro activity of moxiﬂoxacin compared with
other quinolones against clinical isolates of Streptococcus
pneumonia
O. C. Aktepe, P. Zarakolu, M. Altindis
Afyon, Ankara, TR
Objectives: To determine the in vitro activity of moxiﬂoxacin in comparison
with some quinolones such as levoﬂoxacin, sparﬂoxacin, and oﬂoxacin,
against Streptococcus pneumonia isolates.
Methods: A total of 66 clinical isolates of S. pneumonia were investigated. A
part of them (n¼ 30) were isolated during 1999–2000 and the others (n¼ 36)
in 2001–2003. The antibiotic susceptibility tests were performed by standard
disc-diffusion method and the results were interpreted according to NCCLS
recommendations. Penicillin resistance was detected by E-test method (AB
Biodisk, Sweden).
Results: The rate of penicillin nonsusceptible strains was 45.4%, and three of
them (4.5%) had high level resistance which were isolated in 2001–2003. The
rate of moxiﬂoxacin susceptibility were 98.4%. Levoﬂoxacin and sparﬂoxacin
susceptibility among S. pneumonia isolates were found as 93.9%, and 90.9% of
isolates were susceptible to oﬂoxacin.
Conclusion: Newer ﬂuroquinolones had good activity against S. pneumonia
strains, particularly in the era of emerging penicillin resistance. These results
show that moxiﬂoxacin could be considered as an effective alternative among
this group of antibiotics against pneumococcal infections.
P1427 Gatiﬂoxacin activity on slow growth phase
bacteria
H. Carsenti, P. Pugliese, F. Vandenbos, C. Pradier, B. Dunais,
G. Mancini, M. Sabah, P. Dellamonica
Nice, F
Background: Persistence of microorganisms in chronic infections is due to
modiﬁcation of metabolism and bioﬁlm formation. It is well demonstrated in
case of cystic ﬁbrosis and bone infection, and was recently observed in
Streptococcus pneumonia (SP) chronic otitis media.
Objectives: To study bactericidal activity of gatiﬂoxacin (GTF), a new
ﬂuoroquinolone and betalactams on bacteria in different growth phase.
Methods: Bactericidal activity of GTF and ceftazidime was determined in
broth and phosphate buffer for Pseudomonas aeruginosa (1), Escherichia coli (2).
Killing curves were also performed with GTF and oxacillin on Staphylococcus
aureus (5) and S. epidermidis (1). Each experiment was performed twice at
concentrations 2-, 4-, 8-fold the MIC and bactericidal activity was deﬁned as
a decrease of 3 log CFU/mL. For 5 SP, opaque (O) and transparent (T)
variants of each strain were ﬁrst isolated. Killing curves were performed in
brain broth with amoxicillin and GTF.
Results: In phosphate buffer, GTF kept its bactericidal activity on BGNwhile
a decrease of only 1.5–2 log was observed on SA and SE. Ceftazidime,
oxacillin lost their bactericidal activity on all tested bacteria in buffer. An
increase of 8–32-fold MIC was necessary with amoxicillin to be bactericidal
on opaque SP variants while GTF had the same bactericidal activity on Tand
O variants.
Conclusion: For SP increase in concentrations of amoxicillin is necessary to
reach bactericidal activity on opaque variants while there is no activity of
batalactam antibiotics on BGN and staphylococci in slow growth phase. With
GTF a bactericidal activity was observed on BGN and SP even in slow growth
phase. These results may be important to consider to avoid therapeutic failures
in chronic situations.
P1428 Cross-predictability of gatiﬂoxacin and
levoﬂoxacin susceptibility in vitro of clinical enteric isolates
K. Aldridge, J. Wall, C. Robichaux, C. Booth
New Orleans, USA
Objective: Antibiotic formulary changes often require a similar laboratory
change in antibiotics tested to ensure accurate susceptibility (SPT) reporting.
There can be a long time delay for new agents to appear on commercial SPT
panels which can necessitate manual testing of the new agent as occurred at
our institution with gatiﬂoxacin (GAT). This study was designed and
performed to determine if levoﬂoxacin (LEV) SPT from MicroScan corre-
lated with GAT SPT determined by E-test methodology against aerobic
Gram-negative enterics.
Methods: Over 1100 clinical isolates of Enterobacteriaceae were tested for
their SPT to LEVand GAT. Included in the SPT testing were:Citrobacter koseri
(#66); E. coli (#730); Enterobacter aerogenes (#37); E. cloacae (#63); Klebsiella
pneumonia (#105); Proteus mirabilis (#144); Serratia marcescens (#14); and
Shigella sonnei (#5). For LEV SPT to each isolate was tested using Gram-
negative combo panels in the MicroScan WalkAway system. For GAT SPTof
each isolate was tested on the same day using E-test methodology. Inter-
pretation of SPT results was performed to determine discrepancy rates using
NCCLS guidelines for susceptible (S), intermediate (I), and resistant (R)
categories.
Results: Both GAT and LEV showed excellent activity against the isolates
tested. The categorical discrepancy rate between the two agents was 1% (12 of
1164 comparisons). Discrepancies were distributed among the isolates as
follows: C. koseri, 1; E. coli, 4; E. cloacae, 4; K. pneumonia, 2; and P. mirabilis, 1.
Results indicated four major discrepancies (S to GAT and R to LEV) and
occurred in one isolate each of C. koseri, E. coli, E. cloacae, and K. pneumonia.
The remaining discrepancies were considered minor and were as follows: 1 S
to GATand I to LEV; 3 I to GATandR to LEV; 3 I to GATand S to LEV; and
1 R to GAT and I to LEV. Based on overall results major and minor
discrepancies occurred in 0.3 and 0.7% of isolates, respectively.
Conclusions: This study found that categorical SPT results for Entero-
bacteriaceae with GAT and LEV were comparable when tested by two
different methodologies. The overall discrepancy rate was acceptable (1%)
and these results support the use of LEV to predict SPT to GAT among
Enterobacteriaceae.
P1429 Contemporary activity of grepaﬂoxacin:
re-evaluation of antimicrobial features of a potent
ﬂuoroquinolone
R. Jones, K. Gordon, P. Rhomberg, T. Fritsche, H. Sader
North Liberty, USA
Objective: To re-evaluate the potency and usable spectrum of activity for
grepaﬂoxacin against contemporary pathogens collected from clinical infec-
tions in 2001–2002. These results will update the grepaﬂoxacin role compared
with other quinolone agents introduced since 1999, in preparation for
expanded in vitro and in vivo investigations against resistant (R) strains.
Methods: A total of 995 strains of recently isolated bacterial pathogens were
tested by reference NCCLS methods compared with 25 other agents includ-
ing four marketed ﬂuoroquinolones (FQ). The organisms included: Escher-
ichia coli (EC; 52), Klebsiella pneumonia (KPN; 51), Enterobacter cloacae (ECL;
55), Pseudomonas aeruginosa (PSA; ciproﬂoxacin-R, 52; and ciproﬂoxacin-S,
50), methicillin-R S. aureus (MRSA; 104), methicillin-susceptible (S) S. aur-
eus (MSSA; 58), coagulase-negative staphylococci (CoNS; 50), beta-hemo-
lytic streptoccci (BHS; 52), Streptococcus pneumonia (SPN; 167), Haemophilus
inﬂuenzae (HI; 105), Moraxella catarrhalis (MCAT; 91) and Legionella pneumo-
phila (35).
Results:Grepaﬂoxacin activity was comparable to ciproﬂoxacin, levoﬂoxacin
and gatiﬂoxacin against EC, KPN and ECL (MIC90, 0.03–2mg/mL;R¼ 0.0–
7.7%). For PSA, grepaﬂoxacin was active against ciproﬂoxacin-S isolates
(MIC90, 2mg/mL), but not ciproﬂoxacin-R (MIC90, >8mg/mL). Against
MSSA, grepaﬂoxacin S rate was 91.4%, equal to levoﬂoxacin; none of the
FQs were active against MRSA or CoNS. Gatiﬂoxacin and grepaﬂoxacin
had the same MIC90 vs. BHS (0.25mg/mL) and penicillin-susceptible SPN
(0.25mg/mL). Grepaﬂoxacin and other FQ activities were not inﬂuenced by
penicillin R in SPN. Grepaﬂoxacin was very active against HI (MIC90,
0.03mg/mL), MCAT (0.03mg/mL) and Legionella spp. (0.5 mg/mL).
Conclusions: These recent results indicate that grepaﬂoxacin has retained its
potent spectrum against Enterobacteriaceae, methicillin-S staphylococci, and
the pathogens causing community-acquired respiratory tract infections.
Additional potency was observed vs. ciproﬂoxacin-S PSA and other strepto-
cocci. As issues of adverse drug reactions are more accurately evaluated and
minimized, it remains clear that grepaﬂoxacin continues to be an excellent
candidate FQ for ambulatory care practice settings.
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P1430 Antianaerobic activities of garenoxacin,
gatiﬂoxacin, moxiﬂoxacin compared with those of
levoﬂoxacin, ciproﬂoxacin, clindamycin, metronidazole and
two beta-lactams
L. J. Dubreuil, J. Behra-Miellet, L. Calvet
Lille, F
Objectives: MICs were determined on garenoxacin (GAR) moxiﬂoxacin
(MOX), gatiﬂoxacin (GAT), levoﬂoxacin (LEV), ciproﬂoxacin (CIP), coa-
moxyclav (AMC), piperacillin–tazobactam (PTZ), clindamycin (CLN), imi-
penem (IMI) and metronidazole (MOL) against 175 anaerobes isolated from
human clinical samples.
Methods: Reference agar dilution (standard M11A5, NCCLS).
Results: GAR, MOX, GAT, LEVand CIP, inhibited at 4mg/L, respectively,
100, 94, 93, 82, and 44% of the Bacteroides fragilis group strains whereas
resistance rates were, respectively: AMC 1%, PTZ, IMI and MOL 0%, CLN
35%. Considering the three ﬂuoroquinolones, the MIC50/90s (mg/L) can be
seen in the table.
GAR, MOX, and GAT unlike other ﬂuoroquinolones demonstrated high
activity against the B. fragilis group and clostridia but GAR was the more
potent ﬂuoroquinolone. GAR, MOX, and GATwere also more potent than
LEV and CIP against gram positive rods and most anaerobic cocci. At
concentration of 2mg/L, GAR inhibited all strains of Fusobacterium, Porphyr-
omonas, Propionibacterium and Gram-positive cocci. At concentration of 2mg/L,
GAR inhibited all Gram-positive anaerobes (60 strains) and 103 out of 105
Gram-negative anaerobes. Overall 175 anaerobes, GAR inhibited 99 and
100% of the strains investigated at concentrations of 2 and 4mg/L, respec-
tively. Comparatively, at the same concentrations, moxiﬂoxacin inhibited 94
and 98% and GAT inhibited 91 and 96% of the whole anaerobes. Overall
clindamycin resistance rate was 18.5%.
Conclusion:Only GAR, MOX, and GATwere able to inhibit at least 95% of
the anaerobes investigated. MOX and GAR had similar activities but GAR
was the more potent agent. Their broad anaerobic spectrum demonstrated in
vitro is very promising to treat anaerobic or mixed infections; further clinical
evaluations are needed.
P1431 In vitro activity of garenoxacin, moxiﬂoxacin,
and gatiﬂoxacin against Bacteroides fragilis group isolates
with varying degrees of resistance to carbapenems
K. Aldridge, M. Gelfand
New Orleans, Memphis, USA
Objectives: Antimicrobial resistance among the Bfg has increased to beta-
lactams, clindamycin, and now metronidazole therefore new antimicrobial
options are needed. Resistance to Cbs particularly imipenem (IM), results in
cross-resistance to all beta-lactams thus limiting the number of therapeutic
options. Newer quinolones exhibit anti-anaerobic activity but little infor-
mation details activity against Cb-resistant isolates. Here, we compare the
activity of GRN, MXF, and GAT against a select group of Cb-resistant
and -susceptible Bfg isolates.
Methods: Sixty-ﬁve isolates of the Bfg previously tested by broth micro-
dilution assays were used. Of these, 21 had high level (MICs 32mg/L) IM
resistance and were cross-resistant to ertapenem (ERT) (100%), cefoxitin
(FOX) (100%), ticarcillin–clavulanate (T-C) (100%), and piperacillin–tazo-
bactam (P-T) (100%), and clindamycin (CL) (62%). The remaining 44 isolates
were susceptible to IM (MICs 4mg/L) with 11 of the 44 with ERT MICs
8mg/L. All 44 were susceptible to P-T and had varying degrees of suscept-
ibility to FOX, T-C, P-T, and CL. MICs were determined to GRN, MXF,
and GAT using recommended E-test methodology. MICs were collated to
include: MIC range, mode MIC, MIC50, MIC90, and percentage of isolates
inhibited at potential susceptible breakpoints of 1, 2, and 4mg/L.
Results:MIC results indicated varying degrees of activity of GRN, MXF, and
GAT for the Bfg overall. The mode MIC, MIC50, MIC90, and percentage
inhibited at 1, 2, and 4mg/L for the overall group were: GRN: 0.125, 0.38,
32, 83%, 83%, 86%; MXF: 0.38, 0.38, 32, 74%, 77%, 82%; GAT: 0.5, 0.79,
32, 60%, 72%, 77%. Comparison of IM-susceptible or-resistant isolates
showed equal activity for GRN, MXF, and GAT against the two groups;
at 2mg/L GRN inhibited 81% vs. 84%;MXF 77% vs. 76%, and GAT 62% vs.
77%, respectively. Cross-resistance (MIC’s 8mg/L) to GRN, MXF, and GAT
occurred in nine isolates.
Conclusions:Although, still at a low rate, increased reports of Cb resistance in
the Bfg pose a therapeutic challenge due to concurrent cross-resistance to
other beta-lactams. These data show that GRN, MXF, and GAT exhibit
potent but varying rates of activity against a select group of Bfg isolates. The
activity of these agents is independent of Cb (beta-lactam) resistance and
would appear as potential therapeutic options for monotherapy of mixed
aerobic–anaerobic infections.
P1432 Comparative activity of Garenoxacin against
ciproﬂoxacin-susceptible and -resistant Streptococcus
pneumonia isolates: Report from the SENTRY Antimicrobial
Surveillance Program (Europe, 1999–2001)
R. Canto´n, E. Loza, M. I. Morosini, F. Baquero, R. N. Jones,
The Sentry Participants Group
Objective: To comparatively study the activity of garenoxacin, a new des-
ﬂuoro (6) quinolone, in ciproﬂoxacin susceptible and resistant S. pneumonia
isolates.
Methods: A total of 1613 S. pneumonia isolates causing respiratory tract
infections were collected in 30 laboratories from 14 European countries
during the SENTRYAntimicrobial Surveillance Program from 1999 to 2001.
Susceptibility testing (microdilution, NCCLS) was centralized (The Jones
Group, Iowa).
Results:Overall ciproﬂoxacin resistance (MIC 4mg/L) was 3.8%, 0.4% for
levoﬂoxacin and gatiﬂoxacin, and 0.2% moxiﬂoxacin, but nonexistent for
garenoxacin. During the studied period, ciproﬂoxacin-resistant isolates were
concentrated in France (24.6%), Italy (24.6%), Poland (8.2%), Ireland (8.2%),
Spain (6.5%), and UK (6.5%). Quinolone activity in ciproﬂoxacin-susceptible
and -resistant isolates is shown in the table.
Conclusions: Garenoxacin was the most active quinolone tested against
S. pneumonia isolates. Although, 11.5% of ciproﬂoxacin-resistant S. pneumonia
isolates were also resistant to levoﬂoxacin, 9.8% to gatiﬂoxacin, and 5.1% to
moxiﬂoxacin, no garenoxacin resistant isolates were observed in Europe.
Waiting for clinical studies, these results validate the potential utility of this
compound for the treatment of S. pneumonia respiratory tract infections in this
region.
P1433 In vitro activity of gatiﬂoxacin and seven other
antibiotics against respiratory and urinary tract pathogens
from the community: results of the BASIC study
H. Grimm on behalf of a European Multicentre Study Group
Objectives: To obtain present ﬁgures on resistance towards gatiﬂoxacin and
other antibiotics.
Microorganisms (n) GAR MOX GAT LEV CIP
B. fragilis group (71) 0.25/1 0.5/4 0.5/4 2/16 8/64
Other Gram-negative
bacilli (44)
0.12/0.5 0.25/2 0.25/2 0.5/4 1/8
Clostridia (15) 0.25/1 0.25/2 0.5/1 1/4 1/16
Non-sporulated Gram-positive
rods (22)
0.25/1 0.25/1 0.5/1 0.25/2 0.5/16
Peptostreptococcus spp (23) 0.12/0.12 0.25/2 0.5/1 0.5/4 1/2
All anaerobes (175) 0.25/1 0.25/2 0.5/4 1/8 2/32
Ciprofloxacin-Sa
(96.2%)
Ciprofloxacin-Rb
(3.8%)
Levofloxacinc Range 0.12–2 0.5 to >4
MIC50/90 (R%
b) 1/1 (0.0%) 1/4 (11.5%)
Gatifloxacinc Range 0.03–1 0.25–4
MIC50/90 (R%) 0.25/0.5 (0.0%) 0.5/1 (9.8%)
Moxifloxacinc Range 0.03–0.5 0.12–2
MIC50/90 (R%) 0.12/0.12 (0.0%) 0.25/0.5 (5.1%)
Garenoxacind Range 0.03–1 0.03–0.5
MIC50/90 (R%) 0.06/0.06 (0.0%) 0.06/0.12 (0.0%)
S: susceptible; I: intermediate; R: resistant.a2mg/l; b4mg/l; cIþR, NCCLS
criteria, dgatifloxacin criteria were used for garenoxacin.
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Methods: A total of 23 centers in Austria, Belgium, France, Germany, Italy,
Portugal, Spain, and Switzerland are involved in the Bacterial Annual
Susceptibility Information Collection (BASIC) study. The MICs of gatiﬂox-
acin (Gati), ciproﬂoxacin (Cipro), clarithromycin (Clari), benzylpenicillin
(Pen), amoxicillin (Amox), amoxicillin/clavulanic acid (Coamox), cefurox-
ime (Cur) and ceﬁxime (Cix) were determined using the microdilution
method. Each center is requested to investigate about 30 strains each of the
following species: S. pneumonia (Spn), S. pyogenes (Spy), S. aureus (Sau), E.
faecalis (Efa), M. catarrhalis (Mca), H. inﬂuenzae (Hin), E. coli (Eco), K. pneu-
monia (Kpn), P. mirabilis (Pmi) and P. aeruginosa (Pae).
Results: In 2001 and 2002, altogether 5462 strains were enrolled. Apart from
deviations in some regions important MIC90%/percentage susceptible were as
follows:
Conclusion: From the oral antibiotics tested gatiﬂoxacin has the highest
activity and broadest spectrum against all relevant respiratory and urinary
tract pathogens. Gatiﬂoxacin is a promising alternative for therapy of respira-
tory and urinary tract bacterial infections.
P1434 In vitro activity and postantibiotic effect of
ABT-492 and other antimicrobial agents against Legionella
J. Dubois, C. St-Pierre
Sherbrooke, CAN
Background:ABT-492 is a new potent quinolone agent which has enhanced
activity against respiratory pathogens. The in vitro activity and the post-
antibiotic effect (PAE) of ABT-492, moxiﬂoxacin, gatiﬂoxacin, levoﬂoxacin,
oﬂoxacin, ciproﬂoxacin and erythromycin were evaluated against isolates of
L. pneumophila and isolates of L. other than pneumophila.
Methods:MIC values were determined by standard agar dilution procedure
(NCCLS) using buffered yeast extract agar. The PAE was determined by
exposing the isolates to the test antimicrobial for 1 h at 4 times the MIC. The
antibiotic was removed by consecutive centrifugation. The PAE was calcu-
lated by measuring bacterial growth kinetics in similar antimicrobial-free
cultures.
Results: The species tested included L. pneumophila serogroups 1–12 (300
isolates), L. dumofﬁi (30), L. micdadei (30) and L. longbeacheae (25). ABT-492
(MIC< 0.004mg/L) was superior to levoﬂoxacin and gatiﬂoxacin (MIC90
0.016mg/L) and signiﬁcantly (P< 0.001) more active than moxiﬂoxacin
(MIC90 0.03mg/L), ciproﬂoxacin (MIC90 0.03mg/L) and oﬂoxacin (MIC90
0.06mg/L), against L. pneumophila. L. pneumophila serogroups 2–4, 6–9 and 12
strains (MIC90< 0.004mg/L) were more susceptible than L. pneumophila
serogroups 1 and 5 (MIC90 0.03mg/L). Against L. micdadei and L. dumofﬁi,
erythromycin (MIC90 1mg/L) was less active than ABT-492 (MIC90<
0.004mg/L) and levoﬂoxacin (MIC90 0.016mg/L). Against L. longbeacheae,
ABT-492 (MIC90 0.016mg/L) was as active than levoﬂoxacin and was more
active than moxiﬂoxacin, gatiﬂoxacin, oﬂoxacin and ciproﬂoxacin (MIC90
0.03mg/L). Against ERY-resistant L. pneumophila, ABT-492 showed a PAE
at >24h, compared with 3.3 h or less with quinolones tested. Against ERY-
susceptible L. pneumophila, a PAE of 24 h was also observed for ABT-492. For
ERY-resistant Legionella spp. other than L. pneumophila, ABT-492 had PAEs in
excess of >24h, which was signiﬁcantly longer than PAE of tested quinolones
(<4.1 h).
Conclusion:Owing to excellent in vitro activity and signiﬁcant PAE of ABT-
492, additional studies must be performed to determine the in vivo activity of
this agent for the treatment of Legionella infections.
P1435 Predictive value of nalidixic acid resistance in
detecting Salmonellas with decreased ciproﬂoxacin
susceptibility
F. Albayrak, F. Cokca, B. Erdem, D. Aysev
Ankara, TR
Objective: Over the last few years there has been a dramatic increase in the
incidence of human Salmonellosis with nontyphoidal serotypes in developed
countries. Only a few cases of treatment failure due to Salmonella strains
(including S. typhi) that are resistant to nalidixic acid and strains exhibiting
decreased ﬂuoroquinolone susceptibility have been reported. The purpose of
this study was to determine resistance to nalidixic acid could be used to screen
for decreased ciproﬂoxacin susceptibility of our Salmonella strains of com-
munity origin.
Methods: Seventy-three Salmonella strains isolated from stool samples
between January 2000 and October 2001 were serotyped according to
standard procedures. Antimicrobial susceptibility tests were performed on
Mueller–Hinton agar (Difco, USA) using disk diffusion method and on
Mueller–Hinton broth (Difco, USA) using broth macrodilution method.
Escherichia coli (ATCC 25922) was used as a reference standard.
Results: Eight different serotypes were identiﬁed among the 73 Salmonella
isolates studied. All 73 isolates were classiﬁed as ciproﬂoxacin susceptible
(MIC, 1mg/mL) according to NCCLS recommendation and 9 out of all
isolates were found to be nalidixic acid resistant (MIC,32mg/mL) by broth
macrodilution method. Isolates divided into two major groups. First group
with the ciproﬂoxacin MICs ranging from 0.00025 to 0.008mg/mL for
nalidixic acid susceptible population and the second group with the cipro-
ﬂoxacin MICs ranging from 0.004 to 0.032mg/mL for the nalidixic acid
resistant population. There was a 3–4-fold increase in ciproﬂoxacin MICs of
nalidixic acid resistant isolates than susceptible ones. This difference was
statistically different (P< 0.001).
Conclusion: We did not observe typical strains resistant to ciproﬂoxacin for
both nalidixic acid susceptible and resistant strains. MICs for ciproﬂoxacin
were under NCCLS breakpoints for susceptibility. This low level ﬂuoroqui-
nolone resistancemay be clinically important. Vasallo et al. reported cases with
treatment failure with ciproﬂoxacin in Salmonella infections even the strains
are found to be susceptible according NCCLS breakpoints. These strains can
never be recognized in laboratories when NCCLs recommendations are
accepted as breakpoints. In Turkey, Salmonella strains are still susceptible to
quinolones. But there are reports showing nalidixic acid resistance ranging
between 0.5 and 2.5%.
P1436 Detection of decreased ﬂuoroquinolone
susceptibility by use of nalidixic acid disk as screening test
in Salmonella spp. isolates from children with diarrhea
S. Ioannidou, G. Antonaki, M. Tsirepa, E. Lebessi, A. Zaﬁropoulou,
M. Foustoukou
Athens, GR
Objective: Several treatment failures with ciproﬂoxacin (CIP) and other
ﬂuoroquinolones have been reported in infections due to Salmonella spp.
The involved isolates had MICs for CIP 0.125 mg/mL and have been
characterized as isolates with decreased susceptibility. The aim of this study
was the detection of decreased susceptibility to CIP in Salmonella spp., as well
as the validation of resistance to nalidixic acid (NAL) disk as screening test.
Material and methods: During one year period (03/2000–02/2001) a total
number of 190 Salmonella spp. strains from stool specimens of children with
gastroenteritis were tested. Among them, 122 (64%) were S. enteritidis, 51
(27%) S. typhimurium and one S. typhi. The remaining isolates were classiﬁed
to other serogroups. Susceptibility testing was performed by the disk diffusion
method with NAL 30mg and CIP 5 mg disks according to NCCLS criteria.
MICs were determined by E-test.
Results: All isolates were susceptible to CIP (inhibition zone diameter
21mm, MIC 1mg/mL), and 160 isolates (84%) were susceptible to
NAL (inhibition zone diameter 19mm, MIC 16 mg/mL). The resistant
strains were typed as follows: S. enteritidis, 25; S. typhimurium, 2; S. hadar, 2;
and S. typhi, 1. MICs of CIP ranged from 0.008 to 0.5mg/mL. Twenty-eight
isolates had decreased susceptibility to CIP with MIC 0.125mg/mL. The
Table 1
n Gati Cipro Clari Coamox Cur-axetil
Spn 558 0.5/98.9 2/– 64//67.7 1/98.0 4/79.4
Hin 580 0.03/100 0.03/99.8 16/86.0 1/95.3 2/94.8
Mca 361 0.06/100 0.06/99.7 0.5/99.2 0.25/98.9 2/97.8
Sau 589 2/92.0 16/80.5 64/68.1 16/86.1 64/86.8
Eco 670 2/91.3 1/90.0 64/– 16/75.2 8/95.2
Pmi 563 4/88.6 2/89.0 64/– 16/87.6 32/85.6
Pae 569 16/72.1 16/76.3 64/– 16/– 64/–
NCCLS breakpoints not available.
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isolates were divided into two populations based onNAL susceptibility: NAL-
susceptible with MICs of CIP ranging from 0.008 to 0.032 mg/mL and NAL-
resistant with MICs of CIP ranging from 0.064 to 0.5mg/mL. The mean
inhibition zone diameters around CIP of NAL-susceptible and NAL-resistant
isolates were 31.5 and 25mm, respectively. The difference in the mean values
was statistically signiﬁcant. WhenMIC 0.125 mg/mL was selected as break-
point for decreased susceptibility to CIP, screening for resistance to NAL disk
showed sensitivity 96% and speciﬁcity 98%. When MIC of CIP 0.5mg/mL
was selected as breakpoint, screening for resistance to NAL disk showed
sensitivity 100% and speciﬁcity 98.3%.
Conclusion: All Salmonella spp. isolates tested were susceptible to CIP.
Resistance to NAL was found in 16% of isolates and was more frequent
among S. enteritidis strains. Twenty-eight (14.7%) isolates showed decreased
susceptibility to CIP. Determination of NAL resistance by the disk diffusion
method was effective for the detection of decreased susceptibility to CIP. The
method can be employed by diagnostic laboratories as a screening test.
P1437 Effect of quinolones against slowly growing
bacteria
A. Dalhoff, S. Schubert, S. Hakimpur-Zern, P. Bru¨mmer, U. Ullmann
Kiel, D
Background: Bacteria growing in vivo multiply much more slowly than in
vitro. The average generation time (g) of E. coli grown in vitro in kidney
homogenate was 0.6 h as compared with 00.35 h for the broth-grown
counterpart; the same strain causing pyelonephritis in an in vivo infection
model has a generation time of 3.2 h. Therefore, the effect of different
generation times on the bactericidal activity of quinolones was studied in
batch cultures.
Methods: By limiting the nutrient supply, generation times were lengthened
from approximately 0.45–3.9 h. Alternatively, the quinolones were added to
the bacterial cultures during the lag-, exponential- and stationary phase.
Recent clinical isolates of E. coli, S. epidermidis, and S. aureus (three strains
each) were exposed to multiples of theMICs of ciproﬂoxacin, levoﬂoxacin, or
norﬂoxacin. The killing rates were calculated in analogy to the growth rate.
Bacteria were grown in brain heart infusion broth in ambient air at 378C.
Results: The mean killing rates of the three quinolones against the rapidly
growing E. coli and S. aureus and their slowly growing counterparts is sum-
marized in the table (analogous data were obtained for S. epidermidis):
Conclusions: CIP is the most bactericidal agent amongst the quinolones
tested. Slow growth of E. coli affects the activity of CIP minimally, but that of
LEV and NOR signiﬁcantly (P< 0.001). In contrast, the activity of the
quinolones is minimally increased by slow growth of S. aureus.
P1438 Activity of quinolones against attached
Staphylococcus epidermidis: individual resistance
phenotypes
J. K.-M. Knobloch, H. von Osten, M. A. Horstkotte, H. Rohde,
D. Mack
Hamburg, D
Staphylococcus epidermidis is a common pathogen in chronic, medical device-
associated infections, which is able to attach on polymeric surfaces and to
develop multilayered bioﬁlms. Attached S. epidermidis displays reduced sus-
ceptibly against antimicrobial substances and little correlations between
standard susceptibility tests and clinical outcome of antibiotic treatment were
observed. In this study we investigated the effect of ciproﬂoxacin and the
group IV quinolones gatiﬂoxacin, gemiﬂoxacin, and moxiﬂoxacin on three
bioﬁlm-positive wild type strains and their isogenic bioﬁlm-negative mutants.
in the recently developed minimal attachment killing (MAK) assay. Depend-
ing on strain and investigated quinolone a heterogeneous MAK (MAKhetero)
could be distinguished from a homogeneous resistance (MAKhomo) which
corresponds to the model of few persisters within attached cells under
antibiotic treatment. For the bioﬁlm-negative mutants a lower MAKhomo
was observed as for the corresponding wild types for some of the tested
quinolones. This seems to be a result of higher bacterial inocula of wild-type
strains, whereas the MAKhetero concentrations were comparable for mutants
and wild types for nearly all of the tested antibiotics and strains. These data
indicate that bioﬁlm formation is not necessary for persistence of attached
S. epidermidis cells under antibiotic treatment with quinolones and could
explain therapeutic failure in foreign body-associated infections due to
bioﬁlm-negative S. epidermidis isolates. However, due to the increase of cells
within a bioﬁlm similar inoculum effects might be of relevance for some
quinolones as observed for planktonic cells. The individual resistance phe-
notypes of the investigated strains with different antibiotics suppose that the
MAK detection could help to predict the outcome of therapy in foreign
body-associated infections with both bioﬁlm-positive and bioﬁlm-negative
S. epidermidis. Thereby the group IV quinolones displayed relatively high
activity against individual attached staphylococcal isolates, indicating a pos-
sible option for the treatment of foreign body-associated infections due to
these isolates with the respective quinolones.
P1439 Therapeutically aspects in urinary tract
infections: the resistance pattern of Gram-negative bacilli to
aminoglycosides, quinolones and other antibiotics
M. Junie, A. Ferke, D. Vancea, I. Colosi
Cluj Napoca, RO; Rhodes, GR
Background:The objective of our study is to describe the resistance pattern of
strains isolated from patients with urinary infections.
Methods: Antimicrobial susceptibility testing of isolated bacilli was deter-
mined by disk diffusion method as recommended byNCCLS, using a panel of
23 antibiotics: quinolones, aminoglycosides, nitrofurantoin, tetracycline,
trimethroprim–sulfamethoxazole, fosfomycin, and chloramphenicol discs.
Results: The pathogens identiﬁed from urine culture were Pseudomonas sp.,
E. coli, Klebsiella oxytoca, Proteus sp., Acinetobacter, Morganella morganii. Acine-
tobacter calloaceticus strains were resistant to aminoglycosides, P. aeruginosa strains
showed a high resistance to amikacin, netilmicin and a low resistance to
gentamicin and tobramicin.Klebsiella, Proteus, E. coli, P. ﬂuorescens, Enterobacter,
Morganella strains did not show resistance to aminoglycosides. Acinetobacter
strains were resistant to quinolones. All P. aeruginosa strains were resistant to
peﬂoxacin, showing a high resistance to nalidixic acid, ciproﬂoxacin (75%),
oﬂoxacin (50%) and a low resistance to levoﬂoxacin (25%). E. coli strains
showed a low level of resistance to peﬂoxacin (10%) but all were susceptible to
netilmicin. P. ﬂuorescens, Enterobacter, Klebsiella, Proteus,Morganella strains were
susceptible to nalidixic acid, ciproﬂoxacin, peﬂoxacin, oﬂoxacin and levo-
ﬂoxacin. Resistance rates of strains to tetracycline were high for Proteus
mirabilis, A. calloaceticus (100%), P. aeruginosa (75%), E. coli (52.4%). Enterobacter
and Morganella were susceptible to tetracycline. The resistance to trimetho-
prim/sulfamethoxazole signiﬁcantly rose from 0% for Enterobacter and Mor-
ganella, to 14.3% for Klebsiella, to 27.3% for E. coli and 75% for P. aeruginosa.
Nitrofurantoin, is still active against P. ﬂuorescens, E. coli, Klebsiella, Enterobacter
but it is inactive on Proteus, P. aeruginosa, Morganella and Acinetobacter. To
fosfomycin, 50% of Enterobacter and all of Acinetobacter,Morganella strains were
resistant, but fosfomycin is effective against Pseudomonas sp., E. coli, Klebsiella.
Conclusions: There was signiﬁcant increase in prevalence of antibiotic
resistance among the most common uro-pathogens, which raises difﬁculties
in treating urinary tract infections with currently used antibiotics. Amino-
glycosides and quinolones are no longer of ﬁrst choice in treatment of urinary
tract infections.
P1440 Questioning the possible synergistic effect of
gentamicin with three ﬂuoroquinolones (ciproﬂoxacin,
oﬂoxacin, levoﬂoxacin) in subminimal inhibitory
concentrations on virulence factors of uropathogenic
Escherichia coli
H. Baskin, M. Ucar, Y. Dogan, I. H. Bahar
Izmir, TR
Objectives:Gentamicin (G) is one of the powerful antibacterial against Gram-
negative bacteria, has a rapid bactericide effect, has a signiﬁcant effect in
subminimal inhibitory concentrations (sub-MICs), and is relatively cost-
effective. But gentamicin has a narrow antibacterial spectrum and has many
E. coli S. aureus
g ¼ 0.38 h g ¼ 3.72 h g ¼ 0.40 h g ¼ 3.87 h
CIP 65.9 59.1 2.7 3.2
LEV 21.5 12.8 0.8 1.1
NOR 16.5 9.4 1.6 2.1
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dose-dependent side-effects. Fluoroquinolones [oﬂoxacin (O), ciproﬂoxacin
(C), levoﬂoxacin (L)] have broad antibacterial spectrum, have rapid anti-
bacterial effects also in sub-MICs, but are not cost-effective.
Methods: MICs (microplate MIC determinations were done), hydrophobi-
city (3.2–0.2 M of salt aggregations were determined on bacterial surfaces in 1/
2–1/32MICs), hemagglutination (slide agglutination tests were deter-
mined by naked eye in 1/2–1/32MICs), adhesion on uroepthelial cells
(healthy and non smoker ladies’ uroepithelial cells were pooled – bacteria were
counted which adhered to 40 cells in each slide in 1/2–1/32MICs),
motility (swarming zones after 24 h of incubation at 37C were determined
in 1/2–1/32MICs), time-kill determinations (0–612–24 h of colony
counts were done in MIC values) against three strains of Escherichia coli
[ATCC 25922 HA þ mannose resistant, and two clinical isolates: one is
mannose resistant (HAþ 27096), the other is mannose susceptible (HA-
27843)] were realized.
Results: Results showed us a clear-cut decrease in MICs, and synergistic
interactions in adhered bacteria numbers on uroeptihelial cells, in hydro-
phobicity, in motility especially in G þ L combinations in sub-MICs (more
detailed results will be presented in congress hopefully).
Conclusion: In conclusion, this preliminary study may be promising for a
combined therapy protocol in the favor of gentamicin when considered its
dose-related side-effects during prolonged therapies in uropathogenic Escher-
ichia coli related infections.
P1441 The inﬂuence of suprainhibitory concentrations
of ﬂuoroquinolones on some virulence factors of
Stenotrophomonas maltophilia
V. Majta´n, L. Majta´nova´
Bratislava, SK
Objectives: To determine and compare the postantibiotic effect (PAE) of
ﬂuoroquinolones (ciproﬂoxacin, enoxacin, oﬂoxacin, peﬂoxacin) for two
clinical Stenotrophomonas maltophilia strains as well as to evaluate the effect
of this pharmacodynamic parameter on the surface hydrophobicity, motility
and lipase production of both strains studied.
Methods: The PAE was induced by suprainhibitory 2 and 4MIC
concentrations of the antibiotics for 0.5 h and the antibiotics were eliminated
by dilution. The hydrophobicity was determined on the basis of bacterial
adherence to hydrocarbon–xylene (BATH) and salt aggregation test with
ammonium sulfate (SAT). The assay of motility was performed on the
semisolid agar medium (0.35%). The lipase activity was determined spectro-
photometrically in sterile culture ﬁltrates after incubation with Tween 80 in
Tris–HCl and CaCl2 buffers.
Results: The PAE of all ﬂuoroquinolones at 2MIC were on average 2.9 h
longer for strain no. 5777 than for strain no. 27823. The duration of the PAE
was concentration dependent. The longest PAEs were induced at 4MIC by
peﬂoxacin for strain no. 27823 (6.2 h) and by both ciproﬂoxacin and oﬂoxacin
for strain no. 5777 (7.2 and 8.7 h, respectively). The most expressive inhibi-
tion of strain no. 27823 adhesion after ciproﬂoxacin was found at both 2 and
4MIC to 46.5 and 30.5%, respectively. After peﬂoxacin at 4MIC
adhesion was inhibited to 41.8%. Adhesion of strain no. 5777 was inhibited
to 47.1% after 4MIC of ciproﬂoxacin. The lipase production by strain no.
5777 in the PA phase was moderately stimulated. Only ciproﬂoxacin at
4MIC suppressed its production to 23.2% against control. The effect of
suprainhibitory concentrations of ﬂuoroquinolones tested on the motility of
both strains was very weak and was concentration-independent.
Conclusions: The results suggest that any consideration of postantibiotic
effects should include the residual antibiotic effects on virulence factors, in
addition to the deﬁned suppression of bacterial re-growth.
P1442 Antibacterial effects of enoxolone on
periodontopathogenic and capnophilic bacteria isolated
from specimens of periodontitis patients
M. H. Salari, R. Hafezi, Z. Kadkhoda, G. R. Hassanpour, N. Sohrabi
Tehran, IR
Objectives: Enoxolone is a major component of a traditional plant called
Licorice. This substance has several pharmaceutical properties including anti-
inﬂammatory, antiviral and antifungal activities. Microbiological studies have
identiﬁed more than seven periodontopathogen in periodontal pockets,
which less than four species are capnophile. The purpose of this study was
to investigate the in vitro antibacterial effects of enoxolone against isolated
periodontopathogenic and capnophilic bacteria.
Methods: Total specimens were collected with sterile paper points from the
deepest periodontal pockets of 400 patients. The specimens were cultured
under capnophilic condition on selective media. Biochemical tests were used
to identify isolated bacteria. Antibacterial activities of enoxolone against
isolates were investigated by determining minimum inhibitory concentration
(MIC) and minimum bactericidal concentration (MBC) methods.
Results: Isolated bacteria were Actinobacillus actinomycetemcomitans (46.5%),
Eikenella corrodens (30%) and Capnocytophaga species (34%). The MIC of
enoxolone were 8, 16 and 8mg/L, respectively, and the MBC was 16mg/L
for all species.
Conclusion: It is concluded that enoxolone with appropriate concentration is
effective against isolated periodontopathogenic and capnophilic bacteria.
Epidemiology of resistance 5
P1443 Antimicrobial drug resistance patterns of human
Salmonella enterica strains isolated during 2000–2001 in
Greece
L. Politi, P. T. Tassios, M. Lambiri, A. Kansouzidou, D. Mihailidi,
N. Vakalis, J. Kourea-Kremastinou, T. Panagiotopoulos, L. S.
Tzouvelekis, N. J. Legakis
Athens, Thessaloniki, GR
Objectives: Increasingly in recent years, high rates of antimicrobial drug
resistance are being observed in S. enterica, often due to transferable resistance
genes and arising among serotypes previously considered rare. The aim of this
study was to continue the monitoring of antimicrobial drug resistance among
the most important S. enterica serotypes in Greece for the years 2000–2001.
Methods: The study sample consisted of 536 isolates representative of 13
serotypes: Abony (8), Blockley (53), Brandenburg (10), Bredeney (6), Enter-
itidis (253), Hadar (37), Heidelberg (11), Infantis (33), Kottbus (8), Mon-
tevideo (12), Newport (7), Typhimurium (87), Virchow (13). They were
tested on Mueller-Hinton agar by a disc diffusion assay according to NCCLS
recommendations to 16 antimicrobial agents: ampicillin (Am), cefotaxime
(Ctx), ceftazidime (Caz), amoxicillin/clavulanic acid (Amc), kanamycin (K),
amikacin (An), netilmicin (Net), tobramycin (Tm), gentamicin (Gm), strep-
tomycin (S), chloramphenicol (C), tetracycline (Te), sulfonamides (Sss),
trimethoprim (Tmp), nalidixic acid (Na), ciproﬂoxacin (Cip).
Results: All isolates were susceptible to ciproﬂoxacin and amikacin. No high
level resistance was observed in Salmonella Abony, Bredeney, Heidelberg and
Montevideo. Resistance rates to the other antibiotics in the remaining
serotypes ranged from 0.2% (ceftazidime and cefotaxime) to 30% (tetracy-
cline); resistance to nalidixic acid was at 18%.
Conclusions: While resistance to third generation cephalosporins was neg-
ligible and no resistance to ciproﬂoxacin was observed, rates of resistance to
nalidixic acid were considerable, especially for Hadar (95%), Blockley (38%),
and Enteritidis (13%). Nevertheless, in comparison to previous years, mono-
resistance to ampicillin, pentaresistance to AmCSSssTe and SKCTeNa,
Table 1 MIC values of antibacterial in combinations and in their own.
MIC results (mg/L) ATCC 25922 HAþ27096 HA-27843
Ciprofloxacin (C) 0.031 0.062 0.031
Ofloxacin (O) 0.062 0.5 0.031
Levofloxacin (L) 0.125 0.031 0.125
Gentamicin (G) 1.0 1.0 0.5
G þ C 0.062 0.031 0.062
G þ O 0.125 0.125 0.031
G þ I 0.25 0.5 0.25
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remained the dominant resistance phenotypes for Enteritidis (33%), Typhi-
murium (21%) and Blockley (30%), respectively.
P1444 Antibiotic susceptibility of
Listeria monocytogenes in Denmark, 1958–2001
J. Hansen, B. Bruun, P. Gerner-Smidt
Hillerød, Copenhagen, DK
Objectives: In order to see if susceptibility of Danish L.monocytogenes strains
has changed during the years we examined a collection of human isolates from
the period 1958–2001. We furthermore wanted to compare two methods of
in vitro susceptibility testing for L. monocytogenes.
Methods: One hundred and six strains isolated predominantly from blood
cultures and cerebrospinal ﬂuids were examined together with three reference
strains. Susceptibility to the following antibiotics was tested by the E-test
method and by Oxoid discs using Iso-sensitest agar: penicillin G, ampicillin,
meropenem, gentamicin, sulphamethoxazole, trimethoprim, ciproﬂoxacin,
erythromycin, vancomycin, linezolid, chloramphenicol and tetracycline.
Results: Both methods in the main demonstrated sensitivity to all the
antibiotics. Results differed between the two methods for sulphamethoxazole
and ciproﬂoxacin: All strains were sensitive to sulphamethoxazole when
examined by disc diffusion, but only 72% were sensitive using the E-test
method. For ciproﬂoxacin, 96% were intermediate sensitive by disc diffusion,
while 97% were sensitive by the E-test method.
Conclusion: The antibiotic susceptibility of L. monocytogenes has not changed
in Denmark from 1958 to 2001. There is good agreement between results of
E-test and Oxoid disc methods, except for sulphamethoxazole and cipro-
ﬂoxacin.
P1445 Surveillance of linezolid resistance in Germany
J. Brauers, M. Kresken, P. Shah on behalf of the German Linezolid
Resistance Study Group
Objectives:Evaluation of susceptibility to linezolid of grampositive pathogens
from hospitalized patients reported by a network of 86 clinical microbiology
laboratories throughout Germany
Methods:Each laboratory was requested to provide routine susceptibility data
of 100 consecutive strains (35 S. aureus, 30 coagulase-negative staphylococci,
20 enterococci, and 15 streptococci). Most participants used the disk diffusion
test according to NCCLS or German DIN guidelines. As DIN breakpoints
for linezolid do not yet exist, those approved by the European Regulatory
Agency (EMEA) were applied. For quality control retesting of 10% of all
strains as well as strains classiﬁed as resistant to linezolid is ongoing.
Results: The susceptibility results of routine testing comprised 7201 isolates:
3844 Staphyococcus aureus, 773 Stapylococcus epidermidis, 1188 Enterococcus fecalis,
524 Enterococcus fecium, 480 Streptococcus pneumoniae, and 392 Streptococcus
pyogenes. Most specimens were recovered from skin (29.4%), blood
(23.4%), urine (9.6%) and respiratory tract (8%). Most frequent infection
sites were SSTI (30%), upper and lower RTI (19.1%), foreign body/catheter-
infections (10.5%) and UTI (9.8%). In 18.5% of patients the site of infection
was unknown. Oxacillin resistance was observed in 17.1 and 58.7% of
S. aureus and S. epidermidis, respectively. Among the isolates of S. aureus and
S. epidermidis 99.4 and 99.7% were classiﬁed as susceptible to linezolid. In
E. fecalis 96.2 and 99.4% were reported as susceptible to ampicillin and
vancomycin, respectively. Against linezolid 96.9% of strains were classiﬁed
as susceptible and 2.9% as resistant. In E. fecium ampicillin resistance was very
common (83.9%), but vancomycin resistance was low (4.5%). The propor-
tions of linezolid susceptible/resistant isolates were 93.8%/2.3%. Linezolid
resistant streptococci were not reported. Of those isolates, that were reported
as ‘resistant’ to linezolid in routine susceptibility testing and so far re-tested in a
reference laboratory exhibited MICs of 4mg/L or below, i.e. these isolates
were not resistant to linezolid applying both EMEA and NCCLS interpretive
criteria.
Conclusions: Based on routine susceptibility testing the prevalence of line-
zolid resistance in staphylococci and streptococci is extremely low in
Germany. Isolates showing linezolid resistance in routine susceptibility testing
should be re-evaluated.
P1446 Antibioresistance and other virulence aspects in
Aeromonas strains isolated in aquatic environments in
Danube Delta, Romania
M. Balotescu, A. Israil, S. Serban, I. Alexandru, R. Radu, G. Dobre
Bucharest, Fetesti, RO
Introduction: In the last 30 years it was pointed out the evident implication of
aquatic Aeromonas species in human pathology and the high mortality in
extraintestinal Aeromonas infections due to poor knowledge of their anti-
bioresistance patterns.
Purpose: To investigate the relationship between the virulence and antibiotic
resistance determinants in 115 Aeromonas strains isolated in 2001 from
different aquatic sources (salmastre water, aquatic plants, frogs, ﬁsh enteric
content, ﬁsh sapling, snake and oyster shells), as well as their temperature
dependence (48C, 288C, 378C), in order to evaluate the contribution of
aeromonades to the aquatic reservoirs of virulence and resistance.
Methods: Fourteen enzymatic tests (including ELISA and NAD-degradation
for detecting CT-related toxins); diffusion method (NCCLS 2000) and by
phenotypic tests for beta-lactamases.
Results: The Aeromonas strains did not cultivate at 48C in the presence of
antibiotics, while at 288C and 378C they exhibited similar antiobioresistance
patterns: 96.6% exhibited constitutive resistance to penicillins (PEN-R,
AMX-R) by penicillinase production, out of which 45% produced beta-
lactamases sensitive to inhibitors (AMX-R, AMC-S) and 55% beta-lactamases
resistant to inhibitors (AMX-R, AMC-R); 26% were FOX -R, 5.1% were
carbapenemase producers (IMP-R) and a low number of Aeromonas strains
exhibited multiple resistance markers (NOR-R, TCY-R, CHL-R, SXT-R)
indicating the possibility of an efﬂux mechanism. Amylase, caseinase and
lipase tests exhibited constant high positivity undependable of the incubation
temperature; lecithinase at 48C; slime, DNA-se, gelatinase at 288C, esculin
hydrolysis at 288C and 378C and ﬁnally Kanagawa hemolysin at 378C;
exception made the strains isolated from ﬁsh enteral content exhibiting
constantly low levels for the most of the tested factors at 378C. TwoAeromonas
hydrophila group I produced a cholera-like toxin revealed by ELISA speciﬁc
for CT, while 68.5% of the tested strains produced another ADP-rybosilating
toxic factor revealed by NAD-degradation reaction.
Conclusion: The expression of the virulence factors had not signiﬁcantly
differed with the source of isolation, but with the incubation temperature, this
aspect pleading for their speciﬁc role in strains survival, resistance and
pathogenicity. The high levels of antibioresistance and other virulence
features in aquatic Aeromonas strains are pleading for their implication in
human pathology.
P1447 Antibiotic resistance trends in Canadian strains
of Streptococcus pneumoniae
S. Pong-Porter, K. Green, A. McGeer, K. Weiss, D. Church,
R. Davidson, D. Hoban, P. Kibsey, B. Toye, M. Kuhn, Y. Rzayev,
D. E. Low on behalf of the Canadian Bacterial Diseases Network
Objectives: To determine antibiotic resistance trends in Canadian strains of
S. pneumoniae (SP).
Methods: In 1988 and from 1993–June 2002, 16 787 SP isolates from 192 labs
were submitted for susceptibility testing according to NCCLS protocols. Data
on outpatient antibiotic use was obtained from IMS Canada. We examined
the trends in antibiotic use and resistance rates in SP in Canada.
Results: Of the 16 787 SP isolates, 6350 were from blood/CSF, 5709
were respiratory specimens, and 4728 from other sites. The overall use of
1988 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
Pen NS 2.5 5.7 8.1 8.8 12.2 13.4 14.8 13.6 12.6 14.5 15.1
Pen R 0 0.9 1.3 2.2 4.1 6.5 5.6 5.9 5.9 6.8 6.7
Eryth R 1.2 1.9 3.4 3.1 5.1 6.8 10.5 10.0 11.2 12.9 13.1
Clinda R 1.2 0 1.7 1.3 2.4 3.6 5.1 4.9 5.6 5.9 6.1
Tmp/Smx R 3.7 3.8 4.6 9.6 12.6 14.7 12.0 12.0 11.4 11.9 13.3
Tet R 2.5 1.4 2.3 3.4 2.4 6.3 9.0 7.9 8.1 9.2 9.2
Cipro
(4mg/L)
0 0.5 0.8 0.7 0.8 1.8 1.8 1.6 1.4 2.4 2.3
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macrolides have stabilized while ﬂuoroquinolone use continues to rise in
Canada.
Conclusions: Despite decreasing outpatient use of penicillin, TMP/SMX,
and tetracyclin, there is no decrease in resistance to these agents observed.
Increasing ﬂuoroquinolone use is associated with increasing ciproﬂoxacin
resistance which rose in 1996/7 and again in 2000/1 (P¼ 0.03) but has
remained unchanged in the ﬁrst 6months of 2002.
P1448 Prevalence of mupirocin resistance in isolates of
Staphylococcus aureus and Staphylococcus epidermidis in
three Central European countries: results of the
Antimicrobial Resistance Surveillance Study of the
Paul-Ehrlich-Society for Chemotherapy, 2001
M. Kresken, D. Hafner, F.-J. Schmitz, T. A. Wichelhaus on behalf
of the Working Group for Antimicrobial Resistance of the
Paul-Ehrlich-Society for Chemotherapy
Objectives: Mupirocin calcium ointment is a topical antibiotic indicated for
the eradication of nasal carriage of staphylococci, including methicillin
(oxacillin)-resistant strains. Resistance to mupirocin is related to alterations
in the isoleucyl-tRNA synthetase. It is either of low-level (LL) due to
mutations within the its gene or of high-level (HL) due to the acquisition
of the mupA gene. The clinical signiﬁcance of LL is debatable, whereas strains
with HL cannot be eradicated with mupirocin. In this study we assessed the
prevalence of resistance to mupirocin in isolates of S. aureus and S. epidermidis
obtained from clinical specimens.
Methods: In November 2001, a total of 787 isolates of S. aureus and 456
isolates of S. epidermidis were collected from 26 clinical microbiology labora-
tories distributed throughout three Central European countries (Austria,
Germany, and Switzerland). Minimal inhibitory concentrations of mupirocin
were determined using the broth microdilution procedure according to the
standard of the German DIN. The breakpoints used were 4mg/L (suscep-
tible), 8–256mg/L (LL) and 512mg/L (HL).
Results: Rates of LL- and HL-resistance were 2.9 and 0.9% in S. aureus, and
9.4 and 3.3% in S. epidermidis, respectively. Resistance to mupirocin was
almost exclusively observed in oxacillin-resistant isolates. The majority of
oxacillin-resistant isolates exhibited LL-resistance to mupirocin (table).
Conclusion:Resistance to mupirocin was more common in S. epidermidis than
in S. aureus. Moreover, resistance to mupirocin was nearly always related to
oxacillin-resistant isolates. Approximately 3 and 5% of oxacillin-resistant
S. aureus and S. epidermidis, respectively, exhibited HL-resistance to mupir-
ocin. We strongly recommend a judicious use of mupirocin in order to keep
HL-resistance to mupirocin at a low level.
P1449 Retrospective review of the increase in MRSA
bacteremia in one hospital over 10 years
A. P. Gibb, I. Krupova, F. Sloan
Edinburgh, UK
Objectives: To document the increase in MRSA bacteremia in one hospital
from 1992 to 2001, and to analyze available data which might help explain the
increase.
Methods:We analyzed diagnostic laboratory results for the Royal Inﬁrmary
of Edinburgh (RIE) and MRSA typing data from reference laboratories.
Results: The total number of episodes of S. aureus bacteremia (MSSA and
MRSA) increased from 89 in 1992 to 257 in 2001. MRSA bacteremia was
ﬁrst observed in RIE in 1994, and increased in frequency to 148 episodes in
2001. The 1994 MRSA cases coincided with the appearance of EMRSA-15,
and the increase over the next few years paralleled the rising prevalence of
EMRSA-15, though not all of the early MRSA bacteremias were EMRSA-
15. EMRSA-16 was ﬁrst seen in 1997, and has since accounted for a large
proportion of bacteremias. The ratio of bacteremia to other isolates was higher
for MRSA (7.8%) than for MSSA (4.6%), despite extensive screening for
MRSA. The early cases of MRSA bacteremia were associated with a few
specialist clinical areas, and these areas have continued to account for most of
the cases, but almost all specialities have had some cases. There was no obvious
trend to older patients being affected over time. The increase in MRSA
bacteremia could not be explained by other documented changes in health
care practices.
Conclusion: The arrival and spread of EMRSA-15 and EMRSA-16 are the
major documented factors associated with the increase inMRSA bacteraemia.
P1450 Telithromycin resistance among streptococci in
Finland
J. Jalava, M. Pihlajama¨ki, M. Rantala, P. Huovinen
Turku, FIN
Objectives:Telithromycin is a new antibiotic belonging to the ketolide group.
Here we present the results of the ﬁrst year of a 5-year study of the in vitro
activity of telithromycin against Streptococcus pyogenes and Streptococcus pneu-
moniae strains in Finland. Thus far all the S. pneumoniae strains tested have
been susceptible to telithromycin, regardless of their macrolide resistance
mechanisms. It will be interesting to follow the development of telithromycin
resistance levels and mechanisms in S. pyogenes and S. pneumoniae, and relate
this to the antibiotic usage.
Methods:Fifty consecutive clinical isolates of S. pyogenes and S. pneumoniae are
collected each year from each of the 26 FiRe laboratories situated all over
Finland. Strain collection started at the beginning of May 2002. Each strain is
tested for susceptibility to various antibiotics using the agar-dilution techni-
que. Macrolide-resistant genes [mef(A), erm(B) and erm(TR)] are determined
using PCR, and mutations causing macrolide resistance by sequencing.
Antibiotic consumption data is obtained from the National Agency of
Medicines.
Results: During the year 2002, 614 S. pneumoniae and 662 S pyogenes strains
from 13 FiRe laboratories were collected. Of these, 132 S. pneumoniae and 106
S. pyogenes strains have been analyzed thus far. Of the S. pneumoniae strains,
19.6% (26/132) were resistant (MIC 1mg/L) to erythromycin. The
resistance mechanisms were the mef(A/E) and erm(B) genes and an unknown
mechanism in 19, 5 and 4 strains, respectively. Telithromycin MICs of
1–4mg/L were found in 10 strains. All these strains had either the erm(B)
or mef(A/E) gene. Of the S. pyogenes strains, 12.2% (13/106) were erythro-
mycin resistant (MIC 1mg/L). The erm(TR) gene was the most common
(11 strains). Erm(B) was found in two strains and mef(A/E) in one strain. One
strain, constitutively expressing erm(B), had a telithromycin MIC value of
64mg/L.
Conclusion: Preliminary data indicates that macrolide resistance among
S. pneumoniae and S. pyogenes clinical isolates is increasing in Finland. There
are also a few S. pneumoniae strains with elevated telithromycin MICs. Unlike
most of the S. pneumoniae strains, S. pyogenes strains with a constitutively
expressed erm(B) gene are resistant to telithromycin.
P1451 Prevalence of primary antibiotic resistance in
Helicobacter pylori at two different locations in Belgium
(1998–2002)
Y. Glupczynski, H. Nizet, C. Berhin, J.-P. Martinet, M. Melange,
P. De Prez
Yvoir, Brussels, B
Objectives: Antimicrobial resistance and patient non compliance are the two
main factors associated with failure of H. pylori eradication. Our aim was to
survey frequencies and levels of primary in vitro antibiotic resistance in two
different geographical areas in Belgium, and to investigate possible links with
disease severity, gender, age, and ethnicity of patients.
Methods:Gastric antral and body biopsies forH. pylori cultures were received
from two different endoscopy departments: Saint-Luc University hospital
(Brussels), 259 isolates (2000–2002) and Mont-Godinne University hospital
Resistance (% of isolates)
TotalLL HL
S. aureus
Oxa-S (n¼ 624) 0.2 0.3 0.5
Oxa-R (n¼ 163) 15.6 3.5 19.1
S. epidermidis
Oxa-S (n¼ 142) 0.9 0 0.9
Oxa-R (n¼ 314) 17.0 12.9 4.1
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(Yvoir, South Belgium), 345 isolates (1998–2002). Specimens were cultured
and isolates were tested by disc diffusion and/or E-test for susceptibility to
metronidazole (Mtz), clarithromycin (Cla), amoxicillin (Amx) and tetracy-
cline (Tet).
Results: The overall prevalence of H. pylori infection in the attending
population was 27% and did not vary signiﬁcantly over years or between
the two locations. Global resistance rates toMtz and Cla averaged 31 and 18%,
respectively. Less than 1% of the isolates were resistant to Tet while no
resistance to Amx was found. Mtz resistance varied markedly between
population groups (43% in non Belgian-born vs. 26% in Belgian-born
individuals) and between genders (38% in females vs. 26% in males). Break-
down of resistance by location also showed marked geographical resistance for
Mtz resistance (35% in Brussels vs. 27% in Yvoir) and Cla resistance (13% in
Brussels vs. 22% in Yvoir). The higher proportion of non-Belgian born
individuals in Brussels (33% of all patients vs. 9% in Yvoir) mainly accounted
for the higher Mtz resistance rates at the former location. No signiﬁcant
differences in Mtz nor in Cla resistance were observed between ulcer- or
nonulcer dyspepsia-associated H. pylori isolates.
Conclusion: H. pylori Mtz and Cla resistance did vary markedly between the
two different locations with non-Belgian birth being a key risk factor for
infection with a primary Mtz resistance strain. The higher rate of Cla
resistance in Yvoir could possibly reﬂect a higher consumption of macrolides
in this local population.Overall our results highlight the importance of relying
on local resistance ﬁgures in order to adapt and optimize the choice of the
anti-H. pylori treatment strategies.
P1452 The prevalence of ACSSuT-R type
Salmonella enterica serotype Typhimurium in Turkey
B. Erdem, S. Ercis, G. Hasc¸elik, D. Gu¨r, S. Gedikoglu, B. Su¨merkan,
D. Aysev, M. Tugrul, I. Tuncer, A. Tu¨nger, Y. Akgu¨n, I. Ko¨ksal,
M. Tatman-Otkun, N. Acar, M. Gultekin, G. Soyletir – Turkish
Salmonella Study Group
Objectives: Strains of Salmonella enterica serotype Typhimurium phage type
DT104 have become a world-wide health problem. Isolates of this phage type
often possess resistance of ampicillin, chloramphenicol, streptomycin, sul-
phonamides and tetracyclin (ACSSuT). The aim of this study was to
determine prevalence of ACSSuT resistance pattern among human isolates
of S. Typhimurium in Turkey, and to investigate prevalence of decreased
susceptibility to ciproﬂoxacin (MIC, 0.125–1mg/lt) in ACSSuT R-type
S. Typhimurium strains.
Methods: A total of 620 Salmonella isolates from humans (296 Enteritidis,
215 Typhimurium, 37 Paratyphi B, 18 Typhi, 1 Paratyphi A, 53 Seogroup C)
were collected from 10 cities in Turkey, between July 2000-June 2002.
Antimicrobial susceptibilities (ampicillin:A, cefotaxime:Cf, gentamicin:G,
chloramphenicol:C, tetracyclin:T, trimethoprim:Tm, ciproﬂoxacin:Cp,
streptomycin:S, sulphonamides:Su) were determined by agar dilution tests
following the NCCLS guidelines and intermediately resistant strains were
included in the resistant category.
Results: Thirty-two (14.88%) S. Typhimurium isolates were susceptible to all
antimicrobials. Eleven (5.11%) isolates were resistant to a single antimicrobial.
The most prevalent resistance pattern was ACSSuT (156, 72.55%). Other
resistance patterns were consecutively AT (5), ACSSuTTm (4), ACST (2),
ACGSSuTTm (2), ACfCSuTTm (2), AC (1) and ACT (1). Decreased
susceptibility to ciproﬂoxacin was observed in 6.97% (15) of all S. Typhimur-
ium strains and in 5.12% (8) of the strains with ACSSuT resistance pattern.
Conclusions: These results indicated that ACSSuT R-type S. Typhimurium
strains were common in Turkey and decreased susceptibility to ciproﬂoxacin
in multiresistant S. Typhimurium strains was a newly encountered problem.
P1453 High prevalence of ESBL producing multiresistant
E. coli from UTI infections in a university hospital in Egypt
I. Wiegand, M. H. M. Al-Agamy
Bonn, D
Objectives: To determine the antibiotic susceptibilities and the prevalence of
ESBL in clinical E. coli strains from urinary tract infections isolated in Egypt.
Methods:During the period June 2001 to September 2001 103 isolates were
collected from urinary tract infections at a university hospital in Cairo, with 46
strains being E. coli. These isolates were further characterized by determining
MIC values to 33 different antibiotics according to NCCLS recommenda-
tions. Beta-lactamases were phenotypically differentiated by their MIC
proﬁles to 7 beta-lactams and beta-lactamþ beta-lactamase-inhibitor com-
binations. For ESBL producers plasmid proﬁles were determined and con-
jugation experiments were carried out.
Results:The overall resistance of the E. coli isolates was extremely high with a
ciproﬂoxacin resistance of 41.3%, a resistance to aminoglycosides of 69.6%, a
doxycycline resistance of 89.1%, and a resistance to trimethoprim/sulfa-
methoxazol of 97.8% according to NCCLS breakpoints. Only four of the
strains (8.7%) were sensitive to ampicillin, hence producing no other beta-
lactamase than the chromosomally encoded AmpC enzyme in a very small
amount. Fourteen strains (30.4%) were phenotypically classiﬁed as harboring
original spectrum beta-lactamases. The majority of strains (60.9%) produced
extended spectrum beta-lactamases. These strains exhibited a pronounced
multiresistance proﬁle with most strains being resistant to four or ﬁve different
classes of antibiotics. The analysis of plasmid proﬁles excluded the possibility
of the spread of one single ESBL producing clone as eight different proﬁles
were found. However, this ﬁnding also points to an intrahospital spread of
plasmids and/or strains. In conjugations experiments plasmids conjugated
with high efﬁciency.
Conclusion: In this study alarmingly high rates of ESBL producing multi-
resistant E. coli strains were found. Therapeutic options for these strains are
restricted. Full susceptibility was only seen for aminopenicillinsþ beta-lacta-
mase inhibitors, carbapenems and amikacin. There is an urgent need for
appropriate antibacterial management and infection control.
P1454 Stability of ﬂuoroquinolone resistance in
Canadian Streptococcus pneumoniae isolates
H. J. Smith, K. A. Nichol, L. Palatnick, B. Weshnoweski, G. G. Zhanel,
D. J. Hoban
Winnipeg, CAN
Objectives: The surveillance of ﬂuoroquinolone resistance rates is essential as
the respiratory ﬂuoroquinolones, gatiﬂoxacin, levoﬂoxacin, and moxiﬂox-
acin, are increasingly used in the empiric treatment of S. pneumoniae infec-
tions. The aim of this study was to evaluate ﬂuoroquinolone nonsusceptibility
rates for S. pneumoniae isolated in Canada from 1997 to 2002.
Methods: Clinically signiﬁcant isolates of S. pneumoniae were collected
between 1997 and 2002 from 25 medical centers in 9 of the 10 Canadian
provinces as a component of an ongoing national surveillance study and tested
for their susceptibility to ciproﬂoxacin, gatiﬂoxacin, levoﬂoxacin, and moxi-
ﬂoxacin (NCCLS; M7-A5).
Results: The ﬂuoroquinolone nonsusceptibility (  ) rates for S. pneumoniae
isolated in Canada between 1997 and 2002 are summarized in the table below.
Conclusion: Fluoroquinolone nonsusceptibility rates for S. pneumoniae remain
stable in Canada. Overall (1997–2002) nonsusceptibility rates are below 2%
for ciproﬂoxacin and below 1% for gatiﬂoxacin, levoﬂoxacin, and moxiﬂox-
acin.
P1455 In vitro activity of telithromycin against
Streptococcus pneumoniae isolated from respiratory tract
infections in France in 2002
H. B. Drugeon, A. Bensalah, M. E. Juvin, N. Moniot-Ville
Nantes, Levallois-Perret, Paris, F
Objectives: the objective of this study was to evaluate the in vitro activity of
telithromycin (TEL) and other antibiotics commonly used in France against
Streptococcus pneumoniae (SP) isolates responsible for respiratory tract infections
in adult patients.
Year
Ciprofloxacin Gatifloxacin Levofloxacin Moxifloxacin
% n % n % n % n
1997–98 1.38 1179 ND 0 0.42 1179 0 674
1998–99 1.42 1334 ND 0 0.06 1334 0.40 1278
1999–2000 1.63 1593 0.83 1559 1.13 1593 0.96 1559
2000–01 1.76 1421 0.91 1421 0.77 1421 0.77 1421
20001–02 1.88 1276 1.28 1254 1.49 1276 1.18 1276
Overall
(1997–2002)
1.61 6803 0.94 4234 0.90 6803 0.74 6208
Non-susceptibility was defined as 4mg/mL, >1 mg/mL, >2 mg/mL, and >1 mg/mL
for ciprofloxacin, gatifloxacin, levofloxacin, and moxifloxacin, respectively; ND, no
data.
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Methods: Four hundred and eighty-four clinical strains of SP were isolated
from adult respiratory tract infections from February to April 2002 in 42
metropolitan French hospitals. MICs of TEL, penicillin (P), and erythro-
mycin (E) were determined by microdilution method in a central laboratory.
Susceptibility rates were calculated according to the recommendations of the
Comite´ de l’Antibiogramme de la Socie´te´ Franc¸aise de Microbiologie.
Determination of resistance mechanisms to E (ermB and mefA) was per-
formed by PCR.
Results: The mean age of the patients was 58.1 18.6 years and 68.6% of
them were male. The diagnosis associated with the isolated strains were:
pneumonia 58.7%, acute exacerbation of chronic bronchitis 18.4%, sinusitis
4.3%, others 18.6%. One hundred and forty-nine strains were isolated from at
least one blood culture. From a total of 484 strains, 44.8% were susceptible
(PS), 19% intermediate (PI) and 36.2% resistant (PR) to P; 49.4% were
susceptible (ES) and 50.6% intermediate or resistant (EIR) to E. All but two
of the EIR strains carried the ermB gene. The two remaining strains carried
the mefA gene. The percentages of susceptibility to TEL and the MIC50/90
(mg/L) were the following:
All strains (n¼ 484): 98.6% S – 0.015/0.125
PS strains (n¼ 217): 100% S – 0.015/0.015
PI strains (n¼ 92): 97.8% S – 0.015/0.12
PR strains (n¼ 175): 97.1% S – 0.03/0.25
ES strains (n¼ 239): 100% S – 0.015/0.015
EIR strains (n¼ 245): 97.1% S – 0.03/0.25
There was no resistant strain to TEL.
Conclusions: Telithromycin demonstrates high in vitro activity against SP
isolated from adult respiratory tract infections regardless the susceptibility to
penicillin or erythromycin.
P1456 In vitro activity of levoﬂoxacin against
Streptococcus pneumoniae: results of the ﬁrst study period
in 2002
H. B. Drugeon, C. Dib, M. E. Juvin, N. Moniot-Ville
Nantes, Paris, F
Objective: The objective of this study was to evaluate the in vitro activity of
levoﬂoxacin (LVX) against Streptococcus pneumoniae strains isolated from
respiratory tract infections in adult patients, collected from 42 French hospitals
between February and April 2002.
Methods: The MICs of LVX, penicillin (PEN), and erythromycin (ERY)
were determined by the microdilution method in a central laboratory.
Susceptibility rates were calculated according to the recommendations of
the Comite´ de l’Antibiogramme de la Socie´te´ Franc¸aise de Microbiologie.
Quality control was performed with S. pneumoniae ATCC 49619 (wild-type)
strain.
Results: The MICs 50/90 (mg/L) –% S/I/R were the following:
Overall strains (n¼ 484: LVX 1/1–99.6/0/0.4; PEN 0.12/2–44.8/19/36.2;
ERY 2/>16–49.4/2.9/47.7
PEN-susceptible strains (n¼ 217): LVX 1/1–100/0/0; PEN 0.03/0.06–100/
0/0; ERY 0.03/16–87.6/1.4/11
PEN-intermediate strains (n¼ 92): LVX 1/1–100/0/0; PEN 0.5/1–0/100/0;
ERY >16/>16–34.8/4.4/60.8
PEN-resistant strains (n¼ 175): LVX 1/1–98.9/0/1.1; PEN 2/4–0/0/100;
ERY >16/>16–9.7/4/86.3
The majority of isolates was recovered from lower respiratory specimens
(71.9%) and/or blood cultures (30.8%) and was obtained from patients
hospitalized in medical (35.9%) or intensive care units (34.3%). The most
frequent diagnosis were pneumonia (58.7%) and acute exacerbation of
chronic bronchitis (18.4%). Levoﬂoxacin had a good activity against S. pneu-
moniae with 99.6% of susceptible strains. Resistance to penicillin and ery-
thromycin was high, respectively, 36.2 and 47.7%.
Conclusion: The results of this in vitro survey shows the good activity of
levoﬂoxacin against S. pneumoniae whereas a high rate of resistance to peni-
cillin and erythromycin is reported.
P1457 Patterns of organisms and their antimicrobial
susceptibilities isolated from blood cultures in Larnaca
General Hospital, Cyprus 1999–2002
A. Hadjiloucas, P. Jumaa
Frenaros, CY
Objectives: To provide data on the patterns of organisms and their anti-
microbial susceptibilities isolated from blood cultures in a district general
hospital in Cyprus, where the availability of such data is lacking.
Methods:We performed a retrospective survey of all positive blood cultures
received in the microbiology department of Larnaca General Hospital from
1999 to 2002. Isolates were identiﬁed using conventional microbiology
methods and susceptibility tests were performed in accordance with NCCLS
guidelines wherever possible. The clinical and laboratory data were entered
into a database in WHONET 5 and the results analyzed in WHONET 5.
Results: From 1999 to 2002, 5260 blood culture bottles were received in the
microbiology department, comprising 2416 sets. These resulted in 278
episodes yielding positive blood cultures. Of these, 105 (37.8%) were
considered probable contaminants and 173 (62.2%) were considered clinically
signiﬁcant. Of the clinically signiﬁcant isolates the commonest organisms
were coagulase negative staphylococci 38/173 (22.0%), Staphylococcus aureus
34/173 (19.7%), Pseudomonas aeruginosa 17/173 (9.8%), Klebsiella spp. 16/173
(9.2%), Escherichia coli 11/173 (6.4%), Acinetobacter spp. 8/173 (4.6%),Candida
spp. 7/173 (4.0%), Enterobacter spp. 7/173 (4.0%), Enterococcus spp. 7/173
(4.0%) and Streptococcus pneumoniae 5/173 (2.9%). Overall, 47.1% of S. aureus
isolates were methicillin-resistant (MRSA) and the percentage of MRSA
among S. aureus isolates increased from 33.3% in 1999 to 66.7% in 2002. No
glycopeptide-resistant enterococci or penicillin-resistant S. pneumoniae were
isolated. All Candida isolates occurred during 2001 and 2002. Quinolone
resistance was higher among enterobacteriaceae than in P. aeruginosa. Carba-
penem resistance in P. aeruginosa was 31.6% but was not detected in enter-
obacteriaceae or in Acinetobacter spp. Resistance to third generation
cephalosporins was 38.1% among enterobacteriaceae and 50% in Acinetobacter
spp.
Conclusions: MRSA and Candida spp. have emerged as important causes of
bloodstream infection in our hospital. Surveillance of antimicrobial resistance
is essential to optimize the empirical antimicrobial treatment of infection. It is
essential that resources are provided so that such surveys may be carried out in
Cyprus.
P1458 Multicenter study on antibiotic resistance of
Staphylococcus aureus and the analysis of the clonal
structure of MRSA in Poland
E. Mlodzinska, W. Hryniewicz
Warsaw, PL
Objective: To evaluate the antimicrobial susceptibility of Staphylococcus aureus
isolated from 267 Polish medical centers and to reveal the clonal structure of
the MRSA population.
Methods: A total of 1363 S aureus isolates were collected between 1.10.1999
and 15.11.1999 from 276 Polish medical centers. They represented ﬁve
consecutive isolates per center (one isolate/one patient) and were recovered
from various infection sites. Identiﬁcation of methicillin resistance was
performed by the screening technique and conﬁrmed by the PCR detection
of the mecA gene. MICs were determined by the agar dilution method
according to NCCLS. Nineteen antimicrobials were tested forMRSA isolates
and 24 for MSSA. MRSA isolates were typed by PFGE.
Results: Of the 1363 isolates 181 (13%) were methicillin-resistant. All the
isolates were fully susceptible to vancomycin and teicoplanin. MRSA isolates
were usually multidrug resistant. Only 18% of them were susceptible to
tetracycline, 25% to gentamicin, 31% to erythromycin, and 42% to cipro-
ﬂoxacin. Almost 23% of the isolates exhibited resistance to seven different
antimicrobials. Out of MSSA isolates 79% were resistant to penicillin, 38% to
tetracycline, and 9% to erythromycin. Only few isolates were resistant to
mupirocin. The vast majority of the MRSA isolates represented ﬁve different
epidemic clones that had been identiﬁed among Polish MRSA before. Eight
new PFGE patterns have been observed however, they have been character-
ized sporadic isolates from single centers.
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Conclusion: The representation of S. aureus isolates from more than 250
centers gave us the unique opportunity to study antimicrobial susceptibility of
this organism in Poland. Less than 15% of the isolates turned out to be
methicillin-resistant, which indicated that the MRSA frequency has most
probably decreased in recent years. This may be attributed to improved
diagnostic skills and implementation of infection control policy in more
and more medical institutions in the country. Data presenting in this
study revealed the increasing variety of clonal structure of MRSA strains
in Poland.
P1459 The Libra Initiative: surveillance of the
antibiotic susceptibility of urinary-tract infection pathogens
in Europe from outpatients and inpatients during
1999/2000
I. Morrissey, D. Farrell, H.-O. Werling, M. Robbins, D. Felmingham
London, UK; Wuppertal, D
Objectives: To ascertain the prevalence of various uropathogens in out-
patient (OUT) vs. in-patient (IN) urinary-tract infections (UTIs) and deter-
mine the susceptibility of these pathogens to relevant antimicrobials.
Methods: In total 3144 OUT UTI and 2608 IN UTI isolates were collected
from 33 centers within 14 European countries (Belgium, Denmark, Finland,
France, Germany, Greece, Ireland, Italy, the Netherlands, Portugal, Spain,
Switzerland, Sweden and the United Kingdom), transported to a central
laboratory and re-identiﬁed. Antibiotic susceptibility was determined using
the NCCLS agar dilution method.
Results: Seventy-four bacterial species were identiﬁed causing UTIs. Of
these, Escherichia coli was found to be the most prevalent pathogen in both
OUT and IN (61.3 and 55.4%, respectively), followed by Enterococcus fecalis
(8.3 and 8.6%), Proteus mirabilis (7.2 and 6.2%), Klebsiella pneumoniae (5.4
and 6.1%) and Pseudomonas aeruginosa (3.0 and 5.9%). The percentage
susceptibility of E. coli in Europe as a whole for orally available antibiotics
was ciproﬂoxacin (CIP; 93.3%OUT, 90.9% IN), nalidixic acid (87.4, 83.5%),
amoxycillin (55.5, 52.0%), amoxycillin-clavulanate (82.4, 79.4%), cephradine
(55.2, 50.6%), nitrofurantoin (NFT; 94.0, 91.7%), trimethoprim (74.4,
71.1%) and tetracycline (69.8, 66.4%). Therefore, CIP and NFT were the
most active of these antibiotics against E. coli. However, nitrofurantoin is
inactive against P. aeruginosa and only 0.4 and 0% of P. mirabilis fromOUTand
IN were found to be susceptible to NFT. For CIP, 69.9 and 58.1% suscept-
ibility occurred for OUT and IN P. aeruginosa and 85.8 and 85.7% for OUT
and IN P.mirabilis. For antibiotics available for parenteral administration only,
E. coli OUT and IN susceptibilities were: ceftazidime (99.5, 98.6%), imipe-
nem (100, 99.9%) and gentamicin (97.5, 97.2%).
Conclusions:CIP offered the best overall in vitro activity for an oral antibiotic
and CIP activity was good compared with parenteral antibiotics, which is
important because CIP is available in parenteral as well as oral form.
P1460 Identiﬁcation of two widely disseminated strains
of Enterococcus faecalis highly resistant to gentamicin and
ciproﬂoxacin causing bacteremias in the United Kingdom
N. Woodford, R. Reynolds, K. Grant, J. Turton, F. Scott, A. Williams,
D. Livermore
London, Birmingham, UK
Objectives: To investigate the basis of a signiﬁcant association observed
between high-level resistance to ciproﬂoxacin (Cp) and gentamicin (Gm)
in isolates of Enterococcus faecalis collected in the United Kingdom & Ireland as
part of the BSAC Bacteraemia Resistance Surveillance Program, 2001.
Methods: In 2001, 24 laboratories collected 152 consecutive isolates of
E. faecalis from bacteremias; all were from separate patients. MICs to a panel
of antibiotics were determined centrally, and identiﬁcation was conﬁrmed.
Pulsed-ﬁeld gel electrophoresis (PFGE) of SmaI-digested genomic DNAwas
performed to investigate the relatedness of selected isolates, and banding
patterns were analyzed using BioNumerics software. The criterion of >80%
similarity was used to deﬁne strains.
Results: Sixty of 66 E. faecalis isolates with high-level Gm-R (MICs
512mg/L) were resistant to Cp (MICs 32mg/L), compared with only
7 of 86 E. faecalis isolates with normal Gm susceptibility (P< 0.0001). This
association was not seen for other Enterococcus spp. collected during the survey.
To investigate this further, 38 isolates of E. faecalis highly resistant to Gm
(MICs> 2048mg/L) and Cp (MICs> 64mg/L), and from 18 different
hospitals, were compared by PFGE. Two large clusters were apparent after
analysis of banding patterns; cluster 1 contained 14 isolates from seven
hospitals that were related at 85% similarity; cluster 2 contained 10 isolates
from 6 hospitals also related at 85% similarity. Clusters 1 and 2 were not
closely related to each other (60% similarity). Isolates in both clusters were also
resistant to erythromycin (MICs> 256mg/L). Eighteen of 21 comparator
isolates of E. faecalis from the same bacteremia survey (6 high-level Gm-R,
Cp-S; 7 G-‘S’, Cp-R; 8 G-‘S’, Cp-S) did not fall into either of these clusters.
Three comparator isolates grouped with cluster 2; twowere from one hospital
(both Gm MIC 256mg/L, Cp MIC 128mg/L); the third (Gm MIC 16mg/
L, Cp MIC 128mg/L) was from the same hospital as several other group 2
isolates that had high-level Gm-R
Conclusions: The association between high-level Gm-R and Cp-R in
E. faecalis from bacteraemia reﬂected the presence of multiple isolates of
two widely disseminated strains. Dissociated resistance to Cp and Gm in
some isolates of cluster 2 discounts direct genetic linkage of resistance genes.
Further work is needed to characterize these ‘epidemic’ strains and to
investigate the presence of virulence genes.
P1461 Comparison of serotyping and genotyping of
Hungarian Streptococcus pneumoniae isolates
O. Dobay, E. Hajdu´, E. Nagy, M. Knausz, F. Rozgonyi, S. G. B. Amyes
Edinburgh, UK; Szeged, Gyo˜r, Budapest, HUN
Objectives: Streptococcus pneumoniae can cause a wide range of serious diseases
with high morbidity and mortality. It is essential to determine the epide-
miological and genetic relatedness of groups of bacteria in order to control
diseases. Both phenotyping and genotypingmethods are used for this purpose.
In this study we have chosen pulsed-ﬁeld gel electrophoresis (PFGE) for the
molecular characterization of penicillin nonsusceptible Hungarian pneumo-
cocci and we compared the results to those obtained by serotyping as well as by
antibiotic sensitivity.
Methods: Ninety-six Streptococcus pneumoniae strains were included in the
study, all being penicillin nonsusceptible, isolated in Hungary in 2000–2002.
Their identity conﬁrmed by optochin sensitivity and the presence of the lytA
gene. The susceptibility testing was performed according to the NCCLS
guidelines including suitable control strains. Serotyping of the strains was done
with theMAST typing antisera. PFGEwas performed with the ApaI enzyme.
Results: The most prevalent serotypes were 6, 9, 14, 23 and 19. We found a
signiﬁcant correlation between macrolide sensitivity and strain serotype, but
no clear correlation was seen with penicillin intermediate strains. Although 20
PFGE clones were found in all, 69% of the bacteria were in just four clones.
Serogroup 9 showed the least genetic variation whereas serogroup 6 showed
the greatest diversity. Different genetic clones harboured similar phenotypic
features, suggesting horizontal transfer, but, in contrast, there were differences
within one clonal lineage (loss or gain of resistance, serotype switch). We have
found PFGE pattern identity between our serogroup 9 isolates and others
from different countries of the world. Similarly there was identity between the
serogroup 23 isolates from the UK and Hungary, showing some intercountry
dissemination.
Conclusion: In contrast to previous reports, the Hungarian penicillin non-
susceptible pneumococcal population is very heterogeneous. The successful 9
V and 23F international serotypes appear to have reached Hungary. We have
shown considerable diversity within individual serotypes. Indistinguishable
serotype is not indicative of identical or even closely related clones. Addi-
tionally, serotypes do not always show a close correlation with resistance
pattern, therefore serotyping alone is insufﬁcient for epidemiological studies
and the use of molecular typing is essential.
P1462 Quinolone resistance in clinical
Enterobacteriaceae strains from urinary tract infections
V. Skandami, A. Xanthaki, M. Toutouza, A. Tsiringa,
C. Kontou-Castellanou
Athens, GR
Objectives: To study the frequency and antimicrobial susceptibility of qui-
nolone – resistant Enterobacteriaceae strains isolated from patients with urinary
tract infections in our hospital.
Methods: We studied retrospectively the antibiotic susceptibility of 1693
Enterobacteriaceae strains isolated over a 3-year period (2000–2002) from
patients with urinary tract infections. Isolation and identiﬁcation of the
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microorganisms was performed by conventional methods. The sensitivity to
antimicrobial agents was tested by the disc-diffusion method (NCCLS
recommendations).
Results: Of the strains tested 1415 (83.6%) were Escherichia coli, 167 (9.9%)
Klebsiella pneumoniae and 111 (6.5%) Proteus mirabilis. The resistance rates to
ciproﬂoxacin, oﬂoxacin, peﬂoxacin, norﬂoxacin and nalidixic-acid, respec-
tively, was: E. coli (7.7–7.6–7.8–7.6–11.8%), K. pneumoniae (15.2–12.6–13.4–
12.6–30.1%), P. mirabilis (14.4–14.3–15.5–13.6–29.4%). Of the cipR-E. coli
strains 95.5% were also resistant to norﬂoxacin and peﬂoxacin whereas 99% of
all norR-E. coli strains were also resistant to ciproﬂoxacin. All cipR and norR
K. pneumoniae strains were resistant to the other four quinolones and 93.3% of
the cipR-P. mirabilis strains were resistant to norﬂoxacin. Resistace rates to
the other antibiotics for the cipR and norR-E. coli strains were, respectively:
ampicillin 82.8–83.3%, trimethoprim/sulfamethoxazole 82.6%85.2%, gen-
tamicin 27.0–28.1%, cephalothin 60.8–61.2%, cefuroxime 29.4–30.6%, cef-
tazidime 11.8–12.2%, amoxicillin/clavulanic acid 24.5–25.5%. For K.
Pneumoniae: ampicillin 100.0%100.0%, trimethoprim/sulfamethoxazole
86.7–86.7%, gentamicin 43.8–43.8%, cephalothin 87.5–87.5%, cefuroxime
75.0–75.0%, ceftazidime 81.2–81.2%, amoxicillin/clavulanic acid 56.2–
56.2%. For P. mirabilis: ampicillin 88.9–88.9%, trimethoprim/sulfamethox-
azole 100.0–92.3%, gentamicin 33.3–33.3%, cephalothin 86.7–93.3%, cefur-
oxime 86.7–93.3%, ceftazidime 80.0–80.0%, amoxicillin/clavulanic acid
86.7–86.7%.
Conclusions: During the study period we observed a signiﬁcant increase in
the incidence of Enterobacteriaceae strains resistant to quinolones. The increase
use of quinolones has resulted in the emergence of quinolone-resistant stains
in urinary tract infections. We also observed high resistance rates to major
classes of antimicrobial agents (80–100%) for the quinolone-resistant strains.
P1463 Clonal spread of methicillin-resistant
Staphylococcus aureus at a tertiary care hospital
T. Atay, Z. Gu¨lay
Izmir, TR
Objective: To investigate the clonal relationships of methicillin-susceptible
and methicillin-resistant S. aureus recovered from in and out patients.
Methods: Molecular epidemiology of 75 MRSA and 50 MSSA recovered
from clinical specimens was studied by AP-PCR using M13 primer. Sixty-six
of the MRSA and 32 of the MSSAwere from hospitalized patients while the
remaining (9 MRSA and 18 MSSA) were recovered from outpatients.
Results: AP-PCR analysis of MSSA and MRSA isolates produced 19 and 5
patterns, respectively. AmongMRSA isolates, a group designated as pattern A
contained 59 isolates, whereas patterns D and B, both of which differed from
pattern A in only one band, contained 13 and one isolates, respectively. Eight
(89%) of the isolates that were recovered from out-patients had molecular
pattern A, and one (11%) pattern D.
Conclusions: Our results suggest that clonally related MRSA isolates have
disseminated both in community and hospital setting. On the other hand,
clonal spread is limited among MSSA.
P1464 Antibiotic susceptibility patterns and molecular
epidemiology of Streptococcus pneumoniae in Izmir, Turkey
M. Bic¸men, Z. Gu¨lay
Izmir, TR
Objective:To investigate the antibiotic susceptibility and clonal relationship of
Streptococcus pneumoniae strains isolated at a tertiary care hospital located in
Izmir, Turkey.
Methods: A total of 71 S. pneumoniae strains isolated from various clinical
specimens (respiratory system, eye, blood and cerebrospinal ﬂuid) between
February 2001 and December 2002, were taken into the study. Penicillin
(Pen) and erythromycin MICs were determined by E-test (AB Biodisk,
Sweden) and by microdilution, respectively. Susceptibility patterns for other
agents (clindamycin, tetracycline, chloramphenicol, cotrimoxazole, cipro-
ﬂoxacin and levoﬂoxacin) were investigated by disk diffusion. Clonal relation-
ship among the isolates themselves and the similarities with 16 penicillin-
resistant clones deﬁned by the Pneumococcal Molecular Epidemiology
Network (PMEN) were investigated by BOX-PCR using BOX-A1R pri-
mer. Isolates that had only one band difference were classiﬁed as clonally
related.
Results:Three (4.2%) of the pneumococci were found to be high-level PenR;
whereas 22 (30.9%) were low-level resistant and 46 (64.8%) isolates were
susceptible to penicillin. Resistance rates of cotrimoxazole, tetracycline,
erythromycin, clindamycin and chloramphenicol were found as 45, 33.8,
23.9, 23.9 and 12.6%, respectively. Quinolone resistance was not observed
among the penicillin-susceptible and penicillin-resistant strains. Three, 19 and
37 unique BOX-PCR were identiﬁed patterns among PenR, PenI and PenS
isolates, respectively. None of the Izmir isolates shared the same pattern with
PMEN clones.
Conclusion: In spite of a relatively high ratio of penicillin resistance among
pneumococci isolated in Izmir, signiﬁcant clustering of the isolates was not
detected by BOX-PCR and our isolates were different from the 16 wide-
spread isolates over the world.
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P1465 Consumption of antibiotics in Austria: ﬁrst
results of the ESAC retrospective data collection
H. Mittermayer, S. Metz, M. Elseviers, M. Ferech, R. Vander Stichele,
H. Goossens
Linz, A; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, date accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Austria (8.1 million inhabitants in 2001), reimbursement data
(100% social coverage) for the period 1997–2001 but only for Upper Austria,
were provided by the Social Insurance Company of Upper Austria. AC data
for the other regions and HC data are not available yet.
Results: In Upper Austria, AC use of antibiotics is characterized by a high use
of broad-spectrum penicillins and a high use of macrolides.
Strengths and weaknesses: Data collection of AC data is ongoing. Reim-
bursement data will be provided by all regional Social Insurance Companies.
Main problem of the Austrian data collection system remains the incomplete
coverage of different classes of antibiotics. Antibiotics with a lower price than
the prescription fee are not registered and will never be collected within the
framework of the reimbursement system. A project to collect data in DDD
format for HC is in progress.
Conclusions: AC data collection needs to be extended to other regions of
Austria by a comprehensive effort of the health insurers. A complementary
data source, providing sales data, will be necessary to ensure a comprehensive
data collection.
P1466 Consumption of antibiotics in Belgium: ﬁrst
results of the ESAC retrospective data collection
H. Goossens, A. De Swaef, P. Bruynseels, M. Elseviers,
M. Ferech, E. Hendrickx, R. Vander Stichele
Antwerp, Brussels, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, date accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
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Methods: In Belgium (10.3 million inhabitants in 2001), reimbursement data
(90.5% social coverage) are by law available from community and hospital
pharmacies, who transmit to the health insurers and the National Institute of
Health Insurance. Medicinal product packages in ambulatory care and
distribution units in hospital care all have a unique identiﬁer, linked to the
ATC–DDD system. HC data for 2001 are still lacking due to the slow
collection and validation process.
Results: AC use increased from 25.4 DID in 1997 to 26.6 DID in 1999 and
then declined to 24.3 DID in 2001. Seasonal ﬂuctuationas in AC were high.
In 2001, use of penicillins (PEN), cephalosporins (CEP), tetracyclines,
macrolides and quinolones (Q) was 9.1, 3.4, 2.9, 3.4, and 3.2 DID, respec-
tively; the proportion of narrow spectrum PEN, ampicillin/amoxicillin, and
combination with clavulanic acid was 2, 37, and 58% of total PEN use,
respectively. Belgian AC consumption is characterized by a high use of Q and
of amoxillin–clavulanic acid combination. HC use was 2.5 DID in 2000. The
proportion of use in 2000 of PEN, CEP, carbapenems, glycopeptides and Q
was 50, 19, 1, 1, and 10% of total HC use, respectively.
Strengths and weaknesses: As all antibiotics are reimbursed, this collection
system is valid for recording utilization and for expenditures. Delay in routine
data provision is 15–24months.
Conclusions: Although consumption remains high in Belgium, use declined
after 1999. Extensive use is made of amoxicillin–clavulanic acid combination
and newer antibiotics.
P1467 Consumption of antibiotics in Bulgaria: ﬁrst
results of the ESAC retrospective data collection
B. Markova, M. Popova, T. Benisheva, M. Atanassova, J. Valcheva,
M. Elseviers, M. Ferech, R. Vander Stichele, H. Goossens
Soﬁa, BG; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Bulgaria (7.9 million inhabitants in 2001), sales data (aggregated
for AC and HC) were provided by the Bulgarian Drug Agency for 1999 and
2000. In addition, 5 years consumption data of one hospital (the main
multipurpose hospital of Soﬁa) were available.
Results: Total use was 20.2 DID in 2000. Use of tetracyclines and chlor-
amphenicol was still quite substantial. Use of penicillins (PEN) was pre-
dominantly narrow spectrum, ampicillin or amoxicillin. In hospitals, use of
third and fourth generation cephalosporins was early and substantial.
Strengths and weaknesses: The comprehensiveness of wholesaler data
cannot be guaranteed, nor split for AC and HC. New data collection systems
are currently being built, based on reimbursement data for AC and on hospital
pharmacists for HC, all using common ATC–DDD methodology.
Conclusions: In Bulgaria, valid estimation of population exposure to anti-
biotics was possible but without the ability to separate for AC and HC
use.
P1468 Consumption of antibiotics in Croatia: ﬁrst
results of the ESAC retrospective data collection
A. Tambic Andrasevic, I. Francetic, S. Kalenic, R. Vrsalovic,
M. Elseviers, M. Ferech, R. Vander Stichele, H. Goossens
Zagreb, HR; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Croatia (4.4 million inhabitants in 2001), sales data were
collected by a marketing research company and provided in collaboration
by the National Institute of Public Health and by the National Institute of
Statistics, with almost 100% coverage for AC andHC, only for 2000 and 2001.
Results:AC use was 18.4 DID in 2000, and 17.6 DID in 2001. In 2001, use of
penicillins (PEN), cephalosporins (CEP), tetracyclines, macrolides and qui-
nolones (Q) was 8.6, 3.0, 1.4, 1.8, and 1.3 DID, respectively; the proportion
of narrow spectrum PEN, ampicillin/amoxicillin, and combination with
clavulanic acid was 13, 45, and 41% of total PEN use, respectively. HC
was 1.9 DID in 2001, and the proportion of use in 2001 of PEN, CEP,
carbapenems, glycopeptides, and Q was 45, 25, 1, 1, and 9% of total HC use,
respectively; the CEP generations represented (from ﬁrst to fourth) 29, 52, 18,
and 1% of total CEP use.
Strengths and weaknesses: AC data are comprehensive, timely and
expressed in DID. Historical overview is limited. Data collection in AC
and in all individual hospitals is now organized in strong collaboration with
the Croatian Committee for Antibiotic Resistance Surveillance.
Conclusions: In Croatia, prospects for appropriate antibiotic use and com-
prehensive data collection are good.
P1469 Consumption of antibiotics in Czech Republic:
ﬁrst results of the ESAC retrospective data collection
L. Stika, V. Jindrak, P. Urbaskova, M. Elseviers, M. Ferech, R. Vander
Stichele, H. Goossens
Prague, CZ; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Czech Republic (10.3 million inhabitants in 2001), sales data
(aggregated for AC and HC) were provided by the State Institute for Drug
Control. In addition, Institute for Health Information and Statistics (Ministry
of Health) provided reimbursement data collected by some of the health
insurers, covering nearly 100% of insured population, but without guarantee
of comprehensiveness. In HC, only one hospital up to now provided data.
Results: Total use of antibiotics remained constant and varied between 18.6
DID in 1997 and 19.7 DID in 2001. Tetracyclines were largely prescribed (3.5
DID in 2001), while quinolones showed most rapid increase during the
period of observation.
Strengths andweaknesses: Excellent historical data from the former central
wholesaler are available, providing a time series of antibiotic consumption
from 1952 till 1990. Individual hospitals participate actively in drug utilization
studies, often focused on antibiotics. For AC data collection, collaboration
between health insurers needs to be enforced. Support for national coordina-
tion between hospital pharmacists could easily spark valid data collection in
HC.
Conclusions: In Czech Republic, no valid detailed estimation of population
exposure to antibiotics is currently available in the public domain. Unless
cooperation between health insurers and hospital pharmacists is supported,
probably even made mandatory, this situation will persist.
P1470 Consumption of antibiotics in Denmark: ﬁrst
results of the ESAC retrospective data collection
D. Monnet, A. Nielsen, M. Elseviers, M. Ferech, R. Vander Stichele,
H. Goossens
Copenhagen, Bronshoj, DK; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Clinical Microbiology and Infection, Volume 9, Supplement 1, 2003 357
Methods: In Denmark (5.3 million inhabitants in 2001), sales data were
collected from the community pharmacies (AC) and hospital pharmacists
(HC), and provided by the Danish Medicines Agency.
Results: AC remained constant and varied between 12.2 DID in 1997 and
12.8 DID in 2001. Seasonal ﬂuctuations were small. In 2001, use of penicillins
(PEN), cephalosporins (CEP), tetracyclines, macrolides and quinolones (Q)
was 8.0, 0.03, 1.0, 2.1, and 0.2 DID, respectively. Narrow spectrum PEN,
ampicillin/amoxicillin and combinations with clavulanic acid represented 61,
15, and <1% of total PEN use, respectively.
HC use showed a constant but minor increase, from 1.3 DID in 1997 to 1.4
DID in 2001. In 2001, PEN, CEP, carbapenems, glycopeptides and Q
represented 58, 12, 1, 1, and 6% of total HC use, respectively. The different
generations of CEP represented (from ﬁrst to fourth generation) 2, 87, 11, and
0% of total CEP use, respectively.
Strengths and weaknesses: AC data cover the whole country, and the data
are linked to the GP and the patient. HC data cover the whole country and are
available by ward, but certain antibiotics are not registered (<4%). The quality
of the data collection system is high.
Conclusions: In Denmark, AC and HC use remains low. PEN (narrow
spectrum in AC) are the most widely prescribed antibiotics.
P1471 Consumption of antibiotics in England: ﬁrst
results of the ESAC retrospective data collection
P. Davey, A. Custance, M. Elseviers, M. Ferech, R. Vander Stichele,
H. Goossens
Dundee, London, UK; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In England (49.1 million inhabitants in 2001), reimbursement data
were provided by the Department of Health, with >95% coverage for AC.
No data were available for HC.
Results: AC use varied between 16.8 DID in 1997 and 14.6 DID in 2001,
with little seasonal ﬂuctuation. In 2001, use of penicillins (PEN), cephalos-
porins (CEP), tetracyclines, macrolides and quinolones was 6.6, 0.8, 3.1, 2.2,
and 0.4 DID, respectively; the proportion of narrow spectrum PEN, ampi-
cillin/amoxicillin and combination with clavulanic acid was 10, 65 and 12% of
total PEN use, respectively.
Strengths and weaknesses: AC data for England are comprehensive, timely
and, for the ﬁrst time, expressed in DID. Cooperation between Wales,
Scotland, England, and Northern Ireland will be necessary to provide
comprehensive UK data. Linking to the ATC/DDD methodology will be
facilitated by the common use of the British National Formulary.
Conclusions: AC consumption in England has been declining steadily over
the past four years. Currently, there are no national data about hospital
consumption in the UK available and governmental support will be required
to improve the situation.
P1472 Consumption of antibiotics in Finland: ﬁrst
results of the ESAC retrospective data collection
P. Huovinen, P. Paakkari, T. Voipio, M. Elseviers, M. Ferech, R. Vander
Stichele, H. Goossens
Turku, Helsinki, FIN; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Finland (5.2 million inhabitants in 2001), sales data were
provided by the National Agency for Medicines.
Results: AC remained constant and varied between 19.4 DID in 1997 and
19.8 DID in 2001; seasonal ﬂuctuations were low. In 2001, use of penicillins
(PEN), cephalosporins (CEP), tetracyclines (TET), macrolides and quino-
lones (Q) was 6.1, 2.3, 4.6, 2.2, and 0.8 DID, respectively; the proportion of
narrow spectrum PEN, ampicillin/amoxicillin, and combination with cla-
vulanic acid was 35, 45, and 12% of total PEN use, respectively. HC use
showed a constant but minor increase, from 3.5 DID in 1997 to 3.9 DID in
2001. The proportion of use in 2001 of PEN, CEP, carbapenems, glycopep-
tides and Q was 14, 20, 1, 1, and 16% of total HC use, respectively; the CEP
generations represented (from ﬁrst to fourth) 36, 50, 13, and 1% of total CEP
use.
Strengths and weaknesses: Data cover the whole country, but the split
between AC and HC consumption remains to be elucidated.
Conclusion: In Finland, AC use was moderate and TET was largely pre-
scribed. HC use of antibiotics is high in this Scandinavian country, but this
may be due to the inclusion of nursing homes and health center wards
consumption in HC data.
P1473 Consumption of antibiotics in France: ﬁrst results
of the ESAC retrospective data collection
F. Meyer, D. Guillemot, P. Maugendre, S. Leclerc, S. Stamenkovic,
M. Elseviers, M. Ferech, R. Vander Stichele, H. Goossens
Paris, F; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In France (59.0 million inhabitants in 2001), sales data were
provided by AFSSAPS (French Health Products Safety Agency) and collected
on the basis of mandatory annual reporting of the pharmaceutical companies.
Results: AC use was 33.0 DID in 1997, peaked to 34.3 DID in 1999 and
subsequently decreased to 32.9 DID in 2001. In 2001, use of penicillins
(PEN), cephalosporins (CEP), tetracyclines, macrolides (M) and quinolones
(Q) was, respectively, 16.2, 4.2, 3.1, 6.0, and 2.3 DID; the proportion of
narrow spectrum PEN, ampicillin/amoxicillin, and combination with cla-
vulanic acid was 1, 59, and 34% of total PEN use, respectively. HC remained
constant and was 3.6 DID in 2001. The proportion of use in 2001 of PEN,
CEP, carbapenems, glycopeptides and Q was 49, 7, 0.4, 1, and 10% of total
HC use, respectively; the CEP generations represented (from ﬁrst to fourth)
16, 31, 49, and 4% of total CEP use.
Strengths of the data: Exhaustiveness of antibiotic sales and availability since
1988.
Weaknesses of the data:Only national and annual data without more precise
information at a regional or at a monthly or weekly level.
Conclusion: In France, AC and HC use is extremely high. In AC, a very high
broad-spectrum PEN, CEP and M consumption was noted. Consumption of
antibiotics has stabilized during recent years, but a trend towards decline needs
to be conﬁrmed by continuous surveillance of antibiotic consumption.
P1474 Consumption of antibiotics in Germany: ﬁrst
results of the ESAC retrospective data collection
W. V. Kern, J. Guenther, H. Schroeder, K. Nink, E. Meyer,
F. D. Daschner, K. de With, M. Elseviers, M. Ferech, R. Vander Stichele,
H. Goossens
Freiburg, Bonn, D; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Data were to be
collected retrospectively from ambulatory (AC) and hospital care (HC) in 31
countries, using ATC/DDD classiﬁcation (WHO, version 2002), and expres-
sing results in DDD/1000 inhabitants per day (DID).
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Methods: In Germany (82 million inhabitants in 2001), AC data were
provided by WIdO using a 0.4% sample data base of all compulsory health
insurance covered (GKV, 71 million) prescriptions for the years before 2000,
and a total GKV prescriptions database for the year 2001. HC data were
estimated from the SARI project covering 35 intensive care units (ICUs)
located in 17 different regions, and from the MABUSE program covering the
medical and surgical services of 8 university hospitals.
Results:ACuse declined slightly from 14.5DID in 1997 to 13.8 DID in 2001.
Regional differences ranged between 9.6 and 17.3 DID. In 2001 the use of
narrow-spectrum penicillins plus aminopenicillins was 4.1 DID, and the use of
tetracyclines was 3.6 DID. The uses of other drug classes (in DID) were:
macrolides 2.1; aminopenicillin/betalactamase inhibitor combinations plus
oxacillins plus oral cephalosporins, 1.3; and quinolones, 1.1. Between 1997
and 2001, quinolone use was increasing, while tetracycline use decreased.
Mean use in ICUs was 133 DDD/100 patient days (range, 71–250). Use
ranged between 40 and 80 in the medical service areas outside ICU and
between 120 and 150 DDD/100/patient days in the hematology-oncology
services. Rough estimates from these data with extrapolation to the 2252
hospitals (169 million patient days) indicate hospital antibiotic use per
population to be in an order of magnitude of 1–2 DID.
Strengths and weaknesses: Representative HC data so far are not available
while AC data cover 86% of the total population (excluding private
insurance patients). Quarterly AC data have not become available until
recently.
Conclusions: In Germany, there has been no major change in overall medical
use of antibiotics during the past few years. HC use represents 10% of the
total medical antibiotic use. Penicillin/aminopenicillins and tetracyclines are
the most frequently prescribed drug classes.
P1475 Consumption of antibiotics in Greece: ﬁrst results
of the ESAC retrospective data collection
H. Giamarellou, A. Antoniadou, A. Vardika, K. Perrakis, C. Baltsavia,
M. Elseviers, M. Ferech, R. Vander Stichele, H. Goossens
Athens, GR; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Greece (10.9 million inhabitants in 2001), sales data were
provided by the National Organization for Medicines and collected on the
basis of mandatory reporting of the pharmaceutical companies.
Results: AC use increased constantly from 25.1 DID in 1997 to 29.4 DID in
2001, which was due to increased use of macrolides (M) and quinolones (Q);
high seasonal ﬂuctuations were noted. In 2001, use of penicillins (PEN),
cephalosporins (CEP), tetracyclines, M and Q was 10.1, 6.6, 2.7, 6.9, and 2.1
DID, respectively; the proportion of narrow spectrum PEN, ampicillin/
amoxicillin, and combination with clavulanic acid being 5, 56, and 39%
of total PEN use, respectively. HC use varied between 2.1 DID in 1997 and
2.2 DID in 2001. The proportion of use in 2001 of PEN, CEP, carbapenems,
glycopeptides andQwas 28, 26, 2, 2, and 9% of total HC use, respectively; the
CEP generations represented (from ﬁrst to fourth) 2, 70, 23, and 5% of total
CEP use.
Strengths and weaknesses: AC data covered the entire market, including
OTC sales, but also nursing homes, private health care facilities as well as
parallel exports; HC data covered all, but not private, hospitals.
Conclusions: In Greece, a constant increase of AC was noted; Q use was high
both in AC and HC. However, for valid interpretation and European
comparison, parallel export data should be identiﬁed.
P1476 Consumption of antibiotics in Hungary: ﬁrst
results of the ESAC retrospective data collection
G. Ternak, M. Elseviers, M. Ferech, R. Vander Stichele, H. Goossens
Pecs, HUN; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Hungary (9.9 million inhabitants in 2001), complete reimburse-
ment data for the period 1998–2001 were provided by the National Health
Insurance (OEP) for AC. For HC, complete sales data (only for 2001) were
delivered by the same data provider.
Results:AC use remained rather stable from 18.6 DID in 1998 to 19.1 DID in
2001, with an exceptional high use of 23.9 DID in 1999, possibly related to a
serious inﬂuenza outbreak during that year. Seasonal ﬂuctuations were high.
In 2001, use of penicillins (PEN), cephalosporins (CEP), tetracyclines,
macrolides, and quinolones (Q) was 8.7, 2.5, 2.3, 3.3, and 1.2 DID,
respectively; the proportion of narrow spectrum PEN, ampicillin/amoxicil-
lin, and combination with clavulanic acid was 13, 36, and 49% of total PEN
use, respectively. HC use was 1.3 DID in 2001. The proportion of use in 2001
of PEN, CEP, carbapenems, glycopeptides and Q was, 49, 13, 1,<1 and 7%
of total HC use, respectively; the CEP generations represented (from ﬁrst to
fourth): 4, 87, 8, and 1% of total CEP use.
Strengths and weaknesses: AC data were relatively accurate since they
covered 100% of the population and were based on doctor’s prescription. The
hospital consumption, only available since 2001, will be improved by a
broader usage of electronic data collection in the future.
Conclusions: In Hungary, a relative constant use of antibiotics was observed in
AC. Continuation of data collection in HC will need logistic support.
P1477 Consumption of antibiotics in Iceland: ﬁrst
results of the ESAC retrospective data collection
K. Kristinsson, M. Elseviers, M. Ferech, R. Vander Stichele, H. Goossens
Reykjavik, IS; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Iceland (0.3 million inhabitants in 2001), total sales data from
pharmaceutical companies were provided by the Ministry of Health. No
differentiation between AC and HC use could be made.
Results: Total use slowly decreased from 21.5 DID in 1998 to 19.1 DID in
2001. Seasonal ﬂuctuations are small except for the winter of 1998 with a peak
consumption of 27.3 DID. Penicillins (PEN) accounted for half of the total
antibiotic use. In 2001, total use of PEN, cephalosporins (CEP), tetracyclines,
macrolides, and quinolones (Q) was 10.3, 0.5, 4.7, 1.6, and 0.7 DID,
respectively; the proportion of narrow spectrum PEN, ampicillin/amoxicil-
lin, and combination with clavulanic acid was 29, 35, and 20% of total PEN
use, respectively.
Strengths and weaknesses: Complete coverage of all antibiotics sold in
Iceland was obtained. However, it is impossible to differentiate between AC
and HC use.
Conclusions:Use of antibiotics in Iceland is rather high, slowly decreasing and
mainly consisting of penicillins. The data collection system is hampered by the
aggregation of AC and HC data.
P1478 Consumption of antibiotics in Italy: ﬁrst results
of the ESAC retrospective data collection
G. Cornaglia, L. Bozzini, B. Rebesco, M. Elseviers, M. Ferech,
R. Vander Stichele, H. Goossens
Verona, Genoa, I; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
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hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Italy (57.5 million inhabitants in 2001), sales data per year for the
period 1999–2001, covering 90% of population, were provided by the
Ministry of Health (Direzione Generale della Valutazione dei Medicinali e
della Farmacovigilanza). Prescribed, non reimbursed as well as OTC anti-
biotics were included. For HC, data were collected from one hospital for the
period 1997–2000 and from six hospitals for 2001.
Results: AC use varied between 25.0 DID (1999) and 27.3 DID (2001). AC
use is characterised by a high consumption of penicillins (PEN). In 2001, use
of PEN, cephalosporins (CEP), tetracycline, macrolides (M) and quinolones
(Q) was, 11.6, 3.5, 0.5, 5.1, and 3.8 DID, respectively; the proportions of
narrow spectrum PEN, ampicillin/amoxicillin, and amoxicillin plus clavu-
lanic acid were,<1, 52, and 39%, respectively, of total PEN use. In HC, the
proportion of use in 2001 of PEN, CEP, carbapenems, glycopeptides and Q
was 19, 15, 1, 3 and 9% of total HC use, respectively; the CEP generations
represented (from ﬁrst to fourth) 20, 3, 72, and 5% of total CEP use. An
extremely high use of colistin (J01XB01) was observed.
Strengths and weaknesses: AC data were comprehensive but a delay in
delivery was observed. HC data were not yet representative for the whole of
Italy.
Conclusion: In Italy, a high AC consumption was observed with a high
use of Q. For HC data collection, the sample of hospitals needs to be
enlarged.
P1479 Consumption of antibiotics in Latvia: ﬁrst results
of the ESAC retrospective data collection
S. Berzina, G. Ozolins, M. Elseviers, M. Ferech, R. Vander Stichele,
H. Goossens
Riga, LV; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Latvia (2.4 million inhabitants in 2001), only 2001 sales data
from wholesalers were provide by the State Medicinal Agency, separately for
AC and HC. Validation of the use of ATC-methodology, comprehensiveness
of the data, and details on the split between AC and HC could not be assessed.
Results: AC use was 13.1 DID in 2001. In that year, the use of penicillins
(PEN), cephalosporins (CEP), tetracyclines, macrolides and quinolones (Q)
was 10.4, 0.6, 0.1, 0.3, and 0.6 DID, respectively; the proportion of narrow
spectrum PEN, ampicillin/amoxicillin, and combination with clavulanic acid
was 1, 84, and 15% of total PEN use, respectively.
HC consumption was 4.5 DID in 2001, and the proportion of PEN, CEP,
carbapenems, glycopeptides, and Q was 86, 6,<1,<1, and 1% of total HC
use, respectively; the CEP generations represented (from ﬁrst to fourth) 70, 6,
22, and 2% of total CEP use.
Strengths and weaknesses: Data are provided on a yearly basis only. No
major changes in data collection performance are anticipated for the near
future.
Conclusions: In Latvia, no validated, longitudinal estimation of population
exposure to antibiotics is currently available in the public domain. The
proportion of HC use on total exposure appears to be exceptionally high.
Narrow spectrum PEN, ampicillin and amoxicilin dominate antibiotic con-
sumption, both in AC and in HC.
P1480 Consumption of antibiotics in Lithuania: ﬁrst
results of the ESAC retrospective data collection
R. Valinteliene, A. Stefanovic, M. Elseviers, M. Ferech, R. Vander
Stichele, H. Goossens
Vilnius, LIT; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Lithuania (3.7 million inhabitants in 2001), AC data (provided
by the State Patient Fund) are not comprehensive, because of the complex
nature of the reimbursement status of antibiotics (only a limited number of
antibiotics are reimbursed, only for special categories of patients and certain
diseases). HC data stem from a sample of 5 hospitals, which cover up to 15% of
total patient days.
Results: The proportion of HC use in 2001 of penicillins, cephalosporins
(CEP), carbapenems, glycopeptides and quinolones was 55, 12, 2, 1, and 2%
of total HC use, respectively; the CEP generations represented (from ﬁrst to
fourth) 18, 62, 15, and 5% of total CEP use.
Strengths and weaknesses:Unless legislative changes make the provision of
sales data from wholesalers or community pharmacists possible, no valid AC
data collection will be possible. For HC, the current sample of hospitals needs
to be enlarged.
Conclusions: In Lithuania, no valid estimation of population exposure to
antibiotics is currently available from existing databases in the public domain.
P1481 Consumption of antibiotics in Luxemburg: ﬁrst
results of the ESAC retrospective data collection
R. Hemmer, M. Bruch, D. Hansen-Koenig, M. Elseviers, M. Ferech,
R. Vander Stichele, H. Goossens
Luxemburg, LUX; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Luxemburg (0.4 million inhabitants in 2001), reimbursement
data for AC were provided by the National Health Insurance Company; HC
data were collected by the hospital pharmacists.
Results: AC use varied between 25.8 DID in 1997 and 26.4 DID in 2001. In
2001, use of penicillins (PEN), cephalosporins (CEP), tetracyclines macro-
lides and quinolones (Q) was 9.8, 4.9, 2.6, 4.7, and 2.5 DID, respectively; the
proportion of narrow spectrum PEN, ampicillin/amoxicillin, and combina-
tion with clavulanic acid was 2, 43, and 52% of total PEN use, respectively.
HC use remained constant and was 2.0 DID in 1997 and 2.1 DID in 2001.
The proportion of use in 2001 of PEN, CEP, carbapenems, glycopeptides and
Q was 42, 30, 2, 1, and 10% of total HC use, respectively; the CEP
generations represented (from ﬁrst to fourth) 18, 62, 15, and 5% of total
CEP use.
Strengths and weaknesses: AC data are prescription data which covered
96.1% of the total population, i.e. those insured at the national Health
Insurance. HC data covered 89.5% of the hospital occupancy.
Conclusion: In Luxemburg AC use is high, particularly of ampicillin/amox-
icillin and the combination with clavulanic acid.
P1482 Consumption of antibiotics in Malta: ﬁrst results
of the ESAC retrospective data collection
M. Borg, P. Zarb, M. Elseviers, M. Ferech, R. Vander Stichele,
H. Goossens
G’Mangia, MT; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
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Methods: InMalta (0.4 million inhabitants in 2001), no AC data are available.
For HC, comprehensive data are collected by the Government Pharmaceu-
tical Services, covering all public hospitals and 97% of the private hospitals.
Results:HC use was 2.5 DID in 1997, peaked with 4.1 DID in 1999 and was
3.0 DID in 2001. The proportion of HC use in 2001 of penicillins,
cephalosporins (CEP), carbapenems, glycopeptides, and quinolones was
55, 12,<1,<1, and 6% of total HC use, respectively; the CEP generations
represented (from ﬁrst to fourth) 26, 51, 23, and 0% of total CEP use.
Strengths and weaknesses: No valid AC data collection will be available,
unless legislative changes are made.
Conclusions: In Malta, no valid estimation of population exposure to anti-
biotics is currently available in the public domain, despite comprehensive data
collection in hospitals.
P1483 Consumption of antibiotics in the Netherlands:
ﬁrst results of the ESAC retrospective data collection
R. Janknegt, M. Filius, Y. Liem, M. Elseviers, M. Ferech,
R. Vander Stichele
Sittard, Rotterdam, NL; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, the accessibilities, strengths and
weaknesses of national systems were assessed and quarterly data were collected
retrospectively (1997–2001) from ambulatory (AC) and hospital care (HC) in
31 countries. The ATC/DDD classiﬁcation (WHO, version 2002) was used,
and data were expressed in DDD/1000 inhabitants per day (DID).
Methods: In the Netherlands (16.0 million inhabitants in 2001), AC sales data
were collected and analyzed by the Foundation of Pharmaceutical Statistics
(SFK) and provided by SWAB; data from a 88% sample of community
pharmacies were weighted and extrapolated. For HC, data were requested
by SWAB from all Dutch hospital pharmacists; 60 hospitals responded (62%
bed days) and data were extrapolated.
Results: AC use remained surprisingly constant at the low level of 10.0 DID
(the lowest in Europe) from 1997 to 2001, with little seasonal ﬂuctuations. In
2001, use of penicillins (PEN), cephalosporins (CEP), tetracyclines, macro-
lides and quinolones (Q) was 3.9, 0.7, 2.4, 1.3, and 0.9 DID, respectively; the
proportion of narrow spectrum PEN, ampicillin/amoxicillin, and combina-
tion with clavulanic acid was 10, 46, and 31% of total PEN use, respectively.
In HC, antibiotic use remained constant at 0.8 DID. The proportion of use in
2000 of PEN, CEP, carbapenems, glycopeptides, and Q was 55, 11, 1, 1, and
9% of total HC use, respectively; the CEP generations represented (from ﬁrst
to fourth) 22, 48, 28, and 2% of total CEP use.
Strengths andweaknesses:HC data collection was cumbersome. Validation
with other available data sources on AC within health insurers is still to be
performed.
Conclusions: In the Netherlands, use of antibiotics in AC and HC is low,
constant, and apparently appropriate. Integration of data collection of multi-
ple sources through national collaboration is on its way.
P1484 Consumption of antibiotics in Norway: ﬁrst
results of the ESAC retrospective data collection
H. Salvesen Blix, M. Elseviers, M. Ferech, R. Vander Stichele,
H. Goossens
Oslo, N; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2001), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Norway (4.5 million inhabitants in 2001), total sales data were
provided by the National Institute of Public Health. For 1998 and 2001,
separate HC use data were available and differentiation between AC and HC
use could be made by subtracting HC use from total use.
Results: Total use remained stable around 17 DID. In 2001, AC use was 15.7
DID and use of penicillins (PEN), cephalosporins(CEP), tetracyclines,
macrolides, and quinolones (Q) was, 6.7, 0.3, 3.1, 1.8, and 0.4 DID,
respectively; the proportion of narrow spectrum PEN, ampicillin/amoxicil-
lin, and combination with clavulanic acid was 66, 13, and <1% of total PEN
use, respectively. HC use was 1.1 DID in 2001. The proportion of use in 2001
of PEN, CEP, carbapenems, glycopeptides and Q was: 47, 23, 1,<1, and 4%
of total HC use, respectively; the CEP generations represented (from ﬁrst to
fourth): 26, 49, 25, and 0% of total CEP use.
Strengths and weaknesses: Total Norwegian data are complete and com-
prehensive. A prescription database is planned for 2003, with delivery from all
pharmacies to the National Institute of Public Health.
Conclusions: Norway had a stable and low use of antibiotics with a high
proportion of narrow spectrum penicillins used. The new data collection
system will enable the differentiation between AC and HC use.
P1485 Consumption of antibiotics in Poland: ﬁrst results
of the ESAC retrospective data collection
W. Hryniewicz, P. Grzesiowski, M. Cel, M. Elseviers, M. Ferech,
R. Vander Stichele, H. Goossens
Warsaw, PL; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Poland (38.6 million inhabitants in 2001), sales data were
provided by the National Institute of Public Health, for AC as well as for
HC. Data for ESAC were derived from reports of 200 out of 400 wholesalers
(covering about 60% of the market) and were extrapolated for complete
population coverage.
Results: AC use sharply increased from 16.6 DID in 1997 to 24.8 DID in
2001, with an increasing high use of penicillins (PEN), a high use of
tetracyclines and a low use of macrolides. Seasonal ﬂuctuation is high. In
2001, use of PEN, cephalosporins (CEP), tetracyclines, macrolides, and
quinolones (Q) was 11.1, 2.3, 4.2, 2.6, and 1.0 DID, respectively; the
proportion of narrow spectrum PEN, ampicillin/amoxicillin, and combina-
tion with clavulanic acid was 10, 70, and 19% of total PEN use, respectively.
HC varied between 2.7 DID in 1997 and 2.4 DID in 2001. The proportion of
use in 2001 of PEN, CEP, carbapenems, glycopeptides and Q was 41,
19,<1,<1, and 6% of total HC use, respectively; the CEP generations
represented (from ﬁrst to fourth): 8, 60, 32, and 0.3% of total CEP use.
Strengths andweaknesses:Although data for all years could be provided, the
completeness of the data from the ﬁrst years of the observation period could
be questioned. Data are based on reports of half of the wholesalers covering
60% of the sales. Main characteristics of these wholesalers need to be made
available for precise extrapolation.
Conclusions: In Poland, total AC use of antibiotics increased rapidly while
HC use remained stable. Particularly a growing use of penicillins in AC was
observed. Since data was derived from one-half of wholesalers, careful
extrapolation is needed.
P1486 Consumption of antibiotics in Portugal: ﬁrst
results of the ESAC retrospective data collection
L. Caldeira, A. Antonio, A. Fonseca, M. Elseviers, M. Ferech,
R. Vander Stichele, H. Goossens
Lisbon, P; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
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Methods: In Portugal (10.0 million inhabitants in 2001), reimbursement data
for AC, covering 75% of the population, were provided by the Ministry of
Health. For HC, only reimbursement data of 1998 could be delivered.
Results: AC use was at a high level of 24.6 DID in 2001, with an exceptional
high use of quinolones (Q). In 2001, use of penicillins (PEN), cephalosporins
(CEP), tetracyclines, macrolides, and quinolones (Q) was 11.7, 3.1, 1.4, 3.7,
and 3.7 DID, respectively; the proportion of narrow spectrum PEN, ampi-
cillin/amoxicillin, and combination with clavulanic acid was 1, 35, and 59% of
total PEN use, respectively.
Strengths and weaknesses: AC data were relatively accurate since all
antibiotics are included in the reimbursement system. However, data were
delivered in a format, which was difﬁcult to analyze. HC data were only
available for 1998 and were collected within the framework of a national
survey. End 2002, a nationwide on-line collection network will be ﬁnalized,
enabling data collection on a monthly base from all hospitals included in the
national health service.
Conclusions: In Portugal, AC use of antibiotics is rather high. Particularly for
HC, a new system of data collection needs to be established in order to obtain
comprehensive HC use data.
P1487 Consumption of antibiotics in Slovakia: ﬁrst
results of the ESAC retrospective data collection
V. Foltan, L. Langsadl, T. Tesar, A. Vinarova, M. Elseviers, M. Ferech,
R. Vander Stichele, H. Goossens
Bratislava, SK; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Slovakia (5.4 million inhabitants in 2001), wholesalers data were
provided by the Slovak Institute for Drug Control, split for AC and HC, on a
monthly basis, since 1999.
Results: AC use was 25.7 DID in 1999 and 24.1 DID in 2001, with
considerable seasonal ﬂuctuations. In 2001, use of penicillins (PEN), cepha-
losporins (CEP), tetracyclines, macrolides and quinolones was 14.1, 2.0, 2.1,
3.3, and 1.5 DID, respectively; the proportion of narrow spectrum PEN,
ampicillin/amoxicillin, and combination with clavulanic acid was 27, 44, and
29% of total PEN use, respectively.
HC use was 1.4 DID in 2001. In that year, the proportion of use of PEN, CEP,
carbapenems, glycopeptides, and Q was 40, 20,<1,<1, and 15% of total HC
use, respectively; the CEP generations represented (from ﬁrst to fourth) 18,
51, 31, and <1% of total CEP use.
Strengths and weaknesses: The wholesaler data are comprehensive, timely
and monthly, but cannot be used for regional and clinically oriented analysis.
Conclusions: In Slovakia, antibiotic use is high in AC and relatively low inHC.
P1488 Consumption of antibiotics in Slovenia: ﬁrst
results of the ESAC retrospective data collection
M. Cizman, S. Pecar-Cad, M. Stefancic, M. Elseviers, M. Ferech,
R. Vander Stichele, H. Goossens
Llubljana, SI; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Slovenia (2.0 million inhabitants in 2001), reimbursement data
were provided by the Institute of Public Health with 100% coverage for AC.
In HC, hospital pharmacists provided the data. The coverage of bed days was
between 1998 and 2001, 85, 89, 98, and 100%, respectively.
Results:ACuse was 17.5 DID in 1997, with a peak at 19.8 DID in 1999, again
falling to 17.4 DID in 2001, with moderate seasonal variation. In 2001, use of
penicillins (PEN), cephalosporins (CEP), tetracyclines, macrolides and qui-
nolones was 10.2, 0.5, 0.8, 3.3, and 1.3 DID, respectively; the proportion of
narrow spectrum PEN, ampicillin/amoxicillin, and combination with cla-
vulanic acid was 26, 30, and 43% of total PEN use, respectively. HC use varied
between 1.9 DID in 1998 and 1.8 DID in 2001. In HC, the proportion of use
in 2001 of PEN, CEP, carbapenems, glycopeptides, and Q was 43, 19, 1, 1,
and 14% of total HC use, respectively; the CEP generations represented (from
ﬁrst to fourth) 26, 31, 43, and 0% of total CEP use.
Strengths andweaknesses:AC data collection is comprehensive and timely.
HC data had complete coverage in 2001, but was incomplete for the previous
years.
Conclusions: In Slovenia, antibiotic use in AC and HC was moderate and
slightly declining in the last two years.
P1489 Consumption of antibiotics in Spain: ﬁrst results
of the ESAC retrospective data collection
J. Campos, G. Baquero, J. Oteo, E. La´zaro, M. Madurga, F. de Abajo,
M. Sora, M. Elseviers, M. Ferech, R. Vander Stichele, H. Goossens
Madrid, E; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Spain (39.9 million inhabitants in 2001), reimbursement data for
AC were provided by Spanish Drug Agency and obtained from the ECOM
Database of the Ministry of Health; HC data were provided by the Society of
Hospital Pharmacists, and included 15% of hospitals (predominantly big
hospitals).
Results: AC decreased constantly from 21.4 DID in 1997 to 18.8 DID 2001.
In 2001, use of penicillins (PEN), cephalosporins (CEP), tetracyclines,
macrolides (M) and quinolones (Q) was 9.9, 2.2, 0.7, 3.1, and 2.5 DID,
respectively; the proportion of narrow spectrum PEN, ampicillin/amoxicil-
lin, and combination with clavulanic acid was, 1, 48, and 48% of total PEN
use, respectively. In HC, the proportion of use in 2001 of PEN, CEP,
carbapenems, glycopeptides and Q was 47, 15, 2, 2, and 14% of total HC
use, respectively; the CEP generations represented (from ﬁrst to fourth) 21,
36, 39, and 4% of total CEP use.
Strengths and weaknesses: Although the ECOM AC database covers all
prescriptions of the Spanish Social Security System, it underestimates anti-
biotic use in Spain (OTC, prescriptions covered by private insurance com-
panies, and veterinary prescriptions not included).
Conclusion: Although AC use is high in Spain, particularly of the Q, a
constant decrease was noted since 1997. Sampling in HC needs to be enlarged
and stratiﬁed to produce a valid estimation of population exposure.
P1490 Consumption of antibiotics in Sweden: ﬁrst
results of the ESAC retrospective data collection
O. Cars, C. Sta˚lsby Lundborg, M. Elseviers, M. Ferech, R. Vander
Stichele, H. Goossens
Uppsala, S; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Sweden (8.8 million inhabitants in 2001), sales/prescription data
were provided by the National Corporation of Swedish Pharmacies.
Results:AC use remained constant and varied between 14.6 DID in 1997 and
15.8 in 2001; seasonal ﬂuctuation was low. In 2001, use of penicillins (PEN),
cephalosporins (CEP), tetracyclines (TET), macrolides (M) and quinolones
(Q) was 7.5, 0.5, 3.3, 1.0, and 1.1 DID, respectively; the proportion of narrow
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spectrum PEN, ampicillin/amoxicillin and combination with clavulanic acid
was 64, 12, and 3% of total PEN use, respectively. HC use remained constant
and varied between 1.26 DID in 1997 and 1.29 DID in 2001. The proportion
of use in 2001 of PEN, CEP, carbapenems, glycopeptides and Qwas 35, 19, 2,
1, and 14% of total HC use, respectively; the CEP generations represented
(from ﬁrst to fourth) 13, 73, 14, and 0.3% of total CEP use.
Strengths and weaknesses: Data cover the complete consumption in
Sweden. The quality of the data collection system is high.
Conclusion: In Sweden, both AC and HC use is low; in AC, narrow spectrum
PEN are used extensively, whereas in HC, second generation CEP are
frequently prescribed.
P1491 Consumption of antibiotics in Turkey: ﬁrst results
of the ESAC retrospective data collection
S. Unal, I. Yengingu¨c¸, M. Elseviers, M. Ferech, R. Vander Stichele,
H. Goossens
Ankara, TR; Antwerp, B
Objectives: European Surveillance of Antibiotic Consumption, granted by
DG SANCO of the EC (ESAC) is an international network of national
surveillance systems, aiming to collect comparable antibiotic consumption
data in Europe. During the ﬁrst phase, data accessibility and validity, as well as
strengths and weaknesses of national systems were assessed. Quarterly data
were to be collected retrospectively (1997–2001) from ambulatory (AC) and
hospital care (HC) in 31 countries, using ATC/DDD classiﬁcation (WHO,
version 2002), and expressing results in DDD/1000 inhabitants per day
(DID).
Methods: In Turkey (67.6 million inhabitants in 2001), only incomplete sales
data expressed in units were available from Information Medical Statistics
(IMS) Health for AC.
Results: Available data suggest a high antibiotic consumption, slowly declin-
ing over the last ﬁve years, with considerable use of broad-spectrum anti-
biotics and pronounced seasonal variation in prescribing.
Strengths and weaknesses:HC data are absent. Health insurers are building
real time online connections to a great number of community and
hospital pharmacies in this vast country, from which timely and comprehen-
sive data collection could be possible, provided privacy issues are adequately
dealt with.
Conclusions: No valid estimation of population exposure to antibiotics is
available in the public domain for Turkey. Application of ATC/DDD
methodology needs to be considered for future web-based data collection.
Anti-fungals in vitro susceptibility
P1492 A new agardilution assay for testing
voriconazole against isolates of Aspergillus spp.: a
comparison with the NCCLS microdilution reference method
A. Imhof, A. Balajee, K. A. Marr
Seattle, USA
Objectives: The available National Committee for Clinical Laboratory
Standards (NCCLS) microdilution method for the antifungal susceptibility
testing of ﬁlamentous Fungi may not be the most efﬁcient and convenient
procedure for use in the clinical laboratory. We developed an easy to read
susceptibility test assay, using solid RPMI 1640 Agar containing different drug
concentration. The purpose of this study was to evaluate this new method for
susceptibility testing of Aspergillus isolates to the new triazole voriconazole.
Methods:We compared MIC values obtained simultaneously by agardilution
and NCCLS broth microdilution methods after 24- and 48-h of incubation
for reference the novel triazole voriconazole. The 25 clinical isolates evaluated
included 15 A. fumigatus, and 10 A. niger. The MICs of voriconzole in the
agardilution method corresponded to the ﬁrst well with no growth.
Results:Three comparisons of MIC pairs by the two methods were evaluated
to obtain percentages of agreement (1 dilution range): 24- and 48-hMIC by
agardilution vs. corresponding 24- and 48 h NCCLS MICs and 24-h
agardilution vs. 48-h reference MICs. The agreement between the methods
for voriconazole MICs was 92% when both 24- and 48-h agardilution MICs
were compared with 24- and 48-h NCCLS MICs. The agreement was
slightly higher (96%) when 24-h agardilution values were compared with
48-h NCCLS MICs.
Conclusion:These data suggest the potential value of the agardilution assay for
use in the clinical laboratory to test the susceptibilities of common Aspergillus
isolates to voriconazole.
P1493 In vitro activity of ﬂucytosine, caspofungin,
voriconazole, and amphotericin B in 2-drug combinations
against Aspergillus spp.
E. Dannaoui, O. Lortholary, F. Dromer
Paris, F
Objectives:To assess whether two-drug combination will increase the in vitro
activity of antifungals active against Aspergillus spp. and the potential effec-
tiveness of 5FC in this setting.
Methods: A two-dimensional checkerboard based on the NCCLS M-38P
microdilution broth technique was used. Two-drug combinations of ﬂucy-
tosine (5FC) with caspofungin (CAS) or voriconazole (VRZ) were evaluated
against 14 recent clinical isolates of Aspergillus spp. (12 A. fumigatus and 2 A.
terreus). Combination of CAS with amphotericin B (AMB) or VRZ were
tested against 35 isolates (30 A. fumigatus and 5 A. terreus). After 48 h of
incubation microplates were read visually and MICs were deﬁned as the
lowest concentration that gave 50% (CAS, 5FC, VRZ) or 100% (AMB) of
inhibition. FIC indices (FICI) were calculated and interactions were classiﬁed
as synergistic (FICI0.5), additive (FICI> 0.5 and1), indifferent (FICI> 1
and 4), and antagonistic (FICI> 4). All experiments were run in duplicate.
Results: (Table):
For the synergistic interactions the median concentrations of CAS and 5FC in
combination were 0.25mg/mL (range: 0.25–4mg/mL) and 4 mg/mL (range:
2–16mg/mL), respectively. In A. terreus this combination was synergistic for
one strain.
Conclusions: Combination of CAS with either AMB or VRZ was mostly
additive, while a marked synergy was observed for the combination of CAS
with 5FC. On the other hand, combination of VRZwith 5FCwas indifferent
to antagonistic. These results warrant further investigation in animal models of
aspergillosis.
P1494 In vitro interaction of caspofungin with
amphotericin B against clinical isolates of
Trichosporon asahii
S. Arikan, B. Sancak, G. Hasc¸elik
Ankara, TR
Objective: Invasive trichosporonosis is often difﬁcult-to-treat and associated
with high mortality. Currently available antifungal agents frequently have
limited or no activity against the infecting fungus and clinical failure following
treatment with amphotericin B or the azoles is not uncommon. The novel
echinocandin, caspofungin, is also known to lack meaningful activity against
Trichosporon. We investigated whether the combination of caspofungin and
amphotericin B in vitro would yield more enhanced activity than each drug
alone against clinical isolates of Trichosporon asahii.
Methods: A total of 69 T. asahii strains were included in the study. The
individual caspofungin and amphotericin B MICs (mg/mL) were determined
by using NCCLS M27-A2 microdilution method. In vitro interaction of
Interaction
% of A. fumigatus strains
5FCþCAS
(n¼ 12)
5FCþVRZ
(n¼ 12)
CASþAMB
(n¼ 30)
CASþVRZ
(n¼ 30)
Synergistic 92 0 28 9
Additive 0 0 66 68
Indifferent 8 42 6 23
Antagonistic 0 58 0 0
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caspofungin and amphotericin B was explored by using checkerboard method
and determination of fractional inhibitory concentrations (FIC; mg/mL).
MIC-0 endpoint was used for both MIC and FIC readings and the results
were read at 24 and 48 h. The combination test results were evaluated by
calculating the FIC index (FICI) and interpreted as follows: FICI0.5,
synergistic; 0.5< FICI1, additive; 1< FICI4, indifferent; and FICI> 4,
Results: At 24 h, caspofungin and amphotericin B were synergistic, additive,
and indifferent for 3 (4.4%), 17 (24.6%), and 49 (71%) isolates, respectively. At
48 h, the two drugs were synergistic, additive, and indifferent for 9 (13%), 28
(40.6%), and 32 (46.4%) isolates, respectively. Antagonistic interactionwas not
detected.
Conclusions: (i) Caspofungin and amphotericin B tend to be synergistic,
additive or indifferent in vitro against T. asahii. Importantly, antagonism is not
observed in any of the isolates. (ii) At 48 h, synergistic or additive interaction
are observed at a signiﬁcantly higher rate compared with 24 h (54 vs. 29%,
respectively). (iii) These in vitro data appear promising for potential use of
caspofungin and amphotericin B combination in a number of infections due
to T. asahii. Clinical implications and signiﬁcance of these ﬁndings demand to
be validated by in vivo investigations.
P1495 Effect of pH on the in vitro activity of
amphotericin B and ﬂucytosine against yeasts and moulds
D. T. A. te Dorsthorst, J. W. Mouton, C. van den Beukel, P. E. Verweij
Nijmegen, NL
Background: The efﬁcacy of antifungal agents in treating invasive fungal
infections is limited due to several reasons. One reason could be physical
conditions at the side of infection including pH. Since MICs are determined
at pH 7, altered activity of drugs at other pH values will not be detected.
Objectives: To determine the effect of pH on the in vitro activity of
amphotericin B (AMB) and ﬂucytosine (5FC) against yeasts and moulds.
Methods: Susceptibility of four yeast isolates (two Candida krusei and two
Cryptococcus neoformans) and six mould isolates (two Aspergillus fumigatus, two
Rhizopus spp. and two Scedosporium proliﬁcans) to AMB and 5FCwas tested
in triplicate by the NCCLS broth microdilution method. Susceptibility
testing was performed in RPMI 1640, adjusted to pH values ranging from
4.0 to 7.9. Buffering was achieved with citrate (10mM), citrate-phosphate
(10mM) or morpholinepropanesulfonic acid (MOPS; 0.165M). The median
MIC (MIC50) was calculated for each isolate and pH.
Results: For all yeast isolates, A. fumigatus isolates and Rhizopus spp. the
MIC50 of AMB decreased when the medium pH increased. The MIC50 was
between 32 and 64mg/L (depending on the tested isolate) at pH4.0, while at
pH7.9 the MIC50 was between 0.016 and 0.5mg/L. For the S. proliﬁcans
isolates a MIC50 equal to or higher then 32mg/L was found, independent on
the medium pH. For all yeast isolates and A. fumigatus isolates the MIC50 of
5FC increased when the medium pH increased. The MIC50 of 5FC
varied between 0.031 and 1mg/L (depending on the tested isolate) at
pH4.0, while at pH7.9 the MIC50 varied between 4 and 1024mg/L.
For the Rhizopus spp. and the Scedosporium proliﬁcans isolates a
MIC50> 1024mg/L was found.
Conclusions: The in vitro activity of both AMB and 5FC against yeasts and
moulds depends on the medium pH. Susceptibility of AMB decreased with
lowering pH, while the susceptibility of 5FC increased with lowering pH.
Because the pH at the site of infection may be relatively low, these ﬁndings
may have important consequences for therapy.
P1496 Bioﬁlm production and antifungal susceptibility
patterns of Candida spp.
M. Yucesoy, M. Karaman, G. Ergor
Izmir, TR
Objectives: Bioﬁlms serve as a nidus for an infectious disease and are often
associated with antimicrobial resistance of microorganisms. In this study,
bioﬁlm production and antifungal susceptibility of various Candida species
were examined and compared.
Methods: A total number of 165 Candida species (99 C. albicans, 22 C. tro-
picalis, 20 C. glabrata, 12 C. parapsilosis, 10 C. krusei, 1 C. guilliermondii and 1
C. kefyr) isolated from different clinical specimens were included in this study.
The bioﬁlm production of the strains was searched by modiﬁed tube
adherence test and their antifungal susceptibilities against ﬂuconazole and
amphotericin B were determined by microdilution method performed
according to NCCLS M27-A standards.
Results: Forty-ﬁve (27.3%) of the strains were found to be slime producing.
The rate of bioﬁlm formation by different species ranged between 16.7 and
60%. No signiﬁcant difference was found between the bioﬁlm production of
C. albicans and non albicans species (X2¼ 2.04; P¼ 0.15). MIC50 andMIC90
values for ﬂuconazole ranged between 4 and 64 mg/mL and 32–>64mg/mL
for different Candida species while these values changed between 0.25 and
1mg/mL and 0.5–2mg/mL for amphotericin B, respectively. Forty-eight
(29.1%) and 24 (14.5%) of the isolates were found to be dose dependent
susceptible and resistant to ﬂuconazole, respectively. Eleven (6.7%) of the
strains were detected to be resistant to amphotericin B. When the relation
between the bioﬁlm production and the susceptibility categories of the strains
were searched, statistical differences were found (P¼ 0.00 and P¼ 0.02)
which meant that bioﬁlm production and susceptibility categories were
not parallel.
Conclusion: It can be concluded that bioﬁlm production is a potential
virulence factor for Candida species. However this factor does not seem to
correlate with the susceptibility categories of the strains, when the planktonic
cells are used for the susceptibility testing. Antifungal susceptibility of the
sessile cells from bioﬁlms should also be explored.
P1497 In vitro susceptibility testing of voriconazole and
ﬂuconazole: Effects of incubation time and culture medium,
and the ‘trailing’ phenomenon
A. F. Schmalreck, D. Pfruender, W. Fegeler
Munich, Karlsruhe, Munster, D
Objectives: This study aimed at investigating the dependency of antifungal
susceptibility testing on the incubation time and the culture medium.
Furthermore the so-called ‘trailing’ phenomenon (residual growth at con-
centrations greater than the MIC) was investigated.
Methods: In a collaborative study involving 12 centers, microdilution, E-test
and agar diffusion tests with voriconazole and ﬂuconazole were performed.
Two thousand thirty-three freshly isolated yeasts and 23 control strains were
tested according to DIN 58940–84 (microdilution) and DIN 58940–3 (agar
diffusion) with Yeast Susceptibility Test medium (YST, Siﬁn GmbH, Berlin)
and in part (agar diffusion) also with Mueller Hinton medium supplemented
with 2% glucose and 0.5mg/L methylene blue (MHþMB). Results were
read within 24, 48 and 72 h. Minimal inhibitory concentration (MIC)
readings were performed visually; inhibition zone diameter (IZD) determi-
nation was done with an automated video system (BIOMIC, Giles Scientiﬁc,
USA).
Results: Within 24 h, a deﬁnite endpoint could be determined at the
following percentages for voriconazole and ﬂuconazole: 84 and 82% with
microdilution using YST; 79 and 78% with E-test using YST; 77 and 77%
with agar diffusion using YST; 58 and 57% with agar diffusion using
MHþMB. The trailing phenomenon was reported at the following per-
centages: 22 and 25% with microdilution using YST; 31 and 34% with E-test
using YST; 13 and 15% with agar diffusion using YST; 39 and 41% with agar
diffusion using MHþMB. Trailing was reported about 10% more frequently
at 48 h, and signiﬁcantly less frequently at 72 h (4–12%). Test results with
Cryptococcus spp., Rhodotorula spp. C. guilliermondii, C. parapsilosis, C. famata
and Trichosporon asahii were usually not interpretable at 24 h; these species
require incubation of 48 h.
Conclusion: YST medium according to DIN 58940 is suitable for microdilu-
tion and agar diffusion testing (conventional test disks and E-test) of vorico-
nazole and ﬂuconazole. The trailing phenomenon is reduced as compared with
supplementedMueller-Hintonmedium, and comparable and reproducible SIR
assessments within 24h is possible for most yeast species.
P1498 Evaluation of ketoconazole and ﬂuconazole
susceptibility testing with disk-diffusion method on three
different culture media
I. Ruubas, H. Ja¨rv, P. Naaber
Tartu, EST
Objectives: The present study was carried out to compare three different
culture media for antifungal susceptibility testing using disk-diffusion method
with E-test as reference method.
Materials and methods: The tested 45 Candida strains were isolates from
women with acute or recurrent vulvovaginal candidosis. Strains were col-
lected in the microbiology laboratory of Tartu University Clinics, Estonia.
Strains were identiﬁed using routine methods as C. albicans (n¼ 27), C. krusei
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(n¼ 13) and C. glabrata (n¼ 5). The tested antifungal disks were ﬂuconazole
(25mg) and ketoconzole (10mg; MAST Diagnostics, UK). The synthetic
medium RPMI 1640 supplemented with L-glutamin and 2% glucose (Angus
Biochemicals, USA), Yeast Nitrogen Base Medium (YNB, Difco, USA) and
Mueller-Hinton Agar (Oxoid, UK) supplemented with methylene-blue was
used for disk-diffusion. The E-test ranges for tested antifungals were 0.016–
256mg/L for ﬂuconazole and 0.016–256mg/L for ketoconzole (AB Biodisk,
Sweden). The synthetic medium RPMI 1640 was used for E-test. The results
were read after 24 and 48 h accordingly. The inoculum was prepared from
colonies incubated on Sabouraud glucose agar for 24 h at 378C and stock
suspension with a density equivalent to 0.5 McFarland was used.
Results:All strains were susceptible for ketoconazole (MIC 0.002–1.5mg/L),
60% of stains were susceptible, 16%were susceptible dose-dependant and 24%
were resistant for ﬂuconazole (MIC 0.02–>256mg/L). Comparing disk-
diffusion results (inhibition zone mm) on different media with E-test (MIC
valuesmg/L) we found best correlation in case of Mueller-Hinton agar and
incubation time 24 h. For ﬂuconazole the correlation coefﬁcient (r) was
0.85 and for ketoconazole r¼0.81 (P< 0.001). The results after 48 h
incubation did not differ signiﬁcantly from 24 h ones. For YNB incubated for
24 h correlation with E-test was lower (ﬂuconazole r¼ 0.57; P< 0.001;
ketoconazole r¼ 0.42; P< 0.01). All other medium-incubation time
combinations did not gave reliable results comparing with E-test.
Conclusions:Disk-diffusion test onMueller-Hinton Agar supplemented with
methylene-blue could be recommended for susceptibility testing of yeasts as
cost-effective alternative for MIC testing. Shorter incubation time (24 h
instead of 48 h) using this medium gives opportunity for earlier treatment.
P1499 In vitro activities of voriconazole, amphotericin B
and ﬂuconazole against Candida strains isolated from
neutropenic patients with hematologic malignancies
A. Kalkanci, O. Guzel, E. Senol, S. Kustimur
Ankara, TR
The incidence of invasive fungal infections has increased in the last 20 years
also have witnessed an increased resistance to established antifungal agents.
Among the new azole, voriconazole (UK-109, 496; Vfend [Pﬁzer Pharma-
ceuticals, New York]) is a new triazole that has not proposed standard
procedures for antifungal susceptibility testing methods. In this study, we
determined minimal inhibitor concentrations of voriconazol, amphotericin B
and ﬂuconazole by following the NCCLS M27-A broth micrody´lution
method. A total of 111 clinical Candida isolates, including isolates of Candida
albicans (52), Candida glabrata (20), Candida tropicalis (13), Candida parapsilosis
(3), Candida kefry (18), Candida famata (1), Candida krusei (1) were included in
our study. The voriconazole MIC at which 50% of strains were inhibited
(MIC 50) was 0.5mg/mL for C. albicans, it was 0.007mg/mL for C. glabrata,
0.5mg/mL for C. tropicalis, 0.007 mg/mL for C. kefyr, 1mg/mL for C. para-
psilosis. All the tested isolates were inhibited by voriconazole at concentrations
ranging from 0.007 to 2 mg/mL. Voriconazole had consistent and signiﬁcant
activity against isolates of both C. krusei and C. glabrata, as opposed to
ﬂuconazole. MIC 50 of ﬂuconazole was 1mg/mL for C. albicans 32 mg/mL
forC. glabrata, 32mg/mL forC. tropicalis, 0.25mg/mL forC. kefyr, 1mg/mL for
C. parapsilosis. MIC 50 of amphotericin B was 0.0313mg/mL for C. albicans.
MICs of ﬂuconazole for C. glabrata were very high. (MIC 50¼ 32 mg/mL
C. tropicalis isolates surprisingly showed high ﬂuconazole MIC values ranging
from 0.25 to 128mg/mL. The voriconazoleMICs forCandida isolates covered
a narrow range, with no prominent difference among species. All Candida
species appeared potentially susceptible to voriconazole, including isolates of
C. krusei, and C. glabrata.
P1500 In vitro susceptibility of Candida species isolated
from clinical specimens against some antifungal agents
B. Ozcelik, S. Citak, S. Cesur, S. Gocmen, U. Abbasoglu, R. Emral
Ankara, TR
Objective:Antifungal drug resistance is becoming a major problem in certain
populations, especially in immunosuppressed patients. The aim of this study
was determine to resistance of Candida species isolated from blood cultures of
cancer patients and oropharyngeal swabs of diabetic patients to ketoconazole
(KET), ﬂuconazole (FLU), itraconazole (ITRA), amphotericin B (Amp B),
terbinaﬁne (TRB), ﬂucytosine (FCU). The isolates were obtained from the
hospitalized patients in Ankara University, Faculty of Medicine, Department
of Hematology, Medical Oncology and Endocrinology.
Material andmethods:Themost commonly identiﬁed species ofCandidawere
C. albicans (56) (22 of diabetic patients isolates), followed by C. parapsilosis (7),
C. tropicalis (3) (of diabetic patients isolates), C. guillermondii (2) and C. pelliculosa
(1), respectively. An adapted NCCLS M 27-A method was used to evaluate the
activity of KET, FLU, ITRA, Amp B, TRB and FCU. The MICs of the strains
were done using RPMI 1640 medium by microdilution method.
Results: There were no isolates of C. parapsilosis, C. guillermondi, C. pelliculosa
resistant to KETand TRB. There were slight differences in the susceptibility
patterns of 13 nonalbicans Candida spp. isolates. The isolates C. pelliculosa
showed intermediate resistance to FLU (MIC to FLU 31.25 mg/mL). Resist-
ance to KET appeared in 1 of C. tropicalis from diabetic isolates and followed
by 2 FLU, 1 ITRA, 1 AmpB and 3 FCU.Resistance to KETappeared in eight
strains of C. albicans from blood isolates followed by 11 FLU, 24 ITRA, 8
Amp B. Resistance to the diabetic isolates appeared in 1 KET, 14 FLU, 15
ITRA, 10 Amp B and 20 FCU. Resistance to ITRA appeared in 40 strains of
C. albicans (MIC to ITRA> 1mg/mL), 2 strains of C. parapsilosis, 2 strains of
C. guillermondi 1 strain ofC. tropicalis and 1 strain ofC. pelliculosa. Resistance to
FCU appeared in 49 strains of C. albicans (MIC to FLU> 32mg/mL). So
among of the 69 isolates, 22% were resistant to KET, 41% to FLU, 58% to
ITRA, 39% to Amp B and 62% to FCU
Conclusion: The main conclusion of this study is that typing and antifungal
susceptibility pattern will contribute to the prevention of invasive fungal
infections in special hosts such as immunosuppressive patients and diabetic
patients.
P1501 Antifungal susceptibility of bloodstream isolates
of Candida spp. from Kuwait
T. D. Chugh, Z. U. Khan, E. Mokaddas, N. Al-Sweih, R. Chandy
Kuwait, KWT
Objectives: Nosocomial candidiasis is a major problem in critically ill, high-
risk patients with an estimated attributable mortality of 38%. This study
presents antifungal susceptibility data on 308 bloodstream isolates of Candida
(C. albicans – 111, C. parapsilosis – 128, C. tropicalis – 44, C. krusei – 13,
C. glabrata – 12) against four antifungal agents.
Methods: The Candida isolates were collected over a seven-year period
(1996–2002) and minimum inhibitory concentrations (MICs) were deter-
mined by E-test AB Biodisk, Sweden, against amphotericin B (AP), ﬂuco-
nazole (FL), itraconazole (IT), and 5-ﬂucytosine (FC). The test was
performed on RPMI 1640 medium supplemented with 2% glucose, pH
adjusted to 7.0with 0.165Mmorpholinepropanesulfonic acid buffer, according
to the manufacturer’s instruction. Isolates showing breakpoints of >2mg/mL
for AP, >64mg/mL for FL, >1mg/mL for IT, and >32 mg/mL for FC were
graded as resistant. Interpretive breakpoints for FL, IT and FC were the same
as recommended in NCCLS, M27A document.
Results:TheMIC90 (withMIC range) determined at 24h incubation for each
antifungal agents were as follows: C. albicans (n¼ 111), AP 0.38 (0.003–0.75),
FL 1.5 (0.047–32), IT 0.75 (0.012–32), FC 0.125 (0.008–2); C. parapsilosis
(n¼ 128), AP 0.5 (0.004–1.5), FL 2 (0.016–12), IT 0.38 (0.002–1.5), FC 0.25
(0.004–32); C. tropicalis (n¼ 44), AP 0.5 (0.023–0.75), FL 1.0 (0.25–4), IT 1.5
(0.008–32), and FC 0.25 (0.002–32); C. krusei (n¼ 13), AP 0.38 (0.25–1),
FL> 64 (24–>64), IT 4 (0.25–4), FC> 32;C. glabrata (n¼ 12), AP 0.75 (0.25–
1), FL 16 (2–16), IT 32 (1–32), and FC 0.064 (0.012–0.094).
Conclusions: All the Candida isolates were susceptible to amphotericin B.
Resistance to azoles for C. albicans, C. parapsilosis and C. tropicalis was <12%.
Eighty and >50% of the isolates of C. krusei were resistant to itraconazole and
ﬂuconazole, respectively. The resistance of C. glabrata to ﬂuconazole and itra-
conazole was 8 and 66%, respectively. Antifungal susceptibility by E-test can be
conveniently incorporated and performed in a hospital-based clinical laboratory.
Acknowledgement: The work is supported by Kuwait University Research
grant no. MPI-118.
P1502 Development of a bioassay for voriconazole
using a Candida albicans strain lacking major multidrug
transporters and the calcineurin A subunit
V. Nieth, J. Bille, D. Sanglard
Lausanne, CH
Background: Voriconazole (VCZ) is a novel broad-spectrum triazole anti-
fungal with enhanced antifungal properties and high efﬁcacy in the treatment
of fungal diseases refractory to conventional antifungal therapy. The intro-
duction of VCZ in clinical use and its potential related toxicity problems
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require the monitoring of serum levels on some clinical situations (difﬁcult to
treat infections, liver or renal insufﬁciency).
Objectives: To develop a rapid, economic, reliable and sensitive method for
the determination of VCZ serum levels by a bioassay using a C. albicans strain
with high susceptibility to VCZ.
Methods: A C. albicans strain (DSY2621) was constructed lacking major
multidrug transporter genes (CDR1, CDR2, CaMDR1, FLU1) and the
calcineurin A subunit gene CNA. This strain combined the advantage of
having increased susceptibility to VCZ and a lack of VCZ tolerance, thus
increasing detection of low VCZ levels and also facilitating a visual detection
in VCZ susceptibility assays. For the development of a bioassay, VCZ was
added at ﬁxed concentrations in spiked human serum in different agar media
containing the strain DSY2621. The agar plates were incubated at 34 8C for
24 h. Intra- and interrun validation were performed by standard methods and
the results compared with an established HPLC method.
Results: The optimal conditions found for this bioassay used regular Yeast
Nitrogen Base (YNB) agar medium buffered to pH7.0 with phosphate buffer
and containing an inoculum of 1.5 105 cells per mL of medium. The
method was validated by intra- and inter-run experiments for a concentration
range from 0.3 (accuracy intra- and inter-run: 1.6 and 2%; precision intra- and
inter-run: 11 and 3.9%) to 7mg per ml serum (accuracy intra- and inter-run:
7 and 13%; precision intra- and inter-run: 5.5 and 2.6%). This method
was found superior to HPLC in accuracy and precision for low VCZ
concentration ranges (0.3–1.5mg per ml; accuracy intra- and inter-run:
30 and 20.6%; precision intra- and inter-run: 42.1 and 13%), but was
equivalent for higher concentration ranges.
Conclusion: The VCZ bioassay developed with the strain DSY2621 can be
used for determining VCZ serum concentrations, is simple and does not
require a more technically demanding equipment such as HPLC.
P1503 Antifungal susceptibility of yeasts responsible
for bloodstream infections
L. Alcala´, T. Pela´ez, A. Bla´zquez, P. Mun˜oz, M. Rodrı´guez-Creixe´ms,
E. Bouza
Madrid, E
Antifungal susceptibility is essential to guide antimicrobial therapy in episodes
of fungemia. Concerns regarding recent development of antifungal resistance
have been raised.
Objectives: We determined the antifungal susceptibility pattern of clinical
yeasts isolated from bloodstream infections over a two-year period (2000–
2001) and compared it with the previous period (1988–99).
Methods: Susceptibility testing was performed using modiﬁed microdilution
(M-27A, NCCLS), with RPMI-2% glucose medium. Antifungal drugs
tested were amphotericin B (AB), ﬂucytosine (FC), ketoconazole (KZ),
ﬂuconazole (FZ), itraconazole (IZ), voriconazole (VZ), and LY-303366 (LY).
Results: Overall, 89 strains from 74 episodes of fungemia were tested. The
MIC90 (mg/mL) of species tested was as follows:
There were no differences in the susceptibility pattern of this study and the
previous one (1988–99; poster number 225, 40th ICAAC).
Conclusions: VZ and AB showed a good activity against the yeasts isolated,
with an overall MIC90 of 0.25 and 1, respectively. The remaining azoles and
FC were very active except forC. krusei, C. glabrata (FC was active against this
species), and some uncommon yeasts. LY showed good activity against the
isolates tested with the exception of C. parapsilosis, C. neoformans, and some
uncommon yeasts. Despite widespread use of antifungal therapy in recent
years, we were unable to ﬁnd signiﬁcant increases in resistance when
compared this susceptibility pattern with the previous surveillance study
corresponding to the period 1988–99.
P1504 In vitro susceptibility of Candida species isolated
from cancer patients against some antifungal agents
S. Cesur, B. Ozcelik, S. Citak, U. Abbasoglu, F. Icli
Ankara, TR
Objective:Antifungal drug resistance is becoming a major problem in certain
populations, especially in immunosuppressed patients. This study was under-
taken to study the resistance of Candida species isolated from oropharengeal
swabs of cancer patients to ketoconazole (KET), ﬂuconazole (FLU), itraco-
nazole (ITRA), amphotericin B (Amp B), terbinaﬁne (TRB), ﬂucytosine
(FCU) in Ankara University, Faculty of Medicine, Department of Medical
Oncology.
Material and methods: The most commonly identiﬁed species of Candida
wereC. albicans (75), followed byC. tropicalis (9),C. glabrata (8), C. famata (2),
C. krusei (1),C. kefyr (1),C. guillermondii (1), respectively. An adapted NCCLS
M 27-A method was used to evaluate the activity of KET, FLU, ITRA, Amp
B, TRB and FCU. The MICs of the strains were done using RPMI 1640
medium by microdilution method.
Results: There were no C. albicans strains resistant to KET, FLU, Amp B and
TRB. There were slight differences in the susceptibility patterns of 22
nonalbicans Candida spp. isolates. The C. krusei strain showed intermediate
resistance to FLU (MIC to FLU 31.25mg/mL). Resistance to ITRA appeared
in 14 strains of C. albicans (MIC to ITRA> 1mg/mL), 6 strains of C. glabrata,
1 strains of C. tropicalis and 1 strains of C. guillermondi. Resistance to FLU
appeared in four strains of C. albicans (MIC to FLU> 32 mg/mL). So among
the 97 strains, 22–23% were resistance to ITRA and 4% were resistance to
FCU.All strainswere found susceptible toAmpB (MIC toAmpB> 4mg/mL),
KET and FCU.
Conclusion:Themain conclusion of this study is that the prophylactic therapy
planned according to typing and antifungal sensitivity pattern will be con-
tribute to the preventation of invasive fungal infections in immunosuppressive
oncology patients.
P1505 In vitro activity of hexetidine on
Candida albicans
F. Alecu, C. Defta, G. Bancescu, D. Ionescu, S. Dumitriu
Bucharest, RO
Objectives: To evaluate the in vitro effect of 0.1% solution Hexetidine on
Candida albicans. Hexetidine is used as active ingredient of commercially
available mouthwashes for oral hygiene purposes. Candida albicans is part of
normal oral microﬂora, besides aerobe and anaerobe bacteria. The criteria
considered for this assessment were Minimal Inhibitory Concentration
(MIC), killing-time and chlamidospores formation.
Materials and methods:One C. albicans isolate was considered for this study.
For MIC evaluation, broth macrodilution method in Sabouraud broth was
used. The tubes were incubated at 378C by night before reading. For killing-
time assessment the yeast was exposed to Hexetidine 0.1% for a deﬁned period
of time (30; 45; 60; 90; 120 s) and then alliquots from the suspension were
plated onto Sabouraud – dextrose agar and incubated for 48 h at 378C. 0.05%
Hexetidine solution (half the concentration of commercial product) was used
to observe the inhibitory effect on chlamidospores formation after short
period of time of exposure (30; 54; 60 s). The effect was evaluated on Rice
Agar Tween medium, incubated for 48–72 h at 258C.
Results: MIC value was found to be 1/32 (31mL/mL solution or 0.003%)
from the initial concentration. Killing-time was 45 s and inhibition for
Chlamidospores formation was obtained after 45 s exposure at 0.05% Hex-
etidine.
Conclusions: Our results conﬁrmed the usefulness of Hexetidine for oral
purposes if used correctly, according to the manufacturers recommendation
for at least 45 s mouth rinse.
P1506 In vitro interaction between ﬂucytosine and
other antifungals against Cryptococcus neoformans
P. Schwarz, F. Dromer, O. Lortholary, E. Dannaoui
Paris, F
Objectives: to evaluate the in vitro interaction of ﬂucytosine (5FC) in
combination with azoles or amphotericin B (AMB) against clinical isolates
of Cryptococcus neoformans.
Species (n) AB
FC
(%I-R) KZ
FZ
(%SDD-R)
IZ
(%SDD-R) VZ LY
C. albicans (33) 0.5 0.25 (0) 0.01 0.25 (0) 0.06 (6) 0.004 0.01
C. parapsilosis (29) 0.5 0.125 (0) 0.008 1 (0) 0.06 (0) 0.01 4
C. glabrata (8) 1 0.125 (0) 1 32 (38) 0.5 (100) 0.5 0.03
C tropicalis (7) 1 1 (0) 0.008 0.5 (0) 0.06 (0) 0.03 0.06
C. krusei (3) 1 8 (67) 2 64 (100) 0.25 (100) 0.5 0.06
C. neoformans (2) 0.5 2 (0) 0.125 2 (0) 0.125 (0) 0.03 >128
Other (7) 1 0.5 (0) 1 16 (43) 0.5 (7) 0.5 2
Overall (89) 1 0.5 (2) 0.5 16 (10) 0.25 (18) 0.25 4
Flucytosine, >4mg/mL; fluconazole, >8 mg/mL; itraconazole, >0.125mg/mL.
2 Blastoschizomyces capitatus, 2 C. sake, 1 C. guilliermondii, 1 Zygosaccharomyces sp.,
and 1 Saccharomyces cerevisiae.
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Methods: a NCCLS M-27 A microdilution broth technique modiﬁed for
checkerboard studies was used. Two-drug combinations of 5FC with ﬂuco-
nazole (FCZ), itraconazole (ITZ), voriconazole (VRZ), or AMB were
evaluated against 30 recent clinical isolates of C. neoformans. After 72 h of
incubation microplates were read spectrophotometrically and MICs were
deﬁned as the lowest concentration that gave 50% (azoles and 5FC) or 95%
(AMB) of inhibition. FIC indices (FICI) were calculated and interactions
were classiﬁed as synergistic (FICI 0.5), additive (FICI> 0.5 and 1),
indifferent (FICI> 1 and 4), and antagonistic (FICI> 4). All experiments
were run in duplicate.
Results: (see Table)
Geometric mean MICs (range) for the drugs alone were 4 (0.5–64), 1.95
(0.25–8), 0.11 (0.03–0.5), 0.02 (0.004–0.125), and 0.62 mg/mL (0.25–1) for
5FC, FCZ, ITZ, VRZ, and AMB, respectively. Even with some isolates
exhibiting high MICs for 5FC, combination with AMB or azoles was
synergistic.
Conclusions: combination of azoles with 5FC showed similar synergistic
interaction compared with the combination of AMB with 5FC. Antagonism
was not observed.
P1507 Use of the Sensititre Colorimetric Microdilution
Panel for antifungal susceptibility testing of dermatophytes
E. Martin-Mazuelos, C. Castro, M. C. Serrano, A. Valverde, R. Claro,
M. Ramirez, J. Peman, S. Bernal
Seville, E
Objective: Compare the susceptibility of different dermatophytes species to
itraconazole (I), voriconazole (V) and ﬂuconazole (F) by the reference method
(MD) (NCCLS, M38A) and the colorimetric method Sensititre Yeast One
(R).
Material andmethods:We studied a global of 47 strains of dermatophytes (30
T. mentagrophytes, 9 T. rubrum, 8 M. gypseum) isolated from clinical specimens.
The MD reference susceptibillity testing was performed following the
NCCLS M38A document, using drug dilutions from 0.03 to 16mg/L for
I and V, and 0.125–256mg/L for F. The MICs were deﬁned as the lowest
concentration that produced the 50% inhibition of the growth, we read after
4–6 days of incubation at 358C. The Sensititre Yeast One (R) was performed
following the manufacturer’s instructions, and the inoculum used was the
same that for the MD. The MICs were read in the well where the colour
change from pink to blue or purple was observed. Quality control strains:
C. parapsilopsis ATCC 22019 and C. krusei ATCC 6258.
Results: The levels of agreement between the two different methods (2
dilutions) were for T.mentagrophytes 30, 53.3 and 83.3%; T. rubrum 0, 12.5 and
66.6%; M. gypseum 37.5, 44.4 and 75% for for I, F and V, respectively. The
MICs 50/90 (mg/L) for the different species were: T.mentagrophytes 0.25/0.5
(I), 0.12/0.25 (V), 16/64 (F) (MD) and 0.016/0.06 (I), 0.03/0.06 (V), 8/16
(F) (Sensititre). T. rubrum 0.25/1 (I), 0.25/0.5 (V), 8/64 (F) (MD) and 0.008/
0.03 (I), 0.016/0.03 (V), 2/8 (F) (Sensititre).M. gypseum 0.5/1 (I), 0.25/1 (V),
64/256 (F) and 0.016/0.25 (I), 0.06/0.25 (V), 16/256 (F) (Sensititre).
Conclusions: (i) TheMICs obtained were lower by Sensititre than byMD. (ii)
The best correlation between both methods was obtained for F and T.menta-
grophytes (>80%). (iii) T. rubrum showed a very low correlation, perhaps due to
the difﬁculty to obtain standardized inocula because it has low levels of
sporulation or high levels of pleomorphism. (iv) Although Sensititre is an easy
method which could be used in a clinical laboratory, it shows poor agreement
with the reference method for dermatophytes, however, more studies are
necessary.
P1508 Isolation of griseofulvin-resistant strains of
dermatophytes from Isfahan
M. Chadeganipour, S. Shadzi, J. Chabaveizadeh
Isfahan, IR
Objective: The emerge of drug resistance in dermatophytes would affect the
incidence of infection in the society and causes difﬁculties for both physician
and patient. With report of cases of griseofulvin resistant dermatophytes, the
use of new antifungal drugs is recommended which are more expensive or
somehow rare in Iran. Therefore, the necessity of griseofulvin sensitivity
pattern of dermatophytes in Isfahan is perceived which could lead to a more
effective and less expensive treatment for dermatophytoses.
Methods: Fifty isolates of the most prevalent dermatophytes in Isfahan were
isolated from patients and then the standard homogenized suspension from
them were prepared for future inoculation. The minimum inhibitory con-
centration (MIC) of griseofulvin was determined by modiﬁed macrodilution
method for each isolate and then results were compared and analyzed with
standard values of MICs of dermatophytes and resistant strains identiﬁed.
Results: All 100% tested isolates had MIC mode of <0.25, 90% had <8 and
50% ranged between <0.25–1mg/mL. From all isolates, 10% of them
including three Trichophyton verrucosum, one Microsporum canis and one
T.mentagrophytes had MIC out of standardized range therefore, they con-
sidered as griseofulvin resistant isolates.
Conclusion: Although MIC values of drugs at in vivo and in vitro are
somewhat different but in vitro values could be used as additional parameters
in the decision making of treatment for dermatophytoses, in particular its
recalcitrant types or in areas which the resistant species may have high
prevalence.
Nosocomial nonfermenting Gram-negative bacterial infections: clinical and laboratory studies
P1509 Outbreak of hospital-acquired monoclonal
Pseudomonas aeruginosa infection associated with the use
of contaminated commercial mouth swabs in a primary and
a tertiary care hospital in Norway
M. Walberg, A. B. Brantsaeter, E. Lingaas
Oslo, Baerum, N
Objective: We present differences in outbreak epidemiology of hospital-
acquired monoclonal P. aeruginosa outbreak data from a Norwegian primary
care (PCH), Baerum Sykehus, and a tertiary care hospital (TCH), Rikshos-
pitalet. The data are part of a national hospital-acquired outbreak associated
with the use of contaminated commercial mouth swabs.
Methods:During the study period fromDecember 2001 to June 2002 isolates
of P. aeruginosa were stored for later analysis. Pulsed-ﬁeld gel electrophoresis
was used for strain identiﬁcation.
Results: From ultimo December 2001 to ultimo June 2002 the strain was
isolated from 12 patients in the 250-bed PCH and 6 patients in the 585-bed
TCH. In the majority of the patients, the strain was isolated from various
airway secretions (10 patients in the PCH, 5 in the TCH). Most patients were
infected in the ICUs (seven and four of the PCH and TCH patients,
respectively), while the rest were infected in various medical wards. Three
of the patients died of P. aeruginosa-associated multiorgan failure within 2 days
of positive blood culture. Four other patients died during the study period,
P. aeruginosa infection may have contributed. In the PCH, the outbreak started
in December 2001 and lasted until April 2002, while in the TCH the
outbreak started in March 2002 and lasted until June 2002. In February
2002 the Norwegian Institute of Public Health alerted of increasing incidence
of Pseudomonas infection in several hospitals. On 9 April 2002, commercially
available mouth swabs were identiﬁed as the source of the outbreak. Later, it
was recognized that the product was contaminated during the packing process
by the manufacturer. Culture of sputum thrice weekly was part of standard
ICU screening in the TCH, none in the PCH.
Conclusion: The reason for the lower incidence of P. aeruginosa infection in
the TCH and the later peak incidence is unknown. However, different use of
mouth swabs as well as random variations in the use of contaminated batches
may have contributed. Various practice by the laboratory personnel in
Interaction
% of stains
5FCþ FCZ 5FCþ ITZ 5FCþVRZ 5FCþAMB
Synergistic 77 60 80 77
Additive 20 32 20 23
Indifferent 3 8 0 0
Antagonistic 0 0 0 0
Tested on 25 strains
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collecting P. aeruginosa strains may also explain differences. Sputum screening
seems not to have contributed signiﬁcantly. Last but not least, empiric
antibiotic treatment with meropenem may have limited the outbreak in
the ICU of the TCH compared with the PCH in which cephalosporins were
used more widely.
P1510 Nosocomial infections due to Xanthomonas
(Stenotrophomonas) maltophilia: an epidemiologic and
microbiologic surveillance
P. Fazii, G. Calella, L. Cosentino, R. Pelatti, M. Stella, G. Riario Sforza
Pescara, I
Introduction: Xanthomonas (Stenotrophomonas) maltophilia is increasingly
recognized as an important cause of nosocomial infection. Infection primarily,
but not exclusively, affects immunocompromized patients. Although this
organism has been considered to have limited pathogenicity, reports indicate
that infection with S. maltophilia can cause bacteremia and other serious
infection, e.g. bronchopenumonial and catheter-related infections.
Methods:We performed a surveillance about this Gram-negative bacterium
in our hospital (Pescara, Italy) during the years 2001–2002. We isolated 45
strains in patients admitted to ICU, medical and surgical departments.
Microbiological examinations of specimens were performed with McConkei
agar and antimicrobial test with Kirby–Bauer method, according to NCCLS
standard.
Results: Thirty-two out of 45 strains of S. maltophilia were isolated in ICU, 8
out of 45 in surgical departments and 5 out of 45 in medical departments.
Forty-six percent of strains were susceptible to amikacin, 28% to cefotaxim,
75% to ceftazidim, 10% to ceftriaxone and imipenem 75% trimethoprim–
sulfamethoxazole, 28% amoxicillin/clavulanate.
Conclusions: Management of S. maltophilia associated infections is proble-
matic because many strains of the bacterium are frequently resistant to
multiple antibiotics, including those of the carbapenem class. In our experi-
ence, risk factors for S. maltophilia infection include neutropenia, the presence
of CVC, prolonged hospitalization, and previous therapy with antibiotics.
Despite its acknowledged importance as nosocomial pathogen, little is known
of the epidemiology of S. maltophilia, and its reservoirs are often not apparent.
P1511 Adhesion of Acinetobacter spp. to para-xylene
K. Krasnicki, E. Gospodarek
Bydgoszcz, PL
Objective: The objective was measuring adhesion of 200 Acinetobacter spp.
strains to para-xylene describing surface hydrophobicity bacterial cells.
Methods:Hydrophobicity was deﬁned by the Bacterial Adhesion to Hydro-
carbons Test (BATH) method of Rosenberg.
Results: Forty-eight percent strains of Acinetobacter spp. adhered to para-
xylene. Forty percent of strains showed weak hydrophobicity, 7.5%mild and 1
strain strongly adhered to para-xylene. A. baumannii strains adhered to poly-
mers in 52.2%, A. junii in 42.1%, and 20.0% in A. haemolyticus. BATH test is
useful technique for study hydrophobic properties of many bacteria surfaces
attached to polymers.
Conclusions: About half strains of Acinetobacter spp. showed hydrophobic
properties. Signiﬁcantly we ﬁnd weak adhesion to para-xylene than mild and
strong. Mostly adhesion was discovered in A. baumannii and in A. junii strains
than in A. haemolyticus.
P1512 Adhesion of Acinetobacter spp. to polystyrene
K. Krasnicki, E. Gospodarek
Bydgoszcz, PL
Objectives: The objective was estimation adhesive properties Gram-negative
rods Acinetobacter spp. to polystyrene.
Methods: Adhesion was measured by the method Christensen using poly-
styrene 96-well, ﬂat-bottomed tissue culture plates which were ﬁlled diluted
cultures of bacteria in trypcase soy broth (TSB) and in 0.5 TSB. Tissue culture
plates were incubated for 18 h at 37 8C, washed four times and stained with
crystal violet. Adhesion was measured by optical density (OD) of stained
bacteria to polystyrene plates.
Results:Among 200 strains of Acinetobacter spp. 72.5% adhered to polystyrene
in TSB and 68.0% in 0.5 TSB. We discovered adhesive properties in
A. baumannii strains (n¼ 157) in 77.1% when bacteria were incubated in
TSB and in 71.3% in 0.5 TSB. A. junii (n¼ 19) showed adherence to
polystyrene in 57.9% in TSB and in 0.5 TSB. A. haemolyticus (n¼ 15) adhered
in 60.0% in TSB and in 53.3% in 0.5 TSB. Signiﬁcantly we ﬁnd strong
adhesive properties whenA. baumanniiwere incubated in TSB compared with
0.5 TSB.
Conclusions: An optical density of stained bacteria to plastic tissue culture
plates is useful method for study bacterial adherence to medical devices. Most
of all strains of Acinetobacter spp. adhered to polystyrene. Most often strong
adhesion to polystyrene showed bacteria incubated in TSB than in 0.5 TSB.
P1513 Clinical outcomes and effectiveness of
antimicrobial treatment of patients with antibiotic-resistant
Pseudomonas aeruginosa pneumonia
E. Kadusevicius, V. Zmuidaite, I. Stankeviciene, D. Zaliaduonyte
Kaunas, LIT
Objective: To evaluate the clinical outcomes, length of stay and antibimi-
crobial treatment of patients with antibiotic-resistant Pseudomonas aeruginosa
pneumonia.
Methods:Datawere analyzed from histories of 102 patients (pts) with positive
clinical cultures for P. aeruginosa who were treated in ICU of Kaunas Medical
University Hospital. In-hospital mortality and length of stay were examined in
66 pts who had P. aeruginosa resistant to imipenem, meropenem, ceftazidime
or amikacin and compared with the rest of 36 pts that had P. aeruginosa
susceptible to the earlier mentioned antibiotics. The overall in-hospital
mortality in ICU during the year 2000 was 15.47%, the mortality in pts
with susceptible P. aeruginosa was 38.88% vs. to 63.63% of pts from whom
resistant P. aeruginosa was isolated (relative risk [RR], 1.64; 95% conﬁdence
interval [CI], 1.087–2.645). The duration of hospital stay for pts with a
susceptible P. aeruginosa was 9 (8.6 1.2) days vs. 19 (19.4 2.3) days for pts
who had resistant P. aeruginosa isolated (P< 0.001). In pts group with resistant
P. aeruginosa (n¼ 66) treatment with I, M, CF and A was more effective than
that with other antipseudomonal antibiotics (mortality 53.3% vs. 85.7%,
P< 0.05). Relative risk reduction (RRR) 0.378, 95% [CI] (0.118–0.557),
number of patients who need to be treated (NNT) to prevent one death –
3.09, 95% [CI] (1970–12 597), incremental cost per death avoided (ICER) –
1143 s. Descending (strong – weak) empiric treatment was more effective
than ascending (mortality 30% vs. 52.43%, P¼ 0.08), relative risk reduction
(RRR) – 0.428, 95% [CI] ( 0.042–0729), number of patients who need to
be treated (NNT) to prevent one death – 4457 95% [CI] (2383 to inﬁnity),
incremental cost per death avoided (ICER) – 1194.05 s.
Conclusion: Infections caused by antibiotic-resistant P. aeruginosa bacteria
result in higher mortality and prolonged hospital stay. Treatment with I,
M, CF, and A was more effective than that with weak antipseudomonal
activity antibiotics.
P1514 Hydrophobicity of Pseudomonas aeruginosa
clinical isolates: comparison 1991–2002
A. P. Fonseca, R. Costa, A. Pinto, A. F. Fonseca, J. A. Nogueira
Porto, P
Introduction: The versatility of opportunistic bacteria is due to the fact that
different sets of strains can acquire different groups of virulence genes, without
species barrier. Bacterial adhesion to biotic or abiotic surfaces, as the use of
medical indwelling devices is more widespread, is the ﬁrst step of bacterial
pathogenicity. Adherence to liquid hydrocarbons is an indirect method to
assess microbial cell surface hydrophobicity (CSH), which is believed to have
an important role in the adherence of bacteria.
Objective:To determine the correlation between hydrophobicity with origin
products and to compare distributions in the same general hospital in 1991 and
2002
Materials and methods: Fifty random selected clinical isolates of P. aeruginosa
from different biological products (respiratory tract, SB; Urine, U; and pus, P
were assayed in percentage (in an assay for hydrocarbon adhesion (1)) for the
capacity to adhere to n-hexadecane to assess hydrophobicity. All tests were run
in triplicate.
Results:The values are expressed in percentage as mean standard deviation:
SB, 1991: 17 16; 2002: 23 17; U 1991: 31 29; 2002: 20 15; P 1991:
55 23; 2002: 14 5.
Conclusions:Considering that the variation is due to the source of the isolate
an analysis of variance (ANOVA) results in a signiﬁcant difference (P< 0.01)
between adhesion values to epithelia (SB and U) than to no epithelial surfaces
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(P) in 1991. These results were not found in 2002. This can me explained by
the constant exchange of pathogenicity islands of genes between strains of
nosocomial origin, namely genes related to the expression of hydrophobins or
pili.
Acknowledgements: This study was supported by a research grant from
Fundac¸a˜o Calouste Gulbenkian.
Reference
1. Van der Mei et al. Curr. Microbiol 1991, 23, 337–41.
P1515 Serotype and adhesion to biomaterials
Pseudomonas aeruginosa in a general hospital, Portugal
A. P. Fonseca, R. Costa, A. Pinto, A. F. Fonseca, J. A. Nogueira
Porto, P
Introduction: Pseudomonas aeruginosa has been reported to colonize epithelia
and indwelling medical devices. Lipopolyssacarides (LPS) could be involved
in promoting adhesion to biomaterials.
Objectives: To study Pseudomonas aeruginosa epidemiology in a Central
Hospital in Portugal and to compare bacterial surface hydrophobicity in
two periods (1991 and 2002).
Materials andmethods:Fifty randomly selected strains isolated from different
biological products were used in this study. The bacterial serotypes were typed
with P. aeruginosa antisera. The attachment of bacteria to biomaterials was
assayed in percentage for the capacity to adhere to n-hexadecane to assess
hydrophobicity (1). Three different classes of hydrophobicity were obtained
(>0.4¼ 2;<0.1¼ 0;>0.1 and <0.4¼ 1). All tests were run in triplicate.
Results: Frequencies of the serotypes in 1991 and 2002: O:1, 13%, 20%; O:2,
16%, 1%; O:3, 9%, 4%; O:4, 6%, 1%; O:5, 4%, 1%; O:6, 21%, 26%; O:7, 3%,
6%, O:8, 8%, 4%; O:9, 1%, 4%; O:10, 23%, 3%; O:11, 16%, 11%; O:12, 17%,
4%; O:13, 10%, 0%; O:14, 2%, 4%; O:15, 2%, 10%; O:16, 6%, 3%. Serotypes
O:6, O:1, O:11 have higher hydrophobicity values and frequencies in 1991
and 2002, O: 1O had lower frequency but similar hydrophobicity comparing
1991 and 2002.
Conclusions:
1. Serotypes O:6, O:1, and O:11 are the ones with higher frequencies and
hydrophobicity.
2. The results indicate that the surface characteristics of bacterial serotypes are
related to the bacterial adhesion to the surface, but the pathogenesis of the
bacteria surely results from multiple factors.
Acknowledgements: This study was supported by a research grant from
Fundac¸a˜o Calouste Gulbenkian.
Reference
1. Van der Mei et al. 1991 Curr. Microbiol; 23: 337–41.
P1516 Adherence ability to abiotic surfaces in
opportunistic Pseudomonas aeruginosa:
a correlation study
A. P. Fonseca, J. Moura, M. Silva, A. F. Fonseca, J. A. Nogueira
Porto, P
Introduction: Attachment to biotic or abiotic surfaces is the ﬁrst step of
bacterial pathogenicity. There is a need to study how prevalent is this ability to
adhere and create sessile communities in nosocomial bacteria.
Objectives: The aim of the present study was to investigate the correlation
between Pseudomonas aeruginosa adherence potential to different substrata and
to access the involvement of acid–base (AB) interactions in microbial adhe-
sion.
Materials and methods: One hundred randomly selected strains of oppor-
tunistic Pseudomonas aeruginosa, from different sources were screened for their
adhesion capacity to hydrophobic biomaterials such as silicone, hexadecane,
and to electron–accepting chloroform, as assayed previously (1). All tests were
run in triplicate.
Results:Therewas a signiﬁcant correlation (Spearman correlation coefﬁcient)
between silicone and hexadecane (0.67; P¼ 0001), between silicone and
chloroform (0.29; P¼ 0004). The mean standard deviation adhesion values
are: to silicone (0.15 0.08), to hexadecane (0.21 0.14), and to chloroform
(0.50 0.14).
Conclusions: Adhesion to hydrophobic n-hexadecane can be used for
measuring the potential ability to attach to biomaterials because it correlates
well with silicone although it underestimates hydrophobicity. In fact, acid–
base (AB) interactions are absent in n-hexadecane and present in the adhesion
to chloroform, which explains higher adhesion values to this surface (2).
Hydrophobicity assays for large numbers of strains should always involve a
comparison between adhesion to n-hexadecane and adhesion to chloroform
in order to understand physicochemistry involved in microbial adhesion.
Acknowledgements: This study was supported by a research grant from
Fundac¸a˜o Calouste Gulbenkian.
References
1. van der Mei et al. Curr. Microbiol. 1991; 23: 337–41.
2. Busscher et al. Physical Chemistry of Biological Interfaces 2000 (eds A. Baszkin, W. Norde),
431–58.
P1517 Prevalence of swimming, swarming and
twitching in clinical isolates of Pseudomonas aeruginosa:
correlation to the adherence capabilities to biomaterials
A. P. Fonseca, J. Moura, M. Silva, A. F. Fonseca, J. A. Nogueira
Porto, P
Introduction: Pseudomonas aeruginosa is a human opportunistic pathogen able
to organize itself in very structured communities called bioﬁlm, which allows
the bacterium to colonize various environments and infectious sites. Bioﬁlm
formation represents an important aspect of the pathogenic power of this
microorganism. Flagellum and type IV pili are known to be involved in the
ﬁrst step of bioﬁlm formation (1), so it is important to understand their
prevalence among clinical isolates.
Objectives: To study the prevalence of ﬂagella (swimming), ﬂagella and pili
(swarming) and pili (twitching) in a random selected set of nosocomial strains
and to correlate to their adhesion capabilities to abiotic surfaces.
Materials and methods: One hundred randomly selected strains from
different origins of opportunistic Pseudomonas aeruginosa were screened for
their capacity to swim (presence of ﬂagella), swarm (presence of ﬂagella and
pili type IV) and twitching (pili type IV) as previously described (1, 2). The
percentage of adhesion potential to n-hexadecane was obtained as assayed
previously (3) and afterward transformed in a ordinal variable for statistical
analysis. All tests were run in triplicate.
Results: Swimming (58% with ﬂagella only; 42% without); swarming (35%
with ﬂagella and pili type IV; 65% without): Twitching (17% with pili type IV
only; 83%without). Therewas no signiﬁcant relation between swimming and
hydrophobicity and between swarming and hydrophobicity but there was a
signiﬁcant relation between twitching and hydrophobicity (Pearson Chi-
square 6.3: d.f. 2: P¼ 0043).
Conclusions: Surface approach is done by ﬂagella, which justiﬁes higher
prevalence comparing to the presence of pili type IV or both, required for
surface translocation. The presence of pili type IV increases surface hydro-
phobicity which promotes higher adhesion potential to biotic or abiotic
surfaces.
Acknowledgements: This study was supported by a research grant from
Fundac¸a˜o Calouste Gulbenkian.
References
1. Ko¨hler et al., J. Bacteriology, 2000; Nov: 5990–6.
2. De´ziel et al. J. Bacteriology 2001; Feb: 1195–204.
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P1518 The effect of simultaneous application of
therapeutic ultrasound and ceftazidime on growth of
Pseudomonas aeruginosa
N. Kashef, Q. Behzadian Nejad, M. Mokhtari-Dizaji, M. Sattari
Tehran, IR
Objectives: Pseudomonas aeruginosa is an important human opportunistic
pathogen with innate resistance to many antibiotics and disinfectants, pre-
dominantly infecting patients with defects in antibacterial host defenses.
Ultrasound is currently used in medical practice for diagnostic and therapeutic
purposes. A recent and relatively new application of ultrasound is in drug
delivery. There are many reports in the literature suggesting that ultrasound
activates, potentializes or makes more effective some pharmacological agents.
In the present study, we investigated the lethal effect of ultrasound and sMICs
of ceftazidime on growth of Pseudomonas aeruginosa (ATCC 27853) separately
and in combination.
Methods:TheMIC of ceftazidime for this strain was determined in Mueller–
Hinton Broth by the macrodilution technique. The aqueous suspension of
microorganism in a sterile, sealed plate was placed in an ultrasonic tank
operating at 1MHz. Different power output were used: 0.25, 0.5, 1 and
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1.5W. After desired time of exposure to the ultrasound (30 and 60 s), each
sample was plated separately and after incubation, the number of colonies was
counted.
Results: Bactericidal effect of ceftazidime concentration equal to 1 mg/mL
against this bacterium was more than that observed with 0.5 mg/mL statistical
analysis of results showed that there was a signiﬁcant effect of intensity for this
bacterium, with percent killed increasing with increased intensity level and a
signiﬁcant effect of time, with percent killed increasing with increased
duration of exposure. The combination of ultrasound and sMICs of cefta-
zidime was much more lethal to this bacterium than either of the treatments
alone.
Conclusion: These data conﬁrmed that simultaneous application of ultra-
sound and ceftazidime has some efﬁcacy in inactivating Pseudomonas aerugi-
nosa. The physical mechanism of inactivation by ultrasound alone, appears to
be transient cavitation, but the mechanism of synergistic effect of
ultrasound and ceftazidime is unknown. It might be a result of an enhanced
penetration of the antibiotic through the outer membrane. This promising
effect may results in developing a new methodology of killing resistant
bacterial infections.
P1519 Non-fermenting Gram-negative bacilli other than
Pseudomonas aeruginosa from clinical specimens
H. M. Petkar, P. W. J. West, I. A. Al-Obaid, M. Johny
Kuwait, Suleibikhat, KWT
Objectives: To identify nonfermenting Gram-negative bacilli (NFB) other
than Pseudomonas aeruginosa and to determine antimicrobial susceptibility,
clinical relevance and response to therapy.
Methods:TheNFB isolated from outpatients and inpatients seen at the Amiri
Hospital, Kuwait from September to December 2002 were identiﬁed by
conventional methods, the API 20NE and/or Vitek 2. Antimicrobial suscept-
ibility testing was performed by themodiﬁedKirby–Bauer method andwhere
applicable the Vitek 2. Clinical relevance was assessed from the condition of
the patient, source of the specimen and response to therapy.
Results:A total of 88 NFB were isolated from 87 patients. Twenty-six isolates
were from urine, 26 from skin and soft tissues, 24 from the lower respiratory
tract, 7 from peritoneal dialysis ﬂuids, and 5 from blood. Of the total, 47 were
hospital acquired. Thirty-two hospital acquired and eight community-
acquired infections were signiﬁcant. Clinically signiﬁcant hospital infections
were associated with the use of ventilators, catheters or intravenous lines.
Forty-seven isolates were Acinetobacter spp., 16 Stenotrophomonas maltophilia, 6
Alcaligenes spp., 4 Comamonas spp. and 15 isolates from 9 other genera.
Isolates from hospital acquired infections were more resistant to antibiotics
compared with community acquired isolates. Multiple antibiotic resistant
Acinetobacter spp. were isolated from two patients. Signiﬁcant infections
responded to therapy except in three cases.
Conclusions:NFB may be isolated from a wide variety of clinical specimens.
Although they are often encountered as colonizers, signiﬁcant hospital
acquired infections are common. Their accurate identiﬁcation and suscept-
ibility testing may ensure appropriate treatment.
P1520 Typing of clinical isolates of Stenotrophomonas
maltophilia strains by pulsed-ﬁeld gel electrophoresis
R. Schaumann, F. Laurin, A. C. Rodloff
Leipzig, D
Objective:To determine the clonally proﬁles of clinical strains of S. maltophilia
isolated during a 1-year period.
Methods: During a 1-year study period 128 strains of S. maltophilia were
isolated from different specimens of 76 patients at a 1500-bed major tertiary
care teaching university hospital. The strains were identiﬁed by commercial
available API system and genotyped by pulsed-ﬁeld gel electrophoresis
(PFGE) using the CHEF-DR III system. The restriction enzyme was SpeI.
Results: The PFGE proﬁles of the clinical isolates of S. maltophilia strains
varied widely. Only few isolates from different specimens of the same patient
were clonally identical. In other patients the strains of the same patient isolated
from different specimens were clonally different.
Conclusion: Due to the wide variation of their PFGE proﬁles, our results
suggest that there was no outbreak situation of S. maltophilia strains with
identical proﬁles at our hospital.
P1521 Study of the evolution of multiresistant
Acinetobacter baumannii clones isolated in a hospital in
northern Spain
M. Canduela, B. Arrugaeta, I. Rojo, G. Ramos, F. Calvo, L. Gallego
Leioa, E
Objectives:The aim of this study was to analyze the evolution ofA. baumannii
multiresistant clones responsible of nosocomial infections isolated at the
Hospital de Sta. Marina (northern Spain) and the evolution of class 1
integrons.
Methods: The study included all isolates obtained at the Microbiology
Service during the years 1999 and 2002 (a total of 102 and 82 isolates,
respectively). Susceptibility to antimicrobial agents was determined by the
agar dilution method following the NCCLS recommendations. Total DNA
was used as target for PCR-ﬁngerprinting experiments with primersM13 and
ERIC2. To detect class 1 integrons primers 30CS and 50CS were used in
ampliﬁcation experiments.
Results: The same three main clones identiﬁed in 1999 (named I–III) are still
the most important in 2002. However, as clone II was the predominant in
1999, at present the majority of isolates belong to clone I. Concerning the
antibiotic resistance, all clones showed an important increase on resistance to
amikacin. Moreover, clone I showed a general increase to the resistance to all
antibiotics tested specially imipenem andmeropenem. The integrons detected
in 2002 were the same than the ones identiﬁed in 1999 (named a, b and e)
with the difference that isolates from the year 2002 bored combinations of at
least two bands.
Conclusions: The majority of multiresistant A. baumannii isolates in Hospital
de Sta. Marina belonged to clone II in 1999 and to clone I in 2002. The same
class 1 integrons were detected but the isolates obtained in 2002 belonging to
clone I, bored combinations of two or three bands probably related to the
increase of the resistance.
P1522 Achromobacter (Alcaligenes) xylosoxidans in a
Greek cystic ﬁbrosis unit
S. Pournaras, M. Kanellopoulou, H. Iglezos, N. Skarmoutsou,
E. Papafrangas, A. N. Maniatis
Larissa, Athens, GR
Objective:This study was performed to assess the prevalence of Achromobacter
xylosoxidans among Greek Cystic ﬁbrosis (CF) patients, to determine the
sensitivity of isolated strains to antibiotics, to investigate whether these
patients share common genotypes, and whether they persistently carry the
same A. xylosoxidans strain or they acquire a different one.
Methods: A. xylosoxidans isolates that were recovered during 1 year from
CF patients were tested. Quantitative cultures of the sputum were
processed to appropriate media. Isolates were identiﬁed to the species level
by the API 20 NE and Wider systems. MICs were determined by the Wider
system and E-test. They were tested by PCR for the carbapenemase encoding
genes blaIMP and blaVIM and genotyped by pulsed-ﬁeld gel electrophoresis
(PFGE).
Results: Samples from eight of 70 CF patients (11.4%) yielded 32 A
xylosoxidans isolates during the study period. In all cases but one (who
remained in a good clinical condition) Pseudomonas aeruginosa was
concomitantly isolated. All strains were resistant to aztreonam, tobramycin,
gentamicin, all but one resistant to amikacin and cefepime, 90.6% to
ampicillin/sulbactam, 81.2% to ciproﬂoxacin, 50.0% to ticarcillin/clavulanic
acid, 43.7% to colistin, 40.6% to imipenem and meropenem, and 34.4% to
ceftazidime. The most active antibacterial agents were piperacillin (81.2%
sensitive) and its combination with tazobactam (90.6% sensitive). Genes
blaIMP and blaVIM were not detected in the carbapenem-resistant isolates.
Strains that were recovered from most patients belonged to the same
genotype, while the same strain persisted in each patient during the study
period.
Conclusions:The prevalence of respiratory isolation ofA. xylosoxidans among
our CF patients was higher than that reported previously. Piperacillin and its
combination with tazobactam remained effective against most of these
A. xylosoxidans isolates, while colistin was active against only 56.3% of isolates.
The high rate of resistance to carbapenems was not due to the production
of known carbapenemases. The recovery of genetically related isolates from
most patients indicates that A. xylosoxidans was acquired from an unknown
common source and infected CF lungs in a persistent way.
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P1523 An outbreak of multidrug-resistant strains of
Acinetobacter spp. in an Iranian hospital during 2001–2002
K. Bahar, M. Rahbar, A. Fattahi, B. Kia, M. Deldari, R. Atifeh
Tehran, IR
Objective:The aim of this study was to determine antimicrobial susceptibility
of hospital acquired isolates of Acinetobater spp. in Milad Hospital of Tehran.
Methods: From 1st July 2001–30th November 110 strains of Acinetobacter spp.
isolated from urine, blood, wound and other clinical specimens of hospitalized
patients. All isolates identiﬁed according routine microbiological methods.
The antimicrobial susceptibility testing were performed by disk diffusion
method according NCCLS M100-S12 guideline.
Results:Of 110 strains ofAcinetobacter 58 strain (52.75) isolated from urine, 32
strain (29%) isolated from wound, ﬂuids and 20 strain (18.2%) isolated from
blood. More than 80% of strains isolated from patients hospitalized in ICU,
NICU, RCU and pediatric department. All isolated strains were resistant to
ceftazidime, ceftizoxime, cephalotin, ceftriaxon, ceﬁxim cfazoline and ampi-
cilln. Frequency of resistance to ciproﬂoxacin, gentamycin, amikacin, tri-
methoprime–sulfamethoxazol and oﬂoxacin was 65, 76.5, 85.2, 85.7, and
87.5%, respectively.
Conclusion: Our study showed a high rate isolation of multidrug-resistant
Acinetobacter spp. from clinical specimens in this hospital. To prevent spread of
multidrug-resistant strains of Acinetobacter, it is recommended an implementa-
tion of control measures and the rational use of antibiotics.
Gram-negative resistance
P1524 Resistance evolution and extended-spectrum-
beta-lactamase producing E. coli isolated during 4 years
M. A. Orellana, M. Aramendi, G. Galera, T. Sanchez
Madrid, E
Objective: To study the resistance evolution and ESBL producing E. coli
strains isolated in outpatients during the last 4 years.
Methods: Eight thousand nine hundred and seventy-six E. coli strains were
studied in outpatients from January 1999 to October 2002. The identiﬁcation
and susceptibility were performed by the Walkaway MicroScam System
(DADE-Behring). Screening for detection of ESBL-producing strains were:
ceftazidime and/or cefotaxime and/or aztreonam more than 1 mg/mL. The
detection was performed by the double disk synergye test.
Results: The number of E.Coli isolated were: 2666 in 1999, 2234 in 2000,
2586 in 2001 and 1890 in 2002. The number of ESBL-producing E.Coli
were: 30 (13.2%) in 1999, 47 (2.10%) in 2000, 21 (0.81%) in 2001 and 30
(1.58%) in 2002. The susceptibility each year was: Amikacin was: 98, 99, 98
and 99%. Augmentin 89, 90, 89 and 89%. Ampicillin 41, 42, 42 and 41%.
Aztreonam: 93, 87, 83 and 85% Cefotaxime: 97, 99, 97 and 96%. Ceftazi-
dime: 97, 98, 97 and 96%. Imipenem: 98, 99, 99 and 99%. Ciproﬂoxacin: 81,
84, 83 and 83%. Oﬂoxacin: 82, 84, 84 and 82%. Fosfomicin: 97, 97, 96 and
97%. Gentamicin: 91, 92, 92 and 92%. Piperacillin: 44, 44, 43 and 42%. T/S:
70, 72, 72 and 72%. The susceptibility of ESBL-producing E.Coli were: Ak:
97, 96, 95 and 97%. Aug: 67, 66, 57 and 57%. Im: 100, 100, 95 and 97%. Cp:
80, 70, 43 and 67%. Oﬂ: 77, 66, 43 and 53%. Fo: 85, 98, 95 and 90%. Gm: 90,
97, 81 and 100%. Pi: 53, 30, 38 and 23%. T/S: 73, 64, 71 and 57%.
Conclusions: The frecuency of ESBL-producing E. coli strains is similar
during the 4 years studied. The resistance to aminoglycosides, augmentin,
cephalosporines, quinolones, fosfomicin and T/S is similar along the time.
The ESBL-producing E. coli are more resistant to quinolones and augmentin
than non-ESBL producing.
P1525 Antimicrobial resistance of Enterobacteriaceae
isolated in 2002
O. M. Dorobat, T. Biolan, D. Talapan
Bucharest, RO
Objective: To evaluate the prevalence of antimicrobial resistance and of
extended-spectrum beta lactamases (ESBL) in Enterobacteriaceae isolated
in 2002.
Methods: A total of 1515 isolates of Enterobacteriaceae (702 E. coli, 265
K. pneumoniae, 42K. oxytoca, 87 Proteus spp., 79 Enterobacter spp., 15Citrobacter
spp., 140 Shigella spp., 180 Salmonella spp.) were isolated from blood, urine,
stool, lower respiratory tract and another clinical specimens. The resistance
was evaluated by disk diffusion method according to the NCCLS quidelines.
Double disk diffusion method and E-test were performed for the detection of
ESBL producers.
Results: The resistance rate to ampicillin for the majority of species was
between 40 and 89.8%. To amoxicillin/clavulanic acid the prevalence of
resistance varied: 7.1% inK. oxytoca, 12.3% in E. coli, 19.5% in Proteus spp. and
41.5% in K. pneumoniae. Only K. pneumoniae and Enterobacter spp. were highly
resistant to cephalosporins, 26.7 and 35.4% respectively. All Enterobacter-
iaceae strains tested were susceptible to imipenem. For ﬂuoroquinolones the
resistance rate was higher for K. pneumoniae (19.2%) and E. coli (15.5%).
Resistance of Shigella ﬂexneri and Shigella sonnei were, respectively: ampicillin
77.8 to 21.1%, trimethoprim/sulfamethoxazol 62 to 72.6% and nalidixic acid
all susceptible to 18.9%. Non typhoidal Salmonella isolated in stool cultures
which belongs to serogroup D (70%) and B (20.5%) were resistant 23.8% to
nalidixic acid, 8.3% to ampicillin and 5% to trimethoprim/sulfamethoxazol.
There was no resistant strain of Shigella spp. and Salmonella spp. to ﬂuor-
oquinolones. There are some differences in the rate of resistance for E. coli
from urinary tract infections in outpatients comparatively with those from
inpatients: 11.3%, respectively, 19.6% for ciproﬂoxacin and 2.5–6.1% for
cephalosporins. K. pneumoniae recovered from urine was more resistant to
almost antimicrobial agents than isolates from respiratory tract infections. The
rates of ESBL producers was 26.2% inK. pneumoniae, 9.5% inK. oxytoca, 5.3%
in E. coli and 4.5% in Proteus spp.
Conclusions: High level of resistance was seen for ampicillin, amoxicillin/
clavulanic acid and trimethoprim/sulfamethoxazol against majority of species.
The imipenem remain the most potent agent tested against Enterobacter-
iaceae isolated in our laboratory. ESBL producer’s strains were between 4.5%
in Proteus spp. and 26.2% in K. pneumoniae.
P1526 Resistance of Enterobacteriaceae from tracheal
aspirates to beta-lactaman and ciproﬂoxacin in an
emergency hospital, Bucharest, between 2001 and 2002
A. M. Andrei, M. Pana, D. Ghita, M. Valcu, E. Craescu, M. Ghita
Bucharest, RO
Objective: To assess the resistance to beta- lactam and ciproﬂoxacin of
clinically relevant Enterobacteriaceae isolated in tracheal aspirates between
2001 and 2002, in Emergency Hospital, Romania
Methods:During the study the resistance of 234 Enterobacteriaceae isolated
from tracheal aspirates in ICUs was tested by MIC – ‘Microscan walkway –
Dade Behring’ to seven antibiotics: amoxicillin/clavulanic acid (amc), cefo-
perazone (cfp), cefotaxime (ctx), ceftriaxone (cro) ciproﬂoxacin (cip), imi-
penem (ipm), piperacillin/tazobactam (tzp).
Results: The distribution of bacterial species was as follows: Klebsiella
pneumoniae 40.4%, Proteus mirabilis 22.6%, E. coli 18.3%, Enterobacter aerogenes
6.85%, Citrobacter freundii 5.95% and Seratia marcescens 5.5%. The resistance of
the Enterobacteriaceae isolates to beta -lactams and ciproﬂoxacin was:
Klebsiella pneumoniae (amc 66%, cfp 92.8%, ctx 100%, cro 100%, cip
78.5%, ipm 18.2% tzp 51%). Proteus mirabilis (amc 85.2%, cfp 93.3%, ctx
100%, cro 100%, cip 78.5%, ipm 17.5%, tzp 51%). E. coli (amc 30.5%, cfp
72.7%, ctx 77.7%, cro 77.7%, cip 65.6%, ipm 9.5%, tzp 49.4%). Enterobacter
aerogenes (amc 88.8%, cfp 88.8%, ctx 88.8%, ctx 88.8%, cro 88.8%, cip 88.8%,
ipm 37.1%, tzp 55.5%). Citrobacter freundii (amc 93.9%, cfp 60%, ctx 66.6%,
cro 66.6%, cip 89%, ipm 6.6%, tzp 53.5%). Serratia marcescens (amc 83.3%,
cfp 83.3%, ctx 100%, cro 100%, cip 44%, ipm 37.1%, tzp 25%).
Conclusions: For all Enterobacteriaceae imipenemul was the most active
beta – lactam, followed by piperacillin/tazobactam. This study showed the
trend to increasing resistance of Enterobacteriaceae to beta – lactams and
ciproﬂoxacin
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P1527 Analysis of the gastrointestinal system
pathogens, 1987 and 2002, according to their number,
genus and susceptibility patterns
G. Sengoz, F. Yildirim, D. Berzeg, D. Mamcu, O. Nazlican
Istanbul, TR
Objective and method: In the year 1987, 660 stool specimens and in 2002,
1283 stool specimens had been investigated for the gastrointestinal system
pathogens at the Haseki Education and Research Hospital.
Result: The growth rate decreased to percentage 3.3 in 2002 while it was
percentage 9.5 in 1987. Most of the growing microorganisms (65%) had been
found to be Shigella spp. through the year 1987, though the Salmonella spp.
formed the majority by 74% in 2002. The mostly identiﬁed microorganism
was S. paratyphi B in 1987 while it was S. typhi in 2002. S. typhimurium rate has
increased from 4.5% in 1987 to 18% in 2002. The majority of the Shigella spp.
had been found to be S. ﬂexneri in both years. S. boydii strains had formed 31%
in 1987 and it decreased to 9% in 2002. While there is no difference between
the susceptibility patterns of S. typhi in 2 years, there is a clear increase of group
B. salmonella resistance to ampicillin and ampicillin/sulbactam.
Conclusion: The decreased growth rates through a period of 15 years is
pleasing to see the improvement of community hygiene while the increase of
bacterial resistance is very scaring since it causes difﬁculty in treatment.
P1528 Antibiotic susceptibility and the developing
resistance within years of Shigella strains
G. Sengoz, Y. Bilgin, F. Yildirim, K. Urkmez, O. Nazlican
Istanbul, TR
Objectives: Middle socio-economic class of Istanbul forms the patient
population of Haseki Education and Research Hospital. The stool samples
in 10-year period of time have been analyzed for Shigella spp. and resistance
problem that develops along years has been put forward within this work.
Methods and result: Five hundred and eight Shigella strains isolated from
23.556 stool cultures between the years 1993 and 2002 were identiﬁed by
conventional methods. When we look at the distribution of the species,
S. ﬂexneri strains are the most frequent ones with a 61% and S. sonnei strains are
second with a percentage of 30. Analysing the months during which the
Shigella strains were isolated, August and September are the most frequent.
Analysing the years, a gradual decrease was perceived except 1998. The
antibiotic susceptibility of 508 Shigella strains with disk diffusion method,
using Mueller-Hinton medium according to the recommendations of
NCCLS document M2A7 were analyzed. 231 strains (45.4%) were found
resistant to ampicillin; 118 strains (23.2%) to ampicillin/sulbactam and 214
strains (42.1%) to chloramphenicol. A higher resistance was seen in Shigella
ﬂexneri while there was no resistant strain of Shigella boydii. The resistance
percentages of 56 strains isolated in 1993 for ampicillin, ampicillin/sulbactam
and chloramphenicol were 57.1, 17.8 and 0, respectively; while the percen-
tages for 11 strains isolated in 2002 were 81.8, 54 and 63.6, respectively.
Conclusion:The increase of resistance along years is the messenger of possible
difﬁculty in treatment, although the decrease in numbers thanks to the
development of hygiene in community. This increase also necessitates the
regional follow up of the bacterial resistance.
P1529 Study of incidence and antimicrobial
susceptibilities of Shigella serotypes isolated from
shigellosis cases in an Iranian hospital (2000–2001)
S. Hekmat Yazdi, J. Hosseini
Tehran, IR
Background: Shigellosis is the most communicable bacterial diarrheas in our
country specially in warm seasons.
Objective: Determining incidence of common shigella species and their
antibiotic resistance pattern with two standard methods.
Materials andmethods:Direct examination and cultivation of diarrheal stool
specimens, biotyping culture-conﬁrmed cases with classical biochemical tests
and serotyping them for differentiation common shigella spp. then performing
antimicrobial susceptibility tests by two standard methods:
	 broth dilution method for determining minimal inhibitory concentration
(MIC) NCCLS approved method.
	 agar disk diffusion (NCCLS standard method).
Results: From 89 conﬁrmed cases, Shigella sonnei was the serotype most
commonly associated with diarrheal disease (40 cases¼ 44.9%) Shigella dys-
enteriae was the least commonly recoverd species (three cases¼ 3.3%) More
than 95% isolated were sensitive to ciproﬂoxacin, cefotaxime, and ceftriaxone.
TheMIC values were (0.25–2) and (4–16), respectively. Seventy percent were
sensitive to nalidixic asid (MIC¼ 8–32) and less than 50% to Tetracyclin, Co-
trimoxazol, Ampicilin. The MIC values were (8–16) and (4–32) (16–64),
respectively.
Conclusion: Our therpeutic recommendation is to stop prescription of
ampicilin, cotrimoxazol, tetracycline, for shigellosis cases. We suggest nali-
dixic acid for out patients and mild cases, quinolones and third generation of
cephems for more acute as a ﬁrst choice of treatment.
P1530 Seven hundred and twenty-three Salmonella
strains and their antibiotic resistance pattern
G. Sengoz, F. Yildirim, D. Berzeg, H. Gulten, O. Nazlican
Istanbul, TR
Objective: Seven hundred and twenty-three Gram-negative bacteria were
identiﬁed as Salmonella spp. with conventional, cultural and serological
methods from stool samples sent to the Haseki Education and Research
Hospital microbiology laboratory between 1993 and 2002.
Methods: Among the 723 Salmonella isolates most of them were S. typhi-
murium and S. typhi, respectively. The two nosocomial outbreaks in 1995 and
1996 in the Pediatric Clinic were responsible for the S. typhimurium abun-
dance. For the year 1998, the increase of S. typhi isolates is remarkable. The
susceptibility of S. typhimurium strains to ampicillin, ampicillin/sulbactam and
chloramphenicol were determinedwith Kirby-Bauer disk diffusion technique
on Mueller-Hinton medium according the NCCLS document M2A7
recommendations.
Result: The highest resistance against ampicillin, ampicillin/sulbactam and
chloramphenicol were detected in S. typhimurium. Although among the
outbreak strains the resistance pattern for the three antibiotics was 100,
93.3 and 91%, respectively; among the nonoutbreak strains it was 64, 51
and 67%, respectively. No resistance was detected among the S. paratyphi A
strains.
Conclusion: The increasing drug resistance of these frequent bacterial agents
of gastrointestinal system infections is remarkable because of their effect to the
public health.
P1531 Antimicrobial resistances in Campylobacter
jejuni/coli in Italy during 2002: national study of Campyg
Working Group of Italian Association of Clinical
Microbiologists
D. Crotti, M. L. D’Annibale for the Amcli-Campyg, Italian Working
Group (M. Spinelli, F. Lanzini, S. Rossi, C. Rossi)
Objectives: Inside a policentric study concerning intestinal infections by
Campylobacter jejuni/coli we wanted to lay stress on antimicrobial resistances in
these pathogens.
Methods: During 2002, eight laboratories sent own strains of Campylobacter
spp. to central laboratory of Perugia, where theywere identiﬁed, biotyped and
processed for antimicrobial resistances, using modiﬁed agar diffusion method
on blood agar, as recommended.
Results:We studied 205 strains: 180 C. jejuni, 22 C. coli, three other ones. We
observed these resistances: 51.1% to nalidixic acid; 49.4% to ciproﬂoxacin,
oﬂoxacin, norﬂoxacin; 43.3% to tetracycline; 40.0% to minocycline; 2.2% to
erythromycin; 1.1% to rokytamicin; 0.6% to gentamycin; no resistances to
chloramphenicole. The resistances to new quinolones showed a range from
31.3 to 80.7%.
Conclusion: We conﬁrm the low or very low resistances to macrolides, an
increasing resistances to tetracyclines, a still increased resistances to quino-
lones. We must do a surveillance of this aspect, because invasive enteritis
usually by C. jejuni need of antimicrobial therapy.
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P1532 Bacteriological proﬁle of a fastidious
gram-negative organism. Antimicrobial sensitivity pattern of
Serratia marcescens as assessed by the evaluation of 1004
consecutive cultured strains
A. Nanetti, R. Manfredi, R. Valentini, S. Morelli, M. Ferri, L. Calza,
F. Chiodo
Bologna, I
Objective:To investigate the in vitro antimicrobial resistance proﬁle of Serratia
marcescens, a gram-negative organism of growing importance in the immu-
nocompromised and hospitalized host, and in the extreme life ages.
Methods:All consecutive S. marcescens isolates identiﬁed in the years 2000 and
2001 were tested against a broad panel of antibiotic compounds, including
ampicillin, amoxicillin-clavulanate, cephalothin, gentamycin, amikacin,
ciproﬂoxacin, and cotrimoxazole.
Results: One thousand and four S. marcescens strains cultured from clinical
specimens of various origin were identiﬁed and later tested for antimicrobial
sensitivity through standardized laboratory techniques, according to the
updated NCCLS recommendations. The cumulative susceptibility pattern
showed a complete (100% of tested strains) sensitivity to gentamycin,
amikacin, ciproﬂoxacin, and cotrimoxazole, as opposed to a complete
(100%) resistance to ampicillin, amoxicillin-clavulanate, and cephalothin.
No signiﬁcant variations occurred when comparing the year 2000 proﬁle
with the year 2001 one.
Conclusions: Seratia marcescens deserves careful attention by clinicians, pedia-
tricians, andmicrobiologists, due to its environmental source, and its tendency
to cause nosocomial disease (also as hospital outbreaks), usually interesting
immunocompromised hosts, neonates, and the elderly, or patients who
underwent surgery and other invasive diagnostic or therapeutic procedures.
Third-generation cephalosporins, carbapenems, and ﬂuoroquinolones are the
recommended ﬁrst-choice therapy (The Sanford Guide to Antimicrobial
Therapy 2002; Bartlett JG, Pocket Book of Infectious Disease Therapy 2002),
followed by antiPseudomonas semisynthetic penicillins, aztreonam, and gen-
tamycin. According to our extensive experience, carried out on more than
1000 Smarcescens strains, aminoglycosides such as gentamycin or amikacin,
ﬂuoroquinolones like ciproﬂoxacin, and even cotrimoxazole may represent a
ﬁrst-line choice, encompassing also a more favorable pharmacoeconomic
proﬁle compared with third-generation cephalosporins and carbapenems,
pending in vitro susceptibility testing. On the other hand, an empiric
treatment with ampicillin, ﬁrst-generation cephalosporins, and also amox-
icillin-clavulanate is borne by a high risk of clinical and microbiological
failure, due to the elevated in vitro resistance proﬁle showed by S. marcescens
against these last antimicrobial compounds.
P1533 Determination of minimal inhibitory
concentration of trimethoprim sulfamethoxazole against
Stenotrophomonas maltophilia
O. Kurt Azap, F. Ergin Timurkaynak, H. Arslan, E. Kuru Inci, G. Yapar
Ankara, TR
Objectives: To determine the in vitro activity of trimethoprim sulfamethox-
sazole against Stenotrophomonas maltophilia isolates.
Methods: Twenty-nine isolates obtained from blood (17), wound (7),
respiratory specimen (5) were tested against trimethoprim sulfamethoxazole.
The agar dilution method was performed according to the National Com-
mitte for Clinical Laboratory Standards (NCCLS), 2002. Pseudomonas aeru-
ginosa ATCC 27853 was used for quality control.
Results:Only one of the 29 isolates is resistant to TMP-SMX. The same strain
was resistant by disk diffusion method. MIC50 of the isolates is 1 mg/mL,
MIC90 of the isolates is 2mg/mL.
Conclusion: Stenotrophomonas maltophilia, an opportunistic pathogen, has risen
to prominence during the last few years. Its unique antimicrobial susceptibility
pattern guides to therapy. Resistance to TMP-SMX varies from 0% to 33.4%
in the literature. Since the resistance rate is only 3% according to our results
TMP-SMX seems to be appropriate for the infections with S. maltophilia. The
disk diffusion results for TMP-SMX usually correlate well with the MIC
studies. In our study, there was only one resistant strain which was also noticed
resistant by disk diffusion.
P1534 Biotypes and antimicrobial susceptibilies of
Brucella isolates
H. Bodur, N. Balaban, S. Aksaray, V. Yetener, E. Akinci, A. Colpan,
A. Erbay
Ankara, TR
Brucellosis remains a public health problem especially in the Mediterranean
countries. It is a common infectious disease in rural area of Turkey. In this
study, 41 Brucella strains isolated from blood and cerebrospinal ﬂuid (CSF)
cultures of adult patients with brucellosis were identiﬁed to species level and
biotypes were detected. Brucella species were identiﬁed on the basis of typical
Gram staining (faintly staining and minute coccobacillus), CO2 requirements
for growth, production of H2S and urease, growth in the preciseness of aniline
dyes, susceptibility of Tbilisi bakteriophage and agglutination in antisera. All
of the isolates were Brucella melitensis: Two strains of Brucella melitensis biotype-
1 and 39 strains of Brucella melitensis biotype-3. In vitro activities of these
strains were detected byE-test (AB Biodisk) method. According to theMIC90
values, the most active agent was found to be doxycycline (MIC90 0.064 mg/
mL) followed by ciproﬂoxacin (MIC90 0.25 mg/mL), thrimethoprim/sul-
phamethoxazole and ceftriaxone (MIC90 0.38 mg/mL). Rifampin (MIC90
0.75 mg/mL) exhibited the highest MIC90 value (Table 1).
In conclusion, this study suggests that conventional antiBrucella antibiotics are
active against Brucella species in vitro. Thus routine antibiotic susceptibility
tests for Brucellae are not necessary. However, antimicrobial resistance must be
examined periodically.
P1535 Antibiotic resistance of Acinetobacter baumanii:
a study on 101 clinical isolates
Z. Zhiyong, G. Yanyu, L. Xiaoju
Chengdu, CHN
Objective: To assay the antibiotic resistance of clinical isolates of Acineto-
bacter baumanii in order to provide evidences for prudent chemotherapy and
clues for further studying on the resistance.
Methods:Hundred and one strains of A. baumanii were isolated from clinical
specimens from January 2002 to December 2002 in West China Hospital (a
national Medical Center with 3000 beds) and collected. Antimicrobial
susceptibility testing was performed by the agar dilution method according
to the guidelines of the National Committee for Clinical Laboratory Stan-
dards. Muller-Hinton agar was used for susceptibility testing. Fourteen
antimicrobials ansd sulbactam were included in this study.
Results: Resistant proportions of the 101 clinical isolates against 14 anti-
microbials are below (also see Table 1): meropenem 4%; piperacillin-tazo-
Table 1
Antibiotic Range (mg/mL) MIC50 (mg/mL) MIC90 (mg/mL)
TMP/SMX 0.064–1 0.094 0.38
Ciprofloxacin 0.064–0.38 0.125 0.25
Rifampin 0.047–2 0.50 0.75
Ceftriaxone 0.047–2 0.125 0.38
Doxycycline 0.023–0.25 0.047 0.064
Table 1 Antimicrobial susceptibility of 101 clinical isolates of Acinetobacter baumanii
MIC50 MIC90 R I S
Ampicillin 512 >512 71 10 20
Piperacillin 128 512 46 22 33
Piperacillin-tazatobactam 64 128 4 57 40
Subactam 8 32
Cefotaxime 128 512 55 19 27
Ceflazidine 32 256 47 5 49
Cefepime 16 32 11 8 82
Cefoxitin >512 >512 68 13 20
Imipenem 0.125 2 5 1 95
Meropenem 0.5 2 4 3 94
Aztreonam 16 512 16 35 50
Gentamicin >512 >512 71 0 30
Amikacin >512 >512 56 5 40
Ciprofloxacin 32 128 53 2 46
Trimethoprim-sulamethoxazole 304/16 >608/32 74 0 37
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bactam 4%; imipenem 5%; cefepime 11%; aztreonam 16%; piperacillin 46%;
ceftazidime 47%; ciproﬂoxacin 53%; cefotaxime 55%; amikacin 56%; cefox-
itin 68%; ampicillin 71%; gentamicin 71%; and sulfamethoxazole-trimetho-
prim 74%. The data of MIC90, MIC50, intermediate and susceptibility is
available in Table 1.
Conclusions: Clinical isolates of A. baumanii from Western China are
mostly resistance to co-SMX, gentamicin and ampicillin, but less to mer-
openem and imipenem. However, the resistance to carbapenems is found in
several isolates. The study on the mechanism of the resistance to carbapenems
is following.
Mechanisms of resistance 2
P1536 Selection and characterization of
ﬂuoroquinolone resistant Pseudomonas aeruginosa by
ciproﬂoxacin (Cpx) and levoﬂoxacin (Lfx) using high-density
cultures
G. Hansen, J. Blondeau
Saskatoon, CAN
Background: The mutant prevention concentration (MPC) has been pro-
posed as a novel parameter designed to differentiate between compounds
propensity to select for and inhibit resistant mutants present in large hetero-
genous susceptible cultures. When MPC results are applied to FQ pharma-
cokinetics duration of the dosing interval above the MPC can be calculated
(T>MPC). We examined by mutant selection curves (MSC) the different
allelic variants of PA mutants selected by Cpx and Lfx and determined
whether resistant phenotypes predominate throughout large heterogenous
susceptible populations or if their appearance correlates within a deﬁned
concentration spectrum.
Methods:Two susceptible strains of PAwere chosen (MIC¼Cpx 0.125, Lfx
0.25mg/L). One strain was a genetically constructed mexA-efﬂux negative
lab strain. The susceptible strain was inoculated into Mueller-Hinton broth
and grown overnight to produce high density culture (>10 10 cfu/mL).
Aliquots of 1.7 10 10 cfu/mL were applied to agar plates seeded with FQ
antibiotic (range 0.01–20mg/L) and incubated for 24 h. Individual colonies
were counted. Selected colonies from various concentration points were
selected from gyrA and parC gene sequence analysis.
Results: No differences in the number of cells recovered from Cpx and Lfx
plates were observed at concentrations between 0.01 and 0.125mg/L. For
drug concentrations between 1.5 and 7mg/L, the number of recovered cells
on Lfx plates (log reduction 2.39 to 7.36) was 2.5–22 000 times greater
than the number of cells recovered fromCpx plates (log reduction 5.82–7.25).
Between concentration of 8–16mg/L, 3–66 cells were recovered from L
plates. No colonies were recovered from Cpx plates above a concentration of
6mg/L. Testing of inoculum of 1.56 10 5 cfu/mL of the same strain
yielded no signiﬁcant differences in the number of colonies recovered at
various concentrations. Sequence analysis of QRDR region from colonies
recovered from Lfx plates revealed a gyrA Ile83 mutant. No conﬁrmed
QRDR mutants were recovered from colonies present on Cpx plates.
Conclusion: Selection of resistant PA was greater for Lfx than Cpx when
10 10 cfu/mL culture was sampled. No difference in the selection of
mutants were observed with a 10 5 cfu/mL sample of the same culture.
QRDRmutants are selected at high concentrations of Lfx when 10 10 cfu/
mL sampled. Based on data analyzed to date noQRDRmutants were selected
by any concentration of Cpx.
P1537 Rapid selection of Pseudomonas aeruginosa with
decreased ciproﬂoxacin susceptibility by serial exposure to
new antigram-positive quinolones
J. M. Entenza, S. Dargere, P. Francioli, P. Moreillon
Lausanne, CH
Background: Ciproﬂoxacin (CIP) is more active against Gram-negative than
Gram-positive bacteria. In Gram-positive bacteria, CIP rapidly selects for
resistant derivatives that are cross-resistant to newer quinolones with an
improved antiGram-positive spectrum. Conversely, newer antiGram-positive
quinolones are less active against Gram-negative bacteria. Thus, the question
arises as to whether the new antiGram-positive quinolones might favor the
selection of resistant Gram-negative organisms which become cross-resistant
to CIP.
Methods: Five isolates of P. aeruginosa were used. They were either plated
(109CFU/plate) on drug-containing agar to determine the minimal drug
concentration inhibiting the emergence of resistant mutants (mutant preven-
tion concentration or MPC), or serially exposed to increasing drug con-
centrations in liquid cultures. Drugs included CIP, levoﬂoxacin (LVX),
gemiﬂoxacin (GFX), moxiﬂoxacin (MFX), or garenoxacin (GRN). The
MPC and the increase in MIC were followed, and cross resistance between
anti-Gram-positive quinolones and CIP was determined.
Results: The MPC for 90% of P. aeruginosa isolates (MPC90) was 1mg/L for
CIP, 8mg/L for LVX, 16mg/L for GFX, and 32mg/L for both MFX and
GRN. After serial exposure, all quinolones selected for resistance. However,
selection was faster with newer MFX, GFX, and GRN. Resistant P. aeruginosa
selected by these drugs had a 2–4 increase in their MIC of CIP.
Conclusion: The frequency of resistant P. aeruginosa was much higher on
antiGram-positive quinolones than on CIP. Moreover, derivatives resistant to
new antiGram-positive quinolones had 2–4 times increases in their MIC of
CIP. Serial passage in liquid cultures conﬁrmed these results. Blood and tissue
concentrations preventing resistance (i.e. >8mg/L) are not reached in vivo
with recommended dosages of newer anti-Gram-positive quinolones. This
suggests that treatment with newer quinolones might promote populations of
CIP-resistant colonizing pseudomonas in the patient.
P1538 Characteristics of resistance phenotypes of
Pseudomonas aeruginosa hospital strains
E. Tokarska, A. Budak, M. Skalkowska, E. Karczewska
Cracow, PL
Background:Recently there have been more frequently isolated Pseudomonas
aeruginosa strains resistant to many antibiotics, comprising carbapenems. Many
different mechanisms are connected with resistance of these bacteria. The
production of metallo-beta-lactamases is responsible for the carbapenem-
resistance of Gram-negative bacterial species such as P. aeruginosa and Serratia
marcescens. The aim of our study was the analysis of the occurrence and
sensitivity to the different kind of antibiotics P. aeruginosa strains isolated from
patients treated in Rydygier’s Hospital in Krako´w. Then the detection of
metallo-beta-lactamases among carbapenem-resistant strains was carried out.
Material: The study population was the patients hospitalized from 1998 to
2000 into ﬁve wards. From 2482 P. aeruginosa strains isolated from blood,
urine, wounds and sputum 691 were selected and then 187, were fully tested.
Methods: The strains were identiﬁed in the automatic ATB system using ID
32GN strips (bioMerieux). The sensitivity of P. aeruginosa strains to different
drugs was tested with disc diffusion method (inerpretation according to
NCCLS). The following antibiotics were tested: ticarcillin, piperacillin,
piperacillin/tazobactam, ticarcillin/clavulanian acid, cefotaxime, ceftazidime,
imipenem, meropenem, amikacin. Two discs containing ceftazidime, imi-
penem and ﬁltered disc containing EDTA or 2-mercaptopropionic acid
(2MPA) for detection metallo-beta-lactamates were used.
Results: P. aeruginosa strains isolated in the period of three years showed
relatively high resistance to antibiotics from penicillin group (respectively to
ticarcillin in the range from 59.9 to 87%, and piperacillin from 63.8 to 81.4%).
The growth of resistance to ceftazimide was 59% in 2000 years (9% in 1998).
The resistance to imipenem and meropenem was about 22 and 26%,
respectively, and has grown in analyzed period too. The resistance to
carbapenem was metallo-beta-lactamase depended. We isolated strains of
P. aeruginosa of resistance phenotype to all investigated drugs, in the range from
21.5 to 18.4% in 1998–2000.
Conclusions: The present data indicates that the carbapenems are the most
suitaible antibiotics for treatment of infection caused by P. aeruginosa. We also
showed mechanism of resistance strains to carbapenems with connection to
production of metallo-beta-lactamases. Therefore the methods for detection
of this enzyme can be very helpful in daily clinical laboratory testing.
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P1539 In vitro susceptibility and population analysis of
staphylococci after serial passage at sub-MIC levels of
dalbavancin and other glycopeptides
S. Lopez, C. Hac kbarth, R. White, J. Trias
Fremont, USA
Objectives: Dalbavancin (DAL) is a novel, semisynthetic glycopeptide, with
activity against Gram-positive organisms, including resistant strains. It is more
active in vitro and in animal models than vancomycin or teicoplanin. In a
phase 2 study dalbavancin was well tolerated; weekly doses were effective in
deep skin and soft tissue infections and comparable to standard of care. DAL is
currently in phase 3 clinical development as a weekly regimen. Staphylococci
can express heterotypic resistance to glycopeptides. An increased resistant
subpopulation may be an initial step towards the development of resistant
strains. This study was designed to determine whether serial passage in
vancomycin (VAN), teicoplanin (TEI), or DAL increases the glycopep-
tide-resistant subpopulation of S. aureus (MSSA) or S. haemolyticus (SHA).
Methods: MICs of VAN, TEI and DAL were determined after each of 24
serial passages, using preceding 0.5X MIC tube as source of inoculum.
Colonies from the passages were selected to assess their resistance phenotype.
MICs were determined by standard methods. The resistant subpopulation was
calculated as [log10 cfu/mL on BHIAþ 4mg/L drug]/[log10 cfu/mL on
BHIA].
Results: For VAN passage mutants, the MIC increased from 0.5 to 2mg/L in
MSSA and the VAN-resistant subpopulation increased from 10 to 6.10-4.3. In
SHA, VAN MICs increased from 0.5 to 1mg/L and the resistant subpopula-
tion increased from 10 to 6.8-10-3.4. After passage in TEI, mutants in MSSA
and SHA had MICs of 8 and 16mg/L, respectively, and the population was
homogeneously resistant. After passage in DAL, the MIC increased from 0.25
to 0.5mg/L (MSSA) and from 0.125 to 0.5mg/L (SHA). For bothMSSA and
SHA the resistant subpopulations remained low (10–7) after 24 passages in
DAL.
Conclusions: Long-term sub-MIC passage in glycopeptide results in higher
MICs of VAN, TEI and DAL in both MSSA and SHA, although DAL MICs
remained 0.5mg/L. The resistant subpopulation in both VAN and DAL
passaged mutants increased, but the subpopulation was larger after selection in
VAN. Passage in TEI readily selected for increased resistance to TEI.
Staphylococci have a heterotypic response to DAL but it is not easy to
increase the resistant subpopulation by continuous exposure to sub-MIC.
Since projected trough levels of DAL are over MIC, in vivo selection for
clinically relevant resistance to DAL may be more difﬁcult than for other
glycopeptides.
P1540 Determination of the minimal inhibitory
concentration (MIC) and mutation prevention concentration
(MPC) for garenoxacin against clinical isolates of
Streptococcus pneumoniae
J. Blondeau, K. Metzler, G. Hansen, P. Hedlin, S. Borsos
Saskatoon, CAN
Objective: Garenoxacin (GRN) is a novel des-F(6)-quinolone. The MPC is
an unique measurement of antimicrobial potency as it deﬁnes the drug
concentration threshold that would require a microorganism to simul-
taneously possess two or more mutations for growth in the presence of
the drug. Antimicrobial resistance with SP is a global pandemic and is deﬁning
an important role for ﬂuoroquinolones (FQ) for therapy against this organism,
however, emerging resistance to older agents is a concern.We determined the
MIC and MPC for clinical isolates of SP against GRN.
Methods: The MICs were determined by microbroth dilution with inter-
pretation based on NCCLS guidelines. For MPC testing,approximately
10 10 cells were applied to GRN plates containing drug and incubated
for 24 and 48 h. The lowest concentration that prevented growth was
recorded as the MPC.
Results: To date, 344–384 pneumococcal isolates have been tested by both
MIC (n¼ 384) and MPC (n¼ 344) for GRN. The MIC50 (mg/L), MIC90
(mg/L) and range (mg/L), respectively, were as follows: 0.063,
0.125,<0.008–2mg/L. The modal MIC was 0.03mg/L. The MPC50
(mg/L), MPC90 (mg/L) and range, respectively, were as follows: 0.125,
0.5, 0.031–1mg/L. The modal MPC was 0.125mg/L. No differences in
GRN MIC or MPC values were seen between isolates that were sensitive,
intermediate or resistant to penicillin. A total of 14 clinical isolates withMPCs
to levoﬂoxacin (4 to >64mg/L) were genetically characterized and four
contain both parC& gyrAmutations while the remainder hadmutations in the
parC gene, some of which have not previously been associated with FQ. MIC
values for GRN against these isolates ranged from 0.032 to 0.25mg/L (MIC90
0.25mg/L) andMPC values ranged from 0.64 to 1mg/L (MPC90 0.25mg/L)
for 13/14 isolates (1 for 1 isolate). MPC values for four isolates with parC
and gyrA mutants were 0.25, 0.5 and 1(n¼ 2) mg/L.
Conclusion: GRN is an investigational drug with enhanced in vitro activity
against SP. LowMPC values suggest that this compound is less likely to select
for FQ resistance. The GRN MPC values were within clinically achievable
concentration for isolates with high MPC values to levoﬂoxacin suggesting
GRN may be useful for therapy in patients with levoﬂoxacin resistant
mutants. GRN looks like a promising new agent for treating SP infections.
P1541 Genetic mechanisms of macrolide resistance in
S. pneumoniae
J. Van Eldere, J. Verhaegen
Leuven, B
Objective: to analyze the genetic mechanisms responsible for macrolide
resistance in S. pneumoniae
Methods: Two hunderd and forty-three erythromycin resistant clinical
Streptococcus pneumoniae isolates collected between october 1999 and februari
2000 were analyzed. MIC’s of all isolates for erythromycin, telithromycin and
clindamycin were determined via agar dilution. PCR was used to determine
the presence of ermB and mefA. Erythromycin-susceptible strains and ery-
thromycin-resistant strains with known genotype (strain 02J1095 (ermB) and
02J1175 (mefA)) were included in every run as positive and negative controls.
Strains without ermB or mefA genes or strains with both genes were retested
to conﬁrm the genotype
Results: 84.3% of the isolates had only the erm gene and these strains all
displayed anMLSB phenotype; 5.8% had only themef gene and these strains all
displayed the M phenotype. 3.3% had erm plus mef genes and 6.6% had
neither erm nor mef genes. These strains had varying genotypic and pheno-
typic resistance patterns. The ketolide telithromycin retained good activity
against most ery-R strains; the increase in MIC for telithromycin was most
pronounced in mef-positive strains.
Conclusion: Compared with an earlier analysis of pneumococci collected in
Belgium between 1995 and 1997, there was an increase in ery-R strains
without mef nor erm genes. Signiﬁcant regional differences were observed
between the northern part and the southern part of Belgium. In the northern
part, erm containing isolates were signiﬁcantly less present than in the
Southern part (78.2 vs. 90.6%) and mef and double negative strains were
clearly more present (11 vs. 2% for mef and 8.2 vs. 4.7% for double negative
strains).
P1542 Identiﬁcation of macrolide-resistance
mechanisms and distribution of efﬂux gene variants in
Canadian isolates of Streptococcus pneumoniae: results of a
5-year (1997–2002) National Surveillance Study
K. A. Nichol, D. Swedlo, A. K. Wierzbowski, L. P. Palatnick,
H. J. Smith, M. Mulvey, D. J. Hoban, G. G. Zhanel
Winnipeg, CAN
Objectives:Macrolide resistance in S. pneumoniae is largely attributed to either
target modiﬁcation or active drug efﬂux. Ribosomal methylation mediated by
the erm(B) gene confers cross-resistance to macrolides, lincosamides and
streptogramin B antibiotics (MLSB phenotype), while macrolide efﬂux
(mef) genes confer low-level resistance to only 14- and 15-membered
macrolides (M phenotype). Two variants of the mef gene, mef(A) and mef(E),
have recently been shown to reside on different genetic elements, Tn1207.1
and the macrolide efﬂux genetic assembly (mega) insertion element, respec-
tively. The purpose of this study was to evaluate the incidence of erm(B) and
mef genotypes among Canadian isolates of macrolide-resistant S. pneumoniae
and to determine the prevalence of mef(A) and mef(E) gene variants among
these isolates.
Methods: Five hundred and ninety-four macrolide-resistant (erythromycin
MIC, >1mg/mL) S. pneumoniae isolates were collected between 1997 and
2002 as part of an ongoing Canadian Respiratory Organism Susceptibility
Study (CROSS). Susceptibility testing was performed by the NCCLS-
approved broth microdilution method and all isolates were evaluated by
PCR for the presence of erm(B) and mef genotypes. PCR-RFLP analysis was
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performed on 104 randomly selected mef-positive isolates to discriminate
between mef(A) and mef(E) gene variants.
Results: Two hundred and ninety-eight out of 594 (50.2%) S. pneumoniae
isolates were resistant to macrolides alone (M phenotype) and carried the mef
gene. The erm(B) genotype was detected in 259 (43.6%) resistant isolates. 18
(3.0%) isolates were PCR-positive for both mef and erm(B), while 19/594
(3.2%) isolates were negative for all mechanisms tested. Of the 104 macrolide-
resistant mef-positive S. pneumoniae isolates analyzed by PCR-RFLP, 98
(94.2%) carried the mef(E) gene variant. The mef(A) gene was detected in
only 6/104 (5.8%) isolates.
Conclusions: Erm(B) and mef genotypes are equally prevalent among Cana-
dian isolates of macrolide-resistant S. pneumoniae and have remained stable
throughout the 5-year study period. Although both mef gene variants have
been identiﬁed in clinical S. pneumoniae isolates, the mega insertion element is
the primary genetic element that carries the macrolide efﬂux gene in
Canadian isolates of macrolide-resistant S. pneumoniae.
P1543 Rate and mechanism of resistance to linezolid in
Streptococcus pneumoniae susceptible or resistant to
penicillin G or macrolides
F. Vandenbos, M. Galimand, H. Carsenti, C. Pradier, P. Roger,
B. Dunais, M. Sabah, G. Mancini, P. Dellamonica
Nice, Paris, F
Background: The oxazolidinone linezolid (LIN) inhibits translocation of the
peptide chain from the A site to the P site of the ribosome. LIN resistant
mutants, which are not cross-resistant to other drug classes, display mutations
in the 23S rRNA at position 2447 (E. coli numbering) in Staphylococcus aureus
and 2576 in Enterococcus fecium and fecalis.
Objectives:We evaluated the acquisition of resistance to LIN, erythromycin
(ERY) and spiramycin (SPI) of S. pneumoniaewith different levels of resistance
to penicillin G (PEN) and studied the mechanism of LIN resistance
Methods:20 S pneumoniae, 5 susceptible (S) to PEN (MIC< 0.064mg/L) and
ERY; 5 PEN S and resistant (R) to ERY; 5 intermediate (I) to PEN (MIC:
0.125–1mg/L); 5 PEN R (MIC> 1mg/L) were passaged daily in subinhi-
bitory concentrations of LIN, ERY and spiramycin (SPI), a 16-membered
macrolide. The four copies of the 23S rRNA rrl gene of LINRmutants were
ampliﬁed separately and their sequence determined.
Results: mean of number of passages necessary to reach resistant level (R) to
the selecting agent:
LIN R mutants had G2576U mutation in the four copies of the 23S rRNA.
Conclusion: LIN showed the lowest rate of acquisition of resistance and the
mutants did not display cross-resistance to other drug classes (macrolides,
chloramphenicol, tetracyclines, cotrimoxazole, ﬂuoroquinolones). Strains
resistant to ERYor PEN acquired more rapidly resistance to LIN. Resistance
to LIN was secondary to mutation G2576U in domain V of 23S rRNA.
P1544 Resistance mechanisms to macrolide antibiotics
in erythromycin-resistant Streptococcus pneumoniae in
Turkey
Z. Gu¨lay, M. Bic¸men, D. Gu¨r
Izmir, Ankara, TR
Objective: To determine the macrolide resistance mechanisms of S. pneumo-
niae isolated from different regions of Turkey.
Methods: A total of 151 clinical S. pneumoniae (11 highly and, 93 inter-
mediately penicillin-resistant, 47 penicillin-susceptible) isolates, recovered at
7 medical centers located in different cities, were selected randomly for the
study. Erythromycin (E) and clindamycin (CC) susceptibilities were investi-
gated by disk diffusion according to the NCCLS recommendations. MIC
values were determined by the E-test (AB Biodisk). The erm (B) and mef (A)
genes were detected by PCR using speciﬁc primers. Clonal relatedness of the
isolates were analyzed by BOX-PCR using BOX-A1 primer.
Results:Overall, 40 (26.4%) isolates were resistant to erythromycin. Of these,
37 (92.5%) were highly ER with MIC values of >256mg/L. The most
common mechanism (38/40) was target site modiﬁcation due to erm (B)
genes. Only two isolates harbored mef (A) efﬂux gene. All but one erm (B)
positive isolate, were also resistant to CC, suggesting constitutive MLSB
phenotype. The remaining isolate showed inducible resistance phenotype.
Macrolide resistance was more common among penicillin nonsusceptible
isolates. ER isolates belonged to different clonal groups as determined by
BOX-PCR.
Conclusion: The most common mechanism of macrolide resistance in
Turkish S. pneumoniae isolates, is target site modiﬁcation due to the presence
of erm (B). M phenotype is relatively uncommon.
P1545 A new generation of ﬂuoroquinolone resistant
clinical isolates of Streptococcus pneumoniae: Can we meet
the challenge?
J. de Azavedo, A. McGeer, C. Duncan, R. Davidson, D. Low, D. Bast
Toronto, CAN
Objectives: Fluoroquinolone (FQ) resistance in Streptococcus pneumoniae is
increasing and consequently the prevalence of isolates with a mutation both in
the parC and gyrA genes has risen. Although the presence of clinical isolates
with more than one mutation in either parC or gyrA has not been reported,
studies in vitro have demonstrated that ciproﬂoxacin (cipro) or levoﬂoxacin
(levo) can select for a third-step parC mutation resulting in a greater degree of
nonsusceptibility to many FQs. This study was undertaken to determine if the
increased levo use since 2000 in Canada, for the treatment of pneumococcal
infections, has resulted in the selection of such mutants.
Methods: Since January 2000, 37 strains collected from across Canada
showing a cipro MIC> or¼ 32mg/mL were identiﬁed. The quinolone
resistance determining regions of the parC and gyrA genes from these isolates
were ampliﬁed by PCR and the nucleotide sequence determined.
Results: Two isolates with a cipro MIC> or¼ 64mg/mL and a levo MIC of
16mg/mL were identiﬁed; each with a double parC mutation and a single
gyrA mutation. Both were serotype 14 strains and had Ser-79-Phe and Asp-
83-Tyr substitutions in ParC. One isolate showed a Ser-81-Phe substitution in
GyrA and the other a Ser-81-Tyr substitution. Both strains were isolated from
elderly patients (> 65 years) with chronic lymphocytic leukemia who had
been admitted to hospital suffering from pneumonia and who had been
treated unsuccessfully with levo prior to isolation of the strain.
Conclusion: Our ﬁnding demonstrates the existence of a new generation of
mutants which has emerged in parallel with the increase in FQ usage.
However, it is difﬁcult to predict whether or not this trend will continue
as new, more potent quinolones are used for treatment.
P1546 Selection of resistance to and mutagenicity of
different ﬂuoroquinolones in Staphylococcus aureus and
Streptococcus pneumoniae
J. M. Sierra, J. G. Cabeza, M. Ruiz, M. Llagostera, J. Mensa, J. Vila
Barcelona, Bellaterra, E
Objective: To analize the capability of levoﬂoxacin, trovaﬂoxacin, gemiﬂox-
acin, clinaﬂoxacin, moxiﬂoxacin and ciproﬂoxacin to select for an increase in
the MICs for S. pneumoniae and S. aureus, as well as to determine the
mutagenic activity of the above mentioned ﬂuoroquinolones.
Methods: Two strains of S. aureus and ﬁve strains of S. pneumoniae were used.
MICs were determined following NCCLS criteria.The selection of resistance
was performed by serial passages with antibiotic concentrations from 3
doubling dilutions below to 3 doubling dilutions above the MIC. For each
subsequently daily passage an aliquot containing approximately 5 105
bacteria were cultured in the concentrations above mentioned. An aliquot
of bacteria that grow at greater concentration was taken and subcultured in a
blood agar without antibiotic pressure. Then, approximately 5 105 bacteria
were cultured again into the next passage containing each diluted drug. Daily
subculturing was done until mutants with MICs > 4x to the selecting drug
appeared. In eachmutant theMICwere done andmutations in the QRDRof
the gyrA and parC genes were determined by RFLP (Ser 84 of GyrA and
Ser80 of GrlA of S. aureus, and Ser81 of GyrA and Ser79 of ParC of
Table 1
PEN S (n¼ 10)
PEN I (n¼ 5) PEN R (n¼ 5)ERY S (n¼ 5) ERY R (n¼ 5)
ERY 24.4 16.8 – 21.8 14.8 8 (1 strain)
SPI 20.8 8.0 – 11.4 3.5 7 (1strain)
LIN 58.6 10.3 16.6 7.5 44.4 18.9 21.8 10.3
P< 0.05.
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S. penumoniae). The mutagenicity of each ﬂuoroquinolone was performed by
the Salmonella and E. coli assays.
Results: Subculturing S. aureus in ciproﬂoxacin led to the increase in MIC
four-fold after 5–7 passages, 14–16 for moxiﬂoxacin, 6–8 for trovaﬂoxacin, 8–
11 for clinaﬂoxacin, 12–15 for levoﬂoxacin and 8 for gemiﬂoxacin. To
increase four-fold the MIC of ciproﬂoxacin for S. pneumoniae 7–10 passages
were needed, 8–12 for moxiﬂoxacin, 7–12 for trovaﬂoxacin, 10–13 for
levoﬂoxacin, 8–14 for clinaﬂoxacin and 8–10 for gemiﬂoxacin. Levoﬂoxacin
and moxiﬂoxacin were the two ﬂuoroquinolones with lower mutagenic
activity.
Conclusion:Our results suggest that at concentrations close to the MIC there
is a direct relationship between the selection of resistance and the mutagenic
potency of ﬂuoroquinolones, with levoﬂoxacin and moxiﬂoxacin being the
ﬂuoroquinolones showing the less selection of mutants and mutagenicity.
P1547 Molecular characterization of
ﬂuoroquinolone-resistant Streptococcus pneumoniae
isolates from Canada
H. Smith, K. Nichol, L. Palatnick, B. Weshnoweski, G. Zhanel,
D. Hoban
Winnipeg, CAN
Objective: Fluoroquinolones are increasingly used in the empiric treatment of
respiratory tract infections caused by S. pneumoniae. Although the prevalence
of ﬂuoroquinolone resistance in S. pneumoniae remains low (< 2%), it is
essential to continue monitoring resistance rates. The purpose of this study
was to characterize the ﬂuoroquinolone-resistant (ciproﬂoxacin MICs
4mg/mL) clinical isolates of S. pneumoniae obtained from across Canada
throughout 1997–2002.
Methods: Over a ﬁve-year period (1997–2002), 75 ciproﬂoxacin-resistant
S. pneumoniae isolates were collected from 9 of 10 Canadian provinces as a
component of an ongoing annual national respiratory organism surveillance
study. Their susceptibility to ciproﬂoxacin, gatiﬂoxacin, levoﬂoxacin, and
moxiﬂoxacin was determined. The quinolone resistance determining regions
(QRDRs) of GyrA and ParC were sequenced, and active efﬂux was evaluated
via reserpine studies. The isolates were also serotyped and molecularly
ﬁngerprinted.
Results:QRDR mutations in ParC and GyrAwere detected in 65/75 (87%)
and 38/75 (51%) of the isolates, respectively. The most common mutations
were Ser81Phe and Gly85Lys in GyrA and Ser79Phe/Tyr in ParC. 25/75
(33%) of the isolates displayed reserpine-sensitive efﬂux (four-fold or greater
reduction in MIC in the presence of reserpine) of ciproﬂoxacin. Pulsed ﬁeld
gel electrophoresis revealed considerable heterogeneity amongst the isolates.
Conclusions: 87% and 51% of the 75 ciproﬂoxacin-resistant S. pneumoniae
isolates had QRDR mutations in ParC and GyrA, respectively. 33% of the
isolates were ciproﬂoxacin-efﬂux positive. The majority of ciproﬂoxacin-
resistant S. pneumoniae isolates were genetically unrelated indicating that the
spread of ciproﬂoxacin resistance is currently not attributable to clonal
dissemination in Canada.
P1548 Initial description of the L22 mutation
responsible for Quinupristin/Dalfopristin resistance in
Streptococcus pneumoniae: case reports from the SENTRY
Antimicrobial Surveillance Program
R. Jones, D. Farrell, I. Morrissey on behalf of the SENTRY Participants
Group; North Liberty (USA) and London (UK)
Objective: Although resistance (R) to macrolides and clindamycin remains
common and escalating, quinupristin/dalfopristin (Synercid)-R among
S. pneumoniae strains is extremely rare. Recently Malbruny et al. described
an L22 ribosomal protein alteration responsible for Synercid-R in Staphylo-
coccus aureus. A similar mutational insertion in L22 was observed in pneu-
mococcal isolates from the SENTRY Antimicrobial Surveillance Program
(2001–2002).
Methods: Among S. pneumoniae isolates from community-acquired respira-
tory tract infections in the SENTRY Program (North America, 2001), 158
erythromycin (ER) -R strains were initially screened for erm(B) and mef(A)
by multiplex rapid cycle PCR/microwell-format probe hybridization meth-
ods. Nine ER-R pneumococci remained negative (USA 6 strains; Canada 3
strains) after PCR screen and were investigated for 23S, L4 and L22 mutations
by gene sequencing. An isolate from pleural ﬂuid in a 36-year-old-female
living in New York state (17–3167B) had the following MIC (ug/mL)
pattern: Synercid 4, quinupristin 8, dalfopristin 128, ER 1, azithromycin
0.5, clarithromycin 1, rokitamycin 2, roxithromycin 16, and clindamycin
0.12. A second strain (107–6120) with an identical MLSB resistance pattern
was observed in a patient from Kentucky (March, 2002).
Results: A 5 amino acid (AA) insert at the C terminus of the L22 riboprotein
was found in both strains. The insert was a duplication of AA 104–107 of L22
(RTAHI) into AA position 108–112. This insert overlaps with the insert (also
a duplication) described as the mechanism of Synercid-R previously noted in
S. aureus. An A2059G mutation in 1 of 4 alleles of the 23S rRNA gene was
also detected in strain 17–3167B.
Conclusions: This is the ﬁrst report of Synercid-R S. pneumoniae strains
produced by a 5 AA insertion in L22, a mechanism only recently described
in S. aureus (AAC 46 : 2200–7, 2002). Since all nonerm(B), nonmef(A)
MLSB-R isolates occurred in the North American sample, R surveillance
in this region should routinely include expanded molecular characterization.
P1549 Differences in selection of efﬂux-mediated
ﬂuoroquinolone resistance in penicillin-susceptible
and -resistant Streptococcus pneumoniae after repeated
exposure to ciproﬂoxacin and moxiﬂoxacin
P. A. Wickman, A. Hossain, K. S. Thomson, N. D. Hanson
Omaha, USA
Objectives: Increasing interest in the antipneumococcal activity of ﬂuoro-
quinolones (FQs) has raised awareness that FQs may differ in their propensity
to promote the development and spread of resistance. Efﬂux, a mechanism
that can contribute to reduced FQ susceptibility in S. pneumoniae (SP), may
represent an important ﬁrst step in the development of FQ resistance. The
current study aimed to investigate the potential of ciproﬂoxacin (CIP) and
moxiﬂoxacin (MXF) to select efﬂux-mediated resistance.
Methods:Mutants were generated by a selectional step procedure in which 4
strains of SP (2 PenS, 2 PenR) were exposed to inhibitory concentrations of
CIP and MXF. Agar dilution MICs were determined for ethidium bromide
(EB) and norﬂoxacin (NOR), two compounds typically used as substrates to
monitor efﬂux-mediated resistance, and the FQs,MXF, CIP, and levoﬂoxacin.
Sequencing was used to detect mutations within PCR amplicons representing
the promoter and structural gene of pmrA and the quinolone resistance
determining regions (QRDRs) of gyrA, gyrB, parC, and parE.
Results: Sequence analysis in 1st step CIP-selected mutants revealed AA
changes in ParC (Ser79) in 6 of 7 PenS mutants, whereas 0 of 8 PenRmutants
had QRDR mutations. In 1st step MXF-selected mutants, there were no
differences in the prevalence of QRDR mutations in GyrA (Ser81) between
mutants from PenS (4 of 8) or PenR (3 of 6) parents. After 3 exposures to CIP,
18 of 21 mutants (86%) from all 4 strains exhibited 4- to 16-fold increases in
theMIC of EB. In contrast, after 3 exposures toMXF, none of 24 mutants had
an increased MIC of EB. Some 3rd step MXF-selected mutants (58%) were
more susceptible than the parent strains to EB (MIC decreased from 16 to 2
mg/mL), suggesting that MXF may select reduced efﬂux. CIP-selected 3rd
step mutants had four- to eight-fold higherMICs of the efﬂux substrate NOR
than those selected with MXF. There were no promoter or structural gene
alterations in pmrA in any mutants. However, a PenR parent was mutated
within the putative 35 and 10 elements of pmrA, and also harbored six
different AAs in the structural gene when compared with WT PenS parents.
Conclusions: These data suggest that CIP selected mutants with enhanced
efﬂux while MXF either did not select enhanced efﬂux or reversed the
enhanced efﬂux phenotype. In addition, PenR parents had a higher pro-
pensity for producing an efﬂux phenotype, which may reﬂect the differences
observed in the pmrA sequence.
P1550 Different contributions of DNA gyrase and
topoisomerase IV mutations and pump efﬂux to
ﬂuoroquinolone resistance in clinical isolates of
Streptococcus pneumoniae
M. P. Montanari, E. Tili, I. Cochetti, M. Mingoia, A. Manzin,
P. E. Varaldo
Ancona, I
Objectives: S. pneumoniae resistance to ﬂuoroquinolones is acquired in step-
wise fashion with the introduction of chromosomal mutations that alter the
target proteins, DNA gyrase and topoisomerase IV, or decrease intracellular
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drug accumulation by active efﬂux. This study aimed at assessing the different
contributions of such mutations to ﬂuoroquinolone resistance in clinical
pneumococci recently isolated in Italy.
Methods: 15 ciproﬂoxacin-resistant (MIC> 2mg/L) cultures were identiﬁed
among 475 clinical isolates of S. pneumoniae collected from eight hospitals in
central Italy in the course of a 3-year multicenter study (SEMPRE Project).
Using suitable methodologies, test strains were characterized for serotype,
PFGE, susceptibility to several antibiotics, point mutations in the QRDRs of
gyrA and parC, and the presence of efﬂux pumps acting through proton- or
ATP-driven membrane transporters. Reference strains ATCC 49619 and R6
were used as controls.
Results: All 15 isolates (12 belonging to 10 serotypes and 3 untypable)
exhibited different PFGE proﬁles. Only 1 isolate had intermediate or
high-level resistance to all the other ﬂuoroquinolones tested (oﬂoxacin,
uliﬂoxacin, levoﬂoxacin, sparﬂoxacin, trovaﬂoxacin, and moxiﬂoxacin); with
respect to the other drugs, 12 strains were resistant to 3 or more classes of
antimicrobial agents. Mutations in QRDRswere very heterogeneous. Amino
acid changes (consistently to F) at both sites GyrA/S81 and ParC/S79 were
detected in four double mutants. Another double mutant (the most highly
quinolone-resistant isolate) exhibited a K at GyrA/E85 and an F at ParC/S79.
Single mutations (consistently to F) were observed both at GyrA/S81 (1
isolate) and ParC/S79 (6 isolates, all intermediate to levoﬂoxacin). Ostensibly,
there were no amino acid changes in the remaining three isolates. Amultidrug
transporter susceptible to reserpine was expressed by nine isolates, including
the only one susceptible to CCCP which thus bore both efﬂux systems. No
active efﬂux was exhibited by the remaining six isolates.
Conclusion: The emergence of ﬂuoroquinolone-resistant clinical S. pneumo-
niae isolates, though still low in incidence, is a cause for concern. Continued
surveillance and molecular analysis of resistant pneumococci are essential to
predict cross-resistances within this class of antibiotics. However, exposure to
ever-novel ﬂuoroquinolones will likely increase the heterogeneity of muta-
tions, further complicating the issue.
P1551 Macrolide resistance mechanisms in
Streptococcus pneumoniae collected from patients with
community-acquired respiratory tract infections in France,
Spain and Italy over a 10-year period: The Alexander Project
1992–2001
D. Farrell, I. Morrissey, S. Bakker, L. Morris, M. Robbins,
D. Felmingham
London, UK
Objectives: Phenotypic data from S. pneumoniae isolated in 3 European
countries participating in the Alexander Project, with high levels of macrolide
resistance, showed that theMLS(B) phenotype predominated in the later years
of the study but the M phenotype was present in approximately 13.0% of early
isolates, suggesting that efﬂux may once have played a more prominent role.
The aim of this study was to determine the distribution of macrolide resistance
mechanisms in this population over a 10-year period.
Methods: Macrolide resistance mechanisms were determined by PCR in
1591 isolates of macrolide-resistant S. pneumoniae. Isolates were collected over
a 10-year period (1992–2001) in France, Spain and Italy from patients with
community-acquired respiratory tract infections, as part of the Alexander
Project.
Results: Overall, 89.2% of isolates were erm(B), 2.3% mef(A), 0.4% both
erm(B) and mef(A), 0.1% erm(A) subclass erm(TR) and 8.0% negative for the
mechanisms tested. The genotype distribution was relatively constant over the
10 years in each of the three countries. Erm(B)-positive isolates with ery-
thromycin A MICs 16mg/L were tested for inducible expression of the
erm(B) gene by the double disc method and were found to have heterogeneous
inducible expression of erm(B). This form of inducible expression was
prevalent in the early years of the study in France and Spain, but not Italy,
and became rare in the later years of the study.
Conclusions: Genotypic analysis showed that efﬂux was not the cause of the
observed M phenotypes early in the study and that these isolates were, in fact,
erm(B) with heterogeneous inducible expression. These data suggest that the
evolution of macrolide resistance in these countries included a stage in which
the inducible expression of erm(B) was more tightly regulated than at present,
and that resistance mechanisms have evolved over time towards greater
prevalence of poorly regulated inducible resistance responsible for increased
MICs. A total of 8.0% of isolates with the MLS(B) phenotype were shown to
be negative for the methylase and efﬂux genes tested. Further work is needed
to determine the mechanisms involved. These are most likely to be ribosomal
mutations.
P1552 Comparative minimal inhibitory (MI) and mutant
prevention (MP) concentration (C) of gatiﬂoxacin,
garenoxacin, levoﬂoxacin and moxiﬂoxacin against 307
clinical isolates of Streptococcus pneumoniae (SP)
J. Blondeau, G. Hansen, K. Metzler, P. Hedlin, S. Borsos
Saskatoon, CAN
Objective:MIC testing determines antimicrobial susceptibility and compares
in vitro potency between drugs. MPC is a novel concept that determines the
propensity of an antimicrobial compound to select for resistance. It is deﬁned
as the antimicrobial drug concentration threshold that would require an
organism to simultaneously possess two mutations to grow in the presence of
the drug. For community-acquired respiratory tract infections, SP remains a
major pathogen and ﬂuoroquinolones (FQ) have become increasingly impor-
tant for therapy due to increasing pneumococcal resistance to various
compounds. Concerns over FQ resistant SP have emerged. We determined
MICs andMPCs of 3 FQs (gatiﬂoxacin [GA], levoﬂoxacin [Lfx], moxiﬂoxacin
[Mfx]) and garenoxacin (GRN) (an investigational des-F(6)-quinolone [DQ])
against clinical isolates of SP to determine if differences existed between the
compounds for their likelihood to select for FQ/DQ resistant SP.
Methods:MIC testing was performed by microbroth dilution in accordance
with NCCLS guidelines. For MPC testing approximately 10 10 bacterial
cells were applied to agar plates containing drug. Cultures were incubated at
358C in 5% CO2 for 24 and 48 h. Drug concentration that prevented growth
was recorded as the MPC.
Results: To date 307 clinical isolates were tested. MIC and MPC values were
not different against penicillin susceptible or resistant strains so data was
combined. The following represents MIC50/MIC90 values for GA, GRN,
Lfx, Mfx, respectively: 0.25/0.5; 0.063/0.125; 1/1; 0.125/0.25. The
MPC50/MPC90 values, respectively, were as follows: 1/2; 0.125/0.5; 2/4;
0.5/1. Time (h) serum drug concentrations are expected to remain above the
MIC90/MPC90 (T>MPC90) based on conventional dosing is as follows,
respectively: 22/6; >24/>24; 18/3; >24/>24.
Conclusion:Maintaining FQ activity against SP is essential as resistance rates
to other compounds increase. Newer FQs (GA,Mfx)/DQ are more potent in
vitro than Lfx. By MPC testing, Lfx appears more likely to select for ﬁrst-step
resistant mutants as T>MPC90 was the shortest and MPC values were
higher. Both GRN and Mfx maintain T>MPC90 for the entire dosing
interval and appear less likely to select for resistance. Based on theMPCmodel
GRN¼Mfx>GA>Lfx based on measurements completed to date. Use of
the newer FQ/DQ agents with lower MPC values and/or prolonged
T>MPC for SP may prolong the SP susceptibility to all FQ/DQ agents.
P1553 Quinolone-resistance mutations in the gyrA gene
of Acinetobacter baumannii
L. Pe´rez, T. Alarco´n, A. Perkins, M. S. Abanades, E. Escudero,
M. Lo´pez-Brea
Madrid, E
Objective: The aim of this study was to determine gyrA gene mutations in
quinolone- resistant isolates of A. baumannii by using PCR-RFLP.
Methods: A total of 36 clinical isolates of A. baumannii were incluyed in this
study. All isolates were recovered from patients admitted in the Hospital de La
Princesa from 1999 to 2001. Isolates were identiﬁed as A. baumannii using
MicroScan System (Dade-Behring). Susceptibility testing to oﬂoxacin was
performed by an agar dilution method according to NCCLS 1999 break-
points. The mutations in the gyrA gene were determined by using PCR
ampliﬁcation of the Quinolone Resistance Determining Region (QRDR).
The presence or absence of gyrAmutations was determined by the digestion of
the PCR products with HinfI. HinfI digestion of the PCR product from a
quinolone susceptible isolates generated two fragments of 291 bp and 52 bp,
the HinfI restriction site in isolates carrying a mutation at codon 83 was
abolished, resulting in no digestion of the fragment containing the full-length
PCR product. A. baumannii ATCC 19606 was used as control strain for
Susceptibility tests and PCR-RFLP study.
Results:Thirty-ﬁve isolates were quinolone resistant (CMI range to oﬂoxacin
was16–128mg/L) and only one strain was susceptible (CMI¼ 1mg/L). The
HinfI digestion generated one fragment of DNA in all quinolone-resistant
isolates and two fragments in the susceptible isolate and in the A. baumannii
ATCC 19606 strain.
Conclusions:This study showed high level of quinolone-resistance in clinical
isolates of A. baumannii. Mutations affecting the QRDR of the gyrA gene
seem to be related with high MICs to quinolones.
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P1554 Mechanisms of resistance to quinolones and
beta-lactam antibiotics, epidemiology and clinical impact of
Acinetobacter genomospecies 3 isolated in Spain
A., F. Ribera, A. Fernandez-Cuenca, G. Beceiro, L. Bou,
A´. Martı´nez-Martı´nez, J. M. Pascual, J. Cisneros, J. Rodrı´guez-Ban˜o,
J. Pacho´n,
J. Vilaon the behalf of the GEIH-AB 2001 project
Objectives: The aim of this study was to characterize, in depth, 15 strains of
genomic species 3 isolated from 20 hospitals in Spain in November, 2000.
Methods:The strains were identiﬁed by ampliﬁed ribosomal DNA restriction
analysis (ARDRA). In this study, the epidemiological relationship, the
antimicrobial susceptibility and the mechanisms of resistance to different
antimicrobial agents, such as quinolones and beta-lactams, of these species of
Acinetobacter, were performed. To achieve this aim, REP-PCR, PFGE, PCR
ampliﬁcation of different groups of beta-lactamases, IEF, and detection of
mutations in the QRDR of gyrA and parC genes were carried out.
Results: The results showed that all the strains were not epidemiologically
related and that 60% were able to cause infections. Interestingly, and in
agreement with other reports, this species of Acinetobacter presented a high
susceptibility to most of the antibiotics, contrary to what is described for
A. baumannii. Sixty-six percent of the isolates were resistant to ampicillin and
rifampicin, 20% to azithromycin, 6.6% to piperacillin, cefepime, ciproﬂox-
acin, gemiﬂoxacin and gentamicin and 0% to ceftazidime, sulbactam, ampi-
cillin/sulbactam, imipenem,meropenem, amikacin, tobramycin, tetracycline,
doxicycline, minocycline, cotrimoxazol and colistin. Neither ampliﬁcation
nor isolation of any beta-lactamase was possible although, the results of the
IEF assay showed a production of a beta-lactamase at pI> 8 (probably
chromosomal beta-lactamase), thereby suggesting a hyperexpression of the
AmpC or a permeability problem in the resistant strains. Regarding quino-
lones resistance, only one strain was resistant to ciproﬂoxacin and presented a
change from Ser to Leu in the positions 83 of GyrA and 80 of ParC.
Conclusions:Acinetobacter genomospecies 3 isolated in Spain are very hetero-
geneous and highly susceptible to all the antimicrobial agents studied.
However, in these isolates resistant to beta-lactam antibiotics and quinolones,
the resistance is associated with overexpression of AmpC and with mutations
in the gyrA and parC genes, respectively. Finally, a high percentage of isolates
are found to cause infectious diseases.
P1555 Bactericidal activity of ﬂuoroquinolones against
Klebsiella pneumoniae containing the plasmid-mediated
resistance determinant qnr
J. M. Rodrı´guez, A. Pascual, D. Martin, I. Garcı´a, J. Pacho´n,
L. Martinez-Martinez
Seville, E
Objectives: To evaluate the in vitro bactericidal activity of ciproﬂoxacin
(CIP), levoﬂoxacin (LEV) and moxiﬂoxacin (MXF) against K. pneumoniae
IMP17 (wild-type strain) and K. pneumoniae IMP22 (transconjugant from
K. pneumoniae IMP17, containing plasmid pMG252 which codes for the
plasmid-mediated quinolone-resistance determinant qnr).
Methods:MICs and MBCs of FQ were evaluated by microdilution, accord-
ing to NCCLS guidelines. Time-killing kinetics were conducted at drug
concentration of 4 MIC of the three FQ, with a starting inoculum of
106 cfu/mL, and bacterial counts at 2, 4, 8 and 24 h.
Results:MICs of CIP, LEVand MXF against K. pneumoniae IMP17 were 0.5,
0.5 and 0.25mg/L, respectively. MICs againstK. pneumoniae IMP22 (contain-
ing qnr) were 8 (CIP and LEV) to 32 (MXF) times higher than against
K. pneumoniae IMP17. MBCs of the three FQ were the same or one dilution
higher (CIP against K. pneumoniae IMP17) than the corresponding MICs. In
the time-killing assay, CIP, LEVand MXF caused at 4 h a reduction in viable
K. pneumoniae IMP17 (expressed as log10 of cfu/mL) of 3.4, 3.3 and 3.6,
respectively. CIP maintained this activity up to 24 h (3.0 log10 reduction), but
bacterial regrowth was noted after 8 h for LEV and MXF. Against K. pneu-
moniae IMP22 the reduction in viable organisms caused by CIP, LEV and
MXFwere 1.4., 1.8 and 1.7 at 4 h, 2.2, 2.3 and 2.3 at 8 h and 3.1,0,4 and 3.4
at 24 h.
Conclusions:The qnr increases the MICs of CIP, LEVand MXF 8–32 times,
but the MBC/MIC ratios of the three agents were not affected. In the time-
killing assay the bactericidal activity of CIP and MXF against K. pneumoniae
expressing qnr was markedly delayed, while LEV did not express bactericidal
activity.
P1556 Correlation between the macrolide-resistance
phenotypes and genotypes in methicillin-resistant
Staphylococcus aureus isolates from two Greek university
hospitals
I. Spiliopoulou, E. Petinaki, P. Papandreou, G. Dimitracopoulos
Patras, Larissa, GR
Objectives:To analyze the distribution of themacrolide-resistance genes in 63
methicillin- and erythromycin-resistant Staphylococcus aureus clinical isolates
collected in two University Hospitals of central and south-western part of the
country.
Methods:Methicillin-resistant S. aureus isolates (MRSA) were classiﬁed into
clones by Southern-blot hybridization of ClaI digests with the mecA and
Tn554 DNA probes and Pulsed-Field-Gel Electrophoresis (PFGE) of SmaI
digests of chromosomal DNAs (ClaI-mecA::ClaI-Tn554::PFGE). The Etest,
and the modiﬁed disk diffusion method for the characterization of a con-
stitutive or an inducible mechanism determined the resistance phenotypes to
erythromycin, clindamycin and lincomycin. The relative frequency of ermA,
ermB, ermC, msrA and msrB genes was investigated by PCR with speciﬁc
primers. Hybridizations of ClaI DNA digests with the ermA and ermC genes
veriﬁed the PCR results and revealed speciﬁc patterns.
Results: Resistance to erythromycin was detected in 60.5% of the MRSA
clinical isolates. A total of 63 isolates fall into this group 21 MRSA from
Larissa and 42 MRSA from Patras. Inducible resistance to erythromycin was
detected in 5 isolates, belonging to PFGE types C and F. PCR revealed the
presence of ermC gene in 58 isolates, ermA gene in 4 and both ermA and ermC
in one isolate. No other gene was present from the tested group. Hybridiza-
tions of DNA ClaI digests with the ermC probe showed the presence of one
hybridization band of 2.5Kb in 21 strains of X0::KK::B, 9 strains of III0::KK::B
and 2 strains of II::NH::C clones; one hybridization band of 3.5Kb in 21
strains of X0::KK::B and 2 strains of III0::KK::B clones; one hybridization
band of 12.2Kb in 3 strains of clone VII0::NH::F. Hybridization with the
ermA probe showed the presence 2 bands (3.8/9Kb) in the strain II::m::B;
four bands (3/3,8/5/8.5Kb) in the strain III::B::E; two bands (3.8/4.1Kb) in
the strain II0::A::A; one band (4.5Kb) in the strain I::KK::C. The isolate of
clone XII::B::B showed one band of 2.5Kb with the ermC gene and two
bands (3.8/8.5Kb) with the ermA gene.
Conclusions: Inducible resistance to macrolides in the minority of MRSA
isolates correlated with two PFGE types, independently of the presence of
ermA or ermC genes. Most of the isolates possessed the ermC gene in different
DNA bands. The ClaI-ermA hybridization bands correlated with the ClaI-
Tn554 hybridization patterns, verifying the presence of the gene on the
Tn554 transposon.
P1557 Comparative analysis of 11 genes from isolates
of vancomycin-intermediate Staphylococcus aureus (VISA)
and hVISA
M. Wootton, T. Walsh, M. Avison, R. Howe, P. Bennett,
A. MacGowan
Bristol, UK
Background: Comparative genomic analysis of Mu50, a Vancomycin Inter-
mediate Staphylococcus aureus (VISA), against N315 (vancomycin sensitive
(VSSA), revealed differences in several genes. Six genes (mutS, opuD, atl, metB,
prfC and modA) were studied in Mu50 and Mu3 and ﬁve genes (murA,
SA2486, yibM, rnr and odhA) were studied in clinical VISA (9) and hVISA
(10) and VSSA (11) isolates to identify their role in vancomycin resistance.
Methods:MICs and population analysis were used to conﬁrm VISA/hVISA
status. DNA was extracted and used to perform PCR. The resultant ampli-
cons were sequenced and the gene sequences compared with the published
sequences in Mu50 and N315 plus the vancomycin sensitive MW2 strain
using Clustalw
Results:The sequences in Mu50 and Mu3 of the genes mutS, opuD, atl, metB,
prfC and modAwere identical to N315. No clinical strain sequences for yibM
including Mu50 and Mu3 had the published Mu50 mutation. In the murA
gene, none of the strains were found to contain the publishedMu50mutation.
Mu50, 5 VISA and 8 hVISA had identical sequences to N315. However, 4
VISA and 2 hVISA sequences contained a base substitution (BS) at A897T,
which had no affect on amino acid content and was present in the published
MW2 sequence. The published Mu50 mutation in odhA was BS at A2526C
and DEL at 2651. 6 VISA and 9 hVISA had identical sequences to N315.
However, 3 VISA, 1 hVISA and all VSSA plus Mu50 and Mu3 had BS at
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A2526C. The 3 VISA and 1 hVISA also had 17 other BSs plus all VSSA had 2
extra BSs. All strains had an extra 66 bp. The 66 bp INS and all BSs were found
to be present in MW2. In the rnr gene all VISA, hVISA including Mu50 and
Mu3 had identical sequences to N315. The published Mu50 mutation in
SA2486 gene was present in Mu50 andMu3 sequences but not in any clinical
VISA or hVISA
Conclusions:The published Mu50 mutations in the 11 genes were not found
in any clinical VISA or hVISA. The further mutations found to be present in
some genes in the clinical VISA and hVISAwould be unlikely to play any role
in vancomycin resistance as all were also found in vancomycin sensitive MW2
strain.
P1558 Comparing the gene expression of ABC
transporter, protein A and capsule genes between
vancomycin sensitive and resistant S. aureus strains
A. Momenah, I. Alshami, J. Burnie
Manchester, UK
Objectives: This study was to compare the gene expression of three selected
genes (ABC transporter, protein A and capsule genes) between vancomycin
sensitive and resistant S. aureus strains.
Methods: Vancomycin susceptible isolates previously reported and identiﬁed
to be MRSA (A and C) and their vancomycin-resistant derivatives (B and D)
were examined. Vancomycin-resistant derivatives were obtained by Serial
passage of the parental strains in nutrient broth with increasing concentrations
of vancomycin produced vancomycin-resistant isolates (MIC 8mg/L). Fol-
lowing RNA isolation using the RNeasy mini kit (Qiagen), RNA fragments
(containing the target mRNA) are denatured, separated, then transferred to a
sheet of nitrocellulose. The nitrocellulose sheet is hybridized to a single-
stranded DIG-labeled DNA probe which will hybridize to the complemen-
tary target mRNA and incubated with Anti-DIG-alkaline phosphatase
conjugated antibody and substrate for the enzyme is added. Comparing
the intensity of the formed bands reﬂects the amount of speciﬁc transcribed
mRNA between different S. aureus strains, and hence indicates the level of a
gene expression.
Results: Northern blotting analysis of the ABC transporter, and protein A
genes showed that ABC transporter gene was highly expressed in the
vancomycin-resistant strains compared with the sensitive strains while there
were no differences in protein A expression between these strains. This study
showed that the capsule gene was down regulated in the vancomycin resistant
strains.
Conclusions: The up regulation of the ABC transporters may contribute to
vancomycin resistance by increasing the transport of the components required
for cell-wall synthesis, leading to increased cell wall thickness reported before.
The fact that the ABC transporter gene is up regulated in vancomycin resistant
strains indicates that it could be targeted therapeutically to develop a vaccine,
or antibody therapy. The down regulation of S. aureus capsule suggest that the
long list of secreted proteins are also down regulated since they are all known
to be regulated together by the agr global regulation system. This could
explain the signiﬁcant decrease in the pathogenicity of vancomycin
resistant S. aureus strains compared with that of sensitive ones in animal work
observed.
P1559 Alternative activation of the imipenem
resistancegene (cﬁA) of Bacteroides fragilis among
normal microbiota organisms and from clinical infections
J. Soki, K. A´go´, R. Edwards, E. Fodor, E. Urban, E. Nagy
Szeged, HUN, Nottingham UK
Objectives: Screening for carbapenem resistance among normal microbiota
and clinical isolates of Bacteroides strains and examination of their resistance
mechanisms.
Methods: Fecal samples from healthy individuals were incubated anaerobi-
cally in broth cultures containing meropenem (8 and 64mg/mL) in order to
select carbapenem-resistant strains. Such isolates and newly identiﬁed carba-
penem-resistant B. fragilis clinical isolates were examined for the cﬁA resis-
tance gene and for thewell-known activating insertion sequence (IS) elements
by PCR methods and were also examined for production of carbapenemase.
The upstream regions of the cﬁA genes were also ampliﬁed by PCR, using one
forward primer from the conserved upstream region of cﬁA and one reverse
primer from the 50 sequence of cﬁA. In one case, the nucleotide sequence of
this upstream fragment was also determined.
Results: Seven meropenem-resistant (MICs greater than or equal to 8 mg/mL)
Bacteroides isolates were selected from 145 fecal samples: 4 B. fragilis, 1
B. vulgatus, 1 B. distasonis and 1 B. capillosus. Only the B. fragilis isolates
harbored the cﬁA gene. Additionally, 2 carbapenem-resistant B. fragilis strains
which also harbored the cﬁA gene were found among clinical samples in
Hungary during 2001 and 2002. Interestingly, PCR ampliﬁcation revealed
that none of these B. fragilis isolates from normal microbiota and clinical
samples carried any IS insertion in their cﬁA upstream regions but they all
produced a detectable level of carbapenemase. Comparision of the nucleotide
sequence of the upstream fragment of one of the B. fragilis strains from an
infection with that of the upstream region of one cﬁA-positive but imipenem-
susceptible strain (B. fragilis BFr81) strongly suggests that the cﬁA gene of this
strain is activated by a point mutation in a hypothethical promoter.
Conclusion: The examples of the test strains described here indicate that, in
both normal microbiota and in clinical strains, the cﬁA gene of B. fragilis can be
up-regulated by an alternative mechanism(s) to IS element activation.
P1560 Discovery of a NmcA Carbapenem-hydrolyzing
enzyme in the US Paciﬁc North-west
S. Pottumarthy, E. S. Molland, S. Juretschko, S. R. Swanzy,
K. S. Thomson, T. R. Fritsche
Seattle, Omaha, USA
Background:Carbapenems are reliably effective in dealingwith infections due
to organisms producing AmpC and/or ESBL enzymes. In this report we
describe an imipenem resistant isolate of Enterobacter cloacae recovered from the
blood of a leukemic patient. The isolate was found to produce the molecular
class A carbapenem-hydrolyzing beta-lactamase, NmcA.
Methods: Isolate’s susceptibility was determined by disk diffusion and by
Etest. Beta-lactamase production was investigated by analytical isoelectric
focusing (IEF), inhibitor studies, hydrolysis assays, and induction assays. The
gene encoding NmcA enzyme was ampliﬁed by PCR and sequenced using
primers designed from the nmcA gene.
Results: The strain was susceptible to piperacillin, piperacillin-tazobactam,
cefotaxime, ceftazidime, ceftriaxone, cefepime, ciproﬂoxacin, gentamicin and
trimethoprim-sulphamethoxazole. It was resistant to ampicillin, amoxicillin-
clavulanic acid, cefazolin and cefoxitin. By disk diffusion and E-test, the zones
of inhibition around the carbapenems; imipenem, meropenem and ertape-
nem were indistinct with inner colonies extending up to the disk or highest
concentration on the Etest strip and were interpreted as resistant. Carbape-
nemase bioassay using a crude enzyme preparation showed evidence of
hydrolysis of imipenem, meropenem and ertapenem. IEF conﬁrmed the
presence of a clavulanic acid sensitive beta-lactamase with pI of 6.9 which
hydrolyzed imipenem 1 mg/mL on IEF overlay. The enzyme was inducible by
both cefoxitin and imipenem as demonstrated by disk-induction and atte-
nuated IEF assay. Sequence analysis conﬁrmed the enzyme as NmcA with
100% identity to both structural nmcA and regulatory nmcR genes.
Conclusion: This is the ﬁrst report of the detection of the carbapenem-
hydrolyzing enzyme, NmcA in North America. While we assume that the
observed phenotype was the result of NmcA enzyme, it is possible that the
resistance to imipenem resulted from the combined effects of induction of
both AmpC and NmcA. The importance of this ﬁnding both for clinicians
and laboratorians is illustrated by: the ability of the NmcA enzyme to cause
resistance to carbapenems; its occurrence in E. cloacae (a common nosocomial
pathogen); the difﬁculty in its detection and its inducibility. The continued
emergence of novel resistance mechanisms to carbapenems worldwide reem-
phasizes the need for not only prudent carbapenem use, but also antibiotic use
in general.
P1561 Molecular background of multiresistance in a
clinical Escherichia coli isolate
K. J. Sherwood, I. Wiegand, B. Wiedemann
Bonn, D
Objectives: Recently the rate of acquired antibiotic resistance in E. coli has
risen. Resistance causes bacteria to grow more slowly due to the additional
genetic material they have to replicate and express. Yet the multiresistant
strains isolated from hospitals show no such deﬁcits. If bacteria are viable
despite so many resistance genes then an evolution of the genes or of their
arrangement must have taken place. In order to analyze this evolution the
molecular background of such multiresistant strains has to be known. In this
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work, we want to elucidate the molecular background of a clinical E. coli
isolate with multiresistance.
Methods: A representative multiresistant strain of E. coli was selected from a
group of strains isolated in Berlin hospitals in 2000. Minimum inhibitory
concentrations (MICs) of 50 antibiotics were determined. Beta-lactamases
were identiﬁed by PCR, subsequent sequencing of the beta-lactamase genes,
SDS–PAGE and isoelectric focusing. Quinolone resistance was characterized
by sequencing gyrA and parC and the marOR region of the mar-operon. Class
1 integrons and Tn21-family transposons were detected by int1 and tnpA
PCRs, respectively. Conjugation was performed and resultant transconjugants
were analyzed to reveal which resistance markers were transferable. The
plasmids of donor and transconjugants were also prepared and analyzed.
Results: MICs revealed resistance to most beta-lactams, quinolones, amino-
glycosides, tetracyclines, chloramphenicol and cotrimoxazol. The beta-lac-
tam resistance is caused by the production of a Class C and a Class A beta-
lactamase, located on two different transferable plasmids. The quinolone
resistance derives from two chromosomal mutations in gyrA and one in parC.
The strain carries genes for at least three different aminoglycoside-modifying
enzymes, one nontransferable, two transferable but on different plasmids.
Tetracycline, chloramphenicol and cotrimoxazol resistance are all cotransfer-
able. The donor and all transconjugants carry integrons and transposons.
Conclusions: The strain carries at least 11 resistance genes, mostly located on
transferable plasmids, conferring resistance to 43 of 50 tested antibiotics. It is
remarkable that bacteria with so many resistance genes have a viability similar
to their susceptible parent cells. The presence of integrons and transposons
allows the bacteria to rearrange these genes and gives them the potential to
reduce redundancy and optimize gene expression.
P1562 Conjugation of multiple resistance genes in
E. coli in a mouse intestine model
D. Sandvang, T. Andersen, T. Klemmensen, A. Hammerum,
N. Frimodt-Møller
Copenhagen, DK
Objectives: Escherichia coli is the causal agents of many infections and the most
frequent cause of Gram negative bacteraemia. Multiresistant E. coli causing
infection in humans could originate from production animals through the
food chain or it could be transferred from humans. Our previous investigation
of clonality among sulphonamide-resistant E. coli isolates originating from
different production animals as well as human pathogens showed little clonal
relation. The purpose of this investigation was to investigate the possibilities of
transfer of antibiotic resistance genes in vivo.
Methods: The donor for this transfer experiment originated from a swine
production facility and had a resistance proﬁle including ampicillin, apramy-
cin, gentamicin, streptomycin, spectinomycin, sulfonamide, tetracycline, and
trimethoprim. The recipient MG1655 showed phenotypic resistance to
rifampicin and streptomycin. Transfers were done in a mouse intestine model
with streptomycin pretreatment. All transfer experiments were done in vitro
before inoculation of the mice and sulfonamide selection were used in all
conjugation experiments. Transconjugants, donor and recipient were tested
using plasmid proﬁles, susceptibility tests and were pulsed ﬁeld typed using the
enzyme blnI. PCR was used to reveal the resistance genes.
Results: All results indicated that a conjugative plasmid of approximately
84 kb was transferred to the recipient along with the phenotypic resistance to
ampicillin, streptomycin, spectinomycin, sulfonamide and trimethoprim.
The transconjugants were isolated in the mouse fecal sample 24 h after
inoculation. PFGE and digestion of the plasmid proved the conjugation.
We found the conjugative plasmid to contain sulII encoding sulphonamide
whereas streptomycin and spectinomycin are expressed from aadA2.
Conclusions:This illustrates that the conjugation of resistance plasmids in vivo
is possible in a mouse intestine model. This might suggest the possibilities of
resistance gene transfer from an E. coli originating from the food chain to
another human pathogenicE. coli in the intestine. Resistance to ampicillin and
sulphonamides are found frequently in pathogenic E. coli from humans and
the transfer of resistance genes through the food chain might be as important
as transfer of pathogenic organisms.
P1563 Effect of chemical agents on plasmid curing of
Escherichia coli for determination of antibiotic resistance
mechanisms
A. Rezaee, M. Mobrhan
Tehran, IR
Plasmids permit their bacterial hosts to survive better in an adverse environ-
ment or to compete better with other microorganisms occupying the same
ecological niche. The medical importance of plasmids that encode for
antibiotic resistance as well as speciﬁc virulence traits has been well docu-
mented and demonstrated the important role these bacterial genetic elements
play in nature. Elimination of plasmid DNA (curing) is an important step in
identifying the phenotypic traits encoded by a given plasmid. A multitude of
different chemicals including inhibitors of DNA replication, intercalating
drugs and bacterial surface agents has been used as curing agents. However,
apart from its spontaneous loss very little is known about how to cure the
plasmids. Agents that interfere with plasmid replication can result in curing of
the plasmid from bacteria cell. Some chemical agents are Mitomycin C, Ethi-
dium bromide, Acridin orange, Acriﬂavin, SDS. We have classiﬁcated the
agents and introduce the best curing agents effects on E. coli for determination
of source of antibiotic resistance. The results obtained demonstrate that at con-
centrationMIC to 1/8MIC curing agents such as mitomycinC(5–60 ng/mL),
Ethidium bromide(10–125 mg/mL), Acridin orang (10–150mg/mL) had cur-
ing activity on E. coli. The chemical agents are inhibitor of DNA replication.
Curing agents such as SDS(0.05–1.5%), PEG (1–8%) and EDTA(0.05–3%)
are bacterial surface agent.
P1564 Cefotaximase-M type beta-lactamase production
in Escherichia coli isolated at a university hospital in Turkey
Z. Gu¨lay, M. Bic¸men, T. Atay
Izmir, TR
Objective: CTX-M producing Enterobacteriaceae have been reported from
throughout the world but there has been limited data for Turkey. Beginning
from the last 2months of 2001, E. coli producing extended spectrum beta-
lactamases (ESBLs) with a cefotaximase phenotype became prevalent in
several clinics at our hospital. This prompted us to investigate CTX-M
production among these isolates.
Methods:A total of 14 ESBL positive (according to NCCLS criteria) clinical
E. coli isolates were collected from December 2001 to February 2002. PCR
analysis for bla CTX-M genes were performed. Isoelectric focusing (IEF) for
the beta-lactamases and transfer experiments were also done. DNA sequen-
cing was performed for the identiﬁcation of the CTX-M type for ﬁve selected
isolates. Clonal relationship of the isolates were determined by ERIC PCR.
Results: bla genes encoding for CTX-M were ampliﬁed in all 14 isolates.
DNA sequences were identical to CTX-M-3. IEF revealed two beta-lacta-
maseswith pIs of 5.4 and 8.4whichwere cotransferred to recipientE. coli J53-2.
A common plasmid with a molecular size of 68 kb were identiﬁed in 11
(78.6%) of the 14 transconjugants. Seven ERIC-PCR patterns were detected
among the parental isolates.
Conclusions: (i) CTX-M-type ESBL producing E. coli is a rapidly growing
problem in our hospital (ii) Both horizontal and vertical gene transfer is
responsible from the dissemination of CTX-M type beta-lactamases (iii) This
is the ﬁrst report of CTX-M-3 beta-lactamase producing E. coli strains from
Turkey.
P1565 Conjugal transfer of aminoglycoside and
macrolide resistance among Enterococcus faecium in vitro
and in vivo in the intestine of mice
C. Lester, A. Hammerum, N. Frimodt-Møller
Copenhagen, DK
Background: Enterococcus spp. is one of the most common bacterial genus
encountered in clinical specimens. Enterococci are known to harbor different
genetic elements such as conjugative transposons and different types of
plasmids with resistance genes. A hot spot for gene transfer could be the
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gut of different animal species including humans, since transient colonization
of enterococci in the human gut easily takes place after ingestion of food
containing such bacteria. The aadE, aphA-3, and erm(B) encoding resistance
to streptomycin, kanamycin and erythromycin, respectively, are found on the
erm(B)-Tn5405-like element in Enterococcus faecium. This study investigated
the presence of the erm(B)-Tn5405-like element in a multiresistant human
E. faecium isolate together with the presence of aac(60)-Ie-aph(20 0)-Ia. The
transfer of these genes was also studied both in vitro and in vivo in a mouse
model.
Methods:A human E. faecuim isolate 160/00 harboring the erm(B), aac(6 0)-Ie-
aph(2 0 0)-Ia, aadE, and sat4 resistance genes, was used as donor. The strain used
as recipient was E. faecuim 64/3, which is resistant to streptomycin, rifampin,
and fusidic acid. Conjugation in vitro was performed by the ﬁlter mating
procedure. In vivo transfer experiments were carried out in the intestine of
streptomycin treated mice.
Results: 160/00 harbored the erm(B)-Tn5405-like element. Co-transfer of
erm(B), aadE and aphA-3 genes indicated transfer of this element. Co-transfer
of aac(60)-Ie-aph(20 0)-Ia was obtained in all in vivo transconjugants recovered
in feces and in 26 out of 30 in vitro transconjugants tested. in vitro frequencies
of transfer was approximately 2 105 transconjugants/donor. 24 h after
inoculation, transconjugants harboring the erm(B)-Tn5405-like element and
aac(60)-Ie-aph(20 0)-Ia could be recovered in vivo. Throughout the experi-
ment, high numbers of transconjugants approaching 6 log10 CFU/g of feces
was observed. Plasmid proﬁles and Southern blots showed that both the
erm(B)-Tn5405-like element and aac(60)-Ie-aph(20 0)-Ia was placed on the
same large plasmid (> 150 kb).
Conclusion: These results indicate that the intestine could be a hot spot
for gene transfer of resistance genes. Both in vitro and in vivo several
resistance genes were transferred at the same time without any selective
pressure.
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P1566 Penicillin resistance of Streptococcus
pneumoniae isolated from community-acquired lower
respiratory tract infections in Manisa, Turkey
S. Surucuoglu, S. Kurutepe, B. Ozbakkaloglu, H. Gazi, P. Celik
Manisa, TR
Objectives: The increasing frequency of penicillin and multi drug resistant
pneumococci all over the world has resulted difﬁculties in therapy for
pneumococcal infections in recent years. It is recommended that resistance
surveillance programs routinely should follow the resistance at regional areas
and also the ﬁndings of resistance fenotypes should be reported. The aim of
this study is to investigate the rates of resistance to penicillin and other
antimicrobial agents in Streptococcus pneumonia strains isolated from community
acquired lower respiratory tract infections in Manisa, Turkey.
Methods: Seventy-ﬁve strains were assessed in the study and penicillin
resistance was evaluated by using oxacillin disc diffusion test and E-test
methods. Resistance to the other antimicrobial agents were investigated by
disc diffusion method.
Results:We found the rates of intermediate resistance and high resistance to
penicillin as 8.0% and 2.7%, respectively. The rate of multidrug resistance
(MDR) was found as 4.0%. MDR fenotypes, encountered in our region are
associated with macrolide and trimethoprim/sulfamethoxazole resistance as
well as penicillin resistance. We could not able to ﬁnd any strain resistant to
oﬂoxacin, vancomycin or imipeneme. The rates of resistance to trimetho-
prim-sulphamethoxazole, erythromycin, gentamicin, cefaclor, clindamicin,
aztreonam, amoxycillin-clavulanate, chloramphenicol and ceftriaxone were
found as 18.7, 16.0, 5.3, 5.3, 4.0, 2.7, 2.7, 1.3 and 1.3%, respectively.
Conclusions:As the rates of high penicillin resistance were low in our region,
we concluded that penicillin should be the ﬁrst choice in the management of
empirical therapy. But also the surveillance programs monitoring antimicro-
bial resistance against Streptococcus pneumoniae should be performed currently
and the ﬁndings should be reported to clinicians.
P1567 Oropharyngeal carriage and penicillin resistance
of Neisseria meningitidis in primary school children in
Manisa, Turkey
H. Gazi, S. Surucuoglu, B. Ozbakkaloglu, S. Akcali, S. Kurutepe,
N. Ozkutuk
Manisa, TR
Objectives: The mortality and morbidity of epidemic meningitis caused by
Neisseria meningitis are still high in both developing and industrial countries.
The increasing resistance of penicillin which is the ﬁrst treatment choice has
been reported in the recent years. This study aimed to determine the
oropharyngeal carriage rates and serogroups of N. meningitidis in primary
school children in Manisa. Penicillin resistance and resistance mechanisms of
isolates were also investigated.
Methods:Oropharyngeal swabs were obtained from 568 children aged 7–14-
year-old in this study. The specimens were cultured in GC agar enriched vitox
(Oxoid) and Thayer Martin medium (VCNT antibiotic supplement SR91;
Oxoid) and the identiﬁcation was made by biochemical properties using
commercial kits (BBL Crystal N/H ID-Becton Dickenson). The serogroups
were identiﬁed depending on capsular antigens by speciﬁc antisera (Difco).
Penicillin resistance of strains were investigated by using oxacillin disc
diffusion method and E-test methods and then Nitroceﬁn test (Nitroceﬁn
strip, Oxoid) was used to determine the mechanism of resistance.
Results: The results of this study showed that the carriage rate of N.
meningitidis in our region was 6.3% (36 strains) and the serogroups identiﬁed
were serogroup C (36.1%), A (27.8%), B (22.2%), W-135 (11.1%) and D
(2.8%), respectively. The penicillin resistance was found in eight strains
(22.2%), while beta lactamase activity was found in none.
Conclusions: In conclusion, the carriage rate of N. meningitidis and sero-
groups are similar to studies reported from other countries. As penicillin
resistant strains are found in our region, the surveillance programs monitoring
antimicrobial resistance should performed and the risk groups have to be
vaccinated.
P1568 Vancomycin-resistant enteroccoci in Lebanese
farms
Z. Daoud, N. Hakime
Beirut, LBN
Introduction: Resistance against commonly used antibiotics has been
observed since these agents were introduced in medicine. In the modern
chicken farms antibiotics are used in high quantities not only for treatment
and prevention of bacterial diseases, but also as growth promoters (AMGPs).
Several studies correlated between the use of antimicrobial agents as growth
enhancer and the emergence of resistant bacteria. In this study, our aim was to
assess the occurrence of VREs in chicken from different farms in Lebanon.
Materials and methods: This study involves 10 big farms located in the ﬁve
different Lebanese governerates. The concerned population encompasses 223
chickens, 46 chicken consumers and three farmers. Rectal swabs were
obtained and isolation was done on VACC medium (Blood agar added with
vancomycin, amphotericin B, clindamycin and ceftazidim). Identiﬁcation and
MICs were determined as indicated by the NCCLS. A multiplex PCR-assay
was realized to detect the presence of different genes encoding resistance to
glycopeptides
Results: Results are detailed in Table 1. A total of 25 VREs were detected
from the 223 samples of chicken, no VRE detected in humans. These 25
VREs contributed to 11% of the total collected samples. The dominant
species of VRE was E. faecium which contributed to 44% of the total VRE in
chicken, whereas, E. gallinarum represents 40% of the VRE, E. avium
contributes 16% of the VRE No E. faecalis was isolated.
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Discussion:Our results represent the ﬁrst Lebanese data illustrating the actual
situation of resistance to vancomycin among Enteroccoci occurring in
chicken. This study gives an idea about the occurrence of this highly resistant
germ and opens horizons to future studies that should focus on the antibiotics
used in the Lebanese farms and their relationship with the emergence of
resistant strains. It was not surprising to ﬁnd the highest percent of resistance in
Bekaa due to the wide distribution of farms and to the absence of control and
monitoring of antibiotic use. Our data showing the maximum of occurrence
of resistance in E. faecium meets other authors’ data. Van A and Van B
Genotypes of VRE, having an acquired type of resistance, indicate that there
occurrence is most probably correlated with the use of antibiotics as growth
promoters or for therapy.
P1569 Antibiotic resistance in the oral cavity
A. Smith, K. Roy, M. Jackson, D. MacKenzie, J. Bagg, M. Wilson,
M. Lewis, M. Martin, W. Wade, W. Coulter
Glasgow, Cardiff, Liverpool, London, Belfast, UK
Objectives: There are large amounts of data describing the incidence of
antibiotic resistance in a number of different clinical settings and for a wide
range of microorganisms. However, little attention has been paid to the
presence of antibiotic resistance in dental infections. Between January 2001
and January 2002 we conducted a multicenter UK study investigating the
antimicrobial susceptibility patterns of microorganisms isolated from acute
dento-alveolar abscesses.
Methods: A total of 65 pus aspirates from dento-alveolar abscesses were
investigated using routine diagnostic microbiology techniques. Antimicrobial
susceptibility testing was performed using BSAC methodology and E-test
strips.
Results: A total of 263 microbial strains were isolated consisting of 76 (29%)
facultative anaerobes and 181 (71%) strict anaerobes. Low levels of resistance
were detected to the commonly prescribed dental antibiotics. Penicillin
resistance was detected in 3 (1%) of isolates; all of these were found in
Prevotella spp. Cephalexin resistance was detected in 11 (4%) of isolates.
Erythromycin resistance was found in 8 (3%) of isolates, most of which were
from the Fusobacterium spp. Tetracycline resistance was found in 9 (3%), mainly
in the Prevotella spp.
Conclusions:The majority of isolates from acute dento-alveolar infections in
adults remain susceptible to the antibiotics most commonly prescribed for
dental infections.
P1570 Levels of antibiotic resistance in isolates of
E. coli, Enterococcus, Campylobacter and Salmonella species
isolated from pigs and chickens in Hong Kong
C. W. S. Tsang, M. M. O’Donoghue, M. V. Boost
Kowloon, HK
Introduction: Antibiotics are used in animal husbandry for growth promo-
tion, prophylaxis and therapy. There remain considerable concerns that such
use may lead to increased resistance to the antibiotics used in human therapy
due to cross resistance. Resistance in normal ﬂora organisms may be trans-
ferred to other pathogenic species by conjugation and transformation. E. coli,
Enterococcus, Salmonella and Campylobacter are the bacteria most likely to infect
humans from food animals and carry with them antibiotic resistant determi-
nants. This study aimed to determine levels of resistance in isolates of these
organisms from pigs and chickens bred in Hong Kong.
Methods: Organisms were isolated using standard methods from chicken
respiratory tract, intestine and feces and from liver, trachea, intestines and feces
of pigs from livestock farms in HK. Antibiotic sensitivity testing was
performed using disc diffusion technique and interpreted according to
NCCLS recommendations.
Results: 63 samples yielded E. coli with 73% resistant to ampicillin, 98% to
tetracycline, 22% to cephalothin, 54% to ciproﬂoxacin, 76% to cotrimox-
azole, 57% to chloramphenicol and 41% to gentamicin. Twenty-three samples
yielded Enterococci with little differences in resistance between chicken and
pig isolates. Although no high level vancomycin resistance was noted, two
chicken isolates showed intermediate levels of resistance. Resistance to
aminoglycosides (streptomycin 100%, gentamicin 74%) and tetracycline
(100%) was high but to ampicillin was low (4%). Eight samples yielded
Campylobacter all of whichwere resistant to ciproﬂoxacin and tetracycline, 50%
to erythromycin. Salmonella was isolated from four pig specimens. All were
resistant to ampicillin, tetracycline, cotrimoxazole, gentamicin and chloram-
phenicol. There was no resistance to ciproﬂoxacin or cephalothin.
Conclusions: High levels of antibiotic and multidrug resistance were
observed. Regulations to reduce drug use and to limit choices to those
not used in humans have been implemented in some countries. In HK only
two substances, chloramphenicol and avoparcin, are prohibited for animal use,
though levels at the time of slaughter are monitored for 36 other antibiotics.
High levels of chloramphenicol resistance were detected despite its prohibi-
tion. The ban on avoparcin use may be related to the absence of high level
vancomycin resistant enterococci. More stringent controls on antibiotic use
may be appropriate.
P1571 Changing epidemiology of methicillin-resistant
Staphylococcus aureus (MRSA) in Finland
A.-M. Santala, J. Vuopio-Varkila, S. Salmenlinna, O. Lyytikainen
Helsinki, FIN
Background:The prevalence of MRSA amongst invasive S. aureus isolates has
remained low in Finland. However, the annual number of MRSA isolates
reported to the national infectious disease register has constantly increased. In
addition, molecular typing has revealed several outbreaks, especially outside
Helsinki metropolitan area. To get further insight to these changes, we
analyzed the antibiotic resistance proﬁles of MRSA isolates sent to the
national reference laboratory in 1997–2001 and reviewed the diagnostic
methods used for MRSA identiﬁcation in Finnish microbiology laboratories
in 2001.
Methods:The proportion of isolates resistant to methicillin only and of those
expressing multidrug resistance was estimated based on the disk diffusion test
and oxacillin MIC E-test values determined at the national reference labora-
tory. A questionnaire-based survey sent to microbial laboratories assessed, in
addition to diagnostic methods used, the number of MRSA screening
specimens studied and the total number of positive MRSA ﬁndings in
2001. To calculate the rates of MRSA by each 20 hospital districts, data
from the national population register was used as a denominator.
Results: Amongst the total of 1114 MRSA isolates sent to the reference
laboratory, 33% were multidrug resistant. The proportion of isolates resistant
to methicillin only increased from 9.5% in 1997 to 33.6% in 2001; outside
Helsinki from8.8% to30.6%.Of the isolates, 3%had oxacillinMIC< 2mg/mL.
The NCCLS guidelines for the oxacillin disk diffusion test were, in general,
followed, expect for the incubation time,whichwasonly18 h (insteadof24h) in
35% of the laboratories. Half of the laboratories used MRSA-Screen(R) test
routinely.Thenumberofscreeningspecimensstudiedvariedbetween0and2768
per 100 000populationbyhospital district and the ratesofMRSAbetween0 and
48 per 100 000 population; in ﬁve hospital district>17.The high rate ofMRSA
did not always relate to a high rate of screening samples taken.
Conclusions: There was a wide geographic variation in the rates of MRSA,
but also amongst the screening practices. Non-multidrug resistant MRSA
isolates, especially those resistant to methicillin only, showed an emerging
trend. Part of these MRSA strains could remain undetected in some labora-
tories because of current diagnostic techniques used.
Table 1 Represents the distribution of different species of VRE with their
corresponding phenotypes
Beirut Bekaa
Mount
Lebanon North South Total
Number
of samples
12 74 93 13 31 223
VRE 2 11 6 6 0 25
Van A 2 4 4 2 0 12
Van B 0 3 0 0 0 3
Van C 0 4 2 4 0 10
E. Faecium 2 (vanA) 3 (vanA), 1 (vanB) 3 (vanA) 2 (vanA)
E. Faecalis 0 0 0 0 0 0
E. galinarium 0 4(Van C) 2(Van C) 4(Van C) 0 10
E. avium 0 1(A), 2(B) 1(A) 0 0 4
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P1572 Antibiotic susceptibility and strain typing of
animal Staphylococcus aureus
A. R. Robb, D. Morrison, S. Dancer, C. Gemmell
Alexandria, Glasgow, UK
Objectives:Evidence has emerged which strongly indicates that antibiotic use
in animals has created a reservoir of resistant bacteria that have spread through
the food chain to humans. However, little data is available on Staphylococcus
aureus from animal. In this study we have looked at antibiotic susceptibility and
strain types of S. aureus from various animal sources.
Methods: One hundred and forty-four S. aureus isolated in animals were
screened for resistance against 19 antibiotics by BSAC method (Andrews
J.A.C. 2000) and typed by PCR-Ribotyping and PFGE. The S. aureus were
isolated from different geographical locations; Aberdeen, Northern Ireland,
Ayrshire and Inverness and from various sources: milk (53), chicken (37), cow
(34), pheasant (6), pig (4), partridge (3), horse (2), Turkey (2) and lamb, parrot
and unknown (1 each).
Results: Seventeen distinct resistance phenotypes were detected amongst
the 144 isolates tested. 42% were fully sensitive, 27% were resistant to one
antibiotic, 19% were resistant to two antibiotics, 8% were resistant to
three antibiotics and 4% were resistant to ﬁve antibiotics. Resistant to
tetracycline (72%) was the most prevalent followed by ciproﬂoxacin (43%),
streptomycin (23%), clindamycin (16%), erythromycin (14%), tylosin (7%),
sulphamethoxazole (2%), chloramphenicol (2%), rifampicin, amikacin and
tobramycin (1%, respectively). Tetracycline and ciproﬂoxacin resistance pre-
dominated within chicken populations and accounted for 59% of all resistance
detected. The 144 isolates were distinguished into 58 PFGE types (deﬁned as
isolates with 3 or fewer band differences). Two types, Types A and T,
accounted for 17 and 13%, respectively. PFGE Type A was associated with
chickens from Northern Ireland and PFGE Type Twas associated with cattle
from Aberdeen.
Conclusion: Resistance to antibiotics used to treat S. aureus in clinical
medicine is found in animal S. aureus. Further studies are warranted to
investigate whether horizontal transfer of these resistance elements from
animals to man has occurred.
P1573 Evaluation of two rapid methods for detection of
methicillin resistance in Staphylococcus aureus
M. J. Soares, C. Soares, A. C. Mendes, M. L. Amorim, J. M. Cabeda,
J. M. Amorim
Porto, P
Objectives: The rapid and accurate identiﬁcation of methicillin-resistant
S. aureus (MRSA) is important in order to control nosocomial infections.
The purpose of this study was to evaluate the ability of two rapid methods to
detect MRSA, and compare them with the PCR detection of the mecA gene.
Methods:A total of 103 clinical isolates of S. aureus identiﬁed by Vitek System
1, were studied by three methods: MRSA-Screen latex agglutination (Inno-
genetics), Velogene Genomic ID Assay for MRSA (Alexon-Trend) and a
PCR-Multiplex assay for the mecA and femA genes of S. aureus.
Results: Of the 103 isolates tested, 61 (59.2%) were resistant to methicillin,
and only one tested equivocal by the agglutination method (positivity after 3
min). The others 42 (40.8%) isolates were found to be sensitive to methicillin.
Using as reference method the mecA PCR positivity, the Velogene Genomic
IDAssay for MRSA (Alexon-Trend) and the MRSA-Screen latex agglutina-
tion (Innogenetics) assays showed a sensitivity of 100 and 98%, respectively.
There were no false-positive reactions for both methods (100% speciﬁcity).
Conclusions: The correlation between the two methods and PCR, suggests
their use as screening methods for the rapid detection of MRSA. Despiste the
better sensitivity of the Velogene assay, the ease of use, turnaround time and
relative cost of MRSA-Screen latex agglutination, are important factors for its
selection as the routine method for the MRSA screening in a clinical
diagnostic setting.
P1574 Characterization of S. pneumoniae and
S. pyogenes strains isolated from the respiratory tract of
pediatric outpatients in Germany, 2002
R. R. Reinert, N. Neuberger, M. Cil, C. Cremer, M. Lemperle,
R. Lu¨tticken, A. Al-Lahham
Aachen, D
Objectives: Respiratory tract infections caused by pneumococci and S. pyo-
genes are serious health problems world-wide. The objective(s) of this research
is to study the epidemiological resistance and resistance mechanisms among
S. pneumoniae and S. pyogenes among pediatric outpatients in Germany.
Methods: In a multicenter study including 10 clinical laboratories, a total of
239 S. pneumoniae and 236 S. pyogenes strains were collected between January
through December 2002. Serotyping of pneumococci was done with the
quellung reaction. MICs were determined according to NCCLS by micro-
broth dilution method; resistance phenotypes of both pathogens were deter-
mined by disk diffusion test and PCR of macrolide resistant determinants was
performed according to standard methods.
Results:Resistance rates of S. pyogenes isolates were as follows (intermediate and
resistant): Penicillin 0%, cefotaxime 0%, amoxicillin 0%, erythromycin A 14%,
clindamycin 0%, gatiﬂoxacin 0% and telithromycin 0%. S. pneumoniae isolates
showed the following resistance rates (intermediate and resistant): Penicillin
5%, cefotaxime 1.7%, amoxicillin 0.8%, erythromycin 19.7%, clindamycin 7.5%
and gatiﬂoxacin 0%. The new ketolide telithromycin was 100% active against
all pneumococcal and S. pyogenes isolates with MIC50¼ 0.016mg/L and
MIC90¼ 0.125mg/L for pneumococci; and MIC50¼ 0.03mg/L and
MIC90¼ 0.5mg/L for S. pyogenes. Of 47 macrolide-resistant pneumococcal
strains 29 (61.7%) wereMphenotypes pocessing themefA resistant determinants
and 18 (38.3%) were cMLSB pocessing the ermB resistance determinants. 33
isolates of S. pyogeneswere macrolide resistant, among which 31 (93.9%) wereM
phenotypes and 2 (6.1%) strains were inducible (iMLSB).
Conclusions:Macrolide resistance among children is an increasing problem in
Germany. Telithromycin was highly active against all pneumococcal and
S. pyogenes isolates.
P1575 Surveillance of antimicrobial resistance in four
major pathogens of community-acquired
respiratory tract infections in Germany, 2002
M. Kresken, J. Brauers, S. Bagel
Bonn, D
Objectives: Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus inﬂu-
enzae, and Moraxella catarrhalis are key pathogens of community-acquired
respiratory tract infections (CA-RTI). Resistance to various antibiotics was
reported to increase in Germany. The objective of the study was to determine
the prevalence of resistance against commonly used antibiotics applying DIN-
and NCCLS interpretive criteria.
Methods: Twenty-four microbiology laboratories throughout Germany
participated in the study. Strains were sent to a reference laboratory for re-
identiﬁcation and susceptibility testing using the microdilution method
according to DIN-standard 58940. Antibiotics tested were Penicillin G
(PEN), ampicillin/sulbactam (AMP/SBT), cefuroxime (CEF), erythromycin
(ERY), clindamycin (CLI), and levoﬂoxacin (LEV). SBT was tested in
combination with AMP at a ﬁxed concentration of 8 mg/L. As there are
no recommended NCCLS breakpoints for M. catarrhalis and AMP/SBT for
S. pneumoniae/S. pyogenes, those recommended for S. aureus and of AMP for
S. pyogenes, respectively, were applied. Production of beta-lactamase was
detected by nitroceﬁn. From January to April 2002 a total of 1279 isolates
were collected: S. pneumoniae (n¼ 331), S. pyogenes (n¼ 340), H. inﬂuenzae
(n¼ 300), and M. catarrhalis (n¼ 308).
Results: Susceptibility rates (%) were as follows (DIN/NCCLS): S. pneumo-
niae – PEN (95/97), AMP/SBT (100/98), CEF (98/98), ERY(84/79), CLI
(94/93), LEV (–/100); S. pyogenes – PEN (100/100), AMP/SBT (100/100),
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CEF (100/100), ERY (87/84), CLI (97/97) LEV (–/100); H. inﬂuenzae –
PEN (53/–), AMP/SBT (100/100), CEF (98/100), ERY(1/–), LEV (–/100);
M. catarrhalis – PEN (< 1/< 1), AMP/SBT (100/100), CEF (67/99), ERY
(>99/>99), CLI (34/11), LEV (–/100). The rate of beta-lactamase produ-
cing strains was 8.7% forH. inﬂuenzae, while that forM. catarrhaliswas 99.3%.
Conclusions: Our results show that isolates of S. pneumoniae were more
susceptible to PEN than to ERY and that isolates of S. pyogenes were more
susceptible to ERY than those of S. pneumoniae. Comparing DIN andNCCLS
breakpoints, susceptibility rates of S. pneumoniae and S. pyogenes for ERY
according to DIN were higher than those according to NCCLS. AMP/
SBT and LEV showed the highest in vitro activities against the four key
pathogens causing CA-RTI
P1576 Phenotypic and molecular typing of
methicillin-resistant Staphylococcus aureus strains
isolated in an Italian hospital
A. Grossato, C. Boldrin, S. Amato, M. S. Turi
Padua, I
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) is among the
most important pathogens. In Italy the frequency of isolation of MRSA in
nosocomial environment is nearly 35%. Recent reports indicate that the
therapeutic options available for invasive MRSA infections are decreased by
the isolation of strains with reduced susceptibility to glycopeptides. The aim of
the present study was to investigate the antibiotic susceptibility of MRSA in
our hospital.
Methods: 120 MRSA were collected from different hospital wards (Jan –
April 2001). Standard microbiological methods for identiﬁcation of S. aureus
included Gram stain, growth in mannitol salt agar, coagulase test, API ID32
Staph. Methicillin-resistance was screened by disk diffusion test in Mueller
Hinton agar with oxacillin. The presence of mecA gene was determined by
PCR. Antimicrobial susceptibility tests were performed by microdilution
method and the antibiotics were cefazolin (CEF), erythromycin (ERY),
gentamicin (GEN), rifampin (RIF) ciproﬂoxacin (CIP), tetracycline
(TET), fosfomycin (FOS), vancomycin (VAN), teicoplanin (TEC), trimetho-
prim/sulphamethoxazole (TSX). Molecular analysis was performed by SmaI-
pulsed ﬁeld gel electrophoresis (PFGE).
Results: The majority of MRSA were isolated from patients admitted to
surgical wards (61.6%) and intensive care units (30%). All MRSA contained
mecA gene. 15% of strains were resistant only to beta-lactams, but the majority
weremultiresistant. All isolates were susceptible to vancomycin but two strains
were intermediate to teicoplanin (MIC¼ 16mg/L) (TISA). Eleven resistant
phenotypes (antibiotype) were found and 61.6% of strains examined displayed
the same antibiotype. Strains with the same antibiotype exhibited more then
one PFGE type.
Conclusion: In countries such as Italy, in which teicoplanin has been
introduced in clinical medicine many years ago, it is important to identify
TISA. These isolates are not readily detected by disc diffusion method so as
much information as possible should be collected to clarify their role in
therapeutic failure.
P1577 STAR elements and antibiotic resistance
in S. aureus
L. M. Tibor, S. E. Cramton, H. W. Hopf, F. Goetz, T. K. Hunt
San Francisco, USA; Tubingen, D
Objectives: Staphylococcus aureus causes many types of human disease and, in
particular, is the most common bacterium cultured from infected wounds.
There are seven publicly available genome sequences and much is known
about its molecular biology. There is increasing effort to tie molecular
knowledge to improvements in clinical practice, with interest in ways to
predict virulence or establish strain relatedness. The Staphylococcus aureus
repeat element (STAR) is a variable length GC-rich region present inmultiple
copies (<100) on the S. aureus genome. It is highly polymorphic and has
potential as an epidemiological marker. The goal of this study was to
determine if STAR patterns could be used to group strains and predict
antibiotic resistance.We hypothesized that related strains would have the same
STAR pattern and similar resistance.
Methods: In total, 64 different S. aureus strains were investigated. Forty-ﬁve
strains were isolated from wound cultures, ﬁve from central venous catheters
of ICU patients, and 14 were common laboratory control strains. The subject
population consisted of patients treated at the University of Tu¨bingen
(Germany) hospitals and clinics. Strains were isolated in the course of routine
clinical diagnostics. Investigations consisted of assessment of antibiotic resis-
tance at concentrations greater than 5 mg/mL and PCR for STAR elements at
two intergenic regions.
Results: Please see table for results.
Conclusions: There were seven groups of ﬁve or more strains with the same
STAR pattern. Twelve strains exhibited other STAR patterns. Methicillin
resistance was concentrated into two groups. The group with STAR pattern
III/IV had high rates of antibiotic resistance, with every strain resistant to at
least one antibiotic. Therewere two control strains, two ICU isolates, and four
wound isolates in this group. STAR pattern II/I also exhibited methicillin-
resistance, but consisted of seven wound isolates collected from three patients.
The remaining STAR groups exhibited variable amounts of resistance. This
study shows that the STAR element is useful for grouping strains and may aid
in predicting resistance.
P1578 Use of the International Circumpolar Surveillance
System for population-based surveillance of invasive
pneumococcal disease 1999–2001
M. Bruce, D. Parks, T. Tam, M. Lovgren, L. Jette, K. Kristinsson,
G. Sigmundsdottir, F. Stenz, O. Lovoll, P. Nuorti, E. Herva,
A. Parkinson
Anchorage, USA; Ottawa, Edmondton, Ste-Anne-de-Bellevue, CAN;
Reykjavik, IS; Nuuk, DK; Nydalen, N; Helsinki, Oulu, FIN
Background:The International Circumpolar Surveillance (ICS) Project is an
infectious disease surveillance network of hospital and public health labora-
tories working together with public health practitioners in Arctic countries.
In 1999, surveillance for invasive disease caused by Streptococcus pneumoniae
(Sp) began in the US Arctic, Alaska (AK) andNorthern Canada (NCan), then
expanded in 2000 to include Greenland (GN), Iceland (IC), Norway (Nor)
and Finland (Fin).
Methods: We deﬁned a case of invasive Sp as an individual from whom
pneumococci were isolated from a normally sterile site. We analyzed ICS data
on invasive Sp disease from January 1999-December 2001 to determine: (i)
Common clinical syndromes and risk factors; (ii) Rates of disease by country/
region; (iii) serotype distribution; and (iv) Antimicrobial susceptibility pat-
terns. All available isolates were serotyped; antimicrobial susceptibility testing
was done by microbroth dilution (AK and N Can), agar dilution (GN and
Fin), or disc diffusion (IC and Nor).
Results:A total of 3554 cases of laboratory conﬁrmed invasive pneumococcal
disease were reported from AK (343), N Can (133), GN (11), IC (79), Nor
(1729), and Fin (1259). Ethnicity and risk factor data were not available from
Nor or Fin. Serotype data was not available from Nor. Overall, case-fatality
ratios varied by country (range: 3.8–18.2%). Pneumonia (46%), septicemia
(32%), and meningitis (8%) were the most commonly reported clinical
presentations. Smoking was the most commonly reported risk factor in
persons >18 years of age (37%). Crude annual rates of invasive Sp disease
per 100 000 population varied by country (range: 9.7–33.2). Rates of invasive
Sp disease among native (aboriginal) persons in AK andNCanwere 42 and 43
cases per 100 000 persons, respectively. The highest rates of Sp disease
occurred among children < 2 years of age (range: 36–184/100 000). Overall,
72% of Sp isolates from children < 2 years of age were serotypes contained in
the 7-valent vaccine. Among isolates from persons >2 years of age, overall,
88% were serotypes contained in the 23-valent polysaccharide vaccine. The
proportion of isolates fully resistant to penicillin varied by country from <1%
in Fin to 10% in AK.
% Resistance:
STAR
Pattern
Total
Strains Methicillin Tetracycline Erytrhomycin Gallidermin None
III/IV 8 100 13 100 38 0
II/I 7 57 0 14 0 43
IV/II 14 7 21 0 0 29
III/I 7 0 14 0 0 86
III/II 5 0 0 0 0 80
IV/I 6 0 17 50 0 33
VI/II 5 0 20 20 0 20
Other 12 0 8 17 8 42
Total 64 20 13 23 6 39
P< 0.05 compared to other STAR patterns for the same antibiotic.
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Conclusions:Rates of invasive pneumococcal disease are high in natives and
children <2 residing in Arctic countries. Case fatality from invasive disease
appears higher in some countries, warranting further investigation.
P1579 International Inter-Laboratory Quality Control
program for Circumpolar Surveillance of Streptococcus
pneumoniae
A. Parkinson, M. Lovgren, L. Jette, A. Reasonover
Anchorage, USA; Edmondton, Ste-Anne-de-Bellevue, CAN
Background: In 1999, the International Circumpolar Surveillance (ICS) of
invasive diseases caused by Streptococcus pneumoniae (Sp) was established in the
US Arctic (Alaska) and northern Canada(NC). Currently 23 and 14 clinical
laboratories in Alaska (AK) and NC forward isolates from patients with
invasive pneumococcal disease to reference laboratories in AK and Canada,
respectively. To ensure interlaboratory comparability of Sp serotype and
antimicrobial susceptibility between two reference laboratories in Canada
(Alberta and Quebec) and one in the US (AK) we established the ICS Sp
interlaboratory QC program.
Methods:Each reference laboratory was responsible for the export of oneQC
panel of seven Sp isolates each year to each of the other laboratories using a
transportation medium of their choice. Serotyping was performed by Quel-
lung reaction. The antisera inventory included grouping and factoring
antisera for the most common serogroups, including 6, 9, 18, 19, and 23.
Minimum inhibitory concentration (MIC) was determined for each QC
isolate and for ATCC strain 49 619 for those antibiotics which were routinely
tested in each laboratory. MIC results for each laboratory were expected to be
within one log2 dilution of each other regardless of testing method. Dis-
crepancies of results were documented and examined to determine causes and
solutions.
Results: Between January 1999 and December 2002, a total of 12 QC panels
of seven Sp isolates each were shipped and tested by all three reference
laboratories. Serotyping correlation for 84 isolates was 97%. Discrepancies
between serotyping results was attributed to loss of capsule following multiple
passing. Overall correlation of the MIC results, within 1 log2 dilution was
96.8%. Discrepancies among MIC’s between laboratories could be explained
by testing method (i.e agar dilution vs. broth dilution) and incubation
conditions (i.e with or without CO2). Transportation times for QC panels
between the participating laboratories were generally excellent (2–3 days).
Conclusion: Establishment of an international QC program for Sp between
reference laboratories in the US and Canada is feasible. Expansion of the QC
program to include reference laboratories in other circumpolar countries
should be considered. Challenges include the maintenance of infectious agent
speciﬁc importation permits, adherence to international transportation reg-
ulations, and cost of international shipping of infectious agents.
P1580 Detection of OXA-40 carbapememase in an
Acinetobacter baumannii epidemic strain from
Portugal
G. J. Da Silva, M. Correia, E. Bertolo, C. Vital, G. Ribeiro, A. Duarte,
L. Peixe
Coimbra, Lisbon, Porto, P
Objectives: Thirty-eight imipenem-resistant Acinetobacter baumannii (Ab)
clinical isolates from four different hospitals in Portugal were investigated
in order to characterize the mechanism of carbapenem resistance and to
determine their clonal relationship.
Methods: Susceptibility tests were performed by using the agar diffusion
method and MICs of beta-lactams were determined by the E-test method.
Carbapenemase activity was determined in crude extracts by spectrophoto-
metry using as substrate an imipenem solution (0.1mM) in the absence and
presence of zinc or EDTA. Gene detection was performed by PCR with the
PCR SuperMix (Gibco BRL) and blaOXA-24 primers (300mM).
Pcr conditions were: initial desnaturation of 948C/3min, followed by 30
cycles of 948C/1min, 508C/1min and 728C/2min with a ﬁnal extension of
728C/8min. Amplicons were cloned onto pPCR-Script Cam SK(þ) vector
using the PCR-ScriptTM Cam Cloning Kit (Stratagene). Recombinant
plasmids were transformed on Epicurian Coli XL10-Gold Kan competent
cells. Nucleotide sequence was analyzed using Clustal Wand compared with
known sequences. The epidemiological relationship among the isolates was
assessed by RAPD using theM13 primer, REP-PCR and macrorestriction of
chromossomal DNA with ApaI enzyme followed by PFGE.
Results: All the isolates were highly resistant to penicillins, broad
spectrum cephalosporins, aztreonam (MICs> 256mg/L) and imipenem
(MIC > 32mg/L). They were also resistant to ciproﬂoxacin and aminoglyco-
sides, except to tobramycin. Extracts hydrolyzedmoderately imipenem (speciﬁc
activity of 5mU/mg protein). No signiﬁcant differences were observed in the
presence of Zn and EDTA. After sequencing, the deduced protein showed the
typicalmotifs of classDOXA-beta-lactamases andwas identiﬁed as anOXA-40.
DNA ﬁngerprints obtained by RAPD and REP-PCRwere identical. Patterns
obtained by PFGE were identical or differed in only one or two bands.
Conclusions: For the ﬁrst time in Portugal, it was detected a class D
carbapenemase, OXA-40, a recently described carbapenemase and associated
with imipenem resistance. The high incidence of imipenem resistance among
Portuguese Ab isolates was mainly due to an epidemic strain disseminated in
various hospitals.
P1581 Improved tracking of epidemic
methicillin-resistant Staphylococcus aureus in Scotland
using a combination of pulsed ﬁeld gel electrophoresis
and mec-associated drug sequences
R. V. Goering, D. Morrison, K. L. F. Cooper, Z. Al-Doori,
G. F. S. Edwards, C. G. Gemmell
Omaha, USA; Glasgow, UK
Background: Two epidemic methicillin-resistant Staphylococcus aureus strains,
EMRSA-15 and EMRSA-16, ﬁrst observed in England in the early 1990s,
had spread to Scotland by mid 1990. The introduction of these epidemic
strains was followed by a rapid rise in reports of MRSA in Scotland from 565
in 1995 to over 12 203 in 2001. EMRSA-15 and 16 account for 70% and
20% of all Scottish MRSA, respectively. PFGE typing has identiﬁed 150 and
200 clonal variants of EMRSA15 and EMRSA16, respectively. However,
50% and 35% of EMRSA15 and EMRSA16, respectively, are indistinguish-
able by PFGE typing thus complicating epidemiological monitoring. We
evaluated the potential usefulness of PFGE combined with the analysis of
mec-associated dru sequences as a more sensitive approach to tracking MRSA
isolates in Scotland.
Methods: EMRSA-16 and -15 were collected from hospitals throughout
Scotland. The isolates were initially characterized by macro-restriction (SmaI)
analysis using PFGE. In addition, mec-associated dru sequences were also
analyzed by electrophoresis of intact or AluI-digested PCR products and by
direct sequencing.
Results: By PFGE, 90% of EMRSA-15 isolates exhibited one of six patterns
(15a,b,c,d,e, or i), of which 50% were PFGE type 15a. For EMRSA-16
isolates, 79% exhibited one of ﬁve patterns (16a,b,d,m, or p) of which 35%
were PFGE type 16a. Analysis of dru sequences allowed further separation of
isolates (including majority types 15a and 16a) into speciﬁc subtypes originat-
ing from different hospitals and/or geographic regions. This was initially
accomplished by a simple comparison of dru PCR product sizes (either intact
or AluI digested) which differed depending on the number of 40-bp tandem
repeats. Direct sequencing of the dru region was employed to characterize
(and in some instances further subtype) isolates that were otherwise indis-
tinguishable.
Conclusions:A combination of PFGE and dru-sequence analysis appears very
promising for the epidemiological tracking of epidemic MRSA isolates in
Scotland, including strains with apparently highly conserved genetic back-
grounds. This approach may have the potential to identify and monitor the
movement of speciﬁc epidemic MRSA within and between hospitals which
would greatly assist public health and infection control efforts to control the
spread of these problem organisms.
P1582 Antibiotic resistance surveillance on the basis of
high quality routine data: GENARS – German Network for
Antimicrobial Resistance Surveillance
K. Huppertz, I. Noll, B. Wiedemann, the Genars-group
Objectives: Worldwide every day billions of susceptibility tests for human
pathogens are performed for diagnostic reasons. Unfortunately these data are
not sufﬁcient for surveillance studies because of the lack of comparability, due
to methodological variability. The six laboratories of the GENARS-project
measure MIC’s of about 30 antibiotics. Methods are standardized and quality
controlled. This paper describes the reproducibility of the results of the QC
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strains and in addition the quality control by the comparison of MIC-
distributions of clinical isolates.
Methods: In each laboratory involved in the GENARS-project, all clinical
isolates are identiﬁed to species level. Generally, all isolates are tested against 32
different antibiotics. In contrast to usual QC strain evaluation we look for
those data, where the MIC’s of the strains are within the range of the
concentrations tested, which increases the sensitivity of the method. The
second quality control measure is the comparison of MIC-distributions of
clinical isolates, where the modal value of the sensitive population of one
species should be identical for laboratories involved.
Results: Evaluation of QC-strain measurements gives a good impression of
the quality of laboratory work. For the ﬁrst half of 2002 more than 130 tests
for each QC-strain and antibiotic were evaluated. Some examples are shown
in Table 1, demonstrating that the reproducibility of the test modal value 
one dilution step is close to 100% with few exceptions. The second tool to
demonstrate reproducibility of test results is shown in Fig. 1. The MIC-
distribution for cefuroxime with E. coli demonstrates, that the naturally
sensitive population peaks at 4 mg/L.
Conclusions: The high methodological standard of sensitivity testing of the
GENARS-project will not only improve the surveillance including an early
warning system, a demonstration of resistance trends and ﬁnding of new
resistance mechanisms, but will also be advantageous for the patients who
beneﬁt from more reliable test results and better hospital epidemiology.
P1583 Identifying the SCCmec types of MRSA – a
comparison of three primer sets
Z. Al-Doori, G. Edwards, C. Gemmell, N. Woodford, D. Morrison
Glasgow, London, UK
Objectives: The genetic elements associated with methicillin resistance in
Staphylococcus aureus have been designated SCCmec (Staphylococcal Chro-
mosomal Cassette mec). Four SCCmec types and three subtypes have been
deﬁned, ranging in size between 21 and 67 kb. In this study we compared the
effectiveness of three different primer sets (WM,OL, and OH) for identifying
the SCCmec types of various MRSA clones.
Methods: Sixty-six MRSA isolates from UK, including representatives of 31
PFGE deﬁned clones, were analyzed using two multiplex SCCmec PCR
assays, the WM assay (Morrison et al. Proceedings of the 10th ISSSI, Japan,
2002, Abs. 212–01) and the OL assay (Oliveira et al. Antimicrob. Agents
Chemother. 2002; 46: 2155–2161). Isolates with discrepant results were tested
with a third set of primers, OH (Okuma et al. J. Clin. Microbiol. 2002: 40;
4289–4294), which involved ﬁve separate PCR reactions per isolate.
Results: A total of 45 of 66 (68%) isolates yielded identical SCCmec results
with both the WM and OL assays; 2 and 3 isolates were nontypable with the
WM and OL primers, respectively; and 1 and 10 isolates, respectively, gave
‘new’ (presently undeﬁned) typing patterns. Nine isolates gave discrepant
SCCmec typing results with the two primer sets. When tested with a third
primer set, theOH primers, the SCCmec results for 3 of 9 isolates agreedwith
those obtained with the WM assay, 2 isolates gave results that differed from
those of both other assays, and 4 isolates were nontypable, suggesting the
presence of further undeﬁned SCCmec types or subtypes.
Conclusions: It is inevitable that primers directed against different sequences
on the large mec DNA inserts of MRSA will sometimes generate different
results. International standardization of SCCmec typing assays, and of the
deﬁnitions and nomenclature for types and subtypes is essential for meaningful
comparison of data at the global level.
P1584 Erythromycin-resistant Streptococcus pyogenes
in the Florence area: at last a stable incidence?
G. Corti, R. Degl’Innocenti, L. Marrone, C. Chiatto, F. Paradisi
Florence, Prato, I
Objectives: Streptococcus pyogenes (SP) is by far the most common agent of
acute bacterial tonsillo-pharyngitis (ABTP), as well as an increasingly impor-
tant cause of invasive infections. Macrolides are frequently used to treat SP
ABTP, even in patients who are not allergic to penicillin. The worldwide
emergence of erythromycin-resistant (ER) SP strains, primarily in Southern
Europe and the Far East, prompted us to evaluate the incidence of ER SP
isolates in the Florence area during a 9-year period.
Methods:Between 1 January 1993 and 31 December 2001, we isolated a total
of 1294 SP strains from nonconsecutive patients with signs and symptoms of
ABTP (1140 throat swabs) or invasive infections (154 skin or blood cultures).
Commercial latex agglutination tests were used for rapid identiﬁcation of SP
isolates, which were subsequently tested for susceptibility to penicillin and
erythromycin by the disk diffusion method according to the Kirby–Bauer
technique. Statistical analysis was carried out by the Chi-square and Fisher
exact tests whenever appropriate.
Results:All strains were susceptible to penicillin. During the study period, the
rate of all SP isolates that were resistant or intermediate to erythromycin
steadily increased from 5% in 1993 to 47.7% in 1999, then it fell to 38% in
2000 and to 34.7% in 2001, with a global ﬁgure of 35.1%. A very similar trend
was observed for strains isolated from throat swabs, among which the
percentage of nonsusceptible SP isolates steadily increased from 5.4% in
1993 to 47.9% in 1999, then it fell to 39.4% in 2000 and to 35.3% in 2001. On
the other part, a signiﬁcantly (P¼ 0.006) lower percentage of strains from
other sites were not susceptible to erythromycin (25.3%); moreover, the yearly
incidence was more irregular, varying from 0 in the period 1993–1995 to
44.4% in 1999.
Conclusion: The increased incidence of SP isolates that are not susceptible to
erythromycin has currently become a serious problemworldwide. In our area,
preliminary data indicates that the use of macrolides (in particular, the newer
azithromycin and clarithromycin) rose in the early 1990s and subsequently it
kept stable or slightly decreased, therefore, it is possible that the worrisome
trend in ER SP rate we observed, correlates with macrolide consumption.We
conclude that ongoing epidemiological monitoring of ER SP is desirable, and
use of macrolides, primarily for respiratory tract infections, must be weighed
carefully.
P1585 Molecular epidemiology of vancomycin-resistant
enterococci circulating in a large Italian hospital during the
last 13 years
L. Gualco, E. A. Debbia, G. C. Schito, A. Marchese
Genoa, I
Objectives: In the last decade, vancomycin-resistant enterococci (VRE)
emerged as important nosocomial pathogens in several countries, especially
in the USA. In Italy the isolation of VRE is an uncommon ﬁnding. However
during last years at our university hospital an increase of VRE prevalence has
been experienced (from 0.1% in 1991 to 3.1% in 2002). In this study, VRE
circulating in a large Italian hospital during the period 1991–2002 have been
phenotypically and genotypically characterized.
Methods: Fifty VRE (38 E. faecalis and 12 E. faecium) isolated from various
clinical specimens have been studied. Antimicrobial susceptibilities were
determined according to the NCCLS (2002) by broth microdilution method.
PCR ampliﬁcation of vanA and vanB genes was carried out as described by
Dutka-Malen et al. (JCM, 1995). Pulsed-ﬁeld gel electrophoresis (PFGE) was
performed as previously described by Miranda et al. ( JCM, 1991).
Table 1 Percent of tests which are in the range of  one dilution step of the modal
value of all results
Ampicillin Piperacillin Teicoplanin Ciprofloxacin Levofloxacin Meropenem Erythromycin
E. coli
(ATCC 25922)
94.8 97.7 – – – – –
P. aeruginosa
(ATCC 27853)
– 92.4 – 93.9 99.2 99.2
E. faecalis
(ATCC 29212)
97.7 – 99.2 98.1 100 100 97.7
S. aureus
(ATCC 29213)
71.8 – 95.5 – – – 72.7
Figure 1 Distribution of MIC-values of E. coli and cefuroximine for five laboratories.
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Results: All strains proved to have vanA phenotype and genotype. PFGE
proﬁles showed high heterogeneity among the 12 E. faecium (10 different
patterns). Conversely, among E. faecalis, 16 out of 38, belonged to the same
PFGE (proﬁle A) and they had the some biochemical proﬁle and antibiotic
susceptibility pattern (resistant to erythromycin, ciproﬂoxacin, tetracycline
and fosfomycin simultaneously). 14 were correlated to the proﬁle A and the
remaining of isolates (8) showed different patterns. The 16 identical strains
were isolated in 4 different wards from the following samples: urine (11),
blood (1), vesical catheter (2) and bile (2).
Conclusions: The present results indicate the circulation of a clone of E.
faecalis characterized by the possession of a great ability to spread in our
hospital. Increasing prevalence of VRE observed can be ascribed to the spread
of this clone. The presence of some nonclonal strains may be explained by the
transfer of mobile genetic elements coding for the vanA resistance genotype to
unrelated strains of endogenous enterococci.
P1586 Failure of treatment with ceftazidime for
infection by Klebsiella oxytoca overproducing
chromosomal beta-lactamase OXY-1
G. Aubert, N. Fonsale, C. Venet, F. O. Mallaval, A. Carricajo,
A. C. Vautrin, G. Paul, F. Zeni
Saint-Etienne, F
Objectives: To establish the reasons for failure of treatment with ceftazidime
(CAZ) for infection by K. oxytoca overproducing chromosomal beta-
lactamase OXY-1 (Ko OXY-1).
Materials: We discuss the case of a patient who in 2002 developed an
abdominal infection caused by Ko OXY-1 following traumatic contusion
of the tail of pancreas. 10 days of treatment with CAZ (8 g in continuous
infusion over 24 h; serum CAZ concentration: 55mg/L) failed to eradicate
the infection (drainage ﬂuids were consistently positive for Ko OXY-1).
Successful bacteriologic and clinical recovery was achieved only on treatment
with imipenem (IMI) (1 g 4/24 h; serum IMI concentrations: 16mg/L
[peak] and 2.5mg/L [trough]).
Results: The strain of Ko OXY-1 involved exhibited an MIC on dilution in
gelose of 0.5mg/L for CAZ and of 8 mg/L for aztreonam (AZT). The
MICs for CAZ and AZTwith 2 mg/L clavulanic acid (CA) were, respectively,
0.25mg/L and 0.12mg/L. The MIC of IMI was 0.5mg/L both with
and without CA. The MICs of amoxicillin, cephalotine, cefuroxime, cefo-
taxime and ceftriaxone were, respectively (no CA/with 2 mg/L CA:>512/
128, 64/2, 32/2, 0.12/0.015mg/L and 0.12/0.012mg/L. The enzymatic
activity of OXY-1 penicillinase was 100 times superior to that of the activity
of a non OXY-1 penicillinase-producing strain and the isoelectric
point of beta-lactamase was 7.5. Kinetic analysis of bactericidal effects
showed bactericidal activity (decrease in inoculum of 4 log10) within 24 h
for 16mg/L (32MIC) of CAZ and within 6 h for 2 mg/L (4MIC) of
IMI.
Conclusion: These results could account for the therapeutic failure of CAZ
and the efﬁcacy of IMI. Poor diffusion of CAZ at the infection site is a further
possible contributing factor. This strain is considered sensitive to CAZ in
terms of the criteria established by the Antibiogram Committee of the French
Microbiology Society in 2002; nevertheless, in view of these results it would
appear preferable not to use CAZ for treatment of the Ko OXY-1 strain.
Further studies are required.
Infection in the intensive care unit
P1587 Nosocomial bacteremia in the intensive care
unit: a case-controlled study of risk factors and outcomes
A. Cagatay, P. Ozcan, H. Berk, N. Ince, H. O¨zsu¨t, N. Cakar, F. Esen,
H. Eraksoy, S. Calangu
Istanbul, TR
Objectives: A case-control study was conducted to identify the risk factors
(RFs) associated with nosocomial bacteremia in Intensive Care Unit (ICU).
Methods: During 15months, 139 patients with bacteremia and 139 control
patients in ICU were included in this study. Every patient was matched in a
1 : 1 ratio with controls. Patients who met the nosocomial infection deﬁni-
tions of CDC were included in this study. Frequency, percentage, ratio and
categorical variables were analyzed with a chi-square test. Student t-test and
Mann–Whitney U-test were performed for analyzing continuous variables.
Multivariate analysis was conducted with a logistic regression.
Results: Two hundred and seventy-eight patients were enrolled in this study.
There were 174 bacteremic episodes in 139 patients with bacteremia; 109
episodes by Gram-negative bacilli; 62 episodes by Gram-positive cocci; and 3
episodes by Candida spp. K. pneumoniae (21.8%), MRSA (20.7%), P. aeruginosa
(16.1%), E. coli (11.5%) were the most common agents in bacteremia.
Nosocomial pneumonia (31%), primary bloodstream infections (25.8%)
and surgical site infections (9.7%) were the most common infections causing
bacteremia. According to univariate analysis, RFs associated with bacteremia
were the requirement of mechanical ventilation (MV) more than 7 days
(P¼ 0.004), operation (P¼ 0.015), hemoﬁltration (P¼ 0.006), requirement
of total parenteral nutrition (TPN) (P< 0.001) and inotropic drug (ID) use on
admission (P< 0.001) and bronchodilator drug (BD) (P¼ 0.041), previous
antibiotic (PA) use (P< 0.001). The mean values of AST, ALT, creatinine,
leukocyte level and APACHE II and SOFA scores in bacteremic patients were
found signiﬁcantly higher than those of control group (P< 0.001 for all
variables). The mean values of Hb, platelet count and Glasgow coma score in
bacteremic patients were signiﬁcantly lower than those of the control
(P¼ 0.002, P¼ 0.038, P¼ 0.017, respectively). Multivariate analysis revealed
that increased creatinine level [Odds ratio (OR) 4.4, P< 0.001)], requirement
of ID (OR 3.3, P¼ 0.004) on admission, operation (OR 2.1, P¼ 0.022), PA
use (OR 1.8, P¼ 0.034), TPN (OR 5.7, P¼ 0.001) could independently be
associated with bacteremia in ICU.
Conclusions:Requirement of MV more than 7 days, hemoﬁltration and BD
were found remarkable RFs for bacteremia in ICU.
P1588 Risk factors for mortality of nosocomial
bacteremia in intensive care units
A. Cagatay, P. Ozcan, L. Gulec, N. Ince, S. Tugrul, H. O¨zsu¨t,
N. Cakar, H. Eraksoy, S. Calangu
Istanbul, TR
Objectives: The aim of this study was to prospectively follow critically ill
patients in ICU to determine risk factors of mortality and outcome associated
with nosocomial bacteremia (NB).
Methods:This study was conducted in Intensive Care Units (ICU) (including
emergency and general ICU) with 23-bed during 15months. The risk factors
for mortality in 176 patients with bacteremia in ICUwere investigated. A chi-
square test was employed to compare categorical variables, Student t-test and
Mann–Whitney U-test were performed for analyzing continuous variables.
Multivariate analysis was performed with logistic regression.
Results: Two hundred and fourteen bacteremia episodes were found in 176
patients [64 F, 112M; 51.3 21.3 years-old]: 93 of them died and 83 survived.
There were 125 bacteremic episodes by Gram-negative bacilli, and 82
episodes by Gram-positive cocci, 7 episodes by Candida spp. in patients with
NB. K. pneumoniae (21.5%), MRSA (21.5%), P. aeruginosa (14.9%), E. coli
(9.3%) were the most common etiologic agents in bacteremia. Malign
hypertension (P¼ 0.01), requirement of mechanical ventilation (MV) more
than 7 days, prolonged CVC using time (P¼ 0.019) (P< 0.001), having a
hematologic malignancy or solid tumor (P¼ 0.002), increased creatinine level
(> 1.4mg/dL) (P¼ 0.005), hemoﬁltration (P¼ 0.007), requirement of total
parenteral nutrition (TPN) (P< 0.001) and inotropic drug (ID) on admission
(P< 0.001) were determined as risk factors for mortality in patients with
bacteremia. Multivariate analysis showed that requirement of MV more than
7 days [Odds ratio (OR): 6.8, P< 0.001], requirement of TPN [OR: 3.1,
P¼ 0.034], requirement of ID [OR: 12.8, P< 0.001], increased creatinine
level [OR: 2.7, P¼ 0.034] were independent risk factors for mortality of NB
in ICU. The mean values of APACHE II scores, SOFA scores and Glasgow
coma scale in surviving patients with bacteremia were found signiﬁcantly
different than those of other patients (P< 0.001 for all variables).
Conclusions: Although there might be many other mortality causes such as
underlying diseases and nosocomial infections in ICU, requirement of MV
more than 7 days, requirement of TPN, and ID on admission and increased
creatinine level were independent risk factors for mortality in patients with
NB in ICU.
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P1589 Epidemiology of nosocomial infections acquired
in an intensive care unit in Italy
B. Allegranzi, A. Azzini, L. Antozzi, R. Luzzati, A. Luzzani, E. Concia
Verona, Trieste, I
Objective: To assess the epidemiology and etiology of nosocomial infections
(NI) and to identify patterns of antibiotic resistance in a medical-surgical
intensive care unit (ICU).
Methods: From April 2000 to April 2002 we conducted a prospective study
and detected the most frequent NI and risk factors in patients admitted for
more than 48 h to the ICU of theUniversity General Hospital of Verona, Italy.
We also evaluated antimicrobial resistance of isolated microorganisms.
Results:During the 2-year survey, 797 patients were evaluated. Median ICU
stay was 8 days (range 3–151) and total patient-days were 10.941. Mean age
was 64 (SD 19) years and mean APACHE II score 18 (SD 8). Crude mortality
was 15%. Invasive procedures were adopted as follows: urinary catheter in
94% of cases, mechanical ventilation in 80%, arterial catheter in 76%, central
venous catheter (CVC) in 71%. We recorded 234 episodes (21.4/1.000
patient-days) of ICU-acquired infections in 142 patients (18%). Bloodstream
infections (BSI) were the most frequently reported type of infection (141
episodes, 60% of all cases of infection), followed by pneumonia (48 episodes,
21%), urinary tract infections (25 episodes, 11%), wound infections (17
episodes, 8%). Overall the most common pathogens were coagulase-negative
Staphylococci (CNS) (25%), P. aeruginosa (22%), Enterobacteriaceae (18%), S. aur-
eus (17%), Enterococcus spp. (8%), Candida spp. (6%), others (4%). Methicillin
resistance (MR) was 81% among S. aureus (MRSA) and 75% among CNS.
Multi-drug resistance was detected in 14% of P. aeruginosa isolates and fully
resistant strains increased from 2 to 14 from the ﬁrst through the second year.
ICU stay >7 days, CVC retention for >10 days, mechanical ventilation and
tracheotomy resulted as risk factors independently associated with ICU-
acquired infections.
Conclusions:Overall we detected an ICU-acquired infection rate comparable
to other European studies. Nevertheless we observed a different frequency of
distribution of NI; in fact BSI were the predominant type of infection.
Staphylococci were the most frequently isolated pathogens, with very high
levels of MR. We are therefore focussing interventions on staff education
about infection control measures (especially catheter management) and on
identiﬁcation and treatment of patients colonized by MRSA. Knowledge
about antimicrobial resistance patterns has been very useful to implement
periodic antibiotic changes in empiric therapy protocols.
P1590 Prevalence of microbiologic species in intensive
care units in Piedmont (Italy)
D. A. Zeme, A. Gramoni, R. Raiteri, B. Barberis, V. M. Ranieri,
G. Di Perri
Turin, Rivoli, I
Objectives: To assess the principal isolates in Piedmont ICUs and to inves-
tigate the main isolation sites and antibiotical resistance.
Methods:A one-day-point-prevalence study was designed and 21 ICUs were
enrolled (19 nonspecialized and 2 specialized ones). On the study day biologic
samples (for microbiologic survey or etiologic diagnosis) were collected for all
the hospitalized patients. For each sample the cultural test was done and, if
positive, the antibiogram was performed.
Results:Overall, we performed 241 microbiologic tests: 103 bronchoaspira-
tions (70 positives, 33 negatives), 77 urocultures (28 positives, 49 negatives),
43 emocultures (14 positives, 29 negatives) and 18 CVCs cultures (12
positives, 6 negatives). The main isolates were as follows: Enterobacteriaceae
(n¼ 42), Staphylococci (30 S aureus, 11 CNS), Pseudomonaceae (28 P. aeruginosa,
2 B. cepacia and 1 Stenotrophomonas maltophilia) and 6 E. faecalis. There were also
21 fungal isolates: 15Candida albicans, 4Candida nonalbicans and 2A. fumigatus.
The principal isolation sites were summarized in Table 1, while the antibiotic
resistance is shown in Table 2.
Conclusions: The main isolates were Enterobacteriaceae, Staphylococci and
Pseudomonaceae, a result consistent with other studies; the main isolation sites
were respiratory tract and urine. We found only one VRE (E. faecalis). The
MRSA rate was lower than those of EPIC study (72.4%) and of an analogue
study performed in Veneto (75%). Pseudomonaceae showed high rate of
resistance to ceftazidime, ﬂuoroquinolones and aminoglycosides (for P. aeru-
ginosa, respectively: 42.8 vs. 27.7% in EPIC study, 46.4 vs. 26.3%, and 46.4 vs.
46%).
P1591 Two-year-point prevalence of infections in
intensive care units in Piedmont (Italy)
A. Gramoni, D. A. Zeme, R. Raiteri, B. Barberis, V. M. Ranieri,
G. Di Perri
Turin, Rivoli, I
Objectives: To evaluate the prevalence of infections in intensive care units
(ICU) and to compare the rates of two consecutive years.
Methods:There are 33 ICUs in Piedmont. In 2001, 18 nonspecialized ICUs
took part into the study, while in 2002, 19 nonspecialized and 2 specialized (1
neurosurgery and 1 cardiovascular-surgery) were enrolled. The study popula-
tion was deﬁned as all the patients occupying a bed over a 24-h period on the
study day. For all patients demographics, clinical status on admission (SAPS
II), diagnostic and therapeutic interventions up to 1week before the study day
were recorded. The deﬁnitions of infections followed the 1998 CDC
statements. Patient outcome was assessed up to 3weeks after the study day.
Results:The study population (183 patients in 2001 vs. 201 in 2002) consisted
of 254 male (126 in 2001 vs. 128 in 2002) and 130 female (57 in 2001 vs. 73 in
2002). The mean age was, respectively, 61 years in 2001 and 69 years in 2002.
We found 109 infections in 2001 and 135 in 2002. The reported infections
were as follows: ICU-acquired, 54 (49.5%) vs. 77 (57%); hospital-acquired, 29
(26.6%) vs. 34 (25.2%) and community-acquired, 26 (23.9%) vs. 24 (17.8%).
The most frequently reported ICU-acquired infections involved the respira-
tory and the urinary tract (see table).
Conclusions:Most of the reported infections were ICU-acquired. About 30%
of patients who had an ICU-acquired infection showed multiple infectious
events. The infection rates in the 2 study years were similar to those of EPIC
study, being lower than the Italian ones. No signiﬁcant differences was
observed when 2001 and 2002 were compared.
P1592 Prevalence of nosocomial infections in intensive
care units in Turkey: a multicenter 1-day point prevalance
study
S. Esen, H. Leblebicioglu
Samsun, TR
Objective:To determine the prevalence of intensive care unit (ICU)-acquired
infections in Turkish ICUs. To identify associated risk factors, predominant
infecting organisms, and mortality rates
Table 1 Principal isolation sites
Enterobacteriaceae Staphylococci Pseudomonaceae E. faecalis Mycetes
Bronchoaspiration 20 29 28 – 11
Urocolture 16 – 6 3 6
Emocolture 5 3 2 2 2
CVC colture 2 7 – – 1
Other sites 5 – – 1 1
Table 2 Antibiotic resistances
Enterobacteriaceae Staphylococci Pseudomonaceae E. faecalis
beta-lactams 25 (59.5%) 26 (63.4%) 15 (48.4%) –
Fluoroquinolones 5 (11.9%) – 16 (51.6%) 2 (33.3%)
Aminoglycosides 3 (7.1%) – 16 (51.6%) 1 (16.7%)
Carbapenems – – 12 (38.7%) –
Glycopeptides – – – 1 (16.7%)
Type of infection 2001: n (%) 2002 : n (%)
Pneumoniaþ lower respiratory tract 31 (57.4) 33 (42.8)
Urinary tract 10 (18.5) 15 (19.5)
Bloodstream 6 (11.1) 14 (18.2)
Clinical sepsis 3 (5.6) 8 (10.4)
Wound 1 (1.8) 3 (3.9)
Gastrointestinal 2 (3.7) 2 (2.6)
Skin and soft tissue 1 (1.8) 1 (1.3)
Central nervous system 0 0
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Methods: A 1-day point prevalence study. A total of 56 ICU from 22
university or teaching hospitals were participated to the study. Coronary
intensive care and pediatric intensive care units were excluded from the study.
The study was carried out on September 19, 2001.
Results: A total of 236 completed case reports forms was accepted for
analyzes. Eighty percent of these ICUs were situated from university hospitals
and 20.0% in teaching community hospitals. 44.6% of the ICUswere surgical,
35.7% were mixed (medical and surgical) and 19.6% were medical. A total of
115 patients (48.7%) studied had one or more ICU related nosocomial
infections on the study day. Pneumonia and lower respiratory tract infections
(28.0%), laboratory conﬁrmed blood stream infections (23.3%) and urinary
tract infections (15.7%) were the most frequent types of ICU related infec-
tions. Of the nosocomial pneumonia, 81.9% was associated with mechanical
ventilation, and 97.3% of urinary tract infections were associated with urinary
catheters. Endotracheal tube, urinary catheter, multitrauma on admission,
stress ulcer prophylaxis, nasogastric feeding, mechanically ventilation were the
risk factors for ICU related nosocomial infections. The most frequently
reported isolates for ICU related infections were as follows: P. areuginosa
20.8%, S. aureus 18.2%, Acinetobacter spp. 18.2% and Klebsiella spp. 16.1%.
Of the 80.4% Staphylococci were resistant to methicillin. Of the P. aeruginosa
isolates were resistant to amikacin (44.1%), ciproﬂoxacin (42.9%), imipenem
(36.1%) and ceftazidime (44.7%). Resistance rates ofAcinetobacter spp. for same
antimicrobials were; 54.1, 60.5, 30.6, 74.3%, respectively. Of the patient
72.9% were receiving antimicrobials on the day of the study for treatment or
prophylaxis. Most frequent administered antimicrobials were aminoglikozides
percentage 37.2 (of the patients receiving antimicrobials), carbapenems
31.4%, glycopeptides 23.3%, cephalosporins 18.0% and 5.8% antifungals.
At the end of 4weeks follow up overall 70 (29.7%) patients died, 22 (9.3%) of
them died from ICU infections.
Conclusion: This study showed that ICU related infections is common and
often associated with resistant microorganisms
P1593 Antimicrobial resistance of microorganism
isolated from nosocomial infections in intensive care
units of a university hospital in Adana, Turkey
S. Incecik, N. Saltoglu, A. Yaman, M. Ozalevli, M. Gunduz,
I. Karayaylali, R. Burgut
Adana, TR
Objectives: To describe the frequency and resistance rates of bacterial
pathogens from patients admitted to four intensive care units at a university
hospital.
Materials and methods: The isolates collected betweeen July 1999 and June
2001 included in the study were causes of nosocomial infection in intensive
care units. The identiﬁcation and susceptible to antibiotics has been per-
formed in automated system Sceptor (Becton Dickinson) MIC/ID panels as
described by the NCCLS.
Results: Among 3962 patients in the intensive care units, 492 infection
episodes were diagnosed in 272 patients with nosocomial infection. Infection
rate was 12.4%. Isolates from ICU patients were recovered from urinary tract
infections (32%), primary blood stream infections (24%), nosocomial pneu-
monia (20%), surgical-site infections (13%) and other infections (11%).
Pneumonia was the most common nosocomial infection (54%) in anesthe-
siology ICU. The pathogens causing these infections were 39%Gram-positive
bacteria and 52% Gram-negative bacteria and 9% Candida species. S. aureus
(18%) was the most frequently isolated bacteria, followed by P. aeruginosa
(16%), Acinetobacter spp. (10%), Klebsiella (9%), E. coli (9%), CNS (10%),
Enterococcus (9%). Resistance to oxacillin was observed for all of S. aureus
isolates and 95% of the CNS isolates, all isolates were susceptible to vanco-
mycin. 8% of Enterococcus isolates were resistant to vancomycin. Against the
gram negative bacteria the carbapenems were most active with 61% of the
isolates susceptible, followed by amikacin and ciproﬂoxacin. Five percent of
P. aeruginosa and 15% of Acinetobacter spp. are found to be resistant to all
antibiotics. The most active antimicrobial agents; against Acinetobacter spp.
were (IMP) imipenem (73%), tobramycin (46%); against Pseudomonas spp.
were Ticarcillin/clavulanate (56%), piperacillin (44%), IMP (33%); against
Klebsiella spp. were IMP (92%), against E. coli were IMP (94%), AK (94%),
CIP, ciproﬂoxacin (74%); against Enterobacter spp. were CIP (89%), IMP
(78%).
Conclusions:The high rates of resistant pathogens responsible for nosocomial
infection in ICUs suggest that infection preventive procedures should be
implemented, antimicrobial agents must be properly used.
P1594 Methicillin-resistant Staphylococcus aureus
nosocomial infection in the intensive care unit
M. A. Za´rraga, J. A. Carto´n, I. Lopez Lagunas, M. Tuya
Aviles, Oviedo, Aviles. Asturias, E
Introduction: The nosocomial infection (NI) due to methicillin-resistant
Staphylococcus aureus (MRSA) is a growing problem in the world. In large
tertiary hospitals outbreaks of MRSA are commonly encountered in critical
care areas.
Objetives: We study the risk factors predisposing to NI by MRSA, with
special emphasis on the prior antibiotic therapy to try to predict the devel-
opment of this infection and to assess its clinical virulence.
Methods:Unmatched case-control study. The Hospital Central of Asturias is
a teaching institution in north Spain. The hospital has a medical-surgical unit
with an annual admittance rate of 400–500 patients. Our study was conducted
at the Intensive Care Unit (ICU) for one year. All patients satisfying MRSA
NI criteriawere selected as cases. Controls were chosen among ICU-admitted
patients with NI due to methicillin-sensitive Staphylococcus aureus (MSSA).
The customary statistic study was completed with a stepwise logistic regres-
sion analysis.
Results: At the ICU setting, 47 patients with NI caused by MRSA were
compared with the 39 controls who were available. Both groups had quite
similar results with respect to the clinical and epidemiological characteristics.
We failed to identify signiﬁcant differences in severity between MRSA-
infected and MSSA-infected patients (APACHE II index and SAPS index).
Therapeutic interventions did not differ signiﬁcantly between groups (TISS
index). The most important differences between patients infected by MRSA
and the controls were the length of their previous stay (median 19 vs. 4 days;
P< 0.001), the frequency of prior infection (93.6 vs. 25.6%, P< 0.001) and
the previous consumption of antibiotics (100 vs. 59%; P< 0001). The
duration of antimicrobial therapy before the Staphylococcus aureus was isolated
was signiﬁcantly longer (17 vs. 6 days, P< 0001). A simple model allowed the
prediction of the strain infecting with 86% success, considering the previous
infection, the prior consumption of antibiotics and the age. Signiﬁcant
differences concerning mortality between the two groups were not found.
Conclusions: The previous administration of antibiotics was the most closely
related factor to MRSA hospital-acquired infection both at ICU. In our study
the clinical virulence of MRSA nosocomial infection was not greater than
MSSA nosocomial infection, differences cannot be shown.
P1595 Source isolation in intensive care units does not
reduce spread of MRSA beyond that achieved by universal
precautions: a prospective two-center study
J. Cepeda, T. Whitehouse, B. Cooper, J. Hails, K. Jones, F. Kwaku,
L. Taylor, S. Hayman, S. Shaw, C. Kibbler, M. Singer, G. Bellingan,
A. Wilson
London, UK
Objectives: The incidence of methicillin resistant Staphylococcus aureus
(MRSA) is increasing, particularly in ICU patients but many units lack
sufﬁcient single rooms and adopt universal ‘standard precautions’. We con-
ducted a two-center prospective study in two mixed ICUs to assess the
beneﬁts of source and cohort isolation over and above universal precautions.
Methods: Two general ICUs participated in the study over one year. All
patients admitted for >48 h were studied. Patients were screened for MRSA
colonization (nose/groin) on admission, and weekly thereafter. In the ﬁrst and
last three month periods (Phase I/III) MRSA positive patients were moved to
single rooms or cohort bays but not moved in the middle six months (Phase
II). Universal standard precautions for infection control were always used.
Results:The patient populationwas similar in eachmanagement phase. There
was no signiﬁcant difference between the two ICUs in compliance with
Table 1
Phase I/III Phase II P value
Total number of patients staying >48 h 437 418 >0.1
No. (%) MRSAþon admission 68 (15.6%) 69 (16.5%) >0.1
No. (%) becoming colonized
with MRSA in ICU
50 (12%) 40 (11.3%) >0.1
No. (%) infected with MRSA in ICU 15 (3.4%) 11 (2.7%) >0.1
Outcome1 28 (6.6%) 27 (6.6%) >0.1
1Total number of patients dying while active treatment for MRSA (defined as
appropriate antibiotics within 48 h of death.
390 Abstracts
handwashing/disinfection regardless of patient dependency, or presence or
absence of MRSA. The rate of acquisition of, or infection with, MRSA and
mortality was similar whether patients were moved or not, and this was
conﬁrmed by multivariate analysis of risk.
Conclusion:Source or cohort isolation had no signiﬁcant impact in decreasing
MRSA spread in ICU patients when universal precautions were followed.
P1596 Nosocomial infections due to Pseudomonas
aeruginosa in neonates
E. Bilikova, V. Krcmery, M. Kacmarikova, E. Grey
Bratislava, SK
Objectives: P. aeruginosa is one of the commonest cause of nosocomial
infections in adults, and in children.
Methods:We investigated all neonatal infections caused by P. aeruginosawithin
2 years among 246 newborns hospitalized in neonatal ICU. Univariate
analysis to asses risk factors for neonatal infections caused by P. aeruginosa
vs. neonatal infections caused by other organisms was performed.
Results: According to the analysis of risk factors for Pseudomonas aeruginosa
infections, it was found, that ventilatory support (38.46 vs. 12.27%) and
therapy with corticosteroides (15.38 vs. 3.18%) were signiﬁcant predictors for
P. aeruginosa infections. Positive blood cultures/catheter tips (38.46 vs. 9.55%)
were more frequently observed in neonatal infections with P. aeruginosa than
among neonatal infections without P. aeruginosa. Early marker for Pseudomonas
aeruginosa infection was a higher procalcitonin level (PCT) (19.23 vs. 5.45%).
Bacteremia (30.77 vs. 7.73%) and meningitis (7.69 vs. 0.45%) were the
commonest sites of infection with P. aeruginosa, in comparison to the control
group. Outcome was comparable in both groups.
Conclusion: Neonatal infections caused by P. aeruginosa are serious diseases
causing signiﬁcantly more meningitis and bacteremia than other organisms.
Mortality rate 3.85% was lower than in adults (25%), probably due to early
diagnosis and appropriate therapy with meropenem or ceftazidime, in a
combination with an aminoglycoside, used in our neonatal referral center.
P1597 Molecular epidemiology of multiresistant
Pseudomonas aeruginosa and Acinetobacter baumannii
isolates at intensive care units: the importance of
surveillance cultures
T. Atay, M. Bic¸men, M. Eren, C. Altinsoy, M. Akgo¨nu¨l, Z. Gu¨lay
Izmir, TR
Objective: To describe the clonal relationship of multiresistant P. aeruginosa
and A. baumannii which were recovered from clinical specimens of intensive
care unit (ICU) patients and surveillance cultures.
Methods: Between May 2001 and February 2002 a prospective study on the
epidemiology of multiresistant Gram negative bacteria (GNB) was conducted
in the three ICUs (Anaesthesiology and Reamination, Internal Medicine,
Neurosurgery) of Dokuz Eylul University hospital located in Izmir, Turkey.
Surveillance cultures for GNB were obtained weekly from the patients,
inanimate surfaces, and the hands of personnel. Clinical isolates were also
collected during the study period. Isolates were analyzed for clonality by
ERIC PCR.
Results: A total of 40 P. aeruginosa isolates (28 clinical, and 12 surveillance
culture isolates) and 80 A. baumannii isolates (10 clinical, and 70 surveillance
culture isolates) were taken into the study. It was observed that two clones
each of P. aeruginosa andA. baumannii had been disseminated at the ICUs of the
hospital. Organisms which shared the same ERIC PCR pattern with the
clinical isolates were recovered from the hospital environment and the hands
of healthcare personnel. Although a distinction could not be made among
P. aeruginosa isolates according to the resistance proﬁle; A. baumannii clusters
could be differentiated by imipenem susceptibility.
Conclusion: Epidemiological links between hand culture, environmental and
clinical isolates suggested cross transmission of multiresistant P. aeruginosa and
A.baumannii in the ICUs. The importance of surveillance cultures were
shown as colonization preceded infection in several patients. In addition, the
visits and surveillance culture results increased the compliance of healthcare
and other personnel to infection control measures.
P1598 Study colonization of nosocomial pathogens in
tracheal tubes of hospitalized patients in intensive care
units of Iranian hospital
M. Rahbar, K. Bahar, S. Molanai, R. Yaghobi, P. Islami
Tehran, IR
Objective: To determine colonization rate of nosocomial pathogens in
tracheal tubes of Patients hospitalized in intensive care unit of Milad Hospital
and performance of susceptibility testing for high frequency isolates.
Methods: Between July 2001 to November 2002, 249 endotracheal aspirates
specimen from patients hospitalized in ICU andNICU ofMilad hospital were
sent to microbiology laboratory. All specimens were processed according
standard microbiologic methods and all isolated microorganisms identiﬁed by
routine phenotyping methods. Antimicrobial susceptibility testing of all
isolates were determined with disk diffusion methods according NCCLS
guideline M100-S12.
Results:Of 249 endotracheal aspirates 222 (89%) specimen yielded growth of
microorganisms. In total 335 microorganisms isolated. Of 46 (18.4%) speci-
mens more than one microorganisms isolated. Endotrachael aspirates cultures
of this patients showed decreasing frequency of Klebsiella pneumonia 67 (20%),
Pseudomonas aeurginosa 62 strains (18.5%) Acinetobacter spp. 60 (18%) strains,
Staphylococcus aureus 51 (15.2%) strains, Seratia marcescens 32 (9.5%) strains,
Escherchia coli 22 (6.6%) strains. Enterobacter spp. 10 Candida albicans 5 isolates
(1.5%) and miscellaneous 26 isolates (7.7%). More than 90% of isolates of
S. aureus were resistant to oxacillin. All isolates of S. aureus were resistant to
vancomycin. Resitance rate of K. pneumonia to ciproﬂoxacin was 24% and all
isolates were resistant to ampicillin. More than 90% of isolates were resistant to
other commonly used antibiotics. All isolates of Acinetobacter were multidrug
resistant. Susceptibility of P. aeruginosa to ciproﬂoxacin and amikacin was 66
and 50%, respectively.
Conlcusion: This study revealed a high frequency colonization of drug
resistant nosocomial pathogens in tracheal tube of ICU hospitalized patients.
These organisms are major causative agents of nosocomial pneumonia.
P1599 Bacterial colonization of patients in intensive
care unit
A. Kadanali, M. Kizilkaya, U¨. Altoparlak, H. Ku¨rsad, M. Parlak,
M. A Tasyaran
Erzurum, TR
Objective: It is claimed that the origin of resistant microorganisms in the
intensive care unit may be the admission of patients with bacterial coloniza-
tion or infection with these resistant species from other units. We aimed to
evaluate the bacterial colonization of intensive care unit patients at their
admission.
Methods:Nose and throat specimens of 80 patients were taken within 24 h of
their admission to intensive care unit between April 2002 and January 2003.
Both Gram-negative bacilli and methicillin resistant Staphylococcus aureus
(MRSA) were accepted as bacterial colonization. The methicillin sensitive
Staphylococus aureus (MSSA) species which is normal for ﬂora were accepted as
bacterial colonization if they colonized pure and/or intensively.
Results: Bacterial colonization were detected 33 of 80 (41.2%) patients from
their nose and throat specimens. A total 37 different colonization agent were
determined.
Conclusion:Primary nose and throat specimens of patients on their admission
to intensive care unit may be useful in predicting resistant microorganisms and
isolation.
Origin of
patients No:
Colonized
patients MRSA Ent Ps, As Candida Total
Other units 34 21 (61.8%) 8 11 7 1 27
Other hospital 1 1 (100%) 1 1
Community 45 11 (24.4%) 3 5 1 9
Total 80 33 (41.2%) 37
MRSA: Methicillin resistant Staphylococcus aureus, Ent: Enterobactericeae, Ps: Pseudomonas
spp, As: Acinetobacter spp
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P1600 Dynamics of bacterial fecal colonization of
patients at a horacic intensive care unit
A. Ha¨llgren, L. G. Burman, O. Cars, H. Hanberger, B. Isaksson,
B. Olsson-Liljequist, B. Saeedi, S. Walther, L. E. Nilsson
Linko¨ping, Solna, S
Objectives: The aim of this study was to examine the dynamics of fecal
colonization of patients admitted to a thoracic ICU (TICU) at the University
Hospital of Linko¨ping, Sweden
Methods: Patients admitted to the TICU between November 2001 through
January 2002, that had a length of stay more than 5 days were included and
age, gender, cause of admission, length of stay, antibiotics administered,
cultures (species, source, antibiotic susceptibility) taken during the stay on
clinical indications were recorded. Rectal swabbing was performed on all
patients during their stay at the TICU. Two selective chromogenic UTI
medium (Oxoid) were used: one for enterococci with addition of 10mg/L
cephalexin, 75mg/L aztreonam, 15mg/L amphotericin B and one for Gram-
negative bacteria with addition 32mg/L vancomycin and 15mg/L ampho-
tericin B. Susceptibility testing was performed by disc diffusion and E-test
(AB Biodisk)
Results: Eleven patients were included, the majority for postoperative care
after coronary by pass surgery and/or cardiac vault surgery. Length of stay
varied between 8 and 47 days (mean 23 days). Each patient received between 2
and 10 different antibiotics during their stay. Rectal swabbing was performed
on each patient between 1 and 8 times. In seven patients rectal swabbing was
performed 2 times, among these patients an initially mixed Gram-positive
and -negative ﬂora was replaced with only Gram-positive bacteria in ﬁve
patients. Among patients where the same species was found in more than one
culture, a development of resistance was seen. Eight of 11 patients (73%) were
colonized with Enterococci. This was the most commonly found bacteria
followed by E. coli (45%) and coagulase negative Staphylococci (CoNS) (45%).
In cultures taken on clinical indications CoNS was the most common
bacterium. Pathogens found both as faecal colonization and in clinical cultures
from the same patient were: CoNS (4 patients: 3 central venous catheter, 1
introducer), P.mirabilis (2 patients: 1 introducer, 2 respiratory tract), E. faecalis
(1 patient: central venous catheter), S. maltophilia (1 patient: respiratory tract),
E. cloacae (1 patient: abdominal ﬂuid, respiratory tract), K. pneumoniae (1
patient: wound).
Conclusion: In several patients the Gram-negative bacteria of the fecal ﬂora
disappeared during long ICU stay and only Gram-positive bacteria were
detected, and among these a development of resistance was seen.
P1601 Enviromental, equipment and health care
workers contamination during multidrug-resistant
Acinetobacter outbreak in intensive care units of an Iranian
hospital
M. Vanaki, M. Rahbar, M. Yaghobi, A. Reza Shajari, F. Shirazi,
A. Fattahi, S. Movlanaee, K. Bahar, B. Kia Darband-Sary, P. Islami
Tehran, IR
Obejctive: The aim of this study was to determine contamination of
environment,equipment, and skin of personnel’s hands in intensive care units
(ICU) by Acinetobacter baumannii in Milad Hospital of Tehran.
Methods:Behind outbreak of infections caused by multidrug-resistant strains
ofAcinetobacter baumannii in ICU ofMiladHospital we decided for sampling to
detect environmental contamination by this organism. In total 112 sample
were taken from various sections and equipment and personnel’s skin hand.
All specimens processed according routine microbiologic methods. Suscep-
tibility testing performed according NCCLS M100-S12 guideline.
Results:Of 121 environmental samples obtained with swab and skin samples
29 (30%) were positive for Acinetobacter baumannii. The most equipment
contaminated with A. baumannii included: ventilator tubes personnel skin
hands, tap water bedsides ambuobags tracheal tubes desks and computers. Of
27 personnel we isolated A. baumannii from hand of 5 (18.5%) staffs. All
isolates were resistant to commonly used antibiotics such as amikacin,
cefepime ceftazidim and cefotaxim. Both environmental and personnel
isolates had the same phenotyping character, but genotyping could not be
performed.
Conclusion: Environmental contamination may be an important reservoir
in outbreak of infections caused by A. baumannii which in this cases imple-
mentation of infection control measures recommended for controlling infec-
tions
P1602 Hospital-acquired bacteremia due to
Acinetobacter baumannii in critically ill patients
J. Camarena, R. Zaragoza, A. Artero, R. Gonza´lez, S. Sancho,
J. Nogueira
Valencia, E
Objectives:Acinetobacter baumannii is a common cause of bacteremia in ICUs,
frequently associated with pneumonia and use of catheters. The aims of this
study were to know the epidemiology, clinical features and predictors of
mortality of nosocomial bacteremia due to Acinetobacter baumannii in our
setting.
Material and methods:During a ﬁve and a half-year period (1996–2001) we
have evaluated all clinical signiﬁcant hospital-acquired ICU-bacteremias of a
teaching hospital (12 beds) and specially those due to Acinetobacter baumannii.
Epidemiologic clinical and microbiologic features were recorded from clinical
charts. Multivariate analysis was performed to determine the predictors of
mortality by using SPSS package (9.0)
Results: Fifty-three (30%) from 174 hospital-acquired bacteremias in critically
ill patients were due to Acinetobacter baumannii. The mean age of patients was
59.5 18.3 years, and the distribution by sex was 75% men and 25% women.
A rapidly or ultimately fatal underlying disease was present in 38% of cases.
Ninety-two percent of patients had indwelling vascular catheters and 90%
were mechanically ventilated. Septic shock was present in 17% of patients.
The origin of infection was respiratory in 43%, catheter 17%, abdominal 2%,
meningitis 2% and unknown 36%. Ninety percent received prior antimi-
crobial therapy, 89% of isolates were multidrug resistant and inappropriate
empiric antimicrobial treatment was given in 36% of cases. In 25% of cases the
bacteremia was polymicrobial. The crude mortality rate was 53% and the
related mortality to bacteremia 23%. The age of the patients (P¼ 0.026) and
the presence of inappropriate empirical antimicrobial treatment (P¼ 0.023)
were identiﬁed as independent predictors of mortality using multivariate
analysis.
Conclusions: Multiresistant Acinetobacter baumannii was a common cause of
lCU-acquired bacteremia (30%), with high mortality rate. In this study we
identiﬁed two independent predictors of mortality: age of patients and
inappropriate empirical antimicrobial treatment.
P1603 Ventilator-associated pneumonia in patients with
trauma: risk factors concerning mortality
S. Yakovlev, B. Gelfand, D. Protsenko
Moscow, RUS
Objective: The aim of this study was to evaluate the risk factors of death in
ventilator-associated pneumonia (VAP) in patients with trauma.
Methods:One hundred consecutive adult patients with multiple trauma who
received more than 24 h ventilatory support in intensive care unit (ICU) of
municipal emergency hospital were evaluated prospectively. Two patients
were excluded from the analysis because of early death. VAP was deﬁned
according to presence of CDC criteria. Causative microorganisms were
detected by quantitative culture of mini-BAL or blind protected specimen
brush and their susceptibility to antibiotics was performed by disk diffusion
method. Age, sex, level of consciousness (Glasgow Coma Score), surgical
procedures, nutritional status, antibiotic usage, APACHE II, approach to
gastrointestinal protection, period of ventilation were evaluated as the possible
risk factors concerning mortality in VAP. Patients with COPD were not
included in the study. Plural factor of correlation and Student’s t-test were used
for statistical evaluation.
Results: VAP was diagnosed in 68 of 98 patients (69.4%). Overall mortality
was 47.1% (32/68) and in 26 of 32 (81.3%) died patients the pneumonia was
the direct reason of death. Sex and age of patients did not signiﬁcantly
inﬂuence the outcome of VAP. Risk factors leading to death in VAP patients
with trauma were duration of mechanical ventilation more than 48 h (plural
factor of correlation 0.51), APACHE II more than 20 points (0.48), proven
aspiration (0.78), inadequate initial antibacterial therapy (0.56). The presence
392 Abstracts
of P. aeruginosa as etiologic agent of VAP also was associated with mortality
(63% in died patients vs. 25% in cured patients, P< 0.005).
Conclusion: VAP is the most important complication of mechanical ventila-
tion in ICU. Duration of mechanical ventilation more than 48 h, APACHE II
more than 20 points, aspiration, inadequate initial antibacterial therapy and
P. aeruginosa are the independent risk factors leading to death in VAP patients
with trauma.
P1604 Postoperative pneumonia
J. Meszaros, M. Kosieradzki, A. Kwiatkowski, J. Trzebicki,
A. Sawicka-Grzelak, A. Rokosz
Warsaw, PL
Objectives: An assessment of empiric therapy of pneumonia in surgical
patients in relation to clinical disease, severity of infection and etiology.
Methods: The study was open and prospective. Patients with diagnosis of
pneumonia, treated in surgical department or ICU in 1996–2001 were
included. Diagnosis was based on clinical signs and symptoms, chest radio-
grams and positive bronchial aspirate cultures. Antibiotics were usually started
before bacteriologic diagnosis was available.
Results: A total of 140 patients with pneumonia (developed most frequently
postabdominal surgery) were included into the study. Patients were divided in
two groups in relation to clinical disease: early postoperative pneumonia (EP)
in 74 patients, developing in the ﬁrst week following surgery and often with
moderate clinical course (72%) and late septic complication in 66 patients with
acute respiratory failure necessitating mechanical ventilation (VAP), usually in
2nd4th week. In the VAP group septic syndrome was diagnosed in 89% and
septic shock in 11% of patients. Incidence of pneumonia was higher after
emergency surgery and reoperation (58 and 68%). In EP group concomitant
abdominal sepsis was diagnosed in 34% and in VAP group in 62% of patients.
Among isolated pathogens, Gram-negatives prevailed (79%): mainly K. pneu-
moniae, E. coli and E. cloacae in EP group and P. aeruginosa, Acinetobacter spp.,
E. cloacae, S. marcescens in mixed infections with S. aureus or Enterococci (36%) in
VAP group. Empiric therapy in EP group included ceftriaxone, ciproﬂoxacin
and cefepime in the last 2 years. In VAP group, most frequently imipenem/
cilastatin in monotherapy or with amiglycoside or cefepime with metroni-
dazole in patients with abdominal sepsis were used. Empiric therapy had to be
modiﬁed in 36% of patients in EP group because of selection of resistance to
ceftriaxone among enteric rods. In VAP group modiﬁcation of therapy (69%)
was related mainly to superinfections with MRSA, Enterococci, C. difﬁcile,
S. maltophilia and Candida species. Mortality rate was closely related to clinical
diseases, and in VAP group was 45%.
Conclusions: In severe pneumonia with respiratory failure imipenem and
cefepime are the most rational and useful drugs for empiric therapy. Older
cefalosporins, as ceftriaxone, are still of substantial importance in moderate
clinical disease.
P1605 Incidence of sepsis and septic shock in various
hospital wards (results of the epidemiological survey of
the multicenter study ‘IRIS’)
L. S. Stratchounski, D. V. Galkin, R. S. Kozlov
Smolensk, RUS
Introduction: Although ACCP Consensus Conference criteria of sepsis and
related conditions were introduced in 1992, no epidemiologic studies of sepsis
were conducted in Russia that used uniform criteria to evaluate epidemiology
of sepsis and septic shock.
Objective: To determine incidence of sepsis and septic shock in various
hospital wards in Russia.
Methods: Case histories (CS) of hospitalized patients (adults and pediatrics)
from various hospital wards in eight cities throughout Russia were evaluated
to determine incidence of sepsis and septic shock. ACCP Consensus Con-
ference, 1992 deﬁnitions of sepsis and septic shock were applied. CS were
taken for 3-month period from October 1 to December 1, 2001.
Results: Overall, 7445 CS of hospitalized patients were analyzed. Among
them, 2309 CS were from general surgery wards, 1948 – from infectious
surgery wards, and 1202 – from therapeutic wards. From adult ICU 1474 CS
and from pediatric intensive care units, 512 CS were evaluated. The percen-
tage of patients with infections was 94% in infectious surgery wards, 48% in
adult ICUs, 42% in pediatric ICUs, 22% in therapeutic wards and 20% in
general surgery wards. Sepsis in above mentioned patients was revealed in 51%
of cases in adult ICUs, in 16% of cases in infectious surgery wards, 13% in
therapeutic wards and 11% in general surgery wards. In pediatric ICUs
symptoms relevant to sepsis were discovered in 22% of patients with infec-
tions. Septic shock has occurred in 41% of patients with sepsis in adult ICUs,
in 14% of patients with sepsis in pediatric ICUs and in 10% of patients with
sepsis in infectious surgery units.
Conclusion: The results of the study show that sepsis is a real problem in
Russia. There is a major divergence between the incidence of sepsis and septic
shock evaluated with application of international criteria and ofﬁcial data.
Further educational efforts and implementation of international criteria of
sepsis are requested.
P1606 Are infections with resistant pathogens
worsening the outcome of surgical ICU patients?
D. Peres Bota, E. Hajdu´, P. Palagyi, A. Hortobagyi
Szeged, HUN
Background and goal of study:Our hypothesis was that the outcome of ICU
patients in whom an infection with multiresistant microorganisms was proved
could be worse than in patients infected with susceptible strains.
Materials and methods: Data were retrospectively collected for patients
admitted between 1997 and 2002 in a surgical ICU. The following parameters
were compared: SAPS II score, length of stay (LOS) in the ICU, LOS in ICU
before the infection was proved, mechanical ventilation (MV) free-days,
hemodialysis (HD) free-days, the use of antibiotics (AB) before infection
was proved, ICU and in-hospital mortality. CDC criteria were used to deﬁne
infection. Data were compared using analysis of variance (ANOVA) method.
Results:We included 515 patients of whom 136 patients had an infection with
multiresistant strains. We found multiresistant species of Pseudomonas aerugi-
nosa in 45 cases, Enterobacter spp. in 38 cases, Acinetobacter baumanii in 28 cases,
Enterococcus spp. in 15 cases and MRSE in 10 cases. There were no signiﬁcant
differences between SAPS II score, MVandHD free days, ICU and in hospital
mortality. LOS before infection was observed and the total ICU LOS were
longer in patients infected with multiresistant strains. Also the previous use of
antibiotics was signiﬁcantly higher in this group. Results are presented in the
table.
Conclusions: Our results show that there is no difference between the
outcome of ICU patients infected with multiresistant microorganisms and
patients infected with sensible strains. Previous use of antibiotics and longer
ICU stay were associated with infection with resistant strains.
P1607 Epidemiologic investigation of an outbreak due
to imipenem-resistant Klebsiella pneumoniae in the ICU
A. Xanthaki, A. C. Vatopoulos, P. Giakkoupi, S. Smyrni,
C. Kontou-Castellanou, N. J. Legakis
Athens, GR
Background: During a period of approximately 3months (17/9–12/12/02)
an outbreak of imipenem-resistant K. pneumoniaewas detected in our hospital
which included six patients in the ICU. Soon after the ﬁrst two cases were
identiﬁed, an epidemiologic investigation was begun in the ICU including
patients, personnel and the environment.
Methods:K. pneumoniaewas identiﬁed using the Vitek System. Disk diffusion
testing was performed by the Kirby-Bauer method according to NCCLS
guidelines. Imipenem MICs and metallo-beta-lactamases production were
determined by the diffusion based E-test MBL (AB Biodisk, Solna, Sweden).
Positive for MBL production isolates of K. pneumoniae were then screened by
PCR assay for genes of the blaVIM family. Transferability of plasmids carrying
the blaVIM genes were investigated by conjugation experiments. Molecular
typing of VIMþ isolates was performed by ERICII-PCR assay. Hand
cultures were performed on ICU personnel. Environmental samples were
Resistant strains Susceptible strains P value
SAPS II 30 2 29 2 NS
LOS 18 6 12 3 0.03
LOS before infection 8 3 5 3 0.03
MV free days 8 2 7 3 NS
HD free days 9 1 8 2 NS
ICU mortality 40/136 (29%) 108/379 (26%) NS
In hospital mortality 8/136 (6%) 16/379 (4%) NS
Previous AB 80/136 (59%) 118/379 (31%) 0.02
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collected from sinks, disinfectants, bedding, stethoscopes, telephones and
mechanical ventilator system equipment.
Results: Fourteen imipenem-resistant K. pneumoniae strains were isolated
from different clinical samples of six patients. The epidemiologic investigation
revealed that the only environmental source was the monitor keyboard of the
mechanical ventilator system of one of the patients and none of the stuff
members harbored imipenem-resistant K. pneumoniae. All clinical isolates and
the environmental isolate exhibited the same antibiotic resistant proﬁle and
were tested resistant to all major classes of antibiotics and sensitive only to
colistin. Moreover, all isolates produced blaVIM metallo-beta-lactamases and
were genetically related as shown by ERICII-PCR assay. Plasmids carrying
blaVIM genes were easily transferred to E. coli recipients.
Conclusions:These data suggest the hypothesis of a clonal origin of the strain
and a cross infection from patient to patient through the contaminated surface
via the hands of the personnel. The emergence of K. pneumoniae resistant to
imipenem is a new threat particularly in the ICU environment. Clinicians and
laboratory personnel must be aware and cooperate for early identiﬁcation of
the microorganism and prevention of its spread.
P1608 Hyperproduction of AmpC among Enterobacter
spp. isolates from intensive care patients in a Spanish
hospital
C. Borraz, M. A. Domı´nguez, F. Tubau, J. Linares, M. Pujol,
M. J. Argerich, J. Ariza, R. Martin
Barcelona, E
Background: Hyperproduction of AmpC in Enterobacter spp. makes these
bacteria resistant to most beta-lactam antibiotics. Derepressed mutants can be
selected from inducible populations during antimicrobial therapy. Once
selected, mutants are stable and can persist in the hospital microﬂora. In
Hospital Universitari de Bellvitge (HUB), the rate of derepressed Enterobacter
spp. (DEb) isolated from clinical samples among ICU patients was 48.6% (17
out of 35 isolates) during the ﬁrst 6 months in 2002. A 5-month study (July–
November, 2002) was carried out to determine the epidemiology of Deb in
our ICU.
Objectives: (i) To determine the number of patients colonized by DEb in the
ICUs in a 5-month-period; (ii) to characterize the number of infections cause
by DEb; and (iii) to analyze the clones detected.
Methods: Colonization was detected from rectal and axillar swabs taken
weekly from ICU patients until ICU discharge. Specimens were processed in
McConkey plates supplemented with cefotaxime (2 g/L) and ceftazidime
(4 g/L). Antibiotic susceptibility and identiﬁcation of isolates were performed
by MicroScan. Double disk-diffusion tests were used to detect extended-
spectrum beta-lactamase production (ESBL). Genotyping was done by
pulsed-ﬁeld gel electrophoresis.
Results: Colonization studies were performed on 190 patients, 46 of them
were colonized by DEb (24%) (19 E. cloacae and 27 E. aerogenes). Among
colonized patients, 20 (43.5%) had positive clinical samples for DEb (9
E. cloacae and 11 E. aerogenes). Isolates in 45 patients had a resistance pattern
compatible with AmpC hyperproduction. In one patient, colonization by
E. aerogenes ESBL-producer was detected. Isolates from 43 patients were
available for genotyping, and 41 restriction patterns were found. In nine
patients paired strains (clinical and colonizing isolates) were typed, and were
identical in all but three patients.
Conclusion: The DEb colonization rate detected among ICU patients in
HUB was high (24%). In contrast, 10.5% of the patients studied had clinical
samples with DEb and 5.3% had well-documented infections. With the
exception of two cases, no cross transmission was found. Thus, most DEb
might have arisen among patient’s digestive microﬂora under selective anti-
biotic pressure.
Gastro-intestinal infections
P1609 Enteropathogenic bacteria in adult patients with
diarrhea: frequency of isolation and susceptibility to
commonly used antimicrobial agents (a 3-year study)
A. Strouza, K. Tzanetou, G. Ganteris, A. Antoniou, K. Pechlivanidis,
E. Malamou-Lada
Athens, GR
Objectives: To study the bacterial etiology of the inﬂammatory diarrhea, the
frequency of isolation of various enteric pathogens, the predominant species
and serotypes and their susceptibility to commonly used antimicrobial agents.
Materials and methods: During the last 3 years, 1230 patients with diarrhea
were studied. The laboratory examination included: (a) direct microscopy of
stool wet preparation for leukocytes and erythrocytes; and (b) stool culture for
enteric pathogens Salmonella, Campylobacter, Shigella, Yersinia enterocolitica and
Aeromonas with the standard laboratory techniques. The Shigella subgroups
and the Y. enterocolitica serogroups were identiﬁed by slide agglutination test
with antisera, while the serotypes of Salmonella were determined in the
reference center. The antimicrobial susceptibility testing was carried out
by disk diffusion test and the MICs were determined by E-test and by the
automated system Vitek 2.
Results: Enteropathogenic bacteria were isolated in 174 out of the 1230
(14.15%) stool specimens examined by culture (one specimen/patient).
Salmonellawith predominant serotype S. enteritidiswas the commonest enteric
pathogen isolated (69.55%), followed by Campylobacter (23.56%), while
Shigella (predominant subgroup S. ﬂexneri), Y. enterocolitica (serogroup 0 : 3)
and A. hydrophilawere isolated in low proportions (4.02%, 1.72% and 1.15%,
respectively). Leukocytes were detected in 156 (89.65%) out of the 174 cases
of inﬂammatory bacterial enteritis. The antimicrobial susceptibility testing
showed high resistance rate of Salmonella and Shigella to doxycycline (43.8%
and 57.14%), lower to ampicillin (9.91% and 28.6%) and very low to
trimethoprim–sulfamethoxazole (1.65% and 14.3%), respectively. Ten of
the 41 (24.4%) Campylobacter isolates (almost exclusive species of C. jejuni)
were found resistant to ciproﬂoxacin (MIC> 32mg/mL), while all the
isolated strains were susceptible to erythromycin.
Conclusions: Salmonella, followed by Campylobacter are the most common
causative agents of bacterial diarrhea in our country. Despite the very low
resistance rate of Salmonella and Shigella to trimethoprim–sulfamethoxazole,
the ﬂuoroquinolones remain the drug of choice for the treatment of these
enteric pathogens, while erythromycin is the drug of choice for the treatment
of diarrhea caused by Campylobacter (when needed), because of the high
resistance rate to ciproﬂoxacin.
P1611 Isolation of Arcobacter skirrowii in a patient with
chronic diarrhea
I. Wybo, J. Breynaert, F. Lindenburg, K. Houf, S. Lauwers
Brussels, Ghent, B
Objectives: The genus Arcobacter includes four species. A. butzleri and A.
cryaerophilus have been associated with human disease. A. nitroﬁgilis has been
recovered from the roots of a salt marsh plant. The fourth species A. skirrowii
was found in gastroenteritis and abortion in farm animals. Until now, no
association of this species with human infection has been described.We report
here a case of diarrhea in an elderly patient from whom A. skirrowii was
isolated.
Methods: A 73-year-old man was admitted to the hospital after 2 months of
persisting diarrhea. The diarrhea had not responded to dietary measures and
treatment with nifuroxazide. The patient lost weight, was anorexic and
became astenic. He was treated for progressive coughing with levoﬂoxacine
for several days just before hospitalization. A colonscopy showed diverticulosis
but no malignancies. His symptoms resolved during his fortnight stay in the
hospital. Stool specimens were cultured for conventional enteric pathogens.
In addition to a selective Campylobacter-medium incubated at 428C, a ﬁltered
fecal suspension, was inoculated on Columbia blood agar and incubated at
378C.
Results: The conventional cultures for enteric pathogens and Campylobacter
were negative. The Columbia agar plate showed very slow growing, oxidase
positive colonies of Gram-negative curved rods. The strain was able to grow at
158C, which is a distinctive feature to differentiate Arcobacter species from
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Campylobacter species. A multiplex PCR, developed for the simultaneous
identiﬁcation of A. butzleri, A. cryaerophilus and A. skirrowii, identiﬁed the
organism as A. skirrowii.
Conclusions: We believe this to be the ﬁrst isolation of A. skirrowii from a
human stool sample. It is not clear whether this strain was etiologically
associated with the patient’s diarrhea. Because of their fastidious growth,
especially pronounced in A. skirrowii, it is not easy to get an insight into the
occurrence of Arcobacter in human disease. However 20 years experience with
Campylobacter ﬁltration techniques gives us reason to believe that the role of A.
skirrowii in human disease is limited.
P1612 Cryptosporidium gastroenteritis: a retrospective
study of 113 patients
J. Kavaliotis, C. Alexandratos, M. Hadio
Thessaloniki, GR
Objectives: Prevalence rates of Cryptosporidium among children with diarrhea
are between 3 and 4% in industrialized countries, excluding outbreaks which
mainly occur in day-care centers. The objective of this study was to assess
epidemiological features of infection with this parasite in a children popula-
tion.
Methods:Data was drawn from the records of 113 patients admitted between
1984 and 2000. All patients were < 14 years of age and identiﬁcation of the
oocysts was conﬁrmed in their stool.
Results: A total of 113 patients (66 males); 47.7% were <24month, 31.8%
were 24month <n< 5 years old. There was a peak incidence in 1989 (13
cases) and 1998 (15 cases). Seasonal distribution revealed a rise in cases in
months May through August. On admission, 50% had signs of mild dehy-
dration and only three severe. Fever was present in 63% with an average
duration of 3.3 days. Vomiting was a symptom in 88.5%. Fifteen percent had
severe abdominal pain. Diarrhea was watery in 71.7%; 61% had mucus and
only 9.7% had blood in their stool. Convulsions occurred in two patients.
Intravenous ﬂuid administration was necessary in 54.8% for a median of 48 h.
Nine patients received iv antibiotics that were discontinued when diagnosis
was conﬁrmed. Laboratory ﬁndings revealed 11 patients with anemia
(Hgb< 10 g/dL). The WBC had a median value of 8200 (SD¼3181.8)
and there was no marked granulocytosis. Leukopenia (WBC< 5000) was
present in ﬁve patients. The average duration of hospitalization was 3.9 days.
The course of disease was uncomplicated in all cases and no deaths occurred.
Conclusions: Cryptosporidium gatsroenteritis is a self-limited disease and no
antimicrobial therapy is required. It mainly concerns children <2 years of age
and the prevalence remains low.
P1613 Four cases of rhabdomyolysis related to
Salmonella enteritidis gastroenteritis
R. Mauri, E. Rinaldi, A. Tocchetti, A. Allegro, E. Longoni, E. Sala,
M. Spinelli, G. Giana, D. Santoro
Como, I
Objectives: Rhabdomyolysis is a disorder characterized by elevated serum
concentrations of CK due to skeletal muscles injury: it is often a complication
of a broad spectrum of diseases related to infectious and noninfectious causes.
It is rarely associated with gastroenteritis: respiratory and urinary infections
and catheter-related sepsis are the main causes of infectious RM and Gram-
negative organisms are more representative than positive ones. We describe
four rhabdomyolysis cases during GE caused by S. enteritidis in a group of 14
policemen, observed in the Infectious Diseases Department, S. Anna Hospi-
tal, Como.
Methods: All the patients came to our observation for an acute GE. We
performed clinical examination, stool culture, parasitic fecal analysis, blood
cultures (in case of body temperature >37.58C) and routine laboratory
analysis, including CPK. In patients showing CPK increase: ECG, mass-
CPK, mioglobin and troponin-I were performed too. Rhabdomyolysis
diagnosis was stated with GABOW criteria.
Results: The results are shown in Table 1.
The reported cases show a relevant increase in CPK values, without any
increase of acute myocardial infarction markers. Creatinine values were
normal too.
Conclusions: Early recognition of rhabdomyolysis important to avoid severe
and potentially lethal complications, like acute renal failure. In our study, we
consider relevant the percentage of subjects affected by RM: 4/14 (28.4%), all
related to acute gastroenteritis caused by S. enteritidis.
Experimental bacterial infections
P1614 Role of lipo-oligosaccharide on the attachment of
Moraxella catarrhalis to human pharyngeal epithelial
cells
K. Ahmed, M. Turkoz
Ankara, TR
Objective:Bacterial attachment to host cell is the initial step in the pathogen-
esis of infections. It has been shown that attachment ofMoraxella catarrhalis to
human pharyngeal epithelial cell (HPEC) is basis of colonization and sub-
sequent infections. InM. catarrhalis ﬁmbriae act as an adhesin, however, there
are several other surface structures, which may act as an adhesin. In several
bacterial strains, it has been shown that multiple adhesin–receptor interaction
occur for ﬁrm binding of bacteria with host cells. As a major constituent
of surface structures it has been shown that lipopolysaccharide/lipo-
oligosaccharide (LPS/LOS) of several bacteria acts as an adhesin, which
mediate the attachment to host cells. Therefore, this study was done to ﬁnd
out the role of LOS on the attachment of M. catarrhalis to HPEC.
Methods:Strain 2951, aM. catarrhalis strain and its galE mutant which lack the
(Galalpha1–4Galbeta1–4Glc) P(k) epitope of LOS, were used in this study
(kindly provided by Prof. Michael Apicella, University of Iowa, USA). Assay
was done to ﬁnd out the attachment ability of both strains. Thin layer
chromatography (TLC) was done to compare the binding ability between
the wild type and mutant with different glycolipids. For the determination of
surface charge, M. catarrhalis was treated with cationized ferritin particles and
observed under a transmission electron microscopy (TEM). Surface potential
was detected in both strains by atomic force microscope (AFM) equippedwith
surface potential spectroscope.
Results: HPEC taken from 10 healthy normal adults shows that the attach-
ment of mutant strain (25.2 9.3 bacteria/cell) was signiﬁcantly (P< 0.001)
less than the wild strain (38.3 15.4). In both strains, a positive reaction was
obtained in TLC with Gg4Cer and Gg3Cer, but no reactivity was observed
with ganglioside GM1, GM2, GD1a, GD2, GT1b andGQ1b. Both AFM and
TEM showed that thewild type strain is negatively charged.While the mutant
strain has less negatively charged areas.
Conclusion: This study suggests that (Galalpha1–4Galbeta1–4Glc) P(k) epi-
tope of LOS may be one of the factors for the negative surface charge of
M. catarrhalis and intact LOS is necessary for the attachment of M. catarrhalis
with HPEC. The binding of both the wild and the mutant strains with
Gg4Cer and Gg3Cer indicate that other receptor on the HPEC might be
involved in the attachment of M. catarrhalis.
P1615 Increased mortality and spatial memory deﬁcits
in TNF-alpha deﬁcient mice after experimental
pneumococcal meningitis
J. Gerber, M. Hahn, A. Siemer, R. Nau
Go¨ttingen, D
Objectives: Tumor necrosis factor alpha (TNF) is critically involved in
inﬂammation and cellular immune response during bacterial infections.
Table 1
Age
(years) Sex
CPK
(mU/mL)
Mass-CPK
(mg/mL)
Mioglobin
(mg/mL)
Troponin
(mg/mL)
Case 1 27 M 38860 1.3 1083 0.01
Case 2 56 M 2227 1.3 255 0.01
Case 3 25 M 1018 1.3 350 0.01
Case 4 31 M 8350 1.3 820 0.01
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TNF may participate in hippocampal neuronal injury in meningitis. In a
mouse model of pneumococcal meningitis, the inﬂuence of TNF-deﬁciency
on mortality and on spatial memory performance was investigated.
Methods: 57 TNF-deﬁcient mice (males, 2–3months) and 55 sex- and age-
matched controls (C57Bl6) were trained to ﬁnd a hidden under-water
platform within less than 90 s (18 trials over 3 days). Swim tracks and the
latency to escape from the water were recorded by a video camera. Thereafter,
mice were infected by injection of 4 log cfu Streptococcus pneumoniae into the
right forebrain. 30 h later therapy was initiated with ceftriaxone (100mg/kg
twice daily for 5 days). Motor performance was measured by the tight rope
test. Beginning 7 days after infection, water maze was performed (daily in the
ﬁrst week, then three times per week), and mice were killed 6weeks after
infection.
Results: During swim training in the ﬁrst 3 days no differences were seen in
the water maze between TNF-deﬁcient mice and controls. After infection,
tight rope test showed severe impairment during the acute phase of menin-
gitis. A total of 35 (61%) TNF-deﬁcient mice and 22 (40%) controls died
within 6 days (Fisher’s exact test: P¼ 0.04). All other animals fully recovered
from the infection. TNF-deﬁcient mice surviving pneumococcal meningitis
took substantially longer to reach the hidden platform than controls
(P¼ 0.02) and the distance of swim tracks was signiﬁcantly longer
(P¼ 0.02). The swim speed in both groups was similar (P¼ 0.59).
Conclusions: In pneumococcal meningitis, TNF deﬁciency caused increased
mortality and deﬁcits in spatial memory, i.e. the increased vulnerability of
TNF-deﬁcient animals to infection outweighs possible detrimental effects of
TNF release within the CNS.
P1616 Meropenem acts synergistically with
levoﬂoxacin against penicillin-resistant pneumococci in
experimental meningitis and prevents levoﬂoxacin-induced
resistance in vitro
M. Cottagnoud, J. M. Entenza, F. Acosta, F. Ku¨hn, L. Flatz,
P. Cottagnoud
Bern, Lausanne, CH
Objectives: The bactericidal activity of meropenem (MEM) combined with
levoﬂoxacin (L) in experimental meningitis and its effect on quinolone-
induced resistance in vitro were investigated.
Methods: Two penicillin-resistant (penR) strains were used with identical
MICs (mg/L): L:1; MEM:0.5; penG:4. Both strains were used in time-killing
experiments in vitro over 8 h and in checkerboards. WB4 was used in the
rabbit meningitis model.
Results: The bactericidal activity of the different treatment groups are
expressed as killing rates/8 h (delta log 10 cfu/mL 8 h). Untreated controls
(N: 5): þ0.28 0.11; MEM (N: 8): 3.80 0.90; L(N: 8): 3.40 0.66;
MEMþL(8): 6.0 0.9. All CSF samples treated with the combination
were sterile after eight synergy betweenMEM and L was also demonstrated in
vitro in time-killing assays over 8 h and with the checkerboard method.
Sequential exposure of the two penR strains (WB4and KR4) to L led to a 64
increase of the MIC after 10 cycles. In WB4, addition of MEM in sub-
inhibitory concentration (1/4 MIC) prevented the increase of the MIC for L
over 10 cycles. In KR4, addition of MEM led to a twofold increase of the
MIC for L after 10 cycles. The increase of the MICs of these four mutants can
be explained by mutations in the genes responsible for quinolone-resistance.
Conclusions:
1. MEM and L act synergistically against penR pneumococci in vitro and in
experimental meningitis.
2. Addition of MEM in subinhibitory concentrations (1/4 MIC) prevents
L-induced resistance in vitro.
P1617 Comparative efﬁcacies of moxiﬂoxacin and
levoﬂoxacin against Streptococcus pneumoniae using a
novel murine model of pneumonia
D. Bast, M. Yue, C. Duncan, L. Mandell, D. Low, J. de Azavedo
Toronto, CAN
Objective: Moxiﬂoxacin is an 8-methoxy ﬂuoroquinolone with enhanced
activity against Gram-positive bacteria. Our aim was to compare the efﬁcacies
of moxiﬂoxacin and levoﬂoxacin in the treatment of pneumococcal lung
infection using a novel murine model.
Methods:Groups of 19 immunocompetent SwissWebster micewere infected
by peroral tracheal instillation of 105 colony-forming-units of a S. pneumoniae
serotype three strain. Antimicrobial treatment at a dose of 50mg/kg was
administered subcutaneously twice daily beginning at 24 h postinfection and
continuing for 5 days. Skin-temperature was measured twice daily using an
infrared temperature-scanning thermometer as a means of monitoring disease
progression and severity. A drop of at least 38C is predictive of imminent death
in this model and was therefore used as the endpoint. Viable counts in the
lungs of mice sacriﬁced and or surviving at the end of the study were
determined.
Results: Moxiﬂoxacin had a potent effect, reducing the pulmonary bacterial
count to zero in all 19 mice. Skin-temperature changes of moxiﬂoxacin-
treated mice were negligible, as were uninfected mice, but were signiﬁcantly
different from untreated (mean, 4.8 1.38C) or levoﬂoxacin-treated (mean,
5.1 0.88C) mice. In contrast to moxiﬂoxacin-treated mice, 9 of the 19
levoﬂoxacin-treated mice (47%) and 100% of the untreated-mice were either
found dead or were sacriﬁced throughout the study. Viable counts (range,
10Eþ7 to 10Eþ8) were similar for both these groups, including two of the 10
levoﬂoxacin-treated mice remaining at the end of the study. Resistant isolates
were selected in six of the nine mice that failed levoﬂoxacin therapy.
Conclusion: Moxiﬂoxacin showed enhanced activity against S. pneumoniae
compared with levoﬂoxacin as suggested by its 100% reduction in pulmonary
bacterial counts, its prevention of lethal changes in skin-temperature and its
failure to select resistant bacteria.
P1618 Comparative activity between moxiﬂoxacin and
levoﬂoxacin using an in vivo telemetric implant in a
Streptococcus pneumoniae rat infection model
P. G. Higgins, A. Schmidt, A. Dalhoff, J. Ambler, F.-J. Schmitz
Dusseldorf, Wuppertal, D; Utrecht
Objectives: To monitor the course of a streptococcal infection by measuring
the activity and temperature of rats using a telemetric implant and observe the
comparative activity of two ﬂuoroquinolones; moxiﬂoxacin and levoﬂoxacin.
Methods: Female Wistar rats (175–200 g) were implanted in the abdominal
cavity with a VitalView PDT-4000 E-mitter and their postoperative recovery
monitored by temperature and activity integrally every 15min After a
recovery period, animals were infected with Streptococcus pneumoniae 71B
intraperitoneally. Immediately after infection, animals were orally adminis-
tered with either levoﬂoxacin or moxiﬂoxacin at a dose equivalent to a Cmax
of 1.3mg/L. Uninfected control animals and infected but untreated animals
were included in the study.
Results: Uninfected control animals continued with their normal circadian
rhythm of 24-h cycles with greatest activity and higher temperature seen in
the 12-h periods of darkness. Infected animals however, had an interrupted
circadian rhythm that saw an elevated temperature for 30 h (P< 0.05). The
activity of this group was lower than uninfected controls (P< 0.05). Two
infection control animals died; their initial temperature rise was for 6 h
followed by a fall in temperature and their data was excluded from the
statistical analysis. There were no deaths in the antibiotic-treated groups.
Levoﬂoxacin-treated animals showed a signiﬁcant rise in temperature and loss
of activity (P< 0.05) compared with uninfected controls. Moxiﬂoxacin-
treated animals had a small but not statistically signiﬁcant temperature rise
and lowered activity.
Conclusions:These data show that the streptococcal infection model is lethal
to untreated animals. levoﬂoxacin- and moxiﬂoxacin-treated animals are
afforded protection from death but not to the associated temperature rise
and lowered activity. However, moxiﬂoxacin has a signiﬁcant effect in
reducing the temperature and raising the activity associated with the infection
compared with controls.
P1619 Establishment of an in vivo telemetric implant
to monitor the course of a Streptococcus pneumoniae
infection in rats
P. G. Higgins, A. Schmidt, A. Dalhoff, J. Ambler, F.-J. Schmitz
Dusseldorf, Wuppertal, D; Utrecht, NL
Objectives: Animal models of infection and antibiotic treatment have mostly
been quantiﬁed by cumulative death rates and clearance of microbes from the
animal. This method has limitations for predicting antibiotic efﬁcacy in
humans as the infectious dose in most cases is by deﬁnition lethal. In this
study, we have evaluated an implanted telemetric device that continuously
gathers real-time information on an animal by measuring core body tem-
perature (T) and activity (A).
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Methods: Female Wistar rats (175–200 g) were implanted in the abdominal
cavity with a VitalView PDT-4000 E-mitter and their postoperative recovery
monitored by A and T integrally every 15min After 5 days, animals were
infected via the tail vein or intraperitoneally with a sublethal dose of
S. pneumoniae 1707/4 and the course of infection monitored as described
above. Animals were injected with buffered saline as an uninfected control
groups.
Results: The period of full recovery from implantation until resumption of
normal circadian rhythm was 30 h. At this point both A and Tobserved 24 h
cycles corresponding to 12 h illumination/darkness with A and T higher in
dark periods. No signiﬁcant intra or intergroup differences in A and Twere
observed preinfection. Twenty-four hours postinfection, infected animals had
a mean T¼ 0.5–18C higher than uninfected controls. The higher tempera-
ture lasted for 36 h (P< 0.05) until circadian rhythmwas re-established. Mean
A was reduced 30 h postinfection and remained lower for 60 h (P< 0.05).
There was no signiﬁcant difference between infection routes, however,
intraperitoneal-infection was the preferred route as it was more rapid and
caused less stress. The use of heat-killed bacteria did not have an affect on Tor
A. Uninfected control animals continued with normal A and T circadian
rhythm during the experiment.
Conclusions: These data suggest that the continuous monitoring of body
temperature and activity is a good guide to infection in a sublethal infection
model. The 30 h window of infection will allow the monitoring of minor and
early onset differences between efﬁcacies of antimicrobial agents.
P1620 In vivo immunomodulatory proﬁle of
telithromycin in a murine infection model
D. P. Nicolau, P. R. Tessier, I. Rubinstein, C. H. Nightingale
Hartford, Chicago, USA
Objectives: In additional to their bactericidal activity macrolide antibiotics
exhibit a broad spectrum of pharmacologic effects, which include immuno-
modulation. Telithromycin, a novel ketolide antibiotic is structurally related
to macrolides. While the immunomodulatory effects of macrolides are well
described, limited data exist with the ketolides. The objective of this study was
to evaluate the immunomodulatory proﬁle of telithromycin as assessed by ﬁve
cytokines.
Methods: Speciﬁc-pathogen-free, female ICR mice were rendered transi-
ently neutropenic with intraperitoneal cyclophosphamide. Thighs were
inoculated with 106 cfu of a single isolate of S. pneumoniae. Once inoculated,
mice were randomized to receive no treatment (controls); or single doses of
10, 25 or 50mg/kg of oral telithromycin (n¼ 30 each). Blood was collected
for cytokine determinations via cardiac puncture prior to and at 2, 4, 8 and
24 h after dose administration on ﬁve occasions. Cytokine (IL1-beta, IL2, IL6,
IL10, and TNF-alpha) concentrations in serum were quantitatively measured
with murine ELISA kits.
Results: While systemic concentrations of IL2 and TNF-alpha trended
upward over the initial 8-h period post inoculation and a signiﬁcant rise
was noted with IL1-beta over 24 h, no marked immunomodulatory effects of
telithromycin were seen for these cytokines. In contrast, signiﬁcant elevations
of IL6 and IL10 in untreated controls were noted over 24 h, while a
correspondingly signiﬁcant reduction of these two cytokines were noted
after telithromycin administration. Additionally, the suppression of both IL6
and IL10 was observed to be dose-dependent.
Conclusions: While the dose of telithromycin in the current study was not
optimized relative to human exposures currently under investigation in man,
these data reveal the immunomodulatory potential of the ketolide, telithro-
mycin.
P1621 Therapeutic efﬁcacy of moxiﬂoxacin or
imipenem/cilastatin in experimental systemic
aerobic/anaerobic mixed infection in mice
R. Schaumann, R. Blatz, J. Beer, G. Ackermann, A. C. Rodloff
Leipzig, D
Objective: To study the therapeutic efﬁcacy of moxiﬂoxacin (MXF) and
imipenem/cilastatin (IMP) in severe systemic aerobic/anaerobic mixed infec-
tion in mice infected with both, different strains of Bacteroides fragilis and
Escherichia coli.
Methods:A total number of 240 micewere divided in 12 groups each with 20
mice.Micewere infected intravenously with both, different strains ofB. fragilis
(IMP and MXF susceptible or resistant and/or enterotoxin positive or
negative, respectively) and E. coli (IMP and MXF susceptible). Twenty-four
hours postinfection, i.v. therapy with either MXF (2.0mg b.i.d.) or IMP
(2.4mg t.i.d.) was started and continued for 3 days. Control groups were left
untreated. Until day 7 postinfection, survival rates were observed. At day 7,
postinfection surviving mice were killed and numbers of bacteria in liver and
kidneys were determined.
Results: As compared with untreated animals signiﬁcantly less mice died in
the MXF or IMP treated groups. There was no signiﬁcant difference in the
survival rate comparing the two treatment arms irrespective of the infection
with enterotoxin positive or negative strains of B. fragilis and the susceptibility
to MXF and IMP, respectively. However, there was a tendency that B. fragilis
was more often recovered from liver and kidneys of mice infected with
enterotoxin positive strains.
Conclusion:Moxiﬂoxacin was as efﬁcacious as imipenem in the treatment of
severe systemic aerobic/anaerobic mixed infection in mice.
P1622 An electron microscopic investigation of
differential pathogenicities of various Spiroplasma kunkelii
strains to the vector Dalbulus maidis
E. Ozbek, X. Bai, T. Fazzolari, S. Hogenhout
Erzurum, TR; Wooster, USA
Objectives: Spiroplasmas are mollicutes, and closely related to the human-
pathogenic mycoplasmas, e.g. Mycoplasma pneumoniae, M. genitalium, and
Ureaplasma urealyticum. Our research aims to understand the histopathologic
basis of the interactions between pathogens and their vectors.
Methods: We undertook an investigation of pathogenicities of Spiroplasma
kunkelii strains M2 and CS-2B to homopteran vector Dalbulus maidis. Insects
fed S. kunkelii M2- and CS-2B-infected corn plants for 2weeks were col-
lected, and subjected to transmission electron microscopy process. Thin
sections were stained with uranyl acetate and lead citrate, and immunolabeled
with gold particles.
Results: Spiroplasmas enteredD.maidis gut cells by endocytosis. They reached
to the space between plasmalemma and basal lamina by moving through the
cell. They predominantly proliferated in gut muscles, and degraded the basal
lamina to move into the hemolymph. We observed two spiroplasmas con-
nected to each other by a conjugation pilus in the hemolymph and numerous
pili on the surface of S. kunkelii cells (see Fig. 1). Additionally, spiroplasmas
were found in Malphigian tubules, skeletal muscles, nervous tissue, trachea,
macrophages and female genital organs. Although numerous S. kunkelii M2
cells were seen in the cytoplasm and canaliculi of type III secretory cells of the
salivary gland, any spiroplasmas could not be found in the salivary gland
secretory cells of D.maidis infected by S. kunkelii CS-2B.
Conclusions: Pili are hair-like bacterial surface appendages (Low, D et al.
1996) that may facilitate pathogenesis, promote uptake or transfer of DNA or
proteins, contribute to adhesion to speciﬁc receptors on various surfaces, and/
or be involved in motility (Lai, E.M. and Kado, C.I., 2000). The absence of
S. kunkelii CS-2B in salivary gland secretory cells suggests that the CS-2B
strain is nontransmissible because it is unable to reach to the insect saliva.
Besides, the results of our previous study (Bai, X et al. Evolution of Infectious
Diseases Meeting 2002, Maryland, USA) showed that plant infection (or
transmission) of S. kunkeliiM2 was near 100%, whereas that of S. kunkelii CS-
2B did not occur, and also some differences in traE gene expressions of
S. kunkelii strains M2 and CS-2B. It is possible that traE genes affect
transmission because they are associated with virulence.
Figure 1
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P1623 Single dose Ceftriaxone for Borrelia burgdorferi
infection in C3H mice
C. Pavia, G. Wormser
Old Westbury, Valhalla, USA
Objectives: To determine the minimally effective therapeutic dose of the
antibiotic ceftriaxone (CTX) for eliminating an active experimental infection
with the Lyme disease bacterium, B. burgdorferi (Bb).
Methods: Using a mouse infectivity model for Lyme disease, recently
published studies from our laboratory showed that ﬁve equally spaced doses
of CTX, given over a 24-h period, were as effective as the more standard or
routine 5-day treatment regimen with a single dose of CTX in eliminating
viable Bb from mice infected with one strain of Bb. As a follow-up to these
intriguing ﬁndings, in this study we next evaluated an even shorter course of
CTX treatment in C3H mice infected with either of two different, North
American-derived, strains of Bb sensu stricto. Separate groups of C3H mice
(ﬁve per group) were infected intradermally with 100 000 culture-grown, low
passage strain BL206 (mbc for CTX was 0.05 mg/mL) or reference strain 297
(mbc was 0.025mg/mL) of Bb. Strain BL206 has been isolated from the blood
of a patient having erythema migrans. Twoweeks later, the mice were given a
single intramuscular dose of either sterile isotonic saline or CTX (50mg/kg).
One week after treatment, extract cultures of the urinary bladder and ears
were established in BSK media. These cultures were monitored weekly for
motile Bb organisms based on dark-ﬁeld microscopy.
Results: In infected control mice, live Bb organisms were readily isolated and
culturable from extracts of the urinary bladders and ears. In contrast, it was
found that the one-day, single dosage regimen of CTX was 100% effective in
sterilizing the two selected tissue samples frommice infected with either strain
of Bb.
Conclusions: These experiments suggest that shorter courses of antibiotics
than those currently recommended should be considered for study in patients
with early uncomplicated Lyme disease.
P1624 Efﬁcacy of imipenem, sulbactam, and rifampin,
alone and in combination, in experimental pneumonia
caused by multiresistant Acinetobacter baumannii
M. Pacho´n-Iba´n˜ez, M. Jime´nez-Mejı´as, C. Pichardo, D. Martı´n-Lozano,
M. Bernabeu, J. Cisneros, A. Garcı´a-Curiel, J. Pacho´n
Seville, E
Objectives:To compare the activity of imipenem (IMP), sulbactam (SB), and
rifampin (RF) in monotherapy and in combination in an experimental
pneumonia murine model caused by A. baumannii (Ab).
Methods: In vitro studies: MICs and MBCs were determined in 16 bac-
teremic strains. The bactericidal activity and the synergy of the combinations
(time-kill curves) were evaluated in four multiresistant strains. Pharmacoki-
netic/pharmacodynamic parameters (Cmax, AUC, t1/2, and time above the
MIC) were determined after a single dose of each antimicrobial. In vivo
studies: one strain resistant to all antimicrobials was used. The experimental
pneumonia model in C57BL/6 mice was used, with an intratracheal inocu-
lum of approximately 8 log10 cfu/mL. The animals were grouped in CON
(controls, no treatment), IMP (120mg/kg/day), SB (240mg/kg/day), RF
(100mg/kg/day), IMPþ SB, IMPþRF, and SBþRF, receiving treatment
during 72 h. The mortality rate, the bacterial clearance from lungs and the
sterilization of blood cultures were analyzed.
Statistical analysis: w2 and Fisher’s test, ANOVA, and post hoc Turkey and
Dunnett tests.
Results: In vitro: MIC/MBC (mg/L) ranges were as follows: IMP 32–128/
32–128; SB 32–128/32–128; and RF 4–16/4–32. RF was bactericidal against
all strains; IMP and SB were bactericidal against 2 and 1 strains, respectively.
Synergy was found using the following combinations: SBþRF, IMPþRF,
and IMPþ SB, against 3, 2, and 1 strains, respectively. In vivo: The mortality
of CON (69%) was decreased by IMPþ SB (14%, P¼ 0.006) and RF (28%,
P¼ 0.03), without differences of IMP (71%), SB (60%), IMPþRF (73%), or
SBþRF (57%) with CON. The concentration of Ab in the lungs of the
CON (log10 cfu/g: 8.1 3.9) was decreased by RF (3.0 1.9, P¼ 0.01) and
IMPþRF (3.8 2.1, P¼ 0.04); with IMPþ SB (4.2 2.7) and SBþRF
(4.1 2.2) there was a nonsigniﬁcant decrease; IMP (7.8 3.4) and SB
(7.2 4.4) did not decrease the Ab concentration in the lungs. Respect to
the sterilization of blood cultures, RF (78%, P¼ 0.01) was the only therapy
better than the CON (27%), being also better than IMP and SB (31% and
33%, respectively, P< 0.05).
Conclusions: Monotherapy with rifampin or the combination of imipenem
plus sulbactam are efﬁcacious in the treatment of the experimental pneumonia
caused by multiresistant A. baumannii.
P1625 Investigation of cytotoxic capacity of some
adherent enterobacterial opportunistic strains by Mtt assay
and transmission electron microscopy
V. Lazar, M. Balotescu, R. Cernat, M. Ionescu, D. Stewart-Tull,
A. Wardlaw
Bucharest, RO; Glasgow, UK
The purpose of this study was to determine the cytotoxic effect on Caco-2
intestinal cells, HEp-2 cells and rat macrophages of dialysates obtained from
bacterial cultures of some enterobacterial opportunistic strains with different
sources of isolation (food, stool culture, acute diarrhea, urine culture). The
present strains were previously tested and selected for their intensive adher-
ence and invasion capacity to the cellular substratum and also for their
destroying effect on cellular monolayer. In this study the level of cytotoxicity
was appreciated quantitatively by means of MTT assay and qualitatively by
transmission electron microscopy (TEM). The MTT method is using a
tetrazolium salt for the quantitative spectrophotometric assay of Caco-2 cells
survival and proliferation rates in the presence of bacterial dialysates. This test
detects the viable cells, which are able to reduce the tetrazolium salt and offers
the advantages of a very simple, rapid and precise method. For the electro-
microscopic examination the ultrathin sections obtained from samples con-
taining bacterial cells incubated with HEp-2 cells and rat macrophages,
respectively, were prepared following the standard protocol. Our results
showed that the most cytotoxic strain proved to be Enterobacter cloacae 43
isolated from food, followed by Citrobacter freundii 93 strain isolated from stool
culture and E. coli 115 strain isolated from acute diarrhea. These results
correlate well with the electromicroscopic results pointing out the cytotoxic
effect of E. cloacae 43 strain and its ability to induce A/E lesions in HEp-2 cells,
as well as its apoptotic effect on rat macrophages. Besides their great adherence
and invasion capacity, the production and elimination of cytotoxic factors in
extracellular medium represent virulence factors in these strains and could be
responsible for the increase of the pathogenic potential of opportunistic
bacteria and explain their implication in the etiology of severe infections and
food borne diseases. This study proved that the virulence of opportunistic
pathogens is not correlated with the strain’s origin, the most virulent strain
being one strain of E. cloacae isolated from food.
P1626 Efﬁcacy of Ramoplanin in the hamster model of
C. difﬁcile associated colitis
G. Candiani, D. Jabes
Gerenzano, I
Objectives: Ramoplanin (RA) is a novel glycolipodepsipeptide antibiotic
endowed with potent in vitro bactericidal activity against all Gram-positive
aerobes, including vancomycin-resistant enterococci (VRE), and anerobes,
including C. difﬁcile. RA is not absorbed by oral route and exerts its action
locally in the gut. RA is presently in a Phase III trial being conducted by
Genome Therapeutics Corp. for the prevention of VRE bloodstream infec-
tion in at-risk patients. Aim of the study was to evaluate the in vivo efﬁcacy of
RA in the hamster model of clindamycin (CL)-induced colitis in comparison
with vancomycin (VA) or metronidazole (MZ).
Methods: (i) CL-induced colitis. Animals were treated with a single s.c.
injection of 100mg/kg CL, and after 24 h, received oral RA or VA at 50mg/
kg/day for 5 days. (ii) CLþC. difﬁcile 4013 induced colitis. Animals were
challenged orally with a bacterial suspension ofC. difﬁcile and treated 24 h after
with a single s.c. injection of 100mg/kgCL.Oral treatment withRA or VA at
25–50–100mg/kg or MZ at 100–200–400mg/kg started 24 h after CL and
lasted for 5 days. Hamsters were weighed and observed every 24 h for
evidence of diarrhea or moribund conditions. The cecal contents were
analyzed for C. difﬁcile toxin A (ELISA). Mortality was recorded for up to
36 days.
Results: (i) CL alone rapidly induced a fatal enterocolitis with 100% mortality
within 4 days. Autopsy revealed hemorrhagic ceca and watery stools. C.
difﬁcile toxin Awas always detected in these animals. Oral administration of VA
or RA were highly effective in prolonging survival and protecting animals
from death. RA was signiﬁcantly more effective than VA with 80% survival
rate compared with 20% of VA treated animals (P< 0.05). All hamsters that
died had gross pathologic evidence of enterocolitis and cecal contents were
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positive for Toxin A. (ii) The challenge with C. difﬁcile to CL treated animals
also induced a rapidly fatal enterocolitis. Both VA andRAweremore effective
in prolonging survival than MZ (13–17 and 9 days, respectively). Time of
death of RA treated animals was delayed compared with that of VA treated
animals, and 20% survival was recorded at the end of observation period in the
100mg/kg group with RA. No animals treated in the VA or MZ groups
survived.
Conclusions: The efﬁcacy of oral RA in experimental C. difﬁcile associated
colitis warrant its clinical evaluation in the prevention and treatment of C.
difﬁcile associated colitis.
Pneumococcal and central nervous system infections in children
P1627 The Belgian IPD Survey: a one-year prospective
survey of invasive pneumococcal disease in children under 5
A. Vergison, A. Malfroot, D. Tuerlinckx, J. Verhaegen, P. Slachmuylders,
S. Leyman
Brussels, Godinne, Leuven, Louvain-La-Neuve, B
Objectives: To document the incidence of invasive pneumococcal disease
(IPD) in Belgian children less than 5 years of age and to determine the
serogroup and the antibiotic susceptibility of the pneumococci isolated from
these children with IPD.
Methods: A one-year prospective surveillance from March 15th 2002–2003,
in Belgian pediatric wards. Clinical data along with all pneumococci strains
recovered from IPD cases were collected. Serotyping and antibiotic suscept-
ibility testing (E-test) were performed by the Pneumococci National Refer-
ence Laboratory.
Results: After 9 months 204 cases of IPD were recorded. Meningitis was
found in 15%, pneumonia with positive blood culture in 29%, occult
bacteremia in 49%, empyema in 5% and arthritis or peritonitis in 2% of
the cases. 73.5% of the IPDs occurred in children younger than 2 years. The
serogroups included in the 7-valent conjugated pneumococcal vaccine (Pre-
venar(R)) accounted for 89% and 87% of IPD in children less than 2 years or
less than 5 years, respectively. In the cases of meningitis the theoretical
coverage of Prevenar was 92%. 13% of the pneumococci had a penicillin
MIC> 0.06mg/mL (none had a MIC 2mg/mL). All of these pneumococci
belonged to serogroups included in Prevenar and more than half were
serogroup 14. 48.4% of the isolates were resistant to erythromycin and none
to cefotaxim. For the full year, we expect an incidence of IPD of 48.3/100 000
and of pneumococcal meningitis of 7.3/100 000 in children less than 5 years
old. This is higher than the incidence (30.2/100 000 for IPD and 4.3/100 000
for pneumococcal meningitis) calculated in 2000 based on spontaneous
reporting to the Reference Lab. The incidence of meningitis is comparable
to the incidence of Haemophilus inﬂuenzae b (Hib) infections before the
vaccination era.
Conclusions: (1) IPD was common in children, with 75% of isolates in
children under 2 years. (2) Pneumococcal meningitis had an incidence
comparable to that of Hib infections before vaccination. (3) Inclusion of
the Prevenar vaccine in the infant vaccination schedule could prevent 87% of
all IPD in the studied age group. (4) Penicillin resistance in pneumococci was
low.
P1628 Surveillance of antibiotic resistance and
serotypes of Streptococcus pneumoniae in the Comunidad
Valenciana (Spain)
M. Montaner, J. Roma´n, C. Pe´rez-Belle´s, J. Pema´n, E. Canto´n,
M. Gobernado
Valencia, E
Objectives: The surveillance of the most prevalent serotypes (STs) of Strep-
tococcus pneumoniae in our geographical area. Obtain an updated knowledge of
S. pneumoniae antibiotic resistance in order to establish the most efﬁcient
antibiotic policy.
Methods: A total of 390 strains of S. pneumoniae, isolated from patients of
different hospitals of the Comunidad Valenciana (June 1999–December 2001)
were evaluated. STs were determined by Quellung reaction (reagents pro-
vided by Stantens Seruminstitut). MICs of oxacillin (OX), penicillin (PV),
ampicillin (AM), amoxicillin/clavulanic acid (XL), cefuroxime (XM), cefo-
taxime (CT), erythromycin (EM), clindamycin (CM), rifampicin (RI),
vancomycin (VA) and levoﬂoxacin (LE) were determined by E-test method,
and the breakpoints applied were NCCLS 2000 (M7-A5).
Results: 22.2% of S. pneumoniae were from CSF, blood and other sterile
liquids. The most frequent STs were: 19 (23.3%), 6 (13.1%), 3 (11.8%) and 23
(11.5%). The percentage of highly resistant strains were: PV, 8.0%; AM, 0.9%;
XL, 0.0%; XM, 3.2%; CT, 0.0%; EM, 46.5%; CM, 39.4%; RI, 0.0%; VA,
0.0%; and LE, 0.3%. Of the OX resistant (R) strains 81.9% were nonsuscep-
tible (NS) to PV. The prevalent STs among the phenotype OX(R)-PV(NS)
were: 19 (30.0%), 14 (15.8%), 6 (15.3%), 23 (13.7%) and 9 (10.0%). The
percentage of strains with phenotype EM(S)-CM(S) were 52.6%. The 58.3%
of these strains belonging to the STs 3, 19, 9 and 14. The percentage of strains
with phenotype EM(R)-CM(R) were 38.0% and the most frequent STwere
19, 6, 23 and 14.
Conclusions: The 7-valent conjugated pneumococcal vaccine covers 78.3%
of the strains from patients<2 years and the 23-valent polysaccharide vaccine
covers >90% in patients older than 2 years old.
P1629 Invasive Streptococcus pneumoniae from infants:
implications for vaccination in Portugal
I. Serrano, M. Ramirez, J. Melo-Cristino
Lisbon, P
Objectives: Determine the serotype and antimicrobial susceptibility of inva-
sive isolates of Streptococcus pneumoniae recovered from infants (less than 2 years
of age) at the time of introduction of the 7-valent conjugated vaccine.
Methods: S. pneumoniae recovered from normally sterile sites during the years
of 1999–2002 were sent to the Microbiology Laboratory of Faculdade de
Medicina de Lisboa for study. Serotyping was done by the Quellung reaction
using sera from the Statens Serum Institut (Copenhagen, Denmark). Suscept-
ibility testing was performed by disk diffusion (according to NCCLS guide-
lines) and E-test. Antimicrobials tested included penicillin, cefotaxime,
vancomycin, erythromycin, clindamycin, tetracycline, chloramphenicol
and trimethoprim-sulfamethoxazole (SXT).
Results: The origin of the 57 isolates tested was: blood (50), CSF (5), other
sterile ﬂuids (2). Resistance to antimicrobial agents was detected against
cefotaxime (1.8%), erythromycin (17.5%), clindamycin (7.0%), tetracycline
(17.5%), chloramphenicol (7%) and SXT (35.1%). All isolates were suscep-
tible to vancomycin. Penicillin nonsusceptibility was 45.6% (22 isolates low-
level and 4 isolates high level, MIC50¼ 0.032mg/L; MIC90¼ 2mg/L).
Simultaneous resistance to 3 or more antimicrobial classes was detected in
14.0% of the isolates. Penicillin nonsusceptibility was mostly (70%) associated
with serotypes 14 and 23F found in internationally disseminated clones. Four
serotypes accounted for more than half of all isolates: 14 (26%), 23F (16%), 6B
(9%) and 19 A (9%). The remaining 39% of the isolates were distributed in 13
different serotypes. Three isolates from type 3 and two isolates each of types 9
V, 7F, 6 A, 33, 18, 10 and 1. Five isolates had unique types.
Conclusion: The 7-valent conjugated vaccine would cover at best 63%
(considering cross-protection to serotype 6 A) of the cases of invasive disease
among children younger than 2 years of age in Portugal.
P1630 Invasive Pneumococcus infections in an intensive
care unit in the last 5 years
C. Szabo´
Budapest, HUN
Objectives:Our aim was to determine howmany patients were treated in our
ICU because of Streptococcus pneumoniae – induced invasive infection in the last
ﬁve years. How long they stayed in the hospital, which age group was the most
susceptible for the disease and which were the most frequent clinical forms of
it. We also wanted to determine the susceptibility of Pneumococcus for
penicillin therapy.
Methods: A retrospective study was made in the Intensive Care Unit of our
hospital, collecting data of children having suffered from invasive Pneumo-
coccal infection in the period of January 1 1998–December 31 2002. Our
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criterium of diagnosing the disease was detecting Pneumococus from a
normally sterile body ﬂuid (pleural effusion, blood, liquor or abdominal ﬂuid).
Results: During the last 5 years we treated 25 children with invasive
Pneumococcal infection. The vast majority of them were suffering from
pleural effusion (22/25) while there were also cases of meningitis, primary
peritonitis and bronchopneumonia, one of each. Our patients were 3.1-year-
old-on average (range 4 months – 12 years), the majority of them was female
(14/25). None but one of them had had any history of either some chronic
disease or previous severe infections. The average length of stay was 18.6
(range 3–40) days in our department and 24 days in the hospital altogether.We
performed continous pleural suction to all our pleuropneumonia patients, for
9.6 (range 1–31) days on average and derived 790mL (range 160–1920mL)
pleural ﬂuid by using this method. We admitted most of the children in
autumn, winter and early spring. We experienced some complications caused
either by the disease or by the invasive tratment we had to use. Most frequent
complications were respiratory failure, cardiac decompensation, pneu-
mothorax, subcutaneous emphysema, atelectasia, pleural or mediastinal
abscess. We treated one boy with hemolytic uremic syndrome and two
children suffered from multiple organ failure. Pleural ﬂuid culturing was
positive in relatively few cases (13/25) while antigen testing revealed the
bacterium more effectively (21/25). We cultured polyresistent pathogens
from the pleural ﬂuid relatively seldom (2/13).
Conclusion: The most susceptible age group to invasive Pneumococcal
infection are infants. Administering conjugate Pneumococcal vaccine might
be the really cost-effective solution in the long run.
P1631 Use of nasopharyngeal swabs isolates of
Streptococcus pneumoniae from children in Sao Paulo, Brazil
for surveillance of antimicrobial resistance
E. Berezin, M. Otsuka, M. D. Cardenuto, L. Ferreira, E. Toda, M.
Gutierrez, M. L. Guerra, M. C. Brandileone
Sao Paulo, Salvador, BR
Objectives: To determine whether antimicrobial susceptibility of SP isolated
from the upper respiratory tract is representative of data from patients with
invasive infections.
Methods:We collected Nasopharyngeal (NP) swab specimens from children,
between 3 months and 5 years old. Those children attended the outpatient
clinic of two hospitals in Sao Paulo City, between June 16, 1997 and May 20,
1998 (ﬁrst period) and between March 15, 2000 and March 15 2001 (second
period). The results of the surveillance were compared with data obtained
from children admitted in hospital with pneumococal invasive infection (PII)
in two periods: 1996–98 (101 patients) and 2000–2001 (40 patients). NP
specimens were collected pernasally, using a calcium alginate swab and plated
immediately after collection onto trypticose soy agar with 5% sheep blood and
garamicin 5 mg/mL. Penicillin susceptibility of isolates was determined by a
screening with oxacillin 1 mg disk and the minimal inhibitory concentration
by the E-test. Serotyping was performed by the capsule Quellung method
with use of antiserum for 46 serotypes.
Results: SP was recovered from NP of 139 children in the ﬁrst period and 42
in the second period. The prevalence of penicillin nonsusceptible strains
(PNS-S) in the NP carriage and PII was 16.4% and 17%, respectively, in the
ﬁrst period. In the second period PNS-S in the NP carriage was 42% and in
PII was 45%. The serotypes 23F, 6, 14 and 19F were the most common in the
NP study and serotypes 14, 1, 5 and 6 were the most common in invasive
infections. Serotypes 6, 14 and 23Fwere themost prevalent among the PNS-S
in both surveillance.
Conclusions: These ﬁndings suggest that nasopharyngeal isolates of Strepto-
coccus pneumoniae from children with upper respiratory infections can be used
to conduct surveillance for antimicrobial resistance in a deﬁned geographic
area but are not reliable for serotypes in our community.
P1632 Prospective study of bacterial meningitis in
children
I. Marques, J. M. Ribeiro, J. Ribeiro
Viseu, P
From January 2000 to December 2002, we studied all bacterial meningitis
cases with positive cultures, excluding possible contaminations, in children
admitted in the Pediatric’s department of our Hospital. The study included
nine girls and 10 boys, ranging from neonates to 14-year-old-children.
Cerebrospinal ﬂuid (CSF) analysis and blood cultures were performed in
every child at the admission time. Csf tests induced: cell count, glucose and
protein levels, gram stain, latex agglutination tests for the detection of
bacterial antigens, bacteriological culture and antimicrobial susceptibility
tests. Chocolate agar and 5% sheep blood agar were used as isolation media
for bacterial recovering. Blood cultures were performed in the Bactec
ﬂuorescent system 9120. Identiﬁcation and antimicrobial susceptibility tests
were both made in Vitek 1 automated system. Kirby-Bauer disk diffusion
method was also used for the last tests. Glucose and protein levels of CSF was
determinated in the Vitros System 250. In the 19 cases studied, the 20 isolated
microorganisms were: Neisseria meningitidis – 12 (60%), Streptococcus pneumo-
niae – 3 (15%), Haemophilus inﬂuenzae – 2 (10%), group A streptococci – 2
(10%), group B streptococci – 1 (5%). The cell counts were elevated and
segmented neutrophils cells predominated in 16 (84,2%) cases. The CSF
glucose level was decreased in 9 (47.4%), the CSF protein level was elevated in
15 (78.9%), while the gram stain revealed the causative organisms in 16
(84.2%) cases. Rapid tests for bacterial antigens were performed in 13 cases,
from which 4 were positive (30.8%) and 9 were negative (69.2%). Blood and
CSF cultures revealed the same pathogen in 12 cases (63.2%). All gram-
positive and gram negative microorganisms were sensitive to 3rd-generation
cephalosporins. All gram-positive bacteria were sensitive to ampicillin,
penicillin and vancomycin. 100% of the H. inﬂuenzae isolated were resistant
to ampicillin.N. meningitidiswas the most common pathogen found, followed
by S. pneumoniae. The sensitivity of other than the cultural tests was good in a
general way, however, the sensitivity of latex agglutination tests was low.
Antibiotic sensitivity results were within the antimicrobial susceptibility
patterns.
P1633 Mass vaccination campaign following an
outbreak of serogroup C meningococcal disease in the Puy
de Doˆme, France, 2001–2002
V. Chanet, I. Cloix, J. P. Romaszko, J. M. Constantin, J. L. Vaille, M.
Mora, C. Lecadet-Morin, M. Taha, D. Le´vy-Brhul, A. Eschalier, A.
Labbe´, B. Souweine, J. Sirot, J. Beytout, H. Laurichesse
Clermont-Ferrand, Paris, F
Objectives: to control an outbreak of serogroup C invasive meningococcal
disease (IMD) in the Puy de Doˆme, France, 2001–2002.
Methods: A case of IMD was deﬁned as isolation of Nesseiria meningitis
serogoupC from blood or CSF (using culture or PCR) in a resident of the Puy
de Doˆme. Cases were identiﬁed through an active notiﬁcation system.
Epidemiologic, clinical and biologic data along with the outcome under
therapy were prospectively recorded. All strains were sent to the National
Reference Centre for serotyping and multiloci DNA ﬁngerprinting. In
addition to a postexposure prophylaxis using rifampin, the health authorities
decided a vaccination campaign targeting all infants children and young adults
from 2 months to 20 years of age and living in the area where the cases were
identiﬁed using a C monovalent conjugate vaccine (MeningitecR): 3 doses
one month apart before 1 years (y) and 1 dose beyond this age.
Results: From February 2001 to January 2002, 18 cases of IMD (2.9/
100 000p) occurred in the Puy de Doˆme and 12 belonged to the serogroup
C (2/100 000p): half of them occurred between November 2001 and January
2002. Half of the patients were children under 2y; 67% had a purpura
fulminans; 75% were admitted to an ICU; the overall case fatality rate was
25%. The Reference centre identiﬁed a serotype 2a including 3 subtypes: P1-
5 (n¼ 6), P1-2,5 (n¼ 4), P1-2 (n¼ 2); among those, one belonged to the ET-
37 clonal complex. More than 64700 persons were vaccinated (around 90% of
the targeted population) between 16th January 2002 (10 days after the last case
of purpura fulminans) and 2nd February 2002. No severe side-effects were
reported. One additional case of serogroup C IMD was diagnosed in August
2002 in a 17-year-old girl who had not been vaccinated because she was
suffering from an infectious mononucleosis syndrome.
Conclusion: This ﬁrst mass vaccination campaign in France, where the
incidence of IMD is lower (1/100 000p) than in Northern European coun-
tries, is likely to have prevented new cases of serogroup C IMD in the area.
Since then, other departments of Southern France faced a similar challenge
and also decided to vaccinate the youngest population. The increasing
incidence of serogroup C IMD in France together with vaccination policies
implemented in several European countries strongly support a timely decision
to protect the youngest population in France by using recently available C
monovalent conjugate vaccines.
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P1634 Third generation cephalosporins in the treatment
of pediatric bacterial meningitis
G. Kuli-Lito, H. Hoxha, E. Foto, A. Kallfa, F. Plaku
Tirana, AL
Objective: Evaluation of the treatment with third generation cephalosporins
at the clinical course and complications of pediatric bacterial meningitis.
Patients and methods: The study is based on analyzing medical records of
403 children, aged 3 month to 14 years, admitted with diagnosis of purulent
meningitis, during the period 1991–2001. The diagnosis of purulent menin-
gitis is established on CSF pleocytosis with over 90% polimorphonuclear
predominance, positivity of CSF and/or blood culture and/or elevated values
of acute phase reactants. The patients were divided in two groups: the ﬁrst one
treated by the combination of ampicillin and chloramphenicol and second
group where cephalosporin of third generation were used (ceftriaxone or
cefotaxime). The dosage and treatment duration were applied according to
recommended protocols. Clinical data included were: the duration of fever
and meningeal syndrome, improvement of CSF data and incidence of
complications.
Results: 125 children with mean age 3.07 years and 130 children with mean
age 2.8 years belonged to the ﬁrst study and second study group. Bacterial
agents isolated At both groups were: N. meningitidis (36%), S. pneumoniae
(34%),H. inﬂuenzae (20.4%). At 9.4% of cases, no bacteria were found. Mean
fever duration was 3.81 days for the patients of the ﬁrst group and 2.07 for
those of the second group. Meningeal syndrome was present at mean range,
respectively, 5.2 and 3.8 days. The improvement of CSF data was without any
signiﬁcant difference for both groups. Complications, such as hydrocephaly,
psycho motor retardation, epilepsy, hearing impairment, were observed in
13.7% of the cases at the ﬁrst group and 7.4% at the second group.
Conclusions: Cephalosporin of third generation have markly improved
clinical course and complications of bacterial meningitis. The combination
ampicillin and chloramphenicol still remains an effective, alternative treatment
of pediatric bacterial meningitis.
P1635 Haemophilus inﬂuenzae type A meningitis
following ahead injury
T. Goulioti, E. Lebessi, G. Antonaki, P. Dimitriou, J. Papadatos, A.
Constantopoulos, M. Foustoukou
Athens, GR
A 7-year girl was admitted to the ICU of our hospital for fever and partial
seizures. The physical examination revealed nuchal rigidity and right nostril
anosmia. She required intubation and mechanical ventilation. Empiric ther-
apy with cefotaxime IV, dexamethasone, and phenytoin was begun. A
diagnostic lumbar puncture was performed. The CSF contained 1600
WBC/mm3, protein of 177mg/dL and glucose of 50mg/dL. Gram-stain
smear revealed pleomorphic Gram-negative bacilli. Detection of soluble
antigen for H. inﬂuenzae type b (Hib) was negative. Culture of CSF grew
H. inﬂuenzae. The strain was serotyped as type a, by agglutination in type
speciﬁc antisera and as biotype V by apiNH. The organismwas beta-lactamase
negative. By the disk diffusion method, according to the NCCLS criteria, it
was found to be susceptible to ampicillin, amoxicillin/clavulanate, cefotax-
ime, meropenem, clarithromycin, and trimethoprim-sulfamethoxazole.
Blood cultures drawn on admission were negative. Initial laboratory evalua-
tion revealed a WBC count of 14 900/mm3, and a C-reactive protein of
12mg/L, which was increased to 122mg/L in two hours. An immunological
investigation was unremarkable. In 2 days the child was much better, and
transferred from the ICU to the pediatric ward. Past medical history revealed
that 8 months before this episode, the child had been hospitalized in another
pediatric hospital, after a car accident. Otorrhea had been observed. After
pharmaceutical therapy she was discharged home in a good condition. Four
months after the car accident she was hospitalized again because of pneu-
mococcal meningitis. Axial cranial CT showed no bone lesions. There was a
small collection of ﬂuid in the sphenoid sinuses and in the right ethmoidal
cells. After antibiotic therapy the child was discharged. The child had been
completely vaccinated against Hib and Neisseria meningitidis type C. The head
injury history, followed by two episodes of meningitis led the clinicians to ask
for a new axial cranial CT, which showed no bone lesions, but ﬂuid collection
in the ethmoid, maxillary and sphenoid sinuses. Because of the existence of
ﬂuid in the sinuses, a high resolution cranial CT scan was performed, which
revealed a fracture of the cribiform plate, with a ﬁstula into the ethmoid.
The patient was discharged after a 18-day cefotaxime treatment with the
recommendation for vaccination against Streptococcus pneumoniae. She has since
remained well, without antibiotic prophylaxis.
P1636 A case of bacterial meningitis by two
simultaneous agents
I. Marques, E. Santos, J. M. Ribeiro, E. Cardoso, A. Domingues, J.
Ribeiro
Viseu, P
We report a simultaneous case of acute bacterial meningitis and bacteriemia
by two differents agents, followed by septicemia by another agent. A pre-
viously healthy 17 months old child presented with fever, petechial exantema
and prostration, following a ﬁve days history of diarrhea, fever and anorexia.
The patient was admitted in the pediatric department and blood clinical
chemistry, hematological, immunological and microbiological tests were
made. Blood microbiological tests included: bacterial culture, antibiotic
sensitivity and latex particle agglutination tests for the detection of bacterial
antigens. Were also made analysis of cerebrospinal ﬂuid (CSF), that included:
cell count, glucose and protein levels, gram stain, latex agglutination test,
bacteriological culture and antibiotic sensitivity. The blood cultures were
performed in Bactec ﬂuorescent system 9120. The isolation media for
bacterial recovering were chocolate agar and 5% sheep blood agar. Identiﬁca-
tions and antimicrobial susceptibility tests were both made in Vitek 1
automated system. The diffusion technique of Kirby and Bauer was used
in tests of antibiotic sensitivity. The gram stain and latex agglutination tests
were negatives, however, we isolated simultaneously from CSF and blood,
Haemophilus inﬂuenzae and Streptococcus pyogenes. At the same time, imagio-
logical tests (cranial CT scan, heart and abdominal ultra-sonography and chest
roentgenogram) were performed and revealed no abnormalities. The tests of
antibiotic susceptibility permitted continue treatement and after 9 days of
treatment with ceftriaxone and ampicillin e.v., the CSF was sterile, but the
child was febril and two blood cultures indicated a septicemia by Pseudomonas
aeruginosa. Ceftriaxone treatement was stopped. The girl remained on
ampicillin 4 days more and began gentamicine e.v. treatement. She recovered
without sequelae after 20 days of hospitalization. The present case is very
uncommon and we don’t ﬁnd any identical case reported in the reviewed
literature. The laboratory diagnosis was essential for optimal therapy.
P1637 Spinal infection with Actinomyces urogenitalis
I. Wybo, K. Van Rompaey, C. Chaskis, O. Soetens, K. Vandoorslaer, D.
Pie´rard, S. Lauwers
Brussels, B
Objectives: Spinal actinomycosis is a rare cause of central nervous system
infection.We describe the case of a one year-old child with a sacral congenital
dermal sinustract communicating with the dural sac that was complicated by
infection with Actinomyces urogenitalis.
Methods: An 11-month-old-infant with recurrent meningitis underwent
surgery for correction of a sacral durocutaneous ﬁstulisation. Four days after
the intervention the child became irritable, showed neurological detoriation
and a bulging fontanel. The cerebrospinal ﬂuid had a cloudy appearance.
Spinal magnetic resonance imaging visualized the presence of an extensive
lumbosacral abscess. In the cerebrospinal ﬂuid and in the pus obtained during
surgical drainage of the abscess a gram-positive rod was recovered. In addition
to conventional bacteriological testing, partial DNA sequencing of the 16S
rRNA gene was performed.
Results: Conventional bacteriological testing was compatible with the char-
acteristics described in the literature forA. urogenitalis. The obtained sequence
of 275 base pairs was compared with sequences available in GenBank database
by using FASTA program. 100% identity with A. urogenitalis was found.
Several other anaerobes were also isolated in the abscess: Bacteroides ovatus,
Finegoldia magna, Bacteroides urealyticus and Prevotella species. The child was
treated with high dose penicillin IV during 6 weeks followed by oral
amoxicillin. However after four months of oral treatment the intraspinal
lesions expanded again and reintervention was needed. Culture of the lesions
did not grow any micro-organism. The patient was again treated with high
dose penicillin for six weeks and subsequently with chloramfenicol orally.
Until now (3months later) the evolution of the patient is favorable.
Conclusions: We describe a case of spinal infection with A. urogenitalis that
relapsed in spite of a prolonged oral therapy with amoxicillin. Diagnosis of
actinomycosis was very important to take the decision to start a prolonged
therapy with chloramfenicol.
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Clinical aspects of tuberculosis and other mycobacterial infections
P1638 Mycobacterium kansasii infection with normal
chest radiograph
M. V. Leal, A. Gaafar, M. J. Unzaga, J. Mazo, F. Garcı´a, I. Arriaga,
J. A. Crespo, C. Ezpeleta, R. Cisterna
Bilbao, E
Objective: The aim of this work was to study the epidemiologic features of
M. kansasii isolates in patients with normal chest radiograph
Patients and methods:We reviewed 334 records of patients with M. kansasii
isolated from culture specimens from 1994 to 2002. We applied ATS
diagnostic criteria for nontuberculous mycobacterial disease to the cases
and then we utilized modiﬁed criteria in deﬁning all of our cases. One of
them was the presence of several isolates from the respiratory tract with
compatible respiratory symptoms together with a normal chest radiographic.
Different molecular typingmethods including PCR-RFLP and AFLP analysis
were applied to clinical isolates of M. kansasii.
Results: During the study period 36 patients had a normal chest radiograph:
13 (36.1%) HIV positive and 23 (63.9%) HIV negative patients with a male
predominance 4/1 and a mean age 56.50 range [26–88 years]. Only in 12
(33.3%) of HIV negative patients the Chest X-ray show abnormalities of a
COPD. Respiratory samples of 18 patients (50%) were acid-fast smear
positive, 10 patients were HIV positives and 8 HIV negatives. Multidrug
regimen containing isoniazid, rifampicin and ethambutol was initiated in 31
patients (86.1%). Five HIV negatives patient didn’t receive treatment; two of
them died when the microorganism was recovered. Recurrence of clinical
disease occurred in only one patient HIV negative. Five HIV positive patients
had disseminated disease, the mycobacterium were recovered from stool,
respiratory, pus, and urine samples. PCR-RFLP analysis demonstrated that
the type I was the most prevalent M. kansasii (16/17) isolates and only one
isolate was type II. AFLP analysis of type I strains revealed ﬁve clones although
two of them were the most prevalent.
Conclusions: The number of patients with M. kansasii in respiratory samples
with a normal chest radiograph is important and not only in HIV positives
patients where this issue has been described, also is frequent in our cases in
HIV negative patients. The number of acid smear positive is also elevated.
Isolation of M. kansasii from the respiratory tract in HIV positive prompt
initiation of antimycobacterium therapy but this doesn’t occur with HIV
negatives.
P1639 Impact of migration on the prevalence of
mycobacterial infections in HIV-positive patients in Ireland:
1999–2002
E. Brannigan, S. Hopkins, P. Coakley, F. Mulcahy, C. Bergin
Dublin, IRL
Background:With the advent and availability of HAART it was expected that
the prevalence of mycobacterial infections in HIVþ patients would decline
precipitously. However changing demographics in the HIVþ cohort in
Ireland resulting from increased non-national migration has altered the
presentation of mycobacterial infections. In 1999, less than 10% of new
HIV diagnoses were recent migrants from Subsaharan Africa compared with
36% in 2000, 41% in 2001 and 44% in 2002.
Methods: A retrospective analysis of pharmacy records was undertaken to
look at the prescription of antimycobacterial medication to HIV seropositive
persons attending our service from January 1999 to end December 2002.
Information was collected regarding nationality, mycobacterial species, site of
infection & drug regimen prescribed. HIV parameters were also recorded.
Patients receiving antimycobacterial chemoprophylaxis were excluded from
the analysis.
Results: Forty-ﬁve cases of mycobacterial infection were identiﬁed in 42
patients. Twenty-one of 42 were from EU states, 21/42 were non-EU
nationals. Twenty-six of 45 cases were Mycobacterium tuberculosis complex
(MTBC), 4/45 cases presumptive MTB (PMTB), 11/45 cases were con-
ﬁrmed Mycobacterium other than TB (MOTT), 4/45 cases were treated
empirically as MOTT. One MTBC isolate was multidrug resistant
(MDRTB). Fifteen of 42 patients had CD4 counts <50; in this group were
six cases of culture conﬁrmed MOTT, two further were treated empirically,
seven conﬁrmed cases of MTBC and one case of PMTB. Twenty-seven out of
42 patients had CD4 counts >50; in this group were 19 cases of MTBC, 3
were PMTB; 5 cases had MOTT conﬁrmed (clinically interpreted as infec-
tion rather than colonization), 2 patients were empirically treated as MOTT.
Non-EU nationals comprised 33% of MTB cases in 1999 and 2000 (1/3 and
2/6, respectively); 50% (3/6) in 2001 but 80% (12/15) of cases in 2002.
Conclusion: In the era of HAART, nationality now impacts on the prevalence
of MTB infection in HIV seropositive persons.
P1640 Mycobacterium xenopi disease in HIV-infected
patients in the era of highly active antiretroviral therapy
(HAART), compared with the pre-HAART period
R. Manfredi, A. Nanetti, M. Tadolini, R. Valentini, L. Calza, S. Morelli,
G. Marinacci, M. Ferri, F. Chiodo
Bologna, I
Objective and methods: Aim of our survey is to report the epidemiologic,
laboratory, clinical, and therapeutic features of all conﬁrmed HIV-associated
M. xenopi disease observed 1993–2002, with special attention paid for differ-
ences raised after HAART introduction.
Results: Seventeen consecutive episodes of M. xenopi were retrieved in 3022
HIV-infected patients in our 10-year experience, so that a 0.56% frequency of
M. xenopi disease was found. Our 17 episodes involved 14 patients: 2 suffered
from 3 and 2 relapses (5 and 6 years after the 1st episode in the 1st patient, and
18months later in the 2nd patient). No time- and space-clustering was
recognized. The majority of M.xenopi diseases (15) involved the lower
respiratory tract, followed by urinary and lymph node localization. An
advanced HIV disease/AIDS and a low CD4 count (mean 42 cells/mL)
prompted M. xenopi infection, although the pathogenic role of M. xenopi was
difﬁcult to separate from that of coinfecting organism (present in 34% of p).
Most of our patients (76.5%) did not undergo HAART prior to diagnosis.
Comparing the 13 episodes occurred before HAART with the 4 cases
diagnosed in the HAART period, no signiﬁcant difference was found as
to age, gender, HIVexposure, AIDS diagnosis, infection site, number and type
of concurrent AIDS-related illnesses, and frequency of relapses, but a higher
mean CD4 count was seen in HAART-treated p (P< 0.001), as well as lung
cavitations accompanied by exudation, which were never found in absence of
HAART (P< 0.006). These features occurred in p who had a rapid recovery
of CD4 count (280–700%), and should be a part of the immune reconstitution
syndrome. Chemoprophylaxis protected 75% of p against M. xenopi disease
when HAART was administered, while this rate dropped to 23.1% when
HAART was not used. In vitro sensitivity assays identiﬁed ethambutol,
cycloserine, capreomycin and protionamide as the most effective anti-
M. xenopi drugs (100% sensitive strains), followed by isoniazid and rifampicin
(94.1%), PAS, kanamicin, and streptomycin, in absence of temporal changes.
Clinical-microbiological cure was reached in 76.4% of cases.
Conclusions: A reliable and timely clinical and bacteriological diagnosis, and
an optimal treatment of atypical mycobacteriosis remain a challenge for
clinicians facing immunocompromised p. Diagnostic problems posed by late
identiﬁcation due to slow culture and concomitant opportunism, join
therapeutic difﬁculties due to the unpredictable in vitro susceptibility proﬁle
of these organisms.
P1641 Tuberculosis in HIV-1 infected children
O. Bakuba, S. Kapere, R. Semitala
Kampala, UG
Background: (i) To assess the prevalence of mycobacterium tuberculosis (mt)
infection in HIV-1 infected children from Mulago Government Hospital
Pediatric clinic. (ii) To study the clinical and immunological status of the cases
conﬁrmed by culture and bacterial resistance to antituberculosis drugs.
Methods: Prevalence of TB was evaluated in a retrospective study based on
the clinical records of HIV-1 infected children monitored in Mulago hospital
pediatric clinic during a 10-year period of time (1991–2001). Diagnosis of TB
was stratiﬁed as presumptive (clinical and radiological data) and deﬁnitive
diagnosis (positive culture). The patients were classiﬁed according to the CDC
classiﬁcation for children.
Results: From 1176 patients, diagnosis of TB was established in 342 (24.6%)
cases. Two hundred and eighty-six (85.2%) had pulmonary TB and 31 (9.8%)
extra pulmonary/disseminated TB. For the 41 (17.2%) patients (Sex ratio
28 : 13) conﬁrmed by culture, the average at the time of TB diagnosis was
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8 years and 5months. The transmission root was parenteral in 36 (87.8%) cases
and mother to child in 5 (12.2%) cases. At the moment of TB diagnosis, 5
(12.2%) patients were stabilized in class A, 14 (34.1%) in B and 4 (9.7%) in C.
According to the immunological status, 4 (9.7%) patients were classiﬁed: class
1.6 (14.6%) to class 2 and 13 (31.7%) to class 3. Radiology revealed hilar
adenopathy (10 cases), inﬁltrates:alveolar (11 cases), interstitial (4 cases).
Conclusion: Susceptibility to antituberculosis drugs was determined in 10
cases, revealing mt resistance to isoniazid (INH) in 9 cases (90%), for rifampin
(RMP) in 5 (50%) cases, for streptomycin (SM) in 4 (40%) cases.
P1642 The incidence of TB pericarditis in patients with
acute pericardial disease in two years
M. Fallah, F. Fallah
Tehran, IR
Background: Although during the last decades the prevalence of TB has
declined and its prognosis has changed dramatically owing to chemotherapy
cases of TB pericarditis can still be observed. Difﬁculties in early and accurate
diagnosis probably contributed to this phenomenon and may delay diagnosis
and therapy or lead to antituberculous chemotherapy for idiopathic pericar-
ditis. So in this report we studied patients in whom a diagnosis of TB
pericarditis was made by following Adenosin Deaminase Activity and other
procedures.
Patients and method:We now report our experience in a descriptive group
of 30 cases (19 men, 11 women), aged 12–76 years admitted to the hospital for
acute pericardial disease. The diagnosis of TB pericarditis was made by the
following studies: Culture on Lowenstein-Jensen media, Ziehl-neelsen stain-
ing, measurement of ADA of pericardial ﬂuid, biopsy of pericardial tissue and
evaluation of tuberculin test.
Result:We found 13 patients with TB pericarditis. All of them had clinical TB
manifestation. The culture of pericardial ﬂuid in six patients (46%), the
staining in three cases (23%), the culture of pericardial tissue in 6 patients
(46%) were positive. The caseating granuloma in 46% of cases was identiﬁed.
Ten case (77%) had positive PPD reaction. All of them with increased ADA
(>45 m/L) were reported.
Conclusion: Therefore the evaluation of level of ADA may prove a good
screening for TB pericarditis.
P1643 Tuberculous meningitis: retrospective study of 26
cases
A. Kadanali, M. Ertek, Z. O¨zkurt, F. Kacar, M. Parlak
Erzurum, TR
Objective: To review the clinical manifestations, laboratory, radiological
ﬁndings and prognostic factors of patients with tuberculous meningitis
(TM), admitted to our clinic.
Methods: Twenty-six patients with TM hospitalized in our clinic between
January 1998 to January 2003 were evaluated retrospectively. Primary para-
meters were history, physical examinations, routine laboratory and cerebrosp-
inal ﬂuid (CSF) results, cranial tomography (CT) ﬁndings with clinical
prognosis, complications, treatment and prognosis.
Results: The most frequently observed symptoms and/or clinical signs of the
patients were headache (100%), meningeal irritation ﬁndings (80.8%), fever
(65.4%). Acid-fast bacilli were seen in the CSF samples of 2 (7.7%) cases with
Erlich-Ziehl-Neelsen method, Mycobacterium tuberculosis were isolated from 2
of 26 on Lo¨wenstein-Jensen medium. Nine of 26 patients (34.6%) died. The
cases who resulted in death were at phases II and III.
Conclusion: The most important factors affecting the prognosis in TM were
the time between the development of symptoms and treatment as well as the
neurologic phase of the disease.
P1644 Thwaites’ diagnostic scoring and prediction of
tuberculous meningitis
M. Sunbul, A. Atilla, S. Esen, C. Eroglu, H. Leblebicioglu
Samsun, TR
Objective:Rapid and accurate clinical evaluation is required to determine the
type of meningitis. This study was conducted to study applicability of
Thwaites’ diagnostic criteria in order to differentiate tuberculous meningitis
from bacterial meningitis.
Methods: The study was held retrospectively in HIV-negative 126 patients
with meningitis. One hundred and two of the patients had bacterial menin-
gitis and 24 patients had tuberculous meningitis. The diagnosis was conﬁrmed
microbiologically in 59 and 12 patients with bacterial and tuberculous
meningitis, respectively. The prediction of tuberculous meningitis was deter-
mined by Thwaites’ diagnostic scoring using parameters such as, age, history
of illness, white blood cell count (WBC), total cerebrospinal ﬂuid (CSF) white
cell count and the percent of neutrophils in CSF. The diagnostic value of the
model was assessed by calculating the area under the receiver operating
characteristic (ROC) curves.
Results: The sensitivity and the speciﬁcity of Thwaites’ diagnostic scoring
were 95.8% (23/24) and 71.6% (73/102), respectively. In microbiologically
proven cases the sensitivity and the speciﬁcity were 91.7% (11/12), 79.7%
(57/59), respectively. Area under ROC curve was 0.92. The area under ROC
curve value for the diagnostic scoring was 0.92.
Conclusions: It was concluded that Thwaites diagnostic score is helpful in
differential diagnosis of tuberculous meningitis and the usefulness of the
diagnostic scoring should be validated in large series especially in patients with
viral meningitis and low CSF glucose levels.
P1645 Molecular epidemiology of Mycobacterium
tuberculosis from a pediatric population and comparison
with an adult population
V. Garcı´a-Arias, D. Garcı´a de Viedma, M. Marı´n, S. Andre´s, G. Lorenzo,
M.-J. Ruiz-Serrano, E. Bouza
Madrid, E
Objectives: To provide details of the genotypes and clonal distribution of
Mycobacterium tuberculosis (MTB) from the pediatric population, and to
compare this data with the available genotyping proﬁles of MTB isolates
from the adult population in our health district.
Methods: MTB isolates of patients under 15 years of age were selected over
the last 13 years. Molecular typing was performed by spoligotyping. The
typing patterns were compared with those obtained from a selection of the
adult population from the same period. Medical histories and contact
investigation records were examined to determine epidemiologic links.
Results: During the period of study (January 1990–May 2002), 68 culture-
conﬁrmed cases of tuberculosis in children were identiﬁed and 50 isolates
were available for typing. Twenty-nine different spoligotypes were obtained,
58% of which were shared by the adult population. Sixty percent of the
pediatric isolates were clustered, similar to the proportion found in the adult
population (65.8%). All but one of the pediatric isolates in clusters were also
found in the adult population. Pediatric clones were homogeneously dis-
tributed throughout the study period and no epidemiologic link was found
among the clustered isolates, except for three isolates that constituted a
microepidemic.
Conclusions: The molecular features of MTB isolates in pediatric infections,
where tuberculosis is due to recent transmission, match those of the adult
population: (i) there is a high variability of strains (ii) the composition of
clones does not vary throughout the study period (iii) an equivalent percen-
tage of typing proﬁles are clustered (iv) the composition of strains is similar.
These equivalencies in the general molecular parameters of MTB isolates
from children and adults could suggest that recent transmission ofMTB plays a
signiﬁcant role in both populations.
Acknowledgement:This study was supported by a grant fromComunidad de
Madrid (08.2/0029/2001 1)
P1646 Preference for extra-respiratory dissemination by
Mycobacterium tuberculosis correlates with highly efﬁcient
infection of macrophages in vitro
D. Garcı´a de Viedma, G. Lorenzo, D. Folgueira, S. Andre´s, M. Marı´n,
M. -J. Ruiz-Serrano, E. Bouza
Madrid, E
Background: We have previously reported cases of coinfection by two
different Mycobacterium tuberculosis (MTB) strains with different strains infect-
ing at respiratory and extrarespiratory sites (compartmentalization of the
infection). In one of these cases, two different MTB strains were isolated
from the respiratory sample but only one of these two strains was found at the
extrarespiratory site. This suggests clonal selection between the respiratory
strains in order to disseminate to extrarespiratory sites.
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Objective: To explore the role of strain factors which could be related to the
ability of MTB to disseminate to extrarespiratory sites.
Methods: Two MTB strains (A and B) isolated simultaneously from a
respiratory sample (only strain A was recovered from the extrarespiratory
sample) were selected for study. Macrophages were cultured from monocytes
obtained from the peripheral blood of healthy donors. The two respiratory
strains were used to coinfect simultaneously (A:B proportions: 1 : 1, 10 : 1 and
1 : 10) macrophages in vitro. After 24 h, infected macrophages were lysed and
plated to obtain single MTB colonies. Fifty single colonies were analyzed by
spoligotyping to study the proportion of strains A and B after macrophage
infection.
Results: Strain A infected macrophages more efﬁciently in the coinfection
assay. After macrophage infection, the proportion between A and B strains was
24 : 1, 50 : 1, 1 : 3 for the assay proportions 1 : 1, 10 : 1 and 1 : 10, indicating
that strain A infected macrophages more efﬁciently than strain B.
Conclusions: A phenomenon of competition to infect macrophages was
detected between two strains that were coinfecting a patient at the respiratory
site. The strain that showed a preference for disseminating to the extrare-
spiratory site in this patient was also able to infect macrophages in vitro more
efﬁciently. These results suggest that (i) not all MTB strains disseminate with
equal efﬁciency and (ii) strain factors such as infectivity could play a role in
controlling extrarespiratory dissemination.
P1647 Sputum smear conversion during antituberculous
therapy of alcoholics with pulmonary tuberculosis
Z. Yumuk, K. Ince, A. Hazar, V. Du¨ndar
Kocaeli, Istanbul, TR
Objectives: The purpose of this study was to determine whether smear
conversion correlates within the ﬁrst month and sixth month of therapy at
alcoholic patients with pulmonary (TB).
Methods: Forty-ﬁve alcoholic and 45 non alcoholic, totally 90 patients were
studied. AFB smear of each patients were evaluated for the ﬁrst month of
therapy and at the end of the sixth month. Alcoholism was determined by
using CAGE test.
Results: Following initiation of antituberculous therapy, 21 (38%) alcoholic
and 34 (62%) nonalcoholic patients (group 1, responders) had a complete
response to treatment and the amount of acid-fast bacilli (AFB) in the smears
of the patients sputum decreased steadily, during the hospitalization period.
The remaining 24 (69%) alcoholic and 11 (31%) nonalcoholic patients (group
2, nonresponders) had persistent evidence of active disease and demonstrated
little or no decrease in the amount of AFBwith treatment. At the follow-up of
self-administered therapy period, 16 (36%) (7 in group 1, 9 in group 2) from
alcoholic and 8 (18%) (7 in group 1, 1 in group 2) from nonalcoholic patients,
totally 24 (27%) patients were excluded from the study that they had no
regular visits to TB centers and no data available for these patients. At the end
of the sixth month, 18 (62%) (12 in group 1 and 6 in group 2) alcoholic (n:29)
and 30 (81%) (24 in group 1 and 6 in group 2) non alcoholic (n:37) patients
had a clearance of AFB from sputum smear whereas 11 (38%) (2 in group 1
and 9 in group 2) alcoholic and 7 (19%) (3 in group 1 and 4 in group 2) non
alcoholic patients had persistently positive AFB smears. Moreover, multidrug
resistance was determined at 7 (39%) (1 in group 1 and 6 in group 2) alcoholic
and 4 (22%) (1 in group 1 and 3 in group 2) non alcoholic, totally at 11 (61%)
patients that had persistence positive AFB smears (n:18). The predictive value
of smear negativity for the patients at the end of the sixth month at group 1
was found to be 86% for alcoholic and 89% for non alcoholic patients, whereas
for negative predictive value the ratio was 60 and 40%, respectively.
Conclusions: AFB smear conversion in the ﬁrst month of the therapy has a
relation with the AFB smear negativity at the end of the sixth month of
therapy. Given the relationship between this parameter, the model may be of
value in the evaluation of new tuberculosis therapeutics in alcoholic patients
with pulmonary TB, as well as in the care of individual patients.
P1648 Polyclonal primoinfection by Mycobacterium
tuberculosis
M. Marı´n, D. Garcı´a de Viedma, G. Lorenzo, M. J. Ruiz-Serrano,
E. Bouza
Madrid, E
Objectives: Mixed infection by different Mycobacterium tuberculosis (MTB)
strains has been described in recent years, and is usually assumed to be due to
superinfection of an uncured episode with a second TB strain. Our aim is to
explore whether polyclonal infections by MTB can also be caused by
primoinfection by two different strains simultaneously.
Methods: MTB-positive respiratory cultures from children were selected in
order to study patients with documented primoinfection. MTB isolates were
plated onto solid media to obtain single colonies. Thirty independent colonies
from each case were analyzed by spoligotyping. IS6110 RFLP was performed
to conﬁrm typing results when necessary.
Results:During a two-year period, 12 children withMTB respiratory isolates
were available for study. For 11 cases, all the 30 colonies analyzed from each
patient showed a unique spoligotyping pattern, indicating infection by a single
MTB strain. In one case, two different spoligotyping patterns were obtained
(proportion 24 : 6), indicating dual infection by two different MTB strains.
Typing by RFLP conﬁrmed this result. This case corresponded to a 2-year-
old-child with no risk factors for tuberculosis.
Conclusions: In our population, simultaneous infection by more than one
MTB strain was found in 8% of patients with documented tuberculous
primoinfection, as conﬁrmed by molecular typing. From this ﬁnding, it
can be inferred that primoinfection in tuberculosis should not be assumed to
be caused always by a single MTB strain, even in cases with no risk factors for
TB.
Acknowledgement:This study was supported by a grant fromComunidad de
Madrid (08.2/0029/2001 1)
P1649 Demographic, social, and clinical characteristics
of patients diagnosed with tuberculosis and admitted to an
isolation unit
A. Rodriguez, A. Noguerado, P. Zelaya, J. Vidal, M. A. Garcia-Viejo,
M. Jaras, O. Lopez
Madrid, E
Objective: To assess the demographic, social, and clinical characteristics of
tuberculosis in patients admitted to the Isolation Unit during the comprising
period 1998–2001.
Methods:Record ﬁles of 475 patients admitted to the Unit during the period
1998–2001 were evaluated, since their admission to the ﬁnal follow up. Data
were double-checked by the Epidemiology Department of the CM.
Results: Tuberculosis was the ﬁnal diagnosed in 372 patients (78.3%). Mean
age was 40.7 years old (SD 16.75), 68.8% of themwere men. From the total of
patients, 65,1% had been translated from the emergency room and 18% of
them came from other hospital wards. Up to 27, 7% of inpatients were
foreign-born, 46% of them originally from Latin America and 19.4% from
North of Africa. Some risk factors associated with the diagnosis of tubercu-
losis were found in 66.3% of the patients: homeless (16.4%), alcohol abusers
(27.7%), HIV positive (17.7%), drug users (16.9%) and previous contact to
patients with active tuberculosis (21.2%). Concomitant diseases were present
in 54.4% of patients, with HIV infection in 15,3% of patients and liver disease
in 14.5%. Tuberculosis was located in the lungs in 98% of cases, 5.4% of them
complained of constitutional symptoms, 11.9% of respiratory symptoms,
74.7% had both of them and 8.1% presented no symptoms. Microbiological
data reported positive mycobacterium staining at admission in 87.4% of
patients, positive mycobacterium cultures in 90.1% of cases. Sensitivity tests
were performed on 79.6% of cases, 5.1% of them with multidrug resistant
strains and 4.1% with resistant to some of the drugs. Side-effects to the
antituberculosis drugs occurred in 28.5% of patients under treatment. Final
results obtained through the study reported as cured 53.2% of patients, 12.6%
completed treatment, 7.5% of patients were exitus and 23.9% of patients were
lost during the follow up.
Conclusions: In this study, the patients diagnosed of tuberculosis were mainly
young males, over a quarter were foreign born, two thirds of the cases
presented some risk factors and over half of them presented concomitant
pathology at the time of diagnosis. Pulmonary tuberculosis was the primary
affectation, with positive smear tests and with a moderate rate of multidrug
resistance strains. Finally, although the overall rate of cure was high, the rate of
patients lost in the follow up was high as well.
P1650 Fever of unknown origin: a review of 51 patients
with tuberculosis
A. Mert, R. Ozaras, F. Tabak, M. Bilir, M. Yilmaz, R. Ozturk
Istanbul, TR
Objectives: Fever of unknown origin (FUO) is a challenging problem for the
practising physician all over the world, and requires both knowledge and
experience. The criteria includes: fever of more than three weeks’ duration,
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documented fever higher than 38.38C on several occasions, and uncertain
diagnosis after one week of examination and investigation in the hospital. In
this study, we aimed to determine the clinical features of the patients with
tuberculosis admitted with FUO and their rate to all of the patients with FUO
during last 19 years in our unit.
Methods:Between 1984 and 2002, the patients with FUO and their etiology
were determined by their ﬁles. The ﬁles of FUO patients with tuberculosis
were thoroughly investigated. The diagnosis of tuberculosis was established
according to the radiological and/or microbiological and/or histopatholo-
gical and/or clinical response to anti-TB therapy in each clinical form.
Ehrlich-Ziehl-Neelsen staining was used to determine acid-fast bacilli in
clinical samples (ﬂuid or solid). M. tuberculosis was cultured in Lowenstein-
Jensen media.
Results: During last 19 years, 162 patients were followed with FUO and 65
(40%) had tuberculosis. TB constitutes 78% (51/65) of all infectious etiol-
ogies. Out of TB cases, 8 were pulmonary TB (1 reactivation, 7 primary), and
43 were extrapulmonary. Extrapulmonary tb forms were: miliary (n¼ 21),
mediastinal TB lymphadenitis (8), disseminated TB (5), renal TB (3), systemic
TB lymphadenitis (2), primary hepatic TB (1), TB peritonitis (1), Pott’s
disease (1), and mesenteric TB lyphadenitis (1).
Conclusion: Infectious diseases were found to constitute 40% of the FUO
etiology, TB being the majority (approximately 3/4) among infectious ones.
Emerging infections: microbiology and diagnostics
P1651 VTEC O117:K1:H7: a new clonal group of
diarrheagenic E. coli causing chronic travelers’ diarrhea
B. Olesen, C. Jensen, K. E. P. Olsen, V. Fussing, F. Scheutz
Copenhagen, DK
Objectives: We describe ﬁndings of 20 patients with Verocytotoxin-produ-
cing E. coli (VTEC) strains of serotype O117:K1:H7 during a 5-year period
and present molecular and conventional phenotypic characteristics.
Methods: Clinical data were obtained by interview of patients. Stools were
examined for Verocytotoxin-producing E. coli (VTEC) by colony dot blot
hybridization with virulence gene DNA probes and the Vero cell assay.
Serotyping was done by microtiter plate- and tube agglutination and produc-
tion of hemolysin on washed sheep blood agar. Biotyping included 14
carbohydrates. Antimicrobial susceptibility testing towards 11 antibiotics
employed Rosco Neo-Sensitabs. PFGE proﬁling was performed using XbaI
enzyme according to the PulseNet US conditions.
Results: By PFGE, the strains were clonally related and they possessed similar
unusual biochemical markers indicating that VTEC O117:K1:H7 is a clonal
group of diarrheagenic E. coli not previously described. All strains were
positive for the vtx1 gene and negative for the eae gene. Eight strains
(40%) were multiresistant. Eighteen patients had traveled to Asia, Africa or
Cuba. The duration of symptoms was median 11weeks, range 2–100weeks.
Twelve out of 15 (80%) patients had symptoms of diarrhea lasting 30 days or
more (¼chronic infection). Two patients were healthy carriers. No fatal cases
occurred and none developed HUS.
Conclusions:To our knowledge, this is the ﬁrst time a chronic infection with
VTEC has been described. We recommend considering the VTEC
O117:K1:H7 clonal group when diagnosing patients returning from Africa
and Asia, particularly when presenting with long-lasting watery diarrhea.
P1652 Characterization of toxigenic Corynebacterium
ulcerans strains isolated in the UK from humans and
domestic cats
A. De Zoysa, N. Fry, D. Taylor, W. Reilly, R. George, N. Crowcroft,
J. White, A. Efstratiou
Colindale, Glasgow, UK
Objectives: Corynebacterium ulcerans is a veterinary pathogen and causes
mastitis in cattle and other domestic and wild animals. Toxigenic strains of
C. ulcerans have been associated with classical diphtheria as well as milder
symptoms. At least one death within the UK has been attributed to such an
infection. Usually human infections are acquired through contact with
animals or by ingestion of unpasteurized dairy products. Person-to-person
transmission ofC. ulcerans could be possible and it has been recommended that
the public health response to human infection with C. ulcerans should be the
same as for C. diphtheriae. In the UK, the frequency and severity of C. ulcerans
infections appear to be increasing. Between 1986 and November 2002 a total
of 55 C. ulcerans isolates were submitted to the PHLS Streptococcus and
Diphtheria Reference (SDRU) Unit for identiﬁcation. Forty-nine (89%) of
the isolates were toxigenic. Recently, toxigenic C. ulcerans has been isolated
from three cats with bilateral nasal discharge. The organism had not been
identiﬁed previously in cats and our ribotyping data have shown that the
proﬁles produced by isolates from the cats are thus far, indistinguishable from
the two predominant patterns observed amongst human isolates. 16S rRNA
sequencing and other tests were undertaken to conﬁrm both the species
identiﬁcation and other characteristics.
Methods:A total of 68 isolates of C. ulcerans (55 clinical isolates from the UK,
3 isolates from 3 cats in the UK and 10 overseas clinical isolates) were
characterized by biotyping, toxigenicity testing and ribotyping. 16S rRNA
gene sequencing was also carried out on the three isolates from the three cats
to conﬁrm its species identiﬁcation.
Results: Ribotyping revealed nine distinct ribotypes amongst the 65 clinical
isolates from the UK and overseas. Ribotype proﬁles produced by isolates
from the cats have been documented amongst human clinical isolates and 16S
RNA gene sequencing conﬁrmed the species identities of the strains from the
cats as C. ulcerans.
Conclusions: C. ulcerans has not previously been reported in cats; however,
our results suggest that the organism in cats could be a potential source of
human infection. The source of human C. ulcerans infection in the UK is not
often determined and this study highlights the importance of determining the
source of infection. This is one of the objectives of the European Commission
DG SANCO project 122/SID/2001.
P1653 Dry-heat inactivation of parvovirus
B19: evaluation of a new LightCycler RT-PCR infectivity
assay for detection of infectious B19
G. Prikhod’ko
Rockville, USA
Objectives: Parvovirus B19 (B19) is a widely distributed infectious agent,
which causes variety of illnesses including erythema infectiosum (ﬁfth disease)
in children and arthritis, aplastic crisis and hydrops fetalis in pregnant women.
B19 can be transmitted from asymptomatic blood donors to the recipients of
their blood components. High rates of seroconversion, as well as a few cases of
symptomatic illness, have been described in patients receiving RBCs, plate-
lets, solvent-detergent (SD) treated plasma and clotting factor concentrates
derived from plasma pools. Recently a new ﬁbrin sealant product, hemostatic
dressing (HD), has been developed by the American Red Cross (USA), CSL
(Australia) and ZLB (Switzerland). HD, a unique combination of two active
plasma components (ﬁbrinogen and thrombin), rapidly forms a strong ﬁbrin
‘clot’ upon contact with blood in awide range of surgical procedures.We have
evaluated two viral inactivation steps, SD treatment for inactivation of
enveloped viruses such as HIV, HCV and HBV, and dry-heat treatment
for inactivation of both enveloped and nonenveloped viruses such as HAVand
B19 for inclusion in the manufacturing process. However, due to the lack a
suitable cell culture system and an assay for quantitative analysis of the
infectivity of B19, the effect of dry-heat treatment on the inactivation of
B19 has not been investigated in the past.
Methods:Dry-heat treatment was performed for the ﬁbrinogen component
of HD spiked with B19 at 1008 for 0, 1, 2 and 3 h. Real time (LightCycler)
RT-PCR infectivity assay was developed and used for analysis of B19 samples.
Results: B19-speciﬁc LightCycler RT-PCR infectivity assay exhibited rapid
and reproducible quantiﬁcation of infectious B19. The assay designed on
detection of spliced RNA forms of B19 in infected cells may not be affected
by the presence of high amounts of viral DNA. Both a standard of infectious
B19 and a test of B19-speciﬁcity are established. Unique primers are designed
for the ampliﬁcation of all known isolates and clones of B19. B19 infectivity
was reduced dramatically reaching approximately 3.3 and at least 5.1 log-
reduction for 1 and 2 h of dry-heat treatment, respectively. The residual
moisture of samples was 1.4–1.7%.
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Conclusions: Dry-heat treatment completely reduced B19 infectivity to the
assay limit for 2 h suggesting that the dry-heat treatment of HD is effective
with the respect to possible B19 transmission.
P1654 PCR ampliﬁcation in speciﬁc diagnosis of
Neurobrucellosis
S. Mitka, E. Chaidouli, A. Ifantidou, L. Ftika, P. Mamasi,
A. Kansouzidou
Thessaloniki, GR
Background: Brucellosis remains a health problem in Greece. Neurobru-
cellosis is a rare complication of the disease. Brucellosis is usually diagnosed by
isolating the organism from blood culture or by a rising titer of speciﬁc
antibodies in the serum. The speciﬁc diagnosis of neurobrucellosis however,
presents some problems because of obscure presentation and uncommon
isolation of Brucella from the cerebrospinal ﬂuid (CSF). The aim of this study
was the contribution of PCR ampliﬁcation in the early diagnosis of neuro-
brucellosis.
Materials and methods: Six adult patients (three males, three females) who
presented with Brucellosis following by neurological manifestations were
assessed in this study (over a 2-year period, 2001–2002). In four of them,
examination of CSF revealed an elevated cell count (10–100/mm3), elevated
protein levels (45–570mg/dL) and low levels of glucose and in the other two
examination of CSF was within normal limits. Cultures and serological
examinations (SAT, CF, Coombs, B-Capt, ELISA) were performed in blood
and CSF samples from all patients. PCR was performed in all CSF and sera
samples. The Brucella omp2 gene, that encodes a protein of the outer
membrane, was used as DNA target (fragment 282 bp).
Results: PCR ampliﬁcation produced a positive result in all CSF and sera
samples from the patients with elevated results in CSF (4 patients). Brucella
melitensiswas isolated from the blood and CSF cultures in two of them, while
in the other two patients only blood culture was positive for B.melitensis. In
the two patients with normal results in CSF a positive PCR produced only in
sera samples andB.melitensiswas isolated only from blood cultures. Serological
examinations in sera samples from all patients were strongly positive for
Brucellosis, while in all CSF samples they were not indicative for the disease.
Conclusions: PCR is a useful test in the early diagnosis of neurobrucellosis,
especially in cases with negative CSF cultures and doubtful serological tests.
The assay allows distinction between the neurobrucellosis and systemic
brucellosis with neurological manifestations but without actual CNS infec-
tion.
P1655 Evaluation of serodiagnostic tests in human
leptospirosis: an Indian study
C. P. K. Subudhi, S. Shivakumar, G. Sumathi
Salford, UK; Chennai, IND
Objective: Leptospirosis is an important zoonosis in Chennai, India. Ser-
odiagnosis remains an important diagnostic tool for leptospirosis in developing
countries. This study has been done to evaluate the usefulness of three
serological tests.
Methods:A total number of 2053 single samples were received during January
1995–December 1996 at the Institute of Microbiology for serodiagnosis. The
following tests were done: (i) MSAT (Macroscopic slide agglutination test) (ii)
IgM ELISA and (iii) MAT.
Results: Current leptospirosis was conﬁrmed in 898 samples. In 1995, of the
592 samples received, IgM ELISAwas positive in 317 samples. Among these,
MSATwas positive in 310 and MATwas positive in 303. In 1996, MSATand
MATwere used. Of the 1461 samples received, MSATwas positive in 581
samples and MATwas positive in 509.
Conclusions: 43.7% (898/2053) had positive serology. IgM ELISAwas highly
sensitive in diagnosis of current infection. MATwas useful in identifying the
serovar. Autumnalis (48%) and Icterohemorrhagiae (31%) were the most
common serovars detected. MSAT is a simple, quick and sensitive test which
can be used as a screening test for laboratories in developing countries.
P1656 Limited genetic diversity of recent isolates of
Hemophilus inﬂuenzae serotype f
B. Bruun, B. Gahrn-Hansen, H. Westh, M. Kilian
Hillerød, DK
Objectives: Concern about a possible rise in the incidence of invasive
infection due to Hemophilus inﬂuenzae serotype f led us to investigate the
multilocus enzyme electrophoresis (MLEE) proﬁles of 18 recent Danish and
American serotype f isolates and compare them with 6 old (>50 years)
serotype f isolates and 8 recent nonserotype f isolates.
Methods:Biotyping and serotyping (commercial and in-house antisera) were
done by conventional methods. Results of serotyping were conﬁrmed by
PCR detection of the serotype f speciﬁc gene. MLEE typing of 13 metabolic
enzymes was determined according to the method of Selander et al. (1986).
Results: All serotype f strains were found to belong to biotype I. One recent
serotype f strain did not contain the f speciﬁc gene sequence. MLEE typing
demonstrated two genetically distinct subpopulations comprising 15 of 18
serotype f strains.
Conclusions: MLEE typing revealed that recent Danish and American
serotype f strains belong to the same genetic subpopulation, distinct from
older serotype f strains and nonserotype f strains.
P1657 Emergence of vancomycin intermediate
Staphylococcus aureus in Taiwan
J.-J. Lu, S.-Y. Li
Taipei, TW
Objective:One thousand and ﬁve hundred methicillin resistant Staphylococcus
aureus (MRSA) isolates, collected from patients in the Tri-Service General
Hospital in Taiwan, were screened for intermediate level of vancomycin
resistance.
Methods: Brain heart infusion agar plates containing 5mg/L vancomycin
(BHIA-VA5) were used for screening of vancomycin intermediate S. aureus
(VISA). Agar dilution method according to NCCLS and E-test were
performed for further minimal inhibition concentration (MIC) of vanco-
mycin. Multiplex polymerase chain reaction (PCR) and pulse ﬁeld gel
electrophoresis (PFGE) were also performed for genetic information of VISA.
Result: Forty-two (2.8%) of the 230 isolates that grew on BHIA-VA5 plates
were conﬁrmed to be VISA with a vancomycin MIC of 8mg/L. The MICs
results of E-test among the 42 isolates were lower than those tested by the
NCCLS standard method. No vancomycin resistance genes, that are com-
monly present in enterococci, were detected in any of these 42 VISA isolates.
PFGE revealed that these 42 VISA isolates belonged to 13 PFGE types, and
Type A was found to be most prevalent.
Conclusion:This is the ﬁrst report of the emergence and nosocomial spread of
VISA in Taiwan.
P1658 Characterization of Vibrio parahaemolyticus
isolated from patients and environment in 1995–2001
M. J. Park, J. K. Park, Y. I. Kim, S. H. Kim, Y. H. Kang, H. M. Lee,
S. S. Kim, B. K. Lee
Seoul, Gyeongsangbuk-do, KOR
Objectives:Vibrio parahaemolyticus, 148 strains, was isolated from environment
(28) and diarrheal patients (120) in Korea from 1995 to 2001. The isolates
were investigated on the phenotypic and genotypic characterization.
Methods: O and K serotype of isolates were determined by using V. para-
haemolyticus antisera. Kanagawa hemolysin reaction of the isolates was tested.
The antimicrobial susceptibility was studied by the disk diffusion technique.
The production of thermostable direct hemoysin (TDH) determined by using
reversed passive latex agglutination. The detection of tdh, trh, gyrB, toxR gene
was performed by PCR method. The subspecies typing were performed by
enterobacterial repetitive intergenic consensus sequence (ERIC) and pulsed-
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ﬁeld gel electrophoresis (PFGE). The DNA sequence of toxRS gene was
analyzed.
Results: V. parahaemolytcis strains, 148, were isolated from the clinical and
environmental sources. In the antibiotics test, Most of isolates were resistant
against ampicillin, and ticacillin and sensitive to gentamicin, kanamycin,
nalidixic acid, streptomycin and tetracycline. The major O and K serotypes
were O3:KUT (43%) in environmental isolates and O3:K6 (68%) in clinical
isolates. All of the clinical isolates carried toxR, gyrB gene. One hundred and
nine of 120 clinical isolates carried tdh gene and 107 of them showed
Kanagawa Phenomenon. NotI PFGE differentiated 15 subtypes among
the 28 environmental isolates. Twenty-ﬁve strains, selected a representative
strain out of strains isolated from each outbreak, were grouped into three
subtypes in analysis of PFGE and were grouped into four subtypes in ERIC
PCR. In the toxRS DNA sequence analysis of 25 strains, 22 isolates were
determined into ‘new’ group suggested by Matsumoto et al. The remaining
three strains produced urease and carried tdh and trh gene.
Conclusions: Clinical and environmental isolates of V. parahaemolyticus had
similar biochemical characteristics, but almost clinical strains carried speciﬁc
genes of putative virulence factor and revealed hemolytic activity. Mainly new
group caused recent outbreaks of V. parahaemolyticus in Korea. The national
network and collaboration is need to investigate recent outbreaks caused by
V. parahaemolyticus in Asian countries.
P1659 Charaterization of Shiga toxin-producing
Escherichia coli in Korea from 1998 to 2002
J. K. Park, M. J. Park, Y. I. Kim, Y. H. Kang, B. K. Lee
Seoul, KOR
Objective: In Korea, Shiga toxin-producing E. coli (STEC) was ﬁrst isolated
from a patient with brain tumor in 1998. After this case, a number of the
isolates were increased gradually, 2 (1999), 3 (2000), 9 (2001) and 7 cases
(2002). A total of 22 isolates was investigated on the phenotypic and genotypic
characteristics and genomic DNA patterns.
Methods: STEC strains were collected through nationwide health care
centers. O grouping was carried out by bacterial agglutination with antisera
against 43 groups. Flagella H antigens were identiﬁed by agglutination of
motile strains with 22 anti-H sera. Detection of the toxigenic genes was
performed by multiplex PCR. The ability of an isolates to produce Stx1 and
Stx2 was determined by a reversed passive latex agglutination test. Anti-
microbial susceptibility of the isolates was studied by the disk diffusion
technique. The subtypes were determined with the pulse ﬁeld gel electro-
phoresis (PFGE).
Result: All of STEC strains were isolated from sporadic cases except small
outbreak involved two patients infected with serotypeO171. The distribution
of O serotypes was O157 (5), O111 (4), O26 (4), O171 (2), O128 (1), O91
(1), O55 (1) andOUT (8). Ten of the 22 STEC isolates carried stx2 gene only,
6 carried the stx1 gene only and 6 carried both genes. The corresponding
toxins were produced by 21 of 22 strains. The one isolate, which did not
produce Stx, was O128:H4. The eaeA and hlyA genes were detected in all
isolates except 3 and 4 strains, respectively. The identical PFGE patterns were
not shown even among the same O serotype group except O171 serotype
involved outbreak.
Conclusion:There is not yet big outbreak caused by STEC infection in Korea.
But the incidence of infection is gradually increasing. Korea is located close to
Japan, where there are big outbreaks every year, and heavy materials and
travelers come and go to each country. National Institute of Health forced
local health care center to survey actively STEC.
P1660 Studies on detection and type identiﬁcation of
Orientia tsutsugamushi in a single larval mite
of L. scutellare by polymerase chain reaction
C. Min
Nanjing, CHN
Objective: To detect and type the Orientia tsutsugamushi DNA in a single
larva of 61 Leptotrombidium scutellare collected from the endemic areas of
tsutsugamushi disease in Jiangsu province in China.
Methods:The group-speciﬁc primers and the type-speciﬁc primers designed
according to the nucleotides sequence of the gene region encoding the
56 kDa antigen of Ot were used to detect and type theOt by polymerase chain
reaction.
Result:Ot speciﬁc DNA band of about 320 bp were observed in two of the 61
larval mites after PCR ampliﬁcation using the group-speciﬁc primers for
detection, showing that the two larvae carried Ot and theOt. Carrying rate of
these mites was 3.7%. Identifying the DNA using the type-speciﬁc primer
resulted that the two Ot belonged to a new serotype and dominant strain in
epidemic region in Jiangsu and they were similar to Kawasaki strain of Japan
and the homology of their nucleotide sequence was 96.8%.
Conclusion:This method proved to be applied in detecting the Ot in a single
mite larva, which is useful for the epidemiology analysis of the transmitter in
endemic areas of scrub typhus.
P1661 Expression and identiﬁcation of truncated 56 kDa
protein of Orientia tsutsugamushi Gilliam strain in
prokaryotic cells
C. Min
Nanjing, CHN
Objective:The purpose of this studies is to express the truncated 56 kDa gene
of Orientia tsutsugamushi (Ot) Gilliam strain in Escherichia coli to obtain the
abundant recombinant protein with high activity and to play a foundation for
preparing the diagnosis kit of scrub typhus.
Methods: The truncated gene (about 700 bp) encoding for the C-terminus
amino acids of 56 kDa protein of Ot with high hydrophilicity and hemolo-
gization was ampliﬁed by using PCR technique. PCR product was cloned
initially into the PGEX-4T-2 expression vector, then transformed into E. coli
TGI, the plasmid DNA was extracted and digested with enzymes. Plasmids
containing the right insertion were sequenced to conﬁrm its identity and
retransformed the combinants intoE. coliBL21 (DE3). After IPTG induction,
the bacterial lysates were analyzed by SDS–PAGE and Western blot.
Results: The recombinant plasmid containing the aim gene has been
expressed successfully, the expressed fusion protein was visualized on gel at
molecular mass about 58 kDa and can be detected by the positive serum from
patients of scrub typhus by Western blot.
Conclusions:The expression product of the truncated 56 kDa gene ofGilliam
strain has immunoreactivity and may be a promising diagnostic antigen for
further preparing the diagnosis kit of scrub typhus.
P1662 Resuscitation and mouse virulence of viable
nonculturable halophilic noncholera vibrios
G. Sbaraglia, D. Ottaviani
Perugia, Ancona, I
Objectives: When enteric and pathogenic bacteria are released from their
hosts into natural environments, they are challenged by various environmental
stresses. These bacteria may persist outside of the host by entering a viable
nonculturable state (VBNC): cells appear dormant and cannot be cultured,
but are able to return to the active metabolizing state. The VBNC state has
been found in numerous human pathogens, including Vibrio species. Among
halophilic noncholera vibrios, Vibrio vulniﬁcus and Vibrio alginolyticus are able
to entry in the VBNC state. Whether or not V. alginolyticus and V. vulniﬁcus
remain virulent during, entry into and resuscitation from the VBNC state has
not been deﬁnitively demonstrated.
Methods: V. vulniﬁcus and V. alginolyticus obtained from fresh and frozen
seafood were used. The microcosm water method described by Oliver
and Bockian (Appl. Environ. Microbiol. 1995. 61: 2620–2623) was used
to obtain nonculturable cells. The culturability of cells was determined by
spread plate counting on HI agar. To examine both entry to and resuscitation
from the VBNC state in natural environment, we employed the membrane
diffusion chambers described by McFeters and Stuart (Appl. Environ. Micro-
biol. 1972. 24: 805–811) and Oliver et al. (Appl. Environ. Microbiol. 1995.
65: 2624–2630). Virulence assaywas performed as described byOttaviani et al.
(Lett. Appl. Microbiol. 2001. 33 : 61–64) and by Oliver and Bockian (Appl.
Environ. Microbiol. 1995. 61: 2620–2623).
Results: The entry of V. alginolyticus and V. vulniﬁcus into VBNC state was
induced by incubation in 8–158C water with salinity of 12–15% to obtain a
population <0.1 cfu/mL following plating on HI agar within 12 days.
Virulence was determinated using a iron-overload mouse model. Mice were
injected at various time with PBS microcosms before and after cells become
nonculturable and LD50 were calculated. When mice dead as a result of
challenge of PBS containing VBNC cells, culturable cells of the same strain
were isolated from both the peritoneal cavity and blood samples taken from
Clinical Microbiology and Infection, Volume 9, Supplement 1, 2003 407
the dead mice. These data were observed in V. vulniﬁcus and V. alginolyticus
strains showing mouse virulence.
Conclusions: The possibility that V. alginolitycus and V. vulniﬁcus cells might
enter into a dormant state undetectable by routine platingmethods presents an
important epidemiologic problem, especially if bacterial cells are able to retain
virulence during starvation.
P1663 Nanobacteria antigen and antibody titers in USA
controls compared with UK controls and kidney disease
patients
M. A. Miller-Hjelle, S. L. Stobbs, I. R. Poxton, J. T. Hjelle
Peoria, USA; Edinburgh, UK
Background: Nanobacteria (Nb) are newly discovered microbial agents that
are unique due to small size (0.2–0.5 nm) and a calcium apatite shell. Nb are
hypothesized to be the cause of extra-skeletal calciﬁcations, e.g. kidney stones,
atherosclerotic lesions and renal cysts. Nb associated biogenic apatite is both
antigenic and immunogenic; calcium apatite is not.
Objectives: In this initial survey, sera from 22 patients with various chronic
renal diseases (UK-P) and controls (blood donors) from the UK (20; UK-C)
and USA (20; USA-C) were tested for antibody (Ab) and antigen (Ag) to Nb.
Methods: ELISA kits were used (Nanobac Oy, Kuopio, FI). For this study,
unit values of Ab and/or Ag greater or equal to 1.0 were considered positive.
Samples for Ab were diluted 1 : 500; for Ag, 1 : 5 and 1 : 10 due to prozone-
like effect observed at recommended 1 : 1 dilution.
Results: Nb Ab positivity was >2.5-fold (35%) than USA-C (14%); UK-C
positivity was>2-fold than renal patients (18%). Nb Ag positivity was similar
for the three groups (mean 63%; range 59–69). Ag/Ab titers were examined
for various permutations of positivity (see Table 1).
Nb Ab or Ag positivity did not correlate with age (range: 23–68 years) or
gender.
Conclusions: This initial study for Nb Ab and Ag in presumed healthy
individuals in Scotland and Central Illinois revealed a >2-fold difference in
positivity. The relationship between Nb positivity and acute/chronic human
disease(s) involving soft tissue calciﬁcation is unknown. Interestingly, Scotland
has a higher rate of cardiovascular (i.e. calciﬁed plaque) disease than USA.
Kidney patients had lower Nb positivity perhaps due to being on hemodia-
lysis, thus clearing Nb more effectively. Expanded studies are warranted to
determine precise breakpoints for Ag/Ab positivity and negativity in health
and various disease states.
PCR and viruses
P1664 Evaluation of a new quantitative CMV PCR assay
in allogenic stem-cell transplant patients
L. Carden˜oso, J. Garcia-Campos, E. Lomas, T. Alarcon, M. Lopez-Brea,
R. Camara
Madrid, E
Purpose: To evaluate a new commercial available quantitative PCR assay
(afﬁgene1 CMV VL Test) (PCR-AVL), in allogeneic patients (ASCT), by
comparing the results obtained with the new PCR-AVL with those obtained
with Cobas Amplicor CMV MonitorTM assay (PCR-CA) and the pp65
antigenemia (Ag) assays.
Methods:A total of 100 plasma samples from 5 mieloablative allogenic stem-
cell transplant (SCT) patients (from HLA-identical siblings) with a total of
seven CMV episodes were included (15–28 samples per patient). Only one
patient developed a nonfatal CMV disease. Ag was prospectively performed
following standard procedures and was used for patient management. Samples
for PCR were frozen at 808C and tested afterwards. PCRs were performed
following manufacturer recommendations. Ag was considered positive when
at least two positive cells were seen counting two slides (2þ cells/400 000).
PCR-CAwere considered positive when400 DNA-copies/mL and PCR-
AVL when 1 DNA-copies/mL.
Results: Fifty-seven samples (57%) yielded a positive CMV result in at least
one assay: 53/99 (53.5%) with PCR-AVL, 46/99 (46.5%) with PCR-CA and
34/96 (35.4%) with Ag. One sample was excluded due to invalid result by
both PCR assays. Twenty-nine samples were positives by the three methods
and 40 were negative by all three assays. There was a high correlation between
PCR-AVL assay vs. the PCR-CA (r¼ 0.89). The median number of copies
detected by PCR-AVL was lower than PCR-CA. The log10 differences
between the PCR-AVL and the PCR-CA assay were plotted against the
average log10 CMV viral load/mL resulting in up to 1.8 log lower result with
the PCR-AVL assay compared with the PCR-CA. CMV infection was
detected earlier (6–11 days) in four out of seven episodes by PCR-AVL and
PCR-CA assays than by Ag. Moreover, in 1 episode, PCR-AVL detected
infection 7 days earlier than PCR-CA and Ag. The capability of the PCR-
AVL to monitor the viral load in patients during the follow-up was evaluated
by plotting post-transplant day against CMV viral load/mL for the PCR-AL
and PCR-CA assay and Ag. The PCR-AVL was capable of monitoring both
increase and decreases in the CMV viral load with same efﬁcacy as the PCR-
CA and the Ag assay.
Conclusions:The PCR-AVL assay showed a good correlation with the PCR-
CA and the Ag assays. The PCR-AVL assay is also capable of monitoring
increases and decreases in the CMV viral load. This quantitative CMV PCR
seems a useful tool in CMV monitoring after SCT.
P1665 Evaluation of real-time PCR-based assays for the
detection of herpesvirus and enterovirus in CSF
M. L. Amorim, A. C. Mendes, A. P. Castro, J. Cabeda, J. M. Amorim
Porto, P
Objectives: PCR is recognized as a reference standard method for the rapid,
sensitive and speciﬁc detection of enterovirus and herpesvirus in cerebrospinal
ﬂuid (CSF). In the present study we report the analytical evaluation of real-
time PCR-based assays and a one year experience in the routine diagnosis of
enterovirus and herpesvirus of the central nervous system.
Methods: Quality Control for Molecular Diagnostics (QCMD) proﬁciency
panels for Enterovirus, HSV, CMV and UK NEQAS for the Molecular
Detection of Viruses in CSF, long with serial dilutions of positive clinical
samples for EBVand HHV-6 were used to assess the sensitivity and speciﬁcity
of the assays. Enterovirus RNA was ampliﬁed by an ‘in-house’ developed
nested RT-real-time PCR in the SmartCycler (Cepheid, USA) using a
TaqMan probe. HSV-1, HSV-2, CMVand HHV-6 genomes were ampliﬁed
with sets of primers and eclipse probes from Epoch (USA) with Roche’s Fast-
Start-Taq DNA Polymerase in the SmartCycler; VZV and EBV were
ampliﬁed with kits from Artus (Germany) in the LightCycleraˆ (Roche,
Germany). These assays were further applied to a total of 279 CSF samples
collected, during 2002, from patients with clinically suspected viral infection
of the CNS.
Results:All enterovirus containing samples from the proﬁciency panels tested
positive including the most diluted sample (0.036 TCID 50/mL); the
speciﬁcity observed was 100%. Thirty-two percent of the 209 CSF samples
were found positive, a frequency similar to that observed in 2001 (31%) by
conventional nested RT-PCR. The detection limit (copies/mL) of the
Herpesvirus assays was found to be 200 for HSV1, 100 for HSV-2, 500
for VZV and 315 for CMV. HHV-6 was detected up to a 1/50 dilution of a
positive sample, whereas EBVwas detected up to a 1/10 dilution. All negative
samples from the proﬁciency panels were found negative (100% speciﬁcity).
Of the 161 CSF samples tested for herpesvirus, 16 (10%) were found positive
(2 HSV-1, 2 HSV-2, 2 EBV, 5 VZV and 5 HHV-6).
Conclusions:The use of real-time PCR methodology has allowed a dramatic
decrease in the turn-around time: from 48 h for enterovirus and 36 h for
herpesvirus to 4 h in both cases. The speciﬁcity of the assays was maintained at
Table 1 Comparative Ab and Ag results for USA and UK individuals
Ab Ag UK-C (%) USA-C (%) UK-P (%)
þ þ 20 5 9
þ  15 9 9
 þ 40 64 50
  25 22 32
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100% in all cases, whereas the sensitivities were found to be similar or better
(CMV) to the conventional PCR assays. In conclusion, the use of real-time
PCR allows a faster response time, without sacriﬁcing either sensitivity or
speciﬁcity.
P1666 Recovery of HIV-1 RNA from plasma using
magnetic silica particles used for viral load determination
and antiviral drug resistance DNA chip tests
P. van Deursen, J. N. Telles, R. Gonzalez, A. Verhoeven, P. de Bie,
M. Jacobs, P. van de Wiel, G. Vernet, A. Troesch
Boxtel, NL; Marcy l’Etoile, F
Objective: A second-generation manual extraction methodology with
increased sample throughput and user convenience is under development
at bioMe´rieux. The objective of this study was to investigate the suitability of
the new method for the recovery of HIV-1 RNA from plasma samples in
combination with (i) viral load measurement and (ii) antiviral drug resistance
mutations detection using real-time NASBA and DNA Chip technology,
respectively.
Methods: HIV-1 RNA was extracted from human plasma samples using
magnetic silica particles. Brieﬂy, 1mL of plasmawas added to 2mL lysis buffer.
Subsequently the released HIV-1 RNAwas bound to magnetic silica particles
and washed several times using different buffers. The RNA was recovered
from the silica particles by applying heat and a dedicated elution buffer. The
value of this method as a front end for viral load applications was measured by
testing 168 samples that were spiked with different concentrations HIV-1
RNA and 18 EDTA plasma samples obtained fromHIV-1 infected patients in
combination with the bioMe´rieux NucliSens EasyQ HIV-1 assay. As a
reference isolation method, the NucliSens Extractor was used. For the
DNA chip study, nucleic acid from 43 plasma samples were extracted and
analyzed for mutations in a subset of HIV genes by a new HIV-1 DNAChip
(designed by BioMe´rieux and manufactured by Affymetrix).
Results: The analytical sensitivity in combination with NucliSens EasyQ
HIV-1 was 45 IU/mL for the new extraction method, which is comparable to
the analytical sensitivity as measured in combination with the NucliSens
Extractor (62 IU/mL). In the 18 clinical samples that were used for the viral
load study, a good correlation in quantiﬁcation result was found compared
with the known viral load data (y¼ 0.96xþ 0.25 with r2¼ 0.97). The 43
samples analyzed by DNA chip showed a good correlation compared with
sequence analysis. The correct identiﬁcation of key resistance mutations for
the protease and the whole reverse transcriptase was 97% and 94%, respec-
tively. No resistance mutation in the integrase and gp41 were found, muta-
tions in the gag cleavage sites (A431VorQ430R)weremeasured in 21% of the
patients.
Conclusions: The new nucleic acid extraction method was successfully used
to recover HIV-1 RNA from plasma samples in combination with NucliSens
EasyQHIV-1 viral load measurements and for HIV-1 antiviral drug resistance
mutations detection using the DNA Chip technology.
P1667 Determination of human T-cell leukemia virus
proviral load by a multiplex one-tube real-time PCR
quantitation assay
T. Ruckes, G. Taylor, T. Grewing, T. Laue
Hamburg, D; London, UK
Objectives: Current diagnostics of the human T-cell leukemia virus types 1
and 2 (HTLV-1/2) is mainly based on antibody screening using ELISA and
Western blotting (WB). The majority of these assays allow for neither
discrimination between the virus types nor for quantitation of proviral load.
Therefore, the aim of this study was to develop a rapid and highly sensitive
HTLV diagnostic tool based on real-time PCR which allows both a deter-
mination of proviral load and a differentiation between the virus types. To
warrant a high reliability of the assay and to rule out false negative results, an
internal control was to be included.
Methods: For the design of a real-time PCR based diagnostic assay primers
and ﬂuorescence labeled probes speciﬁc for a conserved sequence in the
proviral Tax region of the HTLV genomes were designed. As an internal
control a second heterologous ampliﬁcation system of the house-keeping
gene beta-globin was included. The assay was established on three real-time
instruments (LightCycler1, Rotor-Gene, TaqMan). For quantiﬁcation pur-
poses, a serial dilution of a plasmid mixture containing the HTLV and beta-
globin amplicon was prepared.
Results: The sensitivity of this real-time PCR assay (RealArtTM HTLV PCR
Reagents) was down to 1 copy/PCR on the LightCycler1 instrument for
both HTLV-1 and -2 and for the beta-globin gene.ModiﬁedHTLV detection
systems were established on the Rotor-Gene and the TaqMan real-time PCR
instruments and exhibited a comparably high sensitivity performance. The
beta-globin ampliﬁcation system allowed the determination of the proviral
load per genome equivalents and serves as an internal control. Amelting curve
analysis allowed an unequivocal discrimination between the two HTLV types.
The real-time PCR assay was veriﬁed using clinical specimens of varying
concentrations.
Conclusions:The new real-time PCR assay provides a cost-and-time effective
diagnostic test for the quantitative detection of HTLV-1 and -2. The high
sensitivity of the analytical and the internal control PCR exceeds that of many
serological assays and allows a precise determination of the proviral load. In
addition, the internal control ampliﬁcation indicates an effective DNA
preparation and the absence of PCR inhibitors. In summary, this new
RealArtTM system provides a versatile tool for both routine blood donor
screening and patient treatment success assessment.
P1668 Evaluation of reverse transcription polymerase
chain reaction for detection of tick-borne encephalitis virus
genome
I. Binduga-Gajewska, W. Gut, A. Wielkopolska
Warsaw, PL
Objectives:Tick-born encephalitis virus (TBEv) is endemic in many Eastern
and Central European countries. This pathogen is considered as an important
etiological agent of viral neuroinfection in Poland with 150–200 of TBE cases
reported annually. The laboratory diagnosis of acute TBE infection based on
detection of TBEv-speciﬁc IgM antibodies in serum sample and estimation of
local antibody synthesis by the examination of serum IgG/CSF IgG ratio.
Isolation of TBEv relies on intracerebral inoculation of mice and observations
symptoms of infection. Application of nucleic acid ampliﬁcation techniques
has become more and more popular in diagnosis of neuroinfection. Our aim
was examination of RT-PCR method for diagnosis of TBE based on study
performed on 25 CSF samples selected from subjects with serologically
conﬁrmed acute TBEv neuroinfection. In addition, employment of RT-
PCRmethod for detection of TBEv genome in brain of TBEv infected mice
was investigated. TBE virus propagated in Vero cells and inactivated virus
from TBE vaccine were used as a control of TBEv RT-PCR speciﬁcity.
Methods:Serological designations of serum and CSF samples were performed
using ELISA IgG/IgM assay (PROGEN BIOTECHNIK). RNA was
extracted from CSF sample using QIAamp Viral RNA Mini Kit (Quiagen)
according to kit directions or using phenol–chloroform extraction in a case of
brain samples. RT-PCR was performed in a two-step process. Primer sets
(Gibco-BRL) in TBE ampliﬁcation systemwere directed to 50NCR region of
TBE virus genome and gave a product of ampliﬁcation of 128 bp in size.
Results: Positive results of TBEv speciﬁc RT-PCR were obtained with
propagated in Vero cells TBE virus as well as in brain of infected mice.
Genome of TBE virus was also detected in inactivated TBE vaccine. But from
a total of 25 cerebrospinal ﬂuids samples from patients with serologically
conﬁrmed TBE, only in one subject result of TBEv speciﬁc RT-PCR was
positive.
Conclusions: Typically biphasic course of tick-born encephalitis virus infec-
tion effects that serological designation is more convenient in laboratory
diagnosis of TBE encephalitis than usage of nucleic acid ampliﬁcation
method. Conversely, ampliﬁcation techniques are very effective for detection
TBE genome in brain and other biological materials.
P1669 Comparison of two commercial assays for
hepatitis B virus DNA quantiﬁcation: single vs. double
testing
A. A. Sayiner, S. Kirdar, Y. Dogan, Y. H. Abacioglu
Izmir, TR
Objectives:To compare the performances of Digene Hybrid Capture (DHC)
and Bayer Quantiplex (BQ) HBV DNA assays with regard to precision of the
single vs. double testing of the samples and to determine the conversion
between the two different assay values.
Methods: Intra- and interassay variabilities were tested in ﬁve runs by ﬁve
patient sera containing HBV DNA over the range of 5–2000 pg/mL. Thirty-
six additional sera with the same range of HBV DNAwere tested in duplicate
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by the two commercial assays and coefﬁcients of variation (CV) were
determined. Correlation between HBV DNA results of DHC and BQ
was examined by regression analysis.
Results:The mean intra- and interassay CV for the DHC and BQ assays were
11.6% to 9.3% and 19.3% to 19.2%, respectively. Among the duplicate studied
sera, 3(9.7%) and 7(19.3%) samples required repeat testing in the DHC and
BQ assays, respectively, as their CV exceeded the limit of 30% (P> 0.05) A
good linear relationship was observed between the logarithmic conversions of
HBV DNA levels determined by the two assays (r2¼ 0.969, slope¼ 1.037).
The formula for the conversion of results was log(HBV DNA level by
BQ)¼ 0.934  log(HBV DNA level by DHC)þ 0.372. The difference
between the log10 HBV DNA levels of the two different assays on the same
sample was always <0.5.
Conclusions:The log10 results of the two assays were closely correlated for the
sera containing HBV DNA within the detection range of both assays. The
difference for the same sample was always <0.5 log10. Sera with an unac-
ceptably high within-run CV value were detected in both assays, the number
was higher by BQ but the difference was not signiﬁcant. Single instead of
double testing of sera by BQ may cause inaccurate results in some settings.
P1670 Detection of herpes simplex virus DNA and
enterovirus RNA in cerebrospinal ﬂuid using PCR and
microplate or strip hybridization assay
A. A. Sayiner, I. M. A. Oktem, A. Ergani, C. Ergon, S. Kurul,
Y. H. Abacioglu
Izmir, TR
Objectives: To compare the microplate and strip hybridization assays for the
detection of herpes simplex virus (HSV) DNA and enterovirus (EV) RNA
PCR products in cerebrospinal ﬂuid (CSF) samples.
Methods: Thirty-one CSF samples from patients with a clinical diagnosis of
aseptic meningitis were studied. Nucleic acid was extracted from 200mL of
CSF using High Pure Viral Nucleic Acid Kit (Roche Applied Science).
Primers from the DNA polymerase gene were used for HSV PCR. EV RT-
PCR was performed in a two-step process using primers from the 50
noncoding region. PCR products were labeled with digoxigenin by using
PCR ELISA Dig-Labeling kit (Roche Applied Science). Detection was done
by gel electrophoresis and by biotinylated probe using streptavidin-coated
microplate and streptavidin-coated strips (Roche Applied Science).
Results: Among the 31 CSF samples, three (9.7%) were HSV PCR and 12
(38.7%) were EV RT-PCR positive by gel electrophoresis, microplate and
strip hybridization. Two samples (one HSVand one EV) were only detected
by microplate assay with a low OD value (<600).
Conclusion: Strip hybridization assay might be an alternative to the gel
electrophoresis with an advantage of using sequence speciﬁc probe. It can
be used for a single specimen and takes shorter time than microplate detection
but is not as sensitive.
P1671 Qualitative and quantitative determination of
herpes virus nucleic acid in clinical samples
C. Luger, G. Hochschartner, E. Vales, B. Sammer, M. Stammler,
S. Stumvoll, H. Mittermayer
Linz, A
Objectives:The aim of this study was to compare real-time quantitative PCR
with multiplex nested PCR for the detection of the herpes viruses CMV,
HSV-1, HSV-2, VZV, EBV, and HHV-6 in clinical samples and to determine
the viremias of the positive ones.
Materials and methods: A total of 353 clinical samples and performance
controls were tested by real-time quantitative PCR on the LightCycler
instrument and by multiplex nested-PCR on a conventional thermocycler
(140 samples of brain or CSF (group 1), 55 urogenital swabs (group 2), 22
biopsies from the gastrointestinal tract (group 3), 24 urine samples (group 4),
58 blood samples (group 5), 15 specimens from the respiratory tract (group 6),
12 samples from various organs (group 7), and 16 specimens from external
quality control panels (group 8)).
Results: A total of 325 (92.1%) out of 353 samples gave the same qualitative
result in both methods and only these are included in the following evalua-
tion. CMV, HSV-1, HSV-2, EBV, VZVand HHV-6 were found 1, 8, 2, 9, 6,
and 3 times in 132 samples from group 1. The corresponding numbers were 0,
14, 15, 2, 2, and 0 for 55 samples from group 2; 3, 3, 0, 6, 0, and 5 for 22 group
3 specimens; 12, 0, 0, 0, 0, and 0 for 24 urine samples; 17, 3, 0, 15, 1, and 2 for
58 blood samples; 2, 5, 0, 4, 0, and 0 for 9 group 6 samples; 3, 0, 0, 4, 0, and 0
for 10 samples from various organs, and 0, 5, 5, 0, 2, and 0 for 15 external
quality control samples, respectively. DNA copy numbers of CMV were low
in all kinds of positive specimens (median 500–16.500/mL). HSV-1 DNA
was highest in urogenital swabs (median¼ 33.575.000/mL) followed by
brain/CSF (median¼ 82.130/mL), respiratory samples (median¼ 8.800/
mL), blood (median¼ 459/mL), and biopsies from the gastrointestinal tract
(median¼ 93/mL). HSV-2 was most prevalent in urogenital swabs followed
by brain/CSF and blood, VZV and EBV-DNA were also found highest in
urogenital swabs. HHV-6 positive samples of brain/CSF, GI-tract and blood
contained nearly equal median copy numbers.
Conclusions: Both PCR methods seem to be equally suited for the detection
of herpes virus DNA in clinical samples as 92.1% yielded equal results.
Quantitative values of HSV1-, HSV2-, EBV- and VZV-DNAwere extremely
high in urogenital swabs. Median titers of CMV, HSV-1, HSV-2, VZV, EBV,
and HHV-6 in clinical samples other than urogenital swabs seem to be low.
Treatment of hepatitis band C
P1672 Evaluation of response and safety of chronic HBV
infection treatment with alpha-INF or combined treatment
with alpha-IFN and lamivudine
C. Drakoulis, L. Karasavidou, E. Nikitidis, A. Tsakiri, A. Machairidou,
P. Vavoulis, M. Minadaki
Piraeus, GR
Objective: Effectiveness and safety evaluation of treating HBV infection with
either alpha-IFN or combined treatment with alpha-IFN and lamivudine.
Methodology: Eighteen chronic HBV infection patients have been studied,
13 men and 5 women, average age 44.1, increased transaminase level of 1.5
above normal, HBV-DNA (þ). Three out of 18 HBeAg (þ), 15/18 HBeAg
(). Biochemical response study: 4 months. Virology response study:
6months. Histology response study: 12months. All studies conducted after
treatment end.
Results:
1. 3 HBeAg (þ) patients underwent alpha-IFN monotherapy. Two showed
biochemical response and one showed virological response. One patient
stopped treatment due to praecox side-effects. Improvement of histolo-
gical ﬁndings was diagnosed in none.
2. 15 HBeAg (–) patients underwent alpha-INF treatment, eight showed
biochemical response, seven showed virological response. three inter-
rupted treatment due to side-effects. After treatment end, two patients
had praecox relapse, with increased ALT and PCR (þ) levels. In general,
ﬁve responded to treatment, and one was found with long-term remission
(SVR) Improvement of histological condition was found in two patients
(improvement of infection and ﬁbrosis reduction).
3. 15 HBeAg (–) patients, four underwent combined treatment with alpha-
IFN and lamivudine. Three showed biochemical response and four
virological response. None interrupted treatment due to side-effects.
All patients responded to the treatment. One patient was found with
histological condition improvement.
Conclusions:Combined treatment with alpha-INF and lamivudine adminis-
tered to HBeAg () patients, brings better results compared with alpha-IFN
monotherapy. It seems to be equally safe to monotherapy, but it should be
clearly stated that more cases need to be studied in order to ﬁrmly establish our
conclusions.
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P1673 YMDD mutations during lamivudine therapy in
patients with chronic hepatitis B
I. Ko¨ksal, R. Caylan, N. Kaklikkaya, G. Aktoz Boz, K. Aydin, F. Aydin
Trabzon, TR
Objectives: The emergence of a YMDD mutant resistant to lamivudine
therapy has been reported in patients with chronic hepatitis B treated with
lamivudine therapy. The aim of this study was to evaluate the development the
YMDD mutant during lamivudine therapy.
Methods: We investigated the emergence of the YMMD mutant by reverse
hybridization line probe assay (INNO-LIPA HBV DR) in patients with
chronic hepatitis B who were treated with lamivudine for 12.8 3.8months.
Results:A total of 29 biopsy proven chronic hepatitis B patients who received
lamivudine 100mg daily were included the study. Twenty-two cases were
male and seven were females with their ages averaging 23.7 8.6 (15–
45 years). Family history of hepatitis was positive in 51.7%. Pretreatment
levels of AST, ALT and HBV DNA were 63 30, 89 64 (U/L),
2742 2315, respectively. Mutations in the YMDD motif of the DNA
polymerase gene were identiﬁed in seven patients (24.1%) in the
11.28 2.6month (6–15month) of lamivudine treatment. The mean levels
of HBVDNA in cases with and without YMDDmutation were 4329 2636
and 2237 2013, respectively (P¼ 0.02).
Conclusions: It is determined that YMDD development is affected by the
high levels of HBV DNA in patients with chronic hepatitis B. This ﬁnding
demands new therapeutic approaches such that a tailor-made, individualized
treatment regimen allowing a better insight into the variability in response.
P1674 Afﬁgene1 HBV patient disease management
concept-tools for individualizing HBV treatment
V. To¨rma¨nen, T. Eriksson, N. Finnstro¨m, A. Hedrum
Bromma, S
Background: The outcome of treatment of chronic HBV is dependent on
several different factors, e.g. the level of HBV DNA, and the heterogeneity of
the viral strain (e.g. drug resistant viruses and precore mutants). This indicates
that individualization of treatment of HBV based on these parameters would
be beneﬁcial for the patient, giving increased well-being as well as from a
health economic perspective. The afﬁgene HBV patient disease management
(PDM) concept offers a panel of assays for HBVmonitoring: (i) a quantitative
HBV-DNA assay; afﬁgene HBV VL (ii) a semiquantitative precore/
core mutant assay; afﬁgene HBV mutant VL and (iii) a qualitative lamivudine
resistant assay; afﬁgene HBVDE/3TC. This poster describes the performance
of the three assays and the assessment on clinical material.
Methods: Each assay is based on four major processes. (i) specimen prepara-
tion (ii) PCR ampliﬁcation of target DNA using HBV speciﬁc primers (iii)
hybridization of target speciﬁc probe or elongation of a mini sequencing
primer (iv) colorimetric detection. Afﬁgene HBV mutant VL and afﬁgene
HBV DE/3TC are both based on the mini sequencing technique while the
afﬁgene HBV VL assay is based on a DNA hybridization method. Perfor-
mance studies were evaluated on standardized WHO HBV samples or
artiﬁcial specimens comprised of DNA fragment mixes of different mutant
genotypes. The clinical samples were from patients with chronic HBV
infection. Each clinical sample was prepared once using the afﬁgene HBV
Specimen Preparation kit and analyzed with all three assays. The results were
compared with Amplicor HBV Monitor or sequencing.
Results: Performance data on the afﬁgene HBV PDM concept is shown
in Table 1. The viral load is expressed in international units per ml (IU/mL).
Excellent correlation (r¼ 0.99) was obtained when comparing the afﬁgene
HBV VL and the Amplicor HBVMonitor assays. Both afﬁgene HBV mutant
VL and HBV DE/3TC showed a good agreement to sequencing. However,
data indicate that the afﬁgene HBV mutant VL and DE/3TC are more
sensitive in detecting a mixed population of wild-type and mutants.
Conclusions: The afﬁgene HBV PDM concept offers an extensive view of
the HBV DNA status. The three standardized assays for monitoring patients
with chronic HBV provide guidance for individualized treatment of the
infection.
P1675 Predictive value of serum B2-microglobulin
(B2-m) levels for virological breakthrough, in chronic
hepatitis B patients under long-term lamivudine
treatment
I. S. Elefsiniotis, I. Glynou, D. Kosmatos, I. Magaziotou, M. Simou,
K. D. Pantazis, H. Kada, C. Mavrogiannis
Athens, GR
Objectives: To evaluate the predictive role of serum B-m levels in virological
breakthrough (VB) among HbeAg (–) chronic Hepatitis B (CHB) patients
under long-term lamivudine monotherapy.
Methods: Serum samples were obtained at baseline and every 3months
during treatment, from 25 CHB patients, serologically, biochemically, vir-
ologically and histologically conﬁrmed. Serum HBV-DNA was calculated
using a PCR assay (Amplicor, Roche) and serum B-m levels using a
microparticle enzyme linked immunoassay (AxSyM, Abbott). All CHB
patients were naı¨ve and received LAMmonotherapy for 36months. Statistical
evaluation was done using ANOVA t-test and Cox-regression analysis (P-value
<0.05).
Results: Seven out of 25 (28%), 10 out of 25 (40%) and 13 out of 25 (52%)
CHB patients exhibited VB at month 12, 24 and 36, respectively. All CHB
patients were HBV-DNA (–) at month 6 of treatment. Baseline serum HBV-
DNA and serum B-m levels were comparable between the responders group
(RG) and VB. Eighteen CHB patients exhibited a signiﬁcant elevation of
serum B-m levels at month 3 and 6 of treatment (11 RG/7 VB) and 7 CHB
patients exhibited decline (1 RG/6 VB). Baseline HBV-DNA was signiﬁ-
cantly lower in CHB patients who exhibited elevation of serum B-m levels
than in those who exhibited decline (P< 0001). The duration (in months) of
B2-m elevation was signiﬁcantly higher in the RG than VB (6.6 1.89 vs.
3.5 3.5, P¼ 0024).
Conclusion: Elevation of serum B2-m levels, especially during the ﬁrst
months of LAMmonotherapy, was observed in the majority of CHB patients
with low baseline viremia and was correlated with long-term virological
response, suggesting an activation of endogenous immune response, following
the reduction of viral load, in this group of patients.
P1676 The effect of lamivudine therapy in chronic
hepatitis B patients
H. Kalantari, M. Minakari
Isfahan, IR
Objectives: Lamivudine is an oral nucleoside analogue with a potent antiviral
effect on HBV due to inhibition of viral DNA polymerase. In this study
response to treatment with lamivudine in Iranian patients was evaluated.
Methods:Nineteen patients were studied. Lamivudine 100mg daily per oral
for one year was prescribed. Before the beginning of the treatment, virus
markers (HBSAg, HBV DNA, HBeAg) and liver enzymes were recorded and
liver biopsy were taken. These experiments were repeated after treatment too.
and the results were recorded.
Results: Among the 19 patients under study 12 (63.19%), 14 (73.6%) and 11
(60%) had virological, biochemical response and histological improvement,
respectively.
Conclusion: Several nucleoside analogues active against HBV are being
evaluated. Famciclovir and ganciclovir have only limited activity against
hepatitis B. However, lamivudine which inhibits reverse transcriptase activity
of both HIVand HBV, is a potent and effective agent for patients with chronic
hepatitis B.
Table 1 Performance data on affigene HBV PDM concept
Dynamic range
(IU/ml)
Limit of detection
(LOD) (IU/mL)
Sensitivity at
LOD (% mutant)
Affigene HBV VL up to 8 106 100 n/a
Affigene HBV Mutant VL 500–8 106 5000 5
Affigene HBV DE/3TC 15000–8 106 15000 15
Clinical Microbiology and Infection, Volume 9, Supplement 1, 2003 411
P1677 Clinical side-effects in patients with chronic viral
hepatitis C either of antiviral treatment with alpha-IFN or
combined treatment with ribavirin, or combined treatment
with peg-intron E ribavirin
C. Drakoulis, C. Liarou, A. Machairidou, A. Tsakiri, S. Georgoulas,
P. Vavoulis, C. Malli, C. Bilinis
Piraeus, GR
Introduction: Evaluation of standardized initial treatment of chronic hepatitis
C with recombinant alpha-IFN or in combined treatment with Ribavirin, or
in combined treatment with Peg-Intron and Ribavirin (although this treat-
ment causes numerous side-effects).
Methodology:For the treatment of chronic hepatitis C, we used alpha-IFN at
a dose of 3 MU 3 times a week for a period of six to 12months, or combined
treatment with Ribavirin. Fifteen mg/kg for 6months, or combined treat-
ment with Peg-Intron 100mg per week andRibavirin 15mg/kg to 51 patients
(39 male patients, 12 female ones, average age 42.3-years-old).
Results: The side-effects should be divided as early ones (taking place within
the ﬁrst two weeks) and postponent ones (occurring after two weeks). Early
side-effects include anemia (14/51 patients), leukocytopenia (26/51), throm-
bocytopenia (18/51), myalgia (6/51), inﬂuenza phenomena (6/51), and fever
(7/51). Postponent side-effects include weight-loss (14/51), deﬂuation (14/
51), libido decrease (8/51), insomnia (12/51), headache (5/51), abdominal
pain (4/51), diarrhea (2/51), stress (7/51), itching (3/51), weakness (7/51),
depression (6/51), rash (1/51), dizziness (3/51), xerostomia (1/51), xeroder-
mia (3/51), anorexia (10/51), chills (sense of cold 2/51), surdity (1/51),
arrhythmia (1/51), S. Raynaud (1/51) and ﬁbular nerve paresis (1/51). No
patient mentioned taste disorders. Six patients had to stop treatment because
of the side-effect symptoms’ severity.
Conclusions: The treatment of chronic hepatitis C with either alpha-IFN, or
combined treatment with Ribavirin, or combined treatment with Ribavirin
and Peg-Intron appears to be connected with a variety of side-effects,
although these side-effects rarely lead to the modiﬁcation or interruption
of the treatment.
P1678 Evaluation of chronic HCV infection response and
safety with alpha-IFN or alpha-IFN and ribavirin combined
treatment or peg-intron and ribavirin combined
treatment
C. Drakoulis, L. Karasavidou, C. Liarou, E. Nikitidis, E. Epitropakis,
E. Parisi, M. Minadaki
Piraeus, GR
Objective: Evaluation of chronic HCV infection response and safety with
alpha-IFN or alpha-IFN and ribavirin, or peg-intron and ribavirin combined
treatments.
Methodology: Fifty-one patients were studied. Average age 42.3, transami-
nase increase 1.5 above normal and HBV-RNA (þ). Biochemical response
studied for 4months, virological response for 6months and histological
response for 12months after the end of treatment.
Results:Alpha-IFNMonotherapy: 13 patients, 8 men, 5 women/average age
38.7. Biochemical response: 10; Virological response: 8 patients. Long-term
virological response (SVR): ﬁve patients/HCVRNA non detectable by PCR
method. two patients stopped treatment due to side-effects. Praecox relapse
after treatment end: one patient. Histological examination in two patients one
year after treatment end, showed infection reduction and same degree of
ﬁbrosis. Alpha-IFN and ribavirin combined treatment: 29 patients, 22 men, 7
women/average age 37.3; Biochemical response: 26 patients; Virological
response: 22 patients. Long-term virological response (SVR): 13 patients/
HCVRNA non detectable by PCRmethod. Two patients stopped treatment
due to side-effects. Praecox relapse after treatment end: one patient. Histo-
logical examination in nine patients, showed infection and ﬁbrosis degree
reduction, while ﬁbrosis increase was found in one patient. Peg-intron and
ribavirin combined treatment: nine patients, seven men, twowomen/average
age 40.3. Biochemical response: seven patients; Virological response: seven
patients; two patients stopped treatment.
Conclusions:Alpha-IFN and ribavirin or peg-intron and ribavirin combined
treatments produce better results than a-IFN monotherapy. Combined
treatments are equally safe to monotherapy and the effectiveness of combined
treatments is related to genetypes 2 and 3, the young age of patients and the
initial mildness of the ﬁbrosis.
P1679 Sustained virological response in patients with
chronic hepatitis C virus viremia treated with ribavirin (RIB)
alone followed by interferon alpha and RIB combined
N. Furusyo, H. Nakashima, S. Nabeshima, M. Murata, S. Kashiwagi,
M. Nakamuta, K. Hayashida, J. Hayashi
Fukuoka, JP
Objectives: Combined interferon (IFN) and RIB therapy is widely accepted
for Japanese patients with chronic hepatitis C virus (HCV) viremia. RIB has
been shown to signiﬁcantly increase the virological response to IFN.
Although RIB alone doesn’t have a substantial impact on HCV clearance,
it has been shown to normalize alanine aminotransferase (ALT). The above
suggests that RIBmay modulate the immune system against HCV. The aim of
this study was to investigate the possible relationship between virological
response and expansion of T helper (Th) 1 cells by sequential administration of
IFN and RIB combined after 4weeks of RIB administration.
Methods: Forty consecutive patients with HCV of genotype 1b and with a
high HCV RNA level, over 100KIU/mL, were treated with RIB for
4weeks, after which they received a combined IFN-alpha and RIB treatment
for 24weeks. Changes of serum ALTand the HCVRNA level of each patient
was measured during the observation. Virological response was deﬁned as
negative for HCVRNA in serum.We also used ﬂow cytometry to investigate
sequential changes of IFN-gamma producing (Th1) and interleukin-4 pro-
ducing (Th2) cells from whole blood samples after stimulation with PMA and
ionomycin.
Results: During the 4-week RIB administration, mean ALT did not sig-
niﬁcantly decrease from baseline, but serum HCV RNA levels signiﬁcantly
decreased from 755.6KIU/mL at baseline to 596.5KIU/mL at the end of
week 4, despite no patients having cleared HCV RNA. The mean Th1/Th2
ratio signiﬁcantly increased from 15.9 at baseline to 17.6 at week 4 of RIB
administration, suggesting that RIB administration has more effect on Th1
cell modulation than on Th2 cell modulation. During the combined IFN and
RIB treatment, after 4 weeks of RIB administration, mean ALTand the Th1/
Th2 ratio signiﬁcantly decrease from the start of the combination treatment to
the end of week 4 (from 80.7 IU/L to 49.4 IU/L and from 17.6 to 15.5,
respectively). In 4 patients with virological response at 4 weeks after the start
of the combined treatment, the Th1/Th2 ratio signiﬁcantly decreased, from
16.3 at the start of the combined treatment to 8.4 at the end of week 4.
Conclusion:From these ﬁndings, the 4-weekRIB administration resulted in a
decrease in serum HCV RNA and increased Th1 cell modulation, which
possibly led to the early clearance of HCV RNA seen when RIB alone was
followed by combined IFN and RIB treatment.
P1680 Managing drug toxicities associated with
pegylated interferon alfa-2b and ribavirin for the
treatment of hepatitis C in patients coinfected with HIV
S. E. Peters, Y. Gourlay, R. A. Seaton, R. Fox
Glasgow, UK
Background: Morbidity and mortality secondary to HCV infection is of
increasing concern in patients coinfected with HIV. Treatment with pegylated
interferon (PEG-INF) and ribavirin (RBV) is currently most effective but is
associated with signiﬁcant adverse events.
Methods: We currently offer PEG-INF alfa-2b and RBV therapy to all
coinfected patients in whom there are no contraindications. We describe a
prospective review of adverse events and management of patients treated with
PEG-INF and RBV in our unit.
Results:We have commenced treatment in 10 patients (seven hemophiliacs)
and all have experienced adverse events. Six patients complained of symptoms
of depression and ﬁve patients required antidepressant therapy after review by
a psychiatrist. One patient temporarily discontinued therapy due to severe
hemolytic anemia secondary to zidovudine in combination with RBV.
Following a switch from zidovudine to tenofovir, PEG-INF and RBV were
reintroduced without recurrence of severe hemolysis. Four hemophiliac
patients have required G-CSF for treatment of neutropenia to enable
HCV therapy to be continued at full dose. Dose modiﬁcation of PEG-
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INF alone did not maintain neutrophils >0.5 cells/mL. One patient devel-
oped diabetes requiring diet control. Other adverse events includeweight loss,
alopecia, thyroid function abnormalities, thrombocytopenia, ‘’ﬂu like symp-
toms, splenomegaly,H. inﬂuenzae respiratory tract infection, dry skin and oral
ulceration. No signiﬁcant HIV related problems have arisen other than a mean
fall in CD4 count of 119.45 (SD, 159.3) cells/mL, related to absolute
reductions in white cell count. There have been no episodes of hyperlacta-
temia or symptomatic lactic acidosis. No patients had prolonged periods of
absence from work and generally were able to continue with their activities of
daily living as before.
Conclusions: Treating HCV in HIV coinfected patients is feasible but drug
toxicities are very common. Patients with hemophilia are at increased risk of
signiﬁcant neutropenia. Patients must be well motivated and informed before
embarking on treatment. Most adverse events can be managed safely without
withdrawal of HCV therapy but a multi disciplinary approach with close
monitoring is required.
P1681 The effect of combination interferon and
ribavirin therapy in chronic hepatitis C
H. Kalantari, M. Minakari
Isfahan, IR
Objectives: Combination therapy with interferon and ribavirin has been
studied in many countries, i.e. virilogical respons has been reported approxi-
mately 50% in the USA. The aim of the present study was to evaluate the
effect of combination therapy in Iranian patients.
Methods: Seventeen patients were studied. Three MU interferon Alpha-2b
were injected subcutaneously 3 times a week in combination with ribavirin
1000–1200mg daily per oral for 24weeks. before The beginning of the
treatment virus markers (HCV Ab, HCV RNA) and liver enzymes were
recorded and liver biopsy were taken. These experiments were repeated after
treatment too and the results were recorded.
Results: Among the 17 patients under study, 13 (57.1%), 14 (82.3%), and 7
(41.1%) had histological improvement, biochemical and virological response,
respectively.
Conclusion: Six-month ribavirin, interferon therapy results in a signiﬁcant
reduction of virus load, histological improvement and biochemical response
and thus it is a suitable treatment for patients with chronic hepatitis C.
P1682 Variability in HCV E2 gene and treatment
response
B. Ferna´ndez, M. Basaras, S. Blanco, S. Sa´nchez, E. Arrese, B. de las
Heras, R. Cisterna
Bilbao, E
Background:Because of the lack of a really effective treatment for hepatitis C
virus (HCV) infection, the study of interferon resistance basis became crucial.
In HCV E2 gene two regions seem to be related with non response to therapy,
the HVR1 and PePHD regions. The aim of this study has been to analyze the
relationship between these regions’ variability (expressed as quasispecies
detection) and the viral behavior.
Patients and methods: Samples from 25 patients infected with HCV
chronically were analyzed. The quasispecies were detected by nested RT-
PCR following single-strand conformation polymorphism assay (SSCP). The
bands were visualized by silver staining. Genotyping was performed using non
type-speciﬁc primers of core region following hybridization with HCV
subtype-speciﬁc 50-biotinylated oligonucleotide probes to detect each sub-
type using DEIA (DNA Enzyme Immunoassay). The patients were divided
into three groups with respect to response to therapy: eight patients with
sustained response, nine patients with transient response and eight non-
responders patients.
Results: The results have been different depending on the region. The
variability in HVR1 varies according to the type of sample. In patients with
sustained response a low pattern of heterogeneity was observed. In the rest of
patients the genetic complexity pattern in HVR1 was high or the appearance
of new bandswas detected.Most patients involved in this study that showed an
initial high genetic complexity pattern were infected with 1b genotype
(85.71%) and those who showed a low genetic complexity pattern were
3a genotype (45.45%). By contrast, in PePHD region all samples presented a
low genetic heterogenity pattern and it was independent of patients char-
acteristics, as genotype, sex or age.
Conclusion: The effect of HVR1 region in interferon resistance could be
related to the generation of new genetic variants able to escape from
immune system, so the response is only achieved if the number of quasispecies
in cell is low. But this possibility is not possible in PePHD region. This region
does not present variability and is quite stable. This genetic homogeneity
could be considered as an indirect signal of this region importance on viral
persistence. Moreover, this study implies that the mechanisms used by these
regions are completely different. However, more studies are needed to
evaluate the real role of these regions from E2 gene on the antiviral activated
by the cell.
Tropical public health
P1683 Survey of Eltor cases in Iranshahr county
1996–2002
H. Abdollahzadeh, K. A. kbarzadeh
Iranshahr, IR
Cholera is an acute intestinal infection caused by ingestion of food or water
containing Vibrio cholera serogroup 01–0139. Vibrio cholera has been
recognized as one of the most common causes of acute bacterial diarrheas
throughout the world. During 1998, that was a dramatic increase in the
number of cholera cases worldwide, as well as Asia, compared with 1997, with
the total number of cases almost doubling. In Iran, the number of fatalities
caused by the disease in the 1990s reduced to less than half of those reported in
the 1980s and reached from 38,710 cases to 15,912. This reduction would be
continued at the 20 decade. But the fatality cases reveal a periodically pick
with alternation of 2 years. Iranshahr County is host of Afghan and Pakistani
refugees. This county is struggling with drought for last 6 years. Thus,
conditions would be prepared for some infectious disease as well as the Eltor.
This retrospective study has conducted for survey of reported cases of the Eltor
for identifying its risk factors in Iranshahr County. 3761 stool samples of the
patients with diarrheawere studied during years 1996–2002.Majority of them
were from villages around the county. 115 Vibrio cholera were isolated with
an isolation rate of 3.05%. Fatality rate was 4.35%. Carry Blaire and TCBS
cultures were used as the gold standard for diagnosis of cholera. 104 cases
(90.5%) of these were Ogawa serotype and rest 11 (9.5%) was NAG vibrios.
All the patients (100%) presented with loose stools. 11.3% of affected
individuals were children below 2 years, 32.17% between 2 and 5 years,
22.6% between 5 and 10 years, 33.91% up to 10 years of age. There were
67.5% males and 32.5% females. The patients were using various systems of
water supply (31.3% from ducts, 36.5% from tap water and rest 32.2% from
the other sources, e.g. wells, springs, rivers and so on). It is obvious that the
water supply and its hygiene in villages of this county needs a basically
revision. Training of villagers also would be very useful.
P1684 The health-seeking behavior of parent/carer of
severe malaria children before admission
A. E. Forlack, M. T. Abena Obama, C. Kouam Kouam, E. Manga, M.
Beyeme Owono, J. Mbede, A. Etame Ewane, E. M. Minkoulou
Yaounde, CM
From January 1st to August 31st 2000, we carried out a cross-sectional study of
parents/caretakers of 148 children aged 6–59months, hospitalized for severe
malaria, at the Djoungolo and the Mfou district hospitals, in order to describe
their health seeking behavior. Themean delay between the onset of illness and
arrival at hospital was 3.9 days. Most (79.7%) parents/caretakers resorted to
auto-medication. Antimalarial drugs were most presumedly used (76.6%),
amongst which chloroquine was the most frequent (73.4%). Only 51.1% of
the antimalarial drug were presumedly administered at adequate dose. We
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recommend that for better management of malaria at home, health education
of parents/caretakers should be intensiﬁed.
P1685 Study on the relationship of zinc and iron serum
concentration with giardiasis in children under 12years of
age, referred to hospitals afﬁliated to the Mazandaran
University of Medical Sciences
M. Sharif, H. Ziaee, M. Nasrolahei, A. Khalilian
Sari, IR
Objective: Giardiasis is one of the most prevalent human intestinal parasites,
particularly in children. Its presence in the intestine causes damage to the
deudenum and jejuneum inner cellular wall, which results in malabsorption of
different important substances such as zinc and iron which can lead to the
delay in physical and mental growth, anemia, diarrhea. Since the absorption of
these two elements are trace and are dependent on the certain existing
conditions, these trace elements are essential, and if their absorption is
inhibited, the complications will appear soon. The aim of this research is
to determine the serum concentration of zinc and iron in the children infected
with Giardia lamblia.
Methods: 100 children under 12 years of age were chosen. The presence of
Giardia lamblia in stool samples was identiﬁed by direct and formal ether
methods. This group of patients had no other infectious diseases. The control
group consisted of 100 children under 12 years of age without any clinical and
laboratory ﬁndings. 5mL of blood was drawn from each person and serum
was separated. Questionnaire regarding the age, physical growth status and
clinical condition was prepared and ﬁlled. Serum zinc and iron concentration
was measured with atomic absorption spectrophotometry. A questionnaire
related to the age, height, weight, parents’ level of education, the kind of
residential areas, the drinking water, the clinical characteristics of Giardiasis
was ﬁlled.
Results: In this study, the mean and standard deviation of serum iron in test
and control groups were 0.67 0.25 ppm and 0.77 0.23 ppm, respectively,
and for serum zinc concentration in the test and control groups were
0.64 0.20 ppm and 0.96 0.23 ppm, respectively. On the basis of the T-
test, there was a signiﬁcant differences between the test and control groups on
their serum Iron concentration (P< 0.01). Also there was statistically highly
signiﬁcant differences in zinc serum concentration (P< 0.001) between the
case and control groups.
Conclusion:Considering the above mentioned results, in order to prevent the
deﬁciency of above mentioned elements and prevention of the arisen
complications, the consultant physicians are recommended to change the
therapeutic strategies and control the blood factor and also the pharmaceutic
factories are recommended to add zinc and iron as complement to the
antiparasitic drugs, to help to improve the society welfare.
P1686 Environmental pollution with soil-transmitted
parasites in a healthy village (Kargan) before environmental
sanitation, Ardabil, Iran
A. Daryani, G. Ettehad
Ardabil, IR
Objectives: Some of parasitic diseases especially intestinal parasites transmitted
by water, soil and food are the most important economic and healthy
difﬁculties in the developing countries. Aim of this study was to determine
the sources and rates of parasitic infections in Kargan village, Ardabil.
Methods: In this cross-sectional survey 331 stool samples from village
inhabitants, as well as 30 water samples, 30 waste water and 40 soil samples
from the village were collected and examined for the presence of parasitic eggs
and cysts.
Results: 49.8% of the stool samples were infected by at least one type of
intestinal parasite. 16.6% of the water samples, 42.5% of the soil samples and
36.6% of the waste water samples were found to be positive for parasitic eggs
and cysts.
Conclusions: These results indicate that soil and waste water are heavily
contaminated and parasites are circulated between human and the environ-
ment. Improving environmental sanitation is imperative for the control of
soil-transmitted parasites in this village.
P1687 The outbreak of toxoplasmosis in pension
students in Turkey
L. Doganci, M. Tanyuksel, R. E. Araz, B. A. Besirbellioglu, U. Erdem,
A. C. Ozoguz, N. Yucel, A. Ciftcioglu
Ankara, Izmir, TR
Objective: Human toxoplasmosis originating from infected cats with Tox-
oplasma gondii is a major public health problem. It has been known that
majority of human infections with T. gondii have a benign course in immu-
nocompetent subjects. There are several well-documented reports about
some outbreaks of acute toxoplasmosis. Over the last 10 years the serologic
diagnosis of infection has been based mainly on the enzyme-linked immu-
nosorbent assay (ELISA). Also, ELISA IgG avidity and VIDAS tests are in use
widely. The aim of this present study was to investigate and to evaluate and to
report the largest outbreak of toxoplasmosis by different serologic tests (ELISA
IgG/IgM, IgG avidity, and VIDAS IgM) in the reported studies so far.
Methods: A total of 56 male students who live in a pension high school aged
between 14 and 18 years. They presented with mostly ﬂu-like symptoms
(subfebrile/fever, myalgia, dizziness, headache) with/without cervical lym-
padenopathy. For the investigation, serologic test such as ELISA IgG/IgM
(Equipar, Italy) IgG avidity (Bouty Beia, Italy) and bioMe´rieux Vitek VIDAS
Toxo IgM (France) were used.
Results: Based on serologic tests, all of the reported patients were seropositive
for T. gondii antibodies by ELISA IgG/IgM, and VIDAS IgM. Additionally, 36
(92.3%) of 39 had low IgG avidity and only 3 (7.7%) of 39 displayed discrepant
IgG avidity. All of patients were found with LAP (cervical/submandibular/
retroauricular/suboccipital, ca. 1 cm 1.5 cm size) and otherwise healthy
when examined by infectious disease physicians. Also, none of the student had
evidence of an active chorioretinitis focus in retinal examination by ophthal-
mologist.
Conclusion: Acute toxoplasmosis outbreak was diagnosed according to the
results of presence of anti-T. gondii antibodies by serologic tests (ELISA IgG/
IgM, IgG avidity, and VIDAS IgM). The data suggest that the ELISA IgG
avidity test can be helpful and useful tool in differentiation of recent and past
toxoplasmosis in epidemic settings. No treatment was given to any student
because of healthy immune system and lack of symptom. It remains unclear
(or mystery) how could this toxoplasmosis outbreak occur in spite of much
efforts in searching possible transmission ways (drinking water, cats, etc.). But
this population will be resolutely continuing the follow up research periodi-
cally both serologically and physically.
P1688 Malaria chemoprophylaxis for international
travelers in Bahrain
K. A. Jassim Al Khaja, R. P. Sequeira, A. Y. Ismaeel
Manama, BH
Objective: Inappropriate use of malaria chemoprophylactic regimens is
considered one of the contributing risk factors for acquiring malaria by
travelers destined for endemic areas. We assessed the malaria chemoprophy-
laxis practice in Kingdom of Bahrain.
Methods: A descriptive, questionnaire-based prospective study conducted
between July 2001 and June 2002 in 43 out of a total 50 private-sector
pharmacies.
Results: A total of 201 responses were received by the end of the survey from
23 pharmacies. Among 201 individuals 144 (71.6%), 52 (25.9%) and 5 (2.5%)
sought antimalarials for chemoprophylaxis, treatment, and for standby treat-
ment purposes, respectively. Antimalarials were most commonly dispensed
during June and July. Chloroquine was the most commonly dispensed
antimalarial prophylactic (61.1%), followed by meﬂoquine (27.8%). In 144
individuals who sought chemoprophylaxis and travelled to endemic areas, 101
(70.1%) were provided with inappropriate chemoprophylaxis. Of these, in 73
antimalarials were dispensed for self-medication purpose, whereas, in 20 in
response to advice/prescriptions issued by public health advisory body, and in
8 in response to private clinic-based prescriptions.
Conclusions:We found a considerable disparity between malaria chemopro-
phylactic drugs dispensed and regimens recommended by the World Health
Organization (WHO); more than two-third of travelers who sought che-
moprophylaxis received inappropriate drugs. In order to optimize malaria
chemoprophylaxis and to encourage travelers to seek proper medical advice,
antimalarials should be no longer dispensed on an over-the-counter basis, and
chemprophylaxis advice should be provided only by the public health
advisory body and by physicians.
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P1689 Development of a questionnaire for assessing
medical awareness on bioterrorism issues
G. Pappas, N. Akritidis, E. Tsianos
Ioannina, GR
In the aftermath of the anthrax outbreak of October 2001, we attempted to
assess the awareness of medical graduates and young doctors in our area over
basic issues of bioterrorism.We used a multiple-choice questionnaire focusing
on basic, historical, taxonomic, epidemiologic, clinical, and treatment-related
issues of the usual biological warfare. The results concluded that awareness of
young doctors over matters of bioterrorism is only marginal. The median
score of correct answers was only 38%, falling in the predetermined ‘poor’
category. The questionnaire was also used as a tutorial on basic aspects of
biological weapons: its results moreover emphasized the need for enhanced
medical alert over such issues, in order to minimize the unavoidable media-
fuelled frenzy that accompanies such dire events.
P1690 Sexually transmitted infections and prenatal
control: health services characteristics and user satisfaction
C. Macias, S. Lopez, M. Bronfman
Cuernavaca, Mor, MEX
Aims: In this work one evaluates the satisfaction obtained by the users of the
prenatal control services (PC) and sexual transmitted infections (STI) as well
sexually comparing itself with some characteristics of the supplier and the
basic characteristics of the service of health.
Material and methods: A cross-sectional survey was applied in where 248
pairs of supplier–users of health services in 95 units of attention of ﬁrst level of
eight states ofMexicowere obtained. The information was obtained by means
of the direct observation of the medical consultation, interviews to directors,
suppliers, users and of the application of an examination of knowledge to the
suppliers. The collected data were analyzed using logistic regression in where
the association between the pertinent formation of the suppliers was analyzed,
the treatment that they gave him to the patient in the consultation and the
satisfaction that the users declared.
Results:The satisfaction of the users of the services of PC and STI is associate
to the treatment received in the consultation and to the time that hoped to
receive it, but not to the preparation adapted of the supplier nor to its age or
gender. The treatment received by the user also was associated with its
socioeconomic level, being that the poor users but receive a worse treatment
proportionally.
Conclusions: The evaluation of the satisfaction of the patients can be
fundamental to improve the decision making in the design, organization
and operation of health services, in special in those places in which it exists
shortage of resources and/or conditions of economic inequality. In these cases
the beneﬁt of the health care services can deepen the differences between the
population, affecting more to the poorest population.
P1691 Study of knowledge, attitude and practice of
health personnel of Iranshahr district about the education
methods of malaria prevention
Z. Sheikh, K. Holakouie Naieni, F. Rakhshani
Tehran, Zahedan, IR
Objectives: To describe Iranshahr health personnel’s knowledge, attitude and
practice about educationmethods of malaria prevention and determinewhich
factors inﬂuence the use of methods for malaria prevention education to the
people.
Methods: In January–December 2002, a cross-sectional survey of 144 health
personnel of rural health centers of Iranshahr District (Sistan and Baluchestan
province, souteast Iran)was conducted with respect to malaria education
methods.
Results: The KAP of 66.1% of health personnel was relatively average.
(Mean SD),the KAP of 18.8% was low and 15.1% was high. There was
no signiﬁcant relationship between the KAP and the variables: age, sex,
literacy, marriage, ability to speak in local language, record of service, the
number of under protection population, presence of educational activity
reporting system and kind of multimedia educational means (P< 0.05).
Conclusion:The health personnel were more able to educate by using face to
face (using picture) method. Such methods are more effective in increasing
knowledge. For effective change of the attitude and practice, the methods
such as asking and answering, group discussion, . . . are more effective. Due to
the results, they believe that the present methods are repetitious, not inter-
esting and nonsuitable methods and multimedia education means in the rural
health centers are not enough.
P1692 Medicine management and public health
M. Voitcu, E. M. Carausu, I. Oita, D. Grigore
Iasi, RO
The antibiotic resistance represents an important problem of public health and
we have to ﬁnd all the ways to control it. In a previous work, presented at the
ECCMIDCongress in Milan, we have found the self-medication tendency of
the public from our city and now we continue the study, searching the self
medication causes. In order to determine this we elaborate a speciﬁc ques-
tionnaire formed of 6 questions and we applied it to three homogenous
groups: patients, physicians and, pharmacists, 70 of each category, from our
town. The work contains a great number of ﬁgures (graphs) presenting the
frequencies obtained for the answers. The results evidential that all the
respondents appreciate the following causes: difﬁcult access to health services,
big taxes for health insurance, big expenses for medical assistance and also
small prices of medicines, as being important for the self medication tendency
of the public. A very important question was about other causes of the self
medication, when the patients answered the following: advice from other
people, inﬂuence of nonprofessionists, lack of health education, big prices of
medicines, lack of time, fear of medical procedures.Wewere interested to ﬁnd
what is the pharmacist role in self medication control and we applied a speciﬁc
question, obtaining special results. At the end of the paper we analyzed the
National Formulary 2002 about the dispense of medicines without prescrip-
tion. The law is very ﬁrm: 72% from the pharmaceutical products are
delivered only with medical prescription and 28% without it. In conclusion,
the pharmacist can control the self medication tendency of the public and this
is very important for the case of the antibiotics, being a way to decrease
resistance.
P1693 Provision of communicable diseases screening
and vaccination services to asylum seekers in Ireland
M. Burke, C. Donnelly, J. Cronin, M. Horgan
Cork, IRL
The number of AS applicants to Ireland has dramatically increased in recent
years with over 10 000 applicants yearly since 1999. There is a national policy
of Dispersal and Direct Provision of asylum seekers (AS) to centers throughout
the country where accommodation, food and a small weekly allowance are
provided. Communicable Diseases (CD) screening and vaccination service is
offered to all AS on a voluntary basis within the centers by a mobile team of
public health doctors and nurses with clerical support. A hospital-based liaison
nurse facilitated referrals from screening program to specialty services as
required. By January 2003, 4323 AS were dispersed to 18 accommodation
centers in the Southern Health Authority region in Ireland. We prospectively
collected data on all AS attending the CD and vaccination service over a
6-month period July–December 2002 and entered the data into a modiﬁed
occupational health database. Over 90% AS are from the former Soviet
Republics and sub-Saharan Africa and 45% are female. Interpretative services
were required for 3.5% of consultations. 3047 appointments were sent with
2443 (80%) attendance’s of which 577 were new to the service. Of the 577
new attendees, 575 (99%) completed screening for TB with no evidence of
active infection, 520 (90%) accepted testing for Hepatitis B virus and 517
(89%) for HIV. Pregnancy rate was high at (7%). Only 6% had a record of
vaccination and 86% was deemed to require further vaccination, which was
completed by the mobile team. Mobile units of health professionals providing
services within accommodation centers improved the uptake of CD screening
and vaccination. Hospital-based liaison nurse working with these units
facilitated rapid referral of AS from screening services to specialty services
as required. Vaccine uptake and completion was high.
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P1694 Impact of conjugated meningococcal C
Vaccination in the Netherlands
S. C. de Greeff, L. Spanjaard, S. van den Hof, F. Abbink, H. E. de
Melker, J. Dankert
Bilthoven, Amsterdam, NL
Objective: In response to increasing incidence of meningococcal C disease
since 2000, regular conjugated meningococcal C vaccination was implemen-
ted in September 2002 for children aged 14months. A catch up campaign was
carried out (coverage 90%), targeting children aged 1–5 and 15–18 years in
June–July 2002 and those aged 6–14 years in September–October 2002. To
monitor the impact of vaccination (intensiﬁed) meningococcal disease sur-
veillance was performed.
Methods: Isolates from patients with meningococcal disease collected by the
Netherlands Reference Laboratory for Bacterial Meningitis were analyzed
from 1993 onwards. At the end of 2002, intensiﬁed meningococcal disease
surveillance was started using an electronic questionnaire linked to the
compulsory notiﬁcation system.
Results: The incidence of meningococcal C disease increased from 0.5/
100 000 in 1993–1999, to 0.7 in 2000 and 1.7 in 2001, representing 13%, 19%
and 38% of all meningococcal isolates (remainder mostly serogroup B).
Highest incidences in 2001 were reported for those younger than 19 years,
with a peak at 15–18 years (8.4/100 000) and 1–5 years (7.2). The incidence of
meningococcal C disease amounted to 1.3/100 000 in January–November
2002. The highest incidencewas reported in the months January–March 2002
(3.1, 2.8, and 2.2/100 000, respectively) and decreased afterwards to 0.1 in
November. Simultaneously, a seasonal decrease of serogroup B disease
occurred. Since the start of vaccination only a few (unvaccinated) cases were
reported among the age groups targeted for vaccination.
Conclusions: The increasing incidence of meningococcal C disease in 2000
and 2001 prompted a nationwide vaccination campaign from June 2002
onwards. It is not yet clear to what extent the observed decrease in incidence
during 2002 is due to vaccination or seasonal variation. The impact of
meningococcal C vaccination will only be evident after the annual seasonal
peak in meningococcal disease. Surveillance data of the ﬁrst months of 2003
will be used for this purpose.
P1695 Evaluation of the National Meningococcal C
Vaccination Campaign, client satisfaction and logistics
M. Jambroes, J. Doosje, J. Pal, A. Timen, for the Dutch Meningococcal
research group
Objectives:A national vaccination campaign against group C meningococcal
(MenC) disease was held from June–December 2002. 3.6 million children
aged 1–19 year were eligible for vaccination with a menC-conjugate vaccine.
This campaign was the largest ever held in our country and resulted in >90%
coverage. The national association of Municipal Health Services (MHS) was
responsible for the organization and coordination of the campaign while the
local MHS’s carried it out, in cooperation with national institutes (NI) like the
NI for Public Health and the Environment (RIVM) and the National Co-
ordination Centre for Communicable Diseases (LCI). An evaluation study
was set up addressing the logistics and subject satisfaction.
Methods:Two questionnaires were developed, 1 to evaluate the logistics and
1 for subject satisfaction. All 40 MHS’s in the existing seven regions received
the two lists. The MHS’s distributed >17 000 subject lists among the
vaccinated subjects. The data of the MHS’s were put together per region
for analyzes.
Results:Thirty-four logistic and 8141 subject lists returned, response was resp.
85 and 48%. Subject satisfaction results showed that of the vaccinated subjects,
5–15% doubted the beneﬁt of the intervention. Doubters sought signiﬁcantly
more information about the vaccination at forehand than nondoubters. To
search extra information, 0–4% hit the speciﬁc websites about the campaign.
Between 41 and 59% experienced post vaccine complaints, of which pain at
the site of vaccination or pain in the limbs were most frequent. Subjects
indicated to be very positive about the campaign (89–100%). Logistic results
indicated that MHS’s organized the campaign according to the central
guidelines but peripheral adjustment were made, dependent on the local
situation. Some decided to vaccinate all children at one day on one site, others
arranged over 20 session at different days. In all cases subjects and personnel
were positive about the organization. Multiple vaccination sessions resulted in
high operation costs. MHS’s experienced the central support of the national
association of MHS as crucial.
Conclusions:
1. Subjects experienced the organization of the intervention as positive.
2. Uniform evaluation resulted in best practice recommendations for future
mass campaigns, however, local MHS’s must respond to local circum-
stances
P1696 Community involvement with young orphans
infected and affected by HIV/AIDS. Prevention and care
programs as a way forward to ﬁght stigma and
discrimination
P. Masembe
Kampala, UG
Objectives: The community and relatives of AIDS orphans disassociated
themselves in caring for AIDS orphans because of stigma and discrimination.
Methods: Five years ago, the burden of caring for AIDS orphans was left to
AIDS Service organizations. The community that includes political and
religious leaders, family members discriminated AIDS orphans due to stigma
associated with HIV/AIDS. This was due to lack of information about HIV/
AIDS or lack of knowledge about the disease and what is involved in caring
for War orphans and AIDS orphans. The community and relatives disasso-
ciated themselves from the responsibility of caring for AIDS orphans. Two
years ago, we embarked on building the capacity of community in the
prevention of HIV and care for orphans infected and affected with AIDS
in communities and were mobilized, sensitized and trained in their role in
prevention and care right from the subcounty to the village level. Orphanage
support communities were established in two subcounties of Mateete and
Luwebitukuli in Ssembabule district.
Results:Orphanage support committees were formed, i.e. subcounty orpha-
nage support committees and parish committees, 156 clients accepted to help
these children to outreach centers, which were opened in the community.
Community members offered their own home to be used as out-reach
centers. The numbers of orphans who are not HIV positive are accessing
medical services at our Center, it was unheard of in the past. The number of
orphans reporting for VCT services is increasing, i.e. November 2001–June
2002, 1205 orphan clients reported for VCT at the centers and in the
community out-reaches, orphans and other people were willing to offer
their homes as out-reaches for treatment and VCT, couples accessing VCT
together has also increased unlike in the past. HIV positive couples actively
involved in HIV/AIDS drama, orphans’ drama group has emerged to further
reduce stigma and discrimination in the community.
Conclusion: Involvement of the community in HIV/AIDS prevention and
care reduce stigma and discrimination, hence promoting behavior change,
positive living, pro-longing lives for orphans reducing stigma and discrimina-
tion enhances quality of life for orphans and PHAs do not mind the project
vehicles labeled with the word AIDS Services. The government should
encourage the information of orphanage support committees from subcounty
to the village level. This will encourage people to break the barriers of
effectiveness in HIV/AIDS prevention and care. Only by confronting stigma
and discrimination will the ﬁght against HIV be won.
P1697 Prevention of rabies in Georgia
R. Tsiklauri, R. Urushadze
Tbilisi, GEO
Background:Animal bites are a common but under-recognized public health
problem. It has been estimated that there are 8–10 000 bites each year in
Georgia, and based on an average visit and postexposure treatments cost at list
$120 000 per year. Despite the frequency and expense of these injuries, there
is little information about the incidence of animal bites because of a lack of
systematic reporting and a lack of measurement of the quality and complete-
ness of reported data.
Objectives: To investigate animal bites and rabies reported cases, reveal
unreported cases, analyze and based on study results ﬁnd more effective
epidemiologic measures of animal bites and deaths (due to rabies) prevention
in Georgia.
Methods: The capture–recapture method was used, along with log-linear
modeling. Four sources were used to identify victims: policlinic/ambulatory
reports, hospital reports, animal control reports and victim reports.
Results: In 1980–2001, 150 700 dog and other animal bites were reported.
The capture–recapture method estimated that there were 146 200 unreported
bites. During these period, 118 deaths due to rabies were registered in Georgia
and 67 (57%) cases among them have been registered during the last 6 years.
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The reasons of fatal cases were untreated (47%), uncompleted treated (34%)
and late began postexposure treated (19%) cases of bites (mostly dog bites).
About 56% of bitten people did not know about rabies and its prevention
measures. About 32% had incorrect information about prevention and only
12% of them knewepidemiologic and clinical aspects of disease. About 16% of
physicians who were responsible for quality postexposure treatment had not
an adequate knowledge.
Conclusion:Dog and other animal bites are common but preventable injuries.
To improve surveillance and prevention of rabies in Georgia, the focus should
be on educating the general public about the serious consequences of animal
bite injuries and developing the animal’s vaccination strategy.
P1698 A south-east London outbreak of E. coli
0157:H7 in a day nursery
J. Fearn, I. Sam, M. Strutt, D. O’Sullivan
London, UK
Objectives: This poster reports an outbreak that took place in a South-East
London Day nursery between the latter part of June/early July to mid August
2002. Microbiological evidence conﬁrmed 15 cases from amongst the nursery
children and their contacts. Environmental Health reported a further four
probable cases and six possible cases based on their investigations.
Methods:The outbreak was recognized on 2 July 2002, when E. coli 0157 was
isolated from two samples coming from separate GP surgeries in the same area.
Initial inquiries indicated that both children attended the same day nursery. All
the nursery children and staff were screened revealing that 10 children were
carriers of which ﬁvewere asymptomatic. Three household contacts were also
found. All 15 strains isolated, were serotype positive for E. coli 0157: H7 using
the E. coli 0157 Latex test (Oxoid) in the laboratory. All 15 strains phage typed
21/28. All strains were positive for Verotoxin genes. Only one of the 15
nursery children was hospitalized overnight for i.v. dehydration. None of
these children or their contacts was treated with antibiotics. None of them
developed hemolytic uremic syndrome or any other serious complications.
Environmental Health investigations identiﬁed inadequate toilet facilities but
were unable to trace the source of the infection.
Conclusions: The day nursery was closed and the toilets refurbished. The
children and staff were allowed back after two negative stool cultures.
However further testing indicated some intermittent shedding after two
negative stool cultures and highlights the fact the protocol may need
reviewing.
Protozoan infection – clinical aspects
P1699 Kala-azar in Shefﬁeld, UK
R. Gowda, A. Tunbridge, S. T. Green, M. McKendrick
Shefﬁeld, UK
Introduction: Visceral leishmaniasis is a major cause of morbidity in tropical
countries and, untreated, has a high mortality. Leishmania is endemic in
Southern Europe. It can present atypically depending on the host cellular
immune response. Pancytopaenia and hepatosplenomegaly are recognized
features. Serology is used to aid diagnosis, but both false positives and false
negatives can occur and be misleading. We review 3 challenging clinical cases
with interesting serological results. Case 1: A 51-year-old man who had lived
in Malta gave a 1-year history of a peri-anal lesion. Biopsy was suggestive of
Crohn’s disease; treatment was with oral prednisolone and azathioprine.
18months later he presented with persistence of the peri-anal lesion, hepa-
tosplenomegaly and pancytopaenia, thought to be azathioprine induced.
However, a bone marrow examination revealed Leishman–Donovan bodies
and symptoms resolved on amphotericin. Case 2: A 60-year-old male Maltese
resident presented with fever, hepatosplenomegaly and pancytopaenia. Initial
investigations including serology and bone marrow examination were nega-
tive for leishmania. The blood picture was attributed to splenomegaly
secondary to alcoholic liver disease. Repeat investigations in Shefﬁeld showed
amastigotes in the bone marrow and serology was positive. Symptoms and
hematologic indices improved on treatment. Case 3: A 61-year-old lady who
had lived in South Africa presented with malaise, splenomegaly and pancy-
topaenia. Initial leishmania serology was strongly positive, but lymphocyte
markers and bone marrow biopsy were suggestive of lymphoma. Repeat bone
marrow was again consistent with lymphoma; no amastigotes were seen. The
patient had a raised IgM; further serological assays on IgM depleted serum
were negative for leishmania antibodies.
Discussion:These cases highlight the importance of considering leishmaniasis
even if patients have never left Europe. Reliance on serological tests to make
or refute a diagnosis can lead to errors. Increased awareness of the geographical
distribution and atypical manifestations of disease are key factors in establish-
ing a diagnosis.
P1700 Spectrum of autoimmunity and dysproteinemia
in patients with visceral leishmaniasis
E. Liberopoulos, G. Pappas, A. Kostoula, A. Drosos, E. Tsianos,
M. Elisaf
Ioannina, GR
Aim:To describe ﬁve patients with visceral leishmaniasis (VL), who presented
with fever, dysproteinemia and a variety of autoimmune manifestations that
were initially misdiagnosed as having an autoimmune disease.
Case reports:The ﬁrst patient was a 43-year-old woman who presented with
fever of four weeks’ duration, arthralgias, splenomegaly, and palpable purpura
on the legs. Laboratory investigation revealed marked polyclonal hypergam-
maglobulinemia (gamma globulins 7.2 g/dL), decreased C4 fraction of the
complement (<8mg/dL), high titers of serum rheumatoid factor (RF),
antinuclear antibodies (ANA) and cryoglobulins, as well as positive direct
Coombs’ test. The second patient was a 72-year-old woman, who presented
with prolonged fever, marked splenomegaly, severe anemia and thrombocy-
topenia, positive direct and indirect Coombs tests, positive ANA, elevated
levels of g2-microglobulin (21026mg/L) and biclonal hypergammaglobuli-
nemia. The third patient was a 24-year-old man, who presented with fever,
splenomegaly, pancytopenia, positive ANA, and monoclonal (IgG-b) hyper-
globulinemia. The fourth patient was an 80-year-old woman with fever of
one month’s duration, splenomegaly, decreased C3 and C4, high titers of RF,
ANA and cryoglobulins, as well as positive antithyroid, antismoothmuscle cell
and antineutrophil cytoplasmic autoantibodies. The last patient was an 29-
year-old woman, who presented with fever, positive RF, and positive ANA.
In all cases VL was diagnosed by the presence of intracellular parasites in bone
marrow aspiration and high titers of antileishmania antibodies in serum. Six to
12 months after the initiation of appropriate therapy a nearly complete
recovery of the immune abnormalities was recorded.
Conclusion:Autoimmune manifestations are not uncommon in patients with
VL and can lead to the misdiagnosis of an autoimmune disease. The initiation
of immunosuppressive therapy may have deleterious consequences in such
patients. VL should be included in the differential diagnosis of febrile patients
with evidence of autoimmunity.
P1701 Traveler returns with visceral leishmaniasis
F. Haworth-Brown, D. Lockwood, S. Lucas, M. Kinirons, M. Kazmi
London, UK
An interesting case of a 32-year-old gentleman who presented with a PUO
and subsequently developed the classical pentad of visceral leishmaniasis: fever,
weight loss, splenomegaly, pancytopenia and hypergammaglobulinemia. He
took a year out to travel to South and South-east Asia, Australia and New
Zealand and Central America. He traveled on a budget staying in basic
accommodation, eating out at street stalls and local restaurants. He avoided
high risk activities but did have an unprotected liaison in Laos. He was in
contact with local cats, dogs and bird life but the only bites he sustained were
that of insects. He did trek in the bush often in open-toed sandals and slept
under the stars. He returned to the UK with a 4-week history of fever,
drenching sweats, dry cough and anorexia. On initial presentation he was
found to be spiking fevers up to 398C, anemic, leukopenic and with
splenomegaly of 15 cm. His CRP and ESR were elevated and he had
deranged liver function with elevated transaminases. The initial differential
diagnoses were that of malaria, typhoid, respiratory infection or viral hepatitis.
His fever settled with paracetamol but his liver function remained abnormal.
Malaria ﬁlms, cultures and serology were all negative. With follow-up he
developed progressive pancytopenia with his hemoglobin falling to 7.1,
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neutropenia 0.4, platelets 40 and with elevated CRP, ESR and ferritin. He
had further enlargement of his spleen and lost nearly 20 kg in weight over a 6-
month period. Additional investigations had included negative Leishmania
DAT and latex, negative bone marrow on two occasions, evidence of
hypergammaglobulinemia with DAT positive anemia. Serology and cultures
were negative for tuberculosis, histoplasmosis, brucella, cryptococcus, rick-
ettsial disease, ﬂaviviruses, HIV, HTLV1, coxiella, coccidioides, yersinia,
CMV, parvovirus, and positive serology for EBV, Sin Nombre hantavirus
and toxoplasma, although it was felt that these results did not explain his
clinical picture. The diagnosis was subsequently conﬁrmed on Leishmania
serology (DAT and rK39 antigen test) and repeat bone marrow aspirate and
trephine. It was thought that he had acquired his leishmaniasis whilst visiting
Chitwan National Park in Nepal some 5 months before presentation. The
species was Leishmania donovani and he responded quickly to liposomal
amphotericin.
P1702 Entamoeba histolytica presenting like acute
appendicitis
E. Magira, T. Gounaris, S. Papandreou, T. Kalloniatis,
A. Abouhanditzi, I. Grigoriou, E. Sioula
Athens, GR
A 24-year-old man was admitted to our hospital due to a cramp like pain in
the right lower abdomen, which was accompanied by vomiting and diarrhea.
The diarrhea started 4weeks ago while over the next few days his symptoms
persisted and his general state of health deteriorated. He suffered from mild to
moderate dehydration and he experienced recurrent episodes of diarrhea,
intense abdominal cramps with rebound tenderness and vomiting stimulated
by eating. Hematological investigation measurements of erythrocyte sedi-
mentation rate tests of liver and renal function were within normal ranges.
The major concern about this patient was the possible inﬂammation of the
appendix since his clinical signs mimic acute appendicitis along with/or
inﬂammatory bowel disease. Fibreoptic colonoscopy examination was done
and multiple biopsy samples were taken that revealed normal colon mucosa.
CT abdominal scan was not determined lymphadenopathy or other solid
organs abnormalities. Extensive and more detailed history revealed that the
patient had traveled in tropical countries 6months ago. Parasitologic exam-
ination of the feces was unable to detect cysts and/or trophozoites of parasites
while the serologic examination revealed antibody title of Entamoeba histolytica
IgG: 1/160 and IgM: 1/640. The patient was placed on metronidazol 750mg
three times per day for 10 days and ﬂuid replacing treatment. A great
improvement of symptoms was observed within the following few days
and he was discharged from the hospital. It is concluded that patients with
symptoms of acute appendicitis after travel in tropical areas should be screened
for Entamoeba histolytica. Although the demonstration of hematophagous
trophozoites in feces is the deﬁnite method of diagnosis unfortunately the
test has many drawbacks. Serology can support the diagnosis and a positive test
is highly predictive of current disease.
P1703 Transfusion-transmitted malaria
Z. Ozkurt, S. Erol, A. Kadanali, U. Altoparlak, M. A. Tasyaran
Erzurum, TR
Malaria is a rare but potentially serious complication of blood transfusion.
One case of transfusion-transmitted malaria was presented here. A 47-year-
old woman came to our clinic with fever, diarrhoea, vomiting, and she was
hospitalized. She had total hysterectomy and bilateral salpyngoooforectomy
operation, and taken 1 U blood transfusion before 10 days of admission. One
day before admission, chills, fever, diarrhoea and vomiting began. Patient’s
body temperature raised 39.58C every night and lasted 6-h period during
hospitalization. Laboratory results of the patient are: anemia, elevated lactic
dehydrogenate and hyperbilirubinemie, other parameters were normal. The
diagnosis was made examining blood smears with shown of Plasmodium vivax
trophosoids. Chloroquine and primaquine was initiated for therapy and the
patient was successfully treated. We learned that the donor made his military
service in an endemic area for malaria, but we could not reach him. Because
our region (North-eastern of Turkey) is not an endemic area for malaria and
the patient had no travel history to an endemic area, we considered transmis-
sion route of malaria is blood transfusion in this case. The case illustrates the
importance of considering malaria in diagnosing a febrile illness following
blood transfusion in any patient. Because no approved tests are available to
screen donated blood for malaria, prevention of transfusion-transmitted
malaria requires careful questioning of prospective donors.
P1704 Comparison of efﬁcacy of single dose of
tinidazole with metronidazole (standard dose) in
giardiasis: preliminary report
M. Fallah, A. Moshtaghi
Hamadan, IR
Objective: Giardia intestinalis is the most common intestinal protozoa in the
under developing countries. Treatment of infection has some difﬁculties by
metronidazole because of long course of therapy and some side-effects. The
object of this study was to determine efﬁcacy and side-effects of tinidazole in
treatment ofG. intestinalis infection. This is preliminary report of an ongoing
trial.
Methods: A randomized controlled trial, 47 subjects with G. intestinalis
infection were treated with tinidazole or metronidazole. Tinidazole
50mg/kg single dose and metronidazole 25mg/kg three times a day for 7
days were given orally to 24 and 23 children, respectively. Parasitological cure
was documented when there was 3 times negative stool examination for G.
intestinalis at 1–2weeks after therapy.
Progressive pancytopenia
20 Mar 26 Mar 29 Apr 2 May 20 May 18 Jun
WCC 1.8 2 1.3 1.2 1 1.7
Neutro 0.9 0.8 0.6 0.6 0.5 0.3
Hb 7.6 7.1 6.8 5.9 8.1 7.2
mcv 69 70 75 75 75 71
Plt 176 157 153 139 86 105
ESR 74 110 55 85
Femitin 2313 5390
CRP 71 124 105 114 99
ALT 58 61 27 28 62 66
GGT 66 55 23 28 65 38
ALP 133 120 65 74 190 165
Bil 13 20 9 9 6 12
LDH 956
Alb 27 27 27 27 20 18
Figure 1
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Results: Twenty-one of 23 individuals treated with tinidazole and 20 of 24
children treated with metronidazole had parasitological cure. Cure rates
between two groups was not signiﬁcant statistically. No major side-effect
were observed except one case in metronidazole group who had mild
headache and abdominal pain for 2 days.
Conclusion: We concluded, tinidazole, at the protozacidal lable dosage, has
efﬁcacy equal of metronidazole in the treatment of G. intestinalis. Because of
single dose administration, short course of therapy and good compliance of
patients, this preparation is preferred to metronidazole in Giardia infection
treatment.
P1705 Comparison of short course therapy of giardisis
with standard dose of metronidazole: a randomized
clinical trial
M. Fallah, M. Ghassemi
Hamadan, IR
Background and objective:Giardia intestinalis is the most common intestinal
protozoa in the under developing countries. Treatment of the infection by
metronidazole; this ﬁrst choice drug, has some difﬁculties because of long
course of therapy and some side-effects. The objective of this study was to
determine efﬁcacy and side-effects of short course treatment of the G.
intestinalis infection by metronidazole vs. the long course (standard dose)
of this drug.
Patients and methods: In a randomized controlled clinical trial, 54 subjects
with G. intestinalis infection were treated with metronidazole. Metronidazole
15mg/kg single dose for three days were given for study group and, 5 mg/kg
three times a day for 7 days for control group were given orally to each 27
children, respectively. Parasitological cure was documented when there was 3
times negative stool examination for G. intestinalis at days 7, 10 and 14 after
therapy.
Results: Eighteen out of 27 individuals (66.6%) cured with metronidazole in
the both groups (short course and standard dose) and had parasitological cure
as well. Cure rates between two groups was not signiﬁcant statistically. No
major side-effect were observed in the long course group but, abdominal pain
(ﬁve patients), vomiting (three patients) and diarrhea in asymptomatic cases
(two patients) observed in the short course group.
Conclusion: This study indicated that, the metronidazole in a short course
regimen has efﬁcacy equal of metronidazole, standard dose, in the treatment of
giardiasis. Because short course administration is easy and has good com-
pliance of patients (except some mild side-effects) this regimen could
recommend in treating giardiasis.
European study group corner: Presentation of ESCMID Study Groups and Related Organizations
P1706 ESCMID Study Group on Antibiotic Policies
(ESGAP)
H. Richet, B. Cookson, D. L. Monnet, I. C. Gyssens, F. M. MacKenzie,
M. Cizman, M. Lelekis, H. Westh, I. M. Gould on behalf of ESGAP
ESGAP was founded in March 1999 to provide a uniting European forum for
those actively involved in antibiotic stewardship at local, national and inter-
national levels. Its practical objectives are: (i) to promote awareness of
antibiotic misuse and a better understanding of the factors involved (ii) to
provide an opportunity for training in the appropriate use of antibiotics (iii) to
facilitate collection and establish comparability of antibiotic prescribing data
within Europe (iv) to identify problems of antimicrobial resistance related to
antimicrobial use and to formulate strategies of antibiotic stewardship
designed to control resistance, and (v) to promote the development, imple-
mentation and standardization of antibiotic policies at country level and in
single institutions. ESGAP activities are presented on its Internet site and
promoted through various courses, workshops and symposia arranged by
ESGAP, in collaboration with other ESCMID Study Groups or other
organizations. The proceedings of a symposium at the 11th ECCMID, which
include guidelines on how to develop an antibiotic policy, were published in
Clinical Microbiology & Infection (2001; 7 Supplement 6). In 2003, ESGAP
will arrange the 22nd ESCMID Post-Graduate Education Course on ‘Mea-
suring, Auditing and Improving Antimicrobial Prescribing’ and aworkshop at
the 43rd ICAAC on ‘Monitoring and Evaluating Antimicrobial Use in Health
Care Facilities’. Finally, ESGAP runs, together with three other ESCMID
Study Groups, the ‘Antibiotic Resistance Prevention and Control’ (ARPAC)
project funded by DG-Research of the European Commission. Within the
project, ESGAP is responsible for the collection and analysis of data on
antimicrobial use and antibiotic policies in participating hospitals. To facilitate
standardized data collection, ESGAP developed an Antibiotic Consumption
Calculator (ABC Calc) to transform aggregated data provided by hospital
pharmacies into meaningful antimicrobial utilization rates. The 2003 version
of this simple computer tool is freely available on the ESGAP Internet home
page. New activities in 2003 include the establishment of an international
exchange grant (ESCMID News 2002; no. 3) and teaching activities in
Central and Eastern Europe.
P1707 The ESCMID Study Group for Antimicrobial
Resistance Surveillance (ESGARS)
G. Cornaglia, V. Jarlier, H. Goossens, W. Hryniewicz, H. Mittermayer,
L. Stratchounski, F. Baquero
Verona, I; Paris, F; Antwerp, B; Warsaw, PL; Linz, A; Smolensk, RUS;
Madrid, E
The ESGARS has been established in 1997 by those participating in the
WHO Meeting on ‘The Present Status of Antimicrobial Resistance Surveil-
lance in Europe’. Membership of ESGARS is open to those interested in
resistance surveillance at local, national and international levels, including
representatives from government or corporate bodies. Aims of the ESGARS
are:
	 To provide a uniting forum for those actively involved in antimicrobial
resistance surveillance, in order to promote a better understanding of
antimicrobial resistance.
	 To provide opportunity to enhance co-operation and to establish links
with and between networks of resistance surveillance programs.
	 To promote awareness and facilitate the early detection of emerging
antimicrobial resistance.
	 To contribute to an understanding of the epidemiology of antimicrobial
resistance in Europe.
	 To improve access to European data on surveillance.
	 To provide an opportunity for training in resistance detection and
surveillance.
The Study Group is responsible for organizing ESCMID Post-graduate
Education Courses in collaboration with the other ESCMID Study Groups
whose interests overlap with those of the ESGARS:
	 9th Course ‘The role of antimicrobial resistance surveillance for effective
antibiotic policies’, held in Verona (Italy) on December 8–9th, 1999 (co-
organized with ESGAP and ESGNI)
	 18th Course ‘Diagnostics, characterization and epidemiology of beta-
lactamases’, held in Orta San Giulio (Italy) on April 22nd-23rd, 2002 (co-
organized with ESGNI).
	 26th Course ‘The management of infections in adult ambulatory patients:
from the laboratory to the clinic’, to be held in Smolensk (Russia) on
December, 11th13rd, 2003.
The ESGARS is presently involved in producing the European Recommen-
dations for Antimicrobial Resistance Surveillance, through a consensus
process involving all members of the Study Group.
P1708 ESCMID Study Group on Epidemiological Markers
(ESGEM)
K. Towner on behalf of the ESGEM Executive Committee
Nottingham, UK
Molecular typing is now an essential component of the microbiology and
control of infection services provided across Europe and in many other
countries of the world. Recent quantum advances in comparative genomics
have yielded a wide choice of powerful methods for studying the genomic
relatedness of microbes. The epidemiology of microorganisms does not
recognize international boundaries. Collaboration between scientists working
in different countries is therefore essential to standardize methodology and to
track the spread of particular virulent or resistant microbial pathogens.
ESGEM is a group of ESCMID members who share an interest in epide-
miological typing systems. The key objectives of ESGEM are:
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1. To critically evaluate microbiological typing systems and make recom-
mendations (guidelines) for their appropriate use.
2. To promote collaborative research into microbiological typing systems and
to develop standardized methodology for speciﬁc pathogens.
3. To provide opportunities for the exchange of ideas and the development of
consensus strategies at ECCMID symposia and workshops. ESGEM will
also continue to play a leading role in organizing the triennial International
Meeting on Microbial Epidemiological Markers (IMMEM).
4. To organize multicenter studies and practical training workshops.
5. To work with individuals and companies active in this research area
to foster the development of further technological advances in microbial
typing.
P1709 ESCMID Study Group on Toxoplasmosis (ESGT)
B. Evengard
Stockholm, S
Toxoplasma gondii has a worldwide distribution causing a chronic infection in
>109 people. Toxoplasmosis in immunocompromised patients is usually due
to reactivation of latent infection. However, it may be transmitted by blood or
blood products and by transplanted organs. In contrast to the majority of
immunocompetent patients, immunocompromised ones may have serious
sequelae. In the context of bone marrow transplantation and peripheral blood
stem cell transplantation, profound immunosuppression leads to a high rate of
infectious complications. Toxoplasmosis has been considered a rare oppor-
tunistic infection in patients who undergo BMTor organ transplantation. A
reappraisal of the prevalence of toxoplasmosis in various groups of immu-
nocompromised patients and its clinical impact is needed. Further, the recent
developments in diagnostic assays, including PCR assays, need to be evaluated
in large number of patients, preferably in a multicenter study, because the
number of these patients is comparatively small in each single center. ESGT is
a group of ESCMIDmembers who share an interest in different aspects on the
interaction between humans and Toxoplasma gondii. The primary focus
initially will be on the:
1. Provide information of the prevalence of toxoplasmosis in immunocom-
promised patients in different parts of Europe
2. Provide information on clinical policies and practices within Europe
3. Provide information on the risk proﬁle for toxoplasma infection in
immunocompromised patients
4. Provide information on the diagnostic value of different tests
5. Generate a common European policy proposal for the diagnosis and
management of toxoplasmosis in immunocompromised patients
P1710 European Study Group on Coxiella, Anaplasma,
Rickettsia and Bartonella (ESCAR)
P. Brouqui
Marseille, F
ESCAR encourage basic and applied research in all aspects of rickettsiology
and rickettsial diseases and foster exchange of information and/or materials
among scientists engaged in the research on rickettsiae and rickettsial diseases
through periodic meetings, and other devices or instruments as may be
appropriate. ESCAR will encourage recruitment and training of young
scientists in rickettsiology and rickettsial diseases. We consider and make
recommendations on scientiﬁc and policy matters pertaining to rickettsiae
and rickettsial diseases as may be desirable or necessary for the advancement of
basic and applied knowledge in this ﬁeld. We advise governmental and health
agencies, when appropriate, on matters relevant to rickettsiae and rickettsial
diseases. The ﬁeld of research is epidemiology, genomics and taxonomy,
diagnosis, physiopathology and immunology, and therapy of rickettsiosis,
bartonellosis, anaplasmosis, and coxiellosis of human and animals. ESCAR is a
small society of about 300 members made of medical doctors, scientists,
microbiologists, veterinarians, pharmacists and others. We meet once a year at
the ESCMID and we organize an international meeting every three years in
Europe.We support a European network on diagnostic of tick-borne diseases.
ESCAR members belong to most European countries and also from other
foreign countries including USA, Japan, Russia and others.
P1711 ESCMID Study Group on Antimicrobial Resistance
in Anaerobic Bacteria (ESGARAB)
C. E. Nord
Stockholm, S
Anaerobic bacteria are the predominant constituents of the normal microﬂora
on the skin and the mucous membranes of the human body. They also act as
potent pathogens in a variety of endogenous infections. All types of infections
occurring in humans may involve anaerobic bacteria and no organ or tissue of
the body is immune to infections with these microorganisms. There are four
major sites of anaerobic infections: respiratory, intra-abdominal, female
genital tract, skin and soft tissue infections. The bacteria most commonly
involved in these infections are: Bacteroides fragilis group, Prevotella species,
Porphyromonas species, Fusobacteria, Peptostreptococci and Clostridia. Five groups
of antimicrobial agents are active against most anaerobic bacteria of clinical
importance. These are nitroimidazoles such as metronidazole or tinidazole,
carbapenems such as imipenem or meropenem, chloramphenicol or thiam-
phenicol, combinations of beta-lactam drugs together with a beta-lactamase
inhibitor (clavulanate, sulbactam or tazobactam) and newer quinolones such
as garenoxacin, moxiﬂoxacin and sitaﬂoxacin. Clinical usage of antimicrobial
agents has been accompanied by the isolation of antimicrobial-resistant
bacteria. During the last years there have been reports showing increasing
numbers of anaerobic bacteria resistant to different antimicrobial agents.
Resistance in anaerobic bacteria has a signiﬁcant impact on the selection
of antimicrobial agents for empirical therapy. The development of antibiotic
resistance in anaerobic bacteria has been documented for beta-lactam drugs,
clindamycin, macrolides, tetracyclines and nitroimidazoles. The B. fragilis
group is more resistant to antimicrobial agents than most other anaerobic
bacteria. The Bacteroides genus and new genera Prevotella and Porphyromonas
have become increasingly resistant to many antianaerobic agents. Fusobacterium
strains resistant to beta-lactam drugs are relatively frequent. Resistant Clos-
tridia and Propionibacterium acnes have also been reported. The resistance
mechanisms in anaerobic bacteria are: (i) hydrolysis of the antimicrobial drug
by several enzymes before reaching the site of action (most common,
sometimes plasmid mediated); (ii) decreased permeability of the organisms;
(iii) modiﬁcation at the site of action of the antimicrobial agent; (iv) efﬂux
mechanisms which eliminate the antimicrobial drug from the bacterial cell.
The aim of ESGARAB is (i) to investigate the antimicrobial resistance patterns
in anaerobic bacteria in Europe (ii) to investigate the antimicrobial resistance
mechanisms in anaerobic bacteria (iii) to develop standardization methods for
testing antimicrobial agents against anaerobic bacteria (iv) to organize a
symposium or workshop at each ECCMID, and (v) to organize scientiﬁc
meetings and postgraduate education courses.
P1712 European Helicobacter Study Group
F. Me´graud
Bordeaux, F
Background: This group was founded in 1987 during a meeting in Copen-
hagen (Denmark). It was run informally for several years and became an
ofﬁcial association under French law in 1997. A speciﬁc feature of this group is
to be multidisciplinary, i.e. in addition to gastroenterologists, it includes
pathologists, microbiologists, immunologists, internists, epidemiologists,
pediatricians, etc.
Aim: The aims of the Association are to promote the research and to diffuse
the medical, scientiﬁc and technical knowledge of the bacterium named
Helicobacter pylori, its associated diseases and related microorganisms.
Activities:
	 Organization of a yearly meeting since 1988. The annual 2 and a half day
Workshop has been held in different countries of Western Europe and
once in the US. It has gathered between 500 and 2700 participants. The
16th edition, currently in preparation, will be held in Stockholm,
Sweden, during the ﬁrst week of September 2003.
	 Technical courses have also been organized in the past on laboratory
methods, epidemiology applied to gastric cancer, and clinical trials.
420 Abstracts
	 H. pylori sessions have been organized in the context of the UEGWyearly
since 1992, and in the context the European Congress of Clinical
Microbiology and Infectious Diseases every 2 years since 1989, yearly
after 2000.
	 Post-graduate courses have been organized for doctors from Eastern
Europe (in 1992 in Prague) and for Russian doctors in 1998 and 2001
in collaboration with the Russian Society of Gastroenterology.
	 Conferences to prepare ‘Guidelines for the Management of H. pylori
Infection’ have been held twice in Maastricht and were published as the
Maastricht Consensus Reports (Gut, APT).
	 Ayearly publication has been produced since 1994 which summarizes the
news of the year in the ﬁeld. It was published as a supplement of Current
Opinion in Gastroenterology until 2001 and now as a supplement of
Helicobacter.
	 European multicenter studies concerning the evolution of gastritis (Euro-
hepygast) on resistance to antibiotics have been carried out.
	 Awebsite, created 5 years ago, proposes among others the abstracts of the
meeting and a summary of the oral sessions. A section relative to treatment
aid is also available.
	 Fellowships have been attributed for studies in the ﬁeld.
	 A Pediatric Task Force has been created with specialists from EPSGHAN,
which produced a position paper on management of H. pylori infection in
children.
Organization: The council is comprised of a member from each of the
countries of the European Community plus Switzerland. Most of them are
representatives of national groups. The council meets 3 times a year, including
one meeting at the Workshop. There is a President (1 year mandate) who is
usually the organizer of the year’s Workshop, a treasurer, and a secretary
elected for 3 years. The running costs of the group are covered by part of the
beneﬁt from theWorkshop, when available. The remaining surplus is used for
fellowships. A number of projects are planned including a continuation of the
yearly Workshop, the development of an important project on gastric cancer
in the context of the 6th PCRD, and the publication of a text book.
Current ofﬁcers:
President Prof T. Wadstro¨m, Lund, Sweden
Treasurer Prof A. Hirschl, Vienna, Austria
Secretary Prof F. Me´graud, Bordeaux, France
P1713 European Study on Antimicrobial Consumption
(ESAC): a project funded by DG SANCO of the European
Commission
H. Goossens on behalf of the ESAC Network
Summary:During a two year period, actions will be taken to harmonize the
collection of antimicrobial consumption data in all EU countries. Retro-
spective data for ambulatory care and hospitals will be collected for the period
1997–2001. A prospective data collection system, based on a validated register
of available antibiotic products linked to the correct ATC/DDDclassiﬁcation,
will become effective in 2003. Standardized national data will be assembled in
a European database for international comparison of antibiotic use in relation
to antibiotic resistance patterns and socio-economic and general health
parameters.
Problem: There is an established, albeit complex, relationship between
consumption of antimicrobials and the prevalence of drug resistant bacteria.
Although several antibiotic resistance surveillance programs are operational at
the EU level, a program for the collection of data on the consumption of
antimicrobials is lacking. In most European countries, some information on
the consumption of antimicrobials at a national level exists. Large differences
can be observed, however, in the structure and the accessibility of these
databases. Moreover, in order to compare antimicrobial consumption at the
EU level, internationally applicable methods need to be established including
both a uniform classiﬁcation system and a common unit of measurement.
Aim: This project aims to construct and maintain a European database on
antimicrobial consumption based on standardized and validated national data
using the DDD (Deﬁned Daily Dose)/ATC (Anatomical Therapeutic Che-
mical) classiﬁcation system. Quantitative consumption data will be comple-
mented with a database offering an inventory of projects focused on antibiotic
consumption (published research as well as ongoing projects). The database
will be accessible for health authorities and scientists in order to link antibiotic
consumption to resistance patterns and to assess the impact of intervention
strategies at the community and hospital level.
Expected results:The main results of the pilot phase of the ESAC project will
be the availability of an administrative database of antibiotic consumption in
Europe. Retrospective data (1997–2001) from 27 countries are available. Data
of one current EU country and two ﬁrst wave EU countries are yet missing. In
addition, data from Bulgaria, Croatia, Iceland, Norway and Turkey are
available. Ambulatory care data are available from 25 countries and hospital
care data from 22 countries. Retrospective data will be complemented with
prospective data deriving from the continuous and comprehensive surveil-
lance systems of antibiotic consumption, which should be operational in all
European countries in 2003. A register of all antibiotic products in all package
forms available in each country will be updated on a regular base and
published on the ESAC website enabling the validation of the quality of
the data delivery system. Quantitative consumption data will be comple-
mented with a database offering an inventory of projects focused on antibiotic
consumption (published research as well as ongoing projects). Potential
applications: The results are targeted at the European Commission, health
authorities and scientists in the different Member States. The database should
offer a basis to monitor the use of antibiotics in a prospective and compre-
hensive manner. The results and recommendations should allow health
authorities in the different Member States to promote evidence-based anti-
biotic use. The database should be used as an instrument to study and evaluate
the link between resistance and antibiotic use, appropriate antibiotic pre-
scribing, quality indicators of antibiotic consumption, ecological impact of
antibiotic use, etc. The database will provide opportunities for further research
and international collaboration.
Project web-site: http://www.esac.ua.ac.be.
P1714 European Antimicrobial Resistance Surveillance
System (EARSS): a project funded by DG SANCO of the
European Commission
P. Schrijnemakers, N. Bruinsma, E. Tiemersma, J. E. Degener
Bilthoven, Groningen, NL
Summary: The European Antimicrobial Resistance Surveillance System
(EARSS), funded by DG SANCO of the European Commission and
coordinated by the Dutch National Institute for Public Health and the
Environment (RIVM), is an international network of national surveillance
systems, which collects comparable and validated antimicrobial susceptibility
data for public health purposes. EARSS performs ongoing surveillance of
antimicrobial susceptibility in Streptococcus pneumoniae, Staphylococcus aureus,
Escherichia coli, and Enterococcus faecalis/faecium causing invasive infections, and
monitors variations of antimicrobial resistance in time and from place to place.
In December 2002, around 600 microbiological laboratories serving some
970 hospitals in 27 countries provided susceptibility data on around 88 000
invasive isolates.
Problem: Antimicrobial resistance (AMR) is an emerging public health
problem with local, national, and international dimensions as described in
‘the Copenhagen Recommendations’. Antimicrobial resistance is clearly an
emerging problem, however, the precise impact of this problem is less clear to
the European and scientiﬁc community. Before being able to quantify the
impact on public health it is necessary to have more comparable surveillance
data available. One of the recommendations made at the EUConference ‘The
Microbial Threat’ in 1998 was that a European surveillance system of
antimicrobial resistance should be set up, therefore EARSS has been funded.
Aim: EARSS aims to obtain comparable and reliable antimicrobial resistance
data of main indicator pathogens in Europe to monitor antimicrobial
resistance in time and from place to place. EARSS also aims to assess risk
factors for antimicrobial resistance and EARSS aims to enable policy makers
and health care workers to monitor the impact of their interventions.
Achieved results (ongoing project): For pathogens (Streptococcus pneumoniae,
Staphylococcus aureus, Escherichia coli, and Enterococcus fecalis/fecium) causing
invasive infections, resistance levels are available for important groups of
antimicrobials from 27 European countries. In the EARSS annual report
2001, results are described in detail for all four pathogens collected in 2001, as
well as trends in penicillin nonsusceptible S. pneumoniae (PNSP) and methi-
cillin resistant S. aureus (MRSA) during the period 1999–2001. Aggregated
information is directly available to health care workers, policy makers, and a
wider public, at an interactive website (http://www.earss.rivm.nl). From
EARSS data, it can be concluded that proportions of antimicrobial resistance
vary markedly between European countries, most likely as a result of
differences in hospital infection control and the consumption of antibiotics.
Potential applications: Policies to combat resistance should be tailored
speciﬁc to country and hospital level. The results as presented recently in
the EARSS annual report 2001 emphasize the need to implement the Council
Recommendations on the Prudent Use of Antibiotics in Human Medicine.
As laid down in the Council Recommendations, it has recently been decided
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that multidisciplinary organizations, called Intersectorial Coordinating
Mechanisms (ICMs), will be established at the national level. The ICMs
will be responsible for information exchange and co-operation between the
parties involved at the national level. The ICMs are responsible for imple-
menting the Council’s recommendations and should consider the recom-
mendations as formulated in the EARSS Annual Report 2001. This applies
particularly to countries with high proportions of resistance for all bacterial
species. In order to get more insight into the causes and mechanisms of these
striking differences, in the near future several research initiatives will be set up
in close cooperation with the EARSS network. EARSS already cooperates
closely with the project ‘European Surveillance on Antimicrobial Consump-
tion’(ESAC). EARSS and ESACwill start to cooperate with the project ‘Self-
medication of Antimicrobials and Resistance Levels in Europe’ (SAR) before
the end of 2002, and close cooperationwith the project ‘Antibiotic Resistance
in Mediterranean countries’ (ARMed) will start in 2003. Project web-site:
aggregated information is directly available to health care workers, policy
makers, and a wider public, at an interactive website (http://www.earss.-
rivm.nl).
P1715 Antibiotic Resistance – Prevention and Control
(ARPAC)
F. MacKenzie on behalf of the ARPAC Steering Group
ARPAC is a concerted action project funded by the Research Directorate-
General of the E.C. ARPAC stands for Antibiotic Resistance, Prevention and
Control. Its objectives are to lay the foundations for a better understanding of
the emergence and epidemiology of antibiotic resistance and to evaluate and
harmonize strategies for prevention and control of antibiotic resistant patho-
gens in European hospitals. Speciﬁc aims are to identify antibiotic polices and
prescription patterns associated with low resistance rates and to identify
infection control policies associated with lower incidence rates of transmis-
sible antibiotic resistant strains. The study is being conducted by four
ESCMID study groups, ESGAP, ESGARS, ESGNI and ESGEM. The project
website is at http://www.abdn.ac.uk/arpac/index. Data will be collected
from all willing European hospitals wishing to join the project. Data will
include: antibiotic consumption, antibiotic resistance rates, DNA typing
methods, information on antibiotic prescribing policies and information
on antibiotic stewardship practices and infection control policies and prac-
tices. The data will be modeled to identify (i) antibiotic policies associated
with lower resistance rates and (ii) infection control policies associated with
low incidence rates of transmissible antibiotic resistant bacteria. Speciﬁc
strategies leading to low rates of antibiotic resistance will be recommended
and will form the basis for future intervention studies. The ESCMID Study
Group on Antibiotic Resistance Surveillance (ESGARS) will compile an
inventory of antibiotic resistance data and development of a strategy for
collection, collation, critical assessment and dissemination of resistance data.
The ESCMID Study Group on Antibiotic Policies (ESGAP) will compile an
inventory of antibiotic consumption, prescribing habits, policies and steward-
ship in European hospitals. The ESCMID Study Group on Nosocomial
Infections (ESGNI) will compile an inventory of European hospital policies
and practices for controlling transmissible antibiotic resistant microorganisms.
The ESCMID Study Group on Epidemiological Markers (ESGEM) will
develop a DNA typing database and data exchange format for tracking
epidemic antibiotic-resistant microorganisms. The project will culminate
with a consensus conference to discuss results, which will be held in the
autumn of 2004.
P1716 EUCAST – the European Committee on
Antimicrobial Susceptibility Testing
G. Kahlmeter, D. Brown, A. MacGowan, F. Goldstein, J. W. Mouton,
A. C. Rodloff, M. Steinbakk, M. Kalin, P. Urbaskova, A. Vatopoulos, the
EUCAST General Committee
The EUCAST, formed in 1996 and restructured at ECCMID in Milan 2002,
is the European Committee on Antimicrobial Susceptibility Testing. It
consists of a General Committee with representatives from all European
countries, from the pharmaceutical industry, and from in vitro media and
device industries. EUCAST is led by a Steering Committee appointed by
ESCMID and consisting of a Chairman, a Scientiﬁc Secretary, six National
Breakpoint Committee representatives and two representatives of the
EUCAST General Committee. Decisions are made by the Steering Com-
mittee after consultation with the General Committee.
Since being re-structured in 2002, EUCAST has:
	 Agreed on a principal model for harmonizing breakpoints for new
antibiotics in Europe.
	 Proposed and is testing (with ﬂuoroquinolones) a model for appraising and
hopefully harmonizing breakpoints of registered antibiotics – see
EUCAST symposium at ECCMID, Glasgow 2003.
	 Devised web-based software for the collection and presentation of wild-
type MIC distributions of relevant drug/bug combinations. A link will be
placed shortly from the EUCASTwebsite – http://www.eucast.org
	 Agreed to deﬁne wild type cut-off values for the measurement of
antimicrobial resistance development.
	 Worked closely together with the EARSS (the European Antimicrobial
Resistance Surveillance System)
	 Opened discussions with EMEA, NCCLS, EFPIA, STMA, NEQAS and
other organizations with interests and activities in the ﬁeld of antibiotics.
EUCAST is an open organization that invites anyone with an interest in
antimicrobial agents in general and antmicrobial breakpoints in particular to
make contact, either through the ESCMID or directly with the Chairman
(gunnar.kahlmeter@ltkronoberg.se) or the Scientiﬁc Secretary (dfjb2@
cam.ac.uk) or through one of the National Breakpoint Committees.
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